0.36373233795166016 ||| Guillain-Barré syndrome, dizziness, headache, syncope sometimes accompanied by tonic-clonic movements. ||| Adverse reactions associated with PR interval prolongation (e. g. atrioventricular block, syncope, bradycardia) may occur. ||| 18 Troubles du système nerveux: syndrome de Guillain-Barré, sensation de vertige, céphalée, syncope parfois accompagnée de mouvements tonico-cloniques.
0.13424065709114075 ||| 27/ 61 ||| 27/ 44 ||| 25/ 57
0.390431672334671 ||| In the 25 mg arm (n = 36), all patients had metastatic disease; 4 (11%) had no prior chemo- or immunotherapy; 17 (47%) had one prior treatment, and 15 (42%) had 2 or more prior treatments for RCC. ||| In first line patients, treated with either MabCampath or chlorambucil, there were 21 patients with the 17p deletion, 54 patients with 11q deletion, 34 patients with trisomy 12, 51 patients with normal karyotype and 67 patients with sole 13q deletion. ||| Dans le bras 25 mg (n = 36), tous les patients étaient porteurs d'une forme métastatique; 4 (11%) d'entre eux n'avaient jamais reçu de chimio ou d'immunothérapie, 17 (47%) avaient déjà reçu un traitement et 15 (42%) au moins 2 traitements pour le CRA.
0.604538083076477 ||| Cosmetics (including sunscreens) can be applied over the treated areas, but no sooner than five minutes after application. ||| They are supplied in packs containing 10, 30 or 90 tablets, but these may not all be available in your country. ||| Le maquillage (ainsi que les écrans solaires) peut être appliqué sur les zones traitées, 5 minutes après le traitement.
0.6970547437667847 ||| Method of administration Irbesartan Winthrop is for oral use. ||| Rasburicase is produced by genetechnology in a ||| 113 Mode d’ administration Irbesartan Winthrop se prend par voie orale.
0.2155473530292511 ||| While the clinical significance of decreased indinavir concentrations has not been established, the magnitude of the observed pharmacokinetic interaction should be taken into consideration when choosing a regimen containing both efavirenz and indinavir. ||| Although the clinical significance of the induction of antibodies has not been fully elucidated, the development of neutralising antibodies is associated with reduced efficacy on clinical and MRI variables. ||| Bien que les conséquences cliniques d’ une diminution des concentrations en indinavir n'aient pas été établies, l'importance de l'interaction pharmacocinétique observée doit être prise en considération lorsque le traitement associe l'éfavirenz et l'indinavir.
3.2200945469101905e-13 ||| New publications of State aid decisions on the internet and in the Official Journal are listed in the State Aid Weekly e-News . ||| New publications of State aid decisions on the internet and in the Official Journal are listed in the State Aid Weekly e-News . ||| Le bulletin d'information électronique intitulé « State Aid Weekly e-News » donne la liste des dernières décisions relatives aux aides d'État publiées au Journal officiel et sur l'internet.
0.2512059211730957 ||| 422 • If you have chronic renal failure there is an increased risk of serious problems with your heart or blood vessels (cardiovascular events) if your haemoglobin is kept too high. ||| 39 • if you suffer from any disease that disturbs the interaction between nerves and skeletal muscles (peripheral neuromuscular dysfunction) • if you have or have had swallowing difficulties ||| • Si vous souffrez d’ insuffisance rénale chronique, le risque que vous présentiez des problèmes cardiovasculaires graves est augmenté si votre taux d’ hémoglobine est maintenu à un niveau trop élevé.
0.4623502194881439 ||| Yarvitan 5 mg/ ml oral solution for dogs ||| Zirtec 1mg/ ml soluzione orale Latvia: ||| Yarvitan 5 mg/ ml Solution orale pour chiens
0.325400173664093 ||| 0.025 - 0.035 mg/ kg bodyweight given as a daily subcutaneous injection. ||| Low initial doses of 0.15 - 0.3 mg given as a daily subcutaneous injection. ||| 0,025 - 0,035 mg/ kg de poids corporel par jour en injection sous-cutanée.
0.5979165434837341 ||| Sonata 5 mg hard capsules ||| Tablet containers 2.5 mg 18 months ||| Sonata 5 mg, gélules
0.8513445854187012 ||| FURTHER INFORMATION Me ||| CONTENTS BY UNIT ||| INFORMATIONS SUPPLEMENTAIRES
0.6922493577003479 ||| Zyrtec Portugal: ||| Atorvastatin: ||| Virlix, Zyrtec Portugal:
0.3615744411945343 ||| The ribavirin dose should be administered with food. ||| This dosage regimen should be used when valproate is added ||| La ribavirine doit être administrée avec des aliments.
0.30856257677078247 ||| There are no data available to indicate whether the administration of 23-valent pneumococcal polysaccharide vaccine to unprimed children or to children primed with Prevenar might result in hyporesponsiveness to further doses of Prevenar. ||| As for any vaccine, Menitorix may not completely protect against the infections it is intended to prevent in every vaccinated individual There are no data available on administration of Menitorix in toddlers not already primed with Hib and MenC conjugates. ||| Il n’ y a pas de données disponibles indiquant si l’ administration du vaccin pneumococcique polysaccharidique 23-valent à des enfants ayant ou non reçu une primovaccination par Prevenar pourrait entraîner une diminution de la réponse immunitaire lors de l’ administration ultérieure de doses de Prevenar.
0.8278285264968872 ||| Suspension for injection 5 x 3ml pre-filled pens ||| Ear drops suspension White to off-white oily suspension ||| Suspension injectable, 5 stylos préremplis de 3 ml
0.32276976108551025 ||| Laropiprant and its acyl glucuronide conjugate are the major circulating components in human plasma. ||| Its structure contains the β -lactam ring and thiazolidine ring common to all penicillins. ||| Le laropiprant et son conjugué acyl-glucuronide sont les principaux composants en circulation dans le plasma chez l’ homme.
0.0 ||| Gastrointestinal disorders: ||| Gastrointestinal disorders: ||| Effets gastro-intestinaux:
0.8028421401977539 ||| The first public conference for VICH is scheduled for November 1999 in Brussels. ||| This year's meeting took place in a virtual format. ||| La première conférence publique de la VICH est prévue en novembre 1999 à Bruxelles.
0.04430607706308365 ||| Profender Tablets for Large Dogs ||| Profender Tablets for Medium Dogs ||| Profender comprimés pour grands chiens
0.0 ||| A total of 43% of the patients in the dasatinib arm, and 82% in the imatinib arm had treatment failure, defined as disease progression or cross-over to the other treatment (lack of response, study drug intolerance, etc.). ||| A total of 43% of the patients in the dasatinib arm, and 82% in the imatinib arm had treatment failure, defined as disease progression or cross-over to the other treatment (lack of response, study drug intolerance, etc.). ||| 15 Un total de 43% des patients du bras dasatinib, et 82% du bras imatinib ont été en échec de traitement, échec défini par une progression de la maladie ou un changement vers un autre traitement (réponse insuffisante, intolérance aux traitements de l'étude, etc.).
0.31224995851516724 ||| The effectiveness of buprenorphine, 8 mg per day was similar to that of the moderate active control dose, but equivalence was not demonstrated. ||| In all three studies, the effectiveness of Dukoral, given as either two or three doses, was compared with that of placebo (a dummy vaccine). ||| Bien que l’ équivalence n’ ait pas été démontrée, l’ efficacité de 8 mg par jour de buprénorphine a été jugée similaire à celle de la dose modérée du contrôle actif.
0.08374830335378647 ||| 54 11. ||| 52 11. ||| 58 11.
0.1823747456073761 ||| The European Commission has approved a Belgian scheme of up to €3 billion, financed by the Flemish region, to support companies in the context of the coronavirus outbreak. ||| The European Commission has approved three Hungarian aid measures, with a total budget of around € 900 million, to support the Hungarian economy in the context of the coronavirus outbreak. ||| La Commission européenne a autorisé un régime belge d'un montant pouvant aller jusqu'à 3 milliards d'€, financé par la Région flamande, pour soutenir les entreprises dans le contexte de la pandémie de coronavirus.
0.3495497703552246 ||| Plasma concentrations of drugs principally metabolized by CYP2C9 may be increased during sitaxentan sodium co-administration. ||| Emtricitabine did not inhibit in vitro drug metabolism mediated by the following human CYP450 isoenzymes: ||| Une augmentation des concentrations plasmatiques des médicaments métabolisés par le CYP2C9 est attendue en cas d’ administration concomitante avec le sitaxentan sodique.
0.4443468451499939 ||| Solvents for stripping surface finishes during manufacturing processes ||| Insulating varnishes based on plastics materials ||| Solvants destinés au décapage de finitions de surface lors des procédés de fabrication
0.4011806845664978 ||| Predictability of response and non-response – treatment-naïve patients Early virological response by week 12, defined as a 2 log viral load decrease or undetectable levels of HCV RNA has been shown to be predictive for sustained response (see Tables 2 and 6). ||| Data on time to worsening of neurological status favoured TMZ over procarbazine as did data on time to worsening of performance status (decrease to a KPS of < 70 or a decrease by at least 30 points). ||| 4 Valeur prédictive de l'obtention d'une réponse ou de l'absence de réponse – patients naïfs L’ obtention d’ une réponse virologique précoce à la semaine 12, définie par une diminution de 2 log de la charge virale ou par la non-détection d’ ARN du VHC, s’ est révélée prédictive d’ une réponse prolongée (voir Tableaux 2 et 6).
0.39705485105514526 ||| The mean systemic clearance of lamivudine is approximately 0.3 l/ h/ kg. ||| Pemetrexed has a steady-state volume of distribution of 9 l/ m2. ||| La clairance systémique moyenne de la lamivudine est approximativement de 0,3 l/ h/ kg.
0.4765363335609436 ||| Adhesive sealant compounds ||| Adhesive cements ||| Matériaux adhésifs d'étanchéité
0.0 ||| Hold the pen with the needle pointing upwards. ||| Hold the pen with the needle pointing upwards. ||| Tenez le stylo avec l’ aiguille pointée vers le haut
0.3133227527141571 ||| Haematopoetic growth factor has been used in patients with resistant myelosuppression. ||| Splenic enlargement is a direct effect of treatment with filgrastim. ||| Pour les myélossupressions persistantes, le recours aux facteurs de croissance hématopoïétiques était nécessaire.
0.43581944704055786 ||| Lodi's ICU director reported that every single square metre, every single aisle of the hospital had been re-purposed for severe COVID-19 patients, increasing ICU beds from 7 to 24. ||| Temporary wards were constructed in hospital car parks, and existing wards re-organised to free up 33,000 beds in England and 3,000 in Scotland for COVID-19 patients. ||| Le directeur des soins intensifs de Lodi a rapporté que chaque mètre carré, chaque allée de l'hôpital avait été réaménagé pour les patients COVID-19 sévères, augmentant les lits en soins intensifs de 7 à 24.
0.11183178424835205 ||| The patient should take one 20 mg film-coated tablet per day. ||| The patient should take one 5 mg film-coated tablet per day for 7 days. ||| Le patient doit prendre un comprimé pelliculé à 20 mg par jour.
0.0 ||| The intake of food reduces the bioavailability of lansoprazole: it is recommended to take lansoprazole before the meal. ||| The intake of food reduces the bioavailability of lansoprazole: it is recommended to take lansoprazole before the meal. ||| La prise de nourriture diminue la biodisponibilité du lansoprazole: il est recommandé de prendre le lansoprazole avant les repas.
0.3314433693885803 ||| The plasma elimination half-life ranges from 1 to 2 hours following single or multiple doses in healthy subjects. ||| A slower terminal elimination phase follows with a dose-independent mean terminal elimination half-life of 2 to 3 h. ||| La demi-vie d’élimination plasmatique du lansoprazole est comprise entre 1,0 et 2,0 heures selon les doses uniques ou multiples administrées chez des sujets sains.
0.5596445798873901 ||| gonal-f 300 iu/ 0.5 ml ||| Zarzio 30 MU/ 0.5 ml ||| gonal-f 300 ui/ 0,5 ml
0.5314265489578247 ||| QTcF of > 500 msec was observed in < 1% of these patients. ||| No patient in either group developed a Δ QTc > 60 msec. ||| Un intervalle QTcF > 500 ms a été observé chez moins de 1% des patients.
0.2933262586593628 ||| What EMEND looks like and contents of the pack The 40 mg hard capsule is opaque with a white body and mustard yellow cap with “464” and “40 mg” printed radially in black ink on the body. ||| What CRIXIVAN look like and content of the pack CRIXIVAN 400 mg hard capsules are supplied in HDPE bottles with a polypropylene cap and a foil induction cap containing 18, 90 or 180 capsules. ||| La gélule de 40 mg est opaque avec un corps blanc et une coiffe jaune moutarde, portant les mentions « 464 » et « 40 mg » imprimés radialement à l’encre noire sur le corps.
0.2234877645969391 ||| Other information about Emtriva: ||| Other information about Alimta: ||| 2/ 3 Autres informations relatives à Emtriva:
0.34550511837005615 ||| Nplate should be administered once weekly as a subcutaneous injection. ||| The reconstituted product should be injected subcutaneously once daily for 5 consecutive days. ||| Nplate doit être administré une fois par semaine en injection sous-cutanée.
0.3174744248390198 ||| Metabolism and excretion The apparent terminal half-life of raltegravir is approximately 9 hours, with a shorter α -phase half-life (~1 hour) accounting for much of the AUC. ||| Linearity / non-linearity The Cmax for vildagliptin and the area under the plasma concentrations versus time curves (AUC) increased in an approximately dose proportional manner over the therapeutic dose range. ||| Métabolisme et élimination La demi-vie d'élimination terminale du raltégravir est d'environ 9h, avec une phase α plus courte (environ 1h) représentant la majeure partie de l'ASC.
0.03117184340953827 ||| IntronA 10 million IU/ml powder and solvent for solution for injection or infusion Interferon alfa-2b ||| IntronA 5 million IU/ml powder and solvent for solution for injection or infusion interferon alfa-2b ||| IntronA 10 millions d’UI/ml poudre et solvant pour solution injectable ou pour perfusion Interféron alfa -2b
0.31195783615112305 ||| Dosing of APTIVUS, co-administered with low dose ritonavir, with antacids should be separated by at least a two hours time interval. ||| Therefore, this specific regimen with concomitant administration with high-dose cytarabine (2 g/ m2 per day) by continuous infusion over 24 hours is not recommended. ||| La co-administration d’ APTIVUS, associé au ritonavir à faible dose, avec les antiacides doit être séparée par un intervalle d’ au moins deux heures.
0.26114434003829956 ||| In patients with hypertension, the decrease in blood pressure during treatment with doxazosin was similar in both the sitting and standing position. ||| In patients with hypertension, the decrease in blood pressure during treatment with Doxagamma 4 mg prolonged release tablets and associated names was similar in both the sitting and standing position. ||| Chez les patients hypertendus, la diminution de la pression artérielle, lors du traitement par la doxazosine, a été similaire en position assise et en position debout.
0.3087468147277832 ||| Zoledronic acid is not highly bound to plasma proteins (approximately 43-55% bound) and binding is concentration independent. ||| Protein binding is slight (binding of perindoprilat to angiotensin converting enzyme is less than 30%), but is concentration-dependent. ||| L'acide zolédronique n'est pas fortement lié aux protéines plasmatiques (liaison d'environ 43 à 55%) et la liaison est indépendante de la concentration.
0.353751540184021 ||| The incidence of myocardial infarction was 1.1% (8/ 717 patients) with celecoxib 200 mg twice daily and 1.2% (13/ 1070 patients) with placebo. ||| The incidence of severe or life-threatening bleeding events with eptifibatide was common( > 1/ 100, < 1/ 10); 1.9% vs 1.1% with placebo. ||| L’ incidence d’ infarctus du myocarde était de 1,1% (8 cas/ 717 patients) avec une prise biquotidienne de 200 mg de célécoxib, contre 1,2% (13 cas/ 1070 patients) avec le placebo.
0.016188381239771843 ||| Subjects with renal impairment No study was conducted with Prometax transdermal patches in subjects with renal impairment. ||| Subjects with renal impairment No study was conducted with Exelon transdermal patches in subjects with renal impairment. ||| 82 Sujets insuffisants rénaux Il n’ a pas été mené d’ étude avec les dispositifs transdermiques de Prometax chez des sujets présentant une insuffisance rénale.
0.2562624514102936 ||| Plastic film for insulating purposes ||| Plastic sheeting for agricultural purposes ||| Films plastiques destinés à l'isolation
0.35277020931243896 ||| Reflectors for traffic signals ||| Receiving terminals for signals ||| Réflecteurs de feux de circulation
0.8173536062240601 ||| -2.0 - 79.0 ||| 0 -2.3 -4 ||| -2,0 - 79,0
0.4451723098754883 ||| - Patients with active peptic ulceration or gastrointestinal bleeding. ||| - Patients with established ischaemic heart disease, peripheral arterial disease and/ or ||| - Ulcère peptidique évolutif ou saignement gastro-intestinal.
0.1848522126674652 ||| Plastics pipes [fitted parts of machines] ||| Pipes [fitted parts of machines] ||| Tuyaux en matières plastiques [parties de machines]
0.09041570127010345 ||| No formal interaction studies have been performed. ||| No formal interaction studies have been done. ||| Aucune étude formelle d’ interaction n’ a été réalisée.
0.3098077178001404 ||| Examples include an irregular heart rhythm or if you are prone to low blood pressure or if you are using medicines for your blood pressure. ||| This is particularly important if you are already taking any medicine to treat a heart condition or problems with your blood sugar, kidneys or blood pressure such as medicines containing ||| Les exemples incluent un rythme cardiaque irrégulier ou si vous êtes sujet à une tension artérielle basse ou si vous utilisez des médicaments pour votre tension artérielle.
0.2780412435531616 ||| In most patients, Protaphane was compared with other types of human insulin or insulin analogues. ||| In these patients, Erbitux is used alone or in combination with other anticancer medicines. ||| Chez la plupart des patients, Protaphane a été comparé à d’ autres types d’ insuline humaine ou analogues de l’ insuline.
0.23067019879817963 ||| You should not breast-feed if you are taking Xeloda. ||| You must stop breast feeding if you use Neulasta. ||| Vous ne devez pas allaiter si vous êtes traitée par Xeloda.
0.48570123314857483 ||| The diagnosis of gastroduodenal ulcers and reflux oesophagitis should be confirmed by endoscopy or other appropriate diagnostic means. ||| Continuous combined therapy versus sequential therapy in the prevention of endometrial hyperplasia or carcinoma ||| Le diagnostic d’ ulcère gastro-duodénal et d’ oesophagite par reflux gastro-oesophagien devrait être confirmé par endoscopie ou par d’ autres méthodes diagnostiques appropriées.
0.4066082239151001 ||| Conductive lacquers for dental use ||| Interdental stimulators for use in dental treatment ||| Laques conductrices à usage dentaire
0.0 ||| Very Rare ||| Very Rare ||| Très rares
0.0652705579996109 ||| It is not known whether rasagiline is excreted in human milk. ||| It is not known whether micafungin is excreted in human breast milk. ||| Il n'a pas été établi si la rasagiline était excrétée dans le lait maternel.
0.0 ||| If you stop taking Agopton ||| If you stop taking Agopton ||| Si vous arrêtez de prendre Agopton
0.7535488605499268 ||| 263 Peripheral ischaemia, hypotension§ ||| 28 Extrapyramidal symptoms (EPS): ||| Ischémie périphérique, hypotension§ Très rare:
0.05084019899368286 ||| 37 Skin and subcutaneous tissue disorders: ||| 6 Skin and subcutaneous tissue disorders: ||| Troubles de la peau et du tissu sous-cutané:
0.18685278296470642 ||| How to store Fertavid 6. ||| How to store Pradaxa 6. ||| Comment conserver Fertavid 6.
0.2961488962173462 ||| - if you are allergic to brinzolamide or any of the other ingredients. ||| - If you are allergic to the active substance or to the other ingredients of REGRANEX. ||| - Si vous êtes allergique au brinzolamide ou à l’un des autres composants.
0.11074266582727432 ||| Insuman Comb 50 is supplied in cartridges for OptiClik containing 3 ml suspension, (300 IU). ||| Insulin Human Winthrop Comb 25 is supplied in cartridge for OptiClik containing 3 ml suspension (300 IU). ||| Insuman Comb 50 est fourni en cartouche pour OptiClik contenant 3 ml de suspension (300 UI).
0.2904142141342163 ||| Clinical studies demonstrating haemostasis were conducted in a total of 240 patients (118 TachoSil, 122 argon beamer) undergoing partial liver resection surgery and 185 patients (95 TachoSil, 93 standard surgical treatment) undergoing surgical resection of superficial renal tumour. ||| One was a non-comparative trial in 138 patients (29% received prior chemotherapy), and the other was a randomised active-controlled trial of TMZ vs procarbazine in a total of 225 patients (67% received prior treatment with nitrosourea based chemotherapy). ||| Des études cliniques démontrant l’ hémostase ont été réalisées chez 240 patients (118 Tachosil, 122 laser Argon) ayant subi une résection chirurgicale partielle du foie et chez 185 patients (95 Tachosil, 93 traitement chirurgical conventionnel) ayant subi une résection chirurgicale d’ une tumeur rénale.
0.4911004304885864 ||| Actuators incorporating a gear mechanism for pipeline valves ||| Gas stoves utilising flames in rotating form ||| Actionneurs équipés d'un mécanisme à engrenages pour vannes de conduites
0.277323842048645 ||| How does QUADRAMET work? ||| How does RILUTEK work? ||| Comment QUADRAMET agit -il?
0.33364051580429077 ||| the fever increases at night ||| the fever started to increase last night ||| la fièvre augmente la nuit
0.2203047126531601 ||| TESAVEL 50 mg film-coated tablets ||| INVIRASE 500 mg film-coated tablets. ||| TESAVEL 50 mg, comprimés pelliculés
0.0 ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA) http: / /www. emea. europa. eu
0.21769452095031738 ||| In patients with mild to moderate renal insufficiency (creatinine clearance 40-60 ml/ min) steady state AUC of enalaprilat was approximately two-fold higher than in patients with normal renal function after administration of 5 mg once daily. ||| In patients with pulmonary arterial hypertension treated with doses of 125 and 250 mg twice daily, clinically relevant decreases in haemoglobin occurred in 3.0% and 1.3% of the bosentan- and placebo-treated patients, respectively. ||| Chez les patients ayant une insuffisance rénale légère à modérée (clairance de la créatinine 40- 60 ml/ mn) l’ ASC de l’ énalaprilate à l’ état d’ équilibre a été environ deux fois plus élevée que chez les patients ayant une fonction rénale normale après administration de 5 mg une fois par jour.
0.1505206823348999 ||| What Apidra is and what it is used for 2. ||| What Aerinaze is and what it is used for 2. ||| Qu’ est -ce qu’ Apidra et dans quel cas est -il utilisé 2.
0.113233283162117 ||| 43 10. ||| 44 10. ||| 46 10.
0.8950250148773193 ||| Syrup. ||| România Şos. ||| Sirop.
0.03325667232275009 ||| Usually, your doctor will advise you to take another medicine instead of MicardisPlus, as MicardisPlus is not recommended in early pregnancy, and may cause serious harm to your baby if it is used after 3 months of pregnancy. ||| Usually, your doctor will advise you to take another medicine instead of Kinzalkomb, as Kinzalkomb is not recommended in early pregnancy, and may cause serious harm to your baby if it is used after 3 months of pregnancy. ||| Votre médecin vous recommandera normalement de prendre un autre médicament puisque MicardisPlus est déconseillé au début de la grossesse et peut entrainer des problemes de santé chez l'enfant à naître s’ il est pris à partir du troisième mois de la grossesse.
0.27661845088005066 ||| uncommon: depression, disorientation, anxiety, insomnia, sleep disorder, abnormal dream ||| abnormal dreams, anxiety, depression, middle insomnia, sleep disorder ||| peu fréquents: dépression, désorientation, anxiété, Affections psychiatriques: insomnie, troubles du sommeil, rêves anormaux
0.44524872303009033 ||| Automatic telegraph apparatus ||| Pneumatic actuating apparatus ||| Appareils de télégraphie automatique
0.11897960305213928 ||| Enviage belongs to a new class of medicines called renin inhibitors. ||| Tekturna belongs to a new class of medicines called renin inhibitors. ||| Enviage appartient à une nouvelle classe de médicaments appelés inhibiteurs de la rénine.
0.32237398624420166 ||| Clear colourless solution. ||| Clear colourless solution ||| Solution incolore limpide.
0.5256446003913879 ||| Erectile dysfunction medicinal products: concomitant use is not recommended. ||| *Not known Injection site infections, including cellulitis ||| L'administration concomitante de ces médicaments et de Telzir n'est pas recommandée.
0.05675160884857178 ||| 72 6.6 Special precautions for disposal ||| 7 6.6 Special precautions for disposal ||| 78 6.6 Précautions particulières d’ élimination
0.1930813044309616 ||| 55 ||| 54 ||| 56
0.45583415031433105 ||| Up to three injections in 24 hours may be given. ||| You will usually receive at least 6 treatment cycles. ||| Jusqu'à 3 injections par 24 heures peuvent être administrés.
0.527042031288147 ||| Pharmacovigilance Working Party ||| CVMP Immunologicals Working Party ||| Groupe de travail “ pharmacovigilance”
0.4500037431716919 ||| In vitro resistance: ||| Intravenous infusion: ||| Résistance in vitro:
0.4258313775062561 ||| The CHMP was concerned that the studies had not shown a meaningful benefit of Lacosamide Pain UCB Pharma. ||| The CHMP had concerns that a benefit of Cerepro had not yet been shown. ||| Les réserves du CHMP étaient que les études n’ avaient pas démontré de bénéfice significatif de Lacosamide Pain UCB Pharma.
0.448589563369751 ||| Uncommon: dizziness, neuropathy peripheral, somnolence. ||| - Very common: peripheral oedema, flushing (facial reddening). ||| Peu fréquent: étourdissement, neuropathie périphérique, somnolence
0.25076824426651 ||| Not relevant. ||| Not aplicable. ||| Non applicable.
0.3385986089706421 ||| Studies in animals did not indicate any teratogenic effects in rats or rabbits, but embryotoxicity was observed in rats and rabbits at maternal toxic doses (see section 5.3). ||| Toxicology studies have been conducted in rhesus monkeys and albino rats; in both, the metabolic pathway is similar to that described for humans. ||| Des études chez l’ animal n’ ont pas indiqué d’ effets tératogènes chez le rat ou le lapin, mais une embryototoxicité a été observée chez le rat et le lapin à des doses toxiques pour la mère (voir rubrique 5.3).
0.010090167634189129 ||| 168 TNF and lymphotoxin exist predominantly as homotrimers, with their biological activity dependent on cross-linking of cell surface TNFRs. ||| 14 TNF and lymphotoxin exist predominantly as homotrimers, with their biological activity dependent on cross-linking of cell surface TNFRs. ||| Le TNF et la lymphotoxine existent principalement sous forme d’ homotrimères, leur activité biologique étant dépendante de la réticulation des TNFR à la surface des cellules.
0.5597198009490967 ||| Sildenafil ||| Cisplatin ||| Sildénafil
0.3529183864593506 ||| If a dose greater than 80 units is required, it should be given as two or more injections. ||| When only 1 or 2 cakes are required the volume may be reduced to 0.5 ml. ||| Si une dose supérieure à 80 unités est nécessaire, elle devra être administrée en deux ou plus de deux injections.
0.4399579167366028 ||| Radiopharmaceutical products ||| Radiopharmaceutical precursor ||| Produits radiopharmaceutiques
0.2097409963607788 ||| It is recommended that venlafaxine should be discontinued for at least 7 days before starting treatment with a reversible MAOI (see section 4.4). ||| In these patients the use of prolonged prophylaxis with fondaparinux should be considered for up to an additional 24 days (see section 5.1). ||| Il est recommandé d’ arrêter la venlafaxine au moins 7 jours avant l’ instauration d’ un traitement par un IMAO irréversible (voir rubrique 4.4).
0.317319393157959 ||| dizziness, headache, somnolence sudden onset of sleep, syncope amnesia, dyskinesia, hyperkinesia ||| Bradycardia dysarthria, hypoaesthesia, sensory disturbance miosis, visual acuity reduced dyspnoea, wheezing ||| Sensation vertigineuse, céphalées, somnolence Accès de sommeil d’ apparition brutale, syncope Amnésie, Dyskinésie, hyperkinésie
0.002780014416202903 ||| ViraferonPeg 100 micrograms, powder and solvent for solution for injection in pre-filled pen ||| ViraferonPeg 120 micrograms, powder and solvent for solution for injection in pre-filled pen ||| ViraferonPeg 100 microgrammes, poudre et solvant pour solution injectable en stylo prérempli
0.31358811259269714 ||| 22 Relationship between concentration and effect Using a highly specific NK1-receptor tracer, positron emission tomography (PET) studies in healthy young men have shown that aprepitant penetrates into the brain and occupies NK1 receptors in a dose- and plasma- concentration-dependent manner. ||| The combined effects of strontium distribution in bone (see section 5.2) and increased X-ray absorption of strontium as compared to calcium, leads to an amplification of bone mineral density (BMD) measurement by dual-photon X-ray absorptiometry (DXA). ||| 23 Relation effet/dose A l’aide d’un traceur hautement spécifique du récepteur NK1, des études par tomographie par émission de positrons (TEP) menées auprès de jeunes hommes sains ont montré que l’aprépitant pénètre dans le cerveau et se lie aux récepteurs NK1 de façon dose- et concentrations plasmatiques dépendantes.
0.0 ||| Therapy should be initiated by a physician experienced in the management of HIV infection. ||| Therapy should be initiated by a physician experienced in the management of HIV infection. ||| Le traitement devra être initié par un médecin spécialiste dans la prise en charge de l'infection par le VIH.
0.5016688108444214 ||| An increased incidence of hypertension (all grades) of up to 34% has been observed in Avastin-treated patients in clinical trials compared with up to 14% in those treated with comparator. ||| First, Law and Wald attributed about 20% of the difference in the observed rates of CHD between France and the United Kingdom to the under-certification of CHD in France, relative to the UK. ||| Dans les études cliniques, une augmentation de l’ incidence de l’ hypertension artérielle (tous grades) a été observée jusqu’ à 34% des patients traités par Avastin comparé à 14% des patients du groupe témoin.
0.9022955298423767 ||| Weeks 1 + 2 ||| Days 1 to 3: ||| Semaines 1 + 2
0.277942955493927 ||| In metastatic colorectal cancer, Xeloda taken on its own has been compared with the combination of 5-FU and folinic acid in two studies involving 1,207 patients. ||| In in vitro tests, posaconazole has shown fungicidal activity against most of the approximately 7,000 strains of yeast and filamentous fungi tested. ||| Dans le cancer colorectal métastatique, Xeloda administré en monothérapie a été comparé à l’ association du 5-FU et de l’ acide folinique dans deux études menées auprès de 1 207 patients.
0.44358354806900024 ||| Kepivance should be reconstituted with 1.2 ml water for injections. ||| NovoSeven powder and solvent vials should be at room temperature at reconstitution. ||| Kepivance doit être reconstitué avec 1,2 ml d’ eau pour préparations injectables.
0.6567648649215698 ||| Flavourings for soups ||| Preserves, pickles ||| Arômes pour soupes
0.34298497438430786 ||| Rotating electrical machines ||| Electroplating machines ||| Machines électriques rotatives
0.28454452753067017 ||| Electronic blood oxygen saturation recorders [for medical use] ||| Electronic heart signal monitors [for medical use] ||| Enregistreurs électroniques de saturation du sang en oxygène à usage médical
0.23469184339046478 ||| Take special care with Temodal ||| Take special care with Mixtard ||| Faites attention avec Temodal
0.3706642687320709 ||| C09A A03 ||| LO4A A06 ||| C09AA03
0.34583282470703125 ||| However, it has been reported that people can carry the virus without symptoms longer than two weeks and cured patients discharged from hospitals can carry the virus again, which sends out an alarm to increase the time for quarantine. ||| In the US there is also the recommendation that newborns and mothers should be temporarily separated until transmission-based precautions are discontinued, and that where this is not possible the newborn should be kept 2 metres away from the mother. ||| Cependant, il a été démontré que des individus peuvent être porteurs du virus sans pour autant présenter de symptômes pendant plus de deux semaines et que les patients rétablis peuvent être à nouveau porteurs du virus, ce qui souligne la nécessité d’accroître la durée de mise en quarantaine.
0.12098678946495056 ||| Therefore, the Committee decided that the benefits of Eucreas are greater than its risks for the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets. ||| The Committee decided that Avaglim’ s benefits are greater than its risks for the treatment of type 2 diabetes in patients who are unable to achieve sufficient glycaemic control on optimal dosage of sulphonylurea monotherapy, and for whom metformin is inappropriate because of contraindication or intolerance. ||| Par conséquent, le comité a établi que les bénéfices d'Eucreas sont supérieurs à ses risques pour le traitement des patients diabétiques de type 2 qui n'ont pas la capacité de contrôler suffisamment leur glycémie à leur dose maximale tolérée de metformine orale seule ou qui sont déjà traités au moyen de la combinaison de vildagliptine et de metformine en comprimés distincts.
0.2586338222026825 ||| If you have impaired kidney function, your doctor will decide upon a dose that suits your condition. ||| If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet. ||| Si vous présentez une insuffisance rénale, votre médecin décidera de la dose adaptée à votre état.
0.37906816601753235 ||| Telzir is also available as an oral suspension for those patients unable to swallow the tablets. ||| Patients should be advised not to swallow the desiccant capsule found in the bottle. ||| Telzir est également disponible sous forme de solution buvable pour les patients qui ne peuvent pas avaler les comprimés.
0.7263978719711304 ||| Pottery stone ||| Pumice stone ||| Pierre de Chine
0.020321359857916832 ||| Medicinal products whose plasma levels may be increased when co-administered with Telzir ||| Medicinal products whose plasma levels may be decreased when co-administered with Telzir ||| Médicaments dont les concentrations plasmatiques peuvent être augmentées en cas de co- administration avec Telzir
0.3330026865005493 ||| Dissemination of advertising via online communications networks ||| Transmission of information by electronic communications networks ||| Diffusion d'annonces publicitaires sur des réseaux de communication en ligne
0.26466453075408936 ||| In vitro studies have shown that gemfibrozil is a strong inhibitor of CYP2C9 (an enzyme involved in the metabolism of e. g. warfarin and glimepiride), but also of CYP 2C19, CYP1A2 and UGTA1 and UGTA3 (see Section 4.4). ||| It cannot be excluded that lapatinib will affect the pharmacokinetics of substrates of Pgp (e. g. digoxin), BCRP (e. g. topotecan) and OATP1B1 (e. g. rosuvastatin) (see section 5.2). ||| Des études in vitro ont montré que le gemfibrozil est un inhibiteur puissant de CYP2C9 (enzyme impliquée dans le métabolisme de la warfarine et du glimépiride, entre autres), mais également des CYP2C19, CYP1A2 et UGTA1 et UGTA3 (voir rubrique 4.4).
0.19395694136619568 ||| 5 erlotinib with omeprazole, a proton pump inhibitor (PPI), decreased the erlotinib exposure [AUC] and maximum concentration [Cmax] by 46% and 61%, respectively. ||| Concomitant administration of Tarceva with 300 mg ranitidine, an H2-receptor antagonist, decreased erlotinib exposure [AUC] and maximum concentrations [Cmax] by 33% and 54%, respectively. ||| La co-administration de l’ erlotinib à l’ oméprazole, un inhibiteur de la pompe à protons (IPP), a diminué l’ aire sous la courbe (ASC) et la concentration maximale (Cmax) de l’ erlotinib respectivement de 46% et 61%.
0.5548357963562012 ||| Containers made of horn ||| Knitting yarns made of wool ||| Récipients en corne
0.3724648952484131 ||| A single and repeated dose oral toxicity study in mice suggests no special hazard to humans. ||| In a similar patient population durability of antiviral response over 120 weeks was demonstrated in approximately 70% of subjects. ||| Une étude de toxicité orale à dose unique et à dose répétée chez la souris n’a pas révélé de risque particulier pour l’homme.
0.36559760570526123 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet during your treatment with CellCept, please tell your doctor or pharmacist. ||| • Speak to your doctor as soon as possible if you think you have an infection. • Show the Alert Card and this package leaflet to any doctor involved with your treatment, not only to your neurologist. ||| Si vous remarquez des effets indésirables non mentionnés dans cette notice ou si vous ressentez un des effets mentionnés comme étant sérieux pendant votre traitement par CellCept, veuillez en informer votre médecin ou votre pharmacien.
0.5472358465194702 ||| The reaction is maximal at 2-3 days post vaccination with a maximum area of 3 cm by 8 cm. ||| Each symptom was measured on a scale from 0 to 3, with a maximum total score of 12. ||| La réaction est maximale 2-3 jours après la vaccination, avec une taille maximum de 3 cm sur 8 cm.
0.4197940230369568 ||| Do not use {PRODUCT NAME} 40 mg if you notice visible signs of deterioration. ||| The duration of treatment with {PRODUCT NAME} 10 mg is determined by your doctor. ||| Ne pas utiliser{NOM DU PRODUIT} 40 mg, si vous remarquez des signes visibles de dégradation.
0.5612128376960754 ||| NeoRecormon is also available in a cartridge and a pre-filled syringe. ||| Please refer to the laser user manual, and to the microlens fibre-optic user leaflet. ||| NeoRecormon est également disponible en cartouche et seringue pré-remplie.
0.22221429646015167 ||| What Silapo contains ||| What Kaletra contains ||| Que contient Silapo
0.4043582081794739 ||| Refurbishment of clutches for pneumatic trucks ||| Repair of pipelines by means of encapsulation kits ||| Remise à neuf d'embrayages de camions pneumatiques
0.13028115034103394 ||| 23 Chemical and physical in-use stability of the reconstituted solution has been demonstrated for one month at 2°C-8°C. ||| Physico-chemical stability of the reconstituted product has been shown for 24 hours at 2°C to 8°C. ||| La stabilité physicochimique de la solution reconstituée dans ses conditions d’ utilisation a été démontrée pour une durée d’ un mois entre +2°C et +8°C.
0.21817274391651154 ||| 17 The safety of fentanyl in pregnancy has not been established. ||| The safe use of loratadine during pregnancy has not been established. ||| La sécurité d’ emploi du fentanyl pendant la grossesse n’ a pas été établie.
0.3257400393486023 ||| If your disease responds to TRISENOX, you will be given a second treatment cycle of 25 doses, one infusion every weekday for 5 weeks. ||| After your condition has been brought under control, you will receive regular doses of Binocrit between 17 and 33 IU/ kg, three times a week. ||| Si votre maladie répond au traitement par TRISENOX, vous recevrez un second cycle thérapeutique de 25 doses, soit une perfusion par jour, en semaine, pendant 5 semaines.
0.19875696301460266 ||| 25 May 2005 ||| 25 January 2005 ||| 25 mai 2005
0.2712537944316864 ||| Combination with other antidiabetes medicines led to further decreases in the level of HbA1c, indicating that blood glucose levels had been further reduced. ||| There is a risk that the plasma levels of rasagiline in smoking patients could be decreased, due to induction of the metabolising enzyme CYP1A2. ||| L’ association avec d’ autres médicaments anti-diabétiques a permis d’ obtenir des baisses plus importantes du taux d’ HbA1c, ce qui indique que la réduction de la glycémie a été supérieure.
0.3567458987236023 ||| Patients should be advised to seek medical advice if they experience joint aches and pain, joint stiffness or difficulty in movement. ||| Transport operators are advised to develop strategies in case a passenger falls ill or shows symptoms of coronavirus during the journey. ||| Il est conseillé aux patients de demander un avis médical en cas de gènes ou douleurs au niveau des articulations, de raideurs articulaires ou de difficultés à se mouvoir.
6.149687421623529e-13 ||| Use immediately or within 3 hours of reconstitution. ||| Use immediately or within 3 hours of reconstitution. ||| Le produit reconstitué doit être utilisé immédiatement ou dans les 3 heures.
0.018449068069458008 ||| Hold the PegIntron pre-filled pen with your fingers wrapped around the pen body barrel and your thumb on the dosing button (figure 7). ||| Hold the PegIntron pre -filled pen with your fingers wrapped around the pen body barrel and your thumb on the dosing button (figure 7). ||| Tenez le stylo prérempli PegIntron en plaçant vos doigts autour du cylindre du corps du stylo et votre pouce sur le bouton dose (figure 7).
0.26153478026390076 ||| The 64 mg tablets are packaged in an HDPE bottle with a child resistant closure, desiccant canister and cotton coiler. ||| HDPE bottle with a child-resistant closure containing 30 film-coated tablets and a silica gel desiccant. ||| Les comprimés de 64 mg sont conditionnés dans un flacon en HDPE avec une fermeture de protection à l'épreuve des enfants, un réservoir de dessiccatif et une bobine coton.
0.0 ||| CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES ||| CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES ||| CONDITIONS OU RESTRICTIONS EN VUE D’ UNE UTILISATION SÛRE ET EFFICACE DU MÉDICAMENT DEVANT ÊTRE MISES EN Œ UVRE PAR LES ÉTATS MEMBRES
0.08219476044178009 ||| Read all of this leaflet carefully before your child receives this vaccine. ||| Read all of this leaflet carefully before your child starts receiving this medicine. ||| Veuillez lire attentivement l’intégralité de cette notice avant que votre enfant ne reçoive ce vaccin.
0.2491399645805359 ||| In vivo, probenecid (500 mg every 6 hours) decreased the bound fraction of ertapenem in plasma at the end of infusion in subjects administered a single 1 g intravenous dose from approximately 91% to approximately 87%. ||| When followed by a 2.0 microgram/ kg/ min continuous infusion, this regimen produces a > 80% inhibition of ADP-induced ex vivo platelet aggregation, at physiologic calcium concentrations, in more than 80% of patients. ||| In-vivo, le probénécide (500 mg toutes les 6 heures) a diminué de 91% approximativement à 87% approximativement la fraction de liaison de l’ ertapénème dans le plasma à la fin de la perfusion chez des sujets ayant reçu une dose unique intraveineuse de 1 g.
0.748871386051178 ||| - Treatment of essential hypertension. ||| • Treatment of Multiple myeloma ||| - Traitement de l’ hypertension essentielle
0.10532266646623611 ||| Dispose of your used Actraphane 30 InnoLet carefully without the needle attached. ||| Dispose of your used Insulatard InnoLet carefully without the needle attached. ||| Eliminez votre Actraphane 30 InnoLet usagé prudemment, sans l’ aiguille attachée.
0.43263494968414307 ||| Bondenza prevents loss of bone from osteoporosis, and helps to rebuild bone. ||| Corlentor therefore reduces or prevents the symptoms of angina. ||| 42 Bondenza prévient la perte osseuse provoquée par l’ ostéoporose et aide à la reconstruction de l’ os.
0.4609094262123108 ||| It enables the granting of guarantees on loans to help businesses cover immediate working capital needs. ||| Trade credit insurance protects companies supplying goods and services against the risk of nonpayment by their clients. ||| Il permet l'octroi de garanties sur des prêts afin d'aider les entreprises à couvrir leurs besoins immédiats en fonds de roulement.
0.07101123780012131 ||| The efficacy of hormonal contraceptives may be reduced during and for 28 days after administration of aprepitant. ||| The efficacy of hormonal contraceptives may be reduced during and for 28 days after administration of EMEND. ||| L’ efficacité des contraceptifs hormonaux peut être réduite pendant l’ administration d’ aprépitant et au cours des 28 jours qui suivent cette administration.
0.37924131751060486 ||| In vitro interaction studies did not show any inhibition or induction of the principal isoenzymes of cytochrome P450. ||| Retrograde transsynaptic passage of active Botulinum neurotoxin type A into the central nervous system however has not been found. ||| Des études d’interactions in vitro n’ont révélé aucune inhibition ou induction des principales isoenzymes du cytochrome P450.
0.26450443267822266 ||| 60 A severe allergic reaction (rash, itching, swelling of the face, lips, mouth or throat that may cause difficulty in swallowing or breathing). ||| Tell the doctor or nurse immediately if your child develops a rash (which may be raised or lumpy), tightness of the throat, swelling of the face or neck or shortness of breath. ||| Une réaction allergique grave (éruption cutanée, démangeaisons, gonflement du visage, des lèvres, de la bouche ou de la gorge qui peut entraîner des difficultés à avaler ou à respirer).
0.30687829852104187 ||| Caution should be used when co-administering medicinal products that induce CYP3A or potentially toxic medicinal products which are themselves metabolised by CYP3A (see section 4.3 and below). ||| The risk of interaction with other medicinal products (esp. with those products metabolised through CYP2C9 and CYP2C8) was further emphasised in the harmonised SPC. ||| Des précautions doivent être prises lorsque sont administrés conjointement des médicaments inducteurs du CYP3A ou des médicaments potentiellement toxiques qui sont eux-mêmes métabolisés par le CYP3A (voir rubrique 4.3 et ci-dessous).
0.17644819617271423 ||| The pharmacokinetic properties of enfuvirtide have been evaluated in HIV-1-infected adult and paediatric patients. ||| The pharmacokinetic properties of nelfinavir have been evaluated in healthy volunteers and HIV-infected patients. ||| Les propriétés pharmacocinétiques de l'enfuvirtide ont été évaluées chez l'adulte et chez l'enfant infectés par le VIH-1.
0.4251343011856079 ||| These two studies use authorised glucosamine-containing medicinal products, are long-term 3-years placebo-controlled studies, include an appropriate number of patients with appropriate inclusion criteria and look at relevant endpoints. ||| Whereas biotechnology guidelines relate primarily to the centralised procedures (future, ongoing or earlier ones), guidelines for chemical quality, pre-clinical safety and clinical efficacy also support ongoing or future mutual recognition procedures. ||| Ces deux études utilisent des médicaments autorisés contenant du glucosamine, sont des essais comparatifs avec placebo d'une durée de 3 ans, comprennent un nombre approprié de patients et des critères d'inclusion appropriés et étudient des critères d'évaluation pertinents.
0.29796653985977173 ||| Furthermore, suicidal ideation or attempts were reported more frequently compared to adult patients (2.4% vs 1%) during treatment and during the 6 month follow-up after treatment. ||| At least possibly related adverse reactions were reported in 2/ 201 (1.0%) patients: mild vomiting 48 hours after surgery, and mild photosensitivity 48 hours after study surgery. ||| En outre, les idées suicidaires ou tentatives de suicides au cours du traitement et lors du suivi de 6 mois après traitement ont été rapportés plus fréquemment chez les enfants et adolescents que chez les adultes (2,4% versus 1%).
0.8051711320877075 ||| Dosing adjustments are based on renal function, weight, and aPTT (see section 4.2). ||| There is a linear correlation between dose on the one hand and plasma concentration and AUC on the other. ||| Ces ajustements sont basés sur la fonction rénale, le poids et le TCA (voirrubrique 4.2).
0.015884634107351303 ||| The Skills & Education Guarantee Pilot (S&E Pilot) is a new debt financing initiative dedicated to stimulating investments in education, training and skills - as part of the solution to get more people into jobs and to respond to the European economy's changing needs. ||| The Skills  Education Guarantee Pilot (S  E Pilot) is a new debt financing initiative dedicated to stimulating investments in education, training and skills - as part of the solution to get more people into jobs and to respond to the European economy's changing needs. ||| L'instrument de garantie pilote pour les compétences et l'éducation est une nouvelle initiative de financement par l'emprunt dont le but est de stimuler les investissements dans l'éducation, la formation et les compétences et de contribuer ainsi à amener davantage de personnes vers l'emploi et à répondre à l'évolution des besoins de l'économie européenne.
0.339419424533844 ||| GONAL-f 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml) must be reconstituted with the 1 ml solvent provided before use. ||| A commonly used dose starts with 75-150 IU (0.12-0.24 ml) of GONAL-f together with 75 IU of lutropin alfa. ||| GONAL-f 450 UI/ 0,75 ml (33 microgrammes/ 0,75 ml) doit, avant utilisation, être reconstitué avec 1 ml de solvant joint.
0.267992228269577 ||| Your concentrate for solution for infusion is called Paxene. ||| - TRISENOX is a concentrate for solution for infusion. ||| Le nom de votre solution à diluer pour perfusion est Paxene.
0.5050537586212158 ||| Dry mouth is reported in 10% of patients treated with venlafaxine. ||| HPV types 16 and 18 are responsible for approximately 70% of cervical cancer cases. ||| 45 Une sécheresse de la bouche a été rapportée chez 10% des patients traités par la venlafaxine.
0.2882913053035736 ||| If severe skin reactions occur a fourth time or do not resolve to grade 2 during interruption of treatment, permanent discontinuation of cetuximab treatment is required. ||| Local skin reactions are common but these reactions generally decrease in intensity during therapy or resolve after cessation of imiquimod cream therapy. ||| Si une réaction cutanée sévère survient pour la quatrième fois ou ne régresse pas au grade 2 pendant l’ interruption du traitement, l’ arrêt définitif du traitement par le cetuximab s’ impose.
0.4398634433746338 ||| Laminated building glass incorporating fine electrical conductors ||| Electronic amusement apparatus incorporating a liquid crystal display ||| Verre feuilleté de construction contenant des conducteurs électriques fins
0.5796825885772705 ||| In 1994, she joined the UK Veterinary Medicines Directorate as senior veterinary assessor in the pharmaceuticals and feed additives team. ||| Ms Nuttall held several posts in the Irish Civil Service, serving in the Departments of Health, Finance and the Office of Public Works. ||| En 1994, elle a intégré la Veterinary Medicines Directorate (Royaume-Uni) en tant qu'évaluatrice vétérinaire en chef dans l'équipe des produits pharmaceutiques et des additifs alimentaires.
0.04600786790251732 ||| Mixtard 40 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use ||| Actraphane 40 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use ||| Mixtard 40 NovoLet 100 UI/ ml suspension injectable Insuline humaine, (ADNr) Voie SC
3.713072059020883e-13 ||| Retacrit should also be used with caution in the presence of epilepsy and chronic liver failure. ||| Retacrit should also be used with caution in the presence of epilepsy and chronic liver failure. ||| Retacrit doit également être utilisé avec prudence en présence d’ épilepsie et d’ insuffisance hépatique
0.506009042263031 ||| - patients with a history of tendon disorder related to fluoroquinolone administration ||| suspected sensitivity to calcitonin prior to their treatment with calcitonin. ||| - les patients ayant des antécédents de troubles tendineux imputables à l’ administration d’ une
0.013431446626782417 ||| Each tablet contains 1.2 mg of sucrose. ||| Each tablet contains 1.6 mg of sucrose. ||| Excipient: chaque comprimé contient 1,2 mg de saccharose
0.2671487629413605 ||| Doribax 500 mg powder for solution for infusion ||| Mycamine 50 mg powder for solution for infusion ||| Doribax 500 mg poudre pour solution pour perfusion
0.3343736529350281 ||| The total body and renal clearance are 157-176 and 3-3.5 ml/ min, respectively. ||| The steady state volume of distribution and total clearance are 10 l and 0.6 l/ h, respectively. ||| La clairance totale et la clairance rénale sont respectivement de 157-176 et 3-3,5 ml/ mn.
0.454331636428833 ||| Percentages of subjects with antibody titres ≥ assay cut-off one month after booster vaccination with Menitorix administered alone or co-administered with DTPa-HBV-IPV* vaccine were as follows: ||| When Menitorix was administered as a 3-dose primary vaccination course, a DTPa- HBV-IPV* vaccine (N=796) or a DTPa-IPV vaccine* (N=375) was administered concomitantly. ||| Un mois après la vaccination de rappel par Menitorix administré seul ou avec le vaccin DTCaP-HepB*, les pourcentages de sujets avec des titres en anticorps ≥ à la limite spécifiée dans l’ étude ont été les suivants:
0.6410000920295715 ||| Rental of communication apparatus and implements ||| Teaching and instructional apparatus ||| Location d'appareils et instruments de communication
0.38404276967048645 ||| What PROCOMVAX is and what it is used for 2. ||| What M-M-RVAXPRO is and what it is used for 2. ||| Qu'est -ce que PROCOMVAX et dans quel cas est -il utilisé?
0.10569492727518082 ||| 47.2% ||| 47.3% ||| 70,0%
0.35666534304618835 ||| Temporary suspension of SUTENT is recommended; following resolution, treatment may be resumed at the discretion of the treating physician. ||| 101 At the discretion of the physician, the patient may self-administer the dose for maintenance dosage regimens administered subcutaneously. ||| Il est recommandé d’ interrompre temporairement la prise de SUTENT; après normalisation de l’ état du patient, le traitement pourra être repris selon l’ avis du médecin.
0.21606671810150146 ||| Elimination Lacosamide is primarily eliminated from the systemic circulation by renal excretion and biotransformation. ||| Elimination of abacavir is via hepatic metabolism with subsequent excretion of metabolites primarily in the urine. ||| 25 Le lacosamide est principalement éliminé de la circulation par excrétion rénale et biotransformation.
0.39637452363967896 ||| Treatment with Tandemact requires regular monitoring of glycaemic control. ||| Therapeutic concentration monitoring for saquinavir is recommended. ||| Des contrôles réguliers de la glycémie sont nécessaires avec traitement par Tandemact.
0.7129701972007751 ||| Medical information ||| International aspects ||| Informations médicales
0.2060965597629547 ||| How to store Viraferon 6. ||| How to store Pandemrix 6. ||| Comment conserver Viraferon 6.
0.25967293977737427 ||| Zarzio is available in packs containing 1, 3, 5 or 10 pre-filled syringes with injection needle and with or without a needle safety guard. ||| NeoRecormon is provided as a solution for injection in 1, 4 or 6 pre-filled syringes with 1, 4 or 6 needles. ||| Zarzio est disponible par boîtes de 1, 3, 5 ou 10 seringues préremplies avec aiguille d’ injection munie ou non d’ un dispositif de sécurité.
0.258145809173584 ||| Do not use Cetrotide ||| Do not use Protaphane ||| N’ utilisez jamais Cetrotide
1.0787391662597656 ||| Ciproxin United Kingdom ||| Tipperary, Ireland ||| Royaume-Uni Raison sociale:
0.08508586883544922 ||| 44.8% ||| 39.8% ||| 39,8%
4.2111491160498615e-13 ||| France 34 avenue Léonard de Vinci F-92400 Courbevoie Tél: + 33-(0)1 80 46 40 40 ||| France 34 avenue Léonard de Vinci F-92400 Courbevoie Tél: + 33-(0)1 80 46 40 40 ||| 96 France 34 avenue Léonard de Vinci F-92400 Courbevoie Tél: + 33-(0)1 80 46 40 40
0.03695136681199074 ||| - if you have hepatitis and have been treated recently with medications that suppress the immune system ||| - if you have hepatitis and have been treated recently with medications that suppress the immune ||| - si vous avez une hépatite et avez été récemment traité par des médicaments qui dépriment le
0.21877899765968323 ||| Pharmacotherapeutic group: nucleoside analogue, ATC Code: ||| Pharmacotherapeutic group; protease inhibitor; ATC Code: ||| Classe pharmaco-thérapeutique: analogue nucléosidique, code ATC:
0.018618039786815643 ||| Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed. ||| Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed ||| Utilisation d’ autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.004047147464007139 ||| 11/ 17 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 11/ 16 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 12/ 18 MENTIONS MINIMALES DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.3646554946899414 ||| The immunogens are incorporated in an adjuvant based on dl-α -tocopherol. ||| plasmid hybrid encompassing an interferon alfa-2b gene from human leukocytes. ||| Les antigènes sont incorporés dans un adjuvant à base de dl-α -tocophérol.
0.2294646054506302 ||| OAT3 mediated transport of sitagliptin was inhibited in vitro by probenecid, although the risk of clinically meaningful interactions is considered to be low. ||| The interaction between Nevirapine and the antithrombotic agent warfarin is complex, with the potential for both increases and decreases in coagulation time when used concomitantly. ||| Le transport de la sitagliptine par l'intermédiaire du système anionique organique OAT3 a été inhibé in vitro par le probénécide, bien que le risque d’ interactions cliniquement significatives soit considéré comme faible.
0.27021560072898865 ||| Plavix 75 mg film-coated tablets clopidogrel ||| EVISTA 60 mg film coated tablets raloxifene hydrochloride ||| Plavix 75 mg comprimés pelliculés clopidogrel
0.40296655893325806 ||| Friezes [non-metallic building elements] ||| Irons [non-electric hand tools] ||| Frises [éléments de construction non métalliques]
0.20205208659172058 ||| 94 PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACKS ONLY INTERMEDIATE CARTON (WITHOUT BLUE BOX) BOX OF 42 [50] PATCHES ||| 41 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAPPER LABEL ON MULTIPACKS (10 x 98 TABLETS) WRAPPED IN FOIL (INCLUDING BLUE BOX) ||| 104 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR EMBALLAGES MULTIPLES UNIQUEMENT EMBALLAGE INTERMÉDIAIRE (SANS « BLUE BOX ») BOÎTE DE 42 [50] PATCHS
0.3658657670021057 ||| The company that makes Prialt is carrying out a study looking at the long term use of the medicine, looking in particular at the possibility of development of tolerance to treatment (when doses of a medicine that were effective become less effective over time). ||| The approved aid does not address any damage caused to the company by the coronavirus outbreak and has not been approved in the context of the recent crisis, but is required to address the longer term difficulties faced by Đuro Đaković, which predate the current situation. ||| La société qui fabrique Prialt réalise actuellement une étude sur l’ utilisation à long terme du médicament, portant en particulier sur la possibilité d’ un développement de la tolérance au traitement (lorsque des doses d’ un médicament qui étaient efficaces deviennent au fur et à mesure moins efficaces).
0.4838158190250397 ||| Junction sleeves for fibre optics ||| Smoke projectiles for torpedo tube artillery ||| Manchons de jonction pour fibres optiques
0.2183796763420105 ||| If you are treated with Neupro and levodopa at the same time, some side effects may get more serious, such as seeing or hearing things that are not real (hallucinations), involuntary movements related to Parkinson’s disease (dyskinesia), and swelling of legs and feet. ||| Taking antibiotics to fight mild bacterial infections, such as rhinosinusitis, sore throats, bronchitis or earaches, is often unnecessary [15-19] since, in most cases, your own immune system is able to deal with such mild infections. ||| Si vous êtes traité à la fois par Neupro et la lévodopa, certains effets indésirables peuvent s’ aggraver, comme le fait de voir ou d’ entendre des choses non réelles (hallucinations), des mouvements involontaires associés à la maladie de parkinson (dyskinésie) et des œ dèmes des jambes et des pieds.
0.3255864381790161 ||| These undesirable effects have also been reported with Intron A alone. ||| The following undesirable effects have been reported in association with Cyanokit use. ||| Ces effets indésirables ont également été rapportés avec IntronA seul.
0.3148598372936249 ||| For more detailed dose recommendations, including those for children, see the Package Leaflet of the anti-HIV medicines Norvir is given in combination with. ||| For more information, see the Package Leaflet provided with the other medicine. • Norvir can also be used as an antiviral medicine. ||| Pour des informations posologiques plus détaillées, notamment les doses recommandées chez l’enfant, se reporter à la notice des autres médicaments anti-VIH avec lesquels Norvir est administré.
0.47358202934265137 ||| Solvent: ||| 29 Solvent: ||| - Solvant:
0.2840506434440613 ||| The main measures of effectiveness were the proportions of patients who had complete and partial remission following treatment. ||| The number of eggs recovered and the ongoing pregnancy rate were the main measures of effectiveness. ||| Les principales mesures d’ efficacité étaient la proportion de patients présentant une rémission partielle ou complète à la suite du traitement.
0.2457200139760971 ||| Dose escalation, when indicated, should be conservative in such patients. ||| Additional injections, when indicated, should be conservative in such patients. ||| Lorsqu’ elle est indiquée, l’ augmentation posologique sera faite avec précaution chez ces patients.
0.002454434521496296 ||| 380 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 230 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 383 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES ETIQUETTE DU FLACON
0.05075506120920181 ||| Neupro 6 mg/24 h ||| Neupro 4 mg/24 h ||| Neupro 6 mg/ 24 h
0.25465214252471924 ||| The therapeutic effect of degarelix should be monitored by clinical parameters and prostate specific antigen (PSA) serum levels. ||| The pharmacodynamic effects of bivalirudin may be assessed using measures of anticoagulation including the ACT. ||| La réponse thérapeutique à dégarélix est évaluée par l’ examen clinique et les dosages sanguins de l’ antigène spécifique de la prostate (PSA).
0.0945805087685585 ||| Laser instruments for medical use ||| Laser installations for medical use ||| Instruments laser à usage médical
0.3079993426799774 ||| In the current circumstances, this temporary cooperation appears indeed justifiable under EU antitrust law, in view of its objective and the safeguards put in place to avoid anticompetitive concerns and as long as it remains within the scope communicated to the Commission. ||| It is clear, given the budgetary constraints on the EU budget and the subsidy, that the EMEA will continue to rely heavily in 1997 and 1998 on the resources placed at its disposal by national competent authorities, in particular those for which no compensation is given. ||| Dans les conditions actuelles, cette coopération temporaire apparaît en effet justifiée au regard des règles de concurrence de l'UE, compte tenu de son objectif et des garanties mises en place pour écarter toute préoccupation en matière de concurrence, et sous réserve que le projet respecte les limites communiquées à la Commission.
0.335119366645813 ||| Studies have not been conducted in patients with impaired hepatic function. ||| Long term animal studies evaluating the carcinogenic potential have not been performed. ||| Aucune étude n'a été effectuée chez les patients présentant une insuffisance hépatique.
0.4795489013195038 ||| - It is particularly important to understand the information in section 3. ||| It is important that the recommendations in section 4.2 be followed closely. ||| - Il est particulièrement important de comprendre les informations de la rubrique 3.
0.4670986533164978 ||| Distribution The distribution volume of folinic acid is not known. ||| Elimination The elimination of strontium is time and dose independent. ||| Distribution Le volume de distribution de l’acide folinique est inconnu.
0.2744765281677246 ||| 2 Remove a needle from the pack, fix it securely on to the syringe and remove the protective cap from the needle. ||| Pull the needle shield off the pen (if you have used one) and place the larger needle cap on a flat surface. ||| 2 Prenez une aiguille dans la boite, fixez-la bien sur la seringue et retirez le capuchon protecteur de l'aiguille.
0.0012967560905963182 ||| 1 ml (one vial) contains 200 micrograms of methoxy polyethylene glycol-epoetin beta*. ||| 1 ml (one vial) contains 400 micrograms of methoxy polyethylene glycol-epoetin beta*. ||| Un ml (un flacon) contient 200 microgrammes de méthoxy polyéthylène glycol-epoetin beta*.
0.0 ||| Sucrose ARICLAIM gastro-resistant capsules contain sucrose. ||| Sucrose ARICLAIM gastro-resistant capsules contain sucrose. ||| 5 ARICLAIM en gélules gastro-résistantes contient du saccharose.
0.7046836614608765 ||| Manufacturer Janssen-Cilag SpA Via C. ||| Bayer Plc Ciproxin Bayer House. ||| Fabricant Janssen-Cilag SpA Via C.
0.26643285155296326 ||| Therefore, in case of any symptom indicating an exacerbation of Myastenia gravis a physician must be consulted. ||| In case of any symptom indicating an exacerbation of myastenia gravis, you should therefore consult your doctor. • liver impairment in the past. ||| Par conséquent, en cas de symptômes indiquant une exacerbation de la myasthénie grave, un médecin doit être consulté.
0.39189955592155457 ||| ProQuad is given by injection to persons from 12 months of age. ||| 2 Quintanrix can be given to children who have received hepatitis B vaccine at birth. ||| ProQuad est injecté aux personnes à partir de 12 mois.
0.26686805486679077 ||| Deferasirox caused formation of micronuclei in vivo in the bone marrow, but not liver, of non-iron-loaded rats at lethal doses. ||| Masitinib treatment should only be used in dogs with non-resectable mast cell tumours and which express the mutated c-kit tyrosine kinase receptor. ||| Le déférasirox, aux doses létales, a entraîné la formation de micronuclei in vivo dans la moelle osseuse mais pas dans le foie des rats non surchargés en fer.
0.01766093634068966 ||| EU/ 2/ 97/ 004/ 030 ||| EU/ 2/ 97/ 004/ 020 ||| EU/ 2/ 97/ 004/ 030 Metacam
0.0714564174413681 ||| The safety of Equilis Prequenza Te was studied in several studies under laboratory and field conditions in a large number of horses, from 2 months of age. ||| The safety of Equilis Te was studied in several studies under laboratory and field conditions in a large number of horses, from 2 months of age. ||| La sécurité d’ Equilis Prequenza Te a été étudiée au cours de plusieurs études dans des conditions de laboratoire et sur le terrain chez un grand nombre de chevaux, âgés de deux mois et plus.
0.2812485098838806 ||| Infants and children up to 12 years of age. ||| complications in adults and children above 12 years of age. ||| Nourrissons et enfants de moins de 12 ans.
0.0 ||| Demographic differences between the adolescents and adults include a lower average body weight and fewer adolescents were smokers. ||| Demographic differences between the adolescents and adults include a lower average body weight and fewer adolescents were smokers. ||| Les différences démographiques entre les adolescents et les adultes concernent un poids corporel moyen inférieur et un nombre moins
0.1806958019733429 ||| No specific interaction studies have been carried out, but alendronate was used in clinical trials concomitantly with a number of other commonly prescribed medicines without any evidence of clinically unfavourable interactions. ||| There have been no formal interaction studies for AVANDAMET, however the concomitant use of the active substances in patients in clinical studies and in widespread clinical use has not resulted in any unexpected interactions. ||| Bien qu’ aucune étude d’ interaction spécifique n’ ait été réalisée, au cours des essais cliniques, l’ alendronate a été administré en même temps qu’ un vaste éventail de médicaments couramment utilisés sans qu’ aucune interaction cliniquement pertinente soit mise en évidence.
4.4188364447562967e-13 ||| In study NR15961, patients concurrently treated with stavudine and interferon therapy with or without ribavirin, the incidence of pancreatitis and/ or lactic acidosis was 3% (12/ 398). ||| In study NR15961, patients concurrently treated with stavudine and interferon therapy with or without ribavirin, the incidence of pancreatitis and/ or lactic acidosis was 3% (12/ 398). ||| Dans l'étude NR15961, l'incidence de pancréatite et/ou d'acidose lactique était de 3% (12/398) chez les patients traités conjointement par stavudine et interféron associé ou non à la ribavirine.
0.12058446556329727 ||| For patients switching from immediate-release nicotinic acid to Pelzont, therapy should be initiated at the 1000 mg/ 20 mg dose and advanced to the 2000 mg/ 40 mg maintenance dose after four weeks. ||| Patients switching from less than 2000 mg of prolonged-release nicotinic acid should initiate therapy at the starting dose of 1000 mg/ 20 mg and advance to the 2000 mg/ 40 mg maintenance dose after four weeks. ||| En cas de traitement antérieur par l’ acide nicotinique à libération immédiate, le traitement par Pelzont, doit être instauré à la posologie de 1000 mg/ 20 mg, qui sera augmentée à la dose d’ entretien de 2000 mg/ 40 mg après quatre semaines.
0.40663808584213257 ||| It is expected that a significant proportion of the EU's humanitarian response as part of this package will go to programmes covered by the Global Humanitarian Response Plan for the coronavirus, but the EU will also make funding available directly to the Red Cross / Red Crescent Movement and to Non-Governmental Organizations. ||| The EU will support the full implementation of the Deep and Comprehensive Free Trade Areas (DCFTAs) with Ukraine, Georgia and Moldova, and also encourage enhanced cooperation with non- DCFTA countries, for example through sectoral trade facilitation arrangements of common interest involving all partners. ||| Il est prévu qu'une partie importante de l'intervention humanitaire de l'UE faisant partie de cet ensemble de mesures bénéficie à des programmes relevant du plan mondial d'intervention humanitaire contre le coronavirus, mais l'UE mettra également des fonds directement à la disposition du mouvement international de la Croix-Rouge et du Croissant-Rouge et d'organisations non gouvernementales.
0.7629706859588623 ||| Hypertension Peripheral ischaemia, hypotension§ ||| Posology Predialysis and dialysis adult patients: ||| Ischémie périphérique, hypotension§ Très rare:
0.4978930652141571 ||| Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs Belgium ||| Hungary Bayer Hungária Kft Alkotás ut.50 1123 Budapest Hungary ||| Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs Belgique
8.072720009827394e-13 ||| This may mean there is an infection. ||| This may mean there is an infection. ||| Cela pourrait signifier la présence d’une infection.
0.2877004146575928 ||| Arranging and conducting of training courses ||| Arranging, conducting and organisation of workshops ||| Préparation et coordination de cours de formation
0.2042180597782135 ||| After injection of immunoglobulin the transitory rise of the various passively transferred antibodies in the patients blood may result in misleading positive results in serological testing. ||| Interference with serological testing After injection of immunoglobulin the transitory rise of the various passively transferred antibodies in the patient's blood may result in misleading positive results in serological testing. ||| Après injection d’ immunoglobuline, l’ augmentation transitoire de la concentration de divers anticorps transférés peut être responsable de résultats faussement positifs lors de dosages sérologiques.
0.5695567727088928 ||| (-0.9, -0.5) -0.6‡ ||| (-5.6%; -0.6%)e ||| (-0,9; -0,5) -0,6‡
0.8786637783050537 ||| Risperdal Consta ||| 28108 Alcobendas ||| Risperdal Consta 37,5 mg
0.4240298569202423 ||| If this becomes severe or persistent or you notice that your stool contains blood or mucus you should stop taking [Invented name] immediately and consult your doctor. ||| If you experience swollen face or tongue or if your skin turns red and starts to blister or peel you should seek immediate medical advice. ||| Si elles deviennent sévères ou persistantes ou si vous remarquez du sang ou des mucosités dans vos selles, vous devez arrêter immédiatement de prendre [Nom de fantaisie] et consulter votre médecin.
0.5667918920516968 ||| Blister Aluminium ||| Blister Strip ||| Plaquette en Aluminium
0.04442623257637024 ||| 5.9 Overdose (symptoms, emergency procedures, antidotes) ||| 4.10 Overdose (symptoms, emergency procedures, antidotes) ||| 5.9 Surdosage (symptômes, procédures d’ urgence, antidotes)
0.2009645402431488 ||| Patients treated with Trizivir receive a card detailing these symptoms so that they are aware of them, and must contact their doctor immediately if they develop a reaction. ||| Patients who receive Soliris must be given a special card that explains the symptoms of certain types of infection, instructing them to seek medical care immediately if they experience them. ||| Les patients traités par Trizivir reçoivent une carte détaillant ces symptômes, afin qu’ ils en soient conscients, et doivent immédiatement contacter leur médecin s’ ils développent une réaction.
0.07204024493694305 ||| Since EMADINE contains benzalkonium chloride, close monitoring is required with frequent or prolonged use. ||| Since AZARGA contains benzalkonium chloride, close monitoring is required with frequent or prolonged use ||| EMADINE contenant du chlorure de benzalkonium, une surveillance étroite est nécessaire lors d’ utilisation fréquente ou prolongée.
0.15283183753490448 ||| The 4 mg tablet also contains purified talc and iron oxide yellow (E172). ||| The tablet also contains iron oxide black (E172) and propylene glycol. ||| Le comprimé à 4 mg contient aussi du talc purifié et de l’ oxyde de fer jaune (E172).
0.3216530680656433 ||| Finally hold the syringe with the needle pointing upwards and gently tap the side to force any air bubbles up to the top; then squeeze the plunger until all the air has been expelled, and only Fertavid solution is left in the syringe (d). ||| The tablet must be used immediately once removed from the blister. • Separate one of the blister units from the blister card by tearing apart at the perforations. • Bend the blister unit along the line where indicated. • Peel the blister backing to expose the tablet. ||| Enfin, tenir la seringue aiguille vers le haut et taper doucement pour forcer les bulles d'air à aller vers le haut; pousser alors le piston de la seringue jusqu'à ce que l'air ait été totalement expulsé et qu'il ne reste que la solution de Fertavid dans la seringue (d).
0.3506028652191162 ||| Take off the outer needle cap and keep it to remove the used needle after injection. ||| Use a new injection needle for each injection and dispose of it after each use. ||| Retirez le capuchon extérieur de l’aiguille et gardez-le afin de retirer l’aiguille usagée après l’injection.
0.2169211059808731 ||| The marketing authorisation holder is Pharmion Ltd. ||| The marketing authorisation holder is Pfizer Limited. ||| Le titulaire de l’ autorisation de mise sur le marché est Pharmion Ltd.
0.2585983872413635 ||| Once in the pump, Insulin Human Winthrop Infusat may be kept for up to 2 weeks. ||| Once in the pump, Insuman Infusat may be kept for up to 2 weeks. ||| Insulin Human Winthrop Infusat peut être conservé jusqu'à 2 semaines dans la pompe.
0.4762006998062134 ||| It works by hindering the growth of these abnormal white blood cells, and eventually kills them. ||| It works best against cells which are multiplying quickly – such as cancer cells. ||| La clofarabine permet de stopper la multiplication de ces globules blancs anormaux et finit par les détruire.
0.4406229853630066 ||| Calcium folinate should only be given by intramuscular or intravenous injection and must not be administered intrathecally. ||| Fuzeon should not be given intravenously (directly into your veins) or intramuscularly (directly into your muscle). ||| Le folinate de calcium doit être administré uniquement par voie intramusculaire ou intraveineuse et ne doit pas être administré par voie intrathécale.
0.0 ||| Chronic renal failure patients ||| Chronic renal failure patients ||| 154 Patients insuffisants rénaux chroniques
0.35853666067123413 ||| Only in case of a flare of severe disease not controlled by , treatment with medium potency topical corticosteroids was initiated. ||| Systemic effects may occur with any inhaled corticosteroid, particularly at high doses prescribed for long periods. ||| Un traitement par un corticostéroïde de puissance moyenne n’a été instauré qu’en cas de poussée sévère de la maladie non contrôlée par {Nom de fantaisie}.
0.6426264047622681 ||| Otologic - Corticosteroids and anti-infectives in combination. ||| 28 Co-administration with other HIV protease inhibitors (PIs): ||| Otologie – Association de corticoïdes et d’ anti-infectieux.
0.15099258720874786 ||| Arranging and conducting of promotional events ||| Arranging and conducting of commercial exhibitions ||| Organisation et conduite d'événements promotionnels
0.19656449556350708 ||| The starting dose was agreed to be 10mg/ day given as 2.5ml of the Prozac liquid formulation. ||| The starting dose is 10mg/ day given as 2.5ml of the (Invented name)® liquid formulation. ||| La dose initiale de 10 mg/ jour, administrée par 2,5 ml de Prozac liquide, a été approuvée.
0.2803996205329895 ||| The following side effects have been observed with STELARA: ||| 71 The following side effects have been reported with Cozaar: ||| Les effets indésirables suivants ont été observés avec STELARA:
0.30053484439849854 ||| Repair of electronic apparatus ||| Repair of electrical equipment ||| Réparation d'appareils électroniques
0.27730464935302734 ||| 18 ||| 18. ||| 20
0.3414918780326843 ||| Through 48 weeks of therapy, the proportion of patients with HIV RNA < 400 copies/ ml was 84% for antiretroviral naïve patients and 75% for antiretroviral experienced patients and the mean increase from baseline in CD4 cell count were 404 cells/ mm3 and 284 cells/ mm3 respectively. ||| For an administered activity of 2 590 MBq, the typical radiation dose to the target organ, skeletal metastases, is 86.5 Gy and the typical radiation doses to the critical organs are: normal bone surfaces 17.5 Gy, red marrow 4.0 Gy, urinary bladder wall 2.5 Gy, kidneys 0.047 Gy and ovaries 0.021 Gy. ||| Au cours des 48 semaines de traitement, la proportion de patients avec une charge virale < 400 copies/ ml était de 84% pour les patients naïfs d’ antirétroviraux et 75% pour les patients prétraités et les augmentations moyennes des taux de CD4 par rapport à la valeur initiale étaient respectivement de 404 cellules/ mm3 et de 284 cellules/ mm3.
0.0390852726995945 ||| NovoRapid InnoLet is a simple, compact pre-filled pen able to deliver 1 to 50 units in increments of 1 unit. ||| Insulatard InnoLet is a simple, compact pre-filled pen able to deliver 1 to 50 units in increments of 1 unit. ||| NovoRapid InnoLet est un stylo prérempli simple et compact, capable de délivrer entre 1 et 50 unités par palier de 1 unité.
0.1799522191286087 ||| HOW TO TAKE FARESTON ||| HOW TO TAKE TARCEVA ||| COMMENT PRENDRE FARESTON?
0.7783991098403931 ||| sachet (paper/ LDPE/ alu/ ET copolymer PE/ Alu/ ET copolymer/ paper) ||| bottle (amber glass) sachet (paper/ polyester/ alu/ poly acrylonitrile) ||| Sachet dose (papier/ LDPE/ aluminium/ copolymère ET PET/ aluminium/ copolymère ET/ papier)
0.12684227526187897 ||| Storage water heaters ||| Solar water heaters ||| Chauffe-eau à accumulation
0.22821834683418274 ||| Clinically significant interaction resulting from an increase in the stomach pH due to the didanosine antacid component is unlikely and no dose separation or adjustment is considered necessary when fosamprenavir and didanosine are administered concomitantly (see chapter, Antacids). ||| Therefore, patients taking these substances concomitantly with ciprofloxacin should be monitored closely for clinical signs of overdose, and determination of serum concentrations (e.g. of theophylline) may be necessary (see section 4.5). ||| Par conséquent, en cas d'administration concomitante de fosamprénavir et de didanosine, il n'apparaît pas nécessaire de procéder, ni à une administration séparée, ni à un ajustement de posologie de ces médicaments (cf. paragraphe: anti-acides).
0.06829558312892914 ||| Dosage • You should normally inject Humalog within 15 minutes of a meal. ||| Dosage • You should normally inject Liprolog within 15 minutes of a meal. ||| Posologie • Vous devez normalement injecter Humalog Pen dans les 15 minutes précédant ou suivant un repas.
0.3022361397743225 ||| Xarelto is taken by mouth as one 10 mg tablet once a day, with or without food. ||| Iscover should be given as a single daily dose of 75 mg (one tablet) with or without food. ||| Xarelto est absorbé par voie orale en comprimés de 10 mg une fois par jour, pendant ou en dehors des repas.
0.2851511836051941 ||| Generalised hypersensitivity reactions are potentially life threatening (anaphylactic reactions). ||| Severe cases of generalised reactions, including anaphylactic reaction, may be life-threatening. ||| Les réactions d’ hypersensibilité généralisée peuvent menacer le pronostic vital (réactions anaphylactiques).
0.267915278673172 ||| The absorption is not affected by food. ||| The bioavailability is not affected by food intake. ||| L’ absorption n’ est pas influencée par la présence
0.07514238357543945 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Adenuric on 21 April 2008. ||| The European Commission granted a marketing authorisation valid throughout the European Union for INTEGRILIN on 1 July 1999. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Adenuric le 21 avril 2008.
0.807756781578064 ||| - Common side effects of Tamiflu ||| No adverse effect of rimonabant du ||| - Effets indésirables fréquents de Tamiflu
0.5502661466598511 ||| Dose reduction for patients experiencing haematological toxicities: ||| Preventing recurrence in bipolar disorder: ||| Réduction de dose chez les patients souffrant de toxicités hématologiques:
0.2592788338661194 ||| After a single intramuscular administration of the product at 15 mg/ kg to cattle, mean amoxicillin plasma peak concentration of 2.93 µg/ ml is reached 1.64 hours after dosing. ||| After a single intravenous bolus administration in healthy subjects the total body clearance of palonosetron was 173 ± 73 ml/ min and renal clearance was 53 ± 29 ml/ min. ||| Après administration intramusculaire unique du produit à une dose de 15 mg/ kg à des bovins, le pic plasmatique moyen de l’ amoxiciline de 2,93 µg/ ml est atteint 1,64 heures après l’ injection.
0.3498400151729584 ||| Packs sizes of 1, 6 or 12. ||| Available in packs of 1, 4 or 12. ||| Boîte de 1, 6 ou 12.
0.4378952383995056 ||| You may notice a small air bubble in the pre-filled syringe. ||| Remove excess gas from the syringe (a small gas bubble may remain). ||| Vous pouvez remarquer une petite bulle d’air dans la seringue
0.5389890670776367 ||| PhD in organic chemistry from the Free University of Berlin. ||| Professor of Pharmacology and Toxicology, Free University of Berlin. ||| Diplôme de chimiste et de pharmacienne de l’ université libre de Berlin.
0.39144158363342285 ||| - Before using the vaccine allow it to reach room temperature. ||| If refrigerated, allow the refrigerated solution to reach room temperature before administration. ||| Avant utilisation, laisser le vaccin atteindre la température ambiante.
0.014136703684926033 ||| One ViraferonPeg pre-filled pen contains a sufficient amount of peginterferon alfa-2b to provide 150 micrograms in 0.5 ml of peginterferon alfa-2b when reconstituted as recommended. ||| One PegIntron pre-filled pen contains a sufficient amount of peginterferon alfa-2b to provide 120 micrograms in 0.5 ml of peginterferon alfa-2b when reconstituted as recommended. ||| Un stylo prérempli ViraferonPeg contient une quantité suffisante de peginterféron alfa-2b pour délivrer 150 microgrammes dans 0,5 ml de peginterféron alfa-2b après reconstitution selon les recommandations.
0.04435623809695244 ||| Onsenal 200 mg hard capsules Celecoxib ||| Onsenal 200 mg capsules Celecoxib ||| Onsenal 200 mg gélules Célécoxib
0.36427241563796997 ||| 196 België/ Belgique/ Belgien Sandoz nv-sa Telecom Gardens Medialaan 40 B-1800 Vilvoorde Tél/ Tel: +32 27229797 ||| Malta Cherubino Ltd Delf Building Sliema Road MT-GZR 06 Gzira Malta Tel: +356-21-343270/ 1/ 2/ 3/ 4 ||| België/ Belgique/ Belgien Sandoz nv-sa Telecom Gardens Medialaan 40 B-1800 Vilvoorde Tél/ Tel: +32 27229797
6.977541374547647e-13 ||| Alcohol may intensify and prolong the hypoglycaemic effect of insulin. ||| Alcohol may intensify and prolong the hypoglycaemic effect of insulin. ||| L’ alcool peut intensifier et prolonger l’ effet hypoglycémiant de l’ insuline.
0.4178001582622528 ||| This helps the body eliminate excess methotrexate, and therefore reduces the potential for toxic effects. ||| It can break down methotrexate into substances that do not have any toxic effects. ||| Cela aide l’ organisme à éliminer l’ excès de méthotrexate et réduit donc le risque de toxicité.
0.0 ||| Mean baseline CD4 cell count was 838 cells/ mm3 and mean baseline plasma HIV-1 RNA was 4.7 log10 copies/ ml. ||| Mean baseline CD4 cell count was 838 cells/ mm3 and mean baseline plasma HIV-1 RNA was 4.7 log10 copies/ ml. ||| La valeur moyenne du taux initial de CD4 était de 838 cellules/ mm3 et la charge virale plasmatique avait une valeur moyenne de 4,7 log10 copies/ ml.
0.3547954261302948 ||| conjunctivitis, dry eye, eye discharge, eye rolling, eye swelling, eyelid margin crusting, eyelid oedema, glaucoma, lacrimation increased, ocular hyperaemia, photophobia, vision blurred, visual acuity reduced ||| Vision blurred, diplopia Visual disturbance, eye swelling, visual field defect, visual acuity reduced, eye pain, asthenopia, dry eye, lacrimation increased ||| conjonctivite, sécheresse oculaire, ecoulement oculaire, révulsion oculaire, gonflement oculaire, lésions croûteuses du bord des paupières, oedème palpébral, glaucome, larmoiement accru, hyperémie oculaire, photophobie, vison trouble, diminution de l’ acuité visuelle
0.346934050321579 ||| In all studies, the effects of CIALIS were compared to those of placebo (a dummy treatment), and the main measure of effectiveness was the ability to get and maintain an erection. ||| The study was looking mainly at the safety of the medicine, but it also measured its effectiveness (looking at its effect on reducing levels of GAGs in the urine and on the size of the liver). ||| Dans toutes ces études, les effets de CIALIS ont été comparés à ceux d’ un placebo (traitement factice), et le critère principal d’ efficacité était la capacité à obtenir et maintenir une érection.
0.19771012663841248 ||| Withdraw the required amount of the temsirolimus 10 mg/ ml mixture and then inject rapidly into sodium chloride 9 mg/ ml (0.9%) solution for injection. ||| The appropriate volume of required dose is removed from the vial and further diluted to 100 ml with sodium chloride 9 mg/ ml (0.9%) solution for injection (see section 6.6.). ||| Prélever la quantité nécessaire de solution de temsirolimus à 10 mg/ ml et l'injecter ensuite rapidement dans une solution injectable de chlorure de sodium à 9 mg/ ml (0,9%).
0.0 ||| Haemophiliac patients should therefore be made aware of the possibility of increased bleeding. ||| Haemophiliac patients should therefore be made aware of the possibility of increased bleeding. ||| Les patients hémophiles devront donc être informés de la possibilité d’ augmentation des saignements.
0.25934770703315735 ||| Weighing scales for medical use ||| Electronic weighing scales for personal use ||| Balances à usage médical
0.40681588649749756 ||| In isolated cases, neutralising anti-erythropoietin antibody mediated pure red cell aplasia (PRCA) associated with Nespo therapy have been reported predominantly in ||| Imiquimod cream was evaluated in a photocarcinogenicity bioassay in albino hairless mice exposed to simulated solar ultraviolet radiation (UVR). ||| Des cas isolés d’ érythroblastopénie dus à des anticorps neutralisants dirigés contre l’ érythropoïétine, ont été rapportés principalement chez les patients traités par voie sous- e
0.23631003499031067 ||| No adjustments to the recommended dose escalation guidelines for lamotrigine should be necessary solely based on the use of hormonal contraceptives, but the maintenance dose of lamotrigine will need to be increased or decreased in most cases when starting or stopping hormonal contraceptives (see section 4.2). ||| In patients who are already taking digoxin when ritonavir is introduced, the digoxin dose should be reduced to one-half of the patients’ normal dose and patient need to be followed more closely than usual for several weeks after initiating co-administration of ritonavir and digoxin. ||| Aucun ajustement selon les lignes directrices sur l’ escalade de dose recommandée de la lamotrigine ne devrait être nécessaire pour la seule raison de l’ utilisation de contraceptifs hormonaux, mais la dose d’ entretien de la lamotrigine devra être augmentée ou diminuée dans la plupart des cas lors de l’ instauration ou de l’ arrêt de contraceptifs hormonaux (voir rubrique 4.2).
0.8097864389419556 ||| Not all pack sizes may be available in your country. ||| The needs are obviously bigger than the budget you have. ||| Toutes les tailles de boîtes peuvent ne pas être disponibles dans votre pays.
0.20970948040485382 ||| Gas grills ||| Electric grills ||| Grils à gaz
0.326704740524292 ||| The recommended dose of Vectibix is 6 mg/ kg of bodyweight given once every two weeks. ||| A total amount of 0.3 millilitre Gadovist per kg body weight may be administered at maximum. ||| La dose recommandée de Vectibix est de 6 mg/ kg de poids corporel administrée une fois toutes les deux semaines.
0.37334737181663513 ||| Therefore no adjustment of the dose is necessary for elderly patients. ||| No dosage adjustment is necessary for any of these medicinal products. ||| Par conséquent, aucun ajustement posologique n’ est nécessaire chez les patients âgés.
0.8013343811035156 ||| Drawing instruction ||| Protective tab ||| Enseignement du dessin
0.3522719144821167 ||| As in adults, there is no evidence of clinically significant medicinal product interactions in paediatric patients receiving up to 60 mg/ kg/ day levetiracetam. ||| The re was no evidence of carcinogenic activity after the administration of saquinavir mesilate for 96 to 104 weeks to rats and mice. ||| Comme chez l’ adulte, il n’ a pas été mis en évidence d’ interaction médicamenteuse cliniquement significative chez des enfants recevant jusqu’ à 60 mg/ kg/ jour de lévétiracétam.
0.2607059180736542 ||| Compressors for refrigerators ||| Engines for compressors ||| Compresseurs pour réfrigérateurs
0.5172237157821655 ||| Magnetically encoded credit cards ||| Identity cards, encoded ||| Cartes de crédit encodées magnétiquement
2.6089720661648386e-13 ||| In practice , therapy has been initiated 12 - 24 hours after discontinuation of ciclosporin. ||| In practice , therapy has been initiated 12 - 24 hours after discontinuation of ciclosporin. ||| En pratique, le traitement par doit être instauré 12-24 heures après l’ arrêt de la ciclosporine.
0.3098677396774292 ||| You should tell your doctor if you are taking other calcium lowering drugs, such as bisphosphonates, as the combination of these drugs with FORCALTONIN might cause the amount of calcium in your blood to become too low. lp ||| If you are taking oral vitamin A related medicines, e. g. isotretinoin, you should inform your doctor since these may also increase the amount of abacavir in your blood. ||| Si vous utilisez d’ autres médicaments de réduction du taux de calcium, tels que les biphosphonates, mentionnez -le à votre médecin, car la combinaison de ces produits avec le FORCALTONIN peut causer une réduction excessive du taux de calcium sanguin. mé
0.5679539442062378 ||| There is no change in half-life during treatment. ||| There was no change to Tmax or half-life. ||| Celle -ci n’ est pas modifiée au cours du traitement.
0.005679505877196789 ||| 20 A MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| 30 A MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| TITULAIRE(S) DE L’ AUTORISATION DE FABRICATION RESPONSABLE(S) DE LA LIBERATION DES LOTS
0.47167035937309265 ||| Patients with a creatinine clearance of ≤ 30 ml/ min were not investigated in the clinical trials. ||| Platelets In clinical trials few patients had platelet counts below the lower limit of the normal laboratory range. ||| Les essais cliniques menés n’ ont pas inclus de patient présentant une clairance de la créatinine ≤ 30 ml/ min
0.4403969645500183 ||| Saudi Arabia confirmed the first case on 2 March, a Saudi national returning from Iran via Bahrain. ||| On 27 February, Israel barred entry to foreign nationals travelling from Italy. ||| L'Arabie saoudite a confirmé le premier cas le 2 mars, un ressortissant saoudien revenant d'Iran via Bahreïn.
0.31340986490249634 ||| Efficacy of fluoxetine in children and adolescents in the treatment of moderate to severe major depressive episodes has been demonstrated in three short-term (8-12 weeks duration) placebo- controlled studies. ||| Post-traumatic Stress Disorder The efficacy of paroxetine in the treatment of PTSD in adults was investigated in some short-term and long-term studies. ||| L’ efficacité de la fluoxétine pour le traitement des épisodes dépressifs majeurs modérés à sévères chez les enfants et les adolescents a été démontrée dans trois essais comparatifs avec placebo sur une courte période (durée comprise entre 8 et 12 semaines).
0.2145853340625763 ||| TRITAZIDE should be started at the lowest available dosage. ||| TRITAZIDE and associated names should be started at the lowest available dosage. ||| TRITAZIDE sera débuté à la posologie la plus faible disponible.
0.6282365322113037 ||| Latvija Merck Serono Pā rstā vniecī ba C/ o Ares Trading SA Baltic States Zamenhofo 11-3, LT-44287 Kauņ a, Lietuva Tel: +370 37320603 ||| Novartis s. r. o Praha Nagano III U Nā kladového Nā draž í 10 130 00 Praha 3 Czech Republic ||| 216 Latvija Merck Serono Pā rstā vniecī ba C/ o Ares Trading SA Baltic States Zamenhofo 11-3, LT-44287 Kauņ a, Lietuva Tel: +370 37320603
0.13351759314537048 ||| Why has INVANZ been approved? ||| Why has TOVIAZ been approved? ||| Pourquoi INVANZ a -t-il été approuvé?
0.24556928873062134 ||| Careful monitoring of digoxin levels is recommended when digoxin is concomitantly administered with indinavir/ ritonavir. ||| Nevertheless, monitoring of serum digoxin level should be considered during concomitant administration of digoxin and Levviax. ||| En cas d'administration concomitante avec de l'indinavir/ ritonavir, une surveillance attentive des concentrations de digoxine est recommandée.
0.6394740343093872 ||| People would be more likely to be active if places for recreation were within walking distance. ||| Additionally, tourists from outside were still permitted to leave the area. ||| Les gens sont plus susceptibles d'utiliser les lieux de loisirs si ceux-ci sont accessibles à pied.
0.255671888589859 ||| Bioglan AB, Borrgatan 31, SE-211 24 Malmö, Sweden ||| Manufacturer Bioglan AB Borrgatan 31 SE-211 24 Malmö Sweden ||| • Bioglan AB, Borrgatan 31, SE-211 24 Malmö, Suède
0.021716788411140442 ||| If pain persists for more than 12 hours after medical examination, seek medical advice again. ||| If pain persists for more than 12 hours after examination, seek medical advice again. ||| Si la douleur persiste au-delà de 12 heures à compter de l’ examen médical, consultez à nouveau un médecin.
0.26290959119796753 ||| The steady state AUC of bosentan was 9% higher and the AUC of the active metabolite, Ro 48-5033, was 33% higher in patients with mild hepatic impairment than in healthy volunteers. ||| The mean exposure (AUC) of the active metabolite of prasugrel is approximately 30 to 40% higher in healthy subjects and patients with a body weight of < 60 kg compared to those weighing ≥ 60 kg. ||| Les SSC à l’ état d’ équilibre de bosentan et du métabolite actif Ro 48-5033 étaient augmentées de 9% et de 33% respectivement, chez les patients atteints d’ insuffisance hépatique légère par rapport à celles des volontaires sains.
0.42167550325393677 ||| The objections raised by France and Sweden should not prevent the granting of a marketing authorisation for Compagel gel for horses. ||| Therefore, the CHMP recommended the withdrawal of all Marketing Authorisations for medicinal products containing veralipride throughout Europe. ||| Les objections soulevées par la France et la Suède ne doivent pas entraver l’ octroi d’ une autorisation de mise sur le marché pour Compagel gel pour cheval.
0.5837879180908203 ||| ZAGAM (sparfloxacin) 200 mg ||| Azagly-nafarelin 18.5 mg ||| ZAGAM (sparfloxacine) 200 mg
0.3946892023086548 ||| Food does not affect the bioavailability of dabigatran etexilate but delays the time to peak plasma concentrations by 2 hours. ||| Food intake has no effect on the extent of absorption but may delay the peak concentrations by 1.5 - 2 hours. ||| La présence d’ aliments n’ affecte pas la biodisponibilité du dabigatran etexilate mais retarde de 2 heures le temps nécessaire pour atteindre les concentrations plasmatiques au pic.
0.015749812126159668 ||| 192 6.6 Special precautions for disposal ||| 228 6.6 Special precautions for disposal ||| Précautions particulières d’ élimination
0.4183429479598999 ||| Double glazing panels (Non-metallic -) ||| Mint flavoured sweets (Non-medicated -) ||| Panneaux de double vitrage non métalliques
0.38059884309768677 ||| Parareg is used in adults and elderly patients: • to treat secondary hyperparathyroidism. ||| - Oropharyngeal candidiasis: as first-line therapy in patients who have severe disease or are ||| Parareg est utilisé chez les patients adultes et les personnes âgées: • dans le traitement de l’ hyperparathyroïdie secondaire.
0.3928146958351135 ||| Cefuroxime axetil kills bacteria and it can be used against various sorts of infections. ||| Like other antibiotics, ceftiofur is only effective against certain types of bacteria. ||| CEFUROXIME AXETIL agit en tuant les bactéries et peut être utilisé dans différents types d’ infections.
0.4098626673221588 ||| Reinforced fabrics [textile] ||| Plastic material [substitute for fabrics] ||| Tissus renforcés [textiles]
0.2751484513282776 ||| If you have responded to treatment and are further treated with Ma bThera as continuous (maintenance) treatment, you will receive one infusion of MabThera every 3 months for two years. ||| If you can get pregnant, you must use an effective method of birth control during therapy with MabThera and for 12 months after the last time you were treated with MabThera. ||| Si vous avez répondu au traitement et continuez à être traité par MabThera en traitement prolongé (d’entretien), vous recevrez une perfusion de MabThera tous les 3 mois pendant 2 ans.
0.17411822080612183 ||| Attach the needle ||| Attaching the needle ||| Fixez l' aiguille
0.5057761669158936 ||| Knitted elastic fabrics for gymnastic dresses ||| Knitted fabrics of silk yarn ||| Tissus élastiques tricotés pour tenues de gymnastique
0.2895459830760956 ||| 10 Metformin ||| 26 Metformin ||| Metformine
0.06506392359733582 ||| Always take Efexor exactly as your doctor has told you. ||| Always take Emselex exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.21967916190624237 ||| 13 August 2004 ||| 13 August 1999. ||| 13 août 2004
0.49728643894195557 ||| However, the report shows that citizens do not always have sufficient tools to participate actively in the debate. ||| It was stressed that the measures taken were not a lockdown because people are not required to stay home. ||| Le rapport indique toutefois que les citoyens ne disposent pas toujours d'outils suffisants pour participer activement au débat.
0.8615163564682007 ||| ed 8200 AB Lelystad The Netherlands ||| Berkshire SL6 0PH UK ||| Box 65 8200 AB Lelystad Pays -Bas
0.2864821255207062 ||| Also, tell your doctor immediately if you experience any of the following side effects – you may need medical attention: ||| → Tell your doctor immediately if you get any symptoms of these conditions, as hospitalisation may be necessary. ||| En outre, prévenez votre médecin immédiatement si vous ressentez l’ un des effets indésirables suivants - une prise en charge pourra être nécessaire:
0.1479228287935257 ||| Parents and patients should be informed that such reactions are possible and that if an allergic reaction occurs, treatment should be interrupted and prompt medical attention should be sought. ||| To inform parents and patients that allergic reactions are possible and that if this occurs treatment should be interrupted and prompt medical attention should be sought. ||| Les patients et leurs parents doivent être informés de la possibilité de telles réactions et de la nécessité, en cas de réactions allergiques, d’ interrompre le traitement et de consulter rapidement un médecin.
0.5639065504074097 ||| The first of these are transient and their cause should be investigated if symptoms persist. ||| VOD observed were neither fatal nor severe and resolved in all cases. ||| Les premiers de ces symptômes sont transitoires et il faut en rechercher la cause s’ ils persistent.
0.10298003256320953 ||| 25 single doses 0.5 ml pre-filled syringes with attached needle. ||| 20 single doses, 0.5 ml pre-filled syringes without needles. ||| 25 seringues préremplies unidoses de 0,5 ml avec aiguille sertie.
0.6872313022613525 ||| 150 IU (11 µg)/ vial ||| < 400 copies/ mL vRNA ||| 150 UI (11 µg)/ flacon
0.6751591563224792 ||| Trouser stretchers ||| Oyster openers ||| Tendeurs de pantalons
0.027851242572069168 ||| While this is not documented with Irbesartan BMS, a similar effect should be anticipated with angiotensin-II receptor antagonists. ||| While this is not documented with Irbesartan Winthrop, a similar effect should be anticipated with angiotensin-II receptor antagonists. ||| Bien que cela n’ aie pas été documenté avec Irbesartan BMS, un phénomène similaire est à prévoir avec les antagonistes des récepteurs de l'angiotensine-II.
0.13934798538684845 ||| Apparatus for analysing images [for medical use] ||| Apparatus for analysing substances [for medical use] ||| Appareils pour l'analyse d'images à usage médical
0.3583506941795349 ||| Caution should be exercised in patients with moderate renal impairment. ||| If appropriate, resumption of hepatitis B therapy may be warranted. ||| La prudence s’ impose chez les patients avec une insuffisance rénale modérée.
0.1815059930086136 ||| PROTOPIC 0.1% OINTMENT (30 g, 60 g TUBE) ||| PROTOPY 0.1% OINTMENT (10 g, 30 g, 60 g CARTON) ||| PROTOPIC 0,1% POMMADE (TUBE DE 30 g, 60 g)
0.04971834644675255 ||| 4.125 mg/ 7.5 cm² which release 25 µg fentanyl per hour ||| 8.25 mg/ 15 cm² which release 50 µg fentanyl per hour ||| libérant 25 µg de fentanyl par heure 8,25 mg/ 15 cm2
0.04297337681055069 ||| Psoriatic arthritis and ankylosing spondylitis ||| Psoriatic arthritis and ankylosing spondylitis no ||| Rhumatisme psoriasique et spondylarthrite ankylosante
0.07297784090042114 ||| 3 vials 3 sterile silicone-free syringes ||| 2 vials 2 sterile silicone-free syringes ||| 3 flacons 3 seringues stériles sans silicone
0.18076109886169434 ||| 114 4.7 Effects on ability to drive and use machines ||| 4.7 Effects on ability to drive and use machines a in ||| 4.7 Effets sur l’ aptitude à conduire des véhicules et à utiliser des machines
0.20610970258712769 ||| Human albumin Sodium chloride N-acetyltryptophan Caprylic acid Sodium hydroxide (pH adjustment) Water for injections ||| Trometamol Sodium chloride Hypromellose Hydrochloric acid/ sodium hydroxide (to adjust pH) Purified water ||| Albumine humaine Chlorure de sodium N-acétyltryptophane Acide caprylique Hydroxyde de sodium (pour ajuster le pH) Eau pour préparations injectables
0.39797836542129517 ||| Blood and lymphatic system disorders: ||| Dental and periodontal disorders: ||| Troubles du système sanguin et lymphatique:
0.8613810539245605 ||| "Arie: A similar creature named arie (アリエ) appeared in ""Aotori-kōri"" county, Higo Province, according to the Kōfu Nichinichi Shimbun newspaper dated 17 June 1876, although this report has been debunked by another paper." ||| The Ministry of Health and Public Hygiene published a list of sites, in and around Abidjan, for testing: Yopougon, Abobo, Marcory, Koumassi and Port-Bouët; treatment: Treichville, Cocody, Grand-Bassam, Yopougon, Abidjan, and Anyama; quarantine (Marcory); and for analysis (Pasteur Institute Abidjan). ||| "Arié : Une créature similaire nommée arie (アリエ) est apparue dans le comté ""Aotori-kōri"", de la province de Higo, selon le journal Kōfu Nichinichi Shimbun, daté du 17 juin 1876, bien que ce rapport ait été réfuté par un autre journal."
0.49466121196746826 ||| 7, 10, 14, 15, 20, 28, 30, 50, 56, 84, 90, 98, or 280 tablets. ||| BOX OF 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 90, 100 TABLETS ||| 7, 10, 14, 15, 20, 28, 30, 50, 56, 84, 90, 98 ou 280 comprimés.
0.3298051953315735 ||| Special precautions to be taken by the person administering the veterinary medicinal product to animals Avoid handling the product if hypersensitivity to tetracyclines exists. ||| Additional precautions Patients should be instructed never to give this medicinal product to another person and to return any unused capsules to their pharmacist at the end of treatment. ||| Précautions particulières à prendre par la personne qui administre le médicament vétérinaire aux animaux Éviter la manipulation du produit en cas d’ hypersensibilité aux tétracyclines.
0.1311711072921753 ||| One capsule contains 75 mg of bexarotene. ||| Each capsule contains 400 mg of celecoxib. ||| Une capsule contient 75 mg de bexarotène.
0.52235347032547 ||| The dose may be reduced after the condition of the patient has improved. ||| this group and the dose of your medicine may need to be increased more slowly. ||| La posologie pourra être réduite après amélioration de l’ état du patient.
0.022502213716506958 ||| Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. ||| Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose- isomaltase insufficiency should not take this medicine. ||| Les patients présentant des problèmes héréditaires rares d'intolérance au fructose, de malabsorption du glucose-galactose ou une insuffisance en sucrase-isomaltase ne doivent pas prendre ce médicament.
0.23884473741054535 ||| 5/ 28 1. ||| 5/ 48 8. ||| 6/ 32 1.
0.4615349769592285 ||| Slovenská republika Abbott Laboratories Slovakia s. r. o. ||| Slovenská republika sanofi-aventis Pharma Slovakia s.r.o. ||| Slovenská republika Abbott Laboratories Slovakia s.r.o.
0.4155471920967102 ||| In the context of the Coronavirus pandemic and in line with the revised implementation timeline agreed by the Basel Committee, the date of application is proposed to be deferred by one year to 1 January 2023. ||| In parallel, the Commission has recently proposed to prolong the SGEI de minimis Regulation ,which is not part of the "fitness check" exercise but which will also otherwise expire on 31 December 2020,by three years. ||| Dans le contexte de la pandémie de COVID-19 et conformément au calendrier de mise en œuvre révisé adopté par le Comité de Bâle, il est proposé de reporter cette date d'application d'un an, au 1er janvier 2023.
0.02559671178460121 ||| 243 Intercurrent illness ||| 245 Intercurrent illness ||| Maladies intercurrentes
0.2824668884277344 ||| Having assessed the data available, the CHMP agreed that valsartan 80 mg can be used as a starting dose in patients with reduced kidney function. ||| The CHMP concluded that the data submitted showed only limited effect of veralipride in the treatment of vasomotor symptoms associated with the menopause. ||| 2 données disponibles, le CHMP a accepté que le valsartan 80 mg puisse être utilisé comme dose de départ chez les patients dont la fonction rénale est réduite.
0.1446157991886139 ||| Austria notified to the Commission under the Temporary Framework guarantee schemes to support SMEs affected by the coronavirus outbreak. ||| Estonia notified to the Commission two support schemes to support companies affected by the coronavirus outbreak under the Temporary Framework: ||| L'Autriche a notifié à la Commission, au titre de l' encadrement temporaire , des régimes de garantie visant à soutenir les PME touchées par la pandémie de coronavirus.
0.17456257343292236 ||| How does Micardis work? ||| How does Mycamine work? ||| Comment Micardis agit -il?
0.09844894707202911 ||| Yondelis should not be used in people who may be hypersensitive to trabectedin or any of the other ingredients. ||| Opgenra should not be used in people who may be hypersensitive to eptotermin alfa or any of the other ingredients. ||| Yondelis ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité à la trabectédine ou à l’ un des autres ingrédients.
0.45091012120246887 ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Clomicalm to Novartis Tiergesundheit GmbH, Germany on 1 April 1998, which was renewed in 2003 and 2008. ||| In March 2006 Intervet then submitted an application for a marketing authorisation for this vaccine following a repeat use mutual recognition procedure, with Germany acting as Reference Member State, for Denmark, Poland, Slovakia and Slovenia. ||| La Commission européenne a délivré une autorisation de mise sur le marché valable dans toute l’ Union européenne pour Clomicalm à Novartis Tiergesundheit GmbH, Allemagne, le 1er avril 1998; celle -ci a été renouvelée en 2003 et 2008.
0.5737094879150391 ||| Electric torches ||| Electric diodes ||| Torches électriques
0.19076602160930634 ||| 1 ml of reconstituted solution contains 90 mg enfuvirtide. ||| This reconstituted solution contains 0.05 mg/ ml of trabectedin. ||| 1 ml de la solution reconstituée contient 90 mg d’ enfuvirtide.
0.27106672525405884 ||| Aripiprazole was excreted in the milk of treated rats during lactation. ||| Nateglinide is excreted in the milk following a peroral dose to lactating rats. ||| Chez la rate traitée en cours de lactation, l’ aripiprazole est excrété dans le lait.
0.41175761818885803 ||| If a capsule is damaged, avoid contact with your skin, eyes or nose. ||| You should not inject your medicine into moles, scar tissue, bruises or your navel. ||| Si une gélule est détériorée, éviter tout contact avec la peau, les yeux ou le nez.
0.5815374851226807 ||| IVEMEND is given as part of a combination therapy (see section 4.2). ||| The caseload of SOLVIT , an informal problem-solving tool, increased by 4% overall. ||| IVEMEND est administré en association à un protocole thérapeutique (voir rubrique 4.2).
0.4133208990097046 ||| There were no significant differences in types of anomalies or proportion of pregnancies with an adverse outcome in Silgard and placebo treated subjects. ||| 4 There were no differences in the nature of adverse events between treatment groups regardless of whether patients were aged below or above 80 at inclusion. ||| Il n'y a pas eu de différence significative entre les sujets ayant reçu Silgard et les sujets ayant reçu le placebo, sur les types d'anomalies ou la proportion de grossesses avec une issue défavorable.
0.0 ||| Gastrointestinal disorders ||| Gastrointestinal disorders ||| Désordres gastro-intestinaux
0.0 ||| Mild hypoglycaemic episodes will respond to oral administration of glucose or other sugar or saccharated products. ||| Mild hypoglycaemic episodes will respond to oral administration of glucose or other sugar or saccharated products. ||| 103 Les épisodes d'hypoglycémie légère seront compensés par l'administration orale de glucose ou d'autres sucres ou d'autres produits sucrés.
0.1535729467868805 ||| 1A, Corp clă dire C1, Etaj 3, Sector 1, Bucureş ti Romania ||| 1A, Clă direa C1, Etaj 3 Sector 1, Bucureş ti Romania ||| Bucureş ti-Ploieş ti, nr.1A, Corp clă dire C1, Etaj 3, Sector 1, Bucarest Roumanie
0.32136040925979614 ||| As for any vaccine, adequate treatment provisions, including adrenaline, should be available for immediate use should an anaphylactic or anaphylactoid reaction occur. ||| Caution is warranted and therapeutic drug monitoring of digoxin concentrations, if available, is recommended in case of co-administration of Kaletra and digoxin. ||| Comme pour tout vaccin, un traitement médical approprié comprenant de l’ adrénaline devra être disponible immédiatement, si des réactions anaphylactiques ou anaphylactoïdes survenaient.
0.015417391434311867 ||| 19 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 11 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 20 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.3415684700012207 ||| Repair of elevators ||| Repair of machines ||| Réparation d'ascenseurs
0.3646932542324066 ||| 1 cartridge contains 3 ml equivalent to 300 U. ||| Each container includes 3ml equivalent to 300U insulin lispro. ||| 1 cartouche contient 3 ml soit 300 U.
0.4958302974700928 ||| If you see any bubbles, pull the plunger slightly back; tap the syringe gently, with the needle pointing upwards, until the bubbles disappear. ||| You’ ll feel the cap clicking, and the push-button will rise up • Don’ t put your hand over the push-button when you set the dose. ||| Si vous voyez des bulles, repoussez légèrement le piston; tapotez doucement la seringue, avec l’ aiguille pointée vers le haut, jusqu’ à ce que les bulles disparaissent.
0.5381825566291809 ||| The treatment difference (Advagraf-Prograf) was 3.8% (95% confidence interval [-2.1%, 9.6%]). ||| (62/ 1021) with dalteparin: odds ratio reduction [95%CI] = -25.8% [-49.7%, 9.5%]. ||| La différence entre les traitements (Advagraf – Prograf) était de 3,8% (intervalle de confiance à 95% [- 2,1%, 9,6%]).
0.10485349595546722 ||| Talk to your doctor if you have any questions about how Vidaza works or why this medicine has been prescribed for you. ||| If you have any questions about how SPRYCEL works or why this medicine has been prescribed for you, ask your doctor. ||| Si vous avez des questions sur la façon dont Vidaza agit ou la raison pour laquelle il vous a été prescrit, adressez-vous à votre médecin.
0.03837411850690842 ||| 20 Κύπρος sanofi-aventis Cyprus Ltd. ||| 143 Κύπρος sanofi-aventis Cyprus Ltd. ||| Κύπρος sanofi-aventis Cyprus Ltd.
0.3618853688240051 ||| The capsules should be swallowed whole together with water. ||| The tablets should be swallowed together with some water or other suitable liquid. ||| Les gélules doivent être avalées entières avec de l’eau.
0.09132163226604462 ||| Mycamine should not be used during pregnancy unless clearly necessary. ||| Fabrazyme should not be used during pregnancy unless clearly necessary. ||| Mycamine ne doit pas être utilisé pendant la grossesse à moins d’ une nécessité absolue.
0.3718591332435608 ||| Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines obtained without a prescription. ||| 32 At the end of your treatment you should return all unused capsules to the pharmacist or doctor. ||| Utilisation d’autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez-en à votre médecin ou à votre pharmacien.
0.004413210786879063 ||| 71 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS (40 mg hard gastro- resistant capsules) ||| 73 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS (20 mg hard gastro- resistant capsules) ||| 73 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES (40 mg, gélules gastro-résistantes)
0.19180342555046082 ||| Haematemesis, haematochezia, gastritis, gastrooesophageal reflux disease, abdominal pain, change of bowel habit, abnormal faeces, eructation, aphthous stomatitis, gingival pain, tongue coated ||| Very rare*: bowel obstruction, bowel perforation, pseudomembranous colitis, ischemic colitis, mesenteric thrombosis, necrotising enterocolitis, oesophagitis, ascites, acute pancreatitis ||| Hématémèse, émission de selles sanglantes, gastrite, reflux gastro- œ sophagien, douleur abdominale, modification du transit intestinal, fèces anormales, éructation, stomatite aphteuse, douleur gingivale, langue chargée
0.18980978429317474 ||| Each tablet contains 125 mg, 250 mg or 500 mg of deferasirox. ||| Each capsule, hard contains either 100 mg, 300 mg or 400 mg gabapentin. ||| Chaque comprimé contient 125 mg, 250 mg ou 500 mg de déférasirox.
0.2763862609863281 ||| The recommended starting dose is 0.6 microgram/ kg body weight, administered once every two weeks as a single intravenous or subcutaneous injection in order to increase haemoglobin levels to greater than 10 g/ dl (6.21 mmol/ l). ||| When cetuximab was administered at an initial dose of 400 mg/ m² body surface area, the mean volume of distribution was approximately equivalent to the vascular space (2.9 l/ m² with a range of 1.5 to 6.2 l/ m²). ||| La dose initiale recommandée est de 0,6 microgramme par kg de poids corporel, administrée en une injection intraveineuse ou sous-cutanée toutes les deux semaines afin d’ amener le taux d’ hémoglobine au-dessus de 10 g/ dl (6,21 mmol/ l).
0.06902769207954407 ||| What Tevagrastim looks like and contents of the pack Tevagrastim is a solution for injection or infusion in a pre-filled syringe. ||| What Ratiograstim looks like and contents of the pack Ratiograstim is a solution for injection or infusion in a pre-filled syringe. ||| Qu’ est -ce que Tevagrastim et contenu de l’ emballage extérieur Tevagrastim est une solution injectable ou pour perfusion en seringue préremplie.
0.672420859336853 ||| 4.44 (0.31) ||| (3.45-4.47) ||| 4,44 (0,31)
0.7028372883796692 ||| Tremor, balance disorder ||| proteinuria, renal pain ||| sinusite, dyspnée
0.5500450134277344 ||| If Zestril is given with a potassium-losing diuretic, diuretic -induced hypokalaemia may be ameliorated. ||| Potassium sparing diuretics or potassium supplements ACE inhibitors attenuate diuretic induced potassium loss. ||| Si Zestril est associé à un diurétique hypokaliémiant, l'hypokaliémie provoquée par le diurétique peut être améliorée.
0.23299601674079895 ||| Caution should be used in treating patients with ischaemic heart disease, angina and/ or in patients receiving an antihypertensive medicinal product. ||| Medically appropriate supervision should be maintained when using lumiracoxib in the elderly and in patients with mild renal, hepatic, or cardiac dysfunction. ||| La prudence s’ impose durant le traitement chez des patients présentant une cardiopathie ischémique ou un angor, et/ ou chez ceux qui reçoivent un médicament antihypertenseur.
0.08089134097099304 ||| What Janumet is and what it is used for 2. ||| What Rapamune is and what it is used for 2. ||| Qu'est -ce que Janumet et dans quel cas est -il utilisé 2.
0.27839985489845276 ||| Haemodialysis and peritoneal dialysis appear to have a limited effect on elimination of zidovudine, but enhance the elimination of the glucuronide metabolite. ||| Forced diuresis, alkalinization of urine, haemodialysis, or haemoperfusion may not be useful due to high protein binding. ||| L’ hémodialyse et la dialyse péritonéale semblent n’ avoir qu’ un effet limité sur l’ élimination de la zidovudine, mais facilite l’ élimination du métabolite glucuroconjugué.
0.27338147163391113 ||| A number of cases of death due to respiratory depression have been reported, particularly when buprenorphine was used in combination with benzodiazepines (see section 4.5), or when buprenorphine was not used according to prescribing information. ||| Since these patients had not previously been exposed to either Kaletra or efavirenz, part of the response may be attributed to the antiviral activity of efavirenz, particularly in patients harbouring highly lopinavir resistant virus. ||| Des cas de décès par dépression respiratoire ont été observés, particulièrement lorsque la buprénorphine a été utilisée en association avec des benzodiazépines (voir rubrique 4.5), ou lorsque la buprénorphine n’ a pas été utilisée conformément aux conditions de prescription.
0.3682282567024231 ||| Volibris is supplied as 5 mg and 10 mg film-coated tablets in blister packs of 10 or 30 tablets. ||| Cervarix is available in vials for 1 dose (0.5 ml) in packs of 1, 10 and 100. ||| Volibris est présenté en comprimés pelliculés dosés à 5 mg et 10 mg, par boîtes de 10 ou 30 comprimés.
0.47617822885513306 |||  The needle has been placed in a plastic container to keep it sterile.  To open the plastic container, hold the short, wide end in one hand. ||| Look in the window of the pen and make sure there is a white, to off-white tablet that is whole, or in pieces, or powdered. ||| • L’aiguille a été mise dans un emballage plastique pour la conserver stérile. • Pour ouvrir l’étui en plastique, tenez d’une main l’extrémité courte et large.
4.694982467037812e-13 ||| Clear colourless solution. ||| Clear colourless solution. ||| Solution incolore limpide.
0.2915474772453308 ||| France requested CVMP to consider the therapeutic scheme of these veterinary medicinal products and to indicate if the administration of the product once daily is considered appropriate in terms of efficacy and potential selection of antimicrobial resistant bacteria. ||| Critical steps of the manufacturing process have been investigated by the marketing authorisation holder (MAH), and a modified process step was identified as the most likely strategy to enhance immunogenicity of the HepB component. ||| La France a demandé au comité des médicaments vétérinaires (CVMP) d’ examiner le régime thérapeutique de ces médicaments à usage vétérinaire et d’ indiquer si l’ administration du produit une fois par jour est considérée comme appropriée en termes d’ efficacité et de sélection potentielle de bactéries résistantes aux anti-microbiens.
0.18935078382492065 ||| How does Crixivan work? ||| How does Fendrix work? ||| Comment Crixivan agit -il?
0.5417033433914185 ||| When State aid rules are applicable, Member States can design ample aid measures to support specific companies or sectors suffering from the consequences of the coronavirus outbreak in line with the existing EU State aid framework. ||| Each year, the World Health Organization (WHO) makes recommendations on which flu strains should be included in vaccines for the upcoming flu season. ||| En ce qui concerne les cas dans lesquels les règles en matière d'aides d'État s'appliquent, les États membres peuvent concevoir de vastes mesures d'aide pour soutenir des entreprises ou des secteurs spécifiques souffrant des conséquences de la pandémie de COVID-19, conformément au cadre existant de l'UE relatif aux aides d'État.
0.004941497463732958 ||| Dosage • You should normally inject Humalog Mix50 within 15 minutes of a meal. ||| Dosage • You should normally inject Humalog Mix25 within 15 minutes of a meal. ||| Posologie: • Vous devez normalement injecter Humalog Mix50 dans les 15 minutes précédant un repas.
0.453477144241333 ||| Rotating electrical machines ||| Electroplating solutions ||| Machines électriques rotatives
0.5538304448127747 ||| 1.5 g 5-aminolevulinic acid hydrochloride ||| • Linear dodecyl benzene sulfonic acid ||| 1,5 g de chlorhydrate d’ acide 5-aminolévulinique
0.10206493735313416 ||| Hungary referred the reasons for disagreement to the EMEA on 12 October 2007. ||| Portugal and Germany referred the reasons for disagreement to the EMEA on 15 December 2004. ||| La Hongrie a rapporté les motifs de ces divergences à l’ EMEA, le 12 octobre 2007.
0.4148052930831909 ||| Pack sizes: blister with 14, 28, 56, or 98 tablets or perforated unit dose blisters with 28 x 1 tablets ||| 10 tablets per aluminium blister strips Cartons containing 3 or 10 blister strips (30 or 100 tablets) ||| 45 Présentations: boîtes de 14, 28, 56, 98 comprimés ou plaquettes thermoformées pour délivrance à l’ unité avec 28 x 1 comprimés.
0.45311933755874634 ||| Correction for anaemia may lead to increased appetite, and potassium and protein intake. ||| Low testosterone levels have been linked to low sexual desire and to reduced sexual thoughts and arousal. ||| La correction de l'anémie peut entraîner une augmentation de l'appétit et de l'apport en potassium et en protéine.
1.0686636037898767e-12 ||| Ísland Gróco ehf. ||| Ísland Gróco ehf. ||| 278 Ísland Gróco ehf.
0.3686855733394623 ||| The usual dose of DULOXETINE BOEHRINGER INGELHEIM is 60 mg once a day, but your doctor will prescribe the dose that is right for you. ||| Do not take more than the daily amount of DULOXETINE BOEHRINGER INGELHEIM that has been prescribed for you in one day. ||| La dose habituelle de DULOXETINE BOEHRINGER INGELHEIM est de 60 mg une fois par jour, mais votre médecin vous prescrira la dose qui vous est la plus adaptée.
0.4099539518356323 ||| Carcinogenic potential in rodents was only investigated with orally administered aprepitant. ||| Ocular corneal infiltrates were reported in conjunction with the use of EMADINE. ||| Le potentiel cancérigène chez les rongeurs n'a été étudié qu'avec l'aprépitant administré par voie orale.
0.7988724708557129 ||| 4 6.2 Incompatibilities ||| 9 Differences in Population ||| 6.2 Incompatibilités
0.24146761000156403 ||| As Suboxone pharmacokinetics may be altered in patients with hepatic insufficiency, lower initial doses and careful dose titration in patients with mild to moderate hepatic impairment are recommended (see section 5.2). ||| Patients with renal and/ or hepatic impairment Unless a well-tolerated and effective dosage regimen using oral olanzapine has been established in such patients, ZYPADHERA should not be used. ||| Comme la pharmacocinétique de Suboxone peut être altérée chez les patients présentant une atteinte hépatique, il est recommandé chez les patients présentant une altération hépatique légère à modérée d’ initier le traitement avec une dose plus faible et d’ adapter la posologie avec prudence(voir rubrique 5.2).
0.5067811012268066 ||| Except for one segment II test in the rabbit, no other reproductive toxicity studies were conducted. ||| Both in vitro and in vivo studies showed no signs of QT prolongation. ||| Excepté un test du segment II chez le lapin, aucune autre étude de toxicité sur la fonction de reproduction n’ a été conduite.
0.29740750789642334 ||| • The CHMP came to the conclusion that after the review of available data, the causes of death remain unexplained and it is not possible to establish a causal association with Hexavac. ||| Therefore, at the time of the withdrawal, the CHMP’ s view was that a benefit of Evoltra had not been sufficiently demonstrated and any benefits did not outweigh the identified risks. ||| • Le CHMP est arrivé à la conclusion qu’ après révision des données disponibles, les causes de décès demeurent inexplicables et qu’ il n’ est pas possible d’ établir d’ association causale avec Hexavac.
0.3326132297515869 ||| Since amlodipine is slowly absorbed, gastric lavage can be useful in some cases. ||| Individuals with these conditions may take efavirenz oral solution, which is free from lactose. ||| L’ amlodipine étant absorbée lentement, un lavage gastrique peut être utile dans certains cas.
0.7106554508209229 ||| These interactions are described in the interaction tables below. ||| Other special considerations are discussed below. ||| Ces interactions sont décrites dans les tableaux d’ interactions ci-dessous.
0.1493849754333496 ||| What benefit has TOVIAZ shown during the studies? ||| What benefit has INCRELEX shown during the studies? ||| Quel est le bénéfice démontré par TOVIAZ au cours des études?
0.29145509004592896 ||| If overdose occurs the patient should be monitored for evidence of toxicity (see section 4.8), and standard supportive treatment applied as necessary. ||| If it is used during pregnancy, the patient must be informed of the potential risk to the foetus (see section 5.3) and be monitored carefully. ||| En cas de surdosage, une surveillance médicale du patient avec un éventuel traitement symptomatique est nécessaire (voir rubrique 4.8).
0.5229554176330566 ||| Dry eye Visual disturbance, including vision blurred ||| visual disturbance including vision blurred and visual acuity reduced ||| Yeux secs Troubles de la vision incluant vision floue
0.04625203460454941 ||| After intravenous administration of 0.5 mg, total, renal, and non-renal clearances decreased by 67%, 77% and 50%, respectively, in subjects with severe renal failure but there was no reduction in tolerability associated with the increase in exposure. ||| After intravenous administration of 0.5 mg of ibandronic acid, total, renal, and non-renal clearances decreased by 67%, 77% and 50%, respectively, in subjects with severe renal failure, but there was no reduction in tolerability associated with the increase in exposure. ||| 13 la clairance totale, de la clairance rénale et de la clairance non rénale ont été respectivement réduites de 67%, 77% et 50% chez les insuffisants rénaux sévères, mais cette augmentation de l’ exposition ne s’ est pas accompagnée d’ une réduction de la tolérance.
0.20911012589931488 ||| 23 calcium hydrogen phosphate, anhydrous (E341) croscarmellose sodium (E468) magnesium stearate (E470b) sodium stearyl fumarate ||| anhydrous (E341), croscarmellose sodium (E468), magnesium stearate (E470b), and sodium stearyl fumarate. ||| Cellulose microcristalline (E460) Hydrogénophosphate de calcium anhydre (E341) Croscarmellose sodique (E468) Stéarate de magnésium (E470b) Fumarate de stéaryle sodique
0.21290817856788635 ||| In a separate study in healthy subjects, voriconazole dose of 300mg BID in combination with low dose efavirenz (300 mg once daily) did not lead to sufficient voriconazole exposure. ||| In separate single dose studies, at the recommended doses, paediatric patients had comparable AUC and Cmax values of desloratadine to those in adults who received a 5 mg dose of desloratadine syrup. ||| Dans une étude séparée chez des volontaires sains, l’ administration de voriconazole à la dose de 300 mg deux fois par jour, associée à une faible dose d’ efavirenz (300 mg une fois par jour) n’ a pas conduit à une exposition suffisante en voriconazole
0.3396550416946411 ||| While we will all have to remain careful, the time has come to make concrete preparations for lifting restrictions with countries whose health situation is similar to the EU's and for resuming visa operations." ||| However, this exceptional situation caused by the Coronavirus pandemic means that some of the rules can be used more flexibly at this time so that banks can focus on lending to households and companies. ||| Certes, nous devrons tous rester prudents, mais il est temps de préparer concrètement la levée des restrictions pour les pays dont la situation sanitaire est semblable à celle de l'UE, et la reprise des opérations liées aux visas.»
0.3840126693248749 ||| In Singapore, only one person in six downloaded the TraceTogether App by April 2020; the app was also underused due to the fact that it required users to keep the app open at all times. ||| However, since Ambirix has only been marketed in one Member State (the Netherlands since May 2003), the safety information available for this product is limited due to a low patient exposure. ||| À Singapour, une personne sur six seulement avait téléchargé l'application TraceTogether en avril 2020; l'application a également été sous-utilisée car elle obligeait les utilisateurs à la garder ouverte à tout moment.
0.518214225769043 ||| Abrasive belts for power-operated sanders ||| Radio-controlled miniature aerial targets for sports ||| Courroies abrasives pour ponceuses électriques
0.7613192796707153 ||| Orodispersible tablet ||| maagsapresistente capsule ||| Comprimé orodispersible
0.38642844557762146 ||| 81 For further information on the laboratory testing please contact the Marketing Authorisation Holder or its representative. ||| - the CVMP assessed the information provided by the Marketing Authorisation Holder in response ||| Pour de plus amples informations sur les tests de laboratoire, contactez le titulaire de l’ autorisation de mise sur le marché ou son représentant local.
0.5241841077804565 ||| There is limited evidence of the clinical efficacy of tigecycline against enterococci. ||| Lansoprazole has a wide therapeutic window regarding its clinical efficacy and safety. ||| L’ efficacité clinique de la tigécycline sur les entérocoques est peu démontrée.
0.2676730751991272 ||| How does QUADRAMET work? ||| How does CHAMPIX work? ||| Comment QUADRAMET agit -il?
0.04534884914755821 ||| 29 Me dic ina lP rod uc t ||| 88 Me dic ina lP rod uc t ||| 29 Ce mé dic am ent
0.25563251972198486 ||| If the pen malfunctions, (see instructions for using the pen) the solution may be drawn from the cartridge into a syringe (suitable for an insulin with 100 Units/ ml) and injected. ||| If sensitivity to the solvent occurs, the vials should be reconstituted with water for injections and used as a single use vial (see section 5 ‘ How to store Valtropin’). ||| En cas de mauvais fonctionnement du stylo (voir les Instructions d’ utilisation du stylo), la solution peut être prélevée de la cartouche à l’ aide d’ une seringue (adaptée à une insuline concentrée à 100 Unités/ ml) et injectée.
0.4297870993614197 ||| What is Nobivac Bb? ||| What is Duvaxyn WNV? ||| Qu’ est -ce que Nobivac Bb?
1.008909102095945e-12 ||| Using other medicines: ||| Using other medicines: ||| Utilisation d’ autres médicaments
0.2753252387046814 ||| Turpentine [white spirit] for use as a thinner in varnishes ||| Turpentine substitute for use as a thinner in varnishes ||| Térébenthine [white spirit] pour diluer les vernis
0.36448347568511963 ||| The main measure of effectiveness was the number of patients who did not develop a fungal infection during treatment or the following four weeks. ||| There was no difference seen in median PFS times as more than 50% of patients progressed in both treatment groups before the first scheduled visit. ||| Le principal critère d’ efficacité a été le nombre de patients qui n’ ont pas développé une infection fongique pendant le traitement ou dans les semaines qui ont suivi.
0.24363020062446594 ||| It is particularly important that your doctor knows if you are also taking aminoglycosides (a type of medicine used to treat severe infections), since the combination of these with bisphosphonates may cause the calcium level in the blood to become too low. ||| If you take any medicines that reduce immunity to infections or have any other type of treatment (such as radiotherapy) that affects the immune system, Daronrix can still be given but your response to the vaccine may be poor. ||| Il est particulièrement important que votre médecin sache si vous prenez également des aminosides (une famille de médicaments utilisés pour traiter les infections sévères), puisque la combinaison de ceux -ci avec les bisphosphonates peut entraîner une diminution trop importante du taux de calcium dans le sang.
0.09763738512992859 ||| The Arixtra pre-filled syringes have been designed with a needle protection system to prevent needle stick injuries following injection. ||| The Quixidar pre-filled syringe has been designed with an automatic needle protection system to prevent needle stick injuries following injection. na ||| Le système de sécurité des seringues pré-remplies d’ Arixtra a été conçu avec un système de sécurité, destiné à éviter les piqûres accidentelles après injection.
0.2802146375179291 ||| Macugen 0.3 mg solution for injection Pegaptanib sodium ||| Neupopeg 6 mg injection Pegfilgrastim ||| Macugen 0,3 mg, solution injectable Pegaptanib sodium
0.40224945545196533 ||| Saw blades for use with power tools ||| Lighting being for use with security systems ||| Lames de scies pour outils électriques
0.012268360704183578 ||| No studies on the effects on the ability to drive and use machine have been performed. ||| No studies on the effect on the ability to drive and use machines have been performed. ||| Aucune étude sur l’ aptitude à conduire des véhicules et à utiliser des machines n’ a été réalisée.
0.2674936354160309 ||| Chemical substances for use in treating poisonous gases ||| Chemical substances for use as additives to bitumen ||| Substances chimiques destinées au traitement des gaz toxiques
0.31230494379997253 ||| 120 micrograms PRE-FILLED SYRINGES LABEL ||| 135 μ g PRE-FILLED SYRINGE ||| ETIQUETTE SERINGUE PREREMPLIE de 120 microgrammes
0.27679359912872314 ||| 95 Effect of food: the AUC and Cmax of a single 240 mg dose of efavirenz oral solution in uninfected adult volunteers was increased by 30% and 43% respectively, when given with a high-fat meal, relative to fasted conditions. ||| 22 Effect of food: the bioavailability of a single 600 mg dose of efavirenz hard capsules in uninfected volunteers was increased 22% and 17%, respectively, when given with a meal of high fat or normal composition, relative to the bioavailability of a 600 mg dose given under fasted conditions (see section 4.4). ||| Effet dede la nourritures: l'aire sous la courbe et la Cmax après une dose unique de 240 mg d’ éfavirenz solution buvable chez des volontaires adultes et non infectés sont augmentés respectivement de 30% et 43%, après un repas riche en graisses, par rapport aux valeurs obtenues après la prise du médicament à jeun.
0.5295181274414062 ||| 250 micrograms/ 0.5 ml ||| 0.14 milligram per ml. ||| 250 microgrammes/ 0,5 ml
0.1052786260843277 ||| The maximum daily dose is 20 mg per day. ||| The maximum dose is 8 mg per day. ||| La dose maximale quotidienne est de 20 mg.
0.3380711078643799 ||| Disinfect the stoppers of the dibotermin alfa and solvent vials. ||| Disinfect the stopper of the reconstituted dibotermin alfa vial. ||| Désinfecter les bouchons des flacons de dibotermine alpha et de solvant.
0.3858092427253723 ||| One of the main side effects of chemotherapy is that it stops the bone marrow producing enough blood cells. ||| This is linked to the way your medicine works as it prevents the ability of blood clots to form. ||| Un des principaux effets indésirables de la chimiothérapie est une production insuffisante de cellules sanguines par la moelle osseuse.
0.45229047536849976 ||| Leave the pre-filled syringe at room temperature for approximately 30 minutes. ||| Expose a small area of skin to sunlight for 10 minutes. ||| Laissez la seringue préremplie à température ambiante pendant environ 30 minutes.
0.0 ||| The antigen should be stored for no longer than 12 months at 2-8ºC pending the provision of data supporting a longer period of storage. ||| The antigen should be stored for no longer than 12 months at 2-8ºC pending the provision of data supporting a longer period of storage. ||| 5) L’ antigène ne doit pas être conservé plus de 12 mois à + 2°C - + 8°C, sous réserve de la fourniture de données permettant une conservation plus longue.
4.249046860888006e-13 ||| Type 2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose in the blood or when the body is unable to use insulin effectively. ||| Type 2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose in the blood or when the body is unable to use insulin effectively. ||| Le diabète de type 2 est une maladie dans laquelle le pancréas ne produit pas suffisamment d’ insuline pour réguler la quantité de glucose dans le sang ou lorsque le corps est incapable d’ utiliser l’ insuline de façon efficace.
0.5821341872215271 ||| Synthetic thickeners for foodstuffs ||| Soporific pillows for insomnia ||| Épaississants synthétiques pour aliments
0.0 ||| 6.6 Special precautions for disposal and other handling ||| 6.6 Special precautions for disposal and other handling ||| 81 6.6 Précautions particulières d’ élimination et manipulation
0.4638487696647644 ||| Other information about Plavix: ||| Other information about Tadalafil Lilly: ||| Autres informations relatives à Plavix:
0.29998961091041565 ||| Apparatus for games ||| Apparatus for recording images ||| Appareils pour jeux
0.6154289245605469 ||| Concentrations were thus consistent with the time profile of the pharmacodynamic activity of insulin glargine. ||| This is as a result of the adulticidal, larvicidal and ovicidal properties of the product. ||| Autrement dit, les concentrations étaient conformes au déroulement chronologique de l'activité pharmacodynamique de l'insuline glargine.
0.1013108566403389 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Kentera to Nicobrand Limited on 15 June 2004. ||| The European Commission granted a marketing authorisation valid throughout the EU for Advate to Baxter AG on 2 March 2004. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Kentera à Nicobrand Limited le 15 juin 2004.
0.21389825642108917 ||| Patients with signs or symptoms compatible with autoimmune disorders should be evaluated carefully, and the benefit-risk of continued interferon therapy should be reassessed (see also section 4.4 Chronic hepatitis C, Monotherapy (thyroid abnormalities) and section 4.8). no ||| 17 Peripheral Neuropathy Patients who develop signs or symptoms that might represent a peripheral neuropathy during therapy with Cubicin should be investigated and consideration should be given to discontinuation of daptomycin (see sections 4.8 and 5.3). ||| évocateurs d’ un désordre auto-immun doivent être évalués avec attention et le rapport bénéfice-risque de poursuivre le traitement par interféron doit être reconsidéré (voir aussi rubrique 4.4 Hépatite C chronique, Monothérapie (d'anomalies thyroïdiennes) et rubrique 4.8).
0.16008639335632324 ||| The full EPAR for Protopic is available here. ||| The full EPAR for PritorPlus is available here. ||| L’ EPAR complet est disponible à l’ adresse suivante: cliquez ici.
0.19508948922157288 ||| Therefore, as with other antidepressants, fluoxetine should be introduced cautiously in patients who have a history of seizures. ||| As with other antidepressants, venlafaxine should be used cautiously in patients with a history or family history of bipolar disorder. ||| Par conséquent, comme avec d’ autres antidépresseurs, le traitement par la fluoxétine doit être instauré avec précaution chez les patients ayant des antécédents d’ épilepsie.
0.21454313397407532 ||| In the influenza-positive elderly, oseltamivir significantly reduced the incidence of specified lower respiratory tract complications (mainly bronchitis) treated with antibiotics from 19% (52/ 268) in the placebo group to 12% (29/ 250) in the oseltamivir treated population (p = 0.0156). ||| In the two studies in patients with digital ulcers the incidence of elevated liver aminotransferases (> 3 × ULN) was 11.3% in bosentan-treated patients (N = 168) compared with 0.8% in placebo-treated patients (N = 1 29). ||| Chez les sujets âgés ayant une grippe confirmée, l'oseltamivir a réduit significativement l'incidence des complications des voies respiratoires basses (principalement bronchites) traitées par antibiotiques de 19% (52/ 268) dans le groupe placebo à 12% (29/ 250) dans la population traitée par l'oseltamivir (p = 0.0156).
0.05546511709690094 ||| You can clean the exterior of your Actraphane 30 NovoLet by wiping it with a medicinal swab. ||| You can clean the exterior of your Protaphane NovoLet by wiping it with a medicinal swab. ||| Vous pouvez nettoyer l'extérieur de votre Actraphane 30 NovoLet à l’ aide d’ une compresse antiseptique.
0.4826089143753052 ||| Hair colour changes, skin striae, skin fragility (molluscoid pseudotumor on elbows) ||| - Musculoskeletal: muscle or joint pain, tendinitis, ruptured tendon (see “ Contra- ||| Changement de coloration des cheveux, vergetures, fragilité cutanée (pseudotumeur molluscoïdeau niveau des coudes)
0.4529685974121094 ||| − ||| *** ||| -
0.30505141615867615 ||| Do not stop taking your medicine without first talking to your doctor. ||| Do not change the dose or stop the treatment without talking to your doctor. ||| N’arrêtez pas votre traitement sans en parler préalablement à votre médecin.
0.3077128529548645 ||| a) Percent of patients calculated based on total number of unique patients (234). b) The unexpected decrease in coagulation factor VIII levels occurred in one patient during continuous infusion of ADVATE following surgery (postoperative days 10-14). ||| 2 Patients requiring the administration of ≥ 3 units of packed red blood cells per day for 2 consecutive days without an identified site of bleeding 3 In ENHANCE six patients experienced multiple serious bleeding events during the study drug infusion period (94 events observed in 85 patients). ||| a) Pourcentage de patients calculé sur la base du total de patients individuels (234). b) La diminution inattendue de l’ activité coagulante plasmatique du facteur VIII est survenue chez un patientt sous perfusion continue d’ ADVATE après une chirurgie (jours post-opératoires 10- 14).
0.06174801290035248 ||| The following medicines may also interact with Efexor depot and should be used with caution. ||| The following medicines may also interact with Efexor and should be used with caution. ||| Les médicaments suivants peuvent également interagir avec Efexor depot et doivent être utilisés avec prudence.
0.21826887130737305 ||| As a consequence of increased insulin sensitivity, patients receiving pioglitazone in dual therapy with insulin may be at risk for dose-related hypoglycaemia, and a reduction in the dose of insulin may be necessary. ||| In some patients, cataplexy may return at a higher frequency on cessation of sodium oxybate therapy, however this may be due to the normal variability of the disease. ||| En raison de l’ augmentation de l’ insulino-sensibilité, les patients recevant de la pioglitazone en association à de l’ insuline ont un risque d’ hypoglycémie dose-dépendante; une diminution de la dose d’ insuline peut s’ avérer nécessaire.
0.2509801685810089 ||| Do not use NutropinAq if you notice that the solution is cloudy. ||| Do not use Flebogammadif if you notice that the solution is cloudy or has deposits. ||| N’ utilisez pas NutropinAq si vous constatez que la solution est trouble.
0.7111952304840088 ||| 0.25 mmol/ ml ||| 0.32 milligrams Al ||| 0,25 mmol/ ml
0.5218938589096069 ||| Interferon alfa-2b ||| Interferon alfa- ||| Interféron alfa-2b
4.592714012915944e-13 ||| Keep the vial in the outer carton in order to protect from light. ||| Keep the vial in the outer carton in order to protect from light. ||| Conserver le (les) flacon(s) dans l'emballage extérieur, à l'abri de la lumière.
0.6223646998405457 ||| very common: irritability ||| Very common: low blood sugar ||| Très fréquent: irritabilité
0.26546379923820496 ||| As valproate significantly decreases clearance of Inovelon, a lower maximum dose of Inovelon is recommended for patients < 30 kg being co-administered valproate. ||| It is anticipated that tenofovir exposure will be approximately 35% lower following administration of Atripla on an empty stomach as compared to the individual component tenofovir disoproxil fumarate when taken with food. ||| Le valproate diminuant significativement la clairance d’ Inovelon, il est recommandé de diminuer la dose maximale d’ Inovelon chez les patients de < 30 kg recevant un traitement concomitant par le valproate.
0.7639274597167969 ||| For all patients: ||| To the physician: ||| Pour tous les patients:
0.21405762434005737 ||| or Hb increase ≥ 1 g/ d ||| and Hb increase < 1 g/ dl ||| ou augmentation Hb ≥ 1 g/ dl
0.2828788757324219 ||| Biotransformation Ivabradine is extensively metabolised by the liver and the gut by oxidation through cytochrome P450 3A4 (CYP3A4) only. ||| Cytochrome P450 3A4 (CYP3A4) Ivabradine is metabolised by CYP3A4 only and it is a very weak inhibitor of this cytochrome. ||| Biotransformation L’ ivabradine est fortement métabolisée par l’ intestin et par le foie, par un processus oxydatif impliquant uniquement le cytochrome P 450 3A4 (CYP3A4).
0.7556229829788208 ||| State aid: Coronavirus: Danish liquidity guarantee ||| State aid to Italy, coronavirus ||| Aides d'État: coronavirus: régime danois de garanties de liquidités
0.4924079179763794 ||| The applicable conditions are specified in the EBA guidelines of 2 April 2020 on payment moratoria , which are also intended to ensure that public and private moratoria are being treated similarly to the extent they have the same purpose and similar characteristics. ||| In addition to all documents classified as ‘ public’ the catalogue also covers those classified as ‘ restricted’ and ‘ confidential’, although in some cases the full title may not be given in order to respect the Agency’ s obligations of confidentiality. ||| Les conditions applicables sont précisées dans les orientations de l'ABE du 2 avril 2020 sur les moratoires de paiement, qui visent aussi à garantir un traitement similaire des moratoires publics et privés, dans la mesure où ils ont la même finalité et des caractéristiques similaires.
0.0054317982867360115 ||| OUTER CARTON TEXT Puregon 200 IU/ 0.5 ml 10 vials ||| OUTER CARTON TEXT Puregon 200 IU/ 0.5 ml 5 vials ||| TEXTE DE L'ETUI Puregon 200 UI/ 0,5 ml 10 flacons
0.37215182185173035 ||| The duration of treatment is dependent on clinical response. ||| The duration of treatment will depend on the individual daily dose. ||| La durée du traitement dépend de la réponse clinique.
0.38465404510498047 ||| 435 In such a case, you may develop severe hypoglycaemia (and even faint) before you are aware of the problem. ||| However, it can cause side effects such as headaches (listed in Section 4), and the symptoms of your condition can also make you less fit to drive. ||| 439 Dans ces situations, vous courez le risque d'hypoglycémie sévère (et même de perte de connaissance) sans vous en apercevoir.
0.18637296557426453 ||| These are medicines such as ketoconazole and itraconazole (used to treat fungal infections), atazanavir, indinavir, nelfinavir, ritonavir and saquinavir (medicines used in HIV-positive patients), clarithromycin and telithromycin (antibiotics), and nefazodone (used to treat depression). ||| These can affect how Mimpara works: • medicines used to treat skin and fungal infections (ketoconazole, itraconazole, voriconazole); • antibiotics used to treat bacterial infections (telithromycin, rifampicin); • medicine used to treat HIV infection and AIDS (ritonavir). ||| Il s’ agit, par exemple, de la kétoconazole et de l’ itraconazole (utilisés pour traiter des infections fongiques), de l’ atazanavir, de l’ indinavir, du nelfinavir, du ritonavir et du saquinavir (des médicaments utilisés chez les patients VIH positifs), la clarithromycine et la télithromycine (antibiotiques), et la néfazodone (utilisée pour le traitement de la dépression).
0.4390559196472168 ||| This section contains information on how to give yourself an injection of Neulasta. ||| The following instructions are intended to explain how to prepare Extavia for administration and how to inject Extavia yourself. ||| Ce paragraphe présente les instructions permettant de vous administrer vous -même une injection de Neulasta.
0.39340534806251526 ||| Caution: ||| Powder: ||| Attention:
0.34352776408195496 ||| Gait disturbance Asthenia Fatigue Fall Skin laceration ||| Haemorrhage Fever Injection site reaction Asthenia ||| Troubles de la marche Asthénie Fatigue
0.24947765469551086 ||| This enzyme is involved in producing substances called prostaglandins, which are involved in pain and inflammation. ||| Both substances are protease inhibitors: they block an enzyme called protease that is involved in the reproduction of HIV. ||| Cette enzyme joue un rôle dans la production des prostaglandines, qui sont des substances associées à la douleur et à l’ inflammation.
0.2544654607772827 ||| In metastatic colorectal cancer, Xeloda taken on its own has been compared with the combination of 5-FU and folinic acid in two studies involving 1,207 patients. ||| In one study, the effectiveness of Velcade was compared with that of high-dose dexamethasone (another medicine for multiple myeloma) in 669 patients. ||| Dans le cancer colorectal métastatique, Xeloda administré en monothérapie a été comparé à l’ association du 5-FU et de l’ acide folinique dans deux études menées auprès de 1 207 patients.
0.645122766494751 ||| - If you are pregnant. ||| If you have cancer. ||| - Si vous êtes enceinte
0.20235662162303925 ||| There is no information on the use of Betaferon in children under 12 years of age and therefore Betaferon should not be used in this population. ||| Betaferon should not be used in children under 12 years of age as there is no information on this use. ||| Il n’existe pas d’ information chez l’enfant de moins de 12 ans,et, par conséquent, Betaferon ne doit pas être utilisé dans cette population.
0.0 ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| au 4.5 Interactions avec d’ autres médicaments et autres formes d’ interaction
0.3498888313770294 ||| They are supplied in packs containing 24, 48, 96, 120 or 180 capsules, but these may not all be available in your country. ||| It is supplied in tubes of 15 g, 30 g and 60 g but not all pack sizes may be marketed. ||| Elles sont fournies dans des boîtes contenant 24, 48, 96, 120 ou 180 gélules mais toutes les tailles de boîtes peuvent ne pas être disponibles dans votre pays.
0.5185838937759399 ||| The vials may be used with insulin syringes with a corresponding unit scale. ||| - concomitantly with other vaccines, using separate sites and syringes. ||| Les flacons peuvent être utilisés avec des seringues à insuline portant une graduation adéquate.
0.4288271367549896 ||| In a small number of cases, bleeding in the eye, inside the head, the lung or the joints has also been reported. ||| There have been very rare reports of patients developing a hole in the septum of the nose – the structure, which separates the nostrils. ||| Dans de rares cas, des hémorragies oculaires, cérébra les, pulmonaires ou articulaires ont également été rapportées.
1.03388249874115 ||| Austria Germany Spain France The Netherlands United Kingdom ||| Austria Belgium Finland France Germany Ireland Italy Luxembourg Portugal Spain Sweden United Kingdom ||| DE/ H/ 0740/ 01/ MR Autriche Allemagne Espagne France Pays-Bas
0.081108957529068 ||| This is described in section 2 of this leaflet under “ Take special care with Kivexa”. ||| This is described under “ Take special care with Ziagen ” in section 2 of this leaflet. ||| Cette réaction est décrite à la section “ Faites attention avec Kivexa” de la rubrique 2 de cette notice.
0.0 ||| Hypersensitivity to the active substance or to any of the excipients. ||| Hypersensitivity to the active substance or to any of the excipients. ||| Hypersensibilité au principe actif ou l’ un des excipients.
0.6252145767211914 ||| Imitation toilet preparations being toys ||| Spark plug sockets being hand tools ||| Imitations de produits de toilette [jouets]
0.32135775685310364 ||| 62 5 Upon treatment with antidepressants in general, anxiety and insomnia (which may be symptoms of depression) can develop or become aggravated. ||| Patients taking Ziagen may develop a hypersensitivity reaction (serious allergic reaction) which can be life-threatening if treatment with Ziagen is continued. ||| 5 Au cours d’ un traitement par antidépresseur en général, une anxiété et une insomnie (qui peuvent être des symptômes de la dépression) peuvent apparaître ou s’ aggraver.
0.611172080039978 ||| 14 Table 1 ||| Step 1 2 ||| Tableau 1
0.5417930483818054 ||| Therefore in such patients, the benefit/ risk ratio of FIRMAGON must be thoroughly appraised (see sections 4.5 and 4.8). ||| Therefore before treatment with Advocate, the advice provided in the section ” SPECIAL WARNING(S )“ should be considered. ||| Le rapport bénéfice/ risque de FIRMAGON doit être évalué d’ une façon approfondie chez ces patients (voir rubriques 4.5 et 4.8).
0.4422459304332733 ||| This medication can be taken with or without food, preferably in the evening. ||| The tablets can be taken at any time of the day before, during or after meals. ||| Ce médicament peut être pris avec ou sans repas, de préférence le soir.
0.49610456824302673 ||| Ratiograstim has not been tested in pregnant women. ||| Rhabdomyolysis has also been reported rarely. ||| Ratiograstim n’ a pas été testé chez la femme enceinte.
0.15825361013412476 ||| The other ingredients of the powder contained in the hard capsule are: sodium laurilsulfate, lactose monohydrate, magnesium stearate and sodium starch glycolate. ||| • The other ingredients that are present in the capsule contents are: microcrystalline cellulose, hydrogenated vegetable oil and sodium laurilsulfate. ||| Les autres composants de la poudre contenue dans la gélule sont: laurylsulfate sodique, lactose monohydraté, stéarate de magnésium et carboxyméthylamidon sodique.
0.0 ||| Name and address of the manufacturers of the biological active substance ||| Name and address of the manufacturers of the biological active substance ||| Nom et adresse des fabricants de la substance active d’ origine biologique
0.47132444381713867 ||| The clinical relevance of these findings may be limited. ||| The findings in this report are subject to at least six limitations. ||| Il est possible que la signification clinique de ces observations soit limitée.
0.07032769173383713 ||| What Axura is and what it is used for 2. ||| What Copalia is and what it is used for 2. ||| Qu’est-ce qu’Axura et dans quel cas est-il utilisé 2.
0.0 ||| 30 9. ||| 30 9. ||| 33 9.
0.0 ||| If OptiClik is damaged or not working properly (due to mechanical defects) it has to be discarded, and a new OptiClik has to be used. ||| If OptiClik is damaged or not working properly (due to mechanical defects) it has to be discarded, and a new OptiClik has to be used. ||| 114 Si OptiClik est défectueux ou ne fonctionne pas correctement (dû à des défauts mécaniques) il doit être écarté, et un nouvel OptiClik doit être utilisé.
0.26206183433532715 ||| PREZISTA 400 mg is not for use in children and adolescents, as it has not been studied in patients under 18 years. ||| ProMeris Duo must not be used in puppies less than eight weeks old since it has not been sufficiently studied in these animals. ||| PREZISTA 400 mg ne doit pas être utilisé chez les enfants et les adolescents car il n’a pas été étudié chez les patients de moins de 18 ans.
0.1428346037864685 ||| Orfadin is intended for long-term use. ||| Aldurazyme is designed for long-term use. ||| Orfadin est destiné à un usage à long terme.
0.41297075152397156 ||| Acute renal failure, interstitial nephritis, hyponatraemia ||| renal dysfunction uraemia, acute renal failure oliguria/anuria ||| Insuffisance rénale aiguë, néphrite interstitielle, hyponatrémie
0.3074234127998352 ||| Seed drills for agricultural machines ||| Branching tubes of metal for pipelines ||| Semoirs pour machines agricoles
0.01789327897131443 ||| Press release21 April 2020Brussels ||| Press release20 April 2020Brussels ||| Communiqué de presse21 avril 2020Bruxelles
0.541877806186676 ||| Paroxetine: ||| Metronidazole: ||| Paroxétine:
0.4140457808971405 ||| Haematological response criteria (all responses to be confirmed after ≥ 4 weeks): ||| These haematological effects are not usually observed before four to six week’ s therapy. ||| Critères de réponse hématologique (toutes les réponses étaient à confirmer après ≥ 4 semaines):
0.49893367290496826 ||| 6 patients (0.4%) in the fondaparinux group vs 5 patients (0.3%) in the dalteparin group. ||| 1.29 log10) in the ritonavir group versus-0.01 log10 in the control group. ||| 6 patients (0,4%) dans le groupe fondaparinux vs 5 patients (0,3%) dans le groupe daltéparine.
0.47251102328300476 ||| 3 bottles of 360 tablets with outer carton ||| Two bottles each containing 240 soft capsules ||| 3 flacons de 360 comprimés avec emballage exterieur
0.025862619280815125 ||| For the full list of all side effects reported with Altargo, see the Package Leaflet. ||| For the full list of all side effects reported with Tandemact, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l'utilisation d'Altargo, voir la notice.
0.2988271117210388 ||| Mesothelioma development in rats has been demonstrated following intra-pleural inoculation of phosphorylated chrysotile fibers. ||| The suggested pathophysiologic mechanism includes immune-complex formation and deposition due to development of antibodies against omalizumab. ||| Chez les rats le développement d’un mésothéliome a été provoqué par l'inoculation intra-pleurale de fibres phosphorylées de chrysotile.
2.628215570524284e-13 ||| Elimination Renal clearance of metformin is > 400 ml/ min, indicating that metformin is eliminated by glomerular filtration and tubular secretion. ||| Elimination Renal clearance of metformin is > 400 ml/ min, indicating that metformin is eliminated by glomerular filtration and tubular secretion. ||| Elimination La clairance rénale de la metformine est > 400 ml/ mn, ce qui indique une élimination par filtration glomérulaire et sécrétion tubulaire.
0.2905885577201843 ||| au please tell your doctor or pharmacist. ||| not, talk to your doctor or pharmacist. ||| cette notice, informez-en votre médecin ou votre pharmacien.
0.4451671540737152 ||| Hypersensitivity to the active substance Botulinum neurotoxin type A or to any of the excipients. ||| ● The active substance is human normal immunoglobulin (antibodies of the type IgG). ||| Hypersensibilité à la neurotoxine botulinique de type A ou à l’ un des excipients
0.0343044176697731 ||| In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not differ between the irbesartan (56.2%) and the placebo groups (56.5%). ||| Hypertension: in placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not differ between the irbesartan (56.2%) and the placebo groups (56.5%). ||| Lors des essais cliniques contrôlés versus placebo, menés chez des patients hypertendus, l'incidence globale des évènements indésirables ne présentaient pas de différence entre le groupe traité par irbésartan (56,2%) et le groupe recevant un placebo (56,5%).
0.26268360018730164 ||| • Allergic reactions, including anaphylactic reaction, angioedema, skin rash and urticaria. ||| These reactions include anaphylaxis, angioedema, and exfoliative skin conditions including Stevens-Johnson syndrome. ||| 9 • Réactions allergiques, y compris réactions anaphylactiques, oedème de Quincke, rash cutané et urticaire.
0.37001803517341614 ||| If your child becomes ill, please contact your doctor immediately. ||| If a child swallows some tablets, contact your doctor immediately. ||| Si votre enfant devient malade, veuillez contacter immédiatement votre médecin.
3.8934637848833664e-13 ||| Solvent Water for injections ||| Solvent Water for injections ||| Solvant Eau pour préparations injectables.
0.31362184882164 ||| Compositions for preserving cement [paints] ||| Protective coatings for walkways [paints] ||| Agents de préservation pour ciment [peintures]
0.13916116952896118 ||| Other information about Emtriva: ||| Other information about Fertavid: ||| 2/ 3 Autres informations relatives à Emtriva:
0.6749326586723328 ||| 2 151 000 ||| 49 000 000 ||| 151 000
0.0 ||| Store in the original container. ||| Store in the original container. ||| A conserver dans l’ emballage d’ origine.
2.8537740746903406e-13 ||| For more information, see the Summary of Product Characteristics (also part of the EPAR). ||| For more information, see the Summary of Product Characteristics (also part of the EPAR). ||| Pour plus d’ informations, veuillez consulter le Résumé des caractéristiques du produit, également compris dans l’ EPAR.
0.05413162335753441 ||| Use the appropriate combination of pipettes ||| Use an appropriate combination of pipettes ||| Utiliser la combinaison appropriée de pipettes
0.27507397532463074 ||| If a further dose increase is necessary the daily dose should be increased by 0.54 mg base (0.75 mg salt) at weekly intervals up to a maximum dose of 3.3 mg of base (4.5 mg of salt) per day. ||| An initial single dose of 0.7 mg/ kg body weight is given followed by weekly injections of 1.0 mg/ kg body weight (maximum single dose should not exceed a total of 200 mg). ||| Si une posologie supérieure est nécessaire, la dose quotidienne peut être augmentée de 0,54 mg de forme base (0,75 mg de forme sel) par semaine, jusqu'à la dose maximale de 3,3 mg de forme base (4,5 mg de forme sel) par jour.
0.17170357704162598 ||| Flushing Hypotension Musculoskeletal and connective tissue disorders ||| Musculoskeletal and connective tissue disorders Muscle cramp ||| Bouffées de chaleur Hypotension Troubles musculosquelettiques
0.4694281220436096 ||| The report should provide information on the measures taken to assure and assess the effectiveness of the pregnancy prevention programme. ||| Parliament's culture and education committee has called on the Commission to do everything possible to provide support, clear information and reassurance for participants. ||| Le rapport doit fournir des informations sur les mesures prises pour garantir et évaluer l’ efficacité du programme de prévention de la grossesse.
0.06750893592834473 ||| Pregnancy There are no adequate data on the use of duloxetine in pregnant women. ||| Pregnancy There are no data on the use of duloxetine in pregnant women. ||| 22 Il n'existe pas de données suffisantes sur l'utilisation de la duloxétine chez la femme enceinte.
0.1023295670747757 ||| 56 Reproductive system and breast disorders Common: ||| Reproductive system and breast disorders Common: ||| Affections des organes de reproduction et du sein Fréquent:
0.34234434366226196 ||| Smoking should also be stopped as it could decrease the amount of medicine in the blood. ||| The amount of alcohol in this medicinal product may impair the ability to drive or use machines. ||| L’arrêt du tabac est conseillé pendant le traitement car il peut entraîner une baisse de la quantité de médicament dans le sang.
0.4706435799598694 ||| For further information on how to use Orgalutran, see the Package Leaflet. ||| For further details on use, please follow the instructions provided with the Avostartclip. ||| Pour plus d’ informations sur les modalités d’ utilisation d’ Orgalutran, veuillez vous reporter à la notice.
0.09789148718118668 ||| Ranexa is contraindicated in patients with moderate or severe hepatic impairment (see sections 4.3 and 5.2). ||| Therefore, losartan is contraindicated in patients with severe hepatic impairment (see sections 4.3 and 4.4). ||| Ranexa est contre-indiqué chez l'insuffisant hépatique modéré ou sévère (voir rubriques 4.3 et 5.2).
0.47003239393234253 ||| Exercise balls ||| Tennis pullovers ||| Balles d'exercice
0.2949727475643158 ||| The daily dose is 0.09 g oral paste (5 mg trimetoprim + 25 mg sulfadiazin) per kg body weight. ||| 5 mg trimethoprim and 25 mg sulfadiazine per kg body weight per day to a maximum of 5 days. ||| g de pâte orale (5 mg de triméthoprime + 25 mg de sulfadiazine) par kg de poids corporel.
0.5463824272155762 ||| The increase in the number of mutual recognition procedures is expected to continue in 2000-2001. ||| This is expected for the second half of 1997 and will facilitate such activities in 1998. ||| L’augmentation du nombre de procédures de reconnaissance mutuelle devrait se poursuivre en 2000-2001.
0.324349582195282 ||| If you feel sick and get a positive diagnosis for coronavirus, your public health authority will enable you to confirm this through the app. At that moment, the electronic contact tracing triggers an alert to the people with whom you have been in contact. ||| • drug distribution will only be possible after checking that the patient has effectively received a meningococcal vaccination with a written confirmation • prior to distribution, all health care professionals are provided with information on the following key safety concerns: ||| Si vous ne vous sentez pas bien et que votre test de diagnostic au coronavirus est positif, votre autorité de santé publique vous permettra de confirmer au moyen de l'application que vous êtes infecté.
0.23054273426532745 ||| Education services relating to the application of computer systems ||| Education services relating to the provision of restaurant services ||| Services d'enseignement concernant l'application de systèmes informatiques
2.216384763437454e-13 ||| As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR). ||| As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR). ||| Selon la recommandation du CHMP concernant le Système de Gestion des Risques liés à des médicaments à usage humain, une actualisation du PGR devra être soumise en même temps que le rapport périodique de sécurité (PSUR, Periodic Safety Report Update).
0.39907974004745483 ||| If treatment with an HMG-CoA reductase inhibitor is indicated, pravastatin or fluvastatin is recommended (see section 4.5). ||| In this case close monitoring is required. • lopinavir/ ritonavir combination (used to treat HIV infection) ||| Si un traitement par un inhibiteur de la HMG CoA réductase est indiqué, la pravastatine ou la fluvastatine sont recommandées (voir rubrique 4.5).
0.44599655270576477 ||| Patients with hepatic impairment should be observed carefully and the dose reduced if necessary. ||| These doses are carefully checked by the doctor, so an overdose is very unlikely. ||| En cas d’ insuffisance hépatique, il faut surveiller soigneusement les patients et réduire la dose, si nécessaire.
0.3390839695930481 ||| Eculizumab contains only naturally occurring amino acids and has no known active metabolites. ||| UMAN BIG contains glycine as the excipient, a natural amino acid and therefore not expected to cause any problems. ||| L’ eculizumab contient uniquement des acides aminés naturellement présents et n’ a pas de métabolites actifs connus.
0.013835890218615532 ||| ProQuad - Powder in vial and solvent in pre-filled syringe with 1 unattached needle - Pack of 1, 10, 20 ||| ProQuad - Powder in vial and solvent in pre-filled syringe with 2 unattached needles - Pack of 1, 10, 20 ||| ProQuad - Poudre en flacon et solvant en seringue préremplie avec 1 aiguille séparée - Boîte de 1, 10 et 20
0.31812137365341187 ||| Celecoxib is excreted in the milk of lactating rats at concentrations similar to those in plasma. ||| In rabbits, pegaptanib is eliminated as parent drug and metabolites primarily in the urine. ||| Le célécoxib est excrété dans le lait des rates allaitantes à des concentrations similaires à celles retrouvées dans le plasma.
0.9807982444763184 ||| Fencing weapons ||| Antihistamines ||| Armes d'escrime
0.2699543237686157 ||| Tenofovir is primarily excreted by the kidney by both filtration and an active tubular transport system with approximately 70 to 80% of the dose excreted unchanged in urine following intravenous administration. ||| After absorption, 66% of pravastatin undergoes a first-pass extraction through the liver, which is the primary site of its action and the primary site of cholesterol synthesis and clearance of LDL- ||| Le ténofovir est principalement éliminé par voie rénale, à la fois par filtration et par un système de transport tubulaire actif, environ 70 à 80% de la dose excrétée se retrouvant sous forme inchangée dans les urines après administration intraveineuse.
0.353623628616333 ||| Due to the mechanism of action of fulvestrant, there is a potential risk of osteoporosis. ||| Because Avonex is based on a protein, there is a small chance of an allergic reaction. ||| Etant donné le mécanisme d’ action du fulvestrant, il existe un risque potentiel d’ ostéoporose.
2.803447036146822e-13 ||| Nespo did not reveal any genotoxic potential nor did it have any effect on the proliferation of non- haematological cells in vitro or in vivo. ||| Nespo did not reveal any genotoxic potential nor did it have any effect on the proliferation of non- haematological cells in vitro or in vivo. ||| 286 L’ utilisation de Nespo n’ a pas permis de mettre en évidence une génotoxicité potentielle ni d’ effet sur la prolifération des cellules non hématologiques in vitro ou in vivo.
0.3643565773963928 ||| Medicated supplements for foodstuffs for animals ||| Milk for use as foodstuffs for animals ||| Compléments alimentaires pour animaux à usage vétérinaire
0.4315882921218872 ||| These effects do not depend upon changes in heart rate, blood pressure, or vasodilation. ||| No association was found for age, weight, body mass index and duration of epilepsy. ||| Ces effets ne dépendent des changements ni du rythme cardiaque, ni de la pression sanguine, ni de la vasodilatation.
0.1297539621591568 ||| The measure will help them cover their immediate liquidity needs and continue their essential activities during these difficult times. ||| It will help these farmers to cover their immediate liquidity needs and continue their activities during these challenging times. ||| Cette mesure les aidera à couvrir leurs besoins immédiats de liquidités et à poursuivre leurs activités essentielles en cette période difficile.
0.0 ||| Table 3 presents adverse reactions by system organ class and by frequency category. ||| Table 3 presents adverse reactions by system organ class and by frequency category. ||| Le tableau 3 présente les effets indésirables par système organe et par catégorie de fréquence.
0.6085686087608337 ||| Before taking Exelon it is important that you read the following section and discuss any questions you might have with your doctor. ||| It is essential but may take some time to search for answers to the above and many other questions. ||| Avant de prendre Exelon, il est important de lire attentivement les rubriques suivantes et d'en parler si nécessaire, à votre médecin.
0.3258538842201233 ||| However patients should be advised that their ability to drive and operate machines may be compromised due to their Parkinson’ s disease symptoms. ||| Patients should be instructed to report any new visual problems and symptoms which may be associated with visual field constriction. ||| Toutefois, les patients doivent être informés que cette aptitude peut être compromise par leurs symptômes parkinsoniens.
3.6763371210127294e-13 ||| The subsequent dosage of should be adjusted according to blood pressure response. ||| The subsequent dosage of should be adjusted according to blood pressure response. ||| La posologie de  sera ensuite ajustée en fonction de la réponse tensionnelle.
0.3957737982273102 ||| Pharmaceutical preparations for use in hematology ||| Processing of biopharmaceutical materials for others ||| Produits pharmaceutiques pour l'hématologie
0.4125562608242035 ||| Premedication with antihistamines and/ or glucocorticoids may be considered.  Patients taking beta-blockers It should be noted that patients using beta-blockers do not necessarily respond to the beta-agonists usually used for the treatment of hypersensitivity reactions.  Patients with cardiovascular disease In this group of patients hypersensitivity reactions may be severe. ||| In addition:  if you are being treated after a heart attack, a combination with ACE inhibitors (a medication to treat heart attack) is not recommended.  if you are being treated for heart failure, a triple combination with ACE inhibitors and beta blockers (medications to treat heart failure) is not recommended. ||| Une prémédication à base d’antihistaminiques et/ou de glucocorticoïdes pourra être envisagée.  Patients sous bêtabloquants Il est à noter que les patients sous bêtabloquants peuvent ne pas répondre aux bêta-agonistes habituellement utilisés pour le traitement des réactions d’hypersensibilité.  Patients atteints de maladies cardiovasculaires Chez ces patients, les réactions d’hypersensibilité peuvent être sévères.
0.3770228624343872 ||| kg/tonne* ||| 5 kg/tonne* ||| 10 kg/tonne*
0.22397610545158386 ||| INOmax is a gas for inhalation that contains the active substance nitric oxide diluted in nitrogen gas at 400 parts per million (ppm). ||| Prialt is a solution for infusion containing the active substance ziconotide, at concentrations of 100 or 25 micrograms per millilitre. ||| INOmax est un gaz pour inhalation dont le principe actif est l’ oxyde nitrique, dilué dans de l’ azote à raison de 400 parties par million (ppm).
0.08929479867219925 ||| ARICLAIM 30 mg hard gastro-resistant capsules ARICLAIM 60 mg hard gastro-resistant capsules Duloxetine (as hydrochloride) ||| XERISTAR 30 mg hard gastro-resistant capsules XERISTAR 60 mg hard gastro-resistant capsules Duloxetine (as hydrochloride) ||| ARICLAIM 30 mg, gélule gastro-résistante ARICLAIM 60 mg, gélule gastro-résistante Duloxétine (sous forme de chlorhydrate)
0.29123198986053467 ||| How does Altargo work? ||| How does Kinzalkomb work? ||| Comment Altargo agit -il?
0.438861608505249 ||| In view of the limited data, patients with renal insufficiency should be monitored carefully while on bexarotene therapy. ||| - Difficulty breathing while asleep, called sleep apnoea, should be examined by a specialist. ||| Les données étant limitées, les patients avec une insuffisance rénale seront étroitement surveillés lors du traitement par bexarotène.
0.4976527690887451 ||| The pharmacokinetic profile of AVONEX has been investigated indirectly with an assay that measures interferon antiviral activity. ||| The efficacy of YENTREVE is reinforced when combined with a training program called Pelvic Floor Muscle Training (PFMT). ||| Le profil pharmacocinétique d’ AVONEX a été évalué par une méthode de dosage indirecte qui mesure l’ activité antivirale de l’ interféron.
0.4881916046142578 ||| This intends to boost public health emergency preparedness and response work in countries with weak health systems and limited resilience. ||| These energy savings, diversification and domestic production will help to build a more resilient European economy. ||| Cela vise à renforcer la préparation et la réponse aux situations d'urgence en matière de santé publique dans les pays où les systèmes de santé sont faibles et dont la résilience est limitée.
0.42032432556152344 ||| The additional studies showed that the presence of antibodies was maintained for up to five years. ||| Another study has also looked at the use of Protopic for up to 4 years in about 800 patients. ||| Les études complémentaires ont montré que la présence d’ anticorps avait persisté jusqu’ à cinq ans.
0.6772041320800781 ||| 81 Ireland Merck Serono Ltd. ||| • Novartis Europharm Ltd ||| Ireland Merck Serono Ltd.
0.2264682650566101 ||| Merck Sharp & Dohme BV, Postbus 581, 2003 PC, Haarlem The Netherlands ||| Merck Sharp & Dohme BV PO Box 581 NL-2003 PC Haarlem The Netherlands ||| Merck Sharp & Dohme BV, Postbus 581, 2003 PC, Haarlem Pays-Bas
0.3300231993198395 ||| Foam mats for use on play area surfaces ||| Penetrating oils for use on door locks ||| Tapis en mousse pour aires de jeu
0.24682685732841492 ||| Printed manuals ||| Printed lectures ||| Manuels imprimés
0.4359118342399597 ||| In the second clinical study (ASSERT), 279 patients were randomized to receive either placebo (Group 1, n=78) or 5 mg/ kg infliximab (Group 2, n=201) at 0, 2 and 6 weeks and every 6 weeks to week 24. ||| In the STRIDE-2 trial 93 (38%) of the 246 patients were classified at baseline as NYHA functional class II (mean baseline 6 minute walk distance 370 meters) and 144 (59%) as functional class III (mean baseline 6 minute walk distance 322 meters). ||| Dans la seconde étude clinique (ASSERT), 279 patients ont été randomisés pour recevoir soit du placebo (Groupe 1, n=78), soit 5 mg/ kg d’ infliximab (groupe 2, n=201) aux semaines 0, 2 et 6 puis toutes les 6 semaines jusqu’ à la semaine 24.
0.3757854700088501 ||| Do not use in dogs used for breeding and in lactating or pregnant bitches. ||| Do not use in bitches (prepubertal and adult) intended for breeding. ||| Ne pas utiliser chez les reproducteurs ni chez les chiennes en lactation ou en gestation.
0.3797682523727417 ||| High chairs for babies ||| Hair conditioners for babies ||| Chaises hautes pour enfants
0.2690257430076599 ||| Levellers [machines] ||| Bench presses [machines] ||| Niveleuses [machines]
0.34615981578826904 ||| Burner maintenance and repair ||| Leather cleaning and repair ||| Entretien et réparation de brûleurs
0.20951083302497864 ||| 4.1 ||| 4.2 ||| 4,1
0.270270973443985 ||| People with known hypersensitivity to the macrolide class should avoid contact with the product. ||| People with known hypersensitivity to NSAIDS should avoid contact with the veterinary medicinal product. ||| Les personnes présentant une hypersensibilité connue à la classe des macrolides doivent éviter tout contact avec ce produit.
0.0 ||| Blood and lymphatic system disorders: ||| Blood and lymphatic system disorders: ||| Troubles du système sanguin et lymphatique:
0.48366910219192505 ||| Enbrel 25 mg powder and solvent for solution for injection etanercept ||| In adults taking ribavirin and an alpha interferon product: ||| Enbrel 25 mg poudre et solvant pour solution injectable etanercept
0.06615651398897171 ||| Misuse of Nespo by healthy persons may lead to an excessive increase in packed cell volume. ||| Misuse of Aranesp by healthy persons may lead to an excessive increase in packed cell volume. ||| Un usage détourné de Nespo chez des sujets sains peut entraîner une augmentation excessive de l’ hématocrite.
0.12596003711223602 ||| 0 (0.0%) 1 (0.2%) 1 (0.2%) ||| 3 (0.6%) 0 (0%) 1 (0.2%) ||| 0 (0.0%) 1 (0.2%) 1 (0.2%) 5 (1.1%)
0.003145420690998435 ||| 53 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 51 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 55 MENTIONS DEVANT FIGURER SUR L'EMBALLAGE EXTERIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
0.34662574529647827 ||| Instructions for use – preparation, handling and disposal ||| Instructions for use and handling – reconstitution, dilution and administration ||| Instructions d’ utilisation – préparation, manipulation et élimination
0.07951771467924118 ||| There are no adequate data from the use of tolcapone in pregnant women. ||| There are no adequate data from the use of Vectibix in pregnant women. ||| Il n’ y a pas de données suffisantes sur l'utilisation de tolcapone chez les femmes enceintes.
0.002208027523010969 ||| Ciprofloxacin Bayer and associated names (see Annex I) 750 mg film-coated tablets [See Annex I - To be completed nationally] Ciprofloxacin ||| Ciprofloxacin Bayer and associated names (see Annex I) 100 mg film-coated tablets [See Annex I - To be completed nationally] Ciprofloxacin ||| Ciprofloxacine Bayer et noms associés (voir Annexe I) 750 mg, comprimés pelliculés [Voir Annexe I – À compléter au niveau national] Ciprofloxacine
0.5064924955368042 ||| Doses should be similarly reduced if the platelet count falls below 25 x 109/ l. ||| Typical sizing ranges from 5.5 to 9.0 at an increment of 0.5. ||| Les doses doivent être réduites de la même manière si le nombre de plaquettes est inférieur à 25 x 109/ l.
0.16682817041873932 ||| On 2nd September 2004, Italy (Agencizia Italiana del Farmaco) presented to the EMEA a referral under Article 30 of Directive 2001/ 83/ EC, in order to harmonise the nationally authorised summaries of product characteristics, PL and labelling of the medicinal product Neurontin and associated names. ||| On 24 July 2007 the European Commission presented to the EMEA a referral under Article 30 of Directive 2001/ 83/ EC, as amended, in order to harmonise the nationally authorised Summaries of Product Characteristics (SPC), Labelling and Package Leaflet of the medicinal product Risperdal and associated names. ||| Le 2 septembre 2004, l’ Italie (Agenzia Italiana del Farmaco) a saisi l’ EMEA en vertu de l’ article 30 de la directive 2001/ 83/ CE, en vue d’ une harmonisation de la notice et de l’ étiquetage du médicament Neurotin et dénominations associées et des résumés nationaux autorisés de leurs caractéristiques.
0.13910827040672302 ||| Intramuscular injection Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection or infusion should be dissolved in 3.5 ml of 1% w/ v lidocaine hydrochloride injection solution. ||| Intravenous injection Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection or infusion should be dissolved in 10 ml of water for injections (resulting volume 10.8 ml, concentration 93 mg/ ml). ||| Injection intramusculaire Ceftriaxone Tyrol Pharma et autres dénominations (voir Annexe I) 1 g, poudre pour solution injectable ou pour perfusion doit être dissous dans 3,5 ml d’une solution injectable de chlorhydrate de lidocaïne à 1% (m/v).
0.18816405534744263 ||| - if you have liver problems ||| - if you have severe liver disease ||| - si vous avez des problèmes hépatiques
0.318052738904953 ||| Nervous system disorders Very common: ||| 22 Immune system disorders Very rare: ||| Affections du système nerveux
0.31942304968833923 ||| 3.9-4.5). ||| 3.5-4.6). ||| 3,9 -4,5).
0.7607799172401428 ||| - do not open, crush or chew the capsules. ||| Do not puncture, break or burn even when apparently empty ||| - ne pas ouvrir, écraser ou mâcher les gélules.
0.5021398663520813 ||| Tipranavir ||| Rifampicin ||| 12 Tipranavir
0.6199730634689331 ||| Crematorium services ||| Galvanization services ||| Services de crémation
0.41273754835128784 ||| hostility, confusion and emotional lability, depression, anxiety, nervousness, thinking abnormal ||| - hyperactivity, agitation, confusion, disorientation, hallucinations ||| agressivité, confusion et labilité émotionnelle, dépression, anxiété, nervosité, trouble de la pensée
0.2692817449569702 ||| You should tell your doctor if you have suffered from any other serious illness in the past. ||| Tell your doctor if you have experienced any health problems after previous administration of a vaccine. ||| Informez votre médecin si vous avez présenté une autre maladie grave dans le passé.
0.01353338360786438 ||| Neupro 4 mg/24 h transdermal patch Rotigotine ||| Neupro 6 mg/24 h transdermal patch Rotigotine ||| Neupro 4 mg/ 24 h dispositif transdermique Rotigotine
0.41659867763519287 ||| An alert by the US Federal Bureau of Investigation regarding the possible threat of far-right extremists intentionally spreading the coronavirus mentioned blame being assigned to Jews and Jewish leaders for causing the pandemic and several statewide shutdowns across the US. ||| A number of provincial-level administrators of the Communist Party of China (CPC) were dismissed over their handling of the quarantine efforts in Central China, a sign of discontent with the political establishment's response to the outbreak in those regions. ||| Une alerte du FBI sur la menace d'une propagation intentionnelle potentielle du coronavirus par des activistes d'extrême droite, a fait état que l'on reprochait aux juifs d'avoir provoqué la pandémie ainsi que plusieurs fermetures à l'échelle de l'État aux États-Unis[pas clair].
0.3252461552619934 ||| The company that makes Cubicin will carry out further studies with Cubicin to investigate whether it has an effect on the muscle, and to look at its safety and effectiveness in patients with kidney disease and in the elderly. ||| We are exchanging further with the World Organisation for Animal Health, so that they may benefit from the project's experience in the field, to extend its epidemio-surveillance activities to the presence of coronavirus in wildlife. ||| La société qui fabrique Cubicin réalisera des études supplémentaires relativement à Cubicin pour investiguer s'il a un effet sur le muscle, et concernant sa sécurité et son efficacité chez les patients atteints d'une affection rénale et chez les personnes âgées.
0.24245858192443848 ||| Respiratory, thoracic and mediastinal disorders Common: pulmonary oedema, lung infiltration, pneumonitis Uncommon: bronchospasm, pulmonary hypertenstion, asthma Rare: acute respiratory distress syndrome ||| Respiratory, thoracic and mediastinal disorders Common: pharyngitis, rhinitis Uncommon: cough, dyspnoea Very rare: bronchospasm. ||| 74 Affections respiratoires, thoraciques et médiastinales Fréquent: œ dème pulmonaire, infiltration pulmonaire, pneumonite Peu fréquent: bronchospasme, hypertension pulmonaire, asthme Rare: syndrome de détresse respiratoire aigu
2.9583456452771106e-13 ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| De plus, un PGR mis à jour devra être soumis: • Lors de la réception de nouvelles informations pouvant avoir un impact sur le profil de sécurité d’ emploi, le plan de pharmacovigilance ou les activités de minimisation des risques; • Dans les 60 jours qui suivent la date à laquelle une étape importante (pharmacovigilance ou minimisation des risques) est franchie; • A la demande de l’ EMEA
0.0032222324516624212 ||| 209 Combination therapy PegIntron 1.5 micrograms/kg/week in combination with ribavirin capsules. ||| 186 Combination therapy PegIntron 1.5 micrograms/kg/week in combination with ribavirin capsules. ||| Traitement combiné PegIntron 1,5 microgrammes/ kg/ semaine avec des gélules de ribavirine.
0.4936196208000183 ||| If needed (doses over 100 mg) all the above steps for preparation of the suspension should be repeated. ||| - Addition of a statement that prescribers should use the lowest effective dose, for the shortest ||| Si nécessaire (doses supérieures à 100 mg), réitérer les étapes ci-dessus pour achever la préparation de la suspension.
0.3916704058647156 ||| In the event of substantial overdose, vomiting may be considered to remove unabsorbed active substance. ||| Where there is active bleeding or bleeding tendency it is generally not advisable to administer Refludan. ||| En cas de surdosage important, il peut être envisagé de provoquer des vomissements afin d’ éliminer le médicament non absorbé.
0.9067695140838623 ||| Subjects with a 10% 7.8% weight reduction ||| • 80% reported reduced expenditures; ||| réduction de poids > 10% Différence
0.28826549649238586 ||| To avoid the risk of cross-infection always follow aseptic techniques and use disposable sterile syringes and needles for each administration. ||| The use of rigid catheters as well as intramuscular injections and non-essential handling of the patient should be avoided during treatment with Metalyse. ||| Pour éviter tout risque de contamination, il faut toujours suivre les techniques d'asepsie et utiliser des seringues et des aiguilles à usage unique.
0.5708216428756714 ||| Vertigo ||| Altargo ||| Vertige
0.19489923119544983 ||| Collapse or shock-like state (hypotonic-hyporesponsive episode). ||| Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hours. ||| Collapsus ou état de choc (épisode d'hypotonie-hyporéactivité)
0.0 ||| Your doctor will test your blood to ensure that your white blood cell (cells that fight infection) and red blood cell (cells that carry iron and oxygen) counts, platelets (blood clotting cells) and other laboratory values are at acceptable levels. ||| Your doctor will test your blood to ensure that your white blood cell (cells that fight infection) and red blood cell (cells that carry iron and oxygen) counts, platelets (blood clotting cells) and other laboratory values are at acceptable levels. ||| Votre médecin vérifiera votre sang pour s’assurer que la numération de vos cellules sanguines blanches (cellules qui luttent contre l’infection), cellules sanguines rouges (cellules qui transportent le fer et l’oxygène), plaquettes (cellules pour la coagulation sanguine) et des autres valeurs de laboratoire sont dans des limites acceptables.
0.008075263351202011 ||| The increased efavirenz concentrations observed following administration of SUSTIVA with food may lead to an increase in frequency of adverse reactions (see sections 4.4 and 5.2). ||| The increased efavirenz concentrations observed following administration of SUSTIVA with food may lead to an increase in frequency of adverse reactions (see sections 4.4. and 5.2). ||| Une augmentation des concentrations d’ éfavirenz observée suite à l'administration de SUSTIVA avec de la nourriture peut entraîner une augmentation de la fréquence des effets indésirables (voir rubriques 4.4 et 5.2).
0.2537633776664734 ||| Special caution should be exercised in situations where renal function may become impaired, for example when initiating antihypertensive therapy or diuretic therapy and when starting therapy with an NSAID. ||| If necessary, Liprolog may also be administered intravenously, for example; for the control of blood glucose levels during ketoacidosis, acute illnesses or during intra and post operative periods. ||| Des précautions particulières doivent être observées lorsque la fonction rénale est susceptible de s’ altérer, comme par exemple lors de la mise en place d’ un traitement antihypertenseur ou diurétique, ainsi qu’ au début d’ un traitement par un AINS.
0.16997092962265015 ||| Blister for Januvia 50 mg film-coated tablets ||| Outer carton for Januvia 50 mg film-coated tablets ||| Plaquette thermoformée pour Januvia 50 mg, comprimés pelliculés
0.030208103358745575 ||| In view of the above, to prevent such events, when the ovarian response is excessive, treatment with Pergoveris could be discontinued by your physician and the treatment with hCG abandoned. ||| In view of the above, to prevent such events, when the ovarian response is excessive, treatment with GONAL-f could be discontinued by your physician and the treatment with hCG abandoned. ||| Par conséquent, afin d’ éviter de tels effets, lorsque la réponse ovarienne est excessive, le traitement par Pergoveris pourra être suspendu par votre médecin et le traitement par hCG ne sera pas administré.
0.31069260835647583 ||| Each ml of solution for infusion contains 10 mg lacosamide. ||| One ampoule of solvent contains:1 ml water for injections. ||| Chaque ml de solution pour perfusion contient 10 mg de lacosamide.
0.6854194402694702 ||| Elderly patients (≥ 65 years): ||| Elderly above 75 years: ||| Patients âgés (≥ 65 ans):
0.26873716711997986 ||| The most frequently reported adverse reactions related to VIRAMUNE therapy, across all clinical trials, were rash, allergic reactions, hepatitis, abnormal liver function tests, nausea, vomiting, diarrhoea, abdominal pain, fatigue, fever, headache and myalgia. ||| Parkinson’ s disease, most common adverse events The most commonly (≥ 5%) reported adverse drug reactions in patients with Parkinson’ s disease more frequent with SIFROL treatment than with Placebo were nausea, dyskinesia, hypotension, dizziness, somnolence, insomnia, constipation, hallucination, headache and fatigue. ||| Au cours des essais cliniques, les effets indésirables le plus souvent décrits et imputés à VIRAMUNE ont été des cas d'éruption cutanée, de réactions allergiques, d’ hépatites, des tests de la fonction hépatique anormaux, de nausées, de vomissements, de diarrhées, de douleurs abdominales, d'asthénie, de fièvre, de céphalées, et de myalgies.
0.2693842053413391 ||| After cleaning, do not touch the stopper with your hands. • Remove cap from needle syringe, being careful not to touch needle or let it touch any surface. • Make sure that the plunger is fully inserted into the syringe. ||| Clean the rubber stopper on the vial, but do not remove the stopper. • Use a clean, sterile syringe and needle to pierce the rubber stopper and draw in the amount of Liprolog you want. ||| Ne touchez plus le bouchon après, avec les mains • Enlevez le capuchon de l’aiguille en faisant attention à ne pas toucher l’aiguille, ni à ce qu’elle touche quelque surface que ce soit • Assurez-vous que le piston est complètement inséré dans la seringue.
0.20088553428649902 ||| A clinical trial investigating the combination of telbivudine, 600 mg daily, with pegylated interferon alfa-2a, 180 micrograms once weekly by subcutaneous administration, indicates that this combination is associated with an increased risk of developing peripheral neuropathy. ||| In a 24-week placebo-controlled factorial study of initial therapy, sitagliptin 50 mg twice daily in combination with metformin (500 mg or 1000 mg twice daily) provided significant improvements in glycaemic parameters compared with either monotherapy. ||| Une étude clinique, évaluant l’ association telbivudine 600 mg une fois par jour et interféron alpha-2a pégylé 180 µg une fois par semaine par voie sous-cutanée, montre que cette association est liée à un risque accru de survenue de neuropathie périphérique.
0.5321122407913208 ||| The text in the harmonised SPC is not so dissimilar to the currently approved SPCs that it will significantly change clinical practices. ||| However the wording (and therefore the precise meaning) of the approved indication is very different in the different nationally approved summaries of product characteristics. ||| Le texte du RCP harmonisé ne diffère pas des RCP actuellement approuvés au point de changer notablement les pratiques cliniques.
3.381362030652202e-13 ||| - pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), ||| - pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), ||| - la pentoxifylline, le propoxyphène, les salicylates (tels que l’aspirine, utilisée pour soulager la
0.4003303647041321 ||| QN 01AB08 ||| A08AX01 no ||| QN 01 AB 08
0.27421534061431885 ||| The company that makes Prialt is carrying out a study looking at the long term use of the medicine, looking in particular at the possibility of development of tolerance to treatment (when doses of a medicine that were effective become less effective over time). ||| It noted that the benefit of Truvada has only been shown in patients who have not taken HIV treatment before, but that the simplified dosing regimen offered by the combination tablet taken once a day may help patients to stick to their treatment. ||| La société qui fabrique Prialt réalise actuellement une étude sur l’ utilisation à long terme du médicament, portant en particulier sur la possibilité d’ un développement de la tolérance au traitement (lorsque des doses d’ un médicament qui étaient efficaces deviennent au fur et à mesure moins efficaces).
0.1301315724849701 ||| Please consult your doctor before you receive any vaccines.  Chickenpox: ||| Please consult your doctor before you or the child receive any vaccines.  Chickenpox: ||| Veuillez consulter votre médecin sur ce pointavant de vous faire vacciner. • Varicelle:
0.5224349498748779 ||| The DESI was re-calculated for all countries for previous years to reflect the changes in the choice of indicators and corrections made to the underlying data. ||| The MAH acknowledged that the indication section varies a lot from one Member State to the other but that the wording differences corresponded to three well-identified indications. ||| L'indice DESI a été recalculé pour tous les pays pour les années précédentes afin de tenir compte des changements dans le choix des indicateurs et des corrections apportées aux données sur lesquelles ils se fondent.
0.2138661891222 ||| In a study evaluating the influence of renal function on ranolazine pharmacokinetics, ranolazine AUC was on average 1.7- to 2-fold higher in subjects with mild, moderate, and severe renal impairment compared with subjects with normal renal function. ||| In a study comparing 9 patients with mild (Child-Pugh A) hepatic impairment to 9 controls, the single and multiple dose exposure of tipranavir and ritonavir were increased in patients with hepatic impairment but still within the range observed in clinical studies. ||| Insuffisance rénale: au cours d’ une étude évaluant l’ influence de la fonction rénale sur la pharmacocinétique de la ranolazine, l’ ASC de la ranolazine était en moyenne de 1,7 à 2 fois plus élevée chez les sujets atteints d’ insuffisance rénale légère, modérée et sévère que chez les sujets dont la fonction rénale était normale.
0.3583418130874634 ||| Glass fiber insulation materials for use in construction ||| Textile materials for use as window coverings ||| Matériaux isolants en fibres de verre pour la construction
0.3607088625431061 ||| - clonidine (used to treat high blood pressure), ||| - simvastatin (used to lower cholesterol), ||| - de la clonidine (utilisés pour traiter l’ hypertension artérielle),
0.3204946517944336 ||| If after some weeks on the recommended dose insufficient response is seen some patients may benefit from having their dose increased gradually in 10 mg steps up to a maximum of 50 mg/ day. ||| After one week the dose may be increased to 100 mg daily and then further increased in steps of 100 mg every week, depending on the patient’ s response. ||| En cas de réponse insuffisante après plusieurs semaines de traitement à la dose recommandée, certains patients peuvent tirer bénéfice d’ une augmentation progressive de dose par palier de 10 mg par semaine, jusqu’ à un maximum de 50 mg par jour.
0.6633650064468384 ||| and besides do you have difficulty breathing ||| but i have difficulty breathing ||| avez-vous également des difficultés à respirer?
0.2563588321208954 ||| 1.5 ml of oral suspension in a pre-filled oral applicator (type I glass) with a plunger stopper (rubber butyl) and a protective tip cap (rubber butyl) in pack sizes of 1, 5, 10 or 25. ||| 300 ml brown glass bottle with a child-resistant closure, including a polyethylene sealing disc and a guarantee ring and a polypropylene dosing cup with embossed graduations of 5 to 30 ml in 5 ml increments. ||| 20 1,5 ml de suspension buvable en applicateur pré-rempli pour administration orale (verre de type I) avec un bouchon-piston (gomme butyle) et un capuchon protecteur (gomme butyle) en boîte de 1, 5, 10 ou 25.
0.42846155166625977 ||| The incidence rates of QTc ≥ 500 ms post baseline or QTc increase of ≥ 60 ms is 1.9%, 1.3%, 1.4% and 1.5%, for fesoterodine 4 mg, 8 mg, 12 mg and placebo, respectively. ||| The ACR (American College of Rheumatology) response rates in study YU203 were 27.7% for placebo, 31.9% for 5 mg, 50.5% for 10 mg and 54.5% for 25 mg/ day. ||| Le taux d’ incidence des intervalles QTc ≥ 500 ms après l’ inclusion ou des augmentations de l’ intervalle QTc ≥ 60 ms sont respectivement de 1,9%, 1,3%, 1,4% et 1,5% pour la fésotérodine à 4 mg, 8 mg, 12 mg et pour le placebo.
0.40184032917022705 ||| - tingling or numbness, pain, loss of reflexes, paralysis on a nerve route, itching and rash. ||| - Fits, disturbances in consciousness, tingling and numbness (sometimes painful) in the hands and ||| - Fourmillements ou engourdissements, douleurs, perte des réflexes, paralysie siégeant sur le
0.36628463864326477 ||| See 3 How to use NovoMix 30. ||| How to use NovoMix 50 4. ||| Voir 3 Comment utiliser NovoMix 30.
0.08616973459720612 ||| The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Yarvitan exceed its risks for the management of overweight and obesity in dogs and recommended that Yarvitan be given a marketing authorisation. ||| The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Prac-tic exceed the risks for the treatment and prevention of flea and tick infestations in dogs; and recommended that Prac-tic be given a marketing authorisation. ||| Le comité des médicaments à usage vétérinaire (CVMP) a estimé que le rapport bénéfice/ risque de Yarvitan pour la prise en charge du surpoids et de l'obésité chez les chiens était positif et a donc recommandé la délivrance d'une autorisation de mise sur le marché pour Yarvitan.
0.32903924584388733 ||| Tell your doctor, if any of the above applies to you. ||| Tell your doctor if this applies to you. ||| Si l’un de ces cas s’applique à vous, parlez-en à votre médecin.
0.7255231142044067 ||| Soil, waste or water treatment services [environmental remediation services] ||| - Fitting out, lease & other building related costs - IT, data processing ||| Services de traitement de sols, de déchets ou d'eau [services de dépollution environnementale]
0.38756299018859863 ||| Lift and elevator installation, maintenance and repair ||| Underwater construction, installation and repair ||| Installation, entretien et réparation d'ascenseurs et élévateurs
3.675109804153476e-13 ||| This helps to correct the iron overload and prevent damage due to excess iron. ||| This helps to correct the iron overload and prevent damage due to excess iron. ||| Cela aide à corriger la surcharge de fer et à éviter les lésions induites par cet excès de fer.
0.06936909258365631 ||| WHAT COMBIVIR IS AND WHAT IT IS USED FOR ||| WHAT REVLIMID IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE COMBIVIR ET DANS QUEL CAS EST-IL UTILISE
0.23087751865386963 ||| Ísland Actelion Pharmaceuticals Sverige AB Sími: +46-(0)8 544 982 50 ||| 60 България Actelion Pharmaceuticals Austria GmbH Teл.: +43-(0)1 505 4527 ||| Ísland Actelion Pharmaceuticals Sverige AB Simi: +46-(0)8 544 982 50
0.3376331925392151 ||| No meaningful clinical data on exposure during pregnancy are available. ||| There are no data available on adverse effects in breast-feeding infants. ||| Aucune donnée clinique significative concernant l’ exposition au cours de la grossesse n’ est disponible.
0.1727740466594696 ||| Xeloda is an anticancer medicine. ||| Hycamtin is an anticancer medicine. ||| Xeloda est un anticancéreux.
0.34648680686950684 ||| Do not change your dose unless your doctor has told you to. ||| Under no circumstances should you change the dose without first speaking to your doctor. ||| Ne modifiez pas votre dose sans l’ avis de votre médecin.
0.6811535358428955 ||| Crematorium services ||| Ticker tape services ||| Services de crémation
0.26812121272087097 ||| Clean the rubber stopper of the vial of SOMAVERT with an antiseptic or alcohol swab. ||| Clean the rubber stopper on the top of the vial containing the IntronA solution with a cleansing swab. ||| Désinfecter le bouchon en caoutchouc du flacon de SOMAVERT avec un tampon imbibé d'antiseptique ou d'alcool.
0.5124620199203491 ||| Aquatic herbicides ||| Agricultural pesticides ||| Herbicides aquatiques
3.3865106357187924e-13 ||| In very rare cases (≤ 1/ 10.000), epoetin beta treatment- related anaphylactoid reactions have been reported. ||| In very rare cases (≤ 1/ 10.000), epoetin beta treatment- related anaphylactoid reactions have been reported. ||| De très rares cas (≤ 1/ 10.000) de réactions anaphylactoïdes ont été rapportés.
0.25489377975463867 ||| Do not take Tredaptive if • you are allergic (hypersensitive) to nicotinic acid, to laropiprant, or to any of the other ingredients of Tredaptive (listed in section 6). • you currently have liver problems. • you have an ulcer in your stomach. • you have arterial bleeding. ||| • if you previously had a serious allergic reaction (i. e. life-threatening) to CELVAPAN. • if you are allergic to any of the ingredients or trace residues (formaldehyde, benzonase, sucrose) contained in the vaccine. ||| Ne prenez jamais Tredaptive, si • vous êtes allergique (hypersensible) à l’ acide nicotinique, au laropiprant ou à l’ un des autres composants contenus dans Tredaptive (indiqués en rubrique 6), • vous souffrez d’ un mauvais fonctionnement du foie, • vous avez un ulcère à l’ estomac, • vous présentez des saignements artériels.
0.33430370688438416 ||| The company presented the results of two clinical trials comparing the effects of MULTAQ and placebo (a dummy treatment) on the maintenance of normal heart rhythm. ||| The company presented the results of studies examining the effectiveness of Veraflox against a range of conditions involving bacterial infections in cats and dogs. ||| La société a présenté les résultats de deux études cliniques comparant les effets de MULTAQ et d'un placebo (traitement fictif) sur le maintien d'un rythme cardiaque normal.
0.1699797809123993 ||| Chemical additives for transmission fluids ||| Chemical additives for oils ||| Additifs chimiques pour liquides de transmission
0.11436668038368225 ||| AVANDAMET 2 mg/ 500 mg film-coated tablets rosiglitazone/ metformin HCl ||| AVANDAMET 4 mg/ 1000 mg tablets rosiglitazone/ metformin HCl ||| AVANDAMET 2 mg/ 500 mg comprimés pelliculés rosiglitazone/ metformine HCl
0.5261719226837158 ||| Bowls [games] ||| Cameras [photography] ||| Bowling [jeu]
0.34788423776626587 ||| Monotherapy The list below includes adverse reactions which were reported with a higher incidence in placebo- controlled studies, in patients receiving 1 mg/ day rasagiline (rasagiline group n=149, placebo group n=151). ||| 1000 patient-years, diet alone 18 events/ 1000 patient-years (p=0.01) For metformin used as second-line therapy, in combination with a sulfonylurea, benefit regarding clinical outcome has not been shown. ||| Monothérapie La liste ci-dessous comprend les effets indésirables qui ont été notifiés avec une incidence plus élevée chez les patients recevant 1 mg/ jour de rasagiline au cours des études contrôlées versus placebo (groupe traité par la rasagiline n = 149, groupe recevant le placebo n = 151).
0.3625476658344269 ||| Eucreas is used to treat patients with type 2 diabetes. ||| Caelyx is also used to treat cancer of the ovary. ||| Eucreas est utilisé dans le traitement du diabète de type 2.
3.102478668935704e-13 ||| Renal and urinary system Crystalluria related to the use of ciprofloxacin has been reported (see section 4.8). ||| Renal and urinary system Crystalluria related to the use of ciprofloxacin has been reported (see section 4.8). ||| 87 Système rénal et urinaire Des cas de cristallurie liée à l’utilisation de ciprofloxacine ont été signalés (voir rubrique 4.8).
0.1401609629392624 ||| How has Zyprexa been studied? ||| How has Noxafil been studied? ||| Quelles études ont été menées sur Zyprexa?
0.7838746905326843 ||| How do these break down per Member State? ||| How will these resources be distributed among Member States? ||| Quelle sera leur répartition entre les États membres?
0.6036874055862427 ||| Objectives for response to an outbreak include reducing transmission among staff, protecting people who are at higher risk for adverse health complications, maintaining business operations, and minimizing adverse effects on other entities in their supply chains. ||| The federal government has identified 16 critical infrastructure sectors whose assets, systems, and networks, whether physical or virtual, are considered so vital to the United States that their incapacitation or destruction would have a debilitating effect on security, economic security, public health or safety, or any combination thereof. ||| Les objectifs de réponse à une épidémie comprennent la réduction de la transmission parmi le personnel, la protection des personnes à plus haut risque de complications médicales, le maintien des opérations commerciales et la réduction des effets indésirables sur d’autres entités de leurs chaînes d’approvisionnement.
0.04954060539603233 ||| The Committee recommended that Angiox be given marketing authorisation. ||| The Committee recommended that Ytracis be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Angiox.
0.8332381844520569 ||| Read the following information before you use cream. ||| Collect the necessary items before beginning: ||| Lisez les explications suivantes avant d’utiliser {Nom de fantaisie}crème.
0.360540509223938 ||| The injection button should be pressed in completely. ||| The device is opened and primed by sliding the lever. ||| 235 Le bouton d'injection doit être enfoncé à fond.
0.655609667301178 ||| - correct storage of your insulin while travelling, ||| - your insulin pen does not work properly, ||| - conservation adéquate de votre insuline pendant le voyage,
0.44820576906204224 ||| Please consult your doctor. ed ||| Please consult your doctor. ||| Consultez votre médecin.
0.22831769287586212 ||| Humalog BASAL can be given in conjunction with Humalog. ||| Humalog BASAL can be mixed with or given in conjunction with Humalog. ||| Humalog BASAL peut être administré en association avec Humalog.
0.1389528214931488 ||| Sealing profiles (Non-metallic -) ||| Collecting boxes (Non-metallic -) ||| Profils d'étanchéité non métalliques
0.3414711654186249 ||| The treatment of a vomiting dog should be started with the injection, since vomiting animals might not be able to keep a tablet down (as they might throw the intact tablet up again). ||| Opening the capsule and taking the contents with a small amount of food may be considered for children who cannot swallow the hard capsule and cannot tolerate the oral solution (see How to take SUSTIVA). ||| Le traitement d’ un chien souffrant de vomissements doit commencer par une injection du produit, étant donné que l’ animal souffrant de vomissement ne sera peut-être pas en mesure de conserver le comprimé (il se peut qu’ il rejette le comprimé intact).
0.30056363344192505 ||| The fibrin adhesion system initiates the last phase of physiological blood coagulation. ||| This is followed by the fibrinogen- thrombin reaction which initiates the last phase of physiological blood coagulation. ||| Le système d’ adhésif à base de fibrine déclenche la dernière phase de la coagulation sanguine physiologique.
0.434445858001709 ||| The company that makes BTVPUR Alsap 8 will submit an action plan together with timelines for all of the issues that need to be resolved before the authorisation can revert to normal status. ||| A major goal will be to maintain the record so far of completing opinions for all applications within the 210 day timeframe laid down in the Regulation. ||| La société qui fabrique le BTVPUR AlSap 8 doit envoyer un plan d’ actions ainsi que les délais de mise en place pour tous les problèmes devant être résolus avant que l’ autorisation puisse retrouver le statut normal.
0.822109043598175 ||| PSUR submission when Prepandrix is used during the influenza pandemic: ||| Discontinuation Management of patients discontinuing Raptiva includes close observation. ||| La soumission des PSURs durant la pandémie grippale:
0.3121463358402252 ||| If your doctor increases your dose, the liver tests will have to be repeated before increasing the dose and regularly afterwards. ||| Afterwards regular blood tests by your doctor will be required to define the correct dose and to adjust the dose from time to time. ||| Si le médecin augmente votre dose, les tests hépatiques devront être répétés avant l'augmentation de la dose et renouvelés régulièrement ensuite.
0.47826462984085083 ||| • Individuals with a lowered resistance to diseases. • Pregnant women who have either not had chickenpox or have not been vaccinated against chickenpox. • Newborn infants of mothers who have either not had chickenpox or have not been vaccinated against chickenpox. ||| The number of injections needed varies according to the type of female pig being treated: gilts (female pigs that have not yet had piglets) need to receive three injections; sows (female pigs that have had piglets before) need to receive two injections; and sows that have been vaccinated before need only one injection. ||| • Les sujets présentant une faible résistance aux maladies. • Les femmes enceintes n’ ayant pas eu la varicelle ou n’ ayant pas été vaccinées contre la varicelle. • Les nouveaux-nés de mères n’ ayant pas eu la varicelle ou n’ ayant pas été vaccinées contre la varicelle.
0.4593355655670166 ||| Preparation of special effects for entertainment purposes ||| Provision of telecommunication facilities for educational purposes ||| Préparation d'effets spéciaux à des fins de divertissement
0.49169597029685974 ||| Reproductive toxicity studies have not been performed with Pegasys. ||| Inter- and intraindividual pharmacokinetic variabilities have not been studied systematically. ||| Il n'a pas été conduit d'études de toxicité sur la reproduction avec Pegasys.
0.18873828649520874 ||| Pregnancy There are no adequate data from the use of TESAVEL in pregnant women. ||| Pregnancy No adequate information on the use of VFEND in pregnant women is available. ||| Grossesse Il n'existe pas de données suffisantes sur l'utilisation de TESAVEL chez la femme enceinte.
0.3931930363178253 ||| These dose adjustments have not been confirmed in clinical studies and the clinical response to treatment should be closely monitored in these patients (see sections 4.4 and 5.2). ||| The MAHs were of the opinion that the issues identified during the MRP were issues of clinical management and as such cannot be addressed by conducting further clinical trials. ||| Ces adaptations de la posologie n’ ont pas été confirmées dans le cadre d’ études cliniques et la réponse clinique au traitement doit être étroitement surveillée chez ces patients (voir rubriques 4.4 et 5.2).
0.24844664335250854 ||| Ask your doctor for advice if you become pregnant or intend to become pregnant. ||| Pregnancy Please consult your doctor if you plan to become pregnant. ||| Demandez conseil à votre médecin si vous devenez enceinte ou souhaitez le devenir.
0.3894568681716919 ||| Since national public support for the recapitalisation of some companies can be highly distortive for competition in the EU Single Market, the Commission is proposing a number of safeguards on the conditions for granting State aid as well as for the behaviour of the companies benefitting from it, both on the market and in terms of their governance. ||| The joint development between the EMEA and the WHO was partly motivated by the goal of developing a flexible tool that can be used to improve the information management capability of those competent authorities already using the older version of SIAMED, but also by the goal of making it available to a wider number of other national authorities in European and internationally in the medium to long-term. ||| Étant donné que le soutien public national à la recapitalisation de certaines entreprises peut fausser fortement la concurrence dans le marché unique de l'UE, la Commission propose un certain nombre de garde-fous en ce qui concerne les conditions d'octroi des aides d'État, ainsi que le comportement des entreprises qui en bénéficient, tant sur le marché qu'en termes de gouvernance.
0.14014117419719696 ||| België/ Belgique/ Belgien Sandoz nv-sa Telecom Gardens Medialaan 40 B-1800 Vilvoorde Tél/ Tel: + 32 (0)2 722 97 97 ||| België/ Belgique/ Belgien GE Healthcare BVBA Kouterveldstraat 20 BE-1831 Diegem Tél/ Tel: + 32 (0) 2 719 74 01 ||| België/ Belgique/ Belgien Sandoz nv-sa Telecom Gardens Medialaan 40 B-1800 Vilvoorde Tél: + 32 (0) 2 722 97 97
0.045136358588933945 ||| 35 As with all insulins, in elderly patients and patients with hepatic or renal impairment, glucose monitoring should be intensified and dosage adjusted on an individual basis. ||| As with all insulins, in elderly patients and patients with renal or hepatic impairment, glucose monitoring should be intensified and insulin detemir dosage adjusted on an individual basis. ||| Comme pour toutes les insulines, chez les patients âgés et chez les patients ayant des troubles hépatiques ou rénaux, la surveillance glycémique doit être intensifiée et la posologie ajustée individuellement.
0.1390451192855835 ||| The EIB financing will be provided in three €25 million tranches upon completion of pre-defined milestones. ||| The EIB debt investment will be disbursed in two tranches of €50 million each, following completion of pre-defined milestones. ||| Le financement de la BEI sera versé en trois tranches de 25 millions d'euros au fur et à mesure que la société franchit des étapes prédéfinies.
0.2285330891609192 ||| As with any vaccine, Silgard may not fully protect 100% of those who get the vaccine. ||| As with other vaccines, ProQuad may not completely protect all persons who are vaccinated. ||| Comme tout vaccin, Silgard peut ne pas protéger 100% des personnes vaccinées.
0.3812655210494995 ||| Electric torches ||| Electric woks ||| Torches électriques
0.0 ||| Evoltra is a concentrate that is made up into a solution for infusion (drip into a vein). ||| Evoltra is a concentrate that is made up into a solution for infusion (drip into a vein). ||| Evoltra est un concentré reconstitué en solution pour perfusion (goutte-à-goutte intraveineux).
0.2501540184020996 ||| However, the possibility of these changes resulting in decreased contraceptive efficacy in some patients taking hormonal preparations with lamotrigine cannot be excluded. ||| When ritonavir is co-administered, the effect on hormonal contraceptive concentrations cannot be predicted, therefore, alternative methods of contraception are also recommended. ||| Cependant on ne peut exclure la possibilité que ces changements conduisent à une diminution de l’ efficacité du contraceptif chez certaines patientes prenant des spécialités à base d’ hormones avec un traitement par lamotrigine.
0.5178879499435425 ||| Golf tuition ||| Golf putters ||| Cours de golf
0.5323913097381592 ||| Any unused product should be disposed of in accordance with local requirements. ||| any sharing of data with third parties would have to be defined in law; ||| Tout produit non utilisé ou déchet doit être éliminé conformément à la réglementation nationale en vigueur.
0.3451029658317566 ||| Through 48 weeks of treatment, two types of analyses were performed based on baseline genotypic mutations. ||| During this observational period, other osteoporosis treatments were allowed and additional assessment of vertebral fractures was performed. ||| A 48 semaines de traitement, deux types d'analyses ont été effectués en tenant compte des mutations génotypiques à l'inclusion.
0.4030570387840271 ||| Gas grills ||| Jack plugs ||| Grils à gaz
0.0452265739440918 ||| Volibris should not be used in people who may be hypersensitive (allergic) to soya, ambrisentan or any of the other ingredients. ||| Zomarist should not be used in people who may be hypersensitive (allergic) to vildagliptin, metformin or any of the other ingredients. ||| Volibris ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) au soja, à l’ ambrisentan ou à l'un des autres composants.
0.3674314320087433 ||| For treatment of pigs over 80 kg body weight, divide the dose so that no more than 2 ml are injected at one site. ||| They are combined into one tablet in Synordia in order to reduce the number of tablets the patients need to take every day. ||| Pour le traitement de porcins pesant plus de 80 kg, diviser la dose de manière à ne pas injecter plus de 2 ml au même site d’ administration.
0.8580588102340698 ||| ut Solution for injection. ||| The influenza virion is ||| au Solution injectable.
0.14882056415081024 ||| Liprolog KwikPen is also indicated for the initial stabilisation of diabetes mellitus. ||| Humalog Pen is also indicated for the initial stabilisation of diabetes mellitus. ||| Liprolog KwikPen est également indiqué pour la stabilisation initiale du diabète.
0.007176343351602554 ||| - The active substance is agalsidase beta, one vial contains 35 mg. ||| - The active substance is agalsidase beta, one vial contains 5 mg. ||| - La substance active est l’agalsidase bêta, un flacon contient 35 mg.
0.21250411868095398 ||| Chemical engineering software ||| Mechanical engineering software ||| Logiciel de génie chimique
3.6766637369171906e-13 ||| It is recommended to seek advice on conservation of sperm prior to treatment. ||| It is recommended to seek advice on conservation of sperm prior to treatment. ||| Il est recommandé de se renseigner sur la cryoconservation du sperme avant d’initier le traitement.
0.0 ||| After reconstitution 1 ml contains 50 mg bivalirudin. ||| After reconstitution 1 ml contains 50 mg bivalirudin. ||| Après reconstitution, 1 ml contient 50 mg de bivalirudine.
0.2768838107585907 ||| After cleaning, do not touch the stopper with your hands. • Remove cap from needle syringe, being careful not to touch needle or let it touch any surface. • Make sure that the plunger is fully inserted into the syringe. ||| Clean the rubber stopper on the vial, but do not remove the stopper. • Use a clean, sterile syringe and needle to pierce the rubber stopper and draw in the amount of Humalog Mix50 you want. ||| Ne touchez plus le bouchon après, avec les mains • Enlevez le capuchon de l’aiguille en faisant attention à ne pas toucher l’aiguille, ni à ce qu’elle touche quelque surface que ce soit • Assurez-vous que le piston est complètement inséré dans la seringue.
0.46306943893432617 ||| The dosage recommendations are summarised in the following table: ||| Results are summarised in the Table below. ||| Les posologies recommandées sont résumées dans le tableau suivant:
0.5629993677139282 ||| The three individuals had close contact with the person who was reported to be infected by the virus on 13 March . ||| The patient was a 77-year-old who had acquired the virus through local transmission. ||| Les trois individus ont été en contact étroit avec la personne qui aurait été infectée par le virus le 13 mars.
0.44364726543426514 ||| Foils of metal for insulating ||| Handles of metal for windows ||| Feuilles métalliques isolantes
0.5644617676734924 ||| -4.60 ||| -12.7 ||| -4,60
4.1700789956550244e-13 ||| Any unused product or waste material should be disposed of in accordance with local requirements. ||| Any unused product or waste material should be disposed of in accordance with local requirements. ||| us Tout produit non utilisé ou déchet doit être éliminé conformément à la réglementation en vigueur.
0.22768113017082214 ||| 10 vials with lyophilisate and 10 vials of 0.5 ml solvent, each in 3 ml Type I glass vials closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap, 10 applicators, 10 syringes with needle. ||| 6.5 Nature and contents of container 1 vial (type II glass) with a stopper (chlorobutyl elastomer) and a pure aluminium with internal and external lacquer flanged cap containing 7.5 ml, 15 ml or 30 ml solution for injection. ||| 10 flacons de lyophilisat et 10 flacons de 0,5 ml de solvant, chacun dans un flacon de verre type I de 3 ml fermé par un bouchon en caoutchouc halogénobutyl et scellé à l’ aide d’ une capsule en aluminium, 10 embouts, 10 seringues avec aiguille.
0.018606679514050484 ||| Irbesartan Hydrochlorothiazide Winthrop was more effective than placebo (a dummy treatment) and than hydrochlorothiazide alone in reducing diastolic blood pressure. ||| Irbesartan Hydrochlorothiazide BMS was more effective than placebo (a dummy treatment) and than hydrochlorothiazide alone in reducing diastolic blood pressure. ||| Irbesartan Hydrochlorothiazide Winthrop s’ est révélé plus efficace que le placebo (traitement fictif) et que l’ hydrochlorothiazide seul pour la réduction de la pression sanguine diastolique.
0.4203277826309204 ||| For specific dosing information in patients with renal impairment, refer to the Summary of Product Characteristics (SPC) of the co-administered protease inhibitor. ||| All sirolimus concentrations reported in this Summary of Product Characteristics were either measured using chromatographic methods or have been converted to chromatographic method equivalents. ||| Se reporter au Résumé des Caractéristiques du Produit (RCP) de l’inhibiteur de protéase co-administré avec le ritonavir pour les informations spécifiques relatives à la posologie chez les patients ayant une insuffisance rénale.
0.31779369711875916 ||| In hypertensive patients in whom the diuretic cannot be discontinued, therapy with Zestril should be initiated with a 5 mg dose. ||| Doctors may prescribe a 25 mm, 25 gauge needle to patients for whom such a needle is appropriate to administer an intramuscular injection. ||| Chez les sujets hypertendus chez lesquels le traitement diurétique ne peut pas être interrompu, le traitement par Zestril sera initié à une posologie de 5 mg.
0.509736180305481 ||| Exhibitions (Conducting -) for business purposes ||| Wedding celebrations (Organisation of entertainment for -) ||| Réalisation d'expositions à des fins commerciales
0.040211282670497894 ||| The Member States competent authorities will continue to keep the product under regular review. ||| The Member States’ competent authorities will continue to keep the product under regular review. ||| Les autorités compétentes des États membres continueront à suivre ce produit régulièrement.
0.3007313013076782 ||| Special care should be taken when administering single or combination chemotherapeutic agents which are known to cause severe thrombocytopenia. ||| If severe polycythaemia occurs, conventional methods (phlebotomy) may be indicated to decrease the a ||| Il faut être particulièrement attentif lors de l'administration d'une chimiothérapie connue pour être thrombopéniante.
0.8235344886779785 ||| Trough levels at 24 hours are, however, similar. ||| The GMTs were, however, lower in women above 25 years. ||| Les concentrations minimales à 24 heures sont toutefois similaires.
0.0015962945763021708 ||| 22 To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. ||| 2 To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. ||| 24 Afin de réduire le risque de survenue d'une hypoglycémie nocturne ou de début de journée, les patients qui remplacent leur schéma d'insuline basale de 2 injections journalières d'insuline NPH par une injection quotidienne de Lantus doivent réduire leur dose quotidienne d'insuline basale de 20-30% durant les premières semaines de traitement.
0.6861317157745361 ||| 1.1 EMEA objectives ||| EMEA Procedure number ||| 1.1 Objectifs de l’ EMEA
0.3423882722854614 ||| Review panels will be set up comprising representatives of the Scientific Committees and interested parties to ensure that the performance of the EMEA in the centralised procedure meets the standards set by the Management Board. ||| These two groups meet at the EMEA on a regular basis to develop procedures and guidelines for the harmonisation of GCP and GMP inspections carried out by the Community and for the inspections that are required to complete the evaluation of applications under the Centralised System. ||| Un panel d’évaluation comprenant des représentants des comités scientifiques et des parties intéressées sera créé pour garantir que la performance de l’EMEA dans la procédure centralisée répond bien aux normes fixées par le conseil d’administration.
0.05390436202287674 ||| 8 (10) Very common: ||| 8 (8) Very common: ||| 8 (10) Très fréquent:
0.4161507785320282 ||| Once endorsed by the Council, it will allow Member States to undertake measures to deal adequately with the crisis, while departing from the budgetary requirements that would normally apply under the European fiscal framework. ||| In order to ensure that these amounts will be made available quickly to satisfy the needs in the real economy, it is proposed that the additional funding in 2020 be made available through a targeted revision to the 2014-2020 financial framework. ||| Une fois approuvée par le Conseil, cette activation permettra aux États membres de prendre des mesures afin de faire face de manière adéquate à la crise, tout en dérogeant aux obligations budgétaires qui s'appliqueraient normalement au titre du cadre budgétaire européen.
0.023104263469576836 ||| Patients already taking sitagliptin and metformin as separate tablets should switch to Janumet containing the same doses of both active substances. ||| Patients already taking sitagliptin and metformin as separate tablets should switch to Efficib containing the same doses of both active substances. ||| Les patients prenant déjà la sitagliptine et la metformine sous forme de comprimés séparés devraient prendre Janumet contenant les mêmes doses de ces deux principes actifs.
0.3905884623527527 ||| - The other ingredients are glycine, disodium phosphate anhydrous, sodium dihydrogen phosphate ||| Amorphous aluminium hydroxyphosphate sulphate and sodium borate in 0.9% sodium chloride ||| - Les autres composants sont glycine, phosphate disodique anhydre, phosphate monosodique
0.0039399731904268265 ||| 38 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 37 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 40 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.6163392663002014 ||| 21.1;100), 45.4% (95% CI: -81.5;86.6), 74.7 (95% CI :-386.2;99.6). ||| [49.4, 99.1]† [52.0, 97.5]† [69.6, 100]† ||| 21,1; 100), 45,4% (IC 95%: -81,5; 86,6) et 74,7% (IC 95%: -386,2; 99,6).
0.41271135210990906 ||| It is anticipated that the symptoms of ropinirole overdose will be related to its dopaminergic activity. ||| Due to the nitrate component it has the potential to have serious interaction with vardenafil. ||| Surdosage En cas d’ un surdosage au ropinirole, les symptômes attendus devraient être liés à son activité dopaminergique.
0.2569066286087036 ||| White to off-white lyophilised powder. ||| White to off-white amorphous powder. ||| Poudre lyophilisée blanche à blanc cassé.
0.3186612129211426 ||| Gemfibrozil increases the risk of myopathy when given concomitantly with some HMG-CoA reductase inhibitors. ||| Under simultaneous U. V. exposure, sparfloxacin can exhibit mutagenic properties and carcinogenetic effects. ||| Le gemfibrozil augmente le risque de myopathie quand il est associé à certains inhibiteurs de l’ HMG- CoA réductase.
0.26543405652046204 ||| P-gp substrates or weak inhibitors No relevant interactions with atenolol, digoxin, amlodipine or cimetidine have been observed. ||| No major safety issues were identified with use of abatacept in combination with sulfasalazine, hydroxychloroquine, or leflunomide. ||| Substrats de la gp-P ou inhibiteurs faibles Aucune interaction pertinente avec l’ aténolol, la digoxine, l’ amlodipine ou la cimétidine n’ a été observée.
0.00469403900206089 ||| 74 Dose reduction for patients who use 0.5 μg/kg PegIntron monotherapy must be accomplished by reducing the prescribed volume by one-half. ||| 120 Dose reduction for patients who use 0.5 μg/kg PegIntron monotherapy must be accomplished by reducing the prescribed volume by one-half. ||| Pour les patients recevant 0,5 μ g/ kg de PegIntron en monothérapie, la réduction de dose doit être effectuée en réduisant de moitié le volume prescrit.
0.005053236614912748 ||| 56 A MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| 46 A MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| TITULAIRES DE L’ AUTORISATION DE FABRICATION RESPONSABLES DE LA LIBÉRATION DES LOTS
3.421408935246756e-13 ||| Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. ||| Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. ||| Tous médicaments vétérinaires non utilisés ou déchets dérivés de ce médicament doivent être éliminés conformément aux exigences locales.
3.2432997260078977e-13 ||| Concurrent administration of potentially nephrotoxic drugs should be avoided as there might be an increased risk of renal toxicity. ||| Concurrent administration of potentially nephrotoxic drugs should be avoided as there might be an increased risk of renal toxicity. ||| Eviter l’ administration simultanée avec des produits ayant un potentiel néphrotoxique en raison d’ un risque accru de toxicité rénale.
0.14851513504981995 ||| Hypromellose Titanium dioxide (E171) Polyethylene glycol 400 Ferric oxide (red) (E172) Carnauba wax ||| Hypromellose Titanium dioxide (E171) Glycerol triacetate Iron oxide red (E172) ||| Hypromellose Dioxyde de titane (E171) Polyéthylène glycol 400 Oxyde ferrique (rouge) (E172) Cire de carnauba
0.7175984382629395 ||| Efficacy working party ||| - Compulsive shopping ||| Groupe de travail “ efficacité”
0.2863849401473999 ||| Aldurazyme treatment should be supervised by a doctor experienced in the management of patients with MPS I or other inherited metabolic diseases. ||| Fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease. ||| Le traitement par Aldurazyme doit être supervisé par un médecin expérimenté dans la prise en charge des patients atteints de MPS I ou d’ autres maladies métaboliques héréditaires.
0.260593980550766 ||| Kinzalmono was more effective than placebo at reducing diastolic blood pressure and had similar effects to the other medicines for hypertension. ||| NEVANAC was more effective than placebo and as effective as ketorolac in reducing signs of inflammation. ||| Kinzalmono s’ est révélé plus efficace que le placebo dans la réduction de la pression diastolique et a démontré des effets similaires aux autres médicaments antihypertenseurs.
0.07208030670881271 ||| Shelf-life after first opening of the tube: ||| Shelf-life after first opening of the container: ||| Durée de conservation après première ouverture du tube:
0.012772586196660995 ||| During the marketing of Neoclarityn, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) and rash have been reported very rarely. ||| 88 During the marketing of Neoclarityn, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) and rash have been reported very rarely. ||| 73 Depuis la commercialisation de Neoclarityn, des cas de réactions allergiques sévères (avec gêne respiratoire, sifflements bronchiques, démangeaisons, plaques d'urticaire et gonflements) et d’ éruption cutanée ont été très rarement rapportés.
0.23260200023651123 ||| Truvada should always be used combined with other medicines to treat HIV infection. ||| Trevaclyn can be used by itself or with other medicines to treat cholesterol problems. ||| Truvada doit toujours être utilisé en association avec d’ autres médicaments pour le traitement de l’ infection par le VIH.
0.5736457109451294 ||| The PSUR cycle of Insulin Human Winthrop is aligned with the one of the cross-referred product, Insuman, unless otherwise specified. ||| It contains a live attenuated (weakened) form of the human rotavirus (RIX4414 strain). ||| Le cycle de PSUR d’ Insulin Human Winthrop sera aligné avec celui du produit de référence, Insulin Human Winthrop, sauf si spécifié autrement.
0.045800648629665375 ||| Avastin must be administered under the supervision of a physician experienced in the use of antineoplastic medicinal products. ||| TORISEL must be administered under the supervision of a physician experienced in the use of antineoplastic medicinal products. ||| Avastin doit être administré sous le contrôle d’ un médecin expérimenté dans l’ utilisation des agents antinéoplasiques.
0.8109526634216309 ||| 2 The 10 mg maintenance dose is not recommended. ||| 5 patients administration of factor VIII was necessary. ||| La dose d'entretien de 10 mg n'est pas recommandée.
0.23899711668491364 ||| How to take Sonata 4. ||| How to take Thelin 4. ||| Comment prendre Sonata 4.
0.1669411063194275 ||| Other information about TRISENOX: ||| Other information about TORISEL: ||| Autres informations relatives à TRISENOX:
0.1563771665096283 ||| Mar ______ Jul ______ Nov _____ ||| Apr ______ Aug ______ Dec _____ ||| Mars ______ Juil. _____
0.652488112449646 ||| Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom ||| 45, 51, 76 and 80 New York Avenue, Framingham, MA 01701, USA ||| Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, Royaume-Uni.
2.78546987992484e-13 ||| A higher risk of lipodystrophy has been associated with individual factors such as older age, and with drug related factors such as longer duration of antiretroviral treatment and associated metabolic disturbances. ||| A higher risk of lipodystrophy has been associated with individual factors such as older age, and with drug related factors such as longer duration of antiretroviral treatment and associated metabolic disturbances. ||| 59 facteurs liés au traitement, tels qu'une plus longue durée du traitement antirétroviral avec les anomalies métaboliques qui lui sont associés.
0.16812454164028168 ||| Ultrasonic diagnostic instruments for veterinary use ||| Ultrasonic cleaning instruments for laboratory use ||| Instruments de diagnostic à ultrasons à usage vétérinaire
0.030726470053195953 ||| Zerit does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS. ||| Intelence does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS. ||| Zerit ne guérit pas l’ infection par le VIH ou le SIDA, mais il peut retarder les atteintes du système immunitaire et le développement d’ infections et de maladies liées au SIDA.
0.3018038272857666 ||| Lamictal and associated names (see Annex I) 25 mg dispersible/ chewable tablets. ||| Calcichew-D3 and associated names (see Annex I) 500 mg / 10 µg chewable tablets ||| Lamictal et noms associés (voir Annexe 1) 25 mg comprimés dispersibles ou à croquer.
0.38580936193466187 ||| One of the main side effects of chemotherapy is that it stops the bone marrow producing enough blood cells. ||| This is linked to the way your medicine works as it prevents the ability of blood clots to form. ||| Un des principaux effets indésirables de la chimiothérapie est une production insuffisante de cellules sanguines par la moelle osseuse.
0.21566390991210938 ||| How has PROCOMVAX been studied? ||| How has EMSELEX been studied? ||| Quelles études ont été menées avec PROCOMVAX?
0.3521454930305481 ||| SOLVENT for TAXOTERE 80 mg ||| 2.1 TAXOTERE 80 mg vial ||| SOLVANT pour TAXOTERE 80 mg
0.13997982442378998 ||| As with other vaccines it may be expected that an adequate response may not be achieved in patients receiving immunosuppressive therapy or patients with immunodeficiency. lP ||| It may be expected that in patients receiving immunosuppressive treatment or patients with immunodeficiency, an adequate response may not be achieved. ||| Comme avec d’ autres vaccins, une réponse adéquate à la vaccination peut ne pas être obtenue, chez les sujets recevant un traitement immunosuppresseur ou présentant un déficit immunitaire.
0.05058816820383072 ||| Each capsule contains sunitinib malate, equivalent to 12.5 mg of sunitinib. ||| Each capsule contains sunitinib malate, equivalent to 25.0 mg of sunitinib ||| Chaque gélule contient du malate de sunitinib, équivalant à 12,5 mg de sunitinib.
0.1623322069644928 ||| Tablet core Microcrystalline cellulose Colloidal anhydrous silica Crospovidone Magnesium stearate ||| Tablet core: crospovidone magnesium stearate microcrystalline cellulose silica, colloidal anhydrous ||| Noyau du comprimé Cellulose microcristalline Silice anhydre colloïdale Crospovidone Stéarate de magnésium
0.05280306935310364 ||| The most common side effect with Galvus (seen in between 1 and 10 patients in 100) is dizziness. ||| The most common side effect with Xiliarx (seen in between 1 and 10 patients in 100) is dizziness. ||| L’ effet indésirable le plus fréquent sous Galvus (observé chez 1 à 10 patients sur 100) est la survenance de sensations vertigineuses.
0.20674464106559753 ||| This is more likely at the beginning of treatment or after an increase in the dose. ||| This is especially true at the beginning of the treatment and after increase in dose. ||| Cet effet est plus fréquent au début du traitement ou après augmentation de la dose.
3.419691830056082e-13 ||| Causes of hyperglycaemia ||| Causes of hyperglycaemia ||| 227 Causes de l’ hyperglycémie
1.0830999612808228 ||| BOTTLE LABEL CYSTAGON 150 mg x 100 hard capsules BOTTLE LABEL CYSTAGON 150 mg x 500 hard capsules ||| STRONGHOLD 30 mg STRONGHOLD 45 mg STRONGHOLD 60 mg STRONGHOLD 120 mg STRONGHOLD 240 mg ||| ETIQUETTE FLACON CYSTAGON 150 mg x 100 gélules ETIQUETTE FLACON CYSTAGON 150 mg x 500 gélules
0.0 ||| 73 ANNEX II ||| 73 ANNEX II ||| 77 ANNEXE II
0.6210335493087769 ||| Each push-through strip contains 30 tablets. ||| Each pre- filled pen comes with 1 alcohol pad. ||| Chaque blister contient 30 comprimés.
0.2729541063308716 ||| patients with metastatic breast cancer receiving chemotherapy when administered to target a haemoglobin of 12-14 g/ dl (7.5-8.7 mmol/ l) ct ||| In patients with moderate hypercalcaemia (albumin-corrected serum calcium < 3 mmol/ l or < 12 mg/ dl) 2 mg is an effective dose. ||| 294 métastatique recevant une chimiothérapie, lorsque les ASEs étaient administrés dans le but d’ atteindre des taux cibles d’ hémoglobine compris entre 12 et 14 g/ dl (7,5-8,7 mmol/ l)
0.4660695493221283 ||| Interferons are cytokines that mediate antiviral, antiproliferative and immunomodulatory activities. ||| Inhibition of osteoblast proliferation, direct cytostatic and pro-apoptotic activity on ||| Les interférons sont des cytokines médiatrices d’ activités antivirales, antiprolifératives et immunomodulatrices.
0.4560728967189789 ||| Elimination: the terminal elimination half-life is 1.3±0.2 hours after a single dose, and 1.4±0.2 hours after multiple doses, and is independent of dose. ||| • If several VELCADE doses in a cycle are withheld (≥ 3 doses during twice weekly administration or ≥ 2 doses during weekly administration) ||| Elimination: la demi-vie d'élimination terminale est de 1,3±0,2 heure après l'administration de doses orales uniques et de 1,4±0,2 heure après des doses multiples, et est indépendante de la dose.
0.3228830099105835 ||| As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine. ||| The following dose regimen is recommended for titration, although in all cases the physician should take into account the clinical need of the patient, age and concomitant illness. ||| Comme avec tous les vaccins injectables, il est recommandé de toujours disposer d’ un traitement médical approprié et d’ assurer une surveillance pour le cas rare où surviendrait une réaction anaphylactique suivant l’ administration du vaccin.
0.3041829764842987 ||| Washers of metal ||| Shutters of metal ||| Rondelles en métal
0.2275877594947815 ||| If the rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in four weeks reduce the dose by approximately 25%, depending on the rate of increase. ||| If, after 8 weeks of therapy, the haemoglobin value has not increased by at least 1 g/ dl (0.62 mmol/ l), response is unlikely and treatment should be discontinued. ||| Si le taux d’ hémoglobine augmente de plus de 2 g/ dl (1,25 mmol/ l) sur une période de 4 semaines, réduire la dose d’ environ 25% en fonction de l’ importance de cette augmentation.
0.2203923612833023 ||| Similarly administration of fosamprenavir with ritonavir may modify the pharmacokinetics of other active substances that share this metabolic pathway. ||| Therefore, any medicinal products that either share this metabolic pathway or modify CYP3A4 activity may modify the pharmacokinetics of amprenavir and ritonavir. ||| De la même façon, l’ administration de fosamprénavir avec le ritonavir peut également modifier les paramètres pharmacocinétiques d’ autres substances actives qui suivent cette même voie métabolique.
0.24964387714862823 ||| The following dosing table indicates what volume to administer depending on the weight of the dog: ||| The following table defines the size of pipette to be used according to the weight of the cat. ||| Le tableau posologique suivant indique le volume à administrer en fonction du poids du chien:
0.26796755194664 ||| Washers of rubber for the protection of hooks ||| Strips of rubber for protecting the edges of furniture ||| Rondelles en caoutchouc pour la protection des crochets
3.1061530300982576e-13 ||| Animal studies are insufficient with respect to effects on pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3). ||| Animal studies are insufficient with respect to effects on pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3). ||| Les études animales ne sont pas concluantes pour ce qui est des effets délétères sur la gestation, le développement embryonnaire ou fœ tal, l’ accouchement ou le développement post-natal (voir rubrique 5.3).
0.46866345405578613 ||| The EU's global role: the EU is actively involved within the Financial Action Task Force and on the world stage in shaping international standards in the fight against money laundering and terrorist financing. ||| The ESI is a complementary instrument: it intervenes on top of the efforts made under rescEU and the Joint Procurement Agreement, or under other initiatives at national or EU level. ||| Le rôle de l'UE à l'échelle mondiale: l'UE participe activement, au sein du Groupe d'action financière et sur la scène mondiale, à l'élaboration de normes internationales en matière de lutte contre le blanchiment de capitaux et le financement du terrorisme.
0.4257171154022217 ||| Taking into account that those with an impaired immune response due to congenital or acquired dysfunction or absence of the thymus could have a low immune response and so questionable protection from YF vaccination the warning statement regarding special populations is endorsed. ||| Perceived seriousness encompasses beliefs about the disease itself (e.g., whether it is life-threatening or may cause disability or pain) as well as broader impacts of the disease on functioning in work and social roles. ||| Étant donné que les sujets montrant une réponse immune déficiente due à une anomalie congénitale ou acquise, voire à une absence de thymus, peuvent souffrir d’ une réponse immune faible et par conséquent une protection discutable après un vaccin antiamaril, la mise en garde concernant les populations spécifiques est entérinée.
0.0 ||| General disorders and administration site conditions: ||| General disorders and administration site conditions: ||| Troubles généraux et accidents liés au site d'administration:
0.20061510801315308 ||| Patients treated with immunosuppressants, including Mycophenolate mofetil Teva, are at increased risk for opportunistic infections (bacterial, fungal, viral and protozoal), fatal infections and sepsis (see section 4.8). ||| Renal failure, renal impairment, elevated creatinine, hypophosphataemia and proximal tubulopathy (including Fanconi syndrome) have been reported with the use of tenofovir disoproxil fumarate in clinical practice (see section 4.8). ||| Une immunosuppression excessive augmente la sensibilité aux infections, telles que des infections opportunistes, des infections létales ou des infections généralisées (voir rubrique 4.8).
0.11504732072353363 ||| 10 A-6250 Kundl Austria Tel: + 43-(0)5338 2000 ||| 10 A-6250 Kundl Tel: + 43-(0)5338 2000 ||| 10 A-6250 Kundl Austria Tel. +43 (0)5338 2000
0.4957025647163391 ||| Powder for Injection ||| Solution For Injection ||| Poudre pour injection
0.36537158489227295 ||| In controlled clinical trials, the discontinuation rate due to sildenafil was low and similar to placebo. ||| In early-stage disease, the scores obtained with Neupro showed an improvement compared with placebo in the UPDRS. ||| Dans les études cliniques, le taux d'interruption du traitement dû au sildénafil était faible et similaire au placebo.
0.018651263788342476 ||| 150 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS GONAL-f 300 IU/ 0.5 ML (22 MICROGRAMS/ 0.5 ML) PEN, CARTRIDGE LABEL ||| 158 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS GONAL-f 900 IU/ 1.5 ML (66 MICROGRAMS/ 1.5 ML) PEN, CARTRIDGE LABEL ||| 157 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES ETIQUETTE DE LA CARTOUCHE DU STYLO GONAL-f 300 UI/ 0,5 ML (22 MICROGRAMMES/ 0,5 ML)
0.16815611720085144 ||| Slovakia notified to the Commission under the Temporary Framework a wage subsidy aid scheme that would allow the Slovak authorities to financea part of the wage costs (including employer's social security contributions) of undertakings that, due to the coronavirus outbreak, would otherwise have laid off personnel. ||| Hungary notified to the Commission under the Temporary Framework awage subsidy measure that would allow the Hungarian authorities to finance the wage costs of undertakings that, due to the coronavirus outbreak, would otherwise lay off researchers and developers. ||| La Slovaquie a notifié à la Commission, au titre de l' encadrement temporaire , un régime d'aides sous la forme de subventions salariales qui permettrait aux autorités slovaques de financer une partie des coûts salariaux (y compris les cotisations de sécurité sociale des employeurs) des entreprises qui, en raison de la pandémie de coronavirus, auraient sans cela licencié du personnel.
0.24607473611831665 ||| EU/ 1/ 07/ 433/ 01 ||| EU/ 1/ 07/ 388/… ||| EU/ 1/ 07/ 433/ 001
0.35422325134277344 ||| Based on the prospective study CNA106030 (PREDICT-1), use of pre-therapy screening for the HLA-B*5701 allele and subsequently avoiding abacavir in patients with this allele significantly reduced the incidence of abacavir hypersensitivity reactions. ||| In September 2004, the Marketing Authorisation Holder (MAH) of rofecoxib (a selective Cox-2- inhibitor) informed the EMEA that new clinical trial (APPROVe) data for rofecoxib have revealed a risk of thrombotic cardiovascular (CV) events. ||| D'après les résultats de l'étude prospective CNA106030 (PREDICT-1), le dépistage de l'allèle HLA-B*5701 avant de débuter le traitement, suivi de la non- prescription d'abacavir chez les patients porteurs de cet allèle, a réduit significativement l'incidence des réactions d'hypersensibilité à l'abacavir.
0.17028234899044037 ||| In the first study, viral loads fell by an average of 98% in the patients taking Fuzeon, compared with 83% in the patients not taking Fuzeon. ||| In the second study, viral loads had fallen by more than 99% in the patients taking the higher dose of Viracept, compared with 95% in those taking the comparator medicines. ||| Dans la première étude, la charge virale a diminué en moyenne de 98% chez les patients prenant Fuzeon, contre 83% chez les patients ne prenant pas Fuzeon.
0.45780497789382935 ||| Leave the pre-filled syringe at room temperature for approximately 30 minutes. ||| Wait at least 5 minutes before using make-up or sunscreen on the same areas. ||| Laissez la seringue préremplie à température ambiante pendant environ 30 minutes.
0.378744900226593 ||| Take a standard disposable 1 ml syringe with luer nozzle and connect it to the adapter (3). ||| Swallow Prometax oral solution directly from the syringe or first mix in a small glass with water. ||| Prendre une seringue standard de 1 ml à usage unique avec embout luer, et la connecter à l’adaptateur (3).
0.5222666263580322 |||  Leave the syringe in place. ||| 2) Remove the needle. ||| 304 • Laissez la seringue en place.
0.5647802352905273 ||| Very rare: peripheral neuropathy (paraesthesiae) ||| In vivo resistance (antiretroviral-naïve patients): ||| Très rare: neuropathie périphérique (paresthésie).
0.018952922895550728 ||| Dafiro 5 mg/ 160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg alone. ||| Exforge 5 mg/ 80 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg alone. ||| Dafiro 5 mg/ 160 mg peut être administré chez les patients dont la pression artérielle n'est pas suffisamment contrôlée avec l'amlodipine 5 mg ou le valsartan 160 mg seuls.
0.3365384042263031 ||| The impact of long-term treatment with Enbrel on the development of autoimmune diseases is unknown. ||| There are no data on the long-term effects of fulvestrant on the postmenopausal endometrium. ||| L’ impact à long terme d’ un traitement par Enbrel sur le développement de maladies auto-immunes est inconnu.
0.2432035207748413 ||| If pregnancy occurs during the course of vaccination your doctor should be consulted. ||| If pregnancy occurs during treatment the possibility of genetic counselling should be considered. ||| Si la grossesse survient en cours de vaccination vous devez consulter votre médecin.
0.037960730493068695 ||| 27 August 1997 Date of latest renewal: ||| 27 August 1997 Date of last renewal: ||| 27 Août 1997 Date de dernier renouvellement:
0.0 ||| 5.3 Preclinical safety data ||| 5.3 Preclinical safety data ||| 108 5.3 Données de sécurité préclinique
0.0498785562813282 ||| The Committee recommended that Avandia be given marketing authorisation. ||| The Committee recommended that Evra be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Avandia.
0.19940945506095886 ||| 3 avenue George V FR-75008 Paris France ||| AB Science, 3 avenue George V FR-75008 Paris France ||| 3 avenue George V 75008 Paris France
3.3565576533500785e-13 ||| You should know these factors so that you are able to react correctly to changes in your blood sugar level and to prevent it from becoming too high or too low. ||| You should know these factors so that you are able to react correctly to changes in your blood sugar level and to prevent it from becoming too high or too low. ||| Ainsi, vous serez capable de réagir correctement aux variations de votre glycémie et d’ éviter qu’ elle ne devienne trop élevée ou trop faible.
3.7702547789515706e-13 ||| Not known (frequency cannot be estimated from the available data): • Inflammation of the pancreas and psychotic reactions ||| Not known (frequency cannot be estimated from the available data): • Inflammation of the pancreas and psychotic reactions ||| 85 Fréquence indéterminée (ne peut être estimée sur la base des données disponibles): • Inflammation du pancréas et réactions psychotiques
0.3061714768409729 ||| A clinical trial of adjunctive treatment of partial seizures in paediatric subjects, ranging in age from 3 to 12 years, showed a numerical but not statistically significant difference in the 50% responder rate in favour of the gabapentin group compared to placebo. ||| In other clinical trials evaluating ZOSTAVAX in subjects 50 years of age or older, including a study of concomitantly administered inactivated influenza vaccine, the safety profile was generally similar to that seen in the Adverse Event Monitoring Substudy of the SPS. ||| Une étude clinique dans le traitement des épilepsies partielles en association à d'autres traitements, chez des enfants âgés de 3 à 12 ans, a montré une différence numérique, mais non statistiquement significative, des taux de répondeurs à 50% en faveur du groupe gabapentine comparativement au placebo.
0.09339816868305206 ||| The suspension is contained in type I flint glass vials, sealed with butyl or halobutyl stoppers and secured with aluminium seals. ||| The solution is contained in type I flint glass cartridges, sealed with butyl or halobutyl disc seals and plunger heads and are secured with aluminium seals. ||| La suspension est contenue dans des flacons en verre de type I, fermés par des bouchons en halobutyle et sertis par des capsules en aluminium.
0.5095653533935547 ||| If there is insufficient Enbrel solution in the vial for the second dose, discard the vial and start again with a new tray. ||| Creeling was about replacing the bobbins in the creel while piecing the old disappearing thread with the new; it was done from behind the mule. ||| S’il n’y a pas suffisamment de solution d’Enbrel dans le flacon pour la deuxième dose, jetez le flacon et recommencez avec un nouveau coffret de traitement.
0.381130188703537 ||| (x) Targeted support in the form of wage subsidies for employees for those companies in sectors or regions that have suffered most from the coronavirus outbreak, and would otherwise have had to lay off personnel. ||| The measures include inviting Member States to grant temporary traffic rights for additional cargo operations from outside the EU if restrictions would normally apply, even if these cargo operations are conducted with passenger aircraft. ||| x) soutien ciblé sous la forme de subventions salariales en faveur des salariés des entreprises des secteurs ou régions qui ont le plus souffert de la pandémie de coronavirus et qui, sans ce soutien, auraient été contraintes de licencier du personnel;
0.7562283873558044 ||| Fluid retention Oedema, weight loss Weight gain ||| Serum cholesterol increased, Weight loss ||| Rétention aqueuse Oedème, perte de poids Prise de poids
0.38375401496887207 ||| The main study looked at the effectiveness and safety of Rotarix, and it involved over 63,000 infants. ||| Overall, the clinical studies of Rotarix in humans involved over 72,000 infants and took place in various countries worldwide. ||| L’ étude principale a porté sur plus de 63 000 nourrissons et visait à établir l’ efficacité et la sécurité de Rotarix.
0.0 ||| 4.9 Overdose ||| 4.9 Overdose ||| 147 4.9 Surdosage
0.4011957049369812 ||| The tracking system for the mutual recognition procedure was progressed in 2000 and version 5.2.10 of EudraTrack is currently in use by Member States. ||| 2002 • First prototype to reflect and test implementation of data elements for transmission of reports is in place in accordance with draft VICH guidelines GL 24, GL 30 and GL 35 ||| Le système de suivi de la procédure de reconnaissance mutuelle a progressé en 2000, et la version 5.2.10 d’EudraTrack est actuellement utilisée par certains États membres.
0.44592610001564026 ||| Karvea 75 mg tablets. ||| 150 mg capecitabine. ||| Karvea 75 mg comprimés.
0.3399052023887634 ||| The dose, the frequency of injection and how long it is used for depend on why Silapo is being used, and are adjusted according to the patient’ s response. ||| The doses and dosage schedules (how often NeoRecormon is injected, and for how long) vary depending on why NeoRecormon is used, and are adjusted according to the response. ||| La dose et la fréquence d’ injection, ainsi que la durée de son utilisation dépendent de la raison pour laquelle Silapo est utilisé et sont ajustées en fonction de la réponse du patient.
0.6043281555175781 ||| Audio receivers ||| Flight simulators ||| Récepteurs audio
0.1834021508693695 ||| Caution is needed when administrating this vaccine to persons with a known hypersensitivity (other than anaphylactic reaction) to the active substance, to any of the excipients and to eggs, chicken proteins, kanamycin and neomycin sulphate, formaldehyde and cetyltrimethylammonium bromide (CTAB). ||| History of an anaphylactic (i. e. life-threatening) reaction to any of the constituents or trace residues of eggs, chicken proteins, kanamycin and neomycin sulphate, formaldehyde and cetyltrimethylammonium bromide (CTAB) of this vaccine. ||| L’ administration de ce vaccin doit se faire avec précaution chez les sujets ayant des antécédents d’ hypersensibilité (autre qu’ une réaction anaphylactique) à la substance active, à l’ un des excipients ou aux œ ufs, aux protéines de poulet, à la kanamycine et au sulfate de néomycine, au formaldéhyde et au bromure de cétyltriméthylammonium (CTAB).
0.4182237684726715 ||| 82.18 mg of lactose per capsule. ||| 10.0 mg per gram of oral powder. ||| 82,18 mg de lactose par gélule.
0.27081435918807983 ||| Discontinuation of treatment Acute symptoms such as sweating, insomnia, tremor, anxiety, nausea, or vomiting have been reported very rarely (< 0.01%) when oral olanzapine is stopped abruptly. ||| Following an overdose of 10 times the maximum dose on a single occasion the following adverse effects were seen: vomiting, anorexia, reduced body weight, muscle tremors, seizures, unsteadiness, laboured breathing. ||| Arrêt du traitement Des symptômes aigus tels que sueurs, insomnie, tremblement, anxiété, nausée ou vomissement ont été très rarement rapportés (< 0,01%) lors de l’ arrêt brutal du traitement par olanzapine orale.
0.38818085193634033 ||| Fluid creams [cosmetics] ||| Cellulose derivatives [chemicals] ||| Crèmes fluides [cosmétiques]
0.21290838718414307 ||| Key messages for long-term care facilities - physician and managers ||| Key messages for intensive care unit - physicians and managers ||| Messages clés pour les secteurs de soins de longue durée [médecins et responsables]
0.34021735191345215 ||| Pramipexole alleviates Parkinsonian motor deficits by stimulation of dopamine receptors in the striatum. ||| Moxifloxacin is a poor substrate for active efflux mechanisms in Gram-positive organisms. ||| Le pramipexole atténue les déficits moteurs parkinsoniens en stimulant les récepteurs dopamnergiques du striatum.
0.26028934121131897 ||| CoAprovel 150 mg/ 12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets. ||| Olanzapine Neopharma 2.5 mg, 5 mg, 7.5 mg and 15 mg coated tablets are available in 28 and 56 blister packs. ||| CoAprovel 150 mg/ 12,5 mg comprimés sont fournis en conditionnements de 14, 28, 56 ou 98 comprimés présentés en plaquettes thermoformées.
0.4896199107170105 ||| If you forget to take Thalidomide Celgene at your regular time and • less than 12 hours have passed: take your capsule immediately. • more than 12 hours have passed: do not take your capsule. ||| you have had surgery within the last twelve hours before you receive Xigris, or you are bleeding from a previous surgery, or you might have surgery while you receive Xigris ||| Si vous oubliez de prendre Thalidomide Celgene au moment habituel et • que moins de 12 heures se sont écoulées depuis ce moment: prenez votre gélule immédiatement • que plus de 12 heures se sont écoulées depuis ce moment: ne prenez pas votre gélule.
0.8837141990661621 ||| Not known: ||| None known. ||| Très rare:
0.3910439610481262 ||| - if you have any swallowing or digestive problems ||| - if you have liver ailments or kidney problems, ||| - si vous avez des difficultés à avaler ou des troubles digestifs
0.2773348093032837 ||| Amprenavir: the concomitant use of Kaletra with amprenavir 750 mg twice daily, resulted in an increase in amprenavir AUC by 70% and of Cmin by 4.6-fold, relative to amprenavir 1200 mg twice daily alone. ||| CELSENTRI dose should be decreased to 150 mg twice daily when co-administered with rifabutin in the presence of a PI (except tipranavir/ ritonavir or fosamprenavir/ ritonavir where the dose should be 300 mg twice daily). ||| Amprénavir: l’ association de Kaletra avec amprénavir 750 mg deux fois par jour, entraîne des augmentations de 70% de l’ ASC de l’ amprénavir et de 4,6 fois de la Cmin par rapport à l’ amprénavir, administré seul, à 1200 mg deux fois par jour.
0.34239211678504944 ||| Hepatic impairment Xiliarx should not be used in patients with hepatic impairment, including patients with pre-treatment alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 3x the upper limit of normal (ULN) (see also sections 4.4 and 5.2). ||| The anti-hepatitis B surface antigen (anti-HBs) and anti-hepatitis A virus (anti-HAV) antibody titres observed following a primary vaccination course with Ambirix are in the range of what is seen following vaccination with the monovalent hepatitis A and B vaccines. ||| Insuffisance hépatique Xiliarx ne doit pas être utilisé chez les patients présentant une insuffisance hépatique, incluant les patients présentant des taux d’ alanine aminotransférase (ALAT) ou d’ aspartate aminotransférase (ASAT) avant traitement supérieurs à 3 fois la limite supérieure à la normale (LSN) (voir également rubriques 4.4 et 5.2).
0.226466566324234 ||| Grilled vegetables ||| Cooked fruits ||| Légumes grillés
0.1432926058769226 ||| Ranibizumab is a humanised recombinant monoclonal antibody fragment targeted against human vascular endothelial growth factor A (VEGF-A). ||| Trastuzumab is a recombinant humanised IgG1 monoclonal antibody against the human epidermal growth factor receptor 2 (HER2). ||| Le ranibizumab est un fragment d'anticorps monoclonal humanisé recombinant dirigé contre le facteur de croissance de l'endothélium vasculaire humain de type A (VEGF-A).
0.2865946888923645 ||| If any of the following events occur in temporal relation to receipt of Tritanrix HepB, the decision to give subsequent doses of vaccine containing the pertussis component should be carefully considered. ||| The indication for NeoRecormon treatment and, if given, the single dose should be determined from the required amount of pre-donated blood and the endogenous red cell reserve according to the following graphs. ||| Si l'une des réactions décrites ci-dessous apparaît après l’ administration de Tritanrix HepB, la décision d'administrer les doses suivantes du vaccin contenant la valence coquelucheuse doit être soigneusement évaluée:
0.7859106063842773 ||| Close control of blood pressure. ||| Protect from light. ||| Contrôle attentif de la pression artérielle.
0.15253768861293793 ||| Each AMMONAPS tablet contains 62 mg (2.7 mmol) of sodium, corresponding to 2.5 g (108 mmol) of sodium per 20 g of sodium phenylbutyrate, which is the maximum daily dose. ||| AMMONAPS granules contain 124 mg (5.4 mmol) of sodium per gram of sodium phenylbutyrate, corresponding to 2.5 g (108 mmol) of sodium per 20 g of sodium phenylbutyrate, which is the maximum daily dose. ||| Chaque comprimé d’ AMMONAPS contient 62 mg (2,7 mmol) de sodium, correspondant à 2,5 g (108 mmol) de sodium par 20 g de phénylbutyrate de sodium, ce qui représente la dose maximale quotidienne.
0.07520753890275955 ||| What Cetrotide looks like and contents of the pack ||| What Vectibix looks like and contents of the pack ||| A quoi ressemble Cetrotide et que contient l'emballage extérieur
0.0 ||| Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. ||| Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. ||| Vérifiez votre glycémie et votre cétonurie le plus rapidement possible dès que l'un des symptômes ci -dessus apparaît.
0.02159607782959938 ||| Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of  from baseline body weight in 39.9% of 7% patients. ||| Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of ≥ 7% from baseline body weight in 39.9% of patients. ||| Lors du traitement au long cours par l’ olanzapine (jusqu’ à 12 mois) dans la prévention des récidives chez les patients présentant un trouble bipolaire, une augmentation de poids supérieure ou égale à 7% par rapport au poids initial a été rapportée chez 39,9% des patients.
0.46656137704849243 ||| 10 No experience in the treatment of patients with renal and/ or hepatic impairment is available and therefore it is recommended that such patients be monitored more closely. ||| Our sites (surveillance practices) are currently fixed, and it could be helpful to be able to rapidly onboard practices in regions where there are more cases. ||| Il n'y a aucune expérience du traitement de patients atteints d'insuffisance rénale et/ ou hépatique; il est par conséquent recommandé de surveiller plus attentivement ces patients.
0.4275466501712799 ||| Diagram L ||| Diagram Q rod ||| Figure L
0.3803960978984833 ||| Patients who have severe kidney damage may have a weaker response to treatment. ||| In women undergoing fertility treatment there may be a slightly higher risk of miscarriage. ||| Les patients atteints de dysfonctionnements rénaux graves peuvent réagir moins bien au traitement.
0.1990559995174408 ||| The most common adverse reactions experienced by 30% or more of patients receiving IL-2 and Ceplene (listed in descending order of frequency) were: flushing, headache, fatigue, injection site granuloma, pyrexia and injection site erythema. ||| Signs and symptoms Very common symptoms in overdose (> 10% incidence) include tachycardia, agitation/ aggressiveness, dysarthria, various extrapyramidal symptoms, and reduced level of consciousness ranging from sedation to coma. ||| Les réactions indésirables les plus couramment observées chez au moins 30% des patients traités par l’ IL-2 et Ceplene (énumérées par ordre décroissant de fréquence) étaient: bouffées vasomotrices, céphalée, fatigue, granulome au site d’ injection, fièvre et érythème au site d’ injection.
0.24441435933113098 ||| Neulasta 6 mg solution for injection in a pre-filled pen. ||| Arixtra is a solution for injection in a prefilled syringe. ||| Neulasta 6 mg solution injectable en stylo prérempli.
0.29658615589141846 ||| Installation, maintenance and repair of computer hardware ||| Installation and maintenance of computer programs ||| Installation, entretien et réparation de matériel informatique
0.16839784383773804 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Tredaptive’ s benefits are greater than its risks for the treatment of dyslipidaemia, particularly in patients with combined mixed dyslipidaemia and in patients with primary hypercholesterolaemia. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Puregon’ s benefits are greater than its risks for women who are anovulatory, woman who need to ovulate before fertility treatment, and in men who have hypogonadotrophic hypogonadism. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de Tredaptive sont supérieurs à ses risques pour le traitement de la dyslipidémie, en particulier chez les patients présentant une dyslipidémie mixte ou combinée et chez les patients présentant une hypercholestérolémie primaire.
0.06759805977344513 ||| Pharmaceutical preparations for the prevention of disorders of the endocrine system ||| Pharmaceutical preparations for the prevention of disorders of the genitourinary system ||| Produits pharmaceutiques pour la prévention des troubles du système endocrinien
0.4586787819862366 ||| Anti-oxidants derived from honey ||| Anti-oxidants comprising enzymes ||| Antioxydants dérivés du miel
0.2331998646259308 ||| Doribax is reconstituted and then further diluted prior to infusion. ||| Yondelis must be reconstituted and further diluted prior to infusion. ||| Doribax est reconstitué puis dilué avant perfusion.
0.1967654526233673 ||| The vial of lyophilised product powder for injection must be reconstituted with the supplied solvent [sodium chloride 9 mg/ ml (0.9%) solution] from the pre-filled syringe using the sterile vial adapter reconstitution device. ||| BeneFIX is administered by intravenous (IV) injection after reconstitution of the powder for injection with the supplied solvent (0.234% w/ v sodium chloride solution) in the pre-filled syringe. ||| Le flacon de poudre lyophilisée doit être reconstitué avec le solvant fourni [solution de chlorure de sodium 9 mg/ ml (0,9%)] contenu dans la seringue préremplie en utilisant le dispositif de reconstitution avec adaptateur pour flacon stérile.
0.3093844950199127 ||| Children aged over three months who weigh less than 14 kg should be given the oral solution at a dose of 4 mg per kilogram body weight twice a day, up to a maximum of 300 mg per day. ||| In these studies, a total of 83 subjects at least 2 years of age were treated with doses of 300 to 600 mg/kg body weight every 21 to 28 days for 6 to 12 months. ||| L’ enfant âgé de plus de trois mois et pesant moins de 14 kg devrait se voir administrer la solution orale à une dose de 4 mg par kilogramme de poids corporel deux fois par jour, dans une limite maximale de 300 mg par jour.
0.0643482655286789 ||| 71 Member State ||| 77 Member State ||| 71 État membre
0.08035807311534882 ||| NovoNorm is not recommended for patients below 18 years of age because of a lack of information on safety and effectiveness in this age group. ||| Efficib is not recommended for use in children under 18 years of age because of a lack of information on safety and effectiveness in this group. ||| NovoNorm n’ est pas recommandé chez les patients âgés de moins de 18 ans en raison du manque d’ informations relatives à sa sécurité et son efficacité dans cette tranche d’ âge.
0.3002835512161255 ||| Patients with anorexia, asthenia, nausea, vomiting or diarrhoea may rapidly become dehydrated. ||| Gastrointestinal symptoms such as nausea, vomiting and diarrhoea have been observed in varying percentages. ||| Les patients présentant une anorexie, une asthénie, des nausées, des vomissements ou des diarrhées peuvent rapidement se déshydrater.
0.09072273224592209 ||| Your doctor has prescribed the Nespo pre-filled pen for injection into the tissue just under the skin. ||| Your doctor has prescribed an Aranesp pre-filled syringe for injection into the tissue just under the skin. ||| é Votre médecin vous a prescrit Nespo en stylo prérempli en vue d’une injection dans la région située
0.38511595129966736 ||| Kidney transplantation: ||| - Cardiac transplantation ||| Transplantation rénale:
0.2731020450592041 ||| 83.1 [< 0.0;99.7] ||| 50.8# [< 0.0;99.2] ||| 83,1 [< 0,0; 99,7]
0.45055484771728516 ||| Macrogol 400 Ethanol, anhydrous Poloxamer 188 Citric acid monohydrate Sodium metabisulphite (E 223) Sodium hydroxide Water for injections ||| Cholesterol Triolein Dioleoylphosphatidylcholine (DOPC) Dipalmitoylphosphatidylglycerol (DPPG) Sodium chloride Water for injections ||| Macrogol 400 Éthanol anhydre Poloxamer 188 Acide citrique monohydrate Metabisulfite de sodium (E 223) Hydroxyde de sodium Eau pour préparation injectable
0.3780035376548767 ||| Growth failure in children due to inadequate growth hormone secretion: ||| - Growth disturbance due to insufficient secretion of growth hormone (GH). ||| Retard de croissance chez l’ enfant lié à une sécrétion insuffisante de l’ hormone de croissance:
0.20356924831867218 ||| Ibafloxacin is a synthetic antimicrobial substance of the fluoroquinolone class. ||| Ciprofloxacin is a broad spectrum antibacterial agent that belongs to the fluoroquinolone family. ||| L’ ibafloxacine est un antimicrobien de synthèse de la classe des fluoroquinolones.
0.395249605178833 ||| In late March and early April, concerns about a global condom shortage arose after some factories that manufacture condoms were forced to shut down or reduce their operations, in compliance with government-imposed stay-at-home orders, including Malaysia-based Karex, the world's largest condom producer. ||| Addressing concerns about the spread of misleading or harmful "coronavirus" apps, Apple set limits on which types of organizations could add coronavirus-related apps to its App Store, limiting them to only "official" or otherwise reputable organizations. ||| Fin mars et début avril, des inquiétudes concernant une pénurie mondiale de préservatifs sont apparues après que certaines usines qui fabriquent des préservatifs ont été contraintes de fermer ou de réduire leurs activités, conformément aux ordonnance de maintien à domicile (en) imposées par le gouvernement, notamment Karex (en), basée en Malaisie, premier producteur mondial de préservatifs.
0.6216973066329956 ||| During 1997, the Working Party followed the developments of the VICH process with great interest and provided guidance when requested. ||| Assessments were undertaken by the study investigators and by an independent review panel, blinded to treatment. ||| En 1997, le groupe de travail a suivi les développements de VICH avec le plus grand intérêt et a fourni des conseils lorsque cela lui a été demandé.
0.15982164442539215 ||| EU Number ||| EU number ||| Numéro UE
0.10449482500553131 ||| What is the risk associated with Preotact? ||| What is the risk associated with Competact? ||| Quels sont les risques associés à Preotact?
0.5289278030395508 ||| - Serious illness with blistering of skin, mouth, eyes and genitals; increased hairiness ||| headache, visual disturbances), changes in your state of consciousness or loss of consciousness or coma ||| - Maladie grave avec formation de vésicules sur la peau, dans la bouche, au niveau des yeux et
0.09318779408931732 ||| If your child misses a scheduled injection, talk to your doctor and arrange another visit. ||| 19 If you miss a scheduled injection, talk to your doctor and arrange another visit. ||| 39 Si votre enfant manque une vaccination prévue, informez-en votre médecin et demandez-lui une nouvelle consultation.
0.17493076622486115 ||| Patients with newly-diagnosed glioblastoma multiforme: ||| Adult patients with newly -diagnosed glioblastoma multiforme ||| Patients atteints d’ un glioblastome nouvellement diagnostiqué:
0.37318193912506104 ||| They are usually only mild or moderate problems and they gradually diminish during the course of treatment. ||| Symptoms are similar to the acute form of the disease, but are less severe and last longer. ||| Il s’agit généralement de problèmes peu graves à modérés seulement, dont l’intensité diminue ensuite graduellement au cours du traitement.
0.0 ||| In patients with severe hepatic impairment, the data available are insufficient to establish recommendations. ||| In patients with severe hepatic impairment, the data available are insufficient to establish recommendations. ||| 38 les données disponibles sont insuffisantes pour établir des recommandations.
1.013267993927002 ||| 2.1 0.2 0.05 ||| 0.5 1 1.5 2 ||| 0.2 0.05
0.29206913709640503 ||| The relevance of the hepatocarcinogenic potential of micafungin for the human therapeutic use is not known. ||| Such evaluations indicate that sex does not affect the pharmacokinetics of rufinamide to a clinically relevant extent. ||| La pertinence du potentiel hépatocarcinogène de la micafungine lors de l’ utilisation thérapeutique chez l’ homme n’ est pas connue.
0.040867604315280914 ||| Insulin Human Winthrop Basal is used to reduce high blood sugar in patients with diabetes mellitus. ||| Insulin Human Winthrop Comb 15 is used to reduce high blood sugar in patients with diabetes mellitus. ||| Insulin Human Winthrop Basal est utilisé pour diminuer le taux de sucre dans le sang en cas de diabète sucré.
0.46877521276474 ||| Ear and labyrinth disorders uncommon Cardiac disorders ||| Ear and labyrinth disorders Sudden deafness2 1 System Organ Class: ||| Affections de l’oreille et du labyrinthe peu fréquent Affections cardiaques
0.28433263301849365 ||| Truvada is not recommended for patients with severe renal impairment (creatinine clearance < 30 ml/ min) and in patients who require haemodialysis because appropriate dose reductions cannot be achieved with the combination tablet. ||| In patients with enlargement of the prostate gland, Doxazosin Retard Arrow 4 mg prolonged release tablets and associated names is taken to treat poor and/ or frequent passing of urine. ||| Truvada n’ est pas recommandé chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) et chez les patients qui nécessitent une hémodialyse car les réductions des doses d’ emtricitabine et de ténofovir nécessaires chez ces patients ne peuvent être obtenues avec l’ association fixe.
0.2997075319290161 ||| Furthermore, earlier in 2020, the EU already mobilised €11 million in humanitarian and development funding to the UN's Food and Agricultural Organization (FAO) to help it address the locust outbreak in the region and provide support to affected pastoralists and farmers. ||| The new programmes approved under the Trust Fund for Africa, worth €52.5 million, will focus on increasing resilience, employment and stability in the Sahel and Lake Chad region, while also contributing to the response to the coronavirus pandemic. ||| Par ailleurs, début 2020, l'UE a déjà mobilisé 11 millions d'euros d'aide humanitaire et au développement en faveur de l'Organisation des Nations unies pour l'alimentation et l'agriculture, afin de l'aider à lutter contre l'invasion de criquets dans la région et à fournir un soutien aux pasteurs et aux agriculteurs touchés.
0.3021048307418823 ||| Rental of lighting apparatus ||| Installation of lighting apparatus ||| Location d'appareils d'éclairage
0.22146373987197876 ||| Zometa concentrate is contraindicated in breast-feeding women and in patients with clinically significant hypersensitivity to zoledronic acid, other bisphosphonates or any of the excipients in the formulation of Zometa. ||| The addition of interferon-gamma to the tasonermin perfusate seems not to be associated with significant increases in endogenous production of tasonermin or other inflammatory cytokines as shown in patients with severe trauma. ||| Zometa solution à diluer est contre-indiqué chez la femme allaitante et chez les patients présentant une hypersensibilité cliniquement significative à l’ acide zolédronique, à d’ autres bisphosphonates ou à l’ un des excipients présents dans la formulation de Zometa.
0.37392324209213257 ||| Slovakia notified to the Commission under the Temporary Framework a wage subsidy aid scheme that would allow the Slovak authorities to financea part of the wage costs (including employer's social security contributions) of undertakings that, due to the coronavirus outbreak, would otherwise have laid off personnel. ||| The Expected Credit Loss (ECL) approach under IFRS 9:Today's Interpretative Communication states that the temporary inability of households or businesses to pay back their loans because of the Coronavirus pandemic should not mean that banks have to automatically significantly increase their so-called ECL provisions. ||| La Slovaquie a notifié à la Commission, au titre de l' encadrement temporaire , un régime d'aides sous la forme de subventions salariales qui permettrait aux autorités slovaques de financer une partie des coûts salariaux (y compris les cotisations de sécurité sociale des employeurs) des entreprises qui, en raison de la pandémie de coronavirus, auraient sans cela licencié du personnel.
0.35189056396484375 ||| This pressure reduces the amount of oxygen that can get into the blood in the lungs, making physical activity more difficult. ||| In some people, the amount of uric acid builds up in the blood and may become too high to remain soluble. ||| Cette pression diminue la quantité d’ oxygène pouvant pénétrer dans le sang dans les poumons, ce qui rend l’ activité physique plus difficile.
0.7543770670890808 ||| 6 • The mass spectrometer must be capable of: ||| b) Maintaining sufficient red blood cell levels The maintenance dose: ||| 6 Le spectromètre de masse doit être capable de:
0.4888363480567932 ||| Creams for leather ||| Mastic for leather ||| Crèmes pour le cuir
0.0 ||| 4.9 Overdose ||| 4.9 Overdose ||| 147 4.9 Surdosage
0.4205206632614136 ||| Do not use after the expiry date which is stated on the carton and the bottle after EXP. ||| You should write the date of opening the bottle on the label and/ or outer carton. ||| Ne pas utiliser Lysodren après la date de péremption mentionnée sur la boîte et sur le flacon après EXP.
0.04708230495452881 ||| 73 6.2 Incompatibilities ||| 206 6.2 Incompatibilities ||| 6.2 Incompatibilités
0.07705509662628174 ||| What benefit has Tractocile shown during the studies? ||| What benefit has Neocolipor shown during the studies? ||| Quel est le bénéfice démontré par Tractocile au cours des études?
0.2898795008659363 ||| 2 Patients treated with conjugated equine estrogen (CEE) are not recommended to use Intrinsa, as efficacy has not been demonstrated (see sections 4.4 and 5.1). ||| The effects of an overdose of GONAL-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur (see section 4.4). ||| L’ utilisation d’ Intrinsa est déconseillée chez les patientes traitées par des estrogènes conjugués équins car l’ efficacité n’ a pas été démontrée (voir rubriques 4.4 et 5.1).
0.12419523298740387 ||| 199 5.2 Pharmacokinetic properties ||| ra 5.2 Pharmacokinetic properties ||| 5.2 Propriétés pharmacocinétiques
0.4844663739204407 ||| Cranage services ||| Chelating agents ||| Services de grutage
0.7850472927093506 ||| Anaphylaxis and Stevens Johnson syndrome ||| • Treatment of Friedreich’s ataxia ||| Anaphylaxie et syndrome de Stevens- Johnson
0.3714459538459778 ||| Rockets [projectiles] ||| Basins [receptacles] ||| Fusées [projectiles]
0.3227801024913788 ||| Hypotension may occur at the beginning of treatment, especially if pramipexole is titrated too fast. ||| Discontinuation of duloxetine (particularly when abrupt) commonly leads to withdrawal symptoms. ||| Une hypotension peut survenir au début du traitement, en particulier quand la dose d’ Oprymea est augmentée trop rapidement.
3.43899984444479e-13 ||| Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3). ||| Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3). ||| Les études chez l'animal n'ont pas montré d'effets délétères directs ou indirects sur la gestation, le développement embryonnaire/ fœ tal, la parturition ou le développement post-natal (voir rubrique 5.3).
0.2701478898525238 ||| Maintenance of cleaning machines ||| Maintenance of computer programs ||| Entretien de machines de nettoyage
0.27050623297691345 ||| Education services relating to industry ||| Education services relating to water safety ||| Services de formation industrielle
0.24816489219665527 ||| 25 Hypromellose (HPMC 2910) Titanium dioxide (E171) Macrogol (PEG 400) Talc Indigo carmine aluminium lake (E132) Iron oxide black (E172) Iron oxide red (E172) ||| Glycerol Gelatin Water, purified Red iron oxide paste (E172) Yellow iron oxide paste (E172) Titanium dioxide (E171) Lecithin Medium chain triglycerides EMEA/ CPMP/ 2811/ 03 Black ink ||| Hypromellose (HMPC 2910) Dioxyde de titane (E 171) Macrogol Talc Laque carmin indigo (E132) Oxyde de fer rouge (E172) Oxyde de fer noir (E172)
0.4769349694252014 ||| The toolbox will also focus on developing a common approach for modelling and predicting the evolution of the virus through anonymous and aggregated mobile location data. ||| The first stage will be a pilot project to collate and make available electronically summaries of product characteristics and patient leaflets. ||| La boîte à outils mettra également l'accent sur l'élaboration d'une approche commune permettant de modéliser et de prévoir l'évolution du virus au moyen de données de localisation mobile anonymes et agrégées.
0.12311448901891708 ||| What documentation has the company presented to support its application to the CHMP? ||| What documentation has been presented by the company to support the application to the CHMP? ||| Quelle a été la documentation présentée par la société pour justifier la demande auprès du CHMP?
0.10874250531196594 ||| How has Imprida been studied? ||| How has Revatio been studied? ||| Quelles études ont été menées sur Imprida?
0.30011022090911865 ||| Manufacturer for the batch release: ||| The Manufacturer responsible for batch release is ||| Fabricant responsable de la libération des lots:
0.0 ||| Keep out of the reach and sight of children. ||| Keep out of the reach and sight of children. ||| Tenir hors de la portée et de lavue des enfants.
0.08991693705320358 ||| The Committee recommended that Lysodren be given marketing authorisation. ||| The Committee recommended that Pandemrix be given marketing authorisation. ||| Le CHMP a recommandé que Lysodren reçoive une autorisation de mise sur le marché.
0.5516151189804077 ||| As for any vaccine, vaccination with M-M-RVAXPRO may not result in protection in all vaccinees. ||| - if you are taking certain medicines for treating depression (selective MAO-A plus MAO-B ||| 4 Comme d'autres vaccins, M-M-RVAXPRO peut ne pas protéger tous les sujets vaccinés.
0.058849677443504333 ||| The active substance in Soliris, eculizumab, is a monoclonal antibody. ||| The active substance in Synagis, palivizumab, is a monoclonal antibody. ||| La substance active de Soliris, l’ eculizumab, est un anticorps monoclonal.
0.2521213889122009 ||| In diabetic patients the metabolic effects of testosterone may decrease blood glucose and therefore insulin requirements. ||| In case of diabetes mellitus, the potential systemic effects of the product may influence blood glucose concentrations. ||| Chez les patientes diabétiques, les effets métaboliques de la testostérone peuvent réduire la glycémie et, par conséquent, les besoins en insuline.
4.915798128800331e-13 ||| Solution for injection, 1 vial of 10 ml. ||| Solution for injection, 1 vial of 10 ml. ||| Solution injectable, 1 flacon de 10 ml.
0.5500184297561646 ||| Oseltamivir 75 mg bid ||| Hycamtin 0.25 mg ||| Oseltamivir 75 mg deux
0.058242324739694595 ||| The pharmacokinetic of digoxin was not altered by coadministration of irbesartan. ||| The pharmacokinetic of digoxin was not altered by co-administration of irbesartan. ||| La pharmacocinétique de la digoxine n'a pas été altérée par l'administration simultanée d'irbésartan.
0.18302246928215027 ||| 1 vial of 5 ml rod ||| 1 vial of 10 ml ||| 1 flacon de 5 ml am
0.7377139329910278 ||| Ibaflin 30 mg tablets for dogs Ibaflin 150 mg tablets for dogs Ibaflin 300 mg tablets for dogs Ibaflin 900 mg tablets for dogs ||| Econor 50% premix for medicated feed for pigs Econor 10% premix for medicated feed for pigs Econor 1% premix for medicated feed for pigs Econor 0.5% premix for medicated feed for pigs ||| Ibaflin 30 mg comprimés pour chiens Ibaflin 150 mg comprimés pour chiens Ibaflin 300 mg comprimés pour chiens Ibaflin 900 mg comprimés pour chiens
0.27282607555389404 ||| PL-02-672 Warszawa Tel.: + 48 22 606-10-50 ||| 50123 Firenze Tel.: + 39 055 288860 ||| Domaniewska 41 PL-02-672 Warszawa Tel.: + 48 22 606-10-50
0.2255622148513794 ||| DO NOT touch this area again before giving the injection. ||| Do not touch the area again before injecting. ||| NE TOUCHEZ PLUS à cette zone avant de faire l’injection.
0.28519055247306824 ||| Wholesale services in relation to tobacco ||| Wholesale services in relation to umbrellas ||| Services de vente en gros concernant le tabac
0.43953990936279297 ||| Lovastatin 40mg ||| 40 mg Trudexa ||| Lovastatine 40 mg
0.18149752914905548 ||| - Musculoskeletal and connective tissue disorders ||| Musculoskeletal and connective tissue disorders General disorders ||| - Troubles des tissus musculosquelettique et conjonctif
0.36562609672546387 ||| - After reconstitution, Omnitrope is given as an injection under the skin. ||| Relistor is given as an injection under the skin, once every two days. ||| - Après reconstitution, Omnitrope est administré par une injection sous la peau.
0.0688190758228302 ||| 33 B. ||| 32 B. ||| 34 B.
0.06712984293699265 ||| Based on the results of in vitro experiments and the known major metabolic pathways of abacavir, the potential for P450 mediated interactions with other medicinal products involving abacavir is low. ||| Based on the results of these in vitro experiments and the known elimination pathways of emtricitabine, the potential for CYP450 mediated interactions involving emtricitabine with other medicinal products is low. ||| Sur la base des études in vitro et des principales voies métaboliques connues de l’ abacavir, le risque potentiel d’ interactions médicamenteuses entre l’ abacavir et les médicaments métabolisés par le cytochrome P450 est faible.
3.7438254536434346e-13 ||| Slowly, withdraw 7.0 ml (equal to 35 mg) of the reconstituted solution from each vial up to the total volume required for the patient dose. ||| Slowly, withdraw 7.0 ml (equal to 35 mg) of the reconstituted solution from each vial up to the total volume required for the patient dose. ||| Prélever lentement 7,0 ml (équivalant à 35 mg) de solution reconstituée de chaque flacon jusqu’ au volume total requis pour la dose du patient.
0.5127544403076172 ||| If we all stand up for Europe today - with courage, trust and solidarity - I know that tomorrow Europe's soul will shine brighter than ever before. ||| After all, the desire for a resilient European home which is worth living in is something that unites us all: North and South, East and West. ||| Si nous défendons tous l'Europe aujourd'hui - avec courage, confiance, et solidarité, je sais que demain, l'âme de l'Europe brillera plus fort que jamais.
0.39839810132980347 ||| Withdrawal symptoms seen on discontinuation of fluoxetine treatments: ||| Advice on management of patients upon cessation of romiplostim. ||| Symptômes de sevrage observés à l’ arrêt du traitement par fluoxétine:
0.2958141565322876 ||| The studies either recruited patients who were being treated with chemotherapy (two studies) or used patient populations in which erythropoiesis stimulating agents are not indicated: anaemia in patients with cancer not receiving chemotherapy, and head and neck cancer patients receiving radiotherapy. ||| It is used in patients in whom other treatments have stopped working, and who are not suitable for radiotherapy (treatment with radiation), surgery or systemic chemotherapy (medicines used to treat cancer; ‘ systemic ’ means that they are given as treatments throughout the body). ||| Les études ont inclus des patients traités par chimiothérapie (deux études) où se sont basées sur des populations de patients chez lesquels l’ utilisation d’ agents stimulants l’ érythropoïèse n’ est pas indiquée: anémie touchant des patients cancéreux non traités par chimiothérapie et patients atteints de cancers de la tête et du cou traités par radiothérapie.
0.3604933023452759 ||| Where event incidence differed between Paxene and other paclitaxel clinical studies, the most frequent incidence is presented. ||| The list also includes marked laboratory abnormalities that have been observed with nelfinavir (at 48 weeks). ||| Quand l’ incidence de l’ effet est différente entre celle de Paxene et celle des autres études cliniques sous paclitaxel, l’ incidence la plus fréquente est reportée.
0.14812079071998596 ||| Blankets, electric, for medical purposes ||| Blenders, electric, for household purposes ||| Couvertures électriques à usage médical
0.15117955207824707 ||| Uncommon (> 1/ 1000, < 1/ 100) ||| Uncommon ( 1/ 1000 to < 1/ 100) ||| Peu fréquent (> 1/ 1.000, < 1/ 100)
0.12123298645019531 ||| Trizivir can be taken with or without food. ||| Ziagen can be taken with or without food. ||| Trizivir peut être pris au cours ou en dehors des repas.
0.0 ||| 8 Table 1. ||| 8 Table 1. ||| 9 Tableau 1.
0.40103819966316223 ||| Sprinklers [automatic installations] for watering flowers and plants ||| Devices [oral irrigators] for use by dentists in washing the gums ||| Arroseurs pour fleurs et plantes [installations automatiques]
0.31278789043426514 ||| What is Trocoxil? ||| What is Betaferon? ||| Qu’ est -ce que Trocoxil?
0.338561087846756 ||| You must not breast-feed while taking Siklos. ||| You should not breastfeed when taking INVEGA. ||| Vous ne devez pas allaiter tant que vous prenez Siklos
0.29963967204093933 ||| It is recommended that MabCampath should be interrupted in patients whose platelet count falls to < 25,000/μ l or whose absolute neutrophil count (ANC) drops to < 250/μ l. ||| Myocet should not be administered to individuals with absolute neutrophil counts (ANC) lower than 1,500 cells/μ l or platelets less than 100,000/μ l prior to the next cycle. ||| Il est recommandé d’ interrompre MabCampath chez les patients dont la numération plaquettaire est < 25 000/μ l ou lorsque le taux absolu de polynucléaires neutrophiles (TAPN) diminue en dessous de 250/μ l.
0.39326706528663635 ||| In both studies dexrazoxane treatment prevented the development of necrosis, allowed cancer treatment to continue as scheduled in the majority of patients, and reduced the occurrence of sequelae (only few and mild long-term sequelae were observed). ||| Smokers were 1.4 times more likely to have severe symptoms of COVID-19 and approximately 2.4 times more likely to require intensive care or die compared to non-smokers.Concerns have been raised about long-term sequelae of the disease. ||| Dans les deux études, le traitement par dexrazoxane a évité le développement d'une nécrose, dans la majorité des cas a permis la poursuite de la chimiothérapie selon le planning prévu, et a réduit la survenue des séquelles (seules quelques séquelles légères à long terme ont été observées).
0.5527533292770386 ||| Latvija SIA “Merck Sharp & Dohme Latvija”. ||| 29 Ísland Merck Sharp & Dohme Ísland ehf. ||| 87 Latvija SIA “Merck Sharp & Dohme Latvija”.
0.762515127658844 ||| {CARDBOARD BOXES} ||| CARTON FOLDING BOX ||| {ÉTUIS CARTONNÉS}
0.09238465130329132 ||| Each tablet contains 300 mg of irbesartan. ||| Each tablet contains 150 mg irbesartan. ||| Chaque comprimé contient 300 mg d'irbésartan.
0.030843360349535942 ||| Actraphane InnoLet is designed to be used with NovoFine short cap needles of 8 mm or shorter in length. ||| Insulatard InnoLet is designed to be used with NovoFine short cap needles of 8 mm or shorter in length. ||| Actraphane InnoLet est conçu pour être utilisé avec les aiguilles NovoFine munies d’ une protection courte d’ une longueur maximale de 8 mm.
0.33354076743125916 ||| These inhibitors are invariably IgG immunoglobulins directed against the factor VIII procoagulant activity, which are quantified in Modified Bethesda Units (BU) per ml of plasma. ||| As an aid to optimise dosing, several immunoassays are available for determining tacrolimus concentrations in whole blood including a semi-automated microparticle enzyme immunoassay (MEIA). ||| Ces inhibiteurs sont toujours des immunoglobulines G dirigées contre l’ activité pro-coagulante du facteur VIII et sont quantifiés en Unités Bethesda modifiées (UB) par ml de plasma.
0.19299042224884033 ||| Each Remeron 30 mg film-coated tablet contains 217 mg lactose (as monohydrate). ||| Each 400 mg hard capsule contains 54 mg lactose (as monohydrate). ||| Chaque comprimé pelliculé de Remeron 30 mg contient 217 mg de lactose (monohydraté).
0.046487998217344284 ||| Belgique/ Belgien Tél/ Tel: + 32 (0)2 656 21 11 ||| Belgique/Belgien Tél/ Tel: + 32 (0)2 656 21 11 ||| Belgique/Belgien Tél/Tel: + 32 (0)2 656 21 11
0.18317046761512756 ||| Other information about Invirase: ||| Other information about Exforge: ||| 2/ 3 Autres informations relatives à Invirase:
0.45816314220428467 ||| However, opioid analgesics impair the mental and/ or physical ability required for the performance of potentially dangerous tasks (e. g., driving a car or operating machinery). ||| Hand washing (or handwashing), also known as hand hygiene, is the act of cleaning one's hands for the purpose of removing soil, grease, microorganisms, or other unwanted substances. ||| Toutefois, les morphiniques altèrent les capacités mentales et/ ou physiques nécessaires à la réalisation de tâches potentiellement dangeureuses telles que la conduite d’ un véhicule ou l’ utilisation de machines.
0.3505256772041321 ||| Normally, your body produces a protein that blocks the harmful effects of interleukin-1. ||| Cyclosporin and tacrolimus may be affected by the number of red cells in your blood. ||| Normalement, l’ organisme produit une protéine qui bloque les effets nocifs de l’ interleukine-1.
0.15207545459270477 ||| Pharmacotherapeutic group: other dopaminergic agents, ATC code: ||| Pharmacotherapeutic group: other nervous system drugs, ATC code: ||| Classe pharmacothérapeutique: autres agents dopaminergiques, code ATC:
0.4022538661956787 ||| When the enzyme is blocked, the virus cannot reproduce normally, slowing down the spread of infection. ||| As a result of this binding, the tumour cell can no longer receive the messages needed for growth, progression and spread. ||| Lorsque l’ enzyme est bloquée, le virus ne peut pas se reproduire normalement, ce qui ralentit la progression de l’ infection.
0.408770352602005 ||| Allergic reactions including urticaria, mild skin eruptions, bronchospasm and angioedema ||| lymphoma, solid organ tumours (including breast, ovarian, testicular), squamous cell carcinoma of the skin ||| Réactions allergiques dont urticaire, éruptions cutanées modérées, bronchospasme et angioedème
0.4196510910987854 ||| - Mild to moderate pelvic inflammatory disease (i. e. infections of female upper genital tract, ||| - pimozide (used to treat the symptoms of Tourette's syndrome e. g. vocal outbursts and ||| - infections gynécologiques hautes d’ intensité légère à modérée (y compris salpingites et
6.533543237680073e-13 ||| 6.6 Special precautions for disposal ||| 6.6 Special precautions for disposal ||| 168 6.6 Précautions particulières d’ élimination
0.20321418344974518 ||| For the treatment of acute pain and inflammation associated with musculo-skeletal disorders in cats. ||| This product reduced pain and inflammation associated with musculoskeletal disorders in clinical trials in cats. ||| Traitement de la douleur aiguë et de l’ inflammation associées aux troubles musculo-squelettiques chez les chats.
0.05802994221448898 ||| Respiratory, thoracic and mediastinal disorders ||| - Respiratory, thoracic and mediastinal disorders ||| Affections respiratoires, thoraciques, médiastinales
0.15728411078453064 ||| Insurance services relating to sport ||| Insurance services relating to life ||| Services d'assurances sportives
0.2359381765127182 ||| Therefore, in case of an inadvertent administration of Ytracis, the radiotoxicity for the patient must be reduced by immediate (i. e. within 1 hour) administration of preparations containing chelators like Ca-DTPA or Ca- EDTA in order to increase the elimination of the radionuclide from the body. ||| As leflunomide has a long persistence in the body, a switching to another DMARD (e. g. methotrexate) without performing the washout procedure (see below) may raise the possibility of additive risks even for a long time after the switching (i. e. kinetic interaction, organ toxicity). ||| Dans le cas d’ une administration accidentelle d’ YTRACIS, la radiotoxicité pour le patient doit donc être réduite par l’ administration immédiate (par exemple dans l’ heure) de préparations contenant des agents chélateurs tels que le Ca-DTPA ou le Ca-EDTA afin d’ augmenter l’ élimination corporelle du radionucléide.
0.4790286421775818 ||| In patients not fully healed within this time, the medication is continued at the same dose for another two weeks. ||| Some dogs do not need daily treatment; treatment every other day may be tried once the effective daily dose has been established. ||| Chez des patients dont la cicatrisation n’est pas complète après cette période, le traitement sera poursuivi pendant 2 semaines supplémentaires à la même posologie.
0.36033573746681213 ||| The potential for interactions must be considered in patients receiving AZARGA. ||| Limited data are available on the effects of vaccination in patients receiving Raptiva. ||| La possibilité d’interactions doit être envisagée chez les patients traités avec AZARGA.
0.36063840985298157 ||| Twelve hours after i. v. administration of 200 mg the plasma concentration is still higher than the MIC values of the majority of clinically relevant pathogens (approximately 0.1 µg/ ml). ||| At any visit, the mean diurnal IOP values measured over the 12-month study period differed by no more than 1.3 mmHg throughout the day and were never greater than 18.0 mmHg. ||| Douze heures après une administration intraveineuse de 200 mg, la concentration plasmatique demeure supérieure à la CMI sur la majorité des bactéries pathogènes cliniquement pertinentes (environ 0,1 µg/ ml).
0.09892066568136215 ||| Auxiliary fluids for use with additives for wood pulp ||| Auxiliary fluids for use with additives for paper ||| Fluides auxiliaires utilisés avec des additifs pour pâte de bois
0.35935574769973755 ||| Each powder vial contains 3000 IU octocog alfa. ||| Each 1 ml vial 15 micrograms darbepoetin alfa. ||| Chaque flacon de poudre contient 3000 UI d’ octocog alfa
0.4903923571109772 ||| Alexion Pharma Germany Landsberger Strasse 155 80687 Munich Deutschland ||| KG Industry Park Hoechst 65926 Frankfurt am Main Germany ||| Österreich Alexion Pharma Germany Landsberger Strasse 155 80687 Munich Deutschland
0.030017495155334473 ||| 4.8 Interaction with other medicinal products and other forms of interaction ||| 4.8 Interactions with other medicinal products and other forms of interaction ||| 4.8 Interactions avec d’ autres médicaments vétérinaires et autres formes d’ interaction
0.354666143655777 ||| When compared with levodopa, fewer of the patients taking Sifrol had movement symptoms after 21 months: ||| In patients treated with riluzole 100 mg/ day, survival was significantly higher compared to patients who received placebo. ||| Le nombre de patients présentant des symptômes moteurs était plus faible dans le groupe Sifrol que dans le groupe lévodopa après 21 mois de traitement:
0.06993088871240616 ||| - If you are allergic (hypersensitive) to ziconotide or any of the other ingredients of Prialt. ||| - if you are allergic (hypersensitive) to toremifene or any of the other ingredients of Fareston, ||| - si vous êtes allergique (hypersensible) au ziconotide ou à l'un des autres composants contenus
0.23114708065986633 ||| If in cases of deep pyoderma, sufficient improvement is not seen after a treatment course of 21 days, it is recommended that the treatment is reconsidered. ||| If after 3 months of maintenance dose treatment the patient’ s rate of decline in dementia symptoms is not altered favourably, the treatment should be discontinued. ||| Si dans les cas de pyodermite profonde, une amélioration suffisante n’ a pas été observée après une durée de traitement de 21 jours, il est recommandé de reconsidérer le traitement.
0.5404807329177856 ||| Boilers, other than parts of machines ||| Valves of plastic being other than machine parts ||| Chaudières autres que parties de machines
0.06756509840488434 ||| In one clinical trial in patients with bipolar mania, valproate combination therapy with olanzapine resulted in an incidence of neutropenia of 4.1%; a potential contributing factor could be high plasma ||| 107 In one clinical trial in patients with bipolar mania, valproate combination therapy with olanzapine resulted in an incidence of neutropenia of 4.1%; a potential contributing factor could be high plasma valproate levels. ||| Au cours d'un essai clinique mené chez des patients présentant un épisode maniaque dans le cadre de troubles bipolaires, lors de la prise concomitante de valproate la fréquence des neutropénies a été de 4,1%; un facteur contributif potentiel pourrait être des taux plasmatiques élevés de valproate.
0.2332734763622284 ||| Cardiac disorders: rare: syncope, artrial fibrillation, cerebrovascular accident ||| Cardiac disorders: palpitation, lung oedema, myocardial infarct; ||| Rare: syncope, fibrillation auriculaire, accident vasculaire cérébral
0.0 ||| Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 ||| Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 ||| 530 Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224
0.4050770401954651 ||| 28 tablets in blister packs Nylon/ Aluminum/ PVC. ||| PVC/Aluminium blisters containing 21or 84 hard capsules. ||| 28 comprimés sous blister Nylon/ Aluminium/ PVC.
0.22724640369415283 ||| The effects of 12 days dosing with ambrisentan (10 mg once daily) on the pharmacokinetics of a single dose of oral contraceptive containing ethinyl estradiol (35 μ g) and norethindrone (1 mg) were studied in healthy female volunteers. ||| In the Phase 3 trial, the pharmacokinetics of drotrecogin alfa (activated) were evaluated in 342 patients with severe sepsis administered a 96-hour continuous infusion at 24 µg/ kg/ hr. ||| Les effets de l'administration de l’ ambrisentan pendant 12 jours (10 mg, une fois par jour) sur les propriétés pharmacocinétiques d’ une seule dose d'un contraceptif oral associant de l'éthinylestradiol (35 µg) et de la noréthindrone (1 mg) ont été étudiés chez des femmes volontaires saines.
0.7700108289718628 ||| Precaution for disposal: ||| Absorption and distribution: ||| Précautions d’ élimination:
0.0 ||| The frequency and severity of the most commonly reported adverse reactions with Pegasys are similar to those reported with interferon alfa-2a (see Table 4). ||| The frequency and severity of the most commonly reported adverse reactions with Pegasys are similar to those reported with interferon alfa-2a (see Table 4). ||| La fréquence et la sévérité des principales réactions indésirables avec Pegasys sont similaires à celles rapportées avec l’interféron alfa-2a (voir Tableau 4).
0.28078725934028625 ||| - The other ingredients are glycine, disodium phosphate anhydrous, sodium dihydrogen phosphate ||| This product also contains sugar, preservatives: methyl parahydroxybenzoate and propyl parahydroxybenzoate ||| - Les autres composants sont glycine, phosphate disodique anhydre, phosphate monosodique
0.525801420211792 ||| A systematic review has also been performed involving more than 9’ 000 cancer patients participating in 57 clinical trials. ||| Immunization Week was observed simultaneously for the first time in 2012, with the participation of more than 180 countries and territories worldwide. ||| 97 Une revue systématique a été réalisée impliquant plus de 9000 patients cancéreux ayant participé à 57 essais cliniques.
0.5099329948425293 ||| What NutropinAq contains ||| What Infanrix hexa contains ||| Que contient NutropinAq
0.017550742253661156 ||| Plavix 75 mg film-coated tablets clopidogrel ||| Plavix 300 mg film-coated tablets clopidogrel ||| Plavix 75 mg comprimés pelliculés clopidogrel
0.5448700785636902 ||| Technical consultancy relating to the application and use of computer software ||| Consultancy regarding the organization or managing of a trade company ||| Services de conseils techniques en matière d'application et d'utilisation de logiciels
0.1688847839832306 ||| After reconstitution, each ml suspension contains 25 mg azacitidine. ||| After reconstitution, 1 ml solution for infusion contains 2.5 mg temozolomide. ||| Après reconstitution, chaque ml de suspension contient 25 mg d’azacitidine.
0.458024263381958 ||| Do not touch the sticky side of the system or the gels or allow gels to touch your mouth. ||| Never try to alter the numbers on the counter or detach the counter from the metal can. ||| Ne touchez pas la partie collante du dispositif ou les gels et évitez tout contact des gels avec la bouche.
3.7051674120318345e-13 ||| What Insulin Human Winthrop Basal looks like and contents of the pack After mixing, Insulin Human Winthrop Basal is a uniformly milky fluid (suspension for injection), with no clumps, particles or flocculation visible. ||| What Insulin Human Winthrop Basal looks like and contents of the pack After mixing, Insulin Human Winthrop Basal is a uniformly milky fluid (suspension for injection), with no clumps, particles or flocculation visible. ||| Qu’est-ce que Insulin Human Winthrop Basal et contenu de l’emballage extérieur Après mélange, Insulin Human Winthrop Basal a un aspect laiteux uniforme (suspension), sans agrégats, flocons ou particules visibles.
0.6320663690567017 ||| If you miss/ your child misses the visit scheduled for the second injection, talk to your doctor and arrange another visit as soon as possible. ||| If you want to change your “Patch Change Day” to a different day of the week talk to your doctor. ||| Si vous manquez ou si votre enfant manque la visite prévue pour la deuxième injection, informez -en votre médecin et demandez -lui une nouvelle consultation le plus rapidement possible.
0.36560535430908203 ||| Computer engineering consultancy services ||| Computer software programming services ||| Services de conseils en ingénierie informatique
0.5098642110824585 ||| Lantus 100 Units/ ml solution for injection in a pre-filled pen, OptiSet, is a clear colourless solution. ||| The I-Neb AAD System is a portable, hand-held, vibrating mesh technology nebuliser system. ||| Lantus 100 Unités/ ml solution injectable en stylo prérempli OptiSet, est une solution limpide et incolore.
0.4252132773399353 ||| Beta-blockers may increase the hypoglycaemic effect of antidiabetic agents. ||| Coxibs display pain relief, anti-inflammatory and antipyretic properties. ||| Les bêta-bloquants sont susceptibles d’ augmenter l’ effet hypoglycémiant des antidiabétiques.
0.3641440272331238 ||| Your doctor will discuss with you which combination of medicines is best for you. ||| Your doctor will explain the effects of stopping treatment and discuss other possibilities with you. ||| Votre médecin vous prescrira l’association médicamenteuse qui vous est la plus adaptée.
0.184442937374115 ||| Pregnancy and breast-feeding If you are pregnant, or thinking about becoming pregnant, tell your doctor. ||| Pregnancy and breastfeeding Tell your doctor if you are pregnant or planning to become pregnant. ||| Grossesse et allaitement Si vous êtes enceinte ou si vous envisagez de l’être ou si vous pensez l’être, informez votre médecin.
0.05538024753332138 ||| In a second double-blind study, 201 patients received rotigotine, 200 received pramipexole and 100 patients received placebo. ||| In a second double-blind study, 213 patients received rotigotine, 227 received ropinirole and 117 patients received placebo. ||| Au cours d’ une seconde étude en double aveugle, 201 patients ont reçu de la rotigotine, 200 ont reçu du pramipexole et 100 patients ont reçu un placebo.
0.16570591926574707 ||| What Emtriva is and what it is used for 2. ||| What MabThera is and what it is used for 2. ||| Qu’est-ce qu’Emtriva et dans quel cas est-il utilisé 2.
0.7662168741226196 ||| Carton box 15 and 30 ml bottle ||| Ointment 30 g 60 g ||| Boite de un flacon de 15 et 30 ml
0.29194653034210205 ||| Your doctor can decide whether Retacrit is not working properly for you and will end the treatment, if necessary. ||| Your doctor will make sure you have a blood test and will advise whether or not to continue with Cubicin. ||| Votre médecin peut déterminer si Retacrit n’agit pas correctement et arrêtera le traitement si besoin.
0.16490045189857483 ||| When sildenafil is taken with food, the rate of absorption is reduced with a mean delay in tmax of 60 minutes and a mean reduction in Cmax of 29%. ||| When vardenafil is taken with a high fat meal (containing 57% fat), the rate of absorption is reduced, with an increase in the median tmax of 1 hour and a mean reduction in Cmax of 20%. ||| Lorsque le sildénafil est pris avec de la nourriture, la vitesse d’ absorption est diminuée avec un allongement moyen du Tmax de 60 minutes et une baisse moyenne de la Cmax de 29%.
0.2837491035461426 ||| In rabbits, abortion or early resorption were noted at doses causing significant maternal toxicity, including mortality. ||| In rabbits, vaginal bleedings and abortions possibly associated to prolonged haemostasis, but no foetal abnormalities were noted. ||| Chez le lapin, des avortements ou des résorptions précoces ont été observés à des doses entraînant des effets toxiques importants y compris létaux pour la mère.
0.3939763307571411 ||| Insulating sleeves for power lines ||| Sleeves for holding and protecting stamps ||| Manchons isolants pour lignes électriques
0.5606841444969177 ||| Studies on carcinogenic potential were not performed. ||| All comparisons against placebo were statistically significant. ||| Aucune étude sur le potentiel carcinogène n’ a été menée.
0.22553247213363647 ||| The overall incidence of adverse reactions considered as drug-related in patients treated with the combination of sitagliptin and metformin was comparable to metformin alone (14.0% each) and greater than sitagliptin alone (6.7%), with the differences relative to sitagliptin alone primarily due to gastrointestinal adverse reactions. ||| 2 In this 24-week study of sitagliptin 100 mg once daily in combination with glimepiride, the incidence of adverse reactions considered as drug-related in patients treated with sitagliptin/ glimepiride compared to treatment with placebo/ glimepiride was 11.3% and 6.6%, respectively. ||| L'incidence globale des effets indésirables considérés comme imputables au médicament chez les patients traités par l'association sitagliptine/metformine a été comparable à celle des patients traités par metformine seule (14,0% dans chaque groupe) et supérieure à celle des patients traités par sitagliptine seule (6,7%), les différences par rapport à la sitagliptine seule étant principalement dues aux effets indésirables gastro-intestinaux.
0.46033763885498047 ||| If hypotension occurs, the patient should be placed in the shock position. ||| Your doctor may stop the infusion if this occurs. ||| En cas d’hypotension, le patient doit être mis en position de choc.
0.43357932567596436 ||| Tobacco pipe scrapers ||| Tobacco substitutes ||| Cure-pipes à tabac
0.6227346658706665 ||| Cardiac function should be further monitored during treatment (e. g. every three months). ||| necessary, (i. e according to the serologic status of the patient) for short and long term protection. ||| La surveillance de la fonction cardiaque doit être réévaluée pendant le traitement (par exemple tous les trois mois).
0.5632684230804443 ||| 87% / 11% / 2% / 0% 33% 36% 1% ||| 64% / 24% / 8% 4.2 33.0 20 (6%) ||| 87% / 11% / 2% / 0% 33% 36%
0.06644348055124283 ||| 16/ 48 ANNEX II ||| 15/ 64 ANNEX II ||| 16/ 49 ANNEXE II
0.24503852427005768 ||| After reconstitution, the solution contains 5 mg of alglucosidase alfa/ ml and after dilution, the concentration varies from 0.5 mg to 4 mg/ ml. ||| After reconstitution with the accompanying 10 ml water for injection, each ml of the solution contains approximately 100 IU/ ml nonacog alfa. ||| Après reconstitution, la solution contient 5 mg/ ml d’ alpha alglucosidase et après dilution, la concentration varie de 0,5 mg à 4 mg/ ml.
0.37893128395080566 ||| NovoSeven 2.4 mg (120 KIU) Powder and solvent for solution for injection eptacog alfa (activated) ||| M-M-RVAXPRO Powder and solvent for suspension for injection Measles, mumps and rubella vaccine (live) ||| NovoSeven, 2,4 mg (120 KUI), Poudre et solvant pour solution injectable eptacog alfa (activé)
0.09800999611616135 ||| Magnetically encoded credit cards ||| Magnetically encoded gift cards ||| Cartes de crédit encodées magnétiquement
0.24934914708137512 ||| Any unused solution and the vial should be adequately disposed of, in accordance with local requirements. ||| • The used pre-filled pen should be disposed of in accordance with local requirements. ||| Toute solution non utilisée et le flacon doivent être éliminés en accord avec les exigences locales.
0.33496740460395813 ||| In deciding to initiate treatment with PREZISTA co-administered with 100 mg ritonavir careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. ||| Your doctor should always adapt the amount of KOGENATE Bayer 500 IU to be administered and the frequency of administration according to the clinical effectiveness in your individual case. ||| Lors de l'instauration du traitement par PREZISTA co-administré avec 100 mg de ritonavir, les antécédents thérapeutiques de chaque patient et les profils de resistance associés aux différents antirétroviraux devront être évalués avec attention.
0.2578718066215515 ||| Do not use NeoRecormon: • if you are allergic (hypersensitive) to epoet in beta or any of the other ingredients of NeoRecormon or benzoic acid, a metabolite of benzyl alcohol • if you have blood pressure problems that cannot be controlled • if you are donating your own blood before surgery, and: ||| TORISEL should not be used in people who may be hypersensitive (allergic) to temsirolimus, to its metabolites (the substances that it is broken down into) including sirolimus (a medicine used to prevent rejection of transplanted kidneys), to polysorbate 80 or to any of the other ingredients of the medicine. ||| N'utilisez jamais NeoRecormon: • si vous êtes allergique (hypersensible) à l'epoetin beta ou à l'un des excipients contenus dans NeoRecormon ou à l’ acide benzoïque, un métabolite de l’ alcool benzylique. • si vous avez des problèmes de pression artérielle mal contrôlée • si vous donnez votre propre sang avant une intervention chirurgicale et que:
0.86952143907547 ||| Asthenia Uncommon: ||| Very common Uncommon ||| Asthénie Peu fréquent:
0.0 ||| For a full list of excipients, see section 6.1. ||| For a full list of excipients, see section 6.1. ||| Pour une liste complète des excipients voir rubrique 6.1.
0.3337799310684204 ||| Adefovir is excreted renally, by a combination of glomerular filtration and active tubular secretion. ||| This effect is thought to result from selective blockade of the alpha-1-adrenoceptors located in the vasculature. ||| L’ adéfovir est excrété par voie rénale, par un mécanisme associant une filtration glomérulaire et une sécrétion tubulaire active.
0.31371891498565674 ||| Junction sleeves for fibre optics ||| Thermal insulation jackets for valves ||| Manchons de jonction pour fibres optiques
0.39330345392227173 ||| 4.1.4 Remove the syringe and needle and mix manually by repeated inversions for at least 45 seconds. ||| Swirl and shake the vial contents gently for 30 seconds to insure dissolution. ||| Sortir l’ aiguille et la seringue et mélanger manuellement par 4.1.4 renversements répétés pendant au moins 45 secondes.
0.3390020728111267 ||| If cloudy in appearance or particles are observed, the solution should be discarded. ||| The titration period may be adjusted, if any significant adverse reaction occurs. ||| Si la solution est trouble ou si l’on observe des particules dans cette solution, celle-ci doit être éliminé.
0.1971801221370697 ||| In some patients with compromised renal function (e. g. dehydrated patients or elderly patients with compromised renal function), the co-administration of angiotensin II receptor antagonists and agents that inhibit cyclo-oxygenase may result in further deterioration of renal function, including possible acute renal failure, which is usually reversible. ||| Concomitant use of angiotensin II antagonists or diuretics and NSAIDs may lead to an increased risk of worsening of renal function, including possible acute renal failure, and an increase in serum potassium, especially in patients with poor pre-existing renal function. ||| Chez certains patients dont la fonction rénale est altérée (par exemple les patients déshydratés ou les patients âgés dont la fonction rénale est altérée), l’ association d’ antagonistes des récepteurs de l’ angiotensine II et d’ agents inhibiteurs de la cyclo-oxygénase peut entraîner une dégradation supplémentaire de la fonction rénale, notamment une insuffisance rénale aiguë, généralement réversible.
0.26681312918663025 ||| Elastic stockings [for medical purposes] ||| Electric scalpels [for surgical purposes] ||| Bas élastiques à usage médical
0.19825632870197296 ||| 14 Table 2: ||| 4 Table 2: ||| Tableau 2:
0.0 ||| During the course of treatment, appropriate determination of plasma factor VIII levels is advised to guide the dose to be administered and the frequency of repeated injections. ||| During the course of treatment, appropriate determination of plasma factor VIII levels is advised to guide the dose to be administered and the frequency of repeated injections. ||| 3 Au cours du traitement, il est conseillé d'effectuer une détermination appropriée des taux de facteur VIII plasmatique afin d'évaluer la dose à administrer ainsi que la fréquence du renouvellement des injections.
0.4908345341682434 ||| H-1139 Budapest Tel. :+36 1 465 2100 ||| H-2040 BUDAÖRS Tel. + 36 23 410 410 ||| H-1139 Budapest Tel.: + 36 1 465 2100
0.4222373068332672 ||| - Prescriptions of isotretinoin for women of childbearing potential should be limited to 30 days of ||| When combined they provide experience in 318 loratadine-exposed women during the first trimester of pregnancy. ||| - l’ isotrétinoïne ne doit être prescrite aux femmes en âge de procréer que pour une durée de 30
0.33678507804870605 ||| For intravenous use only ||| For intrathecal use only ||| Voie intraveineuse uniquement
0.09170086681842804 ||| Advisory services relating to the installation of gearboxes ||| Advisory services relating to the installation of passenger lifts ||| Services de conseils liés à la pose de boîtes de vitesses
0.5747472643852234 ||| Hildebrandt and co-chaired by Dr B. van Zwieten-Boot, who was also the co-ordinator for ICH matters, met 4 times in 1997. ||| The structure of the Unit remained stable with Dr Peter Jones as Head of Unit and the Heads of Sector, Dr Jill Ashley-Smith and Dr Kornelia Grein. ||| Hildebrandt et co-présidé par le Dr B. van Zwieten-Boot, qui était également coordinateur pour l’ICH, s’est réuni quatre fois en 1997.
0.44651859998703003 ||| How is Clopidogrel BMS used? ||| What is Fluticasone Furoate GSK? ||| Comment Clopidogrel BMS est -il utilisé?
0.5221381783485413 ||| The schemes have a total budget of approximately €20 billion. ||| The scheme is expected to mobilise €150 million. ||| Ces régimes sont dotés d'un budget total d'environ 20 milliards d'euros.
0.05384247750043869 ||| In diabetic hypertensive patients, Enviage provided additive blood pressure reductions when added to ramipril, while the combination of Enviage and ramipril had a lower incidence of cough (1.8%) than ramipril (4.7%). ||| In diabetic hypertensive patients, Riprazo provided additive blood pressure reductions when added to ramipril, while the combination of Riprazo and ramipril had a lower incidence of cough (1.8%) than ramipril (4.7%). ||| Chez les patients diabétiques hypertendus, Enviage a permis des baisses supplémentaires de la pression artérielle lorsqu’ il était associé au ramipril, avec une incidence plus faible de la toux (1,8%), par rapport au ramipril seul (4,7%).
0.25430184602737427 ||| EU/ 1/ 01/ 185/ 054 1 pack EU/ 1/ 01/ 185/ 066 4 pack ||| EU/ 1/ 07/ 386/ 013 30 tablets EU/ 1/ 07/ 386/ 014 90 tablets ||| EU/ 1/ 01/ 185/ 054 Boîte de 1 EU/ 1/ 01/ 185/ 066 Boîte de 4
0.43416404724121094 ||| It will also ensure adequate focus of these investments and reforms based on the green and digital transitions, to help create jobs and sustainable growth and make the Union more resilient. ||| These funds have been used, among others, to promote peace, support women and youth's economic empowerment, and ensure inclusive and sustainable growth for all. ||| Elle fera aussi en sorte que ces investissements et ces réformes soient suffisamment axés sur les transitions écologique et numérique afin de contribuer à la création d'emplois et à une croissance durable et de rendre l'Union plus résiliente.
0.5798851847648621 ||| When used with Stalevo, the daily dose of selegiline should not exceed 10 mg. ||| In children, only the lowest strength Protopic 0.03% should be used. ||| En association avec Stalevo, la dose quotidienne de sélégiline ne doit pas dépasser 10 mg.
0.32166749238967896 ||| Sodium peroxide ||| Sulfur trioxide ||| Peroxyde de sodium
0.11359746754169464 ||| or th au er ng lo o tn uc od Pr al icin ed M ||| ed is or th au er ng lo o tn uc od Pr al icin ed M ||| é ris to au s lu p st 'e tn en am ic éd m e C
0.4630405306816101 ||| As with all insulin preparations, the duration of action of Humalog Mix50 is dependent on dose, site of injection, blood supply, temperature, and physical activity. ||| Dose adjustment may be required based on the meal size and nutrient composition, time of day (higher insulin requirements in the morning), pre-meal blood glucose concentration, recent or al ||| Comme pour toutes les préparations d'insuline, la durée d'action d'Humalog Mix50 dépend de la dose, du site d'injection, de la vascularisation, de la température et de l'activité physique.
0.4087480902671814 ||| Do not rub the injection site. ||| Do not touch the connection port. ||| Ne pas frotter le site d'injection.
0.5653286576271057 ||| 15 0 ||| 0 2 ||| 150
0.18328514695167542 ||| Cladding panels (Non-metallic -) for roofs ||| Flashings (Non-metallic -) for waterproofing buildings ||| Bardages non métalliques pour toitures
0.30560198426246643 ||| Gastrointestinal symptoms could occur. ||| Gastrointestinal bleeding can occur. ||| Des symptômes gastro- intestinaux peuvent apparaître.
0.4005417823791504 ||| Doctors should only use Mycamine when using other antifungal medicines is not appropriate. ||| Vivanza should not be taken with nitrates (medicines used to treat angina). ||| Les médecins ne doivent utiliser Mycamine que si d’ autres médicaments antifongiques ne sont pas appropriés.
0.13275805115699768 ||| 3 Prophylaxis For long-term prophylaxis against bleeding in patients with severe haemophilia A, the usual doses are 20 to 40 IU of factor VIIIper kg body weight at intervals of 2 to 3 days. ||| For long-term prophylaxis of haemorrhages in patients with severe haemophilia B, doses of 20 to 40 IU of factor IX per kilogram of body weight could be given at intervals of 3 to 4 days. ||| Prophylaxie Pour le traitement prophylactique à long terme des épisodes hémorragiques chez les patients atteints d’ hémophilie A sévère, les posologies habituelles sont de 20 à 40 UI de facteur VIII par kg de poids corporel à des intervalles de 2 à 3 jours.
0.8252447843551636 ||| Brinzolamide has been authorised in the European Union (EU) as Azopt since 2000. ||| Bovilis BVD was first authorised in Germany as Bovilis BVD-MD. ||| Le brinzolamide est autorisé dans l’ Union européenne sous le nom d’ Azopt depuis 2000.
0.38672229647636414 ||| In the osteoporosis treatment trials, FABLYN therapy resulted in consistent, statistically significant suppression of bone resorption and bone formation, as reflected by changes in serum and urine markers of bone turnover (e. g., C-telopeptide and markers of bone formation: osteocalcin, procollagen type 1 N-terminal propeptide, and bone-specific alkaline phosphatase). ||| Degarelix is a selective gonadotrophin releasing-hormone (GnRH) antagonist that competitively and reversibly binds to the pituitary GnRH receptors, thereby rapidly reducing the release of the gonadotrophins, luteinizing hormone (LH) and follicle stimulating hormone (FSH), and thereby reducing the secretion of testosterone (T) by the testes. ||| 10 Dans les études du traitement de l’ ostéoporose, FABLYN a induit une diminution régulière, statistiquement significative, de la résorption et de la formation osseuses, ce qui se traduit par des modifications des marqueurs sériques et urinaires du remodelage osseux (par exemple, le télopeptide C et les marqueurs de la formation osseuse: ostéocalcine, propeptide N terminal du procollagène de type 1 et phosphatase alcaline osseuse).
0.31287842988967896 ||| A medical history and physical examination should be undertaken to diagnose erectile dysfunction and determine potential underlying causes, before pharmacological treatment is considered. ||| The occurrence or aggravation of exertional dyspnea is usually the first clinical sign and requires treatment discontinuation and investigation in a specialised unit (see special warnings). ||| On pratiquera une anamnèse et un examen clinique afin de diagnostiquer la dysfonction érectile et d’ en déterminer les causes sous-jacentes potentielles avant d’ envisager un traitement médicamenteux.
0.2100018858909607 ||| Training services relating to finance ||| Financing services relating to trade ||| Services de formation en matière de finances
0.257748544216156 ||| Studies have not been conducted in patients with impaired hepatic function. ||| The vaccine has not been tested in patients with impaired immunity. ||| Aucune étude n'a été effectuée chez les patients présentant une insuffisance hépatique.
0.2790144979953766 ||| Other adverse reactions to ibandronic acid in reproductive toxicity studies in the rat were those observed with bisphosphonates as a class. ||| There is evidence that mitochondrial DNA toxicity may be associated with specific features of lipoatrophy in patients using stavudine. ||| Les autres effets indésirables de l’ acide ibandronique dans les études de reproduction chez le rat ont été ceux observés avec la classe des bisphosphonates.
0.13757185637950897 ||| Saws [hand tools] ||| Guns [hand tools] ||| Scies [outils]
0.24462774395942688 ||| Serious cardiovascular events, including myocardial infarction and cerebrovascular events have been uncommonly reported during clinical studies with pemetrexed, usually when given in combination with another cytotoxic agent. ||| In clinical studies, the only undesirable effects that were consistently considered to be related to filgrastim administration were musculoskeletal pain, predominantly mild to moderate bone pain and myalgia. ||| 5 Des effets cardiovasculaires graves, y compris des infarctus du myocarde, et des effets cérébrovasculaires ont été peu fréquemment rapportés pendant les études cliniques avec le pemetrexed, habituellement lorsque celui -ci est administré en association avec un autre agent cytotoxique.
0.317668080329895 ||| Evaluation of personnel requirements ||| Evaluation of business opportunities ||| Évaluation des besoins du personnel
0.28528037667274475 ||| The recommended dose of Vectibix is 6 mg/ kg of bodyweight given once every two weeks. ||| Initial treatment is a single oral dose of 0.1 mg meloxicam/ kg body weight on the first day. ||| La dose recommandée de Vectibix est de 6 mg/ kg de poids corporel administrée une fois toutes les deux semaines.
0.2586804926395416 ||| 2.6 (34.6%) ||| 199 (67.0%) ||| 2,6 (34,6%)
0.11702081561088562 ||| Your doctor or his/ her assistant will instruct you how to self-inject Valtropin. ||| Your doctor or hi s/her assistant will instruct you how to self-inject Viraferon. ||| Votre médecin ou son assistant(e) vous apprendront comment vous injecter vous -même Valtropin.
0.8678642511367798 ||| Serious infections ||| Illnesses and injuries ||| Infections graves
0.1304589807987213 ||| The most common side effect with TachoSil (seen in between 1 and 10 patients in 100) is pyrexia (fever). ||| The most common side effect with Riprazo (seen in between 1 and 10 patients in 100) is diarrhoea. ||| L’ effet indésirable le plus couramment observé avec TachoSil (chez 1 à 10 patients sur 100) est la pyrexie (fièvre).
0.41192930936813354 ||| Therefore, the 3 mg blister is not interchangeable with three 1 mg blisters (see sections 4.2, 4.4 and 5.2). ||| Shown on the oral dispenser are marks for 30 mg, 45 mg and 60 mg of the medicine (see figures 1 and 2 above). ||| é interchangeable avec trois doses de 1 mg (voir rubriques 4.2, 4.4 et 5.2).
0.4403113126754761 ||| Swaging machines for use in the assembly of hoses ||| Leasing of machines for cleaning upholstered furniture ||| Machines à rétreindre destinées à l'assemblage de tuyaux
0.4525531530380249 ||| The effects of Alimta in combination with cisplatin were compared with those of cisplatin alone. ||| In the new study, the combination of sitagliptin plus metformin was more effective than metformin or sitagliptin alone. ||| Les effets d’ Alimta en association avec le cisplatine ont été comparés avec ceux du cisplatine en monothérapie.
0.7423155307769775 ||| Study III also had a primary endpoint of changes in quality of life. ||| The second major theme is digitalisation - which is self explanatory. ||| L'étude III avait aussi comme critère de jugement principal les modifications de la qualité de vie.
0.2317991554737091 ||| E4599 was an open-label, randomised, active-controlled, multicentre clinical trial evaluating Avastin as first-line treatment of patients with locally advanced (stage IIIb with malignant pleural effusion), metastatic or recurrent NSCLC other than predominantly squamous cell histology. ||| Clinical studies in HES/ CEL One open-label, multicentre, phase II clinical trial (study B2225) was conducted testing Glivec in diverse populations of patients suffering from life-threatening diseases associated with Abl, Kit or PDGFR protein tyrosine kinases. ||| L’ étude E4599 était une étude ouverte, randomisée, contrôlée, multicentrique, évaluant Avastin en traitement de première ligne du CBNPC localement avancé (stade IIIb avec épanchement pleural malin), métastatique ou en rechute, dès lors que l’ histologie n’ était pas à prédominance épidermoïde.
0.00957912765443325 ||| Some hypertensive patients with no apparent pre-existing renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when Zestril has been given concomitantly with a diuretic. ||| Some hypertensive patients with no apparent pre-existing renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when COVERSYL has been given concomitantly with a diuretic. ||| Chez certains hypertendus sans maladie vasculaire rénale pré-existante apparente, des cas d’augmentation de l'urémie et de la créatininémie, habituellement mineures et transitoires, ont été observées, en particulier lorsque Zestril était associé à un diurétique.
4.5418042157047145e-13 ||| Epoetins are growth factors that primarily stimulate red blood cell production. ||| Epoetins are growth factors that primarily stimulate red blood cell production. ||| 24 Les époétines sont des facteurs de croissance qui stimulent principalement la production de globules rouges.
0.32224446535110474 ||| Due to limited experience the efficacy and safety of Lantus could not be assessed in the following groups of patients: patients with impaired liver function or patients with moderate/ severe renal impairment (see section 4.4). ||| Caution should be exercised in patients with clinically significant pulmonary disease, including diffuse interstitial pulmonary fibrosis and severe chronic obstructive pulmonary disease, as no studies have been performed in these patients. ||| L'expérience étant limitée, l'efficacité et la tolérance de Lantus n'ont pu être évaluées dans les groupes de patients suivants: patients ayant une insuffisance hépatique ou patients ayant une insuffisance rénale modérée à sévère (voir rubrique 4.4).
0.022514253854751587 ||| Beneath ground construction work relating to gas supply pipes ||| Beneath ground construction work relating to water supply pipes ||| Travaux de construction souterrains liés aux conduites d'alimentation en gaz
0.35286182165145874 ||| On 2 March, four further people in England tested positive; all four had recently travelled from Italy. ||| By 20 February, four New Zealand passengers had tested positive for the virus and were being treated in Japan. ||| Le 2 mars, quatre autres personnes sont testées positives en Angleterre.
0.2675720751285553 ||| Tell your doctor or pharmacist before taking Tasigna if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| You should tell your doctor about any medicines, including those medicines you can buy without a prescription, you are taking or planning to take, before you take Kaletra. ||| Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien avant de prendre Tasigna.
0.3016875088214874 ||| Orphan Europe, Immeuble ‘ Le Wilson’, 70 avenue du Général de Gaulle, F-92800 Puteaux, France ||| Immeuble "Le Wilson" 70 avenue du Général de Gaulle F-92800 Puteaux France ||| Orphan Europe, Immeuble « Le Wilson », 70 avenue du Général de Gaulle, F-92800 Puteaux, France
0.29836830496788025 ||| If dilution prior to infusion is required, KIOVIG may be diluted with 5% glucose solution to a final concentration of 50 mg/ml (5% immunoglobulin). ||| All patients being treated with epoetin alfa should receive adequate iron supplementation (e. g. oral iron substitution of 200 mg Fe2+ daily) throughout the course of epoetin alfa treatment. ||| Si une dilution est nécessaire avant la perfusion, KIOVIG peut être diluée avec une solution de glucose à 5% pour atteindre une concentration finale de 50 mg/ml (5% d’immunoglobuline).
0.26844754815101624 ||| Adverse reactions known to occur with each component given singly but which have not been seen in clinical trials may occur during treatment with MicardisPlus. ||| Infections have been noted in all organ systems and have been reported in patients receiving Kineret alone or in combination with immunosuppressive agents. ||| Les effets indésirables déjà observés pour chacune des substances actives prises individuellement peuvent survenir en cas de traitement par MicardisPlus, même s’ ils n’ ont pas été observés au cours du développement clinique.
0.27485764026641846 ||| No sudden discontinuation of antiepileptic therapy should be undertaken as this may lead to breakthrough seizures, which could have serious consequences for both mother and child. ||| Moreover, effective anti-epileptic therapy must not be interrupted, since the aggravation of the illness is detrimental to both the mother and the foetus. ||| L'arrêt brutal du traitement antiépileptique doit être évité car il peut conduire à la recrudescence des crises, ce qui pourrait avoir des conséquences graves pour la mère comme pour l'enfant.
0.18325799703598022 ||| Preclinical studies conducted in rats, dogs and monkeys revealed target organ effects in gastrointestinal tract, kidney, bone and a decrease in serum phosphate concentration. ||| The toxicology of micafungin following repeated intravenous dosing in rats and/or dogs showed adverse responses in liver, urinary tract, red blood cells, and male reproductive organs. ||| Les études précliniques conduites chez le rat, le chien et le singe ont révélé des effets sur les organes cibles, à savoir le tube digestif, les reins, les os et une diminution de la concentration de phosphate sérique.
0.34062474966049194 ||| Elderly and renal impairment: ||| Elderly and patients with renal impairment ||| Sujets âgés et insuffisance rénale:
0.12497051060199738 ||| The Netherlands notified to the Commission under the Temporary Framework a guarantee scheme for working capital and investment loans granted by banks, to help Dutch companies meet their liquidity needs in the context of the coronavirus outbreak. ||| Lithuania notified to the Commission under the Temporary Framework a €110 million guarantee scheme for working capital and investment loans granted by commercial banks to support companies affected by the coronavirus outbreak. ||| Les Pays-Bas ont notifié à la Commission, au titre de l' encadrement temporaire , un régime de garantie des crédits de fonds de roulement et des crédits d'investissement accordés par les banques, afin d'aider les entreprises néerlandaises à couvrir leurs besoins de liquidités dans le contexte de la flambée de coronavirus.
0.5141384601593018 ||| - have liver disease ||| • liver disease; ||| - avez une maladie du foie,
0.3064303398132324 ||| In the event of overdose, general supportive measures should be instituted, including close monitoring of respiratory and cardiac status of the patient. ||| Treatment should be initiated only after a careful benefit/ risk evaluation, due to possible adverse events related to joints and/ or surrounding tissue. ||| En cas de surdosage, une prise en charge globale doit être instituée, comprenant une surveillance étroite de l’ état respiratoire et cardiaque du patient.
0.06255800276994705 ||| Equilis Prequenza, suspension for injection, for horses ||| Equilis Prequenza Te, suspension for injection, for horses ||| Equilis Prequenza, suspension injectable pour chevaux.
0.3261638879776001 ||| Due to their metabolic profile and inherent risk of inducing torsades de pointes, administration of halofantrine and lumefantrine with APTIVUS co-administered with low dose ritonavir, is not recommended. ||| Based upon the safety profile of PREZISTA/ritonavir, this increase in darunavir exposure in the presence of rifabutin does not warrant a dose adjustment for PREZISTA/ritonavir. ||| L’ administration d’ halofantrine et de luméfantrine n’ est pas recommandée avec APTIVUS, associé au ritonavir à faible dose, étant donné leur profil métabolique et le risque inhérent d’ apparition de torsades de pointe.
0.3409801125526428 ||| In the case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant Summary of Product Characteristics for these medicinal products. ||| Please also refer to the Summaries of Product Characteristics of the other antiretroviral medicinal products used in the combination regimen. ||| Dans le cadre d’ un traitement antiviral concomitant de l'hépatite B ou C, se référer également aux Résumés des Caractéristiques des Produits correspondant à ces médicaments.
0.4103236496448517 ||| The package also aims to help the EU tourism sector recover from the pandemic, by supporting businesses and ensuring that Europe continues to be the number one destination for visitors. ||| For this and depending on the nature of the programme, the Commission will work with each Member State to guarantee that every euro contributes to repair, recovery and resilience. ||| Les orientations et recommandations de la Commission visent également à aider le secteur touristique européen à se remettre de la pandémie en soutenant les entreprises et en faisant en sorte que l'Europe reste la première destination touristique.
0.4273207187652588 ||| Perfumed candles ||| Perfume burners ||| Bougies parfumées
0.11017630249261856 ||| Animal studies with Abraxane showed non-reversible, toxic effects on the male reproductive organs at clinically relevant exposure levels. ||| Animal studies showed non-reversible, toxic effects on the male reproductive organs at clinically relevant exposure levels. ||| Les études animales ont montré des effets toxiques, non réversibles sur les organes reproductifs mâles à des niveaux d’ exposition similaires à ceux observés en clinique.
0.0 ||| Appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic reaction following the administration of the vaccine. ||| Appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic reaction following the administration of the vaccine. ||| Comme pour tout vaccin injectable, un traitement médical approprié doit être disponible immédiatement et une surveillance doit être effectuée dans les rares cas où une réaction anaphylactique surviendrait après l'administration du vaccin.
0.33887791633605957 ||| Treatment of patients with chemotherapy induced anaemia Silapo should be administered by the subcutaneous route to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dl (6.2 mmol/l). ||| AZILECT is indicated for the treatment of idiopathic Parkinson’ s disease (PD) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations. ||| − Traitement de l’ anémie induite par la chimiothérapie Silapo doit être administrée par voie sous-cutanée aux patients atteints d’ anémie (taux d’ hémoglobine ≤ 10 g/ dl [6,2 mmol/ l], par ex.).
0.3911095857620239 ||| In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| maintain adequate fluid intake, because dehydration may increase the risk of renal failure. ||| 113 En cas d'insuffisance rénale, les besoins en insuline peuvent être diminués en raison d'une réduction du métabolisme de l'insuline.
0.2859819233417511 ||| Administration of Aldurazyme should be carried out in an appropriate clinical setting where resuscitation equipment to manage medical emergencies would be readily available. ||| The surveillance system should be able to identify areas where COVID-19 spread is taking place that might be suitable for trials of antiviral therapy. ||| L’ administration d’ Aldurazyme doit être effectuée dans un cadre clinique approprié disposant du matériel de réanimation nécessaire au traitement des urgences médicales.
0.16841554641723633 ||| Optisulin 100 Units/ ml solution for injection in a cartridge Insulin glargine ||| Lantus 100 Units/ ml solution for injection in a cartridge for OptiClik Insulin glargine ||| Optisulin 100 Unités/ ml solution injectable en cartouche Insuline glargine
3.4367054015972676e-13 ||| There have been reports of exacerbation of chronic liver dysfunction, including portal hypertension, in patients with underlying hepatitis B or C, cirrhosis and other underlying liver abnormalities. ||| There have been reports of exacerbation of chronic liver dysfunction, including portal hypertension, in patients with underlying hepatitis B or C, cirrhosis and other underlying liver abnormalities. ||| 27 Des cas d’aggravation d’un dysfonctionnement hépatique chronique, incluant une hypertension portale, ont été rapportés chez des patients présentant une hépatite B ou C, une cirrhose ou d’autres anomalies hépatiques sous-jacentes.
0.32269972562789917 ||| After single intravenous doses ranging from 0.25 to 10 mg/ kg, concentrations were dose proportional. ||| Peak concentrations in tissue cage fluid of 31.9 µg/ ml were measured 2 days after administration. ||| Après administration de doses intraveineuses uniques variant de 0,25 à 10 mg/ kg, les concentrations ont été proportionnelles à la dose.
0.1274859756231308 ||| Zyrtec Portugal: ||| Zyrtec Denmark: ||| Virlix, Zyrtec Portugal:
0.4822923243045807 ||| You should only inject it into a muscle if your doctor has told you to. ||| If someone is injecting for you, they can also use the back of your arms. ||| Liprolog Pen peut, si votre médecin vous l'a ordonné, être injecté dans un muscle.
0.4322460889816284 ||| Gabapentin can be given with or without food and should be swallowed whole with sufficient fluid- intake (e. g. a glass of water). ||| The required quantity of product is thoroughly mixed with a feed ingredient of similar physical nature (e. g. wheat middlings) in the proportion: ||| La gabapentine peut être administrée au moment ou en dehors des repas et doit être avalée entière avec une quantité suffisante de liquide (p. ex. un verre d'eau).
0.5732492208480835 ||| Rare: impaired liver function ||| Rare: renal function test abnormal ||| Rare: anomalie de la fonction hépatique
0.4393777549266815 ||| Care must be taken when INOmax is given at the same time as medicines containing prilocaine. ||| - Taking oral medicinal charcoal at the same time as [Invented name] tablets reduces the action of ||| Il convient de rester vigilant si INOmax est administré de façon concomitante avec des médicaments contenant de la prilocaïne.
0.0639120563864708 ||| 5 x 3 ml Liprolog Mix50 cartridges for a 3 ml pen. ||| 5 x 3 ml Humalog Mix50 cartridges for a 3 ml pen. ||| 1 boîte de 5 cartouches de Liprolog Mix50 3 ml pour un stylo de 3 ml.
0.3003511428833008 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Nexavar’ s benefits are greater than its risks for the treatment of hepatocellular carcinoma, and of advanced renal cell carcinoma in patients who have failed prior interferon alfa or interleukin-2 based therapy, or who are considered unsuitable for such therapy. ||| The protective efficacy of a dose of hepatitis B immunoglobulin at birth followed by 3 doses of a previous formulation of Merck’ s recombinant hepatitis B vaccine has been demonstrated for neonates born to mothers positive for both hepatitis B virus surface antigen (HBsAg) and hepatitis B virus e antigen (HBeAg). ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de Nexavar étaient supérieurs à ses risques en ce qui concerne le traitement du carcinome hépatocellulaire et du carcinome rénal avancé pour les patients chez qui un traitement par interféron-alpha ou interleukine-2 avait échoué ou chez les patients ne pouvant recevoir un tel traitement.
0.6865310668945312 ||| Fever ||| Ovine ||| fièvre
0.3164740800857544 ||| 7 tablets 14 tablets 28 tablets 35 tablets 56 tablets 70 tablets ||| 2 tablets 4 tablets 10 tablets 24 tablets 50 tablets ||| 7 comprimés 14 comprimés 28 comprimés 35 comprimés 56 comprimés 70 comprimés
0.5197694897651672 ||| 23 Important information about some of the ingredients of DUKORAL DUKORAL contains approximately 1.1 g sodium per dose. ||| 16 Important information about some of the ingredients of OPATANOL If you wear soft contact lenses. ||| Informations importantes concernant certains composants de DUKORAL DUKORAL contient environ 1,1 g de sodium par dose.
0.0 ||| It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| Ne le donnez jamais à quelqu’ un d’ autre, même en cas de symptômes identiques, cela pourrait lui être nocif • Si l’ un des effets indésirables devient sérieux ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez -en à votre médecin ou votre pharmacien.
0.3064383566379547 ||| The incidence of injection site reactions may be reduced by the use of an autoinjector. ||| An increase in the dose of the anticoagulation treatment is frequently required to prevent the blockage occurring. ||| L’ incidence des réactions au point d’ injection peut être réduite avec l’ utilisation d’ un autoinjecteur.
0.09907827526330948 ||| a) 02.10.96 b) 10.12.97 c) 191 days d) 245 days ||| a) 7.5.1997 b) 10.6.1998 c) 198 days d) 202 days ||| a) 02.10.96 b) 10.12.97 c) 191 Jours d) 245 Jours
4.774488096548346e-13 ||| Like all medicines, Enbrel can cause side effects, although not everybody gets them. ||| Like all medicines, Enbrel can cause side effects, although not everybody gets them. ||| 270 Comme tous les médicaments, Enbrel est susceptible d’avoir des effets indésirables, bien que tous n’y soient pas sujets.
0.5343773365020752 ||| 10 vials of 1 dose ||| 1 blister of 2 tablets ||| 10 flacons de 1 dose
0.2319689393043518 ||| The plasma protein binding of olanzapine was about 93% over the concentration range of about 7 to about 1,000 ng/ ml. ||| The protein binding of ritonavir in human plasma is approximately 98 - 99% and is constant over the concentration range of 1.0 – 100 μg /ml. ||| Le taux de fixation de l’ olanzapine sur les protéines plasmatiques est d’ environ 93%, pour une fourchette de concentration allant d’ environ 7 à 1000 ng/ ml.
0.43939173221588135 ||| Use with antidepressants Caution should be exercised when using XERISTAR in combination with antidepressants. ||| Take special care with Atriance Severe neurological side effects have been reported with the use of Atriance. ||| Utilisation en association avec d’ autres antidépresseurs La prudence s'impose en cas d'utilisation de XERISTAR en association avec d’ autres antidépresseurs.
0.3143596053123474 ||| The main measure of effectiveness was the reduction in diastolic blood pressure (the blood pressure measured between two heartbeats). ||| The antihypertensive effect follows the normal diurnal variations in blood pressure with very small changes over the 24-hour period. ||| Le principal critère d’ évaluation de l’ efficacité était la réduction de la pression diastolique (pression artérielle mesurée entre deux battements de cœ ur).
0.0712984949350357 ||| Do not use Protaphane after the expiry date which is stated on the label and the carton. ||| Do not use Agopton after the expiry date which is stated on each sachet and the carton. ||| Ne pas utiliser Protaphane après la date de péremption mentionnée sur l’ étiquette et sur la boîte.
0.3541050851345062 ||| It works by hindering the growth of these abnormal white blood cells, and eventually kills them. ||| This stops the cells making new DNA and RNA, and slows down the growth of tumour cells. ||| La clofarabine permet de stopper la multiplication de ces globules blancs anormaux et finit par les détruire.
0.6571369171142578 ||| 28 patches ||| 28 sachets ||| 28 dispositifs
0.5647363662719727 ||| - warfarin (medicine to reduce blood clotting) ||| Optaflu is a vaccine against flu (influenza). ||| - de la warfarine (médicament pour réduire la coagulation du sang)
0.09459534287452698 ||| How has Tyverb been studied? ||| How has Doribax been studied? ||| Quelles études ont été menées sur Tyverb?
0.3333761692047119 ||| Patients with renal impairment have less ability to eliminate the active antipsychotic fraction than in adults with normal renal function. ||| Patients with mild and moderate impairment of renal function appear to have a higher plasma exposure than patients with normal renal function. ||| Les patients insuffisants rénaux ont une capacité moindre à éliminer la fraction antipsychotique active que les adultes avec fonction rénale normale.
0.4983622431755066 ||| Cardiac disorders Uncommon ||| 89 Eye disorders uncommon ||| Affections cardiaques Peu fréquent
0.3374212086200714 ||| Just before you start to inhale, break open the glass container containing 1 ml solution, which shows three coloured rings (pink-red-red), and transfer the complete contents into the nebuliser medication chamber. ||| For each inhalation session with the I-Neb AAD, the content of one 1-ml ampoule of Ventavis, showing three coloured rings (pink – red- red), will be transferred into the appropriate nebuliser medication chamber immediately before use. ||| Juste avant de commencer les inhalations, brisez l’ ampoule en verre de 1 ml de solution identifiée par un code couleur composé de trois anneaux (rose-rouge-rouge), puis transférez la totalité de son contenu dans la cuve du nébuliseur.
0.2746814489364624 ||| Why has SonoVue been approved? ||| Why has RoActemra been approved? ||| Pourquoi SonoVue a -t-il été approuvé?
2.735471896740671e-13 ||| Especially patients undergoing long-term treatment (e. g. in cystic fibrosis, osteomyelitis), or patients who are extremely susceptible to infections (e. g. in selective prophylaxis in certain groups of neutropenic patients, artificial ventilation) show the highest risk. ||| Especially patients undergoing long-term treatment (e. g. in cystic fibrosis, osteomyelitis), or patients who are extremely susceptible to infections (e. g. in selective prophylaxis in certain groups of neutropenic patients, artificial ventilation) show the highest risk. ||| Les patients exposés au risque maximal sont particulièrement ceux recevant un traitement prolongé (par exemple en raison d’ une mucoviscidose ou d’ une ostéomyélite) ou extrêmement sensibles aux infections (par exemple prévention sélective dans certains groupes de patients neutropéniques, ventilation artificielle).
0.4644532799720764 ||| Decide which two days each week you are going to change your patch, and change the patch on the same two days each week. ||| Mark the schedule you plan to follow and remember always to change your patch on the same two days of the week you have chosen on your calendar. ||| Vous devez décider des deux jours de la semaine où vous remplacerez votre dispositif transdermique et le remplacer les deux mêmes jours chaque semaine.
0.6904832124710083 ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF REACH AND SIGHT OF CHILDREN ||| READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. ||| MISE EN GARDE SPECIALE INDIQUANT QUE LE MEDICAMENT DOIT ETRE CONSERVE HORS DE PORTEE ET DE VUE DES ENFANTS
0.3688799738883972 ||| - Cardboard box with 1 and 10 vials of 5 doses. ||| Cardboard box with 10 glass vials of 1 ml. ||| - Boîte cartonnée contenant 1 et 10 flacons de 5 doses.
0.298061728477478 ||| In secondary hyperparathyroidism, the recommended starting dose for adults is 30 mg once a day. ||| The recommended dose for Zenapax in adult and paediatric patients is 1 mg/ kg. ||| Dans les cas d’ hyperparathyroïdie secondaire, la dose initiale recommandée chez l'adulte est de 30 mg une fois par jour.
0.0 ||| 4.8 Undesirable effects ||| 4.8 Undesirable effects ||| 57 4.8 Effets indésirables
0.31324899196624756 ||| Blood cell counts Platelet counts should be monitored closely, especially during the first few weeks of filgrastim therapy. ||| Monitoring blood counts Periodic blood count determinations are recommended during the first 12 months of gemfibrozil administration. ||| 25 La numération des plaquettes doit être surveillée de près, en particulier au cours des premières semaines de traitement par le filgrastim.
0.3539273142814636 ||| All changes were considered to be caused by the pharmacological action of valsartan which produces prolonged hypotension, particularly in marmosets. ||| Local skin reactions, such as erythema, are probably an extension of the pharmacologic effect of imiquimod cream. ||| On a jugé que toutes ces altérations résultaient de l’activité pharmacologique du valsartan, qui produit une hypotension prolongée, particulièrement chez le ouistiti.
0.3100275993347168 ||| Additional reactions reported in some cases were myocardial infarction, atrial fibrillation and pulmonary oedema. ||| Respiratory tract infections, otitis media, convulsions and bronchitis were reported only in clinical studies in children. ||| D’ autres réactions ont été rapportées: infarctus du myocarde, fibrillation auriculaire et œ dème pulmonaire.
0.0 ||| The expiry date refers to the last day of that month. ||| The expiry date refers to the last day of that month. ||| La date de péremption fait référence au dernier du jour du mois.
4.1718283558603297e-13 ||| In diabetic patients, good metabolic control over 24 hours can be achieved with a single daily dose. ||| In diabetic patients, good metabolic control over 24 hours can be achieved with a single daily dose. ||| 29 Chez le diabétique, une dose quotidienne unique permet un contrôle métabolique satisfaisant pendant toute la durée du nycthémère.
0.5394833087921143 ||| Such a use is supported by publications and clinical experience. ||| These results are relevant to other populations and routes of administration. ||| Ce type d’ usage est cautionné par les publications et l’ expérience clinique.
0.3479434847831726 ||| Planning and conducting of trade fairs, exhibitions and presentations for economic or advertising purposes ||| Organisation of exhibitions and trade fairs for business and promotional purposes ||| Planification et organisation de foires, d'expositions et de présentations à des fins commerciales ou publicitaires
0.31445521116256714 ||| The immunological response may be diminished if the patient is undergoing immunosuppressant treatment. ||| Therapeutic drug monitoring of the immunosuppressive agent must be done when co-administration occurs. ||| La réponse immuitaire peut être diminuée si le patient est sous traitement immunosuppresseur.
6.760171849390373e-13 ||| Gastrointestinal disorders ||| Gastrointestinal disorders ||| Désordres gastro-intestinaux
0.0039441827684640884 ||| Each SUSTIVA hard capsule contains 200 mg of the active substance efavirenz. ||| Each SUSTIVA hard capsule contains 100 mg of the active substance efavirenz. ||| Que contient SUSTIVA Chaque gélule de SUSTIVA contient 200 mg de principe actif éfavirenz.
0.3186114430427551 ||| On 21 February, Israel confirmed the first case of COVID-19. ||| Five new cases of COVID-19 were confirmed on 3 March. ||| Le 21 février, Israël a confirmé le premier cas de COVID-19.
0.23239348828792572 ||| België/ Belgique/ Belgien UCB Pharma S. A. / N. V. ||| België / Belgique / Belgien Pfizer S. A. / N. V. ||| 28 België/ Belgique/ Belgien UCB Pharma S. A. / N. V.
0.39502018690109253 ||| The subsequent dosage of Zestril should be adjusted according to blood pressure response. ||| No adjustment to paracetamol dosing is required based on these study results. ||| La posologie de Zestril sera ensuite adaptée en fonction de la réponse tensionnelle obtenue.
0.3654285967350006 ||| The EMEA has continued to review and to improve its operational procedures. ||| The EMEA plans to review its key processes in order to rationalise their functioning. ||| L’EMEA a continué à étudier et améliorer ses procédures opératoires.
0.3400588631629944 ||| Elimination Lacosamide is primarily eliminated from the systemic circulation by renal excretion and biotransformation. ||| Biotransformation Ceftriaxone does not undergo systemic metabolism but it is broken down in the small intestine by bacterial action. ||| 25 Le lacosamide est principalement éliminé de la circulation par excrétion rénale et biotransformation.
0.03014458157122135 ||| It is possible that concomitant use of other photosensitising agents (e. g., tetracyclines, sulphonamides, phenothiazines, sulphonylurea hypoglycaemic agents, thiazide diuretics, griseofulvin and fluoroquinolones) could increase the photosensitivity reaction. ||| It is possible that concomitant use of other photosensitising agents (e. g. tetracyclines, sulphonamides, phenothiazines, sulfonylurea, hypoglycaemic agents, thiazide diuretics, and griseofulvin) could increase the potential for photosensitivity reactions. ||| 21 L’ utilisation concomitante d’ autres agents photosensibilisants (tétracyclines, sulfonamides, phénothiazines, sulfonylurées hypoglycémiantes, diurétiques thiazidiques, griséofulvine et fluoroquinolones) pourrait exacerber la réaction de photosensibilité.
0.1711673140525818 ||| The final opinion was converted into a Decision by the European Commission on 13 December 2006. ||| The final opinion was converted into a Decision by the European Commission on 11/ 10/ 2006. ||| L’ avis définitif est devenu décision de la Commission européenne en date du 13 décembre 2006.
0.3176010251045227 ||| In advanced Parkinson’ s disease, patients using Neupro had a greater decrease in their ‘ off ’ time than those taking placebo (a decrease of 2.1 to 2.7 h with Neupro compared with 0.9 h with placebo). ||| In the third study, there was a trend for Prialt to be more effective than placebo, with the VASPI score changing from 81 mm before treatment to 68 mm in patients receiving Prialt and to74 mm in patients receiving placebo. ||| Dans le traitement de la maladie de Parkinson à un stade avancé, les patients utilisant Neupro ont connu une diminution plus importante de leur durée « off » que ceux utilisant le placebo (diminution de 2,1 à 2,7 heures avec Neupro contre une diminution de 0,9 heures avec le placebo).
0.0 ||| General disorders and administration site conditions ||| General disorders and administration site conditions ||| 37 Troubles généraux et anomalies au site d' administration
5.195474042304915e-13 ||| It is not known whether this product is present in human milk. ||| It is not known whether this product is present in human milk. ||| On ignore si les composants de ce médicament sont excrétés dans le lait maternel.
0.26142778992652893 ||| It is not known whether Replagal is excreted in human milk. ||| It is not known if is excreted in human milk. ||| On ne sait pas si Replagal est excrété dans le lait maternel.
0.7279125452041626 ||| 2 - Strictly follow the prescription. ||| 372 Preparing and taking the suspension ||| 2 – Respectez strictement votre ordonnance.
0.28238433599472046 ||| The use of Ribavirin in combination with peginterferon alfa-2b had no observable negative impact on the control of HIV viraemia during therapy or follow-up. ||| Co-administration of raloxifene or hormone replacement therapy with FORSTEO did not alter the effects of FORSTEO on serum or urine calcium or on clinical adverse events. ||| L’ utilisation de Ribavirine en association avec le peginterféron alfa-2b n’ a pas eu d’ impact négatif sur le contrôle de la charge virale VIH pendant le traitement ou la période de suivi.
0.023334868252277374 ||| The MAH should also agree with each Member State prior to the launch of the product: • The feasibility of collecting detailed data relating to the indication in order to monitor closely the off-label use within the national territory • The set-up of national measures to assess the effectiveness of and compliance with the PPP. ||| The Member States should also agree with the MAH prior to the launch of the product: • The feasibility of collecting detailed data relating to the indication in order to monitor closely the off-label use within the national territory. • The set-up of national measures to assess the effectiveness of and compliance with the PPP ||| Le titulaire de l’ AMM, en accord avec chaque Etat Membre et avant la mise sur le marché du médicament, doit s’ assurer de: • La faisabilité au niveau national de collecter des données détaillées relatives aux indications de Revlimid afin de surveiller de près son utilisation hors AMM • La mise en place au niveau national de mesures d’ évaluation de l’ efficacité du PPG et de sa conformité.
1.8711769580841064 ||| Upper Arm ||| on the other ||| Haut du bras
0.3348486125469208 ||| Contra-indications After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Calcium carbonate, the most suitable harmonised Section 4.3 Contraindications text was approved (See Annex III). ||| In consequence, as soon as the pandemic is declared (Phase 6 of the WHO global Influenza preparedness plan) and the prepandemic vaccine is used, the MAH shall submit periodic safety update reports with periodicity and format defined as follows: ||| Contre-indications Après évaluation de la documentation fournie par les TAMM et examen des pratiques cliniques en vigueur dans toute l’ UE à propos de l’ utilisation du carbonate de calcium, le texte harmonisé le plus approprié pour la rubrique 4.3 relative aux contre-indications a été approuvé (voir annexe III).
0.26293057203292847 ||| Solution for injection ||| Solution for injection. ||| 0,5 ml Solution injectable
0.4786219000816345 ||| NovoRapid may be used for Continuous Subcutaneous Insulin Infusion (CSII) in pump systems suitable for insulin infusion. ||| Continuous subcutaneous insulin infusion (CSII) in external insulin infusion pumps is usually ||| NovoRapid peut être administré par perfusion sous-cutanée continue d’ insuline (CSII) à l’ aide d’ une pompe à perfusion d’ insuline.
0.4406808018684387 ||| A reduction in hip fractures has not been demonstrated. ||| There was no effect of Evista on hip fractures. ||| Une réduction des fractures de la hanche n’ a pas été démontrée.
0.045931074768304825 ||| 4.125 mg/ 7.5 cm² which release 25 µg fentanyl per hour ||| 12.375 mg/ 22.5 cm² which release 75 µg fentanyl per hour ||| libérant 25 µg de fentanyl par heure 8,25 mg/ 15 cm2
1.0265883195609282e-12 ||| 8 June 2001 ro ||| 8 June 2001 ro ||| 8 Juin 2001.
0.20980863273143768 ||| GONAL-f 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml) must be reconstituted with the 1 ml solvent provided before use. ||| GONAL-f 1050 IU/ 1.75 ml (77 micrograms/ 1.75 ml) preparation must not be reconstituted with any other GONAL-f containers. ||| GONAL-f 450 UI/ 0,75 ml (33 microgrammes/ 0,75 ml) doit, avant utilisation, être reconstitué avec 1 ml de solvant joint.
0.08712320774793625 ||| SCIENTIFIC CONCLUSIONS AND GROUNDS FOR AMENDMENT OF THE SUMMARIES OF PRODUCT CHARACTERISTICS PRESENTED BY THE EMEA ||| SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION OF THE MARKETING AUTHORISATION OF PROCOMVAX PRESENTED BY THE EMEA ||| CONCLUSIONS SCIENTIFIQUES ET MOTIFS DE LA MODIFICATION DES RÉSUMÉS DES CARACTÉRISTIQUES DU PRODUIT PRÉSENTÉS PAR L' EMEA
0.3166177272796631 ||| Pramipexole has been associated with somnolence and episodes of sudden sleep onset, particularly in patients with Parkinson’ s disease. ||| In type 1 diabetes, untreated hyperglycaemic events eventually lead to diabetic ketoacidosis, which is potentially lethal. ||| L’ administration de pramipexole a été associée à des cas de somnolence et des accès de sommeil d’ apparition soudaine, en particulier chez des patients atteints de la maladie de Parkinson.
0.04378493130207062 ||| EMEA/ CHMP/ 116517/ 2006/ EN SCIENTIFIC CONCLUSIONS ||| EMEA/ CHMP/ 46089/ 2006/ EN SCIENTIFIC CONCLUSIONS ||| EMEA/ CHMP/ 116517/ 2006/ FR CONCLUSIONS SCIENTIFIQUES
0.29167312383651733 ||| This rare but serious side effect has occasionally been fatal. ||| This is a rare but serious side effect; it has occasionally been fatal. ||| Cet effet indésirable rare mais sérieux a parfois été fatal.
0.12892723083496094 ||| Tél/Tel: + 32-(0)2 548 84 84 ||| Tél/Tel: + 32 (0)2 656 21 11 ||| Tél/Tel: + 32 -(0)2 548 84 84
0.32092154026031494 ||| Rash: in clinical studies, 26% of patients treated with 600 mg of efavirenz experienced skin rash compared with 17% of patients treated in control groups. ||| Teratology studies, performed in pregnant rats at approximately 4.3 times and pregnant rabbits at approximately 13 times human exposure did not reveal any teratogenic effects. ||| Eruptions cutanées: au cours des études cliniques, 26% des patients traités par 600 mg d’ éfavirenz ont présenté des éruptions cutanées contre 17% des patients des groupes témoins.
0.617615282535553 ||| There was no difference between groups in the number of late responders thereafter. ||| In relation to the number of new applications, the number is lower than in 2000. ||| Par la suite, il n’ y avait pas de différence entre les groupes dans le nombre de répondeurs tardifs.
0.5325464010238647 ||| In this case, this medicine should be used with caution because the blood pressure may be decreased. ||| Therefore, an alternative, effective and safe method of contraception should be used during treatment. ||| Il est important, dans ce cas, d’ utiliser le médicament avec précaution, car celui -ci est susceptible de faire baisser la pression artérielle.
0.3486081659793854 ||| Diacomit 500 mg hard capsules ||| STOCRIN 50 mg hard capsules ||| Diacomit 500 mg gélule
0.2776045799255371 ||| 45 If you forget to take Enviage If you forget to take a dose of Enviage, take it as soon as you remember and then take the next dose at its usual time. ||| If you forget to take Targretin If you forget to take one dose, take your daily dose with your next meal on the same day, then take your usual dose as normal, the following day. ||| Si vous oubliez de prendre Enviage Si vous oubliez de prendre une dose d’ Enviage, prenez -la dès que vous vous en rendez compte puis prenez la dose suivante au moment habituel.
0.09405692666769028 ||| - if you notice pain in your belly which is radiating to your back, and/or you feel sick or ||| − If you notice pain in your belly which is radiating to your back, and/or you feel sick or have a fever. ||| - si vous ressentez une douleur dans le ventre irradiant vers le dos et/ou si vous avez des
0.40735962986946106 ||| Following a single oral dose of cysteamine bitartrate equivalent to 1.05 g of cysteamine free base in healthy volunteers, the mean (± sd) values for the time to peak and peak plasma concentration are 1.4 (± 0.5) hours and 4.0 (± 1.0) µg/ ml, respectively. ||| Required units (IU) = body weight (kg) x desired factor VIII rise (% or IU/ dl) x 0.5 (IU/ kg per IU/ dl), where 0.5 IU/ kg per IU/ dl represents the reciprocal of the incremental recovery generally observed following infusions of factor VIII. ||| Après administration par voie orale chez le volontaire sain d'une dose unique de bitartrate de cystéamine équivalente à 1,05 g de cystéamine exprimée en base libre, les valeurs moyennes (± écart- type) correspondant au temps d’ apparition du pic plasmatique et à la concentration à ce pic sont respectivement de 1,4 (± 0,5) heures et de 4,0 (± 1,0) µg/ ml.
0.25124838948249817 ||| Helixate NexGen powder should only be reconstituted with the supplied solvent (5.0 ml water for injections) using the supplied sterile Mix2Vial filter transfer device. ||| BeneFIX is administered by intravenous infusion after reconstitution of the lyophilised powder for solution for injection with sterile 0.234% sodium chloride solution (see section 6.6). ||| La poudre d'Helixate NexGen doit uniquement être reconstituée avec le solvant associé (5,0 ml d’ eau pour préparations injectables) en utilisant le dispositif de transfert stérile avec filtre Mix2vial.
0.13795620203018188 ||| Common side effects (likely to occur in fewer than 1 in 10 patients) include: ||| Very common side effects (occurring in at least 1 in 10 patients) are: ||| Des effets indésirables fréquents (survenue probable chez moins de 1 patient su 10) comprennent:
0.580663800239563 ||| - certain medicines affecting the nervous system. ||| - any medicine that changes your blood pressure; ||| - certains médicaments agissant sur le système nerveux.
3.171355322448277e-13 ||| Signs of osteonecrosis are joint stiffness, aches and pains (especially of the hip, knee and shoulder) and difficulty in movement. ||| Signs of osteonecrosis are joint stiffness, aches and pains (especially of the hip, knee and shoulder) and difficulty in movement. ||| Les signes d’ostéonécrose sont une raideur des articulations, des douleurs (en particulier de la hanche, du genou et de l’épaule) et des difficultés pour se mouvoir.
0.5050955414772034 ||| The patient’ s ability to concentrate and react may be impaired as a result of hypoglycaemia or hyperglycaemia from glimepiride or, for example, as a result of visual impairment. ||| The study investigated a) the effect of simvastatin on mortality, b) the effect of simvastatin on major coronary events, and c) the effect of simvastatin on any coronary event. ||| Les capacités de concentration et les réflexes peuvent être diminués en cas d'hypoglycémie due au traitement de glimépiride ou en cas d'hyperglycémie, entre autres en cas de troubles visuels.
0.39934659004211426 ||| Rental of gas-operated welding apparatus ||| Rental of acoustic reproduction equipment ||| Location d'appareils à souder à gaz
0.5072081089019775 ||| Children weighing > 21 kg to < 30 kg: one half of a Ziagen tablet taken in the morning and one whole tablet taken in the evening. ||| The half-life of cetirizine was about 6 hours in children of 6-12 years and 5 hours in children 2-6 years. ||| Enfants pesant de 21 kg à 30 kg: un demi-comprimé de Ziagen le matin et un comprimé entier le soir.
0.0481639988720417 ||| Disease activity outcomes In all three studies, rituximab 2 x 1000 mg significantly increased the proportion of patients achieving at least a 20% improvement in ACR score compared with patients treated with methotrexate alone (Table 7). ||| Disease activity outcomes In all three studies, rituximab 2 x 1000 mg significantly increased the proportion of patients achieving at least a 20% improvement in ACR score compared with patients treated with methotrexate alone ||| Résultats d'efficacité clinique Dans les trois études, le rituximab (2 x 1000 mg) a significativement augmenté la proportion de patients présentant une amélioration d’ au moins 20% du score ACR comparativement aux patients traités par le méthotrexate seul (Tableau 7).
0.06819302588701248 ||| SPRYCEL is not to be used during pregnancy unless clearly necessary. ||| SUTENT is not to be used during pregnancy unless clearly necessary. ||| SPRYCEL ne doit pas être utilisé pendant la grossesse à moins que cela soit clairement nécessaire.
0.26996690034866333 ||| Close monitoring of haematologic parameters is advised in these patients. ||| Therefore, haematological monitoring of patients is indicated. ||| Une étroite surveillance hématologique est conseillée chez ces patients.
0.12317801266908646 ||| • The other ingredients are: ||| - The other ingredients are: ||| - Les autres composants sont:
0.35078421235084534 ||| Brake blocks for vehicles ||| Sleeping berths for vehicles ||| Blocs de freins pour véhicules
0.4125699996948242 ||| Each capsule of REYATAZ 150 mg contains 150 mg atazanavir. ||| Each tablet of AMMONAPS contains 500 mg ||| Chaque gélule de REYATAZ 150 mg contient < (STRENGTH) mg d’ atazanavir.
0.0 ||| The following additional adverse reactions have been reported during post– marketing experience; they are derived from spontaneous reports and therefore, the frequency of these adverse reactions is not known: ||| The following additional adverse reactions have been reported during post– marketing experience; they are derived from spontaneous reports and therefore, the frequency of these adverse reactions is not known: ||| Les réactions indésirables suivantes ont été rapportées au cours de la commercialisation du produit, elles sont issues de déclarations spontannées, ainsi la fréquence de ces réactions indésirables n’ est pas connue:
0.46157100796699524 ||| The risk of shortages is due primarily to the increase in demand for medicines to treat coronavirus patients in hospitals. ||| Hygiene in a variety of settings plays an important role in preventing the spread of infectious diseases. ||| Le risque de pénurie résulte premièrement de l'augmentation de la demande de médicaments destinés à traiter les patients infectés par le coronavirus dans les hôpitaux.
0.7190159559249878 ||| Marketing Authorisation Holder and Manufacturer Liprolog Mix25 100 U/ml Pen, suspension for injection is made by: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France, • Eli Lilly Italia S.p.A., Via A. ||| Eli Lilly and Company, Lilly Technology Center Building 333 and 324, Indianapolis, Indiana, USA Lilly del Caribe, Inc., Puerto Rico Industrial Park, 12.3 KM (PR05), 65th Infantry Road, Carolina, Puerto Rico 00985 Granule Recovery: ||| Titulaire de l'Autorisation de mise sur le marché et fabricant Liprolog Mix25 100 UI/ml Pen, suspension injectable est fabriqué par: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim – France, • Eli Lilly Italia S.p. A., Via A.
0.31107431650161743 ||| 14 TAXOTERE 75 mg/ m² in combination with cisplatin ||| 54 TAXOTERE 75 mg/ m² in combination with prednisone or prednisolone ||| 15 TAXOTERE 75 mg/ m² en association avec le cisplatine
0.6745786666870117 ||| SIFROL can reduce the production of breast milk. ||| Protein binding for TMP and SMX is not very high. ||| SIFROL peut réduire la production de lait.
0.37246108055114746 ||| A population analysis of plasma bexarotene concentrations in patients with cutaneous T-cell lymphoma (CTCL) indicated that concomitant administration of gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene. ||| A component interaction study demonstrated that the exposure (Cmax and AUC) of pseudoephedrine following administration of pseudoephedrine alone was bioequivalent to pseudoephedrine exposure following administration of the Aerinaze tablet. ||| Une analyse de population des concentrations plasmatiques de bexarotène chez des patients présentant un lymphome cutané à cellules T a montré que l'administration concomitante de gemfibrozil provoquait une élévation substantielle des taux plasmatiques de bexarotène.
0.34918922185897827 ||| For any other method that may be used for the assessment of HER2 protein or gene expression, the analyses should only be performed by laboratories that provide adequate state-of-the-art performance of validated methods. ||| Physicians treating patients with Zonegran should try to ensure that appropriate contraception is used, and should use clinical judgement when assessing whether OCs, or the doses of the OC components, are adequate based on the individual patient’ s clinical situation. ||| Pour toutes les autres méthodes qui peuvent être utilisées pour évaluer la surexpression de la protéine HER2 ou l’ amplification du gène HER2, les analyses devront être réalisées uniquement par des laboratoires rompus aux techniques de pointe et qui utilisent des méthodes validées.
0.6072701215744019 ||| Kaletra contains glycerol which is harmful in high doses. ||| Uncommon: serum potassium decreased and sodium decreased. ||| Kaletra solution buvable contient du glycérol qui est nocif à fortes doses.
0.2838248014450073 ||| Treatment with Rebif should be stopped if icterus or other clinical symptoms of liver dysfunction appear (see section 4.8). ||| Avastin should be discontinued permanently in patients who experience Grade 3 or 4 bleeding during Avastin therapy (see section 4.8). ||| Le traitement par Rebif doit être arrêté en cas d’ ictère ou si tout autre symptôme clinique témoin d’ une atteinte hépatique apparaît (voir rubrique 4.8).
0.03468606621026993 ||| Insulin Human Winthrop Rapid 40 IU/ ml solution for injection in a vial ||| Insulin Human Winthrop Rapid 40 IU/ ml solution for injection in a vial. ||| Insulin Human Winthrop Rapid 40 UI/ ml solution injectable en flacon
0.3517566919326782 ||| The overall incidence of adverse events was similar between the desloratadine syrup and the placebo groups and did not differ significantly than the safety profile seen in adult patients. ||| The adverse reactions considered at least possibly related to abacavir or lamivudine are listed by body system, organ class and absolute frequency. ||| L’ incidence globale des effets indésirables était similaire dans le groupe de sujets traités par desloratadine sirop par rapport au groupe de patients recevant le placebo et ne différait pas significativement du profil de sécurité connu chez les sujets adultes.
0.20863163471221924 ||| MicardisPlus is used to treat high blood pressure (essential hypertension) in patients whose blood pressure is not controlled enough when either telmisartan or hydrochlorothiazide is used alone. ||| Starlix is used together with metformin (another antidiabetes medicine) to lower blood glucose (sugar) in patients whose diabetes cannot be controlled by metformin alone. ||| MicardisPlus est utilisé pour traiter une pression artérielle élevée (hypertension artérielle essentielle) chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le telmisartan ou l’hydrochlorothiazide seuls.
0.09400057792663574 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The €30 billion French subordinated loan scheme will enable France to further support companies affected by the coronavirus outbreak. ||| Executive Vice President Margrethe Vestager, in charge of competition policy, said: "The €250 million subordinated loan scheme will support companies in the Flemish region affected by the coronavirus outbreak. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Le régime français de prêts subordonnés de 30 milliards d'EUR permettra à la France de continuer à soutenir les entreprises touchées par la pandémie de coronavirus.
0.19812345504760742 ||| Your doctor may decide to test for the presence of hepatitis B infection before you begin treatment with Enbrel.  Hepatitis C: ||| Your doctor may decide to continue to monitor you for the presence of infections after you stop using Enbrel.  Tuberculosis: ||| Votre médecin peut décider d’effectuer un test de dépistage d’une infection par hépatite B avant que vous commenciez le traitement par Enbrel. • Hépatite C:
0.33176150918006897 ||| XERISTAR should not be used in combination with fluvoxamine, ciprofloxacin or enoxacine (i. e. potent CYP1A2 inhibitors) since the combination results in elevated plasma concentrations of duloxetine (see section 4.5). ||| Agenerase with ritonavir must not be co-administered with medicinal products with narrow therapeutic windows that are highly dependent on CYP2D6 metabolism, e. g. flecainide and propafenone (see section 4.5). ||| Association à la fluvoxamine, à la ciprofloxacine ou à l’ énoxacine (inhibiteurs puissants du CYP1A2), associations entraînant une augmentation des concentrations plasmatiques de duloxétine (voir rubrique 4.5).
0.22736026346683502 ||| In placebo-controlled studies, bosentan-related decreases in haemoglobin concentration were not progressive, and stabilised after the first 4–12 weeks of treatment. ||| From oral pharmacokinetic studies, the half-life of olopatadine in plasma was approximately eight to 12 hours, and elimination was predominantly through renal excretion. ||| Dans les essais cliniques contre placebo, les diminutions du taux de l’ hémoglobine induites par le bosentan se stabilisaient dans les 4 à 12 premières semaines de traitement.
0.13384580612182617 ||| The vaccine also contains an ‘ adjuvant’ (mineral oil) to stimulate a better response. ||| The emulsion contains an ‘ adjuvant ’ (a compound containing oil) to stimulate a better response. ||| Le vaccin contient aussi un « adjuvant » (de l’ huile minérale) pour stimuler une meilleure réponse.
0.4535907506942749 ||| The ulcer usually heals within 4 weeks, but in patients not fully healed within this time, the medication should be continued at the same dose for another 4 weeks. ||| Revlimid is taken in repeated 28-day cycles: the patient takes the medicine once a day for 21 days, followed by seven days off the medicine. ||| L’ ulcère guérit habituellement pendant ces 4 semaines, cependant chez les patients dont la guérison n’ est pas complète après ce délai, le traitement devra être poursuivi pendant encore 4 semaines supplémentaires à la même posologie.
0.4891802668571472 ||| Microprocessors ||| Multimedia projectors ||| Microprocesseurs
0.6807388067245483 ||| Blister Aluminium ||| Canteen furniture ||| Plaquette en Aluminium
0.2911946773529053 ||| 2 (0.2) ||| 4 (1.4) ||| 2 (0,2)
0.16296738386154175 ||| Carefully push the plunger up to eject only the air bubbles back into the vial. ||| Slowly push the plunger up to force the air bubbles out of the syringe. ||| Pousser délicatement le piston pour refouler uniquement les bulles d'air dans le flacon.
0.026412710547447205 ||| Therefore medicinal products for the treatment of anaphylactic reactions should always be available for immediate use following administration of Xolair. ||| Therefore medications for the treatment of anaphylactic reactions should always be available for immediate use following administration of Xolair. ||| Par conséquent, les injections de Xolair devront toujours être réalisées en s’ assurant de la possibilité d’ accéder dans l’ immédiat à un traitement des réactions anaphylactiques.
0.3300536572933197 ||| The tablet may be taken with or without food. ||| The film-coated tablets can be taken with or without food. ||| Le comprimé peut être pris au cours ou en dehors des repas.
0.24478334188461304 ||| You should not take TRITACE if you are breast-feeding. ||| You must NOT breast-feed while you are treated with TAXOTERE. ||| Vous ne devez pas prendre TRITACE si vous allaitez.
0.8139233589172363 ||| Vertigo positional ||| Intravenoususe. ||| Vertige positionnel
0.5104038715362549 ||| Therefore, if a tuberculin test is to be done, it should be administered either any time before, simultaneously with, or at least 4 to 6 weeks after immunization with ProQuad. ||| (a) To be tried at first on a voluntary basis, but, if unsuccessful in one year or at any subsequent period, to be made compulsory ||| Aussi, si un test tuberculinique doit être pratiqué, il doit être fait soit à une date quelconque avant la vaccination, soit simultanément, soit 4 à 6 semaines au moins après vaccination avec ProQuad.
0.25197720527648926 ||| Less commonly, bacterial skin infections, weakness, muscle paralysis, loss of hearing or vision can occur. ||| Other less common symptoms include shortness of breath, a sore throat, headache, muscle pain, or sputum production. ||| Plus rarement, des infections bactériennes de la peau, une faiblesse, une paralysie musculaire, une perte d’ audition ou de vision peuvent survenir.
0.12474697828292847 ||| GANFORT 300 micrograms/ ml + 5 mg/ ml eye drops, solution bimatoprost/ timolol Ocular Use ||| DuoTrav 40 micrograms/ ml + 5 mg/ ml eye drops, solution travoprost/ timolol ||| GANFORT 300 microgrammes/ ml + 5 mg/ ml, collyre en solution. bimatoprost/ timolol Usage ophtalmique.
0.334789514541626 ||| Chemicals for use in the refining of liquid hydrocarbons ||| Cultures of microorganisms used in the fermentation of silage ||| Produits chimiques destinés au raffinage des hydrocarbures liquides
0.25185254216194153 ||| Truffles [confectionery] ||| Lollipops [confectionery] ||| Truffes [confiserie]
0.4649079740047455 ||| Non-electric beard trimmers ||| Non-electric single strand wire ||| Tondeuses à barbe non électriques
0.5216520428657532 ||| SPECIFIC OBLIGATIONS TO BE FULFILLED BY THE MARKETING AUTHORISATION HOLDER ||| HOW THE INTRAVITREAL INJECTION OF MACUGEN IS ADMINISTERED ||| EXIGENCES PARTICULIÈRES DEVANT ÊTRE RESPECTÉS PAR LE TITULAIRE DE L’ AUTORISATION DE MISE SUR LE MARCHÉ
0.22639760375022888 ||| 9 7. ||| 14 7. ||| pl 7.
0.0222487635910511 ||| SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY ||| SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY ||| PRÉCAUTIONS PARTICULIÈRES POUR L’ ÉLIMINATION DES MÉDICAMENTS VÉTÉRINAIRES NON UTILISÉS OU DES DECHETS, LE CAS ÉCHÉANT
0.41685277223587036 ||| Repeat-dose toxicity studies have established that the NOEL (No Observed Effect Level) is about 95 mg zinc/ kg body weight (about 48 times the human therapeutic dose). ||| Therapeutic monitoring The aim of the treatment is to maintain the plasma free copper (also known as non-ceruloplasmin plasma copper) below 250 microgram/ l (normal: ||| Les études de toxicité par administration de doses répétées ont permis de déterminer la DSEO (dose sans effet observé) qui est d’ environ 95 mg de zinc/ kg de poids corporel (environ 48 fois la dose thérapeutique humaine).
0.3899844288825989 ||| Do not administer Caelyx as a bolus injection or undiluted solution. ||| 2 Do not administer as an intravenous push or bolus injection. ||| Ne jamais administrer Caelyx sous forme de bolus ou de solution non diluée.
0.05644390359520912 ||| s ori For a full list of excipients, see section 6.1. ||| uth For a full list of excipients, see section 6.1. ||| Pour la liste complète des excipients, voir rubrique 6.1.
0.06326467543840408 ||| 27 GROUNDS FOR ONE ADDITIONAL RENEWAL ||| 256 GROUNDS FOR ONE ADDITIONAL RENEWAL ||| 27 MOTIFS POUR UN RENOUVELLEMENT SUPPLEMENTAIRE
0.031257860362529755 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Alimta to Eli Lilly Nederland B. V. on 20 September 2004. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Optruma to Eli Lilly Nederland B. V. on 5 August 1998. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Alimta à Eli Lilly Nederland B. V., le 20 septembre 2004.
0.4710479974746704 ||| Your doctor will order regular blood tests to ensure that your medicine is continuing to work properly. ||| The device should be proven to safely and effectively deliver the appropriate vaccinal dose. ||| Votre médecin demandera des analyses sanguines régulières afin de vérifier que le traitement agit toujours convenablement.
0.19615809619426727 ||| Hycamtin also affects non-cancer cells, which causes side effects. ||| Paxene also affects non-cancer cells such as blood cells, which causes side effects. ||| Hycamtin affecte également les cellules non cancéreuses, ce qui entraîne des effets indésirables.
0.02779793180525303 ||| • Replace the big outer needle cap and unscrew the needle (picture 4). ||| • Replace the big outer needle cap and unscrew the needle (picture E). ||| Replacez le grand capuchon externe de l’aiguille et dévissez l’aiguille (figure 4).
0.3259693682193756 ||| Neutropenia (G3/ 4: ||| Arrhythmia (G3/ 4: ||| Neutropénie (G3/ 4:
0.1873747557401657 ||| Oral use Read the package leaflet before use ||| Dilute before use Read the package leaflet before use ||| Lire attentivement la notice avant utilisation.
0.029328305274248123 ||| It may be used in patients on dialysis and in patients not on dialysis. ng lo 4.2 Posology and method of administration no ||| It may be used in patients on dialysis and in patients not on dialysis. ng 4.2 Posology and method of administration lo ||| Il peut être utilisé chez les patients sous dialyse et chez les patients non encore dialysés. 'e
0.2332383692264557 ||| Aptivus is to be taken in combination with low dose ritonavir and other antiretroviral medicines. ||| Zolpidem and ritonavir may be co-administered with careful monitoring for excessive sedative effects. ||| APTIVUS est destiné à être administré en association avec de faibles doses de ritonavir et d’ autres antirétroviraux.
0.0 ||| Nervous system disorders ||| Nervous system disorders ||| Troubles de système nerveux
0.334606409072876 ||| Treatment with Advagraf should only be prescribed by doctors who have experience in the management of transplant patients. ||| No experience is available with the use of Lisonorm in pregnant women from adequately controlled clinical studies. ||| Le traitement par Advagraf ne doit être prescrit que par un médecin ayant l’ expérience de la prise en charge des patients greffés.
0.020209085196256638 ||| Like all medicines, Starlix can cause side effects, although not everybody gets them. ||| Like all medicines, Dynastat can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Starlix est susceptible d’ avoir des effets indésirables, bien que tous n’ y soient pas sujets.
2.4344781290701334e-13 ||| patients with metastatic breast cancer receiving chemotherapy when administered to target a haemoglobin of 12-14 g/ dl (7.5-8.7 mmol/ l) ct ||| patients with metastatic breast cancer receiving chemotherapy when administered to target a haemoglobin of 12-14 g/ dl (7.5-8.7 mmol/ l) ct ||| 72 métastatique recevant une chimiothérapie, lorsque les ASEs étaient administrés dans le but d’ atteindre des taux cibles d’ hémoglobine compris entre 12 et 14 g/ dl (7,5-8,7 mmol/ l)
0.018557807430624962 ||| In more than half of the reported cases, treatment with protease inhibitors was continued, or reintroduced if treatment had been discontinued. ||| In more than a half of the reported cases, treatment with protease inhibitors was continued or reintroduced if treatment had been discontinued. ||| Dans plus de la moitié des cas rapportés, le traitement par inhibiteurs de protéase a été poursuivi ou réintroduit en cas d’ arrêt.
0.14415018260478973 ||| • Keep used pens out of the reach and sight of children. ||| • Keep used syringes out of the reach and sight of children. ||| • Placez les stylos préremplis usagés hors de portée et de vue des enfants.
0.42996644973754883 ||| Any disease other than multiple sclerosis that could better explain signs and symptoms of the patient had to be excluded. ||| Because the disorder is variable in its expression, other organ system signs and symptoms not noted here may occur. ||| Toute maladie autre que la sclérose en plaques expliquant mieux la symptomatologie du patient devait être exclue.
0.013450508937239647 ||| 63 4.4 Special warnings and precautions for use ||| 65 4.4 Special warnings and precautions for use ||| Mises en gardes spéciales et précautions d' emploi
0.19339899718761444 ||| Tipranavir maintains significant antiviral activity (< 4-fold resistance) against the majority of HIV-1 clinical isolates showing post-treatment decreased susceptibility to the currently approved protease inhibitors: amprenavir, atazanavir, indinavir, lopinavir, ritonavir, nelfinavir and saquinavir. ||| Cross-resistance Darunavir has a < 10-fold decreased susceptibility against 90% of 3,309 clinical isolates resistant to amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir and/or tipranavir showing that viruses resistant to most PIs remain susceptible to darunavir. ||| Le tipranavir maintient une activité antivirale significative (résistance 4 fois plus basse) sur la majorité des isolats cliniques du VIH-1, ayant montré après traitement une diminution de la sensibilité aux inhibiteurs de protéase actuellement disponibles, l’ amprénavir, l’ atazanavir, l’ indinavir, le lopinavir, le ritonavir, le nelfinavir et le saquinavir.
0.4163469076156616 ||| Allergic reactions associated with administration of Kineret during clinical trials were rare. ||| Patients with known malignancies were not included in these clinical trials. ||| Lors des essais cliniques, les réactions allergiques associées à l’ administration de Kineret ont été rares.
0.30266672372817993 ||| Trough levels at 24 hours are, however, similar. ||| Trough levels at 24 hours are, however, similar for both formulations. ||| Les concentrations minimales à 24 heures sont toutefois similaires.
0.2713978886604309 ||| Treatment with ViraferonPeg in combination with ribavirin was associated with decreases in absolute CD4+ cell counts within the first 4 weeks without a reduction in CD4+ cell percentage. ||| The plasma concentrations of olanzapine observed across the dose range of 150mg every 4 weeks to 300mg every 2 weeks illustrate increased systemic olanzapine exposure with increased ZYPADHERA doses. ||| Baisse des lymphocytes CD4 Le traitement par ViraferonPeg en association avec la ribavirine a été associé avec des diminutions des taux absolus de cellules CD4+ au cours des 4 premières semaines sans réduction du pourcentage de cellules CD4+.
0.17209194600582123 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Xolair to Novartis Europharm Limited on 25 October 2005. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Sifrol to Boehringer Ingelheim International GmbH on 14 October 1997. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Xolair à Novartis Europharm Limited le 25 octobre 2005.
0.3331092596054077 ||| Treatment should be directed at the major anticipated toxicities, which are bone marrow suppression, mucositis and peripheral neuropathy. ||| This includes an increased risk of skeletal manifestations, exacerbation of cytopenia, haemorrhage, and an increased need for transfusion. ||| Le traitement doit viser les principales complications prévisibles d’ un surdosage que sont la myélosuppression, les neuropathies périphériques et l’ inflammation des muqueuses.
0.0024543595500290394 ||| Subcutaneous use Mixtard 50 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Mixtard 50 NovoLet is for use by one person only ||| Subcutaneous use Mixtard 30 NovoLet is designed to be used with NovoFine needles Resuspend according to instructions Read the package leaflet before use Mixtard 30 NovoLet is for use by one person only ||| Voie sous-cutanée Mixtard 50 NovoLet est conçu pour être utilisé avec les aiguilles NovoFine Remettre en suspension conformément aux instructions de la notice Lire attentivement la notice avant utilisation Mixtard 50 NovoLet est réservé à l’ utilisation par un seul patient
0.24223962426185608 ||| Electronic information services relating to hotels ||| Advertising services relating to data bases ||| Services électroniques d'informations en matière d'hôtellerie
0.44997113943099976 ||| Household containers of precious metal ||| Desktop statuary made of precious metal ||| Récipients à usage ménager en métaux précieux
0.17809781432151794 ||| Burner maintenance and repair ||| Tyre maintenance and repair ||| Entretien et réparation de brûleurs
0.3587072491645813 ||| Other NSAIDS, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. ||| Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose- lowering effect of insulin. ||| Les autres AINS, les diurétiques, les anticoagulants, les antibiotiques aminoglycosides et les molécules fortement liées aux protéines peuvent entrer en compétition pour cette liaison et conduire ainsi à des effets toxiques.
0.30794757604599 ||| * Transient, influenza-like symptoms have been reported in patients receiving intravenous injection of Bondenza 3 mg every 3 months, typically in association with the first dose. ||| Incidents of pre-travel vomiting, usually within two hours post-dosing were commonly reported after administration of the 8 mg/kg dose. ||| * Des symptômes pseudo-grippaux transitoires ont été rapportés chez les patientes recevant Bondenza IV 3 mg tous les 3 mois, habituellement lors de la première injection.
0.16240105032920837 ||| - The active substance is agomelatine. ||| - The active substance is rufinamide. ||| - La substance active est l'agomélatine.
0.5407860279083252 ||| The users’ mobile numbers are the only user-related data, stored on servers managed by the Ministry of Health. ||| With regards to laws on data protection, the app does not use the users’ locations nor personal information. ||| Les numéros mobiles des utilisateurs sont les seules données liées à l'utilisateur, stockées sur des serveurs gérés par le ministère de la Santé, , .
0.5065031051635742 ||| No information is available on the effect of PritorPlus on the ability to drive or operate machinery. ||| Ensure that the use of applications and platforms does not violate students’ data privacy. ||| Aucune information n’ est disponible sur l’ effet de PritorPlus sur l’ aptitude à conduire des véhicules ou à utiliser des machines.
0.44305258989334106 ||| Cholesterol is one of several fats found in your blood. ||| These may be signs there is too much calcium in your blood. ||| Le cholestérol est l’ une des nombreuses graisses présentes dans le sang.
0.02932828851044178 ||| Insulin Human Winthrop Rapid must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of a water-like consistency. ||| Insulin Human Winthrop Infusat must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of a water-like consistency. ||| Insulin Human Winthrop Rapid ne doit être utilisé que si la solution est claire, incolore, sans particules solides visibles, et qu’ elle a la consistance de l'eau.
0.6259790658950806 ||| You can hold it in either your right or left hand. ||| You should lie down on your back with your feet higher than your head. ||| Vous pouvez aussi bien le tenir dans la main droite que la main gauche.
0.012777645140886307 ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| In addition, an updated RMP should be submitted − When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities − Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached − At the request of the EMEA ||| De plus, un PGR mis à jour devra être soumis: • Lors de la réception de nouvelles informations pouvant avoir un impact sur le profil de sécurité d’ emploi, le plan de pharmacovigilance ou les activités de minimisation des risques; • Dans les 60 jours qui suivent la date à laquelle une étape importante (pharmacovigilance ou minimisation des risques) est franchie; • A la demande de l’ EMEA
0.0 ||| MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| TITULAIRE(S) DE L’ AUTORISATION DE FABRICATION RESPONSABLE(S) DE LA LIBÉRATION DES LOTS
0.3304782509803772 ||| However, orlistat may indirectly reduce the availability of oral contraceptives and lead to unexpected pregnancies in some individual cases. ||| Tetracyclines used concurrently with oral contraceptives have in a few cases resulted in either breakthrough bleeding or pregnancy. ||| Toutefois, l'orlistat pourrait réduire indirectement la biodisponibilité des contraceptifs oraux et conduire à des grossesses non souhaitées dans certains cas.
0.17171266674995422 ||| Read the package leaflet before use. ||| Read package leaflet before use. ||| Lire la notice avant emploi.
0.01552114263176918 ||| When prescribing MIRAPEXIN in a patient with Parkinson’ s disease with renal impairment a reduced dose is suggested in line with section 4.2. ||| When prescribing MIRAPEXIN tablets in a patient with Parkinson’ s disease with renal impairment a reduced dose is suggested in line with section 4.2. ||| Il est recommandé de réduire la dose selon le schéma décrit au paragraphe 4.2 en cas d'utilisation de MIRAPEXIN chez les patients atteints de la maladie de Parkinson insuffisants rénaux.
0.15710288286209106 ||| It is recommended that individuals who receive the first dose of Silgard should complete all three doses with Silgard. ||| It is recommended that individuals who receive the first dose should complete all doses of Twinrix Adult. ||| Il est recommandé d’ administrer l’ ensemble complet des trois doses de Silgard aux individus ayant reçu une première dose.
0.5501714944839478 ||| Fastenings for clothing ||| Dyeing of clothing ||| Fermetures pour vêtements
0.1974993199110031 ||| What Revasc contains ||| What Trazec contains ||| Que contient Revasc
0.06515739858150482 ||| EU/ 1/ 97/ 046/ 021 14 tablets EU/ 1/ 97/ 046/ 022 28 tablets EU/ 1/ 97/ 046/ 035 30 tablets EU/ 1/ 97/ 046/ 023 56 tablets EU/ 1/ 97/ 046/ 024 56 x 1 tablets EU/ 1/ 97/ 046/ 032 84 tablets EU/ 1/ 97/ 046/ 038 90 tablets EU/ 1/ 97/ 046/ 025 98 tablets ||| EU/ 1/ 98/ 085/ 016 14 tablets EU/ 1/ 98/ 085/ 017 28 tablets EU/ 1/ 98/ 085/ 030 30 tablets EU/ 1/ 98/ 085/ 018 56 tablets EU/ 1/ 98/ 085/ 019 56 x 1 tablets EU/ 1/ 98/ 085/ 022 84 tablets EU/ 1/ 98/ 085/ 033 90 tablets EU/ 1/ 98/ 085/ 020 98 tablets ||| EU/ 1/ 97/ 046/ 021 14 comprimés EU/ 1/ 97/ 046/ 022 28 comprimés EU/ 1/ 97/ 046/ 035 30 comprimés EU/ 1/ 97/ 046/ 023 56 comprimés EU/ 1/ 97/ 046/ 024 56 x 1 comprimés EU/ 1/ 97/ 046/ 032 84 comprimés EU/ 1/ 97/ 046/ 038 90 comprimés EU/ 1/ 97/ 046/ 025 98 comprimés
0.7278897762298584 ||| Business and market research ||| Advertising and marketing ||| Études commerciales et de marché
0.5246668457984924 ||| Protaphane is an isophane insulin suspension (NPH). ||| IONSYS is an iontophoretic transdermal system (ITS). ||| Protaphane est une suspension d’insuline isophane (NPH).
0.3525654673576355 ||| 7 The robustness of this analysis was confirmed by additional analyses that calculated the 1-sided 97.5% CI, analyses using the unadjusted scores, and analyses using the ITT and interim CSR PP populations. ||| The RMS approved the product on the basis of the results of the fasted study showed unequivocal equivalence as shown by the 90% confidence intervals (CI) for the AUC and Cmax which were within the conventional 80-125% bioequivalence range. ||| La robustesse de cette analyse a été confirmée à l’ aide d’ analyses complémentaires ayant calculé l’ IC unilatéral à 97,5%, des analyses utilisant des scores non ajustés et des analyses utilisant la population ITT et la population PP du rapport d’ étude clinique intérimaire.
0.6004836559295654 ||| Acupressure mats ||| Acupuncture instruments ||| Tapis d’acupression
0.4050915837287903 ||| Cetirizine does not modify the protein binding of warfarin. ||| Stiripentol enhances the central depressant effect of chlorpromazine. ||| La cétirizine ne modifie pas la liaison de la warfarine aux protéines.
1.1327097415924072 ||| Levy, D M (2006). ||| Julia Dunne and Dr. ||| Abadie, V. (1999).
0.30157169699668884 ||| Orlistat may unbalance anticonvulsivant treatment by decreasing the absorption of antiepileptic drugs, leading to convulsions (see section 4.5). ||| Oral contraceptives: bexarotene can potentially induce metabolic enzymes and thereby theoretically reduce the efficacy of oestroprogestive contraceptives. ||| Orlisat peut déséquilibrer le traitement anticonvulsivant en diminuant l’ absorption des médicaments antiépileptiques, conduisant à des convulsions (voir section 4.5).
0.4703647196292877 ||| Provision of training services for industry ||| Provision of scientific advice and protocol assistance ||| Services de formation pour l'industrie
0.4501344561576843 ||| J Janssen-Cilag International NV, Turnhoutseweg 30, B-2340, Beerse, Belgium ||| SP Labo N.V., Industriepark 30, B- 2220 Heist-op-den-Berg, Belgium ||| Janssen-Cilag International NV, Turnhoutseweg 30, B- 2340, Beerse, Belgique
0.41928672790527344 ||| The effectiveness of ProteqFlu-Te was studied in several studies under laboratory and field conditions. ||| All findings in the preclinical safety programme were related to the pharmacological effect of rFVIIa. ||| L’ efficacité de ProteqFlu-Te a été étudiée au cours de plusieurs études dans des conditions de laboratoire et sur le terrain.
0.2922746539115906 ||| When used with an insulin infusion pump, Apidra must not be mixed with other medicinal products. ||| NovoRapid should never be mixed with any other insulin when used in a pump. ||| En cas d’ utilisation dans une pompe à perfusion, Apidra ne doit pas être mélangé avec d’ autres médicaments.
0.1302318274974823 ||| Each pre-filled syringe of 0.5 ml solution contains 75 mg of omalizumab. ||| ed Each 0.8 ml single dose pre-filled syringe contains 40 mg of adalimumab. ||| Chaque seringue préremplie de 0,5 ml de solution contient 75 mg d’ omalizumab.
0.22389721870422363 ||| - certain medicines to treat allergies (e. g. terfenadine, astemizole, mizolastine), heart rhythm ||| - Medicines used for mental disorders (e. g. thioridazine, chlorpromazine, levomepromazine). ||| - certains médicaments pour les allergies (ex. terfénadine, astémizole, mizolastine), les troubles du
0.29258179664611816 ||| Repeated-dose toxicity studies in dogs of up to 4 weeks’ duration and in cynomolgus monkeys of up to 9 months’ duration revealed the liver as the primary target organ of toxicity of nilotinib. ||| In the longer duration chronic monkey study, there was no effect on the erythroid and leukocytic lineages when romiplostim was administered for 6 months where the administration of romiplostim was decreased from thrice weekly to once weekly. ||| Des études de toxicité en administration répétée jusqu’ à 4 semaines chez le chien et jusqu’ à 9 mois chez le singe macaque, ont montré que le foie est le principal organe cible de la toxicité du nilotinib.
0.7007350921630859 ||| Store in a refrigerator. ||| pain at the infusion site ||| 71 A conserver au réfrigérateur.
0.8189774751663208 ||| Tunnel boring machines ||| Pier breakwater building ||| Tunneliers [machines]
0.10920406877994537 ||| Azomyr 0.5 mg/ ml oral solution desloratadine ||| Neoclarityn 0.5 mg/ ml oral solution desloratadine ||| Azomyr 0,5 mg/ ml solution buvable desloratadine
0.5162340998649597 ||| These reactions were reversible in the majority of patients. ||| Some of these infections have been fatal. ||| Ces réactions ont été réversibles chez la majorité des patientes.
0.4044172763824463 ||| What Rapamune contains The active substance is sirolimus. ||| The active substance in REGRANEX is becaplermin. ||| - La substance active est le sirolimus.
0.3233788013458252 ||| Systemic exposure to darunavir co-administered with low dose ritonavir, with or without didanosine was comparable. ||| Systemic exposure to adefovir was not affected when 10 mg adefovir dipivoxil was taken with a high fat meal. ||| L’exposition systémique de darunavir co-administré avec une faible dose de ritonavir, avec ou sans didanosine était comparable.
0.2845637798309326 ||| Caution should be exercised in patients with severe renal or moderate hepatic impairment. ||| Special attention is recommended for patients with reduced performance status and pre-existing cardio-pulmonary disease. ||| Une surveillance s’ impose chez les patients ayant une insuffisance rénale sévère ou une insuffisance hépatique modérée.
0.219384104013443 ||| Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia. ||| Under the influence of sympatholytic active substances such as betablockers, clonidine, guanethidine and reserpine, the signs of adrenergic counterregulation to hypoglycaemia may be reduced or absent. ||| Les bêta -bloquants comme d'autres médicaments sympatholytiques (tels que clonidine, guanéthidine et réserpine), peuvent atténuer ou supprimer complètement les premiers symptômes annonciateurs qui vous aident à reconnaitre une hypoglycémie.
0.41975486278533936 ||| Sealants for pavement joints ||| Dental cement for fillings ||| Mastics pour joints de pavage
0.07757553458213806 ||| The maximum recommended dose is 20 mg. ||| The maximum recommended daily dose is 20 mg. ||| La dose maximale recommandée est de 20 mg.
0.2813946604728699 ||| Co-administration of ritonavir with these medicinal products is expected to substantially increase their concentrations and may result in associated adverse events such as hypotension and prolonged erection (see section 4.5). ||| Co-administration may result in increased plasma concentrations of these medicinal products, leading to QTc prolongation and rare occurrences of torsades de pointes (see section 4.3). ||| La co-administration de ritonavir et de ces médicaments entraîne une augmentation importante de leurs concentrations et peut provoquer des effets indésirables liés à ces médicaments tels qu’une hypotension et une érection prolongée (voir rubrique 4.5).
0.30295491218566895 ||| Twenty-three malignancies were reported in plaque psoriasis patients treated with Enbrel in double-blind and open-label studies of up to 15 months involving 1,261 Enbrel-treated patients. ||| In double-blind and open-label clinical trials, malignancies were reported in 66 of 2,688 abatacept-treated patients during 4,764 patient-years. ||| Ving-trois tumeurs malignes ont été rapportées chez les patients atteints de psoriasis en plaques et traités par Enbrel sur une durée maximale de 15 mois dans les études en double-aveugle et en ouvert, incluant 1261 patients traités par Enbrel.
0.30655187368392944 ||| In obese type 2 diabetic patients insufficiently controlled by antidiabetic agents, data from four one- year clinical trials showed that the percentage of responders (≥ 10% of body weight loss) was 11.3% with orlistat as compared to 4.5% with placebo. ||| Some people have allergic reactions to these drugs.On 12 April, a preliminary clinical trial conducted at a hospital in Brazil was stopped when several people given high doses of chloroquine for COVID-19 infection developed irregular heart rates, causing 11 deaths. ||| Chez les patients obèses diabétiques de type 2 insuffisamment contrôlés par un traitement antidiabétique, les données de quatre études cliniques d'une durée de un an ont montré que le pourcentage de patients répondeurs (perte de poids ≥ 10%) était de 11,3% avec orlistat comparé à 4,5% avec le placebo.
0.3393082022666931 ||| In the open-label study there was no difference in overall survival between patients treated with recombinant human erythropoietin and controls. ||| The rodent-specific association of liver tumours and drug-induced enzyme induction is well documented in the literature. ||| Dans l’ étude en ouvert, il n’ y a pas eu de différence sur la survie globale entre les patients traités avec l’ érythropoïétine humaine recombinante et le groupe contrôle.
0.4817619025707245 ||| diarrhoea, nausea ||| - diarrhoea ||| Diarrhées, nausées
0.016926191747188568 ||| The liver has no significant role in the clearance of ibandronic acid, which is not metabolised but is cleared by renal excretion and by uptake into bone. ||| The liver has no significant role in the clearance of ibandronic acid which is not metabolised but is cleared by renal excretion and by uptake into bone. ||| Le foie ne joue aucun rôle significatif dans la clairance de l’ acide ibandronique, qui n’ est pas métabolisé mais éliminé par excrétion rénale et absorption osseuse.
0.4302855432033539 ||| Steam engine boilers ||| Bicycle handlebars ||| Chaudières de machines
0.3897559344768524 ||| Pressure sensors ||| Temperature sensors ||| Capteurs de pression
0.6061956882476807 ||| 19% of patients had severe neutropenia for > 7 days. ||| Almost 4,000 patients had diabetes without CHD. ||| 19% des patients ont présenté une neutropénie sévère pendant plus de 7 jours.
0.2397400438785553 ||| There is insufficient experience of the use of oral or intravenous topotecan in patients with severely impaired renal function (creatinine clearance < 20 ml/ min). ||| The pharmacokinetics of parathyroid hormone in patients with severe renal impairment (creatinine clearance of less than 30 ml/min) has not been investigated. ||| Il n'existe pas de données suffisantes sur l'utilisation du topotécan oral et intraveineux chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 20 ml/ min).
0.36454033851623535 ||| In dogs treated at the therapeutic dose for ten consecutive days, serum cortisol levels decreased from five days onward and returned to normal values within ten days after the end of treatment. ||| At high dosages and prolonged treatment (3 times the recommended dose for 42 consecutive days and 2.5 times the recommended dose for 92 consecutive days administered once daily) mild to moderate renal lesions were observed. ||| Pour les chiens traités à la posologie recommandée pendant 10 jours consécutifs, les taux de cortisol sérique ont diminué à partir du cinquième jour et sont revenus à la normale dix jours après la fin du traitement.
0.4088042974472046 ||| A dose correction may be needed after six months of treatment (see section 4.4). ||| The dose can be reduced if not tolerated (see section 4.2 and 5.2). ||| Il est possible qu’ un ajustement de la posologie soit nécessaire après 6 mois de traitement (voir rubrique 4.4).
0.5624731779098511 ||| Advocate spot-on solution for small cats Advocate spot-on solution for large cats ||| PACKAGE LEAFLET Profender spot-on solution for small cats Profender spot-on solution for medium cats Profender spot-on solution for large cats ||| Advocate solution pour spot -on pour petits chats Advocate solution pour spot -on pour grands chats
0.6428197026252747 ||| Cutter bars [hand tools] ||| Control clocks [master clocks] ||| Barres d'alésage [outils]
0.31691974401474 ||| However, at doses above 2 mg/ kg, the AUC of panitumumab increases in an approximately dose-proportional manner. ||| However, plasma concentrations of the parent compound are very low and below the quantification limit (0.00025 mg/ l) beyond 2 hours. ||| Cependant, à des doses supérieures à 2 mg/ kg, l’ ASC du panitumumab augmente presque proportionnellement à la dose.
0.1399867683649063 ||| The vaccine can be used during pregnancy. ||| The vaccine can be used during pregnancy and lactation. ||| Peut être utilisé pendant la gestation.
0.3408466577529907 ||| The applicable conditions are specified in the EBA guidelines of 2 April 2020 on payment moratoria , which are also intended to ensure that public and private moratoria are being treated similarly to the extent they have the same purpose and similar characteristics. ||| The GBER declares specific categories of State aid compatible with the Treaty, provided that they fulfil clear conditions, and exempts these categories from the requirement of prior notification and approval to the Commission. ||| Les conditions applicables sont précisées dans les orientations de l'ABE du 2 avril 2020 sur les moratoires de paiement, qui visent aussi à garantir un traitement similaire des moratoires publics et privés, dans la mesure où ils ont la même finalité et des caractéristiques similaires.
0.23635321855545044 ||| The recommended dose for each injection (0.5 ml) is 5 micrograms for children and adolescents (birth through 15 years of age). ||| For children from one to five years of age, the dose is 1.25 mg once a day, taken as 2.5 ml syrup or oral solution. ||| La dose recommandée pour chaque injection (0,5 ml) est 5 microgrammes pour les enfants et les adolescents (de la naissance jusqu'à l'âge de 15 ans).
0.3473164439201355 ||| For type 3 Gaucher disease (which is an extremely rare form of the disease), data from published articles and from the special register of Gaucher’ s patients were used. ||| As the AIDS-KS population is very specific, safety data from a clinical study of 107 AIDS-KS patients are presented separately at the end of Section 4.8. ||| Pour la maladie de Gaucher de type 3 (qui est une forme extrêmement rare de la maladie), des données provenant d’ articles publiés et d’ un registre spécial regroupant les personnes atteintes de la maladie ont été utilisées.
0.37933969497680664 ||| Augmentation refers to the earlier onset of symptoms in the evening (or even afternoon), increase in symptoms, and spread of symptoms to involve other extremities. ||| Angina is more likely to happen when the heart beats faster in situations such as exercise, emotion, exposure to the cold or after eating. ||| Le phénomène d’ augmentation fait référence à une apparition plus précoce des symptômes le soir (voire même dans l’ après-midi), à une aggravation des symptômes et à leur propagation à d’ autres extrémités.
0.006384127773344517 ||| Hydrochlorothiazide: although equivocal evidence for a genotoxic or carcinogenic effect was found in some experimental models, the extensive human experience with hydrochlorothiazide has failed to show an association between its use and an increase in neoplasms. ||| 27 Hydrochlorothiazide: although equivocal evidence for a genotoxic or carcinogenic effect was found in some experimental models, the extensive human experience with hydrochlorothiazide has failed to show an association between its use and an increase in neoplasms. ||| Hydrochlorothiazide: malgré l'existence de données ambiguës sur l'effet génotoxique ou cancérigène dans certains modèles expérimentaux, la longue expérience de l'utilisation de l'hydrochlorothiazide chez l'homme ne permet pas de montrer une association entre son utilisation et une augmentation des néoplasmes.
0.0 ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence européenne des médicaments (EMEA) http: / /www. emea. europa. eu/.
0.7960049510002136 ||| -2.0 - 79.0 ||| -0.4 -0.4 ||| -2,0 - 79,0
0.7033599615097046 ||| blister (PVC/ alu) blister (PVC/ alu) perforated unit dose blister (PVC/ alu) ||| Blisters (PVC/ PE/ PVDC) Blisters (PVC/ PE/ PVDC) ||| plaquette thermoformée avec perforations contenant des doses unitaires (PVC/ alu)
0.6171032190322876 ||| Bridles [harness] ||| Barley wine [Beer] ||| Brides [harnais]
3.558723411442588e-13 ||| Two other smaller, randomised, placebo-controlled trials failed to show a significant improvement in quality of life parameters on the EORTC-QLQ-C30 scale or CLAS, respectively. ||| Two other smaller, randomised, placebo-controlled trials failed to show a significant improvement in quality of life parameters on the EORTC-QLQ-C30 scale or CLAS, respectively. ||| 133 amélioration significative des paramètres de qualité de vie sur les échelles EORTC-QLQ-C30 et CLAS, respectivement.
0.019396089017391205 ||| 84 Gonadotrophin therapy requires a certain time commitment by physicians and supportive health professionals, as well as the availability of appropriate monitoring facilities. ||| Gonadotrophin therapy requires a certain time commitment by physicians and supportive health professionals, as well as the availability of appropriate monitoring facilities. ||| Un traitement par gonadotrophines demande une certaine disponibilité de la part des médecins et des professionnels de santé, ainsi que l’ utilisation des moyens de suivi appropriés.
0.30621516704559326 ||| The public sector loan facility is the third pillar of the Just Transition Mechanism (JTM) and part of the European Green Deal effort to create a climate-neutral economy in Europe by 2050. ||| The focus of the EU cohesion policy in 2021-2027 remains the economic competitiveness through research and innovation, digital transition as well as the European Green Deal agenda and the promotion of the European Pillar of Social Rights . ||| La facilité de prêt au secteur public est le troisième pilier du mécanisme pour une transition juste (MTJ) et fait partie des efforts déployés dans le cadre du pacte vert pour l'Europe en vue de créer une économie neutre pour le climat en Europe d'ici à 2050.
0.14723283052444458 ||| 0.80 ml ||| 0.64 ml ||| 0,80 ml
0.47338247299194336 ||| Via Palermo, 26/ A 43100 Parma Italy ||| Viale Shakespeare, 47 00144 Roma Italy ||| Via Palermo, 26/ A 43100 Parma Italie
0.25665855407714844 ||| Since national public support for the recapitalisation of some companies can be highly distortive for competition in the EU Single Market, the Commission is proposing a number of safeguards on the conditions for granting State aid as well as for the behaviour of the companies benefitting from it, both on the market and in terms of their governance. ||| Recapitalisations above the threshold of €250 million are subject to separate notification and, if they benefit companies with significant market power on at least one of the relevant markets in which they operate, Member States must propose additional measures to preserve effective competition in those markets, in the form of structural or behavioural commitments. ||| Étant donné que le soutien public national à la recapitalisation de certaines entreprises peut fausser fortement la concurrence dans le marché unique de l'UE, la Commission propose un certain nombre de garde-fous en ce qui concerne les conditions d'octroi des aides d'État, ainsi que le comportement des entreprises qui en bénéficient, tant sur le marché qu'en termes de gouvernance.
0.008560212329030037 ||| If you use more KOGENATE Bayer 500 IU than you should: ||| If you use more KOGENATE Bayer 1000 IU than you should: ||| Si vous avez pris plus de KOGENATE Bayer 500 UI que vous n'auriez dû:
0.4225921630859375 ||| In clinical studies, antibodies to romiplostim were examined. ||| Heterozygous females were not studied in the clinical trials. ||| Dans les études cliniques, les anticorps anti-romiplostim ont été étudiés.
0.47680196166038513 ||| Oils for perfumes and scents ||| Chains for spectacles and for sunglasses ||| Huiles pour la parfumerie
0.41160112619400024 ||| Therefore, Kaletra tablets may be taken with or without food. ||| Telzir tablets may be taken without regard to food intake. ||| Par conséquent Kaletra comprimé peut être administré au cours ou en dehors des repas.
0.42213329672813416 ||| Therefore, concomitant treatment should be initiated only if the patient is stable on his alpha blocker therapy. ||| Therefore, Osigraft may only be administered to the defect site under adequate vision and with utmost care. ||| Par conséquent, un traitement concomitant par vardénafil doit être initié uniquement si le patient est stable sous traitement par alpha-bloquant.
0.446736216545105 ||| SINGULAIR 4 mg chewable tablets montelukast For children 2 to 5 years of age ||| Helicobacter Test INFAI for children of the age 3 -11 45 mg powder for oral solution ||| SINGULAIR 4 mg, comprimé à croquer montelukast Pour les enfants de 2 à 5 ans
0.3893284797668457 ||| There is no reliable evidence that the risk of developing vigabatrin attributed VFD decreases after the initial three years of treatment. ||| Up to now there were no adverse events potentially related to a faster release of doxazosin reported. ||| Il n’ existe pas de preuves irrefutables que le risque de développer une ACV imputable au vigabatrin diminue après les trois premières années de traitement.
0.3020758628845215 ||| Do not remove the plastic cover from the needle until you are ready to inject. ||| DO NOT remove the needle cover while allowing it to reach room temperature. ||| N’ enlevez pas le capuchon en plastique de l’ aiguille avant d’ être prêt(e) pour l’ injection.
0.36100953817367554 ||| In many patients, the signs and symptoms of neuroglycopenia are preceded by signs of adrenergic counter- regulation. ||| The pathophysiology of the inflammatory lesions of rosacea is, in part, a manifestation of a neutrophil-mediated process. ||| Chez de nombreux patients, les signes et symptômes de neuroglycopénie sont précédés par des signes de réaction adrénergique compensatrice.
0.4229777455329895 ||| One ml of solution contains 1 mg olopatadine (as hydrochloride). ||| - (polyvinylchloride) bag of 200 ml of diluent ||| Un ml de solution contient 1 mg d'olopatadine (sous forme de chlorhydrate).
0.22725985944271088 ||| Skin and subcutaneous tissue disorders: pruritus, rash, urticaria Immune system disorders: hypersensitivity reactions including anaphylactic reactions ||| Skin and subcutaneous tissue disorders (see Immune system disorders) angioedema skin reactions (e. g. urticaria, pruritis, rash) 5 ||| Affections du système immunitaire: réactions d'hypersensibilité incluant des réactions anaphylactiques.
0.6213210821151733 ||| 32 If you forget to take Viread ||| You should know before taking LITAK that ||| Si vous oubliez de prendre Viread
0.538383960723877 ||| The push-button also rises as you turn the cap • The scale under the push-button shows 20, 40 and 60 units. ||| As the solution fills the syringe, you will see the numbers on the rod go up, such as 1.5 ml, 2.0 ml, 2.5 ml, etc. ||| Le bouton-poussoir remonte lorsque vous tournez le capuchon • L’ échelle située sous le bouton-poussoir indique 20, 40 et 60 unités.
0.19621075689792633 ||| - Barbiturates (used to treat epilepsy/ seizures and some sleep disorders) ||| - Carbamazepine (used to treat epilepsy/ seizures and some forms of pain or depression) ||| - ou d’ autres médicaments pour traiter la dépression, les troubles du sommeil, l' hypertension
0.29842066764831543 ||| Mean Cmax and AUC increased less than proportionally beyond doses of 400 mg administered twice daily. ||| Cmax and to a lesser extent AUC increase disproportionately at doses above 40 mg. ||| Au-delà de 400 mg administrés deux fois par jour, les Cmax et AUC moyennes du sorafénib n’ augmentaient pas proportionnellement à la dose.
0.39840972423553467 ||| Flavoured coffee ||| Flavoured yoghurts ||| Café aromatisé
0.46127766370773315 ||| Powder and solvent for Intravenous use solution for injection ||| Water for injection Solvent for use with Luveris Injection. ||| poudre et solvant pour voie intraveineuse solution injectable
0.23434332013130188 ||| How to store Luveris 6. ||| How to use Luveris 4. ||| Comment conserver Luveris 6.
0.14417116343975067 ||| Distribution The steady-state volume of distribution of nateglinide based on intravenous data is estimated to be approximately 10 litres. ||| Distribution Following intravenous administration the steady-state volume of distribution of tenofovir was estimated to be approximately 800 ml/ kg. ||| Distribution Les données obtenues après administration intraveineuse ont permis d'estimer à environ 10 litres le volume de distribution du natéglinide à l'état d'équilibre.
0.3578621447086334 ||| Also see ribavirin SPC if Viraferon is to be administered in combination with ribavirin in patients with chronic hepatitis C. ||| Caution should be used when adding Viraferon and ribavirin to HAART therapy (see ribavirin SPC). ||| Se reporter également au RCP de la ribavirine si Viraferon est administré en association avec la ribavirine chez les patients atteints d’ hépatite C chronique
0.6644085645675659 ||| What is ECDC doing to keep antibiotics working? ||| What is happening for Evoltra for treatment of ALL in children? ||| Que fait l'ECDC pour préserver l'efficacité des antibiotiques?
0.2351868450641632 ||| Croatia notified to the Commission under the Temporary Framework two schemes, with an overall estimated budget of €1 billion, to support companies affected by the coronavirus outbreak. ||| As of today, the Commission has approved 20 measures notified by Poland under the Temporary Framework worth over €50 billion, in part financed by EU structural funds. ||| La Croatie a notifié à la Commission, au titre de l' encadrement temporaire , deux régimes, dont le budget global estimé est de 1 milliard d'euros et qui visent à soutenir les entreprises touchées par la pandémie de coronavirus.
4.574047846213347e-13 ||| In a prospective, randomised double-blind, placebo-controlled study conducted in 314 lung cancer patients receiving platinum containing chemotherapy there was a significant reduction in transfusion requirements (p < 0.001). ||| In a prospective, randomised double-blind, placebo-controlled study conducted in 314 lung cancer patients receiving platinum containing chemotherapy there was a significant reduction in transfusion requirements (p < 0.001). ||| Lors d’ une étude prospective, randomisée, en double aveugle, contrôlée versus placebo, menée chez 314 patients atteints de cancer du poumon et recevant une chimiothérapie à base de sels de platine, une réduction significative des besoins transfusionnels a été observée (p < 0,001). ic
0.19758793711662292 ||| Genotypic interpretation systems may be used to estimate the activity of amprenavir / ritonavir or fosamprenavir / ritonavir in subjects with PI-resistant isolates. ||| Clinically validated phenotypic interpretation systems may be used in association with the genotypic data to estimate the activity of amprenavir / ritonavir or fosamprenavir / ritonavir in patients with PI- resistant isolates. ||| Les systèmes d’ interprétation génotypique peuvent être utilisés pour estimer l’ activité de l’ association amprénavir / ritonavir ou fosamprénavir / ritonavir chez les sujets dont les isolats sont résistants aux Inhibiteurs de Protease.
0.3863377571105957 ||| The rate of malignancies reported in ustekinumab-treated patients was comparable to the rate expected in the general population (standardised incidence ratio = 0.68 [95% confidence interval: ||| In 119 imiquimod-treated female patients, the combined total clearance rate was 60% as compared to 20% in 105 vehicle-treated patients (95% CI for rate difference: ||| Le taux de survenue des tumeurs malignes rapportées chez les patients traités par l’ ustekinumab a été comparable à celui attendu dans la population générale (ratio standardisé d’ incidence = 0,68 [intervalle de confiance à 95%:
0.2026708722114563 ||| 0.7 ml (150 µg/ 0.5 ml) ||| 0.5 ml (100 µg/ 0.5 ml) ||| 0,7 ml (150 µg/ 0,5 ml)
0.0 ||| While taking olanzapine, elderly patients with dementia may suffer from stroke, pneumonia, urinary incontinence, falls, extreme tiredness, visual hallucinations, a rise in body temperature, redness of the skin and have trouble walking. ||| While taking olanzapine, elderly patients with dementia may suffer from stroke, pneumonia, urinary incontinence, falls, extreme tiredness, visual hallucinations, a rise in body temperature, redness of the skin and have trouble walking. ||| Lors de la prise d’olanzapine, les patients âgés souffrant de démence peuvent présenter un accident vasculaire cérébral (« attaque »), une pneumopathie, une incontinence urinaire, des chutes, une extrême fatigue, des hallucinations visuelles, une augmentation de la température corporelle, une rougeur de la peau et des troubles de la marche.
0.07587330043315887 ||| It is not known whether becaplermin is excreted in human milk. ||| It is not known whether vildagliptin is excreted in human breast milk. ||| Le passage de la bécaplermine dans le lait n'est pas connu.
0.308128297328949 ||| Choosing an injection site g. ||| • Choosing an injection site ||| Choix du site d’injection g.
0.41568660736083984 ||| Online document delivery via a global computer network ||| Entertainment provided via a global communication network ||| Diffusion de documents en ligne via un réseau informatique mondial
0.3662870526313782 ||| Eisai Manufacturing Limited Mosquito Way Hatfield Herts AL10 9SN United Kingdom ||| Almac Pharma Services 22 Seagoe Industrial Estate Craigavon BT63 5QD United Kingdom ||| Eisai Manufacturing Limited Mosquito Way Hatfield Herts AL10 9SN Royaume-Uni
0.42369434237480164 ||| For patients with primary PAH, the treatment effect was 31.1 metres compared to 7.7 metres for patients with PAH associated with CTD. ||| ORR in patients previously treated with autologous bone marrow transplant (ABMT) was 78% versus 43% in patients with no ABMT. ||| Pour les patients présentant une HTAP primitive, l’ effet du traitement a été de 31,1 m comparé à 7,7 m pour les patients présentant une HTAP associée à une maladie du tissu conjonctif.
0.45489534735679626 ||| (1) Most of the patients in whom these events have been reported had pre-existing cardiovascular risk factors (see section 4.4). ||| For laboratory abnormalities, very common events (≥ 1/ 10) not included in Table 2 are also reported. ||| (1) La plupart des patients chez lesquels ces évènements ont été rapportés présentaient des facteurs de risque cardiovasculaires préexistants (voir rubrique 4.4).
0.33366045355796814 ||| Use only the sterilised water for injections and the reconstitution device for preparation of the solution that are provided with each package of ADVATE. ||| Details should be provided of the SPF flocks used as a source of eggs for the preparation of the Working Seed Viruses. ||| Pour la reconstitution, utiliser uniquement l’ eau pour préparations injectables stérilisée et le nécessaire de reconstitution et d’ administration fournis dans chaque coffret d’ ADVATE.
0.3302595019340515 ||| Vials containing Humalog Mix25 should be rotated in the palms of the hands before use to resuspend the insulin until it appears uniformly cloudy or milky. ||| 128 Olanzapine Teva Orodispersible Tablet should be placed in the mouth, where it will rapidly disperse in saliva, so it can be easily swallowed. ||| Faire rouler les flacons d'Humalog Mix25 entre les paumes des mains, avant utilisation, afin de bien mélanger la suspension d'insuline jusqu'à ce qu'elle prenne un aspect uniformément trouble ou laiteux.
0.013078679330646992 ||| Each vial of PegIntron, powder for solution for injection contains 100 micrograms of peginterferon alfa- 2b as measured on a protein basis. ||| Each vial of PegIntron, powder for solution for injection contains 50 micrograms of peginterferon alfa-2b as measured on a protein basis. ||| Chaque flacon de PegIntron, poudre pour solution injectable contient 100 microgrammes de peginterféron alfa-2b exprimé en protéine base.
0.0062143513932824135 ||| CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES ||| CONDITIONS OR RESTRICTION WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES ||| CONDITIONS OU RESTRICTIONS EN VUE D’ UNE UTILISATION SÛRE ET EFFICACE DU MÉDICAMENT DEVANT ÊTRE MISES EN Œ UVRE PAR LES ÉTATS MEMBRES
0.29706111550331116 ||| Each vial of PegIntron, powder for solution for injection contains 100 micrograms of peginterferon alfa- 2b as measured on a protein basis. ||| ed One cartridge contains 30 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 1.2 ml. ||| Chaque flacon de PegIntron, poudre pour solution injectable contient 100 microgrammes de peginterféron alfa-2b exprimé en protéine base.
0.13273239135742188 ||| Advisory services relating to the installation of engines ||| Instructional services relating to the maintenance of vehicles ||| Services de conseils liés à la pose de moteurs
0.9892967939376831 ||| 5 Overview of the European authorisation system ||| Authorisations under the Centralised Procedure ||| 7 Vue d’ ensemble du système européen d’ autorisation
0.3518831729888916 ||| Adequate monitoring for methotrexate-related toxicity is recommended when etoricoxib and methotrexate are administered concomitantly. ||| Mercaptopurine/ azathioprine Febuxostat use is not recommended in patients concomitantly treated with mercaptopurine/ azathioprine (see section 4.5). ||| Une surveillance adéquate de la toxicité du méthotrexate est recommandée lorsque l’ étoricoxib et le méthotrexate sont administrés de façon concomitante.
0.01601354405283928 ||| 24/ 33 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 34/ 48 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 24/ 33 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.20257338881492615 ||| XERISTAR 30 mg hard gastro-resistant capsules ||| ARICLAIM 40 mg hard gastro-resistant capsules. ||| XERISTAR 30 mg, gélule gastro-résistante.
0.47478631138801575 ||| The company will also remind healthcare workers about how the medicine should be used safely and the risks of accidental exposure to fentanyl. ||| Sponsors will receive incentives to bring orphan medicinal products to the market and to the patient in the shortest possible timeframe. ||| La société rappellera également aux professionnels de santé comment le médicament doit être utilisé pour garantir sa sécurité d’ emploi, ainsi que les risques d’ exposition accidentelle au fentanyl.
0.32647156715393066 ||| 0.586 ||| 0.0151 ||| 0,586
0.27057239413261414 ||| Before giving a subsequent course of MabThera treatment, patients should be re-evaluated for any potential risk for infections. ||| Following careful benefit/ risk assessment, a decision should be made to discontinue either breast-feeding or treatment with Parareg. ||| Avant d'être retraités par MabThera, les patients devront être examinés afin de rechercher un éventuel risque d'infection.
0.2637491226196289 ||| Terfenadine preparations must not be used in patients with hypersensitivity to terfenadine or any of the excipients of the formulation. ||| The absorption of nevirapine is not affected by food, antacids or medicinal products which are formulated with an alkaline buffering agent. ||| Les médicaments contenant de la terfénadine ne doivent pas être utilisés chez les patients présentant une hypersensibilité à la terfénadine ou à l'un des composants du produit.
0.3824359178543091 ||| Igniting devices for internal combustion engines ||| Insulators for use in conveying electricity ||| Dispositifs d'allumage pour moteurs à explosion
0.41622328758239746 ||| 119 Hold your FlexPen with the needle pointing upwards and tap the cartridge gently with your finger a few times to make any air bubbles collect at the top of the cartridge. ||| A tippy-tap is a simple technology using a jug suspended by a rope, and a foot-operated lever to pour a small amount of water over the hands and a bar of soap. ||| H Maintenez votre FlexPen avec l’ aiguille pointée vers le haut, et tapotez doucement la cartouche avec votre doigt, plusieurs fois, pour faire remonter les bulles d’ air vers le haut de la cartouche.
0.3727281093597412 ||| Candy boxes ||| Margarita glasses ||| Bonbonnières
0.767299234867096 ||| Crohn’ s disease2 ||| - Hodgkin’ s lymphoma. ||| Crohn2 Maladie de
0.381012886762619 ||| Crank pins of metal ||| Drip mats of cardboard ||| Manetons métalliques
0.5409988164901733 ||| Cartridges filled with toner ||| Credit cards with a magnetic strip ||| Cartouches d'encre [toner] pleines
0.4134637713432312 ||| Place the yellow, active side of the sponge against the wound. ||| Remove the stopper attached to the white cap from the syringe (A). ||| Placez la face jaune, active de l’éponge sur la blessure.
0.3756713271141052 ||| No adverse effects were observed in cats aged 8 weeks and older treated 7 times at two-week intervals with 3-5 times the recommended dose. ||| Repeated dosing (eight administrations) in 14-day intervals at five times the recommended dose was tolerated well in young cats. ||| Aucun effet secondaire n’ a été observé chez des chats âgés de 8 semaines ou plus, traités 7 fois à 2 semaines à 3-5 fois la dose recommandée.
0.0 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| En cas d’intolérance à certains sucres, consultez votre médecin avant de prendre Iscover.
0.146901473402977 ||| You should tell your doctor if this happens to you. ||| If this happens to you, tell your doctor. ||| Prévenez votre médecin en cas d’ apparition de tels symptômes.
0.19011417031288147 ||| Gastrointestinal disorders Very common: ||| Very common Gastrointestinal disorders ||| Affections gastro-intestinales Très fréquents:
0.4622766971588135 ||| Creating and updating of home pages for computer networks ||| Design and graphic arts design for the creation of web pages on the Internet ||| Création et mise à jour de pages d'accueil pour réseaux d'ordinateurs
0.2310129851102829 ||| 0 (0%) 1 (1.3%) ||| 0 (0.0%) 1 (0.2%) ||| 0 (0%) 1 (1,3%)
0.6769930720329285 ||| Will part of the money be loans and will the private sector contribute? ||| The fund will also aim to attract private investments. ||| Une partie des fonds sera-t-elle constituée par des prêts et le secteur privé contribuera-t-il?
0.3777152895927429 ||| Metabolism of lamivudine is a minor route of elimination. ||| The cytotoxicity of cladribine is dose-dependent. ||| Métabolisme La lamivudine est peu métabolisée.
0.1616797149181366 ||| - Keep this leaflet, you may need to read it again. ||| - Keep this leaflet safe as you may need to read it again. ||| Gardez cette notice, vous pourriez avoir besoin de la relire.
0.5824202299118042 ||| ingredients of Flebogammadif (see special warnings about excipients at the end of this section). ||| All studies were performed with Equilis Prequenza Te (comment: double; mentioned in next paragraph). ||| autre composant de Flebogammadif (voir les précautions particulières sur les excipients à la fin de cette rubrique).
0.3563464879989624 ||| Additional activities will include the delivery of opinions on financial systems and procedures, and, in cooperation with the IT sector, the development of a specific tool for financial control that links with the EMEA accounting system, SI2. ||| The focus of its work will be on the continued harmonisation of inspection procedures including the development of a common approach to quality systems implementation and coordination of follow-up actions to GMP inspections as well as providing support for ongoing MRA activities. ||| Parmi les activités supplémentaires, citons la fourniture d'avis sur les procédures et systèmes financiers et, en coopération avec le secteur Technologies de l'information, le développement d'un outil spécifique pour le contrôle financier, assurant la liaison avec le système de comptabilité SI2 de l'EMEA.
5.253341164856984e-13 ||| 75 ||| 75 ||| 79
0.42149433493614197 ||| Qualitative and Quantitative composition: ||| Qualitative and quantitative composition ||| Composition qualitative et quantitative:
0.23174948990345 ||| ADARTREL 1 mg film-coated tablets Ropinirole (as hydrochloride) ||| Aloxi 250 micrograms solution for injection Palonosetron (as hydrochloride) ||| ADARTREL 1 mg, comprimés pelliculés Ropinirole (sous forme de chlorhydrate)
0.3268444836139679 ||| Therefore, the Commission is now launching the second-stage consultation of the social partners, in accordance with Article 154(3) of the Treaty on the Functioning of the European Union (TFEU). ||| 0 At the request of the European Commission the EMEA took over direct responsibility for managing the implementation and operation of the pharmaceutical aspects of the EU-Canada Mutual Recognition Agreement. ||| Ainsi, la Commission lance à présent la deuxième phase de consultation des partenaires sociaux, conformément à l'article 154, paragraphe 3, du traité sur le fonctionnement de l'Union européenne (TFUE).
0.2160312831401825 ||| If you use more TRAVATAN than you should, rinse it all out with warm water. ||| If you use more AZARGA than you should, rinse your eye with warm water. ||| Si vous en avez mis trop de TRAVATAN dans les yeux, rincez-les avec de l’eau tiède.
0.27300822734832764 ||| In patients with an allergy to animal insulin intradermal skin testing is recommended prior to a transfer to Insuman Comb 15, since they may experience immunological cross-reactions. ||| Uric acid may increase with Rebetol due to haemolysis; therefore, the potential for development of gout must be carefully monitored in pre-disposed patients. ||| 124 Chez les patients présentant une allergie à l'insuline d'origine animale, il est recommandé de procéder à des tests intradermiques avant de passer à Insuman Comb 15, en raison de la possibilité de réactions immunologiques croisées.
0.3268161714076996 ||| Solvent Sodium chloride Hydrochloric acid or sodium hydroxide (for pH adjustment) Water for injections. ||| Other ingredients: hydrochloric acid 3.7% and/ or sodium hydroxide (to adjust pH), water for injections. ||| Solvant Chlorure de sodium Acide chlorhydrique et/ ou hydroxyde de sodium (pour l’ ajustement du pH) Eau pour préparation injectable.
0.31914520263671875 ||| Patients should be closely monitored for a decrease in platelet count and medically managed to avoid bleeding upon discontinuation of treatment with romiplostim. ||| Patients were randomized to stay on their treatment at the time of enrollment or to be switched to MIRCERA in order to maintain stable haemoglobin levels. ||| Les patients doivent être étroitement surveillés pour déceler toute diminution du taux de plaquettes et pris en charge médicalement pour éviter tout saignement à l’ arrêt du traitement par romiplostim.
0.38575029373168945 ||| Separators for scrubbing gas ||| Dispensers for liquid soap ||| Séparateurs de nettoyage des gaz
0.25106072425842285 ||| The solution should be used immediately after preparation. ||| Once opened, the solution must be used immediately. ||| La solution doit être utilisée immédiatement après reconstitution.
0.48335760831832886 ||| Boilers, other than parts of machines ||| Explosive substances and devices, other than arms ||| Chaudières autres que parties de machines
0.47887489199638367 ||| Cleaning of public areas ||| Cleansing of public conveniences ||| Nettoyage d'espaces publics
0.39307427406311035 ||| If Zestril is given with a potassium-losing diuretic, diuretic -induced hypokalaemia may be ameliorated. ||| Resistance may be chromosomal or plasmid-encoded and may be transferred if associated with transposons or plasmids. ||| Si Zestril est associé à un diurétique hypokaliémiant, l'hypokaliémie provoquée par le diurétique peut être améliorée.
0.19935405254364014 ||| Semi-refractory bricks, not of metal ||| Refractory bricks, not of metal ||| Briques semi-réfractaires non métalliques
0.18075674772262573 ||| 30 In single-dose crossover studies of Neoclarityn 5 mg orodispersible tablets with Neoclarityn 5 mg conventional tablets or Neoclarityn 5 mg oral lyophilisate, the formulations were bioequivalent. ||| At the recommended dose, Azomyr 5 mg orodispersible tablet was found to be bioequivalent to the Azomyr 5 mg conventional tablet and the Azomyr 5 mg oral lyophilisate formulations of desloratadine. ||| Lors d’ essais croisés en dose unique de Neoclarityn 5 mg comprimés orodispersibles avec Neoclarityn 5 mg comprimés standards ou Neoclarityn 5 mg lyophilisat oral, les formulations étaient bioéquivalentes.
0.3979136347770691 ||| A number of factors have been observed to reduce the immune response to hepatitis B vaccines. ||| Other countries also adopted a variety of measures aimed at limiting the spread of the virus. ||| Certains facteurs peuvent diminuer la réponse immunitaire aux vaccins hépatite B.
0.26646262407302856 ||| In patients with childhood onset isolated GH deficiency (no evidence of hypothalamic-pituitary disease or cranial irradiation), two dynamic tests should be recommended, except for those having low IGF-I concentrations (SDS < -2) who may be considered for one test. ||| (1) in patients with hepatic impairment; (2) when inducers or inhibitors of CYP3A4 are concurrently administered and after their discontinuation (see section 4.5); and/ or (3) if ciclosporin dosing is markedly reduced or discontinued, as these populations are most likely to have special dosing requirements. ||| Chez les patients présentant un déficit somatotrope acquis dans l'enfance (sans antécédent de pathologie hypothalamo-hypophysaire ni d'irradiation encéphalique), deux tests dynamiques doivent être pratiqués, sauf en cas de taux bas d'lGF-I (< -2 SDS), ce qui peut être considéré comme un test.
0.03402792289853096 ||| 6 blister cards of 14 film-coated tablets in PVC/ PVDC/ Aluminium blisters. ||| 1 blister card of 14 film-coated tablets in PVC/ PVDC/ Aluminium blisters. ||| 6 plaquettes thermoformées PVC/ PVDC/ Aluminium de 14 comprimés pelliculés.
0.5594104528427124 ||| Discard if reconstituted vaccine is not used within 30 minutes. ||| Vomiting may occur 5-10 minutes after injection. ||| Jeter le vaccin s'il n'est pas utilisé dans les 30 minutes suivant sa reconstitution.
0.062105655670166016 ||| PritorPlus should not be used in patients with severe renal impairment (creatinine clearance < 30 ml/ min) (see section 4.3). ||| ARICLAIM should not be used in patients with severe renal impairment (creatinine clearance < 30 ml/ min; see section 4.3). ||| PritorPlus ne doit pas être utilisé chez des patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) (voir rubrique 4.3).
0.47844091057777405 ||| There are three main pillars to this strategy: ||| Four key concepts came out of this process: ||| Cette stratégie repose sur trois piliers principaux:
0.4364605247974396 ||| CD4 cell counts increased by 150 and 95 cells/ mm3, respectively. ||| The median baseline CD4 cell count was low (170 cells/ mm3 overall) in both groups. ||| Les numérations des CD4 ont augmenté respectivement de 150 et 95 cellules/ mm3.
0.48046112060546875 ||| 27 reactions resulting in discontinuation from pregabalin treatment groups were dizziness and somnolence. ||| Maternal toxicity occurred at doses similar to those eliciting developmental toxicity. ||| Les effets indésirables les plus fréquents ayant entraîné l’arrêt du traitement par la prégabaline ont été les étourdissements et la somnolence.
0.43238508701324463 ||| Clearance of darbepoetin alfa is 1.9 ml/ hr/ kg (SD 0.56) and the volume of distribution (Vss) is approximately equal to plasma volume (50 ml/ kg). ||| The mean (± SD) volume of distribution (Vz) was 316 (± 752) ml/ kg and the mean (± SD) plasma clearance (CL) was 7.9 (± 14.7) ml/ min/ kg. ||| La clairance de la darbepoetin alfa est de 1,9 ml/ h/ kg (DS = 0,56) et le volume de distribution (Vd) est approximativement égal au volume plasmatique (50 ml/ kg).
0.16814708709716797 ||| Hypromellose (E464) Titanium dioxide (E171) Macrogol Iron oxide red (E172). ||| Talc (E553b) hypromellose (E464) titanium dioxide (E171) macrogol 8000. ||| Pelliculage Hypromellose (E464) Dioxyde de titane (E171) Macrogol Oxyde de fer rouge (E172).
0.23680344223976135 ||| Bicarbonate of soda for pharmaceutical purposes ||| Combinations of calcium salts for pharmaceutical use ||| Bicarbonate de soude à usage pharmaceutique
0.3759787678718567 ||| Perindopril may be used concomitantly with acetylsalicylic acid (when used as a thrombolytic), thrombolytics, beta-blockers and/ or nitrates. ||| For Streptococcus pneumoniae, there is no cross- or co-resistance between telithromycin and other antibacterial classes including erythromycin A and/ or penicillin resistance. ||| Le perindopril peut être utilisé en association avec l’ acide acétylsalicylique (utilisé comme thrombolytique), les thrombolytiques, bêta-bloquants et/ ou dérivés nitrés.
0.18700018525123596 ||| Dose reduction and/ or discontinuation of the diuretic may also be required. ||| Dosage reduction of enalapril and/ or discontinuation of the diuretic may be required. ||| Une réduction de la posologie et/ ou l’ interruption du traitement diurétique pourront également être requises.
0.0525670163333416 ||| For the full list of all side effects reported with Busilvex, see the Package Leaflet. ||| For the full list of all side effects reported with Infanrix Hexa, see the Package Leaflet. ||| Pour une description complète de tous les effets indésirables observés sous Busilvex, voir la notice.
0.1524370014667511 ||| Lietuva MediNet International Ltd. ||| Eesti MediNet International Ltd. ||| Lituanie MediNet International Ltd.
0.268365740776062 ||| The dose, duration of treatment and frequency will depend on the weight and type of animal and condition to be treated. ||| The appropriate dose and frequency of dosing for the child or adolescent will depend on body weight and disease. ||| La dose, la durée et la fréquence de traitement dépendent du poids et du type de l’ animal, ainsi que de la pathologie à traiter.
0.5187150239944458 ||| Arranging of travel by coach ||| Reservation of coach transport ||| Organisation de voyages en autocar
0.29286128282546997 ||| 14 Moderate CYP3A4 Inhibitors No study has been performed evaluating the effect of a moderate CYP3A4 inhibitor (e. g. amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, verapamil) on the pharmacokinetics of fesoterodine. ||| Tolcapone’ s effect on levodopa pharmacokinetics is similar with all pharmaceutical formulations of levodopa/ benserazide and levodopa/ carbidopa; it is independent of levodopa dose, levodopa/ AADC-I (benserazide or carbidopa) ratio and the use of sustained-release formulations. ||| 14 l’ administration concomitante d’ inhibiteurs puissants du CYP3A4 (par ex. atazanavir, clarithromycine, indinavir, itraconazole, kétoconazole, néfazodone, nelfinavir, ritonavir (et tous les régimes IP boostés par ritonavir), saquinavir et télithromycine (voir rubriques 4.2 et 4.4).
0.14669159054756165 ||| Lipodystrophy Lipodystrophy may occur at the injection site as a consequence of failure to rotate injection sites within an area. ||| Lipodystrophy may occur at the injection site as a consequence of failure to rotate injection sites within an area. ||| 5 Une lipodystrophie peut apparaître au site d’ injection si le changement du site d’ injection dans une même zone d’ injection n’ est pas respecté.
0.38329318165779114 ||| Administration of Cervarix should be postponed in subjects suffering from an acute severe febrile illness. ||| • Prevention of acute bone loss due to sudden immobilisation such as in patients with recent tn ||| L’ administration de Cervarix doit être différée chez les sujets souffrant d’ une maladie fébrile aiguë sévère.
0.3224179148674011 ||| RoActemra was more effective than the comparator medicines at reducing the symptoms of rheumatoid arthritis. ||| Unlike some other antipsychotic agents, olanzapine increases responding in an “ anxiolytic” test. ||| RoActemra s’ est avéré plus efficace que les médicaments de comparaison s’ agissant de la réduction des symptômes de la polyarthrite rhumatoïde.
0.0 ||| This means that because of the rarity of this disease it has been impossible to get complete information on this medicine. ||| This means that because of the rarity of this disease it has been impossible to get complete information on this medicine. ||| Cela signifie qu‘ en raison de la rareté de cette maladie, il est impossible d’ obtenir des informations complètes sur ce médicament.
0.08172265440225601 ||| Each tablet contains 80 mg febuxostat. ||| Each tablet contains 80 mg of febuxostat. ||| Chaque comprimé contient 80 mg de fébuxostat.
0.31290629506111145 ||| 6.2 Incompatibilities ||| Incompatibilities: ||| 207 6.2 Incompatibilités
0.3950708508491516 ||| blood pressure), ||| high blood pressure), ||| ou l’hypertension),
0.44091370701789856 ||| (3.2%) 22/ 183 ||| 6% (23/ 386) ||| 7/ 214 (3,3%)
0.08106157183647156 ||| a) 02.10.96 b) 10.12.97 c) 191 days d) 245 days ||| a) 20.01.96 b) 20.11.96 c) 183 days d) 119 days ||| a) 02.10.96 b) 10.12.97 c) 191 Jours d) 245 Jours
0.3607040047645569 ||| One randomised, double blind, placebo controlled clinical study has compared the combination of abacavir, lamivudine and zidovudine to the combination of indinavir, lamivudine and zidovudine in treatment naive patients. ||| The other two studies compared Crixivan, taken with zidovudine and either didanosine or lamivudine (other antiviral medicines), with Crixivan taken alone, and with the combination of zidovudine and either didanosine or lamivudine. ||| Expérience clinique L’ association abacavir – lamivudine – zidovudine a été comparée à l’ association indinavir – lamivudine – zidovudine chez des patients n’ ayant jamais reçu d’ antirétroviraux au cours d’ une étude randomisée, en double aveugle, double placebo.
0.23056769371032715 ||| State aid: Coronavirus: German guarantee measure ||| State aid: Coronavirus: Swedish loan guarantee scheme ||| Aides d'État: coronavirus: mesure de garantie allemande
0.7891348600387573 ||| Cytochrome P450 enzymes: ||| 23 Fibrinogen and Thrombin: ||| + Cytochrome P450:
0.27388012409210205 ||| Aluminium/ PVC/ PE/ PCTFE blisters in cartons of 2, 4, 8 and 12 film-coated tablets. ||| - PVDC/ PE/ PVC/ AL child-resistant blisters with 10, 20, 100 or 500 tablets packed in cardboard ||| Plaquettes thermoformées en aluminium/ PVC/ PE/ PCTFE dans des boîtes de 2, 4, 8 et 12 comprimés pelliculés.
0.006601234432309866 ||| - EOF: epirubicin (50 mg/ m2 as a bolus on day 1 every 3 weeks), oxaliplatin (130 mg/ m2 given as ||| - EOX: epirubicin (50 mg/ m2 as a bolus on day 1 every 3 weeks), oxaliplatin (130 mg/ m2 given as ||| EOF: épirubicine (50 mg/ m2 en bolus le jour 1 toutes les 3 semaines), oxaliplatine (130 mg/ m2
0.13268610835075378 ||| Do not use Paxene: ||| Do not use Pegasys: ||| N’ utilisez pas Paxene:
0.09892892092466354 ||| Blister with 14, 28, 56, or 98 tablets or perforated unit dose blisters with 28 x 1 tablets. ||| Blister with 14, 28, 30, 56, 90, or 98 tablets or perforated unit dose blisters with 28 x 1 tablets. ||| Boîtes de 14, 28, 56 ou 98 comprimés ou plaquettes thermoformées pour délivrance à l’ unité avec 28 x 1 comprimés.
3.2305966712539713e-13 ||| Cases of Vogt-Koyanagi-Harada (VKH) syndrome have been reported in patients with chronic hepatitis C treated with interferon. ||| Cases of Vogt-Koyanagi-Harada (VKH) syndrome have been reported in patients with chronic hepatitis C treated with interferon. ||| Des cas de syndrome de Vogt-Koyanagi-Harada (VKH) ont été rapportés chez des patients atteints d’ hépatite C chronique traités par interféron.
0.12976865470409393 ||| Some patients who stop taking ARICLAIM suddenly have had symptoms such as dizziness, tingling feelings like pins and needles, sleep disturbances (vivid dreams, nightmares, inability to sleep), feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), tremor (shakiness), headaches, feeling irritable, diarrhoea, excessive sweating or vertigo. ||| Some patients, who suddenly stop taking DULOXETINE BOEHRINGER INGELHEIM after more than 1 week of therapy, have had symptoms such as dizziness, tingling feelings like pins and needles, sleep disturbances (vivid dreams, nightmares, inability to sleep), feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), tremor (shakiness), headaches, feeling irritable, diarrhoea, excessive sweating or vertigo.. ||| Certains patients, après avoir arrêté brutalement ARICLAIM, ont ressenti des signes tels qu’ étourdissements, picotements, fourmillements, troubles du sommeil (rêves agités, cauchemars, insomnie), agitation, anxiété, envie de vomir (nausées) ou vomissements, tremblements, maux de tête, irritabilité, diarrhées, transpiration excessive ou vertiges.
0.40211135149002075 ||| Needle holders for surgical use ||| Hydraulically driven winches for marine use ||| Porte-aiguilles à usage chirurgical
0.12493951618671417 ||| Sebivo is used to treat adults with chronic (long-term) hepatitis B, a disease of the liver caused by infection with the hepatitis B virus. ||| ViraferonPeg is used to treat adult patients with chronic (long-term) hepatitis C (a disease of the liver due to infection with the hepatitis C virus). ||| Sebivo est indiqué dans le traitement des patients adultes atteints d’ hépatite B chronique (à long terme), une maladie du foie causée par une infection par le virus de l'hépatite B.
0.3605785369873047 ||| 2 years ||| 2 months ||| 2 ans.
0.31642043590545654 ||| Adhesive pads [other than for household, medical or stationery use] ||| Containers made of synthetic material [other than for household or kitchen use] ||| Pastilles adhésives autres qu'à usage domestique, médical ou papetier
0.05189687758684158 ||| 67 Table 7: ||| 71 Table 7: ||| Tableau 7:
0.334665447473526 ||| Meals with a high fat content have been shown to reduce the absorption of aliskiren substantially. ||| These AUC increases are probably due to reduced uptake of caspofungin by the liver. ||| Les repas à haute teneur en graisse réduisent de façon substantielle l’ absorption de l’ aliskiren.
0.26486068964004517 ||| The full EPAR for Avandia can be found here. ||| The full EPAR summary can be found here. ||| L’ EPAR complet relatif à Avandia est disponible ici.
0.562264084815979 ||| On 20 March, Bolsonaro criticized the governor of Rio de Janeiro, Wilson Witzel (PSC), for asking for the suspension of the arrival of flights from states where contamination by the new coronavirus had been confirmed. ||| On 12 March, Taoiseach Leo Varadkar—speaking from Washington, D.C. where he was meeting U.S. President Donald Trump—announced the closure of all schools, colleges and childcare facilities across Ireland until at least 29 March. ||| Le 20 mars, le président de la République, Jair Bolsonaro, a critiqué le gouverneur de Rio de Janeiro, Wilson Witzel (PSC), pour avoir demandé la suspension de l'arrivée de vols en provenance d'États où la contamination par le nouveau coronavirus est confirmé.
0.2667931318283081 ||| Rarely reported side effects (at least 1 in every 10,000 patients, but less than 1 in every 1,000 patients): pneumonia. ||| Common side effects occurring in less than 1 out of 10 patients, but more than 1 per 100 patients, are: ||| 444 Effets indésirables rarement rapportés (au moins 1 patient sur 10 000, mais moins d’1 patient sur 1 000): pneumonie.
0.2960505485534668 ||| Coffee extracts ||| Chocolate pastes ||| Extraits de café
0.3002283573150635 ||| - if you have osteoporosis. ||| - if you have hypocalcaemia. ||| - si vous présentez une ostéoporose;
0.5139153003692627 ||| It is the first scheme we have approved that will enable capital support to companies under the State aid Temporary Framework. ||| Similar to the first subsidised loan scheme, this new scheme is open to all companies of the real economy. ||| C'est le premier régime que nous avons autorisé qui permettra d'apporter un soutien en capital aux entreprises en vertu de l'encadrement temporaire des aides d'État.
0.293313205242157 ||| BYETTA is not recommended for use in patients with end-stage renal disease or severe renal impairment (creatinine clearance < 30 ml/ min). ||| is not recommended in neonates and in paediatric patients with glomerular filtration rate < 30 ml/ min/ 1.73 m2, as no data are available. ||| BYETTA n’ est pas recommandé chez les patients présentant une insuffisance rénale terminale ou sévère (clairance de la créatinine < 30 ml/ min).
0.6217451691627502 ||| Synthetic resins for use in glass fibre reinforced mouldings ||| Fermented bamboo shoots boiled and preserved in salt (menma) ||| Résines synthétiques pour moulures renforcées en fibre de verre
0.40230661630630493 ||| Neutropenia (ANC < 1.5 x 109/ l) was reported in 2.4% patients receiving Kineret compared with 0.4% of placebo patients. ||| 91.3% versus 74.5% with ciclosporin (p < 0.0005), whereas renal graft survival was similar in both groups. ||| Une neutropénie (PNN < 1,5 x 109/ l) a été observée chez 2,4% des patients traités par Kineret contre 0,4% des patients sous placebo.
0.4221172332763672 ||| Communication services for the electronic transmission of images ||| Downloadable mobile applications for the transmission of data ||| Services de communication pour la transmission électronique d'images
0.12306389212608337 ||| 9/ 28 ||| 9/ 21 ||| 9/ 30
0.2764178514480591 ||| Following multiple doses, nevirapine peak concentrations appear to increase linearly in the dose range of 200 to 400 mg/ day. ||| The decrease in blood pressure is dose-related for once a day doses with a tendency towards plateau at doses above 300 mg. ||| Lors d'administrations réitérées, les concentrations plasmatiques de la névirapine paraissent augmenter de façon linéaire avec des doses de 200 à 400 mg/ jour.
0.5027790069580078 ||| Pommel horses [for gymnastic] ||| Racket cases [for tennis or badminton] ||| Chevaux-d'arçons [gymnastique]
0.29376691579818726 ||| As with other anticoagulants desirudin should be used with caution in conjunction with medicinal products which affect platelet function these medicinal products include: acetylsalicylic acid and NSAIDs, ticlopidine and clopidogrel, glycoprotein IIb/ IIIa antagonists (abciximab, eptifibatide, tirofiban) and iloprost. ||| Do not use in conjunction with other serotonergic agents (e. g. sertraline) and monoamine oxidase inhibitors (MAOIs) [e. g., selegiline hydrochloride (L-deprenyl), amitraz] or tricyclic amines (TCAs) (e. g. amitriptyline and clomipramine). ||| Comme les autres anticoagulants, la désirudine doit être utilisée avec précaution en association avec des médicaments qui modifient la fonction plaquettaire, parmi lesquels l'acide acétylsalicylique et les AINS, la ticlopidine et le clopidogrel, les anti-GP IIb/ IIIa (abciximab, eptifibatide, tirofiban) et l'iloprost.
0.047649648040533066 ||| The Commission therefore concluded that the measure will contribute to managing the economic impact of the coronavirus in France. ||| The Commission concluded that the measure will contribute to managing the economic impact of the coronavirus in the Netherlands. ||| La Commission est donc parvenue à la conclusion que la mesure aidera à gérer l'incidence économique de la pandémie de coronavirus en France.
0.20890472829341888 ||| Moxifloxacin should be used with caution in patients with ongoing proarrhythmic conditions, such as acute myocardial ischaemia or QT prolongation as this may lead to an increased risk for ventricular arrhythmias (incl. torsade de pointes) and cardiac arrest (see also section 4.3). ||| If all the conditions mentioned are excluded and the patient has a sudden drop of haemoglobin associated with reticulocytopenia and anti-erythropoietin antibodies, examination of the bone marrow for the diagnosis of Pure Red Cell Aplasia (PRCA) should be considered. ||| La moxifloxacine sera utilisée avec prudence chez les patients présentant des conditions pro- arythmogènes telle qu’ une ischémie aiguë myocardique ou un allongement de l’ intervalle QT ce qui peut contribuer à une augmentation du risque d’ arythmie ventriculaire (incluant les torsades de pointes) et un arrêt cardiaque (voir aussi la rubrique 4.3. « contre-indications »).
4.937891458570154e-13 ||| Because of individual variability, titration to optimal therapeutic doses is expected for individual patients. ||| Because of individual variability, titration to optimal therapeutic doses is expected for individual patients. ||| 303 recherche de la dose thérapeutique optimale doit être effectuée pour chaque patient.
0.2719917297363281 ||| Analytical services relating to computers ||| Design services relating to integrated circuits ||| Services d'analyses concernant les ordinateurs
0.9488370418548584 ||| Store in the original package. ||| Find your height on the chart. ||| Conserver dans la boîte d’ origine.
0.2096029371023178 ||| Polyethylene bottle containing 10, 32, 100 or 180 ml with a polyethylene dropper, a tamper proof child resistant closure and a polypropylene measuring syringe. ||| 10 ml presentation: amber glass bottle (type III) with polyethylene child resistant closure, polyethylene insert and an amber polypropylenedosing syringe. ||| Flacon de polyéthylène avec bouchon de sécurité enfant, de contenance de 10, 32, 100 ou 180 ml et muni d'un compte-goutte en polyéthylène et d'une seringue-doseuse en polypropylène.
0.12753990292549133 ||| Corlentor 5 mg film-coated tablets ||| Tracleer 125 mg film-coated tablets ||| Corlentor 5 mg comprimés pelliculés
0.07096868753433228 ||| 63 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS PRE-FILLED SYRINGE ||| 46 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS PRE-FILLED ORAL APPLICATOR ||| 68 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.6702055931091309 ||| Rear multistage sprockets ||| Synthetic precious stones ||| Pignons arrière multi-étages
3.5128443123116915e-13 ||| Any patient complaining of ocular symptoms, including loss of visual acuity or visual field must have a prompt and complete eye examination. ||| Any patient complaining of ocular symptoms, including loss of visual acuity or visual field must have a prompt and complete eye examination. ||| 57 d'acuité visuelle ou de champ visuel doit faire l'objet rapidement d'un examen ophtalmologique complet.
0.4766079783439636 ||| ed Check that Viraferon, solution for injection, is clear and colourless in appearance prior to use. ||| The injection button colour will vary based on the formulation of Insuman insulin used. ||| Assurez-vous que Viraferon, solution injectable, a une apparence limpide et incolore avant son utilisation.
0.3706744313240051 ||| Aflunov is a ‘ prepandemic’ vaccine. ||| Silapo is a ‘ biosimilar’ medicine. ||| Aflunov est un vaccin « prépandémique ».
0.05294627696275711 ||| Protaphane NovoLet 100 IU/ ml suspension for injection in a pre-filled pen. ||| Actraphane 20 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen. ||| Protaphane NovoLet 100 UI/ ml suspension injectable en stylo prérempli
0.5637054443359375 ||| Cocoa-based beverages ||| Protein-enriched sports beverages ||| Boissons à base de cacao
0.20401866734027863 ||| The effectiveness of Neupro in the treatment of early-stage Parkinson’ s disease was studied in a total of 830 patients in two studies. ||| The effectiveness of Cetrotide as a treatment to prevent premature ovulation was studied in three studies involving 814 women. ||| L’ efficacité de Neupro dans le traitement de la maladie de Parkinson au stade précoce a été étudiée sur un total de 830 patients dans deux études.
0.24164223670959473 ||| How to take CANCIDAS 4. ||| How to take ADARTREL 4. ||| Comment prendre CANCIDAS 4.
0.2358504980802536 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The French scheme will partly compensate airlines for damages suffered due to the coronavirus outbreak. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "These Austrian schemes will provide guarantees for underlying loans up to an amount of €500,000. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Le régime français compensera en partie les dommages causés par la flambée de coronavirus aux compagnies aériennes.
0.15286892652511597 ||| (18) 1.8% ||| (13) 1.3% ||| (18) 1,8%
0.2158280313014984 ||| Paxene 175 mg/ m2 administered as a 3 hour intravenous infusion, followed by cisplatin 75 mg/ m2 every three weeks or Paxene 135 mg/ m2 as a 24 hour infusion, followed by cisplatin 75 mg/ m2 every three weeks. ||| Paxene 175 mg/m2 of body surface area administrated as a 3 hour infusion into a vein, followed by another medicine, cisplatin, every three weeks; alternatively Paxene 135 mg/m2 given as a 24 hour infusion, followed by cisplatin, every three weeks. ||| Paxene 175 mg/ m2 en perfusion intraveineuse de 3 heures, suivi d'une administration de cisplatine 75 mg/ m2 toutes les 3 semaines ou Paxene 135 mg/ m2 en perfusion de 24 heures, suivi d'une administration de cisplatine 75 mg/ m2 toutes les 3 semaines.
0.30679214000701904 ||| Caution should be used when initiating treatment with Dynastat in patients with dehydration. ||| The use of certain vaccinations should be avoided during treatment with TORISEL. ||| Des précautions devront être prises lors de l’ initiation du traitement par Dynastat chez des patients présentant une déshydratation.
0.24971655011177063 ||| HOW TO USE MIXTARD ||| HOW TO USE HUMALOG ||| COMMENT UTILISER MIXTARD
0.2855771481990814 ||| Tell your doctor or pharmacist before taking Tasigna if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| You must tell your doctor about all the medicines, including those medicines you can buy without a prescription, you are taking or are planning to take before you take Kaletra. ||| Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien avant de prendre Tasigna.
6.343521628121573e-13 ||| Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta). ||| Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta). ||| Puis, mangez un aliment qui augmente durablement votre glycémie (tel que du pain ou des pâtes).
0.38289716839790344 ||| Tel: +420 - 2 20382111 ||| Τηλ: +30 / 2109974000 ||| Tel: +420 - 2 20382111 Danmark
0.3478201925754547 ||| Unprocessed herbs ||| Unprocessed oats ||| Herbes à l'état brut
0.2866218090057373 ||| Lamivudine is predominately cleared unchanged by renal excretion. ||| Lamivudine is predominately cleared by renal excretion of unchanged lamivudine. ||| La lamivudine est essentiellement éliminée par excrétion rénale sous forme inchangée.
0.3673669397830963 ||| On March 27 the government announced that the country would go into a nationwide lock down for 21 days from the 30 March on wards. ||| On 23 March 2020, the Uzbekistan government announced that a lockdown of Tashkent would start on the next day as an effort to contain the coronavirus. ||| Le 27 mars} le gouvernement a annoncé que le pays entrerait en confinement nationale pendant 21 jours à compter du 30 mars.
0.32045572996139526 ||| Concomitant treatment with inducers of CYP3A4 should be avoided due to risk of decreased exposure to lapatinib (see section 4.5). ||| Post-injection syndrome events have occurred with ZYPADHERA leading to symptoms consistent with olanzapine overdose (see sections 4.2 and 4.4). ||| L'administration concomitante d'inducteurs du cytochrome CYP3A4 doit être évitée en raison du risque de diminution de l'exposition au lapatinib (voir rubrique 4.5).
0.0 ||| Treatment with Nespo is divided into two stages – correction and maintenance phase. ||| Treatment with Nespo is divided into two stages – correction and maintenance phase. ||| 28 Le traitement avec Nespo est divisé en deux phases – phase correctrice et phase d’ entretien.
4.389248296418624e-13 ||| Activated charcoal may be useful in the treatment of overdose. ||| Activated charcoal may be useful in the treatment of overdose. ||| Le charbon actif peut s’ avérer utile pour le traitement d’ un éventuel surdosage.
0.2572232484817505 ||| (-0.9, -0.5) -0.6‡ ||| -1.6‡ (-1.8, -1.3) ||| (-0,9; -0,5) -0,6‡
0.3135121464729309 ||| In acute coronary syndrome, Plavix is used together with aspirin and the treatment generally starts with a 300 mg loading dose, which is followed by a daily dose of 75 mg for at least 4 weeks in ST elevation myocardial infarction or for up to 12 months in non-ST elevation syndrome. ||| Pimecrolimus was initially approved for the use in patients with mild to moderate atopic dermatitis (AD) aged 2 years and over for short-term treatment of signs and symptoms and intermittent long-term treatment for prevention of progression to flares. ||| En cas de syndrome coronarien aigu, Plavix est utilisé en association avec l’ aspirine et le traitement débute généralement avec une dose initiale de 300 mg, suivie d’ une dose quotidienne de 75 mg pendant au moins quatre semaines en cas d’ infarctus du myocarde avec sus- décalage du segment ST, ou jusqu’ à 12 semaines en cas de syndrome sans sus-décalage du segment ST.
0.30879175662994385 ||| Solid perfumes ||| Wind instruments ||| Parfums solides
0.5436922907829285 ||| So on both these fronts, we will clarify the rules of the game for Member States very quickly. ||| Substantive work on the legal texts on both sides will continue over the coming weeks. ||| Ainsi, sur ces deux fronts, nous clarifierons très rapidement les règles du jeu pour les États membres.
1.0808930397033691 ||| Maximum concentrations in plasma (4.2 ± 0.9 µg/ml) are reached at approximately 22 hours after administration. ||| Quarantines covered an area of approximately 56,000 square kilometres (22,000 sq mi). ||| Les concentrations plasmatiques maximales (4,2 ± 0,9 µg/ ml) sont atteintes approximativement 22 heures après l’ administration.
0.0 ||| Keep out of the reach and sight of children. ||| Keep out of the reach and sight of children. ||| Tenir hors de la portée et de lavue des enfants.
0.019236093387007713 ||| There is no evidence that enfuviritide may alter the patient’ s ability to drive and use machines, however, the adverse event profile of enfuvirtide should be taken into account. ||| There is no evidence that enfuvirtide may alter the patient’ s ability to drive and use machines, however, the adverse event profile of enfuvirtide should be taken into account. ||| Il n’ y a pas de preuve que l’ enfuvirtide puisse altérer la capacité à conduire les véhicules ou à utiliser des machines, toutefois il convient de tenir compte du profil d'effets indésirables du produit.
0.37423020601272583 ||| Take off the inner needle cap and discard it. ||| Peel apart the foil and open the sachet. ||| Retirez le capuchon intérieur de l’aiguille et jetez le.
0.2737968862056732 ||| Capsule content: hypromellose, Hypromellose Acetate Succinate, sucrose, sugar spheres, talc, titanium dioxide (E171), triethyl citrate. ||| Hypromellose Colour mixture white (polydextrose, hypromellose, glycerol diacetate, macrogol 8000, titanium dioxide E171) ||| Gélule: hypromellose, succinate d’ acétated’ hypromellose, saccharose, sucre en microbilles, talc, dioxyde de titane (E171), triéthyl-citrate.
0.889595091342926 ||| On 9 March, two additional passengers from the special flight from Verona on 7 March tested positive for COVID-19. ||| Times Like These is the second single released from the Foo Fighters' fourth album One by One. ||| Le 9 mars, deux passagers supplémentaires du vol spécial au départ de Vérone du 7 mars ont été testés positifs au Covid-19.
0.0037150904536247253 ||| 20 AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. ||| 48 AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. ||| A moins que le traitement avec un inhibiteur ARAII soit considéré comme essentiel, il est recommandé de modifier le traitement antihypertenseur chez les patientes qui envisagent une grossesse pour un médicament ayant un profil de sécurité établi pendant la grossesse.
0.4070358872413635 ||| If your disease responds to TRISENOX, you will be given a second treatment cycle of 25 doses, one infusion every weekday for 5 weeks. ||| For metastatic cancer, Herceptin is given every week or every three weeks, and the treatment is continued for as long as it remains effective. ||| Si votre maladie répond au traitement par TRISENOX, vous recevrez un second cycle thérapeutique de 25 doses, soit une perfusion par jour, en semaine, pendant 5 semaines.
0.3346562385559082 ||| Hepatic impairment ARICLAIM should not be used in patients with liver disease resulting in hepatic impairment (see sections 4.3 and 5.2). ||| Renal and hepatic impairment There are no pharmacokinetic or pharmacodynamic data in patients with renal or hepatic impairment (see sections 4.2 and 4.4). ||| Insuffisance hépatique ARICLAIM ne doit pas être utilisé chez les patients présentant une pathologie hépatique entraînant une insuffisance hépatique (voir rubriques 4.3 et 5.2).
0.34309178590774536 ||| In patients with PWS, treatment should always be in combination with a calorie-restricted diet. ||| However, as with all CNS-active substances, patients should be advised to avoid alcohol consumption. ||| Chez les patients présentant un syndrome de Prader-Willi, le traitement devra toujours être associé à un régime hypocalorique.
0.5595699548721313 ||| Dissemination of advertising via online communications networks ||| Citizens' use of internet services and online transactions ||| Diffusion d'annonces publicitaires sur des réseaux de communication en ligne
0.0 ||| should be used for the shortest possible duration, as required by the clinical situation. ||| should be used for the shortest possible duration, as required by the clinical situation. ||| La duree d’ administration de devra être la plus courtepossible, en fonction des besoins cliniques.
0.45518505573272705 ||| • Do not refrigerate or freeze. • Keep the vial in the outer carton until time of use in order to protect from light. ||| • Keep out of the reach and sight of children. • Due to sensitivity to light, store in the original container. ||| • Ne pas réfrigérer ni congeler. • Conserver le flacon dans son emballage extérieur à l’ abri de la lumière jusqu’ à l’ emploi.
0.3192022442817688 ||| Humalog Mix25 may be given shortly before meals. ||| NovoMix 50 may also be given soon after the meal. ||| Humalog Mix25 peut être administré peu de temps avant les repas.
0.2903100848197937 ||| 0.75 ml/ pre-filled syringe ||| 3 ml/ pre-filled syringe ||| 0,75 ml/ seringue préremplie
0.10132525861263275 ||| How has Erbitux been studied? ||| How has Viraferon been studied? ||| Quelles études ont été menées sur Erbitux?
0.009801935404539108 ||| Each film-coated tablet contains 15 mg of memantine hydrochloride equivalent to 12.46 mg memantine. ||| Each film-coated tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine. ||| Chaque comprimé pelliculé contient 15 mg de chlorhydrate de mémantine équivalent à 12,46 mg de mémantine base.
0.08603163808584213 ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Masivet to AB Science S. A. on 17 November 2008. ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Startvac to Laboratorios Hipra, S. A. on 11 February 2009. ||| La Commission européenne a délivré une autorisation de mise sur le marché valable dans toute l’ Union européenne pour Masivet à AB Science S. A., le 17 novembre 2008.
2.5118102042753776e-13 ||| HCV/HIV Co-infection The recommended duration of dosing for HCV/HIV co-infected patients is 48 weeks, regardless of genotype. ||| HCV/HIV Co-infection The recommended duration of dosing for HCV/HIV co-infected patients is 48 weeks, regardless of genotype. ||| 100 Co-infection VHC-VIH La durée de traitement recommandée pour les patients co-infectés VHC-VIH est de 48 semaines, quel que soit le génotype.
0.2196681648492813 ||| Other medically significant sequelae of overdose include delirium, convulsion, coma, possible neuroleptic malignant syndrome, respiratory depression, aspiration, hypertension or hypotension, cardiac arrhythmias (< 2% of overdose cases) and cardiopulmonary arrest. ||| 3 Serious cardiovascular events, including myocardial infarction, unstable angina, sudden cardiac death, ventricular arrhythmia, cerebrovascular haemorrhage, transient ischaemic attack, hypertension and hypotension have been reported post-marketing in temporal association with the use of VIAGRA. ||| Les autres effets cliniquement significatifs du surdosage sont: délire, convulsions, coma, éventuel syndrome malin des neuroleptiques, insuffisance respiratoire, fausse route, hypertension ou hypotension, arythmies cardiaques (moins de 2% des cas de surdosage) et arrêt cardio-respiratoire.
0.08972211182117462 ||| The full EPAR for Humira can be found here. ||| The full EPAR for Alli can be found here. ||| L’ EPAR complet relatif à Humira est disponible ici.
0.30429670214653015 ||| Patients who experience hypoglycaemia (low blood sugar levels) while taking Tandemact may need to use a lower dose of the medicine or to return to using separate tablets. ||| If your child is to have a heart operation (cardiac bypass surgery), he or she may be given an extra dose of Synagis after the operation. ||| Les patients souffrant d’ hypoglycémie (faibles taux de sucre dans le sang) pendant la prise de Tandemact peuvent réduire la posologie ou revenir à deux comprimés séparés.
0.41958683729171753 ||| Your doctor may tell you to use Liprolog as well as a longer-acting insulin. ||| Your doctor may advise you to take calcium and vitamin D supplements in addition to OSSEOR. ||| Votre médecin peut vous prescrire Liprolog ainsi qu’une insuline d'action plus prolongée.
0.19348691403865814 ||| The usual starting dose is 10 mg once a day. ||| The recommended starting dose for adults is 30 mg once per day. ||| 44 La dose usuelle initiale est de 10 mg une fois par jour.
0.5171142816543579 ||| If any of these affect you severely, tell your doctor. ||| if you think that your symptoms or problems warrant a better look ||| 27 Si un effet indésirable est sévère, informer votre médecin.
0.3977147340774536 ||| Combivir should not be taken with some other medicines. ||| Glivec may do the same to some other medicines. ||| Combivir ne doit pas être associé à certains médicaments.
0.30131492018699646 ||| In many patients, the signs and symptoms of neuroglycopenia are preceded by signs of adrenergic counter- regulation. ||| However, polymicrobial intra-abdominal infections have shown to respond to treatment with tigecycline in clinical trials. ||| Chez de nombreux patients, les signes et symptômes de neuroglycopénie sont précédés par des signes de réaction adrénergique compensatrice.
0.22658759355545044 ||| Remeron 30 mg film-coated tablets are oval, biconvex, red-brown, scored and coded with ‘ Organon’ on one side and with ‘ TZ/ 5’ on the other side. ||| Ebixa 5 mg film-coated tablets are presented as white to off-white, oval-oblong with imprint ‘ 5’ on one side and imprint ‘ MEM’ on the other side. ||| Les comprimés pelliculés de Remeron à 30 mg sont ovales, biconvexes, rouge-marron, rainurés avec la mention « Organon » d’ un côté et « TZ/ 5 » de l’ autre.
0.21888449788093567 ||| Co-administration of sirolimus (2 mg single dose) with multiple-dose administration of oral voriconazole (400 mg every 12 hours for 1 day, then 100 mg every 12 hours for 8 days) in healthy subjects has been reported to increase sirolimus Cmax and AUC by an average of 7-fold and 11-fold respectively. ||| 13 Following administration of 800 mg per day of posaconazole as a divided dose for treatment of invasive fungal infections, mean trough plasma concentrations from 12 patients 8 - 17 years of age (776 ng/ ml) were similar to concentrations from 194 patients 18 - 64 years of age (817 ng/ ml). ||| Voriconazole (inhibiteur du CYP3A4): la co-administration d’ une dose unique de 2 mg de sirolimus et de doses répétées de voriconazole par voie orale (400 mg toutes les 12 heures pendant 1 jour, puis 100 mg toutes les 12 heures pendant 8 jours) chez des sujets sains entraîne une augmentation moyenne des Cmax et ASC du sirolimus respectivement par des facteurs de 7 et 11.
0.4315105378627777 ||| Mitochondrial dysfunction: ||| Myocardial infarction ||| Atteinte mitochondriale:
0.3822605013847351 ||| The funds that we raise will kick-start an unprecedented global cooperation between scientists and regulators, industry and governments, international organisations, foundations and health care professionals. ||| The Commission is also inviting governments, business leaders, public figures philanthropists, artists and citizens to raise awareness about this global pledging effort. ||| Les fonds collectés donneront le coup d'envoi d'une coopération mondiale sans précédent entre les scientifiques et les régulateurs, l'industrie et les gouvernements, les organisations internationales, les fondations et les professionnels de la santé.
0.5923985242843628 ||| 10 12 2 1 ||| 4 6 1 1 ||| 10 12 2
0.3191836476325989 ||| Remove the rubber tip cap and firmly attach a needle to the syringe. ||| Gently insert the cannula into the teat canal; carefully infuse the product. ||| Retirer l’opercule en caoutchouc qui protège l’embout et fixer solidement une aiguille à la seringue.
0.30166926980018616 ||| Non-metal railings for bridges ||| Non-metallic couplings for tubes ||| Garde-fous non métalliques pour ponts
0.0 ||| If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| Si vous avez d'autres questions sur l'utilisation de ce produit, demandez conseil à votre médecin ou votre pharmacien.
0.3167039752006531 ||| These changes are not considered clinically relevant and no food restrictions are recommended for administration of Trizivir. ||| Genotoxicity and carcinogenic potential were not assessed because these studies are not appropriate for a vaccine. ||| Ces modifications ne sont pas considérées comme cliniquement pertinentes et aucune restriction alimentaire n’ est recommandée lors de l’ administration de Trizivir.
0.6551774740219116 ||| The following “ safety” guidelines were adopted or released for consultation by the CPMP in 1996: ||| Current policy objectives were defined through agenda 20 Deliverables for 2020, agreed in 2017. ||| En 1996, les lignes directrices suivantes en matière de “sécurité” ont été transmises pour consultation par le CPMP:
0.4866977334022522 ||| 0.812 (0.732, 0.902) ||| 0.35 [0.29, 0.43] ||| 0,820 (0,726; 0,927)
0.6491873264312744 ||| The following packs are available: ||| List of available standards: ||| Les présentations suivantes sont disponibles:
0.265313059091568 ||| Gelatine for medical purposes ||| Chinoline for medical purposes ||| Gélatine à usage médical
0.2684132158756256 ||| What Effentora contains The active substance is fentanyl. ||| What CIALIS contains The active substance is tadalafil. ||| Que contient Effentora La substance active est le fentanyl.
0.637117862701416 ||| Image acquisition in analogue and/ or digital word-mode and at least a 128 x 128 matrix is recommended. ||| Make video the default, with tools like Google Docs and Zoom to facilitate live collaboration and connection. ||| Cette acquisition est habituellement réalisé selon une matrice d’ au moins 128x128.
0.526131272315979 ||| Zevalin must be given as a slow infusion lasting 10 minutes. ||| Ceplene must be injected 1 to 3 minutes later. ||| Zevalin doit être administré par perfusion lente d’ une durée de 10 minutes.
0.07118795067071915 ||| Inform your doctor if you are pregnant or planning to become pregnant. ||| Tell your doctor immediately if you are pregnant or intend to become pregnant. ||| Si vous êtes enceinte ou si vous avez l’intention de le devenir, veuillez en faire part à votre médecin.
0.3384225368499756 ||| Solvent for Simulect Water for injections ||| Solvent for solution Water for Injections ||| Solvant pour Simulect Eau pour préparations injectables
0.4487389326095581 ||| 21 Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Drivers of freight vehicles should not be asked to produce any document other than their identification and driving license and if necessary a letter from the employer. ||| Utilisation d’ autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin.
0.6283560991287231 ||| No minimal antibody level associated with protection against CIN of grade 2 or 3 or against persistent infection associated with vaccine HPV types has been identified for HPV vaccines. ||| Under field conditions, only sub-group A is infective and immunisation against sub-group A provides full protection against A, B and C. ||| Il n’ a pas été défini pour les vaccins HPV de taux minimum d’ anticorps protecteur contre les CIN de grade 2 ou 3 ou contre l’ infection persistante due aux types HPV contenus dans le vaccin.
0.386059045791626 ||| Kineret is used to treat the signs and symptoms of rheumatoid arthritis in combination with another medicine called methotrexate. ||| [Neurontin and associated names] belongs to a group of medicines used to treat epilepsy and peripheral neuropathic pain. ||| Kineret permet de traiter les signes et symptômes de la polyarthrite rhumatoïde en association avec un autre médicament: le méthotrexate.
0.37639302015304565 ||| Patients treated with Remicade should be given the package leaflet and the special Alert card. ||| Patients who receive RoActemra should be given the special alert card that summarises the safety information about the medicine. ||| Les patients traités par Remicade devront recevoir la notice ainsi que la carte de signalement.
0.21964554488658905 ||| What is Raptiva? ||| What is Revatio? ||| Qu’ est -ce que Raptiva?
0.35874056816101074 ||| In the event of overdose, supportive measures should be provided as necessary, including sufficient protection from strong light sources (e. g. direct sunlight). ||| However, patients must be cautioned to minimise exposure of treated areas to sunlight or other ultraviolet (UV) light (such as tanning lamps) (see section 5.3). ||| En cas de surdosage, les mesures de soutien nécessaires doivent être appliquées, notamment une protection suffisante contre de fortes sources lumineuses (par exemple exposition directe au rayonnement du soleil).
0.23247912526130676 ||| Temodal 250 mg hard capsules have a opaque white body and cap and are imprinted with black ink. ||| The hard capsules have an opaque white body and cap and are imprinted with black ink. ||| Les gélules de Temodal 250 mg ont un corps et une coiffe opaques blancs, et sont marquées avec une encre noire.
0.3651179373264313 ||| ris Patients in Studies I, II and III were tested at multiple timepoints for antibodies to adalimumab during the 6 to 12 month period. ||| Subjects who were seronegative for anti-HPV 6, 11, 16, 18 in the cLIA at end of study were still protected against clinical disease. ||| Des dosages répétés des anticorps anti-adalimumab ont été faits chez les patients des études I, II et III, Ce
0.4253109097480774 ||| Use only the sterilised water for injections and the reconstitution device for preparation of the solution that are provided with each package of ADVATE. ||| Instructions for use and handling The vial is to be used in conjunction with an appropriate syringe (100 U markings). ||| Pour la reconstitution, utiliser uniquement l’ eau pour préparations injectables stérilisée et le nécessaire de reconstitution et d’ administration fournis dans chaque coffret d’ ADVATE.
0.3186991214752197 ||| Read all of this leaflet carefully including the Instructions for use of Insuman Comb 15, pre-filled pen, OptiSet, before you start using this medicine. ||| Please check section 5 – How to store Insulin Human Comb 15 - of the reverse (insulin) side of this leaflet for OptiSet storage instructions. ||| Veuillez lire attentivement l'intégralité de cette notice, y compris les instructions d’utilisation d’Insuman Comb 15, stylo prérempli, OptiSet, avant d'utiliser ce médicament.
0.23422783613204956 ||| Very common: reduced number of blood cells (neutropenia or lymphopenia, thrombocytopenia), loss of appetite, headache, vomiting, nausea (feeling sick in your stomach), constipation (difficulty passing stools). ||| The most common side effects in dogs are sedation (sleepiness), lethargy (a lack of energy), reduced nervous system activity, hyperglycaemia (high blood sugar levels), bradycardia (slow heart rate), and slow, shallow breathing. ||| 174 Très fréquent: diminution du nombre de cellules sanguines (neutropénie ou lymphopénie, thrombocytopénie), perte d’appétit, mal de tête, vomissements, nausées (sensation d’avoir envie de vomir), constipation (difficulté d’évacuation des selles).
0.22210606932640076 ||| Novartis Animal Health d. o. o., Tel: +386 1 580 2884 Ελλάδα: ||| Luxembourg Pfizer Animal Health s.a., Tél.: + 32 (0)2 554 62 11 ||| Novartis Animal Health d. o. o., Tel: + 386 1 580 2884 Ελλάδα:
0.21263304352760315 ||| 39% (27-49), p < 0.001 ||| 36% (0-59), p=0.046 ||| 39% (27-49), p < 0,001
0.05829871445894241 ||| - patients must be made aware of the possibility of a hypersensitivity reaction to abacavir that ||| - Patients must be made aware of the possibility of a hypersensitivity reaction to abacavir that may ||| - Les patients doivent être informés du risque de réaction d'hypersensibilité à l'abacavir pouvant
0.9033198952674866 ||| GR-104 38 Athens Greece ||| ise F-75013 Paris France ||| GR-104 38 Athens Grèce
0.24352487921714783 ||| Vildagliptin also reduces the amount of glucose made by the liver, by increasing insulin levels and decreasing the levels of the hormone glucagon. ||| By activating this receptor, the medicine increases levels of HDL cholesterol and decreases levels of triglycerides and other types of fat. ||| La vildagliptine diminue également la quantité de glucose produite par le foie, en augmentant les taux d’ insuline et en diminuant les taux de l’ hormone glucagon.
0.0 ||| Dogs and Cats ||| Dogs and Cats ||| Chiens et Chats
0.24665135145187378 ||| Dose related increases in Cmax and AUC were seen for doses up to 1,600 mg; the increases were less than proportional suggesting diminished absorption at higher doses. ||| Dose related increases in Cmax and AUC were seen for doses up to 1,600 mg; the increases were less than proportional ||| L'augmentation des doses donne lieu à une élévation de la Cmax et de l'aire sous la courbe pour les doses allant jusqu’ à 1.600 mg.
0.22888724505901337 ||| Adverse reactions, probably or possibly related to CellCept, reported in ≥ 1/ 10 and in ≥ 1/ 100 to < 1/ 10 of patients treated with CellCept in the controlled clinical trials of renal (2 g data), cardiac and hepatic transplant patients are listed in the following table. ||| The following treatment-related events were reported more than once in the total febuxostat treatment group and were reported as uncommon in subjects taking febuxostat 80 mg/ 120 mg in long-term extension studies (up to 4 years, > 1,900 Patient-years of exposure). ||| Les réactions indésirables probablement ou possiblement liées à CellCept rapportées chez ≥ 1/ 10 et chez ≥ 1/ 100 à < 1/ 10 des patients traités par CellCept au cours des études cliniques contrôlées chez les transplantés rénaux (2 g par jour), cardiaques et hépatiques sont résumées dans le tableau suivant:
0.24552586674690247 ||| Docetaxel Winthrop in combination with cisplatin and 5-fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck. ||| Zyrtec (cetirizine dihydrochloride) is an antiallergic drug indicated for the relief of nasal symptoms of seasonal and perennial allergic rhinitis. ||| Docétaxel Winthrop en association avec le cisplatine et le 5-fluorouracile est indiqué dans le traitement d’ induction des carcinomes épidermoïdes localement avancés des voies aéro-digestives supérieures.
2.592105946119111e-13 ||| Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. ||| Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. ||| Les patients présentant des troubles congénitaux rares d’ intolérance au galactose, une galactosémie, un syndrome de malabsorption du glucose et du galactose ne doivent pas prendre ce médicament.
0.26330435276031494 ||| 1 vial freezedried eptacog alfa (activated) 1.2 mg and excipients 1 vial 2.2 ml Water for injections 1 injection syringe, 3 ml 1 vial adapter for reconstitution 1 infusion set 2 alcohol swabs Package leaflet with instructions for use ||| Lyophilisate and solvent for solution for injection 1 vial with lyophilisate (50,000 IU) for solution for injection, 1 ampoule with preserved solvent (10 ml), 1 reconstitution and withdrawal device, 1 disposable syringe (10 ml), 1 needle 21G2 ||| 1 flacon d’ eptacog alfa (activé) lyophilisé 1,2 mg et excipients 1 flacon de 2,2 ml d’ eau pour préparations injectables 1 seringue pour injection, 3 ml 1 adaptateur pour flacon pour la reconstitution 1 microperfuseur 2 tampons alcoolisés Notice mentionnant les instructions d’ emploi
0.008331633172929287 ||| Furthermore, results seen with saquinavir soft capsules may not predict the magnitude of these interactions with Invirase/ritonavir. ||| Furthermore, results seen with saquinavir soft capsules may not predict the magnitude of these interactions with Invirase/ ritonavir. ||| De plus les résultats observés avec du saquinavir sous forme de capsules molles ne sont pas forcément prédictifs de l'importance de ces interactions avec Invirase/ritonavir.
0.03216279670596123 ||| If you answer yes to any of the following questions talk to your doctor before you start to take CellCept: ||| 71 If you answer yes to any of the following questions talk to your doctor before you start to take CellCept: ||| Si vous répondez oui à l’ une de ces questions, parlez -en à votre médecin avant de débuter le traitement par CellCept:
0.19149377942085266 ||| The name of the medicine was changed to Locatim on 14 September 1999. ||| The name of the medicine was changed to Icandra on 6 February 2009. ||| Le nom de ce médicament a été remplacé par la dénomination « Locatim » le 14 septembre 1999.
0.17348772287368774 ||| Each pre-filled syringe of 0.5 ml solution contains 75 mg of omalizumab. ||| 1 prefilled syringe with 5.0 ml of the solution contains 3023 mg gadobutrol. ||| Chaque seringue préremplie de 0,5 ml de solution contient 75 mg d’ omalizumab.
0.3499729037284851 ||| The effect of medicines containing phenytoin (for epilepsy) may be decreased if given together with Yondelis and this is therefore not recommended. ||| There is no need to change the doses of the other medicines Xelevia is taken with, except when Xelevia is taken with a sulphonylurea. ||| L’ effet des médicaments contenant de la phénytoïne (un antiépileptique) peut être atténué en cas d’ administration simultanée de Yondelis, si bien que cette association est déconseillée.
0.0027492328081279993 ||| The outside of the backing layer is tan-coloured and imprinted with Neupro 2 mg/ 24 h. ||| The outside of the backing layer is tan-coloured and imprinted with Neupro 4 mg/ 24 h. ||| L’ extérieur de la couche de support est de couleur beige et porte l’ impression Neupro 2 mg/ 24 h.
0.2546587884426117 ||| Some patients have been shown to benefit from IntronA 5 million IU/ m2 administered daily subcutaneously in association with cytarabine (Ara-C) 20 mg/ m2 administered daily subcutaneously for 10 days per month (up to a maximum daily dose of 40 mg). ||| Interferon alfa-2b 3 MIU/m2 is administered subcutaneously 3 times a week (every other day) in combination with ribavirin capsules or oral solution administered orally in two divided doses daily with food (morning and evening). ||| Certains patients ont retiré un bénéfice d’ un traitement avec IntronA 5 millions d’ UI/ m² administré quotidiennement par voie sous-cutanée en association avec la cytarabine (Ara-C) 20 mg/ m² administrée quotidiennement par voie sous- cutanée 10 jours par mois (jusqu’ à une dose maximale quotidienne de 40 mg).
0.3120306134223938 ||| In some patients with compromised renal function (dehydrated patients or elderly patients) aliskiren given concomitantly with NSAIDs may result in further deterioration of renal function, including possible acute renal failure, which is usually reversible. ||| Immediate systemic hypersensitivity-like reactions may occur after vaccination, resulting in minor neurological symptoms such as tremors and/ or excitation, which normally resolve within minutes without requiring treatment. ||| Chez certains patients présentant une altération de la fonction rénale (patients déshydratés ou patients âgés) l’ administration concomitante d’ aliskiren avec les AINS peut aggraver la détérioration de la fonction rénale, y compris jusqu’ à une possible insuffisance rénale aiguë, qui est généralement réversible.
0.8821655511856079 ||| Warranty programme services relating to outboard motor engines ||| Airport passenger shuttle services between the airport parking facilities and the airport ||| Services d'un programme de garantie pour moteurs hors-bord
0.23979036509990692 ||| d of 2184 patients were treated; for both groups, patients were treated for at least 5 days and up to 22 ||| A total of 2,192 patients were treated; for both groups, patients were treated for at least 5 days and up to 26 days (mean 7 days). ||| Un total de 2184 patients ont été traités; dans les deux groupes, les patients ont été traités au moins 5 jours et jusqu’ à 22 jours (en
0.165338397026062 ||| Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens (e. g. in oral contraceptives), phenothiazine derivatives, somatropin, sympathomimetic agents (e. g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, protease inhibitors and atypical antipsychotic medicinal products (e. g. olanzapine and clozapine). ||| To be taken into account with concomitant use Others In monotherapy, amlodipine has been safely administered with thiazide diuretics, beta blockers, ACE inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, atorvastatin, sildenafil, anti-acid medicines (aluminium hydroxide gel, magnesium hydroxide, simeticone), cimetidine, non- steroidal anti-inflammatory medicines, antibiotics and oral hypoglycaemic medicines. ||| 299 Les médicaments susceptibles de réduire l'effet hypoglycémiant sont, entre autres, les corticoïdes, le danazol, le diazoxide, les diurétiques, le glucagon, l'isoniazide, les œ strogènes et progestatifs (par exemple dans les contraceptifs oraux), les phénothiazines, la somatropine, les agents sympathomimétiques (par exemple épinéphrine [adrénaline], salbutamol, terbutaline), les hormones thyroïdiennes, les inhibiteurs de protéase et les antipsychotiques atypiques (par exemple olanzapine et clozapine).
0.5394245982170105 ||| On 30 December, a group of doctors at Wuhan Central Hospital alerted their colleagues of a "SARS-like coronavirus". ||| An employee at the Helsinki-Uusimaa Hospital district (HUS) has tested positive for novel coronavirus. ||| Le 30 décembre, un groupe de docteurs de l’hôpital central de Wuhan ont averti leurs collègues d’un « coronavirus semblable au SRAS ».
0.30481815338134766 ||| Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use. ||| Although no other developmental effects were observed, the applied doses were not sufficiently in excess of the human therapeutic dose to provide an adequate margin of safety. ||| Les effets dans des études non cliniques ont uniquement été observés à des expositions jugées suffisamment supérieures à l'exposition humaine maximale indiquant une faible pertinence pour l'usage clinique.
0.39054298400878906 ||| - nervousness, forgetfulness, problems with coordination, confusion, fitting (seizures), abnormal ||| - nervousness or anxiety, emotional instability, irrational thoughts or hallucinations (seeing or ||| - nervosité, troubles de la mémoire, problèmes de coordination, confusion, convulsions (crises
0.42771202325820923 ||| Each tablet contains 90 mg cinacalcet (as hydrochloride). ||| Kaletra contains polyoxyl 40 hydrogenated castor oil. ||| Chaque comprimé contient 90 mg de cinacalcet (sous forme de chlorhydrate).
0.836699903011322 ||| - Stomach pain ||| - Metallic taste ||| - Douleurs gastriques
0.33952492475509644 ||| 4.6 Pregnancy and lactation Pregnancy should not be used during the first trimester of pregnancy. ||| 30 Pregnancy and breast-feeding • Tasigna is not recommended during pregnancy unless clearly necessary. ||| 4.6 Grossesse et allaitement Grossesse ne doit pas être utilisé pendant le premier trimestre de la grossesse.
0.0698208436369896 ||| 29 Congestive heart failure (NYHA II-IV). ||| Congestive heart failure (NYHA II-IV). ||| Insuffisance cardiaque congestive (NYHA II-IV).
0.4055936336517334 ||| The solution must be clear and colourless. ||| solution that is clear and colourless should be injected. ||| La solution doit être transparente et incolore.
0.34664592146873474 ||| Design of equipment for the transportation of freight ||| Arranging for the transport of air freight ||| Conception de matériel pour le transport de fret
0.042365912348032 ||| 74 Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 ||| Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 ||| Ireland Novartis Ireland Limited Tel: +353 1 260 12 55
0.36819902062416077 ||| After repeat dosing, slight accumulation occurred, but a steady state was achieved within 5 days. ||| Following interruption of treatment, complete resolution of muscle cramps occurred, treatment was subsequently resumed. ||| Une légère accumulation a été constatée après l’ administration de doses répétées mais l’ état d’ équilibre a été atteint en 5 jours.
0.18085482716560364 ||| Gamithromycin administered subcutaneously into the neck of cattle at single dosage of 6 mg/ kg body weight, resulted in rapid absorption with peak plasma concentrations observed after 30 to 60 min with a long plasma half-life (> 2 days). ||| In response to subcutaneous doses of Preotact (100 micrograms parathyroid hormone), serum total calcium levels increase gradually and reach peak concentration (mean increase in 129 patients, 0.15 mmol/l) at approximately 6 to 8 hours after dosing. ||| La gamithromycine administrée par voie sous-cutanée dans le cou des bovins, à un dosage unique de 6 mg/ kg de poids vif, permet une absorption rapide avec des pics de concentration plasmatique observés après 30 à 60 minutes et une demi-vie plasmatique longue (> 2 jours).
0.03501052409410477 ||| 3 4.4 Special warnings and precautions for use ||| 2 4.4 Special warnings and precautions for use ||| 4.4 Mises en garde spéciales et précautions d’ emploi
0.0 ||| Only use needles that have been approved for use with OptiSet. ||| Only use needles that have been approved for use with OptiSet. ||| N’ utiliser que des aiguilles approuvées pour être utilisées avec Optiset.
0.2030775547027588 ||| Iloprost elimination is reduced in patients with hepatic dysfunction and in patients with renal failure requiring dialysis (see section 5.2). ||| RELISTOR is not recommended in patients with severe hepatic impairment or with end-stage renal impairment requiring dialysis (see section 4.2). ||| L’ élimination de l’ iloprost est réduite en cas d’ altération des fonctions hépatiques et chez les insuffisants rénaux dialysés (voir rubrique 5.2).
0.6473866701126099 ||| Such a use is supported by publications and clinical experience. ||| This advice is applicable to all indications and to all special populations. ||| Ce type d’ usage est cautionné par les publications et l’ expérience clinique.
0.6019853353500366 ||| After 3 years therapy OPTRUMA decreased fibrinogen (6.71%). ||| Most resistant patients (72%) had received > 600 mg imatinib. ||| Après 3 ans de traitement ont OPTRUMA a réduit le fibrinogène (6,71%).
0.16310571134090424 ||| TPN may be the only feasible option for providing nutrition to patients who do not have a functioning gastrointestinal tract or who have disorders requiring complete bowel rest, including bowel obstruction, short bowel syndrome, gastroschisis, prolonged diarrhea regardless of its cause, very severe Crohn's disease or ulcerative colitis, and certain pediatric GI disorders including congenital GI anomalies and necrotizing enterocolitis. ||| Micafungin treatment should be conducted on a careful risk/ benefit basis, particularly in patients having severe liver function impairment or chronic liver diseases known to represent preneoplastic conditions, such as advanced liver fibrosis, cirrhosis, viral hepatitis, neonatal liver disease or congenital enzyme defects, or receiving a concomitant therapy including hepatotoxic and/ or genotoxic properties. ||| La nutrition parentérale est réservée aux patients ayant une insuffisance intestinale définitive ou transitoire, totale ou partielle résultant d’une obstruction, de troubles de la motricité, d’une résection chirurgicale ou d’une malabsorption (maladie de Crohn, pancréatite aiguë) et se caractérisant par l’impossibilité de couvrir, par la seule voie entérale, les besoins nutritionnels du patient.
0.4108719825744629 ||| In all evaluated patients, the estimated renal clearance of bexarotene was less than 1 ml/ minute. ||| The linear clearance was estimated as a parameter in the population pharmacokinetic analysis and was 12.5 ml/ h. ||| Chez tous les patients évalués, la clairance rénale du bexarotène était estimée inférieure à 1 ml / minute.
0.2971682548522949 ||| On antimicrobial resistance development, no data are available that support the potential selection of resistant bacteria due to the use of TMP/ SDZ in horses. ||| Tests such as ELISA that use antibodies against a mixture of norovirus strains are available commercially, but lack specificity and sensitivity. ||| À propos du développement d’ une résistance aux antimicrobiens, aucune donnée disponible ne va dans le sens d’ une sélection potentielle de bactéries résistantes à la suite de l’ utilisation de TMP/ SDZ chez les chevaux.
0.1355588287115097 ||| Patients treated with dopamine agonists for Parkison’ s disease, including pramipexole, especially at high doses, have been reported as exhibiting sings of pathological gambling, increased libido and hypersexuality, generally reversible upon reduction of the dose or treatment discontinuation. ||| Parkinson’ s disease patients treated with dopamine agonists and other dopaminergic treatments such as entacapone in association with levodopa, especially at high doses, have been reported as exhibiting signs of pathological gambling, increased libido and hypersexuality, which were generally reversible upon reduction of the dose or treatment discontinuation. ||| Il a été rapporté chez des patients traités pour la maladie de Parkinson par des agonistes dopaminergiques dont le pramipexole, en particulier à des doses élevées, l’ apparition de signes de jeux pathologiques, une augmentation de la libido et une hypersexualité, généralement réversibles lors de la diminution de la posologie ou bien à l’ arrêt du traitement.
0.8038649559020996 ||| Nervous system disorders Very rare (< 1/ 10,000) ||| Very common rash (all grades, 18%) ||| Affections du système nerveux Très rares (< 1/ 10 000)
3.108958403219564e-13 ||| Patients should be adequately hydrated and consideration should be given to monitoring renal function after initiation of concomitant therapy, and periodically thereafter. ||| Patients should be adequately hydrated and consideration should be given to monitoring renal function after initiation of concomitant therapy, and periodically thereafter. ||| Les patients doivent être hydratés de façon adaptée et il convient de contrôler la fonction rénale en début de traitement et régulièrement ensuite.
0.3796267807483673 ||| No evidence of photosensitivity was observed in rats following administration of tigecycline. ||| Only minor amounts of reteplase were immunologically detected in the urine. ||| Aucun signe de photosensibilisation n’ a été observé chez le rat après l’ administration de tigécycline.
0.288709819316864 ||| Fishing nets ||| Fishing knives ||| Filets de pêche
0.4021468460559845 ||| It is important that you take your tablets at the same time in relation to food each day. ||| It is important that you take CHAMPIX regularly at the same time each day. ||| important que vous preniez vos comprimés au même moment par rapport à vos repas et ce, tous les jours.
0.10483618080615997 ||| Infants whose mothers have taken AIIRAs should be closely observed for hypotension (see also sections 4.3 and 4.4). ||| Infants whose mothers have taken ACE inhibitors should be closely observed for hypotension (see also section 4.3 and 4.4 )”. ||| Les nouveau-nés de mère traitée par un ARAII doivent être surveillés sur le plan tensionnel (voir rubriques 4.3 et 4.4).
0.19821713864803314 ||| Blankets for outdoor use ||| Watches for outdoor use ||| Couvertures à usage extérieur
0.1581801176071167 ||| TRITACE and associated names (see Annex I) 1.25 mg hard capsules TRITACE and associated names (see Annex I) 2.5 mg hard capsules TRITACE and associated names (see Annex I) 5 mg hard capsules TRITACE and associated names (see Annex I) 10 mg hard capsules [See Annex I – To be completed nationally] ||| TRITAZIDE and associated names (see Annex I) 2.5 mg/12.5 mg tablets TRITAZIDE and associated names (see Annex I) 5 mg/12.5 mg tablets TRITAZIDE and associated names (see Annex I) 5 mg/25 mg tablets [See Annex I - To be completed nationally] ||| TRITACE et dénominations associées (voir Annexe I) 1,25 mg gélules TRITACE et dénominations associées (voir Annexe I) 2,5 mg gélules TRITACE et dénominations associées (voir Annexe I) 5 mg gélules TRITACE et dénominations associées (voir Annexe I) 10 mg gélules
0.26288455724716187 ||| In the studies of treatment-naïve adults, ritonavir-boosted Telzir was as effective as the comparator medicines, but it was less effective in treatment-experienced adults. ||| In the study of treatment-naïve patients, the effectiveness of Reyataz was compared with that of lopinavir (another antiviral medicine), both taken with ritonavir. ||| Au cours des études portant sur des adultes naïfs de traitement, Telzir renforcé par du ritonavir était aussi efficace que les médicaments de comparaison, mais s’ est montré moins efficace chez les adultes ayant suivi un traitement au préalable.
0.43496173620224 ||| If the test needs to be carried out later in the day, only a light meal like tea and toast is recommended. ||| The vaccine should be given in the early morning as this is the main period of water intake or during the cool period on a hot day. ||| Au cas où le test est effectué plus tard dans l’après-midi, il est recommandé que vous preniez un léger repas, comme par exemple du thé et des toasts.
0.9444208145141602 ||| Date of birth ||| Number of patients ||| Date de naissance.
0.33518946170806885 ||| When lumiracoxib was administered to patients with end-stage renal disease, a 33% decrease in lumiracoxib Cmax and a 27% decrease in AUC were observed compared to healthy subjects. ||| During days 9 through 21 in this study, there was as much as a 64% decrease in ethinyl estradiol trough concentrations and as much as a 60% decrease in norethindrone trough concentrations. ||| Lors de l’ administration de lumiracoxib à des patients atteints d’ une insuffisance rénale terminale, une diminution de 33% de la Cmax et de 27% de l'ASC ont été observées comparativement aux sujets sains.
0.328115314245224 ||| Patients should be periodically evaluated for their asthma control. ||| Signs of scoliosis should be monitored during treatment. ||| Le contrôle de l’ asthme doit être régulièrement évalué chez ces patients.
0.36446815729141235 ||| 2.1 0.2 0.05 ||| 0.0009 0.17 ||| 0.2 0.05
0.24560707807540894 |||  340 10. |||  211 1. ||| 363 10.
0.20688186585903168 ||| Leflunomide was embryotoxic and teratogenic in rats and rabbits at doses in the human therapeutic range and exerted adverse effects on male reproductive organs in repeated dose toxicity studies. ||| In reproduction studies, voriconazole was shown to be teratogenic in rats and embryotoxic in rabbits at systemic exposures equal to those obtained in humans with therapeutic doses. ||| Le léflunomide est embryotoxique et tératogène chez le rat et le lapin à des doses correspondant aux doses thérapeutiques humaines et il a montré des effets toxiques sur les organes de reproduction masculins dans les études de toxicité à dose répétée.
0.02106155827641487 ||| 64 Skin and subcutaneous tissue disorders ||| 81 Skin and subcutaneous tissue disorders ||| Affections de la peau et du tissus sous-cutané
0.6430453658103943 ||| Unprocessed polybutylene terephthalate resins ||| - polyethylene terephthalate film, lacquered. ||| Résines de polybutylène téréphtalate à l'état brut
0.2939024567604065 ||| 8/ 28 ||| 28/ 28 ||| 8/ 30
0.5848848819732666 ||| Compilation of directories for publishing on global computer networks or the internet ||| Dissemination of television programmes relayed by cable link to television receivers ||| Compilation de répertoires pour leur publication sur un réseau informatique mondial ou sur Internet
0.2578863501548767 ||| If during treatment with REGRANEX no meaningful healing progress is evident after the first ten weeks of continuous therapy, treatment should be re-evaluated, and factors known to compromise healing (such as osteomyelitis, ischaemia, infection) should be re-assessed. ||| Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient’ s disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance. ||| 2 Si, après les 10 premières semaines de traitement continu par REGRANEX, aucun progrès significatif de la cicatrisation n'est observé, le traitement doit être reconsidéré et les facteurs connus pour freiner la cicatrisation (tels qu'une ostéomyélite, une ischémie ou une infection) doivent être recherchés à nouveau.
0.1528039127588272 ||| The Committee recommended that Lysodren be given marketing authorisation. ||| The Committee recommended that Neupopeg be given marketing authorisation. no ||| Le CHMP a recommandé que Lysodren reçoive une autorisation de mise sur le marché.
0.3762238621711731 ||| Containers adapted for use in vehicle boots ||| Cooking utensils for use with domestic barbecues ||| Conteneurs conçus pour coffres de véhicules
0.4672829508781433 ||| Despite these measures, when medicines prepared from human blood or plasma are administered, the possibility of passing on infection cannot be totally excluded. ||| Authors are warning against reuses by non-professionals, pointing out that even the best scored methods can degrade the mask if not performed properly. ||| Malgré ces mesures, lorsque des médicaments préparés à partir de sang ou de plasma humain sont administrés, le risque de transmission d’infection ne peut être totalement exclu.
0.5392616987228394 ||| Sinutab Decongestif & Antihistaminicum ||| Anticonvulsants Carbamazepine ||| Sinutab Decongestif & 5mg Antihistaminicum
0.22615517675876617 ||| Clinical research ||| Clinical Studies ||| Recherche clinique
0.09517502039670944 ||| Hypersensitivity Reactions Postmarketing reports of serious hypersensitivity reactions in patients treated with Januvia have been reported. ||| Hypersensitivity reactions Postmarketing reports of serious hypersensitivity reactions in patients treated with sitagliptin have been reported. ||| Réactions d'hypersensibilité Depuis la commercialisation, il a été rapporté, chez des patients traités par Januvia, des cas graves de réactions d'hypersensibilité.
0.0239219032227993 ||| Zalasta 7.5 mg orodispersible tablets Olanzapine ||| Zalasta 20 mg orodispersible tablets Olanzapine ||| ZALASTA 7,5 mg comprimés orodispersibles Olanzapine
0.3730260729789734 ||| • After the powder has dissolved (which usually occurs immediately), check that the resulting solution is clear and does not contain any particles. ||| If, after shaking, particles or precipitate can be seen in the solution, take the next dose and see your doctor about a fresh supply. ||| • Une fois que la poudre est dissoute (ce qui habituellement se produit immédiatement), vérifiez que la solution obtenue est limpide et ne contient pas de particules.
0.3656269311904907 ||| This pressure reduces the amount of oxygen that can get into the blood in the lungs, making physical activity more difficult. ||| Your liver uses cholesterol from your blood to do this, which lowers the level of cholesterol in your blood. ||| Cette pression diminue la quantité d'oxygène pouvant pénétrer dans les poumons par le sang, ce qui rend l'activité physique plus difficile.
0.051275767385959625 ||| Please read the following instructions carefully before using your Actrapid FlexPen. ||| Please read the following instructions carefully before using your Insulatard FlexPen. ||| Veuillez lire attentivement les instructions ci-dessous avant d’ utiliser votre Actrapid FlexPen.
0.27945956587791443 ||| One ml contains 20 mg telbivudine. ||| 1 vial containing 230 mg carmellose. ||| Un ml de solution contient 20 mg de telbivudine.
0.24690407514572144 ||| Nelarabine has not been studied in patients with hepatic impairment. ||| Rimonabant has not been studied in patients being treated for epilepsy. ||| La nélarabine n'a pas été étudiée chez les patients ayant une insuffisance hépatique.
0.11344985663890839 ||| Dog (bitches) ||| Dog (bitches). ||| Chiens (chiennes).
0.32431748509407043 ||| In most patients receiving Rapamune tablets with a loading dose of 6 mg followed by an initial maintenance dose of 2 mg, whole blood sirolimus trough concentrations rapidly achieved steady-state concentrations within the recommended target range (4 to 12 ng/ ml, chromatographic assay). ||| The primary endpoint of therapeutic response was a composite serological endpoint requiring suppression of HBV DNA to < 5 log10 copies/ ml in conjunction with either loss of serum HBeAg or ALT normalised. ||| Chez la plupart des patients recevant Rapamune comprimés avec une dose de charge de 6 mg suivie d’ une dose d’ entretien initiale de 2 mg, les concentrations résiduelles de sirolimus dans le sang total atteignent rapidement les concentrations à l’ équilibre comprises dans la fourchette recommandée (entre 4 et 12 ng/ ml – dosage chromatographique).
0.3326835632324219 ||| Sprayers for use in horticulture [parts of machines] ||| Bags for storing firearms [specifically adapted] ||| Pulvérisateurs pour l'horticulture [pièces de machines]
0.2314249873161316 ||| Luxembourg/Luxemburg UCB Pharma SA/NV Tél/ Tel: +32 / (0)2 559 92 00 ||| Luxembourg/Luxemburg Novartis Pharma GmbH Tél/ Tel: +49 911 273 0 ||| Luxembourg/ Luxemburg UCB Pharma SA/ NV Tél/ Tel: +32 / (0)2 559 92 00
0.2862417995929718 ||| Multimedia accelerator boards ||| Electric navigational instruments ||| Cartes d'accélérateurs multimédias
0.07362387329339981 ||| Treatment with NRTIs should be discontinued if there is symptomatic hyperlactatemia and metabolic/ lactic acidosis, progressive hepatomegaly, or rapidly elevating aminotransferase levels. ||| Treatment with nucleoside analogues should be discontinued in the setting of symptomatic hyperlactataemia and metabolic/ lactic acidosis, progressive hepatomegaly, or rapidly elevating aminotransferase levels. ||| Le traitement par INTI doit être interrompu en cas d'hyperlactatémie symptomatique et d'acidose métabolique/ lactique, d'hépatomégalie progressive, ou d’ élévation rapide des transaminases.
0.30243876576423645 ||| Dysphagia: oesophageal dysmotility and aspiration have been associated with antipsychotic drug use, including ABILIFY. ||| In rare instances, thromboembolism has been associated with Puregon/ hCG therapy as with other gonadotrophins. ||| Dysphagie: des troubles de la motilité oesophagienne ont été associés à l’ utilisation des médicaments antipsychotiques, y compris ABILIFY.
0.27681469917297363 ||| The results of initial treatment with Xeomin should be evaluated and may lead to dose adjustment until the desired therapeutic effect is achieved. ||| A routine dosage adjustment of Sonata is not considered necessary, but patients should be advised that the sedative effects might be enhanced. ||| Les résultats du premier traitement par Xeomin doit être évalué et peut conduire à un ajustement des doses jusqu’ à obtention de l’ effet thérapeutique souhaité.
0.16643492877483368 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Remicade to Centocor B. V. on 13 August 1999. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Evicel to Omrix Biopharmaceuticals S. A. on 6 October 2008. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Remicade à Centocor B. V. le 13 août 1999.
0.3588350713253021 ||| The carton contains 5 or 20 hard capsules, individually sealed in sachets. ||| The devices are packed in cartons of 1, 3 or 10 Evohalers. ||| L’ étui contient 5 ou 20 gélules, individuellement scellées dans des sachets.
0.8182989358901978 ||| 13  EMEA 2005 Neutropenia/ Agranulocytosis/ Thrombocytopenia/ Anaemia: ||| 1.0%); Oesophagitis/ dysphagia/ odynop hagia (G3/ 4: ||| Neutropénie/ Agranulocytose/ Thrombocytopénie/ Anémie:
0.5593835711479187 ||| EXP After first opening, use within 28 days. ||| 1 year Use immediately after opening. ||| EXP Après première ouverture, utiliser dans les 28 jours.
0.4609423875808716 ||| Do not remove the rubber stopper. ||| Do not remove cartridge between injections. ||| N’enlevez pas le bouchon en caoutchouc.
0.23929542303085327 ||| Κύπρος Phadisco Ltd Λεωφόρος Γιάννου Κρανιδιώτη 185 CΥ -2235 Λατσιά Τηλ: +357 22 715000 ||| 24 Κύπρος Akis Panayiotou & Son Ltd Γιάννου Κρανιδιώτη 4 CY-225 78, Λευκωσία Τηλ: +357-22677038 ||| Κύπρος Phadisco Ltd Λεωφόρος Γιάννου Κρανιδιώτη 185 CΥ-2235 Λατσιά Τηλ: +357 22 715000
0.2780635356903076 ||| Live vaccines should not be given concurrently with STELARA (see section 4.4). ||| Solutions in lidocaine should not be administered intravenously (see section 4.4). ||| Les vaccins vivants ne doivent pas être donnés de manière concomitante avec STELARA (voir rubrique 4.4).
0.06779082119464874 ||| WHAT KINERET IS AND WHAT IT IS USED FOR ||| WHAT PANRETIN IS AND WHAT IT IS USED FOR ||| QU’EST-CE QUE KINERET ET DANS QUEL CAS EST-IL UTILISE?
3.014027829401078e-13 ||| - The Committee considered the referral made under article 31 of Directive 2001/ 83/ EC, as ||| - The Committee considered the referral made under article 31 of Directive 2001/ 83/ EC, as ||| - le comité a examiné la saisine formée en vertu de l'article 31 de la directive 2001/ 83/ CE, telle que
0.11469738185405731 ||| On 16 March, 30 new cases were confirmed, bringing the total number of cases to 93. ||| On 24 March, 48 new cases were confirmed thus bringing the total to 73 cases. ||| Le 16 mars, 30 nouveaux cas ont été confirmés, portant le nombre total de cas à 93.
0.4016062021255493 ||| Fungal enzymes for use in brewing ||| Enzymes for use in binding ||| Enzymes fongiques destinées au brassage
0.5367938876152039 ||| The record of Elaprase’ s designation as an orphan medicine is available here. ||| Evoltra was designated as an orphan medicine for this condition on 8 May 2003. ||| Le dossier relatif à la désignation d’ Élaprase comme médicament orphelin peut être consulté: ici.
0.591055154800415 ||| One unit (U) of insulin detemir corresponds to one IU of human insulin. ||| 40 IU (International Units) of the active substance insulin human. ||| Une unité (U) d’insuline détémir correspond à une UI d’insuline humaine.
0.3581392765045166 ||| Etoricoxib is a selective inhibitor of COX-2 (cyclooxygenase 2) indicated in the symptomatic relief of osteoarthritis (OA, 30-60mg once daily (od)), rheumatoid arthritis (RA, 90mg od) and the pain and signs of inflammation associated with acute gouty arthritis (120mg od). ||| Quintanrix is a white slightly milky liquid obtained by mixing the vial containing the diphtheria (D), tetanus (T), whole cell pertussis (Pw) and hepatitis B (HBV) liquid (DTPw-HBV) with the vial containing the Haemophilus influenzae type b (HIB) powder. ||| L’ étoricoxib est un inhibiteur sélectif de la COX-2 (cyclooxygénase 2) indiqué dans le soulagement symptomatique de l’ ostéoarthrose (OA, 30-60 mg une fois par jour), de la polyarthrite rhumatoïde (RA, 90 mg une fois par jour) ainsi que de la douleur et des signes d’ inflammation associés à l’ arthrite goutteuse (120 mg une fois par jour).
0.4017868638038635 ||| If patients do not respond to recommended anti-helminth treatment, discontinuation of Xolair should be considered. ||| The protocol allowed patients to receive dexamethasone if they had had a less than optimal response to VELCADE alone. ||| Si les patients ne répondent pas au traitement anti-helminthique recommandé, l’ arrêt de Xolair devra être envisagé.
0.6349480152130127 ||| Prandin 1 mg tablets Repaglinide ||| Emtricitabine dose (mg) ||| Prandin 1 mg, comprimés Répaglinide
0.2878064215183258 ||| Simultaneous administration of Ciprofloxacin and phenytoin may result in increased or reduced serum levels of phenytoin such that monitoring of drug levels is recommended. ||| Co-administration of NSAIDs and cyclosporine D derivatives or tacrolimus have been suggested to increase the nephrotoxic effect of cyclosporin and tacrolimus. ||| L’administration simultanée de ciprofloxacine et de phénytoïne peut entraîner une augmentation ou une réduction des taux sériques de phénytoïne, si bien qu’il est recommandé de contrôler la concentration du médicament.
0.22936776280403137 ||| Dryer felts all for use in the paper making industry ||| Forming fabrics all for use in the paper making industry ||| Feutres sécheurs destinés à l'industrie du papier
0.20071955025196075 ||| Common (≥ 1/ 100 to < 1/ 10): allergic conjunctivitis, asthenopia, blepharitis, cataract, conjunctival oedema, corneal erosion, eye discharge, eyelash darkening, eye pain, foreign body sensation, increased iris pigmentation, ocular burning, ocular dryness, ocular irritation, photophobia, superficial punctate keratitis, tearing, visual disturbance and worsening of visual acuity ||| Uncommon: vasculitic rash, rash erythematous, photosensitivity reaction, contusion, pruritus generalised, rash macular, rash papular, psoriasis, rash generalized, eyelid oedema, face oedema, dermatitis, alopecia, nail disorder, skin discolouration, dermatitis atopic, hair texture abnormal, heat rash, night sweats, pressure sore, ichthyosis, skin nodule. ||| 4 Fréquents (> 1/ 100 à < 1/ 10): conjonctivite allergique, asthénopie, blépharite, cataracte, œ dème conjonctival, érosion de la cornée, écoulement oculaire, assombrissement des cils, douleur oculaire, sensation de corps étranger, augmentation de la pigmentation de l'iris, brûlure oculaire, sécheresse oculaire, irritation oculaire, photophobie, kératite ponctuée superficielle, larmoiements, trouble visuel et baisse de l'acuité visuelle
0.2809024453163147 ||| Developmental toxicity studies were previously conducted in rabbits. ||| No reproductive toxicity studies in female animals have been performed. ||| Des études de la toxicité sur le développement ont été précédemment menées chez le lapin.
0.28635305166244507 ||| Like other agents with immunosuppressive potential, leflunomide may increase susceptibility to infections, including opportunistic infections (see also section 4.4). ||| As with other antibacterial agents, prolonged use of retapamulin may result in overgrowth of non-susceptible micro-organisms, including fungi. ||| Comme les autres produits potentiellement immunosuppresseurs, le léflunomide peut augmenter la sensibilité aux infections, y compris aux infections opportunistes (voir également rubrique 4.4).
0.26921820640563965 ||| Crixivan, taken in combination with other antiviral medicines but without ritonavir, was more effective than comparator medicines in reducing viral loads. ||| Zenapax does not increase this risk when it is used together with other immunosuppressive drugs, including cyclosporine and corticosteroids. ||| Crixivan, pris en association avec d’ autres médicaments antiviraux, mais sans ritonavir, a été plus efficace que les médicaments de comparaison pour réduire les charges virales.
0.22690288722515106 ||| In an open single-dose study in adult patients with Sickle Cell Syndrome the influence of renal function on pharmacokinetics of hydroxycarbamide was assessed. ||| In the first clinical study (IMPACT), efficacy and safety of infliximab were studied in 104 patients with active polyarticular psoriatic arthritis. ||| Une étude ouverte portant sur une administration unique d'hydroxycarbamide chez des patients adultes atteints de drépanocytose a évalué l'influence de la fonction rénale sur la pharmacocinétique de l'hydroxycarbamide.
0.364489883184433 ||| In the fourth study, the medicines were given in combination with methotrexate in 498 patients who had an inadequate response to previous treatment with TNF blockers. ||| The results of the study were analysed separately in 243 patients whose tumours contained KRAS that had not mutated and in 184 patients in whom the KRAS gene contained a mutation. ||| Dans la quatrième étude, les médicaments ont été administrés en association avec le méthotrexate à 498 patients ayant présenté une réponse insuffisante à un traitement précédent par des inhibiteurs du TNF.
0.28964030742645264 ||| Lamivudine and VIRAMUNE can be co-administered without dose adjustments. ||| INTELENCE can be co-administered with proton pump inhibitors without dose adjustments. ||| La lamivudine et VIRAMUNE peuvent être associés sans ajustement posologique.
0.007563798688352108 ||| 48 Combination therapy ViraferonPeg 1.5 micrograms/kg/week in combination with ribavirin capsules. ||| 163 Combination therapy ViraferonPeg 1.5 micrograms/kg/week in combination with ribavirin capsules. ||| Traitement combiné ViraferonPeg 1,5 microgrammes/ kg/ semaine avec des gélules de ribavirine.
0.4158734679222107 ||| What is the Commission doing to save jobs in the tourism sector? ||| What is the EU doing to support Africa to tackle the coronavirus? ||| Que fait la Commission pour sauver des emplois dans le secteur du tourisme?
0.4014367163181305 ||| Fabrazyme is intended for long-term use. ||| ADROVANCE is intended for long-term use. ||| Fabrazyme est conçu pour un usage de longue durée.
0.263190358877182 ||| The diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliomyelitis (DTPa-HBV-IPV) component is a turbid white suspension. ||| The diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliomyelitis (DTPa-HBV-IPV) component is a white, slightly milky liquid presented in a pre-filled syringe (0.5 ml). ||| Le composant diphtérique, tétanique, coquelucheux acellulaire, hépatite B, poliomyélitique inactivé (DTCa-HepB-P) se présente sous forme d'une suspension blanche trouble.
0.44909247756004333 ||| Only a solution without particles should be used and without visible signs of deterioration. ||| It is important to ensure that syringes do not contain traces of any other material. ||| Seule une solution sans particules et ne présentant aucun signe visible de détérioration doit être utilisée.
0.06191267818212509 ||| There is no experience regarding the administration of Kinzalmono in patients with recent kidney transplantation. ||| There is no experience regarding the administration of Micardis in patients with recent kidney transplantation. ||| Aucune donnée n’ est disponible concernant l’ administration de Kinzalmono chez les patients ayant subi une transplantation rénale récente.
0.3843733072280884 ||| The expected immunological response may not be obtained after vaccination of immunosuppressed patients. ||| Because of the potential risk of vaccination failure, vaccination should be administered no ||| La réponse immunitaire attendue risque de ne pas être obtenue après la vaccination chez les patients immunodéprimés. 'es
0.10309846699237823 ||| What is the risk associated with Kineret? ||| What is the risk associated with Ketek? ||| Quel est le risque associé à l’ utilisation de Kineret?
0.6092876195907593 ||| Mixing of insulins ||| Effects of the injection ||| 271 Mélange des insulines
0.29928058385849 ||| A new Strategic Investment Facility built into InvestEU- to generate investments of up to €150 billion in boosting the resilience of strategic sectors, notably those linked to the green and digital transition, and key value chains in the internal market, thanks to a contribution of €15 billion from Next Generation EU. ||| Furthermore, the DESI indicators relevant for the recovery show that EU Member States should step up their efforts to improve the coverage of Very High Capacity Networks, assign 5G spectrum to enable the commercial launch of 5G services, improve citizens' digital skills and further digitise businesses and the public sector. ||| une nouvelle Facilité d'investissement stratégique intégrée dans InvestEU afin de générer des investissements allant jusqu'à 150 milliards d'euros destinés à stimuler la résilience des secteurs stratégiques, notamment ceux liés aux transitions écologique et numérique, et des chaînes de valeur clés du marché intérieur, grâce à une contribution de 15 milliards d'euros de Next Generation EU.
0.19162797927856445 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €30 million Italian scheme will enable the provision of zero-interest rate loans of up to €30,000 per company for SMEs active in the agricultural and fishery sectors in Italy. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €1 billion Hungarian scheme will help Hungarian companies through direct grants, loans and equity measures financed by the European structural funds. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Ce régime italien d'un montant de 30 millions d'euros permettra d'octroyer aux PME opérant dans les secteurs de l'agriculture et de la pêche en Italie des prêts à taux d'intérêt nul à concurrence de 30 000 euros par entreprise.
0.3556995093822479 ||| Dose adjustment of buprenorphine or efavirenz may not be necessary when co-administered. ||| Montelukast should not be abruptly substituted for inhaled or oral corticosteroids. ||| Une ajustement posologique de la buprénorphine ou de l'éfavirenz peut ne pas être nécessaire quand ils sont co-administrés
0.3629010319709778 ||| It can be used in the following ways: • once a day as an add-on to oral anti-diabetes medicines. ||| Gemzar may be given alone or in combination with other anti -cancer medicines, depending on the type of cancer. ||| Elle peut être administrée comme suit: • une fois par jour, en complément des médicaments antidiabétiques oraux.
0.3413664698600769 ||| Vascular disorders Common: flushing Uncommon: hypertension ||| Vascular disorders Common: hypertension, hypotension Uncommon: aggravated hypertension ||| Troubles vasculaires Fréquent: bouffées vasomotrices Peu fréquent: hypertension
0.5617703199386597 ||| Hypertension Peripheral ischaemia, hypotension§ ||| Syncope, Dizziness related to hypotension ||| Ischémie périphérique, hypotension§ Très rare:
0.3045719861984253 ||| In Phase 3 clinical studies, infection-related serious adverse events were more frequently reported for subjects treated with tigecycline (6.7%) vs comparators (4.6%). ||| In clinical trials (n=1,968), rash (all grades, at least possibly related) occurred in 5.6% of patients treated with PREZISTA. ||| Dans les études cliniques de phase 3, les événements indésirables graves liés aux infections ont été plus fréquents chez les patients traités par la tigécycline (6,7%) que chez les patients recevant les médicaments de comparaison (4,6%).
0.35472601652145386 ||| This is a highly contagious disease and a common bacterial infection in horses. ||| Equine influenza is a highly contagious disease that is very common in horses but rarely causes death. ||| Cette maladie est une infection bactérienne fréquente et hautement contagieuse chez le cheval.
0.36798951029777527 ||| Salts of metals ||| Balls of steel ||| Sels de métaux
0.2721205949783325 ||| Disposable cloths ||| Disposable slippers ||| Toiles jetables
0.6046261787414551 ||| PritorPlus 80 mg/ 12.5 mg tablets ||| Cozaar 12.5 mg Inicio 12.5 mg ||| PritorPlus 80 mg/ 12,5 mg comprimés
0.43123218417167664 ||| 28.9 (47.4%) ||| 48% (±31.8%) ||| 28,9 (47,4%)
1.0401734113693237 ||| hypertension, flushing, haematoma ||| Thrombus including fatal thrombus, haematoma ||| Hypertension, congestion, hématomes.
0.03369886428117752 ||| Like all medicines, Thelin can cause side effects, although not everybody gets them. ||| Like all medicines, Savene can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, le Thelin est susceptible d'avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.390666127204895 ||| Brakes for vehicles ||| Tyres for commercial vehicles ||| Freins de véhicules
0.2873001992702484 ||| Metacam 0.5 mg/ ml oral suspension for cats Meloxicam ||| Cerenia 10 mg/ml solution for injection for Dogs Maropitant ||| Metacam 0,5 mg/ ml suspension orale pour chats Méloxicam
0.33177077770233154 ||| 33 If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking Pelzont. ||| Do not inject a double dose to make up for a forgotten dose. • If you are not sure what to do, ask your doctor or pharmacist. ||| Si vous n’ êtes pas certain que l’ une de ces conditions vous concerne, consultez votre médecin ou votre pharmacien avant de prendre Pelzont.
0.212546244263649 ||| Less potent UGT1A1 inhibitors (e. g., indinavir, saquinavir) may also increase plasma levels of raltegravir, but to a lesser extent compared with atazanavir. ||| Co-administration of ISENTRESS with medicinal products that are known to be potent UGT1A1 inhibitors (e. g., atazanavir) may increase plasma levels of raltegravir. ||| Des inhibiteurs moins puissants de l'UGT1A1 (tels que indinavir, saquinavir) peuvent également augmenter les concentrations plasmatiques du raltégravir, mais dans une moindre mesure, comparé à l'atazanavir.
0.4215776324272156 ||| It enhances the images seen with ultrasound and helps your doctor to get a clearer picture (scan) of your heart. ||| SonoVue is a contrast agent that reflects ultrasound waves differently from the tissues of the body and improves the picture from the scan. ||| Il réhausse la qualité des images échographiques et permet à votre médecin d’ obtenir une image plus claire de votre cœ ur.
0.42921578884124756 ||| Do not twist the grey needle cap ||| Pull off the grey needle cap. ||| Ne tournez pas le capuchon gris
0.16732415556907654 ||| 90 Ísland Vistor hf. ||| Ísland Vistor hf. ||| Ísland Vistor hf.
0.48870760202407837 ||| Cardiac disorders: ||| Breast carcinoma: ||| 8 Affections cardiaques:
0.5295267105102539 ||| Two dosing regimens can be recommended: ||| Dosage: the following doses are recommended: ||| Deux schémas posologiques peuvent être recommandés:
0.30697470903396606 ||| Steam sterilizers for floors ||| Firelighters for grills ||| Stérilisateurs à vapeur pour sols
0.24530979990959167 ||| The Committee recommended that Olanzapine Teva be given marketing authorisation. ||| The Committee recommended that Fluticasone Furoate GSK be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Olanzapine Teva.
0.41703641414642334 ||| On 28 February, Belarus confirmed its first case. ||| On 6 March, Pakistan confirmed its sixth case in Karachi. ||| Le 28 février, la Biélorussie a confirmé son premier cas.
0.38328444957733154 ||| While delays to cross border flows of agriculture goods were solved by the introduction of so-called green lanes , which allow the circulation of vehicles transporting critical goods, the aquaculture, agriculture and fish sectors still face serious difficulties. ||| The Commission proposes that 10% of agricultural land should consist of ‘high-diversity landscape features', for instance in the form of hedges or flower strips, and the environmental impacts of the agricultural sector should be significantly reduced by 2030. ||| Même si les problèmes de retards dans les transports transfrontaliers de produits agricoles ont été résolus suite à l'introduction de « corridors prioritaires » qui autorisent la circulation des véhicules transportant des marchandises essentielles, les secteurs de l'aquaculture, de l'agriculture et de la pêche font toujours face à de graves difficultés.
0.26399412751197815 ||| Renagel should only be given to pregnant or lactating women if clearly needed and after a careful risk/ benefit analysis has been conducted for both the mother and the foetus or infant (See 5.3 Preclinical safety data). ||| Females of childbearing potential and their partners must each use an effective contraceptive during treatment and for four months after treatment has been concluded; routine monthly pregnancy tests must be performed during this time (see section 4.4). ||| Renagel ne doit être administré en cas de grossesse ou d’ allaitement qu’ en cas de nécessité et après une évaluation attentive des risques/ bénéfices tant pour la mère que le fœ tus ou le nourrisson (voir 5.3 Données de sécurité précliniques).
0.2554454207420349 ||| A further three studies compared the effectiveness of Mimpara and placebo in a total of 136 patients with primary hyperparathyroidism over up to a year. ||| There were five short-term studies that compared the effectiveness of Abilify and placebo over three weeks in a total of 1,900 patients. ||| Trois nouvelles études ont comparé l’ efficacité du Mimpara contre placebo chez 136 patients atteints d’ hyperparathyroïdie primaire pendant un an maximum.
0.41574814915657043 ||| The duration of the home therapy should not exceed 24 hours. ||| Thus, the duration of the total perfusion should be 90 minutes. ||| La durée du traitement à domicile ne doit pas dépasser 24 heures.
0.24436184763908386 ||| Stabilisation fabrics (Non-metallic -) for use in construction ||| Seals (Non-metallic -) for use in glass lined pressure vessels ||| Tissus non métalliques de stabilisation destinés à la construction
0.3264068365097046 ||| In final data (adjudicated) from the APC trial in patients treated with celecoxib 800 mg daily for up to 3 years, the excess rates over placebo were 11 events per 1000 patients for myocardial infarction (common); and 5 events per 1000 patients for stroke (uncommon; types of stroke not differentiated). ||| Fourteen events in 10/ 132 patients were considered to be related to clofarabine of which acute cholecystitis (1 event), cholelithiasis (1 event), hepatocellular damage (1 event; patient died (see above)) and hyperbilirubinaemia (2 events; patients discontinued therapy (see above)) were considered to be serious. ||| Il ressort des données finales (expertisées) de l’ essai APC mené chez des patients traités par célécoxib à raison de 800 mg/ jour pendant une durée maximale de trois ans, que le surcroît d’ infarctus du myocarde par rapport au placebo était de 11 événements pour 1000 patients (fréquent); et de 5 événements pour 1000 patients pour l’ AVC (peu fréquent; types d’ AVC non différenciés).
0.011559149250388145 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or hospital pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or pharmacist. ||| Si vous ressentez un des effets mentionnés comme graves ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin, votre infirmière ou votre pharmacien hospitalier.
0.8926470279693604 ||| Side effects reported commonly ||| Exceptionally high risks ||| Effets indésirables fréquemment rapportés
0.765044093132019 ||| Suitcase handles ||| Teething soothers ||| Poignées de valises
0.07503916323184967 ||| Use in children and adolescents under 18 years of age ||| Use in children and adolescents under the age of 18 years ||| 24 Utilisation chez les enfants et les adolescents de moins de 18 ans
0.5651192665100098 ||| More than ever, voluntary returns should be prioritised, also because they present a lower health and safety risk. ||| These circumstances demand substantial additional resources, and the need for an increased availability of vitally important medical devices has considerably increased. ||| Plus que jamais, les retours volontaires devraient être prioritaires, en particulier parce qu'ils présentent un risque plus faible pour la santé et la sécurité.
0.0 ||| 4.8 Undesirable effects ||| 4.8 Undesirable effects ||| 57 4.8 Effets indésirables
0.14997664093971252 ||| Sifrol is a medicine containing the active substance pramipexole base. ||| Hepsera is a medicine containing the active substance adefovir dipivoxil. ||| Sifrol est un médicament contenant le principe actif pramipexole base.
0.4910324811935425 ||| ProteqFlu is a vaccine for use in horses. ||| Purevax RCPCh should not be used in pregnant cats. ||| ProteqFlu est un vaccin destiné aux chevaux.
0.356161892414093 ||| Tell your doctor if you are pregnant, think you may be pregnant or are breast-feeding before you receive treatment with Paxene. ||| You should not use Cetrotide 0.25 mg if you are already pregnant, or suspect that you might be pregnant, or if you are breast-feeding. ||| Si vous êtes ou pensez être enceinte ou si vous allaitez, informez -en votre médecin avant de recevoir le traitement par Paxene.
0.21710088849067688 ||| The measure will help them cover their immediate liquidity needs and continue their essential activities during these difficult times. ||| It will help these companies cover their immediate liquidity needs to support them in continuing their crucial activities during these challenging times. ||| Cette mesure les aidera à couvrir leurs besoins immédiats de liquidités et à poursuivre leurs activités essentielles en cette période difficile.
0.5110227465629578 ||| To get the most benefit from the medicine, it should be used regularly and at the same time every day. ||| It is advisable never to use several medicines at the same time without consulting your doctor first. ||| Pour une efficacité optimale du médicament, il convient de l’ utiliser régulièrement et à la même heure chaque jour.
0.24516309797763824 ||| As clinical efficacy studies were performed with abrupt cessation of treatment, no information is available on whether tapering of the dosage would reduce recurrence rate. ||| For diagnostic nuclear medicine investigations, the current evidence suggests that the adverse effects will occur with low frequency because of the low radiation doses incurred. ||| L'impact de la réduction progressive des doses sur la fréquence des récidives n’ est pas connu compte tenu de l'arrêt brutal du traitement au cours des essais cliniques.
0.0027772104367613792 ||| 82 Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| 58 Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Prise d'autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.11762115359306335 ||| Rue de l'Institut 89 B-1330 Rixensart, Belgium ||| Rue de l'Institut 89 B-1330 Rixensart, Belgium lon 8. ||| Rue de l'Institut, 89 B-1330 Rixensart, Belgique
0.5989404320716858 ||| This will prolong the longest period of expansion since the launch of the euro in 1999, with corresponding good news on the jobs front. ||| The league quickly hired English announcers as this proved to be the only professional baseball season being played in the world. ||| La plus longue période d'expansion depuis la création de l'euro en 1999 devrait donc se poursuivre, ce qui est une bonne nouvelle pour l'emploi.
0.33712565898895264 ||| Azithromycin/ Efavirenz (600 mg single dose/ 400 mg once daily) ||| ANTICONVULSANTS Carbamazepine/ Efavirenz (400 mg once daily/ 600 mg once daily) ||| Azithromycin/ Efavirenz (600 mg en dose unique/ 400 mg une fois par jour)
0.004598197527229786 ||| Resuspend according to instructions NovoMix 70 Penfill cartridges are for use by one person only ||| Resuspend according to instructions NovoMix 50 Penfill cartridges are for use by one person only ||| Remettre en suspension comme indiqué sur la notice Les cartouches NovoMix 70 Penfill sont réservées à l’ usage personnel du patient
0.41222649812698364 ||| As a result, the amounts of Atripla or other medicines in your blood may be affected. ||| Nexavar may increase the effects and, in particular, the side effects of these medicines. ||| Ainsi les quantités d’ Atripla ou d’ autres médicaments dans votre sang peuvent être modifiés.
0.3313106298446655 ||| This complements the many other possibilities already available to Member States to mitigate the socio-economic impact of the coronavirus outbreak, in line with EU State aid rules. ||| A significantly enhanced Solidarity and Emergency Aid Reserve will reinforce EU action in response to all aspects of the health crisis, as well as other emergencies. ||| Ceci complète les nombreuses autres possibilités dont disposent déjà les États membres pour atténuer les répercussions socio-économiques de la pandémie de coronavirus, conformément aux règles de l'UE en matière d'aides d'État.
0.7466104626655579 ||| 53 Vascular disorders Common Rare ||| Adults Major Depressive Episodes: ||| Affections psychiatriques Fréquent Rare
0.49691644310951233 ||| Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were excluded. ||| The EU Civil Protection Mechanism has facilitated the repatriation of 447 EU citizens from Wuhan, China. ||| Des cas parmi les individus rapatriés aux États-Unis depuis Wuhan, en Chine, ainsi que les personnes présentes sur le navire de croisière Diamond Princess ont été exclus.
0.26469671726226807 ||| Frequencies are defined as common (> 1/100, 1/1,000, 1/10,000, < 1/1,000); very rare (< 1/10,000). ||| Frequencies are defined as very common (≥ 1/ 10), common (≥ 1/ 100, < 1/ 10) or uncommon (≥ 1/ 1,000, < 1/ 100). ||| Les fréquences sont définies comme fréquente (> 1/100; 1/1.000; 1/10.000; < 1/1.000); très rare (< 1/10.000).
0.4084988534450531 ||| Anti-vibration mountings for machines ||| Anti-corrosive preparations for vehicles ||| Supports anti-vibrations pour machines
0.0 ||| In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| 113 En cas d'insuffisance rénale, les besoins en insuline peuvent être diminués en raison d'une réduction du métabolisme de l'insuline.
3.8955809606756875e-13 ||| United Kingdom Glaxo Wellcome UK Limited, Stockley Park West, Uxbridge Middlesex UB11 1BT United Kingdom ||| United Kingdom Glaxo Wellcome UK Limited, Stockley Park West, Uxbridge Middlesex UB11 1BT United Kingdom ||| Royaume-Uni Glaxo Wellcome UK Limited, trading as Allen & Hanburys; Stockley Park West, Uxbridge, Middlesex UB11 1BT, Royaume- Uni
0.019159354269504547 ||| The company that makes Binocrit will provide information packs for healthcare workers in all Member States, including information on the safety of the medicine. ||| The company that makes Silapo will provide information packs for healthcare workers in all Member States, including information on the safety of the medicine. ||| La société qui fabrique Binocrit fournira des documents d’ information aux personnels de santé de tous les États membres, contenant notamment des informations sur la tolérance du médicament.
0.28201472759246826 ||| According to in vitro studies, significant displacement is not anticipated at therapeutic concentrations of the medicinal products. ||| Non-clinical data revealed no special hazard for humans based on conventional studies of repeated dose toxicity. ||| Selon des études in vitro, aucun déplacement significatif ne devrait se produire aux concentrations thérapeutiques des médicaments.
0.0032143015414476395 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 8416 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu © European Medicines Agency, 2008.
0.05613461881875992 ||| The Committee recommended that Crixivan be given marketing authorisation. ||| The Committee recommended that Vistide be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Crixivan.
0.09367787092924118 ||| If you experience any of these, tell your doctor straight away. ||| If you experience any of these, tell your doctor or nurse straight away. ||| 83 Si vous présentez l'un de ces effets, parlez -en immédiatement à votre médecin.
5.605316558132678e-13 ||| [See Annex I - To be completed nationally] ||| [See Annex I - To be completed nationally] ||| [Voir Annexe I - A compléter nationalement]
6.867044910138786e-13 ||| [To be completed nationally] ||| [To be completed nationally] ||| [À remplir au niveau national]
0.4431772232055664 ||| Mixing is complete when the suspension appears uniform, thick, and milky in color and all the powder is fully dispersed. ||| Repeat the rolling and moving procedures (see pictures A and B) until the liquid does appear uniformly white and cloudy. ||| Le mélange est terminé lorsque la suspension apparaît uniforme, épaisse et de couleur laiteuse et que toute la poudre est complètement dispersée.
2.7077011422946273e-13 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| vous ressentez un des effets mentionnés comme graves ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien. e am
0.2910251319408417 ||| Hypromellose Titanium dioxide (E171) Polyethylene glycol 400 Ferric oxide (red) (E172) Carnauba wax ||| Shellac Lecithin (soya) Simethicone Red iron oxide (E 172) Hydroxypropyl Cellulose. ||| Hypromellose Dioxyde de titane (E171) Polyéthylène glycol 400 Oxyde ferrique (rouge) (E172) Cire de carnauba
0.005101888440549374 ||| Following the amendment, State insurers will in principle be able to step in and provide insurance for short-term export-credit risk for all countries, without the need for the Member State in question to demonstrate that the respective country is temporarily "non-marketable." ||| Following the amendment, State insurers will in principle be able to step in and provide insurance for short-term export-credit risk for all countries, without the need for the Member State in question to demonstrate that the respective country is temporarily "non marketable." ||| Cette modification permettra en principe aux organismes publics d'assurance d'intervenir et de fournir une assurance-crédit à l'exportation à court terme pour tous les pays, sans que l'État membre en question doive démontrer que les risques sont temporairement «non cessibles» dans le pays concerné.
0.28485459089279175 ||| 5 x 5 pack: contains 5 vials of parecoxib 20 mg and 5 ampoule with 1 ml sodium chloride 9 mg/ ml (0.9%) solution. ||| 1 pre-filled syringe with 1.2 ml solvent: sodium chloride solution 5.4 mg/ ml, 1 vial adapter with needle + 2 alcohol wipes ||| Conditionnement 5 x 5: contient 5 flacons de 20 mg de parécoxib et 5 ampoules de 1 ml de solution de chlorure de sodium à 9 mg/ ml (0,9%).
0.32930171489715576 ||| These reactions were mild or moderate in nature and subsided after a couple of hours or days. ||| These adverse reactions were self-limiting within one or two days and did not require additional treatment. ||| Ces réactions étaient légères à modérées et disparaissaient dans les quelques heures ou jours suivants.
0.2780723571777344 ||| The following minor, self-limiting, rare adverse events were reported in the clinical trials and considered at least possibly related to LeukoScan: eosinophilia (3); and facial rash (1). ||| 35 The following rare, serious adverse events have been reported in association with the use of NSAIDs and cannot be ruled out for Dynastat: bronchospasm and hepatitis. ||| Les rares effets indésirables mineurs et régressant spontanément suivants ont été signalés lors d’ essais cliniques et pouvant être pour le moins imputés au LeukoScan: éosinophilie (3), urticaire facial (1).
0.5567503571510315 ||| We are determined to step up our efforts so that we act as a single global actor in this area. ||| I am in discussion with all Member States so that we confront this challenge together, as a Union." ||| Nous sommes déterminés à redoubler d'efforts pour agir comme un seul acteur mondial dans ce domaine.
0.24701043963432312 ||| Clopidogrel is indicated in adults for the prevention of atherothrombotic events in: ||| Noxafil is also indicated for prophylaxis of invasive fungal infections in the following patients: ||| Le clopidogrel est indiqué chez l’adulte dans la prévention des événements liés à l'athérothrombose:
0.35323309898376465 ||| If OptiSet is in cool storage, it should be taken out 1 to 2 hours before injection to allow it to warm up. ||| If the ointment gets on any of these areas, it should be thoroughly wiped off and/ or rinsed off with water. ||| Si OptiSet est conservé dans un endroit frais, il devra être sorti 1 à 2 heures avant l’ injection pour lui permettre de se réchauffer.
0.37148410081863403 ||| The adverse events seen with Crestor are generally mild and transient. ||| The majority of side effects seen with EVISTA have been mild. ||| Les effets indésirables observés avec Crestor sont généralement légers et transitoires.
0.19579383730888367 ||| Zometa concentrate is contraindicated in breast-feeding women and in patients with clinically significant hypersensitivity to zoledronic acid, other bisphosphonates or any of the excipients in the formulation of Zometa. ||| Patients with a family history of or actual defects in glucose-6-phosphate dehydrogenase activity are prone to haemolytic reactions with quinolones, and so ciprofloxacin should be used with caution in these patients. ||| Zometa solution à diluer est contre-indiqué chez la femme allaitante et chez les patients présentant une hypersensibilité cliniquement significative à l’ acide zolédronique, à d’ autres bisphosphonates ou à l’ un des excipients présents dans la formulation de Zometa.
0.26306527853012085 ||| Trevaclyn Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure, indicating little relevance to human use. ||| However, due to the marked pharmacological response in monkey, systemic exposures higher than those achieved in patients at therapeutic doses have not been studied. ||| Trevaclyn Des effets n’ ont été observés chez l’ animal qu’ à des expositions largement supérieures à l’ exposition maximale observée chez l’ homme, et ont peu de signification clinique.
0.6432094573974609 ||| Transparency, communication and provision of information to patients, healthcare professionals and users of medicines ||| Tracing apps must be voluntary, transparent, secure, interoperable and respect people's privacy. ||| Transparence, communication et fourniture d’ informations aux patients, aux professionnels de la santé et aux utilisateurs de médicaments
0.25658684968948364 ||| Tremor usually began within the first month, and in many cases resolved during treatment after between 1 and 3 months. ||| In most cases, an effect was induced within 6-11 days of treatment, and ovulation was generally advanced by 2-3 weeks. ||| Les tremblements commençaient généralement au cours du premier mois du traitement et, dans de nombreux cas, disparaissaient au cours du traitement en un à trois mois.
0.4440268874168396 ||| Rock bits for drilling machines ||| Extra fine oils for motors ||| Trépans pour machines de forage
0.14569838345050812 ||| 27 October 2005 ||| 28 December 2005 ||| 27 octobre 2005
0.2501683831214905 ||| Very rarely patients taking metformin (one of the active substances of Janumet) have experienced a serious condition called lactic acidosis (too much lactic acid in your blood). ||| Metformin hydrochloride, one of the ingredients in Janumet, can cause a rare but serious side effect called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. ||| Très rarement, les patients traités par la metformine (une des substances actives de Janumet) ont présenté un état grave appelé acidose lactique (trop grande quantité d'acide lactique dans le sang).
0.3208656311035156 ||| Less commonly, bacterial skin infections, weakness, muscle paralysis, loss of hearing or vision can occur. ||| Less commonly, upper respiratory symptoms such as sneezing, runny nose or sore throat may be seen. ||| Plus rarement, des infections bactériennes de la peau, une faiblesse, une paralysie musculaire, une perte d’ audition ou de vision peuvent survenir.
0.15713828802108765 ||| 10 vials + 10 pre-filled syringes with attached needle ||| 10 pre-filled syringes with needle guard + 10 needles ||| 10 flacons + 10 seringues pré-remplies avec aiguille jointe
0.38472890853881836 ||| In patients at increased risk of symptomatic hypotension, initiation of therapy and dose adjustment should be closely monitored. ||| The magnitude of antihypertensive effect should be closely monitored after administering the initial dose. ||| En cas de risque accru d'hypotension symptomatique, l'initiation du traitement et l'adaptation posologique doivent faire l'objet d'un suivi étroit.
0.4433530569076538 ||| If such arrangements are not found, Member States should in any case consider disembarking any passengers and crew safely and swiftly, before facilitating their transit home. ||| Where all members of a crew are healthy and if their previous port call took place more than a fortnight ago, they should not be quarantined when they disembark to repatriate. ||| En l'absence de telles dispositions, les États membres devraient, dans tous les cas, examiner les moyens de faire débarquer les passagers et les membres d'équipage rapidement et en toute sécurité, avant de faciliter leur retour chez eux.
0.3879649043083191 ||| The solvent pre-filled syringe provided should be used for reconstitution only and then disposed of in accordance with local requirements. ||| The unreconstituted contents of the vial before radiolabelling are not to be directly administered to patients. ||| La seringue préremplie de solvant fournie ne doit être utilisée que pour la reconstitution; elle doit ensuite être éliminée conformément à la réglementation en vigueur.
0.26748043298721313 ||| No clinically relevant interactions were observed in clinical trials with Aerius tablets in which erythromycin or ketoconazole were co-administered (see section 5.1). ||| * Other oral contraceptive and HRT treatments have not been studied, though they may similarly affect lamotrigine pharmacokinetic parameters (see sections 4.2 and 4.4). ||| Au cours des études cliniques réalisées avec Aerius comprimés dans lesquels les patients recevaient l’ érythromycine ou du kétoconazole en association, aucune interaction cliniquement significative n’ a été observée (voir rubrique 5.1).
0.3004975914955139 ||| Based on the results of in vitro experiments and the known major metabolic pathways of abacavir, the potential for P450 mediated interactions with other medicinal products involving abacavir is low. ||| The opinion should take into account the global safety profile of terfenadine in comparison with existing alternative non sedative anti-histamines (NSAHs) drugs available for the same indications in the European Union. ||| Sur la base des études in vitro et des principales voies métaboliques connues de l’ abacavir, le risque potentiel d’ interactions médicamenteuses entre l’ abacavir et les médicaments métabolisés par le cytochrome P450 est faible.
0.5671625137329102 ||| Barium chloride ||| Barium peroxides ||| Chlorure de baryum
0.21415337920188904 ||| Take the number of capsules as instructed by your doctor. ||| Take the number of capsules or tablets as instructed. ||| Prenez le nombre de gélules prescrit par votre médecin.
0.4844682812690735 ||| Head of Unit Regulatory affairs and pharmacovigilance ||| Part B - Regulatory affairs & pharmacovigilance Total human resources ||| Affaires réglementaires et pharmacovigilance
0.42661556601524353 ||| By binding to IgE, omalizumab ‘ mops up’ the free IgE circulating in the blood. ||| By attaching to hsp90, efungumab blocks the protein’ s normal activities. ||| En se liant aux IgE, l’ omalizumab « nettoie » le sang des IgE libres.
0.39869001507759094 ||| - if you have moderate or severe liver problems. ||| - if you are also receiving heart or blood pressure medicine. ||| - si vous avez des problèmes de foie modérés ou sévères.
0.3984220027923584 ||| A dose correction may be needed after six months of treatment (see section 4.4). ||| Do not exceed the recommended dosage and the duration of treatment (see 4.2). ||| Il est possible qu’ un ajustement de la posologie soit nécessaire après 6 mois de traitement (voir rubrique 4.4).
0.3267025947570801 ||| In both studies, the main measure of effectiveness was the number of patients who formed blood clots in the veins or who died of any cause during the treatment period. ||| The main measure of effectiveness was time until the disease got worse or, for Kaposi’ s sarcoma, the number of patients who responded to treatment. ||| Dans les deux études, le principal critère d’ évaluation de l’ efficacité était le nombre de patients chez lesquels s’ étaient formés des caillots sanguins dans les veines ou qui sont décédés d’ une cause quelconque durant la période de traitement.
0.426422655582428 ||| Patients with renal or hepatic impairment: ||| Patients with contraindications to limb hyperthermia. ||| Insuffisants rénaux ou hépatiques:
0.006963051855564117 ||| 64 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 46 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 67 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.27039507031440735 ||| In locally recurrent and metastatic breast cancer, Grade 3-5 wound healing complications were observed in 1.1% of patients receiving Avastin + paclitaxel and in none of the patients receiving paclitaxel alone. ||| Overall, 54% of patients had a persistent complication, 9% had concurrent bacteraemia and 23% were infected with a levofloxacin resistant uropathogen at baseline. ||| Dans le cancer du sein métastatique ou en rechute locale, des complications de la cicatrisation des plaies de Grade 3-5 ont été observées chez 1,1% des patients traités par Avastin + paclitaxel, et chez aucun des patients traités par paclitaxel seul.
0.21303467452526093 ||| (i) With respect to the guarantee scheme, (i) the underlying loan amount per company is linked to the company's liquidity needs for the foreseeable future, (ii) is limited to a maximum six-year duration, (iii) and entails a guarantee premium that is at least as high as that set in the Temporary Framework. ||| In particular: (i) the aid amounts do not exceed the threshold foreseen by the Temporary Framework, (ii) the grants are granted only to solvent enterprises, (iii) the scheme is of temporary nature, and (iv) is proportionate to remedy the consequences of the serious disturbance caused by the coronavirus outbreak. ||| i) en ce qui concerne le régime de garanties, i) le montant de prêt sous-jacent par entreprise est lié au montant nécessaire pour couvrir les besoins de liquidités de celle-ci dans un avenir prévisible, ii) il a une durée maximale de six ans et iii) il comprend le versement d'une prime de garantie qui est au moins aussi élevée que l'encadrement temporaire le prévoit.
0.2805054187774658 ||| Similarly, co-administration with warfarin did not affect the pharmacokinetics of ambrisentan (see section 4.5). ||| Emtricitabine and tenofovir individually and in combination have shown activity against HBV in pharmacodynamic studies (see section 5.1). ||| De même, la co-administration avec la warfarine n’ a pas affecté les propriétés pharmacocinétiques de l’ ambrisentan (voir rubrique 4.5).
0.43018099665641785 ||| Several MEPs also asked for more certainty regarding travel and movement restrictions that could continue in the coming months, including possible bans on visiting beaches because of social distancing rules. ||| This has been compounded with delays in delivery due to greater restrictions on imports and freight, such as Egypt's 18-day quarantine on condom shipments. ||| Plusieurs députés ont par ailleurs demandé plus de certitude sur les restrictions de voyage et de mouvement qui pourraient perdurer dans les mois à venir, notamment les possibles interdictions de se rendre sur les plages à cause des règles de distanciation sociale.
0.2975394129753113 ||| Pravastatin is not significantly metabolised by cytochrome P450 nor does it appear to be a substrate or an inhibitor of P-glycoprotein but rather a substrate of other transport proteins. ||| Fosaprepitant or aprepitant does not seem to interact with the P-glycoprotein transporter, as demonstrated by the lack of interaction of oral aprepitant with digoxin. ||| La pravastatine n’est pas significativement métabolisée par le cytochrome P450 et ne semble pas non plus être un substrat ou un inhibiteur de la glycoprotéine P mais plutôt un substrat d’autres protéines de transport.
0.27689868211746216 ||| Fatal rhabdomyolysis is a rare event among statin users, with reporting rates much lower than 1 death per million prescriptions in the case of most statins. ||| In a 24-month intramuscular carcinogenicity study in rats, no increased incidence of injection site tumours was seen in either the vehicle or active groups. ||| La rhabdomyolyse à issue fatale est un événement rare parmi les utilisateurs de statines, les taux de cas signalés étant bien inférieurs à un décès par million de prescriptions en ce qui concerne la plupart des statines.
0.215010404586792 ||| The Committee for Medicinal products for Human Use (CHMP) concluded that Truvada’ s benefits are greater than its risks in antiretroviral combination therapy for the treatment of HIV-1 infected adults. ||| The Committee for Medicinal Products for Human Use (CHMP) concluded that Prometax has a modest effectiveness in treating the symptoms of Alzheimer’ s dementia, although this does reflect an important benefit in some patients. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les avantages de Truvada sont supérieurs aux risques pour le traitement des patients adultes infectés par le VIH-1 en association avec d’ autres antirétroviraux.
0.43922650814056396 ||| If a patient develops PML the dosing of MabThera must be permanently discontinued. ||| The immune response to RotaTeq is unaffected when OPV is administered two weeks after RotaTeq. ||| En cas d’ apparition d’ une LEMP, le traitement par MabThera devra être définitivement arrêté.
0.19782420992851257 ||| Tygacil works by blocking the bacteria's ribosomes, the parts of the cell where new proteins are produced. ||| It works by blocking the bacteria's ribosomes, the parts of the cell where proteins are produced, and inhibits the growth of bacteria. ||| Tygacil agit en bloquant les ribosomes des bactéries, les ribosomes étant la zone de la cellule où sont produites de nouvelles protéines.
0.5073859691619873 ||| Veterinary medicine degree from the University of Milan. ||| Qualified medical doctor from the Medical School of the University of Dublin. ||| Diplôme en sciences vétérinaires de l’université de Milan.
0.2430441975593567 ||| Insulin Human Winthrop Comb 50 is injected subcutaneously 20 to 30 minutes before a meal. ||| Insuman Basal is injected subcutaneously 45 to 60 minutes before a meal. ||| Insulin Human Winthrop Comb 50 est injecté par voie sous-cutanée 20 à 30 minutes avant un repas.
0.34184473752975464 ||| Furthermore, suicidal ideation or attempts were reported more frequently compared to adult patients (2.4% vs 1%) during treatment and during the 6 month follow-up after treatment. ||| Discontinuation due to adverse reactions was 4.5% (naïve patients) and 9% (experienced patients) over a 48 week period. ||| En outre, les idées suicidaires ou tentatives de suicides au cours du traitement et lors du suivi de 6 mois après traitement ont été rapportés plus fréquemment chez les enfants et adolescents que chez les adultes (2,4% versus 1%).
0.47188645601272583 ||| The median time to response in clinical trials was 7.6- 11.6 weeks. ||| The median time from diagnosis to start of treatment was 82 months. ||| Dans les études cliniques, le temps médian de réponse a été de 7,6-11,6 semaines.
0.09350264817476273 ||| Storage baskets [furniture] ||| Storage units [furniture] ||| Paniers de rangement [meubles]
0.17257019877433777 ||| As the half-life of alfentanil is prolonged in a four-fold manner in combination with voriconazole, a longer respiratory monitoring period may be necessary). ||| As the half-life of alfentanil is prolonged in a four-fold manner when alfentanil is coadministered with voriconazole, a longer respiratory monitoring period may be necessary. ||| Lorsque l’ alfentanil est co-administré avec le voriconazole, la demi-vie de l’ alfentanil est prolongée de quatre fois, aussi une plus longue période de surveillance respiratoire peut être nécessaire.
0.21839694678783417 ||| Increased number of serious cardiovascular events, mainly myocardial infarction, has been found in a long-term placebo-controlled study in subjects with sporadic adenomatous polyps treated with celecoxib at doses of 200mg BID and 400mg BID compared to placebo (see 5.1). ||| In an open-label investigator study in 35 chronic hepatitis B patients with lamivudine-resistant HBV and co-infected with HIV, continued treatment with 10 mg adefovir dipivoxil resulted in progressive reductions in serum HBV DNA levels and ALT levels throughout the course of treatment up to 144 weeks. ||| En comparaison au placebo, une augmentation du nombre d’ événements cardiovasculaires graves, principalement des infarctus du myocarde, a été observée dans une étude au long cours chez les patients présentant des polypes adénomateux sporadiques traités par le célécoxib à des doses de 200 mg deux fois par jour et 400 mg deux fois par jour (voir rubrique 5.1 Propriétés pharmacodynamiques).
0.5114423632621765 ||| If overdosage occurs, general supportive measures and symptomatic treatment should be conducted. ||| A combination of both containment and mitigation measures may be undertaken at the same time. ||| En cas de surdosage, maintenir les fonctions vitales et assurer un traitement symptomatique.
4.897819888376176e-13 ||| Appropriate precautions must continue to be used. ||| Appropriate precautions must continue to be used. ||| Des précautions adaptées doivent continuer à être prises.
0.42901092767715454 ||| In some rare cases, especially if you are taking other medicines that suppress the immune system, reactivation of HBV can be life-threatening. ||| In such cases, you won't improve your condition by taking antibiotics: antibiotics don't lower fever or symptoms like sneezing. ||| Dans de rares cas, notamment si vous prenez d’ autres médicaments qui diminuent le système immunitaire, la réactivation du VHB peut être mortelle.
0.48605406284332275 ||| In case of shock, standard medical treatment for shock should be implemented. ||| The standard recommended procedures for hepatitis B virus immunisation in infants should be followed. ||| En cas de choc, les traitements médicaux habituels seront appliqués.
0.3183647096157074 ||| Benign digestive symptoms, such as nausea, vomiting and abdominal pain, may be indicative of lactic acidosis development. ||| The most commonly reported adverse reactions are gastrointestinal, including nausea (38%) and vomiting (23%), especially during titration. ||| Des symptômes digestifs bénins, tels que des nausées, des vomissements ou des douleurs abdominales, sont les signes évocateurs possibles d’ une acidose lactique débutante.
0.7689648866653442 ||| Time from Administration of Study Drug (Minutes) ||| Complete Remission Time to Bone Marrow Remission (Median) ||| Temps à partir de l’ administration du médicament à l’ étude (minutes)
0.2742922306060791 ||| If you stop taking BeneFIX ||| If you stop taking ReFacto AF ||| Si vous arrêtez d’utiliser BeneFIX
0.15134255588054657 ||| 38 Indication ||| 34 Indication ||| Indication
0.37816131114959717 ||| Swelling of the retina at the back of the eye which can cause blurred vision (macular oedema) can be a problem for people with diabetes. ||| Stelara is used to treat adults with moderate to severe plaque psoriasis (a disease causing red, scaly patches on the skin). ||| Problèmes oculaires: un gonflement de la partie de la rétine à l’ arrière de l 'œ il pouvant causer une vision floue (œ dème maculaire) peut être un problème pour les personnes atteintes de diabète.
3.7043566998573585e-13 ||| (iv) Safeguards for banks that channel State aid to the real economy: Some Member States plan to build on banks' existing lending capacities, and use them as a channel for support to businesses - in particular to small and medium-sized companies. ||| (iv) Safeguards for banks that channel State aid to the real economy: Some Member States plan to build on banks' existing lending capacities, and use them as a channel for support to businesses - in particular to small and medium-sized companies. ||| (iv) aides sous forme de garanties pour les banques qui acheminent les aides d'État vers l'économie réelle: certains États membres envisagent de s'appuyer sur les capacités de prêt existantes des banques et de les utiliser pour acheminer le soutien vers les entreprises, en particulier les petites et moyennes entreprises.
0.6231939196586609 ||| Advanced malignant hepatic tumours (see section 4.4). ||| Lymphadenopathy (mean duration 47 days). ||| Tumeur hépatique maligne à un stade avancé (voir rubrique 4.4).
0.3946385383605957 ||| The efficacy of lamivudine in patients co-infected with Delta hepatitis or hepatitis C has not been established. ||| Zidovudine has not been shown to affect the number of sperm, sperm morphology and motility in man. ||| L’ efficacité de la lamivudine chez les patients co-infectés par le virus de l’ hépatite Delta (D) ou de l’ hépatite C n’ a pas été établie.
0.39585208892822266 ||| Medis Danmark A/ S, Havelse Mølle 14 DK-3600 Frederikssund Denmark ||| Ferring Pharmaceuticals A/ S Kay Fiskers Plads 11 2300 København S Denmark ||| Havelse Mølle 14, DK-3600 Frederikssund Danemark
0.22470104694366455 ||| Inorganic fibre mixed fabrics ||| Chemical fibre mixed fabrics ||| Tissus mixtes en fibres inorganiques
0.37989258766174316 ||| The Applicant was also requested to justify the indication based on the results of relevant published literature on other ACE-Is in terms of patients to be included and goals of therapy. ||| In conclusion, the warning related to women of childbearing potential proposed by the applicant in section 4.6 Pregnancy and lactation is relevant and sufficient. ||| Le demandeur a également été invité à justifier l’ indication en se fondant sur les résultats de la littérature pertinente publiée sur d’ autres IEC de l’ angiotensine-I en termes de patients à inclure et d’ objectifs thérapeutiques.
0.3154144287109375 ||| 0.8%); Gastrointestinal pain (G3/ 4: ||| 1%); Abdominal pain (G3/ 4: ||| 0,8%); Douleurs gastro- intestinales (G3/ 4:
0.09802081435918808 ||| Store in a refrigerator (2ºC-8ºC). ||| Store in a refrigerator (2ºC to 8ºC). ||| Conservez au réfrigérateur (2ºC-8ºC).
0.10694843530654907 ||| No dosage adjustment is necessary for efavirenz. ||| No dosage adjustment is necessary for rifampicin. ||| Aucun ajustement posologique n’ est nécessaire pour l'éfavirenz.
0.6077613830566406 ||| Administrative processing of purchase orders placed by telephone or computer ||| Transmission of written communications in the forms of telegrams ||| Traitement administratif de commandes d’achats passées par téléphone ou par ordinateur
0.3949066996574402 ||| Genotype 4 with RVR* ||| Genotype 2 or 3 without RVR** ||| Génotype 4 avec RVR*
0.38981693983078003 ||| Restrictions should be lifted first with countries whose epidemiological situation is similar to the EU average and where sufficient capabilities to deal with the virus are in place. ||| At the same time, Member States have to commit to avoid undue cumulation of support measures for the same companies to limit support to meet their actual needs. ||| Les restrictions devraient être levées en premier lieu pour les pays dont la situation épidémiologique est semblable à celle observée en moyenne dans l'UE et qui possèdent des moyens suffisants pour lutter contre le virus.
0.48742911219596863 ||| Activated Protein C is a crucial coagulation regulator. ||| - The active substance is human coagulation factor IX ||| La Protéine C activée est un facteur régulateur essentiel de la coagulation.
0.15861350297927856 ||| t = 0 minutes. ||| t = 5 minutes. ||| t = 0 minutes
0.5834407806396484 ||| Deutschland Astellas Pharma GmbH Neumarkter Str. ||| 42 Boehringer Ingelheim International GmbH Binger Str. ||| Astellas Pharma GmbH Neumarkter Str.
0.3794805407524109 ||| No data are available for the treatment with a combination of lamivudine and zidovudine in humans or animals (see also section 5.3). ||| For these patients and for patients, who are unable to swallow tablets, oral solutions of lamivudine and zidovudine are available. ||| Aucune donnée n'est actuellement disponible sur le traitement associant la lamivudine et la zidovudine chez l'homme ou chez l'animal (voir rubrique 5.3).
0.08756913244724274 ||| 46 B. ||| 47 B. ||| 49 B.
0.47431617975234985 ||| Fertility: busulfan can impair fertility. ||| Fertility Busulfan and DMA can impair fertility in man or woman. ||| Fertilité: le busulfan peut diminuer la fertilité.
0.41237160563468933 ||| If Beromun dry powder or reconstituted solution should come into contact with the skin or mucous membranes, wash thoroughly with water. ||| Dimeticone or silicone emulsion may have been used to treat the cartridge plunger, and/ or the glass cartridge. ||| En cas de contact de la poudre ou de la solution reconstituée de Beromun avec la peau ou les muqueuses, rincer abondamment à l’ eau.
0.2999275326728821 ||| There may be a transient increase in the free fraction and concentration of plasma MPA in patients with delayed renal graft function. ||| The decrease in non-renal clearance in the patients of the study was estimated to give a 20% increase in the AUC of lacosamide. ||| Il peut y avoir une augmentation transitoire de la fraction libre et de la concentration plasmatique du MPA chez les patients ayant
0.3602339029312134 ||| If you are pregnant, or might get pregnant, talk to your doctor before you use AZOPT. ||| - If you have hepatitis B and become pregnant, talk to your doctor about how you can best protect ||| Grossesse et allaitement Si vous êtes enceinte ou si vous pouvez le devenir, parlez-en à votre médecin avant d’utiliser AZOPT.
4.848098918847077e-13 ||| - what you should do in emergency situations when you feel unwell or become ill. ||| - what you should do in emergency situations when you feel unwell or become ill. ||| - ce que vous devez faire dans les situations d’ urgence lorsque vous vous sentez souffrant ou malade.
0.037731386721134186 ||| Read all of this leaflet carefully before you start taking this medicine.  Keep this leaflet. ||| Read all of this leaflet carefully before you start taking your medicine. • Keep this leaflet. ||| Veuillez lire attentivement l'intégralité de cette notice avant d’ utiliser ce médicament.
0.2845260798931122 ||| Details of such a surveillance programme should be agreed with the National Competent Authorities in each member state and put in place prior to marketing of the product. ||| The Marketing Authorisation Holder shall agree the educational material with the national competent authorities in all the Member States prior to the launch of the product. ||| Les détails concernant ce programme de surveillance doivent être approuvés par les autorités nationales compétentes de chaque État membre et mis en place avant la mise sur le marché du produit.
0.34258732199668884 ||| In clinical studies, inadequate response to treatment was seen in 10-15% of the dogs. ||| In a clinical trial, hyperlipaemia was reported as an adverse event in 27% of patients. ||| Dans les études cliniques, une réponse inadéquate au traitement a été observée chez 10 à 15% des chiens.
0.20821620523929596 ||| The same study also showed that, at doses of 2 mg/ kg (of salt) and higher, pramipexole was associated with retinal degeneration in albino rats. ||| However, in one study where Sprimeo was used in combination with an ACEI in a diabetic population, increases in serum potassium were more frequent (5.5%). ||| Au cours de la même étude, il a été observé que l'administration de pramipexole à des doses supérieures ou égales à 2 mg/ kg (de la forme sel) était associée à des dégénerescences de la rétine chez
0.41975414752960205 ||| You are also more likely to get infections. • A low blood platelet count (thrombocytopenia). ||| Those related to the heart: abnormally rapid heart rate (tachycardia), high blood pressure. ||| Vous présentez également un risque accru d’infections. • Nombre réduit de plaquettes sanguines (thrombocytopénie).
0.4508272409439087 ||| What Irbesartan Hydrochlorothiazide Winthrop contains ||| CoAprovel irbesartan/ hydrochlorotiazide Part B ||| Que contient Irbesartan Hydrochlorothiazide Winthrop
0.38119229674339294 ||| Your doctor should decide whether you can take YENTREVE with other medicines. ||| You can take OSSEOR again when you have finished taking these antibiotics. ||| 44 C'est à votre médecin de décider si vous pouvez prendre YENTREVE avec d'autres médicaments.
0.22442124783992767 ||| Adhesive tapes for stationery or household purposes ||| Adhesive tape dispensers for household or stationery use ||| Rubans adhésifs pour la papeterie ou le ménage
0.32639360427856445 ||| As with other blood pressure lowering medicines, the effect of PritorPlus may be reduced when you take NSAIDs (non steroidal anti-inflammatory medicines, e. g. aspirin or ibuprofen). ||| The infusion-associated reactions were managed by a reduction in the infusion rate together with the administration of non-steroidal anti-inflammatory medicinal products, antihistamines and/ or corticosteroids. ||| Comme avec d’ autres médicaments diminuant la pression artérielle, l’ effet de PritorPlus peut être réduit en cas de prise simultanée d’ un AINS (médicament anti-inflammatoire non stéroïdien, par exemple aspirine ou ibuprofène).
0.006614353507757187 ||| Silapo 10000 IU Injection Epoetin zeta iv/sc use ||| Silapo 5000 IU Injection Epoetin zeta iv/sc use ||| Silapo 10 000 UI solution injectable Époétine zêta Voie IV / SC
0.4456448554992676 ||| This instrument will also focus on the EU priorities of the green and digital transitions and on supporting cross-border economic activities. ||| Europe must enhance its strategic autonomy in a number of specific areas, including in strategic value chains and reinforced screening of foreign direct investment. ||| L'instrument mettra aussi l'accent sur les transitions écologique et numérique, qui sont des priorités de l'Union, et sur le soutien aux activités économiques transfrontières.
0.33455178141593933 ||| 8. ||| 8 ||| 12.
0.36931392550468445 ||| A second dose of vaccine should be given after an interval of at least 3 weeks. ||| For the other patients the urine should be collected for at least 6 hours. ||| Une seconde dose de vaccin doit être administrée après un délai d'au moins 3 semaines.
0.42787182331085205 ||| Aluminium hydrate ||| Metal tempering ||| Hydrate d'alumine
4.860133562961666e-13 ||| Regardless of the route of dosing, pronounced pharmacodynamic changes are associated with the administration of Rebif. ||| Regardless of the route of dosing, pronounced pharmacodynamic changes are associated with the administration of Rebif. ||| 44 Indépendamment du mode d’ administration, des changements pharmacodynamiques importants sont associés à l’ administration de Rebif.
3.053061276014901e-13 ||| It has been shown in a clinical study performed with adult haemophilia A patients who undergo a major surgery that KOGENATE Bayer can be used for continuous infusion in surgeries (pre-, during and postoperative). ||| It has been shown in a clinical study performed with adult haemophilia A patients who undergo a major surgery that KOGENATE Bayer can be used for continuous infusion in surgeries (pre-, during and postoperative). ||| 54 Une étude clinique menée chez des patients adultes atteints d’ hémophilie A ayant subi une intervention chirurgicale lourde a montré que KOGENATE Bayer peut être utilisé en perfusion continue en chirurgie (en pré-, per- et postopératoire).
0.08584804087877274 ||| If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia. ||| If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or o thers would be put at risk by hypoglycaemia. ||| Si vous n'êtes pas familiarisé avec les symptômes annonciateurs d'hypoglycémie, évitez les situations - comme de conduire un véhicule - qui pourraient constituer un risque pour vous-même ou des tiers du fait de l'hypoglycémie.
0.0023693921975791454 ||| 81 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 86 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 85 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.43175801634788513 ||| As a result, all the schools and universities were closed, and all public gatherings banned, including sports and cultural events. ||| On 20 March 2020, the government announced that entertainment venues and tea houses would be closed and large weddings and other family gatherings would be prohibited. ||| En conséquence, toutes les écoles et universités ont été fermé et tous les rassemblements publics interdits, y compris les événements sportifs et culturels.
0.2738707661628723 ||| Reconstitution solvents Reconstitute Dynastat 40 mg with 2 ml sodium chloride 9 mg/ ml (0.9%) solution The only other acceptable solvents for reconstitution are: glucose 50 g/ l (5%) solution for infusion sodium chloride 4.5 mg/ ml (0.45%) and glucose 50 g/ l (5%) solution for injection ||| sodium chloride 9 mg/ ml (0.9%) solution glucose 50 g/ l (5%) solution for infusion sodium chloride 4.5 mg/ ml (0.45%) and glucose 50 g/ l (5%) solution for injection Ringer-Lactate solution for injection ||| Les seuls autres solvants admis pour la reconstitution sont: une solution glucosée pour perfusion à 50 g/ l (5%) une solution injectable de chlorure de sodium à 4,5 mg/ ml (0,45%) et de glucose à 50 g/ l (5%).
0.39148688316345215 ||| The study was not powered to show a reduction in clinical fractures in men; the incidence of clinical fractures was 7.5% in men treated with Aclasta versus 8.7% for placebo. ||| In the trial to observe side effects, there were no side effects in 94.2% of cats for the first vaccination and no side effects observed for 99% of cats for the second vaccination. ||| L’ étude n’ était pas conçue pour montrer une réduction sur les fractures cliniques chez les hommes; l’ incidence des fractures cliniques a été de 7,5% chez les hommes traités par Aclasta versus 8,7% chez les hommes sous placebo.
0.39733344316482544 ||| PAH is a debilitating disease where there is severe constriction (narrowing) of the blood vessels of the lungs. ||| Pure red cell aplasia, a condition where the body stopped or reduced the production of red blood cells, has been reported. ||| L’ HTAP est une maladie débilitante dans laquelle une vasoconstriction (rétrécissement) grave des vaisseaux sanguins des poumons se produit.
0.28611642122268677 ||| Ranibizumab is a humanised recombinant monoclonal antibody fragment targeted against human vascular endothelial growth factor A (VEGF-A). ||| Omalizumab is a recombinant DNA-derived humanised monoclonal antibody that selectively binds to human immunoglobulin E (IgE). ||| Le ranibizumab est un fragment d'anticorps monoclonal humanisé recombinant dirigé contre le facteur de croissance de l'endothélium vasculaire humain de type A (VEGF-A).
4.516320585741529e-13 ||| Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed. ||| Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed. ||| Utilisation d’ autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.4920274615287781 ||| - decreased uric acid in blood tests ||| Respiratory: decrease in blood oxygen. ||| - diminution de l’ acide urique plasmatique
0.16038185358047485 ||| If a further dose increase is necessary the daily dose should be increased by 0.54 mg base (0.75 mg salt) at weekly intervals up to a maximum dose of 3.3 mg of base (4.5 mg of salt) per day. ||| Maintenance treatment The individual dose should be in the range of 0.264 mg of base (0.375 mg of salt) to a maximum of 3.3 mg of base (4.5 mg of salt) per day. ||| Si une posologie supérieure est nécessaire, la dose quotidienne peut être augmentée de 0,54 mg de forme base (0,75 mg de forme sel) par semaine, jusqu'à la dose maximale de 3,3 mg de forme base (4,5 mg de forme sel) par jour.
0.03716307133436203 ||| It should also not be used in people with a long-term malabsorption disease (where nutrients from the food are not easily absorbed during digestion), with cholestasis (a liver disorder) or who are breast-feeding. ||| It must also not be used in people with a long-term malabsorption disease (where nutrients from food are not easily absorbed during digestion) or cholestasis (a liver disorder), or in women who are pregnant or breast-feeding. ||| Il ne doit pas non plus être prescrit aux personnes souffrant de malabsorption chronique (maladie dans laquelle les éléments nutritifs des aliments ne sont pas facilement absorbés durant la digestion), de cholestase (trouble du foie), ou aux femmes allaitantes.
0.5318975448608398 ||| Microbial inoculants, other than for medical use ||| Pyrophoric lighters, other than for smokers ||| Inoculants microbiens autres qu'à usage médical
0.34206879138946533 ||| Interactions with substances metabolised by these enzymes, e. g. oral contraceptives, cyclosporin, calcium channel blockers, and HMGCoA reductase inhibitors are not to be expected. ||| Drugs which inhibit Organic Anion Transporting Polypeptides (OATP) The extent of interaction with potent OATP inhibitors (e. g. some statins, proteinase inhibitors, tuberculostatics) is unknown. ||| De ce fait, des interactions avec des substances métabolisées par ces enzymes (contraceptifs oraux, ciclosporine, inhibiteurs calciques et inhibiteurs de la HMG CoA-réductase) ne sont pas attendues.
0.33708611130714417 ||| One capsule contains 200 mg of saquinavir as saquinavir mesilate. ||| 2 ml contains sugammadex sodium equivalent to 200 mg sugammadex. ||| Une gélule contient 200 mg de saquinavir sous forme de mésilate de saquinavir.
0.7320099472999573 ||| Recovery services for vehicles ||| For animal treatment ||| Dépannage de véhicules [remorquage]
0.29976165294647217 ||| Optisulin is a clear, colourless solution for injection containing insulin glargine. ||| Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. ||| Optisulin est une solution injectable, limpide et incolore, contenant de l'insuline glargine.
0.2352156639099121 ||| Tablet coating: hypromellose, titanium dioxide (E171), yellow and red iron oxide (E172), talc. ||| - The other ingredients are sorbitol (E420), sodium dihydrogen citrate (E331[a]), xanthan gum ||| Pelliculage: hypromellose, dioxyde de titane (E171), oxyde de fer jaune et rouge (E172), talc.
0.5816707611083984 ||| How will the 100% financing work? ||| 6) How will CAP funding be allocated? ||| Comment fonctionnera le financement à 100 %?
0.32404983043670654 ||| Plavix is used in adult patients to prevent atherothrombotic events (problems caused by blood clots and hardening of arteries). ||| If you have been diagnosed with angina (chest pain), or peripheral arterial disease (reduced blood flow to the legs): ||| Plavix est utilisé chez l’ adulte pour prévenir les événements athérothrombotiques (problèmes dus à des caillots sanguins et au durcissement des artères).
0.42902711033821106 ||| - If you are allergic (hypersensitive) to pioglitazone, metformin or any of the other ingredients of ||| - Do not take antacids, multi-vitamins or other products that contain calcium (such as milk and ||| - si vous êtes allergique (hypersensible) à la pioglitazone, à la metformine ou à l'un des autres
0.0 ||| Hepato-biliary disorders ||| Hepato-biliary disorders ||| 83 Affections hépato-biliaires
0.31298011541366577 ||| Thus cytochrome P450 metabolism, glucuronide conjugation, and urinary excretion of glucuronidated metabolites represent the primary route of nevirapine biotransformation and elimination in humans. ||| In the kidney, spironolactone inhibits the aldosterone-induced sodium retention leading to increase in sodium and subsequently water excretion, and potassium retention. ||| On peut en conclure que, le métabolisme par le cytochrome P450, la glycuroconjugaison et l'excrétion urinaire de métabolites glycuroconjugués représentent la principale voie de biotransformation et d'élimination de la névirapine chez l'homme.
0.0362740196287632 ||| In a pivotal randomised comparative phase III trial, 2,606 subjects over 60 years of age received 0.1 ml of IDflu by intradermal route and 1,089 subjects over 60 years of age received 0.5 ml of a trivalent inactivated influenza vaccine administered by intramuscular route. ||| In a randomised comparative phase III trial, 1,796 subjects from 18 to 59 years of age received 0.1 ml of IDflu by intradermal route and 453 subjects from 18 to 59 years of age received 0.5 ml of trivalent inactivated influenza vaccine administered by intramuscular route. ||| Au cours d'une étude pivot, comparative, randomisée, de phase III, 2 606 sujets âgés de plus de 60 ans ont reçu 0,1 ml d'IDflu par voie intradermique et 1 089 sujets âgés de plus de 60 ans ont reçu 0,5 ml de vaccin grippal trivalent inactivé administré par voie intramusculaire.
0.05754914879798889 ||| Controlled studies with ACE inhibitors have not been done in humans, but in a limited number of cases with first trimester exposure there do not appear to have been any malformations consistent with human foetotoxicity as described below. ||| Controlled studies with ACE inhibitors have not been done in humans, but a limited number of cases with first trimester toxicity exposure have not appeared to manifest malformations consistent with human foetotoxicity as described below. ||| Des études contrôlées avec des IEC n’ ont pas été réalisées chez l’ homme; sur un nombre limité de cas exposés durant le premier trimestre, il n’ est pas apparu de malformations conséquentes avec foetotoxicité humaine comme décrit ci-après.
0.40867069363594055 ||| These increases in blood pressure can be treated with medicinal products. ||| These blood cells are important for fighting infection and for proper blood clotting. ||| Ces augmentations de la pression artérielle peuvent être contrôlées par un traitement médicamenteux.
0.3574889898300171 ||| Arava 20 mg film-coated tablets Leflunomide ||| Valdoxan 25 mg tablets Agomelatine ||| Arava 20 mg comprimés pelliculés Léflunomide
0.45258447527885437 ||| Grades 3 or 4 neutropenia and thrombocytopenia associated with trabectedin therapy have been very commonly reported. ||| Eight cases were fatal and 5 of them were associated with Common Toxicity Criteria (CTC) grade 4 thrombocytopenia. ||| Une neutropénie et une thrombopénie de grade 3 ou 4 ont été fréquement signalées chez les patients traités par la trabectédine.
0.8333225250244141 ||| The Agency’ s personnel database will be further developed in 2002. ||| This became the first program released by the nascent GNU Project. ||| La base de données "personnel" de l'Agence sera encore développée en 2002.
0.1423855572938919 ||| Yarns made of carbon fibres for textile use ||| Yarns made of synthetic material for textile use ||| Fils en fibres de carbone à usage textile
0.13374637067317963 ||| The most common side-effects (seen in more than 1 patient in 10) are insomnia (difficulty sleeping), constipation, nausea (feeling sick), sweating, headache, and withdrawal syndrome. ||| The most common side-effects (seen in more than 1 patient in 10) are nausea (feeling sick), insomnia (difficulty sleeping), abnormal dreams and headache. ||| Les effets indésirables les plus courants (observés chez plus d' 1 patient sur 10) sont l'insomnie (problème pour dormir), la constipation, les nausées (envie de vomir), la sudation, les céphalées et le syndrome de sevrage.
0.22197982668876648 ||| Pharmacotherapeutic group: other antiepileptics, ATC code: ||| ge Pharmacotherapeutic group: antiparathyroid hormone, ATC code: ||| Classe pharmacothérapeutique: autres anti-épileptiques, code ATC:
0.003753483295440674 ||| Urinary tract infections, increase in certain white blood cells (eosinophilia), allergic reaction (e. g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), slow heart rate (bradycardia), drug rash, eczema (a skin disorder), inflammation of the tendons, ineffectiveness of Pritor and decreased haemoglobin (a blood protein). ||| Urinary tract infections, increase in certain white blood cells (eosinophilia), allergic reaction (e. g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), slow heart rate (bradycardia), drug rash, eczema (a skin disorder), inflammation of the tendons, ineffectiveness of Kinzalmono and decreased haemoglobin (a blood protein). ||| Infections urinaires, augmentation de certains globules blancs du sang (éosinophilie), réaction allergique (par exemple éruptions, démangeaisons, difficulté à respirer, sifflement, gonflement du visage et diminution de la pression sanguine), battements du cœ ur lents (bradycardie), éruption d’ origine médicamenteuse, eczéma (une maladie de peau), inflammation des tendons, inefficacité de Pritor et diminution de l’ hémoglobine (une protéine du sang).
0.2432396113872528 ||| Administration of multiple doses of tenofovir disoproxil fumarate with a meal to HIV infected patients resulted in mean (%CV) tenofovir Cmax, AUC0-∞, and Cmin values of 326 (36.6%) ng/ ml, 3,324 (41.2%) ng·h/ ml and 64.4 (39.4%) ng/ ml, respectively. ||| At the dose of 1250 mg/ m2 on day 14 with administration after food intake, the peak plasma concentrations (Cmax in µg/ ml) for capecitabine, 5'-DFCR, 5'-DFUR, 5-FU and FBAL were 4.67, 3.05, 12.1, 0.95 and 5.46 respectively. ||| Les valeurs moyennes (% CV) de la Cmax, de l’ ASC 0-∞ et de la Cmin, du ténofovir, obtenues chez des patients infectés par le VIH après administration de doses multiples de fumarate de ténofovir disoproxil, étaient respectivement égales à 326 (36,6%) ng/ ml, 3 324 (41,2%) ng·h/ ml et 64,4 (39,4%) ng/ ml.
0.32738035917282104 ||| Use of efavirenz in combination with saquinavir as the sole protease inhibitor is not recommended. ||| Therefore, the combination of valsartan with an ACE inhibitor is not recommended. ||| L’ utilisation de l’ éfavirenz associé au saquinavir comme seul inhibiteur de protéase n’ est pas recommandée.
0.0035217832773923874 ||| 57 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 67 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 58 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.2695792317390442 ||| Each dose contains 0.5 ml of suspension for injection in a vial. ||| One ampoule of solvent contains 1 ml of water for injections. ||| Chaque dose contient 0,5 ml de suspension injectable en flacon.
0.5518162250518799 ||| Scented bathing salts ||| Aerated fruit juices ||| Sels de bain parfumés
0.16920757293701172 ||| As with any antihypertensive agent, excessive reduction of blood pressure in patients with ischaemic cardiopathy or ischaemic cardiovascular disease could result in a myocardial infarction or stroke. ||| Similar considerations apply to patients with ischaemic heart or cerebrovascular disease in whom an excessive fall in blood pressure could result in a myocardial infarction or cerebrovascular accident. ||| Comme pour tout traitement antihypertenseur, une réduction importante de la pression artérielle chez des patients atteints d’ une cardiomyopathie ischémique ou d’ une maladie cardiovasculaire ischémique pourrait entraîner un infarctus du myocarde ou un accident vasculaire cérébral.
0.6708433032035828 ||| Chemical contraceptives ||| Use with hormonal contraceptive ||| Contraceptifs chimiques
0.0 ||| Store in the original package in order to protect from light. ||| Store in the original package in order to protect from light. ||| A conserver dans l'emballage extérieur d’ origine, à l’ abri de la lumière.
0.09252185374498367 ||| ReFacto AF 500 IU powder for solution for injection Moroctocog alfa IV use ||| ReFacto AF 1000 IU powder and solvent for solution for injection Moroctocog alfa ||| ReFacto AF 500 UI, poudre pour solution injectable Moroctocog alfa Utilisation IV
0.028618410229682922 ||| A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) in the body. ||| A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) that is found in the body. ||| Un anticorps monoclonal est un anticorps (un type de protéine) qui a été conçu pour reconnaître et se lier à une structure spécifique (appelée antigène), dans l’ organisme.
0.4009621739387512 ||| Elastomeric sealants in the form of extrudable pastes for joints ||| Chest drainage devices for removal of fluids from the pleural cavity of patients ||| Matériaux d'étanchéité élastomères sous forme de pâtes extrudables pour joints
0.36107486486434937 ||| - if you are allergic (hypersensitive) to any medicinal product in the tetracycline family, ||| - if you are taking fluvoxamine (another medicine used in the treatment of depression) or ||| - si vous êtes allergique (hypersensible) à un médicament de la famille des tétracyclines, y
0.4625205397605896 ||| Efient inhibits the clumping of platelets and so reduces the chance of a blood clot forming. ||| When substance P attaches to these receptors, it causes nausea and vomiting. ||| Efient empêche l’ agrégation des plaquettes et réduit ainsi le risque de formation de caillots sanguins.
0.12620809674263 ||| How does Zactran work? ||| How does Trazec work? ||| Comment Zactran fonctionne -t-il?
0.008081508800387383 ||| 12/ 18 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 12/ 20 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 14/ 20 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.19076359272003174 ||| 90 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (WITH BLUE BOX) (EXCLUDING MULTIPACKS) BOX OF 7 [20] [28] [30] [56] [60] [90] PATCHES ||| 106 PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACKS ONLY OUTER LABEL (WITH BLUE BOX) BOX OF 84 [100] PATCHES CONTAINING 2 BOXES OF 42 [50] PATCHES ||| 100 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR EMBALLAGE EXTÉRIEUR (AVEC « BLUE BOX ») (SAUF EMBALLAGES MULTIPLES) BOÎTE DE 7 [20] [28] [30] [56] [60] [90] PATCHS
0.3224140405654907 ||| For details on safety precautions in the use of insulin pumps, refer to the operator’ s manual. ||| Refer to the operating instructions for detailed information about the infusion pump, its functions and the necessary safety precautions. ||| Pour plus de détails concernant les précautions d'emploi des pompes à insuline, se référer au manuel de l'utilisateur.
0.07292330265045166 ||| What Telzir is and what it is used for 2. ||| What Prialt is and what it is used for 2. ||| Qu'est-ce que Telzir et dans quel cas est-il utilisé 2.
0.3976006805896759 ||| Plastic film for insulating purposes ||| Ligating clips for medical use ||| Films plastiques destinés à l'isolation
0.084877148270607 ||| The medicinal product should not be mixed with other medicinal products. ||| This medicinal product must not be mixed with other medicinal products. ||| Ce médicament ne doit pas être mélangé avec d’ autres médicaments.
0.43849021196365356 ||| The Public Health Agency of Canada (PHAC; French: Agence de la santé publique du Canada, ASPC) is an agency of the Government of Canada that is responsible for public health, emergency preparedness and response, and infectious and chronic disease control and prevention. ||| Korea Centers for Disease Control and Prevention (KCDC; Korean: 질병관리본부; Hanja: 疾病管理本部) is an organisation under South Korean Ministry of Welfare and Health responsible for organ transplant and advancement of public health by managing prevention, survey, quarantine, trial and research on infectious diseases, chronic and rare illnesses and injuries. ||| L’Agence de la santé publique du Canada (Public Health Agency of Canada en anglais) est une agence du Gouvernement du Canada qui est responsable pour la santé publique, les préparations pour les urgences et la réponse aux catastrophes nationales et le contrôle des maladies infectieuses et chroniques.
0.6163442134857178 ||| Rare: impaired hearing. ||| Very rare: hypertensive crisis. ||| Rare: altération de l’ audition.
0.4335777163505554 ||| Supra- ventricular arrhythmia, mainly atrial fibrillation ||| atrial fibrillation, atrioventricular block flushing ||| Arythmie supraventriculaire, principalement à type de fibrillation auriculaire
0.6888891458511353 ||| See section 4.5 of the SPC. ||| IARs are described in section 4.8. ||| Voir rubrique 4.5 du RCP.
0.20112894475460052 ||| Effects of lansoprazole on other drugs ||| The effects of other active substances on lansoprazole ||| 9 Effets du lansoprazole sur d’ autres médicaments
0.4636595845222473 ||| Hydrocortisone aceponate Miconazole as nitrate Gentamicin as sulphate ||| Salmeterol xinafoate and fluticasone propionate ||| Acéponate d’ hydrocortisone Nitrate de miconazole Sulphate de gentamicine
0.6416254043579102 ||| Delirium Nervousness Hallucination Agitation ||| Mania Hallucinations Aggression and anger4 ||| Delirium Nervosité Hallucination Agitation
0.323805570602417 ||| Patients with anorexia, asthenia, nausea, vomiting or diarrhoea may rapidly become dehydrated. ||| - immediately, if you have severe or persistent diarrhoea, nausea, loss of appetite, or vomiting ||| Les patients présentant une anorexie, une asthénie, des nausées, des vomissements ou des diarrhées peuvent rapidement se déshydrater.
0.22824299335479736 ||| In adult patients with moderate liver impairment or in higher weight patients, a dosage adjustment may be necessary (see below). ||| No adjustment of the dose is required in elderly patients, patients with a low bodyweight or in patients with kidney problems. ||| Chez les adultes souffrant d’ insuffisance hépatique modérée ou pesant un poids important, un ajustement de la posologie peut être nécessaire (voir ci-dessous).
0.5260027647018433 ||| 3) The Office of Emergency Services is directed to take necessary steps to ensure compliance with this Order. ||| An Investment Committee composed of independent experts will remain responsible for approving the individual requests. ||| 3) Le Bureau des services d’urgence est tenu de prendre les mesures nécessaires pour assurer le respect de la présente ordonnance.
0.13135382533073425 ||| 7.5 µg ||| 5.0 µg ||| 7,5 µg
0.05816755071282387 ||| Store in a refrigerator (2 °C – 8 °C). ||| Store in a refrigerator (2 °C to 8 °C). ||| A conserver au réfrigérateur (entre 2°C et 8°C).
0.21886980533599854 ||| 10.5 ||| 12.5 ||| 10,5
0.177053302526474 ||| Aprovel is a medicine that contains the active substance irbesartan. ||| Sustiva is a medicine that contains the active substance efavirenz. ||| Aprovel est un médicament dont le principe actif est l'ibesartan.
0.27984997630119324 ||| Masitinib is a protein-tyrosine kinase inhibitor which, in vitro, potently and selectively inhibits the mutated form, in the juxtamembrane (JM) region, of the c-kit receptor. ||| MPA is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. ||| Le masitinib est un inhibiteur de la protéine tyrosine kinase qui, in vitro, inhibe puissamment et de manière sélective la forme mutée, dans la région juxtamembranaire, du récepteur c-kit.
0.4624634087085724 ||| Poland estimates that around 20,000 companies will benefit from around PLN 3.5 billion (€0.7 billion) loans and guarantees under the scheme. ||| Digital tax on companies with a global annual turnover of above €750 million - to generate up to €1.3 billion per year. ||| La Pologne estime qu'environ 20 000 entreprises bénéficieront des 3,5 milliards de PLN (environ 0,7 milliard d'euros) octroyés sous forme de prêts et de garanties dans le cadre de ce régime.
0.22007223963737488 ||| In clinical trials involving patients with relapsed small cell lung cancer, the dose limiting toxicity of oral topotecan monotherapy was found to be haematological. ||| 2 The following regimen is recommended, based on clinical studies with aprepitant, for the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy. ||| Au cours des essais cliniques réalisés chez des patients atteints de cancer du poumon à petites cellules en rechute, la toxicité hématologique du topotécan oral en monothérapie était dose limitante.
0.15243494510650635 ||| In vitro studies demonstrate that rosiglitazone is predominantly metabolised by CYP2C8, with a minor contribution by CYP2C9. ||| In vitro studies indicated that the primary enzyme responsible for the limited metabolism of sitagliptin is CYP3A4, with contribution from CYP2C8. ||| Des études in vitro ont montré que la rosiglitazone était principalement métabolisée par le CYP2C8, le CYP2C9 constituant une voie mineure.
0.24403239786624908 ||| Beyond the immediate crisis response, cohesion policy will be crucial to ensuring a balanced recovery in the longer term, avoiding asymmetries and divergences of growth between and within Member States. ||| There is also a risk that the pandemic could trigger more drastic and permanent changes in attitudes towards global value chains and international cooperation, which would weigh on the highly open and interconnected European economy. ||| au-delà de la réaction immédiate à la crise, la politique de cohésion sera capitale pour garantir une reprise équilibrée à plus long terme, pour éviter les asymétries et les écarts de croissance entre les États membres et en leur sein.
0.24492217600345612 ||| It is used for the treatment of the following diseases: • moderate to severe rheumatoid arthritis (an immune system disease causing inflammation of the joints) in adults. ||| In cats, Onsior tablets are used for the treatment of acute pain and inflammation associated with musculoskeletal disorders (problems with the muscles and bones). ||| Il est utilisé pour le traitement des maladies suivantes: • polyarthrite rhumatoïde modérée à grave (une maladie du système immunitaire provoquant une inflammation des articulations) chez l’ adulte.
0.26490384340286255 ||| In the therapeutic dose-range, agomelatine systemic exposure increases proportionally with dose. ||| Plasma levels increase linearly with the dose and the pharmacokinetic profile is dose-independent. ||| Aux doses thérapeutiques, l'exposition systémique à l'agomélatine augmente proportionnellement à la dose.
0.009923892095685005 ||| As with other anti-HIV medicines, patients taking Agenerase may be at risk of lipodystrophy (changes in the distribution of body fat), osteonecrosis (death of bone tissue) or immune reactivation syndrome (symptoms of infection caused by the recovering immune system). ||| As with other anti-HIV medicines, patients taking Intelence may be at risk of lipodystrophy (changes in the distribution of body fat), osteonecrosis (death of bone tissue) or immune reactivation syndrome (symptoms of infection caused by the recovering immune system). ||| Comme d’ autres médicaments anti-VIH, Agenerase peut entraîner un risque de lipodystrophie (anomalie de la distribution des graisses dans le corps), d’ ostéonécrose (mort du tissu osseux) ou d’ apparition du syndrome de réactivation immunitaire (symptômes de l’ infection dus à la reconstitution du système immunitaire).
0.2762402296066284 ||| A reduction of diabetic complications has been shown in overweight type 2 diabetic patients treated with metformin as first-line therapy after diet failure (see 5.1. ||| One patient treated under a compassionate use program died from cerebral infarct due to leukocytosis, following treatment with chemotherapeutic medicinal products to lower WBC count. ||| Une réduction des complications liées au diabète a été observée chez des patients diabétiques de type 2 en surcharge pondérale traités par la metformine en première intention, après échec du régime alimentaire (voir 5.1.
0.374354749917984 ||| Do not crush, suck, or chew the tablets or break them in half, as this might affect the way the medicine is released from the tablets into your body. ||| If you cannot swallow the tablet(s), you may crush and combine them with a small amount of food or drink, and take all the dose immediately. ||| Ne pas écraser, sucer ou mâcher les comprimés, ni les couper en deux, car la manière dont le médicament est libéré dans votre organisme pourrait être changée.
0.3077048063278198 ||| Manufacturer responsible for Batch Release: ||| Su Manufacturer responsible for batch release ||| Fabricant responsable de la libération des lots:
0.45616477727890015 ||| The additional studies showed that the presence of antibodies was maintained for up to five years. ||| As of 1998, approximately one third of healthcare acquired infections were preventable. ||| Les études complémentaires ont montré que la présence d’ anticorps avait persisté jusqu’ à cinq ans.
0.12484287470579147 ||| Posaconazole is not removed by haemodialysis. ||| Valdecoxib is not removed by haemodialysis. ||| Le posaconazole n’ est pas éliminé par hémodialyse.
0.17773456871509552 ||| The solution must be clear and colourless. ||| The diluted solution must be clear and colourless. ||| La solution doit être transparente et incolore.
0.4877941310405731 ||| Full treatment effect was observed between 2 and 8 weeks. ||| These beneficial effects were maintained for up to 52 weeks. ||| L’ effet optimal du traitement a été observé après 2 à 8 semaines.
0.04664819687604904 ||| ProQuad - Powder in vial and solvent in pre-filled syringe with 1 unattached needle - Pack of 1, 10, 20 ||| ZOSTAVAX - Powder in vial and solvent in pre-filled syringe with one unattached needle - Pack of 1, 10, 20 ||| ProQuad - Poudre en flacon et solvant en seringue préremplie avec 1 aiguille séparée - Boîte de 1, 10 et 20
0.2858918011188507 ||| Serum calcium levels may be transiently decreased to below normal levels following administration of calcitonin, notably upon initiation of therapy in patients with abnormally high rates of bone turnover. ||| In the event of overdose leading to clinically significant hypocalcaemia, reversal may be achieved with supplemental oral calcium and/ or an intravenous infusion of calcium gluconate. ||| Après l'administration de calcitonine, les taux de calcémie peuvent temporairement s'abaisser au- dessous des valeurs normales, en particulier au début du traitement chez les patients présentant un taux anormalement élevé de renouvellement osseux.
0.3123411536216736 ||| Careful monitoring of phenytoin plasma levels is recommended when phenytoin is coadministered with voriconazole. ||| Lithium serum concentration should be monitored closely when initiating or changing parecoxib sodium therapy in patients receiving lithium. ||| Une surveillance étroite des taux plasmatiques de phénytoïne est recommandée en cas de coadministration de voriconazole et de phénytoïne.
0.21164485812187195 ||| Patients with impaired liver function: after multiple dosing of ritonavir to healthy volunteers (500 mg twice daily) and subjects with mild to moderate hepatic impairment (Child Pugh Class A and B, 400 mg twice daily) exposure to ritonavir after dose normalisation was not significantly different between the two groups. ||| In the Phase III dose-optimisation study in patients with chronic phase CML (median duration of treatment approximately 8 months), the incidence of pleural effusion and congestive heart failure/ cardiac dysfunction was lower in patients treated with SPRYCEL 100 mg once daily than in those treated with SPRYCEL 70 mg twice daily (Table 2a). ||| Patients insuffisants hépatiques: le ritonavir a été administré à des doses multiples à des volontaires sains (500 mg deux fois par jour) ainsi qu’à des sujets ayant une insuffisance hépatique légère à modérée (Classe A et B de Child Pugh, 400 mg deux fois par jour): l’exposition au ritonavir après normalisation de la dose n’était pas significativement différente entre les deux groupes.
0.1845991611480713 ||| In those patients in whom tadalafil 10 mg does not produce an adequate effect, 20 mg might be tried. ||| In those patients in whom tadalafil 10 mg does not produce an adequate effect, Tadalafil Lilly 20 mg might be tried. ||| Chez les patients pour lesquels une dose de 10 mg de tadalafil ne produit pas un effet suffisant, une dose de 20 mg peut être préconisée.
0.1736583113670349 ||| Treatment should be initiated and monitored only by a physician experienced in the management of patients with hepatitis C. ||| Treatment should be initiated by and remain under the guidance of a physician experienced in the treatment of sleep disorders. ||| Le traitement doit être initié et suivi uniquement par un médecin expérimenté dans le traitement des patients ayant une hépatite C.
0.3042856454849243 ||| N=151 ||| n=344 ||| N=162
0.6211856007575989 ||| Astatine ||| Manganese ||| Astate
0.029842112213373184 ||| Actraphane 30 40 IU/ ml suspension for injection Insulin human (rDNA) SC use ||| Protaphane 40 IU/ ml suspension for injection Insulin human (rDNA) SC use ||| Actraphane 30, 40 UI/ ml suspension injectable Insuline humaine, (ADNr) Voie SC
0.3742111325263977 ||| Business management services relating to electronic commerce ||| Business management services provided by theatrical agencies ||| Services de gestion commerciale liés au commerce électronique
3.3492707305488034e-13 ||| Depression and suicidal ideation are known to occur in increased frequency in the multiple sclerosis population and in association with interferon use. ||| Depression and suicidal ideation are known to occur in increased frequency in the multiple sclerosis population and in association with interferon use. ||| Les dépressions et les idées suicidaires sont plus fréquentes chez les patients atteints de sclérose en plaques ainsi qu’en association avec l’utilisation d’interféron.
0.37656939029693604 ||| Dysgeusia (G3/ 4: ||| Diarrhoea (G3/ 4: ||| Dysgueusie (G3/ 4:
0.26164883375167847 ||| Pradaxa should also not be used in patients taking quinidine (another medicine used to regulate the heart rhythm). ||| Avandia may be used on its own in patients for whom metformin (an antidiabetes medicine) is not suitable. ||| Pradaxa ne doit pas non plus être utilisé chez les patients prenant de la quinidine (un autre médicament utilisé pour régulariser le rythme cardiaque).
0.307465136051178 ||| However, if you have taken oestrogen in the past and had extreme elevations in triglycerides, you should talk to your doctor before taking EVISTA. ||| If your doctor decides it is inappropriate for you to take ritonavir, you will need to take increased doses of Agenerase (1200 mg twice a day). ||| Cependant, si vous avez pris des œ strogènes par le passé et s’ ils ont entraîné une augmentation importante des triglycérides, vous devez en parler à votre médecin avant de prendre EVISTA.
0.2695392966270447 ||| Although haematological toxicities of neutropenia, thrombocytopenia and anaemia occurred more frequently in HCV/HIV co-infected patients, the majority could be managed by dose modification and rarely required premature discontinuation of treatment (see section 4.4). ||| Viani is indicated for the symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy. ||| Bien que les toxicités hématologiques de type neutropénie, thrombocytopénie et anémie surviennent plus fréquemment chez les patients co-infectés VHC-VIH, la majorité a pu être contrôlée par des modifications de doses et a rarement nécessité des arrêts prématurés de traitement (voir rubrique 4.4).
0.1031324565410614 ||| 14/ 41 ||| 14/ 61 ||| 14/ 43
0.25466740131378174 ||| Pharmacokinetics studies have indicated that the increase in blood levels is mainly a result of increase in oral bioavailability of tacrolimus owing to the inhibition of gastrointestinal metabolism. ||| Laboratory studies have demonstrated that there is a theoretical risk of developing autoimmunity towards the natural (endogenous) BMP proteins in your body following repeat exposure to this medicine. ||| Les études pharmacocinétiques ont montré que l’ augmentation des concentrations sanguines était principalement due à une augmentation de la biodisponibilité orale du tacrolimus en raison de l’ inhibition de son métabolisme gastro-intestinal.
0.33525049686431885 ||| The antimicrobial activity of Convenia following a single injection lasts for up to 14 days. ||| The effectiveness of ProMeris Duo lasted for at least six weeks against fleas and for four weeks against ticks. ||| Après administration unique, l’ activité antimirobienne de Convenia dure pendant 14 jours.
0.12733474373817444 ||| Clinical studies did not include a sufficient number of patients aged 65 and over to determine whether they respond differently than younger patients. ||| Clinical studies of nelarabine did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from younger patients. ||| Sujet âgé: les études cliniques n’ ont pas inclus suffisamment de patients âgés de 65 ans et plus pour permettre de déterminer si cette population répond différemment au traitement que celle des patients plus jeunes.
0.3752710819244385 ||| The ability to induce protection against homologous and heterologous vaccine strains was assessed non-clinically using ferret challenge models. ||| Promote compliance with evidence-based guidelines for diagnosing and managing common infections, and for perioperative antibiotic prophylaxis. ||| La capacité du vaccin à induire une protection contre les souches homologues et hétérologues du vaccin a été évaluée en pré-clinique avec des inoculations d’ épreuve (challenge) chez le furet.
0.22523429989814758 ||| The 2019–20 coronavirus pandemic was confirmed to have reached Monaco on 29 February 2020. ||| The first cases of the 2019–20 coronavirus pandemic in Hungary were announced on 4 March 2020. ||| Le premier cas de contamination à Monaco est confirmé le 28 février 2020.
0.25339776277542114 ||| Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema). ||| If you develop new or worsening symptoms of heart failure (for example shortness of breath, or swelling of your feet), you must contact your doctor immediately. ||| Informez votre médecin le plus rapidement possible si vous avez des signes d’ insuffisance cardiaque tels qu’ une dyspnée (difficulté à respirer) inhabituelle ou une augmentation rapide de poids, ou un gonflement localisé (œ dème).
0.4289485216140747 ||| Construction machines ||| Software creation ||| Machines de construction
0.5903465747833252 ||| Mineral dietary supplements for animals ||| Dietary and nutritional supplements ||| Compléments minéraux destinés aux animaux
0.37478798627853394 ||| The number of confirmed cases increased on 21 February, when sixteen people in Lombardy and Veneto were confirmed to be infected. ||| By 14 March, the number of cases was 31 as two new patients were found positive in Karachi while one was reported in Islamabad. ||| Le nombre de cas bondit au 21 février, lorsque seize personnes de Lombardie et de Vénétie sont confirmées au coronavirus.
0.01497044786810875 ||| One ampoule contains 50 IU recombinant follicle-stimulating hormone (FSH) corresponding to 5 microgram of protein (specific in vivo bioactivity equal to approximately 10 000 IU FSH / mg protein). ||| One vial contains 75 IU recombinant follicle-stimulating hormone (FSH) corresponding to 7,5 microgram of protein (specific in vivo bioactivity equal to approximately 10 000 IU FSH / mg protein). ||| Une ampoule contient 50 UI d’ hormone folliculo-stimulante recombinante (FSH), ce qui correspond à 5 microgrammes de protéine (la bio-activité spécifique in vivo est environ égale à 10 000 UI de FSH / mg de protéine).
0.3187551498413086 ||| Therefore caution should be used in treating such patients. ||| Therefore these patients should be treated with caution. ||| En conséquence, il doit être utilisé avec précaution chez ces patients.
0.0 ||| When telmisartan is taken with food, the reduction in the area under the plasma concentration-time curve (AUC0-∞) of telmisartan varies from approximately 6% (40 mg dose) to approximately 19% (160 mg dose). ||| When telmisartan is taken with food, the reduction in the area under the plasma concentration-time curve (AUC0-∞) of telmisartan varies from approximately 6% (40 mg dose) to approximately 19% (160 mg dose). ||| 9 nourriture, l’ aire sous la courbe des concentrations plasmatiques de telmisartan en fonction du temps (AUC0-∞) varie d'environ 6% pour une dose de 40 mg à environ 19% pour une dose de 160 mg.
0.2586338222026825 ||| If you have impaired kidney function, your doctor will decide upon a dose that suits your condition. ||| If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet. ||| Si vous présentez une insuffisance rénale, votre médecin décidera de la dose adaptée à votre état.
2.7077011422946273e-13 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| vous ressentez un des effets mentionnés comme graves ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien. e am
0.43913137912750244 ||| Dose titration in elderly patients should be exercised with caution (see section 4.4). ||| Since clinical experience in elderly is limited, caution should be exercised .” ||| Sujet âgé: une attention particulière est requise en cas de titration de dose chez le patient âgé (voir rubrique 4.4).
0.2933192253112793 ||| Plasma total immunoglobulin concentrations, total lymphocytes counts, and white cells generally remained within normal limits following MabThera treatment, with the exception of a transient drop in white cells counts over the first four weeks following therapy. ||| Clinical pathology evaluations revealed significant increases in absolute polymorphonuclear leukocyte counts, monocyte counts, percentage of monocytes and decreases in percentage of lymphocyte differential white blood cell counts on day 29 of rats treated with alitretinoin 0.5% gel. ||| Les concentrations plasmatiques d’ immunoglobulines totales, les numérations lymphocytaires totales et le nombre de globules blancs sont restés généralement dans les limites de la normale après un traitement par MabThera, à l’ exception d'une diminution transitoire du nombre de globules blancs pendant les quatre premières semaines suivant le traitement.
0.23082873225212097 ||| How to store INVANZ 6. ||| How to store FABLYN 6. ||| Comment conserver INVANZ 6.
0.15408603847026825 ||| GLASS BOTTLE 50 mg/mL ||| HDPE BOTTLE 50 mg/mL ||| FLACON EN VERRE 50 mg/ml
0.4458610713481903 ||| Discard the protective packaging and attach the needle to the syringe. ||| Swallow the medicine directly from the measuring spoon. ||| Jeter l’emballage protecteur et fixer l’aiguille à la seringue.
0.05808223783969879 ||| 98.4 ||| 94.4 ||| 98,4
0.3099915385246277 ||| Please refer to the patient information leaflets of the other antiretrovirals for guidance on how to take those medicines. ||| Please refer to the Package Leaflets of these other medicines for guidance on how to take them. ||| Veuillez lire les notices de ces autres antirétroviraux afin de savoir comment prendre ces médicaments.
0.457905650138855 ||| Toxic epidermal necrolysis, Stevens-Johnson-Syndrome, psoriasis, including new onset and pustular (primarily palm & soles), erythema multiforme Musculoskeletal and connective tissue disorders Uncommon: ||| Allergic reaction / Chills / Fatigue / Hypotonic-hyporesponsive episode / Malaise / Oedema / Pallor / Swelling or oedema of the entire limb(s) / Transient local lymph node swelling. ||| Nécrolyse épidermique toxique, syndrome de Stevens-Johnson, psoriasis, y compris une première atteinte et atteinte pustuleuse (essentiellement palmo-plantaire), érythème polymorphe
0.42658185958862305 ||| Do not take a double dose to make up for a forgotten oro-dispersible tablet. ||| If this happens skip the missed dose and take the remaining oro-dispersible tablets as normal. ||| Ne prenez pas une double dose pour compenser une gélule oubliée.
0.027124986052513123 ||| In a single dose study (6 subjects/ group), mean plasma MPA AUC observed in subjects with severe chronic renal impairment (glomerular filtration rate < 25 ml min-1 1.73 m-2) were 28-75% higher relative to the means observed in normal healthy subjects or subjects with lesser degrees of renal impairment. ||| In a single dose study (6 subjects/ group), mean plasma MPA AUC observed in subjects with severe chronic renal impairment (glomerular filtration rate < 25 ml• min-1• 1.73 m-2) were 28 – 75% higher 45 relative to the means observed in normal healthy subjects or subjects with lesser degrees of renal impairment. ||| Dans une étude effectuée avec une dose unique (6 sujets/ groupe), l'ASC moyenne du MPA plasmatique chez des patients atteints d'insuffisance rénale chronique sévère (débit de filtration glomérulaire < 25 ml min-1 1,73m-2) était de 28 à 75% supérieure aux ASC moyennes enregistrées chez des sujets sains ou des patients souffrant d'une insuffisance rénale moins sévère.
0.46886125206947327 ||| Exacerbation was measured by worsening of items on the PANSS derived BPRS Positive scale and hospitalization due to worsening of positive psychotic symptoms. ||| * Clinical efficacy has been demonstrated for susceptible isolates in approved clinical indications $Species with natural intermediate susceptibility ||| L’ exacerbation a été mesurée par l’ aggravation des items du score PANSS dérivé de l’ échelle BPRS Positive ainsi que par les hospitalisations dues à l’ aggravation de symptômes psychotiques positifs.
0.424214243888855 ||| 14565 Greece ||| Sweden 10966 ||| 14565 Grèce
0.37003734707832336 ||| Sunitinib and its primary metabolite are mainly metabolized by the liver. ||| Unchanged Halofuginone is the major component in the tissues. ||| Le sunitinib et son métabolite primaire sont essentiellement métabolisés par le foie.
5.825464893458032e-13 ||| Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd Denmark ||| Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd Denmark ||| Novo Nordisk A/ S DK-2880 Bagsværd Novo Allé Danemark
0.20866163074970245 ||| PhotoBarr is contraindicated in patients with severe hepatic impairment. ||| Rasagiline is contraindicated in patients with severe hepatic insufficiency. ||| L'utilisation de PhotoBarr est contre-indiquée chez les patients ayant une insuffisance hépatique sévère.
0.03275066614151001 ||| 4 Because rotigotine decreases prolactin secretion in humans, inhibition of lactation is expected. ||| Because rotigotine decreases prolactin secretion in humans, inhibition of lactation is expected. ||| La rotigotine diminue la sécrétion de prolactine chez l’ être humain, par conséquent, une inhibition de la lactation est attendue.
0.537869393825531 ||| and does this pain move from your chest? ||| do you have any shortness of breath with that chest pain? ||| et la douleur se déplace-t-elle depuis votre poitrine ?
0.2105778157711029 ||| 10.4 16.0 12.1 ||| 10.8 16.4 18.1 ||| 10,4 16,0 12,1 3,2
0.0 ||| Otherwise, the liquid may leak out which can cause inaccurate dosing. ||| Otherwise, the liquid may leak out which can cause inaccurate dosing. ||| Sinon, le liquide risque de s’échapper ce qui peut entraîner un dosage inexact.
0.5013077855110168 ||| The time of infusion is at least 30 minutes. ||| The time to maximum concentration is approximately 0.5 hours. ||| La perfusion doit durer au moins 30 minutes.
0.37673449516296387 ||| For children weighing between 21 kg and 30 kg the recommended oral dose of Combivir is one-half tablet taken in the morning and one whole tablet taken in the evening. ||| Depending on response and tolerability, Vimpat 150 mg tablets may be taken twice a day during the third week and Vimpat 200 mg tablets twice a day during the fourth week. ||| Pour les enfants pesant entre 21 kg et 30 kg, la dose recommandée de Combivir par voie orale est d'un demi-comprimé le matin et d'un comprimé entier le soir.
0.16009268164634705 ||| Neupro 2 mg/ 24 h transdermal patch Each patch releases 2 mg of rotigotine per 24 hours. ||| Neupro 6 mg/24 h Each patch releases 6 mg of rotigotine per 24 hours. ||| Neupro 2 mg/ 24 h dispositif transdermique Chaque dispositif transdermique libère 2 mg de rotigotine par 24 heures.
0.8007223606109619 ||| Diagram T ||| Age Stratum ||| 548 Figure T
0.3730877637863159 ||| During Ovitrelle therapy, a minor thyroid stimulation is possible, of which the clinical relevance is unknown. ||| Sporadic, spontaneous cases of hypercholesterolaemia have been reported, but causality has not been established. ||| Au cours d’ un traitement par Ovitrelle, une légère stimulation thyroïdienne, dont la pertinence clinique est inconnue, est possible.
0.356692910194397 ||| Animal studies with Abraxane showed non-reversible, toxic effects on the male reproductive organs at clinically relevant exposure levels. ||| Safety pharmacology studies with aliskiren did not reveal any adverse effects on central nervous, respiratory or cardiovascular function. ||| Les études animales ont montré des effets toxiques, non réversibles sur les organes reproductifs mâles à des niveaux d’ exposition similaires à ceux observés en clinique.
0.3565855622291565 ||| common: rash, pruritus uncommon: urticaria ||| Common: itching/ pruritus, rash, urticaria ||| fréquent: rash, prurit peu fréquent: urticaire
0.48248541355133057 ||| The 2.7 Orphan medicinal products average time taken by the COMP to adopt recommendations on the designation of orphan medicines in 2002 was 59 days in The Committee for Orphan Medicinal Products (COMP) is average, below the target 90 days. ||| Bali was reported as least able among the 20 most popular destination cities in terms of preparedness, while cities in Australia were considered most able.Australia released its Emergency Response Plan for Novel Coronavirus (COVID-19) on 7 February. |||  EMEA 2003 EMEA rapport annuel pour 2002 EMEA/ MB/ 055/ 02/ fr/ final 2.7 Médicaments orphelins Le comité des médicaments orphelins (COMP) est chargé d'adresser des recommandations à la Commission européenne pour la désignation de médicaments orphelins destinés aux maladies rares.
0.29766032099723816 ||| Chronic Hepatitis C: ||| ge Chronic Hepatitis C: ||| Hépatite C chronique: am
0.3692166209220886 ||| The main measure of effectiveness was the number of patients with a level of HIV in the blood (viral load) that was below 50 copies/ ml after 24 weeks of treatment. ||| Each dose of half a millilitre contains not less than 1000 LD50 units of the virus, which is a measure of the actions of the virus in animals. ||| Le principal critère d’ évaluation de l’ efficacité d’ Intelence était la proportion de patients dont le taux de VIH dans le sang (charge virale) est devenu inférieur à 50 copies/ ml après 24 semaines de traitement.
0.4158326983451843 ||| BeneFIX 1000 IU powder and solvent for solution for injection ||| Powder for injection or infusion 50mg 1 Present ation ||| BeneFIX 1000 UI, poudre et solvant pour solution injectable
0.01831423118710518 ||| Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. ||| Any unused veterinary product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. ||| Tout médicament vétérinaire non utilisé ou déchet dérivé de ce médicament doit être éliminé conformément aux exigences locales.
0.04504483565688133 ||| 5/ 24 ANNEX III ||| 4/ 25 ANNEX III ||| 5/ 24 ANNEXE III
0.7413443326950073 ||| The experience with Glivec in patients with MDS/ MPD associated with PDGFR gene re-arrangements is very limited (see section 5.1). ||| This partially explains why SARS-CoV-2 spread much faster and broader than SARS-CoV. ||| L’ expérience avec Glivec chez les patients atteints de SMD/ SMP associés à des réarrangements du gène du PDGFR est très limitée (voir rubrique 5.1).
0.5730933547019958 ||| Beams of common metal for scaffolding ||| Shock absorbent padding of rubber ||| Poutres en métaux communs pour échafaudages
0.4869304895401001 ||| To help limit the transmission of the virus in Europe and beyond, the EU has closed its external borders to non-essential travel, while ensuring essential goods keep moving across the EU through the introduction of green lanes. ||| It has worked tirelessly to ensure that goods and cross-border workers can continue to move across the EU, to keep hospitals functioning, factories running and shop shelves stocked. ||| Afin de limiter la propagation du virus en Europe et dans d'autres parties du monde, l'Union européenne a fermé ses frontières extérieures aux voyages non essentiels, tout en garantissant la circulation des biens de première nécessité sur le marché intérieur.
0.2393738329410553 ||| CoAprovel 300 mg/ 12.5 mg tablets irbesartan/ hydrochlorothiazide ||| Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12.5 mg ||| CoAprovel 300 mg/ 12,5 mg comprimés irbésartan/ hydrochlorothiazide
0.004832368344068527 ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA), http: / /www. emea. europa. eu/. ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/. ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence Européenne des Médicaments (EMEA) http: / /www. emea. europa. eu/.
0.14022603631019592 ||| Additives (Chemical -) for rubber processing ||| Additives (Chemical -) for cooling agents ||| Additifs chimiques pour le traitement du caoutchouc
0.0 ||| 4.8 Undesirable effects ||| 4.8 Undesirable effects ||| 57 4.8 Effets indésirables
0.36146554350852966 ||| In the therapeutic studies no dosage adjustment was made on the basis of age. ||| The frequency did not exceed that of the control groups in clinical trials. ||| Dans les essais cliniques, aucune adaptation posologique n’ a été effectuée en fonction de l’ âge.
0.31634604930877686 ||| Turbine ventilators [ventilation apparatus] ||| Level controllers [electrical apparatus] ||| Ventilateurs à turbine [appareils de ventilation]
0.005649303086102009 ||| 3 ml solution in a cartridge (type 1 colourless glass) with a plunger (bromobutyl rubber (type 1)) and a flanged cap (aluminium) with a stopper (bromobutyl or laminate of polyisoprene and bromobutyl rubber (type 1)). ||| 3 ml suspension in a cartridge (type 1 colourless glass) with a plunger (bromobutyl rubber (type 1)) and a flanged cap (aluminium) with a stopper (bromobutyl or laminate of polyisoprene and bromobutyl rubber (type 1)). ||| 3 ml de solution en cartouche (verre classe 1 incolore) avec un piston (bromobutyle (type 1)), un sertissage (aluminium) et un bouchon (bromobutyle ou en bromobutyle laminé polyisoprène (type 1)).
0.34218379855155945 ||| Likewise, EVISTA is indicated for the treatment of osteoporosis or established osteoporosis in women with BMD of the spine 2.5 SD below the mean value of a normal young population and/ or with vertebral fractures, irrespective of BMD. ||| Other risk factors which may lead to the development of osteoporosis include early menopause; osteopenia (at least 1 SD below peak bone mass); thin body build; Caucasian or Asian ethnic origin; and a family history of osteoporosis. ||| De la même façon, EVISTA est indiqué pour le traitement de l’ ostéoporose ou de l’ ostéoporose avérée chez les femmes avec une DMO au rachis de 2,5 DS en dessous de la valeur moyenne de la population normale jeune et/ ou avec des fractures vertébrales, quelle que soit la DMO.
0.9973185062408447 ||| 146,074.9 155,518.6 ||| (11,826-105,992) ||| 146 074,9 155 518,6
0.4228147566318512 ||| A transient diffuse swelling may occur at the vaccination site in 50% of the animals, which persists for about 14 days. ||| Elimination follows a first order process and is characterised by a terminal half-life of about 1.3 hours in young healthy volunteers. ||| Un œ dème diffus transitoire peut survenir au point d’ injection chez 50 des animaux et persiste pendant environ 14 jours.
0.2840001583099365 ||| To increase crisis preparedness and crisis management, the Commission will reinforce the European Medicines Agency and give a stronger role to the European Centre for Disease Control (ECDC) in coordinating medical responses in crises. ||| The EU Civil Protection Mechanism is a crisis management structure that allows Member States and Participating States [1] to strengthen their cooperation in the field of civil protection, to improve prevention, preparedness and response to disasters. ||| Pour accroître les capacités de préparation aux crises et de gestion des crises, la Commission renforcera l'Agence européenne des médicaments et le rôle du Centre européen de prévention et de contrôle des maladies (ECDC) en matière de coordination des réactions médicales aux crises.
0.4231151342391968 ||| No dosage adjustment is required in relation to age. ||| This difference in concentrations does not warrant a dose adjustment. ||| Aucune modification de posologie n’ est nécessaire chez les patientes âgées.
1.2032105922698975 ||| 0 Support to EMEA activities ||| 2 Member State EU/ EEA ||| Soutien aux activités de l‘EMEA
0.07336944341659546 ||| Among the opportunistic infections are BK virus associated nephropathy and JC virus associated progressive multifocal leukoencephalopathy (PML). ||| Among these conditions are BK virus associated nephropathy and JC virus associated progressive multifocal leukoencephalopathy (PML). ||| La néphropathie associée au virus BK et la leucoencéphalopathie multifocale progressive (LEMP) associée au virus JC comptent parmi les infections opportunistes.
0.5093799829483032 ||| er The solution is clear, colourless and waterlike with no visible particles. ||| It is clear, colourless to pale yellow, and does not contain flakes or particles. ||| La solution n'est pas limpide, incolore, aqueuse et aucune particule n’ est visible.
0.8915606737136841 ||| How to store MabThera 6. ||| For the Venta-Neb system: ||| Comment conserver M abThera 6.
0.3342305123806 ||| One pen contains 18 million IU of interferon alfa-2b in 1.2 ml of solution. ||| 1 vial with powder for solution for injection contains 300 microgram (9.6 million IU). ||| Un stylo contient 18 millions d’ UI d’ interféron alfa-2b dans 1,2 ml de solution.
0.19802819192409515 ||| You must contact your doctor immediately if you have any of the following early symptoms of allergic (hypersensitivity) reactions: • rash, hives, wheals, generalised itching • swelling of lips and tongue • difficulty in breathing, wheezing, tightness in the chest • general feeling of being unwell • dizziness and loss of consciousness ||| Tell your doctor immediately if you notice any of the following: • Severe rash, hives or other signs of allergic reaction; • Swollen face, hands, feet; • Trouble breathing, swallowing; • Shortness of breath with exertion or upon lying down or swelling of the feet; • Signs and symptoms suggestive of blood disorders such as persistent fever, bruising, bleeding, paleness. ||| Vous devez contacter votre médecin immédiatement si vous ressentez l’un des signes précoces de réaction allergique (hypersensibilité): • rougeurs, urticaire, démangeaisons généralisées • gonflement des lèvres et de la langue • difficulté à respirer, respiration asthmatiforme, oppression thoracique • sensation générale de malaise • vertige et perte de conscience
0.5572211742401123 ||| Patients with mild disease and those unable to walk were not studied. ||| Some people had other illnesses or were taking other medicines. ||| Les cas de maladie discrète et les patients incapables de marcher ont été exclus des études.
0.3523390293121338 ||| Reports of fatal hepatic failure as well as peripheral neuropathy, pancreatitis, and symptomatic hyperlactataemia/ lactic acidosis have been reported with use of ribavirin. ||| Additionally, the pharmacokinetics of Enbrel in rheumatoid arthritis patients, ankylosing spondylitis and plaque psoriasis patients are similar. ||| Des cas d’ insuffisance hépatique fatale, ainsi que de neuropathie périphérique, de pancréatite et d’ hyperlactatémie symptomatique ou d'acidose lactique ont été rapportés lors de l’ utilisation conjointe avec la ribavirine.
0.2744516432285309 ||| In a double-blind placebo-controlled trial designed to assess the efficacy and safety of riluzole in Japanese patients, 204 patients were randomised to riluzole 100 mg/ day (50 mg twice daily) or placebo and were followed-up for 18 months. ||| The efficacy of duloxetine 40 mg given twice daily in the treatment of SUI was established in four double-blind, placebo-controlled studies, that randomised 1913 women (22 to 83 years) with SUI; of these, 958 patients were randomised to duloxetine and 955 to placebo. ||| Dans un essai randomisé en double-aveugle contre placebo, réalisé en vue d'évaluer l'efficacité et la tolérance du riluzole chez des patients japonais, 204 malades ont reçu soit du riluzole à la dose de 100 mg/ jour (50 mg deux fois par jour), soit du placebo et ont été suivis pendant 18 mois.
0.3273082375526428 ||| The Committee for Medicinal products for Human Use (CHMP) concluded that the effectiveness of pioglitazone and metformin in type diabetes 2 had been shown, and that Competact simplifies treatment and improves compliance when a combination of the active substances is required. ||| Efficacy and Safety conclusions The immunogenicity data indicates that Menitorix will be at least as effective as the licensed PRP-T and MenC conjugate vaccines when used for priming and/ or for boosting in accordance with the SPC. ||| Le comité des médicaments à usage humain (CHMP) a conclu que l’ efficacité de la pioglitazone et de la metformine dans le traitement du diabète de type 2 a été démontrée et que Competact simplifie le traitement et améliore l’ adhésion du patient au traitement médicamenteux si l’ administration d’ une combinaison des principes actifs est nécessaire.
0.17565178871154785 ||| The tablets are white to off-white, oblong, film-coated, embossed ‘ 15 / 850’ on one face and ‘ 4833M’ on the other. ||| White to off-white, round, convex and embossed ‘ 4833 G’ on one face and ‘ 30/ 2’ on the other. ||| Les comprimés sont blancs à blanc cassé, ovales, pelliculés, marqués ‘ 15/ 850’ sur une face et ‘ 4833M’ sur l'autre.
0.0028075710870325565 ||| 53 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 56 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 55 MENTIONS DEVANT FIGURER SUR L'EMBALLAGE EXTERIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
0.07280556112527847 ||| The Committee recommended that Sprimeo be given marketing authorisation. ||| The Committee recommended that Myocet be given marketing authorisation. ||| Le CHMP a recommandé que Sprimeo reçoive une autorisation de mise sur le marché.
0.203414648771286 ||| For prevention of surgical site infections following surgery of the colon or rectum, the recommended dose of INVANZ is 1 g administered as a single intravenous dose 1 hour before surgery. ||| For the treatment of post-menopausal osteoporosis and osteoporosis in men, the recommended dose is a single intravenous infusion of 5 mg Aclasta administered once a year. ||| 25 Pour la prévention des infections postopératoires en chirurgie du côlon ou du rectum, la dose recommandée d’ INVANZ est de 1 g en administration intraveineuse unique, dans l’ heure qui précède la chirurgie.
0.42879098653793335 ||| Mix the insulin well immediately before each injection. ||| Later, you must mix the insulin well again immediately before each injection. ||| 753 Bien mélanger l'insuline immédiatement avant chaque injection.
0.21650613844394684 ||| In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not differ between the irbesartan (56.2%) and the placebo groups (56.5%). ||| At 2 years, the rate of non-melanoma skin malignancies was significantly lower in the Rapamune conversion group as compared to the calcineurin inhibitors continuation group (1.8% and 6.9%). ||| Lors des essais cliniques contrôlés versus placebo, menés chez des patients hypertendus, l'incidence globale des évènements indésirables ne présentaient pas de différence entre le groupe traité par irbésartan (56,2%) et le groupe recevant un placebo (56,5%).
0.594753623008728 ||| it is in my chest ||| it hurts in the chest ||| c’est dans ma poitrine
0.47614389657974243 ||| Microporous synthetic sheets for use in manufacture ||| Silicate based color developers for thermoreactive papers ||| Feuilles synthétiques microporeuses destinées à la fabrication
0.4573081135749817 ||| When used with Stalevo, the daily dose of selegiline should not exceed 10 mg. ||| - the dose amount of both Ceplene and IL-2 should be reduced by 20%. ||| En association avec Stalevo, la dose quotidienne de sélégiline ne doit pas dépasser 10 mg.
0.2011573761701584 ||| 231 Tel: + 39- 055 42571 ||| 44 Tel: + 353 (0)1 4955000 ||| Tel: + 39- 055 42571
0.8858984708786011 ||| This conclusion was accepted. ||| This is shown below. ||| Cette conclusion a été acceptée.
0.47098174691200256 ||| MEPs will also look at the general security situation in the EU, in relation to the pandemic. ||| Moreover, it will advise the Commission and perform operational tasks in relation to the Hub. ||| Les députés examineront également la situation générale en termes de sécurité dans l'UE en cette période de pandémie.
0.07217533141374588 ||| In patients with diabetes mellitus optimised glycaemic control delays the onset and slows the progression of late diabetic complications. ||| In patients with diabetes mellitus optimised metabolic control effectively delays the onset and slows the progression of diabetic late complications. ||| Chez les patients atteints de diabète, un contrôle glycémique optimisé retarde l’ apparition et ralentit la progression des complications diabétiques tardives.
0.5199490785598755 ||| Kinzalkomb 40 mg/ 12.5 mg tablets ||| rasburicase 7.5 mg/ 5 ml ||| Kinzalkomb 40 mg/ 12,5 mg comprimés
0.023341502994298935 ||| Take special care with Humalog BASAL Pen • If your blood sugar levels are well controlled by your current insulin therapy, you may not feel the warning symptoms when your blood sugar is falling too low. ||| Take special care with Humalog BASAL KwikPen • If your blood sugar levels are well controlled by your current insulin therapy, you may not feel the warning symptoms when your blood sugar is falling too low. ||| Faites attention avec Humalog BASAL Pen • Si votre glycémie est bien contrôlée par votre insuline actuelle, vous pourriez ne pas ressentir les symptômes précurseurs de l'hypoglycémie.
0.6928564310073853 ||| Interior design services for boutiques ||| Booking agency services for hotel accommodation ||| Services de décoration intérieur pour boutiques
0.3637472987174988 ||| AUC: ↓ 31% (↓ 8 to ↓ 47) Cmin: ↓ 40% A similar reduction in indinavir exposures was observed when indinavir 1000 mg q8h was given with efavirenz 600 mg daily. ||| Co-administration of aliskiren with either valsartan (↓ 28%), metformin (↓ 28%), amlodipine (↑ 29%) or cimetidine (↑ 19%) resulted in between 20% and 30% change in Cmax or AUC of Enviage. ||| ASC: ↓ 31% (↓ 8 à ↓ 47) Cmin: ↓ 40% Une baisse similaire de l'exposition à l'indinavir a été observée lorsque 1000 mg d’ indinavir ont été administrés toutes les 8 heures avec 600 mg d’ efavirenz par jour.
0.36718469858169556 ||| Do not lay the syringe down or let the needle touch anything. ||| - Do not chew, suck or allow the tablet to dissolve in your mouth. ||| Ne posez pas la seringue et ne touchez rien avec l’ aiguille.
0.21578815579414368 ||| The vaccine should not be used after the expiry date which is stated on the syringe label and the outer carton (after EXP). ||| The concentrate for solution for infusion will not be used after the “use by” date that can be found on the vial label and outer carton. ||| Ne pas utiliser Silgard après la date de péremption mentionnée sur l’étiquette de la seringue et de l'emballage extérieur (après EXP).
0.39879634976387024 ||| It is used with ciclosporin and corticosteroids (other medicines used to prevent organ rejection). ||| thyroid hormones (used to treat the thyroid gland disorders), protease inhibitors (used to treat HIV), ||| Il est utilisé en association à la ciclosporine et aux corticoïdes (d’ autres médicaments utilisés pour éviter le rejet d’ organe).
0.07908560335636139 ||| Elderly people • Your starting dose will usually be 0.5 mg twice a day • Your dose may then be gradually adjusted by your doctor to 1 mg to 2 mg twice a day depending on how much you respond to the treatment. ||| Adults • Your starting dose will usually be 2 mg once a day • Your dose may then be gradually adjusted by your doctor depending on how you respond to the treatment • Most people feel better with doses of 1 to 6 mg once a day. ||| Sujets âgés • Votre dose initiale sera généralement de 0,5 mg deux fois par jour • Votre dose pourra être progressivement augmentée par votre médecin de 1 mg à 2 mg deux fois par jour en fonction de votre réponse au traitement.
0.08284088224172592 ||| 9 March 2000 Date of last renewal: ||| 06 March 2003 Date of last renewal: ||| 9 Mars 2000 Date du dernier renouvellement:
0.6053358912467957 ||| I would strongly emphasise once again that we want an agreement - which is why we are urgently working on this - but not at any price. ||| And for that reason, the next seven year budget must be different to what we had imagined, just as Spinelli said. ||| Qu'il me soit permis de le redire très clairement: nous voulons un accord - et nous y travaillons d'arrache-pied -, mais pas à n'importe quel prix.
0.3680952489376068 ||| - increased amounts of certain substances in the blood (transaminases and/or bilirubin) ||| - liver disorders, increased amounts of one substance in the blood (bilirubin), jaundice ||| - augmentation de la quantité de certaines substances dans le sang (transaminases et/ou bilirubine)
0.4289068579673767 ||| An Infectious and Notifiable Diseases Order was issued to take effect from 30 January, which required health practitioners to report any suspected cases under the Health Act 1956. ||| For example, infringement proceedings were opened in February 2020 against all those Member States that failed to notify transposition of the 5th Anti-Money Laundering Directive. ||| Un arrêté sur les maladies infectieuses et à déclaration obligatoire a été délivré pour entrer en vigueur le 30 janvier, obligeant les professionnels de la santé à déclarer tout cas soupçonné en vertu de la Loi sur la santé de 1956.
0.6070131063461304 ||| Within the EU, innovation performance continues to increase at a steady pace. ||| The impact on the cruise line industry was at a level never seen before. ||| Au sein de l'UE, les performances en matière d'innovation continuent d'augmenter à un rythme soutenu.
3.2441481142078676e-13 ||| Based on the review of the initial documentation, the CHMP prepares a list of questions at day 120, which is sent to the company. ||| Based on the review of the initial documentation, the CHMP prepares a list of questions at day 120, which is sent to the company. ||| Sur la base de l’ examen de la documentation initiale, le CHMP prépare une liste de questions (au jour 120), qui est transmise à la société.
0.1410759538412094 ||| Boulevard de la Plaine 17 B-1050 Bruxelles Belgium ||| 17, Boulevards De La Plaine B-1050 Bruxelles Belgium ||| Boulevard de la Plaine 17 B-1050 Bruxelles
0.0015145416837185621 ||| If you stop using Insulin Human Winthrop Comb 15 This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). ||| If you stop using Insulin Human Winthrop Comb 50 This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). ||| 630 Ceci peut entraîner une hyperglycémie sévère (taux très élevé de sucre dans le sang) et une acidocétose (formation d’acide dans le sang lorsque l’organisme dégrade les graisses au lieu du sucre).
0.34167778491973877 ||| It is important to use a separate sterile syringe and needle for each patient to prevent transmission of infectious agents from one individual to another. ||| In these patients, it is recommended to use a different type of dialysis membrane or a different class of antihypertensive agent. ||| Il est important d'utiliser une seringue et une aiguille stérile à usage unique pour chaque patient afin de prévenir la transmission d'agents infectieux d'un sujet à un autre.
0.4247702360153198 ||| As VFEND has been known to affect the liver and the kidney, your doctor should monitor the function of your liver and kidney by doing blood tests. ||| Your kidney function will be checked If you have kidney disease, or are over 65, your kidney function should be checked while you are taking Avaglim. ||| Comme VFEND peut affecter le foie et les reins, votre médecin pourra surveiller le fonctionnement de vos reins et de votre foie par des analyses de sang.
0.46470361948013306 ||| The dosage should be determined on the basis of laboratory measurements of the protein C activity. ||| A single field study was submitted in support of the efficacy of the product. ||| La posologie doit être basée sur les résultats du dosage de l’ activité en protéine C.
0.3861197233200073 ||| No animal studies have been conducted with the combined products of Tandemact. ||| No formal interaction studies have been performed to date with clofarabine. ||| Aucune étude animale n'a été réalisée avec Tandemact.
0.3554331958293915 ||| Pegvisomant is highly selective for the GH receptor, and does not cross-react with other cytokine receptors, including prolactin. ||| Maraviroc selectively binds to the human chemokine receptor CCR5, preventing CCR5-tropic HIV-1 from entering cells. ||| Le pegvisomant est hautement sélectif pour le récepteur de l’ hormone de croissance et n’ interagit pas avec les récepteurs d’ autres cytokines, dont la prolactine.
0.3238603472709656 ||| In the Phase III study in patients with previously untreated multiple myeloma, 27% of patients received prophylactic antivirals in the Vc+M+P arm. ||| The shorter studies in kidney and liver transplant patients showed that Advagraf and Prograf/ Prograft have comparable absorption in the body. ||| Dans l’ étude de phase III chez des patients atteints d’ un myélome multiple non traité au préalable, 27% des patients du bras Vc+M+P ont reçu une prophylaxie antivirale.
0.36739057302474976 ||| Sodium dihydrogen phosphate monohydrate Sodium sulphate Mannitol (E421) Methionine Poloxamer 188 Water for injections ||| Sodium chloride (NaCl) Sodium dihydrogen phosphate dihydrate (NaH2PO4.2 H2O) Water for injections ||| Phosphate monosodique monohydraté Sulfate de sodium Mannitol (E421) Méthionine Poloxamère 188 Eau pour préparations injectables
0.28041374683380127 ||| vial (glass) ||| vial (plastic) ||| Flacon (verre)
0.5818015336990356 ||| Blood pressure decreases to normal or below normal levels after an initial increase. ||| Another 4% had a transient decrease below the lower limit of normal. ||| Après une augmentation initiale, la pression sanguine diminue pour atteindre la normale ou des valeurs légèrement inférieures.
0.18629083037376404 ||| Why has Vectibix been approved? ||| Why has Equilis Te been approved? ||| Pourquoi Vectibix a -t-il été approuvé?
0.4976314604282379 ||| In some cases, it may be necessary to stop treatment with Temodal. ||| It is quite normal to have several courses of treatment with Zarzio. ||| Dans certains cas, il sera nécessaire d’arrêter le traitement par Temodal.
0.09572595357894897 ||| CARTON OF ZYPREXA VELOTAB 15 mg ORODISPERSIBLE TABLETS ||| CARTON OF       OLANZAPINE TEVA 5 mg ORODISPERSIBLE TABLETS ||| ETUI DE ZYPREXA VELOTAB 15 mg COMPRIMES ORODISPERSIBLES
0.39549118280410767 ||| Liver enzymes should be checked prior to the initiation of therapy with Glubrava in all patients. ||| Your doctor will check for interactions between Renagel and other medicines on a regular basis. ||| Chez tous les patients, un dosage des enzymes hépatiques devra être pratiqué avant l'instauration du traitement par Glubrava.
0.4237520396709442 ||| These funds for the WHO will contribute to global preparedness, prevention and containment of the virus and support the countries with the weakest health systems. ||| The European Commission is committed to the principle of universal, equitable and affordable access to vaccines, especially for the most vulnerable countries. ||| Les fonds ainsi destinés à l'OMS permettront de contribuer à la préparation, à la prévention et au confinement du virus au niveau mondial et de soutenir les pays dont les systèmes de santé sont les plus faibles.
0.30401158332824707 ||| Patients receiving CellCept should be instructed to report immediately any evidence of infection, unexpected bruising, bleeding or any other manifestation of bone marrow depression. ||| This included any bone complication needing to be treated either with radiotherapy or surgery, any fractures or any occurrence of spinal compression. ||| Les patients traités par CellCept doivent être informés de la nécessité de contacter immédiatement le médecin pour toute infection, toute ecchymose inexpliquée, tout saignement ou tout autre symptôme de myélosuppression.
0.2868311405181885 ||| Effect of food: the administration of SUSTIVA with food may increase efavirenz exposure (see section 5.2) and may lead to an increase in the frequency of adverse reactions (see section 4.8). ||| Tadalafil has vasodilator properties, resulting in mild and transient decreases in blood pressure (see section 5.1) and as such potentiate the hypotensive effect of nitrates (see section 4.3). ||| Effet de la nourriture: l'administration de SUSTIVA avec de la nourriture peut augmenter l'exposition à l'éfavirenz (voir rubrique 5.2) et peut entraîner une augmentation de la fréquence des effets
0.45507654547691345 ||| Intrathecal treatment of lymphomatous meningitis. ||| • Treatment of amyotrophic lateral sclerosis ||| Traitement intrathécal de la méningite lymphomateuse.
0.32955631613731384 ||| When a patient is given the vaccine, the immune system makes antibodies against the L1 proteins. ||| Ceplene with IL-2 will help your immune system attack any remaining cancer cells after a previous cancer treatment. ||| Lorsque le vaccin est administré, le système immunitaire fabrique des anticorps contre les protéines L1.
0.37871184945106506 ||| Humira was studied in 6593 patients in controlled and open label trials for up to 60 months. ||| Over 4,874 patients were studied in controlled Phase II and III clinical studies. ||| Humira a été étudié chez 6 593 patients dans des essais contrôlés et en ouvert d’ une durée maximale de 60 mois.
0.29440271854400635 ||| The use of filgrastim-mobilised PBPCs has been shown to reduce the depth and duration of thrombocytopenia following myelosuppressive or myeloablative chemotherapy. ||| For the mobilisation of PBPC in patients undergoing myelosuppressive or myeloablative therapy followed by autologous peripheral blood progenitor cell transplantation ||| Il a été montré que l'utilisation de CSP mobilisées par le filgrastim réduit l’ ampleur et la durée de la thrombocytopénie liée à une chimiothérapie myélosuppressive ou myéloablative.
0.4643491506576538 ||| Uncommon (> 1/ 1000, < 1/ 100) ||| (1/ 1000, < 1/ 100) Pharyngitis ||| Peu fréquent (> 1/ 1.000, < 1/ 100)
0.06416944414377213 ||| In pregnant mice, rabbits and rats there were no major effects on embryo-foetal development. ||| In pregnant rats and rabbits there were no major effects on embryo-foetal development. ||| Chez la souris, la rate et la lapine gravides, aucun effet majeur n'a été observé sur le développement embryo-foetal.
0.15747597813606262 ||| The capsule shell is composed of gelatin, yellow iron oxide (E172) and titanium dioxide (E171). ||| The capsule shell is composed of gelatin, red iron oxide (E172), yellow iron oxide (E172) and titanium dioxide (E171). ||| L’ enveloppe de la gélule est composée de gélatine, d’ oxyde de fer jaune (E172), de dioxyde de titane (E171).
0.33997437357902527 ||| Gastrointestinal disorders such as nausea and vomiting may occur particularly when initiating treatment and/ or increasing the dose. ||| Dosage adjustment Concomitant illness, especially infections and feverish conditions, usually increases the patient's insulin requirement. ||| Des troubles gastro-intestinaux tels que nausées et vomissements peuvent survenir particulièrement lors de l’ instauration du traitement et/ ou de l’ augmentation posologique.
0.44115209579467773 ||| A 20 ml measuring cup is provided in the pack. ||| Take the 10 ml syringe out of the package. ||| Une mesurette de 20 ml est fournie dans la boîte.
0.0 ||| INFORMATION IN BRAILLE uc ||| INFORMATION IN BRAILLE uc ||| INFORMATIONS EN BRAILLE mé
0.19699780642986298 ||| Asthemia, pain ||| Asthenia, pain ||| Asthénie, douleur
0.5227649211883545 ||| How to store Helixate NexGen 1000 IU 6. ||| How to store KOGENATE Bayer 500 IU 6. ||| Comment conserver Helixate NexGen 1000 UI 6.
0.2571296691894531 ||| Initial treatment Dosages should be increased gradually from a starting-dose of 0.264 mg of base (0.375 mg of salt) per day and then increased every 5 - 7 days. ||| In clinical trials where a loading dose of 4 mg/ kg trastuzumab followed by a subsequent weekly dose of 2 mg/ kg was used, the mean clearance was 0.225L/ day. ||| Le traitement doit commencer à la dose de 0,264 mg de la forme base (0,375 mg de la forme de sel) par jour, elle doit être augmentée ensuite tous les 5 à 7 jours.
0.194493368268013 ||| OPATANOL 1 mg/ ml eye drops, solution. ||| EMADINE 0.5 mg/ml Eye Drops, solution. ||| OPATANOL 1 mg/ ml, collyre en solution.
0.2849915623664856 ||| These issues were referred to the CHMP during the referral procedure under Article 29 of Directive 2001/ 83/ EC, as amended, on 26 April 2007. ||| Pursuant to Article 33(4) of Directive 2001/ 82/ EC, as amended, the matter was referred to the CVMP. ||| Ces questions ont été transmises au CHMP au cours de la procédure de saisine en vertu de l’ article 29 de la directive 2001/ 83/ CE, telle que modifiée le 26 avril 2007.
0.33516818284988403 ||| Your doctor will tell you whether your illness allows you to drive and to use machines safely. ||| You should be aware of how you react to the medicinal product before you drive or use machinery. ||| Votre médecin vous indiquera si votre maladie vous permet de conduire et d’ utiliser des machines sans risque.
0.39440950751304626 ||| 31 Intravenous injection The dose should be administered over at least 1-5 minutes, depending on the total dose. ||| Revaccination: • One injection at each gestation, at least 2 to 4 weeks before farrowing. ||| a) Injection intraveineuse La dose doit être administrée au moins 1 à 5 minutes, selon la dose totale.
0.3600233197212219 ||| Pharmacokinetic parameters were calculated for amlodipine and lisinopril by the means of Bioequiv 3.5 software using a model independent approach. ||| In PUPs, pharmacokinetic parameters of ReFacto were evaluated using the chromogenic assay. ||| Des paramètres pharmacocinétiques ont été calculés pour l’ amlodipine et le lisinopril au moyen du logiciel Bioequiv 3.5 en utilisant une approche indépendante modèle.
0.3131832480430603 ||| In accordance with standard medical practice for hepatitis B vaccine administration, regular antibody testing should be done in hemodialysis patients. ||| Use of Thyrogen with Tg testing in follow up of post-thyroidectomy well differentiated thyroid cancer patients should be in accordance with official guidelines. ||| Conformément aux pratiques médicales standards pour l'administration de vaccins hépatite B, des contrôles sérologiques réguliers doivent être faits chez les patients hémodialysés.
4.725111361209011e-13 ||| Significant interactions with the clearance of other CYP3A4 substrates are therefore unlikely. ||| Significant interactions with the clearance of other CYP3A4 substrates are therefore unlikely. ||| Des interactions significatives avec la clairance d’ autres substrats du CYP3A4 sont par conséquent improbables.
0.37341511249542236 ||| Also contains lactose monohydrate. ||| This medicinal product contains lactose. ||| Contient du lactose monohydraté.
0.2944769263267517 ||| United Kingdom Glaxo Wellcome UK Limited, Stockley Park West, Uxbridge Middlesex UB11 1BT United Kingdom ||| Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park, Sanderson Road Uxbridge UB8 1DH United Kingdom ||| Royaume-Uni Glaxo Wellcome UK Limited, trading as Allen & Hanburys; Stockley Park West, Uxbridge, Middlesex UB11 1BT, Royaume- Uni
0.2435610145330429 ||| Xeloda is contraindicated during pregnancy. ||| Crestor is contraindicated in pregnancy and lactation. ||| Xeloda est contre-indiqué au cours de la grossesse.
0.016093749552965164 ||| Take special care with Liprolog Mix25 KwikPen • If your blood sugar levels are well controlled by your current insulin therapy, you may not feel the warning symptoms when your blood sugar is falling too low. ||| Take special care with Liprolog Basal KwikPen • If your blood sugar levels are well controlled by your current insulin therapy, you may not feel the warning symptoms when your blood sugar is falling too low. ||| Faites attention avec Liprolog Mix25 KwikPen • Si votre glycémie est bien contrôlée par votre insuline actuelle, vous pourriez ne pas ressentir les symptômes précurseurs de l'hypoglycémie.
0.29976728558540344 ||| Etoricoxib did not inhibit gastric prostaglandin synthesis and had no effect on platelet function. ||| Losartan has no effect on autonomic reflexes and no sustained effect on plasma norepinephrine. ||| L’ étoricoxib n’ a pas inhibé la synthèse des prostaglandines gastriques et n’ a pas eu d’ effet sur la fonction plaquettaire.
0.9323131442070007 ||| 22.4%). ||| section 5.3). ||| 22,4%).
0.21210820972919464 ||| Paliperidone acts mainly by blocking the receptors for the neurotransmitters dopamine and 5-hydroxytryptamine (also called serotonin), which are involved in schizophrenia. ||| It is thought that olanzapine’ s beneficial effect is due to it blocking receptors for the neurotransmitters 5-hydroxytrypamine (also called serotonin) and dopamine. ||| La palipéridone agit principalement en bloquant les récepteurs pour les neurotransmetteurs dopamine et 5-hydroxytryptamine (sérotonine), qui sont impliqués dans la schizophrénie.
0.6066632270812988 ||| Other routes of administration have not been evaluated. ||| All commercial cruises have been suspended until further notice. ||| Les autres voies d’administration n’ont pas été testées.
0.6176013946533203 ||| a) Administering antibiotics to patients according to the prescription; ||| f) Monitoring patient status on a 24 hour basis; and ||| a) administrer des antibiotiques aux patients conformément à la prescription;
0.4210508465766907 ||| Refill packs for cosmetics dispensers ||| Wooden stoppers for industrial packaging containers ||| Recharges pour distributeurs de cosmétiques
0.0 ||| MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE ||| TITULAIRES DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS
0.04023146629333496 ||| 60 mg selamectin ||| 120 mg selamectin ||| 60 mg de selamectine
0.36852145195007324 ||| Erythropoetin is a growth factor that primarily stimulates red blood cell production. ||| Haemoglobin is the protein in red blood cells that carries oxygen around the body. ||| ris L’ érythropoïétine est un facteur de croissance qui stimule essentiellement la production des globules rouges.
0.6742978692054749 ||| Covered tarts ||| Portable desks ||| Tartes couvertes
0.3430485129356384 ||| The following adverse reactions were observed in patients treated with the aprepitant regimen and at a greater incidence than with standard therapy: ||| The most commonly observed adverse events associated with the use of Tasmar, occurring more frequently than in placebo-treated patients are listed in the table below. ||| Les événements indésirables suivants ont été observés avec une incidence supérieure chez les patients traités par aprépitant par comparaison à ceux traités avec un traitement standard:
0.27481406927108765 ||| 10 A population pharmacokinetic analysis was performed to explore the potential effects of selected covariates on panitumumab pharmacokinetics. ||| Race The effect of race on doripenem pharmacokinetics was examined through a population pharmacokinetic analysis. ||| Une analyse pharmacocinétique de population a été effectuée afin d’ étudier les effets potentiels de co- variables sélectionnées sur les propriétés pharmacocinétiques du panitumumab.
0.36853596568107605 ||| A dosage regime of 82 mg/ kg/ day (8 times the human exposure) was associated with reduced foetal survival. ||| This exposure would result in a final dose of 0.5 mg/ kg in a 10 kg infant, assuming 100% absorption. ||| Une posologie de 82 mg/kg/jour (8 fois supérieure à l’exposition humaine) était associée à un taux de survie fœtal réduit.
0.32360947132110596 ||| - The active substance is sodium oxybate. ||| - The active substance is 13C-urea. ||| - La substance active est l’ oxybate de sodium
7.23813045090671e-13 ||| Fold used patches and discard or return to the pharmacy. ||| Fold used patches and discard or return to the pharmacy. ||| 69 Plier les dispositifs utilisés et les jeter ou les rapporter à la pharmacie.
3.6107502079420206e-13 ||| For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information concernant ce médicament, veuillez contacter le représentant local du titulaire de l'autorisation de mise sur le marché.
0.4335889518260956 ||| 3 Hepatic impairment Temsirolimus is cleared predominantly by the liver. ||| Bone marrow suppression (primarily neutropenia) occurs frequently with Abraxane. ||| Insuffisance hépatique Le temsirolimus est éliminé principalement par le foie.
0.3258947730064392 ||| This activity could potentiate the risk of lactic acidosis induced by purine nucleoside analogs (e. g. didanosine or abacavir). ||| - hepatotoxicity based on an increase in hepatic enzymes (e. g. aspartaminotransferase) and a ||| Cette activité peut potentialiser le risque d’ acidose lactique induite par les analogues nucléosidiques de type purine (par exemple didanosine ou abacavir).
0.4227239489555359 ||| You must use the pen as described in these Instructions for Use. ||| Please also refer to the User Manual for instructions on how to use the pen. ||| Vous devez utiliser le stylo tel que décrit dans ces Instructions d’ Utilisation.
1.4075284004211426 ||| On our example schedule each area is split again into 6 injection sites (which adds up to 48 injection sites altogether), left, right, upper, middle and lower part of each area. ||| Upper left section of each area Lower right section of each area Middle left section of each area Upper right section of each area Lower left section of each area Middle right section of each area ||| Dans notre exemple de calendrier, chaque zone est encore divisée en 6 sites d’injection différents (ce qui fait un total de 48 sites d’injection au final): section supérieure, centrale et inférieure dans chaque zone, et côté gauche et droit pour chaque section.
0.5136908292770386 ||| Discharge tubes, electric, for lighting ||| Rotary steam presses, portable, for fabrics ||| Tubes à décharges électriques pour l'éclairage
0.3809075951576233 ||| Gemzar (gemcitabine) is a pyrimidine antagonist (an antimetabolite) that is metabolised intracellularly to active diphosphate and triphosphate nucleosides which inhibit DNA synthesis. ||| ViraferonPeg is a well characterized polyethylene glycol-modified (“pegylated”) derivative of interferon alfa-2b and is predominantly composed of monopegylated species. ||| Gemzar (gemcitabine) est un antipyrimidique (un antimétabolite) qui est métabolisé de façon intracellulaire en nucléosides diphosphate et triphosphate actifs et qui inhibe la synthèse ADN.
0.2579432725906372 ||| Following an oral dose of 14C-labelled clopidogrel in man, approximately 50% was excreted in the urine and approximately 46% in the faeces in the 120-hour interval after dosing. ||| Ioflupane (123I) is cleared rapidly from the blood after intravenous injection; only 5% of the administered activity remains in whole blood at 5 minutes post-injection. ||| Après l'administration par voie orale d'une dose de clopidogrel marqué au 14C chez l'homme, 50% environ de la dose sont éliminés dans les urines et 46% environ dans les selles au cours des 120 heures qui suivent l'administration.
0.24664367735385895 ||| Discontinuation due to any clinical or laboratory adverse event was less frequent for irbesartan-treated patients (3.3%) than for placebo-treated patients (4.5%). ||| 5 The proportion of patients who discontinued treatment due to ADRs was 3.4% for abatacept-treated patients and 2.2% for placebo-treated patients. ||| Les interruptions de traitement dues aux événements indésirables d’ ordre clinique ou biologique étaient moins fréquentes chez les patients traités par irbésartan (3.3%) que chez les patients sous placebo (4.5%).
0.3135347068309784 ||| The suspension is contained in type I flint glass vials, sealed with butyl or halobutyl stoppers and secured with aluminium seals. ||| The suspension is contained in an internally lacquered, 8ml aluminium alloy pressurised container sealed with a metering valve. ||| La suspension est contenue dans des flacons en verre de type I, fermés par des bouchons en halobutyle et sertis par des capsules en aluminium.
0.1397095024585724 ||| (etoricoxib) 90mg dose in AS indication is positive; however, revisions to the contraindications and warnings sections have been added to the summary of product characteristics and package leaflet in relation to cardiorenal safety. ||| dose in the RA and AS indications is positive; however, revisions to the contraindications and warnings sections have been added to the summary of product characteristics and package leaflet in relation to cardiorenal safety. ||| Arcoxia (étoricoxib) à une dose de 90 mg dans l’ indication SA est positif; toutefois, des modifications des sections contre-indications et mises en garde ont été ajoutées au résumé des caractéristiques du produit et à la notice en ce qui concerne la sécurité cardio-rénale.
0.2588692903518677 ||| Caution should be taken when it is given with some medicines, such as rifampicin (used in tuberculosis) or ketoconazole (an antifungal medicine). ||| If you are taking a medicine containing ketoconazole or itraconazole (to treat fungal infections) or containing ritonavir (for HIV). ||| Il convient de faire preuve de prudence lors de l’ association de Sutent avec d’ autres médicaments comme la rifampicine (utilisée en cas de tuberculose) ou le kétoconazole (médicament anti-fongique).
0.4684866964817047 ||| Saquinavir concentrations may be increased. ||| Glucose tolerance may be decreased. ||| Elle peut augmenter les concentrations de saquinavir.
0.6001355648040771 ||| Vildagliptin 50 mg twice daily (N=90) ||| acid 2.5 mg daily (N=334) ||| Vildagliptine 50 mg deux fois par jour (n = 90)
2.5643628388284656e-13 ||| Adolescents, children and infants: undesirable effects and serious laboratory abnormalities reported to occur in paediatric patients ranging in age from birth through adolescence who received stavudine in clinical studies were generally similar in type and frequency to those seen in adults. ||| Adolescents, children and infants: undesirable effects and serious laboratory abnormalities reported to occur in paediatric patients ranging in age from birth through adolescence who received stavudine in clinical studies were generally similar in type and frequency to those seen in adults. ||| Adolescents, enfants et nourrissons: les effets indésirables et les anomalies biologiques graves rapportés chez des patients d'âge compris entre la naissance jusqu'à l'adolescence recevant la stavudine au cours d'essais cliniques, ont été généralement similaires en type et en fréquence à ceux observés chez l'adulte.
0.368213415145874 ||| Less than 1% of the active substance is excreted unchanged in active form, as loratadine or DL. ||| which is an ester, theoretically corresponds to maximally 5.9 mg of sucrose when fully hydrolysed. ||| Moins de 1% de la substance active est excrétée sous la forme active inchangée loratadine ou DL.
0.5318523645401001 ||| This is mostly because of the incomplete transposition and/or incorrect implementation of the EU rules into national legal orders. ||| These documents are released for the purpose of transparency and have no legal force with respect to Directive 2001/83/EC. ||| Ce constat résulte principalement de la transposition incomplète et/ou de la mise en œuvre incorrecte des règles de l'UE dans les ordres juridiques nationaux.
0.7716538906097412 ||| 3 4.9 Amounts to be administered and administration route ||| Overheads - all sectors 17% Initial evaluation 20% ||| 3 4.9 Posologie et voie d’ administration
0.6527405977249146 ||| Lapatinib inhibits CYP3A (Ki 0.6 to 2.3 µg/ ml) and CYP2C8 (0.3 µg/ ml) in vitro at clinically relevant concentrations. ||| ed blood cells < 1,500/ mm3, granulocytes < 1,000/ mm3, thrombocytes < 100,000/ mm3). ||| In vitro, le lapatinib inhibe les cytochromes CYP3A (Ki = 0,6 à 2,3 µg/ ml) et le cytochrome CYP2C8 (Ki = 0,3 µg/ ml) à des concentrations cliniquement pertinentes.
0.40375837683677673 ||| In animal studies glucocorticoids have been shown to induce malformations including cleft palate and intra-uterine growth retardation. ||| In mice, estrogens induce ovarian and testicular tumours as well as hyperostosis and osteosarcomas. ||| Des études effectuées chez l'animal ont montré la survenue de malformations avec fente palatine et des retards de croissance intra-utérine.
0.581859827041626 ||| In 2018, the Commission had proposed a budget of €365 billion in current prices for the CAP, of which € 286.2 billion for the EAGF and around €78.8 billion for the EAFRD. ||| From the overall package of €15.6 billion, €3.25 billion are channelled to Africa, including €2.06 billion for sub-Saharan Africa and €1.19 billion for the Northern African neighbourhood countries. ||| En 2018, la Commission avait proposé un budget de 365 milliards € en prix courants pour la PAC, dont 286,2 milliards € pour le FEAGA et environ 78,8 milliards € pour le Feader.
0.3711254596710205 ||| In all studies, the main measure of effectiveness was the change in symptoms after 8 to 16 weeks. ||| There was no significant difference in any of these parameters over time up to 6 months after transplantation. ||| Au cours de toutes ces études, le critère principal d’ efficacité était une évolution des symptômes après une période de 8 à 16 semaines.
0.08744706213474274 ||| - if you are allergic (hypersensitive) to trabectedin or any of the other ingredients of Yondelis ||| If you are allergic (hypersensitive) to fluticasone furoate or any of the other ingredients of Avamys. ||| - si vous êtes allergique (hypersensible) à la trabectédine ou à l’ un des autres composants
0.5611909627914429 ||| Germicidal lamps ||| Centrifugal drums ||| Lampes germicides
0.17511656880378723 ||| Metabolism of 17β-estradiol, occurs mainly in the liver and gut but also in target organs, and involves the formation of less active or inactive metabolites, including estrone, catecholestrogens and several oestrogen sulphates and glucuronides. ||| Alemtuzumab causes the lysis of lymphocytes by binding to CD52, a highly expressed, non- modulating antigen which is present on the surface of essentially all B and T cell lymphocytes as well as monocytes, thymocytes and macrophages. ||| Le métabolisme du 17ß-estradiol s'effectue principalement dans le foie et l'intestin mais également dans les organes cibles et il implique la formation de métabolites moins actifs ou inactifs, en particulier l’ estrone, les catécholestrogènes et plusieurs sulfates et glycuronides d'estrogènes.
3.2428909817888707e-13 ||| There is no evidence of accumulation following multiple doses in healthy subjects. ||| There is no evidence of accumulation following multiple doses in healthy subjects. ||| Il n’existe pas de preuve d’accumulation après des doses multiples chez des sujets sains.
0.3710005581378937 ||| Concomitant treatment with thrombolytics (e. g. rt-PA or streptokinase) may – increase the risk of bleeding complications – considerably enhance the effect of Refludan on aPTT prolongation. ||| Heart Failure/ Asymptomatic Left Ventricular Dysfunction In the management of symptomatic heart failure , is used in addition to diuretics and, where appropriate, digital is or beta-blockers. ||| L'administration concomitante d'agents thrombolytiques (comme le rt-PA ou la streptokinase) est susceptible de: • majorer le risque de complications hémorragiques; • potentialiser considérablement l'allongement du TCA induit par Refludan.
0.3463921546936035 ||| Biochemical factors that may be indicative of hereditary or acquired predisposition for venous or arterial thrombosis include Activated Protein C (APC) resistance, hyper homocysteinaemia, antithrombin-III deficiency, protein C deficiency, protein S deficiency, antiphospholipid antibodies (anticardiolipin antibodies, lupus anticoagulant). ||| Patients with an inborn lack of antibodies (primary immunodeficiency syndromes (PID)) such as: ● congenital agammaglobulinaemia or hypogammaglobulinaemia, ● common variable immunodeficiency, ● severe combined immunodeficiency, ● Wiskott Aldrich syndrome. ||| Certains facteurs biochimiques peuvent indiquer une prédisposition héréditaire ou acquise à une thrombose veineuse ou artérielle; il s’ agit de la résistance à la protéine C activée (APC), l’ hyperhomocystéinémie, la déficience en antithrombine-III, la déficience en protéine C, la déficience en protéine S, des anticorps antiphospholipidiques (anticorps anticardiolipine, lupus anticoagulant).
0.6073424816131592 ||| SYNAGIS 100 mg Vial Label ||| DUKORAL, vial label 1 dose ||| SYNAGIS 100 mg, Etiquette du flacon:
0.2660309672355652 ||| The Applicant provided an overview of the current knowledge of cancer breakthrough pain (BTP), describing the currently available treatment, and the published data and available safety and efficacy data for other fentanyl products, concluding that fentanyl is an ideal analgesic for treatment of breakthrough pain. ||| In view of the lack of analytical tools to predict immunogenicity in man, the need for regular testing of recombinant HepB batches in clinical trials was considered, in order to ensure consistent high immunogenicity of HBVAXPRO produced in particular according to the new updated/ improved process. ||| Le demandeur a présenté une vue d’ ensemble des connaissances actuelles sur les douleurs paroxystiques du cancer (DPC), décrivant les traitements actuellement disponibles, ainsi que les données publiées et les données de sécurité et d’ efficacité disponibles pour d’ autres médicaments contenant du fentanyl, en concluant que le fentanyl est un analgésique idéal pour le traitement des douleurs paroxystiques.
0.29348668456077576 ||| Always notify your doctor immediately if you have these symptoms or any side effects while taking STOCRIN. ||| If your child shows any side effects after receiving Synagis you should contact your doctor. ||| Informez immédiatement votre médecin de ces symptômes et de tout autre effet indésirable ressenti pendant votre traitement par STOCRIN.
0.548227846622467 ||| Reproductive system and breast disorders Gynaecomastia: very rare in children; uncommon in adults ||| Metabolism and nutrition disorders Mild hyperglycaemia: common (1% in children; 1% - 10% in adults) ||| Affections des organes de reproduction et du sein Gynécomastie: très rare chez l’ enfant; peu fréquent chez l’ adulte
5.802269472179877e-13 ||| Ask your doctor or pharmacist for advice before taking any medicine. ||| Ask your doctor or pharmacist for advice before taking any medicine. ||| Demandez conseil à votre médecin ou à votre pharmacien avant la prise de tout médicament.
0.7949310541152954 ||| i got a fever yesterday ||| and i have a cough too ||| j’ai eu de la fièvre hier
0.5939280986785889 ||| Processed pimientos ||| Constructing porches ||| Piments transformés
0.19862568378448486 ||| Faslodex 250 mg/ 5 ml solution for injection. ||| INCRELEX 10 mg/ml solution for injection. ||| Faslodex 250 mg/5 ml solution injectable.
0.3519258201122284 ||| This may increase the effect of glibenclamide (too low blood sugar level). • probenecid (used to treat gout). ||| Epivir also contains preservatives (parahydroxybenzoates) which may cause allergic reactions (possible delayed). ||| L’ effet du glibenclamide peut augmenter (taux trop bas de sucre dans le sang). • probénécide (utilisé pour le traitement de la goutte).
0.39547497034072876 ||| Only 70 years after the introduction of antibiotics, we are facing the possibility of a future without effective drugs to treat bacterial infections. ||| As of March 2020, it was unknown if past infection provides effective and long-term immunity in people who recover from the disease. ||| Soixante-dix ans seulement après l'introduction des antibiotiques, nous sommes confrontés à la possibilité d'un avenir sans médicaments efficaces pour traiter les patients souffrant d'une infection bactérienne.
4.098949912129113e-13 ||| Aortic and mitral valve stenosis/ hypertrophic cardiomyopathy: ||| Aortic and mitral valve stenosis/ hypertrophic cardiomyopathy: ||| Sténose des valves aortique et mitrale / cardiomyopathie hypertrophique:
0.4533105194568634 ||| Read the package leaflet before use. ||| Read the package insert before use. ||| Lire la notice avant utilisation.
0.2057395577430725 ||| - The other ingredients are sodium chloride, acetic acid, sodium acetate and water for injections. ||| - The other ingredients are methionine, sodium chloride, water for injections, hydrochloric acid ||| - Les autres composants sont chlorure de sodium, acide acétique, acétate de sodium et eau pour
0.6301135420799255 ||| What [Neurontin and associated names] is and what it is used for 2. ||| How to take [Neurontin and associated names] 4. ||| Qu'est -ce que [Neurontin et noms associés] et dans quel cas est -il utilisé 2.
0.41689521074295044 ||| Pull the plunger to withdraw the correct dose into the syringe (see Figure 5). ||| Hold the syringe and vial firmly (see Figure 3). ||| Tirez sur le piston pour aspirer la dose appropriée dans la seringue (voir la figure 5).
0.6676157116889954 ||| 2 Ankylosing spondylitis ||| Areflexia Conjunctivitis Corneal opacity ||| 2 Spondylarthrite ankylosante
0.4538569152355194 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 8416 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ||| (39-06) 59 94 36 66 Fax (39-06) 59 94 34 56 E-mail: n.martini@sanita.it Internet: http://www.sanita.it/farmaci ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu © European Medicines Agency, 2008.
0.23320019245147705 ||| European experts continue to be an important part of the contribution of national competent authorities to the operation of the centralised procedure. ||| The partnership between the EMEA and national competent authorities is a vital part of the functioning of the centralised procedure. ||| Les experts européens représentent une contribution importante des autorités nationales compétentes au fonctionnement de la procédure centralisée.
0.24194276332855225 ||| Cervarix is available in pre-filled syringes with or without needles in packs of 1 and 10. ||| Silgard is available in packs of 1, 10 or 20 pre-filled syringes. ||| Cervarix est disponible en seringues préremplies, avec ou sans aiguilles, conditionnées en boîtes de 1 et 10.
0.2849833071231842 ||| Look out for signs of inflammation or infection soon after you start taking Truvada. ||| • Once you start taking Truvada, look out for possible signs of lactic acidosis. ||| Veillez aux signes d’ inflammation ou d’ infection dès que vous commencez à prendre Truvada.
0.4307994246482849 ||| blood alkaline phosphatase increased, aspartate aminotransferase increased, alanine aminotransferase increased, blood bilirubin increased (including hyperbilirubinaemia), liver function test abnormal ||| jaundice, hepatitis, increased Alanine Aminotransferase (ALT), increased Aspartate Aminotransferase (AST), increased Gamma Glutamyl Transferase (GGT), increased alkaline phosphatase ||| l’ aspartate aminotransférase (ASAT), augmentation de l’ alanine aminotransférase (ALAT), augmentation de la bilirubinémie (y compris hyperbilirubinémie), anomalie des tests hépatiques
0.13222718238830566 ||| 17/ 22 ||| 18/ 22 ||| 18/ 24
0.3260922431945801 ||| Total dose (mg) = Dose (mg/m2) x BSA (m2) ||| Volume (ml) = BSA (m2) x individual dose (mg/ m2) 0.05 mg/ ml ||| Dose totale (mg) = dose (mg/m2) x surface corporelle (m²)
0.5267928242683411 ||| Stirrups of metal ||| Girths of leather ||| Étriers métalliques
0.0040204450488090515 ||| 51 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 49 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 53 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.00955546647310257 ||| Ciprofloxacin Bayer and associated names (see Annex I) 200 mg/100 mL solution for infusion [See Annex I - To be completed nationally] ||| Ciprofloxacin Bayer and associated names (see Annex I) 200 mg/ 100 mL solution for infusion [See Annex I - To be completed nationally] ||| Ciprofloxacine Bayer et noms associés (voir Annexe I) 200 mg/100 ml, solution pour perfusion [Voir Annexe I – À compléter au niveau national]
0.4422476887702942 ||| Adult Use ||| Oral use ||| Chez l’adulte
0.33784282207489014 ||| Remove the protective tab from the injection needle. ||| Remove the pre-filled syringe from the refrigerator. ||| Retirez la languette de protection de l’aiguille.
0.5549561977386475 ||| A gradual dose increase of atorvastatin may be tailored to the clinical response. ||| The absolute and relative risk reduction effect of atorvastatin was as follows: ||| Une augmentation progressive de la dose d’atorvastatine peut être envisagée en fonction de la réponse clinique.
0.42314061522483826 ||| The mean (%CV) tenofovir Cmax and AUC0-∞ values were 223 (34.8%) ng/ ml and 2,050 (50.8%) ng• h/ ml, respectively, in normal subjects compared with 289 (46.0%) ng/ ml and 2,310 (43.5%) ng• h/ ml in subjects with moderate hepatic impairment, and 305 (24.8%) ng/ ml and 2,740 (44.0%) ng• h/ ml in subjects with severe hepatic impairment. ||| The immunogenicity of Gardasil was assessed in 8,915 (Gardasil n = 4,666; placebo n = 4,249) women 18 to 26 years of age and 3,400 female (Gardasil n = 1,471; placebo n = 583) and male (Gardasil n = 1,071; placebo n = 275) adolescents 9 to 17 years of age. ||| Les valeurs moyennes (% CV) de la Cmax et de l’ ASC0-∞ du ténofovir ont été respectivement de 223 (34,8%) ng/ ml et 2.050 (50,8%) ng• h/ ml chez les sujets normaux contre respectivement 289 (46,0%) ng/ ml et 2.310 (43,5%) ng• h/ ml chez les sujets ayant une insuffisance hépatique modérée et 305 (24,8%) ng/ ml et 2.740 (44,0%) ng• h/ ml chez ceux ayant une insuffisance hépatique sévère.
0.0024415357038378716 ||| NovoMix 50 FlexPen 100 U/ ml Suspension for injection in a pre-filled pen Insulin aspart ||| NovoMix 30 FlexPen 100 U/ ml Suspension for injection in a pre-filled pen Insulin aspart ||| NovoMix 50 FlexPen 100 U/ ml Suspension injectable en stylo prérempli Insuline asparte
0.065513975918293 ||| AUC: ↓ 4% (↓ 0 to ↓ 31) Cmax: ↓ 47% (↓ 9 to ↓ 51) Total active HMG Co-A reductase inhibitors: ||| AUC: ↓ 60% (↓ 52 to ↓ 68) Cmax: ↓ 62% (↓ 55 to ↓ 78) Total HMG Co-A reductase inhibitors: ||| ASC: ↓ 4% (↓ 0 to ↓ 31) Cmax: ↓ 47% (↓ 9 to ↓ 51) Totalité des inhibiteurs de l’ HMG CoA- réductase sous forme active:
0.11696023494005203 ||| What benefit has TOVIAZ shown during the studies? ||| What benefit has OPTISON shown during the studies? ||| Quel est le bénéfice démontré par TOVIAZ au cours des études?
0.3828310966491699 ||| If you have any problems, please do not be afraid to ask your doctor or nurse for help and advice. ||| − if you have any other health concerns, discuss these with your doctor as soon as you can. ||| Si vous rencontrez des difficultés, n’hésitez pas à demander aide et conseil à votre médecin ou à l'infirmière.
1.037157416343689 ||| Ibaflin 3% Oral Gel Ibaflin 7.5% Oral Gel ||| Human Milk Fat Globule 1 / Human Milk Fat Globule 1- ||| Ibaflin 3% gel oral Ibaflin 7.5% gel oral
0.1997481882572174 ||| Ebixa 10 mg film-coated tablets. ||| Zocord 40 mg, film-coated tablets. ||| Ebixa 10 mg comprimés pelliculés.
0.0 ||| These state guarantees can cover up to 90% of risk on loans to help businesses cover immediate working capital and investment needs. ||| These state guarantees can cover up to 90% of risk on loans to help businesses cover immediate working capital and investment needs. ||| Ces garanties publiques peuvent couvrir jusqu'à 90 % des risques de crédit afin d'aider les entreprises à couvrir leurs besoins immédiats en fonds de roulement et en investissements.
0.0 ||| In euglycaemic clamp studies in healthy subjects or in patients with type 1 diabetes, the onset of action of subcutaneous insulin glargine was slower than with human NPH insulin, its effect profile was smooth and peakless, and the duration of its effect was prolonged. ||| In euglycaemic clamp studies in healthy subjects or in patients with type 1 diabetes, the onset of action of subcutaneous insulin glargine was slower than with human NPH insulin, its effect profile was smooth and peakless, and the duration of its effect was prolonged. ||| 30 Des études de clamp euglycémique menées chez des sujets sains et des patients atteints de diabète de type 1 ont montré que l'effet de l'insuline glargine sous-cutanée apparaissait plus lentement que celui de l'insuline NPH humaine, que cet effet était régulier, sans pics, et que sa durée d'action était prolongée.
0.30435341596603394 ||| The risk was reduced by 41% over three years, with 21% of the 719 women who took OSSEOR developing a new vertebral fracture, compared with 33% of those 723 who took placebo. ||| Over four years, in comparison with placebo, Evista decreased the number of new vertebral fractures by 46% in women who had osteoporosis and by 32% in women who had osteoporosis and an existing fracture. ||| Le risque a été réduit de 41% sur trois ans, 21% des 719 femmes traitées par OSSEOR ayant développé une nouvelle fracture vertébrale contre 33% des 723 femmes traitées par placebo.
0.3667069673538208 ||| Oscillators for clocks ||| Closures for necklaces ||| Oscillateurs d'horloges
0.3051615357398987 ||| Once the rubber inlay of a cartridge is pierced by a needle, the product may be stored for a maximum of 28 days. ||| The top of the vial and of the cartridge should be wiped with an antiseptic solution in order to prevent contamination of the contents. ||| Une fois le joint d’ obturation en caoutchouc de la cartouche percé par une aiguille, le médicament peut être conservé pendant un maximum de 28 jours.
0.4657507836818695 ||| Compilation of directories for publishing on global computer networks or the internet ||| Business administration services for the processing of sales made on a global computer network ||| Compilation de répertoires pour leur publication sur un réseau informatique mondial ou sur Internet
0.1685035079717636 ||| Building bricks (Non-metallic -) ||| Cladding materials (Non-metallic -) ||| Briques de construction non-métalliques
0.01472916267812252 ||| 12 Skin and subcutaneous tissue disorders Common effects: blisters, erythema, burn, skin hyperpigmentation, photosensitivity reaction, sunburn, skin necrosis. ||| Skin and subcutaneous tissue disorders Common effects: blisters, erythema, burn, skin hyperpigmentation, photosensitivity reaction, sunburn, skin necrosis. ||| Affections de la peau et du tissu sous-cutané Effets fréquents: phlyctène, érythème, brûlure, photosensibilité, coup de soleil, nécrose cutanée.
0.2749401032924652 ||| If in cases of deep pyoderma, sufficient improvement is not seen after a treatment course of 21 days, it is recommended that the treatment is reconsidered. ||| With prolonged treatment for more than 2 years, regular reassessment is recommended to confirm that continuing the selected therapy remains appropriate for the patient. ||| Si dans les cas de pyodermite profonde, une amélioration suffisante n’ a pas été observée après une durée de traitement de 21 jours, il est recommandé de reconsidérer le traitement.
0.40833890438079834 ||| Irbesartan exhibits linear and dose proportional pharmacokinetics over the dose range of 10 to 600 mg. ||| Absorption/ dose proportionality: pharmacokinetics were linear up to a dose of 650 mg/ m2. ||| L'irbésartan présente une pharmacocinétique linéaire et proportionnelle à la dose dans une fourchette de 10 à 600 mg.
0.5798259973526001 ||| Angle joints [parts of machines] ||| Palms [leaves of the palm tree] ||| Joints à angle [parties de machines]
0.01521783322095871 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. ||| If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, contact your doctor. ||| Si vous remarquez des effets indésirables non mentionnés dans cette notice, ou si vous ressentez un des effets mentionnés comme étant graves, veuillez en informer votre médecin.
0.45776599645614624 ||| Shift dresses ||| Quartz watches ||| Robes droites
0.3472970128059387 ||| A transient diffuse swelling may occur at the vaccination site in 50% of the animals, which persists for about 14 days. ||| Occasionally, an infection in the internal portion of the eye can occur after Macugen treatment (in the next two weeks). ||| Un œ dème diffus transitoire peut survenir au point d’ injection chez 50 des animaux et persiste pendant environ 14 jours.
0.34684059023857117 ||| Machines for the production of semiconductors ||| Lacquers for the repair of motor vehicles ||| Machines destinées à la fabrication de semi-conducteurs
0.0 ||| By controlling the blood glucose, the symptoms and complications of diabetes are reduced. ||| By controlling the blood glucose, the symptoms and complications of diabetes are reduced. ||| Le contrôle de la glycémie permet ainsi de réduire les symptômes et les complications du diabète.
0.5288699865341187 ||| A training programme has been developed to cover introductory training, training on the history and main policy of the European Union, management training, and relevant professional training courses. ||| A wide range of documents has now been published by the EMEA, including press releases, general information documents, annual reports and work programmes. ||| Un programme de formation a été mis en place pour assurer la formation initiale, et des formations consacrées aux principales politiques de l’Union européenne, à la gestion ainsi que des cours de formation professionnelle appropriés.
0.3672179579734802 ||| The EMEA continued its contacts with the European Parliament, in particular with the Committee on Environment, consumer protection and public health, and also the Committee on Budgets. ||| Activities with other national competent authorities are primarily focused on relations with the US Food and Drug Administration (FDA) and the Japanese Ministry of Health and Welfare. ||| L’EMEA est restée à l’écoute du Parlement européen, et en particulier de la commission de l’environnement, de la santé publique et de la protection des consommateurs, ainsi que de la commission des budgets.
4.919236675990368e-13 ||| Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| 218 Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000
0.3602265417575836 ||| Women who might get pregnant are advised to use effective contraception during treatment with SUTENT. ||| Genetic counselling is also recommended for patients wishing to have children after therapy. ||| Il est conseillé aux femmes susceptibles d’ être enceintes d’ utiliser une méthode adaptée de contraception pendant le traitement par SUTENT.
5.184586484088816e-13 ||| Read the package leaflet before use ||| Read the package leaflet before use ||| Lire la notice de l’emballage avant utilisation.
0.0 ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/ ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/ ||| Des informations détaillées sur ce produit sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA) http: / /www. emea. europa. eu/..
0.08879843354225159 ||| Olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. ||| ABILIFY is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. ||| Chez les patients ayant initialement répondu au traitement, l’ olanzapine a démontré son efficacité à maintenir cette amélioration clinique au long cours.
0.4463893175125122 ||| A number of guidance documents on using the mutual recognition procedure were published in 2001 to assist applicants and marketing authorisation holders. ||| As described in the RMP, additional risk minimisation activity including educational material will be provided to prescribers. ||| Plusieurs documents d'orientation sur l'utilisation de la procédure de reconnaissance mutuelle ont été publiés en 2001 pour aider les demandeurs et les titulaires d'autorisation de mise sur le marché.
0.3231234550476074 ||| As for other insulin products, hypoglycaemia, in general is the most frequently occurring undesirable effect. ||| ed The most often seen undesirable effect in insulin-treated patients is a change in blood glucose levels. ||| Comme pour les autres insulines, l’ effet indésirable le plus fréquemment observé est généralement l’ hypoglycémie.
0.3829385042190552 ||| The overall incidence of infections was 75.9% in the basiliximab group and 75.6% in the placebo group and the incidence of serious infections was 26.1% and 24.8%, respectively. ||| The 1-year patient survival was 83% in the tacrolimus and 71% in the ciclosporin group, the 2-year survival rates were 76% and 66%, respectively. ||| La fréquence globale des infections était de 75,9% dans le groupe basiliximab et de 75,6% dans le groupe placebo et la fréquence des infections graves était respectivement de 26,1% et 24,8%.
0.39097294211387634 ||| In the cases occurring during treatment, most of these events (16/ 22) occurred in patients presenting no response to Raptiva. ||| Some additional side effects were very rarely reported (1 to 10 in 10,000 patients) after Thyrogen was available for subscription by physicians. ||| La majorité de ces cas (16/ 22) survenant en cours de traitement ont été observés chez des patients non- répondeurs.
0.077985018491745 ||| What benefit has Renagel shown during the studies? ||| What benefit has Tracleer shown during the studies? ||| Quel est le bénéfice démontré par Renagel au cours des études?
0.4382360279560089 ||| This product contains sucrose and sorbitol. ||| These capsules also contain sorbitol. ||| Ce produit contient du saccharose et du sorbitol.
0.3524926006793976 ||| You will need to give yourself the injection into the tissue just under the skin. |||  When the needle is completely inserted into the skin, release the skin that you are holding. ||| pl Vous allez vous injecter le pro duit dans la région située juste sous la peau.
0.4743592143058777 ||| Pressurised inhalation suspension ||| Fluidised bed incineration ovens ||| Suspension pour inhalation en flacon pressurisé
0.05155496299266815 ||| 337 Ελλάδα Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ.: + 30-210 98 97 300 ||| 284 Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ.: + 30-210 98 97 300 ||| Ελλάδα Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ.: + 30-210 98 97 300
0.31488269567489624 ||| The Commission's objective is to build a consensus around a fresh medium-term direction for EU trade policy, responding to a variety of new global challenges and taking into account the lessons learned from the coronavirus crisis. ||| The EU strongly emphasised the need to advance negotiations for an ambitious EU-China Comprehensive Investment Agreement that addresses the current asymmetries in market access and ensures a level playing field. ||| L'objectif de la Commission est de parvenir à un consensus sur la nouvelle direction à donner à la politique commerciale européenne à moyen terme pour répondre à divers nouveaux défis qui se posent au niveau mondial et en tenant compte des enseignements tirés de la crise du coronavirus.
0.187037855386734 ||| In repeated-dose toxicity studies, dose-related liver changes (weight, centrilobular hypertrophy, occasionally necrosis), induction of hepatic drug metabolising enzymes and slightly decreased erythron parameters were seen in mice, rats and dogs. ||| Decreases in parameters of peripheral activity characteristic of psoriatic arthritis (such as number of swollen joints, number of painful/ tender joints, dactylitis and presence of enthesopathy) were seen in the infliximab-treated patients. ||| Lors d’ études de toxicité à doses répétées, des modifications hépatiques dose-dépendants (poids, hypertrophie centro-lobulaire, nécrose occasionnelle), une induction des enzymes hépatiques métabolisant le médicament et une légère diminution des paramètres d’ érythron ont été observés chez la souris, le rat et le chien.
0.44192203879356384 ||| The similarity of Menitorix to already licensed products and the fact that the available safety data do not indicate any unusual problems are both reasons to accept the database provided. ||| The results provided as a whole clearly indicate the non inferiority of the generic product to the reference product and the Applicant considered both products to be fully interchangeable. ||| La similitude de Menitorix avec des produits déjà autorisés et le fait que les données disponibles concernant la sécurité ne font apparaître aucun problème inhabituel constituent deux raisons pour accepter la base de données fournie.
0.4409627914428711 ||| Appropriate studies have been made to show the effectiveness in the various target animals. ||| It was concluded that the product is well tolerated by horses of different age. ||| Des études appropriées ont été réalisées pour démontrer l’ efficacité sur les différents animaux cibles.
0.0 ||| Lactation Rasilez HCT is contraindicated during lactation (see section 4.3). ||| Lactation Rasilez HCT is contraindicated during lactation (see section 4.3). ||| 8 Allaitement Rasilez HCT est contre-indiqué pendant l’ allaitement (voir rubrique 4.3).
0.35847511887550354 ||| 95 Effect of food: the AUC and Cmax of a single 240 mg dose of efavirenz oral solution in uninfected adult volunteers was increased by 30% and 43% respectively, when given with a high-fat meal, relative to fasted conditions. ||| The addition of Avastin 5 mg/ kg every two weeks to 5-FU/ FA resulted in higher objective response rates, longer progression-free survival, and a trend in longer survival, compared with 5-FU/ FA chemotherapy alone (see Table 4). ||| Effet dede la nourritures: l'aire sous la courbe et la Cmax après une dose unique de 240 mg d’ éfavirenz solution buvable chez des volontaires adultes et non infectés sont augmentés respectivement de 30% et 43%, après un repas riche en graisses, par rapport aux valeurs obtenues après la prise du médicament à jeun.
0.407454252243042 ||| Taking Ketek at bedtime may reduce the potential impact of side effects such as visual disturbances and loss of consciousness. ||| Ketek may cause visual disturbances particularly in slowing the ability to accommodate and the ability to release accommodation. ||| La prise de Ketek au moment du coucher peut diminuer les conséquences possibles d’ effets indésirables tels que troubles visuels et perte de connaissance.
0.2855571508407593 ||| Withdraw the entire volume of solvent into the syringe to be used for reconstitution. ||| Inject the entire content of the pre-filled syringe into the vial containing the powder. ||| Prélever la totalité du solvant avec la seringue à utiliser pour la reconstitution.
0.29389089345932007 ||| 143 Controlled clinical trials have not shown significant benefits attributable to the administration of epoetins when haemoglobin concentration is increased beyond the level necessary to control symptoms of anaemia and to avoid blood transfusion. ||| The first controlled clinical trial investigating tissue sealing in lung surgery failed to document superiority over standard treatment measured by air leakage due to the inclusion of a large group of patients (53%) without air leakage. ||| Les essais cliniques contrôlés n’ ont pas montré d’ effets bénéfiques significatifs attribuables à l’ administration des époétines lorsque le taux d’ hémoglobine dépassait le niveau nécessaire au contrôle des symptômes de l’ anémie et pour éviter une transfusion sanguine.
0.5934406518936157 ||| Janssen Cilag, SA Paseo de las Doce Estrellas, 5- 728042 Madrid, Spain ||| Carretera Camprodón, s/ n - La Riba E-17813-Vall de Bianya (Girona) Spain ||| Janssen Cilag, SA Paseo de las Doce Estrellas, 5-7 28042 Madrid, Espagne
0.40628600120544434 ||| A 10% reduction in the initial body weight was observed in 35% and 17% of patients, respectively. ||| This was compared with an increase of 2.6 points from 22.5 in the patients taking placebo. ||| Une diminution de 10% du poids corporel initial a été observée chez respectivement 35% et 17% des patients.
2.592105946119111e-13 ||| Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. ||| Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. ||| Les patients présentant des troubles congénitaux rares d’ intolérance au galactose, une galactosémie, un syndrome de malabsorption du glucose et du galactose ne doivent pas prendre ce médicament.
0.1526447832584381 ||| 11/ 19 ||| 10/ 21 ||| 12/ 21
0.3605024218559265 ||| Arranging of business travel ||| Arranging of passenger transport ||| Organisation de voyages d'affaires
0.3573434352874756 ||| Once the bottle is opened, the product must be used within 30 days ||| Once removed from the refrigerator the medicinal product must be used within this period. ||| Après ouverture du flacon, le produit doit être utilisé dans les 30 jours.
0.23167744278907776 ||| ORENCIA can be taken with other medicines commonly used in the treatment of rheumatoid arthritis, such as steroids or painkillers including non-steroidal anti-inflammatories such as ibuprofen or diclofenac. ||| Revatio should not be taken with nitrates (a group of medicines used to treat angina), with ketoconazole or itraconazole (anti-fungal medicines), or with ritonavir (used to treat HIV infection). ||| La prise d’ ORENCIA est possible avec d’ autres médicaments fréquemment utilisés pour traiter la polyarthrite rhumatoïde tels que les corticoïdes ou les médicaments anti-douleurs incluant les anti- inflammatoires non-steroïdiens comme l’ ibuprofène ou le diclofénac.
0.0 ||| Please discuss this with your doctor. ||| Please discuss this with your doctor. ||| Parlez -en avec votre médecin.
0.416780948638916 ||| NovoRapid is a clear colourless solution for injection. ||| Soliris is a clear and colorless solution. ||| NovoRapid est une solution injectable limpide et incolore.
4.943532562473596e-13 ||| Store in the original package, in order to protect from light. ||| Store in the original package, in order to protect from light. ||| Conserver dans l’ emballage extérieur d’ origine, à l’ abri de la lumière.
0.3471681475639343 ||| Therefore, in patients with renal anaemia the medicinal product has to be administered intravenously. ||| Therefore, these patients should be monitored more closely during administration of Myozyme. ||| Le médicament doit donc être administré par voie intraveineuse chez les patients souffrant d’ anémie rénale.
0.318759948015213 ||| The abnormalities were controlled by conventional therapy for thyroid dysfunction. ||| Any thyroid abnormality detected at that time must be treated with conventional therapy. ||| Ces anomalies ont pu être contrôlées par les traitements conventionnels utilisés lors d’ une dysthyroïdie.
0.19145557284355164 ||| Step 4: ||| Step 1: ||| Étape 4:
0.18447420001029968 ||| Ferrules of non-metallic materials for walking sticks ||| Handrails of non-metallic materials for walkways ||| Viroles en matériaux non métalliques pour cannes
0.003445676062256098 ||| 47 Before you go to receive your PhotoBarr injection, check that there are adequate shades and curtains in your home to keep out bright sunlight. ||| 42 Before you go to receive your PhotoBarr injection, check that there are adequate shades and curtains in your home to keep out bright sunlight. ||| Avant de recevoir votre injection de PhotoBarr, assurez-vous que vous disposez de zones d’ombre ainsi que de rideaux dans votre logement afin de vous protéger de la lumière directe du soleil.
0.018285684287548065 ||| Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Using other medicines Please tell your doctor or pharmacist if you are using or have recently used any other medicines, including medicines obtained without a prescription. ||| Utilisation d'autres médicaments Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment un autre médicament, même s'il s'agit d'un médicament obtenu sans ordonnance.
0.3191218376159668 ||| The most significant drug-related adverse events were common allergic reactions, mainly rashes and urticaria. ||| Some side effects could be serious Serious allergic reactions including swelling, mainly of the face and throat. ||| Les effets indésirables les plus significatifs attribuables au produit étaient les réactions allergiques fréquentes, principalement des rashs et une urticaire.
0.15680041909217834 ||| The duration of treatment depends on the nature and severity of the infection and on the response seen. ||| The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course. ||| La durée du traitement dépend de la nature et de la sévérité de l’ infection et de la réponse observée.
0.4458070993423462 ||| Otologic - Corticosteroids and anti-infectives in combination. ||| Anti-neoplastic preparations from hormones and antagonists ||| Otologie – Association de corticoïdes et d’ anti-infectieux.
0.20936036109924316 ||| Telmisartan is largely bound to plasma protein (> 99.5%), mainly albumin and alpha-1 acid glycoprotein. ||| About 80-85% of fentanyl is bound by plasma proteins, mainly α 1-glycoprotein and to a lesser extent albumin and lipoprotein. ||| Le telmisartan est fortement lié aux protéines plasmatiques (à plus de 99,5%), essentiellement à l’ albumine et à l’ alpha1-glycoprotéine acide.
0.17213889956474304 ||| Each vial contains 100 mg of infliximab. ||| Each vial contains 20 mg of pegvisomant. ||| Chaque flacon contient 100 mg d’ infliximab.
0.2217560112476349 ||| Österreich Merck Sharp & Dohme GmbH Tel: +43 (0) 1 26 044 msd-medizin@merck. com ||| Sverige Merck Sharp & Dohme (Sweden) AB Tel: +46 (0) 8 626 1400 medicinskinfo@merck.com ||| Merck Sharp & Dohme GmbH Tel: +43 (0) 1 26 044 msd-medizin@merck. com
0.021564144641160965 ||| Commonly reported side effects in patients taking tadalafil include back pain, muscle aches, facial flushing, nasal congestion, dizziness, pounding heartbeat sensation, abdominal pain and reflux. ||| Commonly reported side effects in patients taking CIALIS include back pain, muscle aches, facial flushing, nasal congestion, dizziness, pounding heartbeat sensation, abdominal pain and reflux. ||| Les effets indésirables fréquents chez les patients prenant du tadalafil incluent douleurs dorsales, douleurs musculaires, bouffées vasomotrices, congestion nasale, sensations vertigineuses, sensations de palpitation, douleurs abdominales et reflux.
4.860133562961666e-13 ||| Regardless of the route of dosing, pronounced pharmacodynamic changes are associated with the administration of Rebif. ||| Regardless of the route of dosing, pronounced pharmacodynamic changes are associated with the administration of Rebif. ||| 44 Indépendamment du mode d’ administration, des changements pharmacodynamiques importants sont associés à l’ administration de Rebif.
0.747996985912323 ||| 40 10. ||| 50 * ||| 40 11.
0.7306608557701111 ||| Index books ||| General properties ||| Répertoires
0.2822047173976898 ||| Clinical studies on AIDS-KS patients treated at 20 mg/ m2 with Caelyx show that myelosuppression was the most frequent undesirable effect considered related to Caelyx occurring very commonly (in approximately one-half of the patients). ||| Bleeding or bruising more easily than normal due to a drop in a type of blood cell called platelets have been reported very rarely (less than 1 per 10,000 doses of vaccine) with the hepatitis B component of Quintanrix. t uc ||| Les études cliniques chez des patients avec SK-SIDA traités à la dose de 20 mg/ m² de Caelyx, montrent que l'effet indésirable le plus fréquemment observé considéré comme lié à Caelyx est la myélosuppression survenant très fréquemment (chez environ la moitié des patients).
0.43475210666656494 ||| Chromium plating compositions ||| Reactive liquid polymer compositions ||| Compositions pour le chromage
0.6297662258148193 ||| Any unused product must be discarded. ||| IONSYS may be removed at any time. ||| ris utilisé doit être jeté.
0.0 ||| CONDITIONS OF THE MARKETING AUTHORISATION ||| CONDITIONS OF THE MARKETING AUTHORISATION ||| CONDITIONS RELATIVES À L’ AUTORISATION DE MISE SUR LE MARCHÉ
0.01824824884533882 ||| For the full list of all side effects reported with Prialt, see the Package Leaflet. ||| For the full list of all side effects reported with Nplate, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Prialt, veuillez vous reporter à la notice.
0.8213686943054199 ||| *p  0.0001 compared with placebo a. ||| *p-values compared to pamidronate. ||| *p ≤ 0,0001 comparé au placebo a.
0.20780512690544128 ||| Concomitant administration of sunitinib malate with the potent CYP3A4 inhibitor, ketoconazole, resulted in a 49% and 51% increase of the complex [sunitinib + primary metabolite] Cmax and AUC0-∞ values, respectively, after a single dose of sunitinib malate in healthy volunteers. ||| Plasma exposure (AUC and Cmax) to valdecoxib was increased (62% and 19%, respectively) when co- administered with fluconazole (predominantly a CYP2C9 inhibitor), indicating that the dose of parecoxib sodium should be reduced in those patients who are receiving fluconazole therapy. ||| L’ administration concomitante de malate de sunitinib et d’ un puissant inhibiteur du CYP3A4, le kétoconazole, a provoqué des élévations de 49% de la valeur de la Cmax et de 51% de la valeur et de l’ AUC0-∞ du complexe [sunitinib + métabolite principal], après une dose unique de malate de sunitinib chez des volontaires sains.
0.36428016424179077 ||| CARTON FOR ZALASTA 7.5 mg TABLETS ||| ZYPREXA 5 mg COATED TABLETS: ||| ETUI DES COMPRIMES DE ZALASTA 7,5 mg
0.2617133855819702 ||| You should tell your doctor immediately if you experience any new signs or symptoms of abdominal distress, abdominal swelling, abdominal pain, abdominal tenderness, or abdominal rigidity, constipation, fever, chills, nausea or vomiting. ||| Some side effects such as bleeding, bruises, redness, or pain at the site of injection, nausea, headache, feeling hot, dizziness, bruising and increased bleeding may occur during treatment with ATryn. ||| Vous devez immédiatement signaler à votre médecin tout nouveau signe ou symptôme de trouble abdominal, de gonflement abdominal, de douleurs abdominales, de sensibilité abdominale, ou de rigidité abdominale, de constipation, de fièvre, de frissons, de nausées ou vomissements.
0.29908859729766846 ||| If urine succinylacetone is still detectable one month after the start of nitisinone treatment, the nitisinone dose should be increased to 1.5 mg/ kg body weight/ day divided in 2 doses. ||| The dose volume of atipamezole at the concentration of 5 mg/ ml equals the dose volume of Dexdomitor that was given to the dog, regardless of route of administration of Dexdomitor. ||| Si la succinylacétone est encore détectable dans les urines un mois après l’ instauration du traitement par la nitisinone, la dose de nitisinone devra être augmentée jusqu’ à 1,5 mg/ kg de poids corporel / jour divisée en 2 prises.
0.358514666557312 ||| Hallucinations, manic reaction, confusion, agitation, anxiety and associated symptoms (e. g. nervousness), impaired concentration and thought process (e. g. depersonalisation), panic attacks, suicidal thoughts and behaviour (these symptoms may be due to the underlying disease), very rarely serotonin syndrome. ||| ABILIFY solution for injection is used to treat quickly symptoms of agitation and distressing behaviour that may occur in a disease characterised by symptoms such as: hearing, seeing or sensing things which are not there, suspiciousness, mistaken beliefs, incoherent speech and behaviour and emotional flatness. ||| Hallucinations, réaction maniaque, confusion, agitation, anxiété et symptômes associés (telle que la nervosité), troubles de la concentration et du cours de la pensée (telle que la dépersonnalisation), attaques de panique, pensées et comportement suicidaires (ces symptômes pouvant être dus à la maladie elle-même).
0.16329887509346008 ||| Nervous system disorders Common: dizziness, headache Uncommon: syncope, hypoaesthesia, migraine, paraesthesia, dysgeusia, vertigo, tinnitus ||| Uncommon: paraesthesia Rare: convulsions, movements disorders Very rare: dysgeusia, syncope, tremor, dystonia, dyskinesia ||| Peu fréquent: syncope, hypoesthésie, migraine, paresthésie, dysgueusie, vertiges, acouphènes.
0.2904287576675415 ||| MabThera should not be administered to patients with an active and/ or severe infection (e. g. tuberculosis, sepsis and opportunistic infections, see section 4.3). ||| Patients with an acute illness (e. g. pneumonia, sepsis) at the time of Myozyme infusion appear to be at greater risk for IARs. ||| MabThera ne doit pas être administré en cas d’ infection sévère et/ ou évolutive (par exemple tuberculose, septicémie et infections opportunistes, voir rubrique 4.3).
0.10047043859958649 ||| Ribavirin Teva is a ‘ generic medicine’. ||| Olanzapine Teva is a ‘ generic medicine’. ||| Ribavirine Teva est un « médicament générique ».
0.2926214933395386 ||| They will support companies' urgent liquidity needs and help them continue their activities during these difficult times. ||| This will help Spanish businesses cover their immediate working capital and investment needs in these difficult times. ||| Ils soulageront les besoins urgents de liquidités des entreprises et les aideront à poursuivre leurs activités en ces temps difficiles.
0.04274144768714905 ||| These symptoms have been reported more frequently when shosaikoto, a Chinese herbal medicine, is administered concomitantly with interferon alpha (see section 4.4). ||| These symptoms have been reported more frequently when shosaikoto, a Chinese herbal medicine, is administered concomitantly with interferon alpha (see section 4.4). t uc ||| Ces symptômes ont été rapportés plus fréquemment lorsque le shosaikoto, une plante médicinale chinoise, est administré en même temps que l’ interféron alpha (voir rubrique 4.4).
0.22352536022663116 ||| 37 Effects of other substances on tadalafil ||| 17 Effects of vardenafil on other medicinal products ||| Effets d'autres substances sur le tadalafil
0.0 ||| Injecting the solution with the air bubble is harmless. ||| Injecting the solution with the air bubble is harmless. ||| L’injection de la solution avec la bulle d’air n’est pas douloureuse.
0.019036361947655678 ||| The Commission found that the scheme notified by France is compatible with the principles set out in the EU Treaty and is well targeted to remedy a serious disturbance to the French economy. ||| The Commission found that the scheme notified by the Netherlands is compatible with the principles set out in the EU Treaty and is well targeted to remedy a serious disturbance to the Dutch economy. ||| La Commission a estimé que le régime notifié par la France était compatible avec les principes énoncés dans le TFUE et bien ciblé pour remédier à une perturbation grave de l'économie française.
0.23980534076690674 ||| As many pathogens other than pneumococcal serotypes represented in the vaccine may contribute to the burden of pneumonia in children, protection against all clinical pneumonia is expected to be lower than for invasive pneumococcal disease. ||| Since hepatotoxicity has been shown to correlate with induction of hepatic neoplasia in rats, this increased incidence of hepatic tumors in rats was likely secondary to chronic hepatic toxicity at this high dose. ||| Comme beaucoup de pathogènes autres que les sérotypes pneumococciques couverts par le vaccin peuvent causer une pneumonie chez l’ enfant, la protection attendue contre toutes les pneumonies cliniques est plus faible que pour les infections invasives à pneumocoque.
0.3124304413795471 ||| The [90Y]-radiolabelled Zevalin is indicated as consolidation therapy after remission induction in previously untreated patients with follicular lymphoma. |||  28 Appropriate vaccination (hepatitis A and B) should be considered for patients in regular/repeated receipt of human plasma-derived albumin. ||| Zevalin marqué à l’ yttrium-90 est indiqué dans le traitement de consolidation après induction d’ une rémission chez les patients atteints d’ un lymphome folliculaire non traités antérieurement.
0.21853625774383545 ||| The company that makes Revlimid will provide a letter and educational kits for healthcare workers, and brochures for patients, explaining the fact that it is expected to be harmful to the unborn child and detailing the steps that need to be taken for the medicine to be used safely. ||| The company who markets Suboxone will put together information plans for doctors and pharmacists, to ensure that they are aware of the risk of misuse, and that they report on specific safety issues with the medicine such as liver disorders and effect on newborns. ||| La société qui fabrique Revlimid fournira un courrier et des kits éducatifs aux professionnels de santé et des brochures aux patients, expliquant le fait qu’ il pourrait s’ avérer nocif pour l’ enfant à naître et détaillant les étapes à suivre pour une utilisation sans danger du médicament.
0.30234479904174805 ||| Gastrointestinal disorders Nausea (0.5%). ||| Gastrointestinal disorders Common: nausea (7.1% vs. ||| Affections gastro-intestinales Nausées (0,5%).
0.2715906500816345 ||| Repaglinide lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning β -cells in the pancreatic islets. ||| Blocking alpha-1-adrenoreceptors through doxazosin reduces the tonus of the smooth muscle in the prostatic part of the urethra which facilitates the urinary flow. ||| Le répaglinide abaisse fortement la glycémie en stimulant la sécrétion d’ insuline par le pancréas, un effet qui dépend du bon fonctionnement des cellules β des îlots pancréatiques.
0.3890756070613861 ||| To allow banks to benefit from the more favourable treatment already during the coronavirus pandemic, it is proposed to advance the date of application of the specific treatment. ||| Since the EudraWatch database is expected to be fully operational in 1998, the entering of adverse drug reaction reports into the database will facilitate this task. ||| Afin que les banques puissent déjà en bénéficier en cette période, il est proposé d'avancer la date d'application de ce traitement spécifique.
0.20792004466056824 ||| Other antiplatelet medicinal products (acetylsalicylic acid, dipyridamole, sulfinpyrazone, ticlopidine or clopidogrel), and NSAIDs should be used with caution. ||| Other anti-epileptic medicinal products Rufinamide concentrations may be decreased by co-administration with carbamazepine, phenobarbital, phenytoin, vigabatrin or primidone. ||| ris autres médicaments antiagrégants plaquettaires (acide acétylsalicylique, dipyridamole, sulfinpyrazone, ticlopidine ou clopidogrel) et les AINS doivent être utilisés avec précaution.
0.75572669506073 ||| CYP450 interactions Aliskiren does not inhibit the CYP450 isoenzymes (CYP1A2, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A). ||| CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/ 5 or CYP4A9/ 11-2. ||| Interactions avec le CYP450 L’ aliskiren n’ inhibe pas les isoenzymes du CYP450 (CYP1A2, 2C8, 2C9, 2C19, 2D6, 2E1 et 3A).
0.47982388734817505 ||| This study compared two schedules of ViraferonPeg used with ribavirin with the combination of interferon alfa-2b and ribavirin. ||| Peginterferon alfa-2a is very similar to interferon alfa-2a, which is already available in the European Union (EU) as Roferon. ||| Cette étude comparait deux schémas de traitement de ViraferonPeg utilisé en association à la ribavirine avec l’ association de l’ interféron alfa-2b et de la ribavirine.
0.5923675298690796 ||| EMEA financial control ||| EMEA contact points ||| Contrôle financier de l’ EMEA
0.0 ||| 6.2 Incompatibilities ||| 6.2 Incompatibilities ||| 6.2 Incompatibilités mé
0.1711491495370865 ||| Do not put Insuman Comb 15 next to the freezer compartment or a freezer pack. ||| Do not put Insulin Human Winthrop Basal next to the freezer compartment or a freezer pack. ||| Ne pas placer Insuman Comb 15 près du compartiment à glaçons ou d'une poche de congélation.
0.3299557566642761 ||| It will also be applying the rules for cohesion spending with maximum flexibility, thus enabling Member States to use the funds to finance crisis-related action. ||| It will allow Member States to provide a targeted liquidity support to farmers and SMEs aiming at ensuring continuity of their business activity. ||| Elle appliquera aussi les règles relatives aux dépenses de cohésion avec un maximum de flexibilité, ce qui permettra aux États membres d'utiliser les fonds pour financer des mesures liées à la crise.
0.09842251241207123 ||| It is available as light green oval tablets (30, 60 or 90 mg). ||| It is available as blue, oval tablets (150 or 300 mg). ||| Il se présente sous forme de comprimés ovales de couleur vert clair (30, 60 ou 90 mg).
0.3491685092449188 ||| Due to the risk of bleeding and haematological undesirable effects, blood cell count determination and/ or other appropriate testing should be promptly considered whenever clinical symptoms suggestive of bleeding arise during the course of treatment (see section 4.8). ||| Patients experiencing dizziness, fatigue, visual impairment or other undesirable effects with a potential impact on the ability to drive or use machines safely should refrain from these activities as long as the undesirable effects persist (see section 4.8). ||| En raison du risque de saignement et d’effets indésirables hématologiques, une Numération-Formule Sanguine et/ou tout autre examen approprié doivent être rapidement envisagés chaque fois que des signes cliniques évocateurs de saignement surviennent pendant le traitement (voir rubrique 4.8).
0.5803993344306946 ||| The external ear canal should be meticulously cleaned and dried before treatment. ||| Establish and maintain a clear airway and ensure adequate oxygenation and ventilation. ||| Le conduit auriculaire doit être méticuleusement nettoyé et séché avant application.
0.36469390988349915 ||| If latent tuberculosis is diagnosed, appropriate anti-tuberculosis prophylaxis in accordance with local recommendations must be initiated before starting treatment with Trudexa. ||| Treatment with Macugen is for intravitreal injection only and should be administered by ophthalmologists experienced in intravitreal injections. ||| En cas de diagnostic d'une tuberculose latente, une prophylaxie anti-tuberculeuse appropriée, conforme aux recommandations locales, doit être mise en œ uvre avant de commencer le traitement par Trudexa.
0.45404869318008423 ||| Docetaxel did not influence the binding of digitoxin. ||| Entacapone enhances the effects of levodopa. ||| Le docétaxel n'a pas eu d'influence sur la liaison de la digitoxine.
0.45632293820381165 ||| Treatment with Advagraf should only be prescribed by doctors who have experience in the management of transplant patients. ||| In the US a serological test developed by Cellex has been approved for emergency use by certified laboratories only. ||| Le traitement par Advagraf ne doit être prescrit que par un médecin ayant l’ expérience de la prise en charge des patients greffés.
0.3919365704059601 ||| Generally these events are mild to moderate and are self-limiting, however, in some patients they may be severe and/ or prolonged (see section 4.4 Special warnings and precautions for use). ||| Generally, these symptoms are self-limiting and usually resolve within 2 weeks, though in some individuals they may be prolonged (2-3 months or more). ||| Généralement ces symptômes sont d’ intensité légère à modérée et spontanément résolutifs, bien qu’ ils puissent être d’ intensité sévère et/ ou se prolonger chez certains patients (cf. rubrique 4.4 Mises en garde spéciales et précautions particulières d'emploi).
0.07207086682319641 ||| Chemical sizing compositions for use in the manufacture of paperboard ||| Chemical sizing compositions for use in the manufacture of threads ||| Compositions chimiques d'apprêtage destinées à la fabrication de carton
0.4558132290840149 ||| In the MBC and MOC studies a total of two patients experienced Grade 4 congestive heart failure. ||| The data described below reflect exposure to Tasigna in 438 patients in an open-label multicentre study. ||| Dans les études sur le CMS et le CMO, au total deux patients ont présenté une insuffisance cardiaque congestive de grade 4.
0.14993087947368622 ||| Milk ferments for pharmaceutical purposes ||| Fish meal for pharmaceutical purposes ||| Ferments lactiques à usage pharmaceutique
0.3224046230316162 ||| Amlodipin Wörwag tablets can be used in combination with beta-blockers, nitrates or as monotherapy in angina pectoris. ||| NeoRecormon Multidose is provided as a lyophilisate vial and solvent ampoule for solution for injection. ||| Dans l'angine de poitrine, Amlodipin Wörwag comprimés peut être utilisé en combinaison avec des bêta-bloquants, des nitrates, ou en monothérapie.
0.4852027893066406 ||| You should not take a second dose within a single night. ||| You should not take VIAGRA more than once a day. ||| Vous ne devez pas prendre une 2ème dose au cours de la même nuit.
0.06268905103206635 ||| 4.8 Pregnancy and lactation ||| 4.7 Pregnancy and lactation ||| 4.6 Grossesse et allaitement
0.030314937233924866 ||| Each Lamictal 100 mg tablet contains 100 mg lamotrigine. ||| Each Lamictal 50 mg tablet contains 50 mg lamotrigine. ||| Chaque comprimé de Lamictal 100 mg contient 100 mg de lamotrigine.
0.23574110865592957 ||| Whole virion influenza vaccine of pandemic strain, inactivated, containing antigen* equivalent to: ||| Split Influenza virus*, inactivated, containing antigens equivalent to the following strains: ||| Vaccin grippal à virion entier contre la souche pandémique, inactivé, contenant l’ antigène* analogue à:
0.6697905659675598 ||| Celery salt ||| Castor sugar ||| Sel de céleri
0.3056640028953552 ||| 25 Latvija Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK Lielbritā nija Tel: + 44 (0) 1628 494026 E-mail: uk_medinfo@allergan. com ||| 22 België/ Belgique/ Belgien Allergan NV/ SA Terhulpsesteenweg 6D B-1560 Hoeilaart Tél/ Tel: + 32 (0)2 351 24 24 E-mail: uk_medinfo@allergan. com ||| Latvija Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK Lielbritānija Tel: + 44 (0) 1628 494026 E-mail: uk_medinfo@allergan.com
0.7529000639915466 ||| Patient exposure to treatment with VELCADE during Phase II and III studies ||| 51 Phase II clinical trials in CML: ||| Exposition patient au traitement par VELCADE pendant les études de Phase II et de Phase III
0.755874514579773 ||| In addition, no comparative studies have been carried out in children. ||| It has also been successfully implemented in Indonesia. ||| En outre, aucune étude comparative n’ a été effectuée chez les enfants.
0.29531049728393555 ||| Mobile stools [furniture] ||| Tool chests [furniture] ||| Tabourets mobiles [meubles]
0.2764832377433777 ||| The dosage of Mimpara should be titrated every 2 to 4 weeks through sequential doses of 30 mg twice daily, 60 mg twice daily, 90 mg twice daily, and 90 mg three or four times daily as necessary to reduce serum calcium concentration to or below the upper limit of normal. ||| The recommended dose of VIRAMUNE is one 200 mg tablet daily for the first 14 days (this lead-in period should be used because it has been found to lessen the frequency of rash), followed by one 200 mg tablet twice daily, in combination with at least two additional antiretroviral agents. ||| La posologie de Mimpara doit être adaptée toutes les 2 à 4 semaines, en utilisant des paliers de doses de 30 mg deux fois par jour, 60 mg deux fois par jour, 90 mg deux fois par jour et 90 mg trois ou quatre fois par jour, en fonction des besoins thérapeutiques pour atteindre une calcémie inférieure ou égale à la limite supérieure de la normale.
0.26102834939956665 ||| Packaging containers made of wood ||| Packaging containers of metal ||| Récipients d'emballage en bois
0.46719735860824585 ||| In addition, EU countries are to contribute at least 15% in national co-financing to their national programme. ||| Part of the money for projects comes from member states and the rest is co-financed with EU funds. ||| De plus, les États membres de l'Union doivent cofinancer au minimum 15 % du coût de leur programme national.
0.5470962524414062 ||| In Europe, the company Löwenstein Medical producing 1500 ICU-level ventilators and 20,000 home-level ventilator per year for France alone, pointed out of the current high demand and production shortage. ||| Businessman Jack Ma sent 1.1 million testing kits, 6 million face masks, and 60,000 protective suits to Addis Ababa, Ethiopia for distribution by the African Union. ||| En Europe, la société Löwenstein Medical, qui produit 1500 ventilateurs de niveau ICU et 20 000 ventilateurs de niveau domestique par an pour la seule France, a souligné la forte demande actuelle et la pénurie de production.
0.18114100396633148 ||| Some hypertensive patients with no apparent pre-existing renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when Zestril has been given concomitantly with a diuretic. ||| Patients with extensive tumour burden due to metastatic disease have been rarely reported to experience progressive hepatic coma and death during azacitidine treatment, especially in such patients with baseline serum albumin < 30 g/ l. ||| Chez certains hypertendus sans maladie vasculaire rénale pré-existante apparente, des cas d’augmentation de l'urémie et de la créatininémie, habituellement mineures et transitoires, ont été observées, en particulier lorsque Zestril était associé à un diurétique.
0.050103552639484406 ||| No specific information is available on the treatment of overdose with Karvea. ||| No specific information is available on the treatment of overdose with Aprovel. ||| Aucune information spécifique n’ est disponible sur le traitement en cas de surdosage par l'irbésartan.
0.5840802192687988 ||| Processed teff ||| Heat sensitive paper ||| Teff traité
0.3487684726715088 ||| Women of child-bearing potential using hormonal contraceptives are advised to use an additional safe and effective contraceptive method (see Section 4.4 and 4.6). ||| Effective contraceptive precautions must be taken by both male and female patients who are taking Temodal (see also “Take special care with Temodal” above). ||| Il convient de conseiller aux femmes en âge de procréer et sous contraceptif hormonal d’ utiliser un moyen de contraception supplémentaire sûr et efficace (voir rubriques 4.4 et 4.6).
0.41686347126960754 ||| In these cases do not treat more frequently than once a fortnight. ||| Injections should not be repeated more frequently than every 16 weeks. ||| Dans ce cas, il ne faut pas traiter plus d’ une fois tous les 14 jours.
0.29693877696990967 ||| Clinical data have shown that tacrolimus concentrations in systemic circulation after topical administration are low and, when measurable, transient. ||| At clinically relevant concentrations, binding of dasatinib to plasma proteins is approximately 96% on the basis of in vitro experiments. ||| pl Les données cliniques ont montré qu'après application cutanée de tacrolimus, l'exposition systémique est faible et, lorsqu'elle est mesurable, transitoire. st Absorption 'e
0.48447108268737793 ||| Compostable bowls ||| Coating of conduits ||| Bols compostables
0.27572697401046753 ||| However, the second study showed that symptoms returned in 21% of the patients taking Thymanax over 24 weeks (34 out of 165), compared with 41% of the patients taking placebo (72 out of 174). ||| In the first study of restless legs syndrome, symptom scores fell by between 12.8 and 14.0 points after 12 weeks in patients taking Mirapexin, compared with a fall of 9.3 points in the patients taking placebo. ||| Toutefois, la seconde étude a montré que les symptômes réapparaissaient chez 21% des patients prenant Thymanax durant 24 semaines (34 sur 165), contre 41% des patients prenant le placebo (72 sur 174).
0.6465389728546143 ||| Double sided adhesive tapes for household use ||| ed Multidose containers with appropriate overfill: ||| Ruban adhésif double face à usage domestique
0.06590410321950912 ||| The European Commission granted a marketing authorisation valid throughout the European Union for MabThera to Roche Registration Limited on 2 June 1998. ||| The European Commission granted a marketing authorisation valid throughout the European Union for CellCept to Roche Registration Limited on 14 February 1996. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour MabThera à Roche Registration Limited, le 2 juin 1998.
0.6397942304611206 ||| The effect of peritoneal dialysis on adefovir removal has not been evaluated. ||| Sildenafil has a peripheral site of action on erections. ||| L’ effet de la dialyse péritonéale sur l’ élimination de l’ adéfovir n’ a pas été évalué.
5.484152628548733e-13 ||| Impaired hepatic function: ||| Impaired hepatic function: ||| Insuffisance hépatique:
0.4190029799938202 ||| There have been reports of acute overdose in post-marketing experience and clinical studies with montelukast. ||| 21 Only limited experience with overdose is available from clinical studies and post-marketing experience. ||| Des cas de surdosage aigu ont été rapportés depuis la mise sur le marché et au cours des études cliniques réalisées avec le montelukast.
0.25489288568496704 ||| The solvent for reconstitution is presented in 1 ml pre-filled syringes (Type I glass) with a rubber stopper. ||| Advagraf 1 mg is supplied in blisters containing 10 capsules within a protective foil wrapper, including a desiccant. ||| Le solvant pour reconstitution est présenté en seringue préremplie de 1 ml (verre type I) avec bouchon en caoutchouc.
0.18880072236061096 ||| Take special care with Sprimeo ||| Take special care with Prometax ||| Faites attention avec Sprimeo
0.3470301032066345 ||| Adult patients with a history of congestive heart failure, myocardial infarction and/or previous or current arrhythmic disorders, who require IntronA therapy, must be closely monitored. ||| These patients had a wide variety of complex underlying conditions such as haematological malignancies and HIV-infection or were transplant recipients and/ or treated in intensive care. ||| 99 Les patients adultes ayant des antécédents d’ infarctus du myocarde ou d’ insuffisance cardiaque congestive et/ ou ayant souffert ou souffrant de troubles du rythme cardiaque doivent être étroitement surveillés en cas de traitement par IntronA.
0.2720070779323578 ||| Seroneutralisation rates (MN titre > 20) at 21 days after a booster vaccination with the 7.5 µg dose of the A/ Vietnam and A/ Indonesia vaccines, tested against both the homologous and heterologous strains were as follows: ||| In the phase 3 study in adults (N=265) and elderly subjects (N=270) after vaccination with the A/ Vietnam/ 1203/ 2004 strain vaccine the rate of subjects with cross-neutralising antibodies as measured by MN (titre > 20) was as follows: ||| Les taux de séroneutralisation (titres MN > 20) 21 jours après l'administration d'une dose de rappel de 7,5 µg des vaccins à souche A/ Vietnam et A/ Indonesia, testés contre les souches homologues et hétérologues, ont été les suivants:
0.18009591102600098 ||| 64 Very common ||| 133 Very common ||| Très fréquent
0.02960427664220333 ||| Released for consultation in July 96 (revision) ||| Released for consultation in November 96 (revision) ||| Transmise pour consultation en juillet 96 (révision)
0.5985212922096252 ||| The pharmacokinetic properties of lepirudin following intravenous administration are well described by a two-compartment model. ||| Trabectedin pharmacokinetic profile is consistent with a multiple-compartment disposition model. ||| Les propriétés pharmacocinétiques de la lépirudine administrée par voie intraveineuse sont bien décrites par un modèle bicompartimental.
0.2370384931564331 ||| After intravenous administration, gadobutrol is rapidly distributed in the extra cellular space. ||| After intramuscular administration amoxicillin is well absorbed and distributed in the tissues. ||| Le gadobutrol injecté par voie intraveineuse se distribue rapidement dans le compartiment extracellulaire.
3.0139329617109856e-13 ||| In healthy elderly (65 and over) versus non-elderly subjects, the mean elimination half-life was prolonged (51.8 versus 33.8 hr) and the clearance was reduced (17.5 versus 18.2 l/ hr). ||| In healthy elderly (65 and over) versus non-elderly subjects, the mean elimination half-life was prolonged (51.8 versus 33.8 hr) and the clearance was reduced (17.5 versus 18.2 l/ hr). ||| 58 Chez le sujet sain âgé (65 ans et plus), par rapport au sujet sain jeune, la demi-vie moyenne d’ élimination de l’ olanzapine est prolongée (51,8 versus 33,8 heures) et la clairance est réduite (17,5 vs 18,2 l/ heure).
0.5972331166267395 ||| Also, improved food accessibility can improve nutrition in communities that need it the most. ||| Nature also has a beneficial effect on peoples' mental health and welfare; ||| Enfin, l'amélioration de l'accès à la nourriture peut améliorer la nutrition dans les communautés qui en ont le plus besoin.
0.28793323040008545 ||| The Commission's first priority is to use all tools at its disposal to safeguard people's wellbeing and ensure that there is an effective immediate response to the coronavirus outbreak across the board. ||| The objective of the measures is to ensure that these companies have liquidity to help them safeguard jobs and continue their activities faced with the difficult situation caused by the coronavirus outbreak. ||| La priorité principale de la Commission est d'utiliser tous les instruments à sa disposition pour préserver le bien-être de la population et garantir une réaction immédiate et efficace à l'épidémie du coronavirus sur tous les plans.
0.15929430723190308 ||| Blankets, electric, for medical purposes ||| Blankets, electric, not for medical purposes ||| Couvertures électriques à usage médical
0.18071261048316956 ||| In the first study, 19% of the patients adding the approved dose of Rapamune had failed treatment after six months (53 out of 284), compared with 32% of those adding azathioprine (52 out of 161). ||| In the second study, 52% of the patients receiving Relistor opened their bowels at least twice within four hours of the first four doses (32 out of 62), compared with 8% of those receiving placebo (6 out of 71). ||| Dans la première étude, chez 19% (53 sur 284) des patients ayant ajouté la dose approuvée de Rapamune, le traitement avait échoué à six mois, contre 32% (52 sur 161) des patients ayant ajouté l’ azathioprine.
0.37801527976989746 ||| For women with a gestational age greater than 24 weeks there was no difference in mortality rate (1.7% in the placebo group and 1.5% in the atosiban group). ||| Stomatitis was reported more frequently in the combination therapy group (16%) than in the monotherapy group (3%), and most cases were grade 2 or less in severity. ||| Pour les femmes dont le terme de la grossesse était supérieure à 24 semaines, aucune différence dans le taux de mortalité n’ a pu être observé (1,7% dans le groupe placebo et 1,5% dans le groupe atosiban).
0.07803942263126373 ||| It is produced by a method known as ‘ recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce anakinra. ||| Eptotermin alfa is produced by a method known as ‘ recombinant DNA technology’: it is made by cells that have received a gene (DNA), which makes them able to produce it. ||| Il est fabriqué selon une méthode connue sous le nom de « technologie de l’ ADN recombinant »: il est produit par une bactérie ayant reçu un gène (de l’ ADN), qui la rend capable de synthétiser l’ anakinra.
0.2962060570716858 ||| The pharmacokinetics of risperidone are also linear in the dose range of 25-50 mg injected every 2 weeks. ||| The pharmacokinetics of topotecan given as a 30-minute infusion for 5 days were evaluated in two studies. ||| La pharmacocinétique de la rispéridone est également linéaire dans l’ intervalle de doses compris entre 25-50 mg injectés toutes les 2 semaines.
0.08866523951292038 ||| Kinzalkomb 40 mg/ 12.5 mg tablets are red and white, oval-shaped two-layer tablets engraved with the code number'H4 '. ||| MicardisPlus 80 mg/ 12.5 mg tablets are red and white, oval-shaped, two-layer tablets engraved with the company logo and the code'H8 '. ||| Le comprimé de Kinzalkomb 40 mg/ 12,5 mg est ovale rouge et blanc à deux couches portant le code ‘ H4’.
0.2652105391025543 ||| Likewise, EVISTA is indicated for the treatment of osteoporosis or established osteoporosis in women with BMD of the spine 2.5 SD below the mean value of a normal young population and/ or with vertebral fractures, irrespective of BMD. ||| For active immunisation of dogs of 6 months of age or older against Babesia canis to reduce the severity of clinical signs associated with acute Babesiosis (B. canis) and anaemia as measured by Packed Cell Volume (PCV). ||| De la même façon, EVISTA est indiqué pour le traitement de l’ ostéoporose ou de l’ ostéoporose avérée chez les femmes avec une DMO au rachis de 2,5 DS en dessous de la valeur moyenne de la population normale jeune et/ ou avec des fractures vertébrales, quelle que soit la DMO.
0.37939316034317017 ||| It provides contrast enhancement and facilitates visualization and helps with the characterization of focal lesions and abnormal structures in the CNS and liver in patients with known or highly suspected pathology. ||| Gd-based contrast agents are frequently administered prior to contrast-enhanced dynamic liver MRI and may improve both detection and classification of focal liver lesions. ||| Optimark renforce le contraste, facilite la visualisation et aide à la caractérisation des lésions focales et des structures anormales du SNC et du foie chez les patients qui présentent une pathologie connue ou fortement suspectée.
0.3102378249168396 ||| Based on the required dose for the patient expressed in mg, aseptically withdraw the corresponding premix volume containing 10 mg/ ml docetaxel from the appropriate number of premix vials using graduated syringes fitted with a needle. ||| At the end of the perfusion, the perfusate should be collected into the reservoir while washout fluid is added simultaneously to the circuit and circulated at the same flow rate of 35 to 40 ml/ litre limb volume/ minute. ||| En tenant compte de la posologie requise pour le patient exprimée en mg, extraire de façon aseptique, le volume correspondant de solution de prémélange contenant 10 mg/ ml de docétaxel du nombre approprié de flacons de solution de prémélange à l'aide d'une seringue graduée munie d'une aiguille.
0.3365146815776825 ||| Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent. ||| Treatment was temporarily interrupted and there was complete reversal of all abnormalities within one week. ||| En l’ absence d’ amélioration clinique, le traitement doit être arrêté au bout de 10 jours maximum.
0.005764025263488293 ||| 7.5 mg benzyl alcohol For a full list of excipients, see section 6.1. ||| 2.5 mg benzyl alcohol For a full list of excipients, see section 6.1. ||| Pour la liste complète des excipients, voir rubrique 6.1.
0.20894622802734375 ||| The other ingredients in the vaccine are: sodium chloride, water for injections. ||| - The other ingredients in Ambirix are: sodium chloride and water for injections. ||| Les autres constituants du vaccin sont: chlorure de sodium et eau pour préparations injectables.
0.25808122754096985 ||| Mixing of Ultratard with phosphate buffered insulin preparations is not recommended due to the risk of precipitation of zinc-phosphate, leading to an unpredictable timing of such insulin mixtures. ||| When decarboxylation of levodopa is reduced with the co-administration of a DDC inhibitor, a lower dose of levodopa can be used and the incidence of undesirable effects such as nausea is reduced. ||| Il est déconseillé de mélanger Ultratard avec les préparations d’ insuline contenant un tampon de phosphate car un précipité de phosphate de zinc pourrait se former, modifiant de façon imprévisible le profil d’ action du mélange d’ insuline.
0.42136362195014954 ||| 457 Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). ||| of the vaccine, vaccination does not induce production of antibodies against CSF virus antigens, other than E2. cin ||| Un traitement par l'insuline peut entraîner la formation par l'organisme d'anticorps anti-insuline (substances qui agissent contre l'insuline).
0.41694897413253784 ||| In both trials, treatment with Tracleer resulted in significant increases in exercise capacity. ||| In clinical trials in man , was shown to effect weight loss by enhancing satiety. ||| Les deux essais ont montré une augmentation significative de la distance parcourue au cours du test de marche sous Tracleer.
0.3420026898384094 ||| Please also inform your doctor if you are taking any of the following medicines: ||| - if you are currently taking any of the following medicines: ||| Veuillez informer votre médecin si vous prenez l’ un des médicaments de la liste suivante.
0.37220728397369385 ||| Pradaxa should also not be used in patients taking quinidine (another medicine used to regulate the heart rhythm). ||| Alpheon was to be used with an antiviral medicine, ribavirin, except when patients could not take ribavirin. ||| Pradaxa ne doit pas non plus être utilisé chez les patients prenant de la quinidine (un autre médicament utilisé pour régulariser le rythme cardiaque).
0.669704258441925 ||| Entertainment, education and instruction services ||| Business assistance, management and administrative services ||| Services éducatifs, d'enseignement et de divertissement
0.3705703616142273 ||| No additional food should be consumed for up to 2 hours after administration of efavirenz. ||| If required, a second administration of meloxicam can be given after 24 hours. ||| Aucune nourriture supplémentaire ne doit être consommée pendant au moins 2 heures après l'administration de l 'éfavirenz.
0.5165690779685974 ||| The treatment differences in mean reduction in both SBP and DBP were significant (8.2 and 6.7 in the lisinopril vs 4.5 (p < 0.0004) and 4.7 (p < 0.006) mmHg in the placebo groups, respectively). ||| The overall selection frequency for M184V or M184I was high (54%), and less common was the selection of L74V (5%), K65R (1%) and Y115F (1%) (see Table). ||| Les différences de réduction moyenne de la PSA et la PSD étaient significatives (8,2 et 6,7 dans le groupe sous lisinopril vs 4,5 (p < 0,0004) et 4,7 (p < 0,006) mmHg dans les groupes placebo, respectivement).
0.408789724111557 ||| What is OPATANOL? ||| What is MULTAQ? ||| Qu’ est -ce qu’ OPATANOL?
0.2947724461555481 ||| Commonly reported adverse drug reactions in association with the statins include gastrointestinal disturbances, headache, myalgia, dyspepsia, central nervous system disturbances and sleep disorders. ||| Other undesirable central nervous effects have been reported in literature such as memory defects, aggressiveness, central vestibular syndrome, dysarthria, or Parkinson syndrome. ||| Les réactions indésirables associées aux statines les plus souvent signalées incluent troubles intestinaux, maux de tête, myalgie, dyspepsie, troubles du système nerveux central et troubles du sommeil.
0.006546637509018183 ||| An updated Risk Management Plan should be provided as per the CHMP Guideline on Risk Management Systems for medicinal products for human use. ||| An updated Risk Management Plan should be provided as per the CHMP Guideline on Risk Management System for medicinal products for human use. ||| Une mise à jour du Plan de gestion du risque doit être fourni conformément au Guideline du CHMP sur les systèmes de gestion du risque pour les médicaments à usage humain.
0.00963641982525587 ||| 11/ 25 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 13/ 25 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 11/ 25 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.033960066735744476 ||| Concurrent administration of potentially nephrotoxic medicinal products should be avoided. ||| Concurrent administration of potentially nephrotoxic drugs should be avoided. ||| L’ administration concomitante de médicaments potentiellement néphrotoxiques doit être évitée.
0.25960874557495117 ||| General disorders and administration site conditions na ||| General disorders and administration site conditions oedema ||| 5 Troubles généraux et affections du site d’ administration
0.5223100185394287 ||| 30 mg film-coated tablets 60 mg film-coated tablets 90 mg film-coated tablets 120 mg film-coated tablets [See Annex I - To be completed nationally] ||| {INVENTED NAME} 100 mg film-coated tablets {INVENTED NAME} 200 mg film-coated tablets {INVENTED NAME} 400 mg film-coated tablets ||| 30 mg comprimés pelliculés 60 mg, comprimés pelliculés 90 mg, comprimés pelliculés 120 mg, comprimés pelliculés [Voir Annexe I – A compléter au niveau national]
0.2678927779197693 ||| Alcohol consumption must be avoided during treatment with trabectedin due to the hepatotoxicity of the medicinal product (see section 4.4). ||| After application of the veterinary medicinal product into the ear canal, absorption of miconazole and gentamicin through the skin is negligible. ||| La consommation d’ alcool doit être évitée pendant le traitement par la trabectédine en raison de l’ hépatotoxicité du médicament (voir rubrique 4.4).
5.867217519120449e-13 ||| - Do not take a double dose to make up for a forgotten dose. ||| - Do not take a double dose to make up for a forgotten dose. ||| - Ne prenez pas de dose double pour compenser la dose que vous avez oublié de prendre
0.23312397301197052 ||| The tablets should be taken orally, swallowed with water, and can be taken either with or without food. ||| The oral solution may be diluted in a glass of water and may be taken with or without food. ||| Les comprimés sont à prendre par voie orale avec de l’ eau, au cours ou en dehors des repas.
0.7863861322402954 ||| Epoetin alfa ||| Epistaxis ||| Époétine alfa
0.09432874619960785 ||| How to use Liprolog Mix25 Pen 4. ||| How to use Liprolog Mix50 4. ||| Comment utiliser Liprolog Mix25 Pen 4.
0.4368804693222046 ||| The Agency will also see the establishment of a new audit-advisory committee, following an open tender in 2005. ||| The possible creation of a task force for arbitrations in 1997 and perhaps a dedicated Sector for Arbitration procedures in 1998 could take on this task. ||| L’ Agence verra également la création d’ un nouveau comité consultatif d’ audit après un appel d’ offres ouvert en 2005.
0.17571315169334412 ||| Treatment with antiretroviral medicines has not been shown to reduce the risk of passing HIV infection on to others by sexual contact or by blood transfer. ||| Patients should be advised that current antiretroviral therapy has not been proven to prevent the risk of transmission of HIV to others through blood or sexual contact. ||| Un traitement par des médicaments antirétroviraux ne réduit pas le risque de transmission sexuelle ou sanguine du VIH à une autre personne.
0.23756496608257294 ||| Rare: acne, clammy skin, exfoliative dermatitis, drug eruption, exanthema, livedo reticularis, papular rash, pruritus, skin discoloration, skin lesion, zosteriform rash. ||| Common: allergic reaction, urticaria, vesiculobullous rash, pustular rash, maculopapular rash, pruritus, rash, and skin discolouration (hyper-pigmentation) ||| Rare: acné, moiteur de la peau, dermatite exfoliative, éruption médicamenteuse, exanthème, livedo réticulaire, érythème papulaire, prurit, décoloration de la peau, lésion de la peau, éruption de type zona.
0.17157956957817078 ||| MabCampath should be administered under the supervision of a physician experienced in the use of cancer therapy. ||| DepoCyte should be administered only under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. ||| MabCampath doit être administré uniquement sous la surveillance d’ un médecin familiarisé avec l’ usage des traitements anticancéreux.
0.4863813519477844 ||| Manure baskets [non-metallic] ||| Pneumatic hammers [hand-held] ||| Paniers à engrais non métalliques
0.004332108423113823 ||| 20 AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. ||| 62 AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. ||| A moins que le traitement avec un inhibiteur ARAII soit considéré comme essentiel, il est recommandé de modifier le traitement antihypertenseur chez les patientes qui envisagent une grossesse pour un médicament ayant un profil de sécurité établi pendant la grossesse.
1.036466360092163 ||| Further Information ||| For more information ||| Informations supplémentaires
0.3700864911079407 ||| products containing St John’s wort (Hypericum perforatum) as this may stop Norvir from working properly. ||| - if you are taking products containing St John’ s Wort (Hypericum perforatum) as this may stop ||| produits contenant du millepertuis (Hypericum perforatum) car ils peuvent empêcher Norvir d’agir correctement.
0.04589631408452988 ||| 120 film-coated tablets ||| 180 film-coated tablets ||| 120 comprimés pelliculés
0.40803053975105286 ||| "There's no doubt that the Commission is working hard to tackle the existential threat now facing the cultural and creative and the media sectors and that it shares our view that these sectors need to be vibrant, as they are essential pillars of European society and democracy." ||| L. whereas this is a moment of truth for the Union that will determine its future and that can only pull through this crisis if Member States and European institutions stand together in solidarity and responsibility, and when a strong and united voice of the European Parliament is needed more than ever; ||| "Il ne fait aucun doute que la Commission européenne travaille d'arrache-pied pour faire face à la menace existentielle qui pèse désormais sur les secteurs de la culture, de la création et des médias et qu'elle est d'accord sur le fait que ces secteurs doivent être dynamiques, étant donné qu'il s'agit de piliers essentiels de la société et de la démocratie européennes.
0.3433493375778198 ||| - Blood found in the urine on laboratory testing. ||| - Blood detected in the stools by a laboratory test ||| - Détection de la présence de sang dans les urines par une analyse
0.28864815831184387 ||| Comparisons to published pharmacokinetic data with ritonavir-enhanced amprenavir and saquinavir regimens are also described. ||| Toxicologic findings in these co-administration studies were consistent with those seen with nicotinic acid and laropiprant administered individually. ||| Des comparaisons aux données publiées de pharmacocinétique avec les schémas posologiques d’ amprénavir et de saquinavir potentialisés par le ritonavir sont également décrites.
0.48818957805633545 ||| It is not known whether TMZ is excreted in human milk; thus, breast-feeding should be discontinued while receiving treatment with TMZ. ||| Because the active substance used in HBVAXPRO was already authorised for use in the EU, there have been no formal studies of HBVAXPRO. ||| 22 On ne sait pas si TMZ est excrété dans le lait maternel; par conséquent, l’ allaitement doit être interrompu pendant le traitement par TMZ.
0.31620025634765625 ||| 13 System organ class Blood and lymphatic system disorders ||| System Organ Class / Adverse reaction Blood and lymphatic system disorders ||| Système organe classe Affections hématologiques et du système lymphatique
0.3847832977771759 ||| The EIB has built a pipeline of projects of around €6 billion of financing with partners in the health and life science sectors. ||| We have mobilised €140 million of public and private funding for promising research on vaccines, diagnosis and treatment. ||| La BEI a constitué une réserve de projets, représentant environ 6 milliards de financements, avec des partenaires des secteurs de la santé et des sciences de la vie.
0.007244857028126717 ||| Duration of treatment For patients who exhibit virological response at Week 12, treatment should be continued for at least another three-month period (i.e., a total of six months). ||| Duration of treatment For patients who exhibit virological response at Week 12, treatment should be continued for at least another three-month period (i. e., a total of six months). ||| 28 Durée du traitement Pour les patients présentant une réponse virologique à la 12ème semaine, le traitement doit être poursuivi au moins 3 mois de plus (soit une durée totale de 6 mois).
0.3933591842651367 ||| 10 doses (10 x 1 ml) ||| 10 tubes 10 x 1 dose (1.5 ml) ||| 10 doses (10 x 1 ml):
0.38188475370407104 ||| Do not try to remove this air bubble before making the injection - you may lose some of the medicine if you do. ||| If they are not together, do not use this pen because you may not be able to dial your dose (figure 3). ||| N’essayez pas de retirer cette bulle d'air avant l'injection, vous risquez de perdre du produit.
1.5450389385223389 ||| N Baseline HbA1c(%) HbA1c(%) change from base line ||| 2H2N(13CO)NH2 + 2H2O ||| N Taux de l’ HbA1c (%) à l’ inclusion
0.4528757929801941 ||| However, no dosage adjustment is expected to be necessary in hepatic or renal impairment (see section 5.2). ||| 15/ 17 • In exceptional circumstances a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment. ||| Cependant, en cas d'insuffisance hépatique ou rénale, un ajustement de posologie ne semble pas nécessaire (voir rubrique 5.2).
0.32872843742370605 ||| It works by blocking an enzyme called ‘ DNA gyrase’, which is important in allowing bacteria to make copies of their DNA. ||| It works by interfering with the DNA within cells, preventing them from making more copies of DNA and making proteins. ||| Il agit en bloquant une enzyme appelée « ADN gyrase » qui joue un rôle important en permettant aux bactéries de faire des copies de leur ADN.
0.2681366205215454 ||| This causes an increased demand for cholesterol in the liver cells, resulting in the dual effects of increasing transcription and activity of the cholesterol biosynthetic enzyme, hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase, and increasing the number of hepatic low-density lipoprotein receptors. ||| Gemcitabine (difluoro- deoxy-cytidine (dFdC)) is a cytotoxic anti-cancer agent, which exhibits cell phase specificity, primarily killing cells undergoing DNA synthesis (S-phase) and under certain conditions blocking the progression of cells through the G 1/S phase boundary. ||| Il en résulte un accroissement des besoins en cholestérol dans les cellules du foie, entraînant un double effet d’ augmentation de la transcription et de l’ activité de l’ hydroxy-méthylglutaryl-coenzyme A (HMG-CoA) réductase, enzyme de biosynthèse du cholestérol, et d’ augmentation du nombre de récepteurs hépatiques des lipoprotéines de basse densité.
0.14606335759162903 ||| WHAT FIRMAGON IS AND WHAT IT IS USED FOR ||| WHAT ProQuad IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE FIRMAGON ET DANS QUEL CAS EST-IL UTILISE
0.35702353715896606 ||| Use in dogs with impaired function of the heart, kidneys or liver or in dogs that are dehydrated, have low volume of circulating blood or have low blood pressure may involve additional risk. ||| disease, have high blood lipids or take medicines which may cause high blood lipids, have uncontrolled diabetes mellitus (sugar diabetes), have had gall bladder or biliary tract disease, or consume excessive amounts of alcohol. ||| L’ utilisation chez le chien insuffisant cardiaque, rénal ou hépatique, ou chez le chien déshydraté, hypovolémique ou hypotendu peut faire courir un risque supplémentaire.
0.08408096432685852 ||| What Rasilez is and what it is used for 2. ||| What Doribax is and what it is used for 2. ||| Qu’ est -ce que Rasilez et dans quel cas est -il utilisé 2.
3.4889430754192485e-13 ||| Severe allergic reactions to insulin may occur which may become life-threatening. ||| Severe allergic reactions to insulin may occur which may become life-threatening. ||| 456 Des réactions allergiques sévères à l’ insuline peuvent survenir et mettre la vie en danger.
0.0 ||| The use of gloves, goggles and protective clothing is recommended. ||| The use of gloves, goggles and protective clothing is recommended. ||| L’ utilisation de gants, de lunettes et de vêtements de protection est recommandée.
0.011440315283834934 ||| Women of childbearing potential must use effective contraception during and up to 6 months after treatment. ||| Women of childbearing potential must use effective contraception during and up to 16 weeks after treatment. ||| Les femmes en âge d’avoir des enfants doivent utiliser une contraception efficace pendant le traitement et au cours des 6 mois suivant son arrêt.
0.1936328411102295 ||| Neoclarityn syrup relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites). ||| Aerinaze is used to treat the symptoms of seasonal allergic rhinitis (hayfever, inflammation of the nasal passages caused by an allergy to pollen) in patients who have nasal congestion (a blocked nose). ||| Neoclarityn sirop soulage les symptômes associés à la rhinite allergique (inflammation nasale provoquée par une allergie, par exemple, le rhume des foins ou l’ allergie aux acariens).
0.00420916173607111 ||| 12/ 35 Manufacturing authorisation holder responsible for batch release Merial Laboratoire Porte des Alpes Rue de l'Aviation F-69800 Saint Priest ||| 27/ 35 Manufacturing authorisation holder responsible for batch release Merial Laboratoire Porte des Alpes Rue de l'Aviation F-69800 Saint Priest ||| 12/ 35 Titulaire de l’ autorisation de fabrication responsable de la libération des lots Merial Laboratoire Porte des Alpes Rue de l'Aviation F-69800 Saint Priest
0.380553662776947 ||| Transmission of sound and vision via satellite or interactive multimedia networks ||| Broadcasting of television and radio programs via cable or wireless networks ||| Transmission de sons et d'images par satellite ou par le biais de réseaux multimédias interactifs
0.21837198734283447 ||| Chemical additives for lubricants ||| Chemical additives for mortars ||| Additifs chimiques pour lubrifiants
0.06238117069005966 ||| Azomyr orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). ||| Azomyr oral lyophilisate is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). ||| Azomyr comprimés orodispersibles est aussi utilisé pour soulager les symptômes associés à l'urticaire (atteinte cutanée provoquée par une allergie).
0.36519670486450195 ||| To support further streamlining of the system, the Commission will set up a gateway service,aninterface to efficiently receive and pass on relevant information from national contact tracing apps and servers. ||| The Agency will continue upgrading its electronic document management system, as this forms the bedrock for effective publishing of core business information to the Web interface, and will undertake the necessary development of records management (including retention policies) and mail registration. ||| Pour continuer à rationaliser le système, la Commission mettra en place un service passerelle, à savoir une interface permettant de recevoir et de transmettre efficacement les informations pertinentes provenant des applications et serveurs nationaux de traçage des contacts.
0.34655117988586426 ||| In vitro studies did not show any significant involvement of oxidative metabolism by cytochrome P450 enzymes. ||| Furthermore the EEG monitoring did not show proconvulsive effects related to the administration of vaccines. ||| Les études in vitro n'ont pas montré l’ existence d’ un métabolisme oxydatif médié par le cytochrome P450.
0.0 ||| For a full list of excipients, see section 6.1. ||| For a full list of excipients, see section 6.1. ||| Excipients Pour la liste complète des excipients, voir rubrique 6.1
0.47453010082244873 ||| Similar results were seen in the study of children and adolescents. ||| Similar side effects are seen in adults and in children. ||| L’ étude sur les enfants et les adolescents a conduit à des résultats similaires.
0.0 ||| EU Number ||| EU Number ||| Numéro UE
0.2709566056728363 ||| Distribution At clinically relevant concentrations of imatinib, binding to plasma proteins was approximately 95% on the basis of in vitro experiments, mostly to albumin and alpha-acid-glycoprotein, with little binding to lipoprotein. ||| Moreover, Clinical interaction studies with nelfinavir, a moderately potent OATP inhibitor, and pravastatin, a low affinity OATP inhibitor, did not result in clinically significant changes in sitaxentan plasma levels. ||| Distribution A des concentrations d’ imatinib cliniquement significatives, la fraction liée aux protéines plasmatiques est approximativement de 95%, sur la base des études in vitro; il s’ agit principalement d’ une liaison à l’ albumine et aux alpha-glycoprotéines acides, et dans une faible mesure aux lipoprotéines.
0.017062433063983917 ||| Irbesartan Hydrochlorothiazide Winthrop is a combination of an angiotensin-II receptor antagonist, irbesartan, and a thiazide diuretic, hydrochlorothiazide. ||| Irbesartan Hydrochlorothiazide BMS is a combination of an angiotensin-II receptor antagonist, irbesartan, and a thiazide diuretic, hydrochlorothiazide. ||| 70 Irbesartan Hydrochlorothiazide Winthrop est l'association d’ un antagoniste des récepteurs de l'angiotensine-II, l'irbésartan, et d’ un diurétique thiazidique, l'hydrochlorothiazide.
3.32595821543602e-13 ||| The inducing effect may persist for at least 2 weeks after cessation of treatment with St John’ s wort (see section 4.3). ||| The inducing effect may persist for at least 2 weeks after cessation of treatment with St John’ s wort (see section 4.3). ||| L’ effet inducteur peut persister au minimum deux semaines après l’ arrêt du millepertuis.
0.25085386633872986 ||| Fluticasone Furoate GSK is used to treat the symptoms of allergic rhinitis. ||| Fluticasone furoate GSK works to decrease inflammation caused by allergy (rhinitis). ||| Fluticasone Furoate GSK est utilisé pour traiter les symptômes de la rhinite allergique.
0.062408480793237686 ||| No specific information is available on the treatment of overdose with Karvea. ||| No specific information is available on the treatment of overdosage with Bonviva. ||| Aucune information spécifique n’ est disponible sur le traitement en cas de surdosage par l'irbésartan.
0.029233483597636223 ||| For the full list of all side effects reported with Retacrit, see the Package Leaflet. ||| For the full list of all side effects reported with ProQuad, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de Retacrit, voir la notice.
0.24752934277057648 ||| 153 neutropenia, thrombocytopenia, or anemia developed in a few dogs treated with 8 or 10 mg/ kg/ day (total olanzapine exposure [AUC] is 12- to 15-fold greater than that of a man given a 12-mg dose). ||| IRMA 2 was a placebo-controlled double blind morbidity study in 590 patients with type 2 diabetes, microalbuminuria (30-300 mg/ day) and normal renal function (serum creatinine ≤ 1.5 mg/ dl in males and < 1.1 mg/ dl in females). ||| Une neutropénie réversible, une thrombocytopénie périphérique ou une anémie sont survenues chez quelques chiens traités par 8 ou 10 mg/ kg/ j (l’ exposition totale à l’ olanzapine [ASC] étant 12 à 15 fois plus élevée que celle d’ un homme ayant reçu une dose de 12 mg).
0.4870322346687317 ||| Antibiotics should not be used when they are not needed, e.g. for viral infections such as common colds or influenza; ||| It may be used on its own or with other drops e. g. beta-blockers, which also reduce pressure. ||| Les antibiotiques ne doivent pas être utilisés lorsque cela n'est pas nécessaire, notamment pour les infections virales telles que les rhumes ou la grippe;
0.281492680311203 ||| If it is almost time for your next dose, do not take the missed dose. ||| Do not put in any more drops until it is time for your next regular dose. ||| Si vous êtes proche du oment de la prise suivante, ne prenez pas la dose oubliée.
0.35134750604629517 ||| The excretion of retapamulin in milk has not been studied in animals. ||| The use of Janumet in combination with insulin has not been adequately studied. ||| L’ excrétion de rétapamuline dans le lait n’ a pas été étudiée chez l’ animal.
0.0029050717130303383 ||| 124 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 123 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 146 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.3320382833480835 ||| Packaging containers made of wood ||| Decorative plaques made of wax ||| Récipients d'emballage en bois
0.3593435287475586 ||| Vials containing Humalog Mix25 should be rotated in the palms of the hands before use to resuspend the insulin until it appears uniformly cloudy or milky. ||| OPTISON in the non-resuspended form has a white layer of microspheres on top of the liquid phase that requires resuspension before use. ||| Faire rouler les flacons d'Humalog Mix25 entre les paumes des mains, avant utilisation, afin de bien mélanger la suspension d'insuline jusqu'à ce qu'elle prenne un aspect uniformément trouble ou laiteux.
0.8038755655288696 ||| Graphic novels ||| Musical score books ||| Romans graphiques
0.24898061156272888 ||| Side effects observed with Fendrix were generally comparable to those seen in pre-haemodialysis and haemodialysis patients. ||| The reactogenicity profile of Fendrix in healthy subjects was generally comparable to that seen in pre- haemodialysis and haemodialysis patients. ||| Les effets indésirables observés avec Fendrix étaient généralement comparables à ceux observés chez les patients pré-hémodialysés et hémodialysés.
0.1668650209903717 ||| Digoxin bioavailability may be slightly decreased by Enviage. ||| Digoxin bioavailability may be slightly decreased by Tekturna. ||| La biodisponibilité de la digoxine peut être légèrement réduite par Enviage.
0.11558209359645844 ||| Keep Telzir out of the sight and reach of children. ||| Keep Lamictal out of the sight and reach of children. ||| 71 Tenir hors de la portée et de la vue des enfants.
0.2922794222831726 ||| Tell your doctor if you have hepatitis C. ||| 26 If you have viral hepatitis tell your doctor. ||| Veuillez informer votre médecin si vous avez une hépatite C.
0.012998292222619057 ||| Neupro 4 mg/24 h transdermal patch Rotigotine ||| Neupro 3 mg/24 h transdermal patch Rotigotine ||| Neupro 4 mg/ 24 h dispositif transdermique Rotigotine
0.006169794127345085 ||| Co-administration of Zerene together with inducers of CYP3A4 such as rifampicin, carbamazepine and phenobarbitone, may result in a reduction of zaleplon’ s efficacy. ||| Co-administration of Sonata together with inducers of CYP3A4 such as rifampicin, carbamazepine and phenobarbitone, may result in a reduction of zaleplon’ s efficacy. ||| L’ administration concomitante de Zerene et des inducteurs du CYP3A4 comme la rifampicine, la carbamazépine et le phénobarbital peut conduire à une diminution de l’ efficacité de zaleplon.
0.38935965299606323 ||| Animal studies do not indicate direct harmful effects with respect to pregnancy, parturition or postnatal development. ||| Multiple pregnancy, specially high order, carries an increase risk in adverse maternal and perinatal outcomes. ||| Les études animales n’ ont montré aucun effet délétère sur la gestation, la parturition ou le développement post-natal.
0.37081199884414673 ||| 57 Table 3: ||| 60 STEP 3: ||| Tableau 3:
0.19330242276191711 ||| Caution is advised when Agenerase is used concomitantly with PDE5 inhibitors (e. g. sildenafil and vardenafil) (see section 4.5). ||| Therapeutic concentration monitoring is recommended for tricyclic antidepressants (e. g. desipramine and nortriptyline) when co-administered with Telzir (see section 4.5). ||| La prudence est conseillée en cas d’ utilisation concomitante d’ Agenerase et d’ inhibiteurs de la PDE5 (le sildénafil et le vardénafil par exemple) (voir rubrique 4.5).
0.40751707553863525 ||| Treatment with the enzyme has been shown to reduce accumulation of Gb3 in many cell types including endothelial and parenchymal cells. ||| Therefore, no information is available about the penetration of anidulafungin into the cerebrospinal fluid (CSF) and/ or across the blood-brain barrier. ||| L’ administration de cette enzyme réduit donc l’ accumulation de Gb3 dans de nombreux types de cellules, notamment les cellules endothéliales et parenchymales.
0.2454536259174347 ||| In patients with moderate renal impairment, FORSTEO should be used with caution. ||| Therefore, EXUBERA should be used with caution in patients of low body weight. ||| Chez les patients présentant une insuffisance rénale modérée, FORSTEO doit être utilisé avec prudence.
0.2387327253818512 ||| What Diacomit 500 mg contains • The active substance is stiripentol. ||| What Erbitux contains • The active substance is cetuximab. ||| Que contient Diacomit 500 mg • La substance active est le stiripentol.
0.23436029255390167 ||| In clinical studies in hypertensive patients, Riprazo had no clinically important effects on total cholesterol, high density lipoprotein cholesterol (HDL-C), fasting triglycerides, fasting glucose or uric acid. ||| In patients with a history of mild liver disease or abnormal alanine aminotransferase (ALT), aspartate aminotransferase (AST) and/ or bilirubin at baseline, bimatoprost had no adverse reactions on liver function over 24 months. ||| Au cours d’ études cliniques réalisées chez des patients hypertendus, Riprazo n’ a exercé aucun effet cliniquement significatif sur le cholestérol total, le HDL-cholestérol, les triglycérides à jeun, le glucose à jeun ou l’ acide urique.
0.1410553753376007 ||| The usual maintenance dose is 20 mg daily. ||| The usual maintenance dose is 1,1 mg per day. ||| La dose habituelle d'entretien est de 20 mg par jour.
0.27871641516685486 ||| Most of these side effects develop within the first three weeks of treatment. ||| In general these reactions disappear within 3 weeks after the first vaccination. ||| La plupart de ces effets indésirables apparaissent au cours des trois premières semaines de traitement.
0.12434358894824982 ||| EU/ 1/ 08/ 470/ 004 14 film-coated tablets EU/ 1/ 08/ 470/ 005 56 film-coated tablets EU/ 1/ 08/ 470/ 006 168 film-coated tablets ||| EU/ 1/ 98/ 074/ 001 14 film coated tablets EU/ 1/ 98/ 074/ 002 28 film coated tablets EU/ 1/ 98/ 074/ 003 84 film coated tablets ||| EU/ 0/ 00/ 000/ 000 14 comprimés pelliculés EU/ 0/ 00/ 000/ 000 56 comprimés pelliculés EU/ 0/ 00/ 000/ 000 168 comprimés pelliculés
0.3287379741668701 ||| Plasma clearance of total topotecan (active and inactive form) in patients with hepatic impairment only decreased by about 10% compared with the control group of patients. ||| Most skin reactions were limited to the application site and resulted in discontinuation in only 2.4% of the patients in the Exelon 9.5 mg/ 24 h transdermal patch group. ||| La clairance plasmatique du topotécan total (formes active et inactive) chez l'insuffisant hépatique n'a diminué que d'environ 10% par rapport aux patients du groupe témoin.
0.07617446780204773 ||| Protaphane is an isophane insulin suspension (NPH). ||| Insulatard is an isophane insulin suspension (NPH). ||| Protaphane est une suspension d’insuline isophane (NPH).
0.0 ||| Voriconazole is metabolised by cytochrome P450 isoenzymes, CYP2C19, CYP2C9 and CYP3A4. ||| Voriconazole is metabolised by cytochrome P450 isoenzymes, CYP2C19, CYP2C9 and CYP3A4. ||| Le voriconazole est métabolisé par les isoenzymes CYP2C19, CYP2C9 et CYP3A4 du cytochrome P450.
0.07089797407388687 ||| What REYATAZ looks like and contents of the pack ||| What TOVIAZ looks like and contents of the pack ||| Qu’ est -ce que REYATAZ et contenu de l’ emballage extérieur
0.43628406524658203 ||| Patients should be advised to keep capsules out of the reach and sight of children, preferably in a locked cupboard. ||| They should be reminded of the importance of removing the Alert Card included in the pack, and keeping it with them at all times. ||| Les patients devront être avertis de tenir les gélules hors de la portée et de la vue des enfants, de préférence dans un endroit fermé à clé.
0.23467206954956055 ||| There is limited evidence of the clinical efficacy of tigecycline against enterococci. ||| There is no effect of a high fat meal on the pharmacokinetics of aripiprazole. ||| L’ efficacité clinique de la tigécycline sur les entérocoques est peu démontrée.
0.5240809321403503 ||| Administrative services relating to dental health insurance ||| Individual medical counseling services provided to patients ||| Services d'administration d'assurance de soins dentaires
0.000942645943723619 ||| The non-confidential version of the decision will be made available under the case number SA.57219 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.56812 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.57219 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.016383619979023933 ||| If you forget to take Epivir If you forget to take a dose of Epivir, take it as soon as you remember and then continue as before. ||| If you forget to take Combivir If you forget to take a dose of Combivir, take it as soon as you remember and then continue as before. ||| Prenez la dose oubliée dès que possible, puis poursuivez votre traitement selon la prescription de votre médecin.
0.27681636810302734 ||| - Methylparahydroxybenzoate (E 218) ||| - Hydroxypropylmethylcellulose (E 464) ||| - Parahydroxybenzoate de méthyle
0.3984171152114868 ||| Furniture locks (Non-metallic -) ||| Iced confectionery (Non-medicated -) ||| Serrures non métalliques pour meubles
0.02173352614045143 ||| - When new information is received that may impact on the current Safety Specification, ||| - when new information is received that may impact on the current Safety Specification, ||| - si de nouvelles informations reçues sont susceptibles d’ avoir des conséquences sur le profil de
0.39598608016967773 ||| The substantial participation of market investors in the transaction is a positive signal that the Commission strongly encourages, as it limits the distortion of competition while contributing to the recovery of undertakings affected by the coronavirus outbreak." ||| However, the impact of the pandemic and the economic fall-out, are compounding existing needs, making it all the more important that the Union is equipped to demonstrate solidarity with the rest of the world. ||| La participation substantielle d'investisseurs du marché à l'opération constitue un signal positif que la Commission encourage vivement car cela permet de limiter la distorsion de concurrence tout en contribuant à la relance des entreprises touchées par la pandémie de COVID-19.»
2.8632266913311555e-13 ||| It blocks the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses. ||| It blocks the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses. ||| Elle bloque l’ activité de la transcriptase inverse, une enzyme produite par le VIH qui lui permet d’ infecter les cellules et de produire plus de virus.
0.11235405504703522 ||| of Azomyr, in particular colouring agent E110. ||| of Aerius, in particular colouring agent E110. ||| composants contenus dans Azomyr, en particulier le colorant E 110.
0.3321363031864166 ||| The company that makes Vectibix will supply the results of additional studies looking at the safety and effectiveness of the medicine in patients with colorectal cancer with and without mutated KRAS, as well as at the quality of life in patients receiving it. ||| The Committee for Medicinal Products for Veterinary Use concluded that the vaccine has been shown to be safe and to be effective in preventing disease in poultry and could be a useful tool in controlling an outbreak of avian influenza infection. ||| La société qui fabrique Vectibix fournira les résultats de études supplémentaires examinant la sécurité et l’ efficacité du médicament chez les patients souffrant de cancer colorectal avec ou sans gène KRAS muté, ainsi que la qualité de vie des patients auxquels il est administré.
4.501620159535341e-13 ||| Gastrointestinal haemorrhage ||| Gastrointestinal haemorrhage ||| Hémorragie gastro-intestinale
0.47027841210365295 ||| See sections 4.4, 4.8 and 6.1. ||| (See sections 4.5 and 5.2.) ||| Voir rubriques 4.4, 4.8 et 6.1.
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist. ||| Si l’un des effets indésirables devient grave ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez-en à votre médecin, à votre infirmière ou à votre pharmacien.
0.21394896507263184 ||| Absorption Following administration of a single 25 mg intravenous dose of temsirolimus in patients with cancer, mean Cmax in whole blood was 585 ng/ ml (coefficient of variation, CV = 14%), and mean AUC in blood was 1627 ng• h/ ml (CV = 26%). ||| Sitagliptin Absorption Following oral administration of a 100-mg dose to healthy subjects, sitagliptin was rapidly absorbed, with peak plasma concentrations (median Tmax) occurring 1 to 4 hours post-dose, mean plasma AUC of sitagliptin was 8.52 μ M• hr, Cmax was 950 nM. ||| Absorption Après administration d'une dose intraveineuse unique de 25 mg de temsirolimus chez des patients cancéreux, la Cmax moyenne dans le sang total a été de 585 ng/ ml (coefficient de variation CV = 14%) et l'ASC moyenne de 1 627 ng • h/ ml (CV = 26%).
0.5174610614776611 ||| Chapter 3 Key objectives for medicines for human use........................... 19 ||| Chapter 5 Key objectives for technical coordination.............................. .35 ||| Chapitre 3 Objectifs clés pour les médicaments à usage humain......... ..19
0.3214014172554016 ||| Gadovist should not be used in patients with uncorrected hypokalemia. ||| GONAL-f should not be given to men with irreversible testicular damage. ||| Gadovist ne doit pas être utilisé chez des patients présentant une hypokaliémie non corrigée.
0.015324234031140804 ||| 103 Breast-feeding Inform your doctor if you are breast-feeding. ||| 85 Breast-feeding Inform your doctor if you are breast-feeding. ||| Allaitement Informez votre médecin si vous allaitez.
0.3199073076248169 ||| PegIntron, when given alone, is usually given at a dose of 0.5 or 1.0 microgram/kg once a week, for at least 6 months, and possibly for 1 year. ||| GONAL-f should be given at a dosage of 150 IU three times a week, concomitantly with hCG, for a minimum of 4 months. ||| PegIntron, administré seul, est habituellement donné par dose de 0,5 ou 1,0 microgramme/ kg une fois par semaine, pendant au moins 6 mois, et parfois pendant 1 an.
0.4362369775772095 ||| 4 pens ||| 10 pr ||| 4 stylos
0.34827885031700134 ||| Take special care with Insuman Comb 15 ||| Take special care with Insuman Basal ||| Faites attention avec Insuman Comb 15
0.0036215418949723244 ||| 85 België/ Belgique/ Belgien Rue de Stalle/ Stallestraat 73 B-1180 Bruxelles/ Brussel/ Brüssel Tél/ Tel: + 32-(0)2 370 92 11 ||| 22 België/ Belgique/ Belgien Rue de Stalle/ Stallestraat 73 B-1180 Bruxelles/ Brussel/ Brüssel Tél/ Tel: + 32-(0)2 370 92 11 ||| België/ Belgique/ Belgien Rue de Stalle/ Stallestraat 73 B-1180 Bruxelles/ Brussel/ Brüssel Tél/ Tel: + 32-(0)2 370 92 11
0.11570140719413757 ||| DATE OF REVISION OF THE TEXT ||| DATE OF REVISION OF TEXT ||| DATE DE MISA A JOUR DU TEXTE
0.14965251088142395 ||| Gemcitabine, in combination with c isplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). ||| “Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non small cell lung cancer. ||| La gemcitabine, en association avec le cisplatine, est indiquée dans le traitement en première ligne des patients atteints de cancer bronchique non à petites cellules (CBNPC) localement avancé ou métastatique.
0.06129731237888336 ||| The following instructions explain how to use Pegasys pre-filled syringes to inject yourself. ||| The following instructions explain how to use MIRCERA pre-filled syringes to inject yourself. ||| 178 Les instructions suivantes expliquent comment utiliser la seringue pré-remplie de Pegasys afin de vous faire l’injection vous-même.
0.05657128989696503 ||| If it gets worse, your doctor will decide whether or not your Rebetol treatment needs to be changed. ||| If it gets worse, your doctor will decide whether or not your ribavirin treatment needs to be changed. ||| Si elle s’ aggrave, votre médecin décidera si votre traitement par Rebetol doit ou non être modifié.
0.7580005526542664 ||| Fortzaar 100 mg/ 12,5 mg film- coated tablets ||| 1 part Econor 50% premix to 20 parts feed ingredient. ||| Fortzaar 100 mg/ 12,5 mg comprimé pelliculé
0.05496528372168541 ||| Exforge contains two active substances, amlodipine and valsartan. ||| Dafiro contains two active substances, amlodipine and valsartan. ||| Exforge contient deux substances actives: l’ amlodipine et le valsartan.
0.25679415464401245 ||| 17/ 125 Do not use in animals suffering from impaired hepatic, cardiac or renal function and haemorrhagic disorders, or where there is evidence of ulcerogenic gastrointestinal lesions. ||| In particular, patients should be evaluated for hypothyroidism, adrenocortical deficiency, hyperprolactinemia and pituitary or hypothalamic tumours, and appropriate specific treatment given. ||| 17/ 129 Ne pas administrer aux animaux présentant une insuffisance hépatique, cardiaque ou rénale, des désordres hémorragiques, des lésions gastro-intestinales avérées.
0.05729161947965622 ||| Taking other medicines Tell your doctor or pharmacist if you’ re taking any other medicines, if you’ ve taken any recently, or if you start taking new ones — these include herbal medicines or other medicines you bought without a prescription. ||| Other medicines and Telzir Tell your doctor or pharmacist if you’ re taking any other medicines, if you’ ve taken any recently, or if you start taking new ones – these include herbal medicines or other medicines you bought without a prescription. ||| Prise d'autres médicaments Si vous prenez, commencez à prendre ou avez pris récemment un autre médicament, y compris un médicament à base de plantes ou obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.0084052924066782 ||| 48 France BRISTOL-MYERS SQUIBB SARL Tél: + 33 (0)810 410 500 ||| 30 France BRISTOL-MYERS SQUIBB SARL Tél: + 33 (0)810 410 500 ||| France BRISTOL-MYERS SQUIBB SARL Tél: + 33 (0)810 410 500
0.31168508529663086 ||| Clinical Efficacy Xigris was studied in one Phase 3 international, multi-centre, randomised, double-blind, placebo- controlled trial (PROWESS) in 1690 patients with severe sepsis. ||| Further Clinical Experience In a Phase 3b international, single-arm, open-label clinical trial (ENHANCE), 2378 adult patients with severe sepsis received drotrecogin alfa (activated). ||| Efficacité Clinique Xigris a été évalué lors d’ une étude de phase 3 internationale, multicentrique, randomisée, en double aveugle et contrôlée versus placebo (étude PROWESS) sur 1690 patients présentant un sepsis sévère.
0.31522151827812195 ||| Mechanical transmissions [other than for land vehicles] ||| Safety alarms [other than for vehicles] ||| Transmissions mécaniques autres que pour véhicules terrestres
0.2552875578403473 ||| ATC vet code: ||| ATCvet Code: ||| Code ATC-Vet:
0.2537980377674103 ||| The most common adverse reactions experienced by 30% or more of patients receiving IL-2 and Ceplene (listed in descending order of frequency) were: flushing, headache, fatigue, injection site granuloma, pyrexia and injection site erythema. ||| The following undesirable effects were commonly (> 1/ 100, < 1/ 10) reported in clinical trials: erythema, tenderness, swelling over the implant site, and heterotopic ossification/ myositis ossificans. ||| Les réactions indésirables les plus couramment observées chez au moins 30% des patients traités par l’ IL-2 et Ceplene (énumérées par ordre décroissant de fréquence) étaient: bouffées vasomotrices, céphalée, fatigue, granulome au site d’ injection, fièvre et érythème au site d’ injection.
0.14755618572235107 ||| EU/ 1/ 01/ 171/ 009-10 ||| EU/ 1/ 06/ 366/ 005-10 ||| EU/ 01/ 171/ 009-10
0.2957279682159424 ||| For upper respiratory tract infections such as tonsillitis, otitis media, sinusitis and pharyngitis: ||| The infections consisted primarily nasopharyngitis, upper respiratory tract infection, and sinusitis. ||| Infections respiratoires hautes telles que angines, otites moyennes, sinusites, pharyngites:
0.3770717978477478 ||| Österreich ESTEVE GmbH Max-Planck-Strasse 11 D-85716 Unterschleissheim, Deutschland HRB München 99927 Tel: +49-89-321419-64 ||| România Nycomed România Strada Despot Vodă nr.32A, Sect.2 Bucureşti, Cod 020656-RO Tel: + 40212123848 ||| ESTEVE GmbH Max-Planck-Strasse 11 D-85716 Unterschleissheim, Deutschland HRB München 99927 Tel: +49-89-321419-64
0.3952207565307617 ||| The matter was referred to the Co-ordination Group for Mutual Recognition and Decentralised Procedures CMD(v) and subsequently to the Committee for Medicinal Products for Veterinary Use. ||| Tritace has been identified as needing harmonisation by the Co-ordination Group on the Mutual and Decentralised Procedures – Human (CMD(h)). ||| Cette question a été renvoyée au groupe de coordination pour la reconnaissance mutuelle et les procédures décentralisées [vétérinaire CMD(v)] et ultérieurement au comité des médicaments vétérinaires.
0.03577752783894539 ||| Actraphane may cause hypoglycaemia (low blood sugar). ||| Actraphane may cause hypoglycaemia (low blood glucose). ||| Actraphane peut entraîner une hypoglycémie (faible taux de sucre dans le sang).
0.24586032330989838 ||| RoActemra was more effective than the comparator medicines at reducing the symptoms of rheumatoid arthritis. ||| Kineret is for patients whose response to methotrexate on its own is not good enough to control the rheumatoid arthritis. ||| RoActemra s’ est avéré plus efficace que les médicaments de comparaison s’ agissant de la réduction des symptômes de la polyarthrite rhumatoïde.
0.2995924651622772 ||| What Irbesartan Hydrochlorothiazide BMS looks like and contents of the pack ||| What benefit has Irbesartan Hydrochlorothiazide Winthrop shown during the studies? ||| A quoi ressemble Irbesartan Hydrochlorothiazide BMS et contenu de l'emballage extérieur
0.50013267993927 ||| Apparatus for analysing gases ||| Apparatus for use in angiography ||| Appareils pour l'analyse de gaz
0.6384497880935669 ||| How to store Ceftriaxone Tyrol Pharma 2g 6. ||| Table 3a Dose modification guidelines for PegIntron monotherapy ||| Comment conserver Ceftriaxone Tyrol Pharma 2 g 6.
0.21192295849323273 ||| Metformin is excreted into milk in lactating rats. ||| Lumiracoxib is excreted in the milk of lactating rats. ||| Chez le rat, la metformine est excrétée dans le lait.
0.2069673240184784 ||| 264 9. ||| 438 5. ||| 280 9.
5.53969413744082e-13 ||| Topotecan is not recommended to be used in these patients. ||| Topotecan is not recommended to be used in these patients. ||| Il n’ est pas recommandé d’ utiliser topotécan chez ces patients.
0.3277078866958618 ||| The company that makes Prialt is carrying out a study looking at the long term use of the medicine, looking in particular at the possibility of development of tolerance to treatment (when doses of a medicine that were effective become less effective over time). ||| When looking only at the patients who were receiving their first treatment for metastatic breast cancer, there was no difference between the medicines in terms of measures of effectiveness such as the time until the disease got worse and survival. ||| La société qui fabrique Prialt réalise actuellement une étude sur l’ utilisation à long terme du médicament, portant en particulier sur la possibilité d’ un développement de la tolérance au traitement (lorsque des doses d’ un médicament qui étaient efficaces deviennent au fur et à mesure moins efficaces).
0.14691293239593506 ||| Providing information relating to the repair or maintenance of sewing machines ||| Providing information relating to the rental of sewing machines ||| Mise à disposition d'informations en matière de réparation ou d'entretien de machines à coudre
0.27391916513442993 ||| Kepivance should be reconstituted with 1.2 ml water for injections. ||| Beromun should be reconstituted by adding 5 ml of solvent for infusion. ||| Kepivance doit être reconstitué avec 1,2 ml d’ eau pour préparations injectables.
0.47131457924842834 ||| Discard used needles immediately after injection. ||| Use your Avonex injection just before bedtime. ||| Jetez les aiguilles utilisées immédiatement après l'injection.
0.11732558161020279 ||| Using other medicines Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, because they might interact. ||| Using other medicines Always tell your doctor if you are taking or have recently taken any other medicines, including medicines you buy without a prescription. ||| Indiquez toujours à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment un autre médicament, même s'il s'agit d'un médicament obtenu sans ordonnance, car ils pourraient interagir.
0.4311430752277374 ||| Hypersensitivity Angiooedema. ||| Dehydration SIADH Hypo-natremia ||| Hypersensibilité Angio-œ dème.
0.06611662358045578 ||| 197 Keep out of the reach and sight of children. ||| ► Keep out of the reach and sight of children. ||| Tenir hors de la portée et de la vue des enfants.
0.560461699962616 ||| Boehringer M annheim ||| G alenus Mannheim ||| Boehringer Mannheim DE
0.0 ||| In a placebo-controlled polysomnography study over 3 weeks pramipexole significantly reduced the number of periodic limb movements during time in bed. ||| In a placebo-controlled polysomnography study over 3 weeks pramipexole significantly reduced the number of periodic limb movements during time in bed. ||| Dans une étude polysomnographique contrôlée contre placebo d’ une durée de 3 semaines, le pramipexole a significativement diminué le nombre des mouvements périodiques des jambes pendant la nuit.
0.35449522733688354 ||| The EMEA, in conjunction with other EU bodies and the Commission, is testing the SI2 budgetary system with a target production date of 1 April 1998. ||| The application tracking system developed jointly by the World Health Organisation (WHO) and the EMEA – SIAMED – will be further developed for general use at the EMEA in 2002. ||| L’EMEA, en association avec d’autres organismes communautaires et la Commission, teste le système budgétaire SI2 avec la date cible de production du 1er avril 1998.
0.421441912651062 ||| After intravenous administration, gadobutrol is rapidly distributed in the extra cellular space. ||| Human normal immunoglobulin is immediately and completely bioavailable in the recipient’ s circulation after intravenous administration. ||| Le gadobutrol injecté par voie intraveineuse se distribue rapidement dans le compartiment extracellulaire.
0.22859907150268555 ||| 422 • If you have chronic renal failure there is an increased risk of serious problems with your heart or blood vessels (cardiovascular events) if your haemoglobin is kept too high. ||| Treatment with Binocrit may be associated with an increased risk of blood clotting after the surgery (postoperative thrombotic/ vascular disorders) if your levels of the red blood pigment are too high. ||| • Si vous souffrez d’ insuffisance rénale chronique, le risque que vous présentiez des problèmes cardiovasculaires graves est augmenté si votre taux d’ hémoglobine est maintenu à un niveau trop élevé.
0.0 ||| Patients with endocrinological disorders are more prone to develop an epiphysiolysis. ||| Patients with endocrinological disorders are more prone to develop an epiphysiolysis. ||| Les patients souffrant de troubles endocriniens sont plus exposés aux risques de développer une épiphysiolyse.
0.33521032333374023 ||| Myozyme is supplied as a white to off-white powder. ||| ADVATE is a white to off-white friable powder. ||| Myozyme est fourni sous forme de poudre blanche à blanchâtre.
0.3809760808944702 ||| ADROVANCE 70 mg/ 5600 IU tablets Alendronic acid as alendronate sodium trihydrate/ colecalciferol ||| Activelle Estradiol (as hemihydrate) 0.5 mg Film-coated tablets Oral use + Norethisterone acetate 0.1 mg ||| ADROVANCE 70 mg/ 5600 UI, comprimés Acide alendronique sous forme d’ alendronate monosodique trihydraté/ colécalciférol
0.15160512924194336 ||| In the MRP the United Kingdom is the Reference Member State and Austria, Belgium, Finland, France, Germany, Italy, Ireland, Luxembourg, Portugal, Spain and Sweden are Concerned Member States. ||| In the MRP United Kingdom is the Reference Member State (RMS) and Austria, Belgium, Finland, France, Germany, Italy, Ireland, Luxembourg, Portugal, Spain and Sweden are Concerned Member States (CMS). ||| L'État membre de référence pour cette MRP est le Royaume-Uni, et les États membres concernés sont l’ Autriche, la Belgique, la Finlande, la France, l’ Allemagne, l’ Italie, l’ Irlande, le Luxembourg, le Portugal, l’ Espagne et la Suède.
0.43115970492362976 ||| 46 For adults and older people, the recommended starting dose is 7.5 mg daily. ||| In mild hypertension, the recommended initial dose is 5 to 10 mg. ||| Pour les adultes et les personnes âgées: la dose initiale recommandée est de 7,5 mg par jour.
0.47741588950157166 ||| Later, impeachment cases were brought up against the President for his participation in the parade, which some viewed as anti-democratic, and also for posing a threat to public health. ||| These bots are claiming China intentionally created the virus, that it's a biological weapon, that Democrats are overstating the threat to hurt Donald Trump and more. ||| Plus tard, des accusations de mise en accusation ont été portées contre le Président pour sa participation au défilé, que certains considéraient comme antidémocratique, et aussi pour avoir menacé la santé publique.
0.6126489043235779 ||| Electrodes for external defibrillators ||| Implantable defibrillators ||| Électrodes pour défibrillateurs externes
0.32497864961624146 ||| The analysis of all recorded in vivo recoveries in previously treated patients demonstrated a mean rise of 2% per IU/ kg body weight for Helixate NexGen. ||| The observed excess risk of fractures for women in this dataset on pioglitazone is therefore 0.8 fractures per 100 patient years of use. ||| L'analyse de la récupération in vivo chez les patients préalablement traités a montré pour Helixate NexGen une augmentation moyenne du taux de facteur VIII plasmatique de 2% par UI/ kg de poids corporel.
0.03168599307537079 ||| EU/ 1/ 96/ 022/ 026 - ZYPREXA - 10 mg - coated tablets - 35 tablets, per box. ||| EU/ 1/ 96/ 022/ 031 - ZYPREXA – 7.5 mg - coated tablets - 70 tablets, per box. ||| ZYPREXA - 10 mg - comprimés enrobés - 35 comprimés par boîte.
0.4394723176956177 ||| CONDITIONS OF THE MARKETING AUTHORISATION ||| DATE OF RENEWAL OF THE AUTHORISATION ||| CONDITIONS RELATIVES A L’ AUTORISATION DE MISE SUR LE MARCHÉ
0.017708968371152878 ||| TESAVEL 50 mg film-coated tablets ||| TESAVEL 100 mg film-coated tablets ||| TESAVEL 50 mg, comprimés pelliculés
0.0 ||| Powder and solvent for solution for injection ||| Powder and solvent for solution for injection ||| au Poudre et solvant pour solution injectable
0.6780996322631836 ||| We will get out of the sanitary crisis, while keeping our fundamental rights intact. ||| The world needs to come out stronger from this pandemic. ||| Nous sortirons de la crise sanitaire, tout en préservant nos droits fondamentaux.»
0.217058002948761 ||| A separate infusion line must be used for the infusion, and the line must be flushed with sterile sodium chloride 9 mg/ ml (0.9%) solution for injection at the end of infusion. ||| To ensure complete injection of the contrast medium, the injection should be followed by a 5 ml flush of sodium chloride 9 mg/ ml (0.9%) injection. ||| Une ligne de perfusion séparée doit être utilisée pour la perfusion, et la ligne doit être rincée avec une solution injectable stérile de chlorure de sodium à 9 mg/ ml (0,9%) à la fin de la perfusion.
0.29785510897636414 ||| The dose of Caelyx is diluted in 250 ml 5% (50 mg/ ml) glucose solution for infusion and administered by intravenous infusion over 30 minutes. ||| Patients should be given intravenous diphenhydramine 25 to 50 mg (or similar antihistamine) approximately 30 minutes before the start of each dose of temsirolimus. ||| La dose de Caelyx est diluée dans 250 ml de glucose à 5% (50 mg/ ml) solution pour perfusion et administrée en perfusion intraveineuse sur 30 minutes.
0.13540780544281006 ||| For short term travelling, the non -reconstituted product can be kept out of the refrigerator at or below 25°C for a period up to four weeks before use. ||| For short term t ravelling, the solution can be kept out of the refrigerator at or below 25°C for a period up to seven days before use. ||| 409 Pour des voyages de courte durée et avant utilisation, le produit non reconstitué peut être conservé en dehors du réfrigérateur à une température ne dépassant pas 25°C pendant une période ne dépassant pas 4 semaines.
0.41217705607414246 ||| These effects have been seen in people using Avonex, but we do not know how likely they are to happen. ||| Although these adverse events were not observed, there is the possibility that they may also occur with Luveris. ||| Ces effets ont été observés chez des personnes prenant Avonex mais on ignore leur probabilité..
0.7873533368110657 ||| Improving the level playing field and protecting EU business and citizens ||| Strengthening the Single Market and adapting it to the digital age: ||| Améliorer les conditions de concurrence et protéger les entreprises et les populations de l'Union
0.41940441727638245 ||| Clearance normalised for body weight was 2.66 and 2.10 ml/ min/ kg for males and females, respectively. ||| The number of male and female patients receiving vildagliptin 50 mg once daily or 100 mg daily was 2,069 and 1,715, respectively. ||| La clairance normalisée en fonction du poids corporel est de 2,66 ml/ min/ kg chez les hommes et de 2,10 ml/ min/ kg chez les femmes.
0.3266994059085846 ||| 28/ 94 The binding of ropinirole to plasma proteins is not high (< 40%), with no effect on the distribution, which is very extensive (volume of distribution in the order of 7 l/ kg). ||| Nevirapine concentrations in human cerebrospinal fluid (n = 6) were 45% (± 5%) of the concentrations in plasma; this ratio is approximately equal to the fraction not bound to plasma protein. ||| Distribution La fixation du ropinirole aux protéines plasmatiques est peu importante (< 40%), sans incidence sur la distribution qui est très large (volume de distribution de l’ ordre de 7 l/ kg).
0.24143429100513458 ||| Use in adults, adolescents ≥ 16 years of age and elderly ||| Use in children (including neonates) and adolescents < 16 years of age ||| Utilisation chez l’ adulte, l’ adolescent ≥ 16 ans et les personnes âgées
0.08530112355947495 ||| CPMP/ 6214/ 03 SCIENTIFIC CONCLUSIONS ||| CPMP/ 1333/ 03 SCIENTIFIC CONCLUSIONS |||  EMEA 2004 CPMP/ 6214/ 03 CONCLUSIONS SCIENTIFIQUES
0.26744237542152405 ||| 11 (12.8%) ||| 18 (16.1%) ||| 11 (12,8%)
0.41057541966438293 ||| 33 Olanzapine tablets contain lactose monohydrate. ||| Alendronate HEXAL tablets contain lactose. ||| Lactose Les comprimés de OLANZAPINE MYLAN contiennent du lactose.
0.3045084476470947 ||| Haemodialysis does not have an effect on the pharmacokinetics of loratadine or its active metabolite in subjects with chronic renal impairment. ||| Amyloidosis The impact of proteasome inhibition by bortezomib on disorders associated with protein accumulation such as amyloidosis is unknown. ||| L’ hémodialyse n’ a pas d’ effet sur la pharmacocinétique de la loratadine et de son métabolite actif chez les patients ayant une insuffisance rénale chronique.
0.37620607018470764 ||| For children from the age of 3, Helicobacter Test INFAI for children aged 3 to 11 is available. ||| What Helicobacter Test INFAI for children of the age 3-11 years is and what it is used for 2. ||| Pour les enfants de plus de 3 ans, le test INFAI Helicobacter pour âges 3 à 11 ans est disponible.
0.4875136613845825 ||| Arranging for the provision of advertising space in newspapers ||| Providing and rental of advertising space on the internet ||| Organisation de mise à disposition d'espaces publicitaires dans des journaux
0.4708726406097412 ||| Pharmacological data ||| Pharmacology ||| Données pharmacologiques
0.56636643409729 ||| Registration services (legal) ||| Fan club services (entertainment) ||| Services d'enregistrement juridique
0.7891991138458252 ||| Do not use Zenapax i dic ||| Fondaparinux does not bind lP ||| N’ utilisez jamais Zenapax Ce
0.3526178002357483 ||| In the event of substantial overdose, vomiting may be considered to remove unabsorbed active substance. ||| To minimize the possibility of agglutination, it is important to limit the amount of blood entering the tubing. ||| En cas de surdosage important, il peut être envisagé de provoquer des vomissements afin d’ éliminer le médicament non absorbé.
0.2437552958726883 ||| 967 kcal, 67 grams fat, 33 grams protein, 58 grams carbohydrate) did not alter plasma amprenavir pharmacokinetics (Cmax, tmax or AUC0- ∞) compared to the administration of this formulation in the fasted state. ||| Administration of the fosamprenavir oral suspension formulation with a high fat meal (967 kcal, 67 grams fat, 33 grams protein, 58 grams carbohydrate) reduced plasma amprenavir AUC(0- ∞) by 28% and Cmax by 46% and delayed Tmax by 0.72 hours. ||| 967 kcal, 67 grammes de lipides, 33 grammes de protéines, 58 grammes de glucides) ne modifie pas les paramètres pharmacocinétiques plasmatiques (Cmax, Tmax ou ASC0-∞) comparativement à la prise à jeun de cette forme pharmaceutique.
0.2769407629966736 ||| Absorption: in HIV-infected patients (n=33, combined studies), multiple dosing of REYATAZ 300 mg once daily with ritonavir 100 mg once daily with food produced a geometric mean (CV%) for atazanavir, Cmax of 4466 (42%) ng/ ml, with time to Cmax of approximately 2.5 hours. ||| Absorption In healthy adult subjects (males and females), following administration of FOSAVANCE 70 mg/ 5600 IU after an overnight fast and two hours before a meal, the mean area under the serum- concentration-time curve (AUC0-80 hrs) for vitamin D3 (unadjusted for endogenous vitamin D3 levels) was 490.2 ng• hr/ ml. ||| Chez des patients infectés par le VIH (n = 33, études combinées), des doses répétées de REYATAZ 300 mg associé au ritonavir 100 mg une fois par jour avec de la nourriture ont donné une moyenne géométrique (CV%) de la Cmax de 4466 (42%) ng/ ml pour l’ atazanavir avec un temps pour la Cmax d’ environ 2,5 heures.
0.012671658769249916 ||| 219 Adult patients with chronic renal failure ||| 243 Adult patients with chronic renal failure ||| Adultes insuffisants rénaux chroniques
0.07784850150346756 ||| 8/ 39 ANNEX II ||| 8/ 33 ANNEX III ||| 8/ 43 ANNEXE II
0.3192809820175171 ||| 20, 28, 30, 50, 56, 60, 84, 90, 100, 112, 120, 168 & 180 ||| Pack sizes of 20, 28, 30, 50, 56, 60, 84, 90, 100, 112, 120, 168 & 180. ||| 20, 28, 30, 50, 56, 60, 84, 90, 100, 112, 120, 168 & 180 capsules
0.5999012589454651 ||| Uncommon ||| Common Uncommon ||| Fréquent
4.325382283246193e-13 ||| Erythropoietin is a growth factor that primarily stimulates red cell production. ||| Erythropoietin is a growth factor that primarily stimulates red cell production. ||| L’ érythropoïétine est un facteur de croissance qui stimule principalement la production des globules
0.03625515103340149 ||| Selamectin 60 mg ||| Selamectin 45 mg ||| Selamectine 60 mg
5.184586484088816e-13 ||| Read the package leaflet before use ||| Read the package leaflet before use ||| Lire la notice de l’emballage avant utilisation.
0.2138645350933075 ||| In case of shock, standard medical treatment for shock should be implemented. ||| In case of shock, the current medical standards for shock treatment should be observed. ||| En cas de choc, les traitements médicaux habituels seront appliqués.
0.16821718215942383 ||| The solvent is clear and colourless. ||| The solvent is a clear colourless solution. ||| Le solvant: est limpide et incolore.
0.027417778968811035 ||| 15 Patients at increased risk should be followed closely. ||| 5 Patients at increased risk should be followed closely. ||| Les patients à risque élevé devront faire l’ objet d’ une étroite surveillance.
0.2435198724269867 ||| In addition, the BWP proposed a revision of the CPMP note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products, which was released for consultation. ||| The CHMP began an arbitration review for Prozac, following an application by the marketing authorisation holder to extend the indication to include the treatment of major depressive episodes in children and adolescents. ||| Le BWP a en outre proposé une révision de la note explicative du CPMP concernant la minimisation du risque de transmission des agents de l’ encéphalopathie spongiforme animale par le biais de médicaments, diffusée à des fins de consultation.
0.37711554765701294 ||| The frequency and severity of the most commonly reported adverse reactions with Pegasys are similar to those reported with interferon alfa-2a (see Table 4). ||| The frequency of vaccine-related adverse experiences after the second dose of ZOSTAVAX was generally similar to that seen with the first dose. ||| La fréquence et la sévérité des principales réactions indésirables avec Pegasys sont similaires à celles rapportées avec l’interféron alfa-2a (voir Tableau 4).
0.460685133934021 ||| The dosage should be determined on the basis of laboratory measurements of the protein C activity. ||| The accuracy of the test strongly depends on the quality of the breath analysis. ||| La posologie doit être basée sur les résultats du dosage de l’ activité en protéine C.
0.4077199697494507 ||| The vaccine may not prevent hepatitis B infection in such cases. ||| A vaccine is available to prevent infection with HBV. ||| Dans de tels cas, il se peut que la vaccination ne prévienne pas l’ hépatite B.
0.27803170680999756 ||| Renal insufficiency/ Haemodialysis Treatment with VISTIDE must not be initiated in patients with creatinine clearance ≤ 55 ml/ min, or ≥ 2+ Proteinuria (≥ 100 mg/ dl), as the optimum induction and maintenance doses for patients with moderate to severe renal impairment are not known. ||| 41 Hepatic impairment: no clinical trials were conducted with SPRYCEL in patients with moderate to severe hepatic impairment (trials excluded patients with ALT and/ or AST > 2.5 times the upper limit of the normal range and/ or total bilirubin > 2 times the upper limit of the normal range). ||| Insuffisance rénale/ hémodialyse Le traitement par VISTIDE ne doit pas être débuté chez les patients ayant une clairance de la créatinine ≤ 55 ml/ min ou une protéinurie ≥ 2+ (≥ 100 mg/ dl), étant donné que les doses optimales de traitement d'induction et d’ entretien pour les patients souffrant d'une insuffisance rénale modérée à sévère ne sont pas connues.
0.44329267740249634 ||| Patients who have problems with their liver (including hepatitis B or C infection) may be at an elevated risk of liver damage when taking Crixivan. ||| Many patients with osteoporosis have no symptoms but they are still at risk of breaking bones because osteoporosis has made their bones weaker. ||| Les patients présentant des troubles du foie (notamment une infection par l’ hépatite B ou C) peuvent présenter un risque élevé de lésions du foie en cas de prise de Crixivan.
4.290911701475275e-13 ||| No other clinically significant drug interaction has been reported during GONAL-f therapy. ||| No other clinically significant drug interaction has been reported during GONAL-f therapy. ||| Aucune autre interaction cliniquement significative avec des médicaments n’ a été rapportée lors d’ un traitement par GONAL-f.
0.42561259865760803 ||| Median duration of treatment on dasatinib was 3 months with 2% treated for > 24 months to date. ||| The vaccination schedule for Ambirix is two doses given six to 12 months apart. ||| La durée médiane du traitement par dasatinib était de 3 mois avec 2% des patients traités pendant > 24 mois à ce jour.
0.41433924436569214 ||| Bundling machines ||| Foundry machines ||| Machines à enliasser
0.007277735974639654 ||| If an excessive response is obtained, treatment should be stopped and hCG withheld (see section 4). ||| If an excessive response is obtained, treatment should be stopped and hCG withheld (see Section 4). ||| Si une réponse excessive est obtenue, le traitement sera interrompu et l’hCG ne devra pas être administrée (se reporter à la rubrique 4).
0.3012038469314575 ||| Caution should be applied when considering cidofovir treatment of patients with diabetes mellitus due to the potential increased risk of developing ocular hypotony. ||| It should be noted that patients with factor IX inhibitors may be at an increased risk of anaphylaxis with subsequent challenge with factor IX. ||| Il faut être prudent lorsque l’ on envisage un traitement par cidofovir chez des patients atteints de diabète, en raison du risque potentiel accru de développer une hypotonie oculaire.
0.24438858032226562 ||| Standard doses of voriconazole and standard doses of efavirenz must not be coadministered. ||| Co-administration of higher doses of either efavirenz or carbamazepine has not been studied. ||| L’ administration concomitante d’ efavirenz et de voriconazole aux doses habituelles est contre-indiquée.
0.08139485120773315 ||| WHAT WILZIN IS AND WHAT IT IS USED FOR ||| WHAT GALVUS IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE WILZIN ET DANS QUEL CAS EST-IL UTILISE
0.302557110786438 ||| This scheme aims at supporting companies that face difficulties due to loss of income and liquidity resulting from the economic impact of the coronavirus outbreak. ||| The scheme aims at supporting companies, as well as liberal professions, affected by the economic impact of the coronavirus outbreak. ||| Ce régime vise à soutenir les entreprises qui connaissent des difficultés à la suite des pertes de revenus ou de liquidités qu'elles subissent en raison de l'impact économique de la pandémie.
0.31700849533081055 ||| Antoine CUVILLIER Direct telephone (44-20) 74 18 84 28 E-mail: antoine.cuvillier@emea.eudra.org ||| (33-1) 55 87 30 14 Fax (33-1) 55 87 30 12 E-mail: philippe.duneton@afssaps.sante.fr ||| Antoine CUVILLIER Téléphone direct (44-20) 74 18 84 28 E-mail: antoine.cuvillier@emea.eudra.org
6.149687421623529e-13 ||| Use immediately or within 3 hours of reconstitution. ||| Use immediately or within 3 hours of reconstitution. ||| Le produit reconstitué doit être utilisé immédiatement ou dans les 3 heures.
0.2574397325515747 ||| As a precautionary measure, breast-feeding should not be continued during treatment with Iscover. ||| For precautionary measures, breast-feeding should be discontinued during treatment with lacosamide. ||| Par mesure de précaution, l’allaitement ne devrait pas être continué en cas de traitement par Iscover.
0.7165263295173645 ||| Do not blow into the mouthpiece. ic ||| DO NOT push air into the BeneFIX vial. ||| Ne soufflez pas dans l’embout buccal. m
0.5401443243026733 ||| The Working Party also finalised the guideline on excipients used in veterinary medicinal products. ||| This article is intended to cover the expenditure relating to early childhood centres and crèches. ||| Le groupe de travail a également finalisé la ligne directrice sur les excipients utilisés dans les médicaments vétérinaires.
0.2751741111278534 ||| Excretion Oxybutynin is extensively metabolised by the liver, see above with less than 0.1% of the administered dose excreted unchanged in the urine. ||| Results from a mass balance study with radioactive 14C-etravirine showed that < 1.2% of the administered dose of etravirine is excreted in the urine. ||| 6 Elimination L'oxybutynine est essentiellement métabolisée par le foie, voir ci-dessus, avec moins de 0,1% de la dose administrée éliminée sous forme inchangée dans les urines.
0.33170151710510254 ||| Dose reduction with each cycle or within a cycle may be applied based upon the grade of toxicity experienced by the patient. ||| Titration and maintenance dose Depending on the patient’ s tolerability to the active substance, the dose should be gradually increased. ||| Une réduction de dose à chaque cycle ou au cours d’un cycle pourra être envisagée en fonction du grade de toxicité présenté par la patiente.
0.19504287838935852 ||| Non-toxic enamels for use in the food industries ||| Non-toxic enamels for use in the oenological industries ||| Émaux non toxiques destinés à l'industrie alimentaire
0.2877689003944397 ||| How to take Aerius orodispersible tablet 4. ||| How to store orodispersible tablet 6. ||| Comment prendre Aerius comprimés orodispersibles 4.
0.2417108416557312 ||| CIALIS is a medicine containing the active substance tadalafil. ||| Tadalafil Lilly is a medicine containing the active substance tadalafil. ||| CIALIS est un médicament dont le principe actif est le tadalafil.
0.4801692068576813 ||| 1 vial 10 vials 50 mg/ 25 ml ||| 1 vial 180 micrograms in 1 ml ||| 1 flacon 10 flacons 50 mg/ 25 ml
0.4970839023590088 ||| • one sterile injection needle (e. g. ||| 2 ml syringe) and needle (e. g. ||| • une aiguille pour injection stérile (p. ex.
0.0271802619099617 ||| In all clinical assessments parecoxib was administered at a fixed time interval whereas the opioids were administered on as needs basis (PRN). ||| In all clinical assessments parecoxib was administered at a fixed time interval whereas the opioids were administered on as needed basis (PRN). ||| Lors de toutes les évaluations cliniques, le parécoxib a été administré à intervalles fixes, tandis que les opiacés ont été administrés à la demande.
0.3738732933998108 ||| Control valves (Thermostatic -) for central heating radiators ||| Valves (Level controlling -) being parts for sanitary installations ||| Vannes de commande thermostatiques pour radiateurs de chauffage central
0.0 ||| Treatment of gastric ulcer: ||| Treatment of gastric ulcer: ||| Traitement de l’ ulcère gastrique:
0.19050553441047668 ||| Following the administration of a double dose in chickens and ducks, no adverse reactions other than those described in section 4.6 have been observed. ||| Following the administration of a double dose of vaccine, no side-effects other than those described under 4.6 have been observed except for some depression at the day of vaccination ||| Suite à l’ administration d’ une double dose chez la poule et le canard, il n’ a pas été observé d’ autres effets que ceux décrits au paragraphe 4.6.
0.4645176827907562 ||| As with all insulins, Protaphane may cause hypoglycaemia (low blood glucose). ||| caffeine or theophylline (these substances help restore mental alertness). ||| Comme avec toutes les insulines, Protaphane peut entraîner une hypoglycémie (faible taux de sucre dans le sang).
0.5604857802391052 ||| Box containing 1 vial of 100, 250 or 500 ml Not all pack sizes may be marketed. ||| Pack Sizes 1 x 500ml 6 x 500ml Not all pack sizes may be marketed ||| Une boite contenant un flacon de 100, 250 ou 500 ml Toutes les présentations peuvent ne pas être commercialisées.
0.2871496081352234 ||| - ringing in the ear (tinnitus), transient hearing loss (particularly high frequencies) ||| Rare: tinnitus, transient hearing loss (particularly high frequencies). ||| - bourdonnements dans les oreilles (acouphènes), perte transitoire de l’ ouïe (notamment des
0.03637470677495003 ||| EU/ 1/ 06/ 358/ 009– pack of 1 EU/ 1/ 06/ 358/ 010 – pack of 10 EU/ 1/ 06/ 358/ 011 – pack of 20 ||| EU/ 1/ 05/ 323/ 005 – pack of 1 EU/ 1/ 05/ 323/ 006 – pack of 10 EU/ 1/ 05/ 323/ 007 – pack of 20 ||| EU/ 1/ 06/ 358/ 009 – boîte de 1 EU/ 1/ 06/ 358/ 010 – boîte de 10 EU/ 1/ 06/ 358/ 011 – boîte de 20
3.325882050233403e-13 ||| There was no evidence of any carcinogenicity in life long studies in mice and rats. ||| There was no evidence of any carcinogenicity in life long studies in mice and rats. ||| Aucun effet carcinogène n’ a été observé lors d’ études vie entière chez la souris et le rat.
0.6654664874076843 ||| Einaudi 11, 00012 Guidonia Montecelio (Rome) Italy ||| 2.800 04010 Sermoneta (Latina) Italy ||| Einaudi 11, 00012 Guidonia Montecelio (Rome) Italie
0.4907047152519226 ||| In this function, he will act as the official representative of the European Commission in Italy under the political authority of President Ursula von der Leyen. ||| Mr Parenti, an Italian national, is currently the Head of the Economic, Trade and Development section in the Delegation of the European Union to the United Nations. ||| À ce titre, il agira en tant que représentant officiel de la Commission européenne en Italie sous l'autorité politique de la présidente Ursula von der Leyen.
0.324969619512558 ||| Depending on clinical response, the dosage may be increased to 8 mg doxazosin once daily. ||| When taken according to the dosage recommendations each 15 ml dose contains approximately 5 g of sorbitol. ||| Selon la réponse clinique obtenue, la posologie peut être accrue à hauteur de 8 mg de doxazosine en une prise quotidienne.
0.43584969639778137 ||| While we continue to ensure a high level of preparedness in the EU and support Member States, the protection of health for all will always remain a top priority and we will continue to remain in solidarity with China." ||| Over this Presidency, we will do our utmost to find an agreement with the United Kingdom on our new relationship - while respecting our principles and preserving our European unity. ||| Même si nous continuons de garantir un degré de préparation élevé au sein de l'UE et d'aider les États membres en la matière, la protection de la santé pour tous restera toujours une priorité absolue, et nous demeurerons solidaires de la Chine».
0.30872946977615356 ||| Coadministration of voriconazole and low dose ritonavir (100 mg twice daily) should be avoided, unless an assessment of the benefit/ risk to the patient justifies the use of voriconazole (see section 4.3 and 4.4). ||| In combination with capecitabine, for patients 60 years of age or more, a starting dose reduction of capecitabine to 75% is recommended (see capecitabine summary of product characteristics). ||| L’ administration concomitante de voriconazole et de ritonavir à faible dose (100 mg deux fois par jour) doit être évitée, sauf si une évaluation du rapport bénéfice/ risque pour le patient justifie l’ utilisation du voriconazole (voir rubriques 4.3 et 4.4).
0.67548668384552 ||| 224 Ελλάδα Merck A. E. ||| Alpharma AS, P. O. ||| Ελλάδα Merck A. E.
0.4995971620082855 ||| Your doctor will work out your exact dose. ||| Your doctor will determine the exact dosage schedule and ||| Votre médecin calculera votre dose exacte.
0.3607364892959595 ||| The Commission is putting forward a draft amending budget - a proposal to reorganise part of the EU spending for the year in line with the latest priorities - to secure funding for these operations. ||| The Agency plans to undertake a major refurbishment project to increase meeting facilities for the Agency’ s scientific committees and working groups, following entry into force of the new legislation. ||| La Commission présente un projet de budget rectificatif, dans lequel elle propose de réorganiser une partie des dépenses de l'Union de l'année en fonction des priorités les plus récentes, afin d'assurer le financement de ces opérations.
0.4250769317150116 ||| Explosive signals ||| Explosives ||| Signaux explosifs
0.22650718688964844 ||| HOW TO STORE GADOVIST ||| HOW TO STORE HUMIRA ||| COMMENT CONSERVER GADOVIST
0.5641358494758606 ||| Do not use on rabbits. ||| Do not administer to cats. ||| Ne pas utiliser chez les lapins.
3.8474250369825713e-13 ||| Combination antiretroviral therapy has been associated with redistribution of body fat (lipodystrophy) in HIV patients including the loss of peripheral and facial subcutaneous fat, increased intra-abdominal and visceral fat, breast hypertrophy and dorsocervical fat accumulation (buffalo hump). ||| Combination antiretroviral therapy has been associated with redistribution of body fat (lipodystrophy) in HIV patients including the loss of peripheral and facial subcutaneous fat, increased intra-abdominal and visceral fat, breast hypertrophy and dorsocervical fat accumulation (buffalo hump). ||| Les traitements par association d’ antirétroviraux ont été associés, chez les patients infectés par le VIH, à une redistribution de la masse grasse corporelle (lipodystrophie), incluant une perte du tissu adipeux sous- cutané périphérique et facial, une augmentation de la masse grasse intra-abdominale et viscérale, une hypertrophie mammaire et une accumulation de la masse grasse au niveau rétro-cervical (bosse de bison).
0.46230870485305786 ||| Discard if reconstituted vaccine is not used within 8 hours. ||| The reconstituted solution should not be stored above 25ºC. ||| Jeter le vaccin s’ il n'est pas utilisé dans les 8 heures.
0.3695679008960724 ||| One of the most significant developments in terms of public health is the introduction of the European policy for encouraging medicines for rare diseases (‘ orphan medicinal products’). ||| In April 2000 the EMEA began an important new role in stimulating the development of medicinal products for rare diseases – ‘ orphan medicines’. ||| Une des avancées les plus significatives, en termes de santé publique, a été l’ introduction d’ une politique européenne de soutien aux médicaments destinés aux maladies rares (« médicaments orphelins »).
0.4303094744682312 ||| At two years, 80.1% and 68.8% of patients met this criterion in the 3 mg every 3 months injection arm and the 2.5 mg daily arm (p=0.001). ||| The overall mean age was 59.4 years; 56.6% of patients had an ECOG performance status of 0, 43% had a value of 1 and 0.4% had a value of 2. ||| A deux ans, 80,1% et 68,8% des patientes respectivement sous Bonviva IV 3 mg tous les 3 mois et sous acide ibandronique oral 2,5 mg une fois par jour ont été définies comme répondeurs (p=0,001).
0.0052926987409591675 ||| RISPERDAL and associated names (see Annex I) 2 mg film-coated tablets ||| RISPERDAL and associated names (see Annex I) 1 mg film-coated tablets ||| RISPERDAL et dénominations associées (Voir Annexe I) 2 mg comprimés pelliculés
0.4172072410583496 ||| However, no dosage adjustment is expected to be necessary in hepatic or renal impairment (see section 5.2). ||| One pitfall for the renal paediatric indication is, however, the lack of long- term data. ||| Cependant, en cas d'insuffisance hépatique ou rénale, un ajustement de posologie ne semble pas nécessaire (voir rubrique 5.2).
0.36638695001602173 ||| Rosiglitazone was associated with increases in weight. ||| Elimination of fondaparinux decreases with weight. ||| Le traitement par la rosiglitazone s'est accompagné d'une prise de poids.
0.5364235639572144 ||| 22 January: Amiran Gamkrelidze, head of the Georgian National Centre for Disease Control, warns Georgian travellers from visiting Wuhan, the point of origin of the COVID-19 outbreak. ||| After the case was announced, Kazakh President Kassym-Jomart Tokayev announced a state of emergency in Kazakhstan, and promptly closed the border with Uzbekistan. ||| 22 janvier : Amiran Gamkrelidze, chef du Centre national géorgien de lutte contre les maladies, avertit les voyageurs géorgiens de visiter Wuhan, le foyer d'origine de l'épidémie de Covid-19.
0.3766580820083618 ||| By controlling the level of blood glucose, the symptoms and complications of diabetes are reduced. ||| This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection. ||| Le contrôle du niveau de glucose dans le sang permet d’ atténuer les symptômes de la maladie et de réduire les complications diabétiques.
0.4208106994628906 ||| It is not recommended for use in children, due to a lack of information on the safety and effectiveness of the medicine in this group. ||| However, for the use of the product confirmation of the presence of a specific infection and confirmation of a bacteriological cure is required. ||| Il n’ est pas recommandé chez l’ enfant en raison d’ un manque d’ information sur la tolérance et l’ efficacité du médicament dans ce groupe d’ âge.
0.3292783498764038 ||| The second study compared the effectiveness of Evicel with that of Surgicel (a material used to help control bleeding) in reducing bleeding during abdominal surgery (surgery of organs in the tummy). ||| Effectiveness was measured by looking at whether air leaked from the lungs after surgery.  The final study looked at the effectiveness of TachoSil in surgery on the heart or major blood vessels. ||| La seconde étude comparait l’ efficacité d’ Evicel à celle de Surgicel (un matériau utilisé pour aider à contrôler le saignement) pour réduire le saignement au cours d’ une intervention chirurgicale abdominale (chirurgie des organes du ventre).
0.4679083526134491 ||| Before you take Myfenax 3. ||| Before you use Firazyr 3. ||| Comment prendre Myfenax?
0.005253523122519255 ||| 1 pre-filled syringe contains 30000 IU Epoetin zeta ||| 1 pre-filled syringe contains 40000 IU Epoetin zeta ||| 1 seringue préremplie contient 30 000 UI d’ époétine zêta
0.5962265729904175 ||| Biodegradable prostheses ||| Antimicrobial mouthwashes ||| Prothèses biodégradables
0.05174139887094498 ||| Doxazosin “ Winthrop” 4 mg prolonged release tablets and associated names (Doxazosin) is receptor alfa blocking agent used in the treatment of patients with essential hypertension and in the symptomatic treatment of patients with benign prostatic hyperplasia. ||| Doxastad 4 mg prolonged release tablets and associated names (Doxazosin) is 1 is a receptor alfa blocking agent used in the treatment of patients with essential hypertension and in the symptomatic treatment of patients with benign prostatic hyperplasia. ||| Doxazosine « Winthrop » 4 mg, comprimés à libération prolongée, et dénominations associées (doxazosine), est un agent bloquant des récepteurs alpha utilisé dans le traitement des patients atteints d’ hypertension essentielle et dans le traitement symptomatique des patients atteints d’ hyperplasie bénigne de la prostate.
0.326325923204422 ||| The presence of antibodies appears to bear no relationship to allergic reactions, which are rare. ||| As with all injectable vaccines, there is an extremely small risk of allergic reactions. ||| La présence d'anticorps ne semble avoir aucun rapport avec les réactions allergiques, qui sont rares.
0.34798678755760193 ||| The recommended dose of Sprimeo is 150 mg once a day, either taken alone or in combination with other medicines for hypertension. ||| Ribavirin Teva capsules are to be administered orally each day in two divided doses with food (morning and evening). ||| La dose recommandée de Sprimeo est de 150 mg une fois par jour, soit seul soit en association avec d’ autres antihypertenseurs.
0.17668788135051727 ||| Agenerase 150 mg soft capsules are supplied in a pack with two plastic bottles each containing 240 soft capsules. ||| Agenerase 50 mg soft capsules are supplied in plastic bottles containing 480 soft capsules. ||| Les capsules molles d'Agenerase 150 mg sont conditionnées dans un coffret contenant deux flacons en plastique.
0.31374645233154297 ||| Providing information relating to the rental of air conditioning apparatus ||| Providing information relating to the appraisal of precious stones ||| Mise à disposition d'informations en matière de location d'appareils de climatisation
0.1204933300614357 ||| If any of the side effects happens to you, ask your doctor for advice. ||| If you are worried by any of these side effects, ask your doctor for advice. ||| Si vous remarquez l’ un de ces effets indésirables, demandez conseil à votre médecin.
0.47079694271087646 ||| Each film-coated tablet of Karvezide 300 mg/ 12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide. ||| Each tablet contains 5/10/15/20 mg of memantine hydrochloride equivalent to 4.15/8.31/12.46/16.62 mg memantine. ||| Chaque comprimé pelliculé de Karvezide 300 mg/ 12,5 mg contient 300 mg d'irbésartan et 12,5 mg d'hydrochlorothiazide.
0.024901671335101128 ||| To avoid injection of air and ensure proper dosing: • Hold Mixtard 10 NovoLet with the needle pointing upwards • Tap the cartridge gently with your finger a few times. ||| To avoid injection of air and ensure proper dosing: • Hold Insulatard NovoLet with the needle pointing upwards • Tap the cartridge gently with your finger a few times. ||| Pour éviter toute injection d’ air et garantir un dosage correct: • maintenez Mixtard 10 NovoLet avec l’ aiguille pointée vers le haut • tapotez doucement la cartouche avec votre doigt plusieurs fois.
0.8908499479293823 ||| • Bayovac CSF Marker • live vaccine ||| • Zubrin • tepoxalin • Part B ||| Bayovac CSF Marker live vaccine Part A
0.45566409826278687 ||| Using FORSTEO with food and drink Forsteo can be given with or without food. ||| Using ABILIFY with food and drink ABILIFY can be administered regardless of meals. ||| Aliments et boissons FORSTEO peut être administré avec ou sans nourriture.
0.7076644897460938 ||| Do not administer Caelyx as a bolus injection or undiluted solution. ||| Insulin aspart is equipotent to human insulin on a molar basis. ||| Ne jamais administrer Caelyx sous forme de bolus ou de solution non diluée.
0.22095675766468048 ||| Caution should be exercised when prescribing Atripla to the elderly, keeping in mind the greater frequency of decreased hepatic or renal function in these patients. ||| Due to the higher plasma levels in the elderly it is advisable to administer a doses based on creatinine clearance and severity of disease. ||| La prudence est recommandée lors de la prescription d’ Atripla à des personnes âgées, en gardant à l’ esprit la fréquence plus importante de diminution de la fonction hépatique ou rénale chez ces patients.
0.2874191999435425 ||| 5 Low plasma zinc levels have been associated with deferiprone, in a minority of patients. ||| Dose-related increases in blood pressure have been commonly reported with venlafaxine. ||| Chez une minorité de patients, des taux en zinc plasmatique bas ont été associés à la défériprone.
0.7072333097457886 ||| The carton contains one bottle. ||| This is a multidose container. ||| L’ étui contient un flacon.
0.02099321037530899 ||| Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. ||| Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and, in rare cases, could result in the loss of the affected finger if prompt medical attention is not given. ||| L’ injection accidentelle/ l’ auto-injection peuvent provoquer de fortes douleurs et un gonflement intense, notamment en cas d’ (auto)injection dans une articulation ou un doigt de la main, et peut conduire dans de rares cas à la perte du doigt si un examen médical n'est pas effectué rapidement.
0.5110524296760559 ||| Cattle and pigs ||| Cattle, Pigs ||| Bovins et porcs
0.43014198541641235 ||| Equilis Te is a vaccine for use in horses. ||| Xeomin is a medicine that relaxes the muscles. ||| Equilis Te est un vaccin destiné aux chevaux.
0.3867132067680359 ||| - In patients with a history of myocardial infarction who have residual atrial nodal, or ventricular ||| - Benign hyperplasia and concomitant congestion of the upper urinary tract, chronic urinary ract ||| - Chez les patients avec des antécédents d'infarctus du myocarde présentant des troubles
0.17838464677333832 ||| Why has Nplate been approved? ||| Why has Aerius been approved? ||| Pourquoi Nplate a -t-il été approuvé?
0.5084947347640991 ||| Flavoured coffee ||| Flavoured mineral water ||| Café aromatisé
0.022751204669475555 ||| It should be used with caution in patients who have severe problems with their liver. ||| It should be used with caution in patients who have problems with their liver. ||| Le médicament doit être utilisé avec précaution chez les patients présentant une insuffisance hépatique sévère.
0.012151816859841347 ||| EU/1/00/131/035 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/036 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/037 (6 pens, 6 injection needles and 12 cleansing swabs) EU/1/00/131/038 (12 pens, 12 injection needles and 24 cleansing swabs) ||| EU/1/00/131/047 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/048 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/049 (6 pens, 6 injection needles and 12 cleansing swabs) EU/1/00/131/050 (12 pens, 12 injection needles and 24 cleansing swabs) ||| EU/ 1/ 00/ 131/ 035 (1 stylo, 1 aiguille et 2 tampons nettoyants) EU/ 1/ 00/ 131/ 036 (4 stylos, 4 aiguilles et 8 tampons nettoyants) EU/ 1/ 00/ 131/ 037 (6 stylos, 6 aiguilles et 12 tampons nettoyants) EU/ 1/ 00/ 131/ 038 (12 stylos, 12 aiguilles et 24 tampons nettoyants)
0.27778786420822144 ||| The usual daily dose of Epivir in adults and adolescents over 12 years of age is 300 mg (30 ml). ||| The recommended daily dose in adults or elderly is 100 mg (50 mg every 12 hours). ||| Chez l’ adulte et l’ adolescent de plus de 12 ans, la posologie journalière recommandée est de 300 mg (30 ml).
0.10983811318874359 ||| Rebif 44 micrograms/ 0.5 ml solution for injection Interferon beta-1a SC use ||| Rebif 44 micrograms/0.5 ml solution for injection in cartridge Interferon beta-1a ||| Rebif 44 microgrammes/ 0,5 ml solution injectable Interféron beta-1a Voie SC
3.641561336330257e-13 ||| For HCV monoinfected patients and HIV-HCV co-infected patients, for treatment regimens, duration of therapy and study outcome see Tables 6, 7, 8 and Table 14, respectively. ||| For HCV monoinfected patients and HIV-HCV co-infected patients, for treatment regimens, duration of therapy and study outcome see Tables 6, 7, 8 and Table 14, respectively. ||| Les schémas thérapeutiques, la durée du traitement et les réponses virologiques des patients atteints d’ une mono-infection par le VHC ou d’ une co-infection par le VIH et le VHC sont présentés respectivement dans les tableaux 6, 7, 8 et 14.
0.3146982192993164 ||| There are no adequate data from the use of ibandronic acid in pregnant women. ||| There are no data on the pharmacokinetics of the active substance in man. ||| Il n’ existe pas de données suffisantes concernant l’ utilisation de l’ acide ibandronique chez la femme enceinte.
0.25437766313552856 ||| All patients and parents/ caregivers should be advised that if the patient develops signs and symptoms suggestive of blood dyscrasias or infections (e. g., persistent fever, sore throat, bruising, bleeding, paleness) whilst on Enbrel, they should seek immediate medical advice. ||| The following reactions have also occurred in isolated patients with normal or low blood pressure: hypertensive crisis with encephalopathy-like symptoms (e.g. headaches and confused state) and generalised tonoclonal seizures, requiring the immediate attention of a physician and intensive medical care. ||| Tous les patients et les parents/ entourage doivent être informés qu’ en cas d’ apparition de signes ou de symptômes évoquant une atteinte hématologique ou une infection (tels que fièvre persistante, douleurs pharyngées, ecchymoses, saignement, pâleur) chez le patient sous Enbrel, ils doivent immédiatement consulter un médecin.
0.27533113956451416 ||| The effectiveness of Purevax RCCh has been studied in several trials in laboratory conditions where cats were vaccinated and infected with virulent herpesvirus, calicivirus or C. felis. ||| The effectiveness of Purevax FeLV has been studied in several trials in laboratory conditions where cats were vaccinated and infected with FeLV. ||| L’ efficacité de Purevax RCCh a fait l’ objet de plusieurs études réalisées en laboratoire, dans lesquelles des chats ont été vaccinés et infectés par l’ herpèsvirus, le calicivirus ou C. felis virulents.
0.14119230210781097 ||| The other ingredients of the tablet core are: croscarmellose sodium, microcrystalline cellulose, sodium laurilsulfate, hydroxypropylcellulose, lactose monohydrate, and magnesium stearate. ||| {PRODUCT NAME} tablets also contain the inactive ingredients: calcium carbonate, microcrystalline cellulose, lactose, croscarmellose sodium, polysorbate 80, hydroxypropyl cellulose and magnesium stearate. ||| Les autres composants du comprimé nu sont: croscarmellose de sodium, cellulose microcristalline, laurylsulfate de sodium, hydroxypropylcellulose, lactose monohydraté et stéarate de magnésium.
0.5647391676902771 ||| Malta notified to the Commission under the Temporary Framework a scheme to support investments in the production of coronavirus-relevant products. ||| The Member States shall ensure that the MAH implements a pregnancy prevention programme (PPP) within their territory. ||| Malte a notifié à la Commission, au titre de l' encadrement temporaire , un régime visant à soutenir les investissements dans la fabrication de produits utiles pour combattre le coronavirus.
0.4296613931655884 ||| The direct grant covers 90 % of the costs of the stockpile while the remaining 10 % are borne by the Member State. ||| The Commission finances 100% of the transport costs, whereas the EU partners remain responsible for the procurement of the humanitarian material. ||| La subvention directe couvre 90 % des coûts de la réserve, les 10 % restants étant à la charge de l'État membre.
0.5374962091445923 ||| Emeralds ||| Almanacs ||| Émeraudes
0.2669171094894409 ||| Regulators for machines ||| Regulators for engines ||| Régulateurs pour machines
0.3252584636211395 ||| Prezista should not be taken by patients who may be hypersensitive (allergic) to darunavir or any of the other ingredients. ||| It should also not be used by patients who have porphyria (an inability to break down porphyrins) or during pregnancy. ||| Prezista ne doit pas être administré aux patients pouvant présenter une hypersensibilité (allergie) au darunavir ou à l’ un des autres composants.
0.591806173324585 ||| David Drakeford worked with Telecom Eireann where he managed the implementation of a national data communication network. ||| Norway: The Smittestopp app that is developed by the Norwegian government needs Bluetooth and GPS signals. ||| David Drakeford a travaillé chez Telecom Eireann, où il gérait la mise en œ uvre d'un réseau national de communication de données.
0.279776930809021 ||| In case of bleeding in the brain events related to the nervous system have been reported e. g. drowsiness (somnolence), speech disorders, palsy of parts of the body (hemiparesis) and fits (convulsions). ||| Fluid collection around the kidney, swelling of the extremities, fever, pain Impaired healing (this may include separation of the layers of a surgical wound or suture line), swelling, infections (including life-threatening infections) ||| En cas de saignements dans le cerveau, des effets indésirables liés au système nerveux, tels que somnolence, troubles du langage, paralysie de certaines parties du corps (hémiparésie) et convulsions, ont été rapportés.
0.32381483912467957 ||| Luminity is a solution for injection or infusion (drip into a vein) that contains microspheres (tiny bubbles) of perflutren gas as the active substance. ||| Fibrinogen is converted into fibrin monomers which spontaneously polymerise to a fibrin clot, which holds the collagen sponge tightly to the wound surface. ||| Luminity est une solution injectable ou pour perfusion (goutte-à-goutte dans une veine), qui contient des microsphères (bulles minuscules) de gaz perflutren comme principe actif.
0.7248588800430298 ||| Agricultural machines for sowing ||| Beer and brewery products ||| Machines agricoles pour ensemencement
0.0 ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| PRECAUTIONS PARTICULIÈRES D’ ÉLIMINATION DES MEDICAMENTS NON UTILISES OU DES DECHETS PROVENANT DE CES MEDICAMENTS S’ IL Y A LIEU
0.10916329175233841 ||| If indicated, elimination of unabsorbed active substance is to be achieved by emesis or gastric lavage. ||| If indicated, elimination of unabsorbed atazanavir should be achieved by emesis or gastric lavage. ||| Si cela est indiqué, l’ élimination de la substance active non absorbée doit être obtenue par vomissement ou lavage gastrique.
0.3518483638763428 ||| In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| Transient visual disturbances may occur especially on initiation of treatment, due to changes in blood glucose levels. ||| 173 En cas d'insuffisance rénale, les besoins en insuline peuvent être diminués en raison d'une réduction du métabolisme de l'insuline.
0.6598307490348816 ||| Maintenance of personnel records [for others] ||| Real estate selection and acquisition [on behalf of others] ||| Tenue de dossiers de personnel pour le compte de tiers
5.74252505356615e-13 ||| This means that it helps to prevent blood clots from forming. ||| This means that it helps to prevent blood clots from forming. ||| Cela signifie qu’ il contribue à prévenir la formation de caillots sanguins.
0.5189815163612366 ||| You should not be given Aclasta if you are breast-feeding. ||| In this case you should not be switched to NeoRecormon. ||| Vous ne devez pas recevoir Aclasta si vous allaitez.
0.28591153025627136 ||| Voriconazole is metabolised by cytochrome P450 isoenzymes, CYP2C19, CYP2C9 and CYP3A4. ||| Cytochromes P450- CYP1A2 and P450-CYP2D6 contribute to the formation of the N-desmethyl and 2-hydroxymethyl ||| Le voriconazole est métabolisé par les isoenzymes CYP2C19, CYP2C9 et CYP3A4 du cytochrome P450.
0.35121631622314453 ||| Since the very beginning of the crisis, the European Commission has designed and implemented a set of measures to protect its staff in view of the evolving developments in the spread of the coronavirus (COVID-19). ||| Since the outbreak of the coronavirus pandemic, Member States, backed by the Commission, have been assessing the effectiveness, security, privacy, and data protection aspects of digital solutions to address the crisis. ||| Depuis le tout début de la crise, la Commission européenne a élaboré et mis en œuvre un ensemble de mesures destinées à protéger son personnel face à l'évolution de la propagation du coronavirus (COVID-19).
0.8473748564720154 ||| Table 1 - Dosing for Combination Therapy ||| 4.1 Setting-up the Technical Co-ordination Unit ||| Tableau 1 – Doses à utiliser en bithérapie
0.2733972668647766 ||| The blood level of this medicine can be increased or reduced. • caffeine (used as a stimulant), pentoxifylline (used to treat circulatory disorders in the limbs) and mexiletine (used to treat irregular heart beat). ||| impaired hepatic function), do not take Ketek while taking other medicines containing any of the following active substances: • ketoconazole (anti fungal treatment) • a medicine called protease inhibitor (anti HIV treatment) ||| Le taux de ce médicament dans le sang peut augmenter ou diminuer. • caféine (utilisée comme stimulant), pentoxifylline (pour le traitement des troubles de la circulation dans les membres inférieurs) et mexilétine (pour le traitement de l’ arythmie).
0.4557950496673584 ||| Most of these reactions occurred within 2 hours after the first and subsequent injections of Xolair but some started beyond 2 hours and even beyond 24 hours after the injection. ||| The first laser light session occurred 40-50 hours after injection and a second session, if indicated, occurred 96-120 hours after injection. ||| La plupart de ces réactions sont survenues dans les deux heures suivant la première injection de Xolair ou les injections suivantes mais certaines de ces réactions sont apparues au-delà de 2 heures et même au-delà de 24h après l’ injection.
0.0 ||| In children less than two years of age, the most common side effects are diarrhoea (3.7%), fever (2.3%) and insomnia (difficulty sleeping; 2.3%). ||| In children less than two years of age, the most common side effects are diarrhoea (3.7%), fever (2.3%) and insomnia (difficulty sleeping; 2.3%). ||| Chez l’ enfant de moins de 2 ans, les effets indésirables les plus fréquents sont la diarrhée (3,7%), la fièvre (2,3%) et l’ insomnie (difficulté à trouver le sommeil; 2,3%).
0.5282974243164062 ||| The use of gloves is recommended. ||| Always use the needles recommended. ||| L'utilisation de gants est recommandée.
0.060958132147789 ||| 57 ANNEX III ||| 47 ANNEX III ||| 63 ANNEXE III
0.20098230242729187 ||| 32 9. ||| 32 14. ||| 32 EXP:
0.12124733626842499 ||| L 290 of 5.12.95 OJ No. ||| L 143 of 27.06.95 8 OJ No. ||| L 290 du 5.12.95 JO No.
0.21553529798984528 ||| Macugen 0.3 mg solution for injection Pegaptanib sodium ||| Neulasta 6 mg solution for injection Pegfilgrastim ||| Macugen 0,3 mg, solution injectable Pegaptanib sodium
0.5143689513206482 ||| Computer software for processing digital music files ||| Computer software for controlling self-service terminals ||| Logiciels pour le traitement de fichiers de musique numérique
0.3782559037208557 ||| • If you still feel sick, vomit or are unable to drink fluids and therefore pass less urine despite being given anti-sickness medicines. ||| Tiredness, feeling faint, becoming easily breathless or if you look pale (since you might have less haemoglobin than normal which is very common). ||| 41 • si vous éprouvez des nausées, si vous vomissez ou êtes incapable d’ avaler des liquides et donc urinez moins, malgré les médicaments contre les nausées
0.3573821187019348 ||| Thalidomide has sedative properties thus may enhance the sedation induced by anxiolytics, hypnotics, antipsychotics, H1 anti-histamines, opiate derivatives, barbiturates and alcohol. ||| Other medicinal products: palonosetron has been administered safely with analgesics, antiemetic/ antinauseants, antispasmodics and anticholinergic medicinal products. ||| Le thalidomide possède des propriétés sédatives susceptibles d’ augmenter la sédation due aux anxiolytiques, aux hypnotiques, aux antipsychotiques, aux antihistaminiques H1, aux dérivés d’ opiacés, aux barbituriques et à l’ alcool.
0.31688040494918823 ||| In controlled clinical trials, the discontinuation rate due to sildenafil was low and similar to placebo. ||| Patients received low-dose acetylsalicylic acid prior to randomization and throughout the two CABG surgery studies. ||| Dans les études cliniques, le taux d'interruption du traitement dû au sildénafil était faible et similaire au placebo.
0.24492698907852173 ||| The recommended dose of Paxene is 100 mg/ m2 administered as a 3 hour intravenous infusion every two weeks. ||| A 60-minute infusion of 400 mg ciprofloxacin every 8 hours is equivalent with respect to AUC to 750 mg oral regimen given every 12 hours. ||| La dose de Paxene recommandée est de 100 mg/ m2, administrée en perfusion intraveineuse de 3 heures toutes les deux semaines.
0.22109737992286682 ||| In volunteers with severe renal impairment (creatinine clearance < 30 ml/ min) the mean AUC was increased by 21% and the mean Cmax decreased by 23%, compared to volunteers with no renal impairment. ||| However, the mean single dose MPAG AUC was 3 – 6 fold higher in subjects with severe 21 renal impairment than in subjects with mild renal impairment or normal healthy subjects, consistent with the known renal elimination of MPAG. ||| Chez les volontaires présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min), l’ AUC moyenne était augmentée de 21% et la Cmax moyenne diminuée de 23% par rapport aux volontaires sans insuffisance rénale.
0.1034616231918335 ||| Concomitant administration of sunitinib malate with the potent CYP3A4 inhibitor, ketoconazole, resulted in a 49% and 51% increase of the complex [sunitinib + primary metabolite] Cmax and AUC0-∞ values, respectively, after a single dose of sunitinib malate in healthy volunteers. ||| Concomitant use of SUTENT with the CYP3A4 inducer, rifampin, resulted in a 23% and 46% reduction of the complex [sunitinib + primary metabolite] Cmax and AUC0-∞ values, respectively, after a single dose of SUTENT in healthy volunteers. ||| L’ administration concomitante de malate de sunitinib et d’ un puissant inhibiteur du CYP3A4, le kétoconazole, a provoqué des élévations de 49% de la valeur de la Cmax et de 51% de la valeur et de l’ AUC0-∞ du complexe [sunitinib + métabolite principal], après une dose unique de malate de sunitinib chez des volontaires sains.
0.3873019814491272 ||| The half-life of reteplase was increased in patients with AMI as compared to healthy volunteers. ||| Haemolytic activity during the course of the study was effectively blocked in both female and male mice. ||| La demi-vie de retéplase est augmentée chez les patients atteints d'IAM par rapport aux volontaires sains.
0.15429459512233734 ||| Co-administration of Zerene together with inducers of CYP3A4 such as rifampicin, carbamazepine and phenobarbitone, may result in a reduction of zaleplon’ s efficacy. ||| Concomitant use of medicinal products that are inducers of CYP3A4, such as carbamazepine, phenobarbital and phenytoin may reduce indinavir plasma concentrations. ||| L’ administration concomitante de Zerene et des inducteurs du CYP3A4 comme la rifampicine, la carbamazépine et le phénobarbital peut conduire à une diminution de l’ efficacité de zaleplon.
0.6472450494766235 ||| Secondary prevention of cardiovascular events has been approved in all Member States, Iceland and Norway. ||| Saint Vincent and Grenadines called for a fair and effective allocation of resources and vaccines. ||| Son indication dans la prévention secondaire d’ évènements cardio-vasculaires a été approuvée par tous les États membres, l’ Islande et la Norvège.
0.34023696184158325 ||| As a precautionary measure, breast-feeding should not be continued during treatment with Iscover. ||| Women should not breast-feed during treatment with Tasigna, as a risk to the infant cannot be excluded. ||| Par mesure de précaution, l’allaitement ne devrait pas être continué en cas de traitement par Iscover.
0.28826549649238586 ||| To avoid the risk of cross-infection always follow aseptic techniques and use disposable sterile syringes and needles for each administration. ||| The use of rigid catheters as well as intramuscular injections and non-essential handling of the patient should be avoided during treatment with Metalyse. ||| Pour éviter tout risque de contamination, il faut toujours suivre les techniques d'asepsie et utiliser des seringues et des aiguilles à usage unique.
0.33849674463272095 ||| Orodispersible tablet. ||| Oro-dispersible tablet ||| Comprimés orosipersibles.
0.27396291494369507 ||| Herceptin is prescribed by doctors for the treatment of patients with early breast cancer, where it is used after you have finished your chemotherapy, and for the treatment of patients with metastatic breast cancer (i. e., breast cancer that has spread beyond the original tumour) who have tumours that produce large amounts of HER2. ||| Although the risk for people with weak immune systems becoming infected with B. bronchiseptica is extremely low, it is advised that cats which are in close contact with such people are not vaccinated with Nobivac Bb, since they can shed the bacteria intermittently for up to a year after vaccination. ||| Les médecins prescrivent Herceptin soit pour traiter une tumeur primitive du sein localisée (traitement adjuvant) après que vous ayez terminé votre chimiothérapie, soit pour traiter des patients atteints d’un cancer du sein métastatique (cancer du sein qui s’est étendu au-delà de la tumeur primitive).
0.4965965747833252 ||| A 10% reduction in the initial body weight was observed in 35% and 17% of patients, respectively. ||| Inter and intra patient variabilities in plasma exposure were lower than 20% and 10%, respectively. ||| Une diminution de 10% du poids corporel initial a été observée chez respectivement 35% et 17% des patients.
0.434296578168869 ||| If you get any of these signs, eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest. ||| Don’ t take any insulin if you feel a hypo coming on. lon Carry glucose tablets, sweets, biscuits or fruit juice with you, just in case. ||| Si vous ressentez l’ un de ces signes, avalez des comprimés de glucose ou un produit riche en sucre (bonbons, biscuits, jus de fruits) puis reposez -vous.
0.3444027900695801 ||| The company that makes Evoltra will carry out a study to look at the use of Evoltra in patients with kidney disease, and set up a registry to monitor the medicine ’ s side effects. ||| The company that makes Atriance will supply information from studies into the safety of Atriance in children and young adults, including one study of Atriance taken in combination with other anticancer medicines. ||| La société qui produit Evoltra réalisera une étude afin d’ analyser l’ utilisation d’ Evoltra chez des patients atteints d’ affections rénales, et établira un registre en vue d’ inventorier les effets indésirables du médicament.
0.27089837193489075 ||| The Committee for Medicinal products for Human Use (CHMP) concluded that the effectiveness of pioglitazone and metformin in type diabetes 2 had been shown, and that Competact simplifies treatment and improves compliance when a combination of the active substances is required. ||| On the basis of the limited information on effectiveness and safety that was submitted, the Committee for Medicinal Products for Human Use (CHMP) concluded that Carbaglu was effective in reducing blood ammonia to normal levels. ||| Le comité des médicaments à usage humain (CHMP) a conclu que l’ efficacité de la pioglitazone et de la metformine dans le traitement du diabète de type 2 a été démontrée et que Competact simplifie le traitement et améliore l’ adhésion du patient au traitement médicamenteux si l’ administration d’ une combinaison des principes actifs est nécessaire.
0.16060085594654083 ||| Advisory services relating to the installation of engines ||| Advisory services relating to the use of energy ||| Services de conseils liés à la pose de moteurs
4.073157555597312e-13 ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.244965597987175 ||| 166 Мерк Шарп и Доум България ЕООД Тел.: +359 2 819 3740 info-msdbg@merck.com ||| Sverige Merck Sharp & Dohme (Sweden) AB Tel: +46 (0) 8 626 14 00 medicinskinfo@merck.com ||| България Мерк Шарп и Доум България ЕООД Тел.: +359 2 819 3740 info-msdbg@merck. com
2.5510257968541783e-13 ||| Clinical resistance: patients in clinical trials initially treated with entecavir 0.5 mg (nucleoside-naive) or 1.0 mg (lamivudine-refractory) and with an on-therapy PCR HBV DNA measurement at or after Week 24 were monitored for resistance. ||| Clinical resistance: patients in clinical trials initially treated with entecavir 0.5 mg (nucleoside-naive) or 1.0 mg (lamivudine-refractory) and with an on-therapy PCR HBV DNA measurement at or after Week 24 were monitored for resistance. ||| Résistance clinique: les patients des études cliniques initialement traités par entecavir 0,5 mg (naïfs de nucléoside) ou 1,0 mg (résistants à la lamivudine) avec dosage de l’ ADN du VHB par PCR à ou après la semaine 24 de traitement ont bénéficié d’ une analyse virale de résistance.
0.03931349888443947 ||| Like all medicines, Temodal can cause side effects, although not everybody gets them. ||| Like all medicines, Trazec can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Temodal est susceptible d’avoir des effets indésirables, bien que tout le monde n’y soit pas sujet.
0.31125545501708984 ||| Treatment with Xeloda monotherapy may be resumed when bilirubin decreases to ≤ 3.0 x ULN or hepatic aminotransferases decrease to ≤ 2.5 x ULN. ||| Patients with baseline neutrophil counts of < 1.5 x 109/ L and/ or thrombocyte counts of < 100 x 109/ L should not be treated with Xeloda. ||| Le traitement par Xeloda en monothérapie peut être repris lorsque le taux de bilirubine est ≤ à 3 fois la normale ou le taux de transaminases hépatiques ≤ à 2,5 fois la normale.
0.12117291241884232 ||| In advanced Parkinson’ s disease, in combination treatment with levodopa, dyskinesias can occur during the initial titration of Oprymea. ||| 3 In advanced Parkinson’ s disease, in combination treatment with levodopa, dyskinesias can occur during the initial titration of Pramipexole Teva. ||| A un stade avancé de la maladie de Parkinson, en association à la lévodopa, des dyskinésies peuvent apparaître lors de la phase initiale de traitement par Oprymea.
0.3290747106075287 ||| Amlodipin Wörwag tablets can be used in combination with beta-blockers, nitrates or as monotherapy in angina pectoris. ||| Amlovita tablets can be used in combination with beta-blockers, saluretics, ACE inhibitors, or as monotherapy. ||| Dans l'angine de poitrine, Amlodipin Wörwag comprimés peut être utilisé en combinaison avec des bêta-bloquants, des nitrates, ou en monothérapie.
0.25116628408432007 ||| Kinzalmono was compared with placebo (a dummy treatment) and with other medicines for hypertension (atenolol, lisinopril, enalapril and amlodipine). ||| Tractocile was compared with ritodine, terbutaline and salbutamol (all from a different class of medicines used in pre-term labour called beta-agonists). ||| Kinzalmono a été comparé à un placebo (traitement factice) et à d’ autres médicaments antihypertenseurs (aténolol, lisinopril, enalapril et amlodipine).
0.529325544834137 ||| Renal function (creatinine clearance in ml/ min) ||| ≤ 25 ml/ min (including dialysis dependence*) ||| Fonction rénale (clairance de la créatinine en ml/ min)
0.0 ||| 6.4 Special precautions for storage ||| 6.4 Special precautions for storage ||| 90 6.4 Précautions particulières de conservation
0.41400521993637085 ||| Therefore, FABLYN should be used for the treatment of osteoporosis only after the treatment of breast cancer, including adjuvant therapy, has been completed. ||| After this period, Rapamune can be used as ‘ maintenance therapy ’ in patients who are able to stop ciclosporin. ||| Par conséquent, FABLYN ne doit être utilisé dans le traitement de l’ ostéoporose qu’ après la fin du traitement du cancer du sein, y compris d’ un traitement adjuvant.
0.10855686664581299 ||| Each film-coated tablet contains 150 mg irbesartan. ||| Each film-coated tablet contains 20 mg olanzapine. ||| Chaque comprimé pelliculé contient 150 mg d'irbésartan.
0.0028730633202940226 ||| 21 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 22 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 22 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.48297369480133057 ||| Gemcitabine For intravenous use after reconstitution ||| ori For intravenous use after dilution ||| Gemcitabine Pour voie intraveineuse après reconstitution.
0.2756766080856323 ||| A pharmacokinetic overexposure of zidovudine can occur, therefore close safety monitoring is warranted in these patients. ||| However, discontinuation isotretinoin may be insufficient to alleviate symptoms and therefore further psychiatric psychological evaluation may be necessary. ||| Une surexposition pharmacocinétique à la zidovudine peut survenir; une surveillance attentive de la sécurité d'emploi est par conséquent justifiée chez ces patients.
0.43713879585266113 ||| The objective response rate for fulvestrant was 19.2% compared with 16.5% for anastrozole. ||| The fraction of the dose extracted during haemodialysis is 51.9 ± 11.0%. ||| Le taux de réponse objective était de 19,2% dans le groupe fulvestrant, de 16,5% dans le groupe anastrozole.
0.32003265619277954 ||| When it is clinically necessary to co-administer rifabutin with Agenerase, a dosage reduction of at least half the recommended dose of rifabutin is advised, although no clinical data are available. ||| Since it is recommended that didanosine be administered on an empty stomach, VIRACEPT should be administered (with food) one hour after or more than 2 hours before didanosine. ||| Bien qu’ aucune donnée clinique ne soit disponible, si la co- 9 administration avec Agenerase s’ avère cliniquement nécessaire, il est conseillé de diminuer la posologie recommandée de rifabutine d’ au moins 50%.
0.07312782108783722 ||| Paroxetine/ Efavirenz (20 q. d. / 600 q. d.) ||| Pravastatin/ Efavirenz (40 q. d. / 600 q. d.) ||| Paroxétine/ Efavirenz (20 q. d. / 600 q. d.)
0.4688429534435272 ||| You should inform your doctor if you are taking or have recently taken any other medicines, even those not prescribed. ||| - about any other cancer treatments you are on or have been taking, as particular care needs to be ||| Si vous prenez ou avez récemment pris un autre médicament, veuillez en informer votre médecin, même s’il s’agit d’un médicament obtenu sans ordonnance.
0.686900794506073 ||| • Experience with hepatitis B vaccine: ||| • Anaemia in premature infants ||| • Expérience avec le vaccin de l’ hépatite B:
0.06699743866920471 ||| Do not use Liprolog Mix25 Pen after the expiry date which is stated on the label and the carton. ||| Do not use Liprolog Basal KwikPen after the expiry date which is stated on the label and the carton. ||| Ne pas utiliser Liprolog Mix25 Pen après la date de péremption mentionnée sur l’étiquette et la boîte.
0.41326412558555603 ||| Stalevo contains three active substances (levodopa, carbidopa and entacapone) in one film-coated tablet. ||| maraviroc a combination medicine containing efavirenz, emtricitabine and tenofovir, which is currently known as ATRIPLA. ||| Stalevo contient trois substances actives (la lévodopa, la carbidopa et l’ entacapone) dans un même comprimé pelliculé.
2.858006528921181e-13 ||| For immunisation of horses against Streptococcus equi to reduce clinical signs and occurrence of lymph node abscesses. ||| For immunisation of horses against Streptococcus equi to reduce clinical signs and occurrence of lymph node abscesses. ||| Immunisation active des chevaux contre Streptococcus equi, afin de réduire les signes cliniques et la formation d’ abcès au niveau des ganglions lymphatiques.
0.1376364529132843 ||| Tablet coating: hypromellose, titanium dioxide (E171), yellow and red iron oxide (E172), talc. ||| capsule shell: gelatine, titanium dioxide (E171), indigo carmine (E132) and yellow iron oxide (E172) ||| Pelliculage: hypromellose, dioxyde de titane (E171), oxyde de fer jaune et rouge (E172), talc.
0.15191742777824402 ||| Common side effects (likely to occur in fewer than 1 in 10 patients) include: ||| Common side effects (occurring in more than 1 in 100 patients) are: ||| Des effets indésirables fréquents (survenue probable chez moins de 1 patient su 10) comprennent:
0.6145933270454407 ||| Marketing Authorisation ||| Investigator Assessment ||| Titulaire de l’ autorisation
0.30328166484832764 ||| If you are intolerant to some sugars, consult your doctor before taking Micardis. ||| If you have epilepsy, talk to your doctor about driving and using machines. ||| Si vous ne tolérez pas certains sucres, consultez votre médecin avant de prendre Micardis.
0.15742406249046326 ||| Occasional side effects of Loxicom are those seen with NSAIDs, such as loss of appetite, vomiting, diarrhoea, blood appearing in the stools, renal failure and apathy (lack of vitality). ||| The most commonly reported adverse reactions of Docetaxel Winthrop alone are: decrease in the number of red blood cells or white blood cells, alopecia, nausea, vomiting, sores in the mouth, diarrhea and tiredness. ||| Les effets indésirables occasionnels de Loxicom sont ceux observés avec les AINS, notamment perte d’ appétit, vomissements, diarrhée, sang dans les selles, troubles rénaux et apathie (manque de vitalité).
0.39482027292251587 ||| Therefore the pleuromutilins appear to inhibit bacterial protein synthesis by multiple mechanisms. ||| The other nonstructural proteins in the complex assist in the replication and transcription process. ||| Par conséquent les pleuromutilines semblent inhiber la synthèse protéique bactérienne par des mécanismes multiples.
0.4903641939163208 ||| The schemes for subsidised loans are complemented by another scheme approved by the Commission on 24 March 2020 , under which guarantees on loans can be provided. ||| This work - which involved the joint testing of products by the European Commission and European authorities selected by the Member States- led to 652 products being tested for safety. ||| Les régimes de prêts bonifiés sont complétés par un autre régime autorisé par la Commission le 24 mars 2020 et prévoyant la mise à disposition de garanties sur les prêts.
0.36517736315727234 ||| Therefore such medicinal products or foodstuffs should be taken after a period of 2 to 3 hours following ingestion of doxycycline. ||| Suboxone sublingual tablets are to be placed under the tongue until dissolved, which usually requires 5 to 10 minutes. ||| C’ est pourquoi de tels produits ou médicaments ne doivent être absorbés que dans un intervalle de 2 à 3 heures suivant l’ ingestion de doxycycline.
0.4117521345615387 ||| Via Complutense, 140 E-28805 Alcalá de Henares Madrid Spain ||| Avda. de la Industria 30 28108 Alcobendas Madrid Spain. ||| Via Complutense, 140 E-28805 Alcalá de Henares Madrid Espagne
0.3338147699832916 ||| This may lead to a loss of virologic response and possible resistance to VIRACEPT (see section 4.5). ||| Allergic reactions have occurred in close temporal association with development of factor IX inhibitor (see also section 4.4). ||| Ceci peut conduire à une perte de la réponse virologique et à une possible résistance à VIRACEPT (voir rubrique 4.5).
0.5634771585464478 ||| Recommended posology ||| Recommended dose ||| Posologie recommandée
0.11056530475616455 ||| Remain aware of local antibiotic resistance patterns in your department, your hospital and in the community [31] [expert consensus]. ||| Remain aware of local antibiotic resistance patterns in the community, hospital and department [31] [expert consensus]. ||| Restez informés des données de résistance aux antibiotiques (écologie microbienne) dans votre service, votre hôpital et dans la communauté [31] [consensus d'experts].
0.2988792657852173 ||| After the last day of treatment with Pirsue, milk from treated cows should not be used for 5 days. ||| After the last day of treatment with EQUIOXX, horses should not be slaughtered for 26 days. ||| Après le dernier jour de traitement par Pirsue, le lait des vaches traitées ne doit pas être utilisé pendant 5 jours.
0.2124047875404358 ||| Patients with impaired renal function: there is no significant difference in pharmacokinetic parameters between patients with moderate or severe chronic renal insufficiency (creatinine clearance between 10 and 50 ml. min-1) and healthy volunteers after a single oral dose of 50 mg riluzole. ||| Ketek is not recommended as first choice in patients with severe renal impairment (creatinine clearance < 30ml/ min) or patients with both severe renal impairment and co-existing hepatic impairment, as an optimal dosage format (600 mg) is not available. ||| Insuffisants rénaux: après administration orale d’ une dose unique de 50 mg de riluzole, il n’ y a pas de différence significative entre les paramètres cinétiques obtenus chez des patients insuffisants rénaux modérés ou sévères (clairance de la créatinine comprise entre 10 et 50 ml. min-1) et des volontaires sains.
0.16592374444007874 ||| Wholesale services in relation to educational supplies ||| Wholesale services in relation to refrigerating equipment ||| Services de vente en gros concernant les fournitures scolaires
0.012107804417610168 ||| Where a dose of hepatitis B vaccine is given at birth, Infanrix hexa can be used as a replacement for supplementary doses of hepatitis B vaccine from the age of six weeks. ||| Where a dose of hepatitis B vaccine is given at birth, Infanrix Penta can be used as a replacement for supplementary doses of hepatitis B vaccine from the age of six weeks. ||| Lorsqu’ une dose de vaccin contre l’ hépatite B a été administrée à la naissance, Infanrix hexa peut être utilisé en remplacement de doses supplémentaires de vaccin contre l’ hépatite B dès l’ âge de six semaines.
0.15082238614559174 ||| Paroxetine/ Efavirenz (20 q. d. / 600 q. d.) ||| Methadone/ Efavirenz (35-100 q. d. / 600 q. d.) ||| Paroxétine/ Efavirenz (20 q. d. / 600 q. d.)
0.015715202316641808 ||| Do not use Humalog Mix25, if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. ||| Do not use Humalog BASAL, if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. ||| Ne pas utiliser Humalog Mix25, si la suspension présente des grumeaux visibles ou si des particules blanches restent collées au fond de la cartouche ou sur les parois, lui donnant un aspect givré.
0.43272924423217773 ||| Based on empirical knowledge from similar medicinal products, clinically relevant pharmacokinetic interactions are unlikely to occur. ||| There is insufficient data available to draw any definite conclusions regarding intrinsic pharmacokinetic factors such as age, gender, race and weight. ||| D’ après les connaissances empiriques sur des produits similaires, la survenue d’ interactions d’ origine pharmacocinétique cliniquement pertinentes est peu probable.
0.32892441749572754 ||| Pancreatic cancer The recommended dose of gemcitabine is 1000 mg/m2, given by 30-minute intravenous infusion. ||| Intravenous midazolam 2 mg was given 1 hour after oral administration of a single dose of oral aprepitant 125 mg. ||| Cancer du pancréas La dose recommandée est de 1 000 mg/m², administrée en perfusion I.V. de 30 minutes.
4.672179526946096e-13 ||| - a significant reduction of the absolute risk of diabetes-related mortality: metformin ||| - a significant reduction of the absolute risk of diabetes-related mortality: metformin ||| - Une réduction significative du risque absolu de mortalité liée au diabète: metformine
0.02463383972644806 ||| Press release21 April 2020Brussels ||| Press release17 April 2020Brussels ||| Communiqué de presse21 avril 2020Bruxelles
0.13914963603019714 ||| 33/ 44 ||| 34/ 45 ||| 32/ 44
0.37593984603881836 ||| Interferon beta-1b has been shown to change the response of the immune system and to help to reduce disease activity. ||| Lacosamide is also thought to be involved in the development of nerve cells that have been damaged. ||| Il a été démontré que l’interféron ß-1b modifie la réponse du système immunitaire et contribue à réduire l’activité de la maladie.
0.010238961316645145 ||| Information services relating to the combination of colours, paints and furnishings for interior design ||| Information services relating to the combination of colours, paints and furnishings for exterior design ||| Services d'information concernant la combinaison de couleurs, de peintures et de mobiliers pour l'aménagement intérieur
0.0 ||| Change your injection site each time. ||| Change your injection site each time. ||| Changez de site d’ injection à chaque fois.
0.20432054996490479 ||| How to take Combivir 4. ||| How to take Zonegran 4. ||| Comment prendre Combivir 4.
0.5931072235107422 ||| Store in a refrigerator After activation: ||| Unopened vials Store in a refrigerator. ||| A conserver au réfrigérateur Après activation:
0.39733052253723145 ||| Cases of hepatitis (severe and life-threatening hepatoxicity, including fatal fulminant hepatitis) have been reported in patients treated with VIRAMUNE. ||| Severe and life-threatening skin reactions, including Stevens-Johnson syndrome, were reported in less than 1% of patients included in the clinical development programme. ||| Des cas d’ hépatite (hépatotoxicité sévère menaçant le pronostic vital, y compris des cas fatals d’ hépatite fulminante) sont survenus chez des patients traités par VIRAMUNE.
0.44238048791885376 ||| 51 (24.4%) 53 (25.4%) 41 (19.6%) 59 (28.2%) ||| [19.9%, 27.1%] 64 (11.6%)* 65 (11.8%) ||| 51 (24,4%) 53 (25,4%) 41 (19,6%) 59 (28,2%)
0.23594826459884644 ||| Bimatoprost was not mutagenic or carcinogenic in a series of in vitro and in vivo studies. ||| Vildagliptin was not mutagenic in conventional in vitro and in vivo tests for genotoxicity. ||| Le bimatoprost ne s’ est pas révélé mutagène ou cancérogène dans les études in vitro et in vivo.
0.25475573539733887 ||| Adverse reactions are often dose related and occur most frequently in the first couple of weeks after initiation of therapy. ||| Typically, such reactions have been observed within the first few weeks or months of initiation of CART. ||| Les réactions secondaires sont souvent liées à la dose et surviennent dans la majeure partie des cas au cours des deux premières semaines suivant le début du traitement.
0.6964106559753418 ||| IV/ SC 0.3 ml ||| 180 tablets N/ A ||| IV/ SC 0,3 ml
0.4095219373703003 ||| As anaphylactoid reactions were observed in isolated cases, it is recommended that the first dose be administered under medical supervision. ||| Since this is below the predefined threshold of one infection per year, this indicates that the medicine is effective as replacement therapy. ||| En raison de réactions anaphylactoïdes observées dans des cas isolés, il est recommandé d’ administrer la première dose du produit sous surveillance médicale.
0.5399436950683594 ||| The Board will in particular review the scope of the special activities and projects for 2001. ||| The consultation covers all relevant topics to the EU trade policy, with a special focus on the following: ||| Le Conseil examinera en particulier la portée des activités et projets spéciaux pour 2001.
0.45922935009002686 ||| This demand has led to the increase in prices of up to twenty times the normal price and also induced delays on the supply of medical items for four to six months. ||| After a significant increase in the number of applications received over 1995-1997 this number is expected to stabilise over the coming two years. ||| Cette demande a conduit à une augmentation des prix allant jusqu’à vingt fois le prix normal et a également entraîné des retards dans la fourniture des dispositifs médicaux pour une durée de quatre à six mois.
0.3174889087677002 ||| 40 after failure of prior platinum-based chemotherapy, the recommended dose is 75 mg/ m² as a single agent. ||| It is recommended that a dose of 37.5 mg/ day of prolonged-release venlafaxine be used for 7 days. ||| Après échec d’ une chimiothérapie à base de sels de platine, la dose recommandée est de 75 mg/ m² de docétaxel en monothérapie.
1.0567948818206787 ||| Do not use STAMARIL after the expiry date which is stated on the carton. ||| To open, lift here and pull CARTON HAS BEEN OPENED ||| Ne pas utiliser STAMARIL après la date de péremption mentionnée sur la boîte.
0.19874651730060577 ||| At the recommended dose, in clinical trials involving adults and adolescents in a range of indications including allergic rhinitis and chronic idiopathic urticaria, undesirable effects with Aerius were reported in 3% of patients in excess of those treated with placebo. ||| With the exception of dry skin, rash, and taste perversion, the incidence of clinical adverse reactions was similar or higher among patients treated with antiretroviral nucleoside analogue controls than among patients treated with CRIXIVAN alone or in combination. ||| 9 A la dose recommandée, lors des études cliniques impliquant des adultes et des adolescents et conduits dans les indications rhinite allergique et urticaire chronique idiopathique, les effets indésirables ont été rapportés chez 3% de patients de plus que ceux traités par le placebo.
0.24307572841644287 ||| If an anaphylactic reaction or other serious allergic reaction occurs, administration of Humira should be discontinued immediately and appropriate therapy initiated. ||| If pneumonitis or lung infiltrates are diagnosed, Vectibix should be discontinued and the patient should be treated appropriately. ||| En cas de survenue d'une réaction anaphylactique ou d'une autre réaction allergique grave, l'administration d’ Humira doit être immédiatement interrompue et un traitement approprié mis en œ uvre.
0.587547779083252 ||| Method of administration Irbesartan Winthrop is for oral use. ||| • Appropriate techniques for administration of ustekinumab. ||| 113 Mode d’ administration Irbesartan Winthrop se prend par voie orale.
0.03860482573509216 ||| In patients not fully healed within this time, the medication is continued at the same dose for another two weeks. ||| In patients not fully healed within this time, the medication should be continued at the same dose for another 2 weeks. ||| Chez des patients dont la cicatrisation n’est pas complète après cette période, le traitement sera poursuivi pendant 2 semaines supplémentaires à la même posologie.
0.6829959154129028 ||| Janssen 04010 Borgo San Michele Latina Italy ||| Hoche 75114 Paris Cedex 08 France ||| Janssen IT-04010 Borgo San Michele Latina Italie
0.3937649130821228 ||| Elderly In a multivariate analysis, age was not found to be an independent factor of any of the pharmacokinetic parameters studied. ||| 52 revealed that BSA and gender were the most significant covariates to explain inter-individual variability in pharmacokinetic parameters. ||| Personnes âgées Dans une analyse multifactorielle, l’ âge n’ est apparu comme un facteur indépendant pour aucun des paramètres pharmacocinétiques étudiés.
0.14601601660251617 ||| Very common: nausea, vomiting, diarrhoea, mucosal inflammation, constipation, stomatitis, abdominal pain ||| Common: abdominal pain, diarrhoea, flatulence, nausea, vomiting, constipation. ||| Très fréquent: nausée, vomissement, diarrhée, inflammation des muqueuses, constipation, stomatite, douleur abdominale.
0.36083245277404785 ||| In placebo-controlled trials with oral RISPERDAL in this population, the incidence of mortality was 4.0% for RISPERDAL-treated patients compared to 3.1% for placebo- treated patients. ||| Progression to cirrhosis occurred in 4/ 68 (6%) patients with the YMDD variant, whereas no patients without the variant progressed to cirrhosis. ||| Dans des essais contrôlés versus placebo réalisés avec RISPERDAL oral dans cette population, l’ incidence de la mortalité était de 4,0% pour les patients traités par RISPERDAL comparés à 3,1% pour les patients traités par placebo.
0.3648301959037781 ||| However, the retinal changes may also represent a direct drug-induced effect. ||| If such inhibitors occur, the condition may manifest itself as an insufficient clinical response. ||| Les modifications rétiniennes pourraient toutefois résulter également d'un effet direct du produit.
0.6024004220962524 ||| Do I need to change the needle every time I use my NutropinAq Pen? ||| You will push it in when you are ready to self-inject the ViraferonPeg. ||| Dois -je changer d’ aiguille chaque fois que j’ utilise mon stylo NutropinAq Pen?
0.7146413326263428 ||| INSTRUCTIONS ON USE M ||| ADMINISTRATOR’ S INSTRUCTIONS ||| INDICATIONS D’ UTILISATION
0.18763315677642822 ||| DepoCyte was to be used in the treatment of solid tumour neoplastic meningitis: this is a disease where cancer cells, originally from a solid tumour (such as lung or breast cancer), spread to the membranes of the nervous system. ||| DepoCyte is used to treat lymphomatous meningitis: this is a condition where lymphoma tumour cells have spread to the spinal fluid and the membranes that surround the brain and spinal cord (meninges). ||| DepoCyte devait être utilisé dans le traitement des méningites néoplasiques à tumeur solide: il s’ agit d’ une maladie dans laquelle les cellules cancéreuses, provenant à l’ origine d’ une tumeur solide (comme pour un cancer du poumon ou du sein), se sont propagées aux membranes du système nerveux.
0.4223259687423706 ||| The intravenous tubing should be well flushed with saline after injection to ensure that all of the medicinal product is administered. ||| It is supplied as a powder which will be mixed with sterile water before it is given (see information for Health Care Professionals) ||| Il faudra injecter de la solution saline en quantité suffisante dans le cathéter pour s'assurer que le médicament a été administré dans sa totalité.
9.006038102776781e-13 ||| 37 ANNEX II ||| 37 ANNEX II ||| 41 ANNEXE II
0.5617027878761292 ||| SBL Vaccin AB S-105 21 Stockholm Sweden ||| Ísland Meda AB Box 906 S-170 09 Solna Svíþjóð. ||| SBL Vaccin AB S-105 21 Stockholm Suède
0.3226556181907654 ||| NovoMix doses might also need to be adjusted when given with a number of other medicines which can have an effect on blood glucose. ||| In some cases these medicines may reduce the efficacy or increase the side effects of Tarceva and your doctor may need to adjust your treatment. ||| La posologie de NovoMix peut également nécessiter un ajustement lorsqu’ il est administré avec certains médicaments pouvant avoir un effet sur la glycémie.
0.38400426506996155 ||| A decrease in lamotrigine levels has been associated with loss of seizure control. ||| Increase in serum creatinine level and/ or acute renal failure have been observed. ||| Une diminution des taux de lamotrigine a été associée à une perte de contrôle des crises.
0.5000371932983398 ||| Orfadin 10 mg hard capsules. ||| Contains 4.5 mg metacresol. ||| Orfadin Gélules 10 mg
0.4085908532142639 ||| Ibuprofen may reduce the ability of your baby ’ s blood to clot. ||| Somatropin may interfere with the body’ s use of insulin. ||| L’ ibuprofène peut diminuer la capacité du sang à coaguler.
0.5353180170059204 ||| Loratabs ||| Trudexa ||| Loratadin
0.04268128424882889 ||| It is very important that you tell your doctor if you or the child have ever had tuberculosis, or have been in close contact with someone who has had tuberculosis. ||| It is very important that you tell your doctor if you have ever had tuberculosis, or have been in close contact with someone who has had tuberculosis. ||| Il est très important de dire à votre médecin si vous ou l’enfant avez déjà contracté la tuberculose ou avez été en contact étroit avec quelqu’un qui a eu la tuberculose.
0.29280275106430054 ||| Efficib A bioequivalence study in healthy subjects demonstrated that the Efficib (sitagliptin/ metformin hydrochloride) combination tablets are bioequivalent to co-administration of sitagliptin phosphate and metformin hydrochloride as individual tablets. ||| AVANDAMET Absorption No statistically significant difference was observed between the absorption characteristics of rosiglitazone and metformin from the AVANDAMET tablet and those obtained from rosiglitazone maleate and metformin hydrochloride tablets, respectively. ||| Efficib Une étude de bioéquivalence chez des volontaires sains a démontré que l’ association composant Efficib (sitagliptine/ chlorhydrate de metformine) est bioéquivalente au phosphate de sitagliptine et au chlorhydrate de metformine co-administrés sous forme de comprimés séparés.
0.5595626831054688 ||| 21, 45) reduction in the incidence of all pneumococcal AOM. ||| 1 SR80= sero-response in 80% of vaccinated rabbits ||| [21%; 45%]) de l’ incidence de toutes les OMA pneumococciques.
0.10450830310583115 ||| Information on the prescription status of this product may be found on the labelling. ||| Information on the prescription status of this product may be found on the label of the carton. ||| Pour toute information relative à la prescription de ce produit, veuillez consulter l’ étiquetage du produit.
4.4712923142654903e-13 ||| There is no information to suggest that Gardasil affects your ability to drive or use machinery. ||| There is no information to suggest that Gardasil affects your ability to drive or use machinery. ||| 67 Il n'y a aucune information permettant d'établir que Gardasil affecte votre capacité à conduire ou à utiliser certains outils ou machines.
0.02598288655281067 ||| 76 Eesti Österreich Sandoz d. d. ||| 96 Eesti Österreich Sandoz d. d. ||| Eesti Österreich Sandoz d. d.
0.3056265711784363 ||| Women of childbearing potential should be advised to use effective contraception to avoid pregnancy while they are receiving TMZ. ||| Women of childbearing potential must use effective contraception during treatment and after discontinuation of treatment as long as mitotane plasma levels are detectable. ||| Si l’ administration est envisagée pendant la grossesse, la patiente doit être prévenue du risque potentiel pour le fœ tus.
0.3077089786529541 ||| How to take Pramipexole Teva 4. ||| How does Pramipexole Teva work? ||| Comment prendre Pramipexole Teva 4.
0.3585473895072937 ||| Therefore the benefit-risk balance for Hexavac remains positive and no further regulatory action is necessary at this point in time. ||| Therefore, the Benefit/ Risk ratio of the product is still favourable and remains unchanged at the end of this arbitration procedure. ||| Par conséquent, le rapport bénéfice-risque pour Hexavac demeure positif et aucune nouvelle mesure réglementaire ne doit être prise à ce stade.
0.14940787851810455 ||| PANRETIN EPAR summary for the public ||| TARGRETIN EPAR summary for the public ||| Résumé EPAR à l’ intention du public
0.37350374460220337 ||| Cosmetics in the form of lotions ||| Confectionery in the form of tablets ||| Cosmétiques sous forme de lotions
0.4130593538284302 ||| HOW TO TAKE HELICOBACTER TEST INFAI ||| HOW TO USE EPOETIN ALFA HEXAL ||| COMMENT PRENDRE HELICOBACTER TEST INFAI
0.3796260356903076 ||| Packs of 4, 5 and 10 cartridges are available. ||| Packs of 1, 2, 4 and 5 vials of 10 ml are available. ||| Disponible en boîtes de 4, 5 et 10 cartouches.
0.025519108399748802 ||| If psychiatric symptoms persist or worsen, or suicidal ideation is identified, it is recommended that treatment with ViraferonPeg be discontinued, and the patient followed, with psychiatric intervention as appropriate. ||| If psychiatric symptoms persist or worsen, or suicidal ideation is identified, it is recommended that treatment with IntronA be discontinued, and the patient followed, with psychiatric intervention as appropriate. ||| Si les symptômes psychiatriques persistent ou s’ aggravent, ou si des idées suicidaires sont identifiées, il est recommandé d’ interrompre le traitement par ViraferonPeg, et de suivre le patient, avec une prise en charge psychiatrique appropriée.
1.1391200482879782e-12 ||| EXP {MM/ YYYY} ||| EXP {MM/ YYYY} ||| 97 EXP {MM/AAAA}
0.03650319576263428 ||| 53 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 48 For any information about this medicine, please contact the local representative of the Marketing Authorisation holder. ||| 56 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.44549185037612915 ||| This dose of Lysodren was continued or decreased in function of side effects and plasma mitotane levels. ||| Patients were randomised to continued treatment with sodium oxybate at their stable dose or to placebo. ||| Cette dose de Lysodren était maintenue ou diminuée en fonction des effets indésirables et du mitotane plasmatique.
0.19112971425056458 ||| The pH is adjusted with hydrochloric acid, and if necessary sodium hydroxide. ||| The pH may have been adjusted with sodium hydroxide and/ or hydrochloric acid. ||| Le pH est ajusté avec de l’ acide chlorhydrique et, si nécessaire, avec de l’ hydroxyde de sodium.
0.6801503300666809 ||| Opaque blisters (PVC/ PVDC/ aluminium). ||| Blister (Al/ Aclar/ PVAc/ PVC) ||| Plaquette thermoformée opaque (PVC/ PVDC/ Aluminum).
0.3985702097415924 ||| Other information about Cervarix: ||| Other information about PhotoBarr: ||| Autres informations relatives à Cervarix:
0.378356397151947 ||| The dose may be reduced or treatment interrupted in patients who have certain side effects affecting the blood or the nerves. ||| It also reduced the symptoms of the disease, particularly in patients whose cancer was producing high hormone levels. ||| La dose peut être réduite, ou le traitement interrompu, si la patiente manifeste certains effets indésirables affectant le sang ou les nerfs.
0.22191426157951355 ||| Losartan prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax which in turn lowers the blood pressure. ||| Telmisartan blocks the effect of angiotensin II so that the blood vessels relax, and your blood pressure is lowered. ||| Le losartan empêche la liaison de l'angiotensine II à ces récepteurs entrainant la dilatation des vaisseaux sanguins et une diminution de la pression artérielle.
0.0669192224740982 ||| The full EPAR for Herceptin can be found here. ||| The full EPAR for Abraxane can be found here. ||| L’ EPAR complet relatif à Herceptin est disponible ici.
0.43527841567993164 ||| CYP2D6 inhibitors: ||| CYP2C19 poor metabolisers ||| Inhibiteurs du CYP2D6:
0.44018009305000305 ||| Therefore, concomitant treatment should be initiated only if the patient is stable on his alpha blocker therapy. ||| - If transfer from another oral antidiabetic agent is intended: discontinue the other agent and initiate ||| Par conséquent, un traitement concomitant par vardénafil doit être initié uniquement si le patient est stable sous traitement par alpha-bloquant.
0.16235697269439697 ||| Powder and solvent for solution for injection ||| powder and solvent for solution for injection ||| Forme Pharmaceutique Poudre et solvant pour solution injectable
0.2480272650718689 ||| Nephrotic syndrome has been reported following high doses of plasma derived Factor IX to induce immune tolerance in haemophilia B patients with factor IX inhibitors and a history of allergic reactions. ||| Hypertension and oedema As with other drugs known to inhibit prostaglandin synthesis, fluid retention and oedema have been observed in patients taking lumiracoxib in clinical trials. ||| L’ apparition d’ un syndrome néphrotique après induction d’ une tolérance immune avec de fortes doses de facteur IX plasmatique humain a été rapportée chez des patients atteints d’ hémophilie B avec inhibiteurs du facteur IX et des antécédents de réactions allergiques.
0.6951888799667358 ||| OUTER CARTON 360 micrograms PRE-FILLED SYRINGE ||| IMMEDIATE PACKAGING – TRIFOLD – 3-day treatment pack ||| EMBALLAGE EXTERIEUR - SERINGUE PREREMPLIE de 360 microgrammes
0.33182668685913086 ||| The following types of reactions have been reported mainly from post-marketing experience with Glivec. ||| is The following adverse reactions have been identified during postmarketing use of Nespo: ||| Les types de réactions suivantes ont principalement été observées au cours de la commercialisation de Glivec.
0.0 ||| Name and address of the manufacturer responsible for batch release ||| Name and address of the manufacturer responsible for batch release ||| Nom et adresse du fabriquant responsable de la libération des lots
0.09431681036949158 ||| The full EPAR for TOVIAZ can be found here. ||| The full EPAR for PROCOMVAX can be found here. ||| L’ EPAR complet relatif à TOVIAZ est disponible ici.
0.30911755561828613 ||| In addition, a subgroup analysis by age suggested that the benefit of clopidogrel in patients over 75 years was less than that observed in patients ≤ 75 years. ||| There was no apparent difference in efficacy for entecavir based on gender (≈ 25% women in the clinical trials) or age (≈ 5% of patients > 65 years of age). ||| De plus, une analyse en sous- groupe par âge a suggéré que le bénéfice du clopidogrel chez les malades de plus de 75 ans était inférieur à celui observé chez les malades âgés de 75 ans ou moins.
0.1756793111562729 ||| NeoSpect should not be used in women who are pregnant or breast-feeding. ||| Docetaxel must not be used in pregnant or breast-feeding women. ||| NeoSpect ne doit pas être utilisé chez les femmes enceintes ou pendant l’ allaitement.
0.6455138921737671 ||| Courses (Training -) relating to insurance ||| Acquisitions (Advice relating to -) ||| Cours de formation en matière d'assurances
0.002314668847247958 ||| 155 Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT. ||| 145 Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT. ||| Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
0.41092079877853394 ||| Significant differences in comparison to the reference product have been identified with regard to the indications’ section of the SPCs. ||| There is further no information of relevance to the safety assessment in addition to what is stated in other parts of the SPC. ||| Des différences considérables en comparaison avec le produit de référence ont été identifiées eu égard au paragraphe Indications du RCP.
0.3597210645675659 ||| Implantable materials for use in guided tissue regeneration ||| Implants for guided tissue regeneration ||| Matériaux implantables destinés à la régénération tissulaire guidée
0.40160495042800903 ||| Additional signs may include myoglobinuria (rhabdomyolysis) and acute renal failure. ||| In addition, rhabdomyolysis, secondary to NMS or severe dyskinesia, has been observed. ||| Des signes cliniques supplémentaires peuvent inclure une myoglobinurie (rhabdomyolyse) et une insuffisance rénale aiguë.
0.1481376439332962 ||| 50 mg/ 2ml ||| 30 mg/ 3 ml ||| 50 mg/ 2 ml
0.3475782573223114 ||| Concomitant administration should be considered before the patient is switched to AVAGLIM. ||| Therapy with Cozaar Comp should be discontinued and the patient observed closely. ||| Une administration concomitante doit être envisagée avant de mettre le patient sous AVAGLIM.
0.11425849050283432 ||| Among patients with candidaemia, favourable response rates at the end of IV study therapy were comparable for caspofungin (72% [66/ 92]) and amphotericin B (63% [59/ 94]) in the primary efficacy analysis (MITT analysis) [% difference 10.0 (95.0% CI -4.5, 24.5)]. ||| Two hundred twenty-four patients were included in the primary efficacy analysis (MITT analysis) of response at the end of IV study therapy; favourable response rates for the treatment of invasive candidiasis were comparable for caspofungin (73% [80/ 109]) and amphotericin B (62% [71/ 115]) [% difference 12.7 (95.6% CI -0.7, 26.0)]. ||| Chez les patients ayant une candidémie, les taux de réponse favorable à la fin du traitement IV de l'étude ont été comparables dans le groupe caspofungine (72% [66/ 92]) et dans le groupe amphotéricine B (63% [59/ 94]) dans l'analyse primaire d'efficacité (analyse ITTM) [différence 10,0% (IC 95,0% -4,5; 24,5)].
0.28900641202926636 ||| acute myocardial infarction, myocardial infarction, angina pectoris, prolonged electrocardiogram QT, sinus bradycardia, tachycardia, palpitations ||| Oedema peripheral Ventricular fibrillation, ventricular arrhythmia, syncope, supraventricular arrhythmia, supraventricular tachycardia, tachycardia, bradycardia ||| infarctus aigu du myocarde, infarctus du myocarde, angine de poitrine, allongement de l’intervalle QT, bradycardie sinusale, tachycardie, palpitations
0.11595803499221802 ||| Manufacturer for the batch release: ||| Manufacturers for the batch release: ||| Fabricant responsable de la libération des lots:
0.38507068157196045 ||| The adverse reactions listed in Table 1 are based on experience from clinical trials and post-marketing. ||| The data on the effectiveness of the vaccine was based on published scientific papers and internal company reports. ||| Les effets indésirables rapportés après la mise sur le marché sont également décrits dans le Tableau 1 ci-dessous.
0.28993353247642517 ||| 48 Because therapy with Neupro is initiated at a low dose and gradually titrated according to clinical tolerability to obtain the optimum therapeutic effect, adjustment of the dose based on gender, weight, or age is not necessary. ||| Patients should be maintained on a single formulation of tacrolimus with the corresponding daily dosing regimen; alterations in formulation or regimen should only take place under the close supervision of a transplant specialist (see sections 4.2 and 4.8). ||| Groupes particuliers de patients Comme le traitement par Neupro débute à faible dose et est augmenté progressivement en fonction de la tolérance clinique pour obtenir un effet thérapeutique optimal, aucun ajustement de la dose en fonction du sexe, du poids ou de l’ âge n’ est nécessaire.
0.392198383808136 ||| What Tarceva contains: ||| What Myfenax contains: ||| Que contient Tarceva:
0.32266324758529663 ||| Zometa can be used to prevent bone complications in patients with advanced cancer that is affecting the bone. ||| Neulasta is used in cancer patients to help with some of the side effects of their treatment. ||| Zometa peut être utilisé pour éviter les complications osseuses chez des patients atteints d’ un cancer à un stade avancé qui affecte les os.
0.18553736805915833 ||| General disorders and administration site conditions Very common: pain and redness at the site of injection, fatigue Common: swelling and induration at the site of injection, shivering, fever Uncommon: injection site pruritis ||| General disorders and administration site conditions Very common: induration, swelling, pain and redness at the injection site, fever, fatigue Common: shivering, influenza like illness, injection site reactions (such as warmth, pruritus) Uncommon: malaise ||| Troubles généraux et anomalies au site d’ administration Très fréquents: douleur et rougeur au site d’ injection, fatigue Fréquents: gonflement et induration au site d’ injection, frissons, fièvre Peu fréquent: prurit au site d’ injection
0.34836840629577637 ||| Endocarditis, otitis externa ||| hypertension, aortic aneurysm ||| endocardite, otite externe
0.4079292416572571 ||| Rebif 22 micrograms solution for injection Interferon beta-1a SC use ||| EXUBERA 3 mg inhalation powder pre-dispens ed Insulin human ||| Rebif 22 microgrammes solution injectable Interféron beta-1a Voie SC
0.4814465641975403 ||| 42 If you take too many tablets, your blood sugar may become too low, leading to a hypo. ||| Zonegran can make you perspire less, which can cause your body temperature to increase. ||| Si vous prenez trop de comprimés, cela pourra faire baisser exagérément votre taux de sucre dans le sang et induire une hypo.
0.44781380891799927 ||| The recommended dose is 30 mg once daily for 2 weeks. ||| The second week 1 mg twice daily or 2 mg once daily can be given. ||| La posologie recommandée est de 30 mg une fois par jour pendant 2 semaines.
0.45824337005615234 ||| It cannot be excluded that this is also relevant to man on prolonged Ventavis therapy. ||| In addition the events listed below have been deemed to be related to romiplostim treatment. ||| Il n’ est pas exclu qu’ il en soit de même chez l’ homme en cas de traitement prolongé par Ventavis.
0.11113877594470978 ||| What Tasigna is and what it is used for 2. ||| What Zonegran is and what it is used for 2. ||| Qu'est -ce que Tasigna et dans quel cas est -il utilisé 2.
0.36014413833618164 ||| Alendronate is not recommended for patients with impaired renal function if the GFR is less than 35 ml/ min (see section 4.2). ||| If hypotension persists (systolic blood pressure less than 90 mm Hg for more than 1 hour) then Zestril should be withdrawn. ||| L’ administration d’ alendronate est déconseillée chez les patients présentant une insuffisance rénale lorsque le TFG est inférieur à 35 ml/ min (voir rubrique 4.2).
0.4189909100532532 ||| Sprayer wands for garden hoses ||| Nesting boxes for household pets ||| Lances pour tuyaux d'arrosage
0.4531550407409668 ||| The fentanyl is contained inside a reservoir. ||| Calcitonins are secreted into the milk. ||| Le principe actif (fentanyl) est contenu dans un réservoir.
0.13526341319084167 ||| Advagraf is a medicine containing the active substance tacrolimus. ||| Fasturtec is a medicine containing the active substance rasburicase. ||| Advagraf est un médicament dont le principe actif est le tacrolimus.
3.653687595528421e-13 ||| Renal and urinary disorders: ||| Renal and urinary disorders: ||| Effets rénaux et urinaires:
0.5299192070960999 ||| Secondary prevention of cardiovascular events has been approved in all Member States, Iceland and Norway. ||| The multi-dose presentation is licensed only in the Czech Republic, France and Latvia. ||| Son indication dans la prévention secondaire d’ évènements cardio-vasculaires a été approuvée par tous les États membres, l’ Islande et la Norvège.
0.039138078689575195 ||| If enalapril is used in such patients, periodic monitoring of white blood cell counts is advised and patients should be instructed to report any sign of infection. ||| If perindopril is used in such patients, periodic monitoring of white blood cell counts is advised and patients should be instructed to report any sign of infection. ||| Si l’ énalapril est utilisé chez de tels patients, un contrôle périodique du nombre de leucocytes est conseillé et les patients doivent être avertis de signaler tout signe d’ infection.
0.04578973352909088 ||| Which measures are being taken to ensure the safe use of Intrinsa? ||| Which measures are being taken to ensure the safe use of Tasigna? ||| Quelles sont les mesures prises pour garantir une utilisation sans danger d’ Intrinsa?
0.6215696334838867 ||| We stand ready to do more as the situation evolves. ||| The Commission stands ready to take further action as the situation evolves. ||| Nous sommes prêts à en faire plus à mesure que la situation évolue.
0.4897063076496124 ||| Tisanes [medicated beverages] ||| Whiteners [dairy] for beverages ||| Tisanes [boissons à usage médical]
0.8182815909385681 ||| INFORMTION FOR THE USER ||| INFORMATION FOR INJECTING YOURSELF ||| INFORMATION DE L’UTILISATEUR
0.29294276237487793 ||| Lending of books and other publications ||| Lending of books and periodicals ||| Prêts de livres et d'autres publications
5.669802192846685e-13 ||| MERIAL 29 avenue Tony Garnier 69007 LYON FRANCE ||| MERIAL 29 avenue Tony Garnier 69007 LYON FRANCE ||| MERIAL 29 avenue Tony Garnier 69007 LYON France
0.41529661417007446 ||| This fat passes out of your body and may cause changes to your bowel movements. ||| When these blood vessels bleed or leak fluid, it causes a loss of vision. ||| Ces graisses sont directement éliminées par votre organisme, ce qui peut modifier vos selles.
0.320462167263031 ||| Check with your doctor immediately if you have any of these symptoms or any other symptoms that are troubling. ||| Talk to your doctor or healthcare professional about these or any other unusual conditions you may find. ||| Contactez immédiatement votre médecin en cas d’ apparition d’ un de ces symptômes ou de n’ importe quel autre symptôme vous inquiétant.
0.1298181712627411 ||| 39 1. ||| 38 1. ||| 40 1.
0.09836134314537048 ||| Do not use Insulin Human Winthrop Basal ||| Do not use Insulin Human Winthrop Infusat ||| N’utilisez jamais Insulin Human Winthrop Basal
0.15776532888412476 ||| In the MRP the United Kingdom is the Reference Member State and Austria, Belgium, Finland, France, Germany, Italy, Ireland, Luxembourg, Portugal, Spain and Sweden are Concerned Member States. ||| In the MRP Sweden is the Reference Member State (RMS) and Austria, Belgium, Finland, France, Germany, Italy, Ireland, Luxembourg, Portugal, Spain and the United Kingdom are Concerned Member States (CMS). ||| L'État membre de référence pour cette MRP est le Royaume-Uni, et les États membres concernés sont l’ Autriche, la Belgique, la Finlande, la France, l’ Allemagne, l’ Italie, l’ Irlande, le Luxembourg, le Portugal, l’ Espagne et la Suède.
0.0 ||| 15 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 15 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 15 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.5803841352462769 ||| 8 EFFICACY ASPECTS ||| POSSIBLE SIDE EFFECTS ||| 8 EFFICACITE
0.48982542753219604 ||| The CHMP considered that the data from these trials may not be sufficient to demonstrate the claimed benefit. ||| We will analyse whether the current scope of operators subject to these rules is adequate. ||| Le CHMP a considéré que les données de ces essais pouvaient ne pas suffir à démontrer le bénéfice revendiqué.
0.4196787178516388 ||| Liver aminotransferase elevations may reverse spontaneously while continuing treatment with sitaxentan sodium. ||| Increased fexofenadine levels may lessen over time as induction develops. ||| L’ augmentation des transaminases hépatiques peut régresser spontanément lors de la poursuite du traitement.
0.06080792099237442 ||| Cardoreg 4 mg prolonged release tablets and associated names [See Annex I] Doxazosin ||| Cardoreg 4 mg prolonged release tablets and associated names [See Annex I] (Doxazosin) ||| Cardoreg 4 mg comprimés à libération prolongée et dénominations associées [voir annexe I] Doxazosine
0.2843593955039978 ||| Adult haemodialysis patients: ||| Adults receiving haemodialysis ||| Patients adultes en hémodialyse:
0.331411212682724 ||| It is recommended that women do not breast feed during treatment with Vectibix and for 3 months after the last dose. ||| Remember that the first dose of Menitorix should not be given before your child is 2 months of age. ||| Il est recommandé aux femmes de ne pas allaiter pendant le traitement par Vectibix et pendant 3 mois après administration de la dernière dose.
0.7098922729492188 ||| - fasting or malnutrition, ||| - Difficulties in breathing. ||| - de jeûne ou de dénutrition,
0.013646416366100311 ||| Olanzapine Teva 7.5 mg film-coated tablet is a white, biconvex, round tablet, with the inscription “OL 7.5” on one side. ||| Olanzapine Teva 5 mg film-coated tablet is a white, biconvex, round tablet, with the inscription “OL 5” on one side. ||| Olanzapine Teva 7,5 mg, comprimés pelliculés, se présente sous forme de comprimé rond biconvexe blanc portant l’ inscription « OL 7,5 » sur une face.
0.2559748888015747 ||| Occurrence of lactic acidosis (in the absence of hypoxaemia) sometimes fatal, and usually associated with severe hepatomegaly with steatosis have been reported with the use of nucleoside/ nucleotide analogues. ||| As a consequence of different but complementary mechanisms of action, dual oral therapy of rosiglitazone with a sulphonylurea or metformin resulted in additive effects on glycaemic control in type 2 diabetic patients. ||| Des cas d’ acidose lactique (en l’ absence d’ hypoxémie), parfois fatals, généralement associés à une hépatomégalie importante et à une stéatose hépatique, ont été rapportés en cas de traitement par des analogues nucléosidiques/ nucléotidiques.
0.392370343208313 ||| Conversely, the coadministration of food or a glucose infusion results in an enhancement of insulin secretion. ||| In case of alkalinization of the urine, a partial resorption takes place. ||| A l'inverse, l'administration simultanée d'aliments ou d'une perfusion de glucose renforce nettement la sécrétion d'insuline.
9.02543827435015e-13 ||| Paediatric population ||| Paediatric population ||| 110 Population pédiatrique
0.3712238073348999 ||| IONSYS should only be activated by the patient, to avoid potential overdosing. ||| Special care must, therefore, be taken by the operator not to introduce pathogens into the teat. ||| IONSYS ne doit être activé que par le patient, afin d’ éviter un éventuel surdosage.
0.0337725467979908 ||| More frequent adverse drug reactions in combination with levodopa was dyskinesia. ||| More frequent adverse drug reaction in combination with levodopa was dyskinesia. ||| Les effets indésirables les plus fréquents en association avec la lévodopa sont les dyskinésies.
0.42703139781951904 ||| It is therefore prudent to withhold administration of hCG in cases where OHSS is developing and not to have sexual intercourse or use barrier methods for at least four days. ||| Shortage in single-use medical mask and field reports of reuse lead to the question of which process could properly sanitise these PPE without altering their filtering capacity. ||| Par conséquent, en cas de SHO, il est recommandé de ne pas administrer l’ hCG et de ne pas avoir de rapport sexuel ou d’ utiliser des moyens contraceptifs mécaniques pendant au moins 4 jours.
2.956982532095753e-13 ||| Table 1 provides dose interval adjustment guidelines based on simulations of increasing renal impairment in patients being coadministered potent CYP3A4 inhibitors. ||| Table 1 provides dose interval adjustment guidelines based on simulations of increasing renal impairment in patients being coadministered potent CYP3A4 inhibitors. ||| Le tableau 1 présente des recommandations l’ ajustement des intervalles de doses basées sur des simulations d’ insuffisance rénale croissante chez des patients recevant de façon concomitante des inhibiteurs puissants du CYP3A4.
0.3296585977077484 ||| Females of child-bearing age should take the necessary precautions to avoid pregnancy for 3 months, or according to doctor’ s recommendation, after they have been given the vaccine. ||| In order to advise women who are inadvertently vaccinated when pregnant or who become pregnant within 3 months after vaccination, the physician should be aware of the following: ||| Les femmes en âge d'avoir des enfants doivent prendre les précautions nécessaires pour éviter toute grossesse dans les 3 mois suivant la vaccination, ou selon les recommandations du médecin après avoir été vaccinées.
0.08573445677757263 ||| CYMBALTA 60 mg hard gastro-resistant capsules Duloxetine ||| YENTREVE 40 mg hard gastro-resistant capsules Duloxetine ||| CYMBALTA 60 mg, gélule gastro-résistante Duloxétine
0.521060049533844 ||| The outbreak of the coronavirus is affecting all countries and member states and the EU are determined to tackle it together. ||| The shock to the EU economy is symmetric in that the pandemic has hit all Member States. ||| La pandémie de coronavirus affecte l'Europe toute entière et l'Union européenne est déterminée à y faire face, unie.
0.28870412707328796 ||| Haemorrhage Fondaparinux should be used with caution in patients who have an increased risk of haemorrhage, such as those with congenital or acquired bleeding disorders (e. g. platelet count < 50,000/ mm3), active ulcerative gastrointestinal disease and recent intracranial haemorrhage or shortly after brain, spinal or ophthalmic surgery and in special patient groups as outlined below. ||| Levetiracetam efficacy was established in a 24-week double-blind, placebo-controlled study, which included adults, adolescents and a limited number of children suffering from idiopathic generalized epilepsy with primary generalized tonic-clonic (PGTC) seizures in different syndromes (juvenile myoclonic epilepsy, juvenile absence epilepsy, childhood absence epilepsy, or epilepsy with Grand Mal seizures on awakening). ||| 14 troubles acquis ou congénitaux de la coagulation (par exemple, numération plaquettaire < 50 000/ mm3), maladie ulcéreuse gastro-intestinale en poussée, hémorragie intracrânienne récente ou dans les suites récentes d'une intervention chirurgicale cérébrale, rachidienne ou ophtalmique, et dans les populations particulières mentionnées ci-dessous.
0.3103482723236084 ||| Roof gutters, not of metal ||| Modular silos, not of metal ||| Chéneaux non métalliques
0.005516267381608486 ||| 132 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 138 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 136 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.37294137477874756 ||| Children and adolescents Tasigna is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy (see section 5.1). ||| If no improvement is noted within 10 weeks, treatment with (Invented name)® should be reconsidered. • Children and adolescents aged 8 to 18 years with depression: ||| Enfants et adolescents Tasigna ne doit pas être utilisé chez l'enfant et l’ adolescent en dessous de 18 ans compte tenu de l’ insuffisance de données concernant la sécurité et l'efficacité (voir rubrique 5.1).
0.23988613486289978 ||| In a long-term trial designed to assess the maintenance of effect, INVEGA was significantly more effective than placebo in maintaining symptom control and delaying relapse of schizophrenia. ||| In this review, progestogen addition as continuous therapy was more effective than sequential therapy in reducing the risk of endometrial hyperplasia at longer duration of treatment. ||| Dans un essai long terme conçu pour évaluer le maintien de l’ effet, INVEGA était significativement plus efficace que le placebo sur le maintien du contrôle des symptômes et pour retarder la survenue des rechutes de la schizophrénie.
0.8823108077049255 ||| If you take more MIRAPEXIN than you should If you accidentally take too many tablets, ||| 52 If your child takes more SINGULAIR than he/ she should ||| Si vous avez pris plus de MIRAPEXIN comprimés que vous n’ auriez dû:
0.41424423456192017 ||| The efficacy of prasugrel was independent of the ASA dose (75 mg to 325 mg once daily). ||| Raltegravir AUC and Cmax increase dose proportionally over the dose range 100 mg to 1600 mg. ||| L'efficacité du prasugrel a été indépendante de la dose d'acide acétylsalicylique (75 mg à 325 mg une fois par jour).
0.4541448652744293 ||| Lubricants for mounting pneumatic tyres ||| Propelling pyrotechnic mixtures for ammunition ||| Lubrifiants pour le montage de pneumatiques
0.0 ||| EMEND was administered orally 1 hour prior to chemotherapy treatment on Day 1 and in the morning on Days 2 and 3. ||| EMEND was administered orally 1 hour prior to chemotherapy treatment on Day 1 and in the morning on Days 2 and 3. ||| 26 EMEND a été administré par voie orale 1 heure avant le début de la chimiothérapie à J1 et le matin de J2 et de J3.
0.2420482188463211 ||| Nephrotic syndrome has been reported following high doses of plasma derived Factor IX to induce immune tolerance in haemophilia B patients with factor IX inhibitors and a history of allergic reactions. ||| Ischemic heart disease Under ischemic conditions, a deterioration of cardiac function and a decrease in coronary blood flow could theoretically arise from antagonism of bradykinin receptor type 2. ||| L’ apparition d’ un syndrome néphrotique après induction d’ une tolérance immune avec de fortes doses de facteur IX plasmatique humain a été rapportée chez des patients atteints d’ hémophilie B avec inhibiteurs du facteur IX et des antécédents de réactions allergiques.
0.1183442547917366 ||| Instruction for self-administration is mentioned in the Package Leaflet. lP ||| ra Instruction for self-administration is mentioned in the Package Leaflet. ||| Les instructions pour auto-administration sont présentées dans la notice. m
0.5187452435493469 ||| Musculoskeletal and connective tissue disorders Rhabdomyolysis Renal and urinary disorders Urinary hesitation Reproductive system and breast disorders Priapism General disorders and administration site conditions Asthenia Fatigue Oedema Investigations Elevated plasma prolactin levels8 1 ||| RADIATION ABSORBED DOSES Organ Adrenals Brain Chest Gallbladder Ascending colon wall Descending colon wall Small intestine Myocardial wall Kidneys Liver Lungs Muscle Ovaries Pancreas Red marrow Bone surfaces Skin Spleen Stomach Testes Thymus Thyroid Urinary bladder wall Uterus Effective dose (mSv/ MBq) ||| Affections musculo-squelettiques et systémiques et osseuses Rhabdomyolyse Affections du rein et des voies urinaires Dysurie Affections des organes de reproduction et du sein Priapisme Troubles généraux et anomalies au site d'administration Asthénie Fatigue Oedème Investigations Augmentation de la prolactinémie 8 1
0.6415960788726807 ||| Malignant Pleural Mesothelioma: ||| Myeloid Blast Phase CML: ||| Mésothéliome pleural malin:
0.3148002028465271 ||| Target surveillance apparatus [electric] ||| Process controlling apparatus [electronic] ||| Appareils de surveillance de cibles [électriques]
0.2045624554157257 ||| Saws [hand tools] ||| Shovels [hand tools] ||| Scies [outils]
0.5849273204803467 ||| How many people (crews and passengers) have been stranded on cruise ships because of coronavirus? ||| How will crew members and passengers travel on to their home countries if hardly any flights/international trains are running? ||| Combien de personnes (membres d'équipage et passagers) ont été bloquées sur des navires de croisière à cause du coronavirus?
0.48668116331100464 ||| Preotact should therefore not be used in patients with severe renal impairment (see section 4.3). ||| For patients with severe infections, initiate effective antibiotic treatment as soon as possible [31,74]. ||| En conséquence, Preotact ne doit pas être utilisé chez les patientes ayant une insuffisance rénale sévère (voir rubrique 4.3).
0.1231955736875534 ||| You should check with your doctor or pharmacist if you are not sure. ||| If you are not sure, speak to your doctor or pharmacist for advice. ||| En cas d’incertitude, consultez votre médecin ou votre pharmacien.
0.2884436249732971 ||| Ammunition bags ||| Ammunition casings ||| Sacs de munitions
0.5838736295700073 ||| Incandescent light bulbs ||| Super luminescent laser diodes ||| Ampoules à incandescence
0.5797163248062134 ||| er hypoglycaemia. ||| - diabetic ketoacidosis. ||| une hypoglycémie. éd
0.35475438833236694 ||| • Repeated occurrence of malignant disease cannot be excluded. ||| As a result re-occurrence of blockade might be observed. ||| • La récidive d'une affection maligne ne peut pas être exclue.
0.32197514176368713 ||| The company will also remind healthcare workers about how the medicine should be used safely and the risks of accidental exposure to fentanyl. ||| Therefore health care providers need to assess the benefits and potential risks of administering the vaccine in that population. ||| La société rappellera également aux professionnels de santé comment le médicament doit être utilisé pour garantir sa sécurité d’ emploi, ainsi que les risques d’ exposition accidentelle au fentanyl.
0.8502535820007324 ||| We are ready to lead and support the global response. ||| To further strengthen the collaboration with the national ||| Nous sommes prêts à mener et à soutenir la réponse mondiale.
0.3516324758529663 ||| Electrically operated hearing aids ||| Electrically heated hair brushes ||| Prothèses auditives électriques
0.3991040289402008 ||| Take off the inner needle cap and discard it. ||| Dispose of it carefully and put the pen cap back on. ||| Retirez le capuchon intérieur de l’aiguille et jetez le.
0.4009854793548584 ||| Electronic cruise control apparatus ||| Electronic coding apparatus ||| Régulateurs électroniques de vitesse
0.3984524607658386 ||| Insert the needle into the pinched skin at an angle of 45° to 90°. ||| Push the needle into the skin at a slight angle (45 degrees) with a quick, short motion. ||| Introduisez la seringue dans la peau qui a été pincée avec un angle de 45° à 90°.
0.20025229454040527 ||| The most frequently reported adverse reactions related to VIRAMUNE therapy, across all clinical trials, were rash, allergic reactions, hepatitis, abnormal liver function tests, nausea, vomiting, diarrhoea, abdominal pain, fatigue, fever, headache and myalgia. ||| The most commonly (≥ reported adverse reactions in patients with Parkinson’ s disease more 5%) frequent with pramipexole treatment than with placebo were nausea, dyskinesia, hypotension, dizziness, somnolence, insomnia, constipation, hallucination, headache and fatigue. ||| Au cours des essais cliniques, les effets indésirables le plus souvent décrits et imputés à VIRAMUNE ont été des cas d'éruption cutanée, de réactions allergiques, d’ hépatites, des tests de la fonction hépatique anormaux, de nausées, de vomissements, de diarrhées, de douleurs abdominales, d'asthénie, de fièvre, de céphalées, et de myalgies.
0.2683299779891968 ||| Aflunov is a ‘ prepandemic’ vaccine. ||| Celvapan is a ‘ mock-up’ vaccine. ||| Aflunov est un vaccin « prépandémique ».
0.19947858154773712 ||| Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Aprovel, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/ or heart failure. ||| Nexavar is used to treat patients who have: • hepatocellular carcinoma, • advanced renal cell carcinoma (a type of kidney cancer that affects the cells of the renal tubules) when anticancer treatment with interferon alfa or interleukin-2 has failed or cannot be used. ||| Hyperkaliémie: comme avec les autres médicaments agissant sur le système rénine-angiotensine- aldostérone, une hyperkaliémie peut survenir au cours d’ un traitement par Aprovel, en particulier en présence d’ une insuffisance rénale, d'une protéinurie avérée liée à une atteinte rénale due au diabète, et/ ou d’ une insuffisance cardiaque.
0.4868798851966858 ||| Velosulin is a fast-acting insulin. ro ||| Insuman Rapid is a neutral insulin solution (regular insulin). ||| Velosulin est une insuline d’ action rapide.
0.3994775414466858 ||| When a pregnancy is planned or confirmed, the switch to an alternative treatment should be initiated as soon as possible. ||| A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. ||| Si une grossesse est projetée ou confirmée, un traitement alternatif doit être initié dès que possible.
0.01901521533727646 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist. ||| 115 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist. ||| Si l’un des effets indésirables devient grave ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez-en à votre médecin, à votre infirmière ou à votre pharmacien.
0.3071185350418091 ||| However, significant liver toxicity has not been observed in patients treated in clinical studies, either during administration of Agenerase or after discontinuation. ||| However, based on field trial data, the incidence of pseudopregnancy in treated bitches is not greater than in control (untreated) bitches. ||| 64 Toutefois, aucune hépatotoxicité significative n'a été observée chez les patients traités lors des essais cliniques, que ce soit lors de l'administration d’ Agenerase ou après son arrêt.
0.16362741589546204 ||| Aptivus is to be taken in combination with low dose ritonavir and other antiretroviral medicines. ||| PREZISTA must be taken in combination with a low dose of ritonavir and other anti-HIV medicines. ||| APTIVUS est destiné à être administré en association avec de faibles doses de ritonavir et d’ autres antirétroviraux.
0.07556627690792084 ||| 80 mg sucrose (in the 80 mg capsule). ||| 125 mg sucrose (in the 125 mg capsule). ||| 80 mg de sucrose (dans la gélule de 80 mg).
0.302420437335968 ||| According to in vitro studies, significant displacement is not anticipated at therapeutic concentrations of the medicinal products. ||| Overall, the results of the preclinical studies do not suggest any significant safety hazard for use of Sonata at recommended doses in humans. ||| Selon des études in vitro, aucun déplacement significatif ne devrait se produire aux concentrations thérapeutiques des médicaments.
6.656874487406816e-13 ||| 35 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 35 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 36 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.37773826718330383 ||| - numbness or tingling of skin ||| - tingling or numbness of the mouth, dry mouth ||| - engourdissement ou fourmillement cutané
0.4851503074169159 ||| Solution for injection in a pre-filled pen, OptiSet. ||| Preotact is injected using the re-usable pen, Preotact pen. ||| Solution injectable en stylo prérempli OptiSet.
0.36732667684555054 ||| The second study showed that patients taking MIRCERA and those taking darbepoetin alfa had similar increases in haemoglobin levels (around 2 g/ dl). ||| Moreover, one endometrial sample from a woman who received the E2 1 mg/ NETA 0.1 mg combination was evaluated as “ disordered proliferative” state. ||| La deuxième étude a montré que les patients prenant MIRCERA et ceux prenant de la darbépoétine alpha présentaient des augmentations similaires du taux d’ hémoglobine (environ 2 g/ dl).
0.498477041721344 ||| The majority of rashes were of mild to moderate severity. ||| Epistaxis was generally mild to moderate in intensity. ||| La plupart de ces éruptions étaient d’ intensité légère à modérée.
0.22829388082027435 ||| 30 mg ||| 10 mg ||| 15 mg
0.23020559549331665 ||| Pseudoephedrine is a nasal decongestant, which exerts its sympathomimetic effects indirectly, predominantly through release of adrenergic mediators from postganglionic nerve terminals. ||| Mechanism of action: oxybutynin acts as a competitive antagonist of acetylcholine at post-ganglionic muscarinic receptors, resulting in relaxation of bladder smooth muscle. ||| La pseudoéphédrine est un décongestionnant nasal qui a des effets sympathomimétiques indirects, notamment par libération d’ agents adrénergiques à partir des terminaisons nerveuses postganglionaires.
0.32431846857070923 ||| Children and adolescents below 18 years of age: ||| Children 3 years of age or older and adolescents: ||| 2 Enfants et adolescents de moins de 18 ans:
0.43970781564712524 ||| Remedial services for wall coverings ||| Solutions for disinfecting contact lenses ||| Services de réparation de revêtements muraux
0.2535303831100464 ||| • Hypersensitivity to the active substance or to any of the excipients. • Hypersensitivity to Chinese hamster ovary (CHO) cell products or other recombinant human or humanised antibodies. • Pregnancy (see section 4.6). • Avastin is contraindicated in patients with untreated CNS metastases (see sections 4.4 and 4.8). ||| • Hypersensitivity to enalapril, to any of the excipients or any other ACE inhibitor • History of angioedema associated with previous ACE inhibitor therapy • Hereditary or idiopathic angioedema • Second and third trimesters of pregnancy (see 4.6 Pregnancy and lactation). ||| • Hypersensibilité à la substance active ou à l’ un des excipients. • Hypersensibilité aux produits des cellules ovariennes de hamster Chinois (CHO) ou à d’ autres anticorps recombinants humains ou humanisés. • Grossesse (voir rubrique 4.6).
0.5714982151985168 ||| 87.2% (85.2, 89.0) ||| 31% (25.2– 36.8) 8% ||| (85,2; 89,0) 57,5%
0.4091150760650635 ||| Given the importance of tests in the current situation and the rapid development of the pandemic, the Commission is also insisting on pooling resources for the validation of coronavirus tests at EU-level. ||| Along with the higher profile of the Agency has come an increased demand for information from the press and other sources, and a new communications policy will be explored in 1997. ||| Compte tenu de l'importance des tests dans la situation actuelle et de l'évolution rapide de la pandémie, la Commission insiste en outre sur la mise en commun des ressources pour la validation des tests liés au coronavirus au niveau de l'Union.
0.2956330180168152 ||| Berlimed S. A., Poligono Industrial Santa Rosa s/ n, 28806 Alcalá de Henares, Madrid, Spain ||| Glaxo Wellcome S.A., Avenida de Extremadura 3, 09400 Aranda de Duero, Burgos, Spain. ||| Berlimed S. A., Poligono Industrial Santa Rosa s/ n, 28806 Alcala de Henares, Madrid, Espagne
0.6921073198318481 ||| Sauces for chicken ||| Rice meal for forage ||| Sauces pour poulet
1.6780951023101807 ||| Sitagliptin with Sitagliptin with Sitagliptin with 1 2 ||| Ciproxina OD Ciproxina Ciproxina Ciproxina ||| sitagliptine + sulfamide hypoglycémiant2
0.30355802178382874 ||| The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 13 years and above, is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection. ||| MIRAPEXIN is indicated for symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in dosages up to 0.54 mg of vase (0.75 mg of salt) (see section 4.2). ||| La posologie recommandée pour les patients âgés de 13 ans et plus atteints d’arthrite juvénile idiopathique polyarticulaire est de 40 mg d’adalimumab en dose unique toutes les deux semaines, en injection sous-cutanée.
0.28165140748023987 ||| The following adverse reaction (ADR) data are based on two placebo-controlled studies involving 2642 postmenopausal osteoporotic women of whom 1341 received parathyroid hormone. ||| The following adverse reaction data is based on a clinical study of bivalirudin in 6000 patients undergoing PCI, half of whom were treated with bivalirudin (REPLACE-2). ||| Les données relatives aux effets indésirables (EI) sont issues de deux études contrôlées versus placebo, incluant 2642 patientes présentant une ostéoporose post-ménopausique dont 1341 ont reçu de
0.07357501983642578 ||| Via Palermo, 26/ A 43100 Parma Italy ||| Via Palermo 26/ A 43100 Parma Italy ||| Via Palermo, 26/ A 43100 Parma Italie
0.28677958250045776 ||| Lactation It is not known whether losartan is excreted in human milk. ||| Lactation Human data demonstrate that tacrolimus is excreted in breast milk. ||| Allaitement On ne sait pas si le losartan est excrété dans le lait maternel humain.
0.21292489767074585 ||| uth and your partner must each use an effective contraceptive during the time you are taking ribavirin and for 7 months after stopping treatment. ||| You and your partner must each use an effective contraceptive during the time you are taking the treatment and for 4 months after stopping treatment. ||| Si vous êtes un homme, vous et votre partenaire devez chacun utiliser une méthode de contraception efficace pendant toute la durée de votre traitement et pendant les 7 mois suivant son arrêt.
0.46339696645736694 ||| Just take your next capsule at the usual time, then go on as before. ||| In that case, just carry on with the next dose as normal. ||| Prenez juste la gélule suivante à l’ heure habituelle, continuez ensuite comme auparavant.
0.26588451862335205 ||| Each dispersible/chewable tablet contains 2 mg, 5 mg, 25 mg, 50 mg, 100 mg or 200 mg lamotrigine. ||| Each RISPERDAL film-coated tablet contains either 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg or 6 mg of risperidone. ||| Chaque comprimé dispersible ou à croquer contient 2 mg, 5 mg, 25 mg, 50 mg, 100 mg ou 200 mg de lamotrigine.
0.39447420835494995 ||| How to store Fentanyl-ratiopharm 6. ||| What Fentanyl-ratiopharm contains ||| Comment conserver Fentanyl-ratiopharm 6.
0.22188664972782135 ||| 10/ 34 10 DATE OF REVISION OF THE TEXT ||| 5 10 DATE OF REVISION OF THE TEXT ||| DATE DE MISE À JOUR DU TEXTE
0.35616254806518555 ||| Your doctor will decide if Trevaclyn is right for you. ||| Your doctor will decide if you should receive CELVAPAN. ||| Votre médecin déterminera si vous pouvez prendre Trevaclyn.
0.07706177234649658 ||| Reported Adverse Events in ESPRIT * Very common (> 1/ 10), Common (> 1/ 100 , 1/ 1,000 , 1/ 10,000, < 1/ 1,000), Very rare (< 1/ 10,000) ||| Reported Adverse Events in PURSUIT at 30 Days* Very common (> 1/ 10), Common (> 1/ 100 , 1/ 1,000 , 1/ 10,000, < 1/ 1,000, Very rare (< 1/ 10,000) ||| Effets indésirables rapportés dans l’ étude ESPRIT* Très fréquent (> 1/ 10), Fréquent (> 1/ 100,  1/ 1.000,  1/ 10.000, < 1/ 1.000), Très rare (< 1/ 10.000)
0.49199002981185913 ||| The Agency will also see the establishment of a new audit-advisory committee, following an open tender in 2005. ||| In the first quarter of 2021, the Commission will propose to set up an EU-level supervisor. ||| L’ Agence verra également la création d’ un nouveau comité consultatif d’ audit après un appel d’ offres ouvert en 2005.
0.3530017137527466 ||| (-0.9, -0.5) -0.6‡ ||| -1.6 ‡ (-1.8, -1.3) ||| (-0,9; -0,5) -0,6‡
0.36116132140159607 ||| Syringes in the nature of pens ||| Enamels in the nature of paints ||| Seringues sous forme de stylos
0.40226900577545166 ||| - fainting, inflammation of the blood vessel (vasculitis) ||| - inflammation in the mouth, fungal infection in the mouth (Candida infection) ||| - évanouissement, inflammation de la paroi des vaisseaux sanguins (vascularite)
0.24171194434165955 ||| The mean plasma elimination half-life (t½) is 1.3 hr. ||| The terminal elimination half-life (t1/2) is 5.4 hours. ||| La demi-vie d'élimination plasmatique moyenne (t½) est de 1,3 h.
0.4444667100906372 ||| For single use only. ||| Disposal For single use only. ||| Pour usage unique seulement.
0.6976674795150757 ||| Savings scheme services ||| Contactless payment services ||| Services de plans d'épargne
0.20996388792991638 ||| The pharmacokinetics of duloxetine in patients who are poor metabolisers with respect to CYP2D6 has not been specifically investigated. ||| The effects of CYP2C9 inducers such as rifampicin on the pharmacokinetic of irbesartan have not been evaluated. ||| La pharmacocinétique de la duloxétine chez les patients "métaboliseurs lents" vis à vis du CYP2D6 n 'pas fait l'
0.16107681393623352 ||| In long-term carcinogenicity studies in rats and mice with adefovir dipivoxil, no treatment-related increase in tumour incidence was found in mice or rats (systemic exposures approximately 10 and 4 times those achieved in humans at the therapeutic dose of 10 mg/ day, respectively). ||| In rats, oral administration of bosentan for 2 years produced a small, significant increase in the combined incidence of thyroid follicular cell adenomas and carcinomas in males, but not in females, at plasma concentrations about 9 to 14 times the plasma concentrations achieved at the therapeutic dose in humans. ||| Dans les études du potentiel carcinogène à long terme de l’ adéfovir dipivoxil conduites chez le rat et la souris, aucune augmentation liée au traitement de l’ incidence de tumeurs n’ a été retrouvée (expositions systémiques respectives environ 10 et 4 fois supérieures à l’ exposition humaine après administration de la dose thérapeutique de 10 mg/ jour).
0.5251958966255188 ||| 2 days Not authorised for use in laying birds producing eggs for human consumption. ||| Broiler chicken litter is also taken for incineration to produce power (about 40% in The Netherlands). ||| 2 jours Ne pas utiliser chez les oiseaux pondeurs d’œ ufs destinés à la consommation humaine.
0.0 ||| Please make sure that Liprolog is mentioned in the leaflet accompanying your pen. ||| Please make sure that Liprolog is mentioned in the leaflet accompanying your pen. ||| Assurez-vous que Liprolog Mix50 est mentionnée dans la notice accompagnant votre stylo.
0.43271976709365845 ||| In replacement therapy the dosage may need to be individualised for each patient dependent on the pharmacokinetic and clinical response. ||| Subjects were selected by appropriate inclusion criteria and the regimen was standardized, excluding factors influencing pharmacokinetic interactions. ||| Dans les traitements substitutifs, la posologie doit être individualisée pour chaque patient en fonction de la réponse pharmacocinétique et clinique.
0.6018663644790649 ||| Finland, Sweden, Denmark and the Netherlands are the leaders in overall digital performance in the EU. ||| Bulgaria, Greece, Romania and Italy have the lowest scores on the index. ||| La Finlande, la Suède, le Danemark et les Pays-Bas enregistrent globalement les meilleurs résultats de l'UE en matière de numérique.
0.533168613910675 ||| Put the protective cap on the top of the device. ||| Information to appear on the inside of the flap ||| Mettre le capuchon de protection sur le dispositif.
0.2777329981327057 ||| - The active substance is sodium phenylbutyrate. ||| - The active substance is alglucosidase alfa 50 mg. ||| - La substance active est le phénylbutyrate de sodium.
0.47227758169174194 ||| 8 (5.1) 2 (1.3) 2 (1.3) 0 (0.0) ||| 130 (4.8) 99 (3.6) 66 (2.4) 37 (1.4) ||| 8 (5,1) 2 (1,3) 2 (1,3) 0 (0,0) 0 (0,0)
0.24664731323719025 ||| REYATAZ oral powder contains 7.3 g sucrose per 300 mg daily dose. ||| VIRAMUNE tablets contain 636 mg of lactose per maximum recommended daily dose. ||| REYATAZ poudre orale contient 7,3 g de sucrose pour une dose journalière de 300 mg.
0.5022247433662415 ||| Therefore, no special precautions or dose adjustments are required in these patients. ||| Not all dosage forms and strengths are appropriate for some indications. ||| Par conséquent, aucune précaution particulière ou adaptation de posologie ne sont requises chez ces patients.
0.3156827986240387 ||| Curtain hooks made of metal ||| Gussets made of metal ||| Crochets métalliques pour rideaux
0.5076318383216858 ||| Preparations for preserving metal against rust ||| Asbestos gloves for protection against accidents ||| Produits pour la protection des métaux contre la rouille
0.6910535097122192 ||| disorder, abnormal dreaming, apathy Nervous system disorders§ i ||| Common Injection site pain, fatigue, rigors, fever ||| lus nerveux§ Céphalée, étourdissements Très fréquent:
0.3419317901134491 ||| As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable. ||| Thrombotic events can be a risk in this population and this possibility should be carefully weighed against the benefit to be derived from the treatment in this patient group. ||| Il est donc utile de disposer d’ informations sur la prévalence de la résistance locale, particulièrement pour le traitement des infections sévères.
0.1317606270313263 ||| At two years, 80.1% and 68.8% of patients met this criterion in the 3 mg every 3 months injection arm and the 2.5 mg daily arm (p=0.001). ||| At two years, 87.1% (p < 0.001) and 70.5%, of patients met this criterion in the 150 mg monthly and 2.5 mg daily arms respectively. ||| A deux ans, 80,1% et 68,8% des patientes respectivement sous Bonviva IV 3 mg tous les 3 mois et sous acide ibandronique oral 2,5 mg une fois par jour ont été définies comme répondeurs (p=0,001).
0.09696334600448608 ||| However, if you take more Azomyr orodispersible tablet than you were told to, contact your doctor or pharmacist. ||| However, if you take more Neoclarityn oral solution than you were told to, contact your doctor or pharmacist. ||| Cependant, si vous avez pris plus d’ Azomyr comprimés orodispersibles que vous n’ auriez dû, prévenez votre médecin ou votre pharmacien.
0.33779481053352356 ||| Burners for the combustion of oil in boiler units ||| Devices for heating tobacco for the purpose of inhalation ||| Brûleurs pour la combustion du mazout dans des chaudières
0.15216279029846191 ||| Bulgaria: ||| Belgium: ||| 46 Bulgarie:
0.8855979442596436 ||| TWINRIX PAEDIATRIC ||| SANOFI PASTEUR MSD SNC ||| TWINRIX PEDIATRIQUE
0.36559057235717773 ||| Via Palermo, 26/ A 43100 Parma Italy ||| Via Aurelia, 58 00165 Roma Italy ||| Via Palermo, 26/ A 43100 Parma Italie
0.6547759175300598 ||| Swelling and peripheral oedema ||| Abdominal discomfort; Flatulence ||| Gonflement et œ dème périphérique
0.43534374237060547 ||| 5 Cases of worsening dyspnoea of unclear aetiology have been reported shortly after starting Volibris therapy. ||| s difference in biopsy-proven acute rejection remained statistically different at one-year posttransplant ||| 5 Des cas d'aggravation de dyspnée d'étiologie indéterminée ont été rapportés peu de temps après le début d'un traitement par Volibris.
0.8574836850166321 ||| Pitch and bitumen ||| Nausea and vomiting ||| Poix et bitume
0.0 ||| DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION ||| DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION ||| POSOLOGIE POUR CHAQUE ESPECE, VOIE(S) ET MODE D’ADMINISTRATION
0.39432793855667114 ||| However naturally-occurring varicella-zoster virus infection is known to sometimes cause foetal harm. ||| Serious hypoglycaemia may cause a heart attack or brain damage and may be life -threatening. ||| Cependant, l’ infection naturelle par le virus varicelle-zona est connue pour avoir parfois des effets néfastes sur le fœ tus.
0.35887426137924194 ||| What is Tygacil? ||| What is Yttriga? ||| Qu’ est -ce que Tygacil?
0.27707958221435547 ||| Over the infusion period (study days 0-6) the number of patients experiencing CNS bleeding was 5 versus 1 (2.1% versus 0.4%) for the overall population (drotrecogin alfa (activated) versus placebo), with 4 of the 5 events in the drotrecogin alfa (activated) group occurring in patients ≤ 60 days old or ≤ 3.5 kg bodyweight. ||| In the Time to loss of virological response (TLOVR) analysis for the ITT(E) population, the proportion of patients achieving < 400 copies/ ml was 73% (315 / 434) in the fosamprenavir with ritonavir group compared to 71% (317 / 444) of patients receiving lopinavir / ritonavir, with a 95% confidence interval of the difference of [-4,84%; 7; 05%]. ||| Pendant la perfusion (jours J0 à J6 de l’ étude), le nombre de patients ayant présenté une hémorragie au niveau du SNC était de 5 versus 1 (2,1% versus 0,4%) dans la population globale (drotrécogine alfa (activée) versus placebo), avec 4 des 5 événements survenus dans le groupe drotrécogine alfa (activée) chez des patients d’ âge ≤ 60 jours ou d’ un poids ≤ 3,5 kg.
0.4484092593193054 ||| One 30 ml mixing and administration glass vial with cap. ||| 210 ml oral solution with a measuring spoon. ||| Un flacon de mélange et d’ administration en verre de 30 ml avec un capuchon.
0.2896936535835266 ||| Insulin Human Winthrop Comb 50 is injected subcutaneously 20 to 30 minutes before a meal. ||| Insuman Comb 50 is injected under the skin 20 to 30 minutes before a meal. ||| Insulin Human Winthrop Comb 50 est injecté par voie sous-cutanée 20 à 30 minutes avant un repas.
0.05132944509387016 ||| Lietuva UAB “Roche Lietuva” Tel: +370 5 2546 799 ||| Lietuva UAB “Roche Lietuva” Tel: +370 5 2546799 ||| Lietuva UAB “ Roche Lietuva” Tel: +370 5 2546799
0.01738518849015236 ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE ANDMANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| TITULAIRE DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBÉRATION DES LOTS ET FABRICANT DU PRINCIPE ACTIF D’ ORIGINE BIOLOGIQUE
0.31147703528404236 ||| - a sulphonylurea, only in patients who show intolerance to metformin or for whom metformin is ||| - Fusariosis in patients with disease that is refractory to amphotericin B or in patients who are ||| - un sulfamide hypoglycémiant, uniquement chez les patients intolérants à la metformine ou
0.2481187880039215 ||| tho concomitant methotrexate, the incidence was 12.4%, compared to 0.6% when adalimumab was used as add-on to methotrexate. ||| In patients not given concomitant methotrexate, the incidence was 22/ 86 (25.6%), compared to 5/ 85 (5.9%) when adalimumab was used as add-on to methotrexate. ||| Chez les patients ne recevant pas simultanément du méthotrexate, la fréquence a été de 12,4%, contre 0,6% lorsque l'adalimumab était ajouté au méthotrexate.
0.20536497235298157 ||| How does Micardis work? ||| How does MicardisPlus work? ||| Comment Micardis agit -il?
0.4304228723049164 ||| The key messages need to be carefully adapted as well, since professionals across Europe might have different roles than those described in the document. ||| This needs to be carefully coordinated nationally across the network and may require PHE to ensure individuals are not contacted by multiple agencies. ||| Les messages-clés doivent aussi être soigneusement adaptés, puisque les professionnels répartis dans toute l'Europe peuvent avoir des rôles différents de ceux décrits dans le document.
0.3010064363479614 ||| Hold the syringe barrel and gently take the cover from the needle without twisting. ||| Wipe the wound surface gently before placing the sponge on the wound. ||| Prendre le corps de la seringue et retirer avec précaution le capuchon de l’ aiguille sans le tourner.
0.39747101068496704 ||| Your doctor will advise you. ||| You should visit your eye specialist. ||| Votre médecin vous conseillera.
0.33513307571411133 ||| If an erection lasts longer than 4 hours, you should get medical help immediately to avoid permanent damage to your penis. ||| You may need to stop taking these tablets 4 to 6 weeks before the operation, to reduce the risk of a blood clot. ||| Si la durée d’ une érection est de plus de quatre heures, vous devez consulter immédiatement un médecin afin d’ éviter des lésions irréversibles du pénis.
0.43745869398117065 ||| For patients with diabetes mellitus, the insulin dose may require adjustment after NutropinAq therapy is instituted. ||| In this study, Zenapax was added to the children ’ s existing immunosuppressive medicines. ||| Pour les patients diabétiques, il faut éventuellement adapter la dose d’ insuline après la mise en route du traitement par NutropinAq.
0.28981709480285645 ||| Masivet is used to treat dogs with mast-cell tumours (a type of cancer). ||| Gliolan is used in adult patients with malignant glioma (a type of brain tumour). ||| Masivet est utilisé pour traiter les chiens souffrant de tumeurs mastocytaires (un type de cancer).
0.1851045936346054 ||| The active substance in IVEMEND, fosaprepitant, is a ‘ prodrug ’ of aprepitant. ||| The active substance in NEVANAC, nepafenac, is a ‘ prodrug ’ of amfenac. ||| Le principe actif d’ IVEMEND, le fosaprépitant, est une « pro-drogue » d’ aprépitant.
0.06757396459579468 ||| Olanzapine belongs to a group of medicines called antipsychotics. ||| Olanzapine Teva belongs to a group of medicines called antipsychotics. ||| OLANZAPINE MYLAN appartient à une famille de médicaments appelés antipsychotiques.
0.05647706612944603 ||| 23.7%); Vomiting (G3/ 4: ||| 2.9%); Vomiting (G3/ 4: ||| 23,7%); Vomissements (G3/ 4:
0.4662690758705139 ||| Refrigerating bottles ||| Refrigeration condensers ||| Bouteilles réfrigérantes
0.009838046506047249 ||| 15 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 16 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 15 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
4.2015929581015743e-13 ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l'autorisation de mise sur le marché.
0.16743844747543335 ||| 21 February 2006 EMEA/ CHMP/ 373108/ 2005 ||| 15 September 2005 EMEA/ CHMP/ 230471/ 2005 ||| 21 février 2006 EMEA/ CHMP/ 373108/ 2005
9.940440397898653e-13 ||| macular oedema ||| macular oedema ||| oedème maculaire
0.4445878565311432 ||| Overdosage with Macugen has not been reported in clinical trials. ||| Repeated exposure to Ovitrelle was investigated in male patients only. ||| Aucun surdosage avec Macugen n’ a été décrit dans les essais cliniques.
7.817283062191982e-13 ||| Bayer Animal Health GmbH, D-51368 Leverkusen, Germany ||| Bayer Animal Health GmbH, D-51368 Leverkusen, Germany ||| Bayer Animal Health GmbH D-51368 Leverkusen
0.3878140449523926 ||| The public support will take the form of direct grants, repayable advances and tax advantages. ||| The support will take the form of loans and public guarantees on loans. ||| Les aides publiques seront octroyées sous la forme de subventions directes, d'avances remboursables et d'avantages fiscaux.
0.390208899974823 ||| This Registry will collect long-term safety and efficacy data in patients treated with Aldurazyme as well as data on the natural progression of the disease in patients not on treatment. ||| During the pandemic, the applicant will collect clinical safety and effectiveness data of the pandemic vaccine and submit this information to the CHMP for evaluation. ||| Ce registre permettra le recueil de données relatives à l’ efficacité et à la tolérance à long terme chez des patients traités par Aldurazyme, ainsi que de données sur l’ évolution naturelle de la maladie chez des patients non traités.
0.16002391278743744 ||| Olanzapine Teva 20 mg film-coated tablets ||| Vivanza 20 mg film-coated tablets Vardenafil ||| Olanzapine Teva 20 mg, comprimés pelliculés.
0.0 ||| In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. ||| In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. ||| En cas d’ ingestion accidentelle, demandez immédiatement conseil à un médecin et montrez -lui la notice.
0.2933923006057739 ||| The tablet shell, along with insoluble core components, is eliminated from the body; patients should not be concerned if they occasionally notice in their stool something that looks like a tablet. ||| Although skin contact with the product is unlikely, if this occurs the exposed area should be washed immediately, as these types of substances may be absorbed through the skin. ||| L’ enveloppe du comprimé, ainsi que les composants insolubles du noyau du comprimé, sont éliminés de l’ organisme; les patients ne doivent pas s’ inquiéter s’ ils observent occasionnellement dans leurs selles quelque chose ressemblant à un comprimé.
0.23418734967708588 ||| Electric cooking stoves [for household purposes] ||| Textile washing machines [for industrial purposes] ||| Cuisinières électriques [à usage domestique]
0.2485099583864212 ||| If you feel faint or confused do not drive, use machines or perform any other tasks that require your attention. ||| Do not drive or use any tools or machines if you feel tired or sleepy, or are confused. ||| Si vous remarquez de tels effets, vous ne devez pas conduire ni utiliser des machines ou effectuer d’ autres tâches qui nécessitent de la vigilance.
0.2617923617362976 ||| In rats and rabbits, tacrolimus caused embryofoetal toxicity at doses which demonstrated maternal toxicity (see section 5.3). ||| Developmental toxicity in rabbits (embryolethality, decreased litter size and decreased foetal weights) occurred at a maternally toxic dosage. ||| Chez le rat et le lapin, des effets toxiques sur l’ embryon et le fœ tus ont été observés à des doses materno-toxiques (voir rubrique 5.3).
0.08113348484039307 ||| Fabrics of organic fibres for use as insulation ||| Fabrics of carbon fibre for use as insulation ||| Tissus en fibres organiques pour l'isolation
0.2354976087808609 ||| For more information, talk to your doctor. ||| Please talk to your doctor for further information. ||| Pour plus d'informations parlez -en à votre médecin.
0.23059189319610596 ||| Paediatric patients (below 18 years) Enviage is not recommended for use in children and adolescents below age 18 due to a lack of data on safety and efficacy (see section 5.2). ||| Section 4.2 (Posology): “ Paediatric patients Gadograf is not recommended for use in population below age 18 due to a lack of data on efficacy and safety. ||| Enfants et adolescents (moins de 18 ans) Enviage ne doit pas être utilisé chez l’ enfant et les adolescents en dessous de 18 ans compte tenu de l’ absence de données concernant la sécurité et l’ efficacité (voir rubrique 5.2).
0.34002622961997986 ||| may happen within 30 minutes after injection of the medicine. ||| It is given within 12 hours after the onset of symptoms. ||| selles peut survenir dans les 30 minutes suivant l’ injection du médicament.
0.3636009693145752 ||| For this reason, tetracycline preparations should be administered at least two hours before or four to six hours after oral intake of calcium. ||| After regular intake of grapefruit juice, this effect may last for at least three days after the last ingestion of grapefruit juice. ||| Il est recommandé de décaler la prise de tétracyclines au moins 2 heures avant ou 4 à 6 heures après la prise orale de calcium.
0.03928229212760925 ||| 230 Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| 297 Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| 243 Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000
0.347528338432312 ||| Peak plasma levels were generally achieved at 2 to 3 hours after administration. ||| Maximum concentrations were reached 2 hours after treatment for both active substances. ||| Les pics plasmatiques ont généralement été atteints après 2 à 3 heures suivant l’ administration.
0.3324650228023529 ||| The pen should be returned to the refrigerator immediately after use. ||| The infusion is to be prepared immediately prior to use. ||| Le stylo doit être remis au réfrigérateur immédiatement après utilisation.
0.5476770401000977 ||| Omnitrope 3.3 mg/ ml solution for injection ||| Bonviva 3 mg injection every 3 months ||| Omnitrope 3,3 mg/ ml solution injectable
0.5273674726486206 ||| Coarse gravel ||| Garlic puree ||| Gros gravier
0.613498866558075 ||| The mean increase in olanzapine AUC was 52% and 108% respectively. ||| Chinese estimates of the asymptomatic ratio range from few to 44%. ||| 150 L’ augmentation moyenne de l’ ASC de l’ olanzapine était respectivement de 52% et de 108%.
0.5382998585700989 ||| 68 KRKA, d. d., Novo mesto, Š marješ cesta 6, 8501 Novo mesto, Slovenia ka ||| Eli Lilly Č R, s. r. o, Pobř ež ní 1A, 186 00 Praha 8 Czech Republic ||| KRKA, d. d., Novo mesto, Š marješ cesta 6, 8501 Novo mesto, Slovenie ka
0.3081905245780945 ||| Synagis is not indicated for use in adults. ||| Prevenar is not intended for use in adults. ||| Synagis n’ est pas indiqué chez l’ adulte.
0.6555565595626831 ||| A total of 2,122 patients received Starlix in all trials combined. ||| We are delivering 40 tons of humanitarian cargo in total on board the three flights to the DRC. ||| Au total, Starlix été administré à 2122 patients, toutes études confondues.
0.5243769288063049 ||| No evidence supports these claims. ||| These data are not recommendations for storage. ||| Aucune preuve n'étaye ces allégations.
0.8822050094604492 ||| 108 Handling of the pen ||| 77 Causes of a hypo ||| Manipulation du stylo
0.4028818607330322 ||| The guidelines also make recommendations for each mode of transport and call for coordination among Member States in light of re-establishment of gradual connections between them. ||| At the same time, the Temporary Framework sets a number of safeguards to avoid undue distortions of competition in the Single Market. ||| Les orientations fournissent en outre des recommandations spécifiques pour chaque mode de transport et appellent à la coordination entre les États membres à la lumière du rétablissement progressif des liaisons entre pays de l'UE.
0.5524570345878601 ||| Low viral load= ≤ 800,000 IU/ mL; High viral load= > 800,000 IU/ mL RVR = rapid viral response (HCV RNA undetectable) at week 4 and HCV RNA undetectable at week 24 ||| 14 Baseline HIV-1 RNA < 30,000 copies/ml ≥ 30,000 and < 100,000 copies/ml ≥ 100,000 copies/ml Baseline CD4 count (x 106/l) ||| Charge virale faible: ≤ 800 000 UI/ ml Charge virale élevée: > 800 000 UI/ ml RVR = réponse virologique rapide (ARN du VHC indétectable) à semaine 4 et ARN du VHC indétectable à semaine 24
0.4050229787826538 ||| − Muscle pain, tenderness or weakness, particularly in combination with antiretroviral therapy including protease inhibitors and nucleoside analogues. ||| Cardiovascular depression should be treated with plasma expanders, pressor agents, antiarrhythmic agents or other appropriate techniques. ||| − Des douleurs, une sensibilité ou une faiblesse musculaires, notamment en cas de multithérapie antirétrovirale associant des inhibiteurs de la protéase et des analogues nucléosidiques.
0.0827600359916687 ||| Levemir has been studied in 1,575 patients with type 1 diabetes, when the pancreas cannot produce insulin, and over 2,400 patients with type 2 diabetes, when the body is unable to use insulin effectively. ||| Mixtard has been studied in a total of 294 patients with type 1 diabetes, when the pancreas cannot produce insulin, and type 2 diabetes, when the body is unable to use insulin effectively. ||| Levemir a fait l’ objet d’ études sur 1575 patients atteints de diabète de type 1, dans lequel le pancréas ne peut pas produire d’ insuline, et sur 2400 patients atteints de diabète de type 2, dans lequel l’ organisme est incapable d’ utiliser efficacement l’ insuline.
0.3681405186653137 ||| If you have mild heart failure and you are being treated with Remicade, your heart failure status must be closely monitored by your doctor. ||| If you have taken SUSTIVA during your pregnancy, your doctor may request regular blood tests and other diagnostic tests to monitor the development of your child. ||| Si vous présentez une insuffisance cardiaque légère et que vous allez être traité par Remicade, votre fonction cardiaque doit être étroitement surveillée par votre médecin.
0.11156493425369263 ||| Renal impairment As metformin is excreted by the kidney, serum creatinine concentrations should be monitored regularly: ||| 16 As metformin is excreted by the kidney, serum creatinine concentrations should be monitored regularly: ||| 3 Insuffisance rénale Dans la mesure où la metformine est éliminée par le rein, les concentrations de créatinine sérique doivent être mesurées régulièrement:
0.2546878457069397 ||| Each vial contains 0.9 mg/ ml of thyrotropin alfa when reconstituted with 1.2 ml water for injection. ||| Each vial contains 100 mg palivizumab, providing 100 mg/ ml of palivizumab when reconstituted as recommended. ||| Chaque flacon contient 0,9 mg/ ml de thyrotropine alfa après reconstitution dans 1,2 ml d’ eau pour injection.
0.44011932611465454 ||| Vice-President Maroš Šefčovič, in charge of interinstitutional relations and foresight, said: "The recovery will need strong policy direction. ||| Commissioner for Crisis Management, Janez Lenarčič, said: "The safe return of our citizens is a priority. ||| Maroš Šefčovič, vice-président de la Commission chargé des relations interinstitutionnelles et de la prospective, a ajouté: «La reprise nécessitera une orientation forte sur l'action à mener.
0.5078815817832947 ||| Providing access to websites on the Internet or any other communications network ||| Providing business information, also via internet, the cable network or other forms of data transfer ||| Fourniture d'accès à des sites Web sur Internet ou tout autre réseau de communication
0.0 ||| Hypersensitivity to the active substanceor to any of the excipients. ||| Hypersensitivity to the active substanceor to any of the excipients. ||| 81 Hypersensibilité à la substance active ou à l’ un des excipients.
7.076195098626448e-13 ||| 63 ||| 63 ||| 65
0.4027591943740845 ||| This regresses during the course of continued therapy. ||| The response is maintained during chronic therapy. ||| Ce phénomène régresse au cours du traitement.
0.07693348824977875 ||| Despite this, your doctor may prescribe Remeron for patients under 18 because he/ she decides that this is in their best interests. ||| Despite this, your doctor may prescribe CYMBALTA for patients under 18 because he/ she decides that this is in their best interests. ||| Néanmoins, il est possible que votre médecin décide de prescrire Remeron à des patients de moins de 18 ans, si il/ elle décide que c'est dans l’ intérêt du patient.
0.05582243204116821 ||| DO NOT touch this area again before giving the injection. ||| Do not touch this area again before giving the injection. ||| NE TOUCHEZ PLUS à cette zone avant de faire l’injection.
0.26337894797325134 ||| Nippers [hand operated tools] ||| Keyhole saws [hand operated tools] ||| Pinces [outillage manuel]
0.4828958511352539 ||| Powdered garlic ||| Crystallized ginger ||| Ail en poudre
0.37216079235076904 ||| An open label, non-comparative study (AC-052-362; BREATHE-4) was performed in 16 patients with WHO Class III PAH associated with HIV infection. ||| Clinical studies in DFSP One phase II, open label, multicentre clinical trial (study B2225) was conducted including 12 patients with DFSP treated with Glivec 800 mg daily. ||| Un essai en ouvert, non comparatif (AC-052-362; BREATHE-4) a été réalisé chez 16 patients présentant une hypertension artérielle pulmonaire en classe fonctionnelle OMS III associée à une infection par le VIH.
0.7422194480895996 ||| Obedience training for animals ||| Co-administration with weight loss agents ||| Dressage d'animaux à l'obéissance
0.46377241611480713 ||| It will provide financial assistance to Member States to address sudden increases in public expenditure for the preservation of employment. ||| The EU's support has contributed to measurable improvements in quality primary health care around the world. ||| Il fournira une assistance financière aux États membres afin qu'ils puissent financer une augmentation soudaine des dépenses publiques nécessaire à la préservation de l'emploi.
0.286025732755661 ||| You may find that your vision is blurred for a time just after you use EMADINE. ||| Driving or using machines You may find that your vision is blurred for a time just after you use AZOPT. ||| Vous pouvez trouver que votre vision est trouble juste après avoir utilisé EMADINE.
0.15525595843791962 ||| Protease Inhibitors: ||| Protease Inhibitors ||| Inhibiteurs de protéase (IP):
0.47709324955940247 ||| Flavourings for foods ||| Bellows for musical instruments ||| Arômes pour aliments
0.7319071292877197 ||| Nelfinavir metabolite M8: ||| Plasma HIV-1 RNA at ||| Métabolite Nelfinavir M8:
0.4302535057067871 ||| Comtess was more effective than placebo in both studies. ||| Advagraf was as effective as both comparator medicines. ||| Comtess a été plus efficace que le placebo dans les deux études.
0.0969545841217041 ||| You should normally use Liprolog within 15 minutes of a meal. ||| You should normally use Humalog within 15 minutes of a meal. ||| Vous utiliserez normalement Liprolog Pen 15 minutes avant ou après le repas.
0.3266253173351288 ||| Your doctor will take regular blood samples to measure how your anaemia is responding and may adjust your dose as necessary. ||| Your doctor may increase or decrease your dose or temporarily stop your treatment to adjust your haemoglobin level, as appropriate for you. ||| Votre médecin effectuera des prises de sang régulières afin de contrôler la correction de l’anémie et adaptera si nécessaire la posologie.
0.1740175485610962 ||| The safety of the veterinary medicinal product has not been established during pregnancy and lactation in queens. ||| The safety of this veterinary medicinal product has not been investigated in pregnant and lactating dogs. ||| L’ innocuité du médicament vétérinaire n’ a pas été établie pendant la gestation et la lactation des chattes.
0.2501034736633301 ||| Triatec Comp Mite 2.5 mg/12.5 mg tabletter, Triatec Comp 5 mg/25 mg tabletter ||| Tritace 2.5 Plus 2.5 mg/12.5 mg таблетки, Tritace 5 Plus 5 mg/25 mg таблетки ||| Triatec Comp Mite 2,5 mg / 12,5 mg tabletter, Triatec Comp 5 mg / 25 mg tabletter
0.5865766406059265 ||| This agreement - once in force - will help both the EU and Mexico to support our respective economies and boost employment." ||| The EU will not abandon the Syrian people in most urgent need for assistance inside the country as well as in the region." ||| L'entrée en vigueur de cet accord aidera l'UE et le Mexique à soutenir leurs économies et à stimuler l'emploi.»
0.2239600121974945 ||| Allergic hypersensitivity reactions ranging from mild skin eruptions and urticaria to angioedema and anaphylaxis have been reported ||| Hypersensitivity reactions including rash, urticaria, angioedema and anaphylactic reactions have been reported rarely. ||| Des réactions d’ hypersensibilité depuisune éruption cutanée modérée ou une urticaire jusqu’ à un angioedème ou une réaction anaphylactique, ont été rapportées.
0.08729029446840286 ||| 5 x 3 ml Liprolog Mix50 100 U/ ml KwikPens 2 x (5 x 3 ml) Liprolog Mix50 100 U/ ml KwikPens ||| 5 x 3 ml Humalog Mix25 100 U/ ml KwikPens 2 x (5 x 3 ml) Humalog Mix25 100 U/ ml KwikPens ||| Emballage multiple de 2 boîtes de 5 stylos Liprolog Mix50 100 UI/ ml
0.0 ||| 6.2 Incompatibilities ||| 6.2 Incompatibilities ||| 6.2 Incompatibilités mé
0.000642727711237967 ||| Risk Management Plan The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 1.2 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| Risk Management Plan The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 1.0 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| Plan de gestion des risques Le titulaire de l’ autorisation de mise sur le marché s’ engage à réaliser les études et les activités additionnelles de pharmacovigilance décrites dans le plan de pharmacovigilance, en accord avec la version 1.2 du plan de gestion des risques (PGR) présenté dans le module 1.8.2 de l’ Autorisation de Mise sur le Marché et des mises à jour du PGR acceptées par le CHMP.
3.7544598506522586e-13 ||| 4 Observed for fasting normal levels at baseline (< 5.56 mmol/ l) which increased to high (≥ 7 mmol/ l). ||| 4 Observed for fasting normal levels at baseline (< 5.56 mmol/ l) which increased to high (≥ 7 mmol/ l). ||| 121 4 Observée pour des taux à jeun normaux au début de traitement (< 5.56mmol/ l) qui sont devenus élevés (≥ 7mmol/ l).
0.18511244654655457 ||| Remeron 30 mg film-coated tablets are oval, biconvex, red-brown, scored and coded with ‘ Organon’ on one side and with ‘ TZ/ 5’ on the other side. ||| Ebixa 20 mg film-coated tablets are presented as are pale red to grey-red, oval-oblong with imprint ‘ 20’ on one side and imprint ‘ MEM’ on the other side. ||| Les comprimés pelliculés de Remeron à 30 mg sont ovales, biconvexes, rouge-marron, rainurés avec la mention « Organon » d’ un côté et « TZ/ 5 » de l’ autre.
0.3700147569179535 ||| Sawing of timber ||| Processing of rubber ||| Sciage de bois
0.5979708433151245 ||| It will contribute to the European effort in the fight against the coronavirus outbreak. ||| Will programmes be put on hold to prioritise the fight against the coronavirus? ||| Il contribuera à l'effort européen de lutte contre la pandémie de coronavirus.
0.21204671263694763 ||| The frequency of possible side effects listed below is defined using the following convention: very common (affects more than 1 user in 10) common (affects 1 to 10 users in 100) uncommon (affects 1 to 10 users in 1,000) rare (affects 1 to 10 users in 10,000) very rare (affects less than 1 user in 10,000) not known (frequency cannot be estimated from the available data). ||| Side effects may occur with certain frequencies, which are defined as follows: very common: affects more than 1 user in 10 common: affects 1 to 10 users in 100 uncommon: affects 1 to 10 users in 1,000 rare: affects 1 to 10 users in 10,000 very rare: affects less than 1 user in 10,000 not known: frequency cannot be estimated from the available data. ||| La fréquence des éventuels effets indésirables listés ci-dessous est définie en utilisant la convention suivante: très fréquent (affecte plus d' 1 personne sur 10) fréquent (affecte de 1 à 10 personnes sur 100) peu fréquent (affecte de 1 à 10 personnes sur 1 000) rare (affecte de 1 à 10 personnes sur 10 000) très rare (affecte moins d' 1 personne sur 10 000)
0.14776426553726196 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Nexavar’ s benefits are greater than its risks for the treatment of hepatocellular carcinoma, and of advanced renal cell carcinoma in patients who have failed prior interferon alfa or interleukin-2 based therapy, or who are considered unsuitable for such therapy. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Sprycel’ s benefits are greater than its risks for the treatment of adults with chronic, accelerated or blast phase CML, and for the treatment of adults with Ph+ ALL and lymphoid blast CML, with resistance or intolerance to prior therapy. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de Nexavar étaient supérieurs à ses risques en ce qui concerne le traitement du carcinome hépatocellulaire et du carcinome rénal avancé pour les patients chez qui un traitement par interféron-alpha ou interleukine-2 avait échoué ou chez les patients ne pouvant recevoir un tel traitement.
0.0 ||| - If you have any further questions, ask your doctor or pharmacist. ||| - If you have any further questions, ask your doctor or pharmacist. ||| - Si vous avez toute autre question, demandez plus d’ informations à votre médecin ou votre
0.610962986946106 ||| - erection problems (impotence) ||| Constipation (obstruction) can ||| - problèmes d’ érection (impuissance)
0.4183178246021271 ||| Printed manuals ||| Animated cartoons ||| Manuels imprimés
0.36815309524536133 ||| All Genotypes All ||| s All Genotypes ||| Tous les génotypes Tous
0.29050150513648987 ||| Moxifloxacin undergoes Phase II biotransformation and is excreted via renal and biliary/ faecal pathways as unchanged drug as well as in the form of a sulpho-compound (M1) and a glucuronide (M2). ||| 9 Treatment of overdosage of Tandemact primarily consists of preventing absorption of glimepiride by inducing vomiting and then drinking water or lemonade with activated charcoal (adsorbent) and sodium-sulphate (laxative). ||| La moxifloxacine subit une biotransformation de Phase II et est excrétée par les voies rénale et biliaire/ fécale à l’ état inchangé mais également sous la forme de deux métabolites, l’ un sulfoconjugué (M1) et l’ autre glucuroconjugué (M2).
0.5479848384857178 ||| Xeloda is used with other anticancer medicines, including a platinum-containing anticancer medicine such as cisplatin; • locally advanced or metastatic breast cancer (breast cancer that has begun to spread to other parts of the body). ||| In the late 1990s and early part of the 21st century, alcohol rub non-water-based hand hygiene agents (also known as alcohol-based hand rubs, antiseptic hand rubs, or hand sanitizers) began to gain popularity. ||| Xeloda est indiqué en association avec d’ autres anticancéreux, notamment un anticancéreux contenant du platine comme la cisplatine. • du cancer du sein localement avancé ou métastatique (cancer du sein qui a commencé à se propager à d’ autres parties du corps).
0.38372018933296204 ||| When using alternate injection sites, it is particularly important to create enough surface tension on the site to be able to successfully complete the injection. ||| To minimise the potential for inhalation, it is recommended that the product is applied in open air or in well ventilated rooms. ||| Lorsque vous utilisez un autre site d’ injection, il est important d’ étirer suffisamment la peau afin de réussir l’ injection.
0.2724788188934326 ||| Efficacy of oseltamivir in the treatment of subjects with chronic cardiac disease and/ or respiratory disease has not been established. ||| Thelin has been shown to be effective in primary (no other cause) pulmonary hypertension and pulmonary hypertension caused by connective tissue disease. ||| L'efficacité d'oseltamivir chez les patients ayant des pathologies chroniques cardiaque et/ ou respiratoire, n'a pas été établie.
0.20489442348480225 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €30 million Italian scheme will enable the provision of zero-interest rate loans of up to €30,000 per company for SMEs active in the agricultural and fishery sectors in Italy. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This Hungarian guarantee scheme, expected to mobilise at least €314 million, will support the Hungarian agriculture and food industry, as well as the wider agriculture and bio-economy value chain. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Ce régime italien d'un montant de 30 millions d'euros permettra d'octroyer aux PME opérant dans les secteurs de l'agriculture et de la pêche en Italie des prêts à taux d'intérêt nul à concurrence de 30 000 euros par entreprise.
0.11213690787553787 ||| How to take Irbesartan Hydrochlorothiazide Winthrop 4. ||| How to take Irbesartan Hydrochlorothiazide BMS 4. ||| Comment prendre Irbesartan Hydrochlorothiazide Winthrop 4.
5.434872387202749e-13 ||| As with any intravenous protein product, allergic type hypersensitivity reactions are possible. ||| As with any intravenous protein product, allergic type hypersensitivity reactions are possible. ||| Tout comme avec n’ importe quel produit intraveineux à base de protéine, une hypersensibilité de type allergique est toujours possible.
0.36862701177597046 ||| However, in the current exceptional situation of the coronavirus outbreak this should exceptionally be allowed to ensure that operations already implemented in response of the crisis can receive EU support. ||| The initial target of €7.5 billion will not be enough to ensure the distribution of coronavirus health technologies worldwide, as this involves significant costs in terms of production, procurement and distribution. ||| Toutefois, dans la situation exceptionnelle actuellement créée par la pandémie de COVID-19, il convient de l'autoriser à titre exceptionnel afin que des opérations déjà mises en œuvre en réponse à la crise puissent bénéficier d'un soutien de l'UE.
0.563705563545227 ||| Therefore, the effectiveness of Filgrastim ratiopharm was shown to be equivalent to that of Neupogen. ||| Epoetin alfa HEXAL has the highest possible purity according to the present state of the art. ||| Il a donc été démontré que Filgrastim ratiopharm était tout aussi efficace que Neupogen.
0.21030783653259277 ||| The recommended dose of Telzir for adults and children weighing more than 39 kg is 700 mg twice a day. ||| An initial dose of 10 mg every other day is recommended for adults and children weighing more than 30 kg . ||| La dose recommandée de Telzir pour les adultes et les enfants de moins de 39 kg est de 700 mg deux fois par jour.
0.29830121994018555 ||| In patients with type 2 diabetes over a wide range of renal function the pharmacokinetic differences between insulin lispro and soluble human insulin were generally maintained and shown to be independent of renal function. ||| There were no clinically significant differences in the percent decrease in serum uric acid concentration in healthy subjects irrespective of their renal function (58% in the normal renal function group and 55% in the severe renal dysfunction group). ||| Chez les patients présentant un diabète de type 2, les différences pharmacocinétiques entre l’ insuline lispro et l’ insuline rapide humaine sont en général maintenues pour de larges variations de la fonction rénale et se sont révélées être indépendantes de la fonction rénale.
0.11619646847248077 ||| Do not use Janumet after the expiry date which is stated on the blister and the carton. ||| Do not use Mimpara after the expiry date which is stated on the outer carton and on the blister. ||| Ne pas utiliser Janumet après la date de péremption mentionnée sur la plaquette thermoformée et la boîte.
0.4556499123573303 ||| Transport of textiles by road ||| Transport of travellers by road ||| Transport de textiles par route
0.19984868168830872 ||| Viraferon is given in combination with ribavirin. no ||| IntronA is given in combination with ribavirin. ||| Viraferon est donné en association avec la ribavirine.
0.2724507451057434 ||| Ivabradine should therefore be used with precaution in this population. ||| Fuzeon should be used with caution in these populations. ||| L’ ivabradine doit donc être utilisée avec précaution dans cette population.
0.4861934185028076 ||| Serving platters ||| Setting pliers ||| Plats de service
0.330508828163147 ||| Coronavirus: Commission adopts package of measures to further support the agri-food sector ||| Coronavirus: European Commission backs international initiative to facilitate trade in healthcare products ||| Coronavirus: la Commission adopte un train de mesures visant à renforcer l'aide au secteur agroalimentaire
0.25151824951171875 ||| Caution should be used in treating patients with ischaemic heart disease, angina and/ or in patients receiving an antihypertensive medicinal product. ||| ADVATE is used in patients with haemophilia A for prevention or treatment of spontaneous or surgery-related bleeding. ||| La prudence s’ impose durant le traitement chez des patients présentant une cardiopathie ischémique ou un angor, et/ ou chez ceux qui reçoivent un médicament antihypertenseur.
0.2138606607913971 ||| Tablet core: cellulose microcrystalline, calcium hydrogen phosphate anhydrous, sodium starch glycolate, magnesium stearate ||| - capsule content: anhydrous lactose, colloidal anhydrous silica, sodium starch glycolate type A, ||| Comprimé nu: cellulose microcristalline, phosphate d’hydrogène de calcium anhydre, glycolate d’amidon sodique, stéarate de magnésium
0.38478541374206543 ||| Hydraulic fluids containing four or more carbon atoms ||| Chemical compositions containing derivatives of humic acids ||| Fluides hydrauliques contenant au moins quatre atomes de carbone
0.49059897661209106 ||| The Commission aims to have these measures adopted by the end of April. ||| This is the third mandate of the Board and members are appointed until the end of 2002. ||| La Commission entend faire adopter ces mesures d'ici la fin du mois d'avril.
0.5018607378005981 ||| What Effentora contains The active substance is fentanyl. ||| What Tadalafil Lilly contains The active substance is tadalafil. ||| Que contient Effentora La substance active est le fentanyl.
0.407111257314682 ||| The proposal is for financial control to be replaced by an internal audit function within each of the EU decentralised bodies, including the EMEA. ||| It serves the institutions of the European Union, as well as the decentralised agencies and bodies located in the EU Member States. ||| La proposition consiste à remplacer le contrôle financier par une fonction d’audit interne au sein de chacun des organismes communautaires décentralisés, notamment de l’EMEA.
0.48675766587257385 ||| Generica Kg Südwestpark 50 D-90449 Nürnberg Germany ||| Stryker Biotech 9 Technology Drive West Lebanon NH 03784 USA ||| Generica Kg Südwestpark 50 D-90449 Nürnberg Allemagne
0.053937505930662155 ||| Neoclarityn 2.5 mg orodispersible tablet ||| Neoclarityn 5 mg orodispersible tablets ||| 60 Neoclarityn 2,5 mg comprimés orodispersibles
0.4084354043006897 ||| SonoVue can be used in Doppler tests for large blood vessels, such as those in the head, those leading to the head or the main vein to the liver, or for smaller blood vessels such as those in lesions (areas of disease) in the breast or liver. ||| These enzymes can be found in some receptors at the surface of cancer cells, such as the ‘ KIT’ receptors on the surface of GIST cells and similar receptors on the surface of RCC cells, where they are involved in the growth and spread of cancer cells. ||| SonoVue peut être utilisé lors d’ examens Doppler de gros vaisseaux, comme les artères cérébrales, celles menant à la tête ou la veine principale du foie, ou de vaisseaux sanguins plus petits, comme ceux de lésions (zones pathologiques) dans le sein ou le foie.
0.1463492214679718 ||| the CHMP has recommended the granting of the Marketing Authorisations for which the valid Summary of Product Characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure are set out in Annex III for Sanohex and associated names (see Annex I). ||| The CHMP has recommended the granting of the Marketing Authorisation for which the Summary of Product Characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure as mentioned in Annex III for Vantas. ||| le CHMP a recommandé l’ octroi des autorisations de mise sur le marché pour lesquelles le résumé des caractéristiques du produit valide, l’ étiquetage et la notice sont les versions finales résultant de la procédure du groupe de coordination et figurant dans l’ annexe III pour Sanohex et les dénominations associées (voir annexe I).
0.8769078254699707 ||| 93.9 (13.20) -16.3 (21.81) < 0.001 -12.9 (2.34) ||| TG +2.9% -7.2% -10.6% -14.7% -15.0% -18.7% ||| -16,3 (21,81) < 0,001 -12,9 (2,34)
0.46684256196022034 ||| Sodium chloride Acetic acid (99%) Sodium acetate Water for injections ||| • Benzoic acid, sodium salt (Benzoate) ||| Chlorure de sodium Acide acétique (99%) Acétate de sodium Eau pour préparations injectables
0.0 ||| Virological response is defined as absence of detectable HCV-RNA at Week 12. ||| Virological response is defined as absence of detectable HCV-RNA at Week 12. ||| 73 définie par un niveau indétectable d’ ARN-VHC à la 12ème semaine de traitement.
0.2174690067768097 ||| OPTRUMA should not be used in patients with signs or symptoms of endometrial cancer as safety in this patient group has not been adequately studied. ||| Renal impairment Sonata is not indicated to treat patients with severe renal impairment as it has not been adequately studied in those patients. ||| OPTRUMA ne doit pas être utilisé chez les patientes ayant des signes ou des symptômes de cancer de l’ endomètre, la sécurité d’ emploi dans ce groupe de patientes n’ ayant pas été suffisamment étudiée.
0.4957289695739746 ||| This helps to protect against the diseases that these bacteria and viruses cause. ||| Humans appear to be capable of spreading the virus to some other animals. ||| Cela aide à assurer une protection contre les maladies que ces bactéries et virus
0.27717703580856323 ||| Method of Administration Premedication with glucocorticoids should be considered if MabThera is not given in combination with glucocorticoid-containing chemotherapy for treatment of non-Hodgkin’ s lymphoma and chronic lymphocytic leukaemia. ||| In case anti-erythropoietin antibody- mediated PRCA is diagnosed, therapy with NeoRecormon must be discontinued and patients should not be switched to another erythropoietic protein (see section 4.4). ||| Une prémédication par glucocorticoïde doit être envisagée si MabThera n’ est pas associé à une chimiothérapie contenant un glucocorticoïde pour le traitement d’ un lymphome non-hodgkinien et d’ une leucémie lymphoïde chronique.
0.19575518369674683 ||| Lactic acidosis Lactic acidosis is a very rare, but serious, metabolic complication that can occur due to metformin accumulation. ||| Lactic acidosis Lactic acidosis is a very rare, but serious (high mortality in the absence of prompt treatment), metabolic complication that can occur due to metformin accumulation. ||| Acidose lactique L'acidose lactique est une complication métabolique rare mais grave qui peut survenir en cas 3 d'accumulation de metformine.
0.2853831648826599 ||| Breastfeeding should be discontinued prior to, during and following treatment with Evoltra (see section 4.6). ||| Breast-feeding is contraindicated during treatment and 3 months thereafter (see section 4.3). ||| L’ allaitement sera interrompu avant, pendant et après le traitement par Evoltra (voir rubrique 4.6).
0.23749393224716187 ||| Platform steps (Non-metallic -) for use with scaffolding ||| Suspension rods (Non-metallic -) for hanging up articles ||| Plates-formes à escaliers pour échafaudages
0.37122005224227905 ||| 23 Instruction on self-administration by subcutaneous injection is included in the Package Leaflet. ||| Instructions for preparing and giving an injection of Enbrel (See overleaf). ||| Les instructions pour auto-administration par injection sous-cutanée sont incluses dans la notice.
0.10985517501831055 ||| How has Baraclude been studied? ||| How has Avaglim been studied? ||| Quelles études ont été menées sur Baraclude?
0.5169391632080078 ||| On-site water purification services ||| On-line publishing services ||| Services d'épuration de l'eau sur place
0.30531156063079834 ||| The available pre-clinical data on growth suggested an impairment of bone development/ growth in young rodents exposed to fluoxetine. ||| Population pharmacokinetic analyses with data from over 1300 RA patients revealed a trend toward higher apparent clearance of adalimumab with increasing body weight. ||| Les données précliniques disponibles sur la croissance semblent indiquer un déficit de croissance et de développement osseux chez les jeunes rongeurs exposés à la fluoxétine.
0.3679336905479431 ||| Buffer solutions for scientific purposes ||| Reagent paper for medical purposes ||| Solutions tampons à usage scientifique
0.44542810320854187 ||| Treatment* ||| Site* ||| Traitement*
0.5901820063591003 ||| The bioavailability is increased in women compared to men. ||| Clearance for women is approximately 25% lower than the values for men. ||| La biodisponibilité est augmentée chez la femme par rapport à l’ homme.
0.23183473944664001 ||| Take special care with Aranesp ||| Take special care with Neupopeg ||| Faites attention avec Aranesp
0.45756179094314575 ||| For smaller wounds, e. g. in minimal invasive surgery the smaller size sponges (4.8 cm x 4.8 cm or 3.0 cm x 2.5 cm) are recommended. ||| For smaller wounds, the smaller sponges are recommended (4.8 × 4.8 cm or 3.0 × 2.5 cm). ||| Pour des lésions plus petites, par ex. lors de chirurgie invasive minimale, il est recommandé d’ utiliser des éponges de taille plus petite (4,8cm x 4,8 cm ou 3,0 cm x 2,5 cm).
0.6921771764755249 ||| They can also spread around the injection site. ||| They should also be transferable to another traveller. ||| Ces réactions peuvent aussi s'étendre autour du point d'injection.
0.3616862893104553 ||| The ramipril treatment was started 3 to 10 days after the acute myocardial infarction. ||| - 327 patients undergoing hip fracture surgery treated for 3 weeks following an initial prophylaxis ||| Le traitement par ramipril a été débuté 3 à 10 jours après l’ infarctus aigu du myocarde.
0.3568660616874695 ||| Skin and subcutaneous tissue disorders Uncommon Rare Not known ||| Reproductive system and breast disorders Uncommon Not known ||| Affections de la peau et du tissus sous-cutané Peu fréquent Rare Fréquence indéterminée
0.2369488775730133 ||| 172 Danmark BRISTOL-MYERS SQUIBB Tlf: + 45 45 93 05 06 ||| BRISTOL-MYERS SQUIBB GESMBH Tel: + 43 1 60 14 30 ||| Danmark BRISTOL-MYERS SQUIBB Tlf: + 45 45 93 05 06
0.46266117691993713 ||| The tremor often disappears without needing to stop the treatment. ||| The tablets are fragile and should not be pushed through the blister. ||| Les tremblements disparaissent souvent sans avoir besoin d’ arrêter le traitement.
0.32784873247146606 ||| 66/ 72 ||| 64/ 64 ||| 69/ 75
0.3165910243988037 ||| Danmark Novartis Healthcare A/ S Tlf: +45 39 16 84 00 ||| Danmark Swedish Orphan A/S Tlf: +45 3296 6869 ||| 147 Danmark Novartis Healthcare A/ S Tlf: +45 39 16 84 00
0.07308699190616608 ||| b) the disease to which the veterinary medicinal product is intended to confer immunity is largely absent from the territory. ||| the disease to which the veterinary medicinal product is intended to confer immunity is largely absent from the territory. ||| b) la maladie contre laquelle le médicament vétérinaire est supposé conférer une immunité est largement absente du territoire en question. >
0.5743109583854675 ||| Similar results were seen in children aged six years and above. ||| This occurs in both men and women of all ages. ||| Des résultats similaires ont été observés chez des enfants âgés de six ans et plus.
0.21041372418403625 ||| The metabolism of saquinavir is mediated by cytochrome P450, with the specific isoenzyme CYP3A4 responsible for 90% of the hepatic metabolism. ||| Lopinavir is extensively metabolised by the hepatic cytochrome P450 system, almost exclusively by isozyme CYP3A. ||| Le saquinavir est métabolisé par le cytochrome P450, l’ isoenzyme CYP3A4 étant responsable de 90% de ce métabolisme hépatique.
0.6463133096694946 ||| Proposal for a core-data for Calendula flos (Calendulae flower) (*) ||| Proposal for a core-data for Menthae piperitae aetheroleum (Peppermint oil) (*) ||| ovatae testa (Ispaghula husk) (*) Proposal for a core-data for Calendula flos (Calendulae
0.28448623418807983 ||| Laboratory tests did not show an interaction between epoetin alfa and G-CSF or GM-CSF (G-CSF and GM-CSF are medicines to stimulate the immune-system e. g. when receiving a chemotherapy for cancer or in case of HIV). ||| Rarely abnormal blood clottings (blood clots in blood vessels) have been seen to occur with similar medicines, so this could possibly occur with GONAL-f / hCG therapy or GONAL-f / lutropin alfa/ hCG therapy. ||| Les analyses biologiques n'ont mis en évidence aucune interaction entre Binocrit et le G-CSF ou le GM-CSF (médicaments qui stimulent le système immunitaire, nécessaires par exemple en cas de chimiothérapie ou en cas de traitement du sida).
0.3932666778564453 ||| After 12 months treatment with bimatoprost eye drops alone, the incidence was 1.5% and did not increase following 3 years treatment. ||| Among 480 patients with > 2 log viral reduction but detectable virus at Week 12, altogether 188 patients continued therapy. ||| Après un traitement de 12 mois par un collyre contenant du bimatoprost seulement, l’ incidence a été de 1,5% et n’ a pas augmenté pendant les 3 années de traitement.
0.3275747299194336 ||| Nervous system disorders: headaches, dizziness Kidneys and urinary tract: blood in the urine, fever and pain in the side (acute interstitial nephritis) ||| Tell your doctor if you or the child have multiple sclerosis, optic neuritis (inflammation of the nerves of the eyes) or transverse myelitis (inflammation of the spinal cord). ||| Désordres du système nerveux: maux de tête, vertiges Reins et tractus urinaire: sang dans les urines, fièvre et douleur sur le côté (néphrite aigüe interstitielle)
0.049499694257974625 ||| Preparing Liprolog Mix25 • Cartridges containing Liprolog Mix25 should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend insulin until it appears uniformly cloudy or milky. ||| 233 Preparing Humalog BASAL • Cartridges containing Humalog BASAL should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend insulin until it appears uniformly cloudy or milky. ||| Préparation de Liprolog • Faites rouler la cartouche de Liprolog Mix25 10 fois entre les paumes de vos mains et renversez la 10 fois à 180°juste avant son utilisation, afin de remettre l'insuline en suspension jusqu'à ce qu'elle ait aspect uniformément trouble ou laiteux.
0.49074751138687134 ||| The decision to adopt these harmonised standards for medical devices represents an additional measure taken by the Commission to respond to the coronavirus outbreak. ||| The Commission assessed the measure, which provides for both compensation for damages and liquidity support, under two legal bases: ||| La décision d'adopter ces normes harmonisées relatives aux dispositifs médicaux représente une mesure supplémentaire prise par la Commission pour faire face à l'épidémie de coronavirus.
0.5031402707099915 ||| The studies showed that the vaccine is effective in stimulating the production of antibodies in chickens and in their eggs. ||| In the 1970s, scientists discovered that a vaccine could be made using only a single key protein from the virus. ||| Les études ont montré que le vaccin est efficace s’ agissant de la stimulation de la production d’ anticorps chez les poules et dans leurs œ ufs.
0.05318848788738251 ||| 120 µg/ 0.3 ml ||| 50 µg/ 0.3 ml ||| 120 µg/ 0,3 ml
0.32630521059036255 ||| Over a dose range of 2.5 to 20 mg, exposure (AUC) increases proportionally with dose. ||| Following titration to a daily dose of 40 mg (12 weeks of treatment), LDL-C was reduced by 53%. ||| Pour des doses comprises entre 2,5 et 20 mg, l’ exposition systémique (AUC) augmente proportionnellement à la dose.
0.32253727316856384 ||| When these alterations are coupled with the increase in total body water and bone mass, the overall effect of somatropin therapy is to modify body composition, an effect that is maintained with continued treatment. ||| 15 Although no specific study has been conducted to assess the effect on the neurological signs and symptoms, the results also indicate that patients may achieve reduced pain and enhanced quality of life upon enzyme replacement therapy. ||| Quand ces modifications sont associées à l’ augmentation de la masse totale en eau et à celle de la masse osseuse, l’ effet global du traitement par somatropine est une modification de la composition du corps, cet effet se maintenant quand le traitement est poursuivi.
0.3170280456542969 ||| In the event of an overdose, it is reasonable to employ the standard supportive measures, e. g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring (including obtaining an electrocardiogram), and institute supportive therapy if required. ||| The injection procedure should be carried out under aseptic conditions, which includes the use of surgical hand disinfection, sterile gloves, a sterile drape and a sterile eyelid speculum (or equivalent) and the availability of sterile paracentesis (if required). ||| En cas de surdosage, les mesures habituelles devront être mises en œ uvre, c’ est-à-dire l'élimination du produit non absorbé du tube digestif, l'instauration d'une surveillance clinique (y compris électrocardiographique) et la mise en route d'un traitement symptomatique si nécessaire.
0.6014086008071899 ||| Business management of theaters ||| Business management of an airline company ||| Gérance organisationnelle de théâtres
0.11579316854476929 ||| 30 België/ Belgique/ Belgien Abbott SA Parc Scientifique Rue du Bosquet, 2 B-1348 Louvain-la-Neuve Tél/ Tel: + 32 10 475311 ||| Luxembourg/Luxemburg Abbott SA Parc Scientifique Rue du Bosquet, 2 B-1348 Louvain-la-Neuve Belgique/Belgien Tél/Tel: + 32 10 475311 ||| België/ Belgique/ Belgien Abbott SA Parc Scientifique Rue du Bosquet, 2 B-1348 Louvain-la-Neuve Tél/ Tel: + 32 10 475311
0.10425025224685669 ||| No data are available with regard to overdose of Competact. ||| No data are available with regard to overdose of AVANDAMET. ||| Il n'existe pas de données disponibles concernant le surdosage avec Competact.
0.1886206418275833 ||| If you notice any of these, contact your doctor. ||| If any of these apply, you should inform your doctor. ||| Si vous remarquez l’ un de ces effets, contactez votre médecin.
0.3523046672344208 ||| If you are not sure, talk to your doctor or pharmacist before taking Trevaclyn. ||| Tell your doctor or pharmacist if you are taking anticoagulants. ||| En cas de doute, consultez votre médecin ou votre pharmacien avant de prendre Trevaclyn.
0.5470275282859802 ||| Clinical trials in Restless Legs Syndrome ||| 28 Indication Treatment of refractory Fungal Infections ||| Essais cliniques dans le syndrome des jambes sans repos
0.5108025670051575 ||| Later, impeachment cases were brought up against the President for his participation in the parade, which some viewed as anti-democratic, and also for posing a threat to public health. ||| According to one poll, 64% of Brazilians rejected the way Bolsonaro had been handling the pandemic, while 44.8% supported his impeachment, an all-time high. ||| Plus tard, des accusations de mise en accusation ont été portées contre le Président pour sa participation au défilé, que certains considéraient comme antidémocratique, et aussi pour avoir menacé la santé publique.
0.40288400650024414 ||| Dose reduction ||| Dose calculation ||| Diminution de la dose
0.18213501572608948 ||| 2/ 3 Other information about Sifrol: ||| 2/ 3 Other information about Caelyx: ||| Autres informations relatives à Sifrol:
0.4476613402366638 ||| The oral solution should be used in patients below three months of age. ||| In patients of 12 to 18 years old, the treatment regimen will be: ||| La solution buvable doit être utilisée chez des patients âgés de moins de trois mois.
0.2802828252315521 ||| The measure will help them cover their immediate liquidity needs and continue their essential activities during these difficult times. ||| This will help businesses to address their immediate liquidity constraints and continue their activities in these difficult times. ||| Cette mesure les aidera à couvrir leurs besoins immédiats de liquidités et à poursuivre leurs activités essentielles en cette période difficile.
0.01033133827149868 ||| The MAH must ensure that the system of pharmacovigilance, as described in version 3.0 presented in Module 1.8.1 of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| The MAH must ensure that the system of pharmacovigilance, as described in version 2.0 presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the product is on the market. ||| Le Titulaire de l'Autorisation de Mise sur le Marché s'assure que le système de pharmacovigilance, comme décrit dans la version 3.0 présentée dans le Module 1.8.1. de la Demande d'Autorisation de Mise sur le Marché, est en place et fonctionne avant et pendant la commercialisation du produit.
0.25809532403945923 ||| Due to reduced clearance of lansoprazole in the elderly an adjustment of dose may be necessary based on individual requirements. ||| Due to delayed elimination of lansoprazole in the elderly it may be necessary to administer the treatment in doses of 15-30 mg adjusted to individual requirements. ||| En raison de la clairance réduite du lansoprazole chez les personnes âgées, un ajustement individuel de la dose peut être nécessaire.
0.19926822185516357 ||| Coadministration of voriconazole and low dose ritonavir (100 mg twice daily) should be avoided, unless an assessment of the benefit/ risk to the patient justifies the use of voriconazole (see section 4.3 and 4.4). ||| With the exception of ritonavir for which co-administration with sildenafil is not advised (see section 4.4) a starting dose of 25 mg should be considered in patients receiving concomitant treatment with CYP3A4 inhibitors (see section 4.5). ||| L’ administration concomitante de voriconazole et de ritonavir à faible dose (100 mg deux fois par jour) doit être évitée, sauf si une évaluation du rapport bénéfice/ risque pour le patient justifie l’ utilisation du voriconazole (voir rubriques 4.3 et 4.4).
3.361568022639677e-13 ||| Reversible effects consistent with elevated prolactin in rats included decreased weights of ovaries and uterus and morphologic changes in vaginal epithelium and in mammary gland. ||| Reversible effects consistent with elevated prolactin in rats included decreased weights of ovaries and uterus and morphologic changes in vaginal epithelium and in mammary gland. ||| Les effets réversibles compatibles avec une élévation de la prolactine chez le rat comprenaient une diminution du poids des ovaires et de l'utérus, ainsi que des changements morphologiques de l'épithélium vaginal et de la glande mammaire.
0.1239335685968399 ||| Distillation apparatus for scientific purposes ||| Distillation apparatus not for scientific purposes ||| Appareils pour la distillation à usage scientifique
0.65181964635849 ||| AUC: ↔ Cmax: ↔ Cmin: ↓ 12% (↓ 24 to ↑ 1) (CYP3A4 induction) Interaction not studied. ||| SPID30 mean (+/ - SD) EFFENTORA=3.2(2.60) p < 0.0001 Mean (SEM) Pain Intensity Differences ||| ASC: ↔ Cmax: ↔ Cmin: ↓ 12% (↓ 24 à ↑ 1) (induction du CYP3A4)
0.3758707046508789 ||| Rockets [projectiles] ||| Hat frames [skeletons] ||| Fusées [projectiles]
0.02122173085808754 ||| Purevax RC contains small amounts of weakened or killed viruses that cause the diseases listed above. ||| Purevax RCP contains small amounts of weakened or killed viruses that cause the diseases listed above. ||| Purevax RC contient de petites quantités de virus affaiblis ou tués, dont les souches d’ origine provoquent les maladies énumérées ci-dessus.
0.42834189534187317 ||| Should you experience any reaction like this, please tell your doctor immediately. ||| If these events continue or become severe, tell your doctor. rod ||| Par conséquent, si vous venez à manifester une telle réaction, vous devez en informer immédiatement votre médecin.
0.25310906767845154 ||| Your doctor may then want to follow your treatment up more closely. ||| this case your doctor will want to monitor you more closely. ||| Prévenez votre médecin si vous avez (ou avez eu) une des affections suivantes.
0.3614824116230011 ||| Plavix is used in adult patients to prevent atherothrombotic events (problems caused by blood clots and hardening of arteries). ||| Problems with your small blood vessels (capillaries) may develop when using medicines like Betaferon (systemic capillary leak syndrome). ||| Plavix est utilisé chez l’ adulte pour prévenir les événements athérothrombotiques (problèmes dus à des caillots sanguins et au durcissement des artères).
0.2818969190120697 ||| Your doctor will decide how often you should receive the infusions. ||| Your doctor or nurse will tell you how frequently it should be injected. ||| Votre médecin décidera du rythme d’administration des perfusions qui vous seront nécessaires.
0.3154488801956177 ||| Trudexa has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate. ||| Treatment with Aerius also significantly reduced interference with sleep and daytime function, as measured by a four-point scale used to assess these variables. ||| Il a été montré que Trudexa ralentit la progression des dommages structuraux articulaires mesurés par radiographie et améliore les capacités fonctionnelles lorsqu'il est administré en association au dic
0.3437011241912842 ||| Elimination Following intravenous administration, tocilizumab undergoes biphasic elimination from the circulation. ||| Distribution and elimination In man, the disposition of tacrolimus after intravenous infusion may be described as biphasic. ||| Elimination Après l’ administration intraveineuse, le tocilizumab est éliminé de la circulation de manière biphasique.
0.1858270913362503 |||  Pull the needle completely out of the vial. ||| - Pull the needle straight out of the skin. ||| 305 • Retirez complètement l'aiguille du flacon.
0.0 ||| Route of Administration ||| Route of Administration ||| d’ administration
0.2233697772026062 ||| Design of restaurants ||| Design of games ||| Conception de restaurants
0.14105740189552307 ||| Blood and lymphatic system disorders Nervous system disorders ||| Blood and lymphatic system disorders Immune system disorders: ||| Troubles sanguins et du système lymphatique
0.6270015239715576 ||| Adverse reactions Frequency estimate: ||| Reactions (frequency*) ||| Evénements indésirables Estimation de fréquence:
2.445871196549154e-13 ||| Contact a doctor immediately • Vomiting • Constipation • Visual disturbances • Severe liver problems, abnormal liver function, increased liver enzymes in your blood. ||| Contact a doctor immediately • Vomiting • Constipation • Visual disturbances • Severe liver problems, abnormal liver function, increased liver enzymes in your blood. ||| 46 • Problèmes visuels • Problèmes hépatiques sévères, dysfonctionnement hépatique, augmentation des enzymes hépatiques dans votre sang.
3.57446711118925e-13 ||| Treatment with Aranesp is divided into two stages – correction and maintenance phase. ||| Treatment with Aranesp is divided into two stages – correction and maintenance phase. ||| 41 Le traitement avec Aranesp est divisé en deux phases – phase correctrice et phase d’ entretien.
0.2594033479690552 ||| Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. ||| Clearance of lamotrigine is primarily metabolic with subsequent elimination of glucuronide-conjugated material in urine. ||| L’ absorption de l’ hydrochlorothiazide est diminuée en présence de résines échangeuses d’ anions.
0.049837544560432434 ||| • Your doctor will prescribe Emtriva with other antiretroviral medicines. ||| • Your doctor will prescribe Truvada with other antiretroviral medicines. ||| • Votre médecin a prescrit Emtriva avec d’autres médicaments antirétroviraux.
0.7619389295578003 ||| See a doctor as soon as possible. ||| Take it as soon as you remember. ||| Consultez un médecin dès que possible.
0.3741368353366852 ||| For the treatment of infected skin wounds, Altargo and cefalexin had similar response rates: when the results of both skin wound studies were taken together, around 90% of both groups of patients responded to treatment. ||| However, some differences were seen between the two medicines: more patients experienced a return of the disease after treatment with Alpheon was stopped than with the reference medicine, and there were more side effects with Alpheon. ||| Concernant le traitement des plaies cutanées infectées, Altargo et la céfalexine ont montré des taux de réponse similaires: dans les deux études sur les plaies cutanées considérées ensemble, environ 90% des patients des deux groupes ont répondu au traitement.
0.338032603263855 ||| If ALT levels remain > 3X the upper limit of normal, therapy should be discontinued. ||| Treatment should be discontinued after the first year of treatment if the height velocity SDS is below + 1. ||| Si le taux d’ ALAT reste à plus de 3 fois la limite supérieure de la normale, le traitement devra être arrêté.
0.313896507024765 ||| No initial dose adjustment of Rasilez HCT is required in elderly patients. ||| No dosage adjustment of entacapone is required for elderly patients. ||| 31 Aucun ajustement de la dose initiale de Rasilez HCT n’ est nécessaire chez les patients âgés.
0.14978662133216858 ||| 1, 79639 Grenzach-Wyhlen, Germany. ||| 1, D-79639 Grenzach-Wyhlen, Germany ||| 1, 79639 Grenzach-Wyhlen, Allemagne.
0.3927695155143738 ||| Because the elimination of infliximab may take up to six months, monitoring should be continued throughout this period. ||| However, data indicate that protection against pertussis may be waning at 7-8 years of age with this 3-5-12 months schedule. ||| 6 prendre jusqu’ à 6 mois, la surveillance doit être maintenue pendant toute cette période.
4.5278291207519195e-13 ||| If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin. ||| If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin. ||| Si votre glycémie est trop élevée (hyperglycémie), vous pouvez ne pas avoir injecté assez d’ insuline.
0.3918858468532562 ||| Allow the pre-filled syringe to reach room temperature before injecting. ||| Read all instructions thoroughly before using the pre-filled syringe. ||| Laisser la seringue préremplie atteindre la température ambiante avant l'injection.
0.44457298517227173 ||| A New Zealand evacuation flight arrived in Auckland on 5 February; its passengers (including some from Australia and the Pacific) were quarantined at a naval base in Whangaparoa, north of Auckland. ||| On 4 February, the cruise ship Diamond Princess was quarantined by Japanese authorities in Yokohama after passengers were confirmed to have COVID-19. ||| Un vol d’évacuation néo-zélandais est arrivé à Auckland le 5 février ; ses passagers (notamment en provenance de l’Australie et du Pacifique) ont été mis en quarantaine sur une base navale de Whangaparaoa, au nord d’Auckland.
0.3468703031539917 ||| A disruption or early ending of the treatment with somatropin may impair the success of the growth hormone therapy. ||| The indication in cats is reduction of post-operative pain after a spay operation and minor soft tissue surgery. ||| Une interruption ou un arrêt prématuré du traitement par somatropine est susceptible de compromettre le résultat du traitement par l’ hormone de croissance.
0.12174759805202484 ||| After 15 weeks of treatment, the mean serum 25-hydroxyvitamin D levels were significantly higher (26%) in the ADROVANCE (70 mg/ 2800 IU) group (56 nmol/ l [23 ng/ ml]) than in the alendronate-only group (46 nmol/ l [18.2 ng/ ml]). ||| After 24-weeks of treatment, the mean serum 25- hydroxyvitamin D levels were significantly higher in the Vitamin D3 5600 group (69 nmol/ l [27.6 ng/ ml]) than in the Vitamin D3 2800 group (64 nmol/ l [25.5 ng/ ml]). ||| Après 15 semaines de traitement, les taux moyens sériques de 25-hydroxyvitamine D étaient significativement plus élevés (26%) dans le groupe ADROVANCE (70 mg/ 2800 UI) (56 nmol/ l soit 23 ng/ ml) que dans le groupe alendronate seul (46 nmol/ l soit 18,2 ng/ ml).
0.06562323868274689 ||| Do not use Kepivance after the expiry date which is stated on the carton and vial label, after EXP. ||| - Do not use Lucentis after the expiry date which is stated on the carton and vial label after EXP. ||| Ne pas utiliser Kepivance après la date de péremption mentionnée sur la boîte et l’ étiquette du flacon après EXP.
0.022331707179546356 ||| Silapo 5000 IU/0.5ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.5 ml solution for injection contains 5000 international units (IU) epoetin zeta (recombinant human erythropoietin). ||| Retacrit 3000 IU/0.9ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.9 ml solution for injection contains 3000 international units (IU) epoetin zeta (recombinant human erythropoietin). ||| Silapo 5 000 UI/0,5 ml solution injectable en seringue préremplie 1 seringue préremplie de 0,5 ml de solution injectable contient 5 000 unités internationales (UI) d’époétine zêta (érythropoïétine humaine recombinante).
0.20243442058563232 ||| He joined the EMEA in September 1997 and was appointed Head of Sector for new chemical substances in June 1998 and Head of Sector for orphan drugs and scientific advice in January 2001. ||| He joined the EMEA in August 1996 as Head of Sector for regulatory affairs and pharmacovigilance and was appointed Head of Unit in September 2000. ||| Il a rejoint l’ EMEA en septembre 1997 et a été nommé chef du secteur des nouvelles substances chimiques en juin 1998 et chef du secteur des médicaments orphelins et des avis scientifiques en janvier 2001.
0.37810027599334717 ||| The mechanism of action of glucosamine in humans is unknown. ||| Its biochemical mechanism of action is unknown. ||| Le mécanisme d’ action de la glucosamine chez les humains n’ est pas connu.
0.2839353084564209 ||| The dosage may be increased on the second day to 4 mg. ||| Following an additional week the dosage may be increased to 450 mg per day. ||| La posologie peut être augmentée à 4 mg le 2ème jour.
0.5462231040000916 ||| It is not known if BYETTA passes into your milk. ||| Do not use FORSTEO if it is, or has been, frozen. ||| Le passage de BYETTA dans le lait maternel n’ est pas établi.
0.5940494537353516 ||| Cargo slings of rope or fabric ||| Statues of stone, concrete or marble ||| Élingues en corde ou en tissu
0.0 ||| The dose you receive is based on your body weight in kilograms. ||| The dose you receive is based on your body weight in kilograms. ||| La dose que vous recevez se base sur votre poids corporel en kilogrammes.
0.04059087485074997 ||| 2/ 16 Member State / Marketing Authorisation Number ||| 6/ 16 Member State / Marketing Authorisation Number ||| 2/ 18 État membre / Numéro de l’ autorisation de mise sur le marché
0.18785396218299866 ||| Danmark Abbott Laboratories A/S Emdrupvej 28C DK-2100 København Ø Tlf: + 45 39 77-00-00 ||| Danmark Cephalon Pharma Aps Sluseholmen 2-4 DK - SV 2450 København Tlf: +45 3694 4868 ||| Danmark Abbott Laboratories A/ S Emdrupvej 28C DK-2100 København Ø Tlf: + 45 39 77-00-00
5.231144293779688e-13 ||| Liprolog Mix25 should only be given by subcutaneous injection. ||| Liprolog Mix25 should only be given by subcutaneous injection. ||| Liprolog Mix 25 doit être administré par injection sous-cutanée stricte.
0.5061157941818237 ||| Temodal may cause permanent infertility. ||| Lamictal also treats bipolar disorder. ||| Temodal peut causer une infertilité permanente.
0.438892662525177 ||| Both ribavirin and its triazole carboxamide and triazole carboxylic acid metabolites are also excreted renally. ||| *Sodium acetate is formed by titrating glacial acetic acid with sodium hydroxide. ||| La ribavirine comme ses métabolites, le carboxamide triazolé et le carboxyacide triazolé, sont excrétés par les reins.
0.007590442895889282 ||| Acute (single-dose) toxicity Signs of oral toxicity in rodents were characteristic of potent antipsychotic compounds: hypoactivity, coma, tremors, clonic convulsions, salivation, and depressed weight gain. ||| Acute (single-dose) toxicity Signs of oral toxicity in rodents were characteristic of potent neuroleptic compounds: hypoactivity, coma, tremors, clonic convulsions, salivation, and depressed weight gain. ||| Toxicité aiguë (dose unique) Les signes de toxicité après administration orale chez les rongeurs sont caractéristiques des antispychotiques puissants: hypoactivité, coma, tremblements, convulsions cloniques, hypersalivation, et diminution de la prise de poids.
0.5340516567230225 ||| Ísland Servier Laboratories C/ o Icepharma hf Sími: +354 540 8000 ||| Orion Pharma Eläinlääkeet PL 425 FIN-20101 Turku Puh/ Tel: ||| Ísland Servier Laboratories c/ o Icepharma hf Sími: +354 540 8000
0.03259001672267914 ||| Merck Sharp & Dohme Limited Hertfordshire Road Hoddesdon Hertfordshire EN11 9BU United Kingdom ||| Merck Sharp & Dohme Ltd Hertford Road Hoddesdon Hertfordshire EN11 9BU United Kingdom ||| Merck Sharp & Dohme Limited Hertfordshire Road Hoddesdon Hertfordshire EN11 9BU Royaume Uni
0.21582576632499695 ||| Women who might get pregnant are advised to use effective contraception during treatment with SUTENT. ||| 7 Women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with SUTENT. ||| Il est conseillé aux femmes susceptibles d’ être enceintes d’ utiliser une méthode adaptée de contraception pendant le traitement par SUTENT.
0.553700864315033 ||| Selective Immunosuppressive Agent, ATC code: ||| Selective Estrogen Receptor Modulator (SERM), ATC code: ||| Agent immunosuppresseur sélectif, code ATC:
0.0 ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| FABRICANTDE LA SUBSTANCE ACTIVE D’ ORIGINE BIOLOGIQUE ET TITULAIRE DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS
0.2288348227739334 ||| Clips made of plastics for cables ||| Numerals made of plastics for buildings ||| Serre-câbles en matières plastiques
0.378473162651062 ||| Your doctor will tell you how much and how often you must take Nespoin order to maintain a ed ||| Your doctor will tell you how many Olanzapine Mylan tablets to take and how long you should continue to take them. ||| des examens sanguins, votre médecin a décidé de vous prescrire Nespo car votre taux
6.280295294230909e-13 ||| Do not use if box has been opened. ||| Do not use if box has been opened. ||| 32 Ne pas utiliser si la boîte a été ouverte.
0.46008390188217163 ||| Where physical distancing is more difficult to ensure, additional safeguards and measures should be put in place, for example, the wearing of face masks. ||| Where COVID-19 hazards cannot be eliminated, the most effective controls are engineering controls, followed by administrative controls, and lastly personal protective equipment. ||| lorsqu'il s'avère difficile d'établir des distances physiques, il convient de mettre en place des garanties et des mesures supplémentaires, par exemple imposer le port de masques.
0.43178099393844604 ||| Be careful when you start or stop taking another medicine. ||| Be very careful if you do change insulin. ||| Soyez prudent quand v ous commencez ou arrêtez un autre traitement.
0.5654870271682739 ||| Carcinogenesis, Mutagenesis, Impairment of Fertility: ||| Merck Hepatitis B (Recombinant) Vaccine Common reactions ||| Carcinogenèse, mutagenèse, effets sur la fertilité:
0.35663580894470215 ||| Croatia does not fulfil the exchange rate criterion. ||| Poland does not fulfil the price stability and exchange rate criteria. ||| La Croatie ne remplit pas le critère relatif au taux de change.
0.4437929689884186 ||| CNS medicinal products: the risk of using duloxetine in combination with other CNS-active medicinal products has not been systematically evaluated, except in the cases described in this section. ||| 26 This section addresses the effects of other medicinal products on voriconazole, the effects of voriconazole on other medicinal products and two-way interactions. ||| Médicaments du SNC: le risque lié à l’ association de la duloxétine avec d’ autres médicaments agissant sur le SNC n’ a pas été systématiquement évalué, en dehors des cas décrits ci-dessous.
0.1865319311618805 ||| Common reported side effects (experienced in more than 1 in 100 but less than 1 in 10 patients) • Skin and allergic reactions Reactions at the injection site may occur (such as reddening, unusually intense pain on injection, itching, hives, swelling or inflammation). ||| Changing the injection site with each injection may help to prevent such skin changes. • Skin and allergic reactions 3 to 4% of patients may experience reactions at the injection site (such as reddening, unusually intense pain on injection, itching, hives, swelling or inflammation). ||| Effets indésirables fréquents (rapportés chez plus de 1 patient sur 100 mais moins de 1 patient sur 10) • Réactions cutanées et allergiques Des réactions peuvent survenir au point d’ injection (rougeur, douleur d’ intensité inhabituelle lors de l’ injection, démangeaisons, urticaire, œ dème ou inflammation).
0.2678394913673401 ||| Electrical recorders ||| Electrical transmitters ||| Enregistreurs électriques
0.34916722774505615 ||| Neoclarityn 0.5 mg/ ml syrup desloratadine ||| 0.5 mg/ ml Dexmedetomidine hydrochloride ||| Neoclarityn 0,5 mg/ ml sirop desloratadine
0.0 ||| Oral gel ||| Oral gel ||| Gel oral.
0.9482271671295166 ||| France sanofi-aventis France Tél: ||| NRTIs/ Efavirenz ||| 93 France sanofi-aventis France Tél:
0.27129095792770386 ||| • 28.05.2001 ||| • 02.05.2000 ||| 28.05.2001
0.34195274114608765 ||| Neurological disorders, such as encephalomyelitis, neuritis and Guillain Barré syndrome ||| Very rare Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis ||| Troubles neurologiques tels que encéphalomyélite, névrite et syndrome de Guillain-Barré
0.5634797215461731 ||| Gastrointestinal disorders Uncommon: ||| Influenza like illness* Musculoskeletal system ||| Troubles gastro-intestinaux Peu fréquent: flatulence
0.24643591046333313 ||| The application of this treatment in the context of the coronavirus pandemicwould incentivise banks to extend lending to employees and pensioners. ||| The measures will allow the KfW to provide liquidity in the form of subsidised loans to companies affected by the Coronavirus outbreak. ||| L'application de ce traitement plus favorable dans le contexte de la pandémie de COVID-19 encouragerait les banques à accorder des prêts aux salariés et aux retraités.
0.2726849913597107 ||| It is mainly in cells infected by virus that the mechanism of replication is stopped both by destruction of mRNA and by inactivation of translation proteins (2'5 'oligo-adenylate synthetase activation). ||| Pharmacodynamic effects After administration of tenecteplase dose dependent consumption of α 2-antiplasmin (the fluid-phase inhibitor of plasmin) with consequent increase in the level of systemic plasmin generation have been observed. ||| C’ est essentiellement dans les cellules infectées par le virus que le mécanisme de réplication est stoppé à la fois par destruction des mRNA et par inactivation des protéines de traduction (activation de la 2’ 5’ oligo-adénylate synthétase).
0.1083751916885376 ||| Suspension for injection 10 syringes 10 needles 10 x 1 dose 1 dose (0.5 ml) ||| Suspension for injection 50 syringes 50 x 1 dose 1 dose (0.5 ml) ||| Suspension injectable 10 seringues 10 aiguilles 10 x 1 dose 1 dose (0,5 ml)
0.0915488451719284 ||| Treatment with Zeffix should be initiated by a doctor who has experience in the management of chronic hepatitis B. ||| Treatment with Baraclude should be started by a doctor with experience in the management of chronic hepatitis B. ||| Le traitement par Zeffix doit être instauré par un médecin expérimenté dans la prise en charge de l’ hépatite B chronique.
0.39296334981918335 ||| Clinical intervention (aspiration and/ or surgical removal) may be required if symptoms persist (see section 4.8). ||| These symptoms can be ameliorated or avoided if premedication and dose escalation are utilised (see section 4.4). ||| Une intervention médicale (aspiration et/ou enlèvement du matériel chirurgical) peut être nécessaire si les symptômes persistent (voir rubrique 4.8).
0.4264303743839264 ||| 3 Hepatic impairment Temsirolimus is cleared predominantly by the liver. ||| ra Severe hepatic impairment Dosing adjustment of fondaparinux is not necessary. ||| Insuffisance hépatique Le temsirolimus est éliminé principalement par le foie.
0.5902166366577148 ||| On this basis, the Commission approved the measures under EU State aid rules. ||| The Code applies to all European experts and EMEA members of staff. ||| Sur cette base, la Commission a autorisé la mesure en vertu des règles de l'UE en matière d'aides d'État.
0.05265755206346512 ||| 617 Ísland Vistor hf. ||| 758 Ísland Vistor hf. ||| Ísland Vistor hf.
0.3559025526046753 ||| Flebogammadif may reduce the effectiveness of certain type of vaccines such as measles, rubella, mumps and varicella. ||| Treatment with lansoprazole may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter. ||| Flebogammadif peut atténuer l’ efficacité de certains vaccins tels que la rougeole, la rubéole, les oreillons et la varicelle.
0.607932984828949 ||| Rare: blood bilirubin increased, blood glucose increased ||| Increased, Haemoglobin decreased, Blood calcium abnormal ||| Rare: élévation de la bilirubinémie, élévation de la glycémie.
0.3670600950717926 ||| Do not throw the larger cap away as it will be used later for proper needle removal and disposal. ||| Be careful not to bend or twist the cover during removal to avoid damage to the needle. ||| Ne jetez pas le plus gros capuchon car il sera réutilisé pour le retrait et l’ élimination de l’ aiguille de manière appropriée.
0.4267168939113617 ||| Insurance premium financing services ||| Insurance underwriting services ||| Services de financement de primes d'assurance
0.41810277104377747 ||| The usual starting dose is 10-20 mg/ day given as a single dose in the evening. ||| The same dose is given every 6 hours throughout a period of 72 hours. ||| La dose initiale usuelle est de 10 à 20 mg/jour administrée en une prise unique le soir.
0.2609153389930725 ||| Any patient complaining of ocular symptoms, including loss of visual acuity or visual field must have a prompt and complete eye examination. ||| Any patient complaining of decrease or loss of vision must have a prompt and complete eye examination. ||| 57 d'acuité visuelle ou de champ visuel doit faire l'objet rapidement d'un examen ophtalmologique complet.
0.0180169939994812 ||| Lipid alterations Undesirable alterations in lipids have been observed in olanzapine-treated patients in placebo-controlled clinical trials (see section 4.8). ||| Lipid alterations Undesirable alterations in lipids have been observed in olanzapine-treated patients in placebo- controlled clinical trials (see section 4.8). ||| Anomalies lipidiques Des anomalies lipidiques ont été observées chez des patients traités par l’ olanzapine au cours d’ essais cliniques versus placebo (voir rubrique 4.8).
0.0 ||| Metabolism and nutrition disorders ||| Metabolism and nutrition disorders ||| 127 Troubles du métabolisme et de la nutrition
0.5331317186355591 ||| Vardenafil is metabolised predominantly by hepatic metabolism via cytochrome P450 (CYP) isoform 3A4 with some contribution from CYP3A5 and CYP2C isoforms. ||| 7.5 µg of PRP from Haemophilus influenzae type b as PRP-OMPC 125 µg of Neisseria meningitidis OMPC 5.0 µg of hepatitis B surface antigen produced in recombinant yeast cells ||| Le vardénafil est principalement métabolisé par métabolisme hépatique via l'isoforme 3A4 du cytochrome P450 (CYP) avec la contribution des isoformes CYP3A5 et CYP2C.
0.5339088439941406 ||| On 16 March, the state of Bavaria declared a state of emergency for 14 days and introduced measures to limit public movement and provide additional funds for medicine supplies. ||| Many events have been cancelled, and Singapore did start advising residents to stay at home on 28 March, but schools reopened on time after holiday break on 23 March. ||| Le 16 mars, l'État de Bavière déclare l'état d'urgence pour 14 jours et impose des mesures pour limiter les déplacements et fournir des fonds pour les besoins de la médecine.
0.37499934434890747 ||| A decrease in peripheral vascular resistance may contribute to this effect. ||| However a local immunosuppressive effect in the skin cannot be excluded. ||| Une diminution de la résistance périphérique vasculaire peut contribuer à cet effet.
0.30168354511260986 ||| Calibration services relating to electronic apparatus ||| Renovating services relating to discharge conduits ||| Services de calibrage liés à des appareils électroniques
0.3812774419784546 ||| In these patients, treatment should be started under close medical supervision with low doses and careful dose titration. ||| Close supervision of patients and in particular those at high risk should accompany treatment especially in early treatment and following dose changes. ||| Le traitement doit alors être instauré sous surveillance médicale attentive, à posologie faible, avec une augmentation prudente des doses.
0.03879082202911377 ||| - a long needle (for example 0.8 x 40 mm [21 gauge 1.5 inch]) to be used to add water for ||| - a long needle (for example 0.8 × 40 mm [21 gauge 1.5 inch]) to be used to add water for injections to ||| - une aiguille longue (par exemple 0,8 x 40 mm [gauge 21 1,5 inch]) utilisée pour ajouter l’eau
0.700886607170105 ||| Efficacy working party ||| Efficacy in adults ||| Groupe de travail “ efficacité”
1.2445917129516602 ||| Detailed information on this medicine is available on the European Medicine Agency (EMEA) website: http: / /www. emea. europa. eu/. ||| Join us on Facebook: http://www.facebook.com/EAAD.EU ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA): http: / /www. emea. europa. eu/.
0.2314695566892624 ||| Following administration of an oral dose of radiolabeled raltegravir, approximately 51 and 32% of the dose was excreted in faeces and urine, respectively. ||| Elimination studies in dogs have shown that 29.8% and 44% of the dose was excreted in urine and faeces, respectively by 14 days following dosing. ||| Après administration d'une dose orale de raltégravir radiomarqué, environ 51% et 32% de la dose sont éliminés respectivement dans les fèces et dans l'urine.
0.49513158202171326 ||| 0*** ||| 0% *** ||| 0,0***
0.3339340090751648 ||| Much of the joint pathology in rheumatoid arthritis and ankylosing spondylitis and skin pathology in plaque psoriasis is mediated by pro-inflammatory molecules that are linked in a network controlled by TNF. ||| For the treatment of respiratory tract As for Germany infections, urogenital, gastrointestinal and skin infections caused by pathogens sensitive to trimethoprim and sulfamethoxasole in pigs and poultry (broilers). ||| La majorité des atteintes articulaires de la polyarthrite rhumatoïde et de la spondylarthrite ankylosante, et des atteintes cutanées du psoriasis en plaques est médiée par des molécules pro-inflammatoires qui appartiennent à un réseau contrôlé par le TNF.
0.9092140197753906 ||| Symptoms and signs ||| Questions and Answers ||| Signes et symptômes
0.2413771152496338 ||| In an open single-dose study in adult patients with Sickle Cell Syndrome the influence of renal function on pharmacokinetics of hydroxycarbamide was assessed. ||| The safety and efficacy of docetaxel in combination with prednisone or prednisolone in patients with hormone refractory metastatic prostate cancer were evaluated in a randomized multicenter phase III trial. ||| Une étude ouverte portant sur une administration unique d'hydroxycarbamide chez des patients adultes atteints de drépanocytose a évalué l'influence de la fonction rénale sur la pharmacocinétique de l'hydroxycarbamide.
0.06456132233142853 ||| After reconstitution the product should be used immediately. ||| After reconstitution, the product should be used immediately. ||| Après reconstitution, le produit doit être utilisé immédiatement.
0.27630558609962463 ||| Hypophosphatemia As with other nicotinic acid medicinal products, Pelzont was associated with small decreases in phosphorus levels. ||| The interpatient variability in pharmacokinetic parameters for zoledronic acid was high, as seen with other bisphosphonates. ||| Hypophosphatémie Comme avec d'autres spécialités à base d'acide nicotinique, Pelzont a été associé à de légères réductions des taux de phosphore.
0.3135257661342621 ||| Oral ||| Coral ||| orale
0.017286106944084167 ||| This scheme aims at supporting companies that face difficulties due to loss of income and liquidity resulting from the economic impact of the coronavirus outbreak. ||| This scheme aims at supporting companies that face difficulties due to loss of income and liquidity shortages resulting from the economic impact of the coronavirus outbreak. ||| Ce régime vise à soutenir les entreprises qui connaissent des difficultés à la suite des pertes de revenus ou de liquidités qu'elles subissent en raison de l'impact économique de la pandémie.
0.6385809779167175 ||| Transmission of information via computers connected to the same telematic network ||| Providing communication services through the use of phone cards or debit cards ||| Transmission d'informations via des ordinateurs reliés au même réseau télématique
0.5135307908058167 ||| Parasol stands ||| Optical finders ||| Pieds de parasols
0.01242254301905632 ||| 69 Mutagenicity Olanzapine was not mutagenic or clastogenic in a full range of standard tests, which included bacterial mutation tests and in vitro and in vivo mammalian tests. ||| Mutagenicity Olanzapine was not mutagenic or clastogenic in a full range of standard tests, which included bacterial mutation tests and in vitro and in vivo mammalian tests. ||| L’ olanzapine n’ a montré aucun effet mutagène ni clastogène, lors d’ une série complète de tests standard, tels que tests de mutation bactérienne, et tests in vitro et in vivo sur mammifères.
0.0 ||| Haemolytic anaemia, i.e. haemoglobin 1.5 ULN and haptoglobin < 0.1 g/dL, Anaemia due to lack of regeneration, i.e. haemoglobin < 10 g/dL and reticulocytes < 80,000/mm3. ||| Haemolytic anaemia, i.e. haemoglobin  1.5 ULN and haptoglobin < 0.1 g/dL, Anaemia due to lack of regeneration, i.e. haemoglobin < 10 g/dL and reticulocytes < 80,000/mm3. ||| Anémie hémolytique, c’est-à-dire hémoglobine 1,5 LSN et haptoglobine < 0,1 g/dl Anémie due à un défaut de régénération, c’est-à-dire hémoglobine < 10 g/dl et réticulocytes < 80 000/mm3.
0.08756096661090851 ||| Mycamine should not be used during pregnancy unless clearly necessary. ||| Nitisinone should not be used during pregnancy unless clearly necessary. ||| Mycamine ne doit pas être utilisé pendant la grossesse à moins d’ une nécessité absolue.
0.03512171655893326 ||| The InnoLet that is not being used is to be stored in a refrigerator (2°C - 8°C). ||| The NovoLet that is not being used is to be stored in a refrigerator (2°C - 8°C). ||| ActraphaneInnoLet non utilisé est à conserver au réfrigérateur (entre 2°C et 8°C).
0.226048082113266 ||| If any of these apply to you, or if you are not sure, tell your doctor before taking Ketek. ||| If any of the above apply to you, or if you are not sure, tell your doctor who will decide what to do. ||| Si vous êtes concerné par une de ces situations ou en cas de doute, parlez-en à votre médecin avant de prendre Ketek.
0.386567085981369 ||| Try to take your daily dose at about the same time each day. ||| Try to use Avonex at the same time on the same day each week. ||| 120 prendre votre dose quotidienne approximativement à la même heure chaque jour.
0.0024517534766346216 ||| 12 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 20 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 12 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR OU, EN L’ ABSENCE D’ EMBALLAGE EXTÉRIEUR, SUR LE CONDITIONNEMENT PRIMAIRE
0.009934471920132637 ||| 6/ 28 Special precautions to be taken by the person administering the veterinary medicinal product to animals ||| 7/ 48 Special precautions to be taken by the person administering the veterinary medicinal product to animals ||| 7/ 32 Précautions particulières à prendre par la personne qui administre le médicament vétérinaire aux animaux
0.6565861105918884 ||| Mustache and beard trimmers ||| Radar jamming warheads ||| Rasoirs à moustache et à barbe
0.21199876070022583 ||| Musculoskeletal, connective tissue and bone disorders Rhabdomyolysis When clinical information on the patients was available to make a judgement, approximately 50% of the cases occurred in patients with pre-existing renal insufficiency, or in those receiving concomitant medications known to cause rhabdomyolysis. ||| Consideration should be given to official guidance on the appropriate use of antibacterial agents.There have been 3 reported cases of meningococcal infection in Soliris treated patients: two in vaccinated PNH patients and one in an unvaccinated patient with idiopathic membranous glomerulonephropathy. ||| Affections musculo-squelettiques et systémiques Rhabdomyolyse Environ 50% des patients chez qui l’ on disposait d’ informations cliniques suffisantes, étaient atteints d’ une insuffisance rénale préexistante ou recevaient en même temps des médicaments connus pour être à l’ origine de rhabdomyolyse.
0.42384064197540283 ||| Due to limited experience the efficacy and safety of Lantus could not be assessed in the following groups of patients: patients with impaired liver function or patients with moderate/ severe renal impairment (see section 4.4). ||| 144 Gender, race, elderly: although limited data suggest that females as well as Asian and Pacific Island patients may have higher exposure to efavirenz, they do not appear to be less tolerant of efavirenz. ||| L'expérience étant limitée, l'efficacité et la tolérance de Lantus n'ont pu être évaluées dans les groupes de patients suivants: patients ayant une insuffisance hépatique ou patients ayant une insuffisance rénale modérée à sévère (voir rubrique 4.4).
0.2588615417480469 ||| depression, confusional state, disorientation, anxiety, altered mood, sleep disorder, abnormal dreams, nightmare, decreased libido, restlessness ||| difficulty in sleeping anxiety symptoms, confusion and disorientation, depression, mood changes, nightmare, hallucination, mental disorders ||| dépression, état confusionnel, désorientation, anxiété, troubles de l’humeur, troubles du sommeil, rêves anormaux, cauchemars, diminution de la libido, agitation
0.32608622312545776 ||| The metabolism of aprepitant occurs largely via oxidation at the morpholine ring and its side chains and the resultant metabolites were only weakly active. ||| As Luminity consists of microspheres that are stable and small enough for transpulmonary passage, enhanced echo signals in the left heart and systemic circulation are obtained. ||| Le métabolisme de l’ aprépitant intervient largement via l’ oxydation au niveau du cycle de la morpholine et de ses chaînes latérales, les métabolites qui en résultent n’ étant que faiblement actifs.
0.32976365089416504 ||| Studies with human platelets indicate that sildenafil potentiates the antiaggregatory effect of sodium nitroprusside in vitro. ||| Other potential interactions that may increase systemic exposure of tacrolimus Prokinetic agents such as metoclopramide and cisapride. ||| Des études sur les plaquettes sanguines humaines montrent que le sildénafil potentialise l’ effet antiagrégant du nitroprussiate de sodium in vitro.
1.1739228963851929 ||| Table 1 Undesirable Effects in Clinical Studies ||| Frequently Asked Questions about Injecting Your Dose ||| 39 Tableau 1 Effets indésirables observés dans les études cliniques
0.448650062084198 ||| Arranging of competitions for education or entertainment ||| Arranging of finance for sporting, cultural and entertainment projects ||| Préparation de concours à des fins d'éducation ou de divertissement
0.0069938232190907 ||| This scheme aims at supporting companies that face difficulties due to loss of income and liquidity resulting from the economic impact of the coronavirus outbreak. ||| The scheme aims at supporting companies that face difficulties due to loss of income and liquidity resulting from the economic impact of the coronavirus outbreak. ||| Ce régime vise à soutenir les entreprises qui connaissent des difficultés à la suite des pertes de revenus ou de liquidités qu'elles subissent en raison de l'impact économique de la pandémie.
0.32654067873954773 ||| In case of infections, antibiotic treatment should be initiated as required. ||| Any inflammatory symptoms should be evaluated and treatment instituted when necessary. ||| En cas d'infection, une antibiothérapie doit être instaurée si elle est cliniquement nécessaire.
6.533543237680073e-13 ||| 6.6 Special precautions for disposal ||| 6.6 Special precautions for disposal ||| 168 6.6 Précautions particulières d’ élimination
0.6913032531738281 ||| THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| DILUTION OF CONCENTRATE WITH THE SUPPLIED DILUENT ||| TITULAIRE(S) DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBÉRATION DES LOTS
0.4138542413711548 ||| Tritace 1,25 mg, comprimés Tritace 2,5 mg, comprimés Tritace 5 mg, comprimés Tritace 10 mg, comprimés ||| Tritace 1.25 mg tablety, Tritace 2.5 mg tablety, Tritace 5 mg tablety, Tritace 10 mg tablety ||| Tritace 2,5 mg, comprimés Tritace 5 mg, comprimés Tritace 10 mg, comprimés
0.41124022006988525 ||| Electrical shavers for removing threads from fabric [hand instruments] ||| Water inlets [valves of plastic] for water pipes ||| Rasoirs électriques pour éliminer les fils dépassant des tissus [instruments à main]
0.2282925844192505 ||| * in a subgroup of infants not administered hepatitis B vaccine at birth, 89.9% of subjects had anti-HBs titres ≥ 10 mIU/ ml † cut-off accepted as indicative of protection †† vaccine response:% of subjects considered to have responded to the Bordetella pertussis antigen ||| Immune response after booster injection In the pivotal clinical study where toddlers received HEXAVAC as a booster dose after having been primed with HEXAVAC, antibody titres equal to or greater than 0.1 IU/ ml were achieved by all toddlers to tetanus and by 98.8% to diphtheria. ||| * dans un sous groupe de nourrissons n’ ayant pas reçu de vaccin contre l’ hépatite B à la naissance, 89,9% des sujets avaient des titres anti-HBs ≥ 10 mUI/ ml † Valeur seuil acceptée comme indicateur de protection †† réponse vaccinale:% de sujets considérés comme ayant répondu à l’ antigène Bordetella pertussis
0.2621493935585022 ||| The Commission's first priority is to use all tools at its disposal to safeguard people's wellbeing and ensure that there is an effective immediate response to the coronavirus outbreak across the board. ||| The objective of the measures is to ensure that these companies have sufficient liquidity to safeguard jobs and continue their activities faced with the difficult situation caused by the Coronavirus outbreak. ||| La priorité principale de la Commission est d'utiliser tous les instruments à sa disposition pour préserver le bien-être de la population et garantir une réaction immédiate et efficace à l'épidémie du coronavirus sur tous les plans.
0.339962363243103 ||| -5- augmentation after longer use of SIFROL and the appropriate management of these events have not been evaluated in controlled clinical trials. ||| Therefore, routine measurement of coagulation parameters is not currently indicated in the management of patients on APTIVUS. ||| La fréquence de ce phénomène après une utilisation prolongée de SIFROL et la prise en charge appropriée de ces évènements n’ ont pas été évaluées dans les études cliniques contrôlées.
0.11121734976768494 ||| It can not be excluded that other inducers, e. g. phenytoin, carbamazepine, phenobarbital, St John’ s wort, may have a similar effect. ||| It cannot be excluded that other inducers (e. g. phenytoin, carbamazepine, phenobarbital, St John’ s wort) may also affect rosiglitazone exposure. ||| Il n’ est pas exclu que d’ autres inducteurs comme par exemple la phénytoïne, la carbamazépine, le phénobarbital, le millepertuis, puissent présenter un effet similaire.
0.7686982750892639 ||| - Increased sensitivity to light ||| Persistent lack of antibody production ||| - Augmentation de la sensibilité à la lumière
0.3156546354293823 ||| Caution should be used when administering CELSENTRI in patients with a history of postural hypotension or on concomitant medicinal products known to lower blood pressure. ||| Tritanrix HepB can be administered simultaneously at separate sites or in any temporal relationship with other paediatric vaccines if this fits conveniently in the immunisation scheme. ||| La prudence est de rigueur lors de l’ administration de CELSENTRI chez des patients présentant des antécédents d’ hypotension orthostatique ou recevant des médicaments associés connus pour abaisser la tension artérielle.
0.431865930557251 ||| The solvent is contained in colourless neutral glass ampoules (2 ml). ||| The solvent comes in vials of neutral glass of hydrolytic type I. ||| Le solvant est contenu dans une ampoule de verre incolore neutre (2 ml).
0.2943282127380371 ||| These reactions usually disappear within 1-2 days without treatment. ||| These usually disappear within one to two days without treatment. ||| Ces réactions disparaissent généralement sans traitement en 1 ou 2 jours.
0.43184876441955566 ||| It enhances the images seen with ultrasound and helps your doctor to get a clearer picture (scan) of your heart. ||| Your doctor will then take a picture (scan) of your lungs using a special camera. ||| Il réhausse la qualité des images échographiques et permet à votre médecin d’ obtenir une image plus claire de votre cœ ur.
0.39909446239471436 ||| When the receptors are blocked, histamine cannot have its effect, and this leads to a decrease in the symptoms of allergy. ||| If bleeding occurs in the brain, this can lead to a stroke, which can be life-threatening. ||| Lorsque les récepteurs sont bloqués, l’ histamine ne peut plus jouer son rôle habituel et les symptômes allergiques sont alors diminués.
0.429561972618103 ||| It will develop the scientific requirements for DNA vaccines and gene therapy and review extensively the scientific developments in the field of combined vaccines, new methodology for viral testing for plasma-derived products and in TSE. ||| TSE/CJD, nuclear amplification technique testing methodologies • further develop the procedures for the evaluation of medicinal products containing genetically modified organisms and ancillary medical devices ||| Il élaborera les exigences scientifiques pour les vaccins à base d’ADN et la thérapie génique, et effectuera un examen approfondi des progrès scientifiques réalisés dans le domaine des vaccins combinés, des TSE et de la nouvelle méthodologie concernant les recherches virologiques portant sur les produits dérivés du plasma.
0.7162481546401978 ||| (median) ||| 1997 (estimate) ||| (médiane)
3.246290768751242e-13 ||| The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch. ||| The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch. ||| Le nom et l'adresse du fabricant responsable de la libération du lot concerné doivent figurer sur la notice imprimée du médicament.
0.0725756362080574 ||| The Marketing Authorisation Holder commits to performing the pharmacovigilance activities detailed in the Pharmacovigilance Plan. ||| The Marketing Authorisation Holder commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan. ||| Le titulaire de l’ autorisation de mise sur le marché s’ engage à réaliser les activités de pharmacovigilance détaillées dans le Plan de Pharmacovigilance.
0.6135692596435547 ||| a) Tablets b) 50mg c) 1 Presentation ||| Presentation a) Form b) Dosage c) No. of presentations ||| a) Comprimés b) 50mg c) 1 Présentation
0.5463948249816895 ||| Your doctor will carefully monitor the effect of VIRAMUNE and any of these medicines if you are taking VIRAMUNE and any of these medicines together. ||| Some medicines may affect how SINGULAIR works, or SINGULAIR may affect how your child’ s other medicines work. ||| Votre médecin surveillera avec attention les effets de VIRAMUNE et de ces médicaments si vous prenez VIRAMUNE avec un de ces médicaments.
0.16942618787288666 ||| Long-term studies have not been performed to evaluate the carcinogenic potential of infliximab. ||| Long-term studies in animals to evaluate carcinogenic potential have not been conducted with retapamulin. ||| Des études à long terme pour évaluer le potentiel carcinogène de l’ infliximab n’ ont pas été effectuées.
0.5918644666671753 ||| In the long term, the itching scores fell from an average of around 3.9 on the first day, falling to 0.8 for Emadine and 2.0 for levocabastine after six weeks. ||| Similar reductions in redness scores were seen, falling from 4.5 to 3.7 after five minutes and 2.7 after two hours. ||| À long terme, les scores de démangeaison sont passés d’ une moyenne de l'ordre de 3,9 le premier jour à 0,8 pour Emadine et à 2,0 pour la lévocabastine au bout de six semaines.
0.2608889937400818 ||| For information on how to inject Dynepo yourself, please read the instructions at the end of this leaflet. ||| The instructions on how to inject yourself are at the end of this leaflet (see section 7, How to inject AVONEX). ||| Pour des informations sur la manière de pratiquer vous -même une injection de Dynepo, veuillez lire les instructions à la fin de cette notice. e
0.36503076553344727 ||| Uncommon: between 1 and 10 in every 1000 patients are likely to get these. ||| Between 1 and 10 out of every 1,000 patients will experience these side effects. ||| Peu fréquents: effets indésirables pouvant survenir chez 1 à 10 patients sur 1000.
0.6557533144950867 ||| Humalog Mix25 may be given shortly before meals. ||| Never take two Bondenza tablets within the same week. ||| Humalog Mix25 peut être administré peu de temps avant les repas.
0.29634255170822144 ||| Additional studies looked at the effect of Myozyme in 15 patients with late-onset disease. ||| The company will continue to study the effect of Myozyme in late-onset patients. ||| Des études supplémentaires ont analysé les effets de Myozyme sur 15 patients atteints de la forme tardive de la maladie.
0.3110814094543457 ||| 1.81 ||| 1.9% ||| 1,67
0.46698635816574097 ||| Seropositivity rates for anti-HBs antibodies were 74.2% one month after the first dose and 100% after the second dose given at month 6 (i. e. month 7). ||| Virological responses after 1 year of treatment and 6 months of follow-up were 36% for genotype 1 and 81% for genotype 2/ 3/ 4. ||| Les taux de séropositivité pour les anticorps anti-HBs étaient de 74,2% un mois après la première dose et de 100% après la deuxième dose administrée 6 mois plus tard (au mois 7).
0.42827853560447693 ||| Metal brackets for use in the construction and assembly of decking ||| Industrial robots for use in the mounting of workpieces to be worked on ||| Équerres métalliques pour la construction et l'assemblage de planchers
0.48152434825897217 ||| Those countries have expressed a high-level political commitment to implement an action plan agreed with FATF to address their strategic deficiencies. ||| Along with bold measures taken by the European Central Bank, this provides unprecedented fiscal and financial firepower. ||| Ces pays ont exprimé un engagement politique à haut niveau de mettre en œuvre un plan d'action convenu avec le GAFI pour remédier à leurs carences stratégiques.
0.2763289213180542 ||| Robotic cleaning [polishing] machines for floors ||| Floor maintenance machines [electric] for polishing ||| Machines robotisées de nettoyage des sols par lustrage
0.1696205735206604 ||| Tracleer 62.5 mg film-coated tablets. ||| Xeloda 150 mg film-coated tablets. ||| Tracleer 62,5 mg comprimés pelliculés.
0.012395976111292839 ||| Patients with renal insufficiency Efficib should not be used in patients with moderate or severe renal impairment (creatinine clearance < 60 ml/ min) (see sections 4.3 and 4.4). ||| Patients with renal insufficiency Janumet should not be used in patients with moderate or severe renal impairment (creatinine clearance < 60 ml/ min) (see sections 4.3 and 4.4). ||| Patients insuffisants rénaux Efficib ne doit pas être utilisé chez les patients présentant une insuffisance rénale modérée ou sévère (clairance de la créatinine < 60 ml/ mn) (voir rubriques 4.3 et 4.4).
0.3600764870643616 ||| Electrical shavers for removing threads from fabric [hand instruments] ||| Ceramic compositions for sintering [granules and powders] ||| Rasoirs électriques pour éliminer les fils dépassant des tissus [instruments à main]
0.46555203199386597 ||| On March 9, the Lynn Valley outbreak resulted in the first coronavirus death in Canada, by a man in his 80s with pre-existing health conditions. ||| Injury prevention efforts began in the early 1960s when activist Ralph Nader, exposed the automobiles as being more dangerous than necessary with his book Unsafe at Any Speed. ||| Le 8 mars, l'éclosion de Lynn Valley a causé le premier décès au Canada ; la personne était un octogénaire avec des problèmes de santé préexistants,.
0.37821024656295776 ||| Robotic compressed air pumps ||| Metered gasoline pumps ||| Pompes robotisées à air comprimé
0.0 ||| SPECIAL WARNING(S), IF NECESSARY ||| SPECIAL WARNING(S), IF NECESSARY ||| MISE(S) EN GARDE ÉVENTUELLE (S)
0.34238845109939575 ||| There have been no reports explicitly relating to effects of DepoCyte treatment on the ability to drive or use machines. ||| No data are available on the concomitant use of EVISTA and agents used in the treatment of early or advanced breast cancer. ||| Il n'y a pas eu de cas rapporté relatif aux effets d'un traitement par DepoCyte sur l'aptitude à conduire des véhicules ou à utiliser des machines.
0.4730904698371887 ||| Demographics and baseline disease characteristics were comparable between the Nexavar and the placebo group with regard to ECOG status (status 0: ||| Population pharmacokinetic parameters for ATryn derived from the same study revealed (mean ± SD): • Area under the curve: ||| Les données démographiques et les caractéristiques initiales de la maladie étaient comparables entre le groupe Nexavar et le groupe placebo selon le statut ECOG (statut 0:
0.4306936264038086 ||| 6 clicks ||| 10 drops ||| 1,8 6 clics
0.3329828977584839 ||| 1 g of solution contains 100 mg sorbitol E420 and 0.5 mg potassium, see section 4.4. ||| 1 sachet= 15 g powder contains of 2.4 g ketoprofen and exipients to 15 g. ||| 1 g de solution contient 100 mg de sorbitol E420 et 0,5 mg de potassium, voir rubrique 4.4.
0.12125439941883087 ||| PHARMACOLOGICAL PROPERTIES a ||| PHARMACOLOGICAL PROPERTIES ||| PROPRIÉTÉS PHARMACOLOGIQUES
0.05458603799343109 ||| 48 6.3 Shelf life ||| 55 6.3 Shelf life ||| 6.3 Durée de conservation
0.3868524134159088 ||| After reconstitution with 52 ml of water, the usable volume of oral suspension allows for the retrieval of a total of 10 doses of 75 mg oseltamivir. ||| Using a 10-ml syringe with a large bore needle (18-20 G), draw formulation buffer that will result in a combined total volume of 10 ml. ||| Après reconstitution avec 52 ml d'eau, le volume de suspension buvable utilisable correspond à un total de 10 doses d'oseltamivir 75 mg.
0.23371094465255737 ||| Therefore the use of Zomarist is not recommended in this population. ||| Therefore, the use of Xiliarx is not recommended in these patients. ||| Son utilisation est donc déconseillée chez ces patients.
0.25392407178878784 ||| Flebogammadif should not be mixed with other medicines or intravenous solutions and it should be administered by a separate intravenous line. ||| However, other medicinal products should not be added to the MabCampath infusion or simultaneously infused through the same intravenous line. ||| Flebogammadif ne doit pas être mélangé à d’ autres médicaments ou solutions pour perfusion et doit être administré séparément.
0.3583506941795349 ||| Caution should be exercised in patients with moderate renal impairment. ||| If appropriate, resumption of hepatitis B therapy may be warranted. ||| La prudence s’ impose chez les patients avec une insuffisance rénale modérée.
0.444981187582016 ||| This product contains sucrose and sorbitol. ||| This medicinal product contains sucrose. ||| Ce produit contient du saccharose et du sorbitol.
0.5440201759338379 ||| Congenital disorders: see further details in section 4.6. ||| For information on adverse reactions, see section 4.6. Adverse reactions. ||| Affections congénitales: voir rubrique 4.6 pour des informations complémentaires.
0.5018662810325623 ||| Adverse effects commonly seen were vomiting, a loss of appetite, and fever. ||| Common symptoms include fever, cough, and shortness of breath. ||| Des vomissements, une perte d’ appétit et de la fièvre ont été également notés.
0.6358140110969543 ||| Reins ||| Hoes ||| Rênes
0.022044043987989426 ||| It is strongly recommended that every time Privigen is administered to a patient, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product. ||| It is strongly recommended that every time EVICEL is administered to a patient, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product. ||| Il est fortement recommandé d’enregistrer le nom et le numéro du lot du produit chaque fois que Privigen est administré à un patient, afin de conserver un lien entre le patient et le numéro de lot du produit.
0.28327423334121704 ||| This can lead to graft rejection or increased incidence of side effects, including under- or overimmunosuppression, due to clinically relevant differences in systemic exposure to tacrolimus. ||| In addition to peripheral neuropathy, there may be a contribution of autonomic neuropathy to some adverse reactions such as postural hypotension and severe constipation with ileus. ||| Cela peut entrainer un rejet du greffon ou une augmentation de l’ incidence des effets indésirables, y compris sous- immunosuppression ou sur-immunosuppression, en raison de différences cliniquement significatives en terme d’ exposition systémique au tacrolimus.
0.32616013288497925 ||| A total of 11 of 31 (36%) patients in the weekly treatment group versus 5 of 31 (16%) patients in the placebo group had an increase in FEV1 of at least 200 cc at or before the end of the study, indicating a dose-related improvement in airway obstruction. ||| However, based on interim data from a long-term follow-up study, 12 (14%) of 84 children had a > 15 percentile decrease in rate of linear growth, of whom 5 (6%) children had a > 30 percentile decrease despite being off treatment for more than 1 year. ||| Un total de 11 patients sur les 31 patients (36%) appartenant au groupe sous traitement hebdomadaire contre 5 patients sur les 31 patients (16%) appartenant au groupe sous placebo ont montré une augmentation du FEV1 d’ au moins 200 cc avant ou au terme de l’ étude.
0.17333395779132843 ||| Installation, repair and maintenance of air reheaters ||| Installation, repair and maintenance of boiler tubes ||| Installation, réparation et entretien de réchauffeurs d'air
0.3472813069820404 ||| During the 1 month Induction phase of treatment, DepoCyte was administered intrathecally as 50 mg every 2 weeks, and unencapsulated cytarabine as 50 mg twice a week. ||| Patients received Lucentis 0.3 mg or 0.5 mg intravitreal injections or sham injections once a month for 3 consecutive doses, followed by a dose administered once every 3 months. ||| Durant la phase d'induction du traitement de 1 mois, le DepoCyte était administré par voie intrathécale à une dose de 50 mg toutes les 2 semaines, et la cytarabine non encapsulée à une dose de 50 mg deux fois par semaine.
0.6614612340927124 ||| Secretarial services ||| Special advisers ||| Services de secrétariat
0.31009113788604736 ||| Tell your doctor as soon as possible if you get these symptoms. ||| Tell your doctor as soon as possible if this applies to you. ||| Parlez -en à votre médecin dès que possible si vous avez ces symptômes.
0.34809088706970215 ||| A new Recovery and Resilience Facility of €560 billion to be used for investments and reforms for recovery and resilience, including in relation to the green and digital transitions, in line with the objectives identified in the European Semester. ||| To inform the preparation and the implementation of Member States' recovery and resilience plans, the Council will also have the opportunity to discuss, in the context of the European Semester, the state of recovery, resilience and adjustment capacity in the Union, based on Commission documents available. ||| une nouvelle facilité pour la reprise et la résilience, dotée de 560 milliards €, à utiliser pour des investissements et des réformes favorisant la reprise et la résilience, notamment en ce qui concerne les transitions écologique et numérique, conformément aux objectifs définis dans le cadre du Semestre européen.
0.1534622460603714 ||| 30 mg/ kg twice daily ||| 6 mg/ kg once daily ||| 30 mg/ kg 2 fois par jour
0.27761077880859375 ||| Glitter for cosmetic purposes ||| Lint for cosmetic purposes ||| Paillettes à usage cosmétique
0.1215364933013916 ||| 35 LABELLING ||| 26 LABELLING ||| 38 ETIQUETAGE
0.3365747332572937 ||| Gas grills ||| Jack cables ||| Grils à gaz
0.049103885889053345 ||| PritorPlus 80 mg/ 12.5 mg tablets telmisartan/ hydrochlorothiazide ||| MicardisPlus 80 mg/ 12.5 mg tablets telmisartan/ hydrochlorothiazide ||| PritorPlus 80 mg/ 12,5 mg comprimés telmisartan/ hydrochlorothiazide
0.008431695401668549 ||| 30 In single-dose crossover studies of Neoclarityn 5 mg orodispersible tablets with Neoclarityn 5 mg conventional tablets or Neoclarityn 5 mg oral lyophilisate, the formulations were bioequivalent. ||| In single-dose crossover studies of Neoclarityn 5 mg orodispersible tablets with Neoclarityn 5 mg conventional tablets or Neoclarityn 5 mg oral lyophilisate, the formulations were bioequivalent. ||| Lors d’ essais croisés en dose unique de Neoclarityn 5 mg comprimés orodispersibles avec Neoclarityn 5 mg comprimés standards ou Neoclarityn 5 mg lyophilisat oral, les formulations étaient bioéquivalentes.
1.0272676944732666 ||| High chairs for babies ||| for medium/ large sized dogs ||| Chaises hautes pour enfants
0.4207726716995239 ||| Acticam is presented as an oral suspension 1.5 mg/ ml for dogs (to be given mixed with food) and a solution for injection 5mg/ ml. ||| Aivlosin is available as a premix for medicated feeding stuff and as an oral powder for pigs, and as granules for use in drinking water for chickens. ||| Acticam se présente sous la forme d’ une suspension orale de 1,5 mg/ ml pour chiens (à mélanger avec les aliments) et d’ une solution injectable de 5 mg/ ml.
0.08373645693063736 ||| Magnesium hydroxide for medicinal use ||| Magnesium hydroxide for industrial use ||| Hydroxyde de magnésium à usage médical
0.3286297917366028 ||| Summary of Product Characteristics, section 4.2.). ||| Summary of Product lo Characteristics, section 4.2) no ||| Résumé des caractéristiques du produit, rubrique 4.2.).
0.28785964846611023 ||| Ferrules of non-metallic materials for walking sticks ||| Nonferrous metals in powder form for printers ||| Viroles en matériaux non métalliques pour cannes
0.44999775290489197 ||| Standard methods to increase elimination of the medicinal product, e.g., dialysis, have not been shown to be useful. ||| Other methods of administration not specified in section 4.2 (e. g. intra-arterial injection) are not recommended. ||| L’ utilité des méthodes standard afin d’ augmenter l’ élimination du médicament, e. g., la dialyse, n’ a pas été montrée.
0.43152350187301636 ||| DO NOT use Enbrel if all the powder in the vial is not dissolved within 10 minutes. ||| Now 100 ml of 100% orange juice must be drunk by the patient without delay. ||| NE PAS utiliser Enbrel si la poudre dans le flacon ne s’est pas complètement dissoute en 10 minutes.
0.19570893049240112 ||| Most adverse reactions were mild to moderate and transient in nature. ||| The adverse reactions reported were transient, and generally mild or moderate. ||| La plupart des effets indésirables ont été légers à modérés et transitoires.
0.20094449818134308 ||| 44 8. ||| 32 8. ||| 44 9.
0.1940714567899704 ||| Subsequent PSURs will be submitted in accordance to the legislation, unless otherwise specified. ||| Subsequent PSURs will be submitted in accordance with the European legislation unless otherwise requested by the CHMP. ||| Les rapports suivants seront soumis conformément à la réglementation, sauf autre indication.
0.10299494117498398 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Kentera to Nicobrand Limited on 15 June 2004. ||| The European Commission granted a marketing authorisation valid throughout the European Union for DaTSCAN to GE Healthcare Limited on 27 July 2000. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Kentera à Nicobrand Limited le 15 juin 2004.
0.07811423391103745 ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck.com ||| 176 Eesti Österreich Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck.com ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck. com
0.4898885190486908 ||| Do not stop Insuman Rapid without speaking to a doctor, who will tell you what needs to be done. ||| You need to know about important signs and symptoms to look out for while you’ re taking Telzir. ||| N’arrêtez pas Insuman Rapid sans en parler à votre médecin, qui vous dira ce qu’il y a besoin de faire.
0.7471466064453125 ||| If bleeding is not kept under control hospital care is mandatory. ||| If he/ she is unavailable seek emergency assistance. ||| Si l'hémorragie n'est pas contrôlée, une hospitalisation est indispensable.
0.3117695748806 ||| In the treatment of central neuropathic pain due to spinal cord injury the incidence of adverse events in general, CNS adverse events and especially somnolence was increased (See 4.4). ||| Pre-specified events that occurred with the highest incidence in all three treatment groups involved the category of surgical wound complications, including deep surgical infections and sternal wound healing events. ||| Dans le traitement des douleurs neuropathiques centrales dues à une lésion de la moelle épinière, l’incidence des événements indésirables en général, les événements indésirables touchant le SNC et la somnolence en particulier, ont été accrus (voir 4.4).
0.18910977244377136 ||| Yellow fever vaccine-associated viscerotropic disease Very rarely, yellow fever vaccine-associated viscerotropic disease (YEL-AVD) resembling fulminant infection by wild-type virus has been reported following vaccination (see section 4.8). ||| Yellow fever vaccine associated neurotropic disease Very rarely, yellow fever vaccine-associated neurotropic disease (YEL-AND) has been reported following vaccination, with sequelae or with fatal outcome in some cases (see section 4.8). ||| Maladie viscérotrope associée à la vaccination anti-amarile (YEL-AVD) Très rarement, des cas de maladies viscérotropes associées à la vaccination anti-amarile (YEL-AVD) ressemblant à une infection fulminante par le virus sauvage ont été rapportés (voir rubrique 4.8).
0.0892016738653183 ||| Olanzapine Neopharma is a ‘ generic medicine’. ||| Olanzapine Mylan is a ‘ generic medicine’. ||| Olanzapine Neopharma est un "médicament générique".
0.6952770948410034 ||| This makes it impossible to set a uniform dosage scheme. ||| A task of this size can only happen if the world unites. ||| De ce fait, il est impossible de définir un schéma posologique unique.
0.4336963891983032 ||| Nervous system disorders Common: headache ||| Vascular disorders: hypertension. ||| Affections du système nerveux Fréquent: céphalées.
0.2516099214553833 ||| The pharmacokinetics of tenofovir have been studied in patients with hepatic impairment and no dose adjustment is required in these patients. ||| In clinical pharmacology studies, the potential for tadalafil to augment the hypotensive effects of antihypertensive agents was examined. ||| La pharmacocinétique du ténofovir a en revanche été étudiée chez ces patients et aucune adaptation de la dose n’ est apparue nécessaire.
0.14095064997673035 ||| If it is not used immediately it must be stored in a refrigerator (2°C – 8°C) and used within 24 hours. ||| After reconstitution, the product must be kept in a refrigerator (2°C - 8°C) and must be used within 6 hours. ||| Si ce n’est pas le cas, elle doit être conservée au réfrigérateur (entre +2°C et +8°C) et utilisée dans les 24 heures.
0.324736088514328 ||| A local reaction with swelling, pain, pruritis or hair loss at the injections site may be observed. ||| Sensation of warmth, pain, paraesthesia and rash at the site of application were also commonly observed. ||| Une réaction locale avec inflammation, douleur, prurit ou alopécie au site d'injection peut être observée de manière occasionnelle.
0.3606719374656677 ||| Photographic duplicating ||| Photographic restoration ||| Duplicateur de photographies
0.29816749691963196 ||| The response rates among patients with pulmonary disease and extrapulmonary disease were 47% (21/ 45) and 28% (5/ 18), respectively. ||| Rash (81% vs 67% respectively) and gastrointestinal manifestations (70% vs 54% respectively) were more frequently reported in children compared to adults. ||| Les taux de réponse parmi les patients ayant une maladie pulmonaire et extrapulmonaire ont été de 47% (21/ 45) et 28% (5/ 18), respectivement.
0.4568210244178772 ||| In Table 1 the frequency of patients reporting (treatment related) undesirable effects is presented from clinical trials in naïve patients treated for one year. ||| Table 1 lists adverse reactions recorded in the trials (events were recorded irrespective of a determination of causality). ||| La fréquence des effets indésirables (liés au traitement) rapportés au cours des études cliniques réalisées chez le patient naïf traité pendant un an nt
0.7705119848251343 ||| - Bacterial enteritis ||| erectile dysfunction ||| - Entérites bactériennes
0.31841859221458435 ||| Tasmar therapy should only be initiated by physicians experienced in the treatment of Parkinson’ s disease to ensure an appropriate risk-benefit assessment. ||| Increasing capacity and adapting healthcare for the needs of COVID-19 patients is described by the WHO as a fundamental outbreak response measure. ||| 49 Le traitement par Tasmar ne doit être instauré que par un médecin habitué au traitement de la maladie de Parkinson afin de permettre une évaluation correcte du rapport bénéfice/ risque.
0.0036958197597414255 ||| 121 If you switch from another insulin to insulin glulisine, your dosage may have to be adjusted by your doctor. ||| 138 If you switch from another insulin to insulin glulisine, your dosage may have to be adjusted by your doctor. ||| Si vous passez d’ une autre insuline à l’ insuline glulisine, il peut être nécessaire que votre médecin ré- évalue votre posologie.
0.4813849925994873 ||| Thyroid function testing is recommended at baseline and if abnormal, every 6-12 months following initiation of therapy. ||| For grade 3 sensory neuropathy withhold treatment until resolution to grade 1 or 2, followed by a dose reduction for all subsequent courses. ||| Des dosages thyroïdiens sont recommandés avant instauration du traitement; s’ ils sont anormaux, ils seront répétés tous les 6 à 12 mois.
0.024853643029928207 ||| If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Janumet. ||| If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Trevaclyn. ||| Si vous n’êtes pas certain(e) que l’un des points ci-dessus vous concerne, demandez conseil à votre médecin ou à votre pharmacien avant de prendre Janumet.
0.02235780470073223 ||| The combination of these ingredients has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone. ||| The combination of these substances has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone. ||| L’ association de ces principes actifs permet une additivité de leurs effets antihypertenseurs, et une réduction de la pression artérielle plus importante que celle observée avec chaque principe actif pris séparément.
2.7119284465651483e-13 ||| This overfill ensures that after dilution with the entire contents of the accompanying solvent for Docetaxel Winthrop vial, there is a minimal extractable premix volume of 8 ml containing 10 mg/ ml docetaxel which corresponds to the labelled amount of 80 mg per vial. ||| This overfill ensures that after dilution with the entire contents of the accompanying solvent for Docetaxel Winthrop vial, there is a minimal extractable premix volume of 8 ml containing 10 mg/ ml docetaxel which corresponds to the labelled amount of 80 mg per vial. ||| Ce surremplissage permet d'assurer qu'après dilution avec la totalité du flacon de solvant accompagnant le flacon de Docétaxel Winthrop que le volume minimal extractible de prémélange de 8 ml contient 10 mg/ ml de docétaxel, ce qui correspond à la quantité indiquée de 80 mg par flacon.
0.19229954481124878 ||| Conducting of business feasibility studies ||| Conducting financial feasibility studies ||| Réalisation d'études de faisabilité commerciale
0.16053016483783722 ||| Advisory services relating to the installation of generators ||| Design services relating to the installation of baths ||| Services de conseils liés à l'installation de générateurs
0.25280502438545227 ||| The recommended dose of Trudexa is 40 mg given every 2 weeks as a single subcutaneous injection (under the skin). ||| The recommended initial dose for olanzapine injection is 10 mg, administered as a single intramuscular injection. ||| La dose recommandée de Trudexa est de 40 mg toutes les deux semaines, administrée par injection unique par voie sous-cutanée (sous la peau).
0.18085390329360962 ||| Reactions (redness, swelling, inflammation, itching and bruising) at the injection site may occur. ||| Reactions (redness, swelling, itching) at the injection site may occur (local allergic reactions). ||| Des réactions (rougeur, gonflement, inflammation, démangeaison et ecchymose) peuvent survenir au site d’injection.
0.5961518287658691 ||| - Lactation (see section 4.6) ||| (See 4.6 Pregnancy & Lactation). ||| - Allaitement (voir rubrique 4.6)
0.33659636974334717 ||| On 19 March 2020, the Commission adopted a State aid Temporary Framework based on Article 107(3)(b) TFEU to enable Member States to use the full flexibility foreseen under State aid rules to support the economy in the context of the coronavirus outbreak. ||| Confirming the trend established since the launch of the EMEA, two-thirds of applications in 1998 continued to be optional, where the applicant had the choice of procedures under Part B of the Annex to Council Regulation (EEC) No 2309/ 93. ||| Le 19 mars 2020, la Commission a adopté un encadrement temporaire des aides d'État sur la base de l'article 107, paragraphe 3, point b), du TFUE, afin de permettre aux États membres d'exploiter pleinement la flexibilité prévue par les règles en matière d'aides d'État pour soutenir l'économie dans le contexte de la pandémie de coronavirus.
0.9257578253746033 ||| The marketing authorisation holder is Cephalon Europe. ||| Portugal Serviço local de Atendimento ao utilizador de EXUBERA Tel: ||| Le titulaire de l’ autorisation de mise sur le marché est Cephalon Europe.
0.5926294326782227 ||| Mixtures for making frozen confections ||| Confectionery for decorating Christmas trees ||| Mélanges pour faire des confiseries glacées
0.0 ||| If not, change the needle and repeat the procedure no more than six times. ||| If not, change the needle and repeat the procedure no more than six times. ||| Si ce n’est pas le cas, changez d’aiguille et ne répétez l’opération pas plus de six fois.
0.29203879833221436 ||| • White polyvinyl chloride (PVC) laminated with polychloro-trifluoroethylene (PCTFE)/ aluminium push- through layer. ||| 26 • Oriented polyamide (OPA)-aluminium-polyvinyl chloride (PVC)/ aluminium push-through layer. ||| Chlorure de polyvinyl (PVC) laminé blanc avec couche en polychloro-trifluoroéthylène (PCTFE)/ aluminium pour extraction du comprimé.
0.9801701903343201 ||| weight increase ||| Weight decreased ||| prise de poids
0.2795238792896271 ||| Biogen Idec Limited, Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, United Kingdom. ||| Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Herts, AL10 9SN, UK ||| Biogen Idec Limited, Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, Royaume-Uni
0.3873003125190735 ||| A dose adjustment of Kaletra 400 mg/ 400 mg twice daily has allowed compensating for the CYP 3A4 inducer effect of rifampicin. ||| Increasing the dose to 300 mg irbesartan and 25 mg hydrochlorothiazide may give a further decrease in blood pressure. ||| Une adaptation posologique de Kaletra à 400 mg/ 400 mg deux fois par jour a permis de compenser l’ effet inducteur de la rifampicine sur le CYP 3A4.
6.401578486053827e-13 ||| If you are unsure about this, ask your doctor. ||| If you are unsure about this, ask your doctor. ||| En cas de doute, n’ hésitez pas à demander l’ avis de votre médecin.
0.0 ||| Eli Lilly Nederland BV, Grootslag 1-5, NL-3991 RA Houten, The Netherlands. ||| Eli Lilly Nederland BV, Grootslag 1-5, NL-3991 RA Houten, The Netherlands. ||| Eli Lilly Nederland BV, Grootslag 1-5, NL-3991 RA Houten, Pays Bas.
0.250144898891449 ||| Bicycle sheds [structures] of non-metallic materials ||| Changing rooms [structures] of non-metallic materials ||| Abris pour vélos [structures] en matériaux non métalliques
0.55970299243927 ||| OMRIX Biopharmaceuticals Ltd Plasma Fractionation Institute Sheba Hospital, Tel Hashomer Ramat Gan 52621, Israel Att: ||| FARMASERVE LILLY S.A.Cl 15 Km National Road Athens-Lamia Kifissia, 14564 Greece ||| OMRIX Biopharmaceuticals Ltd Plasma Fractionation Institute Sheba Hospital, Tel Hashomer Ramat Gan 52621, Israël Att:
0.05666056647896767 ||| Store in the original carton in order to protect from light. ||| Store in the original container in order to protect from light. ||| A conserver dans l’ emballage extérieur d’ origine à l’ abri de la lumière.
0.8950594067573547 ||| 324 Diagram 17. ||| Median 100 75 33 ||| Schéma 17.
0.1077590137720108 ||| Computerweg 10, 3542 DR Utrecht The Netherlands ||| Computerweg 10 3542 DR Utrecht The Netherlands ||| Computerweg 10, 3542 DR Utrecht Pays-Bas
0.29924720525741577 ||| The plasma half-life of perindopril is equal to 1 hour. ||| Naloxone has a mean half-life from plasma of 1.2 hours. ||| 20  EMEA 2005 La demi-vie plasmatique du perindopril est de 1 heure.
0.42720872163772583 ||| The enzyme DNA-gyrase plays a crucial role in this process. ||| Thrombin plays a central role in the process of blood clotting. ||| L’ ADN-gyrase joue un rôle essentiel dans ce processus.
0.2745395600795746 ||| However, the majority of common adverse reactions were mild to moderate, they usually start early in therapy, and most tended to disappear even as therapy was continued. ||| In dogs, these side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. ||| Ces troubles ont été fr équents en début de traitement et la plupart ont tendu à disparaître lors de la poursuite de celui -ci.
0.20090794563293457 ||| 4 (0.9) 2 (0.4) 15 (3.2) 18 (3.9) 12 (2.6) 7 (1.5) ||| 8 (5.3) 6 (3.9) 5 (3.3) 4 (2.6) 3 (2.0) ||| 7 (0,7) 5 (0,5) 14 (1,4) 10 (1,0) 21 (2,1) 28 (2,9)
0.7690383791923523 ||| What is the role of the EIB Group in the new proposal? ||| The company Wish.com has recently joined the initiative. ||| Quel rôle la nouvelle proposition attribue-t-elle au Groupe BEI?
0.8216844797134399 ||| Post-marketing experience ||| ed Postmarketing Experience ||| 9 Expérience après commercialisation
0.0007994537008926272 ||| 40 In smoking subjects with mild hepatic dysfunction, mean elimination half-life (39.3 hr) was prolonged and clearance (18.0 l/ hr) was reduced analogous to non-smoking healthy subjects (48.8 hr and 14.1 l/ hr, respectively). ||| 54 In smoking subjects with mild hepatic dysfunction, mean elimination half-life (39.3 hr) was prolonged and clearance (18.0 l/ hr) was reduced analogous to non-smoking healthy subjects (48.8 hr and 14.1 l/ hr, respectively). ||| Chez les sujets fumeurs avec une insuffisance hépatique modérée, la demi-vie d’ élimination moyenne est prolongée (39,3 heures) et la clairance (18,0 l/ heure) est réduite de la même façon que chez les sujets sains (respectivement 48,8 heures et 14,1 l/ heure).
0.3642299473285675 ||| Once the oral powder is mixed with these, it should be used within 6 hours. ||| The cream should be applied prior to normal sleeping hours and remain on the skin for approximately 8 hours. ||| Une fois mélangée avec ces derniers, elle doit être utilisée dans les 6 heures.
0.28836536407470703 ||| Do not remove the plastic cover from the needle until you are ready to inject. ||| After injecting the liquid, remove the needle and let go of your skin. ||| N’ enlevez pas le capuchon en plastique de l’ aiguille avant d’ être prêt(e) pour l’ injection.
0.8384567499160767 ||| Arterial thromboembolism: ||| Chromolithographs [chromos] ||| Thromboembolies artérielles:
0.24902130663394928 ||| EXP MM/ YYYY ||| MM/ YYYY ||| EXP: mois/ année
0.3983233571052551 ||| 1 ml reconstituted vaccine, via subcutaneous injection. ||| 80 mg administered as one subcutaneous injection ||| 1 ml de vaccin reconstitué, par voie sous-cutanée.
0.44294923543930054 ||| Since the effectiveness of Lucentis was slightly greater in the patients receiving the 0.5 mg dose and the most common side effects were not serious, the Committee recommended that this dose of Lucentis should be given a marketing authorisation. ||| From the results it can be concluded that efficacy results of the 20 mg maintenance dose were more favourable, on the other hand, the safety results favoured the 10 mg daily maintenance dose. ||| Étant donné que l’ efficacité de Lucentis était légèrement supérieure chez les patients recevant la dose de 0,5 mg et que les effets indésirables les plus fréquents n’ étaient pas graves, le comité a recommandé d'octroyer à cette dose de Lucentis une autorisation de mise sur le marché.
0.09632885456085205 ||| Caution is warranted and clinical monitoring of patients is recommended. ||| Caution is warranted and clinical monitoring is recommended. ||| Une vigilance particulière et un suivi clinique des patients sont recommandés.
0.025982726365327835 ||| 2 Laguno M, Murillas J, Blanco J.L et al. ||| 2 Laguno M, Murillas J, Blanco J. L et al. ||| 2 Laguno M, Murillas J, Blanco J. L. et al.
0.28303295373916626 ||| Cosmetics in the form of milks ||| Steels in the form of reels ||| Cosmétiques sous forme de laits
0.33244627714157104 ||| In the current circumstances, this temporary cooperation appears indeed justifiable under EU antitrust law, in view of its objective and the safeguards put in place to avoid anticompetitive concerns and as long as it remains within the scope communicated to the Commission. ||| As a result, certain conditions under the Temporary Framework, in particular certain governance commitments intended to provide incentives for an exit by the State and redemption of the State aid as soon as possible, are not appropriate or necessary to the same extent in these circumstances. ||| Dans les conditions actuelles, cette coopération temporaire apparaît en effet justifiée au regard des règles de concurrence de l'UE, compte tenu de son objectif et des garanties mises en place pour écarter toute préoccupation en matière de concurrence, et sous réserve que le projet respecte les limites communiquées à la Commission.
0.13270120322704315 ||| Animal studies with alendronate do not indicate direct harmful effects with respect to pregnancy, embryonal/ foetal development, or postnatal development. ||| Animal studies do not indicate direct or indirect harmful effects with respect to fertility, pregnancy, embryonal/ foetal development. ||| Les études chez l’ animal avec l’ alendronate n’ indiquent pas d’ effets directement néfastes sur la grossesse, le développement embryo-fœ tal ou le développement post-natal.
0.0 ||| • The needle cover of the syringe contains natural rubber (latex). ||| • The needle cover of the syringe contains natural rubber (latex). ||| • Le capuchon de la seringue contient du caoutchouc naturel (latex).
0.40689271688461304 ||| You should not take DULOXETINE BOEHRINGER INGELHEIM if you are taking, or have recently taken within the last 14 days, another antidepressant medicine called a monoamine oxidase inhibitor (MAOI). ||| Based on the half-life of duloxetine, at least 5 days should be allowed after stopping DULOXETINE BOEHRINGER INGELHEIM before starting an MAOI (see section 4.3). ||| Inhibiteurs de la monoamine oxydase (IMAO): vous ne devez pas prendre DULOXETINE BOEHRINGER INGELHEIM en association avec un IMAO ou dans les 14 jours suivant l’ arrêt d'un IMAO.
0.482089638710022 ||| The clinical relevance of these findings is uncertain as this has not been studied in patients. ||| It has not undergone the clinical studies needed to show it is safe and effective for the disease. ||| La pertinence clinique de ces résultats est incertaine puisque aucune n’ a été réalisée chez des patients.
0.3579946756362915 ||| Do not store the insulin inhaler in the refrigerator or freezer. ||| ed Do not refrigerate or freeze the insulin inhaler. ||| u Ne pas conserver l'inhalateur d’insuline au réfrigérateur ou au congélateur.
0.35580822825431824 ||| Lansoprazole 30 mg combined with clarithromycin 250 or 500 mg and amoxicillin 1g, or clarithromycin 250 and metronidazole 400-500 mg twice daily was associated with eradication rates meeting the above described requirements. ||| However, Ciprofloxacin 2mg/ ml Solution for Infusion has been shown to be compatible with Ringer's solution, 0.9% sodium chloride solution, 5% and 10% glucose solutions, glucose/ saline and fructose 10% solution. ||| L'association lansoprazole 30 mg, clarithromycine 250 ou 500 mg et amoxicilline 1 g, ou clarithromy- cine 250 et métronidazole 400 à 500 mg deux fois par jour a permis d'obtenir des taux d'éradication répondant aux critères susmentionnés.
0.23232658207416534 ||| The application of this treatment in the context of the coronavirus pandemicwould incentivise banks to extend lending to employees and pensioners. ||| In the context of the Coronavirus pandemic, it is essential that banks continue lending to SMEs and supporting infrastructure investments. ||| L'application de ce traitement plus favorable dans le contexte de la pandémie de COVID-19 encouragerait les banques à accorder des prêts aux salariés et aux retraités.
0.46794629096984863 ||| Connecting in an affected area may lead to entry restrictions later on, and if you've been in an affected area recently some countries won't even let you change planes. ||| The European Commission has said they can be considered as critical workers, but understandably, many don't wish to leave home. Lower production could in turn have an impact on prices. ||| Une correspondance dans une zone touchée peut entraîner des restrictions d’entrée ultérieurement et, si vous avez récemment été dans une zone touchée, certains pays ne vous laisseront même pas changer d’avion.
0.5037052631378174 ||| On the night of 4 October 2001, Theodore Roosevelt and CVW-1 launched the initial strikes of Operation Enduring Freedom against al-Qaeda in Afghanistan from the North Arabian Sea. ||| Moore enlisted in the 8th Battalion, Duke of Wellington's Regiment (8 DWR) at the beginning of the Second World War, stationed in Cornwall. ||| Dans la nuit du 4 octobre 2001, le Roosevelt et CVW-1 lancent les premières frappes tactiques contre Al-Qaïda, marquant ainsi l'ouverture des hostilités de l'opération Enduring Freedom.
0.4054161310195923 ||| Gabapentin was given in the diet to mice at 200, 600, and 2000 mg/ kg/ day and to rats at 250, 1000, and 2000 mg/ kg/ day for two years. ||| Daily doses of 150, 450 and 1,000 mg/kg were administered to mice and doses of 50, 150 and 500 mg/kg were administered to rats. ||| La gabapentine a été administrée dans l'alimentation à des souris à des doses de 200, 600 et 2.000 mg/ kg/ jour et à des rats à des doses de 250, 1.000 et 2.000 mg/ kg/ jour pendant deux ans.
0.5436073541641235 ||| Igniting magnetos ||| Calibrating rings ||| Magnétos d'allumage
0.29284125566482544 ||| ViraferonPeg is supplied as a powder of peginterferon alfa-2b at a strength of 80 micrograms for single use. ||| ATryn is presented as a powder for solution for infusion containing nominally 1750 IU antithrombin alfa per vial. ||| ViraferonPeg se présente sous forme de poudre de peginterféron alfa-2b à la dose de 80 microgrammes pour une seule administration.
0.371189147233963 ||| The concentrations were comparable to those reported previously in patients with metastatic breast cancer. ||| The exposure levels were lower than those with the recommended clinical dose in humans. ||| Les concentrations étaient comparables à celles reportées précédemment dans le cancer du sein métastatique.
0.11311618238687515 ||| 2/ 11 ||| 2/ 14 ||| 3/ 11
0.22447828948497772 ||| The recommended dose of Epivir for patients over 12 years of age is 300 mg daily. ||| The recommended dose of Trizivir in adults (18 years and over) is one tablet twice daily. ||| La dose recommandée d’ Epivir pour les patients âgés de plus de 12 ans est de 300 mg par jour.
0.387234091758728 ||| Always take (Invented name)® exactly as your doctor has told you. ||| Always take {PRODUCT NAME} 40 mg exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.4429495334625244 ||| Table centres [ornaments] made of wood ||| Model vehicles [ornaments] made of terra-cotta ||| Centres de table [décorations] en bois
0.02351776883006096 ||| EU/ 1/ 00/ 153/ 006 ||| EU/ 1/ 00/ 153/ 008 ||| EU/ 1/ 00/ 153/ 007
0.3355228304862976 ||| Bone discolouring was observed in rats which was not reversible after two weeks of dosing. ||| Advasure was also studied in fattening pigs where a single vaccination was given at age 10 weeks. ||| Chez le rat, une coloration des os, non réversible après deux semaines de traitement, a été observée.
2.292846359823464e-13 ||| In the case of major surgical interventions in particular, a precise monitoring of the substitution therapy by means of coagulation analysis is indispensable. ||| In the case of major surgical interventions in particular, a precise monitoring of the substitution therapy by means of coagulation analysis is indispensable. ||| 82 chirurgicale majeure tout particulièrement, un contrôle minutieux du traitement substitutif est indispensable à l'aide des tests de coagulation.
0.43127718567848206 ||| Diarrhoea** Stomatitis Dyspepsia Flatulence Skin and subcutaneous tissue disorders ||| Peripheral neuropathy* Tremor Dizziness Paraesthesia Dysaesthesia Somnolence ||| Diarrhées** Stomatite Dyspepsie Flatulence Affections de la peau et du tissu sous-cutané
0.4079931080341339 ||| Irrespective of treatment, mortality was lower in the group of patients treated with a beta blocker, suggesting that the known beta blocker benefit in this population was maintained in this trial. ||| According to March data from the United States, 89% of those hospitalised had preexisting conditions.Availability of medical resources and the socioeconomics of a region may also affect mortality. ||| Quel que soit le traitement, la mortalité a été inférieure dans le groupe de patients traités par un bêtabloquant, ce qui suggère que le bénéfice connu des bêtabloquants dans cette population s’est maintenu pendant cette étude.
0.36290043592453003 ||| Pharmacokinetics in children and the elderly: in children between the ages of 2 and 13 years, the clearance of orally administered nelfinavir is approximately 2 to 3 times higher than in adults, with large intersubject variability. ||| In addition, alendronate 10 mg and alendronate 5 mg were effective irrespective of age (< 65 years as against ≥ 65 years), gender, baseline BMD, baseline bone turnover and concomitant use of a number of common medicines. ||| Pharmacocinétique chez les enfants et les sujets âgés: chez les enfants âgés de 2 à 13 ans, la clairance du nelfinavir administré par voie orale est 2 à 3 fois plus élevée que chez l’adulte avec une grande variabilité interindividuelle.
0.0 ||| r 4.1 Therapeutic indications ||| r 4.1 Therapeutic indications ||| lus 4.1 Indications thérapeutiques
0.41153421998023987 ||| Solvent Colourless glass ampoule, type I glass, containing 5 ml water for injections. ||| Cardboard box with 1 or 12 colourless glass injection vial(s) of 100 ml. ||| 8 Solvant Ampoule en verre incolore de type I, contenant 5 ml d’ eau pour préparations injectables.
0.6067823171615601 ||| Further instructions for preparation for infusion ||| Instruction for all areas of indication ||| Guide de préparation de la solution pour perfusion
0.37464386224746704 ||| BYETTA is not recommended for use in patients with end-stage renal disease or severe renal impairment (creatinine clearance < 30 ml/ min). ||| For the long-term treatment of growth failure in children and adolescents with severe primary insulin- like growth factor-1 deficiency (Primary IGFD). ||| BYETTA n’ est pas recommandé chez les patients présentant une insuffisance rénale terminale ou sévère (clairance de la créatinine < 30 ml/ min).
0.0905391126871109 ||| Advate is used for the treatment and prevention of bleeding in patients with haemophilia A (an inherited bleeding disorder caused by lack of factor VIII). ||| Helixate NexGen is used for the treatment and prevention of bleeding in patients with haemophilia A (an inherited bleeding disorder caused by lack of factor VIII). ||| Advate est utilisé pour le traitement et la prévention des hémorragies chez les patients souffrant d’ hémophilie A (un trouble hémorragique héréditaire dû à une déficience en facteur VIII).
0.24236103892326355 ||| Do not stop using your medicine unless your doctor tells you to. ||| Do not stop taking Tracleer unless your doctor tells you to. ||| N’ interrompez pas votre médicament à moins que votre médecin ne vous l’ ait demandé.
0.321807324886322 ||| In this group, over 3 years of treatment, PROTELOS reduced the risk of hip fracture by 36% relative to the placebo group (table 2). ||| Contrast-enhancing tumour was resected in 64% of patients in the experimental group compared to 38% in the control- group (p < 0.001). ||| Dans ce groupe, après 3 ans de traitement, PROTELOS a réduit le risque de fracture de hanche de 36% par rapport au placebo (tableau 2).
0.25040188431739807 ||| tocopherol, colloidal anhydrous silica, sodium stearyl fumarate, methacrylic acid – ethyl acrylate co-polymer (1:1), macrogol, and titanium dioxide (E171). ||| Tablet coat: polyvinyl alcohol polyethylene glycol 400, 3350 and 8000 talc soya-lecithin hypromellose titanium dioxide (E171) yellow iron oxide (E172) ||| tocophérol, silice colloïdale anhydre, fumarate de stéaryle sodique, copolymère d’acide méthacrylique et d’acrylate d’éthyle (1:1), macrogol et dioxyde de titane (E171).
0.2699752449989319 ||| It works by blocking an enzyme called ‘ xanthine oxidase’, which is needed to make uric acid in the body. ||| ADENURIC tablets are used to treat gout, which is associated with an excess of a chemical called uric acid (urate) in the body. ||| Il agit en bloquant une enzyme appelée « xanthine oxydase », qui est nécessaire pour produire l’ acide urique dans l’ organisme.
0.04148844629526138 ||| From a microbiological point of view, the product should be used immediately. ||| From a microbiological point of view, the solution must be used immediately. ||| D’ un point de vue microbiologique, le médicament doit être utilisé immédiatement.
0.4223155975341797 ||| "On 27 January, after the first infections in Germany, the government continued to regard the probability of a spread as ""very low""." ||| "In the early stages of the outbreak, the Chinese National Health Commission said they had no ""clear evidence"" of human-to-human transmissions." ||| Le 27 janvier, après les premiers cas constatés en Allemagne, le gouvernement considère toujours que la probabilité de propagation de la maladie est très faible.
0.5605310201644897 ||| Not all pack sizes or strengths may be available in your country. ||| This leaves only a few, or no antibiotics available for treatment. ||| Toutes les présentations ou tous les dosages peuvent ne pas être commercialisés dans votre pays.
0.5314799547195435 ||| - To minimise foam formation in solutions of ORENCIA, the vial should be rotated with gentle ||| Development of a non-splash type of spindle bearing, more particularly for new mules ||| - Pour minimiser la formation de mousse dans les solutions d'ORENCIA, remuer doucement le flacon
0.4446353018283844 ||| Luer tapers for medical use ||| Shock wave apparatus for medical use ||| Connexions Luer à usage médical
0.014119015075266361 ||| The Commission found that the Hungarian measures are in line with the conditions set out in the Temporary Framework. ||| The Commission found that the Romanian measures are in line with the conditions set out in the Temporary Framework. ||| La Commission a estimé que les mesures hongroises étaient conformes aux conditions énoncées dans l'encadrement temporaire.
0.004743505734950304 ||| 24 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 23 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 26 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’Autorisation de Mise sur le Marché.
0.40659263730049133 ||| Organon, Kloosterstraat 6, 5349 AB Oss, The Netherlands • Organon (Ireland) Ltd., Drynam Road, Swords, Co. ||| Les Laboratoires Servier Industrie, 905, route de Saran – 45520 Gidy, France Servier (Ireland) Industries Ltd, Gorey Road - Arklow - Co. ||| Organon, Kloosterstraat 6, 5349 AB Oss, Pays-Bas • Organon (Ireland) Ltd., Drynam Road, Swords, Co.
0.2399817407131195 ||| How does Rebetol work? ||| How does Ovitrelle work? ||| Comment Rebetol agit -il?
0.5427412986755371 ||| The residues were rapidly depleted. ||| The other layers of retina were not affected. ||| La déplétion des résidus a été rapide.
0.3083023428916931 ||| The undesirable reactions associated with the use of teriparatide in osteoporosis clinical trials are summarised in the table below. ||| The mechanisms of vigabatrin-induced retinotoxicity need further clarification through a series of preclinical studies focusing on: ||| Les effets indésirables liés à l’ utilisation du tériparatide dans les essais cliniques portant sur l’ ostéoporose sont résumés dans le tableau ci-dessous.
0.6784112453460693 ||| Content 90 µl ||| 90µl ||| Contenu 90 µl
0.07861924916505814 ||| The apparent peripheral volume of distribution of rimonabant appears to be related to body weight, with obese patients having a higher volume of distribution than normal-weight subjects. lp ||| The apparent peripheral volume of distribution of rimonabant appears to be related to body weight, with obese patients having a higher volume of distribution than normal-weight dic ||| Le volume de distribution périphérique apparent du rimonabant semble relié au poids corporel, les patients obèses ayant un volume de distribution plus important que les sujets de poids normal.
0.048339344561100006 ||| NovoRapid FlexPen should only be used in combination with products that are compatible with them and allow the pens to function safely and effectively. ||| NovoRapid Penfill should only be used in combination with products that are compatible with them and allow the Penfill to function safely and effectively. ||| NovoRapid FlexPen doit exclusivement être utilisé avec des produits compatibles garantissant son fonctionnement sûr et efficace.
0.2796963155269623 ||| The recommended dose is 30 mg once daily for 2 weeks. ||| A starting dose of 0.25 mg twice daily is recommended. ||| La posologie recommandée est de 30 mg une fois par jour pendant 2 semaines.
0.19657324254512787 ||| Each vial contains 100 mg bevacizumab. ||| 1 vial contains 80 mg tocilizumab. ||| Chaque flacon contient 100 mg de bevacizumab.
0.7758816480636597 ||| Therapeutic Monitoring and Dose Adjustment ||| Assays to Measure Immune Response ||| Surveillance thérapeutique et ajustement posologique
0.4133029580116272 ||| Patients who develop a new infection while undergoing treatment with Trudexa should be monitored lP ||| What are the consequences of the withdrawal for patients undergoing clinical trials with MULTAQ? ||| Les patients chez qui apparaît une nouvelle infection en cours de traitement par Trudexa doivent faire l'objet d'une surveillance soigneuse.
0.20644119381904602 ||| 31.2 (± 38.69) ||| 71.9 (± 30.93) ||| 31,2 (± 38,69)
0.008196098729968071 ||| 486 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51 ||| 783 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51 ||| Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51
0.3189444839954376 ||| The starting dose may be adjusted by your doctor depending on how your anaemia responds to treatment; you will usually receive Retacrit until 1 month after the end of chemotherapy. ||| Your doctor may advise you to take this drug 1 hour before or 3 hours after Renagel intake, or he/ she may consider monitoring the blood levels of that drug. ||| La dose d’attaque peut être ajustée par votre médecin selon la manière dont votre anémie réagit au traitement; vous recevrez généralement Retacrit jusqu’à 1 mois après la fin de la chimiothérapie.
0.28791099786758423 ||| After administration of Helixate NexGen, peak factor VIII activity decreased by a two-phase exponential decay with a mean terminal half-life of about 15 hours. ||| The plasma concentration of AsIII declines from peak plasma concentration in a biphasic manner with a mean terminal elimination half-life of 10 to 14 hours. ||| Après administration d'Helixate NexGen, la décroissance du pic d’ activité en facteur VIII est de type exponentiel biphasique, avec une demi-vie terminale moyenne d’ environ 15 heures.
0.0 ||| Pigs (sows and gilts) ||| Pigs (sows and gilts) ||| Porcs (truies et cochettes)
0.25226330757141113 ||| Elimination Following administration of an oral [14C]sitagliptin dose to healthy subjects, approximately 100% of the administered radioactivity was eliminated in faeces (13%) or urine (87%) within one week of dosing. ||| Biotransformation and elimination One week following administration of a single oral dose of 1 mg immediate-release 14C-paliperidone, 59% of the dose was excreted unchanged into urine, indicating that paliperidone is not extensively metabolised by the liver. ||| Elimination Après administration d'une dose orale de [14C]sitagliptine à des sujets sains, environ 100% de la radioactivité administrée ont été éliminés dans les fèces (13%) ou dans l'urine (87%) au cours de la semaine qui a suivi l'administration.
0.25358206033706665 ||| Indinavir AUC ↓ 56% Indinavir Cmin ↓ 27% (Relative to Indinavir 800 mg TID alone) ||| Rifabutin AUC: ↑ 173% Rifabutin Cmin: ↑ 244% (Relative to rifabutin 300 mg QD alone) ||| Indinavir ASC: ↓ 56% Indinavir Cmin: ↓ 27% (Par rapport à indinavir 800 mg seul, trois fois/ jour)
0.38445693254470825 ||| Following intravenous administration, choriogonadotropin alfa is distributed to the extracellular fluid space with a distribution half-life of around 4.5 hours. ||| Oxybutynin is transported across intact skin and into the systemic circulation by passive diffusion across the stratum corneum. ||| Après administration par voie intraveineuse, la choriogonadotropine alfa a une demi-vie de distribution dans le liquide extracellulaire d’ environ 4,5 heures.
0.37307435274124146 ||| Colon, colorectal and advanced gastric cancer: meta-analysis A meta-analysis of six clinical trials (studies SO14695, SO14796, M66001, NO16966, NO16967, M17032) supports Xeloda replacing 5-FU in mono- and combination treatment in gastrointestinal cancer. ||| 14 Clinical and Laboratory Standards Institute™ (CLSI) MIC and disc diffusion breakpoints for Staphylococcus spp. and fastidious organisms (M100-S17, 2007) and MIC breakpoints for anaerobes (M11-A7, 2007): ||| Cancer du côlon, cancer colorectal et cancer gastrique avancé: méta-analyse Une méta-analyse sur six études cliniques (études SO14695, SO14796, M66001, NO16966, NO16967, M17032) supporte le remplacement par Xeloda du 5-FU en monothérapie comme en association dans le traitement des cancers digestifs.
0.5640861988067627 ||| Electric terminal lugs ||| Electric cable hoists ||| Cosses électriques
0.0 ||| It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine. ||| It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine. ||| Il a pour objectif d’ expliquer comment l’ évaluation effectuée par le comité des médicaments à usage humain (CHMP), sur la base des études réalisées, a conduit aux recommandations relatives aux conditions d’ utilisation.
0.5456494688987732 ||| Rosiglitazone therapy is usually initiated at 4 mg/ day. ||| Erbitux is usually infused once a week. ||| Le traitement par la rosiglitazone pourra être instauré à la dose de 4 mg par jour.
0.020827123895287514 ||| Axura works by blocking special types of receptor called NMDA receptors, to which the neurotransmitter glutamate normally attaches. ||| Ebixa works by blocking special types of receptor called NMDA receptors to which the neurotransmitter glutamate normally attaches. ||| Axura agit en bloquant des types spéciaux de récepteur, appelés les récepteurs NMDA, auxquels le neurotransmetteur glutamate se fixe normalement.
0.007209014147520065 ||| Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice. ||| Patients with pre-existing liver dysfunction including chronic hepatitis have an increased frequency of liver function abnormalities during combination anti-retroviral therapy and should be monitored according to standard practice. ||| 6 ayant des troubles préexistants de la fonction hépatique (y compris une hépatite chronique active) ont, au cours d’ un traitement par association d’ antirétroviraux, une fréquence plus élevée d’ anomalies de la fonction hépatique et doivent faire l’ objet d’ une surveillance appropriée.
0.2783070504665375 ||| Pigments for use in the manufacture of pharmaceuticals ||| Preservatives for use in the pharmaceutical industry ||| Pigments destinés à la fabrication de produits pharmaceutiques
0.17110151052474976 ||| However, for patients who are receiving dialysis therapy, a longer dosing interval may be considered (see section 5.2). ||| However, a longer dosing interval may be considered for patients who are receiving dialysis therapy. ||| Toutefois, une augmentation de l’ intervalle entre les prises pourra être envisagée chez les patients dialysés (voir rubrique 5.2).
0.6833245754241943 ||| Melatonin is associated with the control of circadian rhythms and entrainment to the light-dark cycle. ||| • involuntary rhythmic movements of the tongue, mouth and face. ||| La mélatonine participe au contrôle des rythmes circadiens et à la régulation du rythme jour-nuit.
0.33329588174819946 ||| Radiation dose to the body can be limited by promoting a diuresis and frequent voiding of urine. ||| Vigorous shaking/ agitation should be avoided to prevent foaming of the product. ||| La dose de rayonnements délivrée à l’ organisme peut être diminuée en augmentant la diurèse et la fréquence des mictions.
0.22771108150482178 ||| In the event of overdose, Doribax should be discontinued and general supportive treatment given until renal elimination takes place. ||| In the event of overdose, EMEND should be discontinued and general supportive treatment and monitoring should be provided. ||| En cas de surdosage, l’administration de Doribax doit être interrompue et un traitement symptomatique donné jusqu'à complète élimination rénale.
0.2218756377696991 ||| However, there has been no evidence of an increase in the occurrence of AIDS-related infections associated with the use of CELSENTRI in clinical studies ||| Based on the available data, there is no possible link between an immunological reaction caused by the hexavalent vaccines and an increase of SUD occurrence. ||| Toutefois, il n’a pas été mis en évidence dans les études cliniques une augmentation de l’incidence des infections opportunistes du SIDA associée à l’utilisation de CELSENTRI.
0.2289729118347168 ||| Belgique/ Belgien Tél/ Tel: + 32 (0)2 656 21 11 ||| Tél/ Tel: +32 (0) 2 735 45 34 (België / Belgique) ||| Belgique/Belgien Tél/Tel: + 32 (0)2 656 21 11
0.002903509885072708 ||| 44 Intravascular volume depletion: volume and/ or sodium depletion should be corrected prior to administration of Irbesartan Hydrochlorothiazide Winthrop. ||| 58 Intravascular volume depletion: volume and/ or sodium depletion should be corrected prior to administration of Irbesartan Hydrochlorothiazide Winthrop. ||| 47 Hypovolémie: l'hypovolémie et/ ou une déplétion sodée devront être corrigées préalablement à l'administration de Irbesartan Hydrochlorothiazide Winthrop.
0.38635191321372986 ||| Information and consultancy services relating to vehicle repair ||| Medical care and analysis services relating to patient treatment ||| Services de conseil et d'information en matière de réparation de véhicules
0.4421176314353943 ||| Spray crystallized maltose for industrial use ||| Petroleum jelly for veterinary use ||| Maltose cristallisé par atomisation à usage industriel
0.274140864610672 ||| Dose-proportional pharmacokinetics were observed following single dose intravenous administration of 2.5 to 10 g of Cyanokit in healthy volunteers. ||| The pharmacokinetics of ViraferonPeg following a single subcutaneous dose of 1.0 microgram/kg were not affected by age. ||| Une pharmacocinétique proportionnelle à la dose a été observée après administration intraveineuse d’ une dose unique de 2,5 à 10 g de Cyanokit à des volontaires sains.
0.4217889904975891 ||| The MINE project will be a cooperative venture, where the Agency’ s role will be to harness the knowledge and judgment of professional networks across Europe, including universities and public agencies. ||| The EMEA is the central part of the pan-European network bringing together national structures for the authorisation and supervision of medicines for human and veterinary use. ||| Le projet MINE sera une initiative collective, dans laquelle le rôle de l’ Agence consistera à exploiter les connaissances et le jugement de réseaux professionnels dans toute l’ Europe, notamment des universités et autorités publiques.
0.9319982528686523 ||| Tablets are taken morning and evening, with or without food. ||| Before, during, and after preparing food. ||| Les comprimés sont pris matin et soir, au cours ou en dehors des repas.
0.0 ||| In the 3.5 year PROactive study, 44/ 870 (5.1%) of pioglitazone-treated female patients experienced fractures compared to 23/ 905 (2.5%) of female patients treated with comparator. ||| In the 3.5 year PROactive study, 44/ 870 (5.1%) of pioglitazone-treated female patients experienced fractures compared to 23/ 905 (2.5%) of female patients treated with comparator. ||| 42 Dans l'étude PROactive, étude de morbi-mortalité cardiovasculaire menée sur 3,5 ans, 44/ 870 (5,1%) des patientes traitées par la pioglitazone ont présenté des fractures contre 23/ 905 (2,5%) des patientes traitées par un comparateur.
0.2801780104637146 ||| The use of Kentera in patients with hepatic impairment should be carefully monitored. ||| Close monitoring of haematological parameters is advised in patients with hepatic impairment. ||| L'utilisation d'Kentera chez les patients présentant une insuffisance hépatique doit être suivie avec attention.
0.06389422714710236 ||| Providing medical information in the field of geriatrics ||| Providing medical advice in the field of geriatrics ||| Fourniture d'information médicale dans le domaine de la gériatrie
0.5752749443054199 ||| 50 mg / 2 ml ||| 100 ml 50 ml ||| 50 mg/ 2ml
0.06452514231204987 ||| 17 Nervous system disorders ||| 18 Nervous system disorders ||| Désordres du système nerveux
0.31163614988327026 ||| If your doctor detects clinical signs, symptoms or laboratory abnormalities suggestive of pancreatitis they will stop treatment with Trizivir immediately. ||| Please contact your doctor if you think that the frequency and/ or severity of the convulsions have changed when taking Xenical together with antiepileptic drugs. ||| Le traitement par Trizivir doit être interrompu immédiatement en cas de signes cliniques ou biologiques évocateurs de pancréatite.
0.5190584659576416 ||| Preparation of reports relating to medical matters ||| Publication of the results of clinical trials ||| Préparation de rapports dans le domaine médical
0.4235069155693054 ||| It was amended on 3 April and 8 May 2020. ||| The Temporary Framework was amended on 3 April and 8 May 2020. ||| Il a été modifié le 3 avril et le 8 mai 2020.
0.2974218726158142 ||| Adverse reactions reported both in adults and paediatric patients as more than an isolated case are listed below, by system organ class and by frequency. ||| Table 4 lists the adverse reactions recorded in clinical studies in the total safety population treated with Xolair by system organ class and by frequency. ||| Les effets indésirables observés chez l’ adulte et l’ enfant, en dehors des cas isolés, sont repris ci- dessous: ils sont classés par organe et par ordre de fréquence.
0.33163753151893616 ||| This medicinal product is for single use only. ||| The solution is for single use only. ||| Ce médicament est à usage unique.
0.3625467121601105 ||| Chain guards for bicycles ||| Heat exchangers for fireplaces ||| Protège-chaînes de vélos
0.2627648115158081 ||| The starting dose of Kuvan in adult and paediatric patients with PKU is 10 mg/ kg body weight once daily. ||| Therefore to achieve similar adult and paediatric exposure, the recommended dose for neonates is 4 mg/ kg/ day. ||| La dose initiale de Kuvan chez l'adulte et l'enfant atteints de PCU est de 10 mg/ kg poids corporel, une fois par jour.
0.6592234969139099 ||| This is normal. ||| This soon disappears. ||| Cela est normal.
0.7313223481178284 ||| Water sterilizers ||| Lavender water ||| Stérilisateurs d'eau
0.1387675404548645 ||| 10 vials of suspension (5 dose size) + 10 vials of emulsion (5 dose size) 25 doses: ||| 1 vial of suspension (5 dose size) + 1 vial of emulsion (5 dose size) 10 x 5 doses: ||| 10 flacons de suspension (taille pour 5 doses) + 10 flacons d’ émulsion (taille pour 5 doses) 25 doses:
0.3417857587337494 ||| Specifically, the SURE instrument will act as a second line of defence, supporting short-time work schemes and similar measures, to help Member States protect jobs and thus employees and the self-employed against the risk of unemployment and loss of income. ||| The public support, which will take the form of direct grants, repayable advances, equity injections, and subsidised loans, aims at ensuring that companies have sufficient liquidity to maintain their activities during and after the outbreak. ||| Plus précisément, l'instrument SURE fera office de «deuxième ligne de défense», en soutenant les dispositifs de chômage partiel et les mesures similaires, afin d'aider les États membres à préserver les emplois et, ainsi, à protéger les salariés et les travailleurs indépendants contre le risque de chômage et de perte de revenus.
0.253619909286499 ||| The resulting solution is then further diluted with sodium chloride 9 mg/ml (0.9%) solution for infusion. ||| The solution may be diluted with sodium chloride 0.9% w/ v solution for injection for more convenient injection. ||| La solution qui en résulte sera alors diluée avec une solution de chlorure de sodium à 9 mg/ ml (0,9%) pour perfusion.
0.3086467981338501 ||| CoAprovel is used in the treatment of high blood pressure (essential hypertension), when treatment with irbesartan or hydrochlorothiazide alone did not provide adequate control of your blood pressure. ||| 21 Depression, suicidal ideation and behaviour Although ARICLAIM is not indicated for the treatment of depression, its active ingredient (duloxetine) also exists as an antidepressant medication. ||| CoAprovel est utilisé dans le traitement de l'hypertension artérielle (pression artérielle élevée), lorsqu'un traitement par l'irbésartan seul ou l'hydrochlorothiazide seul ne contrôle pas de façon adéquate votre pression artérielle.
0.2562997341156006 ||| In a 6-month study of 599 patients with hypertension, type 2 diabetes mellitus, and nephropathy, all of whom were receiving losartan 100 mg and optimised antihypertensive background therapy, addition of Enviage 300 mg achieved a 20% reduction versus placebo in urinary albumin: creatinine ratio (UACR), i. e. from 58 mg/ mmol to 46 mg/ mmol. ||| Race: a clinical study conducted to evaluate the pharmacokinetics of riluzole and its metabolite N- hydroxyriluzole following repeated oral administration twice daily for 8 days in 16 healthy Japanese and 16 Caucasian adult males showed in the Japanese group a lower exposure of riluzole (Cmax 0.85 [90% CI 0.68-1.08] and AUC inf. ||| Dans une étude de 6 mois chez 599 patients hypertendus, diabétiques de type 2 et présentant une néphropathie, tous traités par 100 mg de losartan et un traitement antihypertenseur de fond optimisé, l’ ajout de 300 mg d’ Enviage a permis une diminution de 20% versus placebo du rapport albumine/ créatinine urinaire (RAC urinaire), c'est-à-dire de 58 mg/ mmol à 46 mg/ mmol.
0.013299399986863136 ||| 13 Patients with renal impairment No dosage adjustment is necessary in patients with impaired renal function (creatinine clearance > 4 ml/ min) (see section 5.2). ||| Patients with renal impairment No dosage adjustment is necessary in patients with impaired renal function (creatinine clearance > 4 ml/ min) (see section 5.2). ||| Insuffisant rénal Aucune adaptation posologique n'est nécessaire chez les patients atteints d'une insuffisance rénale (clearance de la créatinine > 4 ml/ min) (voir paragraphe 5.2).
0.19421522319316864 ||| Co-administration of tenofovir disoproxil fumarate and didanosine at a dose of 400 mg daily has been associated with a significant decrease in CD4 cell count, possibly due to an intracellular interaction increasing phosphorylated (i. e. active) didanosine. ||| Therefore, due to a possible decrease in efficacy, caution should be exercised when deferasirox is combined with substances metabolised through CYP3A4 (e. g. ciclosporin, simvastatin, hormonal contraceptive agents, bepridil, ergotamine). ||| La co- administration du fumarate de ténofovir disoproxil avec la didanosine à une dose de 400 mg par jour a été associée à une baisse significative du taux de CD4, pouvant être
0.0 ||| 6.5 Nature and contents of container ||| 6.5 Nature and contents of container ||| 24 6.5 Nature et contenu de l’emballage extérieur
0.8517417907714844 ||| The high sustained response rate in this subgroup of patients was identified in an interim analysis (n=49) and prospectively confirmed (n=48). ||| Initial safety data will be submitted when available (anticipated 2010), final data will be submitted when available (anticipated 2016). ||| Le pourcentage important de réponse virologique prolongée obtenu dans ce sous-groupe de patients a été mis en évidence lors d’ une analyse intermédiaire (n = 49) et confirmé de façon prospective (n = 48).
0.31042367219924927 ||| Do not use Effentora if: • You have not been using a prescribed opioid pain medicine every day on a regular schedule, for at least a week, to control your persistent pain. ||| Before you start treatment with Rapinyl, you must have been regularly taking or using a prescribed strong pain-relieving medicine, called an opioid, to control your persistent pain. ||| Ne prenez pas Effentora: • Si vous ne prenez pas, depuis au moins une semaine, d’ antalgique de type morphinique sous ordonnance selon un schéma thérapeutique quotidien régulier pour contrôler votre douleur persistante.
0.5165544748306274 ||| Patients should be screened for hypertension and controlled as appropriate. ||| Any person with symptoms is asked to stay at home / self-isolate. ||| L’ hypertension doit être dépistée et si nécessaire traitée de façon appropriée.
0.1518671065568924 ||| By blocking TNF, adalimumab improves the inflammation and other symptoms of the diseases. ||| By blocking TNF-alpha, certolizumab was expected to improve the inflammation and other symptoms of the disease. ||| En bloquant le TNF, l’ adalimumab agit sur l’ inflammation et sur les autres symptômes de ces maladies.
0.31091511249542236 ||| The following adverse reactions were observed in patients treated with the aprepitant regimen and at a greater incidence than with standard therapy: ||| 36 The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy. ||| Les événements indésirables suivants ont été observés avec une incidence supérieure chez les patients traités par aprépitant par comparaison à ceux traités avec un traitement standard:
0.14880186319351196 ||| • The other ingredients are croscarmellose sodium, glycerol triacetate (E1518), hypromellose (E464), indigo carmine aluminium lake (E132), lactose monohydrate, magnesium stearate (E572), microcrystalline cellulose (E460), pregelatinised starch (gluten free) and titanium dioxide (E171). ||| Each sachet contains 500 mg of stiripentol. • The other ingredients in this medicine are povidone K29/ 32, sodium starch glycolate type A, glucose liquid (spray dried), erythrosine (E127), titanium dioxide (E171), aspartame (E951), tutti frutti flavour (contains sorbitol), carmellose sodium, hydroxyethylcellulose. ||| l’hypromellose (E464), la laque aluminique d’indigotine (E132), le lactose monohydraté, le stéarate de magnésium (E572), la cellulose microcristalline (E460), l’amidon prégélatinisé sans gluten, le dioxyde de titane (E171).
0.4501544237136841 ||| The active substance in Kineret, anakinra, is an immunosuppressive medicine. ||| The active substance in Zypadhera, olanzapine, is an antipsychotic medicine. ||| Le principe actif de Kineret, l’ anakinra, est un médicament immunosuppresseur.
0.2343292385339737 ||| HOW TO USE YTRACIS ||| HOW TO USE TAXOTERE ||| COMMENT UTILISER YTRACIS
0.5643177032470703 ||| Electrophoretic coating materials [paints] ||| Stroboscopic lamps [light effects] ||| Matériaux de revêtement électrophorétique [peinture]
0.37560468912124634 ||| Cefuroximaxetil 500 are white to slightly yellowish capsule-shaped tablets. ||| Ceftriaxone Tyrol Pharma 1 g is a white to yellowish crystalline powder. ||| Cefuroximaxetil 500 sont des comprimés blanc à légèrement jaunâtre en forme de gélules.
0.309425950050354 ||| Other transporter-related interactions cannot be excluded. ||| Dose-related adverse events cannot be excluded. ||| D’ autres interactions relatives aux transporteurs ne peuvent pas être exclues.
0.2608165144920349 ||| In clinical trials adverse events seen on abrupt treatment discontinuation occurred in approximately 45% of patients treated with CYMBALTA and 23% of patients taking placebo. ||| 5 Reported clinical and laboratory abnormalities among all adult patients treated with CANCIDAS (total 989) were typically mild and rarely led to discontinuation. ||| Dans les essais cliniques, les effets indésirables observés à l’ arrêt brutal du traitement sont survenus chez environ 45% des patients traités par CYMBALTA et 23% des patients traités par placebo.
0.24001067876815796 ||| Cystadane should not be used by patients who may be hypersensitive (allergic) to betaine. ||| People who are hypersensitive (allergic) to quinolones should avoid any contact with Ibaflin. ||| Cystadane ne doit pas être utilisé chez les patients pouvant présenter une hypersensibilité (allergie) à la bétaïne.
0.09133180975914001 ||| In Dukoral, the cholera toxin is produced by a method known as ‘ recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce the toxin. ||| The active substance in Insuman, insulin human, is produced by a method known as ‘ recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin. ||| La toxine cholérique qui est utilisée dans Dukoral est produite par un procédé connu sous le nom de « technique de l’ ADN recombinant »: elle est fabriquée par une bactérie ayant reçu un gène (ADN) qui la rend apte à produire la toxine.
0.02248530276119709 ||| Silapo 5000 IU/0.5ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.5 ml solution for injection contains 5000 international units (IU) epoetin zeta (recombinant human erythropoietin). ||| Retacrit 6000 IU/0.6ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.6 ml solution for injection contains 6000 international units (IU) epoetin zeta (recombinant human erythropoietin). ||| Silapo 5 000 UI/0,5 ml solution injectable en seringue préremplie 1 seringue préremplie de 0,5 ml de solution injectable contient 5 000 unités internationales (UI) d’époétine zêta (érythropoïétine humaine recombinante).
0.23403745889663696 ||| The dose may later be increased to 300 mg once daily depending on blood pressure response. ||| Based upon individual response, the dose may be increased to 8 mg once daily. ||| La dose peut être ultérieurement augmentée jusqu'à 300 mg en une prise par jour en fonction de la réponse sur la pression artérielle.
0.0 ||| Genotype 2, 3 ||| Genotype 2, 3 ||| Génotyp e 2, 3
0.35906559228897095 ||| Treatment-naïve Metastatic Renal cell Carcinoma (MRCC) A phase 3 randomized, multicenter, international, study evaluating the efficacy and safety of sunitinib compared with IFN-α in patients with treatment-naïve metastatic RCC was conducted. ||| Two studies involving subjects with sporadic adenomatous polyps were conducted with celecoxib i. e., the APC trial (Adenoma Prevention with Celecoxib) and the PreSAP trial (Prevention of Spontaneous Adenomatous Polyps). ||| Cancer du rein métastatique (MRCC) non prétraité Une étude randomisée de phase 3, multicentrique, internationale évaluant l’ efficacité et la tolérance du sunitinib versus IFN-α chez des patients atteints d’ un MRCC non prétraités a été menée.
0.2989330291748047 ||| 1 (1.3%) 0 (0%) 1 (1.3%) 0 (0%) ||| 0 (0.0%) 0 (0.0%) 0 (0.0%) ||| 1 (1,3%) 0 (0%) 1 (1,3%) 0 (0%)
0.09467370808124542 ||| 74 9. ||| 97 9. ||| 77 9.
0.036048538982868195 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Fabrazyme to Genzyme Europe B. V. on 3 August 2001. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Renagel to Genzyme Europe B. V. on 28 January 2000. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l'Union européenne pour Fabrazyme à Genzyme Europe B. V., le 3 août 2001.
0.2692159414291382 ||| VISTIDE should be used with caution in diabetic patients due to the potential increased risk of developing ocular hypotony (low pressure in the eye). ||| Rotarix is indicated for the active immunisation of infants from the age of 6 weeks for prevention of gastro-enteritis due to rotavirus infection (see section 4.2). ||| VISTIDE doit être utilisé avec précautions chez les diabétiques car il augmente chez eux le risque d'hypotonie oculaire (baisse de la pression dans l 'œ il).
0.0 ||| General disorders and administration site conditions Common: ||| General disorders and administration site conditions Common: ||| Troubles généraux et anomalies au site d’administration Fréquents:
0.5966729521751404 ||| Reproductive toxicity studies have not been performed with Pegasys. ||| Oral contraceptives No interaction study has been performed with oral contraceptives. ||| Il n'a pas été conduit d'études de toxicité sur la reproduction avec Pegasys.
0.6804829835891724 ||| 24 Other antihypertensive drugs Additive effect. ||| Contra-indicated concomitant medications: ||| Autres antihypertenseurs Effet additif.
0.030767442658543587 ||| Therefore, your doctor may wish to do blood tests occasionally, particularly if you have been taking Efexor for a long time. ||| Therefore, your doctor may wish to do blood tests occasionally, particularly if you have been taking Efexor depot for a long time. ||| Par conséquent, votre médecin peut souhaiter effectuer de temps en temps des bilans sanguins, surtout si vous prenez Efexor depuis longtemps.
0.321371853351593 ||| 313 Taking other medicines ||| 238 Using other medicines ||| Utilisation d’autres médicaments
0.1932225227355957 ||| Glutamic acid for industrial purposes ||| Glucose powder for industrial purposes ||| Acide glutamique à usage industriel
0.17244452238082886 ||| If the rate of rise in haemoglobin is greater than 2 g/ dl (1.24 mmol/ l) over a month or if the haemoglobin level is increasing and approaching 12 g/ dl (7.45 mmol/ l), the dose is to be reduced by approximately 25%. ||| If it occurs, appropriate dose adjustment should be made as provided. If the rate of rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in one month or if the haemoglobin level is increasing and approaching 12 g/ dl (7.45 mmol/ l), the dose is to be reduced by approximately 25%. ||| 39 Si l’ augmentation du taux d’ hémoglobine est supérieure à 2 g/ dl (1,24 mmol/ l) en un mois ou si le taux d’ hémoglobine augmente pour approcher 12 g/ dl (7,45 mmol/ l), la dose doit être réduite d’ environ 25%.
0.01626541279256344 ||| 25 If you require laboratory tests, it is important to remind your doctor that you take AMMONAPS, since sodium phenylbutyrate may influence certain laboratory test results. ||| If you require laboratory tests, it is important to remind your doctor that you take AMMONAPS, since sodium phenylbutyrate may influence certain laboratory test results. ||| Si vous devez subir des examens de laboratoire, il est important de rappeler à votre médecin que vous prenez AMMONAPS car le phénylbutyrate de sodium peut influencer les résultats de certains examens de laboratoire.
0.24100589752197266 ||| You may find that your vision is blurred for a time just after you use EMADINE. ||| Your sight may become blurred for a short time just after using LUMIGAN. ||| Vous pouvez trouver que votre vision est trouble juste après avoir utilisé EMADINE.
0.40051352977752686 ||| Audio discs ||| Bass guitars ||| Disques audio
0.3154010772705078 ||| Kaletra is likely to increase plasma concentrations of medicinal products that are primarily metabolised by CYP3A. ||| Grapefruit juice and other foods that are known to inhibit CYP3A4 should be avoided. ||| Kaletra est susceptible d’ augmenter les concentrations plasmatiques des médicaments principalement métabolisés par l’ isoforme CYP3A.
0.4571618437767029 ||| Flashing safety lights ||| Controlled volume pumps ||| Clignotants de sécurité
0.38734060525894165 ||| Refill packs for cosmetics dispensers ||| Mounting racks for telecommunications hardware ||| Recharges pour distributeurs de cosmétiques
0.3232158422470093 ||| Colorants for use in formulating paints ||| Surfactants for use in detergent compositions ||| Colorants destinés à la formulation de peintures
0.44975078105926514 ||| independent assessment% (95% CI) ||| (95% CI) Hazard ratio: ||| évaluation indépendante% (IC 95%)
0.0 ||| 32 9. ||| 32 9. ||| 32 EXP:
0.331826776266098 ||| The following types of reactions have been reported mainly from post-marketing experience with Glivec. ||| is The following adverse reactions have been identified during postmarketing use of Nespo: ||| Les types de réactions suivantes ont principalement été observées au cours de la commercialisation de Glivec.
0.3198552131652832 ||| Pastes for gluing leather [other than for household purposes] ||| Yarns of carbon fibres [other than for use in textiles] ||| Pâtes pour le collage du cuir autres qu'à usage domestique
0.389087438583374 ||| Other side effects that have been reported where frequency has not been established • Hypersensitivity (allergic) reactions ||| Adverse drug reactions such as dizziness and fatigue may occur (see section 4.8 undesirable effects). ||| Autres effets indésirables reportés sans fréquence: • Réactions d’hypersensibilité (allergie).
0.38823893666267395 ||| The Commission also encourages local, regional and national health authorities to use existing bi-lateral and regional agreements and clarify the mutual recognition of professional medical qualifications. ||| A benchmarking exercise will begin in 2001 to compare good regulatory practices and quality management systems of competent authorities both in the European Economic Area and central and eastern European countries. ||| La Commission encourage également les autorités sanitaires locales, régionales et nationales à utiliser les accords bilatéraux et régionaux existants, et à clarifier la reconnaissance mutuelle des qualifications professionnelles dans le secteur médical;
0.3468065857887268 ||| Replace the cap on the bottle, leaving the bottle adaptor in place. ||| While holding the adapter in the package, place the vial adapter over the vial. ||| Remettez le bouchon sur le flacon en laissant l’ adaptateur sur le goulot.
0.21409457921981812 ||| Fibreglass fabrics for textile use ||| Chopped plastic fibres for textile use ||| Tissus en fibres de verre à usage textile
0.07813256233930588 ||| What Emtriva looks like and contents of the pack ||| What Rebif looks like and contents of the pack ||| Qu’est-ce qu’ Emtriva et contenu de l’emballage extérieur
0.23228615522384644 ||| Musculoskeletal, connective tissue and bone disorders Rhabdomyolysis When clinical information on the patients was available to make a judgement, approximately 50% of the cases occurred in patients with pre-existing renal insufficiency, or in those receiving concomitant medications known to cause rhabdomyolysis. ||| 19 Change in clinical status of patients with previously controlled type 2 diabetes A patient with type 2 diabetes previously well controlled on Efficib who develops laboratory abnormalities or clinical illness (especially vague and poorly defined illness) should be evaluated promptly for evidence of ketoacidosis or lactic acidosis. ||| Affections musculo-squelettiques et systémiques Rhabdomyolyse Environ 50% des patients chez qui l’ on disposait d’ informations cliniques suffisantes, étaient atteints d’ une insuffisance rénale préexistante ou recevaient en même temps des médicaments connus pour être à l’ origine de rhabdomyolyse.
0.8393341302871704 ||| Saquinavir concentrations may be increased. ||| Ibuprofen may increase the ||| Elle peut augmenter les concentrations de saquinavir.
0.40489742159843445 ||| Due to the high volume of tests required, the decision was made to use mobile units parked outside health clinics; individuals not experiencing severe symptoms who require testing must contact authorities to book a time and location. ||| Mobile tracing will complement traditional tracing that is done manually by public health authorities when they interview patients with symptoms, typically over the phone, to understand with whom they have been in contact over the past 48 hours. ||| En raison du volume élevé de tests requis, la décision a été prise d'utiliser des unités mobiles stationnées à l'extérieur des dispensaires; les personnes ne présentant pas de symptômes graves qui nécessitent un test doivent contacter les autorités pour réserver une heure et un lieu.
0.2663007974624634 ||| If you experience sudden decrease or loss of vision, stop taking CIALIS and contact your doctor immediately. ||| If you develop severe allergic reaction or hives, notify your doctor or nurse immediately. ||| En cas de diminution ou de perte soudaine de la vision, vous devez arrêter votre traitement par CIALIS et contacter immédiatement votre médecin.
0.46595442295074463 ||| After the start of the maintenance dose infusion, blood for AT activity levels should be drawn at 45 minutes after the start of the loading dose infusion. ||| When injecting Orgalutran in the afternoon the last Orgalutran injection should be given in the afternoon prior to the day of triggering ovulation. ||| Après le début de la perfusion de la dose d’ entretien, un prélèvement de sang doit être effectué 45 minutes après le début de la perfusion de la dose de charge pour la mesure de l’ activité en AT.
0.37469834089279175 ||| • In some patients the body may fail to produce enough of the blood cells that help your body fight infections or help you to stop bleeding. ||| The capsules work by preventing some of the fat you eat from being absorbed but you can still eat foods from all the main food groups. ||| 182 • Chez certains patients l'organisme peut ne pas parvenir à fabriquer assez de cellules sanguines qui aident votre organisme à lutter contre les infections ou à arrêter les hémorragies.
0.41971439123153687 ||| Treatment with imiquimod cream can be resumed after the skin reaction has moderated. ||| Exercise taken immediately after a meal may increase the risk of hypoglycaemia. ||| Le traitement par la crème imiquimod peut être repris après atténuation de la réaction cutanée.
0.18522974848747253 ||| The combination of these ingredients has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone. ||| The combination of the two active substances has an additive effect, reducing the blood pressure more than either medicine alone. ||| L’ association de ces principes actifs permet une additivité de leurs effets antihypertenseurs, et une réduction de la pression artérielle plus importante que celle observée avec chaque principe actif pris séparément.
0.051659222692251205 ||| 9 pre-filled pens ||| 4 pre-filled pens ||| 9 stylos pré- remplis
0.10212428867816925 ||| Fertavid 200 IU/ 0.5 ml solution for injection ||| Puregon 100 IU/ 0.5 ml solution for injection ||| Fertavid 200 UI/ 0,5 ml solution injectable
0.2263067066669464 ||| PritorPlus is available in blisters packs containing 14, 28, 30, 56, 90 or 98 tablets, or unit dose blister packs containing 28 x 1 tablets. ||| The tablets are provided in blister packs containing 7, 28, 56, 84, 90 or 112 film-coated tablets or 56 film-coated tablets in a unit dose pack. ||| PritorPlus est disponible en plaquettes thermoformées de 14, 28, 30, 56, 90 ou 98 comprimés, ou plaquette de doses unitaires contenant 28 x 1 comprimés.
0.4393234848976135 ||| - if you have recently had a heart attack or if you have heart failure or serious problems with your ||| − If you have had depression or are depressed or previously had thoughts of suicide. ||| - si vous avez eu récemment une crise cardiaque ou si vous présentez une insuffisance cardiaque
0.26635053753852844 ||| (± 93 days) ||| (± 24 days) ||| 93 jours)
0.5457537174224854 ||| Do not apply a new patch to that same location of skin twice within 14 days. ||| Avoid repeated injections at the exact same spot previously used. ||| N’ appliquez pas un nouveau dispositif transdermique 2 fois au même endroit pendant 14 jours.
0.5721897482872009 ||| Follow these instructions completely each time you use SoloStar to ensure that you get an accurate dose. ||| Follow these instructions carefully to make sure you will benefit from FOSAVANCE. ||| Chaque fois que vous utilisez SoloStar, suivez intégralement ces instructions pour vous assurez que vous recevrez la bonne dose.
0.89795982837677 ||| This will force the medicine back into the bottle. ||| Afterward, it returned to the sea. ||| Cela repoussera le médicament dans le flacon.
0.1299932450056076 ||| 8.8 ||| 9.2 ||| 8,8
0.5437935590744019 ||| Maintenance and repair of electronic display panels ||| Design and development of electronic dictionaries ||| Entretien et réparation de panneaux d'affichage électroniques
8.351166980169467e-13 ||| Austria Germany Spain France The Netherlands United Kingdom ||| Austria Germany Spain France The Netherlands United Kingdom ||| DE/ H/ 0740/ 01/ MR Autriche Allemagne Espagne France Pays-Bas
0.29744476079940796 ||| The aim of the scheme is to help businesses cover their immediate working capital or investment needs, thus ensuring the continuation of their activities. ||| The scheme aims at providing liquidity to companies affected by the coronavirus outbreak, thus enabling them to continue their activities, start investments and maintain employment. ||| Ce régime a pour objectif d'aider les entreprises à couvrir leurs besoins immédiats en fonds de roulement ou en investissements, assurant ainsi la poursuite de leurs activités.
0.2554561495780945 ||| 84 Hypoglycaemia. ||| Hypoglycaemia. ||| Hypoglycémie.
0.1994035840034485 ||| Insuman Rapid is an insulin preparation with a rapid onset and short duration of action. ||| Insuman Infusat is an insulin with rapid onset and short duration of action. ||| Insuman Rapid est une préparation d'insuline qui a une action d'installation rapide et de courte durée.
0.340030699968338 ||| The Commission is also issuing guidance to Member States to ensure that the resumption of visa operations abroad is well coordinated with the gradual lifting of the travel restrictions. ||| These measures will be used exclusively during the coronavirus pandemic, and will be revoked once the current health crisis in the EU/EEA has been surpassed. ||| La Commission publie également des orientations à l'intention des États membres afin que la reprise, à l'étranger, des opérations liées aux visas soit en phase avec la levée progressive des restrictions en matière de déplacements.
0.8060490489006042 ||| • Pharmacia Enterprise ||| • Intervet International ||| Pharmacia Enterprise
0.32422035932540894 ||| In some patients whose blood pressure is not adequately controlled, the dose can be increased to 160 mg and to a maximum of 320 mg. ||| However, in individual patients not responding to the initial 75 mg/ day, increases up to a maximum dose of 225 mg/ day may be considered. ||| Chez certains patients dont la pression artérielle n’ est pas suffisamment contrôlée, il est possible d’ augmenter la posologie à 160 mg jusqu’ à un maximum de 320 mg.
0.45244869589805603 ||| Frequency not ||| Frequency ||| Fréquence
0.3956471085548401 ||| Marking stamps ||| Scraping brushes ||| Tampons à marquer
0.21256938576698303 ||| InductOs should be used by a qualified surgeon. ||| Osigraft should be used by an appropriately qualified surgeon. ||| InductOs doit être utilisé par un chirurgien chevronné.
0.21378546953201294 ||| NovoMix is administered subcutaneously (under the skin) by injection in the abdominal wall (tummy), or the thigh. ||| NovoMix 70 is administered subcutaneously by injection in the thigh or in the abdominal wall. ||| NovoMix est administré par injection sous-cutanée (sous la peau) dans la paroi abdominale (du ventre) ou dans la cuisse.
0.287297785282135 ||| Mean clearance of Replagal in children aged (7-11 years), in adolescents (aged 12-18 years), and adults was 4.2 ml/ min/ kg, 3.1 ml/ min/ kg, and 2.3 ml/ min/ kg, respectively. ||| Apparent oral clearance was approximately 14 ml/ min/ kg for infants ages 5 weeks to 15 years, 12 ml/ min/ kg for infants ages 14 to 28 days, and 5 ml/ min/ kg for infants on the day of birth. ||| La clairance moyenne du Replagal chez l’ enfant (âgé de 7 à 11 ans), chez l’ adolescent (âgé de 12 à 18 ans) et chez l’ adulte était respectivement de 4,2 ml/ min/ kg, 3,1 ml/ min/ kg et de 2,3 ml/ min/ kg,.
0.461758017539978 ||| In addition, calculations show that the initiative has increased EU GDP by 1.3% and it is set to increase EU GDP by 1.9% by 2022. ||| The contraction in 2020 is, therefore, projected to be significantly greater than the 7.7% projected for the euro area and 7.4% for the EU as a whole in the Spring Forecast. ||| En outre, les calculs montrent que l'initiative a permis d'accroître le PIB de l'UE de 1,3 %, ce chiffre devant atteindre 1,9 % d'ici à 2022.
0.5531772375106812 ||| Arranging the distribution of advertising samples ||| Registration and transcription of written communications ||| Organisation de la distribution d'échantillons publicitaires
0.3728914260864258 ||| - elevated levels of some liver or blood enzymes, high blood levels of uric acid, low blood levels ||| - abnormal blood test results, including increase in white blood cells, low potassium levels ||| - taux élevé de certaines enzymes du foie ou du sang, taux élevé d’ acide urique dans le sang,
0.28986281156539917 ||| Containers for cosmetics ||| Containers for flowers ||| Récipients pour cosmétiques
0.06064503639936447 ||| What NovoMix 30 contains ||| What NovoMix 70 contains ||| Que contient NovoMix 30
0.5253093242645264 ||| Fire hose nozzles ||| Cordless sweepers ||| Lances à incendie
0.14659038186073303 ||| Table 8. ||| Table 8 ||| Tableau 8:
0.2675333619117737 ||| Patients who “ failed to respond to ” in the target population is defined by insufficient response (PASI < 50 or PGA less than good), or worsening of the disease while on treatment, and who were adequately dosed for a sufficiently long duration to assess response with at least each of the three major systemic therapies as available. ||| A ‘ response’ was defined as a combination of a 10% improvement in exercise capacity (measured by looking at how far the patient could walk in six minutes) and an improvement of the patient ’ s condition (the severity of the disease going down by at least one class), without a worsening of pulmonary hypertension or death. ||| Les patients « en échec » dans la population cible sont définis comme présentant une réponse insuffisante (PASI < 50 ou PGA insatisfaisant), ou une aggravation de la maladie au cours du traitement avec au moins chacun des trois traitements systémiques majeurs disponibles utilisés à une posologie adéquate pendant une durée suffisamment longue pour évaluer la réponse au traitement.
0.0 ||| Check the appearance of Kineret. ||| Check the appearance of Kineret. ||| Vérifiez l’ aspect de Kineret.
0.39673447608947754 ||| The 30 mg capsules are blue and white and are printed with ‘ 30 mg’ and the code ‘ 9543’. ||| The capsules are white with ‘ 7767‘ and ‘ 200‘ marked in gold ink. ||| Les gélules 30 mg sont bleues et blanches portant imprimées les mentions ‘30 mg’ et le code ‘9543’.
0.7487510442733765 ||| Mechanism of action ||| Mechanism of Resistance ||| 94 Mécanisme d’ action
0.2650468349456787 ||| White or off-white, round, flat, bevel-edged tablet with a score line on one side and with an engraving „ A+L” on the reverse side. ||| White to off-white, round, flat-faced, bevelled-edge tablets, debossed with “ GILEAD” and “ 10” on one side and a stylised shape of a liver on the other side. ||| Comprimé rond, plat, à bords chanfreinés, de couleur blanche ou blanc cassé, comportant une barre de cassure sur une face et l’ inscription „ A+L” en relief sur l’ autre face.
0.29472655057907104 ||| Xiliarx is not recommended for patients who have moderate or severe problems with their kidneys, including those on haemodialysis (a blood clearance technique) with end-stage renal disease. ||| Therefore, GANFORT should be used with caution in patients with known risk factors for macular oedema (e. g. aphakic patients, pseudophakic patients with a torn posterior lens capsule). ||| L’ utilisation de Xiliarx n’ est pas recommandée chez les patients présentant des troubles rénaux modérés ou sévères, notamment chez les patients hémodialysés (technique d’ épuration du sang) présentant une insuffisance rénale au stade terminal.
0.34146633744239807 ||| Pelzont In the event of an overdose, it is reasonable to employ the usual symptomatic and supportive measures. ||| There is no specific antidote for rimonabant; therefore, appropriate supportive measures should be initiated in case of overdose. ||| Pelzont En cas de surdosage, les mesures habituelles de traitement symptomatique et de prise en charge sont recommandées.
0.4591940641403198 ||| Cervarix also stimulates production of antibodies in females 10-14 years of age. ||| The plasma concentration of celecoxib is approximately 100% increased in elderly women (> 65 years). ||| Cervarix stimule également la production d’anticorps chez les jeunes filles âgées de 10 à 14 ans.
0.326680064201355 ||| Press release - Coronavirus: Commission presents practical guidance on implementing the temporary restriction on non-essential travel to the EU, 30 March 2020 ||| Communication on the second assessment of the application of the temporary restriction on non-essential travel to the EU, 8 May 2020 ||| Communiqué de presse - Coronavirus: la Commission présente des orientations pratiques concernant la mise en œuvre de la restriction temporaire des déplacements non essentiels vers l'UE, 30 mars 2020
0.3407107889652252 ||| Separation instruments for medical use ||| Adhesive compositions for medical use ||| Instruments de séparation à usage médical
0.3436228036880493 ||| Time to relapse (≥ 50% loss of improvement) was evaluated in Study ACD2058g and IMP 24011 for patients who were classified as responders (≥ 75% improvement on PASI) after 12 weeks of treatment. ||| Amongst those who responded at Week 16 (n=144), the Pediatric ACR 30/ 50/ 70/ 90 responses were maintained for up to two years in the OLE phase in patients who received Humira throughout the study. ||| Le délai de rechute (perte de 50% et plus du bénéfice obtenu en termes de PASI) a été évalué au cours des études ACD2058g et IMP 24011 chez les patients considérés comme répondeurs (≥ 75% d'amélioration de leur score PASI) après 12 semaines de traitement.
0.21044965088367462 ||| In the final study, the 10-microgram twice-daily dose of Byetta decreased HbA1c by 1.01% after a year, compared to 0.86% with biphasic insulin. ||| In combination with pioglitazone, 100 mg Xelevia reduced HbA1c levels by 0.88% after 24 weeks, compared to 0.18% in the patients adding placebo. ||| Dans la dernière étude, une dose biquotidienne de 10 microgrammes de Byetta a fait baisser l’ HbA1c de 1,01% après un an, contre 0,86% avec l’ insuline biphasique.
0.24360299110412598 ||| No interaction studies have been performed in humans. ||| No studies in pregnant women have been conducted. ||| Aucune étude d’interaction n’a été réalisée chez l’homme.
0.11698009818792343 ||| Effect of other agents on the pharmacokinetics of aprepitant Concomitant administration of EMEND with active substances that inhibit CYP3A4 activity (e. g., ritonavir, ketoconazole, clarithromycin, telithromycin) should be approached cautiously, as the combination results in increased plasma concentrations of aprepitant. ||| Concomitant administration of EMEND with active substances that inhibit CYP3A4 activity (e. g. ritonavir, ketoconazole, clarithromycin, telithromycin) should be approached cautiously, as the combination results in increased plasma concentrations of aprepitant (see section 4.5). ||| Effet d’autres médicaments sur la pharmacocinétique de l’aprépitant La co-administration d’ EMEND et de substances actives inhibant l’activité du CYP3A4 (tels que le ritonavir, le kétoconazole, la clarithromycine, la télithromycine) doit être envisagée avec précaution; cette association entraîne une augmentation des concentrations plasmatiques en aprépitant.
0.02084469050168991 ||| Fire surrounds [mantles and mantlepieces] of metal ||| Fire surrounds [mantles and mantlepieces] of plastic ||| Tours de cheminée [manteaux et tablettes] métalliques
0.19043457508087158 ||| 95 Table 5: ||| 10 Table 5: ||| 99 Tableau 5:
0.3008766770362854 ||| The clinical relevance of the different peak plasma concentrations after intravenous and subcutaneous administration of cladribine has not been examined. ||| Pharmacokinetic parameters of recombinant Factor IX have also been determined after single and multiple intravenous doses in different species. ||| L'importance clinique des concentrations plasmatiques maximales différentes après l'administration intraveineuse et sous-cutanée de cladribine n'a pas été examinée.
0.22428500652313232 ||| INFORMATION IN BRAILLE uc ||| INFORMATION IN BRAILLE t uc ||| INFORMATIONS EN BRAILLE mé
0.1652127504348755 ||| The Commission therefore concluded that the measure will contribute to managing the economic impact of the coronavirus in Germany.It is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| The Commission concluded that the Spanish scheme is necessary, appropriate and proportionate to remedy both a serious disturbance in the economy of a Member State, as well as contribute to fight the health crisis, in line with Article 107(3)(b) TFEU, Article 107(3)(c) TFEU and the conditions set out in the Temporary Framework. ||| Celle-ci est nécessaire, appropriée et proportionnée pour remédier à une perturbation grave de l'économie d'un État membre, conformément à l'article 107, paragraphe 3, point b), du TFUE et aux conditions énoncées dans l'encadrement temporaire.
0.026778269559144974 ||| This also applies to any unknown or emerging viruses or other types of infections. ||| This also applies to any unknown or emerging viruses, or other types of infections. ||| Ceci s’applique également aux virus inconnus ou émergents ou à d’autres types d’infections.
0.30736327171325684 ||| The safety of Equilis Prequenza Te was studied in several studies under laboratory and field conditions in a large number of horses, from 2 months of age. ||| The effectiveness of Netvax has been studied in several trials under laboratory and field conditions in chickens and their chicks. ||| La sécurité d’ Equilis Prequenza Te a été étudiée au cours de plusieurs études dans des conditions de laboratoire et sur le terrain chez un grand nombre de chevaux, âgés de deux mois et plus.
6.095381361106988e-13 ||| Pregnancy and breast-feeding FOSAVANCE is only intended for use in postmenopausal women. ||| Pregnancy and breast-feeding FOSAVANCE is only intended for use in postmenopausal women. ||| Grossesse et allaitement FOSAVANCE n’ est indiqué que chez les femmes ménopausées.
0.3015967011451721 ||| Slovenija Abbott Laboratories d.o.o. ||| Slovenija Lundbeck Pharma d.o.o. ||| Slovenija Abbott Laboratories d. o. o..
0.23848120868206024 ||| In clinical trials involving patients with relapsed small cell lung cancer, the dose limiting toxicity of oral topotecan monotherapy was found to be haematological. ||| In clinical trials involving congenital antithrombin deficient patients (n=35) one mild undesirable effect of “ Application site pruritis” was reported as related to treatment with ATryn. ||| Au cours des essais cliniques réalisés chez des patients atteints de cancer du poumon à petites cellules en rechute, la toxicité hématologique du topotécan oral en monothérapie était dose limitante.
0.5608517527580261 ||| In some patients this can cause irritation in the inside of the nose. ||| It usually occurs in one part of the body and can last for several weeks. ||| Chez certains patients, ce composant peut provoquer une irritation de la muqueuse du nez.
0.2778400778770447 ||| Which measures are being taken to ensure the safe use of Revlimid? ||| Which measures are being taken to ensure the safe use of Thalidomide Celgene? ||| Quelles sont les mesures prises pour assurer la sécurité de Revlimid?
0.2539723217487335 ||| - itraconazole (medicine to treat fungal infections) ||| - efavirenz (another medicine to treat HIV-infection) ||| - de l’ itraconazole (médicament pour traiter les infections fongiques)
0.5091468691825867 ||| The sticky side of the patch should not be touched. ||| - The sealed plastic tray is damaged or opened. ||| La face adhésive du dispositif transdermique ne doit pas être touchée.
0.03255513310432434 ||| Humira was studied in 6593 patients in controlled and open label trials for up to 60 months. ||| Humira was studied in 6,593patients in controlled and open label trials for up to 60 months. ||| Humira a été étudié chez 6 593 patients dans des essais contrôlés et en ouvert d’ une durée maximale de 60 mois.
0.16873612999916077 ||| Hooks (Door -) of metal ||| Catches (Door -) of metal ||| Crochets de portes en métal
0.2974810302257538 ||| This may happen: • If you take too little NovoNorm • If you have an infection or a fever • If you eat more than usual • If you exercise less than usual. ||| This may happen: • If you take too much Prandin • If you exercise more than usual • If you take other medicines or suffer from liver or kidney problems (see other sections of 2. ||| Cela peut arriver: • si vous prenez trop peu de NovoNorm • si vous avez une infection ou de la fièvre • si vous prenez un repas plus important que d’ habitude • si vous faîtes moins d’ exercice que d’ habitude.
0.31632712483406067 ||| In patients with end stage renal disease undergoing haemodialysis, there is a 25% to 45% reduction in the clearance, and doses of 135 micrograms result in similar exposure as 180 micrograms doses in patients with normal renal function (see section 4.2). ||| Maximum daily exposures (AUC) at the No Observed Adverse Effect Levels in the 3-month study in rat were 3.6 times and in the 4 week study in dog were 9.4 times the AUC in humans after a subcutaneous dose of 30 mg. ||| Chez des patients présentant une fonction rénale normale une exposition similaire est observée pour des doses de 135 microgrammes et de 180 microgrammes (voir rubrique 4.2).
0.2207096815109253 ||| Co-administration of SUTENT with potent CYP3A4 inhibitors, such as ketoconazole, should be avoided (see sections 4.4 and 4.5). ||| Therefore YENTREVE should not be administered in combination with potent inhibitors of CYP1A2 like fluvoxamine (see section 4.3). ||| L’ administration concomitante de SUTENT et d’ inhibiteurs puissants du CYP3A4 tels que le kétoconazole devra être évitée (voir rubriques 4.4 et 4.5).
0.15913568437099457 ||| APTIVUS is a medicine containing the active substance tipranavir. ||| TESAVEL is a medicine containing the active substance sitagliptin. ||| APTIVUS est un médicament dont le principe actif est le tipranavir.
0.3490719199180603 ||| Nelarabine is for intravenous use only and must only be administered under the supervision of a physician experienced in the use of cytotoxic agents. ||| How VELCADE is given You will receive VELCADE in a specialised medical unit, under the supervision of a health care professional experienced in the use of cytotoxic medicinal products. ||| La nélarabine doit être administrée par voie intraveineuse uniquement, et sous le contrôle d'un médecin expérimenté dans l'utilisation des agents cytotoxiques.
0.2312639057636261 ||| However, the second study showed that symptoms returned in 21% of the patients taking Thymanax over 24 weeks (34 out of 165), compared with 41% of the patients taking placebo (72 out of 174). ||| 8% of the patients who received Herceptin experienced a re-appearance of their cancer (127 out of 1,693), compared with 13% of the patients who did not receive it (219 out of 1,693). ||| Toutefois, la seconde étude a montré que les symptômes réapparaissaient chez 21% des patients prenant Thymanax durant 24 semaines (34 sur 165), contre 41% des patients prenant le placebo (72 sur 174).
0.3576907515525818 ||| Median duration of treatment on dasatinib was 3.5 months with 12% of patients treated for > 24 months to date. ||| control patients (median duration of treatment was 5.7 months for Trudexa and 5.5 months for control- treated patients). ||| La durée médiane du traitement par dasatinib a été de 3,5 mois avec 12% de patients
0.35774731636047363 ||| Bonviva 3 mg solution for injection ibandronic acid ||| Faslodex 250 mg solution for injection. fulvestrant ||| Bonviva 3 mg solution injectable Acide ibandronique
0.7154672145843506 ||| 10 A-6250 Kundl Austria ||| Armagh BT63 5QD United Kingdom ||| 10 A-6250 Kundl Autriche
0.5312740802764893 ||| Do not administer YTRACIS directly to the patient. ||| Do not initiate Soliris therapy in patients: ||| Ne pas administrer YTRACIS directement au patient.
0.2668042778968811 ||| In clinical studies, elevations of serum transaminases (> 3 times the upper limit of the normal range) have been observed in patients treated with Valdoxan particularly on a 50 mg dose (see section 4.8). ||| In clinical trials, Pegasys treatment was associated with decreases in both total white blood cell (WBC) count and absolute neutrophil count (ANC), usually starting within the first 2 weeks of treatment (see section 4.8). ||| Au cours des essais cliniques, une élévation des transaminases sériques (> 3 fois la limite supérieure des valeurs normales) a été observée chez des patients traités par Valdoxan plus particulièrement à la dose de 50 mg (voir rubrique 4.8).
0.45071935653686523 ||| GONAL-f 150 IU powder for solution for injection Follitropin alfa Subcutaneous use. ||| 15% soluble insulin and 85% crystalline protamine insulin; • Insulin Human Winthrop Comb 25: ||| GONAL-f 150 UI poudre pour solution injectable Follitropine alfa Voie sous-cutanée
0.3667364716529846 ||| 300 mg aliskiren and 25 mg hydrochlorothiazide). ||| hemifumarate) and 25 mg hydrocholorothiazide. ||| 300 mg d'aliskiren et 25 mg d'hydrochlorothiazide).
0.2329055666923523 ||| Pregnancy and breast feeding Kivexa is not recommended during pregnancy. ||| Pregnancy and breast feeding Hycamtin is not recommended for pregnant women. ||| Grossesse et allaitement L'utilisation de Kivexa n’ est pas recommandée pendant la grossesse.
0.6714460253715515 ||| References (not all submitted are listed) ||| [Not requested on the immediate label] ||| Bibliographie (non exhaustive)
0.18455539643764496 ||| Truvada is not recommended for patients with severe renal impairment (creatinine clearance < 30 ml/ min) and in patients who require haemodialysis because appropriate dose reductions cannot be achieved with the combination tablet. ||| Therefore, caution should be made when administering higher doses of NSAIDs or aspirin at higher dosage, concurrently with pemetrexed to patients with normal function (creatinine clearance > 80 ml/ min). ||| Truvada n’ est pas recommandé chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) et chez les patients qui nécessitent une hémodialyse car les réductions des doses d’ emtricitabine et de ténofovir nécessaires chez ces patients ne peuvent être obtenues avec l’ association fixe.
0.0024059799034148455 ||| {PRODUCT NAME} 80 mg are available in blister packs containing 4, 7, 10, 14, 20, 28, 30, 50, 56, 84, 98 and 100 film-coated tablets and hospital packs containing 200 (10 x 20) or 500 film-coated tablets. ||| {PRODUCT NAME} 20 mg are available in blister packs containing 4, 7, 10, 14, 20, 28, 30, 50, 56, 84, 98 and 100 film-coated tablets and hospital packs containing 200 (10 x 20) or 500 film-coated tablets. ||| {NOM DU PRODUIT} 80 mg est disponible en plaquettes thermoformées contenant 4, 7, 10, 14, 20, 28, 30, 50, 56, 84, 98 et 100 comprimés pelliculés et en emballages hospitaliers contenant 200 (10x20) ou 500 comprimés pelliculés.
0.33937060832977295 ||| No death reduction was observed in the subgroup of patients with lower disease severity. ||| The incidence of fever and documented infections were not reduced in either setting. ||| Il n’ a pas été observé de réduction de la mortalité dans le sous-groupe de patients moins sévères.
0.2314886748790741 ||| In patients who experienced either febrile neutropenia, neutrophil < 500 cells/ mm3 for more than one week, severe or cumulative cutaneous reactions or severe peripheral neuropathy during docetaxel therapy, the dose of docetaxel should be reduced from 100 mg/ m2 to 75 mg/ m2 and/ or from 75 to 60 mg/ m². ||| In combination with cisplatin For patients who are dosed initially at docetaxel 75 mg/ m2 in combination with cisplatin and whose nadir of platelet count during the previous course of therapy is < 25,000 cells/ mm3, or in patients who experience febrile neutropenia, or in patients with serious non-hematologic toxicities, the docetaxel dose in subsequent cycles should be reduced to 65 mg/ m2. ||| Chez les patientes ayant présenté, pendant le traitement par le docétaxel, une neutropénie fébrile, un nombre de polynucléaires neutrophiles < 500/ mm3 pendant plus d’ une semaine, des réactions cutanées sévères ou répétées ou une neuropathie périphérique sévère, la dose de docétaxel doit être réduite de 100 mg/ m2 à 75 mg/ m2 et/ ou de 75 à 60 mg/ m2.
0.2909092307090759 ||| What is INCRELEX used for? ||| What is CYSTAGON used for? ||| Dans quel cas INCRELEX est -il utilisé?
0.2672005891799927 ||| In two clinical studies in de novo liver transplant patients the use of sirolimus plus ciclosporin or tacrolimus was associated with an increase in hepatic artery thrombosis, mostly leading to graft loss or death. ||| There is limited experience from treatment with fondaparinux in haemodynamically unstable patients and no experience in patients requiring thrombolysis, embolectomy or insertion of a vena cava filter. ||| Dans deux études cliniques chez des transplantés hépatiques de novo, l’ utilisation du sirolimus plus ciclosporine ou tacrolimus a été associée à une augmentation des thromboses de l’ artère hépatique, conduisant le plus souvent à la perte du greffon ou au décès.
0.5972289443016052 ||| They also vowed to help rebuild communities that have been hit hard by the pandemic, in a fair and just way. ||| While online platforms have taken positive steps during the pandemic, they need to step up their efforts. ||| Ils ont également promis de contribuer à la reconstruction, de manière juste et équitable, des communautés qui ont été durement touchées par la pandémie.
0.3376925587654114 ||| Bundling machines ||| Labelling services ||| Machines à enliasser
0.23670178651809692 ||| Constipation, diarrhoea, bone pain, arthralgia, muscle spasms and peripheral oedema were observed less commonly and have been of mild to moderate severity. ||| Many of those listed below occur commonly (nausea, vomiting, diarrhoea, fever, lethargy, rash) in patients with abacavir hypersensitivity. ||| On a observé des effets indésirables moins fréquents, tels que constipation, diarrhée, douleurs osseuses, arthralgies, spasmes musculaires et œ dème périphérique, et ces effets étaient de sévérité légère à modérée.
0.243964284658432 ||| Persons who are breast-feeding or intend to breast-feed should tell the doctor. ||| Tell your doctor if you are breast-feeding or intending to breast-feed. ||| Les personnes qui allaitent ou qui ont l'intention d'allaiter doivent en informer leur médecin.
0.3430231511592865 ||| Based on experience with glimepiride and with other sulphonylureas the following adverse reactions have to be mentioned. ||| These results should of course be balanced against the well-known tolerability issues of Casodex (bicalutamide). ||| Sue la base de l’ expérience acquise avec le glimépiride et les autres sulfamides hypoglycémiants, les effets indésirables suivants sont à souligner:
0.3916252851486206 ||| (*) Including supplementary and amending budgets as adopted by the Management Board Annex 6 CPMP opinions in 1996 on medicinal products for human use ||| The full list of all Community marketing auth- orisations Decisions approved by the European Commission since October 1995 for human medicines are set out in annex 6. ||| (*) Y compris les ajustements budgétaires approuvés par le Conseil d’Administration Annexe 6 Avis du CPMP en 1996 sur les médicaments à usage humain
0.30998554825782776 ||| Thrombocytopenia Thrombocytopenia may occur during Raptiva treatment and may be associated with clinical signs such as echymoses, spontaneous bruising or bleeding from muco-cutaneous tissues. ||| In some susceptible patients, continued use of topical NSAIDs may result in epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration or corneal perforation. ||| Thrombocytopénie Une thrombocytopénie peut survenir au cours d'un traitement par Raptiva et être associée à des signes cliniques tels que: ecchymoses, hématomes ou saignements cutanéo-muqueux spontanés.
0.5379151701927185 ||| If you forget for more than 12 hours, simply take the next single dose at the usual time. ||| After taking one of them, wait at least 2 to 3 hours before taking the other. ||| Si vous vous en apercevez au delà des 12 heures suivantes, prenez simplement le comprimé suivant à l’heure habituelle.
0.33427056670188904 ||| In clinical trials, it was recommended that treatment with imatinib be discontinued at least 7 days before starting treatment with SPRYCEL. ||| These results were confirmed during period II of the study where patients were randomized to continue losartan or placebo, after three weeks of treatment. ||| 72 Dans les études cliniques, il a été recommandé d'interrompre le traitement par imatinib au moins 7 jours avant le traitement par SPRYCEL.
0.0 ||| The time course of action of any insulin may vary considerably in different individuals or at different times in the same individual. ||| The time course of action of any insulin may vary considerably in different individuals or at different times in the same individual. ||| L’ évolution dans le temps de l’ action de toute insuline peut varier de façon importante d'un sujet à un autre ou à différents moments chez le même sujet.
0.7541527152061462 ||| (a) Solution for injection ||| a) Preparing a dose ||| a) Solution injectable
0.5914288759231567 ||| 21 February 2006 EMEA/ CHMP/ 373108/ 2005 ||| 29 March 2005 CHMP/ 187488/ 2004 ||| 21 février 2006 EMEA/ CHMP/ 373108/ 2005
0.606584906578064 ||| Chewable tooth cleaning preparations ||| Make-up removing creams ||| Préparations de nettoyage dentaire à mâcher
0.2073620855808258 ||| Packs of 3, 4, 5, 6, 9 or 10 cartridges are available. ||| Packs of 1, 3, 4, 5, 6, 8, 9 and 10 cartridges are available. ||| Disponible en boîtes de 3, 4, 5, 6, 9 ou 10 cartouches.
0.1634806990623474 ||| However, very rarely some people experience drowsiness, which may affect their ability to drive or use machines. ||| However, patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines. ||| Cependant, très rarement ont été rapportés des cas de somnolence susceptible d’ affecter l’ aptitude à conduire ou à utiliser des machines.
0.1643882542848587 ||| GlaxoSmithKline A. E. B. E Leof. ||| 32 Ελλάδα GlaxoSmithKline A. E. B. E. ||| Grèce GlaxoSmithKline A. E. B. E Leof.
0.4218556582927704 ||| Conducting of entertainment activities ||| Conducting of business research ||| Conduite d’activités de divertissement
0.11214981973171234 ||| 52 Docetaxel Winthrop 75 mg/ m² in combination with capecitabine ||| 14 Docetaxel Winthrop 75 mg/ m² in combination with cisplatin ||| 55 Docétaxel Winthrop 75 mg/ m² en association avec la capécitabine
4.013902925315005e-13 ||| [140-age (years)] x weight (kg) CLcr (ml/ min) = ----------------------------------------- 72 x serum creatinine (mg/ dl) ||| [140-age (years)] x weight (kg) CLcr (ml/ min) = ----------------------------------------- 72 x serum creatinine (mg/ dl) ||| 66 [140-âge (années)] x poids (kg) CLcr( ml/ min) = ------------------------------------------- 72 x créatinine sérique (mg/ dl)
0.34014642238616943 ||| drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Rasilez HCT). ||| "Potentially serious side effects from chloroquine or hydroxychloroquine include irregular heartbeats, tinnitus, blurred vision, muscle weakness or ""mental changes""." ||| généralisée, somnolence, douleurs ou crampes musculaires, nausées, vomissements, ou battements de cœ ur anormalement rapides qui pourraient indiquer un effet excessif de l’ hydrochlorothiazide (contenu dans Rasilez HCT).
0.34587907791137695 ||| AUC: ↔ Cmax: ↑ 11% (↑ 3 to ↑ 19) (CYP3A4 induction) Rash developed in 46% of uninfected volunteers receiving efavirenz and clarithromycin. ||| Active substance(s) FeLV recombinant Canarypox virus (vCP97)......... ≥ 10 7.2 CCID50 (cell culture infective dose 50%) For a full list of excipients, see section 6.1. ||| ASC: ↔ Cmax: ↑ 11% (↑ 3 à ↑ 19) (induction du CYP3A4) Un rash s’ est développé chez 46% des volontaires non infectés lors d’ un traitement associant l'éfavirenz à la clarithromycine..
0.17774075269699097 ||| Preotact should therefore not be used in patients with severe renal impairment (see section 4.3). ||| Agenerase oral solution should not be used in patients with hepatic impairment or failure (see section 4.3). ||| En conséquence, Preotact ne doit pas être utilisé chez les patientes ayant une insuffisance rénale sévère (voir rubrique 4.3).
5.546789156457566e-13 ||| Lipodystrophy (thickening or pitting of the skin) is uncommon (≥ 1/1,000 to < 1/100). ||| Lipodystrophy (thickening or pitting of the skin) is uncommon (≥ 1/1,000 to < 1/100). ||| 207 La lipodystrophie (épaississement ou cicatrice sur la peau) est peu fréquente (≥1/1 000 à < 1/100).
0.14745047688484192 ||| ► If you are pregnant or you think you may be, tell your doctor. ||| If you are pregnant, or think that you might be pregnant tell your doctor. ||| ► Si vous êtes enceinte ou si vous pensez l’être, informez-en votre médecin.
0.6192783117294312 ||| 9.9 (123/1,242) 7.7, 12.1 ||| 1866(100.0) 24 (1.3) 258(13.8) ||| 9,9 (123/ 1 242) 7,7; 12,1
0.5888768434524536 ||| Provision of access to television via decoding apparatus ||| Transmission of information by teletypewriter, by satellite ||| Services d'accès à la télévision via des appareils de décodage
0.2684338390827179 ||| Any calcium you take as part of a meal will not seriously affect uptake. ||| Dietary calcium as part of a meal does not significantly affect absorption. ||| Le calcium présent dans un repas n'a pas d'incidence grave sur l'effet du médicament.
0.4051198959350586 ||| Patients exhibiting depression should be monitored closely during therapy with Betaferon and treated appropriately. ||| General Patients must be assessed prior to administration of Zometa to ensure that they are adequately hydrated. ||| Les patients présentant une dépression doivent recevoir un traitement approprié et faire l’ objet d’ une surveillance attentive durant le traitement par Betaferon.
0.07834871858358383 ||| The effect of peritoneal dialysis on adefovir removal has not been evaluated. ||| The elimination of adefovir by peritoneal dialysis has not been studied. ||| L’ effet de la dialyse péritonéale sur l’ élimination de l’ adéfovir n’ a pas été évalué.
0.3427002727985382 ||| Microporous synthetic sheets for use in manufacture ||| Plastisizers for use in natural polymers ||| Feuilles synthétiques microporeuses destinées à la fabrication
0.08220702409744263 ||| Inhibition of ACE results in a reduction of angiotensin II in the plasma, which leads to increased plasma renin activity (by inhibition of the negative feedback of renin release) and reduced secretion of aldosterone. ||| Inhibition of ACE results in decreased plasma angiotensin II, which leads to increased plasma renin activity (due to removal of negative feedback of renin release), and decreased aldosterone secretion. ||| L’ inhibition de l’ ECA induit une diminution de l’ angiotensine II dans le plasma, conduisant à une augmentation de l’ activité plasmatique de la rénine (par inhibition du rétrocontrôle négatif de la libération de rénine) et à une diminution de la sécrétion d’ aldostérone.
0.47228074073791504 ||| Computer software to enable the provision of electronic media via the Internet ||| Computer software to enhance the audio-visual capabilities of multimedia applications ||| Logiciel informatique qui permet la fourniture de médias électroniques via l'internet
0.08080925047397614 ||| Changes in fasting glucose from borderline at baseline (≥ 5.56 - < 7 mmol/ l) to high (≥ 7 mmol/ l) were very common. ||| Changes in total fasting cholesterol levels from borderline at baseline (≥ 4.39 - < 5.17 mmol/ l) to high (≥ 5.17 mmol/ l) were very common. ||| Une augmentation des taux de glucose à jeun ayant une valeur limite au début du traitement (≥ 5.56 - < 7 mmol/ l) à une valeur élevée (≥ 7 mmol/ l) a été très fréquente.
0.25374579429626465 ||| A study of approximately 7100 osteoarthritis patients compared the gastrointestinal tolerability of etoricoxib 90 mg (1.5 times the recommended OA dose) with diclofenac 150 mg. ||| The third study compared the effectiveness of 4 mg/ kg Bridion with that of neostigmine after deep relaxation of the muscles using rocuronium or vecuronium in 182 patients. ||| Une étude portant sur environ 7 100 patients atteints d’ arthrose, a comparé la tolérance gastro- intestinale de l’ étoricoxib 90 mg (1,5 fois la dose recommandée pour l’ arthrose) à celle du diclofénac 150 mg.
0.05340968072414398 ||| Change the needle and try again. • If no insulin comes out after changing the needle, your SoloStar may be damaged. ||| Change the needle and try again. • If no insulin comes out after changing the needle, your OptiSet may be damaged. ||| Changez l’aiguille et réessayez. • Si même après avoir changé l’aiguille, l’insuline n’apparaît toujours pas, votre SoloStar peut être endommagé.
1.0302221775054932 ||| Reduced dose (75%) ||| *lower than recommended dose ||| Nombre de (75%)
0.34691518545150757 ||| Beams of common metal for formwork systems ||| Handles of plastics materials for hollowware ||| Poutres en métaux communs pour systèmes de coffrage
0.18442489206790924 ||| What Opgenra is and what it is used for. ||| 1) What Agenerase is and what it is used for. ||| Qu'est-ce qu’Opgenra et dans quel cas est-il utilisé.
0.8437149524688721 ||| ELAPRASE ||| EPP ITT ||| ÉLAPRASE
0.1295691430568695 ||| Levetiracetam is excreted in human breast milk. ||| Levodopa is excreted in human breast milk. ||| 18 Le lévétiracétam est excrété dans le lait maternel.
0.21760493516921997 ||| Other haemorrhagic manifestations (e. g., gynaecological haemorrhages, gastrointestinal bleedings and other cutaneous or mucous bleedings) have been reported rarely (see ‘ Precautions’, Haemorrhage). ||| The haemorrhagic events that have been observed in clinical studies were predominantly tumour- associated haemorrhage (see below) and minor mucocutaneous haemorrhage (e. g. epistaxis). ||| D’ autres manifestations hémorragiques (tels que hémorragies gynécologiques, saignements gastro- intestinaux et autres saignements cutanéo-muqueux) ont rarement été rapportés (cf. rubrique 4.4 Mises en garde et précautions particulières d’ emploi – Hémorragies).
0.4211938679218292 ||| Japanese rice bowls [chawan] ||| Korean soy sauce [ganjang] ||| Bols à riz japonais [chawan]
0.06424224376678467 ||| Thyroid dysfunction during treatment with Rebetol and interferon alfa-2b has been observed. ||| Thyroid dysfunction during treatment with interferon alfa-2b and ribavirin has been observed. ||| Des dysthyroïdies apparues en cours du traitement par Rebetol et interféron alfa-2b ont été observées.
0.18665580451488495 ||| Caution is advised when Agenerase is used concomitantly with delavirdine (see section 4.5). ||| Caution is recommended when sorafenib is co-administered with docetaxel (see section 4.5). ||| La prudence est conseillée en cas d’ utilisation concomitante d’’ Agenerase et de la delavirdine (voir rubrique 4.5).
0.22328412532806396 ||| Latches, not of metal ||| Pitons, not of metal ||| Loquets non métalliques
0.0032143015414476395 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 8416 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu © European Medicines Agency, 2008.
0.16522356867790222 ||| 1 ml Vimpat solution for infusion contains 10 mg lacosamide. ||| 1 ml Vimpat syrup contains 15 mg lacosamide. ||| 1 ml de Vimpat solution pour perfusion contient 10 mg de lacosamide.
0.06067037582397461 ||| NeoRecormon 30,000 IU injection IV/SC use ||| NeoRecormon 1000 IU injection IV/SC use ||| NeoRecormon 30 000 UI injectable Voie I. V. / S. C.
0.3154969811439514 ||| In uninfected volunteers, multiple doses of 200 - 400 mg per day for 10 days resulted in a lower than predicted extent of accumulation (22 - 42% lower) and a shorter terminal half-life compared with single dose administration (see below). ||| At the end of the study (with individual patient treatment durations ranging from 60 to 150 weeks; mean follow-up period of 119 weeks) 14 of 16 patients were alive and 9 of 16 patients were alive and free of invasive ventilatory support. ||| Chez les volontaires non infectés, l'administration réitérée de 200 à 400 mg par jour, pendant 10 jours, s’ est traduite par une accumulation inférieure à celle prévue (de 22 à 42% inférieure) et des demi-vies d’ élimination plus courtes comparé à l'administration d'une dose unique (voir ci-dessous).
0.19875097274780273 ||| One study compared the effects of Ziagen taken once and twice a day, in combination with lamivudine and efavirenz (other antiviral medicines) in 784 patients. ||| In all three studies, doses of Invega between 3 and 15 mg a day were compared with placebo (a dummy treatment) and with olanzapine (another antipsychotic medicine). ||| L’ une des études comparait les effets de Ziagen pris une fois et deux fois par jour, en association à la lamivudine et à l’ efavirenz (autres médicaments antiviraux) chez 784 patients.
0.38532260060310364 ||| The actions proposed today will feed into future EU work on disinformation, notably the European Democracy Action Plan and the Digital Services Act. ||| The two strategies present a new clean energy investment agenda, in line with the Commission's Next Generation EU recovery package and the European Green Deal . ||| Les actions proposées aujourd'hui alimenteront les futurs travaux de l'UE sur la désinformation, en particulier le plan d'action pour la démocratie européenne et la législation sur les services numériques.
0.365239679813385 ||| • Put the cap back on the pen, with 0 next to the dosage indicator (picture E) • Check that the push-button is fully down. ||| With the needle pointed at the vial align the “ 0.5 ml” mark on the syringe with the edge of the dose preparation guide. ||| • Replacez le capuchon sur le stylo de façon à ce que le 0 se trouve face à l’ indicateur de dose (figure E)
0.16987407207489014 ||| Gastrointestinal disorders: nausea, vomiting, diarrhoea, abdominal pain ||| Gastrointestinal disorders: nausea, diarrhoea, dyspepsia, dry mouth. ||| Nausées, vomissements, diarrhée, douleurs abdominales
0.03072175569832325 ||| Patients should be monitored closely to ensure that the lowest approved dose of Epoetin alfa is used to provide adequate control of the symptoms of anaemia. ||| Patients should be monitored closely to ensure that the lowest approved dose of NeoRecormon is used to provide adequate control of the symptoms of anaemia. ||| Les patients doivent faire l’ objet d’ une surveillance étroite afin de s’ assurer que la plus faible dose d’ époétine alfa possible soit utilisée et permette de contrôler convenablement les symptômes de l’ anémie.
0.0 ||| If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| Si vous avez d'autres questions sur l'utilisation de ce produit, demandez conseil à votre médecin ou votre pharmacien.
0.2541976273059845 ||| Since bacteriostatic drugs may interfere with the bactericidal action of cephalosporins, it is advisable to avoid giving tetracyclines, macrolides, or chloramphenicol in conjunction with cefuroxime axetil. ||| Reconcile tablets should not be given concomitantly with veterinary medicinal products that lower the seizure threshold (e. g. phenothiazines such as acepromazine or chlorpromazine). ||| Les antibiotiques bactériostatiques peuvent interférer avec l’ action bactéricide des céphalosporines et il est donc recommandé de ne pas associer une tétracycline, un macrolide ou le chloramphénicol au céfuroxime axétil.
0.23036417365074158 ||| Tools [parts of machines] ||| Regulators [parts of machines] ||| Outils [parties de machines]
0.26547688245773315 ||| The effects of concomitant administration of erlotinib with H2 antagonists and antacids are unknown; however, reduced bioavailability is likely. ||| There are no data on concomitant use of Menitorix with whole cell pertussis and oral poliomyelitis vaccines, however, no interference is expected. ||| Les effets de l’ administration concomitante de l’ erlotinib à des antagonistes H2 et à des antiacides ne sont pas connus; cependant, une diminution de la biodisponibilité est probable.
2.894027519798753e-13 ||| The European Medicines Agency (EMEA) will review any new information on the medicine every year and this leaflet will be updated as necessary. ||| The European Medicines Agency (EMEA) will review any new information on the medicine every year and this leaflet will be updated as necessary. ||| L’Agence Européenne du Médicament (EMEA) réévaluera chaque année toute nouvelle information disponible, et si nécessaire cette notice sera mise à jour.
0.3986649513244629 ||| The starting dose may be adjusted by your doctor until your condition is controlled. ||| The first dose will be given on a date agreed with your doctor. ||| La dose d’attaque peut être ajustée par votre médecin jusqu’à ce que votre condition soit contrôlée.
0.15990743041038513 ||| In mice, a 2-year carcinogenicity study with pravastatin demonstrates at doses of 250 and 500 mg/kg/day (≥ 310 times the maximum human mg/kg dose), a statistically significant increases in the incidence of hepatocellular carcinomas in males and females, and lung adenomas in females only. ||| In a 2-year study in mice, incidences of hepatocellular adenoma in males and hepatocellular carcinomas in females were increased at the maximum dose used, and the maximum dose used was 250-fold higher than the highest human dose on a mg/ kg body-weight basis. ||| Chez la souris, une étude de carcinogénicité sur deux ans avec la pravastatine, a démontré aux doses de 250 et 500 mg/kg/jour (≥ 310 fois la dose maxima le chez l'homme en mg/kg), des augmentations statistiquement significatives de l'incidence des carcinomes hépatocellulaires chez les mâles et chez les femelles, et des adénomes pulmonaires chez les femelles uniquement.
0.31044623255729675 ||| The dose may later be increased to 300 mg (four tablets a day) once daily depending on blood pressure response. ||| At each step, the increase or reduction in dose should be of 25 IU/ kg 3 times per week. ||| La dose peut être ultérieurement augmentée jusqu'à 300 mg (4 comprimés par jour) en une prise par jour en fonction de la réponse sur la pression artérielle.
0.053056322038173676 ||| WHAT REVASC IS AND WHAT IT IS USED FOR ||| WHAT REBIF IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE REVASC ET DANS QUEL CAS EST-IL UTILISÉ
0.46155065298080444 ||| If you miss a period or think you may be pregnant, contact your doctor right away. ||| If you are over 65 years of age your doctor may monitor your health more closely. ||| S’ il manque un cycle dans vos règles ou pensez être enceinte, contactez immédiatement votre médecin.
0.5828898549079895 ||| In this leaflet: ||| This side of the leaflet: ||| au Dans cette notice:
0.34678950905799866 ||| White to off-white cake/ powder. ||| Off-white to pale yellow powder. ||| Agglomérat/ poudre blanche à presque blanche.
0.5058764219284058 ||| Improving epidemiology and public health, including our preparedness and response to outbreaks. ||| The aim is to improve diagnostics, preparedness, clinical management and treatment. ||| L'amélioration de l'épidémiologie et de la santé publique, y compris pour ce qui concerne notre préparation et notre réaction aux épidémies.
0.319563090801239 ||| Very common: if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium. ||| Blood pressure and heart rate Duloxetine has been associated with an increase in blood pressure and clinically significant hypertension in some patients. ||| 121 Très fréquents: si vous souffrez d’ une élévation de la pression artérielle et d’ un diabète de type 2 avec atteinte rénale, les tests sanguins peuvent montrer une élévation du taux de potassium.
0.7904343008995056 ||| EU/ 1/ 07/ 389/ 003 ||| EU/1/97/045/004 ||| EU/ 1/ 07/ 389/ 003 ORENCIA
0.08149076253175735 ||| Onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus, Chlamydophila felis and panleucopenia components. ||| Onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus and Chlamydophila felis components. ||| La mise en place de l’ immunité a été démontrée 1 semaine après la primo-vaccination pour les valences rhinotrachéite, calicivirose, Chlamydophila felis et panleucopénie infectieuse féline.
0.4804413318634033 ||| HOW TO TAKE PROTELOS ||| HOW TO TAKE ||| COMMENT PRENDRE PROTELOS
0.28434857726097107 ||| One third of the patients on Zometa have reported headache and a flu-like syndrome consisting of fever, fatigue, weakness, drowsiness, chills and bone, joint and/ or muscle ache. |||  403 At the beginning of treatment with IntronA, you may experience a flu-like reaction, with fever, fatigue, headache, muscle ache, joint pain and chills/rigors. ||| Un tiers des patients traités par Zometa ont rapporté des maux de tête et un syndrome grippal se manifestant par: fièvre, fatigue, faiblesse, somnolence, frissons et douleurs osseuses, articulaires et/ ou musculaires.
0.1572168469429016 ||| Education services relating to the agricultural industry ||| Educational courses relating to the travel industry ||| Services d'enseignement relatif à l'industrie agricole
0.04427172243595123 ||| Shock absorbing cylinders [parts of machines] ||| Shock absorbing cylinders [parts of vehicles] ||| Cylindres pour amortisseurs [pièces de machines]
0.31131044030189514 ||| LYRICA may be associated with blurred vision or other changes in eyesight. ||| Vimpat treatment has been associated with dizziness or blurred vision. ||| LYRICA peut être associé à une vision trouble ou à d’autres modifications de la vue.
0.37872809171676636 ||| Patients should be regularly reassessed by a doctor, so that the strength of they are receiving remains optimal and is only changed on medical advice. ||| In these situations the treatment should be carefully supervised, and the clinical benefit of Ebixa reassessed by your doctor on a regular basis. ||| Le médecin devra vérifier régulièrement que le dosage prescrit de  est bien adapté à l’ état clinique du patient.
0.3990548253059387 ||| Bitumen latex emulsions for construction purposes ||| Modified pregelatinized starches for industrial purposes ||| Émulsions de latex-bitume pour la construction
0.032521672546863556 ||| 0.5 ml (300 IU/ ml) ||| 0.5 ml (150 IU/ ml) ||| 0,5 ml (300 UI/ ml)
4.3700644231786656e-13 ||| Insulin suspensions are never to be administered intravenously. ||| Insulin suspensions are never to be administered intravenously. ||| Les suspensions d’ insuline ne doivent jamais être administrées par voie intraveineuse.
0.2475098967552185 ||| If therapy with Kivexa has been discontinued for any reason and restarting therapy is under consideration, the reason for discontinuation must be established to assess whether the patient had any symptoms of a hypersensitivity reaction. ||| Since the possibility of increased risk of cancer development in patients with newly diagnosed dysplasia treated with Remicade is not established, the risk and benefits to the individual patients must be carefully reviewed and consideration should be given to discontinuation of therapy. ||| Si le traitement par Kivexa a été interrompu quelle qu’ en soit la raison et qu’ une reprise du traitement est envisagée, le motif de l’ arrêt doit être clairement établi afin d’ identifier si le patient avait présenté un des symptômes d’ une réaction d’ hypersensibilité.
0.3168185353279114 ||| VIRACEPT should be taken in combination with other medicines that are active against HIV. ||| 178 SUSTIVA must be taken with other medicines that act against the HIV virus. ||| VIRACEPT doit être pris en association avec d’autres médicaments actifs contre le VIH.
0.16947072744369507 ||| What Enviage looks like and contents of the pack Enviage 150 mg film coated tablets are light-pink, biconvex round tablets, imprinted “ IL ” on one side and “ NVR” on the other side. ||| What Emselex looks like and contents of the pack Emselex 7.5 mg prolonged-release tablets are round, convex white tablets and are debossed with “ DF” on one side and “ 7.5” on the other. ||| Qu’ est -ce qu’ Enviage et contenu de l’ emballage extérieur Enviage 150 mg comprimés pelliculés se présente sous forme de comprimés ronds, biconvexes, roses clairs, portant l’ inscription « IL » sur une face et « NVR » sur l’ autre face.
0.6061868071556091 ||| The following information should also be provided in the appropriate brochure: ||| The applicant was requested to provide the following information: ||| Les informations suivantes doivent également être contenues dans les différentes brochures:
0.0692928284406662 ||| No information is available on the safety and efficacy from the concurrent use of this vaccine with any other. ||| Limited information is available on the safety and efficacy from the use of this vaccine with any other. ||| Aucune information n’ est disponible sur l’ innocuité et l’ efficacité lors de l’ utilisation concomitante de ce vaccin avec d’ autres vaccins.
0.004375173710286617 ||| Ciprofloxacin is present in plasma largely in a non- ionised form and has a large steady state distribution volume of 2-3 L/ kg body weight. ||| Ciprofloxacin is present in plasma largely in a non- ionised form and has a large steady state distribution volume of 2-3 L/kg body weight. ||| La ciprofloxacine est largement présente dans le plasma sous forme non ionisée et le volume de distribution à l’équilibre est important, de l’ordre de 2-3 l/kg de masse corporelle.
0.34898877143859863 ||| Later on, when the cartridge has been inserted into the pen, the insulin must be resuspended again prior to each injection. ||| The vial is shaken and, after complete dissolution, the suspension obtained is withdrawn into this same syringe for injection. ||| 230 Par la suite, après avoir inséré la cartouche dans le stylo, l'insuline doit de nouveau être remise en suspension avant chaque injection.
0.004623676184564829 ||| Some patients have been shown to benefit from IntronA 5 million IU/ m2 administered daily subcutaneously in association with cytarabine (Ara-C) 20 mg/ m2 administered daily subcutaneously for 10 days per month (up to a maximum daily dose of 40 mg). ||| Some patients have been shown to benefit from IntronA 5 million IU/m2 administered daily subcutaneously in association with cytarabine (Ara-C) 20 mg/m2 administered daily subcutaneously for 10 days per month (up to a maximum daily dose of 40 mg). ||| Certains patients ont retiré un bénéfice d’ un traitement avec IntronA 5 millions d’ UI/ m² administré quotidiennement par voie sous-cutanée en association avec la cytarabine (Ara-C) 20 mg/ m² administrée quotidiennement par voie sous- cutanée 10 jours par mois (jusqu’ à une dose maximale quotidienne de 40 mg).
0.3486059308052063 ||| Each treatment period should not be extended beyond 4 weeks due to missed doses or rest periods. ||| Treatment of lesions that have not shown a decrease in area and/ or height by week 12 should be discontinued. ||| Chaque période de traitement ne doit pas être prolongée au delà de 4 semaines, même en cas d’oublis de doses et de périodes de repos.
0.2296116054058075 ||| Very rare side effects (affects less than 1 patient in 10,000): jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions; swelling in the mouth; blisters of the skin; skin allergy; inflammation of the mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; taste disorders. |||  Uncommon (may occur in less than 1 in 100, but more than 1 in 1,000 patients): serious infections (including pneumonia, deep skin infections, joint infections, blood infection, and infections at various sites); localized swelling of the skin (angioedema); low blood platelet count; hives (elevated patches of red or pale skin that often itch); psoriasis; rash; inflammation or scarring of the lungs. ||| Effets indésirables très rares (touchant moins de 1 patient sur 10 000): jaunisse, douleur abdominale sévère avec ou sans douleur dans le dos; fièvre, difficultés respiratoires, parfois associées à de la toux; réactions allergiques généralisées; gonflement de la bouche; décollement de la peau; allergie cutanée; inflammation de la muqueuse buccale (stomatite); baisse de tension; confusion; hallucinations; douleurs articulaires; douleurs musculaires; troubles du goût.
0.6109123229980469 ||| Missile trackers ||| Pouring spouts ||| Suiveurs de missiles
0.5187836289405823 ||| No child had severe symptoms or had to discontinue because of nervous system symptoms. ||| No child must be left behind in the aftermath of the coronavirus crisis. ||| Aucun enfant n'a présenté de symptômes sévères ni d'interruption de traitement en raison de symptômes neurologiques.
0.28548961877822876 ||| If therapy with Kivexa has been discontinued for any reason and restarting therapy is under consideration, the reason for discontinuation must be established to assess whether the patient had any symptoms of a hypersensitivity reaction. ||| review of Botulinum neurotoxin type A treatment as an adequate therapy if no adverse reactions have occurred during the initial treatment, an additional course of treatment can be performed under the following conditions: ||| Si le traitement par Kivexa a été interrompu quelle qu’ en soit la raison et qu’ une reprise du traitement est envisagée, le motif de l’ arrêt doit être clairement établi afin d’ identifier si le patient avait présenté un des symptômes d’ une réaction d’ hypersensibilité.
0.1843835711479187 ||| The efficacy and safety of Clomicalm has not been established in dogs weighing less than 1.25 kg or under six months of age. ||| The safety of the veterinary medicinal product has not been established in dogs weighing less than 2.5 kg or under 3 months of age. ||| L’ efficacité et l’ innocuité de Clomicalm n’ ont pas été étudiées chez des chiens pesant moins de 1,25 kg ou âgés de moins de 6 mois.
0.348934531211853 ||| 71% ||| 27% ||| 30%
0.08987870067358017 ||| Each sublingual tablet contains 2 mg buprenorphine as buprenorphine hydrochloride and 0.5 mg naloxone as naloxone hydrochloride dihydrate. ||| Each tablet contains 2 mg buprenorphine (as buprenorphine hydrochloride) and 0.5 mg naloxone (as naloxone hydrochloride dihydrate). ||| Chaque comprimé sublingual contient 2 mg de buprénorphine sous forme de chlorhydrate de buprénorphine et 0,5 mg de naloxone sous forme de chlorhydrate de naloxone dihydraté.
0.3996082544326782 ||| Pack-sizes of 40, 60 or 180 tablets. ||| Box of 5, 10, or 25 syringes. ||| Emballages de 40, 60 ou 180 comprimés.
0.5964556932449341 ||| Influenza was confirmed in 163 out of 377 index cases. ||| Hypoacusis was reported in 15 subjects (20%). ||| La grippe a été confirmée chez 163 des 377 cas index.
0.289591908454895 ||| Since lamivudine and the virus pass into breast milk it is recommended that mothers taking Epivir do not breast-feed their infants. ||| Therefore, it is recommended that mothers being treated with tenofovir disoproxil fumarate do not breast-feed their infants. ||| Comme la lamivudine et le virus sont retrouvés dans le lait maternel, l’ allaitement est déconseillé chez la femme traitée par Epivir.
0.009560654871165752 ||| 50 Your doctor will normally advise you to stop taking Pritor as soon as you know you are pregnant. ||| 56 Your doctor will normally advise you to stop taking Pritor as soon as you know you are pregnant. ||| Votre médecin vous demandera d’ arrêter Pritor dès que vous savez que vous êtes enceinte.
0.2704133689403534 ||| Prometax 3.0 mg hard capsules Rivastigmine ||| TARGRETIN 75 mg soft capsules Bexarotene ||| Prometax 3,0 mg gélules Rivastigmine
0.3598361313343048 ||| Vaniqa is a white cream that contains 11.5% of the active substance eflornithine. ||| Pruban is a white to off-white cream containing resocortol butyrate as the active substance. ||| Vaniqa est une crème blanche contenant 11,5% du principe actif eflornithine.
0.8575104475021362 ||| Article 2 2 0 — Total ||| 1 – 25.0 1 ||| Total de l'article 2 2 0
0.02473371848464012 ||| Efficacy of Aerius syrup has not been investigated in paediatric trials in children less than 12 years of age. ||| Efficacy of Azomyr syrup has not been investigated in paediatric trials in children less than 12 years of age. ||| L’ efficacité d’ Aerius sirop n’ a pas été étudiée lors d’ études pédiatriques chez l’ enfant de moins de 12 ans.
0.008052617311477661 ||| THE WORDS "FOR ANIMAL TREATMENT ONLY" AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable ||| THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable ||| LA MENTION “ USAGE VÉTÉRINAIRE” ET CONDITIONS OU RESTRICTIONS DE DELIVRANCE ET D’ UTILISATION, le cas échéant
7.537860309894673e-13 ||| Mixing of insulins ||| Mixing of insulins ||| 271 Mélange des insulines
0.03296813368797302 ||| Insulin Human Winthrop Infusat 100 IU/ml solution for injection in a vial Insulin human ||| Insulin Human Winthrop Infusat 100 IU/ml solution for injection in a cartridge Insulin human ||| Insulin Human Winthrop Infusat 100 UI/ml solution injectable en flacon Insuline humaine
2.3720749756789283e-13 ||| If inactive (‘ latent’) tuberculosis is diagnosed, appropriate treatment for latent tuberculosis must be started with anti-tuberculosis prophylaxis therapy before the initiation of Humira, and in accordance with local recommendations. ||| If inactive (‘ latent’) tuberculosis is diagnosed, appropriate treatment for latent tuberculosis must be started with anti-tuberculosis prophylaxis therapy before the initiation of Humira, and in accordance with local recommendations. ||| En cas de diagnostic d'une tuberculose inactive (« latente »), un traitement anti-tuberculeux approprié, adapté à une tuberculose latente et conforme aux recommandations locales doit être mis en œ uvre avant de commencer le traitement par Humira.
0.6195900440216064 ||| Brokerage of credit agreements ||| Leasing of casino games ||| Courtage d'accords de crédit
0.4022688865661621 ||| From 1990 to 1994, he was Technical Counsellor in Clinical Evaluation at the Spanish Ministry of Health, Member of the CPMP/EWP and involved in the Efficacy Group of the ICH. ||| Dr Papaluca has acted as EU rapporteur for an ICH efficacy topic and as a member of the International CIOMS Working Groups I and II on pharmacovigilance. ||| De 1990 à 1994, il a été conseiller technique en évaluation clinique du ministère de la Santé espagnol, membre du CPMP/EWP et impliqué dans le groupe « efficacité » de l’ICH.
0.26205962896347046 ||| The effect of teriparatide on human foetal development has not been studied. ||| The carcinogenic potential of topotecan has not been studied. ||| L’ effet du tériparatide sur le développement du fœ tus humain n’ a pas été étudié.
0.31511494517326355 ||| A cross-study analysis in 217 patients with advanced solid tumours indicated that gender did not affect the pharmacokinetics of HYCAMTIN capsules to a clinically relevant extent. ||| 13 Analysis of population-based pharmacokinetics of TMZ revealed that plasma TMZ clearance was independent of age, renal function or tobacco use. ||| Une analyse croisée incluant 217 patients avec des tumeurs solides à un stade avancé indiquait que le sexe ne modifiait pas la pharmacocinétique d’ HYCAMTIN gélule de manière cliniquement pertinente.
0.49015653133392334 ||| Filgrastim HEXAL contains no preservative: ||| What Filgrastim HEXAL contains ||| 16 Filgrastim HEXAL ne contient aucun conservateur.
0.3557993769645691 ||| In all studies, the main measure of effectiveness was the reduction in weekly partial seizure rate. ||| The results showed that treatment with perindopril once daily resulted in a significant absolute reduction in the primary endpoint. ||| Dans toutes les études, la principale mesure de l’ efficacité était la réduction de la fréquence hebdomadaire des crises partielles.
0.2772291898727417 ||| Care should be taken when transferring patients to therapy, particularly if there is any reason to suppose that adrenal function is impaired from previous systemic steroid therapy. ||| Treatment of patients with end-stage renal disease should be made with caution as there is little clinical experience and accumulation of a metabolite (with no known pharmacological activity). ||| Des précautions devront être prises lors du relais de la corticothérapie générale par notamment chez les patients susceptibles de présenter une fonction surrénalienne altérée.
0.0 ||| DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION ||| DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION ||| DATE DE PREMIEERE AUTORISATION/ DE RENOUVELLEMENT DE L’ AUTORISATION
0.3286541700363159 ||| Ankylosing spondylitis Ankylosing spondylitis is an inflammatory disease of the spine. ||| Rheumatoid arthritis Rheumatoid arthritis is an inflammatory disease of the joints. ||| Spondylarthrite ankylosante La spondylarthrite ankylosante est une maladie inflammatoire du rachis.
0.2031298279762268 ||| Oprymea tablets should be swallowed with water, with or without food. ||| Keppra tablets may be taken with or without food and are swallowed with liquid. ||| Les comprimés d’ Oprymea doivent être avalés avec de l’ eau, au cours ou en dehors des repas.
0.15569894015789032 ||| • 05.11.2001 • 11.12.2001 ||| • 31.10.2000 • 15.11.2001 ||| 05.11.2001 11.12.2001
0.34574228525161743 ||| - If you are allergic (hypersensitive) to peginterferon alfa-2b or any of the other ingredients of ||| - If you or any member of your family have glucose-6-phosphate dehydrogenase deficiency (a ||| - si vous êtes allergique (hypersensible) au peginterféron alfa-2b ou à l’un des autres composants
3.2098932886692744e-13 ||| Additional information on the individual components Adverse drug reactions previously reported with one of the individual components (amlodipine or valsartan) may be potential undesirable effects with Exforge as well, even if not observed in clinical trials or during the post-marketing period. ||| Additional information on the individual components Adverse drug reactions previously reported with one of the individual components (amlodipine or valsartan) may be potential undesirable effects with Exforge as well, even if not observed in clinical trials or during the post-marketing period. ||| 20 Informations supplémentaires sur les composants individuels Les effets indésirables précédemment rapportés avec l'un des composants individuels (amlodipine ou valsartan) peuvent également être des effets indésirables potentiels avec Exforge, même s'ils n'ont pas été observés dans les essais cliniques ou au cours de la commercialisation.
0.38011568784713745 ||| Scissors for surgery ||| Scissors for kitchen use ||| Ciseaux pour la chirurgie
0.3056420087814331 ||| There were no significant effects of carboplatin or paclitaxel on the pharmacokinetics of erlotinib. ||| Others Interaction trials showed that lacosamide had no effect on the pharmacokinetics of digoxin. ||| Il n’ y a pas eu d’ effets significatifs du carboplatine ou du paclitaxel sur les paramètres pharmacocinétiques de l’ erlotinib.
0.23129212856292725 ||| Solvent Sodium chloride Hydrochloric acid or sodium hydroxide (for pH adjustment) Water for injections. ||| Sodium chloride Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Water for injections ||| Solvant Chlorure de sodium Acide chlorhydrique et/ ou hydroxyde de sodium (pour l’ ajustement du pH) Eau pour préparation injectable.
0.41058212518692017 ||| Insulin suspensions are never to be administered intravenously. ||| Most anti-cancer medicines are administered intravenously. ||| Les suspensions d’ insuline ne doivent jamais être administrées par voie intraveineuse.
0.2516409754753113 ||| WHAT LIPROLOG MIX25 IS AND WHAT IT IS USED FOR ||| WHAT M-M-RVAXPRO IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE LIPROLOG MIX25 ET DANS QUEL CAS EST-IL UTILISE
0.4604259133338928 ||| Via Provinciale Schito, 131 I-80058 Torre Annunziata - Napoli Italy ||| Strada Statale 156 Km 50 04010 Borgo San Michele (Lt) Italy ||| Via Provinciale Schito, 131 I-80058 Torre Annunziata - Napoli Italie
0.21952107548713684 ||| Aprovel is a medicine that contains the active substance irbesartan. ||| Irbesartan BMS is a medicine that contains the active substance irbesartan. ||| Aprovel est un médicament dont le principe actif est l'ibesartan.
0.5630319714546204 ||| Meat slicing machines ||| Heating armatures ||| Trancheuses à viande
0.2615663409233093 ||| If the patient becomes pregnant or plans to become pregnant while taking Betaferon, she should be informed of the potential hazards and discontinuation of therapy should be considered (see section 5.3). ||| Because a potential risk to the breast-feeding infant cannot be ruled out, when treating with tigecycline, caution should be exercised and interruption of breast-feeding should be considered (see section 5.3). ||| En cas de début de grossesse ou de désir de grossesse au cours d’ un traitement par Betaferon, la patiente doit être informée des risques éventuels et l’ arrêt du traitement doit être considéré (voir rubrique 5.3).
0.17275848984718323 ||| Ceftriaxone Tyrol Pharma and associated names (See Annex I) 2 g powder for solution for infusion [See Annex I - To be completed nationally] ||| Menitorix and associated names (see Annex I) solvent for solution for injection [See Annex I – To be completed nationally] I. M. ||| Ceftriaxone Tyrol Pharma et autres dénominations (voir Annexe I) 2 g, poudre pour solution pour perfusion [voir Annexe I – A compléter dans chaque pays]
0.5849597454071045 ||| Gravel paper for bird cages ||| Cloth bibs for adult diners ||| Papier sablé pour cages d'oiseaux
0.47950929403305054 ||| Clean the site of injection with an alcohol swab. ||| 10 Transfer the recommended dose to an infusion bag. ||| Nettoyer le site d’ injection avec un tampon d’ alcool.
0.21769341826438904 ||| No adjustment of the initial dose is required for patients with mild to moderate hepatic impairment (see section 5.2). ||| A reduction of the daily dose to 35 mg is recommended for adults with moderate hepatic impairment. ||| Aucun ajustement de la dose initiale n’ est nécessaire chez les patients présentant une insuffisance hépatique légère à modérée (voir rubrique 5.2).
0.6927136182785034 ||| • Treatment of soft tissue sarcoma ||| - a family history of osteoporosis ||| Treatment of soft tissue sarcoma
5.573892042365358e-13 ||| Effects of ciprofloxacin on other medicinal products: ||| Effects of ciprofloxacin on other medicinal products: ||| 248 Effets de la ciprofloxacine sur les autres produits médicamenteux:
0.36527103185653687 ||| These medicines are used to prevent and treat a wide variety of fungal infections. ||| These medicines are used to treat serious fungal infections. ||| Ces médicaments sont utilisés pour prévenir et traiter diverses infections fongiques.
0.5044890642166138 ||| 6 At one year, pegaptanib 0.3 mg exhibited a statistically significant treatment benefit for the primary efficacy endpoint; proportion of patients losing less than 15 letters of visual acuity (prespecified pooled analysis, pegaptanib 0.3 mg 70% versus Sham 55%, p = 0.0001; EOP 1003 pegaptanib 0.3 mg 73% versus Sham 59%, p = 0.0105; EOP1004 pegaptanib 0.3 mg 67% versus Sham 52%, p = .0031). ||| What Effentora looks like and contents of the pack The buccal tablets are flat-faced, round bevelled-edge tablet, embossed one side with a “ C” and on the other side with “ 1” for Effentora 100 micrograms, with “ 2” for Effentora 200 micrograms, with “ 4” for Effentora 400 micrograms, with “ 6” for Effentora 600 micrograms, with “ 8” for Effentora 800 micrograms. ||| Après un an, le pegaptanib 0,3 mg a montré un bénéfice thérapeutique statistiquement significatif pour le critère d’ efficacité principal, la proportion de patients perdant moins de 15 lettres d’ acuité visuelle (analyse groupée prédéfinie, pegaptanib 0,3 mg 70% versus injection simulée 55%, p=0,0001; EOP1003 pegaptanib 0,3 mg 73% versus injection simulée 59%, p=0,0105; EOP1004 pegaptanib 0,3 mg 67% versus injection simulée 52%, p=0,0031).
0.29184195399284363 ||| As with all NRTIs, Trizivir may also cause lactic acidosis (a build-up of lactic acid in the body) and, in the babies of mothers taking Trizivir during pregnancy, mitochondrial dysfunction (damage to the energy-producing components within cells that can cause problems in the blood). ||| Furthermore, genetic alterations in asbestos-activated macrophages may result in the release of potent mesothelial cell mitogens such as platelet-derived growth factor (PDGF) and transforming growth factor-β (TGF-β) which in turn, may induce the chronic stimulation and proliferation of mesothelial cells after injury by asbestos fibres. ||| Comme pour tous les autres INTI, Trizivir peut aussi entraîner une acidose lactique (une formation d’ acide lactique dans l’ organisme) et, chez les bébés de mères sous Trizivir pendant la grossesse, un dysfonctionnement mitochondrial (atteinte des éléments producteurs d’ énergie à l’ intérieur des cellules, qui peut entraîner des problèmes sanguins).
0.3951558470726013 ||| Like all medicines, Quixidar can cause side effects, although not everybody gets them. ||| Certain medicines, if given together with Pedea, may cause side effects. ||| to Comme tous les médicaments, Quixidar peut provoquer des effets indésirables, bien qu’ils ne se
0.3675713837146759 ||| Given the economic impact of the coronavirus outbreak, the risk of insurers not being willing to issue this insurance has become higher. ||| The pandemic has already led to extension of some contracts, potentially with a negative impact on wellbeing of seafarers. ||| Étant donné l'incidence économique de la pandémie de coronavirus, la probabilité que les assureurs refusent de couvrir un risque est devenue plus élevée.
0.2380947470664978 ||| The main measure of effectiveness was the proportion of vaccinated children who developed protective levels of antibodies one month after the last injection. ||| In all of the studies, the main measure of effectiveness was the production of protective levels of antibodies after lon the final vaccination. ||| Le principal critère d’ évaluation de l’ efficacité était la proportion d’ enfants vaccinés ayant développé des taux protecteurs d’ anticorps un mois après la dernière injection.
0.31792396306991577 ||| Remove the protective cap from the Pergoveris powder vial, pick up your syringe and slowly inject the solvent into the vial of powder. ||| Removing the syringe Pull the syringe out quickly and apply pressure to the site with a swab containing disinfectant. ||| Enlevez le capuchon protecteur en plastique du flacon de poudre de Pergoveris, prenez votre seringue et injectez lentement le solvant dans le flacon de poudre.
0.2732454538345337 ||| Rare cases of pancytopenia and very rare cases of aplastic anaemia, some with fatal outcome, have been reported in patients treated with Enbrel. ||| Moreover, rare cases of hypoglycaemia and thrombocytopenia in neonates have been reported in case of exposure near term. ||| 33 De rares cas de pancytopénies et de très rares cas d’ aplasies médullaires, dont certains d’ évolution fatale, ont été rapportés chez des patients traités par Enbrel.
0.6356161832809448 ||| - shortness of breath including asthmatic symptoms ||| - any form of severe mental disorder like psychosis ||| - essoufflement, y compris symptômes asthmatiques
0.3447619080543518 ||| Bonviva 150 mg ibandronic acid once monthly 2.5 mg daily (N=396) (N=395) (%) (%) ||| ibandronic acid Placebo 2.5 mg daily (N=975) (N=977) (%) (%) ||| Bonviva 150 mg Acide une fois par ibandronique mois 2,5 mg une fois (N=396) par jour (%) (N=395) (%)
0.48720550537109375 ||| It should be discarded according to the time specified in the Patient Information Leaflet, even if it still contains insulin. ||| The maximum quantity of virus that may be blended (which should be linked to what has been shown safe) should be specified. ||| Il doit être jeté après le temps d'utilisation spécifié dans la notice d’utilisation, même s'il contient encore de l'insuline.
0.37671536207199097 ||| Neutropenia (G3/ 4: ||| Lacrimation increased (G3/ 4: ||| Neutropénie (G3/ 4:
0.15000171959400177 ||| Any unused product should be disposed of in accordance with local requirements. ||| Disposal Any unused product should be disposed of in accordance with local requirements. ||| Tout produit non utilisé ou déchet doit être éliminé conformément à la réglementation nationale en vigueur.
0.5154420137405396 ||| The CHMP has recommended the granting of the Marketing Authorisation(s) for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Ciprofloxacin Kabi and associated names (see Annex I). ||| CHARACTERISTICS, LABELLING AND PACKAGE LEAFLETS Whereas, • the CHMP considered the referral made under Article 6(12) of Commission Regulation EC No 1084/ 2003, for Prozac and associated names (see Annex I), ||| Le CHMP a recommandé l’ octroi de l’ autorisation/ des autorisations de mise sur le marché pour lesquelles le Résumé des caractéristiques du produit, l’ étiquetage et la notice sont définis à l’ Annexe III pour Ciprofloxacine Kabi et dénominations associées (voir Annexe I).
0.6756407618522644 ||| Treatment of gastric ulcer: ||| Dosage in type 1 Gaucher disease ||| Traitement de l’ ulcère gastrique:
0.3012714385986328 ||| SIA Merck Sharp & Dohme Latvija Skanstes 13 Riga, LV-1013 Latvia ||| Merck Sharp & Dohme UAB, Lithuania Gelezinio Vilko 18A 01112 Vilnius Lithuania ||| Latvija, Skanstes 13 Riga, LV-1013 Latvia UAB, Merck Sharp & Dohme“,
0.8206255435943604 ||| Pharmaceutical companies are racing to develop antibodies and vaccines against the virus. ||| initially included a fleet of firefighting planes and helicopters. ||| Les compagnies pharmaceutiques s’emploient toutes à développer des anticorps et des vaccins contre le virus.
0.18630075454711914 ||| 135 μ g in 1 ml ||| 180 μ g in 0.5 ml ||| 135 µg dans 1 ml
0.4465602934360504 ||| What is the risk associated with Fendrix? ||| What are the causes of resistant E. coli? ||| Quel est le risque associé à l’ utilisation de Fendrix?
0.286083847284317 ||| Although toxicity data for the target animal may be scarce, the adverse effects connected to ephedrine treatment are well known from human use, and the applicant has provided some post-marketing information regarding the use in dogs. ||| Furthermore, the data generated for Rapinyl and the substantial additional cancer patient exposure data demonstrate that volunteers and patients have similar pharmacokinetics, negating the need for additional studies in healthy volunteers. ||| Bien que les données de toxicité chez l’ animal cible soient limitées, les effets indésirables liés à un traitement par éphédrine sont bien connus chez l’ être humain; le demandeur a également fourni certaines informations post- commercialisation concernant l’ utilisation chez le chien.
0.12284964323043823 ||| No dosage adjustment is necessary in patients with renal impairment whose creatinine clearance is ≥ 30 ml/ min. ||| No dosage reduction is required for patients with mild renal impairment (creatinine clearance > 50 ml/ min). ||| Une adaptation posologique n’ est pas nécessaire chez les patients dont la clairance de la créatinine est ≥ 30 ml/ min.
0.039114125072956085 ||| Each vial of powder contains 75 IU of lutropin alfa and each vial of solvent contains 1 ml of water for injection. ||| Each vial of powder contains 75 IU of lutropin alfa and each ampoule of solvent contains 1 ml of water for injection. ||| Chaque flacon de poudre contient 75 UI de lutropine alfa et chaque flacon de solvant contient 1 ml d’ eau pour préparations injectables.
0.3712192177772522 ||| Curtain hooks made of metal ||| Horological instruments made of gold ||| Crochets métalliques pour rideaux
0.15941298007965088 ||| 3.15 ml solution in a cartridge (type 1 colourless glass) with a plunger (fluoropolymer coated rubber (type 1, mixture of chlorobutyl and natural rubber)), a flanged cap (aluminium) and a stopper with hole (bromobutyl rubber (type 1), a Luer cone attachment (colourless polyethylene) and a Luer cap (colourless polyethylene). ||| Powder in a vial (type I glass) with a stopper (fluor-resin laminated butyl rubber), a strip (aluminium) and a cap (green polypropylene flip-off), and 1 ml of solvent in a cartridge (type I glass) with a stopper (fluor-resin laminated chlorobutyl elastomer), a strip (lacquered aluminium) and a cap (white polypropylene flip-off). ||| 3,15 ml de solution en cartouche (verre classe 1 incolore), avec un piston en caoutchouc revêtu de fluoropolymère (type 1, mélange de chlorobutyle et de caoutchouc naturel), un sertissage (aluminium et un bouchon avec un trou (bromobutyle (type 1)), un cône Luer (polyéthylène incolore) et une capsule Luer (polyéthylène incolore).
0.1561162918806076 ||| This ensures that fleas infesting the animal are killed, no viable flea eggs are produced by these fleas, and larvae (found only in the environment) are also killed. ||| Following administration of the product, the adult fleas on the animal are killed, no viable eggs are produced, and larvae (found only in the environment) are also killed. ||| Ainsi, les puces présentes sur l’ animal sont tuées, leurs œ ufs ne sont pas viables, et les larves (présentes dans l’ environnement) sont tuées.
0.5785770416259766 ||| 15 D- 06796 Brehna Germany ||| 76 35 041 Marburg Germany ||| 15 D- 06796 Brehna Allemagne
0.3073996901512146 ||| In this patient population, the presence of hepatic metastases could potentially lead to hepatic insufficiency and reduced metabolism. ||| Oversuppression of the immune system can also increase susceptibility to infection including opportunistic infections, fatal infections, and sepsis. ||| Dans cette population de patients, la présence de métastases hépatiques pourrait potentiellement conduire à une insuffisance hépatique et à une diminution du métabolisme.
3.3441123676626605e-13 ||| The Marketing Authorisation Holder shall complete the following programme of studies within the specified time frame, the results of which shall form the basis of the annual reassessment of the benefit/ risk profile. ||| The Marketing Authorisation Holder shall complete the following programme of studies within the specified time frame, the results of which shall form the basis of the annual reassessment of the benefit/ risk profile. ||| Le titulaire de l’ autorisation de mise sur le marché doit mener à son terme le programme d’ études suivant, selon le calendrier indiqué, les résultats obtenus serviront de base pour la réévaluation annuelle du rapport bénéfice/ risque.
0.14966529607772827 ||| Further, an increase in rectal temperature up to 2°C may occur on the day of vaccination. ||| An increase in body temperature of up to 2°C may occur on the day of vaccination. ||| De plus, une augmentation de la température rectale pouvant atteindre 2°C peut survenir le jour de la vaccination.
0.2918732762336731 ||| 107 Additional information on special populations In clinical trials in elderly patients with dementia, olanzapine treatment was associated with a higher incidence of death and cerebrovascular adverse reactions compared to placebo (see section 4.4). ||| Reduction of zoster pain severity-by-duration in vaccinated individuals who developed zoster With regard to the acute pain (pain between 0-30 days) there was no statistically significant difference between the vaccine group and the placebo group. ||| Information complémentaire concernant des populations particulières Au cours d’ essais cliniques chez des patients âgés déments, le traitement par olanzapine a été associé à une incidence supérieure de décès et d’ événements indésirables vasculaires cérébraux par rapport au placebo (voir rubrique 4.4).
0.12682363390922546 ||| EU/ 1/ 00/ 153/ 006 ||| EU/ 1/ 00/ 160/ 061 ||| EU/ 1/ 00/ 153/ 007
0.3591836392879486 ||| Lung problems (including inflammatory processes of varying histopathology and/ or fibrosis) have been reported rarely. ||| The risk of intra-uterine death or severe birth defects, primarily phocomelia, is extremely high. ||| Des troubles de la fonction hépatique (foie) ont été rarement rapportés, avec de très rares cas d’ hépatites.
0.02862115018069744 ||| 87 Follow your doctor’ s instructions carefully. ||| 94 Follow your doctor’ s instructions carefully. ||| Respectez scrupuleusement les instructions de votre médecin.
0.19738340377807617 ||| Orthopaedic implants ||| Orthopaedic instruments ||| Implants orthopédiques
0.08178523927927017 ||| If this combination proves essential, careful monitoring of serum lithium level is recommended during concomitant use. ||| If this combination proves essential, serum lithium level monitoring is recommended during concomitant use. ||| Si cette association s’ avère indispensable, la lithémie doit être surveillée étroitement pendant le traitement concomitant.
0.2027955800294876 ||| What is Equilis Te used for? ||| What is TachoSil used for? ||| Dans quel cas Equilis Te est -il utilisé?
0.16186562180519104 ||| Xolair 150 mg powder for solution for injection Omalizumab Subcutaneous use ||| Vidaza 25 mg/ml powder for suspension for injection Azacitidine Subcutaneous use ||| Xolair 150 mg poudre pour solution injectable Omalizumab Voie sous-cutanée
0.31619930267333984 ||| If you have any further questions on the use of this product, ask your doctor. ||| Consult your doctor if you have any questions about safe disposal of these items. ||| Si vous avez d’ autres questions sur l’ utilisation de ce médicament, demandez plus d’ informations à votre médecin
0.014930736273527145 ||| 48 PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING ||| 47 PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING ||| 50 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.061195410788059235 ||| 452 Insulin Human Winthrop Rapid is supplied in cartridges containing 3 ml solution (300 IU). ||| 432 Insulin Human Winthrop Rapid is supplied in vials containing 5 ml solution (500 IU). ||| Insulin Human Winthrop Rapid est fourni en cartouche contenant 3 ml de solution (300 UI).
0.17589876055717468 ||| Each tablet contains 0.7 mg pramipexole equivalent to 1 mg pramipexole dihydrochloride monohydrate. ||| Each film coated tablet contains 60 mg raloxifene hydrochloride, equivalent to 56 mg raloxifene free base. ||| Chaque tablet contient 0,7 mg de pramipexole correspondant à 1 mg de dihydrochlorhydrate de pramipexol monohydraté.
0.3503599166870117 ||| The efficacy and safety have not been fully evaluated in patients with severe renal impairment (creatinine clearance < 30 ml/ min, see section 5.2). ||| Bioavailability following subcutaneous and intramuscular injection in humans is high and similar for the two routes of administration (71% and 66%, respectively). ||| L’ efficacité et la tolérance n’ ont pas été totalement évaluées chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) (voir rubrique 5.2).
0.10041771829128265 ||| 5/ 18 ANNEX II ||| 5/ 35 ANNEX II ||| 5/ 18 ANNEXE II
1.4246551990509033 ||| Meetings Evaluations Translation Studies and consultants Publications EU programmes ||| CPMP meetings COMP meetings Other meetings ||| Réunions Évaluations Traduction Études et conseillers Publications
0.40811896324157715 ||| It is recommended that the platelet count is regularly monitored during the first 8 weeks of therapy. ||| Close metabolic monitoring is recommended during the transition and in the initial weeks thereafter. ||| Il est conseillé de surveiller la numération plaquettaire à intervalles réguliers pendant les 8 premières semaines de traitement.
0.41122114658355713 ||| Water for Injections, benzyl alcohol 0.9% Solvent for use with GONAL-f 450 IU/ 0.75 ml ||| 13% (w/ w) ethanol 95% in water for injections 6 ml (Fill 7.33 ml) ||| Eau pour préparations injectables, alcool benzylique (0,9%) Solvant pour utilisation avec GONAL-f 450 UI/ 0,75 ml
0.46941399574279785 ||| Wood surrounds [furniture] for electronic apparatus ||| Pressure supervision apparatus [safety apparatus for water pipes] ||| Châssis en bois [meubles] pour appareils électroniques
0.1539727747440338 ||| Do not use in case of hypersensitivity to the active substance or to any of the excipients. ||| Do not use in case of hypersensitivity to macrolide antibiotics or to any of the excipients. ||| Ne pas utiliser en cas d’ hypersensibilité au principe actif ou à l’ un des excipients.
0.0 ||| Line up the needle with the pen, and keep it straight as you attach it (screw or push on, depending on the needle type). ||| Line up the needle with the pen, and keep it straight as you attach it (screw or push on, depending on the needle type). ||| Alignez l’ aiguille avec le stylo et maintenez -la bien droite lorsque vous la fixez sur le stylo (en la vissant ou en la poussant selon le type d'aiguille).
0.4057099223136902 ||| - if you have hepatitis and have been treated recently with medications that suppress the immune system ||| - if you have recently received or are about to receive a vaccine against yellow fever. ||| - si vous avez une hépatite et avez été récemment traité par des médicaments qui dépriment le
0.3000299334526062 ||| Caution should be exercised if patients are required to take medicinal products that inhibit platelet function or anticoagulants. ||| If abnormalities develop, dose reduction of therapy, or change of treatment to another immunosuppressive agent should be considered. ||| Des précautions doivent être prises chez les patients nécessitant un traitement par des médicaments antiagrégants plaquettaires ou par anticoagulants.
0.05571337789297104 ||| Do not use RILUTEK after the expiry date which is stated on the carton and the blister. ||| Do not use CANCIDAS after the expiry date which is stated on the carton and the vial. ||| Ne pas utiliser RILUTEK après la date de péremption mentionnée sur la boîte et le blister.
0.6038004159927368 ||| D-sorbitol, water for injections. ||| ra Inhalation powder, pre-dispensed. ||| D-sorbitol, eau pour préparations injectables.
0.3621146082878113 ||| Therefore, RELISTOR should not be used for treatment of patients with constipation not related to opioid use. ||| LYRICA is not intended to be used alone, but should always be used in combination with other anti-epileptic treatment. ||| Par conséquent, RELISTOR ne doit pas être utilisé pour traiter les patients présentant une constipation non liée à l’ utilisation d’ opioïdes.
0.16422313451766968 ||| 35 Study 1: ||| 48 Study 1: ||| 38 Étude 1:
0.24383960664272308 ||| In dogs given tadalafil daily for 6 to 12 months at doses of 25 mg/ kg/ day (resulting in at least a 3-fold greater exposure [range 3.7 – 18.6] than seen in humans given a single 20 mg dose) and above, there was regression of the seminiferous tubular epithelium that resulted in a decrease in spermatogenesis in some dogs. ||| The difference in lipid-lowering efficacy between rosuvastatin 5 mg and 10 mg is that anticipated with a statin, i. e. a doubling of the dose from 5 mg to 10 mg (either through start dose or through up-titration) produces an average incremental reduction of LDL-C of 6%, from an average 41% to 47%. ||| Chez les chiens ayant reçu quotidiennement du tadalafil pendant 6 à 12 mois à des doses de 25 mg/ kg/ jour (représentant une exposition au moins 3 fois supérieure [de 3,7 à 18,6] à celle observée chez l’ homme à la dose unique de 20 mg) et plus, une régression de l'épithélium des tubes séminifères a été observée, entraînant une diminution de la spermatogénèse chez certains chiens.
0.5353647470474243 ||| No patients in either group progressed to cirrhosis. ||| Patients with secondary MDS were excluded from the study. ||| Aucun patient n'a développé de cirrhose, quel que soit le groupe.
0.10258152335882187 ||| The full EPAR for Zevalin is available here. ||| The full EPAR for Glubrava is available here. ||| L’ EPAR complet relatif à Zevalin est disponible ici.
0.08226517587900162 ||| 4 (0.9) 2 (0.4) 15 (3.2) 18 (3.9) 12 (2.6) 7 (1.5) ||| 7 (0.7) 14 (1.4) 21 (2.1) 40 (4.1) 18 (1.8) 3 (0.3) ||| 7 (0,7) 5 (0,5) 14 (1,4) 10 (1,0) 21 (2,1) 28 (2,9)
0.4119716286659241 ||| 10 Slovenia ||| 5 Iceland ||| Slovénie
0.3895934820175171 ||| The difference was driven by the outcome in the group of patients with ≥ 5% weight loss after 12 weeks of treatment with orlistat representing 19% of the initial population. ||| There was also a continued level of improvement in the quality of financial transactions submitted in 2000, with an average of 1.05% of submissions requiring revision (1.37% in 1999). ||| La différence était principalement liée au résultat obtenu dans le groupe de patients ayant perdu ≥ 5% de leur poids après 12 semaines de traitement par orlistat, qui représentait 19% de la population initiale.
0.515062153339386 ||| Regardless of the route of dosing, pronounced pharmacodynamic changes are associated with the administration of Rebif. ||| Numerically all of the components of the clinical composite endpoint were in favour of the PCI only regimen: death: ||| 44 Indépendamment du mode d’ administration, des changements pharmacodynamiques importants sont associés à l’ administration de Rebif.
0.0 ||| Suomi/ Finland Wyeth Puh/ Tel: +358 20 7414 870 Fax: +358 20 7414 879 ||| Suomi/ Finland Wyeth Puh/ Tel: +358 20 7414 870 Fax: +358 20 7414 879 ||| Suomi/Finland Wyeth Puh/Tel:+358 20 7414 870 Fax:+358 20 7414 879
0.26753485202789307 ||| Due to extensive atorvastatin binding to plasma proteins, haemodialysis is not expected to significantly enhance atorvastatin clearance. ||| This may result in an enhanced anticoagulant effect of lepirudin, possibly due to delayed renal elimination of active lepirudin-antihirudin complexes. ||| En raison de l'importante liaison de l’ atorvastatine aux protéines plasmatiques, l'hémodialyse ne devrait pas significativement augmenter la clairance de l'atorvastatine.
0.35641181468963623 ||| 7 Adverse reactions for each treatment regimen are presented below by system organ class and absolute frequency. ||| The adverse reactions considered at least possibly related to the treatment are listed below by body system, organ class and absolute frequency. ||| Les effets indésirables pour chaque traitement sont présentés ci-dessous, par système organe et par fréquence absolue.
0.18527455627918243 ||| HOW TO STORE MACUGEN ||| HOW TO STORE CUBICIN ||| COMMENT CONSERVER M ACUGEN?
0.0020681400783360004 ||| One vial contains 150 IU recombinant follicle-stimulating hormone (FSH) in 0.5 ml aqueous solution. ||| One vial contains 75 IU recombinant follicle-stimulating hormone (FSH) in 0.5 ml aqueous solution. ||| Un flacon contient 150 UI d’ hormone folliculo-stimulante recombinante (FSH) dans 0,5 ml de solution aqueuse.
0.1952625811100006 ||| Other information about Circovac: ||| Other information about Actos: ||| Autres informations relatives à Circovac:
0.2403639405965805 ||| HOW TO TAKE COMBIVIR ||| HOW TO TAKE MYFENAX ||| COMMENT PRENDRE COMBIVIR
0.17295238375663757 ||| The full EPAR for PROTELOS is available here. ||| The full EPAR for Glustin is available here. ||| L’ EPAR complet est disponible à l’ adresse suivante: ici.
0.2941034734249115 ||| This may happen: • If you take too little NovoNorm • If you have an infection or a fever • If you eat more than usual • If you exercise less than usual. ||| This may happen: • If you take too much NovoNorm • If you exercise more than usual • If you take other medicines or suffer from liver or kidney problems (see other sections of 2. ||| Cela peut arriver: • si vous prenez trop peu de NovoNorm • si vous avez une infection ou de la fièvre • si vous prenez un repas plus important que d’ habitude • si vous faîtes moins d’ exercice que d’ habitude.
0.30966511368751526 ||| The dose may later be increased to 300 mg (four tablets a day) once daily depending on blood pressure response. ||| For most patients, the right dose is between 6 mg and 8 mg per day (reached within 3 to 4 weeks). ||| La dose peut être ultérieurement augmentée jusqu'à 300 mg (4 comprimés par jour) en une prise par jour en fonction de la réponse sur la pression artérielle.
0.4381287097930908 ||| To give one important example: if we want to minimise permanent layoffs and damage to the European aviation sector, urgent action is necessary. ||| As we stand together, we must reject the idea once and for all that a vaccine and having quality health care is a privilege of affluence. ||| Pour donner un exemple important, si nous voulons réduire au minimum les licenciements économiques permanents et les préjudices causés au secteur de l'aviation européenne, des mesures sont nécessaires d'urgence.
0.5564101934432983 ||| The three individuals had close contact with the person who was reported to be infected by the virus on 13 March . ||| On 13 March, the third case was also confirmed, is a person who has had direct contact with the first two cases. ||| Les trois individus ont été en contact étroit avec la personne qui aurait été infectée par le virus le 13 mars.
0.3162453770637512 ||| AstraZeneca Belgium Egide Van Ophemstraat 110 B-1180 Brussels, Belgium ||| NV AstraZeneca SA, rue Egide Van Ophem straat ,110 B-1180 Brussels Belgium ||| Egide Van Ophemstraat 110 B-1180 Bruxelles, Belgique
0.023306829854846 ||| A connection between visceral lipomatosis and protease inhibitors and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised. ||| A connection between visceral 5 lipomatosis and protease inhibitors and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised. ||| L'hypothèse d'une relation entre lipomatose viscérale et inhibiteurs de protéase (IP) d'une part, et lipoatrophie et inhibiteurs nucléosidiques de la transcriptase inverse (INTI) d'autre part, a été émise.
0.2096058428287506 ||| The CHMP has recommended the suspension of the Marketing Authorisations for Hexavac. ||| - the CPMP has recommended the withdrawal of the Marketing Authorisations for cerivastatin ||| Le CHMP recommande la suspension de l’ Autorisation de Mise sur le Marché de l’ Hexavac.
0.2080879509449005 ||| What Rapamune contains The active substance is sirolimus. ||| What Vimpat contains The active substance is lacosamide. ||| - La substance active est le sirolimus.
0.4630260765552521 ||| Romania ||| Danmark ||| Roumanie
0.5158833861351013 ||| In other parts of our Union, the economy was supported by strong public investment from the very beginning of the crisis. ||| From the beginnings of human civilization, communities promoted health and fought disease at the population level. ||| Dans d'autres parties de l'Union, l'économie a été soutenue par de solides investissements publics dès le début de la crise.
0.3248565196990967 ||| If you are breast-feeding, don’ t use AZOPT; it may get into your milk. ||| If you are breast-feeding, DuoTrav may get into your milk. ||| Si vous allaitez, n’utilisez pas AZOPT; il peut passer dans votre lait.
0.0 ||| VFEND 200 mg ||| VFEND 200 mg ||| VFEND 40 mg/ ml
0.4508858919143677 ||| The reaction has been studied in controlled trials in susceptible animals. ||| Alternative dosing regimens have been used in clinical studies. ||| Lors d’ essais cliniques contrôlés, ces effets secondaires ont été étudiés chez des animaux prédisposés.
0.40415698289871216 ||| Betaferon is available in pack sizes of: ||| Fasturtec is supplied as a pack of: ||| 93 Betaferon est disponible en emballage de:
0.44395768642425537 ||| Common: nausea. ||| Common: malaise. ||| 33 Fréquent: nausées.
0.07730132341384888 ||| LIST OF THE INVENTED NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES AND NORWAY AND ICELAND ||| LISTE REPRENANT LES NOMS, LES FORMES PHARMACEUTIQUES, LES DOSAGES DES MÉDICAMENTS, LA VOIE D'ADMINISTRATION ET LES TITULAIRES DE L'AUTORISATION DE MISE SUR LE MARCHÉ DANS LES ÉTATS MEMBRES
0.883463978767395 ||| Should be avoided ||| Patients should therefore be ||| Doit être évité
0.313662588596344 ||| This depends on your body weight and the results of a blood test carried out before the start of the treatment to measure the amount of IgE in your blood. ||| An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. ||| Cela dépend de votre poids et des résultats d’ un examen de sang pratiqué avant le début du traitement afin de mesurer la quantité d'IgE présente dans votre sang.
0.11898849904537201 ||| Sabumalin is a ‘ generic medicine’. ||| Myfenax is a ‘ generic medicine’. ||| Sabumalin est un « médicament générique ».
0.13263580203056335 ||| Uncommon side effects (may occur in more than 1 in 1,000 patients but less that 1 in 100 patients) ||| Uncommon side effects (likely to occur in more than 1 of 1,000 patients but less than 1 of 100 patients): ||| Effets indésirables peu fréquents d’ Arava (1 pour 1 000 à moins de 1 patient sur 100):
0.1307981163263321 ||| au must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes. ||| Glucose must also be given intravenously if the patient does not respond to glucagon within 10 to 15 minutes. ||| Du glucose doit également être administré par voie intraveineuse si le patient ne répond pas au glucagon dans les 10 à 15 minutes.
0.2953840494155884 ||| Efficacy results are presented in Table 8: ||| Efficacy results are summarized in the following table: ||| Les résultats d’ efficacité sont présentés dans le Tableau 8:
0.3149569034576416 ||| What Stalevo contains ||| What Soliris contains ||| Que contient Stalevo
1.0350511074066162 ||| Ciproxin Ciproxine Ciprobay Ciproxin Ciproxin Ciflox Ciprobay; Ciprofloxacin ANTIBAC Ciproxin Ciproxin Ciproxin Ciproxin Ciproxine Ciproxin Ciproxin Ciproxina Ciprobay Ciprobay Baycip Ciproxin Ciproxin ||| Ciproxine Ciprobay Uro Ciprobay Uro Ciproxin Ciproxine Ciproxin Ciprobay Uro Ciproxin ||| Ciprobay; Ciprofloxacin ANTIBAC Ciproxin Ciproxine Ciproxin Baycip Ciproxin Ciflox Ciproxin Ciproxin Ciproxin Ciproxin Ciproxine Ciproxin Ciproxin Ciproxina Ciprobay Ciprobay Ciproxin Ciprobay Ciproxin
2.7077011422946273e-13 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| vous ressentez un des effets mentionnés comme graves ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien. e am
0.08292785286903381 ||| MicardisPlus 40 mg/ 12.5 mg tablets ||| MicardisPlus 80 mg/ 12.5 mg ||| MicardisPlus 40 mg/ 12,5 mg comprimés
0.3990181088447571 ||| i ||| in ||| p
0.3331007659435272 ||| In reproduction toxicity studies decreased fertility in male rats was observed. ||| In reproductive toxicology studies, evidence of impaired fertility was seen in rats. ||| Au cours des études de toxicité sur la reproduction, une diminution de la fertilité des rats mâles a été observée.
0.37569576501846313 ||| However, evidence of reversibility was observed after recovery. ||| However, no significant effect on fracture rates was demonstrated. ||| Toutefois, des signes de réversibilité ont été observés après la période de récupération.
0.22041955590248108 ||| The reconstituted preparation results in a colourless to pale yellow, clear solution. ||| The reconstituted solution is a clear and colourless to slightly yellowish fluid. ||| La solution reconstituée doit être incolore à jaune pâle et limpide.
0.3796694576740265 ||| In vitro binding of emtricitabine to human plasma proteins was < 4% and independent of concentration over the range of 0.02-200 µg/ ml. ||| N-Desethyl-brinzolamide accumulated in RBCs to steady state within 20-28 weeks reaching concentrations ranging from 6-30 µM. ||| Distribution: la liaison in vitro de l’ emtricitabine aux protéines plasmatiques humaines a été < 4% et indépendante de la concentration sur l’ intervalle 0,02-200 µg/ ml.
0.24296344816684723 ||| Clinical efficacy and safety The safety and efficacy of ustekinumabwas assessed in 1,996 patients in two randomised, double-blind, placebo-controlled studies in patients with moderate to severe plaque psoriasis and who were candidates for phototherapy or systemic therapy. ||| The safety and efficacy of anidulafungin were evaluated in a pivotal Phase 3, randomised, double- blind, multicentre, multinational study of primarily non-neutropenic patients with candidaemia and a limited number of patients with deep tissue Candida infections or with abscess-forming disease. ||| Efficacité et tolérance clinique La tolérance et l’ efficacité de l’ ustekinumab ont été évaluées dans deux études randomisées, en double aveugle versus placebo chez 1 996 patients présentant un psoriasis en plaques modéré à sévère et qui étaient candidats à la photothérapie ou à un autre traitement systémique.
0.27208584547042847 ||| Pyrimethamine toxicity: • In case of high dose pyrimethamine or prolonged treatment with low doses, calcium folinate 5 to 50 mg/ day should be simultaneously administered, based on the results of the peripheral blood counts. ||| If an unsatisfactory reduction in blood phenylalanine levels is observed, then the dose of Kuvan can be increased weekly to a maximum of 20 mg/ kg/ day, with continued weekly monitoring of blood phenylalanine levels over a one month period. ||| Toxicité de la pyriméthamine: • Dans le cas de fortes doses de pyriméthamine ou d’un traitement prolongé à faibles doses, 5 à 50 mg/jour de folinate de calcium doivent être administrés simultanément, selon les résultats des numérations sanguines périphériques.
0.4090278744697571 |||  446 Do not use if discolouration or particulate matter is present. ||| Do not u se if discolouration or particulate matter is present. ||| Ne l’utilisez pas si un jaunissement ou des particules sont présents.
0.47742730379104614 ||| Adjustments of daily dosage, including dose reduction should be considered on the basis of clinical status. ||| o Direct grants, in the form of waiving of the applicable fee on guarantees awarded. ||| La posologie quotidienne peut être adaptée, une réduction de dose pourra être considérée en fonction de l’ état clinique du patient.
0.3071972131729126 ||| Reported cases of lactic acidosis in patients on metformin have occurred primarily in diabetic patients with significant renal failure. ||| Several cases of allergic reactions in humans following the ingestion of food containing penicillin residues were reviewed. ||| Les cas d’ acidose lactique rapportés chez les patients traités par la metformine sont survenus principalement chez des patients diabétiques présentant une insuffisance rénale significative.
0.017670348286628723 ||| Adjunctive therapy WITHOUT valproate and WITHOUT inducers of lamotrigine glucuronidation (see section 4.5): ||| Adjunctive therapy WITHOUT valproate and WITH inducers of lamotrigine glucuronidation (see section 4.5): ||| Traitement en association SANS le valproate et SANS inducteur de la glucuronisation de la lamotrigine (voir rubrique 4.5):
0.1808253824710846 ||| Hedge cutters [machines] ||| Side cutters [machines] ||| Coupe-haies [machines]
0.3111937642097473 ||| Fertavid solution for injection in cartridges has been developed for use in a pen injector called Puregon Pen and should be administered subcutaneously. ||| It should only be administered with the Omnitrope Pen 5, an injection device specifically developed for use with Omnitrope 3.3 mg/ ml solution for injection. ||| 59 Fertavid solution injectable en cartouche a été développé pour être utilisé avec un stylo injecteur appelé Puregon Pen et doit être administré par voie sous-cutanée.
0.3999071717262268 ||| The increase in the number of mutual recognition procedures is expected to continue in 2000-2001. ||| The Agency expects the number of inspections to remain stable in 2006. ||| L’augmentation du nombre de procédures de reconnaissance mutuelle devrait se poursuivre en 2000-2001.
0.4312973618507385 ||| Upon multiple dosing exposure increased by an accumulation factor of 1.3 to 2.3. ||| Area under the curve increased approximately in proportion to the increase in dose. ||| Après l’ administration de doses multiples, l’ exposition a augmenté par un facteur d’ accumulation allant de 1,3 à 2,3.
0.4337819218635559 ||| The safety of repeat doses has not been established in children and adolescents, in patients with renal impairment, or the elderly. ||| This will include information on its side effects and its safety in the elderly, pregnant women, patients with severe conditions, and people who have problems with their immune systems. ||| L’ innocuité d’ administrations répétées chez l’ enfant, l’ adolescent, l’ insuffisant rénal et le sujet âgé n’ a pas été démontrée.
0.01657285913825035 ||| Marketing Authorisation Holder and Manufacturer Liprolog Mix25 100 U/ml Pen, suspension for injection is made by: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France, • Eli Lilly Italia S.p.A., Via A. ||| Marketing Authorisation Holder and Manufacturer Humalog Mix25 100 U/ml suspension for injection in cartridge is made by: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France, • Eli Lilly Italia S.p.A., Via A. ||| Titulaire de l'Autorisation de mise sur le marché et fabricant Liprolog Mix25 100 UI/ml Pen, suspension injectable est fabriqué par: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim – France, • Eli Lilly Italia S.p. A., Via A.
5.455813752164307e-13 ||| Remove as much as possible of the amount administered before the next instillation. ||| Remove as much as possible of the amount administered before the next instillation. ||| Retirer le plus possible de la quantité administrée avant l'instillation suivante.
0.6613845825195312 ||| Gardeners' knives ||| Artists' materials ||| Couteaux de jardinier
0.3232826292514801 ||| Betaine supplementation was shown to improve the metabolic abnormalities in the cerebrospinal fluid of patients with homocystinuria. ||| Sildenafil showed no effect on cardiac output, and did not impair blood flow through the stenosed coronary arteries. ||| Une supplémentation en bétaïne a montré une amélioration des anomalies métaboliques du liquide céphalorachidien chez les patients atteints d’ homocystinurie.
0.2958710193634033 ||| The following statements reflect the pharmacokinetic properties of the individual active substances of Competact. ||| The pharmacokinetics of Humalog Mix25 are representative of the individual pharmacokinetic properties of the two components. ||| Les informations ci-après concernent les propriétés pharmacocinétiques de chacune des substances actives de Competact.
0.8232861161231995 ||| Week 2 Week 12 Week 24 ASAS 50 ||| Day 15 Month 6 Month 12 ACR 50 ||| Semaine 2 Semaine 12 Semaine 24 ASAS 50
0.02754259668290615 ||| This might just be for the first injection or it may be a gradual change over several weeks or months. • Inject Liprolog under the skin. ||| This might just be for the first injection or it may be a gradual change over several weeks or months. • Inject Humalog under the skin. ||| Ce changement peut être effectué lors de la première injection ou progressivement au cours de plusieurs semaines ou plusieurs mois. • Injectez Liprolog sous la peau.
0.02927396073937416 ||| To administer EQUIOXX at the dose of 0.1 mg firocoxib/ kg, set the syringe plunger to the appropriate dose division for the horse’ s weight. ||| To administer Previcox at the dose of 0.1 mg firocoxib/ kg, set the syringe plunger to the appropriate dose division for the horse’ s weight. ||| Pour administrer EQUIOXX à la dose de 0,1 mg firocoxib/ kg, ajuster le piston de la seringue pour administration orale jusqu’ à la graduation correspondant au poids du cheval.
0.0 ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| FABRICANT DU(ES) PRINCIPE(S) ACTIF(S) D’ ORIGINE BIOLOGIQUE ET TITULAIRE DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBÉRATION DES LOTS
0.6430477499961853 ||| Reconstituted Visudyne is an opaque dark green solution. ||| Do not store reconstituted NovoSeven in plastic syringes. ||| La solution reconstituée de Visudyne est une solution opaque, vert foncé.
0.4642779529094696 ||| Musical education services ||| Video entertainment services ||| Services d'éducation musicale
0.5755455493927002 ||| Automated payment services ||| Unified communications software ||| Services de paiement automatisé
0.7913194894790649 ||| Milk: zero days. ||| 35 days Milk: ||| Lait: zéro jour.
0.2871423661708832 ||| Trastuzumab binds selectively to an antigen called human epidermal growth factor 2 (HER2). ||| Via its binding to a specific cytoplasmic immunophilin (FKBP12), tacrolimus inhibits calcium- ||| Le trastuzumab se lie sélectivement à un antigène appelé facteur de croissance épidermique humain 2 (HER2).
0.4207831025123596 ||| The increase in the number of authorised veterinary medicines will result in a considerable increase in pharmacovigilance activities, which now falls within the responsibility of this Sector. ||| One of the major activities of the sector within the EMEA for 1998-99 will consist of the handling of incoming safety information relating to centrally-authorised products. ||| L’augmentation du nombre de médicaments à usage vétérinaire autorisés se traduira par une hausse sensible des activités de pharmacovigilance, qui comptent désormais parmi les attributions de ce secteur.
0.5054190754890442 ||| uc rod lP i na dic Me ||| OTHER lp i na dic Me ||| 'es tn en am dic mé Ce
0.15533572435379028 ||| • The CHMP considered that the benefit/ risk balance of Hexavac for primary and booster vaccination of children against diphtheria, tetanus, pertussis, Hepatitis B caused by all known subtypes of viruses, poliomyelitis and invasive infections caused by Haemophilus influenzae type b, was not favourable. ||| This combined vaccine is indicated for primary and booster vaccination of children against diphtheria, tetanus, pertussis, hepatitis B caused by all known subtypes of viruses, poliomyelitis and invasive infections caused by Haemophilus influenzae type b. ||| • Le CHMP a considèré que le rapport bénéfices/ risques de l’ Hexavac en primo-vaccination et en vaccination de rappel chez l’ enfant contre la diphthérie, le tétanos, la coqueluche, l’ Hépatite B causés par tous les sous-types de virus connus, la poliomyélite et les infections invasives causées par l’ Haemophilus influenzae type b, n’ est pas favorable.
0.3064928650856018 ||| Advisory services relating to computer software used for printing ||| Design services relating to model making for play purposes ||| Services de conseil concernant des logiciels utilisés pour l'impression
0.09345032274723053 ||| The vaccine also contains an ‘ adjuvant’ (mineral oil) to stimulate a better response. ||| The vaccine contains an ‘ adjuvant’ (a compound containing squalene) to stimulate a better response. ||| Le vaccin contient aussi un « adjuvant » (de l’ huile minérale) pour stimuler une meilleure réponse.
0.40653496980667114 ||| Romiplostim is produced by recombinant DNA technology in Escherichia coli (E. coli). ||| Darbepoetin alfa is produced by gene-technology in Chinese Hamster Ovary Cells (CHO-K1). ||| Le romiplostim est produit par la technique de l’ ADN recombinant dans des cellules d’ Escherichia coli (E. coli).
0.0037170983850955963 ||| 25 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 24 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 25 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.3271234333515167 ||| Nondepolarizing skeletal muscle relaxants (e. g. tubocurarine): the effect of nondepolarizing skeletal muscle relaxants may be potentiated by hydrochlorothiazide; ||| Other antihypertensive agents: the antihypertensive effect of Irbesartan Hydrochlorothiazide BMS may be increased with the concomitant use of other antihypertensive agents. ||| Myorelaxants non-dépolarisants (par exemple tubocurarine): l'effet des myorelaxants non- dépolarisants peut être potentialisé par l'hydrochlorothiazide;
0.0 ||| NAME OF THE VETERINARY MEDICINAL PRODUCT ||| NAME OF THE VETERINARY MEDICINAL PRODUCT ||| DÉNOMINATION DU MÉDICAMENT VÉTERINAIRE
0.022800076752901077 ||| 23 carbohydrate chains are attached via three N-glycosidic bonds and one O-glycosidic bond to the protein. ||| The four carbohydrate chains are attached via three N-glycosidic bonds and one O-glycosidic bond to the protein. ||| Les quatre chaînes glucidiques sont fixées via trois liaisons N-glycosidiques et une liaison O-glycosidique à la protéine.
0.2906098961830139 ||| In the first kidney disease study, Irbesartan Winthrop was more effective than placebo at reducing the risk of developing kidney damage as measured by protein excretion. ||| As a consequence the observed 25% risk reduction with losartan versus atenolol brings the protective effect of losartan on stroke in the same range as for other antihypertensives. ||| Dans la première étude consacrée à l’ atteinte des reins, Irbesartan Winthrop s’ est révélé plus efficace que le placebo pour la réduction du risque de survenue d’ atteinte rénale, mesuré par l’ excrétion de protéine.
0.39972272515296936 ||| SOLVENT for TAXOTERE 80 mg ||| VIAL/ TAXOTERE 20 mg ||| SOLVANT pour TAXOTERE 80 mg
0.26261258125305176 ||| Clear and colourless aqueous solution. ||| Clear, colourless, aqueous solution. ||| Solution aqueuse, limpide et incolore.
0.3261743485927582 ||| Since this difference is not considered to be clinically relevant, the combination of PREZISTA co-administered with 100 mg ritonavir and nevirapine can be used without dose adjustments. ||| No data are currently available on interactions of APTIVUS, co-administered with low dose ritonavir, with protease inhibitors other than those listed above. ||| Etant donné que cette différence n’est pas considérée comme cliniquement significative, l’association de PREZISTA co-administré avec 100 mg de ritonavir et de la névirapine peut être utilisée sans adaptation posologique.
0.5253615379333496 ||| • For administration with a syringe pump: ||| For use in an infusion pump system: ||| • Administration avec une seringue électrique:
0.3029111325740814 ||| Emtriva does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS. ||| Reproduction is authorised provided the source is acknowledged. but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS. ||| Emtriva ne permet pas de guérir l’ infection par le VIH ou le SIDA, mais de retarder la détérioration du système immunitaire et le développement des infections et pathologies associées au SIDA.
0.3465612530708313 ||| Systemic exposure is limited with the topical use of tacrolimus, however a local immunosuppressive effect in the skin cannot be excluded. ||| Tacrolimus is not metabolised in human skin, indicating that there is no potential for percutaneous interactions that could affect the metabolism of tacrolimus. ||| L’ utilisation topique du tacrolimus limite l’ exposition systémique, toutefois, un effet immunosuppresseur local au niveau de la peau ne peut pas être exclu.
0.5470367074012756 ||| Gases for laser cutting ||| Winches incorporating a lock ||| Gaz de découpe laser
0.46060657501220703 ||| No change in dabigatran exposure was seen in 12 subjects with moderate hepatic insufficiency (Child Pugh B) compared to 12 controls (see sections 4.2 and 4.4). ||| The highest number of withdrawals from the centralised procedure continue to fall within the ATC categories of blood (class B), neurology (class N) and oncology (class L). ||| Aucune modification de l’exposition au dabigatran n’a été observée chez 12 sujets présentant une insuffisance hépatique modérée (Child Pugh B) comparativement à 12 témoins (voir rubriques 4.2 et 4.4).
3.0217237674719233e-13 ||| Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human M ||| Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human M ||| Ces résultats sur la survie globale n’ ont pas pu être expliqués de façon satisfaisante par des différences d’ incidence de survenue de thromboses et de leurs complications en
0.3008230924606323 ||| Thus, the use of Enbrel in pregnant women is not recommended, and women of child-bearing potential should be advised not to get pregnant during Enbrel therapy. ||| However, due to the results of animal studies in breast-feeding mothers and neonates (see section 5.3), breast-feeding is contraindicated in women taking CYSTAGON. ||| Les femmes en âge de procréer doivent être averties qu’ il faut éviter une grossesse pendant le traitement par Enbrel.
0.002075448865070939 ||| Mixtard 30 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA) ||| Mixtard 50 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA) ||| Mixtard 30 Penfill 100 UI/ ml suspension injectable en cartouche Insuline humaine (ADNr)
0.02914760261774063 ||| 17 The safety of fentanyl in pregnancy has not been established. ||| 50 The safety of fentanyl in pregnancy has not been established. ||| La sécurité d’ emploi du fentanyl pendant la grossesse n’ a pas été établie.
0.5735387802124023 ||| PegIntron monotherapy was not studied in HCV/HIV co-infected patients. ||| Such patients are unresponsive to GONAL-f/ hCG therapy. ||| PegIntron en monothérapie n’ a pas été étudié chez les patients co-infectés VHC-VIH.
0.4994708001613617 ||| Any unused product must be discarded. ||| - Partially used vials must be discarded. ||| ris utilisé doit être jeté.
0.6232579946517944 ||| Caution should be exercised and frequent monitoring of mitotane plasma levels is highly recommended. ||| Particular attention should be paid to maintaining haemodynamic status. ||| La prudence est recommandée et des mesures fréquentes de la concentration plasmatique du mitotane sont fortement recommandées.
0.46568334102630615 ||| After reconstitution the product should be used immediately. ||| Do not open before use The reconstitued product should be used immediately ||| Après reconstitution, le produit doit être utilisé immédiatement.
0.24419623613357544 ||| Some patients may benefit from starting treatment at a dose of 20 mg twice a day for two weeks before increasing to 40 mg twice a day, to reduce nausea (feeling sick) and dizziness. ||| If hypotension occurs (systolic blood pressure less than or equal to 100 mm Hg) a daily maintenance dose of 5 mg may be given with temporary reductions to 2.5 mg if needed. ||| Chez certaines patientes, il est conseillé de commencer par une dose de départ de 20 mg deux fois par jour pendant deux semaines, puis de passer à 40 mg deux fois par jour afin de réduire les risques de nausées (sensation de malaise) et de vertiges.
0.28754326701164246 ||| In a study with 18 male subjects with diabetes mellitus type 1 aged 21 to 50 years, insulin glulisine displays dose-proportionality for early, maximum and total exposure in the dose range 0.075 to 0.4U/ kg. ||| Pharmacokinetic data on 33 patients (age range 0.77 – 13.7 years) in the intensive sampling group demonstrated that clearance of nevirapine increased with increasing age in a manner consistent with increasing body surface area. ||| Dans une étude avec 18 sujets masculins diabétiques de type 1 âgés de 21 à 50 ans, l’ effet de l’ insuline glulisine (exposition précoce, maximale et totale) a été proportionnel à la dose dans l’ intervalle de doses allant de 0,075 à 0,4 U/ kg.
0.05901147425174713 ||| 135 μ g in 1 ml ||| 180 μ g in 1 ml ||| 135 µg dans 1 ml
0.40119343996047974 ||| Tasigna is used to treat adults with chronic myelogenous leukaemia (CML), a type of cancer of the white blood cells where granulocytes (a type of white blood cell) start growing out of control. ||| This is a cancer of the lymph tissue (part of the immune system) that affects a type of white blood cell called B-lymphocytes, or B-cells. ||| Tasigna est utilisé dans le traitement d’ adultes atteints de leucémie myéloïde chronique (LMC), un cancer des globules blancs dans lequel les granulocytes (un type de globules blancs) se multiplient de façon incontrôlée.
0.2345183789730072 ||| Ziagen oral solution contains 340 mg/ ml of sorbitol. ||| INCRELEX contains 9 mg/ ml benzyl alcohol as a preservative. ||| La solution buvable de Ziagen contient 340 mg/ ml de sorbitol.
0.19040319323539734 ||| Before administration, visually inspect the solution for particulate matter and discolouration. ||| Visually inspect the infusion solution for particulate matter or discolouration. ||| Avant administration, inspecter visuellement la solution afin de déceler la présence de particules et d’ une coloration.
0.23798716068267822 ||| There have been many reports of increases in oral anti-coagulant activity in patients receiving antibacterial agents, including fluoroquinolones. ||| tho Increased anticoagulant activity has been reported in patients simultaneously treated with anticoagulants and antibiotics, including telithromycin. ||| Une augmentation de l’activité de l’anticoagulant oral a été mise en évidence chez un grand nombre de patients sous antibiotiques, y compris les fluoroquinolones.
0.08680237829685211 ||| VFEND 50 mg film-coated tablets Voriconazole Oral use ||| VFEND 200 mg film-coated tablets Voriconazole ||| VFEND 200 mg comprimés pelliculés Voriconazole Voie orale
0.1986868977546692 ||| Courses (Training -) relating to customer services ||| Courses (Training -) relating to philosophical subjects ||| Cours de formation en matière de service client
0.5483341813087463 ||| Any planned national measure restricting access to medical and protective equipment must be discussed with the Commission and with the other Member States. ||| The Commission has set up a dedicated mailbox and telephone number to assist Member States with any queries they have. ||| Toute mesure nationale prévue limitant l'accès au matériel médical et aux équipements de protection doit être discutée avec la Commission et les autres États membres.
0.0 ||| Single-dose administration of Fertavid to rats induced no toxicologically significant effects. ||| Single-dose administration of Fertavid to rats induced no toxicologically significant effects. ||| 13 L'administration d'une dose unique de Fertavid chez le rat n'a induit aucun effet toxicologique significatif.
0.3502975106239319 ||| Insulatard is given subcutaneously (under the skin) by injection, usually in the thigh. ||| GONAL-f is intended for subcutaneous use, that means given by injection just under the skin. ||| Insulatard est administré par voie sous-cutanée (sous la peau), par une injection généralement effectuée dans la cuisse.
0.0 ||| Bone metabolism: ||| Bone metabolism: ||| Métabolisme osseux:
0.2840474247932434 ||| Ingrown hair, oedema face, dermatitis, oedema mouth, papular rash, bleeding skin, herpes simplex, eczema, cheilitis, furunculosis, contact dermatitis, abnormal hair texture and abnormal hair growth, hypopigmentation, flushing skin, lip numbness, skin soreness ||| Pyrexia, rigors, mucosal inflammation, oedema, lethargy, malaise Hyperpyrexia, chest pain, chest tightness, pain, difficulty in walking, abnormal gait, thirst, chest pressure sensation, feeling cold, feeling jittery, influenza-like illness, submandibular mass, fall, impaired healing ||| Poil incarné, œ dème de la face, dermatite, œ dème de la bouche, rash papulaire, saignements cutanés, herpes, eczéma, chéilite, furonculose, dermatite de contact, anomalie de la structure des cheveux, croissance anormale des cheveux, hypopigmentation, flush, lèvres insensibles, douleurs cutanées.
0.6326384544372559 ||| The CHMP agreed with the harmonised text but maintained its lower age limit of 2 years. ||| The election of the 33rd Dáil was therefore held using the new boundaries, for 160 seats. ||| Le CHMP a marqué son accord avec le texte harmonisé, mais il a maintenu sa réduction de l’ âge limite à deux ans.
0.4208407402038574 ||| The apparent volume of distribution is 0.50 l/ kg. ||| This corresponds to a strength of 400 IU/ ml. ||| Le volume de distribution apparent est de 0,50 l/ kg.
0.5500460863113403 ||| Timber laminates ||| Timber mouldings ||| Bois laminés
0.444042444229126 ||| Pegasys treatment has been associated with decreases in platelet count, which returned to pre- treatment levels during the post-treatment observation period (see section 4.8). ||| During these two phase III studies, the safety profile of docetaxel was consistent with the safety profile observed in phase II studies (see section 4.8). ||| Le traitement par Pegasys s’ est accompagné d’ une diminution du nombre de plaquettes, qui revenait à sa valeur initiale durant la phase d’ observation post-thérapeutique (voir rubrique 4.8).
0.031753551214933395 ||| The recommended starting dose is 1.3 mg per square metre body surface area (calculated using the patient ’ s height and weight). ||| The recommended dose is 260 mg per square metre of body surface area (calculated using the patient ’ s height and weight). ||| La dose initiale recommandée est de 1,3 mg par mètre carré de surface corporelle du patient (qui se calcule sur la base de la taille et du poids du patient).
0.32506445050239563 ||| Catheters for urological purposes ||| Cachets for medicinal purposes ||| Cathéters destinés à l'urologie
0.012347768992185593 ||| Please read the following instructions carefully before using your Actraphane 30 NovoLet. ||| Please read the following instructions carefully before using your Actraphane 50 NovoLet. ||| Veuillez lire attentivement les instructions ci-dessous avant d’ utiliser votre Actraphane 30 NovoLet.
0.5555620789527893 ||| Construction of structures for the transportation of natural gas ||| Delivery of bottled water to homes and offices ||| Construction de structures pour le transport du gaz naturel
0.8323788642883301 ||| Systemic Inflammatory Response Syndrome (SIRS) or capillary leak syndrome: ||| NMS (Neuroleptic Malignant Syndrome): ||| 7 Syndrome de Réponse Inflammatoire Systémique (SRIS) ou syndrome de fuite capillaire:
2.487677490219109e-13 ||| In patients with baseline haemoglobin ≤ 10 g/ dl (n=899), the hazard ratio point estimate for survival was 0.98 (95% CI 0.68 to 1.40). ||| In patients with baseline haemoglobin ≤ 10 g/ dl (n=899), the hazard ratio point estimate for survival was 0.98 (95% CI 0.68 to 1.40). ||| Chez les patients ayant une hémoglobine initiale ≤ 10 g/ dl (n=899), le risque relatif estimé pour la survie était de 0,98 (IC 95%, 0,68 à 1,40).
0.5091003179550171 ||| White to off-white lyophilised powder. ||| A dark red to reddish brown lyophilised powder or cake. ||| Poudre lyophilisée blanche à blanc cassé.
0.3781417906284332 ||| There is no difference in the oral bioavailability of nicotinic acid in men and women receiving Pelzont. ||| However, the administration of gadoversetamide does not cause a true decrease in serum calcium. ||| La biodisponibilité orale de l’ acide nicotinique n’ est pas différente chez les hommes et les femmes recevant Pelzont.
0.22270706295967102 ||| Method and route of administration: ||| Method and route of administration ||| Voie et mode d’ administration:
0.4378652274608612 ||| A maximum tolerated dose of Xolair has not been determined. ||| The upper limit of the target haemoglobin concentration should not be exceeded. ||| La dose maximale tolérée de Xolair n’ est pas établie.
0.010649529285728931 ||| 63 Women of childbearing potential: pregnancy should be avoided in women treated with efavirenz. ||| 112 Women of childbearing potential: pregnancy should be avoided in women treated with efavirenz. ||| Les femmes traitées par éfavirenz doivent éviter toute grossesse.
0.15034282207489014 ||| Higher exposure to lansoprazole in comparison to adults has been seen in infants below the age of 2-3 months with doses of both 1.0 mg/kg and 0.5 mg/kg body weight given as a single dose. ||| The investigation of a dose of 17 mg/m2 body surface or 1 mg/kg body weight also resulted in comparable exposure of lansoprazole in children aged 2-3 months up to one year of age compared to adults. ||| Une plus forte exposition au lansoprazole comparé aux adultes a été signalée chez des enfants de moins de 2-3 mois avec des doses à la fois de 1,0 mg/kg et 0,5 mg/kg de poids corporel données en dose unique.
0.1924871802330017 ||| 10 ml of either sodium chloride 9 mg/ ml solution for injection or water for injections should be slowly injected through the centre of the rubber stopper into the vial pointing the needle towards the wall of the vial. ||| The needle of the syringe containing the 4 ml of water for injections should be inserted through the rubber top of the azacitidine vial followed by injection of the water for injections into the vial. ||| Injecter lentement 10 ml de solution injectable de chlorure de sodium (9 mg/ ml) ou d’ eau pour préparations injectables à travers le centre du bouchon en caoutchouc dans le flacon en dirigeant l’ aiguille vers la paroi du flacon.
0.5814531445503235 ||| a) Leadership commitment: ensuring the necessary resources in terms of staff, technology and budget are available. ||| However, they need to be adequately supported with the necessary human, technical and financial resources. ||| a) l'engagement des dirigeants: afin de veiller à ce que les ressources nécessaires en termes de personnel, de technologies et de budget soient disponibles.
0.3988376557826996 ||| 5 included the incidence, duration and severity of oral mucositis and the requirement for opioid analgesia. ||| The duration of treatment and the interval between injections will vary with the severity of the haemorrhage, the invasive ||| Les autres critères d’ évaluation ont été l’ incidence, la durée et la sévérité de la mucite buccale ainsi que le recours aux analgésiques morphiniques.
0.27732306718826294 ||| AVONEX is provided as ready to use solution for injection in a pre-filled syringe. ||| The prepared MabThera solution should be administered as an intravenous infusion through a dedicated line. ||| AVONEX est fourni sous forme d’ une solution injectable prête à l’ emploi, en seringue préremplie.
0.6388782262802124 ||| ** either SRH area ≥ 25 mm2 if baseline sample negative or 50% increase in SRH area if baseline sample > 4 mm² *** geometric mean increase ||| N ≥ 90% improvement ≥ 75% improvement ≥ 50% improvement PGA of cleared (0) or minimal (1) PGA of cleared (0), minimal (1), or mild (2) All nails cleared c ||| surface SRH ≥ 25 mm² (si l'échantillon de référence est négatif) ou hausse de 50% dans la surface SRH ** si l'échantillon de référence > 4 mm² *** hausse des moyennes géométriques
0.37599611282348633 ||| The CHMP is of the opinion that a new epidemiological study of breast cancer in Implanon users is not justified at the present time. ||| Therefore, the CHMP is of the opinion that one additional five-year renewal on the basis of pharmacovigilance grounds is required. ||| Le CHMP est d’ avis qu’ une nouvelle étude épidémiologique portant sur le cancer du sein chez les utilisatrices d’ Implanon n’ est pas justifiée à l’ heure actuelle.
0.5756319761276245 ||| Electric power distribution apparatus ||| Artificial internal organ apparatus ||| Machines de distribution de courant électrique
0.126102477312088 ||| Each capsule contains rivastigmine hydrogen tartrate corresponding to rivastigmine 6.0 mg. ||| 1 capsule contains rivastigmine 6.0 mg present as rivastigmine hydrogen tartrate. ||| Chaque gélule contient de la rivastigmine sous forme d’ hydrogénotartrate, correspondant à 6,0 mg de rivastigmine.
0.1088217943906784 ||| Store in a refrigerator (2°C - 8°C). ||| 126 Store in a refrigerator (2°C - 8°C). ||| Conserver au réfrigérateur (2°C - 8°C).
0.3923802375793457 ||| Less potent UGT1A1 inhibitors (e. g., indinavir, saquinavir) may also increase plasma levels of raltegravir, but to a lesser extent compared with atazanavir. ||| The nucleoside analogues (e. g. didanosine and zalcitabine) like zidovudine, are not eliminated by this mechanism and are unlikely to interact with lamivudine. ||| Des inhibiteurs moins puissants de l'UGT1A1 (tels que indinavir, saquinavir) peuvent également augmenter les concentrations plasmatiques du raltégravir, mais dans une moindre mesure, comparé à l'atazanavir.
0.5103050470352173 ||| Taiwanese authorities have been ordered to use all possible means to track whether the messages were linked to instructions given by the Communist Party of China. ||| These Member States were not able to reach an agreement and therefore the United Kingdom referred the reasons for disagreement to the CHMP on 27 July 2007. ||| Les autorités taïwanaises ont enquêté pour savoir si ces messages sont en lien avec des instructions données par le Parti communiste chinois.
0.37221577763557434 ||| Multiple injection sites permit Xeomin more uniform coverage of the innervated areas of the dystonic muscle and are especially useful in larger muscles. ||| Cardoreg 4 mg prolonged release tablets and associated names works by relaxing muscle around the bladder exit and prostate gland, making it easier to pass urine. ||| Le choix de sites d’ injection multiples permet une diffusion plus uniforme de Xeomin dans les zones innervées du muscle dystonique et s’ avère particulièrement utiles dans les gros muscles.
0.014187884517014027 ||| CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT ||| CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EEFECTIVE USE OF THE MEDICINAL PRODUCT ||| CONDITIONS OU RESTRICTIONS EN VUE D’ UNE UTILISATION SURE ET EFFICACE DU MEDICAMENT
0.22073772549629211 ||| Ref.: ||| Lot.: ||| Calib.:
0.07372473925352097 ||| What ZYPREXA is and what it is used for 2. ||| What CYSTAGON is and what it is used for 2. ||| Qu’ est -ce que ZYPREXA et dans quel cas est -il utilisé 2.
0.0 ||| Typical adverse drug reactions of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. ||| Typical adverse drug reactions of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. ||| Les effets indésirables typiques des Anti-Inflammatoires Non Stéroïdiens (AINS) tels que perte d'appétit, vomissements, diarrhée, méléna, apathie et insuffisance rénale ont été rapportés occasionnellement.
4.2294314751833983e-13 ||| - the Summaries of Products Characteristic, labelling and package leaflet proposed by the Marketing ||| - the Summaries of Products Characteristic, labelling and package leaflet proposed by the Marketing ||| - les résumés des caractéristiques des produits, l’ emballage et la notice proposés par les titulaires de
0.2482391595840454 ||| EU/ 1/ 06/ 358/ 009– pack of 1 EU/ 1/ 06/ 358/ 010 – pack of 10 EU/ 1/ 06/ 358/ 011 – pack of 20 ||| EU/ 1/ 07/ 387/ 001 30 capsules EU/ 1/ 07/ 387/ 002 50 capsules EU/ 1/ 07/ 387/ 009 100 capsules ||| EU/ 1/ 06/ 358/ 009 – boîte de 1 EU/ 1/ 06/ 358/ 010 – boîte de 10 EU/ 1/ 06/ 358/ 011 – boîte de 20
0.19008609652519226 ||| 24 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Blister (275 mg) ||| Helicobacter Test INFAI 45 mg 32 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 24 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.3389590382575989 ||| The Commission therefore concluded that the measure will contribute to managing the economic impact of the coronavirus in Germany.It is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| Finally, in a Joint Communication of June 2019 , the Commission and the High Representative concluded that while the European elections of May 2019 were not free from disinformation, the actions taken by the EU have contributed to narrow down the space for third-country influence as well as coordinated campaigns to manipulate public opinion. ||| Celle-ci est nécessaire, appropriée et proportionnée pour remédier à une perturbation grave de l'économie d'un État membre, conformément à l'article 107, paragraphe 3, point b), du TFUE et aux conditions énoncées dans l'encadrement temporaire.
0.3065807819366455 ||| ADARTREL 1 mg film-coated tablets Ropinirole (as hydrochloride) ||| OPTRUMA 60 mg film coated tablets raloxifene hydrochloride ||| ADARTREL 1 mg, comprimés pelliculés Ropinirole (sous forme de chlorhydrate)
0.25978127121925354 ||| In a clinical curative trial involving 175 preterm newborn infants less than 35 weeks of gestational age, the incidence of bronchopulmonary dysplasia at 36 weeks post-conceptional age was 13/ 81 (16%) for indomethacin versus 23/ 94 (24%) for ibuprofen. ||| Children and adolescents (< 18 years of age) Pharmacokinetic profiles were obtained following single intravenous administration of daptomycin 4 mg/ kg in paediatric patients with proven or suspected Gram-positive infection, divided into three age groups (2-6 years, 7-11 years and 12-17 years). ||| Lors d’ un essai clinique sur l’ effet curatif de Pedea chez 175 nouveau-nés de moins de 35 semaines d’ âge gestationnel, l’ incidence des dysplasies bronchopulmonaires à l’ âge post-conceptionnel de 36 semaines a été de 13/ 81 (16%) pour l’ indométhacine et de 23/ 94 (24%) pour l’ ibuprofène.
0.3708043098449707 ||| The placebo-corrected increases in walk distance compared to baseline were 76 metres (p = 0.02; t-test) and 44 metres (p = 0.0002; Mann-Whitney U test) at the primary endpoint of each trial, respectively. ||| In Study 1, TORISEL 25 mg was associated with a statistically significant advantage over IFN-α in the primary endpoint of OS at the 2nd pre-specified interim analysis (n = 446 events, p = 0.0078). ||| Les augmentations de la distance de marche corrigées par rapport au placebo ont été de 76 mètres (p = 0,02; test- t) et de 44 mètres (p = 0,0002; test de Mann-Whitney U) respectivement.
0.2441721260547638 ||| Thermal imaging apparatus [other than for medical use] ||| Laboratory instruments [other than for medical use] ||| Appareils d'imagerie thermique [autres qu'à usage médical]
0.41561704874038696 ||| Endocrine disorders Common: acquired hypothyroidism ||| toothache, tooth disorder Hepatobiliary disorders Common: ||| Affections endocriniennes Fréquent: hypothyroïdisme acquis
0.6707225441932678 ||| Printing machines for electronic duplicating processes ||| Downloadable electronic greeting cards for sending by regular mail ||| Machines d'imprimerie pour procédés de duplication électroniques
0.5749766230583191 ||| The 2019–20 coronavirus pandemic spread to South Africa with Minister of Health Zweli Mkhize announcing the first confirmed case on 5 March 2020 - the patient being a South African returning from Italy. ||| Doctor Zhang Jixian observed a cluster of pneumonia cases of unknown cause on 26 December, upon which her hospital informed Wuhan Jianghan CDC on 27 December. ||| La pandémie de Covid-19 en Afrique du Sud se propage depuis le 1er mars 2020, date à laquelle le premier cas confirmé de Covid-19 arrive sur le territoire, de retour d'Italie.
0.009946146979928017 ||| 1 pre-filled syringe with 0.8 ml solution for injection contains 8000 international units (IU) epoetin zeta* (recombinant human erythropoietin). ||| 1 pre-filled syringe with 0.5 ml solution for injection contains 5000 international units (IU) epoetin zeta* (recombinant human erythropoietin). ||| 1 seringue préremplie de 0,8 ml de solution injectable contient 8 000 unités internationales (UI) d’ époétine zêta* (érythropoïétine humaine recombinante).
0.3983684182167053 ||| Infection with the hepatitis B virus may cause the liver to become swollen (inflamed). ||| It causes the liver to become swollen (inflamed). ||| L'infection par le virus de l’ hépatite B peut entraîner un gonflement du foie (inflammation).
0.6880065202713013 ||| Sweet pickle [condiment] ||| Needle (example) ||| Marinade sucrée [condiment]
0.45633530616760254 ||| 17 Your doctor will assess whether you should take Avamys with these medicines. ||| You can take PROTELOS again when you have finished taking these antibiotics. ||| Votre médecin évaluera si vous pouvez prendre Avamys avec ces médicaments.
0.17427420616149902 ||| If you take more Ciprofloxacin Bayer than you should ||| 348 If you take more Ciprofloxacin Bayer than you should ||| Si vous avez pris plus de Ciprofloxacine Bayer que vous n’auriez dû
0.3634631633758545 ||| Although no clear association with clinical outcome or undesirable effects could be observed in clinical studies, the possibility of developing neutralising antibodies or hypersensitivity-type reactions cannot be excluded. ||| "If there are threats of serious or irreversible environmental damage, lack of full scientific certainty should not be used as a reasoning for postponing measures to prevent environmental degradation. ||| Bien qu’aucune association évidente avec le résultat clinique ou les effets indésirables n’ait été observée au cours des études cliniques, le développement potentiel d’anticorps neutralisants ou de réaction de type hypersensibilité ne peut être exclu.
0.35648879408836365 ||| The EU has also made available more than €11.3 million in small grants to civil society organisations. ||| The EU has funded humanitarian operations in Afghanistan since 1992, providing close to €935 million to date. ||| L'UE a également mis à disposition plus de 11,3 millions d'euros de petites subventions en faveur d'organisations de la société civile.
0.2508334815502167 ||| After preparation, the intravenous infusion solution can be used at room temperature (15ºC - 30ºC) for a period up to 14 hours. ||| However, the prepared syringe can be stored in the fridge (between 2 °C and 8 °C) for up to 6 hours before you inject. ||| Après dilution, la solution pour perfusion intraveineuse peut être utilisée pendant 14 heures à température ambiante (15°C - 30°C).
0.43139851093292236 ||| One pack contains 1 vial. ||| Pack containing 1 single-use vial. ||| Une boîte contient un flacon.
0.32556360960006714 ||| Cubicin was as effective as the standard treatments. ||| It was as effective as the standard combination chemotherapy. ||| Cubicin s'est montré aussi efficace que les traitements classiques.
0.3729313015937805 ||| Adapter cables (Electric -) ||| Shaver sockets (Electric -) ||| Câbles adaptateurs électriques
0.27594155073165894 ||| Agents inducing CYP3A metabolism Co-administration of TORISEL with rifampicin, a potent CYP3A4/ 5 inducer, had no significant effect on temsirolimus Cmax (maximum concentration) and AUC (area under the concentration vs. time curve) after intravenous administration, but decreased sirolimus Cmax by 65% and AUC by 56%, compared to TORISEL treatment alone. ||| In a study comparing EVRA to an oral contraceptive containing norgestimate (parent drug of norelgestromin) 250 µg/ ethinyl estradiol 35 µg, Cmax values were 2-fold higher for NGMN and EE in subjects administered the oral contraceptive compared to EVRA, while overall exposure (AUC and Css) was comparable in subjects treated with EVRA. ||| Inducteurs du CYP3A L'administration intraveineuse concomitante de TORISEL et de rifampicine, puissant inducteur du CYP3A4/ 5, n'a eu aucun effet significatif sur la Cmax (concentration maximale) et l'ASC (aire sous la courbe des concentrations en fonction du temps) du temsirolimus; toutefois, par rapport à TORISEL en monothérapie, cette association a réduit la Cmax et l'ASC du sirolimus respectivement de 65% et 56%.
0.32788753509521484 ||| 120 film-coated tablets ||| 100 film coated tablets ||| 120 comprimés pelliculés
0.06403105705976486 ||| Consultancy services relating to the repair of buildings ||| Advisory services relating to the maintenance of buildings ||| Services de conseil en matière de réparation de bâtiments
0.10360406339168549 ||| 1/ 2 EU/ 1/ 09/ 506/ 018 ||| 1/ 2 EU/ 1/ 06/ 357/ 017 ||| EU/ 1/ 09/ 506/ 018
0.4172211289405823 ||| NutropinAq 10 mg/ 2 ml (30 IU) solution for injection Somatropin ||| Ciprofloxacin Hikma 2mg/ ml 200mg/ 100ml Solution for Infusion ||| NutropinAq 10 mg/ 2 ml (30 UI), solution injectable Somatropine
0.0 ||| NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT ||| NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT ||| NOM ET ADRESSE DU TITULAIRE DE L’ AUTORISATION DE MISE SUR LE MARCHE ET DU TITULAIRE DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS, SI DIFFERENT
0.3676155209541321 ||| Keep the bottle tightly closed in order to protect from moisture. ||| Keep the bottle tightly closed when not in use. ||| Conservez le conditionnement primaire soigneusement fermé à l’ abri de l'humidité.
0.2982294261455536 ||| The mechanism of action of Botox in hyperhidrosis is thought to be the inhibition of cholinergically-induced excessive sweating by blockage of autonomic sympathetic nerve fibres innervating sweat glands. ||| Treatment with doxazosin has been shown to result in regression of left ventricular hypertrophy, inhibition of platelet aggregation as well as enhanced capacity of tissue plasminogen-activator. ||| On pense que le mécanisme d’ action de Botox dans l’ hyperhidrose est l’ inhibition de la sudation excessive d’ origne cholinergique par bloquage des fibres nerveuses sympathiques autonomiques qui innervent les glandes sudoripares.
0.2458457350730896 ||| The increased incidence of benign hepatic adenomas in female mice was likely secondary to cytotoxic liver changes manifested by single-cell necrosis and is considered to have no relevance for humans at intended therapeutic exposures. ||| Chronic administration of omalizumab was well tolerated in non-human primates, with the exception of a dose-related and age-dependent decrease in blood platelets, with a greater sensitivity in juvenile animals. ||| La fréquence plus élevée d'adénomes hépatiques bénins a été vraisemblablement due aux changements hépatiques cytotoxiques suggérés par la nécrose uni-cellulaire et on considère qu'elle n'a pas d'incidence pour l'homme aux expositions thérapeutiques prévues.
0.37773939967155457 ||| Your doctor may decide to change the way that your injection is given (either under the skin or into a vein). ||| The solution for injection must be administered into a vein only, and not anywhere else in the body. ||| Votre m édecin peut décider de changer la voie d’administration (sous la peau ou dans une veine).
0.3467017412185669 ||| Flowers or leaves for use as tea substitutes ||| Chicory extracts for use as substitutes for coffee ||| Fleurs ou feuilles en tant que succédanés de thé
0.3082805573940277 ||| 59 When diluted in glucose 50 mg/ ml (5%) solution, filgrastim is compatible with glass and a variety of plastics including polyvinylchloride, polyolefin (a copolymer of polypropylene and polyethylene) and polypropylene. ||| The Composite foil containing the following layers from outside to inside: coated Kraft paper, low density polyethylene foil, aluminium foil, Surlyn (thermoplastic ethylene-methacrylic acid copolymer). ||| Après dilution dans une solution de glucose à 50 mg/ ml (5%), Filgrastim HEXAL est compatible avec le verre et diverses matières plastiques, y compris le chlorure de polyvinyle, la polyoléfine (un copolymère de polypropylène et de polyéthylène) et le polypropylène.
0.21168315410614014 ||| Following administration of an oral dose of radiolabeled raltegravir, approximately 51 and 32% of the dose was excreted in faeces and urine, respectively. ||| Unchanged dasatinib accounted for 0.1% and 19% of the dose in urine and faeces, respectively, with the remainder of the dose as metabolites. ||| Après administration d'une dose orale de raltégravir radiomarqué, environ 51% et 32% de la dose sont éliminés respectivement dans les fèces et dans l'urine.
0.23910009860992432 ||| The recommended dose of Trudexa is 40 mg given every 2 weeks as a single subcutaneous injection (under the skin). ||| The recommended posology of Rebif is 44 micrograms given three times per week by subcutaneous injection. ||| La dose recommandée de Trudexa est de 40 mg toutes les deux semaines, administrée par injection unique par voie sous-cutanée (sous la peau).
0.08379890769720078 ||| Do not store above 25°C. ||| Do not store above 30°C. ||| Ne pas conserver à plus de +25°C.
0.15369418263435364 ||| 39 Pharmacokinetics in paediatric patients ||| 27 Pharmacokinetics in paediatrics ||| Pharmacocinétique chez les enfants
0.0032157432287931442 ||| OUTER CARTON TEXT Puregon 250 IU/ 0.5 ml 1 vial ||| OUTER CARTON TEXT Puregon 200 IU/ 0.5 ml 1 vial ||| TEXTE DE L'ETUI Puregon 250 UI/ 0,5 ml 1 flacon
0.25148850679397583 ||| TEVA UK Ltd Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG United Kingdom ||| Glaxo Group Limited, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom ||| TEVA UK Ltd Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG Royaume-Uni
0.32814890146255493 ||| Machines for use in the manufacture of electrical and electronic circuitry ||| Electronic chips for the manufacturer of integrated circuits ||| Machines servant à la fabrication de circuits électriques et électroniques
0.27029144763946533 ||| Due to the pharmacological properties of fesoterodine, treatment may cause mild to moderate antimuscarinic effects like dry mouth, dry eye, dyspepsia and constipation. ||| If patients experience nausea, vomiting and diarrhoea following the administration of Abraxane, they may be treated with commonly used anti-emetics and constipating agents. ||| 5 En raison des propriétés pharmacologiques de la fésotérodine, le traitement peut avoir des effets antimuscariniques légers à modérés tels que sécheresse buccale, sécheresse oculaire, dyspepsie et constipation.
0.27275046706199646 ||| Fees payable to the EMEA for services are set out in Council Regulation (EC) No 297/ 95, as last amended by Council Regulation (EC) No 2743/ 98 (OJ L No 345, 19.12.1998, p. ||| which are be accepted in accordance with Council Regulation (EEC) No 2377/ 90 and in accordance with Article 31 (3b) of Council Regulation (EEC) No 2309/ 93 of 22 July 1993, as amended. ||| Le règlement (CE) n° 297/ 95 du Conseil, tel que modifié par le règlement (CE) n° 2743/ 98 du Conseil (JO L 345, 19.12.1998, p.
0.2583789825439453 ||| After oral administration of tenofovir disoproxil fumarate, tenofovir is distributed to most tissues with the highest concentrations occurring in the kidney, liver and the intestinal contents (preclinical studies). ||| The poliomyelitis vaccine is obtained from the propagation of poliomyelitis viruses types 1, 2 and 3 on Vero cells, purified, then inactivated by formaldehyde. ||| Après administration orale de fumarate de ténofovir disoproxil, le ténofovir diffuse dans la plupart des tissus, les concentrations les plus élevées étant atteintes dans les reins, le foie et l’ intestin (études précliniques).
0.15617096424102783 ||| Capsule shell: gelatine, anhydrized liquid sorbitol (mixture of sorbitol, sorbitol anhydrides and mannitol), glycerol, titanium dioxide (E171), sunset yellow (E110) medium-chain triglycerides, lecithin ||| Includes: propylene glycol, polyoxyl 35 castor oil, anhydrized liquid sorbitol (mixture of sorbitol, sorbitol anhydrides and mannitol), glycerol and sunset yellow (E110). ||| Enveloppe de la capsule: gélatine, sorbitol liquide anhydre (mélange de sorbitol, de sorbitol anhydre et de mannitol), glycérol, dioxyde de titane (E171), colorant jaune orangé (E 110), triglycérides à chaîne moyenne, lécithine.
0.35637691617012024 ||| Renal and urinary disorders Very rare: acute renal failure, interstitial nephritis ||| Skin rash with or without severe itching and wheal formation (urticaria) Renal and urinary problems: ||| Affections du rein et des voies urinaires Très rare: insuffisance rénale aiguë, néphrite interstitielle
0.269795298576355 ||| Concomitant use with posaconazole should be avoided unless the benefit to the patient outweighs the risk (see section 4.5). ||| Ciprofloxacin should be avoided in these patients unless the potential benefit is considered to outweigh the possible risk. ||| L’ utilisation concomitante avec le posaconazole doit être évitée sauf si le bénéfice attendu pour le patient est supérieur au risque encouru (voir rubrique 4.5).
0.05758117884397507 ||| Children and adolescents Tasigna is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy (see section 5.1). ||| Children and adolescents IVEMEND is not recommended for use in children below the age of 18 years of age due to insufficient data on safety and efficacy (see section 5.2). ||| Enfants et adolescents Tasigna ne doit pas être utilisé chez l'enfant et l’ adolescent en dessous de 18 ans compte tenu de l’ insuffisance de données concernant la sécurité et l'efficacité (voir rubrique 5.1).
0.1575397253036499 ||| België/Belgique/Belgien Rue de Stalle/Stallestraat 73 B-1180 Bruxelles/Brussel/Brüssel Tél/Tel: + 32-(0)2 370 92 11 ||| Luxembourg/Luxemburg Rue de Stalle 73 B-1180 Bruxelles/Brüssel Belgique/Belgien Tél/Tel: + 32-(0)2 370 92 11 ||| België/Belgique/Belgien Rue de Stalle/Stallestraat 73 B-1180 Bruxelles/Brussel/Brüssel
0.21485409140586853 ||| • The other ingredients are: hypromellose, sucralose, polysorbate 80, calcium chloride dihydrate, artificial grape bubblegum flavour, natural peppermint flavour, purified water, propylene glycol, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216). ||| Sucrose, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), citric acid, propylene glycol, sodium citrate, artificial strawberry flavour, artificial banana flavour, purified water. ||| • Les autres composants sont: hypromellose, sucralose, polysorbate 80, chlorure de calcium dihydraté, arôme artificiel de chewing-gum au raisin, arôme naturel de menthe poivrée, eau purifiée, propylène glycol, parahydroxybenzoate de méthyle (E218), parahydroxybenzoate de propyle (E216).
0.0801224410533905 ||| Arranging of competitions for advertising purposes ||| Arranging of displays for advertising purposes ||| Organisation de concours à des fins publicitaires
0.5384318828582764 ||| Monitoring of cholesterol levels and subsequent dosage adjustment should be considered. ||| Odds ratios were calculated and adjustment for centre was included in the protocol. ||| Une surveillance du taux de cholestérol ainsi qu’ une adaptation de la posologie, si besoin, doivent être envisagées.
0.15769952535629272 ||| The Committee decided that Telzir’ s benefits are greater than its risks for the treatment of HIV-1 infected adults and children of six years and above in combination with other antiretroviral medicinal products. ||| The Committee decided that Zerit’ s benefits are greater than its risks in combination with other antiretroviral medicinal products for the treatment of HIV infected patients. ||| Le comité a estimé que les bénéfices de Telzir sont supérieurs à ses risques pour le traitement des patients adultes, et enfants de six ans ou plus, porteurs du VIH-1 en association à d’ autres médicaments antirétroviraux.
0.0 ||| Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. ||| Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. ||| Vérifiez votre glycémie et votre cétonurie le plus rapidement possible dès que l'un des symptômes ci -dessus apparaît.
0.2565065026283264 ||| C. ||| D. ||| O.
0.26129430532455444 ||| Personal ornaments of precious metal ||| Mugs of precious metal ||| Ornements personnels en métal précieux
2.7967192906160065e-13 ||| Adherence of the patient to the dosage and dietary regimen, correct insulin administration and awareness of hypoglycaemia symptoms are essential to reduce the risk of hypoglycaemia. ||| Adherence of the patient to the dosage and dietary regimen, correct insulin administration and awareness of hypoglycaemia symptoms are essential to reduce the risk of hypoglycaemia. ||| Pour réduire le risque d'hypoglycémie, il est essentiel que le patient respecte les consignes posologiques et diététiques, administre correctement l'insuline et connaisse les symptômes de l'hypoglycémie.
0.0 ||| Frequencies are defined as: very common (≥ 1/ 10), common (≥ 1/ 100, < 1/ 10), uncommon (≥ 1/ 1,000, < 1/ 100), rare (≥ 1/ 10,000, < 1/ 1,000), very rare (< 1/ 10,000). ||| Frequencies are defined as: very common (≥ 1/ 10), common (≥ 1/ 100, < 1/ 10), uncommon (≥ 1/ 1,000, < 1/ 100), rare (≥ 1/ 10,000, < 1/ 1,000), very rare (< 1/ 10,000). ||| Les fréquences sont définies ainsi: très fréquents (> 1/ 10), fréquents (> 1/ 100 et 1/ 1000 et < 1/ 100), rares (≥ 1/ 10 000 et < 1/ 1000) et très rares (< 1/ 10 000).
0.40490999817848206 ||| Fluvoxamine, an inhibitor of CYP2C19, increased the plasma concentrations of lansoprazole up to 4- fold. ||| Entecavir-TP is a weak inhibitor of cellular DNA polymerases α, β, and δ with Ki values of 18 to 40 µM. ||| La fluvoxamine, un inhibiteur de la CYP2C19, peut multiplier par 4 les concentrations plasmatiques de lansoprazole.
0.24959635734558105 ||| Glubrava tablets are an anti-diabetic medicine used to treat type 2 (non-insulin dependent) diabetes mellitus. ||| Baraclude oral solution is an anti-viral medicine, used to treat chronic hepatitis B virus (HBV) infection in adults. ||| Glubrava comprimés est un antidiabétique utilisé dans le traitement du diabète sucré de type II (non insulino-dépendant).
0.24944719672203064 ||| The effect on breastfed infants of Ambirix administered to the mothers has not been evaluated in clinical studies. ||| Specific studies to evaluate the effect of deslorelin when administered during pregnancy have not been conducted. ||| L'effet, sur les enfants nourris au sein, de l'administration d‘ Ambirix chez leurs mères n'a pas été étudié dans des études cliniques.
0.3070801794528961 ||| You should tell your doctor if: • you are allergic to doxorubicin or any of the ingredients contained in Myocet. • you are pregnant, or think you may be pregnant, or are breast-feeding. • you have a history of cardiovascular disease (for example heart attacks, heart failure or long- standing high blood pressure) • you have problems with your liver. ||| 83 Inform your doctor if you have a disease of • the bone marrow, • kidney, • liver, • heart, • thyroid, • or if you have experienced depression, • or if you have any history of epileptic seizures, so that he/she can closely monitor your treatment and any worsening of these conditions. ||| Informez votre médecin: • si vous êtes allergique à la doxorubicine ou à l’ un des excipients contenus dans Myocet. • si vous êtes enceinte, pensez l’ être ou allaitez. • si vous avez des antécédents de maladie cardio-vasculaire (par exemple crise cardiaque, insuffisance cardiaque ou hypertension artérielle de longue durée) • si vous avez des problèmes de foie
0.2721070647239685 ||| 7 After removing Insulatard vial from the refrigerator it is recommended to allow the vial to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use. |||  467 Measuring the dose of IntronA Take the pen out of the refrigerator about one-half hour before administering the dose so that the solution in the pen is at room temperature when it is injected. ||| Après avoir sorti un flacon d’ Insulatard du réfrigérateur, il est recommandé d’ attendre que le flacon arrive à température ambiante (sans dépasser 25°C) avant de remettre l’ insuline en suspension, comme indiqué dans les instructions concernant la première utilisation.
0.24145953357219696 ||| It must not be chewed or crushed. ||| Must not be chewed, divided or crushed. ||| Il ne doit pas être mâché ni écrasé.
0.5310996174812317 ||| Rice milk ||| Fried chicken ||| Lait de riz
0.2799944281578064 ||| In all placebo-controlled studies, the most frequently reported adverse event with Kineret was injection site reaction (ISRs), which was mild to moderate in the majority of patients. ||| The most common clinical toxicity of VIRAMUNE is rash, with VIRAMUNE attributable rash occurring in 13.6% of patients in combination regimens in controlled studies. ||| Dans toutes les études contrôlées contre placebo, l’ effet indésirable le plus fréquemment rapporté avec Kineret a été une réaction au point d’ injection (RPI), d’ intensité légère à modérée chez la majorité des patients.
0.1638554334640503 ||| Lighting apparatus and installations ||| Heating apparatus and installations ||| Appareils et installations d'éclairage
0.32896560430526733 ||| Your doctor will take regular blood samples to measure how your anaemia is responding and may adjust your dose as necessary. ||| Your doctor may adjust your dose of Revlimid or stop your treatment based on the results of your blood tests and on your general condition. ||| Votre médecin effectuera des prises de sang régulières afin de contrôler la correction de l’ anémie et adaptera si nécessaire la posologie.
0.020540768280625343 ||| Within the study period of two years, CDMS occurred in 45% of the placebo group compared to 28% of the Betaferon group (Kaplan-Meier estimates). ||| Within the study period of two years, CDMS occurred in 45% of the placebo group compared to 28% of the Extavia group (Kaplan-Meier estimates). ||| Au cours des deux années de l’étude, une sclérose en plaques cliniquement définie est survenue chez 45% des patients traités par placebo contre 28% des patients traités par Betaferon (estimation Kaplan-Meier).
0.33992061018943787 ||| 2 inappropriate, dose reduction of stavudine may be considered, while the symptoms of peripheral neuropathy are under close monitoring and satisfactory virological suppression is maintained. ||| Special warnings and precautions for use As with any paramagnetic contrast agent, enhancement of MRI with Optimark may impair the visualization of existing lesions. ||| Dans les rares cas où cela n'est pas possible, une réduction de la dose de stavudine peut être envisagée tout en surveillant attentivement les symptômes de neuropathie et en s'assurant qu'une suppression virologique satisfaisante est maintenue.
0.13390196859836578 ||| International non-proprietary name (INN): glucarpidase ||| International non-proprietary name (INN): ketoprofen ||| Dénomination commune internationale (DCI): glucarpidase
0.002345152199268341 ||| 114 In patients with chronic renal failure and clinical evidence of ischaemic heart disease or congestive heart failure, the target haemoglobin should be determined individually. ||| 90 In patients with chronic renal failure and clinical evidence of ischaemic heart disease or congestive heart failure, the target haemoglobin should be determined individually. ||| pl Chez les patients insuffisants rénaux chroniques présentant des manifestations cliniques d'ischémie myocardique ou d'insuffisance cardiaque congestive, le taux d'hémoglobine à atteindre doit être st déterminé individuellement.
0.3070538341999054 ||| The spray apparatus should be free from sediments, corrosion and traces of disinfectants and ideally should be used for vaccination purposes only. ||| The presence of disinfectant and/ or antiseptic in water and material used for the preparation of vaccine solution is not compatible with an effective vaccination. ||| 3/ 18 doit être exempt de sédiments, corrosion et de traces de désinfectant, et idéalement, devrait être réservé pour la vaccination.
0.5468171834945679 ||| AbbottSRL I 04011 Campoverde di Aprilia, (Latina) Italy ||| ed Strada Statale No 17, km22 67019 Scoppito (L’ Aquila) Italy ||| Abbott SRL I 04010 Campoverde di Aprilia (Latina) Italy
0.3661997318267822 ||| As ibuprofen may inhibit platelet aggregation, premature neonates should be monitored for signs of bleeding. ||| Nausea, vomiting, flushing and dizziness are known to be dose dependent when calcitonin is administered parenterally. ||| L’ ibuprofène peut inhiber l’ agrégation plaquettaire; une surveillance des signes éventuels de saignement doit être instaurée chez les nouveau-nés prématurés.
0.20948559045791626 ||| Cerenia 16 mg tablets for dogs Cerenia 24 mg tablets for dogs Cerenia 60 mg tablets for dogs Cerenia 160 mg tablets for dogs ||| Onsior 5 mg tablets for dogs Onsior 10 mg tablets for dogs Onsior 20 mg tablets for dogs Onsior 40 mg tablets for dogs ||| Cerenia 16 mg comprimés pour chiens Cerenia 24 mg comprimés pour chiens Cerenia 60 mg comprimés pour chiens Cerenia 160 mg comprimés pour chiens
0.1468067616224289 ||| Today, the Commission announced the next steps in the Coronavirus Global Response , the global action for universal access to affordable coronavirus vaccination, treatment and testing. ||| It is a milestone under the Coronavirus Global Response , the global action for universal access to affordable coronavirus vaccination, treatment and testing. ||| Aujourd'hui, la Commission a annoncé les prochaines étapes de la Réponse mondiale au coronavirus , l'initiative mondiale pour un accès universel, à un prix abordable, à la vaccination, au traitement et aux tests pour le coronavirus.
0.42802733182907104 ||| People identified as at risk of spreading COVID-19 should have access to appropriate health care, either in the country of arrival or in the country of departure, and this should be coordinated between the two. ||| Due to the spread of the disease, you are advised not to travel unless necessary, to avoid being infected, quarantined, or stranded by changing restrictions and cancelled flights. ||| Les personnes identifiées comme présentant un risque de propagation du COVID-19 devraient avoir accès à des soins de santé appropriés, soit dans le pays d'arrivée, soit dans le pays de départ, et ceci devrait être coordonné entre ces deux pays.
0.5061048269271851 ||| Preserving boxes of metal ||| Erection of climbing formworks ||| Boîtes à conserves métalliques
6.239211079207829e-13 ||| Do not soak, wash or lubricate the pen as this may damage it. ||| Do not soak, wash or lubricate the pen as this may damage it. ||| Ne pas faire tremper, laver ou lubrifier le stylo, cela peut l’ endommager
0.47618675231933594 ||| The conjugated antibody has an apparent affinity constant for the CD20 antigen of approximately 17 nM. ||| The component MI could be defined as asymptomatic with enzymatic elevation of CK-MB or new Q wave. ||| La constante d’ affinité apparente de l'anticorps conjugué pour l'antigène CD20 est de l'ordre de 17 nM.
0.0 ||| Keep the container in the outer carton in order to protect from light. ||| Keep the container in the outer carton in order to protect from light. ||| A conserver dans l’emballage extérieur d’origine à l’abri de la lumière.
0.8545452356338501 ||| EXP.: ed ||| EXP.: in ic ||| EXP.: éd
0.2930179238319397 ||| The most frequent adverse drug reaction was eye pain, reported at an overall incidence of 2.0%. ||| The overall incidence of vaginal bleeding was low (≤ 2.6% in all treatment groups). ||| L'effet indésirable lié au traitement le plus fréquent était la douleur oculaire, rapportée à une incidence globale de 2%.
0.13423044979572296 ||| Dose reduction in patients with a creatinine clearance of < 50 ml/ min is necessary (see section 4.2). ||| Kivexa is not recommended for use in patients with a creatinine clearance < 50 ml/ min (see section 5.2). ||| Il est donc nécessaire de réduire la posologie chez les patients ayant une clairance de la créatinine inférieure à 50 ml/ min (voir section 4.2).
0.1936851441860199 ||| There is no experience in children or adolescents below 18 years of age. ||| There is no clinical experience in children and adolescents under the age of 18 years. ||| Il n’ y a pas d’ expérience chez l’ enfant ou l’ adolescent de moins de 18 ans.
0.47029441595077515 ||| Installation of automobile accessories ||| Design of office automation equipment ||| Installation d'accessoires pour voitures
5.480629513589241e-13 ||| 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 71 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.1487826108932495 ||| The most common side effects with Intanza (seen in more than 1 patient in 10) are headache, myalgia (muscle pain), malaise (feeling unwell) and local reactions at the site of the vaccination (redness, swelling, hardening of the skin, pain and itching). ||| The most common side effects with Infanrix Hexa (seen in more than 1 in 10 doses of the vaccine) are loss of appetite, fever of 38ºC or more, local swelling, pain and redness at the injection site, fatigue (tiredness), abnormal crying, irritability and restlessness. ||| Les effets indésirables les plus couramment observés sous Intanza (chez plus d’ un patient sur 10) sont: maux de tête, myalgie (douleur musculaire), sensation de malaise et réactions locales au site d’ injection (rougeur, gonflement, durcissement de la peau, douleur et démangeaisons).
0.3029380738735199 ||| Cases of ileus have been uncommonly reported (see section 4.8); therefore patients who experience constipation should be closely monitored. ||| Prolonged bleeding time has been reported in patients treated with mitotane and this should be taken into account when surgery is considered (see section 4.8). ||| Des cas d’ iléus ayant été peu fréquemment rapporté (voir rubrique 4.8), les patients présentant une constipation doivent être étroitement surveillés.
0.44605982303619385 ||| The starting dose is maintained for at least seven days. ||| The onset of protection is from 4 days onwards. ||| La dose initiale est maintenue pendant au moins sept jours.
0.14285728335380554 ||| 5.325 mg/ g 5 mg/ g ||| 106.5 mg/ g 100 mg/ g ||| 5,325 mg/ g 5,00 mg/ g
0.05863720923662186 ||| 39 Taking other medicines: ||| 45 Taking other medicines: ||| Utilisation d'autres médicaments
0.30228108167648315 ||| Efient inhibits the clumping of platelets and so reduces the chance of a blood clot forming. ||| By blocking the protein Yarvitan decreases the absorption of fats from the gut. ||| Efient empêche l’ agrégation des plaquettes et réduit ainsi le risque de formation de caillots sanguins.
0.09258602559566498 ||| The Commission found that the Hungarian measures are in line with the conditions set out in the Temporary Framework. ||| The Commission found that the Italian measures are in line with the conditions of the Temporary Framework. ||| La Commission a estimé que les mesures hongroises étaient conformes aux conditions énoncées dans l'encadrement temporaire.
0.7936015129089355 ||| Bengal lights ||| Mercury levels ||| Feux de Bengale
0.8628904819488525 ||| Wealth management ||| Monthly tablet ||| Gestion de patrimoine
0.5307552814483643 ||| In Europe, the company Löwenstein Medical producing 1500 ICU-level ventilators and 20,000 home-level ventilator per year for France alone, pointed out of the current high demand and production shortage. ||| Former Newport executives, government officials and executives at rival ventilator companies suspect Covidien acquired Newport to prevent the frugal $3,000 ventilator design from disturbing its profitable ventilation operation. ||| En Europe, la société Löwenstein Medical, qui produit 1500 ventilateurs de niveau ICU et 20 000 ventilateurs de niveau domestique par an pour la seule France, a souligné la forte demande actuelle et la pénurie de production.
0.17714741826057434 ||| Common Common Common Uncommon ||| Common Common Uncommon ||| Fréquent Fréquent Fréquent Peu fréquent
0.28706806898117065 ||| XERISTAR should not be used in the treatment of children and adolescents under the age of 18 years. ||| (Invented name)® should not be used in the treatment of children under the age of 8 years. ||| L’ utilisation de XERISTAR est déconseillée chez les enfants et adolescents de moins de 18 ans.
0.4474707245826721 ||| Patients were given a 96-hour constant rate infusion of Xigris at 24 µg/ kg/ hr (n=850) or placebo (n=840). ||| The median duration of survival was 10.5 months (Xeloda + cisplatin) versus 9.3 months (5-FU + cisplatin). ||| Les patients ont reçu soit une perfusion de Xigris (n = 850) à débit constant de 24 µg/ kg/ h pendant 96 heures soit le placebo (n = 840).
0.203404039144516 ||| Taking Aerinaze with food and drink Aerinaze tablets may be taken with or without food. ||| 98 Taking Agenerase with food and drink Agenerase oral solution can be taken with or without food. ||| Aliments et boissons Aerinaze comprimés peut être pris pendant ou en dehors des repas.
0.41285693645477295 ||| Compostable bowls ||| Inflatable boats ||| Bols compostables
0.12485774606466293 ||| Each capsule contains 25 mg lenalidomide. ||| Each tablet contains 500 mg deferiprone. ||| Chaque gélule contient 25 mg de lénalidomide.
0.0 ||| Pancreatitis ||| Pancreatitis ||| Pancréatite.
0.5173107385635376 ||| OJ No C 197/4 of 27.06.97 ||| C 329/7 of 31.10.97 ||| JO No C 197/4 du 27.06.97
0.5157892107963562 ||| Questions and answers: An EU Strategy for Energy System Integration ||| European Coordinated Response on Coronavirus: Questions and Answers ||| Questions/réponses: Une stratégie de l'UE sur l'intégration du système énergétique
0.08500109612941742 ||| Agalsidase beta is a recombinant form of human α -galactosidase A and is produced by recombinant DNA technology using a mammalian Chinese Hamster Ovary (CHO) cell culture. ||| Galsulfase is a recombinant form of human N-acetylgalactosamine 4-sulfatase and is produced by recombinant DNA technology using mammalian Chinese Hamster Ovary (CHO) cell culture. ||| L’ agalsidase bêta est une forme humaine recombinante d’α -galactosidase A, produite par la technique de l’ ADN recombinant à l’ aide d’ une culture de cellules de mammifères extraites d’ ovaire de hamster chinois (CHO).
0.38217923045158386 ||| Rarely: ||| Rare: ||| Très rare:
0.06562820076942444 ||| The Committee recommended that Sebivo be given marketing authorisation. ||| The Committee recommended that Zarzio be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Sebivo.
0.28571197390556335 ||| However, the maximum daily dose of 30 mg should be used with caution in patients with severe hepatic impairment (see section 5.2). ||| In case of severe vomiting associated with rivastigmine treatment, appropriate dose adjustments as recommended in section 4.2 must be made. ||| Cependant, la dose quotidienne maximale de 30 mg peut être utilisée avec précaution chez les patients atteints d'une insuffisance hépatique sévère (cf rubrique 5.2).
0.39800435304641724 ||| ● Wash your hands well to reduce the risk of bacterial infections. ||| Explain to patients how to relieve symptoms of colds and flu without antibiotics. ||| • Lavez-vous soigneusement les mains pour réduire le risque d'infection bactérienne.
0.32063376903533936 ||| Immunoglobulins are excreted into the milk and may contribute to the transfer of protective antibodies to the neonate. ||| The E2 glycoprotein is considered to be the main immunogen of the CSF virus against which the neutralising antibodies are directed. ||| Les immunoglobulines sont sécrétées dans le lait et peuvent contribuer au transfert d’ anticorps protecteurs au nouveau-né.
0.3447987139225006 ||| Ovarian hyperstimulation syndrome was observed in approximately 4% of patients treated with Ovitrelle. ||| No WHO Grade 3 or 4 renal toxicity was observed in patients treated with Herceptin. ||| Un syndrome d’ hyperstimulation ovarienne a été observé chez approximativement 4% des patientes traitées par Ovitrelle.
0.2944665849208832 ||| 5.2 Pharmacokinetic particulars ||| 73 Pharmacodynamic characteristics ||| 5.2 Caractéristiques pharmacocinétiques >
0.19261428713798523 ||| Pregnancy and breast-feeding Tell your doctor if you are pregnant, think you might be pregnant or if you intend to become pregnant. ||| Pregnancy and breast-feeding Before starting treatment, you must tell your doctor if you are pregnant, if you think you are pregnant or if you intend to become pregnant. ||| Informez votre médecin si vous êtes enceinte, pensez l’ être ou si vous envisagez une grossesse.
0.4816802740097046 ||| Air filtering installations ||| Heating installations ||| Installations de filtrage d'air
0.11907287687063217 ||| It is not known if Tadalafil Lilly is effective in patients who have undergone pelvic surgery or radical non-nerve-sparing prostatectomy. ||| It is not known if CIALIS is effective in patients who have undergone pelvic surgery or radical non- nerve-sparing prostatectomy. ||| L’ efficacité de Tadalafil Lilly chez les patients ayant subi une intervention chirurgicale pelvienne ou une prostatectomie radicale sans préservation des bandelettes nerveuses n’ est pas connue.
0.17964306473731995 ||| When necessary Humalog can be given soon after meals. ||| Humalog may be given shortly before meals. ||| Quand cela est nécessaire, Humalog peut être administré juste après les repas.
0.06247291713953018 ||| Since EMADINE contains benzalkonium chloride, close monitoring is required with frequent or prolonged use. ||| Since DuoTrav contains benzalkonium chloride, close monitoring is required with frequent or prolonged use. ||| EMADINE contenant du chlorure de benzalkonium, une surveillance étroite est nécessaire lors d’ utilisation fréquente ou prolongée.
0.06432507932186127 ||| If you are receiving HAART, the addition of Pegasys + ribavirin may increase your risk of lactic acidosis or liver failure. ||| If you are receiving HAART, the addition of ViraferonPeg and ribavirin may increase your risk of lactic acidosis and of liver failure. ||| Si vous prenez déjà un traitement antiviral, l’association de Pegasys et de la ribavirine peut augmenter le risque de survenue d’acidose lactique ou d’insuffisance hépatique.
0.3726704716682434 ||| Hypersensitivity to the active substance Botulinum neurotoxin type A or to any of the excipients. ||| Meloxicam is metabolised to an alcohol, an acid derivative and to several polar metabolites. ||| Hypersensibilité à la neurotoxine botulinique de type A ou à l’ un des excipients
0.2742598056793213 ||| Tritanrix HepB should be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramuscular administration to these subjects. ||| Infanrix Penta should not be given if the infant has had encephalopathy (brain disease) of unknown cause within seven days of a previous vaccination with a vaccine containing pertussis components. ||| Tritanrix HepB doit être administré avec précaution chez les sujets souffrant de thrombocytopénie ou d'un trouble de la coagulation dans la mesure où l’ injection intramusculaire peut provoquer des saignements.
0.42045044898986816 ||| Chemical reagents for veterinary use ||| Antibacterials for systemic use. ||| Réactifs chimiques à usage vétérinaire
0.27446693181991577 ||| Zalasta 7.5 mg tablets are: round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription 7.5. ||| Tablets are round, slightly biconvex, slightly yellow tablets with possible individual yellow spots and an inscription “ 5”. ||| 220 Les comprimés de ZALASTA 7,5 mg ronds, légèrement d’ éventuelles tâches jaunes, sur lesquels sonts inscrits 7,5.
0.35415130853652954 ||| Latvija Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820 ||| España Biogen Idec Iberia SL Tel: +34 91 310 7110 ||| 39 Latvija Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820
0.10589215904474258 ||| 37/ 42 ||| 37/ 44 ||| 37/ 43
0.26225656270980835 ||| Increases in serum potassium were minor and infrequent in patients with essential hypertension treated with Tekturna alone (0.9% compared to 0.6% with placebo). ||| The upper GI benefit for etoricoxib compared with diclofenac was not statistically significant in patients taking concomitant low-dose aspirin (approximately 33% of patients). ||| Chez les patients atteints d’ hypertension artérielle essentielle et traités par Tekturna en monothérapie, les augmentations de la kaliémie étaient mineures et peu fréquentes (0,9% par rapport à 0,6% avec le placebo).
0.6507167816162109 ||| Secretarial employment services ||| Temporary personnel services ||| Services d'emploi de secrétariat
0.23424026370048523 ||| For initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see also section 4.4) should be used. ||| In order to prevent re-occurrence of neuromuscular blockade, the recommended doses for routine or immediate reversal (see section 4.2) should be used. ||| Pour débuter ou poursuivre un traitement dans l’ indication des symptômes post-ménopausiques, la dose minimale efficace doit être utilisée pendant la durée la plus courte possible (voir rubrique 4.4).
0.19011569023132324 ||| HOW TO STORE HUMALOG MIX50 PEN ||| HOW TO STORE LIPROLOG MIX25 ||| 5 COMMENT CONSERVER HUMALOG MIX50 PEN
0.6091884970664978 ||| Pharmacotherapeutic group: nucleoside and nucleotide reverse transcriptase inhibitors ||| Calcium folinate rescue in methotrexate therapy: ||| Classe pharmacothérapeutique: analogues nucléosidiques et nucléotidiques de la transcriptase inverse Code ATC:
0.0033424380235373974 ||| IntronA 5 million IU/ml powder for injection or infusion interferon alfa-2b SC/IV ||| IntronA 3 million IU/ml powder for injection or infusion interferon alfa-2b SC/IV ||| IntronA 10 millions UI/ ml poudre pour solution injectable ou pour perfusion interféron alfa-2b SC/ IV
0.5437836050987244 ||| Automatic switching apparatus [for telecommunication] ||| Single-channel radio communication apparatus for fixed stations ||| Autocommutateurs pour télécommunications
0.3379288911819458 ||| Secretarial services ||| Internal services ||| Services de secrétariat
0.3885524272918701 ||| Exelon is used for the treatment of dementia in patients with Parkinson’ s disease. ||| This radiopharmaceutical is used for the treatment of bone pain due to your disease. ||| Exelon est utilisé pour le traitement de la démence chez les patients atteints de la maladie de Parkinson.
0.08891011029481888 ||| Adopted by the Management Board on 18 December 2001 ||| Adopted by the Management Board on 5 February 1997 ||| Adopté par le conseil d'administration le 18 décembre 2001
0.09022917598485947 ||| What benefit has Arixtra shown during the studies? ||| What benefit has Prepandrix shown during the studies? ||| Quel est le bénéfice démontré par Arixtra au cours des études?
0.11506876349449158 ||| Drums [parts of machines] ||| Hangers [parts of machines] ||| Tambours de machines
0.22366535663604736 ||| 184 Where should I give my injection? ||| Where should I give my injection? na ||| 198 Où dois-je me faire l'injection?
0.3437022864818573 ||| Stacking machines ||| Skimming machines ||| Machines à empiler
0.30369091033935547 ||| No adjustments to the recommended dose escalation guidelines for lamotrigine should be necessary solely based on the use of hormonal contraceptives, but the maintenance dose of lamotrigine will need to be increased or decreased in most cases when starting or stopping hormonal contraceptives (see section 4.2). ||| Although the results of a single dose drug interaction study with an oral contraceptive suggest the lack of a pharmacokinetic interaction, the results cannot exclude the possibility of changes in the pharmacokinetics that might affect the efficacy of the oral contraceptive during long term treatment with Rapamune. ||| Aucun ajustement selon les lignes directrices sur l’ escalade de dose recommandée de la lamotrigine ne devrait être nécessaire pour la seule raison de l’ utilisation de contraceptifs hormonaux, mais la dose d’ entretien de la lamotrigine devra être augmentée ou diminuée dans la plupart des cas lors de l’ instauration ou de l’ arrêt de contraceptifs hormonaux (voir rubrique 4.2).
0.29187506437301636 ||| Cats: as vaccination is contra-indicated in the symptomatic phase of FeLV/ FIV infections, the effect of VIRBAGEN OMEGA on cat vaccination has not been evaluated. ||| A history of febrile convulsions, a family history of convulsions or Sudden Infant Death Syndrome (SIDS) do not constitute a contraindication for the use of Infanrix hexa. ||| Chats: toute vaccination étant contre-indiquée pendant la phase symptomatique des infections par le FeLV et le FIV, les effets de VIRBAGEN OMEGA sur la vaccination des chats n’ ont pas été évalués.
0.36686941981315613 ||| Endocrine disorders ||| Respiratory disorders ||| Affections endocriniennes
0.15451452136039734 ||| Pharmacotherapeutic group: other antiepileptics, ATC code: ||| Pharmacotherapeutic group: antiparathyroid hormone, ATC code: ||| Classe pharmacothérapeutique: autres anti-épileptiques, code ATC:
0.009748430922627449 ||| Other side effects include • Systemic allergic reactions Associated symptoms may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema, shortness of breath, a fall in blood pressure with rapid heart beat and sweating. • Eye reactions A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. ||| 647 Other side effects include • Systemic allergic reactions Associated symptoms may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema, shortness of breath, a fall in blood pressure with rapid heart beat and sweating. • Eye reactions A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. ||| Les symptômes associés peuvent comprendre des réactions cutanées étendues (rash et démangeaison sur l’ ensemble du corps), un gonflement sévère de la peau ou des muqueuses (œ dème de Quincke), une gêne respiratoire, une diminution de la pression artérielle avec des battements cardiaques rapides et une transpiration abondante.
0.4354063868522644 ||| Unprocessed sugar crops ||| Recycled compound plastics ||| Plants de sucre brut
0.0822288766503334 ||| Your doctor will tell you exactly how many tablets of Galvus to take. ||| Your doctor will tell you exactly how many tablets of Xiliarx to take. ||| Votre médecin vous dira exactement combien de comprimés de Galvus vous devez prendre.
0.33746057748794556 ||| 45 Co-administration of parecoxib sodium and heparin did not affect the pharmacodynamics of heparin (activated partial thromboplastin time) compared to heparin alone. ||| Tolcapone did not influence the effect of ephedrine, an indirect sympathomimetic, on hemodynamic parameters or plasma catecholamine levels, either at rest or during exercise. ||| L'administration concomitante de parécoxib sodium et d’ héparine n'a pas affecté les paramètres pharmacodynamiques de l'héparine (temps de thromboplastine partiel activé) comparé à l'héparine seule.
7.53163211051483e-13 ||| Metabolism: ||| Metabolism: ||| 47 Métabolisme:
0.43464791774749756 ||| Very rare (seen in less than 1 in 10,000 people) ||| Very rare (Les than 1 out of 10.000 patients): ||| Très rares (observés chez moins d’ une personne sur 10 000)
5.749745840034903e-13 ||| - if you think hypoglycaemia (low blood sugar) is starting. ||| - if you think hypoglycaemia (low blood sugar) is starting. ||| - Si vous estimez qu'une hypoglycémie (abaissement du sucre dans le sang) est imminente.
0.6695132255554199 ||| Chronic Phase ||| Correction Phase ||| Phase Chronique
0.35161563754081726 ||| Maximal enzyme induction is generally not seen for 2-3 weeks but may be sustained for at least 4 weeks after cessation of therapy. ||| Anaemia occurs shortly after initiation of dosing, but is rapidly reversible upon cessation of treatment. ||| L'induction enzymatique maximale n'est généralement pas effective pendant 2-3 semaines mais elle peut être prolongée pendant au moins 4 semaines après l’ arrêt du traitement.
0.2684348225593567 ||| 143 Controlled clinical trials have not shown significant benefits attributable to the administration of epoetins when haemoglobin concentration is increased beyond the level necessary to control symptoms of anaemia and to avoid blood transfusion. ||| Before treatment is initiated, patients should be informed of the possibility of eyelash growth, darkening of the eyelid skin and increased iris pigmentation since these have been observed during treatment with bimatoprost and GANFORT. ||| Les essais cliniques contrôlés n’ ont pas montré d’ effets bénéfiques significatifs attribuables à l’ administration des époétines lorsque le taux d’ hémoglobine dépassait le niveau nécessaire au contrôle des symptômes de l’ anémie et pour éviter une transfusion sanguine.
3.977037883046153e-13 ||| Administer the dose into the mouth by placing the tip of the syringe against the inside of the cheek. ||| Administer the dose into the mouth by placing the tip of the syringe against the inside of the cheek. ||| Administrer la dose à l’intérieur de la bouche en plaçant l’extrémité de la pipette doseuse contre l’intérieur de la joue.
0.444981187582016 ||| This product contains sucrose and sorbitol. ||| This medicinal product contains sucrose. ||| Ce produit contient du saccharose et du sorbitol.
0.2553015351295471 ||| In these trials, 603 patients were randomised to treatment with Xeloda (1250 mg/ m2 twice daily for 2 weeks followed by a 1-week rest period and given as 3-week cycles). ||| The FIT study included two placebo-controlled trials in which alendronate was given daily (5 mg daily for two years and 10 mg daily for a further one or two years). • FIT 1: ||| Dans ces essais, 603 patients ont été randomisés pour le traitement par Xeloda (1250 mg/ m2 deux fois par jour pendant 2 semaines, suivi d' 1 semaine sans traitement, le tout étant considéré comme un cycle de 3 semaines).
0.17411184310913086 ||| 6.5 Nature and contents of the container ||| Nature and contents of the container ||| 6.5 Nature et contenu de l'emballage extérieur
0.24598076939582825 ||| Information from clinical studies in acute tibia fractures, indicated that the use of InductOs in patients receiving glucocorticoids was not associated with any apparent adverse effect. ||| The combination of NovoMix 30 with pioglitazone should only be considered following clinical evaluation of the patient’ s risk of developing signs or symptoms of fluid-related adverse events. ||| Les données issues des études cliniques sur les fractures du tibia montrent que l’utilisation d’InductOs chez des patients recevant des glucocorticoïdes n'a été associée à aucun effet indésirable apparent.
0.29626697301864624 ||| Since the adoption of the 5th Anti-Money Laundering Directive, the criteria by which a third country is assessed have been extended substantially, thereby requiring the Commission to carry out an autonomous assessment. ||| As defined under the 4th and 5th Anti-Money Laundering Directives, the EU has to establish a list of high-risk third countries, to make sure that the EU's financial system is equipped to prevent money laundering and terrorist financing. ||| Depuis l'adoption de la 5e directive anti-blanchiment, les critères à l'aune desquels les pays tiers sont évalués sont beaucoup plus étendus, ce qui oblige la Commission à effectuer une évaluation autonome.
0.2558351755142212 ||| Adhesive tapes for use with floor coverings ||| Adhesive flanges for use with ostomy bags ||| Rubans adhésifs pour revêtements de sol
0.6001673340797424 ||| In RA study III, improvement in physical function was maintained through Week 260 (60 months) of open-label treatment. ||| An environmental risk was detected during the risk assessment Phase II Tier A for dung fauna organisms. ||| Dans l'étude III sur la PR, l'amélioration des capacités fonctionnelles était maintenue jusqu’ à la semaine 260 (60 mois) du traitement en ouvert.
0.004232706036418676 ||| MIRCERA 75 micrograms/ 0.3 ml solution for injection in pre-filled syringe. ||| MIRCERA 100 micrograms/ 0.3 ml solution for injection in pre-filled syringe. ||| MIRCERA 75 microgrammes/ 0,3 ml solution injectable en seringue préremplie.
0.25394564867019653 ||| e For a full list of excipients, see section 6.1 ||| Excipient For a full list of excipients, see section 6.1 ||| us Pour une liste complète des excipients, voir point 6.1.
0.26777327060699463 ||| Ranexa 500 mg prolonged-release tablets ||| Emselex 15 mg prolonged-release tablets ||| Ranexa 500 mg comprimés à libération prolongée
0.017183035612106323 ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/ ||| 15 Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/ ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence
0.24254731833934784 ||| If the patient proceeds to PCI, an additional bolus of 0.5 mg/ kg should be administered and the infusion increased to 1.75 mg/ kg/ h for the duration of the procedure. ||| For a patient who weighs ≥ 70 kg, it is recommended that a bolus dose of 5,000 units is given, followed by a constant intravenous infusion of 1,000 units/ hr. ||| Si le patient doit bénéficier d’ une ICP, un bolus additionnel de 0,5 mg/ kg doit être administré et la perfusion augmentée à 1,75 mg/ kg/ h durant l’ intervention.
0.06377831101417542 ||| Each tablet contains 30 mg of aripiprazole. ||| Each ml contains 7.5 mg of aripiprazole. ||| Chaque comprimé contient 30 mg d’ aripiprazole.
0.2719619870185852 ||| < 1000 ||| < 60 ||| < 1 000
0.16242745518684387 ||| How has Baraclude been studied? ||| How has Cystadane been studied? ||| Quelles études ont été menées sur Baraclude?
0.36481475830078125 ||| Robotic cleaning [polishing] machines for floors ||| Machines for washing clothing [electric] ||| Machines robotisées de nettoyage des sols par lustrage
0.5175936818122864 ||| In 1997 a total of 84 break-out sessions were organised by reference Member States and held at the EMEA. ||| However, since 2003, STAMARIL has been marketed under two different presentations in the EU (1 dose and 10 doses). ||| En 1997, un nombre total de 84 réunions de petits groupes de travail ont été organisées par des Etats membres de référence et se sont tenues à l’EMEA.
0.6417796015739441 ||| Providing interactive multi-player computer games via the internet and electronic communication networks ||| Art gallery services provided on-line via a telecommunications link ||| Mise à disposition de jeux informatiques interactifs multijoueurs via Internet et des réseaux de communications électroniques
0.2781732380390167 ||| Stop using Extavia and tell your doctor immediately if any of these happens to you. ||| If a side effect is preventing you from taking Norvir, tell your doctor straight away. ||| Arrêtez de prendre Extavia et prévenez immédiatement votre médecin si l’une de ces situations s’applique à vous.
0.2825070321559906 ||| Uncommon (less than 1 in 100 patients but more than 1 in 1,000 patients): difficulty in sleeping, changes in liver function tests and accidental falls. |||  493 Uncommonly reported side effects (at least 1 in every 1000 patients, but less than 1 in every 100 patients): bacterial infection and feeling of pins and needles. ||| Peu fréquent (moins de 1 patient sur 100 mais plus de 1 patient sur 1 000): troubles du sommeil, modifications des tests de la fonction hépatique et chutes accidentelles.
0.5732847452163696 ||| However, lipid effects were greater when {PRODUCT NAME} and colestipol were coadministered than when either medicinal products was given alone. ||| Cimetidine An interaction study with cimetidine and {PRODUCT NAME} was conducted, and no interaction was seen. ||| Toutefois, les effets hypolipidémiants sont plus importants lorsque {PRODUCT NAME} et le colestipol sont administrés ensemble par rapport à chacun des médicaments administrés seul.
0.2503727674484253 ||| Aclasta is used for the treatment of the following diseases: • osteoporosis (a disease that makes bones fragile), both in women who have been through the menopause and in men. ||| Rebetol is used to treat adults and children aged 3 years and older who have chronic (long term) hepatitis C (a disease of the liver due to an infection by the hepatitis C virus). ||| Aclasta est utilisé pour le traitement des maladies suivantes: • l’ ostéoporose (maladie qui fragilise les os) tant chez les femmes ménopausées que chez les hommes.
0.08767852932214737 ||| 50 tablets. ||| 100 tablets. ||| 50 comprimés.
0.1202242523431778 ||| Insuman Comb 25, pre-filled pen, SoloStar, is not designed to allow any other insulin to be mixed in the cartridge. ||| Insulin Human Winthrop Comb 50, pre-filled pen, OptiSet, is not designed to allow any other insulin to be mixed in the cartridge. ||| Insuman Comb 25 stylo prérempli, SoloStar n'est pas conçu pour permettre de mélanger une autre insuline dans la cartouche.
0.4140610694885254 ||| Therefore safety and efficacy have not been studied (see section 5.2). ||| 10 The need for a booster dose has not been established (see section 5.1). ||| Par conséquent la sécurité et l’ efficacité n’ ont pas été étudiés (voir rubrique 5.2).
0.08065253496170044 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged cells, and causes them to multiply uncontrollably. ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. eu. int http: / /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Preotact for up to 2 years, and their bone density was measured. ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Comment Tasigna agit -il?
0.3717564344406128 ||| Study 1 ||| Study 3 ||| Etude 1
0.0 ||| 27 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 27 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 30 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.2499779462814331 ||| HOW TO STORE REMERON ||| HOW TO STORE ARANESP ||| COMMENT CONSERVER REMERON
0.2594902217388153 ||| • if you have a bacterial heart infection • if you have very severe kidney disease. → Tell your doctor if you think any of these applies to you. ||| If you are not sure whether you are allergic, please discuss with your doctor • if you suffer from a certain type of heart rhythm disorder (second or third degree AV block) ||| composants contenus dans Quixidar • si vous saignez de manière excessive • si vous souffrez d'une infection cardiaque bactérienne si vous souffrez d'une affection rénale très sévère.
0.41548511385917664 ||| Outdoor furniture ||| Computer furniture ||| Meubles d'extérieur
0.1932346373796463 ||| HOW TO STORE RAPAMUNE ||| HOW TO STORE INTRINSA ||| COMMENT CONSERVER RAPAMUNE
0.025146761909127235 ||| If overdose occurs the patient should be monitored for evidence of toxicity (see section 4.8), and standard supportive treatment applied as necessary. ||| If overdose occurs, the patient should be monitored for evidence of toxicity (see section 4.8), and standard supportive treatment provided as necessary. ||| En cas de surdosage, une surveillance médicale du patient avec un éventuel traitement symptomatique est nécessaire (voir rubrique 4.8).
0.27409207820892334 ||| Barrier or other non-hormonal methods of contraception should be considered when administering ritonavir at therapeutic or low doses as ritonavir is likely to reduce the effect and change the uterine bleeding profile when co-administered with estradiol-containing contraceptives. ||| • to improve glycaemic control in combination with a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. ||| Ethinyl estradiol: l’utilisation de méthodes contraceptives de barrières ou d’autres méthodes non hormonales doit être envisagée en cas d’administration de ritonavir à doses thérapeutiques ou à faibles doses, car le ritonavir peut diminuer l’effet des contraceptifs contenant de l’estradiol et modifier le cycle menstruel.
0.024656010791659355 ||| Soluble insulin aspart*/ protamine-crystallised insulin aspart*………… 100 U/ ml in the ratio of 30/ 70 ||| Soluble insulin aspart*/ protamine-crystallised insulin aspart*…… ..100 U/ ml in the ratio of 70/ 30 ||| Insuline asparte soluble*/ insuline asparte* protamine cristallisée...... ..100 U/ ml dans un rapport de 30/ 70
0.1463100016117096 ||| EMEA/ CHMP/ 116517/ 2006/ EN ||| EMEA/ CHMP/ 123448/ 2006/ EN 7. ||| EMEA/ CHMP/ 116517/ 2006/ FR médiastinaux
0.31126439571380615 ||| OAT3 mediated transport of sitagliptin was inhibited in vitro by probenecid, although the risk of clinically meaningful interactions is considered to be low. ||| 47 The use of other types of infusion sets could have a negative impact on the amount and potency of drotrecogin alfa (activated) administered. ||| Le transport de la sitagliptine par l'intermédiaire du système anionique organique OAT3 a été inhibé in vitro par le probénécide, bien que le risque d’ interactions cliniquement significatives soit considéré comme faible.
0.33543574810028076 ||| Uncommon: thirst, hypokalaemia, gout Rare: hypoglycaemia Very rare: increase in serum urea. ||| Nervous system disorders Very common: headache Uncommon: dizziness Rare: hypoaesthesia, paraesthesia ||| Peu fréquents: soif, hypokaliémie, goutte Rares: hypoglycémie Très rares: augmentation du taux d’ urée sérique.
0.3655652403831482 ||| In a prospective, randomised double-blind, placebo-controlled study conducted in 314 lung cancer patients receiving platinum containing chemotherapy there was a significant reduction in transfusion requirements (p < 0.001). ||| This indication is based on safety and efficacy data from two double-blind, placebo-controlled trials of 48 weeks duration in treatment-experienced patients (see section 5.1). ||| Lors d’ une étude prospective, randomisée, en double aveugle, contrôlée versus placebo, menée chez 314 patients atteints de cancer du poumon et recevant une chimiothérapie à base de sels de platine, une réduction significative des besoins transfusionnels a été observée (p < 0,001). ic
4.327057375602683e-13 ||| Finland ||| Finland ||| Finlande
0.0 ||| As with other immunosuppressive agents, owing to the potential risk of malignant skin changes, exposure to sunlight and UV light should be limited by wearing protective clothing and using a sunscreen with a high protection factor. ||| As with other immunosuppressive agents, owing to the potential risk of malignant skin changes, exposure to sunlight and UV light should be limited by wearing protective clothing and using a sunscreen with a high protection factor. ||| Comme avec d’ autres agents immunosuppresseurs, en raison du risque potentiel de survenue de lésions cutanées malignes, l’ exposition au soleil et aux rayons UV doit être limitée par le port de vêtements protecteurs et l’ utilisation d’ un écran solaire à fort indice de protection.
0.40535447001457214 ||| Because of the importance of an adequate pain management for the mother, the CHMP agrees, in accordance with the “ guideline on summary of product characteristics”, that the proposed text stays in section 4.6 and should not be included as a contra-indication. ||| The impact of the coronavirus pandemic on the results of the report has been limited, as most of the historical data used in the report refer to the period before the outbreak of the crisis, as prescribed by the methodology strictly defined in the Treaty. ||| Considérant l’ importance d’ une prise en charge adéquate de la douleur chez la mère, le CHMP accepte, conformément aux instructions sur le Résumé des caractéristiques du produit, que le texte proposé reste dans la section 4.6 et ne soit pas mentionné comme une contre-indication.
0.5952110290527344 ||| On 23 March, organisers of the Azerbaijan Grand Prix announced that the race had been postponed. ||| On 23 March, it was reported that former president Martti Ahtisaari had contracted the disease. ||| Le 23 mars, les organisateurs du Grand Prix automobile d'Azerbaïdjan ont annoncé que la course avait été reportée.
0.024218706414103508 ||| Dunajska 22 SI-1000 Ljubljana Tel. + 386 01 3001070 ||| Dunajska 22 SI-1000 Ljubljana Tel: + 386 01 3001070 ||| Dunajska 22 SI-1000 Ljubljana Tel: + 386 01 3001070
0.39428022503852844 ||| - Patients receiving remission-induction chemotherapy for acute myelogenous leukemia (AML) ||| • Inhalation anthrax (post-exposure prophylaxis and curative treatment) ||| - Patients recevant une chimiothérapie d’ induction- et de consolidation pour une leucémie
0.6155779361724854 ||| Optical couplers ||| Optical readers ||| Coupleurs optiques
0.10647861659526825 ||| 139 1. ||| 141 1. ||| 146 1.
0.4020105004310608 ||| In the event of severe and persistent diarrhoea, Tekturna therapy should be stopped. ||| - If you develop severe or persistent diarrhoea (passing of frequent watery stools) discontinue ||| En cas de diarrhée sévère et persistante, le traitement par Tekturna doit être arrêté.
0.0 ||| 5.3 Preclinical safety data ||| 5.3 Preclinical safety data ||| 145 5.3 Données de sécurité précliniques
0.15123030543327332 ||| Take special care with INTANZA ||| Take special care with AZILECT ||| Faites attention avec INTANZA
0.3319898843765259 ||| Xolair treatment should be initiated by physicians experienced in the diagnosis and treatment of severe persistent asthma. ||| IONSYS is indicated for the management of acute moderate to severe post-operative pain for use in a hospital setting only. ||| Le traitement par Xolair doit être instauré par un médecin expérimenté dans le diagnostic et le traitement de l’ asthme persistant sévère.
0.12428433448076248 ||| The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Olanzapine Mylan has been shown to have comparable quality and to be bioequivalent to Zyprexa. ||| The Committee for Medicinal Products for Human Use (CHMP) considered that, in accordance with European Union requirements, Valtropin has been shown to have a comparable quality, safety and efficacy profile to Humatrope. ||| Le comité des médicaments à usage humain (CHMP) a conclu que, compte tenu des exigences de l’ Union européenne, Olanzapine Mylan est manifestement comparable, du point de vue de la qualité, et bioéquivalent à Zyprexa.
0.07817801088094711 ||| Coating compositions for application to brickwork [paints or oils] ||| Coating compositions for application to concrete [paints or oils] ||| Produits de revêtement pour la maçonnerie de briques [peintures ou huiles]
0.3815438747406006 ||| Take the long needle and place it firmly onto the tip of the syringe. ||| Turn the vial upside down with the needle still in it and hold the vial in one hand. ||| Prenez l’aiguille longue et fixez-la fermement à l’extrémité de la seringue.
0.6515966653823853 ||| This helps to control the blood sugar level. ||| This means your body may fight infection better. ||| Ceci aide à contrôler le taux de sucre dans le sang.
0.43842026591300964 ||| Both the liver and the kidney have been shown to be important protein catabolising organs for growth hormone. ||| These can block the blood supply to important parts of your body such as the kidneys and lungs. ||| Le foie aussi bien que les reins sont des organes importants pour le catabolisme des protéines et donc pour l’ hormone de croissance.
0.262406587600708 ||| Filters for use with apparatus for steam generating ||| Filters for use with apparatus heating ||| Filtres pour appareils produisant de la vapeur
0.7166005373001099 ||| Swimming instruction ||| Swimming-pool maintenance ||| Cours de natation
0.37130820751190186 ||| Your child may be asked to stay in the surgery or vaccination area for a short time after vaccination to check that he or she does not have an immediate allergic reaction. ||| If VIAGRA does not help you to get an erection, or if your erection does not last long enough for you to complete sexual intercourse you should tell your doctor. ||| On pourra demander que votre enfant reste au cabinet du médecin ou sous surveillance médicale pendant un court moment après la vaccination pour vérifier qu’ il ne se développe pas une réaction allergique immédiate.
0.5594750642776489 ||| Industrial paraffins ||| Fruit preserves ||| Paraffines industrielles
0.3026641011238098 ||| Xeloda is used with other anticancer medicines, including a platinum-containing anticancer medicine such as cisplatin; • locally advanced or metastatic breast cancer (breast cancer that has begun to spread to other parts of the body). ||| Xeloda is used with or without other anticancer medicines in patients who have had surgery for ‘ stage III’ or ‘ Dukes’ stage C’ colon cancer; • metastatic colorectal cancer (cancer of the large bowel that has spread to other parts of the body). ||| Xeloda est indiqué en association avec d’ autres anticancéreux, notamment un anticancéreux contenant du platine comme la cisplatine. • du cancer du sein localement avancé ou métastatique (cancer du sein qui a commencé à se propager à d’ autres parties du corps).
0.22258511185646057 ||| can be used alone if the patient cannot take methotrexate. • psoriatic arthritis (a disease causing red, scaly patches on the skin and inflammation of the joints) in patients who have not responded adequately to other treatments, rod ||| Protopic is used for the treatment of moderate to severe atopic dermatitis (eczema, an itchy red rash of the skin- atopic means that is linked to an allergy) in adults who do not respond well or do not tolerate usual treatments. ||| administré en monothérapie en cas d'intolérance au méthotrexate; • polyarthrite psoriasique (maladie provoquant l’ apparition de plaques rouges et squameuses sur la peau et l’ inflammation des articulations); chez les patients chez lesquels la réponse à dic
0.3574058413505554 ||| The main measure of effectiveness in the studies was the number of treatments required to stop each new bleed. ||| The design of the main studies essentially focused on the safety and how well the medicine was tolerated by the patient. ||| Les critères principaux d’ efficacité dans les études étaient le nombre de traitements requis pour arrêter chaque nouveau saignement.
0.2619895935058594 ||| 300 mg aliskiren and 25 mg hydrochlorothiazide). ||| 8 mg rosiglitazone and 4 mg glimepiride). ||| 300 mg d'aliskiren et 25 mg d'hydrochlorothiazide).
0.27621200680732727 ||| In pregnant women, overdoses of calcium and vitamin D should be avoided as permanent hypercalcaemia has been related to adverse effects on the developing foetus. ||| Concomitant administration with known hepatotoxic drugs, and alcohol abuse must be avoided during treatment with treatment, since either may increase the risk of hepatic reactions. ||| Chez la femme enceinte, tout surdosage en calcium et en vitamine D doit être évité car l’hypercalcémie permanente a été associée à des effets négatifs sur le développement du fœtus.
0.3272565007209778 ||| It will also be applying the rules for cohesion spending with maximum flexibility, thus enabling Member States to use the funds to finance crisis-related action. ||| The Commission also proposes to advance the date of application of several agreed measures that incentivise banks to finance employees, SMEs and infrastructure projects. ||| Elle appliquera aussi les règles relatives aux dépenses de cohésion avec un maximum de flexibilité, ce qui permettra aux États membres d'utiliser les fonds pour financer des mesures liées à la crise.
0.1457625925540924 ||| 21 March 2007 ||| 21 February 2007 ||| 21 Mars 2007
0.4921027719974518 ||| 67.2, 100) and 100% (95% CI: ||| 22-33%) and 79% (90% CI: ||| 67,2 - 100) et de 100% (IC à 95%:
0.5971328616142273 ||| 0.5 mg/L ||| 25,000/ mm ||| R > 1 mg/l
0.5030521154403687 ||| Electric central heating boiler systems ||| Electric ice crushing machines ||| Chaudières électriques de chauffage central
0.5500235557556152 ||| Hand operated cement mixers ||| Stick-type vacuum cleaners ||| Bétonnières de chantier manuelles
0.6041718125343323 ||| Concomitant administration of both a CYP3A4 inhibitor and a CYP2C9 inhibitor should be avoided (see section 4.5). ||| Very few medicinal products are known to be metabolised predominantly by UGT2B4 or UGT2B7. ||| L’ administration concomitante d’ un inhibiteur de CYP3A4 et d’ un inhibiteur de CYP2C9 doit être évitée pendant le traitement par Tracleer (voir rubrique 4.5).
0.3175143599510193 ||| Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema). ||| Tell your doctor immediately if you notice itching, a feeling of mild swelling in your throat or tongue, which might be a first sign of some allergy-like reaction. ||| Informez votre médecin le plus rapidement possible si vous avez des signes d’ insuffisance cardiaque tels qu’ une dyspnée (difficulté à respirer) inhabituelle ou une augmentation rapide de poids, ou un gonflement localisé (œ dème).
1.0740669965744019 ||| are you still having the chest pain ||| and she is sorta have the same symptoms ||| avez-vous encore des douleurs dans la poitrine?
0.5689446926116943 ||| The advisability of driving should be considered in these circumstances. ||| Such coordination would be contrary to antitrust rules in normal circumstances. ||| La décision de conduire devra être considérée dans ces circonstances.
0.14029927551746368 ||| — 1 4 15 22 25 23 — 90 1 3 6 5 4 19 9 12 43 — — 63 — 4 — — 4 176 ||| — 1 5 29 27 25 24 — 111 4 8 9 6 5 32 14 14 44 — — 72 1 4 — — 5 220 ||| — 1 4 15 22 25 23 — 90 1 3 6 5 4 19 9 12 43 — — 63 — 4 — — 4
0.3740957975387573 ||| For enquiries concerning certificates for centrally authorised medicines for human or veterinary use ||| For matters relating to pharmacovigilance for medicinal products for veterinary use ||| Pour les demandes concernant des certificats pour des médicaments à usage humain ou vétérinaire autorisés via la procédure centralisée
0.26810422539711 ||| Each film-coated tablet contains 100 mg of leflunomide and 138.42 mg of lactose. ||| Each ml of concentrate contains 0.150 mmol sodium, which is 3.45 mg sodium. ||| Chaque comprimé pelliculé contient 100 mg de léflunomide, et 138, 42 mg de lactose.
0.3372294306755066 ||| The following adverse reactions listed in the table below were observed in clinical studies or with post-marketing experience. ||| Progression-free survival and overall survival data for patients with locally advanced disease are summarised in the following tables: ||| Les effets indésirables recensés dans le tableau ci-dessous ont été observés lors des essais cliniques ou après commercialisation.
0.04324716702103615 ||| The pen is designed to deliver its contents of 30 million IU in doses ranging from 2.5 to 10 million IU. ||| ori The pen is designed to deliver its contents of 60 million IU in doses ranging from 5 to 20 million IU. ||| Le stylo est conçu pour délivrer son contenu de 30 millions d’ UI en doses allant de 2,5 à 10 millions d’ UI.
0.3565843105316162 ||| Misuse of Nespo by healthy persons may lead to an excessive increase in packed cell volume. ||| Taking Stocrin with food may lead to an increase in the frequency of side effects. ||| Un usage détourné de Nespo chez des sujets sains peut entraîner une augmentation excessive de l’ hématocrite.
0.008388392627239227 ||| Using other medicines Please tell your doctor or pharmacist if you are using or have recently used any other medicines, including medicines obtained without a prescription Vivanza will usually be fine with most medicines. ||| Using other medicines Please tell your doctor or pharmacist if you are using or have recently used any other medicines, including medicines obtained without a prescription Levitra will usually be fine with most medicines. ||| Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.23244883120059967 ||| In controlled clinical trials, angioedema occurred rarely during treatment with Riprazo with rates comparable to treatment with placebo or hydrochlorothiazide. ||| In addition, median daily opioid dose did not vary meaningfully from baseline in either methylnaltrexone bromide-treated patients or in placebo-treated patients. ||| Dans les études cliniques contrôlées, des angiœ dèmes sont rarement survenus durant le traitement par Riprazo avec des fréquences comparables à celles observées sous traitement par le placebo ou par l’ hydrochlorothiazide.
0.21531176567077637 ||| Using other vaccines There are currently not sufficient data available regarding immune response of the concomitant administration of HEXAVAC with PREVENAR (pneumococcal polysaccharide conjugated vaccine, adsorbed). ||| Data on concomitant administration of Infanrix hexa with Prevenar (pneumococcal saccharide conjugated vaccine, adsorbed) have shown no clinically relevant interference in the antibody response to each of the individual antigens when given as a 3 dose primary vaccination. ||| 40 On ne dispose pas actuellement de données suffisantes sur la répnse immunitaire d’ HEXAVAC lorsqu’ il est administré de façon concomitante avec PREVENAR (vaccin pneumococcique osidique conjugué, adsorbé).
0.5766586065292358 ||| There is little experience from re-administration after more than 8 weeks since the previous dose. ||| There was no increased benefit thereafter, up to 1 year. ||| L'expérience de la ré-administration du traitement au-delà de 8 semaines après la dose précédente est limitée.
0.3664398491382599 ||| CRIXIVAN 400 mg hard capsules indinavir ||| AVANDIA 2 mg tablets rosiglitazone ||| CRIXIVAN 400 mg, gélules indinavir
0.171194389462471 ||| 50/ 250 ||| 50/ 100 ||| 50/ 100
0.4834657311439514 ||| Porcilis PCV emulsion for injection for pigs ||| Ambirix, suspension for injection HAB vaccine IM ||| Porcilis PCV, émulsion pour injection pour porcs.
0.5659812688827515 ||| Some broadband indicators are collected by the Commission services from the Member States through the Communications Committee . ||| The majority of DESI indicators come from Eurostat, the statistical office of the European Union. ||| Certains indicateurs relatifs au haut débit sont recueillis par les services de la Commission auprès des États membres, par l'intermédiaire du comité des communications .
0.42285868525505066 ||| Electrical recorders ||| Electric sharpeners ||| Enregistreurs électriques
4.346027661014662e-13 ||| The adverse event profile remained comparable between treatment groups. ||| The adverse event profile remained comparable between treatment groups. ||| 6 indésirables est resté comparable dans les groupes de traitement.
0.4915645718574524 ||| Dose reduction and/ or discontinuation of the diuretic may also be required. ||| Dose reduction/ taper or discontinuation should be considered. ||| Une réduction de la posologie et/ ou l’ interruption du traitement diurétique pourront également être requises.
0.05696544796228409 ||| B-type natriuretic peptide (BNP) levels were reduced by 25% in the aliskiren arm compared to placebo. ||| B-type natriuretic peptide (BNP) levels were reduced by 25% in the Sprimeo arm compared to placebo. ||| Les taux de peptide natriurétique de type B (PNB) ont été réduits de 25% dans le bras aliskiren par rapport au placebo.
0.5345128774642944 ||| The Commission has published on 20 May (along with the Farm to Fork and Biodiversity strategies) its assessment. ||| This vaccine complies with the WHO recommendations (Northern Hemisphere) and EU decision for the 2006/ 2007 season. ||| La Commission a publié cette évaluation le 20 mai (en même temps que les stratégies «De la ferme à l'assiette» et «Biodiversité»).
0.2964586317539215 ||| In patients with severe renal impairment (CrCl < 30 ml/ min), the dosage of Doribax should be 250 mg every 12 hours. ||| The long-term safety of filgrastim administration above 2.4 MIU (24 μ g)/ kg/ day in patients with SCN has not been established. ||| Chez les patients ayant une insuffisance rénale sévère (CrCl < 30 mL/ min), Doribax doit être administré à la dose de 250 mg toutes les 12 heures.
0.02490304782986641 ||| Cerenia can be used to treat or prevent vomiting either as tablets or as solution for injection once daily for up to five days. ||| Cerenia can be used to treat or prevent vomiting either as tablets or as solution for injection once daily for up to five days ||| Pour traiter ou prévenir les vomissements, Cerenia peut être utilisé une fois par jour jusqu’ à 5 jours, soit en comprimés, soit en solution pour injection.
0.34180736541748047 ||| Glass slabs for use in building ||| Fuel for use in barbecues ||| Dalles en verre destinées au bâtiment
0.3714754581451416 ||| Statins When Cholestagel was co-administered with statins in clinical studies, an expected add-on LDL-C lowering effect was observed, and no unexpected effects were observed. ||| The CHMP had concerns that the studies presented by the Company had not sufficiently shown that Depocyte was as effective as, or more effective than intrathecal methotrexate. ||| 4 Statines Dans les études cliniques où Cholestagel a été administré conjointement à des statines, un effet attendu de réduction supplémentaire du LDL-C a été observé et aucun effet inattendu n’ a été constaté.
0.3183917999267578 ||| Fasting should be continued for at least 30 minutes after taking the tablet. ||| The symptoms may be delayed for up to 24 hours after ingestion. ||| Le jeûne doit être poursuivi au moins 30 minutes après la prise du comprimé.
0.003717666957527399 ||| 120 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51 ||| 125 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51 ||| 130 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51
0.2652468979358673 ||| Enbrel is reconstituted with 1 ml bacteriostatic water for injections before use, and administered by subcutaneous injection. ||| Viraferon solution for injection, may be injected directly after withdrawal of the appropriate doses from the lon vial with a sterile injection syringe. ||| Enbrel est reconstitué avec 1 ml d’ eau bactériostatique pour préparations injectables avant utilisation, et administration de l’ injection sous-cutanée.
0.0 ||| 4.2 Posology and method of administration ||| 4.2 Posology and method of administration ||| 4.3 Posologie et mode d’ administration
0.2134113907814026 ||| 16 July 2006 ||| 25 June 2006 ||| 16 juillet 2006
0.13251908123493195 ||| Why has Viracept been approved? ||| Why has Celvapan been approved? ||| 2/ 3 Pourquoi Viracept a -t-il été approuvé?
0.6250823140144348 ||| Emtriva may cause dizziness. ||| You may get constipation. ||| Emtriva peut provoquer des vertiges.
0.39012670516967773 ||| Always put the dosing cup back onto the cap after use and cleaning. ||| Pull on the coloured tab while continuing to rotate the plunger as needed. ||| Toujours replacer le gobelet-doseur sur le bouchon après utilisation et rinçage.
0.3945487439632416 ||| There is no difference in the oral bioavailability of nicotinic acid in men and women receiving Pelzont. ||| The content of vitamin D in FOSAVANCE is not suitable for correction of vitamin D deficiency. ||| La biodisponibilité orale de l’ acide nicotinique n’ est pas différente chez les hommes et les femmes recevant Pelzont.
0.34002482891082764 ||| After multiple dosing, less than 3% of the lopinavir dose is excreted unchanged in the urine. ||| After oral administration 45% is excreted unchanged in the urine and 25% is excreted in the faeces. ||| Après plusieurs doses, moins de 3% de la dose de lopinavir se retrouvaient inchangés dans les urines.
0.29705119132995605 ||| Therefore, higher doses of rFVIIa may be needed in paediatric patients to achieve similar plasma concentrations as in adult patients (see section 5.2). ||| In patients ≥ 75 years, fondaparinux should be used with care, as renal function decreases with age (see section 4.4). ||| En conséquence, des doses plus importantes de rFVIIa peuvent être nécessaires chez les enfants pour atteindre des concentrations plasmatiques similaires à celles des adultes (voir rubrique 5.2).
0.06507611274719238 ||| 0.8 ml (10000 IU/ ml) ||| 0.6 ml (50000 IU/ ml) ||| 0,8 ml (10 000 UI/ ml)
0.3214123547077179 ||| The suspension should be injected subcutaneously (under the skin) once daily for 5 consecutive days. ||| Pandemrix is given by injection into the upper arm muscle in two doses, at least three weeks apart. ||| La suspension doit être injectée par voie sous-cutanée (sous la peau) une fois par jour pendant 5 jours consécutifs.
0.3979014456272125 ||| Median time to progression (weeks) ||| Time on study (weeks) ||| Temps moyen de progression (semaines)
0.5884898900985718 ||| The patient should set a date to stop smoking. ||| As the patient grows the doctor will adjust the dose. ||| Le patient doit fixer une date pour arrêter de fumer.
0.31197428703308105 ||| Ovarian hyperstimulation syndrome was observed in approximately 4% of patients treated with Ovitrelle. ||| Thus seroconversion is expected to occur in most patients treated with Myozyme. ||| Un syndrome d’ hyperstimulation ovarienne a été observé chez approximativement 4% des patientes traitées par Ovitrelle.
0.5319756865501404 ||| EU institutions, EU Member States and other donors have so far allocated resources amounting to €5 billion to the Emergency Trust Fund for Africa. ||| All EU Member States, plus Albania and Switzerland, monitor their bathing sites according to the provisions of the EU's Bathing Water Directive. ||| Les ressources allouées à ce fonds par les institutions européennes, les États membres de l'UE et d'autres donateurs s'élèvent actuellement à 5 milliards d'euros.
0.4345310926437378 ||| Anti-vibration tape ||| Anti-friction metal ||| Ruban anti-vibration
0.03526708483695984 ||| Ceftriaxone Tyrol Pharma and associated names (See Annex I) 2 g powder for solution for infusion [See Annex I - To be completed nationally] ||| Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection or infusion [See Annex I - To be completed nationally] ||| Ceftriaxone Tyrol Pharma et autres dénominations (voir Annexe I) 2 g, poudre pour solution pour perfusion [voir Annexe I – A compléter dans chaque pays]
0.32707637548446655 ||| The recommended dose is 150, 300 or 600 mg twice a day, depending on the other medicines that the patient is taking. ||| The dose, which has been adjusted for you and your condition, will generally be between 150 mg and 600 mg each day. ||| La dose recommandée est de 150, 300 ou 600 mg administrée deux fois par jour, selon les autres médicaments pris par le patient.
0.2453761249780655 ||| In very rare cases an anaphylactoid reaction with oedema, pruritis, respiratory and cardiac distress, severe gastrointestinal signs or shock has been seen during the first hours after vaccination. ||| Clinical manifestations of severe hepatic injury were uncommon with a lower than 1% incidence of individual signs and symptoms including jaundice, hepatomegaly or liver pain. ||| Dans de très rares cas une réaction de type anaphylactique avec œ dème, prurit, détresse cardiaque et respiratoire, symptômes gastro-intestinaux sévères ou choc peut être observée dans les premières heures après la vaccination.
0.0 ||| 4.6 Pregnancy and lactation ||| 4.6 Pregnancy and lactation ||| 4.6 Grossesse et allaitement
0.2507284879684448 ||| In an open label trial completed in 1998 in HIV infected, clinically stable children there was a significant difference (p = 0.03) in the detectable RNA levels in favour of a triple regimen (ritonavir, zidovudine and lamivudine) following 48 weeks treatment. ||| In controlled clinical studies, the incidence of clinically important elevations in serum transaminases (ALT and/ or AST ≥ 3 X ULN, consecutive) was 1.0% for patients treated with Trevaclyn with or without a statin. ||| Dans un essai clinique ouvert réalisé en 1998 chez des enfants infectés par le VIH, cliniquement stables, il y a eu une différence significative (p=0,03) dans les taux détectables d’ARN en faveur d’une trithérapie (ritonavir, zidovudine et lamivudine) après 48 semaines de traitement.
0.34843602776527405 ||| No dosage adjustment is necessary for efavirenz. ||| No dose adjustment for nelfinavir is recommended. ||| Aucun ajustement posologique n’ est nécessaire pour l'éfavirenz.
0.763812780380249 ||| 32/ 44 ||| 96 to 114 ||| 31/ 44
0.2746056914329529 ||| At the time of donating blood, Abseamed should be administered after the completion of the blood donation procedure. ||| If GANFORT is administered until delivery, the neonate should be carefully monitored during the first days of life. ||| Au moment du don de sang, Abseamed doit être administré une fois la procédure de don terminée.
0.022295624017715454 ||| NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT ||| NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THEMANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT ||| NOM ET ADRESSE DU TITULAIRE DE L’ AUTORISATION DE MISE SUR LE MARCHE ET DU TITULAIRE DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS, SI DIFFERENT
0.3580111861228943 ||| For patients at risk of hyperuricemia, the use of allopurinol should be considered. ||| Medicines containing sorbitol should not be taken if you have hereditary fructose intolerance. ||| Pour les patients susceptibles de développer une hyperuricémie, l'utilisation de l'allopurinol doit être envisagée.
1.1106986999511719 ||| [Chancellor Merkel: […] The fact that it is two women makes me very happy. ||| Q3 Madam Chancellor, Madam President, I have a question on the rule of law. ||| [Chancelière Merkel: […] Je me réjouis qu'il s'agisse ici de deux femmes.
0.1718897819519043 ||| The other ingredients are mannitol, methionine, poloxamer 188, diluted phosphoric acid, sodium hydroxide, water for injections. ||| The other ingredients of Kepivance are mannitol, sucrose, L-histidine, polysorbate 20 and diluted hydrochloric acid. ||| Les autres composants sont: mannitol, méthionine, poloxamer 188, acide phosphorique dilué, hydroxyde de sodium, eau pour préparations injectables.
0.5279096364974976 ||| However, MPA Cmax was decreased by 40% in the presence of food. ||| On the other hand, the AUC of lopinavir decreases by 38%. ||| Toutefois, la Cmax du MPA a été réduite de 40% en présence d'aliments.
0.4189486503601074 ||| Dose reduction of Ceplene is normally not required in hepatically impaired patients, but caution should be used in these patients. ||| The vaccine does not provide complete protection and it is important to adhere to dietary and hygiene advice to avoid diarrhoeal diseases. ||| Une réduction de la dose de Ceplene n’ est normalement pas nécessaire chez les patients insuffisants hépatiques, mais le médicament doit être utilisé avec prudence chez ces patients.
6.08481689513829e-13 ||| • Always remove the needle after each injection and store your FlexPen without the needle attached. ||| • Always remove the needle after each injection and store your FlexPen without the needle attached. ||| • Jetez toujours l’aiguille après chaque injection et conservez votre FlexPen sans l’aiguille attachée.
0.48344966769218445 ||| If it appears to be a dry powder you should constitute the oral suspension by following the instructions below. ||| Choose a new area of skin where you will apply a new patch, then follow the instructions above. ||| Si elle se présente sous forme de poudre sèche, vous devez reconstituer la suspension buvable en suivant les indications ci- dessous.
0.4593380093574524 ||| Patients should be monitored until symptoms resolve. ||| Most patients completely recover after appropriate measures are taken. ||| Les patients doivent être surveillés jusqu'à disparition des symptômes.
0.28601181507110596 ||| Close monitoring of haematologic parameters is advised in these patients. ||| More frequent monitoring of hepatic function was recommended in all instances. ||| Une étroite surveillance hématologique est conseillée chez ces patients.
0.43319088220596313 ||| Transmission of radio programs ||| Transmission of digital files ||| Transmission d'émissions de radio
0.42097800970077515 ||| No food should be consumed for at least one hour after the dose is taken. ||| It should be taken preferably as a single night-time dose before going to bed. ||| Le patient ne doit consommer aucun aliment pendant une heure au moins après la prise du médicament.
0.31942984461784363 ||| If your child misses a scheduled injection, talk to your doctor and arrange another visit. ||| If injecting in the lower abdominal area is not possible, ask your nurse or doctor for advice. ||| 39 Si votre enfant manque une vaccination prévue, informez-en votre médecin et demandez-lui une nouvelle consultation.
0.16896679997444153 ||| If you experience a reaction like this, you should tell your doctor immediately. ||| Should you experience any of these reactions, you should contact your physician immediately. ||| Si vous avez une telle réaction, vous devez en informer immédiatement votre médecin.
0.21321138739585876 ||| For total hip BMD, 82.3% of patients receiving 3 mg injection every 3 months were responders at one year, compared with 75.1% of patients receiving 2.5 mg daily orally (p=0.02). ||| After 2 years of treatment, 85.6% of patients receiving 3 mg injections and 77.0% of patient receiving 2.5 mg oral therapy had increased or maintained total hip BMD (p=0.004). ||| A un an, la DMO de la hanche totale a augmenté ou s’ est maintenue (définition des patients répondeurs) chez 82,3% des patientes sous Bondenza IV 3 mg tous les 3 mois versus 75,1% des patientes sous acide ibandronique oral 2,5 mg une fois par jour (p= 0,02).
0.16959886252880096 ||| Unprocessed lychee fruit ||| Processed lychee fruit ||| Fruit lychee non préparé
0.482366681098938 ||| Elastic stockings [for medical purposes] ||| Degreasing agents [not for household use] ||| Bas élastiques à usage médical
0.11453498899936676 ||| State aid: Coronavirus: Commission approves German measures ||| State aid: Coronavirus: Commission approves UK schemes ||| Aides d'État: coronavirus: la Commission autorise les mesures allemandes
0.34473472833633423 ||| In clinical trials the tablets have been studied for up to 14 days treatment. ||| Efficacy was demonstrated in controlled trials in patients treated for up to 29 weeks. ||| Dans les essais cliniques, les comprimés ont été étudiés sur des durées de traitement jusqu’ à 14 jours.
0.12390846014022827 ||| Pigments for use in the manufacture of pharmaceuticals ||| Esters for use in the manufacture of pharmaceutical products ||| Pigments destinés à la fabrication de produits pharmaceutiques
0.3759996294975281 ||| These increases in blood pressure can be treated with medicinal products. ||| Some medicines can affect the ability of blood to carry oxygen. ||| Ces augmentations de la pression artérielle peuvent être contrôlées par un traitement médicamenteux.
0.49085259437561035 ||| For preparation and administration instructions, see section 6.6. ||| (See section 12, for detailed instructions of product preparation) ||| Pour les instructions de préparation et d’ administration, voir rubrique 6.6.
0.09369821846485138 ||| ATC vet code: ||| ATCvet code: ||| Code ATC-Vet:
0.14315366744995117 ||| Arava 20 mg film-coated tablets Leflunomide ||| Vimpat 200 mg film-coated tablets Lacosamide ||| Arava 20 mg comprimés pelliculés Léflunomide
0.3475465178489685 ||| Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human erythropoietin and those in the control group. ||| A continuous systemic exposure of the dams during the (unknown) sensitive phase of the organogenesis as a pre-requisite for the induction of teratogenic effects cannot necessarily be assumed. ||| Ces résultats sur la survie globale n’ ont pas pu être expliqués de façon satisfaisante par des différences d’ incidence de survenue de thromboses et de leurs complications associées, entre les patients recevant une érythropoïétine humaine recombinante et ceux des groupes contrôles.
0.26079392433166504 ||| There have been reports of increased bleeding, including spontaneous skin haematomas and haemarthroses, in haemophiliac patients type A and B treated with protease inhibitors. ||| Bleeding drug-related events, ranging from petechiae and epistaxis to severe gastrointestinal haemorrhage and CNS bleeding, were reported in patients taking SPRYCEL (see section 4.4). ||| Patients hémophiles: des cas d’augmentation de saignements comprenant des hématomes cutanés spontanés et des hémarthroses ont été signalés chez les patients hémophiles de type A et B traités avec les inhibiteurs de protéase.
0.08086685836315155 ||| 76 B. ||| 87 B. ||| 82 B.
0.0 ||| Do not rub the injection site. ||| Do not rub the injection site. ||| Ne pas frotter le site d'injection.
0.10994391143321991 ||| ZACTRAN 150mg/ ml solution for injection for cattle ||| DRAXXIN 100 mg/ ml solution for injection for cattle ||| 15/ 18 NOTICE ZACTRAN 150mg/ ml solution injectable pour bovins
0.49234265089035034 ||| If the needle guard is not activated, an incomplete injection may have occurred. ||| If left untreated, however, it can result in broken bones. ||| Si le système de protection de l’aiguille ne s’est pas activé, une injection incomplète a pu avoir lieu.
0.04126957058906555 ||| Vocational education relating to avoidance of drug related problems ||| Vocational education relating to avoidance of health related problems ||| Formation professionnelle concernant la prévention de problèmes liés aux drogues
0.07655037939548492 ||| INFORMATION IN BRAILLE uc ||| INFORMATION IN BRAILLE na ||| INFORMATIONS EN BRAILLE mé
0.5110983848571777 ||| At the beginning of the fourth week, you should take Neupro 8 mg (package marked with ”Week 4“). ||| Triple pack 2 is designed to help you prepare the next 3 injections (days 7, 9 and 11). ||| Au début de la quatrième semaine, utilisez Neupro 8 mg (emballage portant la mention « Semaine 4 »).
0.6269470453262329 ||| - angry behaviour, mood being affected, seeing or hearing things that are not really there ||| - hallucination (seeing or hearing things that are not there) ||| - comportement coléreux, sauts d'humeur, voir ou entendre des choses qui ne sont pas réellement
0.31684255599975586 ||| Abraxane is a white to yellow powder for suspension for infusion available in glass vials containing 100 mg paclitaxel. ||| This vial contains a white to pale yellow lyophilised (“ freeze-dried”) powder for concentrate for solution for infusion. ||| Abraxane est une poudre blanche à jaune pour suspension injectable par perfusion disponible dans des flacons de verre contenant 100 mg de paclitaxel.
0.2878536581993103 ||| In the study where AZILECT was used alone, patients taking 1 mg of the medicine once a day had an average fall in UPDRS score of 0.13 points over the 26-week study from a starting value of 24.69. ||| Among the 61 patients treated at an initial dose of 300 mg/ m2/ day, the overall response rate, according to a global assessment by the physician, was 51% (31/ 61) with a clinical complete response rate of 3%. ||| Dans l’ étude sur AZILECT en monothérapie, les patients prenant 1 mg de médicament une fois par jour ont présenté une baisse moyenne du score UPDRS de 0,13 points sur les 26 semaines de l’ étude par rapport à une valeur de départ de 24,69.
0.47636908292770386 ||| Each carton contains two glass vials (each glass vial packed in one cardboard box), two sterile transfer devices, one sterile intravenous infusion set and one sterile short catheter for administration to children. ||| It is available as immediate release film coated tablets, modified release film coated tablets, granules and solutions for oral suspension, solutions for infusion in bags, solutions for infusion in bottles and sachets. ||| Chaque carton contient deux flacons en verre (chaque flacon en verre étant emballé dans une boîte en carton), deux dispositifs de transfert stériles, un set de perfusion intraveineuse stérile et un cathéter court stérile pour l’ administration à des enfants.
0.6008456945419312 ||| In less than two months, it has spread all over China and near 50 other countries globally at the time of this writing. ||| The epidemic started in Wuhan, China, and quickly spread throughout the entire country and to near 50 others all over the world. ||| En moins de deux mois, au moment de la rédaction de ce rapport, elle s’est étendue à toute la Chine ainsi qu’à près de 50 autres pays à travers le monde.
6.269054286106579e-13 ||| Light paraffin oil.............................................................................................................. ||| Light paraffin oil.............................................................................................................. ||| Huile de paraffine légère................................................................................
0.016808435320854187 ||| Accidental use of the drug by a pregnant women should not produce any harmful effects on the foetus. ||| Accidental use of the drug by a pregnant woman should not produce any harmful effects on the foetus. ||| L'utilisation accidentelle lors de la grossesse ne devrait pas affecter le fœ tus.
2.890456970994215e-13 ||| Nervous system symptoms: symptoms including, but not limited to, dizziness, insomnia, somnolence, impaired concentration and abnormal dreaming are frequently reported undesirable effects in patients receiving efavirenz 600 mg daily in clinical studies (see section 4.8). ||| Nervous system symptoms: symptoms including, but not limited to, dizziness, insomnia, somnolence, impaired concentration and abnormal dreaming are frequently reported undesirable effects in patients receiving efavirenz 600 mg daily in clinical studies (see section 4.8). ||| 112 Symptômes affectant le système nerveux: des symptômes incluant, entre autres, sensations vertigineuses, insomnie, somnolence, troubles de la concentration et perturbation des rêves sont des effets indésirables fréquemment rapportés par les patients recevant 600 mg par jour d’ éfavirenz au cours d’ études cliniques (voir rubrique 4.8).
3.326433909139198e-13 ||| Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| 218 Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000
6.435158937841134e-13 ||| Store in a refrigerator (2°C-8°C). ||| Store in a refrigerator (2°C-8°C). ||| A conserver au réfrigérateur (2°C-8°C).
0.4082053303718567 ||| In the largest of these trials, the Shingles Prevention Study (SPS), 38546 subjects received a single dose of either the frozen formulation of ZOSTAVAX (n=19270) or placebo (n=19276) and were monitored for safety throughout the study. ||| SARS-CoV-2 was found to be a new type of beta-CoV with more than 99.98% genetic identity among 10 sequenced samples collected from the original site of the outbreak, the Huanan Seafood Market in Wuhan. ||| Dans la plus vaste de ces études, l’ Etude de Prévention du Zona (EPZ), 38546 sujets ont reçu une dose de ZOSTAVAX dans sa formulation congelée (n=19270) ou d’ un placebo (n=19276) et ont été suivis pour la tolérance durant toute la durée de l’ étude.
0.3469429910182953 ||| What is Olanzapine Mylan? ||| What is Neoclarityn? ||| Qu'est -ce qu’ Olanzapine Mylan?
0.3083930015563965 ||| Efficacy Results for Study E3200 ||| Efficacy results for study E4599 ||| Résultats d’ efficacité de l’ étude E3200
0.2619490921497345 ||| Gastrointestinal bleeding, development of duodenal ulcer, hypertension, phlebitis, leucopenia, haemolytic and non-haemolytic anaemia, thrombocytopenia, agranulocytosis, chest pain, dyspnoea and paraesthesia have occurred rarely with levodopa/ carbidopa. ||| Severe skin reactions, collapse or shock-like state (hypotonic-hyporesponsiveness episode), faints, seizures in patients with pre-existing seizure disorders, hypoaesthesia, paraesthesia, relapse of nephrotic syndrome, arthralgia, petechiae and/ or purpura. ||| De rares cas d'hémorragies digestives, de développement d'un ulcère duodénal, d'hypertension artérielle, de phlébite, de leucopénie, d'anémie hémolytique et non hémolytique, de thrombopénie, d'agranulocytose, de douleurs thoraciques, de dyspnée et de paresthésies ont été observés avec la lévodopa/ carbidopa.
0.04043515771627426 ||| ut Major bleeding during the initial treatment period was observed in 1.3% of fondaparinux patients, compared to 1.1% with unfractionated heparin. ||| 30 Major bleeding during the initial treatment period was observed in 1.3% of fondaparinux patients, compared to 1.1% with unfractionated heparin. ||| Pendant la phase initiale du traitement, des saignements majeurs ont été observés chez 1,3% des patients traités par le fondaparinux et 1,1% de ceux traités par l’ héparine non fractionnée
0.0012022315058857203 ||| 118 There have been rare reports of patients, including rheumatoid factor positive patients, who have developed other autoantibodies in conjunction with a lupus-like syndrome or rashes that are compatible with subacute cutaneous lupus or discoid lupus by clinical presentation and biopsy. ||| 93 There have been rare reports of patients, including rheumatoid factor positive patients, who have developed other autoantibodies in conjunction with a lupus-like syndrome or rashes that are compatible with subacute cutaneous lupus or discoid lupus by clinical presentation and biopsy. ||| Ont été rapportés, de rares cas de patients (y compris ceux ayant un facteur rhumatoïde positif), ayant développé d’ autres auto-anticorps associés à un syndrome lupique ou à des éruptions compatibles sur le plan clinique et après biopsie, avec un lupus cutané subaigu ou un lupus discoïde.
0.542599081993103 ||| ori 3. ||| or 3. ||| tor 3.
0.3524816930294037 ||| In particular you should tell your doctor if you are using antiepileptics or antidepressants ||| Especially tell the doctor if you/your child takes insulin or other anti-diabetes medicines. ||| Vous devez tout particulièrement informer votre médecin si vous utilisez des médicaments antiépileptiques ou des antidépresseurs.
0.11040791869163513 ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND ng MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE lo ||| FABRICANT(S) DES PRINCIPE(S) ACTIF(S) BIOLOGIQUE(S) ET TITULAIRE(S) DE L'AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS
0.4014251232147217 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The Luxembourg scheme that we approved today enables the granting of guarantees on loans at favourable terms to help business cover immediate working capital and investment needs and continue their activities in these difficult times. ||| Trade Commissioner Phil Hogan and Mexican Minister of Economy Graciela Márquez Colín - in a phone call today - agreed on the exact scope of the reciprocal opening of public procurement markets and a high level of predictability and transparency in public procurement processes. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Le régime luxembourgeois que nous avons autorisé ce jour permet l'octroi de garanties sur des prêts à des conditions préférentielles afin d'aider les entreprises à couvrir leurs besoins immédiats en fonds de roulement et en investissements et à poursuivre leur activité en ces temps difficiles.
0.35341882705688477 ||| Very rarely patients with asthma may experience worsening of their condition. ||| In patients with normal renal function and no other complicating factors, neutropenia occurs rarely. ||| 183 Les patientes souffrant d'asthme peuvent très rarement observer une aggravation de leur asthme.
2.670536589175626e-13 ||| 721 cancer patients receiving non-platinum chemotherapy were included in three placebo-controlled studies, 389 patients with haematological malignancies (221 multiple myeloma, 144 non-Hodgkin's lymphoma, and 24 other haematological malignancies) and 332 with solid tumours (172 breast, 64 gynaecological, 23 lung, 22 prostate, 21 gastrointestinal, and 30 other tumour types). ||| 721 cancer patients receiving non-platinum chemotherapy were included in three placebo-controlled studies, 389 patients with haematological malignancies (221 multiple myeloma, 144 non-Hodgkin's lymphoma, and 24 other haematological malignancies) and 332 with solid tumours (172 breast, 64 gynaecological, 23 lung, 22 prostate, 21 gastrointestinal, and 30 other tumour types). ||| 721 patients cancéreux recevant une chimiothérapie sans cisplatine ont été inclus dans trois études contrôlées par placebo, 389 patients atteints de malignités hématologiques (221 myélomes multiples, 144 lymphomes non hodgkiniens et 24 autres malignités hématologiques) et 332 atteints de tumeurs solides (172 tumeurs du sein, 64 tumeurs gynécologiques, 23 tumeurs pulmonaires, 22 tumeurs de la prostate, 21 tumeurs gastro-intestinales et 30 autres types de tumeur).
8.415403248383801e-13 ||| Undesirable effects ||| Undesirable effects ||| Effets indésirables:
0.011961309239268303 ||| Anemia symptoms and sequaelea may vary with age, gender and overall burden of disesase; a physician´s evaluation of the individual patient´s clinical course and condition is necessary. ||| 132 Anemia symptoms and sequaelea may vary with age, gender and overall burden of disesase; a physician´s evaluation of the individual patient´s clinical course and condition is necessary. ||| Les symptômes et séquelles de l’ anémie peuvent varier selon l’ âge, le sexe et l’ impact global de la maladie; une évaluation par le médecin de l’ état de santé et de l’ évolution clinique de chaque patient est nécessaire.
0.23808112740516663 ||| In studies performed in rats and rabbits no clinically relevant evidence of harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development was observed. ||| A fertility and early embryonic development study in rats revealed no evidence of impaired fertility, reproductive performance or early embryonic development due to vildagliptin. ||| Dans les études effectuées chez le rat et chez le lapin, aucun effet délétère cliniquement significatif sur la gestation, le développement embryo-foetal, la mise bas ou le développement postnatal n’ a pu être observé.
0.41995924711227417 ||| The applicant was asked to further justify the broad indication “ treatment of osteoporosis in men” for Alendronate HEXAL. ||| The submitted data for the indication “symptomatic gastroesophageal reflux disease” support this the indication. ||| Le demandeur a été prié de justifier l’ indication large de « traitement de l’ ostéoporose chez l’ homme » pour l’ alendronate HEXAL.
0.37415099143981934 ||| Posaconazole was shown to be non-inferior to fluconazole for clinical success rates at Day 14 as well as 4 weeks after the end of treatment. ||| These results support efficacy for ZYPADHERA over 8 weeks of treatment and a drug effect that was observed as early as 1 week after starting treatment with ZYPADHERA. ||| Cette étude montre que le posaconazole est non-inférieur au fluconazole sur les taux de succès cliniques à J 14 ainsi que 4 semaines après la fin du traitement.
0.0 ||| Very common ||| Very common ||| 19 Très fréquent
0.6091588139533997 ||| Shake well before use. ||| Do not open before use. ||| Agiter avant emploi
0.016659807413816452 ||| Press release22 March 2020Brussels ||| Press release25 March 2020Brussels ||| Communiqué de presse22 mars 2020Bruxelles
0.02283981442451477 ||| The benefit of the treatment on the criteria indicated above is not known in patients over the age of 65 years, who were not included in the study. ||| The benefit of the treatment on the criteria indicated above is not known in patients over the age of 65 years, who could not be included in the study. ||| Le bénéfice du traitement sur les critères cités ci-dessus n'est pas connu chez les patients âgés de plus de 65 ans, qui ne pouvaient pas être inclus dans l’ étude.
3.627113529230258e-13 ||| See your delivery system manual for further instructions ► Disinfect the rubber membrane with a medicinal swab ► Always use a new needle for each injection to prevent contamination. ||| See your delivery system manual for further instructions ► Disinfect the rubber membrane with a medicinal swab ► Always use a new needle for each injection to prevent contamination. ||| Pour plus d’ informations, consultez le mode d’ emploi de votre système d’ administration ► désinfectez la membrane en caoutchouc à l’ aide d’ une compresse antiseptique. ► utilisez toujours une aiguille neuve pour chaque injection afin d’ éviter les contaminations.
0.01457177847623825 ||| The patient's ability to concentrate and react may be impaired as a result of hypoglycaemia or hyperglycaemia or, for example, as a result of visual impairment. ||| 5 The patient's ability to concentrate and react may be impaired as a result of hypoglycaemia or hyperglycaemia or, for example, as a result of visual impairment. ||| Les capacités de concentration et les réflexes peuvent être diminués en cas d'hypoglycémie ou d'hyperglycémie ou, par exemple, en cas de troubles visuels.
0.5314595699310303 ||| These reactions had occurred either with at least a 2% difference compared to the control arm (NCI-CTC grade 3-5 reactions) or with at least a 10% difference compared to the control arm (NCI-CTC grade 1-5 reactions), in at least one of the major clinical trials. ||| The systemic exposure at this dose was approximately 0.5 times the clinical exposure at the recommended clinical dose of 2 g/ day for renal transplant patients and approximately 0.3 times the clinical exposure at the recommended clinical dose of 3 g/ day for cardiac transplant patients. ||| Ces effets sont survenus soit avec une incidence supérieure d’ au moins 2% par rapport au groupe témoin (réactions de Grade 3-5 NCI- CTC) soit avec une incidence supérieure d’ au moins 10% par rapport au groupe témoin (réactions de Grade 1-5 NCI-CTC), dans au moins l’ une des principales études cliniques.
0.2424151450395584 ||| Imatinib was teratogenic in rats when administered during organogenesis at doses ≥ 100 mg/ kg, approximately equal to the maximum clinical dose of 800 mg/ day, based on body surface area. ||| Calcium folinate rescue is necessary when methotrexate is given at doses exceeding 500 mg/ m2 body surface and should be considered with doses of 100 mg – 500 mg/ m2 body surface. ||| 103 L’ imatinib est tératogène chez les rats lorsqu’ il est administré au cours de l’ organogenèse, à des doses ≥ 100 mg/ kg, approximativement équivalente à la dose clinique maximale de 800 mg/ j, basée sur la surface corporelle.
0.0 ||| It is recommended that the date of the first use be noted on the label. ||| It is recommended that the date of the first use be noted on the label. ||| Il est recommandé d'inscrire la date de première ouverture du flacon sur l’ étiquette.
0.11436426639556885 ||| What is Crixivan used for? ||| What is Mirapexin used for? ||| Dans quel cas Crixivan est -il utilisé?
0.29820477962493896 ||| Elimination Lacosamide is primarily eliminated from the systemic circulation by renal excretion and biotransformation. ||| Telbivudine is eliminated primarily by urinary excretion of unchanged substance. ||| 25 Le lacosamide est principalement éliminé de la circulation par excrétion rénale et biotransformation.
0.37731730937957764 ||| The majority of cases resolved after dose reduction or discontinuation of treatment. ||| Rebound (worsening of symptoms after abrupt discontinuation of treatment) can not be excluded. ||| Dans la plupart des cas, elle a été normalisée après la diminution de la dose ou l’ arrêt du traitement.
0.013888707384467125 ||| Dafiro 5 mg/ 160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg alone. ||| Copalia 5 mg/ 160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg alone. ||| Dafiro 5 mg/ 160 mg peut être administré chez les patients dont la pression artérielle n'est pas suffisamment contrôlée avec l'amlodipine 5 mg ou le valsartan 160 mg seuls.
0.24253180623054504 ||| Chemical compositions for use in the conditioning of concrete ||| Chemical compositions for use in the manufacture of colours ||| Compositions chimiques destinées au traitement du béton
0.27158719301223755 ||| If you or the child have an infection of any kind. ||| If you have an infection of any kind. ||| Si vous ou l’ enfant avez une infection quelle qu’elle soit.
0.4472830295562744 ||| The Cmax, AUC and Cmin of amprenavir were unchanged. ||| ViraferonPeg Cmax and AUC measurements increase in a dose-related manner. ||| La Cmax, l’ ASC et la Cmin de l’ amprénavir étaient inchangées.
0.366508424282074 ||| hypertension, flushing, haematoma ||| ischaemia, hypotension, ||| Hypertension, congestion, hématomes.
0.23905181884765625 ||| Marketing Authorisation Holder: na ||| Marketing Authorisation Holder: lp ||| Titulaire de l'Autorisation de Mise sur le Marché
0.19490081071853638 ||| Hepatic Impairment The pharmacokinetics of doripenem in patients with hepatic impairment have not been established. ||| Renal impairment The pharmacokinetics of etravirine have not been studied in patients with renal insufficiency. ||| Insuffisance hépatique La pharmacocinétique du doripénème n’a pas été étudiée chez les patients insuffisants hépatiques.
0.2943252623081207 ||| Electric power distribution apparatus ||| Electric communication apparatus ||| Machines de distribution de courant électrique
0.3141578435897827 ||| Ritonavir also blocks the activity of a liver enzyme called CYP3A, which is very important in the breakdown of medicines, including some other protease inhibitors. ||| Drug discrimination studies show that GHB produces a unique discriminative stimulus that in some respects is similar to that of alcohol, morphine and certain GABA-mimetic drugs. ||| Le ritonavir bloque également l’ activité d’ une enzyme du foie appelée CYP3A, qui est très active dans la dégradation des médicaments, y compris certains autres inhibiteurs de protéase.
0.35222306847572327 ||| 22 Although consideration should be given to initiating therapy with 75 mg in patients over 75 years of age, dosage adjustment is not usually necessary for the elderly. ||| The need for an increased dose relative to that used for adults and older children should be anticipated when treating younger children with ReFacto AF. ||| En dehors du sujet âgé de plus de 75 ans, chez lequel le traitement pourra être initié à la dose de 75 mg/ j, aucune adaptation posologique n’ est habituellement nécessaire chez le sujet âgé.
0.06633651256561279 ||| Insulatard FlexPen 100 IU/ ml suspension for injection Insulin human (rDNA) SC use ||| Insulatard InnoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use ||| Insulatard FlexPen 100 UI/ ml suspension injectable Insuline humaine (ADNr) Voie SC
0.007359468378126621 ||| The MAH must ensure that the system of pharmacovigilance, as described in version 3.0 presented in Module 1.8.1 of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| The MAH must ensure that the system of pharmacovigilance, as described in version 3 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Le Titulaire de l'Autorisation de Mise sur le Marché s'assure que le système de pharmacovigilance, comme décrit dans la version 3.0 présentée dans le Module 1.8.1. de la Demande d'Autorisation de Mise sur le Marché, est en place et fonctionne avant et pendant la commercialisation du produit.
0.03033026121556759 ||| Do not use it if the date has passed the last day of the month shown. ||| Do not use if the date has passed the last day of the month shown. ||| Ne l’utilisez pas si la date a dépassé le dernier jour du mois indiqué.
0.3671971559524536 ||| It can also be noticed that the monitoring of the endometrial thickness by pelvic ultrasound showed a significant increase, even with 0.5 mg E2, which was not reported in the placebo group. ||| The in vivo bioequivalence study shows an equivalent but statistically significant superiority for the test product for Cmax and a shorter Tmax, indicating that the test product has a slightly higher peripheral deposition. ||| Il a également été remarqué que la surveillance de l'épaisseur de l'endomètre au moyen de l'échographie pelvienne a montré une augmentation significative, même avec l'E2 0,5 mg, ce qui n'a pas été rapporté dans le groupe placebo.
0.01827022060751915 ||| 41 The plasma clearance of olanzapine is lower in elderly versus young subjects, in females versus males, and in non-smokers versus smokers. ||| The plasma clearance of olanzapine is lower in elderly versus young subjects, in females versus males, and in non-smokers versus smokers. ||| La clairance plasmatique de l’ olanzapine est plus faible chez les sujets âgés que chez les sujets jeunes, chez les femmes que chez les hommes, et chez les non fumeurs que chez les fumeurs.
0.02933666855096817 ||| Pick up your pre-filled syringe of solvent and slowly inject all the solvent (1 ml) into the vial of GONAL-f powder. ||| Pick up your pre-filled syringe of solvent and slowly inject all the solvent (0.75 ml) into the vial of GONAL-f powder. ||| Prenez votre seringue préremplie de solvant et injectez lentement tout le solvant (1 ml) dans le flacon de poudre de GONAL-f.
0.5848413705825806 ||| The company that makes Binocrit will provide information packs for healthcare workers in all Member States, including information on the safety of the medicine. ||| The Human and Veterinary Medicines Evaluation Units will continue to produce at least two newsletters per year, in four languages. ||| La société qui fabrique Binocrit fournira des documents d’ information aux personnels de santé de tous les États membres, contenant notamment des informations sur la tolérance du médicament.
0.22809463739395142 ||| White high-density polyethylene (HDPE) bottle fitted with a child-resistant closure, containing 30 hard capsules. ||| White, high-density polyethylene bottle with or without a child-resistant cap containing 30 tablets. ||| Flacon en polyéthylène haute densité (PEHD) blanc muni d’ un bouchon avec fermeture de sécurité enfants, contenant 30 gélules.
0.6835048794746399 ||| Plaster ||| vaccine ||| Plâtre
0.14416110515594482 ||| The full EPAR for PROTELOS is available here. ||| The full EPAR for OSSEOR is available here. ||| L’ EPAR complet est disponible à l’ adresse suivante: ici.
0.370288610458374 ||| Combined Phase 1 pharmacokinetic data at nelarabine doses of 104 to 2,900 mg/ m2 indicate that mean (%CV) clearance (Cl) values for nelarabine are 138 l/ h/ m2 (104%) and 125 l/ h/ m2 (214%) in adult and paediatric patients, respectively, on day 1 (n = 65 adults, n = 21 paediatric patients). ||| Following the intravenous administration of 500 and 1000 mg doses of rituximab on two occasions, two weeks apart, mean Cmax values were 183 μ g/ mL (range, 81.8 to 279 μ g/ mL) and 370 μ g/ mL (212 to 637 μ g/ mL), and mean half-lives were 17.9 days (range, 12.3 to 31.3 days) and 19.7 days (range, 12.3 to 34.6 days), respectively. ||| Les données combinées de pharmacocinétique des études de Phase I, à des doses de nélarabine allant de 104 à 2 900 mg/ m2, indiquent des valeurs de clairance (Cl) moyennes (% CV) de nélarabine chez les patients adultes et les patients pédiatriques de respectivement 138 l/ h/ m2 (104%) et 125 l/ h/ m2 (214%) au jour 1 (n = 65 patients adultes, n = 21 patients pédiatriques).
0.6671550869941711 ||| Harpoons ||| Winnowers ||| Harpons
0.29943376779556274 ||| In the 25 mg arm (n = 36), all patients had metastatic disease; 4 (11%) had no prior chemo- or immunotherapy; 17 (47%) had one prior treatment, and 15 (42%) had 2 or more prior treatments for RCC. ||| Before enrolling in the trial, 58 of the 61 patients (95%) had received 2 to 4 different induction regimens and 18/ 61 (30%) of these patients had undergone at least 1 prior haematological stem cell transplant (HSCT). ||| Dans le bras 25 mg (n = 36), tous les patients étaient porteurs d'une forme métastatique; 4 (11%) d'entre eux n'avaient jamais reçu de chimio ou d'immunothérapie, 17 (47%) avaient déjà reçu un traitement et 15 (42%) au moins 2 traitements pour le CRA.
0.007194756530225277 ||| From the fourth week on, the recommended dose is 40 drops once a day (1x20 mg). ||| From the fourth week on, the recommended dose is 40 drops once a day (1x 20 mg). ||| À partir de la quatrième semaine, la dose recommandée est de 40 gouttes une fois par jour (1 x 20 mg).
0.31478074193000793 ||| Viread 245 mg film-coated tablets are supplied in bottles containing 30 tablets. ||| Rapinyl tablets are contained in blisters, available in cartons of 10 or 30 tablets. ||| Les comprimés pelliculés Viread 245 mg sont fournis en flacon de 30 comprimés.
1.12468683719635 ||| Lower weight children: ||| Women Low Activity ||| Enfants de faible poids:
2.956033042043199e-13 ||| Relevant examples are cytomegalovirus retinitis, generalised and/ or focal mycobacterial infections, and pneumonia caused by Pneumocystis jiroveci (formerly known as Pneumocystis carinii). ||| Relevant examples are cytomegalovirus retinitis, generalised and/ or focal mycobacterial infections, and pneumonia caused by Pneumocystis jiroveci (formerly known as Pneumocystis carinii). ||| Des exemples pertinents sont les rétinites à cytomégalovirus, les infections mycobactériennes généralisées et/ ou localisées, et les pneumopathies à Pneumocystis jiroveci (anciennement appelé Pneumocystis carinii).
3.9184017901032486e-13 ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN ||| MISE EN GARDE SPECIALE INDIQUANT QUE LE MÉDICAMENT DOIT ETRE CONSERVE HORS DE PORTEE ET DE VUE DES ENFANTS
0.33617645502090454 ||| Carcinogenicity studies with nilotinib have not been performed. ||| Mortality and morbidity studies with atorvastatin have not yet completed. ||| Il n’ a pas été mené d’ études de carcinogénicité avec le nilotinib.
0.31750714778900146 ||| Such conditions should be corrected before the administration of Micardis. ||| Such conditions should be corrected before the administration of Irbesartan Winthrop. ||| Ces troubles doivent être corrigés avant toute administration de Micardis.
0.12717708945274353 ||| The Committee recommended that Tasigna be given marketing authorisation. ||| The Committee recommended that Enviage be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Tasigna.
0.0 ||| - If you have had a problem with your liver (other than hepatitis C). ||| - If you have had a problem with your liver (other than hepatitis C). ||| - si vous avez eu un problème avec votre foie (autre que l’ hépatite C).
0.2828090488910675 ||| Ceplene is a solution for injection that contains the active substance histamine dihydrochloride (0.5 mg/ 0.5 ml). ||| Protopic is a dermatological medicinal product that contains the calcineurin inhibitor tacrolimus at a 0.1% and 0.03% concentration. ||| Ceplene est une solution pour injection qui contient le principe actif histamine dichlorhydrate (0,5 mg/ 0,5 ml).
0.010184723883867264 ||| The final opinion was converted into a Decision by the European Commission on 15 September 2005. ||| The final opinion was converted into a Decision by the European Commission on 7 November 2005. ||| L’ avis définitif est devenu décision de la Commission européenne en date du 15 septembre 2005.
0.7181150317192078 ||| Liver transaminases increased ||| - Transaminases Elevations ||| Augmentation des transaminases hépatiques
0.3665156960487366 ||| The most serious, although rare, adverse reactions which may be caused by terfenadine are those related to QT prolongation. ||| Of these, liver failure, subsequently determined to be not related to bexarotene, was the only one to occur in a CTCL patient. ||| Bien que rares, les réactions indésirables les plus graves provoquées par la terfénadine sont liées à un allongement de QT.
0.3660581111907959 ||| Dynamo pulleys for vehicles ||| Pneumatic tires for automobiles ||| Poulies de dynamos pour véhicules
0.31418365240097046 ||| In May 2020, the European Commission presented its revised proposal for the successor to the Investment Plan for Europe under the next Multiannual Financial Framework starting in 2021: the InvestEU Programme. ||| At the end of May 2020, the Commission put forward a proposal for temporary recovery instrument Next Generation EU together with a revamped long-term budget 2021-2027. ||| En mai 2020, la Commission européenne a présenté sa proposition révisée relative au successeur du plan d'investissement pour l'Europe au titre du prochain cadre financier pluriannuel commençant en 2021, à savoir le programme InvestEU.
0.3217703402042389 ||| Kaplan-Meier analysis showed shorter time to treatment failure in patients treated with gliclazide, compared with pioglitazone. ||| Only constipation and dyspepsia were reported by a higher percentage among those receiving Cholestagel, compared with placebo. ||| L’ analyse de Kaplan- Meier a montré un délai plus court de survenue de l’ échec au traitement chez les patients traités avec le gliclazide, comparé à la pioglitazone.
0.020947465673089027 ||| For the full list of all side effects reported with Mycamine, see the Package Leaflet. ||| For the full list of all side effects reported with Thymanax, see the Package Leaflet. ||| 2/ 3 Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de Mycamine, voir la notice.
1.0613354444503784 ||| 2/ 9 ANNEX II ||| CHAPTER 1 1 — TOTAL ||| 2/ 9 ANNEXE II
3.165783607483874e-13 ||| In MS inflammation destroys the protective sheath (called myelin) around the nerves of the CNS and stops the nerves from working properly. ||| In MS inflammation destroys the protective sheath (called myelin) around the nerves of the CNS and stops the nerves from working properly. ||| L’ inflammation liée à la sclérose en plaques détruit la gaine protectrice (appelée myéline) qui enveloppe les nerfs du SNC et les empêche de fonctionner correctement.
0.8354580998420715 ||| 3.8 mmHg (low dose), 3.2 mmHg (medium dose), 5.6 mmHg (high dose). ||| 55ml: ≤ 10 kg bodyweight, 120ml: ≤ 22 kg bodyweight, 210ml: ≤ 40 kg bodyweight. ||| 3,8 mm Hg (faible dose), 3,2 mm Hg (dose moyenne), 5,6 mm Hg (forte dose).
0.3974634110927582 ||| In elderly subjects (over 65 years old), a 15% increase in AUC was observed as compared to younger subjects. ||| In general, older patients (over 65 years of age) tolerate cytotoxic therapy less well than younger individuals. ||| Une augmentation d'environ 15% de l’ ASC a été observée chez le sujet âgé sain (plus de 65 ans) comparativement au sujet plus jeune.
0.3782832622528076 ||| How do I give my injection? ||| How should I take antibiotics? ||| Comment me faire l'injection?
0.784717321395874 ||| Risk related to rufinamide: ||| - Bradycardia of any cause ||| Risque lié au rufinamide:
0.6897196769714355 ||| The quality management initiative begun in 1997 began to show tangible results during 1998. ||| The mutual recognition procedure has made considerable progress during 1998. ||| Lancée en 1997, l’ initiative de gestion de la qualité a commencé à produire des résultats concrets en 1998.
0.5438277721405029 ||| DULOXETINE BOEHRINGER INGELHEIM 40 mg ||| HOW TO TAKE DULOXETINE BOEHRINGER INGELHEIM ||| DULOXETINE BOEHRINGER INGELHEIM 40 mg.
0.04828238487243652 ||| Treating physicians should refer to national and / or international consensus documents regarding the treatment of anthrax. ||| The treating physician should refer to national and/ or international consensus documents regarding treatment of anthrax. ||| Le médecin traitant doit se référer aux recommandations nationales et/ou internationales concernant le traitement de la maladie du charbon.
0.49263131618499756 ||| Infections and infestations Uncommon Psychiatric disorders ||| Investigations Psychiatric disorders Injury, poisoning and ||| Infections et infestations Peu fréquent Affections psychiatriques
0.06065310537815094 ||| s SP Europe, 73, rue de Stalle, B-1180 Bruxelles, Belgium ||| SP Europe, 73, rue de Stalle, B-11 80 Bruxelles, Belgium ||| SP Europe, 73, rue de Stalle, B-1180 Bruxelles, Belgique
0.0 ||| Store in the original package in order to protect from light. ||| Store in the original package in order to protect from light. ||| A conserver dans l'emballage extérieur d’ origine, à l’ abri de la lumière.
6.727490743305142e-13 ||| See the advice in 4 What to do in an emergency. ||| See the advice in 4 What to do in an emergency. ||| Voir les recommandations de la section 4 Que faire en cas d’ urgence.
0.32692161202430725 ||| Milk ||| Honey ||| Lait
0.2697303891181946 ||| Since there is no change in pharmacokinetics in patients with impaired renal function and since there are no signs that doxazosin aggravates existing renal impairment, normal dose can generally be used in these patients. ||| However, as previous treatment with alkylating agents is widespread prior to Zevalin treatment, one does not know the exact role of Zevalin when these cancers occur after treatment with Zevalin, since radiation may potentially also cause these cancers. ||| Aucune altération des caractéristiques pharmacocinétiques n’ est notée chez les patients atteints d’ insuffisance rénale et rien n’ indique que la doxazosine puisse aggraver une insuffisance rénale existante.
0.16246455907821655 ||| What Mycamine looks like and contents of the pack ||| What Mab Thera looks like and contents of the pack ||| Qu’ est -ce que Mycamine et contenu de l’ emballage extérieur
0.1282579004764557 ||| Menitorix is a vaccine that can be given to children after the age of 2 months up to 2 years to prevent infectious diseases caused by Haemophilus influenzae type b (Hib) and Neisseria meningitidis group C (MenC) bacteria. ||| Active immunization of infants from the age of 2 months and toddlers up to the age of 2 years for the prevention of invasive diseases caused by Haemophilus influenzae type b (Hib) and Neisseria meningitidis group C (MenC). ||| MENITORIX est un vaccin destiné aux enfants à partir de l’ âge de 2 mois et jusqu’ à 2 ans pour prévenir les maladies dues aux bactéries appelées Haemophilus influenzae type b (Hib) et Neisseria meningitidis du groupe C (MenC).
0.24353717267513275 ||| Filgrastim HEXAL is available in strengths of 30 MU/ 0.5 ml and 48 MU/ 0.5 ml. ||| Zarzio is available in strengths of 30 MU/ 0.5 ml and 48 MU/ 0.5 ml. ||| 2 Filgrastim HEXAL est disponible aux doses de 30 MU/ 0,5 ml et 48 MU/ 0,5 ml.
0.15927654504776 ||| Hepatic impairment Etravirine is primarily metabolised and eliminated by the liver. ||| Impaired hepatic function: atazanavir is metabolised and eliminated primarily by the liver. ||| Insuffisance hépatique L’étravirine est principalement métabolisée et éliminée par le foie.
0.3398863673210144 ||| Thus, contraindicating the use of nifedipine in women of childbearing potential, which amounts to contraindicating it from the beginning of the first trimester of pregnancy, should result in a loss of chance in this target population since nifedipine cannot be considered as a teratogenic product. ||| Due to the potential risk of adverse effects on the cartilage in patients under the age of 18 years, and the fact that PID mostly affects young women, the existing wording of the contraindication in children and adolescents was further specified namely that it is contraindicated in patients below 18 years of age. ||| Dès lors, contre-indiquer nifedipine chez les femmes en âge de procréer, ce qui équivaut à le contre- indiquer dès le début du premier trimestre de la grossesse, reviendrait à réduire les possibilités chez cette population cible car nifedipine est un produit qui ne peut pas être considéré comme tératogène.
0.1035165935754776 ||| 39 Pharmacokinetics in paediatric patients ||| Pharmacokinetics in paediatric patients ||| Pharmacocinétique chez les enfants
0.4692913591861725 ||| Instruments for measuring milk quality parameters ||| Test rigs for manometer adjustments ||| Instruments de mesure des paramètres de qualité du lait
0.0 ||| Fill the syringe by drawing the plunger out slowly and smoothly. ||| Fill the syringe by drawing the plunger out slowly and smoothly. ||| Remplir la seringue en tirant doucement et lentement le piston.
0.08649320155382156 ||| Chemical and physical in-use stability has been demonstrated for 4 hours when stored at 2 to 8°C. ||| Chemical and physical in-use stability has been demonstrated for 3 hours at temperatures up to 25oC. ||| La stabilité physico-chimique a été démontrée pendant 4 heures quand le produit est conservé entre 2 et 8°C.
0.0 ||| ra 4. ||| ra 4. ||| pl 4.
0.35091906785964966 ||| If concomitant use of the above mentioned agents is deemed appropriate, regular monitoring of serum potassium is recommended (see section 4.5). ||| Note that the historical comparisons to ritonavir-enhanced protease inhibitor regimens should be interpreted with caution (see details of combinations below). ||| Si l’ administration simultanée des agents susmentionnés est jugée appropriée, une surveillance régulière du potassium sérique est recommandée (voir rubrique 4.5).
0.07281309366226196 ||| Do not use Insulin Human Winthrop Comb 50 after the expiry date which is stated on the carton and on the label of the cartridge. ||| Do not use Insulin Human Winthrop Infusat after the expiry date which is stated on the carton and on the label of the vial. ||| Ne pas utiliser Insulin Human Winthrop Comb 50 après la date de péremption mentionnée sur la boîte et sur l’étiquette de la cartouche.
0.0 ||| PURSUANT TO ARTICLE 30 OF COUNCIL DIRECTIVE 2001/ 83/ EC FOR ||| PURSUANT TO ARTICLE 30 OF COUNCIL DIRECTIVE 2001/ 83/ EC FOR ||| CONFORMÉMENT À L’ ARTICLE 30 DE LA DIRECTIVE 2001/ 83/ CE DU CONSEIL
9.693046061978738e-13 ||| • OTHER CONDITIONS ||| • OTHER CONDITIONS ||| 25 • AUTRES CONDITIONS
0.0 ||| Infections in horses caused by micro-organisms sensitive to trimethoprim + sulphonamide ||| Infections in horses caused by micro-organisms sensitive to trimethoprim + sulphonamide ||| Maladies infectieuses équines causées par des micro- organismes sensibles au triméthoprime + sulphonamide.
0.07923534512519836 ||| 111 9. ||| 110 9. ||| 122 9.
0.43403327465057373 ||| Some rats in the mid dose group experienced similar reactions but only after administration of anaesthesia. ||| Patients taking either of two doses of Zerit also had similar survival rates over 22 weeks. ||| Certains animaux du groupe à dose intermédiaire ont présenté des réactions comparables, mais seulement après l’ administration de l’ anesthésie.
0.07720087468624115 ||| From the fourth week on, the recommended dose is 40 drops once a day (1x20 mg). ||| From the fourth week on, the usual dose is 2 tablets once a day (1x 20 mg). ||| À partir de la quatrième semaine, la dose recommandée est de 40 gouttes une fois par jour (1 x 20 mg).
0.2699279487133026 ||| Seretide 25/ 50 micrograms strength is not appropriate in adults and children with severe asthma; it is recommended to establish the appropriate dosage of inhaled corticosteroid before any fixed combination can be used in patients with severe asthma. ||| NovoMix 30 can also be used with other antidiabetic medicines that can be taken by mouth in combination with insulin, but it should only be used with pioglitazone once the patient ’ s risk of fluid-related side effects has been evaluated. ||| Le dosage 50/ 25 microgrammes de Seretide ne convient pas aux adultes et aux enfants atteints d’ asthme sévère; la dose appropriée de corticoïdes inhalés devra être ajustée individuellement avant d’ instaurer un traitement par une association fixe chez des patients atteints d’ asthme sévère.
0.05407126992940903 ||| 103 These may be signs of a very serious condition called diabetic ketoacidosis. ||| These may be signs of a very serious condition called diabetic ketoacidosis. ||| Ces signes peuvent indiquer que vous souffrez d 'état très grave appelé acidocétose diabétique.
0.797584593296051 ||| Freezing destroys the vaccine. ||| Administration of Osigraft requires surgery. ||| La congélation détruit le vaccin.
0.37854382395744324 ||| A study on embryo/ foetal toxicity in monkeys showed no evidence of reproductive disturbances. ||| Higher doses resulted in maternal and foetal toxicity without evidence of teratogenicity. ||| Une étude de toxicité foeto-embryonnaire réalisée chez le singe n’ a pas mis en évidence d’ anomalie de la fonction de reproduction.
0.25985556840896606 ||| Adults and adolescents over 12 years of age: ||| In adults and adolescents (12 years of age and over): ||| Adultes et adolescents de plus de 12 ans:
0.4005853235721588 ||| This makes it all the more important for you to keep your appointments with the doctor even if you are feeling well. ||| Checking your blood sugar levels regularly is especially important if you are taking any of these medicines, even if you are feeling well ||| C’est pourquoi il est d’autant plus important que vous respectiez les rendez-vous avec le médecin, même si vous vous sentez bien.
0.24697086215019226 ||| Solution for injection, 1 vial of 10 ml. ||| 1 vial with 5.0 ml water for injections. ||| Solution injectable, 1 flacon de 10 ml.
0.3722435235977173 ||| Cranage services ||| Drainage machines ||| Services de grutage
0.27857470512390137 ||| Pregnancy and breast-feeding Ziagen is not recommended for use during pregnancy. ||| Pregnancy and breast-feeding EXJADE is not recommended during pregnancy unless clearly necessary. ||| Grossesse et allaitement L'utilisation de Ziagen n’est pas recommandée pendant la grossesse.
0.4435010850429535 ||| Film-coated tablet The tablets are capsule-shaped, white and engraved with “ RPR 202 ” on one side. ||| The tablets are off-white, oval and embossed with “ UCY 500”. ||| Les comprimés sont oblongs, blancs et portent la mention « RPR 202 » gravée sur une de leurs faces.
0.43179112672805786 ||| In whole human blood in vitro, the protein binding of manganese is approximately 27% but binding of fodipir to protein is negligible. ||| The principle route of excretion in dogs is via the bile (> 80%) with the remainder via the urine. ||| In vitro, dans le sang humain total, la fixation du manganèse aux protéines est approximativement de 27% tandis que la fixation du fodipir aux protéines est négligeable.
0.2484801858663559 ||| No particular studies are reported on the pharmacokinetics of levodopa and carbidopa in patients with renal impairment. ||| Pharmacokinetics and pharmacodynamics of prasugrel in patients with severe hepatic impairment have not been studied. ||| Aucune étude particulière de la pharmacocinétique de la lévodopa et de la carbidopa n'a été réalisée chez des patients atteints d'insuffisance rénale.
0.14285510778427124 ||| Adults and adolescents (12 years of age and older): take one 5 mg Azomyr orodispersible tablet once a day. ||| Children 6 to 11 years of age: take one 2.5 mg Azomyr orodispersible tablet once a day. ||| Adultes et adolescents (12 ans et plus): prendre une dose d’ Azomyr 5 mg comprimés orodispersibles une fois par jour.
0.441325306892395 ||| Some key measures to be financed under Next Generation EU - such as the increased support to Member States and Regions most affected - need to start as soon as possible because citizens and companies are relying on the EU's support to get back on their feet. ||| While we are doing everything we can to provide support of our citizens, we also need to assist our partners in our direct neighbourhood and beyond to address the impact it will have on their livelihoods, stability and security, as their problems are our problems. ||| La mise en œuvre de certaines mesures clés à financer au titre de Next Generation EU - telles que le soutien accru aux États membres et aux régions les plus touchés - doit commencer dès que possible car les citoyens et les entreprises comptent sur l'aide de l'UE pour se relever.
0.4354156255722046 ||| Following the approval by the Commission of a Czech scheme to support investment in the production of coronavirus relevant products on 15 April 2020 , Czechia notified to the Commission under the Temporary Framework an aid scheme to support coronavirus related R D activities. ||| One Article 11 referral for the resolution of divergent national decisions initiated in 1996 by the marketing authorisation holder for an interferon a- containing product resulted in a Commission Decision amending the existing national marketing authorisations. ||| Après l'autorisation, le 15 avril 2020 , d'un régime tchèque visant à soutenir les investissements dans la fabrication de produits utiles pour combattre le coronavirus, la Tchéquie a notifié à la Commission, au titre de l' encadrement temporaire , un régime d'aides visant à soutenir les activités de R D liées à la flambée de coronavirus.
0.06656491756439209 ||| 228 10. ||| 217 10. ||| 233 10.
0.2789928913116455 ||| ed The pharmacokinetics of darbepoetin alfa has been studied clinically in chronic renal failure patients following intravenous and subcutaneous administration. ||| In clinical pharmacology studies, intravenous insulin glargine and human insulin have been shown to be equipotent when given at the same doses. ||| Les propriétés pharmacocinétiques de la darbepoetin alfa ont fait l'objet d'études cliniques chez des patients insuffisants rénaux chroniques après administration intraveineuse et sous-cutanée.
0.201856791973114 ||| TOVIAZ 4 mg prolonged-release tablets are light blue, oval, curved outwards on both sides, film- coated tablets, and engraved on one side with the letters ‘FS’. ||| Prolonged-release tablets The 8 mg tablets are blue, oval, biconvex, film-coated, and engraved on one side with the letters ‘ FT’. ||| Les comprimés à libération prolongée de TOVIAZ 4 mg sont bleu clair, ovales, bombés des deux côtés, pelliculés et portent les lettres « FS » gravées sur une face.
0.2631798982620239 ||| On the basis of the grounds for referral, the point considered by the CHMP was whether it is appropriate to introduce initial maintenance therapy with the fixed dose combination of salmeterol and fluticasone propionate in all patients with chronic persistent asthma. ||| The Applicant further considered the current bridging strategy to be appropriate for the approval of Rapinyl over the 100-800µg dose range for the treatment of BTP in patients as Rapinyl delivers fentanyl within a plasma concentration range already established as safe and effective. ||| Sur la base des motifs de la saisine, le point que le CHMP devait examiner consistait à déterminer s’ il est approprié d’ inclure le traitement d’ entretien initial par l’ association à doses fixes de salmétérol et de propionate de fluticasone chez tous les patients atteints d’ asthme chronique persistant.
0.1623891294002533 ||| What Silgard looks like and contents of the pack ||| What Rapilysin looks like and content of the pack ||| 6 1 Qu'est ce que Silgard et contenu de l’emballage extérieur
0.3238084316253662 ||| Women receiving Foscan must not breast feed for at least one month following injection. ||| Everyone who takes Foscan will become sensitive to light for about 15 days after injection. ||| Les femmes recevant Foscan ne doivent pas allaiter pendant au moins un mois après l’ injection.
0.4267531633377075 ||| Usually these financial instruments have to be linked to investments, under this new measure, they can help farmers with their cash flow to finance costs or compensate temporary losses. ||| This would enable them to coordinate the response at European level without delay, and direct the necessary resources to where they are most needed, be they material like face masks, respirators and medicines or financial aid. ||| Dans le cadre de cette nouvelle mesure, ils peuvent aider les agriculteurs dans leurs flux de trésorerie pour financer des coûts ou compenser des pertes temporaires.
0.27551865577697754 ||| Clear glass syringe (type I glass) with stainless steel needle, rubber needle cover and plastic plunger. ||| Clear glass vial (4 ml, type I glass) with rubber stoppers, aluminium seals, and flip-off plastic caps. ||| Seringue en verre transparent (verre de type I) avec une aiguille en acier inoxydable, un protège aiguille en caoutchouc et un piston en plastique.
0.3476497232913971 ||| au DK-2880 Bagsvaerd Denmark ||| au Novo Allé DK-2880 Bagsværd Denmark ||| au DK-2880 Bagsværd Danemark
0.0 ||| In clinical studies with 73 previously treated patients (PTP, defined as having more than 100 exposure days), followed over four years, no de-novo inhibitors were observed. ||| In clinical studies with 73 previously treated patients (PTP, defined as having more than 100 exposure days), followed over four years, no de-novo inhibitors were observed. ||| 7 Dans les études cliniques portant sur 73 patients préalablement traités (PTP, définis comme ayant plus de 100 jours d’ exposition) et suivis pendant 4 ans, aucun inhibiteur de novo n’ a été observé.
0.0 ||| • Advise your doctor if you have a history of recurrent infections or other conditions that increase the risk of infections. ||| • Advise your doctor if you have a history of recurrent infections or other conditions that increase the risk of infections. ||| 163 • Avertissez votre médecin si vous avez des antécédents d’infections récurrentes ou d’autres problèmes de santé qui pourraient accroître le risque d’infection.
0.46660667657852173 ||| Turnip cutters [knives] ||| Meat choppers [cleavers] ||| Coupe-racines [couteaux]
0.4435393810272217 ||| - if you have recently had a heart attack or have severe circulatory problems, such as ‘shock’ or ||| - if you have a severe infection or are seriously dehydrated (have lost a lot of water from your ||| - si vous avez eu récemment une crise cardiaque ou si vous avez des problèmes circulatoires
0.3442598283290863 ||| Analysis of plasma and urine samples from subjects who received indinavir indicated that indinavir metabolites had little proteinase inhibitory activity. ||| The in vitro data and in vivo interaction data on oral contraceptives, digoxin and warfarin indicate that no significant enzyme 58 induction is expected in vivo. ||| L’ analyse des échantillons de plasma et d'urines de sujets qui ont reçu de l’ indinavir a montré que les métabolites de l’ indinavir ont peu d’ activité d’ inhibition de la protéase.
0.8091235756874084 ||| body weight (in kg) ||| Body weight above 100 kg ||| Poids corporel (en kg)
0.4287862181663513 ||| The list of product names concerned is given in the Annex I. ||| The conditions of the Marketing Authorisation are listed in Annex IV. ||| La liste des dénominations concernées figure à l’ annexe I.
0.30223798751831055 ||| Rare cases of pancytopenia and very rare cases of aplastic anaemia, some with fatal outcome, have been reported in patients treated with Enbrel. ||| There have been postmarketing reports of pancytopenia and aplastic anaemia, some of which had fatal outcomes (see section 4.4). ||| 33 De rares cas de pancytopénies et de très rares cas d’ aplasies médullaires, dont certains d’ évolution fatale, ont été rapportés chez des patients traités par Enbrel.
0.5803763270378113 ||| Some agricultural and food markets have been hit hard by the crisis. ||| The crisis has hit this airline, as many other companies in the aviation sector, particularly hard. ||| Certains marchés agricoles et alimentaires ont été durement touchés par la crise.
0.44839155673980713 ||| The increase in the number of authorised veterinary medicines will result in a considerable increase in pharmacovigilance activities, which now falls within the responsibility of this Sector. ||| A number of activities are common to the operational sectors in charge of centralised applications or are shared with the Sector for Regulatory affairs and pharmacovigilance. ||| L’augmentation du nombre de médicaments à usage vétérinaire autorisés se traduira par une hausse sensible des activités de pharmacovigilance, qui comptent désormais parmi les attributions de ce secteur.
0.4582589268684387 ||| Recombinant Factor IX Summary of Pharmacokinetic Parameters for Activity Data by Month in Previously Treated Patients ||| Mean Plasma Concentration Versus Time Profiles Following Singles Doses of EFFENTORA and OTFC in Healthy Subjects ||| Facteur IX recombinant: résumé des paramètres pharmacocinétiques d’ activité chez les patients précédemment traits
0.3416622281074524 ||| Just before you start to inhale, break open the glass container containing 1 ml solution, which shows three coloured rings (pink-red-red), and transfer the complete contents into the nebuliser medication chamber. ||| In a box of Avonex there are four or twelve ready to use (pre-filled) syringes, each with 0.5 ml of a clear, colourless liquid inside. ||| Juste avant de commencer les inhalations, brisez l’ ampoule en verre de 1 ml de solution identifiée par un code couleur composé de trois anneaux (rose-rouge-rouge), puis transférez la totalité de son contenu dans la cuve du nébuliseur.
0.4220861792564392 ||| Bondenza is not recommended for patients who have severe kidney problems. ||| Some patients taking Norvir can develop serious problems with their pancreas. ||| Bondenza n'est pas recommandé chez les patientes présentant des troubles rénaux sévères.
0.28921306133270264 ||| The solution should be clear and colourless or pale yellow and practically free from visible particles. ||| The solution should be clear and colourless to pale yellow with no lumps, flakes or particles. ||| La solution doit être limpide et incolore ou jaune pâle et pratiquement exempte de particules visibles.
0.21471351385116577 ||| - difficulty sleeping, abnormal dreams, nightmares, sweating at night, difficulty concentrating, ||| - abnormal dreams, difficulty concentrating, dizziness, headache, difficulty sleeping, drowsiness ||| - Difficulté à dormir, rêves anormaux, cauchemars, sueurs nocturnes, difficulté de concentration,
0.47764405608177185 ||| Bathing suits ||| Drinking horns ||| Maillots de bain
0.7542310953140259 ||| Epoxy grout ||| Chloroform ||| Mortier époxy
0.35612183809280396 ||| 6 D - 63128 Dietzenbach Tel: +49 6074 812160 ||| 2 BG-София 1407 Tел.: +359 2 806 3030 ||| 6 D - 63128 Dietzenbach Tel: +49 (0)6074 812160
0.13494540750980377 ||| What benefit has Azomyr shown during the studies? ||| What benefit has Kinzalmono shown during the studies? ||| Quel est le bénéfice démontré par Azomyr au cours des études?
0.6892824172973633 ||| Hypertension ||| Hypoxia ||| Constipation
0.43188947439193726 ||| As these concerns were not resolved during the course of the variation procedure, a notification of an official referral for Arbitration, under Article 6(12) of Commission Regulation EC No 1084/ 2003, to the CHMP was made by Belgium on 19 October 2007. ||| The Committee did not support the objection of The Netherlands to the summary of product characteristics agreed by the reference and other concerned Member States (OJ C 49, 22.2.2002, p. ||| Ces inquiétudes n’ ayant pas été résolues au cours de la procédure de modification, une saisine officielle d’ arbitrage conformément à l’ article 6, paragraphe 12, du règlement (CE) n° 1084/ 2003 de la Commission a été notifiée par la Belgique au CHMP, le 19 octobre 2007.
0.41090404987335205 ||| Nimesulide 3% gel / cream has not been studied in children. ||| Ibaflin 7.5% Oral Gel should not be used in cats. ||| Le nimésulide 3% gel/ crème n’ a pas été étudié chez l’ enfant.
0.7230163812637329 ||| 32 Worsening of hepatitis C ||| Transmission of hepatitis B ||| Aggravation d’ hépatite C
0.16231942176818848 ||| Varicella-zoster virus1, Oka/ Merck strain, (live, attenuated) not less than 19400 PFU (plaque-forming units). ||| Varicella-zoster virus, Oka/ Merck strain, (live, attenuated) ≥ 19400 PFU* *PFU = Plaque-forming units ||| 1 Virus varicelle-zona, souche Oka/ Merck, (vivant, atténué) pas moins de 19400 UFP (unités formant plages).
0.0 ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| PRECAUTIONS PARTICULIÈRES D’ ÉLIMINATION DES MEDICAMENTS NON UTILISES OU DES DECHETS PROVENANT DE CES MEDICAMENTS S’ IL Y A LIEU
0.5840433239936829 ||| body weight (in kg) ||| Weight (kg) 30 ||| Poids corporel (en kg)
0.3063993453979492 ||| The event rate of biopsy confirmed acute rejection within the first 24 weeks after transplantation was 32.6% in the Advagraf group (N=237) and 29.3% in the Prograf group (N=234). ||| Haematological Decreased absolute neutrophil counts of grade 3 and 4 severity were reported in 10% and 1.7% of patients on the phase 3 GIST study, respectively and in 16% and 1.6% of patients on the phase 3 MRCC study, respectively. ||| Le taux de rejets aigus biopsie prouvés au cours des 24 premières semaines suivant la transplantation était de 32,6% dans le groupe Advagraf (n = 237) et de 29,3% dans le groupe Prograf (n = 234).
0.06974811106920242 ||| - Numbness, tingling, pain and/ or burning sensation in the arms and/ or legs ||| - Numbness, tingling, pain and/ or burning sensation in the arms and/ or legs or around the mouth ||| - Engourdissement, fourmillements, douleur et/ ou sensation de brûlure dans les bras et/ ou les
0.25139713287353516 ||| EU/ 1/ 06/ 358/ 009– pack of 1 EU/ 1/ 06/ 358/ 010 – pack of 10 EU/ 1/ 06/ 358/ 011 – pack of 20 ||| EU/ 1/ 02/ 234/ 005… 1 x 3 ml EU/ 1/ 02/ 234/ 006 5 x 3 ml EU/ 1/ 02/ 234/ 007 10 x 3 ml ||| EU/ 1/ 06/ 358/ 009 – boîte de 1 EU/ 1/ 06/ 358/ 010 – boîte de 10 EU/ 1/ 06/ 358/ 011 – boîte de 20
0.7166537046432495 ||| Active substance: ||| - active substance ||| Principe actif:
0.3461858630180359 ||| No clinically relevant difference in ulcer prevention between the 15 and 30 mg dose of lansoprazole could be demonstrated. ||| A single dose of lansoprazole has an inhibitory effect on gastric acid secretion lasting more than 24 hours. ||| Aucune différence à pertinence clinique dans la prévention de l'ulcère entre la dose de 15 et de 30 mg de lansoprazole n'a pu être démontrée.
0.4077034592628479 ||| Nervous system disorders Common: headache ||| Parathyroid disorder System disorders: ||| Affections du système nerveux Fréquent: céphalées.
0.7572479248046875 ||| The cap is imprinted with “ Temodal”. ||| It is called ‘ EVRA’ in this leaflet. ||| La coiffe est marquée avec « Temodal ».
0.26025280356407166 ||| If you are going to have an operation, please tell your doctor if you have been given NeuroBloc as it can interfere with medicines you may be given before a general anaesthetic. ||| Remember to tell your doctor that you are receiving Silapo if you have to visit the hospital or family doctor for any treatmentincluding a blood test, as Silapo may affect the results. ||| 25 avez pris NeuroBloc, ce produit pouvant modifier l'effet de médicaments que vous êtes susceptible de recevoir avant une anesthésie générale.
0.30211126804351807 ||| In case of shock, standard medical treatment for shock should be implemented. ||| In case of severe allergic reactions, alternative therapy should be considered. ||| En cas de choc, les traitements médicaux habituels seront appliqués.
0.06978096067905426 ||| The Commission assessed the measure under Article 107(2)(b) of the Treaty on the Functioning of the European Union (TFEU), which enables the Commission to approve State aid measures granted by Member States to compensate specific companies or specific sectors (in the form of schemes) for the damages directly caused by exceptional occurrences. ||| The Commission assessed the measure under Article 107(2)(b) of the Treaty on the Functioning of the European Union (TFEU), which enables the Commission to approve State aid measures granted by Member States to compensate specific companies or sectors for damage directly caused by exceptional occurrences. ||| La Commission a examiné la mesure au regard de l' article 107, paragraphe 2, point b) , du traité sur le fonctionnement de l'Union européenne (TFUE), qui permet à la Commission d'approuver les aides d'État accordées par les États membres afin d'indemniser certaines sociétés ou certains secteurs (sous la forme de régimes d'aides) pour des dommages causés directement par des événements extraordinaires.
0.34500521421432495 ||| RotaTeq may be given to infants who were born prematurely provided that the period of gestation was at least 25 weeks. ||| Sows and gilts which have not been vaccinated with the product should be given two injections with an interval of six weeks. ||| RotaTeq peut être administré à des nourrissons nés prématurés, à condition que la durée de la grossesse soit de 25 semaines au moins.
0.3056434988975525 ||| The European Globalisation Adjustment Fund, that supports the reintegration in the labour market of workers who lose their jobs as a result of major restructuring events; ||| The EU Emergency Trust Fund for Africa was established in 2015 to address the root causes of instability, forced displacement and irregular migration and to contribute to better migration management. ||| le Fonds européen d'ajustement à la mondialisation, qui soutient la réinsertion sur le marché du travail des travailleurs ayant perdu leur emploi à la suite de restructurations majeures;
0.4097789525985718 ||| Monitoring plasma homocysteine levels has demonstrated that the onset of action of betaine occurred within several days and that a steady-state response was achieved within one month. ||| The decline from peak plasma concentration of AsIII occurs in a biphasic manner and is characterized by an initial rapid distribution phase followed by a slower terminal elimination phase. ||| La surveillance de la concentration plasmatique de l’ homocystéine a démontré que la bétaïne commençait à agir au bout de plusieurs jours et que l’ état d’ équilibre de la réponse était obtenu en un mois.
0.6726014614105225 ||| Malignancies ||| Emollients ||| Tumeurs malignes
0.5710484981536865 ||| Electronic musical apparatus and instruments ||| Sound effects machines being musical instruments ||| Équipements et instruments de musique électroniques
0.4342881441116333 ||| FP ||| lon ||| FP4
0.327428936958313 ||| Having assessed the data available, the CHMP agreed that valsartan 80 mg can be used as a starting dose in patients with reduced kidney function. ||| 1 The CHMP also expressed concerns about the degree of use of Protopy in children under the age of 2 (not approved) when the immune system is still developing. ||| 2 données disponibles, le CHMP a accepté que le valsartan 80 mg puisse être utilisé comme dose de départ chez les patients dont la fonction rénale est réduite.
3.0158132393286186e-13 ||| The clinical data available suggest that those patients whose initial haemoglobin is very low ( 8 g/dl or> 5 mmol/l). ||| The clinical data available suggest that those patients whose initial haemoglobin is very low ( 8 g/dl or> 5 mmol/l). ||| 108 Les données cliniques disponibles semblent indiquer que les patients dont le taux d'hémoglobine initial est très faible ( 8 g/ dl ou > 5 mmol/ l).
0.40205591917037964 ||| It will provide a letter and educational kits for healthcare workers and brochures for 2/ 3 patients, detailing the steps that need to be taken for the medicine to be used safely. ||| The ones that will be working on diagnostic tools intend to develop devices that can be used anywhere, such as in the doctor's surgery or in a patient's own home, and can deliver fast results in 14-40 minutes. ||| Elle mettra à disposition une lettre et des kits éducatifs à l’ intention des professionnels de santé, ainsi que des brochures destinées aux patients, expliquant en détails les mesures qu’ il est nécessaire de prendre pour assurer la sécurité d’ emploi du médicament.
0.4293636083602905 ||| In elderly patients, sleep latency was often significantly decreased with Sonata 5 mg and was consistently decreased with Sonata 10 mg compared with placebo in 2-week studies. ||| 60-120) minutes), whereas Cmax was similar to that observed in younger subjects with type 2 diabetes and slightly lower than in subjects with type 1 diabetes. ||| Chez les patients âgés, le temps d'endormissement a été souvent diminué de manière significative avec Sonata à 5 mg et à été constamment diminué avec Sonata à 10 mg dans des études sur 2 semaines versus
0.3328602910041809 ||| The consequence of treatment with Busilvex at the recommended dose and schedule is profound myelosuppression, occurring in all patients. ||| Ingelvac CircoFLEX can cause a mild, temporary increase in body temperature, usually on the day of vaccination. ||| Une myélosuppression profonde rapportée chez tous les patients traités par Busilvex à la posologie recommandée est une conséquence du traitement.
0.09021124243736267 ||| What benefit has Xiliarx shown during the studies? ||| What benefit has Lysodren shown during the studies? ||| Quel est le bénéfice démontré par Xiliarx au cours des études?
0.4935554265975952 ||| Therefore, an additional check of the AT activity level should be done after the surgery. ||| - A measure of relative reporting rate of signals for each reported PT should be provided if ||| Par conséquent, une vérification supplémentaire de l’ activité en AT doit être effectuée après l’ intervention.
0.30785322189331055 ||| For the treatment of adult patients with acute coronary syndromes (unstable angina/ non-ST segment elevation myocardial infarction (UA/ NSTEMI)) planned for urgent or early intervention. ||| Intrinsa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy. ||| Traitement des patients atteints d’ un syndrome coronarien aigu (angor instable/ infarctus du myocarde sans sus décalage du segment ST (AI/ IDM ST-)) devant bénéficier d’ une intervention urgente ou précoce.
0.4114037752151489 ||| Adults and children above the age of 12 ||| Children between the ages of 5 and 12 ||| Adultes et enfants âgés de plus de 12 ans
0.23156189918518066 ||| Some systemic adverse reactions, including headache (3.7%), influenza-like symptoms (1.1%), and myalgia (1.5%) were also reported. ||| Some systemic adverse reactions, including back pain (1.1%) and influenza-like symptoms (0.5%) were reported by imiquimod cream patients. ||| Quelques réactions indésirables systémiques, à type de céphalées (3,7%), de syndrome pseudo-grippal (1,1%) et de myalgies (1,5%), ont également été rapportées.
0.30338096618652344 ||| Risk Management Plan ||| Risk Management System ||| Plan de gestion de risque
0.3046987056732178 ||| Patients should be instructed to seek medical advice if signs/ symptoms (e. g., persistent cough, wasting/ weight loss, low grade fever) suggestive of a tuberculosis infection occur during or after therapy with Humira. ||| The following symptoms may be observed in neonates if the mother has used an SSRI/ SNRI late in pregnancy: irritability, tremor, hypotonia, persistent crying, and difficulty in sucking or in sleeping. ||| Les patients devront être informés qu’ il leur faudra consulter leur médecin en cas de survenue de signes ou symptômes (par exemple toux persistante, cachexie/ amaigrissement, fébricule) évocateurs d'une infection tuberculeuse, pendant ou après le traitement par Humira.
0.0 ||| After injection, the site of injection should not be massaged. ||| After injection, the site of injection should not be massaged. ||| Après l’ injection, il ne faut pas masser le site d’ injection.
0.19769644737243652 ||| 8 (10) Very common: ||| 6 (7) Very common: ||| 8 (10) Très fréquent:
2.258160428396036e-13 ||| The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| 53 L'étude "Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2)" montre qu'irbésartan 300 mg retarde la progression vers une protéinurie avérée chez des patients ayant une microalbuminurie.
0.6144495606422424 ||| Engraving plates ||| Unloading cargo ||| Planches à graver
0.0011037490330636501 ||| To avoid injection of air and ensure proper dosing: • Hold Mixtard 50 NovoLet with the needle pointing upwards • Tap the cartridge gently with your finger a few times. ||| To avoid injection of air and ensure proper dosing: • Hold Mixtard 30 NovoLet with the needle pointing upwards • Tap the cartridge gently with your finger a few times. ||| Pour éviter toute injection d’ air et garantir un dosage correct: • maintenez Mixtard 50 NovoLet avec l’ aiguille pointée vers le haut • tapotez doucement la cartouche avec votre doigt plusieurs fois.
0.04048820585012436 ||| AVANDAMET combines two antihyperglycaemic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: rosiglitazone maleate, a member of the thiazolidinedione class and metformin hydrochloride, a member of the biguanide class. ||| AVAGLIM combines two antidiabetic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: rosiglitazone maleate, a member of the thiazolidinedione class and glimepiride, a member of the sulphonylurea class. ||| 66 AVANDAMET associe 2 agents hypoglycémiants aux mécanismes d'action complémentaires qui améliorent le contrôle glycémique chez les patients diabétiques de type 2: le maléate de rosiglitazone, de la classe des thiazolidinediones et le chlorhydrate de metformine, de la classe des biguanides.
0.08243802189826965 ||| 64 B. ||| 59 B. ||| 62 B.
0.28064629435539246 ||| No interaction studies have been conducted with Kepivance. ||| There have been no formal interaction studies for Icandra. ||| Aucune étude d’ interaction n’ a été réalisée avec Kepivance.
0.23223158717155457 ||| The documentation on efficacy and safety in patients less than 18 years old is limited; therefore, the use of is not recommended in these patients. ||| Safety and effectiveness in children and adolescents has not been established, therefore use in patients under 18 years of age is not recommended. ||| Enfants: les données d’ efficacité et de sécurité d’ emploi chez les patients âgés de moins de 18 ans étant limitées, l'utilisation de chez ces patients n'est pas recommandée.
0.3738917112350464 ||| Then continue with your regular schedule of patch-change days, even if this means discarding a patch after you have worn it for less than 3-4 days. ||| No matter what day this happens, continue with the same twice-a-week schedule for your next patch, even if it means changing the new patch before 3 to 4 days have elapsed. ||| Continuez ensuite à remplacer votre dispositif transdermique aux jours habituels, même si cela implique de retirer un dispositif transdermique après l’avoir porté pendant moins de 3 ou 4 jours.
0.4243936240673065 ||| Mechanical egg timers ||| Handheld personal computers ||| Minuteurs mécaniques
0.24978160858154297 ||| XERISTAR should not be used in combination with fluvoxamine, ciprofloxacin or enoxacine (i. e. potent CYP1A2 inhibitors) since the combination results in elevated plasma concentrations of duloxetine (see section 4.5). ||| Co-administration of posaconazole with CYP3A4 substrates may result in large increases in exposure to CYP3A4 substrates as exemplified by the effects on tacrolimus, sirolimus, atazanavir and midazolam below. ||| Association à la fluvoxamine, à la ciprofloxacine ou à l’ énoxacine (inhibiteurs puissants du CYP1A2), associations entraînant une augmentation des concentrations plasmatiques de duloxétine (voir rubrique 4.5).
0.4760964512825012 ||| Somatropin may induce insulin resistance. ||| Sorbitol can have a mild laxative effect. ||| La somatropine peut induire une résistance à l’ insuline.
1.3532639741897583 ||| Not applicable. ct du ro ed M ||| e d is EU number ||| Sans objet. tn en am ic éd m e C
2.746135025107066e-13 ||| If the rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in four weeks reduce the dose by approximately 25%, depending on the rate of increase. ||| If the rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in four weeks reduce the dose by approximately 25%, depending on the rate of increase. ||| Si le taux d’ hémoglobine augmente de plus de 2 g/ dl (1,25 mmol/ l) sur une période de 4 semaines, réduire la dose d’ environ 25% en fonction de l’ importance de cette augmentation.
0.040607839822769165 ||| Overdose in chicken will result in a strongly diminished water- and feed intake and retarded growth. ||| Chronic overdose in chicken will result in a strongly diminished water- and feed intake and retarded growth. ||| Chez les poulets, le surdosage provoquera une forte diminution de l'absorption d'eau et d'aliments, et un retard de croissance.
0.7056635618209839 ||| Manual rectifiers ||| authorisation Holder ||| Redresseurs manuels
0.22056421637535095 ||| Administration of doxazosin to patients with prostatic hyperplasia results in a significant improvement in urodynamics and symptoms as a result of a selective blockade of alpha-adrenoceptors located in the prostatic muscular stroma, capsule and bladder neck. ||| There is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system. ||| L’ administration de doxazosine chez les patients atteints d’ hyperplasie de la prostate permet d’ obtenir une amélioration significative des valeurs urodynamiques et des symptômes par suite de l’ inhibition sélective des récepteurs adrénergiques alpha situés dans le stroma musculaire de la prostate, la capsule prostatique et le col vésical.
0.35110390186309814 ||| If you have used more Omnitrope than you should, please ask your doctor for advice. ||| If you inject more ADVATE than recommended, tell your doctor as soon as possible. ||| Si vous avez utilisé une dose d’ Omnitrope trop élevée, demandez l’ avis de votre médecin.
1.1440150737762451 ||| Check with your doctor: ||| With your other hand, ||| Prévenez votre médecin:
0.4211310148239136 ||| Materials for use in protecting buildings [paints] ||| Rolled paper for use in computers [sensitized] ||| Produits destinés à la protection de bâtiments [peintures]
0.0922699049115181 ||| Keep the pre-filled pen in the outer carton. ||| Keep the pre-filled syringe in the outer carton. ||| Garder le stylo prérempli dans l’ emballage extérieur
0.3501705229282379 ||| The normal dose is 50 mg per kilogram body weight, divided into two or three doses during the day. ||| For children, it is 70 mg per kilogram body weight up to a maximum dose of 5 g. ||| La dose habituelle est de 50 mg par kilogramme de poids corporel, répartis en deux ou trois doses au cours de la journée.
0.598528265953064 ||| In an analysis adjusting for potential bias from unscheduled assessments the hazard ratio for PFS was 0.49 (95% CI: ||| This compared with a very similar increase of 0.66 points with the comparator contrast agent, from a baseline of 1.60 points. ||| Au cours d’ une analyse d’ ajustement des biais potentiels à partir d’ évaluations non programmées, le risque relatif de la SSP a été de 0,49 (IC 95%:
0.25916001200675964 ||| Patients should be instructed to seek medical advice if signs/ symptoms (e. g., persistent cough, wasting/ weight loss, low grade fever) suggestive of a tuberculosis infection occur during or after therapy with Humira. ||| Dose adjustment may also be required, for example, if the patient's weight or life-style changes, change of timing of insulin dose or other circumstances arise that increase susceptibility to hypo-or hyperglycaemia (see section 4.4). ||| Les patients devront être informés qu’ il leur faudra consulter leur médecin en cas de survenue de signes ou symptômes (par exemple toux persistante, cachexie/ amaigrissement, fébricule) évocateurs d'une infection tuberculeuse, pendant ou après le traitement par Humira.
0.3169570565223694 ||| If symptomatic hypotension should occur, supportive treatment should be instituted. ||| If jaundice is observed, therapy should be discontinued. ||| Si une hypotension symptomatique apparaît, un traitement approprié sera initié.
0.4944899082183838 ||| Adult patients with psoriatic arthritis ||| Experience from rheumatoid arthritis ||| Patients adultes atteints de rhumatisme psoriasique
0.39487823843955994 ||| In the current circumstances, it is particularly relevant to staff working in healthcare systems and public servants as well as to teachers and professors and their students. ||| Thus, mental health care should be provided to COVID-19 patients, suspected individuals, and people in contact with them as well as the general public who are in need. ||| Dans les circonstances actuelles, cela revêt une importance particulière pour les professionnels de la santé et les fonctionnaires, ainsi que pour les enseignants et leurs élèves.
0.27118736505508423 ||| Each film-coated tablet of Karvezide 300 mg/ 12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide. ||| TOVIAZ 4 mg 1 prolonged-release tablet contains 4 mg fesoterodine fumarate, equivalent to 3.1 mg of fesoterodine. ||| Chaque comprimé pelliculé de Karvezide 300 mg/ 12,5 mg contient 300 mg d'irbésartan et 12,5 mg d'hydrochlorothiazide.
0.24568365514278412 ||| If signs or symptoms that may be associated with cardiac arrhythmia occur during treatment with Fareston, treatment should be stopped and an ECG should be performed. ||| If any symptoms occur after accidental exposure to Naxcel, for example a skin rash, then the advice of a doctor should be sought immediately. ||| En cas de survenue de signes ou des symptômes pouvant être associés à une arythmie cardiaque avec Fareston, le traitement doit être arrêté et un ECG de contrôle effectué.
0.16037824749946594 ||| CELSENTRI is not recommended for use in children due to lack of data on safety, efficacy and pharmacokinetics (see section 5.2). ||| PREZISTA is not recommended for use in children and adolescents because there are no data on safety, efficacy and pharmacokinetics. ||| Enfants: l’ utilisation de CELSENTRI n’ est pas recommandée chez l’ enfant en raison de l’ absence de données de tolérance, d’ efficacité et de pharmacocinétique (voir rubrique 5.2).
0.3144802749156952 ||| Ranexa is supplied in cartons containing 30, 60, or 100 tablets in blister strips or 60 tablets in plastic bottles. ||| Ribavirin Teva is available in different pack sizes containing 84, 112, 140 or 168 capsules to be swallowed. ||| Ranexa est disponible en boîtes de plaquettes de 30, 60 ou 100 comprimés ou de flacons en plastique de 60 comprimés.
0.3322284519672394 ||| Nplate should be administered once weekly as a subcutaneous injection. ||| Luveris should be given as a course of daily injections simultaneously with FSH. ||| Nplate doit être administré une fois par semaine en injection sous-cutanée.
0.010097403079271317 ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/. ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu. ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne du médicament (EMEA)web site: http://www.emea.europa.eu/
0.2743973433971405 ||| Combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia (see section 4.4). ||| Investigations: electrolyte imbalance (including hypokalaemia and hyponatraemia, see section 4.4), hyperuricaemia, glycosuria, hyperglycaemia, increases in cholesterol and triglycerides ||| Les traitements par association d’antirétroviraux ont été associés à des anomalies métaboliques telles que des hypertriglycéridémie, hypercholestérolémie, résistance à l'insuline, hyperglycémie et hyperlactatémie (voir rubrique 4.4).
0.004630012903362513 ||| What Liprolog Mix50 100 U/ml KwikPen, suspension for injection contains ||| What Liprolog Mix25 100 U/ml KwikPen, suspension for injection contains ||| Que contient Liprolog Mix50 100 UI/ml KwikPen, suspension injectable
0.2706548571586609 ||| If risk factors for hypoglycaemia are present (including renal insufficiency, low body weight, malnourishment, co-administration with certain other medicinal products (see section 4.5) or if the patient’ s life-style changes) it may be necessary to revert to concomitant therapy and down titrate the glimepiride dose. ||| To avoid a delay in diagnosis and minimise the risk of a life-threatening hypersensitivity reaction, abacavir must be permanently discontinued if hypersensitivity cannot be ruled out, even when other diagnoses are possible (respiratory diseases, flu-like illness, gastroenteritis or reactions to other medicinal products). ||| Si le patient présente des facteurs de risque d’ hypoglycémie (tels une insuffisance rénale, un faible poids corporel, une malnutrition, une co-administration avec certains médicaments (voir rubrique 4.5) ou si le patient change de style de vie) il peut être nécessaire de reprendre un traitement associant rosiglitazone et glimépiride pris séparément et de diminuer la dose de glimépiride.
0.12644563615322113 ||| This summary was last updated in 12-2007. ||| This summary was last updated in 12-2005 ||| Dernière mise à jour du présent résumé:
0.2722836136817932 ||| 3 five-year extension studies, no differences were found in the incidence of malignancies and LPDs between immunosuppressive regimens with or without combination of basiliximab (see section 4.8). ||| 14 high drug exposures, jaundice due to indirect (unconjugated) hyperbilirubinaemia (without associated liver function test changes) or PR interval prolongations may be observed (see sections 4.4 and 4.8). ||| L’ analyse groupée des données d’ extension à 5 ans de deux études n’ a pas montré de différence de fréquence des affections malignes et des syndromes lymphoprolifératifs entre les traitements immunosuppresseurs avec ou sans association au basiliximab (voir rubrique 4.8).
0.267363041639328 ||| Withdraw the needle quickly and apply pressure over the injection site with a dry, sterile pad. ||| Dissolve the powder completely using a gentle swirling motion and inspect the reconstituted product before use. ||| Retirez l'aiguille rapidement et comprimez le point d'injection à l'aide d'une compresse stérile et sèche.
0.33482760190963745 ||| This increases the amount of oxygen carried in the blood in the arteries, helping to reduce the symptoms of anaemia. ||| When it stimulates growth of cells in the long bones of the legs and spine, it causes an increase in height. ||| Il en résulte une augmentation de la quantité d’ oxygène transportée dans le sang à travers les artères, ce qui contribue à réduire les symptômes d’ anémie.
0.6150646209716797 ||| The hospital was being tested 7 days later. ||| The WHO was informed on the same day. ||| L'hôpital a été installé 7 jours plus tard.
0.3481880724430084 ||| - if you have inflammation of the colon (ulcerative colitis) or intestinal tract (Crohn’ s disease) ||| - if you have ever experienced abnormal movements of the tongue or face (Tardive Dyskinesia). ||| - si vous avez une colite ulcéreuse (inflammation du colon) ou maladie de Crohn (inflammation
0.6505809426307678 ||| Darunavir demonstrates antiviral activity in vitro against a broad panel of HIV-1 group M (A, B, C, D, E, F, G) and group O primary isolates with EC50 values ranging from < 0.1 to 4.3 nM. ||| The Child-Pugh classification divides patients into groups A, B, and C, or "Mild", "Moderate" and "Severe" corresponding to scores of 5-6, 7-9 and 10-15, respectively. ||| Le darunavir a démontré une activité antivirale in vitro sur un large éventail d’isolats primaires du VIH-1 du groupe M (A, B, C, D, E, F, G) et du groupe O avec des valeurs de CE50
0.16713735461235046 ||| Spur wheel pulley blocks [parts of machines] ||| Suspension ball joints [parts of machines] ||| Poulies à roues dentées [pièces de machines]
0.23363396525382996 ||| With your other hand, hold the syringe as you would a pencil. ||| With your other hand, pick up the pen and hold it as you would a pencil. ||| Avec l’ autre main, tenez la seringue comme vous le feriez avec un crayon.
1.0285717248916626 ||| Table 11 Induction of Clinical Remission and Response (Percent of Patients) Week 4 ||| 1 Primary and Secondary Outcome of double-blind Trial Primary Outcome ||| Induction d'une rémission clinique et d'une réponse (pourcentage de patients)
0.1906745284795761 ||| Bronchitis, nasopharyngitis, sinusitis, fungal infection, viral infection,. ||| Common: pneumonia, bronchitis, sinusitis, nasopharyngitis, herpes simplex. ||| Bronchite, rhinopharyngite, sinusite, infection fongique, infection virale
0.2078242301940918 ||| There is increasing evidence that malfunctioning of glutamatergic neurotransmission, in particular at NMDA-receptors, contributes to both expression of symptoms and disease progression in neurodegenerative dementia. ||| In pulmonary arterial hypertension and heart failure, in the absence of endothelin receptor antagonism, elevated ET-1 concentrations are strongly correlated with the severity and prognosis of these diseases. ||| Il apparaît de plus en plus clairement que le dysfonctionnement de la neurotransmission glutamatergique, en particulier au niveau des récepteurs NMDA, contribue à la fois à l’ expression des symptômes et à la progression de la maladie dans la démence neurodégénérative.
0.3758672773838043 ||| Additionally, improvements in symptomatology and other organ dysfunction abnormalities were reported by the investigators in the case reports. ||| The CHMP requested clarifications on treatment continuation and more details specific to the individual indications, in particular breast cancer and ovarian cancer. ||| 47 les investigateurs ont rapporté dans ces observations individuelles des améliorations de la symptomatologie et des dysfonctionnements d’ autres organes.
0.5356587767601013 ||| 3.7 -1.20 ||| 97.10 -1.41 ||| 3,7 3,8
0.33443179726600647 ||| After reconstitution, each ml solution for injection contains approximately 100 IU octocog alfa. * The potency (International Units) is determined using the chromogenic assay against an in-house standard that is referenced to the WHO standard. ||| The trigger value of 0.1 µg/ l that is used in some assessment frameworks as a surrogate zero for pollutants in groundwater is not mentioned in the Groundwater Directive (80/ 68/ EEC) and is specific for pesticides and biocides in the replacement Groundwater Directive. ||| Chaque flacon contient nominalement 500 UI * de facteur VIII (rDNA) de coagulation humain, octocog alfa * * Après reconstitution, chaque millilitre de solution pour injection contient approximativement 100 UI d’ octocog alfa. * Le titre (Unité Internationale) est déterminé par dosage chromogénique par rapport à un standard interne référencé au standard de l'OMS.
0.49905312061309814 ||| Headache, paraesthesia ||| Paraesthesia, somnolence ||| Céphalées, paresthésie.
0.04595094174146652 ||| Tractocile should not be used in people who may be hypersensitive (allergic) to atosiban or any of the other ingredients. ||| Prialt should not be used in patients who may be hypersensitive (allergic) to ziconotide or any of the other ingredients. ||| Tractocile ne doit pas être utilisé chez les patientes susceptibles de présenter une hypersensibilité (allergie) à l’ atosiban ou à l’ un des autres composants.
0.41350555419921875 ||| Blister for Velmetia 50 mg/ 850 mg film-coated tablets ||| Tablet coat for 5/ 15/ 20 mg film-coated tablets: ||| Plaquette thermoformée pour Velmetia 50 mg/ 850 mg, comprimés pelliculés
0.8032912015914917 ||| Praziquantel is a pyrazinoisoquinoline derivative effective against tapeworms such as Dipylidium caninum, Taenia spp., Echinococcus multilocularis and Echinococcus granulosus. ||| Cyathostomum spp, Cylicocyclus spp., Cylicodontophorus spp., Cylicostephanus spp., Gyalocephalus spp., Ascarids: ||| Le praziquantel est un dérivé de la pyrazinoisoquinoléine et est efficace contre les vers plats comme Dipylidium caninum, Taenia spp., Echinococcus multilocularis et Echinococcus granulosus.
0.39560824632644653 ||| Chemical preparations for assisting the starting of internal combustion engines ||| Preparations for undersealing the exposed surfaces of motor vehicles ||| Préparations chimiques pour aider au démarrage de moteurs à combustion interne
0.27128028869628906 ||| Thermal imaging apparatus [other than for medical use] ||| Diagnostic ultrasound apparatus, other than for medical use ||| Appareils d'imagerie thermique [autres qu'à usage médical]
0.2871140241622925 ||| HOW TO USE OPGENRA ||| HOW TO USE OPATANOL ||| COMMENT UTILISER OPGENRA
0.12377561628818512 ||| How to use Silgard 4. ||| How to use Humira 4. ||| Comment utiliser Silgard 4.
0.603909969329834 ||| Observers ||| Capsules ||| Membres
0.3055706322193146 ||| Polyethylene bottle containing 10, 32, 100 or 180 ml with a polyethylene dropper, a tamper proof child resistant closure and a polypropylene measuring syringe. ||| Each carton contains one bottle and both a calibrated polypropylene measuring cup and a calibrated polypropylene low-density polyethylene dropper. ||| Flacon de polyéthylène avec bouchon de sécurité enfant, de contenance de 10, 32, 100 ou 180 ml et muni d'un compte-goutte en polyéthylène et d'une seringue-doseuse en polypropylène.
0.2278200089931488 ||| In some patients with compromised renal function (e. g. dehydrated patients or elderly patients with compromised renal function), the co-administration of angiotensin II receptor antagonists and agents that inhibit cyclo-oxygenase may result in further deterioration of renal function, including possible acute renal failure, which is usually reversible. ||| Since the use of factor IX complex concentrates has historically been associated with the development of thromboembolic complications, the risk being higher in low purity preparations, the use of factor IX-containing products may be potentially hazardous in patients with signs of fibrinolysis and in patients with disseminated intravascular coagulation (DIC). ||| Chez certains patients dont la fonction rénale est altérée (par exemple les patients déshydratés ou les patients âgés dont la fonction rénale est altérée), l’ association d’ antagonistes des récepteurs de l’ angiotensine II et d’ agents inhibiteurs de la cyclo-oxygénase peut entraîner une dégradation supplémentaire de la fonction rénale, notamment une insuffisance rénale aiguë, généralement réversible.
0.4788680672645569 ||| In these trials, 603 patients were randomised to treatment with Xeloda (1250 mg/ m2 twice daily for 2 weeks followed by a 1-week rest period and given as 3-week cycles). ||| Ninety-seven patients were enrolled at various doses and schedules; 55 patients received 50 mg at the recommended treatment schedule 4 weeks on / 2 weeks off (“ schedule 4/ 2”). ||| Dans ces essais, 603 patients ont été randomisés pour le traitement par Xeloda (1250 mg/ m2 deux fois par jour pendant 2 semaines, suivi d' 1 semaine sans traitement, le tout étant considéré comme un cycle de 3 semaines).
0.03162514418363571 ||| Because of the nature of the adverse events seen with the combination of etanercept and anakinra therapy, similar toxicities may also result from the combination of anakinra and other TNF-antagonists. ||| tho the nature of the adverse events seen with the combination of etanercept and anakinra therapy, similar toxicities may also result from the combination of anakinra and other TNF-antagonists. ||| En raison de la nature des effets indésirables observés avec le traitement par l'association étanercept et anakinra, des effets néfastes similaires peuvent aussi résulter de l'association d'anakinra et d'autres anti-TNF.
3.4747487005770683e-13 ||| No severe hypoglycaemic events were reported in the vildagliptin arms. ||| No severe hypoglycaemic events were reported in the vildagliptin arms. ||| Aucun événement hypoglycémique sévère n’ a été observé dans les groupes recevant de la vildagliptine.
0.7409008741378784 ||| Uncommon: respiratory distress ||| Uncommon Injection site abscess ||| Peu fréquents: détresse respiratoire
0.020923741161823273 ||| Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Please inform your doctor if you are taking or have recently taken any other medicines, including medicines obtained without prescription. ||| Prise d'autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin.
0.4527357220649719 ||| In 1995 she joined the French Medicines Agency as Head of Unit for pharmaco-toxico-clinical assessment. ||| He jo ined the Pharmaceutical Inspectorate of the Belgian Ministry of Public Health as head of medical assessors in 1997. ||| En 1995, elle a rejoint l'Agence française du médicament comme chef d'unité pour l'évaluation pharmaco-toxico-clinique.
0.006867268588393927 ||| 754 Many factors may influence your blood sugar level. ||| 764 Many factors may influence your blood sugar level. ||| De nombreux facteurs sont susceptibles de modifier votre glycémie.
0.6087687611579895 ||| Administrative processing of purchase orders placed by telephone or computer ||| Mobile automotive oil change services provided at the customer's location ||| Traitement administratif de commandes d’achats passées par téléphone ou par ordinateur
0.33498209714889526 ||| Erythropoetin is a growth factor that primarily stimulates red blood cell production. ||| Angiotensin II causes blood vessels to tighten, which increases the blood pressure. ||| ris L’ érythropoïétine est un facteur de croissance qui stimule essentiellement la production des globules rouges.
0.2807157635688782 ||| Agenerase capsules are contraindicated in patients with severe hepatic impairment when used in combination with ritonavir (see section4.3). ||| Caution should be used when prescribing Posaconazole SP to patients with hypersensitivity to other azoles. ||| Les capsules d'Agenerase sont contre-indiquées lorsqu'elles sont administrées en association au ritonavir chez les patients ayant une insuffisance hépatique sévère (voir rubrique 4.3).
0.2867504358291626 ||| Lactic acidosis: the class of medicines to which Trizivir belongs (NRTIs) can cause a condition called lactic acidosis (excess of lactic acid in your blood), together with an enlarged liver. ||| This is a condition in which the parathyroid glands in the neck produce too much parathyroid hormone (PTH). ‘ Secondary ’ means that the hyperparathyroidism is caused by another condition. ||| La classe de médicaments à laquelle appartient Trizivir (analogues nucléosidiques inhibiteurs de la transcriptase inverse) peut induire un effet indésirable appelé acidose lactique (excès d’ acide lactique dans le sang) avec augmentation de la taille du foie.
0.04089106246829033 ||| Kaletra tablets should be swallowed whole and not chewed, broken or crushed ||| Kaletra tablets should be swallowed whole and not chewed, broken or crushed. ||| Kaletra comprimé doit être avalé en entier sans être ni mâché, ni coupé, ni broyé.
0.0 ||| 260 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 260 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 274 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.05339249595999718 ||| Ísland Hörgatún 2 IS-210 Garðabær Sími: + 354 535 70 00 ||| Ísland Hörgatún 2 IS -210 G arðabær Sími: + 354 535 70 00 ||| 51 Ísland Hörgatún 2 IS-210 Garðabær Sími: + 354 535 70 00
0.0 ||| Severe hypoglycaemia may lead to unconsciousness and/ or convulsions and may result in temporary or permanent impairment of brain function or even death. ||| Severe hypoglycaemia may lead to unconsciousness and/ or convulsions and may result in temporary or permanent impairment of brain function or even death. ||| Une hypoglycémie sévère peut entraîner une perte de connaissance et/ou des convulsions et causer une altération transitoire ou définitive des fonctions cérébrales, voire le décès.
0.33566728234291077 ||| J05A B04. ||| M05B A 06 ||| J05A B04
0.0 ||| Nervous system disorders ||| Nervous system disorders ||| Troubles de système nerveux
0.6530411243438721 ||| blister (PVC/ alu) blister (PVC/ alu) perforated unit dose blister (PVC/ alu) ||| Blister (PVC/ aluminium) Blister (PVC/ aluminium) ||| plaquette thermoformée avec perforations contenant des doses unitaires (PVC/ alu)
0.5366683602333069 ||| Audiovisual transmission services ||| Electronic instructions transmission services ||| Services de transmission audiovisuelle
0.42399805784225464 ||| There have been few reported cases of pemetrexed extravasation, which were not assessed as serious by the investigator. ||| However, a link to Protopy ointment treatment has not been confirmed or refuted on the available evidence so far. ct ||| Quelques cas d’ extravasation de pemetrexed ont été rapportés et ont été considérés comme non graves par les investigateurs.
0.21921397745609283 ||| Junction sleeves for fibre optics ||| Junction sleeves for electric cables ||| Manchons de jonction pour fibres optiques
0.2661086320877075 ||| In patients with mild to moderate renal insufficiency (creatinine clearance 40-60 ml/ min) steady state AUC of enalaprilat was approximately two-fold higher than in patients with normal renal function after administration of 5 mg once daily. ||| Treated patients also experienced a mean decrease in urinary glycosaminoglycan excretion of 238 ± 17.8 μ g/ mg creatinine ± SE following 24 weeks of treatment relative to placebo-treated patients. ||| Chez les patients ayant une insuffisance rénale légère à modérée (clairance de la créatinine 40- 60 ml/ mn) l’ ASC de l’ énalaprilate à l’ état d’ équilibre a été environ deux fois plus élevée que chez les patients ayant une fonction rénale normale après administration de 5 mg une fois par jour.
0.05402836948633194 ||| The full EPAR for Axura can be found here. ||| The full EPAR for Byetta can be found here. ||| L’ EPAR complet est disponible à l’ adresse suivante: ici.
6.894396078344078e-13 ||| rod ||| rod ||| am
0.26559048891067505 ||| The procedure started on 13 March 2006. ||| This procedure started on 04 August 2004. ||| La procédure a été lancée le 13 mars 2006.
0.002253581304103136 ||| 146 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 145 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 154 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.4978255033493042 ||| 0.6%) ||| 0.1%). ||| 0,3%)
0.28882765769958496 ||| It is recommended that a test for FeLV antigenaemia be carried out prior to vaccination. ||| It is recommended to monitor the white blood cell count to permit detection of a possible leucopoenia. ||| Il est recommandé de vérifier le statut antigénique vis-à-vis du FeLV avant la vaccination.
0.032480884343385696 ||| To remove the detachable labels, rotate the plunger until the coloured tab becomes visible. ||| 25 To remove the detachable labels, rotate the plunger until the coloured tab becomes visible. ||| Afin de retirer les étiquettes détachables, tourner le piston jusqu'à ce que la languette colorée devienne visible.
0.007594897877424955 ||| 203 Sertraline, a medicine used to treat depression, as your doctor may need to change your dose of sertraline. ||| 212 Sertraline, a medicine used to treat depression, as your doctor may need to change your dose of sertraline. ||| La sertraline, un médicament utilisé pour traiter la dépression, étant donné que votre médecin devra peut-être changer votre dose de sertraline.
0.29624342918395996 ||| Tel: + 421 220 663 111 Suomi/ Finland Oy Eli Lilly Finland Ab Puh/ Tel: + 358-(0) 9 85 45 250 Sverige Eli Lilly Sweden AB Tel: + 46-(0) 8 7378800 United Kingdom Eli Lilly and Company Limited Tel: + 44-(0) 1256 315999 ||| Tel: + 34-91-623-1732 France Lilly France SAS Tél: +33-(0) 1 55 49 34 34 Ireland Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 Ísland Icepharma hf. ||| Tel: + 421 220 663 111 Suomi/Finland Oy Eli Lilly Finland Ab Puh/Tel: + 358-(0) 9 85 45 250 Sverige Eli Lilly Sweden AB Tel: + 46-(0) 8 7378800 United Kingdom Eli Lilly and Company Limited Tel: + 44-(0) 1256 315999
0.5194050073623657 ||| 4.7 Use during pregnancy, lactation or lay ||| Use during pregnancy and lactation Cattle and pigs: ||| 4 4.7 Utilisation en cas de gravidité, de lactation ou de ponte
0.598344087600708 ||| Processed teff ||| Calendered paper ||| Teff traité
0.3656291961669922 ||| No meaningful clinical data on exposure during pregnancy are available. ||| Sufficient data from pregnant or lactating women are not available. ||| Aucune donnée clinique significative concernant l’ exposition au cours de la grossesse n’ est disponible.
0.02789127640426159 ||| Do not use Agopton after the expiry date which is stated on the blister and carton. ||| Do not use Bondronat after the expiry date which is stated on the blister and carton. ||| N’utilisez pas Agopton après la date de péremption indiquée sur le blister ou la boîte.
0.4289202094078064 ||| Discontinuation of IntronA should be considered in patients who develop new or worsening ophthalmological disorders. ||| They can occur in the very seldom cases of IgA deficiency with anti-IgA antibodies. ||| Un arrêt du traitement par IntronA doit être envisagé chez les patients développant des troubles nouveaux ou lors d’ aggravation de troubles préexistants.
0.24390670657157898 ||| Your doctor will usually reduce your dose once your condition has stabilised. ||| Your doctor will usually reduce your Advagraf dose once your condition has stabilised. ||| En général, votre médecin diminuera la dose de lorsque votre état sera stabilisé.
0.4480466842651367 ||| The event rate of biopsy confirmed acute rejection within the first 24 weeks after transplantation was 32.6% in the Advagraf group (N=237) and 29.3% in the Prograf group (N=234). ||| The median duration of exposure in days was 245 (1-502) for the CML-CP patients and 138 (2-503) for the CML- AP patients. ||| Le taux de rejets aigus biopsie prouvés au cours des 24 premières semaines suivant la transplantation était de 32,6% dans le groupe Advagraf (n = 237) et de 29,3% dans le groupe Prograf (n = 234).
0.3172701895236969 ||| In chronic renal insufficiency, renal function should be below 50 percent of normal before institution of therapy. ||| The contribution of renal excretion to total clearance in subjects with normal renal function was 65-85%. ||| Dans le cas d'une insuffisance rénale, la fonction rénale devra être diminuée de 50% par rapport à la normale avant d’ initier le traitement.
0.3167232275009155 ||| Cardiomyopathy, that may be reversible upon discontinuation of interferon alpha, has been reported rarely in patients without prior evidence of cardiac disease (see section 4.4). ||| Caution should be taken when S. aureus is the suspected pathogen and there is a likelihood of erythromycin resistance based on local epidemiology. i ||| De rares cas de cardiomyopathie, pouvant être réversibles à l’ arrêt du traitement par interféron alfa, ont été rapportés chez des patients exempts d’ antécédents cardiaques (voir rubrique 4.4).
0.10548356175422668 ||| PritorPlus should not be used in patients with severe renal impairment (creatinine clearance < 30 ml/ min) (see section 4.3). ||| No dosage adjustment is necessary in patients with impaired renal function (creatinine clearance > 4 ml/ min) (see section 5.2). ||| PritorPlus ne doit pas être utilisé chez des patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) (voir rubrique 4.3).
0.31746894121170044 ||| 11 As clinical efficacy studies were performed with abrupt cessation of treatment, no information is available on whether tapering of the dosage would reduce recurrence rate. ||| Potential rebound effects following cessation of treatment with AZOPT have not been studied; the IOP-lowering effect is expected to last for 5-7 days. ||| L'impact de la réduction progressive des doses sur la fréquence des récidives n’ est pas connu compte tenu de l'arrêt brutal du traitement au cours des essais cliniques.
0.4061780571937561 |||  280 Discontinue treatment with IntronA in patients with chronic hepatitis who develop prolongation of coagulation markers which might indicate liver decompensation. ||| Soliris therefore restores terminal complement regulation in the blood of PNH patients and inhibits terminal complement mediated intravascular haemolysis in PNH patients. ||| Il faut interrompre le traitement par IntronA chez les patients atteints d’ hépatites chroniques qui développent un allongement des tests de la coagulation, ce qui pourrait indiquer une décompensation hépatique.
0.3250306248664856 ||| Washing installations for vehicles ||| Glazing services for buildings ||| Installations de lavage pour véhicules
0.03795071691274643 ||| This means that Tevagrastim is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘ reference medicine’). ||| This means that Silapo is similar to a biological medicine that is already authorised in the European Union (EU) and contains a similar active substance (also known as the ‘ reference medicine’). ||| Cela signifie que Tevagrastim est similaire à un médicament biologique déjà autorisé dans l’ Union européenne (UE), qui contient la même substance active (il également appelé « médicament de référence »).
0.31958332657814026 ||| Hypoglycaemia may occur in combination with sulphonylureas or insulin. ||| During administration of micafungin, anaphylactoid reactions including shock may occur. ||| Un épisode d'hypoglycémie peut survenir en association avec les sulfamides hypoglycémiants ou l'insuline.
0.29304978251457214 ||| Each film-coated tablet contains 100 mg of leflunomide and 138.42 mg of lactose. ||| - Each film-coated tablet contains 56.25 mg of ibandronic acid, monosodium salt, monohydrate, ||| Chaque comprimé pelliculé contient 100 mg de léflunomide, et 138, 42 mg de lactose.
0.12969037890434265 ||| Revatio 20 mg film-coated tablets ||| Levitra 5 mg film-coated tablets ||| Revatio 20 mg comprimés pelliculés
0.44747790694236755 ||| - decrease of red blood cells (anaemia, with symptoms such as skin pallor and fatigue), decrease ||| - vaginal Candida infection (fungal infection associated with local itching, burning and white ||| - diminution des globules rouges (anémie, accompagnée de symptômes comme paleur cutanée et
0.40952226519584656 ||| Aranesp is used to treat symptomatic anaemia that is associated with chronic renal failure (kidney failure) in adults and children. ||| Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer. ||| Aranesp est utilisé pour le traitement de l'anémie symptomatique liée à l'insuffisance rénale chronique (dysfonctionnement rénal) chez l'adulte et l'enfant.
0.2647550106048584 ||| A warning was included in section 4.4 with a cross reference to section 4.9 stating that central nervous system stimulation with convulsions or cardiovascular collapse with accompanying hypotension may be produced by sympathomimetic amines and that these effects may be more likely to occur in children, the elderly, or in cases of overdose. ||| Evaluations in patients who may be considered at higher risk of adverse events when treated with other antianginal medicinal products, e. g. patients with diabetes, Class I and II heart failure, or obstructive airway disease, confirmed that these conditions were not associated with clinically meaningful increases in the incidence of adverse events. ||| Une mise en garde a été insérée sous la rubrique 4.4 avec mention d’ une référence croisée à la rubrique 4.9 indiquant que la stimulation du système nerveux central accompagnée de convulsions ou collapsus cardio-vasculaire et hypotension est susceptible d’ être produite par des amines sympathomimétiques et que ces effets peuvent intervenir chez les enfant, les sujets âgés ou en cas de surdose.
0.6735709309577942 ||| USB web keys for automatically launching pre-programmed website URLs ||| LAN [local area network] computer cards for connecting portable computer devices to computer networks ||| Clés web USB pour lancer automatiquement des URL de sites web préprogrammés
0.6550482511520386 ||| On 28 February, Iceland confirmed the first case of COVID-19, an Icelandic male in his forties, who had been on a ski trip to Andalo in Northern Italy and returned home on 22 February; when he developed symptoms after his arrival, he was quarantined at Landspítali hospital in Reykjavík. ||| The Danish director Nils Malmros's movie, Facing the Truth (original Danish title At Kende Sandheden) from 2002, portrays the dilemma that faced Malmros's father, Richard Malmros, when treating his patients in the 1940s. ||| Le 28 février, l'Islande a confirmé son premier cas de Covid-19, un homme islandais d'une quarantaine d'années, qui avait fait un voyage de ski à Andalo dans le nord de l'Italie et est rentré chez lui le 22 février; lorsqu'il a développé des symptômes après son arrivée, il a été mis en quarantaine à l'hôpital Landspítali de Reykjavik,.
0.12463563680648804 ||| MIRAPEXIN 0.088 mg ||| MIRAPEXIN 0.088 mg tablets ||| MIRAPEXIN 0,088 mg
0.30508357286453247 ||| In the coming year, the Agency will continue to build on the priorities set out in its long-term strategy, and will focus on the following areas: ||| In the field of transparency, the Agency will build on the achievements of previous years, and will concentrate its efforts in three areas: ||| Au cours de l’ année, l’ Agence continuera de renforcer les priorités définies dans sa stratégie à long terme et axera ses efforts sur les domaines suivants:
0.3644528388977051 ||| Shelving for sale in kit form ||| Boats for sale in kit form ||| Étagères vendues en kits
0.028818495571613312 ||| Textile fabrics for use in the manufacture of beds ||| Textile fabrics for use in the manufacture of sheets ||| Tissus textiles destinés à la fabrication de lits
0.04943566024303436 ||| every 3 - 4 weeks to obtain IgG trough level of at least 4 - 6 g/ l ||| every 3 – 4 weeks to obtain IgG trough level of at least 4 – 6 g/l ||| Toutes les 3 à 4 semaines afin d’ obtenir un taux résiduel d’ IgG d’ au moins 4 à 6 g/ l
0.4770832657814026 ||| The transition period will therefore end on 31 December 2020, in line with the provisions of the Withdrawal Agreement. ||| The scheme is intended to cover interest on existing debt obligations until 31 December 2020 and for a maximum period of six months. ||| La période de transition prendra donc fin le 31 décembre 2020, conformément aux dispositions de l'accord de retrait.
0.434350848197937 ||| Support mattresses for medical use ||| Ligating clip applicators for medical use ||| Matelas de soutien à usage médical
0.25471633672714233 ||| In the following table adverse reactions are listed by system organ class and MedDRA preferred term. ||| The reactions are listed below as MedDRA preferred term by system organ class and absolute frequency. ||| Dans le tableau suivant, les effets indésirables sont présentés par classe de systèmes d’ organes et selon la terminologie MedDRA.
0.5404860973358154 ||| Hypromellose Titanium Dioxide (E171) Macrogols Triacetin ||| Monothioglycerol Succinic Acid Glycerol Formal ||| Hypromellose Dioxyde de titane (E171) Macrogols Triacétine
0.38589292764663696 ||| Downpoles of metal for the ducting of wires ||| Rotating junctions of metal for pipes ||| Poteaux métalliques pour le passage de fils
0.6574939489364624 ||| Pipe stands [smokers requisites] ||| Chest expanders [exercisers] ||| Porte-pipe [articles pour fumeurs]
0.5291386246681213 ||| Hypertension Peripheral ischaemia, hypotension§ ||| Flushing, Hypotension, Hypertensive crisis ||| Ischémie périphérique, hypotension§ Très rare:
0.08269931375980377 ||| 66 5. ||| 69 5. ||| 69 5.
0.1886271834373474 ||| HOW TO TAKE GLIVEC ||| HOW TO TAKE CANCIDAS ||| COMMENT PRENDRE GLIVEC
0.2826278805732727 ||| It can also be used to prevent the recurrence of these episodes (when symptoms come back) in adults with bipolar disorder (a mental illness with alternating periods of high mood and depression) who have responded to an initial course of treatment. ||| However, the occurrence of these cytopenias is likely to be related to the stage of the disease being treated and they were more frequent in patients with accelerated phase CML or blast crisis as compared to patients with chronic phase CML. ||| Il peut également servir à empêcher la récidive de ces épisodes (la réapparition des symptômes) chez les patients adultes atteints de troubles bipolaires (maladie mentale avec alternance de périodes d’ euphorie et de dépression) ayant répondu à une première cure thérapeutique.
0.16923367977142334 ||| Vice-President for Promoting our European Way of Life, Margaritis Schinas, said: "The overall objective of limiting the spread of coronavirus via reduced social interaction remains. ||| Vice-President for Promoting our European Way of Life, Margaritis Schinas, said: "EU unity and solidarity are vital in the fight against Coronavirus. ||| M. Margaritis Schinas, vice-président chargé de la promotion de notre mode de vie européen, a déclaré: «L'objectif global de limitation de la propagation du coronavirus en réduisant les interactions sociales demeure.
6.631752980969241e-13 ||| 153 9. ||| 153 9. ||| 165 9.
4.389238809649615e-13 ||| Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Utilisation d'autres médicaments Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment un autre médicament, même s'il s'agit d'un médicament obtenu sans ordonnance.
0.4053226709365845 ||| In one year clinical trials, pioglitazone consistently gave a statistically significant reduction in the albumin/ creatinine ratio compared to baseline. ||| Secondary Efficacy Endpoints A statistically significant improvement in bone pain score was shown for intravenous Bondronat 6 mg compared to placebo. ||| 10 Dans les études cliniques sur un an, la pioglitazone entraîne uniformément une réduction statistiquement significative du ratio albumine/ créatinine par rapport à la valeur de base.
0.23602654039859772 ||| After 2 consecutive injections of Macugen, if a patient does not demonstrate a treatment benefit (loss of less than 15 letters of visual acuity) at the 12-week visit, consideration should be given to stopping or withholding Macugen therapy. ||| If reactions do not resolve (to ≤ grade 2) after withholding 1 or 2 doses of Vectibix, or if reactions recur or become intolerable at 50% of the original dose, the use of Vectibix should be permanently discontinued. ||| Lors de la visite à 12 semaines, si un patient ne démontre pas de bénéfice thérapeutique (perte de moins de 15 lettres d’ acuité visuelle) après 2 injections consécutives de Macugen, l’ arrêt ou le report du traitement par Macugen doit être pris en considération.
0.3233162760734558 ||| These parameters were consistent with dose linear pharmacokinetics over a wide dose range (0.5 to 8 µg/ kg weekly and 3 to 9 µg/ kg every two weeks). ||| Congenital neutropenia The recommended starting dose is 1.2 MU/ kg/ day (12 μ g/ kg/ day) as a single dose or in divided doses. ||| Ces paramètres correspondaient à une pharmacocinétique dose- linéaire pour une large échelle de doses (de 0,5 à 8 µg/ kg une fois par semaine et de 3 à 9 µg/ kg toutes les deux semaines).
0.27374160289764404 ||| Dexmedetomidine also induces a number of other α 2-adrenoceptor mediated effects, which include piloerection, depression of motor and secretory functions of the gastrointestinal tract, diuresis and hyperglycaemia. ||| In repeat-dose toxicity studies, daily oral administration of capecitabine to cynomolgus monkeys and mice produced toxic effects on the gastrointestinal, lymphoid and haemopoietic systems, typical for fluoropyrimidines. ||| La dexmédétomidine induit également un certain nombre d'autres effets associés aux récepteurs α 2-adrénergiques notamment: pilo-érection, dépression des fonctions motrices et sécrétoires du tractus gastro-intestinal, diurèse et hyperglycémie.
0.28322815895080566 ||| Dark yellow, oval film-coated tablet, imprinted with “ NVR ” on one side and “ ECE” on the other side. ||| Pale, yellowish-brown, multifaceted, super-elliptical tablet, marked “ GSEC7” on one side and “ 25” on the other. ||| Comprimé pelliculé ovale, jaune foncé, portant l'inscription « NVR » sur une face et « ECE » sur l'autre face.
0.31464093923568726 ||| Bimatoprost did not impair fertility in rats up to doses of 0.6 mg/ kg/ day (approximately 103-times the intended human exposure). ||| Renal clearance has been estimated to be approximately 160 ml/ h/ kg (approximately 210 ml/ min), which is in excess of the glomerular filtration rate. ||| Le bimatoprost n’ a pas eu d’ incidence sur la fertilité des rats pour des doses allant jusqu’ à 0,6 mg/ kg/ jour (environ 103 fois supérieures à l’ exposition humaine).
0.05272822082042694 ||| In addition, an updated RMP should be submitted: • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA. ||| In addition, an updated RMP should be submitted: • When new information is received that may impact on the current Safety specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 says of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA. ||| Dès réception d'une nouvelle information pouvant impacter les spécifications en cours relatives à la tolérance, le Plan de Pharmacovigilance, ou les activités de minimisation du risque Dans un délai de 60 jours à compter d'une étape importante (de pharmacovigilance ou de minimisation du risque) A la demande de l' EMEA
0.14519071578979492 ||| Non-chemical additives for coolants ||| Non-chemical additives for transmission oils ||| Additifs non chimiques pour réfrigérants
0.29855841398239136 ||| 6 Telithromycin is excreted in the milk of lactating animals, at concentrations about 5 times those of maternal plasma. ||| 3 Lactation When oxybutynin is used during lactation, a small amount is excreted in the mother’ s milk. ||| Chez l’ animal, la télithromycine est excrétée dans le lait à des concentrations 5 fois supérieures à celles du plasma maternel.
0.1742485910654068 ||| WHAT ADROVANCE IS AND WHAT IT IS USED FOR ||| WHAT INTELENCE IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE ADROVANCE ET DANS QUEL CAS EST-IL UTILISE
3.0343257203732654e-13 ||| Medicines that may cause your blood sugar level to rise (hyperglycaemia) include: ||| Medicines that may cause your blood sugar level to rise (hyperglycaemia) include: ||| 637 Les médicaments pouvant provoquer une augmentation de votre glycémie (hyperglycémie) comprennent:
0.10178864002227783 ||| The pharmacokinetics of Viraferon and ribavirin (dose-normalized) are similar in adults and children or adolescents. t ||| The pharmacokinetics of Rebetol and interferon alfa-2b (dose-normalized) are similar in adults and children or adolescents. ||| Les propriétés pharmacocinétiques de Viraferon et ribavirine (dose normalisée) sont similaires chez les adultes et les enfants ou adolescents.
0.0922168716788292 ||| Long-term studies have not been performed to evaluate the carcinogenic potential of infliximab. ||| Long-term studies in animals have not been conducted to evaluate the carcinogenic potential of anidulafungin. ||| Des études à long terme pour évaluer le potentiel carcinogène de l’ infliximab n’ ont pas été effectuées.
0.23878544569015503 ||| Cardiac disorders: arrhythmia, palpitations, tachycardia, hypertension, blood pressure increased, heart rate increased ||| Cardiac disorders: heart block, cardiac arrest, arrhythmia, syncope, bradycardia, cardiac failure, congestive heart failure. ||| Affections cardiaques: arythmie, palpitations, tachycardie, hypertension, augmentation de la tension artérielle, accélération du rythme cardiaque
0.4404843747615814 ||| Liver enzyme monitoring Rare cases of hepatic dysfunction (including hepatitis) have been reported. ||| Thyroid function Cases of hypothyroidism have been reported and monitoring of thyroid function should be considered. ||| Surveillance des enzymes hépatiques De rares cas de dysfonctionnement hépatique (incluant des hépatites) ont été observés.
0.06659826636314392 ||| 105 9. ||| 107 9. ||| 109 9.
0.017851904034614563 ||| In the absence of comparability studies, this medicinal product must not be mixed with other medicinal products. ||| In the absence of compability studies, this medicinal product must not be mixed with other medicinal products. ||| En l’ absence d’ études comparatives, ce médicament ne doit pas être mélangé avec d’ autres médicaments.
0.3112412691116333 ||| In Sudan,the EU is working to ensure access to clean water and hygiene and raise awareness about the virus through a humanitarian project worth €10 million. ||| To tackle the economic challenges, the EU will advance the payment of €40 million direct financial support to the Palestinian Authority to address immediate needs. ||| Au Soudan, l'UE œuvre à garantir l'accès à l'eau propre et à l'hygiène et à sensibiliser le public au virus, dans le cadre d'un projet humanitaire d'un montant de 10 millions d'euros.
0.08863985538482666 ||| 89.9* [9.4; 99.8] ||| 89.9* [9.4;99.8] ||| 89,9* [9,4; 99,8]
0.38548821210861206 ||| Any child exposed in utero to nucleoside and nucleotide analogues, even HIV negative children, should have clinical and laboratory follow-up and should be fully investigated for possible mitochondrial dysfunction in case of relevant signs or symptoms. ||| The programme will include information about the risk of venous thromboembolism, changes in the womb that may occur when taking the medicine, and the need to investigate unexplained bleeding from the womb. ||| Tout enfant exposé in utero à des analogues nucléosidiques ou nucléotidiques, y compris les enfants séronégatifs pour le VIH, devra faire l’ objet d’ un suivi clinique et biologique et d’ un bilan approfondi à la recherche d’ un éventuel dysfonctionnement mitochondrial devant tout signe ou symptôme évocateur.
0.07296891510486603 ||| The full EPAR for Avandia can be found here. ||| The full EPAR for Bondenza can be found here. ||| L’ EPAR complet relatif à Avandia est disponible ici.
0.0018692357698455453 ||| 94 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| 88 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Prise d'autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez en à votre médecin ou à votre pharmacien.
0.31085073947906494 ||| In a study conducted in beagle dog by intravenous bolus injection for 9 months, testicular findings (degeneration/ necrosis of the seminiferous epithelium) have been observed. ||| For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, in combination with CT scan or chest X-ray, in patients with solitary pulmonary nodules. ||| Dans une étude conduite chez le chien beagle avec injection de bolus intraveineux pendant 9 mois, des effets sur les testicules (dégénerescence/ nécrose de l'épithelium séminifère) ont été observés.
0.33406877517700195 ||| 15 Data from a placebo-controlled clinical trial did not establish efficacy of Xigris in paediatric patients suffering from severe sepsis, acute infection, systemic inflammation and respiratory and cardiovascular organ dysfunction. ||| Antiviral activity in vitro: the in vitro antiviral activity of lopinavir against laboratory and clinical HIV strains was evaluated in acutely infected lymphoblastic cell lines and peripheral blood lymphocytes, respectively. ||| Les données issues d’ un essai clinique contrôlé versus placebo n’ ont pas démontré l’ efficacité de Xigris dans la population pédiatrique atteinte de sepsis sévère, d’ infection aiguë, d’ inflammation systémique et de défaillances d’ organe cardiovasculaire et respiratoire.
0.23416432738304138 ||| Cyanokit is used as an antidote to treat known or suspected poisoning with cyanide, a highly poisonous chemical. ||| Cyanokit is an antidote for the treatment of known or suspected cyanide poisoning. ||| Cyanokit est utilisé comme antidote pour traiter les intoxications confirmées ou suspectées au cyanure, une substance chimique hautement toxique.
0.3831191956996918 ||| Your doctor might avoid treating you with these medicines while you are receiving Tarceva. ||| You should not take Revatio if you are taking these medicines. ||| Votre médecin devrait éviter de vous traiter avec ces médicaments pendant votre traitement par Tarceva.
2.2913959683672214e-13 ||| Therapy with AVAGLIM should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5X upper limit of normal) or with any other evidence of liver disease. ||| Therapy with AVAGLIM should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5X upper limit of normal) or with any other evidence of liver disease. ||| 22 les patients ayant des enzymes hépatiques élevées (ALAT > 2,5 fois la limite supérieure de la normale) ou présentant tout autre signe d'une affection hépatique.
0.25377440452575684 ||| Peach film-coated tablet of biconvex, oblong shape with the marking ‘ 500’ on the one side and ‘ Xeloda’ on the other side. ||| Volibris 10 mg tablet is a deep pink, oval, convex tablet engraved with ‘ GS ’ on one face and ‘ KE3’ on the other. ||| Comprimé pelliculé de couleur pêche, biconvexe, oblong avec inscription « 500 » sur une face et « Xeloda » sur l’ autre face.
0.4623996615409851 ||| PhD in organic chemistry from the Free University of Berlin. ||| Graduated in pharmacology from Kings College, London University. ||| Diplôme de chimiste et de pharmacienne de l’ université libre de Berlin.
0.41831403970718384 ||| In vitro metabolism studies have confirmed that the parent compound is rapidly metabolised to 3-O- acetyltylosin. ||| In vitro studies have shown that paliperidone is a P-glycoprotein (P-gp) substrate. ||| Des recherches in vitro sur le métabolisme ont confirmé que le précurseur est rapidement métabolisé en 3-O-acétyltylosine.
0.2467346340417862 ||| Matrix for InductOs 12 mg kit for implant Type I bovine collagen ||| Powder for InductOs 12 mg kit for implant, dibotermin alfa ||| Matrice pour InductOs 12 mg kit pour implant Collagène bovin de type I
0.026283588260412216 ||| If you are treated with Actraphane 20 Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin. ||| If you are treated with Actrapid Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin. ||| Si vous êtes traité avec Actraphane 20 Penfill et une autre insuline en cartouche Penfill, vous devez utiliser deux systèmes d’ administration d’ insuline, un pour chaque type d’ insuline.
0.7399880886077881 ||| Rice scoops ||| Fresh soursops ||| Pelles à riz
0.29496002197265625 ||| Studies of sitagliptin in combination with metformin In a 24-week, placebo-controlled clinical study to evaluate the efficacy and safety of the addition of sitagliptin 100 mg once daily to ongoing metformin, sitagliptin provided significant improvements in glycaemic parameters compared with placebo. ||| In May 2001, the MAH investigated the potential pharmacokinetic interaction with gemfibrozil via a randomised 2-way crossover study assessing the influence of a 3 day pre and co-treatment of 600mg bid of gemfibrozil on the pharmacokinetics of a single oral dose of 0.2mg cerivastatin. ||| 10 Etudes de la sitagliptine en association avec la metformine Dans une étude clinique de 24 semaines versus placebo menée pour évaluer l'efficacité et la sécurité d’ emploi de l’ ajout de 100 mg de sitagliptine une fois par jour au traitement en cours par la metformine, la sitagliptine a entraîné des améliorations significatives des paramètres glycémiques par rapport au placebo.
0.1219697892665863 ||| EU/ 1/ 02/ 218/ 010 20 x 50 film-coated tablets EU/ 1/ 02/ 218/ 015 10 x 98 film-coated tablets ||| EU/ 1/ 07/ 430/ 001 30 film-coated tablets EU/ 1/ 07/ 430/ 002 3 x 30 film-coated tablets ||| EU/ 1/ 02/ 218/ 010 20 x 50 comprimés pelliculés EU/ 1/ 02/ 218/ 015 10 x 98 comprimés pelliculés
0.2008359581232071 ||| Polska Medagro International Sp. z o. o. ||| Polska Sanofi Pasteur Sp. z o.o. ||| Polska Ελλάδα Medagro International Sp. z o. o.
0.4732949435710907 ||| Symptomatic relief of pain associated with sprains and acute traumatic tendinitis. ||| The risk of acute infusion related reactions and delayed hypersensitivity reactions. ||| Traitement symptomatique des douleurs dues aux entorses et aux tendinites traumatiques aiguës
0.3541589677333832 ||| The majority of adverse reactions were noted at a higher incidence at doses greater than 300 mg/ m2/ day. ||| At steady state, the average inhibition level observed with a dose of 75 mg per day was between 40% and 60%. ||| La majorité des effets indésirables ont été observés plus fréquemment avec des doses supérieures à 300 mg/ m2/ jour.
0.42972531914711 ||| There is limited clinical experience with Dynastat treatment beyond three days. ||| Clinical improvement with Reconcile tablets is expected within 1 to 2 weeks. ||| L’ expérience clinique d’ un traitement de plus de 3 jours avec Dynastat est limitée.
0.26004478335380554 ||| The safety and efficacy of the combination have not been established in this population, and there are insufficient data to give adequate dose recommendations. ||| The safety and efficacy of the combination have not been established in patients with impaired renal or hepatic function, and there are insufficient data to give adequate dose recommendations. ||| L’ innocuité et l’ efficacité de l’ association dans cette population n’ ont pas été établies et les données sont insuffisantes pour pouvoir recommander une dose adaptée.
0.45331957936286926 ||| Limited data suggest there is no clinically significant effect on valproic acid pharmacokinetics. ||| No clinically significant effect on efavirenz pharmacokinetics. ||| Des données limitées suggèrent qu’ il n’ y a pas d’ effet cliniquement significatif sur la pharmacocinétique de l'acide valproïque.
0.21070805191993713 ||| Platelet counts should be monitored prior to treatment, within 6 hours of administration, and at least once daily thereafter while on therapy and immediately at clinical signs of unexpected bleeding tendency. ||| Hepatobiliary disorders Liver enzymes should be checked before treatment, 1 month after the start of treatment, and subsequently at 3 monthly intervals unless more frequent monitoring is clinically indicated. ||| Des numérations plaquettaires doivent être effectuées avant le traitement, dans les 6 heures suivant le début de l’ administration, au moins quotidiennement pendant la durée du traitement et immédiatement dès l’ apparition de signes cliniques évoquant des saignements inattendus.
0.0 ||| PURSUANT TO ARTICLE 30 OF COUNCIL DIRECTIVE 2001/ 83/ EC FOR ||| PURSUANT TO ARTICLE 30 OF COUNCIL DIRECTIVE 2001/ 83/ EC FOR ||| CONFORMÉMENT À L’ ARTICLE 30 DE LA DIRECTIVE 2001/ 83/ CE DU CONSEIL
0.06143130734562874 ||| ► In insulin infusion pumps ► If InnoLet is dropped, damaged or crushed there is a risk of leakage of insulin ► If it hasn’ t been stored correctly or been frozen (see 6 How to store Mixtard) ► If it’ s not uniformly white and cloudy when it’ s resuspended. ||| In insulin infusion pumps If FlexPen is dropped, damaged or crushed there is a risk of leakage of insulin If it hasn’ t been stored correctly or been frozen (see 6 How to store Protaphane) If it’ s not uniformly white and cloudy when it’ s resuspended. ||| ► dans une pompe à perfusion d’ insuline ► si InnoLet est tombé, a été endommagé ou a été écrasé, car il y a un risque de fuite d’ insuline ► s’ il n’ a pas été conservé correctement ou s’ il a été congelé (voir 6 Comment conserver Mixtard) ► s’ il n’ apparaît pas uniformément blanc et opaque après remise en suspension.
0.3489866256713867 ||| RILUTEK is not recommended for use in children, due to a lack of data on the safety and efficacy of riluzole in any neurodegenerative diseases occurring in children or adolescents. ||| As no clinical data on exposure to clopidogrel during pregnancy are available, it is preferable not to use clopidogrel during pregnancy as a precautionary measure. ||| Enfants: l’ usage de RILUTEK n’ est pas recommandé chez l’ enfant, en l’ absence de données sur l'efficacité et la sécurité d’ emploi du riluzole dans les maladies neurodégénératives de l'enfant ou de l'adolescent.
0.22278732061386108 ||| 3 4.4 Special warnings and precautions for use ||| 4.4 Special warnings and precautions for use lP ||| 4.4 Mises en garde spéciales et précautions d’ emploi
0.4718666076660156 ||| The targeted changes envisaged in the legislative proposal need to happen quickly in order to have the intended effect. ||| This preliminary assessment will serve to identify the first steps to make and the decisions to take. ||| Pour que les changements ciblés qu'elle prévoit aient l'effet recherché, ils doivent avoir lieu rapidement.
0.29142019152641296 ||| The most common adverse reactions in pivotal study PA.3 in pancreatic cancer patients receiving Tarceva 100 mg plus gemcitabine were fatigue, rash and diarrhoea. ||| RA study V evaluated 799 methotrexate-naïve, adult patients with moderate to severely active early rheumatoid arthritis (mean disease duration less than 9 months). ||| Les évènements indésirables les plus fréquents dans l’étude pivot PA.3, chez des patients atteints d’un cancer du pancréas qui recevaient Tarceva 100 mg associé à la gemcitabine, ont été l’asthénie, les éruptions cutanées et les diarrhées.
0.37861061096191406 ||| On 2 August 2006, the European Commission referred the matter to the EMEA under Article 31 of Directive 2001/ 83/ EC, as amended, for piroxicam containing medicinal products. ||| Similarly, EU VAT law ( Council Directive 2009/132/EC ) has mirroring provisions as regards exemption from VAT on the final importation of certain goods. ||| Le 2 août 2006, la Commission européenne a saisi l’ EMEA de cette question conformément à l’ Article 31 de la Directive 2001/ 83/ CE, telle que modifiée, concernant les médicaments contenant du piroxicam.
0.7224361300468445 ||| - Safety and efficacy issues ||| Occupational safety and health ||| - Questions de sécurité et d’ efficacité
0.2900315821170807 ||| Patients should be instructed to seek medical advice if signs/ symptoms (e. g., persistent cough, wasting/ weight loss, low grade fever) suggestive of a tuberculosis infection occur during or after therapy with Humira. ||| Severe infusion-related side effects include: • severe breathing difficulties which develop rapidly • hives • fainting • chest pain (a symptom of side effects on your heart) If such symptoms occur, speak to a doctor immediately. ||| Les patients devront être informés qu’ il leur faudra consulter leur médecin en cas de survenue de signes ou symptômes (par exemple toux persistante, cachexie/ amaigrissement, fébricule) évocateurs d'une infection tuberculeuse, pendant ou après le traitement par Humira.
0.2058756798505783 ||| The effectiveness of Adenuric has been studied in two main studies involving a total of 1,834 patients with hyperuricaemia and gout. ||| Aloxi has been studied in three main studies involving 1,842 adults receiving chemotherapy that was a strong or a moderate trigger of nausea and vomiting. ||| L’ efficacité d’ Adenuric a fait l’ objet des deux études principales incluant au total 1.834 patients atteints d’ hyperuricémie et de goutte.
0.03565879911184311 ||| Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU United Kingdom ||| Merck Sharp & Dohme Ltd; Hertford Road, Hoddesdon, Hertfordshire EN119BU, United Kingdom ||| Titulaire de l’ Autorisation de Mise sur le Marché Merck Sharp & Dohme Limited Hertford Road, Hoddesdon Hertfordshire EN11 9BU Royaume-Uni
0.4997415840625763 ||| No interaction studies have been conducted with Kepivance. ||| Neupro has not been investigated in this patient group. ||| Aucune étude d’ interaction n’ a été réalisée avec Kepivance.
0.46160346269607544 ||| Patients should be observed closely for hypersensitivity reactions especially during the first and second infusions. ||| • Patients who have failed to respond to a full and adequate course of a beta-interferon. ||| Les patients doivent être strictement surveillés en raison du risque de réactions d’ hypersensibilité, particulièrement pendant la première et la seconde perfusion.
0.7109465599060059 ||| DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED ||| WHAT YOU SHOULD CONSIDER BEFORE YOU USE INTRINSA ||| DATE D’APPROBATION DE LA DERNIÈRE NOTICE
0.01208741869777441 ||| CRIXIVAN 400 mg hard capsules indinavir ||| CRIXIVAN 100 mg hard capsules indinavir ||| CRIXIVAN 400 mg, gélules indinavir
0.5512298345565796 ||| Vacuum measuring instruments ||| Aftershave moisturising cream ||| Instruments de mesure à vide
0.3239458501338959 ||| The excretion of retapamulin in milk has not been studied in animals. ||| The absolute bioavailability of fosamprenavir in humans has not been established. ||| L’ excrétion de rétapamuline dans le lait n’ a pas été étudiée chez l’ animal.
0.11629659682512283 ||| EMEA/ CHMP/ 123464/ 2006/ΕΝ ||| EMEA/ CHMP/ 123448/ 2006/ EN ||| EMEA/ CHMP/ 123464/ 2006/ FR
0.33356577157974243 ||| Acute, irreversible neuro- and nephrotoxicity have been described in individual patients treated at a dose which was ≥ 4 times higher than the recommended regimen for hairy cell leukaemia. ||| Overdose Meloxicam has a narrow therapeutic safety margin in cats and clinical signs of overdose may be seen at relatively small overdose levels. ||| Une neurotoxicité et une néphrotoxicité aiguës irréversibles ont été décrites chez des patients traités à une dose ≥ 4 fois la dose recommandée dans le traitement de la leucémie à tricholeucocytes.
0.0 ||| Aranesp did not reveal any genotoxic potential nor did it have any effect on the proliferation of non- haematological cells in vitro or in vivo. ||| Aranesp did not reveal any genotoxic potential nor did it have any effect on the proliferation of non- haematological cells in vitro or in vivo. ||| 246 L’ utilisation d’ Aranesp n’ a pas permis de mettre en évidence une génotoxicité potentielle ni d’ effet sur la prolifération des cellules non hématologiques in vitro ou in vivo.
0.4340043365955353 ||| Elderly ||| Elderly Me ||| Sujet âgé
0.021564144641160965 ||| Commonly reported side effects in patients taking tadalafil include back pain, muscle aches, facial flushing, nasal congestion, dizziness, pounding heartbeat sensation, abdominal pain and reflux. ||| Commonly reported side effects in patients taking CIALIS include back pain, muscle aches, facial flushing, nasal congestion, dizziness, pounding heartbeat sensation, abdominal pain and reflux. ||| Les effets indésirables fréquents chez les patients prenant du tadalafil incluent douleurs dorsales, douleurs musculaires, bouffées vasomotrices, congestion nasale, sensations vertigineuses, sensations de palpitation, douleurs abdominales et reflux.
0.3100570738315582 ||| Caution is advised and additional monitoring may be appropriate in patients receiving such agents orally (see section 4.4). ||| If such combinations are needed, close monitoring of toxicities is required (see section 4.4). ||| La prudence est recommandée et une surveillance supplémentaire peut être appropriée chez les patients recevant ce type de médicament par voie orale (voir rubrique 4.4).
5.733193867568653e-13 ||| If you or the child in your care have Wegener’ s granulomatosis talk to your doctor. ||| If you or the child in your care have Wegener’ s granulomatosis talk to your doctor. ||| Si vous avez une granulomatose de Wegener, parlez-en à votre médecin.
0.21771140396595 ||| Patients with impaired liver function: after multiple dosing of ritonavir to healthy volunteers (500 mg twice daily) and subjects with mild to moderate hepatic impairment (Child Pugh Class A and B, 400 mg twice daily) exposure to ritonavir after dose normalisation was not significantly different between the two groups. ||| Renal Complications of Diabetes Mellitus In hypertensive patients with type 2 diabetes mellitus and incipient nephropathy, the dose is 10 mg Zestril once daily which can be increased to 20 mg once daily, if necessary, to achieve a sitting diastolic blood pressure below 90 mm Hg. ||| Patients insuffisants hépatiques: le ritonavir a été administré à des doses multiples à des volontaires sains (500 mg deux fois par jour) ainsi qu’à des sujets ayant une insuffisance hépatique légère à modérée (Classe A et B de Child Pugh, 400 mg deux fois par jour): l’exposition au ritonavir après normalisation de la dose n’était pas significativement différente entre les deux groupes.
0.08756913244724274 ||| 46 B. ||| 47 B. ||| 49 B.
0.33244019746780396 ||| Push the plunger slowly to inject the water into the powder vial. ||| Gently rotate the vial to dissolve the powder. ||| Appuyez doucement sur le piston pour injecter l’ eau dans le flacon de poudre.
0.27924400568008423 ||| The effectiveness of Humalog was compared to Humulin R (a soluble recombinant DNA human insulin), when added to one or two daily doses of long-acting insulins. ||| In one clinical study, plasma bexarotene AUC and Cmax values were substantially higher following the administration of a fat-containing meal versus those following the administration of a glucose solution. ||| L’ efficacité d’ Humalog a été comparée à Humulin R (insuline humaine soluble produite par la technologie de l’ ADN recombinant), en association avec une ou deux doses journalières d’ insulines à action prolongée.
0.057577945291996 ||| Name and address of the manufacturer responsible for batch release ||| Name and address of the manufacturers responsible for batch release ||| Nom et adresse du fabriquant responsable de la libération des lots
0.4134599268436432 ||| More than 760,000 South Korean citizens have signed a petition lobbying the government to ban Chinese tourists from entering the country. ||| The EU called on G20 members to assist each other in repatriating citizens stranded abroad who wish to return home. ||| Plus de 500 000 Sud-Coréens ont signé une pétition pour interdire l’entrée du territoire aux touristes chinois,.
0.23113304376602173 ||| Adverse reactions are listed below by system organ class and frequency. ||| Adverse reactions are listed by MedDRA system organ class and absolute frequency. ||| Les réactions indésirables sont énumérées ci-après, par classe anatomico-fonctionnelle et par fréquence.
0.0 ||| 4.6 Pregnancy and lactation ||| 4.6 Pregnancy and lactation ||| 5 4.6 Grossesse et allaitement
0.5619173645973206 ||| You should take extra care if you drink alcohol while taking ARICLAIM. ||| - if you experience frequent abdominal pain, particularly after eating or taking EXJADE. ||| Vous devez être très prudentes en cas de prise d 'alcool pendant un traitement par ARICLAIM.
0.4401352107524872 ||| Distribution Raltegravir is approximately 83% bound to human plasma protein over the concentration range of 2 to 10 µM. ||| The average molecular mass is approximately 60 kDa of which the protein moiety plus the carbohydrate part constitutes approximately 30 kDa. ||| Distribution Le raltégravir est lié aux protéines plasmatiques humaines à environ 83% sur l'intervalle de concentrations de 2 à 10 µM.
0.536376953125 ||| -0.104 (-0.550, 0.342) ||| -0.23d (-0.44; -0.02)b ||| -0,104 (-0,550; 0,342)
0.07476502656936646 ||| The marketing authorisation was renewed on 18 March 2003 and on 18 March 2008. ||| The marketing authorisation was renewed on 23 February 2003 and on 23 February 2008. ||| L’ autorisation de mise sur le marché a été renouvelée le 18 mars 2003.
0.21760773658752441 ||| Once in the pump, Insulin Human Winthrop Infusat may be kept for up to 2 weeks. ||| Before use, Insulin Human Winthrop Infusat must be kept at room temperature for 1 to 2 hours. ||| Insulin Human Winthrop Infusat peut être conservé jusqu'à 2 semaines dans la pompe.
0.41918349266052246 ||| Connections for electric cables ||| Adapters for wireless network access ||| Connecteurs de câbles électriques
0.028705686330795288 ||| Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycaemia. ||| Omission of a meal or unplanned strenuous physical exercise may lead to hypoglycaemia. ||| L'omission d’ un repas ou un exercice physique important non prévu peut entraîner une hypoglycémie.
0.3584168553352356 ||| In patients with severe kidney problems or who are likely to develop fluid retention, treatment should start with the lowest dose and the patient’ s kidneys should be monitored closely. ||| It is recommended that you keep track of and rotate your injection sites, so that one area is not injected too frequently in order to minimise the risk of injection site necrosis. ||| Chez les patients souffrant de graves problèmes de reins ou présentant un risque élevé de développer une rétention de liquide, la dose de départ du traitement doit être la plus faible et les reins de ces patients doivent être étroitement surveillés.
0.20206527411937714 ||| Single point cutting tools [machines] ||| Single point cutting tools [parts for machines] ||| Outils à tranchant unique [machines]
0.2589777410030365 ||| When concomitant administration with co-trimoxazole is warranted, patients should be monitored clinically. ||| Caution is warranted and clinical monitoring is recommended, when co-administration of clotrimazole is required. ||| Lorsque l’ administration concomitante de Trizivir et de cotrimoxazole est indiquée, une surveillance clinique est nécessaire.
0.773953378200531 ||| Hazard ratio (95% C. I.) Log rank p-value ||| (%) Total Toxicity Grade, n (%) ||| Médiane (IC 95%) HR (IC 95%) Log-rank p
0.21194420754909515 ||| Take special care with Fertavid: ||| Take special care with Pandemrix: ||| Faites attention avec Fertavid
0.12273445725440979 ||| 20 mg/ kg body weight twice daily with a maximum of 750 mg per dose. ||| 10 mg/kg body weight three times a day with a maximum of 400 mg per dose. ||| 20 mg/kg 2 fois/jour avec un maximum de 750 mg par dose
0.040481556206941605 ||| Posology and administration are the same as for adults 18-64 years of age. ||| Posology and administration are the same as for adults 18 to 64 years of age. ||| La posologie et l'administration sont identiques à celles de l'adulte de 18 à 64 ans.
0.4281954765319824 ||| Electronic games ||| Games software ||| Jeux électroniques
0.0 ||| 4.4 Special warnings and precautions for use ||| 4.4 Special warnings and precautions for use ||| 4.4 Mises en garde spéciales et precautions d’ emploi
0.2798806130886078 ||| In both studies, the main measure of effectiveness was the number of patients who formed blood clots in the veins or who died of any cause during the treatment period. ||| The Committee was also concerned over the number of deaths in patients receiving Tygacil with more serious infections, especially in the study of patients who had caught pneumonia in hospital. ||| Dans les deux études, le principal critère d’ évaluation de l’ efficacité était le nombre de patients chez lesquels s’ étaient formés des caillots sanguins dans les veines ou qui sont décédés d’ une cause quelconque durant la période de traitement.
0.22025281190872192 ||| Other important adverse events that were reported in clinical studies with rasagiline (other dose or in studies without placebo control) occurred in two patients each were rhabdomyolysis (both cases were following fall and prolonged immobilization) and inappropriate antidiuretic hormone (ADH) secretion. ||| In preclinical safety studies performed with co-administration of telmisartan and hydrochlorothiazide in normotensive rats and dogs, doses producing exposure comparable to that in the clinical therapeutic range caused no additional findings not already observed with administration of either substance alone. ||| Les autres événements indésirables graves qui ont été notifiés au cours des études cliniques avec la rasagiline (administrée à une autre dose ou au cours d'études sans groupe de contrôle recevant le placebo), survenus chacun chez deux patients, ont été une rhabdomyolyse (les deux cas étaient consécutifs à une chute et une immobilisation prolongée) et une anomalie de la sécrétion d'hormone antidiurétique (ADH).
0.31078869104385376 ||| The company that makes Evoltra will carry out a study to look at the use of Evoltra in patients with kidney disease, and set up a registry to monitor the medicine ’ s side effects. ||| The company that makes Orfadin has established a post-marketing surveillance program to monitor the use and safety of the medicine in the treatment of HT-1. ||| La société qui produit Evoltra réalisera une étude afin d’ analyser l’ utilisation d’ Evoltra chez des patients atteints d’ affections rénales, et établira un registre en vue d’ inventorier les effets indésirables du médicament.
0.220443457365036 ||| Due to the risk of severe hepatoxicity, saquinavir/ritonavir should not be given together with rifampicin. ||| Treatment with efavirenz in combination with amprenavir and saquinavir is not recommended, as the exposure to both protease inhibitors would be decreased. ||| En raison du risque de toxicité hépatique sévère, l’association saquinavir/ritonavir ne doit pas être co-administrée avec la rifampicine.
0.20155102014541626 ||| In a clinical study, the concomitant use of erlotinib and rifampicin (600 mg orally once daily for 7 days), a potent CYP3A4 inducer, resulted in a 69% decrease in the median erlotinib AUC. ||| The co-administration of duloxetine (40 mg twice daily) increases steady state AUC of tolterodine (2 mg twice daily) by 71%, but does not affect the pharmacokinetics of its active 5-hydroxyl metabolite and no dosage adjustment is recommended. ||| Dans une étude clinique, l’ utilisation concomitante d’ erlotinib et de rifampicine (600 mg par voie orale une fois par jour pendant 7 jours), inducteur puissant du CYP3A4, a conduit à une diminution de 69% de la médiane de l’ ASC de l’ erlotinib.
0.4963846206665039 ||| The Guidance Note is a tool which helps address a number of questions received by the Commission from donors, NGOs, banks and other actors involved in humanitarian activities, and from national authorities. ||| The positive response has been equally evident in a variety of conferences and meetings involving those with a major interest in the system, including health care professions and consumer groups. ||| La note d'orientation se veut un outil qui apporte des réponses à un certain nombre de questions que la Commission a reçues de la part de donateurs, d'ONG, de banques et d'autres acteurs humanitaires, ainsi que des autorités nationales.
0.011022319085896015 ||| If there is bleeding, cover with an adhesive bandage. • Discard the ViraferonPeg pre-filled pen with the needle safely in a closed rigid container. ||| If there is bleeding, cover with an adhesive bandage. • Discard the ViraferonPeg pre -filled pen with the needle safely in a closed rigid container. ||| Si cela saigne, couvrez avec un pansement adhésif. • Jetez avec précaution le stylo prérempli ViraferonPeg avec l’aiguille dans un récipient rigide et fermé.
0.012997835874557495 ||| Tekturna has been evaluated for safety in more than 7,800 patients, including over 2,300 treated for over 6 months, and more than 1,200 for over 1 year. ||| Sprimeo has been evaluated for safety in more than 7,800 patients, including over 2,300 treated for over 6 months, and more than 1,200 for over 1 year. ||| La sécurité d’ emploi de Tekturna a été évaluée chez plus de 7 800 patients, dont plus de 2 300 patients traités pendant plus de 6 mois, et plus de 1 200 patients traités pendant plus d’ un an.
0.07268229126930237 ||| Imprida is used in patients who have essential hypertension (high blood pressure) that is not adequately controlled on either amlodipine or valsartan taken alone. ‘ Essential ’ means that the high blood pressure is not caused by any other condition. ||| PritorPlus is used in patients who have essential hypertension (high blood pressure) that is not adequately controlled by telmisartan alone. ‘ Essential ’ means that the high blood pressure is not caused by any other condition. ||| Imprida est utilisé chez les patients souffrant d’ hypertension artérielle essentielle (pression artérielle élevée) que ni l’ amlodipine ni le valsartan en monothérapie ne permettent de contrôler de manière adéquate. « Essentielle » signifie que la tension artérielle élevée ne résulte pas d’ une quelconque autre affection.
0.1972493976354599 ||| The schemes aim at providing businesses which are particularly affected by the coronavirus outbreak with sufficient liquidity to cover their immediate working capital and investment needs, thus enabling them to continue their activities, start investments and maintain employment. ||| The aim of the scheme is to help businesses in these sectors cope with the liquidity issues brought about by the coronavirus crisis by giving them access to the financial means they need to cover their immediate working capital and investment needs, thus ensuring the continuation of their activities. ||| Les régimes ont pour but de fournir aux entreprises qui sont particulièrement touchées par la pandémie de coronavirus des liquidités suffisantes pour couvrir leurs besoins immédiats en fonds de roulement et en investissements, leur permettant ainsi de poursuivre leurs activités, d'investir et de maintenir l'emploi.
0.17440582811832428 ||| No dosage adjustment is required for patients with mild and moderate renal impairment (see section 5.2). ||| Patients with renal impairment: no dosage adjustment is needed (see section 5.2). ||| Aucune adaptation posologique n’est nécessaire en cas d’insuffisance rénale légère à modérée (voir rubrique 5.2).
0.38895145058631897 ||| EMEA/MB/002/97 3.2 Committee for Veterinary Medicinal Products ||| EMEA/MB/002/97 2.3 Centralised applications for marketing authorisations ||| EMEA/MB/002/97 3.2 Comité des médicaments vétérinaires
0.011247916147112846 ||| 1 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES ||| 1 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES ||| 1 CONDITIONS OU RESTRICTIONS EN VUE D’ UNE UTILISATION SURE ET EFFICACE DU MEDICAMENT DEVANT ETRE IMPLEMENTEES DANS LES ETATS MEMBRES
0.5937449932098389 ||| Porcine ||| Incense ||| Porcin
0.30478495359420776 ||| Paroxetine inhibits the neuronal uptake of serotonin and thereby facilitates serotonergic transmission. ||| Ciprofloxacin inhibits DNA-gyrase, resulting in inhibition of DNA synthesis. ||| La paroxétine inhibe le recaptage neuronal de la sérotonine et facilite ainsi la transmission sérotonergique.
0.3291177451610565 ||| For patients with baseline blood phenylalanine levels ≥ 600 µmol/ l, 41.9% (13/ 31) of those treated with sapropterin and 13.2% (5/ 38) of those treated with placebo had blood phenylalanine levels < 600 µmol/ l at the end of the 6-week study period (p=0.012). ||| Across dose groups, ritonavir oral clearance (CL/F/m2) declined with age with median values of 9.0 L/h/m2 in children less than 3 months of age, 7.8 L/h/m2 in children between 3 and 6 months of age and 4.4 L/h/m2 in children between 6 and 24 months of age. ||| Parmi les patients avec des taux sanguins initiaux de phénylalanine ≥ 600 µmol/ l, 41,9% (13/ 31) de ceux traités par saproptérine et 13,2% (5/ 38) de ceux ayant reçu le placebo ont présenté des taux sanguins de phénylalanine < 600 µmol/ l à la fin de la période d’ étude de 6 semaines (p=0,012).
0.09565046429634094 ||| Pack size of 1 ||| Pack size of 2 ||| Boîte de 1
0.36076366901397705 ||| See the Package Leaflet for the list of the medicines that may interact with Nexavar. ||| You should refer to the package leaflet for dexamethasone for further information on its use and effects. ||| Pour une liste complète des interactions médicamenteuses, voir la notice.
3.770182137406014e-13 ||| In some cases, a prior increase in body weight has been reported which may be a predisposing factor. ||| In some cases, a prior increase in body weight has been reported which may be a predisposing factor. ||| Dans certains cas, une prise de poids antérieure, qui pourrait être un facteur prédisposant, a été
0.24993625283241272 ||| Saquinavir/ ritonavir should not be given together with rifampicin, due to the risk of severe hepatotoxicity (presenting as increased hepatic transaminases) if the three medicines are given together (see section 4.5). ||| In patients with renal impairment in which mycophenolate mofetil and ganciclovir or its prodrugs, e. g. valganciclovir, are co-administered the dose recommendations for ganciclovir should be observed and patients monitored carefully. ||| Saquinavir/ ritonavir ne doit pas être co-administré avec la rifampicine, en raison d’ un risque d’ hépatotoxicité sévère (se traduisant par une augmentation des transaminases hépatiques) lorsque les trois médicaments sont administrés simultanément (voir rubrique 4.5).
0.32697793841362 ||| Helixate NexGen has also been studied as a continuous infusion in 15 patients with haemophilia A undergoing major surgery. ||| The company also performed a laboratory study in chickens with a vaccine similar to Nobilis Influenza H7N1. ||| Helixate NexGen a également été étudié comme perfusion continue auprès de 15 patients souffrant d’ hémophilie A subissant une intervention chirurgicale importante.
0.18437844514846802 ||| Retacrit should be given by the intravenous route. ||| Abseamed should be given by the intravenous route. ||| Retacrit doit être administré par voie intraveineuse.
0.3582276999950409 ||| Renal elimination of unchanged trabectedin in humans is low (less than 1%). ||| The rate and extent of absorption of tacrolimus is greatest under fasted conditions. ||| Chez l’ homme, l’ élimination rénale de la trabectédine inchangée est faible (moins de 1%).
0.0 ||| Clinically significant interactions are not expected since the NRTIs are metabolised via a different route than efavirenz and would be unlikely to compete for the same metabolic enzymes and elimination pathways. ||| Clinically significant interactions are not expected since the NRTIs are metabolised via a different route than efavirenz and would be unlikely to compete for the same metabolic enzymes and elimination pathways. ||| Aucune interaction cliniquement significative n’ est attendue puisque les INTIs sont métabolisés par une autre voie que l'éfavirenz et ne devraient pas entrer en compétition avec les mêmes enzymes métaboliques et voies d’ élimination.
0.43831929564476013 ||| Spraying machines in the form of trailers ||| Smartphones in the shape of a watch ||| Pulvérisateurs sous forme de remorques
0.6056311130523682 ||| 5.6 Use during pregnancy and lactation ||| - pregnancy and lactation ||| 5.6 Utilisation pendant la grossesse et l’ allaitement
0.3705553114414215 ||| Lifting installations for the transport of persons and goods ||| Operation of locks and bridges used for transport purposes ||| Installations de levage pour le transport de personnes et de marchandises
0.18945933878421783 ||| - If you are allergic (hypersensitive) to pioglitazone, metformin or any of the other ingredients of ||| - If you are allergic (hypersensitive) to fentanyl, adhesive bandages or tapes, or any of the ||| - si vous êtes allergique (hypersensible) à la pioglitazone, à la metformine ou à l'un des autres
0.36050689220428467 ||| Kepivance should be reconstituted with 1.2 ml water for injections. ||| Fuzeon must only be reconstituted with 1.1 ml of Water for Injections. ||| Kepivance doit être reconstitué avec 1,2 ml d’ eau pour préparations injectables.
0.21898207068443298 ||| The increased efavirenz concentrations observed following administration of SUSTIVA with food may lead to an increase in frequency of adverse reactions (see sections 4.4 and 5.2). ||| Application to broken skin could result in increased systemic absorption of imiquimod leadling to a greater risk of adverse events (refer to section 4.8 and 4.9) ||| Une augmentation des concentrations d’ éfavirenz observée suite à l'administration de SUSTIVA avec de la nourriture peut entraîner une augmentation de la fréquence des effets indésirables (voir rubriques 4.4 et 5.2).
4.1643582028919046e-13 ||| If you forget to take Karvezide If you accidentally miss a daily dose, just take the next dose as normal. ||| If you forget to take Karvezide If you accidentally miss a daily dose, just take the next dose as normal. ||| 110 Si vous oubliez de prendre Karvezide Si par inadvertance vous oubliez un jour de prendre votre médicament, prenez la dose suivante comme d'habitude.
0.3950510025024414 ||| Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycaemia. ||| Massive overdose may result in pronounced hypotension requiring active cardiovascular support. ||| L'omission d’ un repas ou un exercice physique important non prévu peut entraîner une hypoglycémie.
0.37178629636764526 ||| KG Tel: +49 (0) 69 50 50 83 09 Eesti Boehringer Ingelheim Pharma GmbH Tel: + 37 2 60 80 940 Ελλάδα ΦΑΡΜΑΣΕΡΒ -ΛΙΛΛΥ Α .Ε .Β .Ε. ||| Tél/ Tel: + 32-(0)2 548 84 84 България ТП "Ели Лили Недерланд "Б .В. - България тел. + 359 2 491 41 40 Č eská republika ELI LILLY Č R, s. r. o. ||| KG Tel: +49 (0) 69 50 50 83 09 Eesti Boehringer Ingelheim Pharma GmbH Tel: + 37 2 60 80 940 Ελλάδα ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε.
7.9273989716383e-13 ||| Marketing authorisation holder and manufacturer: ||| Marketing authorisation holder and manufacturer: ||| Titulaire de l’Autorisation de mise sur le marché et fabricant
0.200564906001091 ||| Pancreas transplantation A multicentre study using oral Prograf included 205 patients undergoing simultaneous pancreas- kidney transplantation who were randomised to tacrolimus (n = 103) or to ciclosporin (n = 102). ||| Bone histology Bone biopsies were obtained from the iliac crest 1 year after the third annual dose in 152 post- menopausal patients with osteoporosis treated with Aclasta (N=82) or placebo (N=70). ||| Transplantation pancréatique Une étude multicentrique utilisant du Prograf par voie orale a inclus 205 receveurs d’ une double transplantation rein-pancréas, randomisés dans le groupe tacrolimus (n = 103) ou dans le groupe ciclosporine (n = 102).
0.25625258684158325 ||| Polska Medagro International Sp. z o. o. ||| Polska GSK Commercial Sp. z o.o. ||| Polska Ελλάδα Medagro International Sp. z o. o.
0.2937200367450714 ||| Vice-President for Promoting our European Way of Life, Margaritis Schinas, said: "The pandemic has direct consequences on the way EU asylum and return rules are being implemented and a disruptive effect on resettlement. ||| Commissioner for Transport Adina Vălean said: "In light of the mass cancellations and delays passengers and transport operators face due to the COVID-19 pandemic, the Commission wants to provide legal certainty on how to apply EU passenger rights. ||| M. Margaritis Schinas, vice-président chargé de la promotion de notre mode de vie européen, a déclaré à ce propos: «La pandémie a des répercussions sur la mise en œuvre des règles de l'UE en matière d'asile et de retour, et elle perturbe la réinstallation.
0.0 ||| Detailed information on this medicine is available on the European Medicine’ s Agency (EMEA) web site: http: / /www. emea. europa. eu ||| Detailed information on this medicine is available on the European Medicine’ s Agency (EMEA) web site: http: / /www. emea. europa. eu ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA) http: / /www. emea. europa. eu.
0.19386765360832214 ||| Implants [prosthesis] for use in facial surgery ||| Implants [prosthesis] for dental surgery ||| Implants pour la chirurgie de la face [prothèses]
0.02911260351538658 ||| The primary non-responders were excluded from the studies and therefore these patients were not further evaluated. lP ||| The primary non-responders were excluded from the studies and therefore these patients were not further evaluated. t uc ||| Les non-répondeurs primaires ont été exclus des études et ces patients n'ont par conséquent pas fait l'objet d'autres évaluations.
0.19133305549621582 ||| dodecahydrate, sodium hydroxide, potassium dihydrogen phosphate, potassium chloride, pentetic acid, hydrochloric acid (diluted), water for injection ||| zinc chloride, glycerol, metacresol, phenol, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid, protamine sulphate and water for injections. ||| phosphate disodique dodécahydraté, hydroxyde de sodium, phosphate monopotassique, chlorure de potassium, acide pentétique, acide chlorhydrique (dilué), eau pour préparations injectables
0.0 ||| 6.5 Nature and contents of container ||| 6.5 Nature and contents of container ||| 24 6.5 Nature et contenu de l’emballage extérieur
0.08221946656703949 ||| 59 9. ||| 58 9. ||| 62 9.
0.7819825410842896 ||| The six pillars are as follows: ||| The table contains four columns: ||| Les six piliers sont les suivants:
0.5679690837860107 ||| These will be closely linked to the EU priorities (climate change, circular economy and fair taxation). ||| Italy will continue to support cooperative actions, international solidarity and the global response to defeat COVID-19. ||| Elles seront étroitement liées aux priorités de l'UE (changement climatique, économie circulaire et fiscalité équitable).
0.36476683616638184 ||| Uncommon side effects (These can affect at least 1 in every 1,000 patients treated, but less than 1 in every 100 patients treated) ||| This is a serious but rare side effect, which affects more than 1 out of 10,000 patients but fewer than 1 out of 1,000 patients. ||| Effets indésirables peu fréquents (Peuvent affecter au moins 1 patient sur 1000 traités mais moins de 1 patient sur 100 traités)
3.184883455055465e-13 ||| Patients in the TMZ + RT arm received concomitant TMZ (75 mg/m2) once daily, starting the first day of RT until the last day of RT, for 42 days (with a maximum of 49 days). ||| Patients in the TMZ + RT arm received concomitant TMZ (75 mg/m2) once daily, starting the first day of RT until the last day of RT, for 42 days (with a maximum of 49 days). ||| Les patients dans le bras TMZ + RT ont reçu TMZ concomitant (75 mg/ m2) une fois par jour, en commençant le premier jour de la RT jusqu’ au dernier jour de la RT, pendant 42 jours (avec un maximum de 49 jours).
0.5914438962936401 ||| 35 Response rates are presented in Table 6. ||| Results at 48 weeks are presented in the table. ||| Les taux de réponse sont présentés dans le Tableau 6.
0.23318509757518768 ||| Nifedipine Pharmamatch 30 mg tablets are available as prolonged-release tablets in a calendar packaging of 28 tablets (2 blisters of 14 tablets). ||| Nifedipine Pharmamach retard tablets come in a calendar packing of 28 tablets (2 blisters of 14 tablets each). ||| Les comprimés Nifedipine Pharmamatch 30 mg sont commercialisés sous la forme de comprimés à libération prolongée en plaquette calendaire de 28 comprimés (2 plaquettes de 14 comprimés).
0.16411347687244415 ||| Viread is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected adults over 18 years of age. ||| REYATAZ is indicated for the treatment of HIV-1 infected adults in combination with other antiretroviral medicinal products. ||| Viread est indiqué, en association avec d’ autres médicaments antirétroviraux, pour le traitement des patients adultes de plus de 18 ans, infectés par le VIH-1.
0.013934994116425514 ||| Vildagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor. ||| 8 Vildagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor. ||| La vildagliptine, par l’ intermédiaire d’ un effet inhibiteur puissant et sélectif de la dipeptidylpeptidase 4 (DPP-4), amplifie l’ effet incrétine sur les îlots de Langerhans.
0.11555583775043488 ||| Pramipexole Teva 0.35 mg tablets ||| Pramipexole Teva 0.18 mg tablets ||| Pramipexole Teva 0,35 mg, comprimé
0.2628079950809479 ||| - The other ingredients are microcrystalline cellulose, magnesium stearate and colloidal ||| - The other ingredients are silica colloidal anhydrous and stearic acid. ||| - Les autres composants sont la cellulose microcristalline, le stéarate de magnésium et la silice
0.26608580350875854 ||| In combination with insulin, the current insulin dose can be continued upon initiation of pioglitazone therapy. ||| Therefore, digoxin levels should be monitored following initiation and termination of Ranexa therapy. ||| 28 En association à l’ insuline, la dose d’ insuline peut être maintenue lors de l’ initiation du traitement par pioglitazone.
0.29716360569000244 ||| Why has Aivlosin been approved? ||| Why has Ratiograstim been approved? ||| Pourquoi Aivlosin a -t-il été approuvé?
0.15514102578163147 ||| 6 clicks ||| 13 clicks ||| 1,8 6 clics
0.23593920469284058 ||| Precision grooving tools [parts of machines] ||| Disc shaped rotating grinding tools [parts for machines] ||| Outils à rainurer de précision [pièces de machines]
0.29580870270729065 ||| In clinical trials, topotecan was discontinued if the dose needed to be reduced below 1.5 mg/ m2. ||| If a suspected reaction is not manageable with dose delays, then temsirolimus may be reduced by 5 mg/ week decrements. ||| Au cours des essais cliniques, le topotécan était arrêtée s’ il était nécessaire de réduire la dose à moins de 1,5 mg/ m².
0.29674607515335083 ||| If an 800/100 mg once daily dose of PREZISTA/ritonavir is missed within 12 hours of the time it is usually taken, patients should be instructed to take the prescribed dose of PREZISTA and ritonavir with food as soon as possible. ||| Dosage adjustment: if STOCRIN is coadministered with voriconazole, the voriconazole maintenance dose must be increased to 400 mg every 12 hours and the STOCRIN dose must be reduced by 50%, i. e., to 300 mg once daily. ||| Si une dose de PREZISTA/ritonavir 800/100 mg une fois par jour est oubliée dans les 12 heures qui suivent l’horaire de la prise habituelle, les patients doivent être informés qu’ils doivent prendre dès que possible la dose prescrite de PREZISTA et de ritonavir avec de la nourriture.
0.0 ||| {DD/ MM/ AAAA} (12h CET) ||| {DD/ MM/ AAAA} (12h CET) ||| {JJ/ MM/ AAAA} (12h CET)
0.49313753843307495 ||| Febrile neutropenia, anaemia ||| Vaccine against feline leukaemia. ||| Neutropénie fébrile, anémie
4.3113592123472655e-13 ||| If you do not respond to glucagon treatment, you will have to be treated in a hospital. ||| If you do not respond to glucagon treatment, you will have to be treated in a hospital. ||| Si vous ne répondez pas au traitement par glucagon, vous devrez être traité à l’ hôpital.
0.20864340662956238 ||| Cigarette holders of precious metal ||| Cigar boxes of precious metal ||| Fume-cigarettes en métaux précieux
0.005566365085542202 ||| 180 As a fluoroquinolone antibacterial agent, the bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. ||| As a fluoroquinolone antibacterial agent, the bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. ||| Son activité bactéricide résulte de l’inhibition de la topo-isomérase de type II (ADN-gyrase) et de la topo-isomérase IV, nécessaires à la réplication, la transcription, la réparation et la recombinaison de l'ADN bactérien.
0.0 ||| In the same clinical trials, cerebrovascular adverse events (CVAE e. g., stroke, transient ischemic attack), including fatalities, were reported. ||| In the same clinical trials, cerebrovascular adverse events (CVAE e. g., stroke, transient ischemic attack), including fatalities, were reported. ||| 51 Des événements indésirables vasculaires cérébraux (tels qu’ accidents vasculaires cérébraux, accidents ischémiques transitoires), dont certains à issue fatale, ont été rapportés dans ces mêmes essais cliniques.
0.00444266851991415 ||| It can also be used to prevent the recurrence of these episodes (when symptoms come back) in adults with bipolar disorder (a mental illness with alternating periods of high mood and depression) who have responded to an initial course of treatment. ||| It can also be used to prevent the recurrence of these episodes (when symptoms come back) in adults with bipolar disorder (a mental illness causing alternating periods of high mood and depression) who have responded to an initial course of treatment. ||| Il peut également servir à empêcher la récidive de ces épisodes (la réapparition des symptômes) chez les patients adultes atteints de troubles bipolaires (maladie mentale avec alternance de périodes d’ euphorie et de dépression) ayant répondu à une première cure thérapeutique.
0.3027302324771881 ||| Bowls for floral decorations ||| Bows for decorating packaging ||| Bols pour décorations florales
0.13341276347637177 ||| Each film-coated tablet contains lamivudine 100 mg ||| 1 film-coated tablet contains 15 mg mirtazapine ||| Chaque comprimé pelliculé contient 100 mg de lamivudine.
0.12757575511932373 ||| OTHER SPECIAL WARNING(S), IF NECESSARY Me ||| OTHER SPECIAL WARNING(S), IF NECESSARY lp ||| AUTRE(S) MISE(S) EN GARDE SPECIALE(S), SI NECESSAIRE
0.1091589480638504 ||| - This medicine has been prescribed for you. ||| This medicine has been prescribed for you. ||| - Ce médicament a été prescrit pour vous.
0.313332736492157 ||| - Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adult and ||| The risk of opportunistic infections and tuberculosis (TB) in patients treated with Remicade. ||| - traitement de l'anémie symptomatique associée à l’ insuffisance rénale chronique (IRC)chez
0.053996846079826355 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Kentera to Nicobrand Limited on 15 June 2004. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Lyrica to Pfizer Limited on 6 July 2004. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Kentera à Nicobrand Limited le 15 juin 2004.
0.2978377938270569 ||| Efient inhibits the clumping of platelets and so reduces the chance of a blood clot forming. ||| It also increases the absorption of calcium from food and prevents too much calcium being lost in the urine. ||| Efient empêche l’ agrégation des plaquettes et réduit ainsi le risque de formation de caillots sanguins.
0.4507269859313965 ||| Compilation of directories for publishing on global computer networks or the internet ||| Commissioned writing of computer programs, software and code for the creation of web pages on the Internet ||| Compilation de répertoires pour leur publication sur un réseau informatique mondial ou sur Internet
0.011356467381119728 ||| Janumet 50 mg/ 850 mg tablets sitagliptin/ metformin HCl ||| Janumet 50 mg/ 1,000 mg tablets sitagliptin/ metformin HCl ||| Janumet 50 mg/ 850 mg, comprimés sitagliptine/ chlorhydrate de metformine
0.34448426961898804 ||| Briquetting machines ||| Extracting machines ||| Machines à briqueter
0.2798795998096466 ||| Agents that may enhance the risk of haemorrhage should not be administered concomitantly with fondaparinux. ||| Subcutaneous use is preferable in patients who are not receiving haemodialysis to avoid the puncture of peripheral veins. ||| Les traitements susceptibles d’ accroître le risque hémorragique ne doivent pas être administrés en association avec le fondaparinux.
0.3215041160583496 ||| Fatal outcome was reported in approximately a third of serious cases of gastrointestinal perforations, which represents between 0.2%-1% of all Avastin treated patients. ||| In the Paget’ s disease trials, symptomatic hypocalcaemia was observed in approximately 1% of patients, in all of whom it resolved. ||| Dans environ un tiers des cas de perforations gastro-intestinales graves, l’ évolution a été fatale, ce qui représente entre 0,2 et 1% de l’ ensemble des patients traités par Avastin.
0.2442069947719574 ||| Chemical substances for use in the manufacture of scented detergents ||| Chemicals for use as intermediates in the manufacture of pesticides ||| Substances chimiques destinées à la fabrication de détergents parfumés
0.2447790801525116 ||| It is recommended that pretreatment with corticosteroids be considered for patients in whom local tumour expansion may compromise vital anatomic structures. ||| When D. caninum infection is present, concomitant treatment against intermediate hosts such as fleas and lice should be considered to prevent reinfection. ||| Il est recommandé d’ envisager un traitement préalable par corticostéroïdes chez les patients dont le développement local de la tumeur peut compromettre les structures anatomiques vitales.
0.06016898155212402 ||| There is no experience of an overdose of Starlix in clinical trials. ||| There is no experience of an overdose of Trazec in clinical trials. ||| Il n'y a eu aucun cas de surdosage au cours des essais cliniques de Starlix.
0.039330072700977325 ||| In the CLL first-line study, the overall incidence of grade 3 or 4 cardiac disorders was low (4% R-FC, 3% FC). ||| In the CLL first-line study, the overall incidence of grade 3 or 4 nervous system disorders was low (4% R-FC, 4% FC). ||| Dans l’ étude en première ligne de traitement dans la LLC, l’ incidence globale des troubles cardiaques de grade 3 et 4 était faible (R-FC 4% vs FC 3%).
0.3098807632923126 ||| When there is substantial transmission in the local community, in addition to social distancing strategies, extended school dismissals may be considered. ||| Public health authorities may implement other forms of social distancing, such as school closings, when needing to control an epidemic. ||| En cas de transmission importante dans la population locale, outre les stratégies de distanciation sociale, un prolongement des vacances scolaires peut être envisagé.
0.291306734085083 ||| The recommended dose of FORSTEO is 20 microgram given once daily by injection under the skin (subcutaneous injection) in the thigh or abdomen. ||| Patients generally receive a total of five monthly injections, given as an intramuscular injection (into the muscle of the thigh) at a dose of 15 mg per kilogram body weight. ||| La posologie recommandée de FORSTEO est de 20 microgrammes administrés quotidiennement par injection sous la peau (injection sous-cutanée) au niveau de la cuisse ou de l’ abdomen.
0.09725072979927063 ||| 89 1. ||| 86 1. ||| 100 1.
4.0497726699895154e-13 ||| In patients with an allergy to animal insulin intradermal skin testing is recommended prior to a transfer to Insulin Human Winthrop Comb 15, since they may experience immunological cross-reactions. ||| In patients with an allergy to animal insulin intradermal skin testing is recommended prior to a transfer to Insulin Human Winthrop Comb 15, since they may experience immunological cross-reactions. ||| Chez les patients présentant une allergie à l'insuline d'origine animale, il est recommandé de procéder à des tests intradermiques avant de passer à Insulin Human Winthrop Comb 15, en raison de la possibilité de réactions immunologiques croisées.
0.4108586311340332 ||| Do not touch the inside of the cap or the syringe tip. ||| Do not allow the sides of the strip to contact the side of the tank. ||| Ne touchez pas l’intérieur de l’embout ou l’extrémité de la seringue.
0.2688904404640198 ||| Medical screening services in the field of asthma ||| Health screening services in the field of sleep apnea ||| Services d'examens médicaux dans le domaine de l'asthme
0.7982917428016663 ||| Changes at the injection site. ||| Number of mutations at baseline* ||| Réactions au site d’injection.
0.02649042382836342 ||| 104 6.4 Special precautions for storage ||| 92 6.4 Special precautions for storage ||| 6.4 Précautions particulières de conservation
0.4454246759414673 ||| Furniture cabinets ||| Reclining chairs ||| Armoires [meubles]
0.25403892993927 ||| After single-dose administration of fluoxetine in patients with mild, moderate or complete (anuria) renal insufficiency, kinetic parameters have not been altered when compared to healthy volunteers. ||| Pharmacokinetic data from patients with hepatocellular carcinoma having mild to moderate hepatic impairment indicate that AsIII or AsV do not accumulate following twice-weekly infusions. ||| Après administration unique de fluoxétine chez des patients ayant une insuffisance rénale légère, modérée ou totale (anurie), les paramètres pharmacocinétiques ne sont pas modifiés comparativement au sujet sain.
0.5629063844680786 ||| Metalyse 6,000 U Powder for solution for injection. ||| To mix Insulatard with fast-acting insulin 76 1. ||| Metalyse 6 000 U Poudre pour solution injectable.
0.2568018436431885 ||| Treatment with Fertavid (like pregnancy itself) may increase the risk of thrombosis (the formation of a blood clot in a blood vessel, most often in the veins of the legs or the lungs). ||| Foscan is used to relieve the symptoms of advanced head and neck squamous cell carcinoma (a type of cancer that starts in the cells lining the mouth, nose, throat or ear). ||| Le traitement par Fertavid (ainsi que la grossesse elle-même) peut augmenter le risque de thrombose (formation de caillots sanguins dans un vaisseau, le plus souvent dans les veines des jambes ou des poumons).
0.36211419105529785 ||| 19 Some patients have had an increase in lipase and amylase levels (digestive enzymes) in their blood, which do not require treatment and usually return to normal after stopping treatment with Kepivance. ||| Rapinyl is a treatment for people who must already regularly be taking strong pain-relieving medicine (opioids) for their persistent cancer pain, but require treatment for their breakthrough pain. ||| Certains patients ont présenté une augmentation sanguine des taux de lipase et d'amylase (enzymes digestives); celle -ci ne nécessite pas de traitement et les taux se normalisent habituellement à l'arrêt de Kepivance.
0.19897103309631348 ||| 97.9% ||| 78.7% ||| 97,9%
0.2560511529445648 ||| In light of the increasing rate of quinolone resistance in urinary pathogens in Europe, an optimal dosage regimen is therefore considered important, because underdosing may lead to an impaired clinical response and pose a risk for emergence of resistant strains. ||| If sequential tests of haemostasis indicate an uncontrolled or worsening coagulopathy that significantly increases the risk of bleeding, the benefits of continuing the infusion must be weighed against the potential increased risk of bleeding for that patient. ||| Compte tenu de l’ augmentation des cas de résistance à la quinolone chez les pathogènes urinaires en Europe, un régime posologique optimal est donc considéré comme essentiel, tout sous-dosage pouvant donner lieu à une diminution de la réponse clinique et présentant un risque d’ apparition de souches résistantes.
0.3169567883014679 ||| Most of the side effects seen in patients taking Neulasta in studies are due to their underlying disease or chemotherapy. ||| Renal and/ or hepatic disorders have been reported in very rare cases in dogs administered the recommended treatment dose. ||| La plupart des effets indésirables observés chez les patients sous Neulasta au cours des études sont dus à la maladie sous-jacente dont ils sont atteints ou à la chimiothérapie.
0.02231680415570736 ||| Do not use Truvada after the expiry date which is stated on the bottle and carton after {EXP}. ||| Do not use Viread after the expiry date which is stated on the bottle and carton after {EXP}. ||| Ne pas utiliser Truvada après la date de péremption figurant sur le flacon et la boîte après{EXP}.
0.28251388669013977 ||| In clinical studies approximately 5% of subjects receiving abacavir develop a hypersensitivity reaction. ||| Adverse reactions were reported in approximately 41% of patients treated with tigecycline. ||| Dans les études cliniques, des réactions d’ hypersensibilité ont été observées chez environ 5% des patients traités par l’ abacavir.
0.3991923928260803 ||| Pharmaceutical preparations for the prevention of disorders of the metabolic system ||| Points to consider on the evaluation of new anti-fungal agents for invasive fungal infections ||| Produits pharmaceutiques pour la prévention des troubles du système métabolique
0.5124082565307617 ||| (Latina) Tel: + 39 06 928921 ||| Tel. + 44 (0) 208 600 1400 (Jungtinė Karalystė) ||| Tel: + 39 06 928921
0.34189021587371826 ||| Package containing one or four pre-filled syringe(s) of a 15 µg Nespo solution for injection in 0.375 ml (40 µg/ ml). ||| Component of a multipack comprising 5 packs, each containing 10 single-dose (0.5 ml) pre-filled syringes without needle. ||| Emballagecontenant une ou quatre seringues préremplies, de Nespo 15 µg, solution injectable de 0,375 ml (40 µg/ ml). e
0.26366230845451355 ||| In clinical trials, interactions between Kineret and other medicinal products (including nonsteroidal anti-inflammatory drugs, corticosteroids, and DMARDs) have not been observed. ||| There was no clinical evidence in the vehicle-controlled studies of interactions with systemic antiretroviral agents, including protease inhibitors; macrolide antibiotics and azole antifungals. ||| Lors des essais cliniques, aucune interaction entre Kineret et d’ autres médicaments (dont les anti-inflammatoires non stéroïdiens, les corticoïdes et les traitements de fond de la polyarthrite rhumatoïde (DMARDs)) n’ a été observée.
0.6583501100540161 ||| Re-occurrence of blockade: ||| Dose re-adjustment: ||| Réapparition du bloc neuromusculaire:
0.15990737080574036 ||| If a patient misses a dose by more than 6 hours of the time it is usually taken, the patient should be told not to take the missed dose and simply resume the usual dosing schedule. ||| If this was noticed later than 6 hours of the time it is usually taken, the missed dose should not be taken and the patient should resume the usual dosing schedule. ||| Si le patient oublie une dose plus de 6 heures après l’ horaire de la prise habituelle, il doit être informé qu’ il ne doit pas prendre la dose oubliée et simplement poursuivre le schéma posologique habituel.
0.3483816385269165 ||| Rasilez HCT may have been prescribed to you because your previous treatment did not lower your blood pressure enough. ||| Your doctor has prescribed Januvia to help lower your blood sugar, which is too high because of your type 2 diabetes. ||| Rasilez HCT peut vous avoir été prescrit parce que votre traitement précédent n’ avait pas fait diminuer suffisamment votre pression artérielle.
0.1935930848121643 ||| • 17.7.2002 • 30 days ||| • 9.10.2002 • 52 days ||| 17.7.2002 30 jours
0.360612154006958 ||| • Put the cap back on the pen, with 0 next to the dosage indicator (picture D) • Check that the push-button is fully down. ||| Use the injection technique advised by your doctor • Deliver the dose by pressing the push-button fully down (picture 3). ||| • Replacez le capuchon sur le stylo de façon à ce que le 0 se trouve face à l’ indicateur de dose (figure D) • Vérifiez que le bouton-poussoir est totalement enfoncé.
0.5818456411361694 ||| Navigation services ||| Reference documents ||| Services de navigation
0.5516766309738159 ||| Meat slicing machines ||| Lace making machines ||| Trancheuses à viande
0.3803447484970093 ||| Topotecan inhibits topoisomerase-I by stabilising the covalent complex of enzyme and strand-cleaved DNA which is an intermediate of the catalytic mechanism. ||| Becaplermin is produced by insertion of the gene for the B chain of human platelet derived growth factor into the yeast, Saccharomyces cerevisiae. ||| Topotécan inhibe la topoisomérase I en stabilisant le complexe covalent enzyme/ ADN (ayant une cassure monobrin), étape intermédiaire du mécanisme catalytique.
0.5012608766555786 ||| There were too few children aged below two years to determine the safety and effectiveness of Bridion in this age group. ||| The indication will specify that the target population is “ Children and adolescents aged 2 to 12 years“. ||| Le nombre d’ enfants âgés de moins de deux ans était trop faible pour déterminer la sécurité et l’ efficacité de Bridion pour ce groupe d’ âge.
0.13221968710422516 ||| 211 • Prepare the injection solution: ||| • Prepare the injection solution: ||| • Préparez la solution à injecter:
0.06958010792732239 ||| SmithKline Beecham plc 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom ||| SmithKline Beecham PLC, 980 Great West Road, Brentford, Middlesex TW8 9GS United Kingdom ||| SmithKline Beecham plc 980 Great West Road, Brentford, Middlesex TW8 9GS, Royaume-Uni
0.590333104133606 ||| Cerium ||| Cartridge ||| Cérium
0.24104219675064087 ||| It has been shown that the antihypertensive effect is sustained under long term therapy lasting 2 years. ||| In clinical studies of at least one year's duration, the antihypertensive effect was maintained with continued therapy. ||| Il a été démontré que l’ effet antihypertenseur persiste lors d’ un traitement à long terme durant 2 ans.
2.9546720972661866e-13 ||| Co-administration of a single 100 mg oral dose of sitagliptin and a single 600 mg oral dose of cyclosporine increased the AUC and Cmax of sitagliptin by approximately 29% and 68%, respectively. ||| Co-administration of a single 100 mg oral dose of sitagliptin and a single 600 mg oral dose of cyclosporine increased the AUC and Cmax of sitagliptin by approximately 29% and 68%, respectively. ||| 21 unique par voie orale de 100 mg de sitagliptine et d’ une dose unique de 600 mg de ciclosporine a augmenté l'ASC et la Cmax de la sitagliptine, respectivement d'environ 29% et 68%.
0.28598037362098694 ||| If an individual patient should require dosages outside the recommended regimen, appropriate doses of beta-agonist and/ or corticosteroid should be prescribed. ||| Prior chemotherapy must have included at least an anthracycline and a taxane unless patients are unsuitable for these treatments. ||| Si les dosages disponibles de cette association fixe ne répondent pas aux nécessités pour ajuster les posologies en fonction de l’ état du patient, bêta-2 agonistes et/ ou corticoïdes devront être prescrits individuellement.
0.5570940375328064 ||| Humalog BASAL is a white, sterile suspension. ||| Medicated sponge TachoSil is an off-white sponge. ||| Humalog BASAL est une suspension stérile et de couleur blanche.
0.4340081214904785 ||| The risk of serious skin rashes in children is higher than in adults. ||| The overall survival rate was about 80% for the disease in newborn babies. ||| Ce risque d’ éruptions cutanées graves est plus élevé chez l’ enfant que chez l’ adulte.
0.08806930482387543 ||| 1/ 2 EU/ 1/ 01/ 195/ 017 ||| 2/ 4 EU/ 1/ 01/ 185/ 045 ||| EU/ 1/ 01/ 195/ 017
0.056615911424160004 ||| The European Commission has approved a €5 million direct grant scheme to support the Lithuanian economy in the context of the coronavirus outbreak. ||| The European Commission has approved a €1.2 billion Greek aid scheme to support the Greek economy in the context of the coronavirus outbreak. ||| La Commission européenne a autorisé un régime de subventions directes d'un montant de 5 millions d'euros visant à soutenir l'économie lituanienne dans le contexte de la pandémie de coronavirus.
0.3050183355808258 ||| Providing information in the field of computer software development ||| Providing information on repair services in the aviation sector ||| Mise à disposition d'informations dans le domaine du développement de logiciels
0.0 ||| Dose modification for all patients If severe adverse reactions or laboratory abnormalities develop during treatment with ViraferonPeg monotherapy or ViraferonPeg in combination with ribavirin, modify the dosages of each product as appropriate, until the adverse reactions abate. ||| Dose modification for all patients If severe adverse reactions or laboratory abnormalities develop during treatment with ViraferonPeg monotherapy or ViraferonPeg in combination with ribavirin, modify the dosages of each product as appropriate, until the adverse reactions abate. ||| Modification des doses chez tous les patients Si des effets indésirables ou des anomalies sévères des analyses de laboratoire apparaissent pendant le traitement par ViraferonPeg en monothérapie ou en association avec la ribavirine, modifier de manière appropriée les posologies de chaque produit, jusqu’ à ce que les effets indésirables cessent.
0.33854299783706665 ||| Air mattresses for use when camping ||| Waterproof membranes for use in manufacture ||| Matelas pneumatiques pour le camping
0.8996058702468872 ||| • Hepsera • adefovir dipivoxil ||| Amlodipine, diltiazem, nifedipine ||| Hepsera adefovir dipivoxil
0.4479498863220215 ||| The elevated insulin levels did not persist beyond the time of the meal challenge. ||| The median overall survival had not been reached for any of the four treatment groups. ||| La forte concentration d’ insuline n’ a pas persisté au-delà de la stimulation liée au repas.
0.3328028917312622 ||| The results of 3 phase III pivotal efficacy studies showed that treatment with imiquimod for sixteen weeks was significantly more effective than treatment with vehicle as measured by total clearance of treated warts. ||| Of the 182 treated patients who were assessed for antibodies to murine IgG, 10 showed a statistically significant upward trend by linear regression analysis and 2 displayed a sustained peak or transient spike. ||| Les résultats de trois études cliniques pivot d’efficacité de phase III ont montré qu’un traitement par imiquimod jusqu’à 16 semaines était significativement plus efficace qu’un traitement par placebo sur la disparition totale des verrues.
0.25987038016319275 ||| In the first study, patients taking Tracleer had an average of 1.4 new digital ulcers after 16 weeks, compared with 2.7 in the patients taking placebo. ||| In study AC-052-331, patients had to have at least one digital ulcer of recent onset, and across the two studies 85% of patients had ongoing digital ulcer disease at baseline. ||| Dans la première étude, les patients sous Tracleer présentaient en moyenne 1,4 nouvel ulcère digital après 16 semaines, contre 2,7 chez les patients sous placebo.
0.3484388589859009 ||| Reproduction studies by oral administration of buprenorphine: naloxone (ratio 1:1) indicated that embryolethality occurred in rats in the presence of maternal toxicity at all doses. ||| Studies with both hemodialysis and CAPD (chronic ambulatory peritoneal dialysis) indicate that A771726, the primary metabolite of leflunomide, is not dialysable. ||| Des études de reproduction par administration orale de buprénorphine: naloxone (ratio 1:1) ont révélé l’ apparition d’ une embryoléthalité chez le rat en présence d’ une toxicité maternelle quelle que soit la dose administrée.
0.3528047800064087 ||| The maximum dose of CYSTAGON used in clinical trials was 1.95 g/ m2/ day. ||| 6 VASOVIST has been tested in humans up to a dose of 0.15 mmol/ kg (5 times the clinical dose). ||| La dose maximale de CYSTAGON utilisée dans les essais cliniques a été de 1,95 g/ m²/ jour.
0.31425654888153076 ||| Insulating doors of non-metallic materials ||| Non-metallic building materials for draught proofing ||| Portes isolantes en matériaux non métalliques
0.3762970566749573 ||| The committee decided that Cystadane’ s benefits outweighed its risks in the adjunctive treatment of homocystinuria, when it is used according to its indication. ||| At this point in time, the CHMP was of the opinion that the benefits of Valdoxan/ Thymanax did not outweigh its risks. ||| Le comité a estimé que le profil bénéfice-risque de Cystadane était positif en adjonction pour le traitement de l’ homocystinurie, lorsqu’ il est utilisé conformément à son indication.
0.7820725440979004 ||| Harps ||| Month ||| Harpes
0.4274481534957886 ||| - skin breakdown and tissue destruction (necrosis) at injection site* ||| - Reaction or inflammation at the site of injection, fever ||| - déchirure de la peau et destruction des tissus (nécrose) au site d’injection*
0.37356096506118774 ||| Salts Water for injections. ||| Solvent: water for injections. ||| Sels Eau pour préparations injectables
0.3768573999404907 ||| Each vial contains 5 ml of concentrate. ||| Each vial of diluent contains: ||| Chaque flacon contient 5 ml de solution à diluer.
0.02337281033396721 ||| If not used immediately, it must be stored at 2°C - 8°C in the refrigerator and used within 24 hours. lp ||| If not used immediately, it must be stored at 2°C - 8°C in the refrigerator and used within 24 hours. t uc ||| elle doit être conservée entre 2°C et 8°C au réfrigérateur et utilisée dans les 24 heures.
0.3184486925601959 ||| Enbrel has been studied in 2,680 patients with rheumatoid arthritis in double-blind and open-label trials. ||| Over 4,400 allergic asthma patients were randomised in controlled efficacy trials with Xolair. ||| 189 Enbrel a été étudié chez 2680 patients atteints de polyarthrite rhumatoïde lors d’ essais en double aveugle et en ouvert.
0.2528648376464844 ||| Findings were only observed in association with maternal toxicity at ≥ 150 mg/kg and included a transient decrease in body weight and reduced motor activity in the F1 generation. ||| F1 fertility was not affected, while an increased number of resorptions and a decreased number of viable foetuses was noted at 45 mg/ kg/ day. ||| Des effets n’ ont été observés qu’ en association avec une toxicité maternelle à des doses ≥ 150 mg/ kg et ont inclus une diminution transitoire du poids et une réduction de l’ activité motrice dans la génération F1.
0.010780001059174538 ||| - If you have received an organ transplant, either kidney or liver, interferon treatment may increase ||| - if you have received an organ transplant, either kidney or liver, interferon treatment may increase ||| - si vous avez été transplanté, soit d’ un rein soit du foie, le traitement par interféron peut
5.177105489098666e-13 ||| Idiopathic thrombocytopenic purpura ||| Idiopathic thrombocytopenic purpura ||| Purpura thrombopénique idiopathique
0.3173711597919464 ||| Mean (SD) PegIntron elimination half-life is approximately 40 hours (13.3 hours), with apparent clearance of 22.0 ml/hr·kg. ||| Excretion Posaconazole is slowly eliminated with a mean half-life (t½) of 35 hours (range 20 to 66 hours). ||| La demi-vie d’ élimination moyenne de PegIntron est approximativement de 40 heures (σ = 13,3 heures), avec une clairance apparente de 22,0 ml/ h. kg.
0.03275100141763687 ||| PritorPlus is available in blisters packs containing 14, 28, 30, 56, 90 or 98 tablets, or unit dose blister packs containing 28 x 1 tablets. ||| 64 Pritor is available in blister packs containing 14, 28, 30, 56, 90, 98 or 280 tablets, or unit dose blister packs containing 28 x 1 tablets. ||| PritorPlus est disponible en plaquettes thermoformées de 14, 28, 30, 56, 90 ou 98 comprimés, ou plaquette de doses unitaires contenant 28 x 1 comprimés.
0.0925799161195755 ||| 20.6.1997 22.10.1997 125 days 0 days ||| 25.7.1997 19.11.1997 119 days 0 days ||| 18.02.97 22.10.97 208 Jours 34 Jours
3.666049939749644e-13 ||| pulmonary oedema, pharyngeal oedema, pleural effusion, pleurisy ||| pulmonary oedema, pharyngeal oedema, pleural effusion, pleurisy ||| Oedème pulmonaire, œ dème pharyngé, Rare épanchement pleural, pleurésie.
0.3497905731201172 ||| Provision of investment savings plans ||| Provision of pension schemes ||| Fourniture de plans d'épargne d'investissement
0.23666909337043762 ||| Study 2 Study 2 was a randomised, double-blind, multi-centre, outpatient trial to evaluate the efficacy, safety, and pharmacokinetics of three dose levels of TORISEL when administered to previously treated patients with advanced RCC. ||| The safety and effectiveness of once every three weeks dosing of Aranesp therapy in reducing the requirement for red blood cell transfusions in patients undergoing chemotherapy was assessed in a randomised, double-blind, multinational study. ||| Étude 2 L'étude 2 a consisté en un essai multicentrique en ambulatoire, randomisé et en double aveugle, ayant pour objectifs d'évaluer l'efficacité, la tolérance et la pharmacocinétique de trois paliers de dose de TORISEL administrés à des patients porteurs d'un CRA déjà traités.
0.44926315546035767 ||| Any emergency measures must be limited in time and be strictly proportionate. ||| Research indicates that measures must be applied rigorously and immediately in order to be effective. ||| Toutes les mesures d'urgence doivent être limitées quant à leur durée et strictement proportionnées.
0.4083825945854187 ||| Metabolism and nutrition disorders Very common: decreased appetite Common: dehydration ||| Very common: crying abnormal, irritability, restlessness Common: nervousness ||| Troubles du métabolisme et de la nutrition Très fréquent: perte d’ appétit Fréquent: déshydratation
0.4817645251750946 ||| Bondenza is not recommended for patients who have severe kidney problems. ||| People who handle Halocur repeatedly may develop skin allergies. ||| Bondenza n'est pas recommandé chez les patientes présentant des troubles rénaux sévères.
0.6130724549293518 ||| AUC: ↓ 38% (↓ 28 to ↓ 47) Cmax: ↓ 32% (↓ 15 to ↓ 46) Cmin: ↓ 45% (↓ 31 to ↓ 56) Efavirenz: ||| Morning AUC: ↑ 18% (↑ 6 to ↑ 33) Evening AUC: ↔ Morning Cmax: ↑ 24% (↑ 12 to ↑ 38) Evening Cmax: ↔ Morning Cmin: ↑ 42% (↑ 9 to ↑ 86)b Evening Cmin: ↑ 24% (↑ 3 to ↑ 50)b Efavirenz: ||| ASC: ↓ 38% (↓ 28 à ↓ 47) Cmax: ↓ 32% (↓ 15 à ↓ 46) Cmin: ↓ 45% (↓ 31 à ↓ 56) Efavirenz:
0.7874115705490112 ||| Burkholderia cepacia$+ Pseudomanas aeruginosa* ||| a) Piglets b) Neonatal colibacillosis ||| Burkholderia cepacia$+ Pseudomonas aeruginosa*
0.11412985622882843 ||| Arranging of displays for educational purposes ||| Arranging of exhibitions for advertising purposes ||| Organisation d'exposés à des fins didactiques
0.3181397616863251 ||| Cetuximab has not been studied in patients with pre-existing haematological disorders (see section 4.4). ||| Pelzont was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia. ||| Le cetuximab n'a pas été étudié chez des patients présentant des troubles hématologiques préexistants (voir rubrique 4.4).
0.5490185618400574 ||| Thrombocytopenia Anaemia, leukopenia, neutropenia, pancytopenia* Aplastic anaemia* ||| Febrile neutropenia Neutropenia Leukopenia Thrombocytopenia Anaemia ||| Thrombocytopénie Anémie, leucopénie, neutropénie, pancytopénie* Aplasie médullaire*
0.3452496826648712 ||| If you experience a reaction like this, you should tell your doctor immediately. ||| Your doctor will treat you, as appropriate, if you have any side effects. ||| Si vous avez une telle réaction, vous devez en informer immédiatement votre médecin.
0.35792824625968933 ||| Preparation: ||| Presentation: ||| Préparation:
0.3722352981567383 ||| Treatment of peripheral neuropathic pain ||| Treatment of diabetic peripheral neuropathic pain in adults. ||| 30 Traitement des Douleurs Neuropathiques Périphériques
0.3586597442626953 ||| ra − nefazodone (anti-depressor) Please inform your doctor or pharmacist if you are taking or have recently taken the above mentioned medicines or any other medicines, including those obtained without a prescription such as St John ’ s ||| to anti-erythropoietin antibodies was observed in some patients treated with other ESAs. – If your doctor suspects or confirms that you have these antibodies in your blood you must not be treated with MIRCERA. ||| st Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment les médicaments mentionnés ci-dessus ou tout autre médicament, même s’il s’agit de médicaments n'e
0.19836173951625824 ||| Levemir Penfill that is not being used is to be stored in the refrigerator at 2°C - 8°C, away from the freezer compartment. ||| Monotard vials that are not being used are to be stored in the fridge at 2°C - 8°C, away from the dic ||| Levemir Penfill non utilisé est à conserver au réfrigérateur entre 2°C et 8°C à distance du compartiment de congélation.
0.7024088501930237 ||| Maximum daily dose was not specified in some of the approved SPCs. ||| 1 The number of person-days of interpretation needed for active spoken languages. ||| La dose quotidienne maximum n’a pas été spécifiée dans certains des textes RCP approuvés.
0.27780306339263916 ||| Cetuximab has not been studied in patients with pre-existing haematological disorders (see section 4.4). ||| Topotecan has been shown to cause embryo-foetal lethality and malformations in preclinical studies (see section 5.3). ||| Le cetuximab n'a pas été étudié chez des patients présentant des troubles hématologiques préexistants (voir rubrique 4.4).
0.027583714574575424 ||| For the full list of all side effects reported with Tamiflu, see the Package Leaflet. ||| For the full list of all side effects reported with Tractocile, see the Package Leaflet. ||| Pour la liste complète des effets indésirables observés sous Tamiflu, voir la notice.
0.46429499983787537 ||| Portable signs [non-luminous, non-mechanical, non-metallic] for roads ||| Signs, non-luminous and non-mechanical, of metal ||| Panneaux routiers mobiles [non lumineux, non mécaniques, non métalliques]
0.6871474981307983 ||| Harpoons ||| Risperidon ||| Harpons
0.7503480315208435 ||| Somatropin and analogues; ATC code: ||| CPK elevations and rhabdomyolysis: ||| Somatropine et analogues; code ATC:
0.12585267424583435 ||| Treatment of symptomatic chemotherapy induced anaemia in cancer patients ||| Treatment of symptomatic chemotherapy-induced anaemia in cancer patients: ||| Traitement de l’ anémie symptomatique induite par la chimiothérapie chez les patients cancéreux
0.42097628116607666 ||| Reconstituting Omnitrope ||| Injecting Omnitrope ||| Reconstitution d’ Omnitrope
0.05273410677909851 ||| 10ml (3.5 mg/ ml) ||| 10 ml (1.4 mg/ ml) ||| 10 ml (3,5 mg/ ml)
0.08754408359527588 ||| The analysis of all recorded in vivo recoveries in previously treated patients demonstrated a mean rise of 2% per IU/ kg body weight for Helixate NexGen. ||| The analysis of all recorded in vivo recoveries in previously treated patients demonstrated a mean rise of 2% per IU/ kg body weight for KOGENATE Bayer. ||| L'analyse de la récupération in vivo chez les patients préalablement traités a montré pour Helixate NexGen une augmentation moyenne du taux de facteur VIII plasmatique de 2% par UI/ kg de poids corporel.
0.4128432869911194 ||| Only use it if the solution is clear, colourless and has no visible particles in it. ||| It is a clear, almost colourless solution that is prepared and diluted before it is used. ||| Ne l’utilisez que si la solution est limpide, incolore et ne contient pas de particules visibles.
0.3442695140838623 ||| Treatment of respiratory infections due to Pasteurella multocida and Mannheimia haemolytica. ||| Progressive atrophic rhinitis is caused by toxins from the bacteria Pasteurella multocida. ||| Traitement des infections respiratoires dues à Pasteurella multocida et Mannheimia haemolytica
0.13849791884422302 ||| The active substance in Avandia, rosiglitazone, makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces. ||| Pioglitazone makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces. ||| Le principe actif d’ Avandia, la rosiglitazone, rend les cellules (graisseuses, des muscles et du foie) plus sensibles à l’ insuline, ce qui signifie que le corps utilise mieux l’ insuline qu’ il fabrique.
0.26210421323776245 ||| The mean maximum decreases in supine systolic blood pressure following 20 mg and 40 mg vardenafil were – 6.9 mmHg under 20 mg and – 4.3 mmHg under 40 mg of vardeanfil, when compared to placebo. ||| For the triglycerides an average decrease of 6.9% was seen under rimonabant 20 mg (baseline TG 1.62 mmol/ l) compared to an increase of 5.8% for placebo (baseline TG 1.65 mmol/ l). ||| La baisse moyenne maximale de la pression artérielle systolique en position couchée, après administration de 20 mg et 40 mg de vardénafil a été respectivement de - 6,9 mmHg et de - 4,3 mmHg, comparativement au placebo.
3.663710502511963e-13 ||| Medicines should not be disposed of via wastewater or house hold waste. ||| Medicines should not be disposed of via wastewater or house hold waste. ||| 91 Les médicaments ne doivent pas être jetés au tout-à-l’égout ou avec les ordures ménagères.
0.17036449909210205 ||| OUTER CARTON TEXT (5 x 3ml cartridges) ||| OUTER CARTON TEXT (5 x 3ml Pens) ||| CONDITIONNEMENT EXTERIEUR (5 x 3ml en cartouches)
0.2827357053756714 ||| For bipolar disorder, the recommended starting dose is 15 mg by mouth once a day, either on its own or in combination with other medicines. ||| Then, the usual dose is one 75 mg tablet of Plavix per day to be taken orally with or without food, and at the same time each day. ||| Pour les troubles bipolaires, la dose de départ recommandée est de 15 mg par voie orale une fois par jour, soit seul, soit en combinaison avec d’ autres médicaments.
0.3296061158180237 ||| Image processors ||| Application processors ||| Processeurs d'images
0.18622182309627533 ||| Following the administration of a double dose in chickens and ducks, no adverse reactions other than those described in section 4.6 have been observed. ||| Following the administration of overdoses of vaccine, no side-effects other than those described under 4.6 have been observed. ||| Suite à l’ administration d’ une double dose chez la poule et le canard, il n’ a pas été observé d’ autres effets que ceux décrits au paragraphe 4.6.
0.3397994339466095 ||| Female patients in clinical studies were found to be more susceptible than male patients to gastrointestinal adverse reactions and weight loss. ||| Children and adults with chronic renal failure and end-stage renal disease tend to have decreased clearance compared to normal subjects. ||| Dans les études cliniques, il a été observé que les femmes étaient plus susceptibles que les hommes de présenter des troubles gastro-intestinaux et une perte de poids.
5.682150713490208e-13 ||| The following information is intended for medical or healthcare professionals only: ||| The following information is intended for medical or healthcare professionals only: ||| Les informations suivantes concernent uniquement les professionnels de santé:
0.19130772352218628 ||| Do not use in case of hypersensitivity to the active substance or to any of the excipients. ||| - Known hypersensitivity to the active substance or to any of the excipients of this product. ||| Ne pas utiliser en cas d’ hypersensibilité au principe actif ou à l’ un des excipients.
0.66283118724823 ||| Undesirable effect Spleen disorder ||| Increased cyber resilience. ||| Effets indésirables Troubles spléniques
0.3547841012477875 ||| An effect of this magnitude is not generally expected to be clinically relevant. ||| This is considered a species-specific effect and of no clinical relevance. ||| Un effet de cette ampleur n’ a généralement pas de pertinence clinique attendue.
0.3374733328819275 ||| If you use more Evoltra than you should If you think you may have been given too much medicine, tell your doctor straight away. ||| If you have used more Ceplene than you should You must use this medicine exactly as it has been prescribed for you. ||| Si vous avez utilisé plus d’ Evoltra que vous n’ auriez dû Si vous pensez que vous avez peut-être reçu trop de médicament, parlez -en à votre médecin immédiatement.
1.1284334659576416 ||| Tel: +371 7364 224 msd_lv@merck.com ||| ho lv-epasts@gsk.com ||| Tel: +371 7364 224 msd_lv@merck. com
0.2571084201335907 ||| MIRCERA 75 micrograms/ 0.3 ml solution for injection in pre-filled syringe. ||| Rebif 44 micrograms/ 0.5ml solution for injection in cartridge ||| MIRCERA 75 microgrammes/ 0,3 ml solution injectable en seringue préremplie.
0.1676655411720276 ||| In vitro studies using human liver preparations demonstrated that cytochrome P450 1A2 is the principal isoenzyme involved in the metabolism of riluzole. ||| In vitro metabolism studies with human liver microsomes indicated that CYP3A4 is the predominant CYP isoform involved in tipranavir metabolism. ||| Des études in vitro sur préparations de cellules de foie humain ont montré que le cytochrome P 450 1A2 est la principale isoenzyme impliquée dans le métabolisme du riluzole.
0.31449341773986816 ||| Cleaning agents for deep freezers ||| Fire ventilators for exhausting gases ||| Produits de nettoyage pour congélateurs
0.47176480293273926 ||| Urinary retention, urinary incontinence, dark urine, priapism. ||| Urinary retention (including feeling of residual urine; micturition disorder); Urinary hesitation ||| Rétention d'urine, incontinence urinaire, urines foncées, priapisme.
0.24762167036533356 ||| Do not use MIRCERA after the expiry date which is stated on the outer carton and pre-filled syringe label after ‘EXP’. ||| Do not use Ciprofloxacin Bayer after the expiry date, which is stated on the blister or carton after “EXP”: ||| Ne pas utiliser MIRCERA après la date de péremption mentionnée sur l’ emballage extérieur et l’ étiquette de la seringue préremplie après « EXP ».
0.10481052845716476 ||| DuoTrav can only be obtained with a prescription. ||| Fertavid can only be obtained with a prescription. ||| Ce médicament peut uniquement être obtenu sur ordonnance.
0.8755028247833252 ||| ANC (x 10 / l) ||| Placebo (n = 157) No. ||| PNN (x 10 / l)
0.36766231060028076 ||| However, accumulation of brinzolamide is unlikely as renal elimination is the major route. ||| These data indicate that elimination of micafungin is primarily non-renal. ||| Cependant, l’ élimination rénale étant la voie principale, l’ accumulation de brinzolamide est improbable.
0.1724732667207718 ||| Infants whose mothers have taken angiotensin II receptor antagonists should be closely observed for hypotension (see also sections 4.3 and 4.4). ||| Newborns whose mothers have taken ACE inhibitors should be closely observed for hypotension, oliguria and hyperkalaemia (see also sections 4.3 and 4.4). ||| Les nouveaux- nés de mère traitée par ARAII doivent être surveillés sur le plan tensionnel (voir rubriques 4.3 et 4.4).
0.26605117321014404 ||| Pharmaceutical preparations and substances for use in urology ||| Pharmaceutical preparations and substances with analgesic properties ||| Substances et préparations pharmaceutiques utilisées en urologie
0.3812809884548187 ||| Before using Vaniqa, tell your doctor of any other medical problems (especially related to your kidneys or liver). ||| Your doctor will also perform tests to monitor your kidney function and, possibly, your liver function, during therapy with Rapamune. ||| avant d'utiliser ce produit, parlez à votre médecin de vos autres problèmes médicaux (spécialement ceux touchant les reins ou le foie).
0.3834482729434967 ||| The guidelines also make recommendations for each mode of transport and call for coordination among Member States in light of re-establishment of gradual connections between them. ||| They should operate in complementarity to the REACT-EU initiative and under more flexible rules and allow for quicker reaction to emergency situations at national and regional level. ||| Les orientations fournissent en outre des recommandations spécifiques pour chaque mode de transport et appellent à la coordination entre les États membres à la lumière du rétablissement progressif des liaisons entre pays de l'UE.
0.0 ||| The initial dose is 150 IU/ kg given subcutaneously 3 times per week. ||| The initial dose is 150 IU/ kg given subcutaneously 3 times per week. ||| 94 La dose initiale est de 150 UI/ kg, administrée par voie sous-cutanée, 3 fois par semaine.
0.42626985907554626 ||| Such reactions are generally mild/moderate, occur early in treatment and last only for a short time. ||| These reactions are usually mild and last only for a short time. ||| De telles réactions sont généralement légères / modérées, surviennent en début de traitement et ne durent pas longtemps.
0.40088337659835815 ||| Coatings for the finishing of concrete ||| Coating compositions in the form of paint ||| Revêtements (lacques) pour la finition du béton
0.6514987945556641 ||| What is the Commission doing to save jobs in the tourism sector? ||| How is the EU going to stop money laundering and terrorist financing? ||| Que fait la Commission pour sauver des emplois dans le secteur du tourisme?
0.600587010383606 ||| Ascites ||| Ovens ||| Ascite
0.48770973086357117 ||| Freezers (Installation of -) ||| Buildings (Insulation to existing -) ||| Installation de réfrigérateurs
0.20354010164737701 ||| What is Crixivan used for? ||| What is Virbagen Omega used for? ||| Dans quel cas Crixivan est -il utilisé?
0.17314699292182922 ||| - The other ingredients are microcrystalline cellulose, croscarmellose sodium, povidone, lactose ||| - The other ingredients are lactose monohydrate, crospovidone, poloxamer 188, silica colloidal ||| - Les autres composants sont: cellulose microcristalline, croscarmellose sodique, povidone,
0.3428713083267212 ||| The most benefit from Gardasil is expected before infection with any of the Human Papillomavirus types covered by the vaccine. ||| Health experts are concerned that the next flu pandemic could be caused by the H5N1 strain of the virus. ||| Le bénéfice le plus élevé de Gardasil est attendu s'il est administré avant l'infection par l'un des types de Papillomavirus Humains couverts par le vaccin.
0.15808171033859253 ||| 3/ 19 Vaccination Administer one dose of 2 ml by intramuscular injection in the neck, in the area behind the ear, according to the following schedule: ||| Administer one dose (2 ml), by intramuscular injection in the neck in the area behind the ear, according to the following schedule: ||| Vaccination Injection intramusculaire de 2 ml de vaccin par animal au niveau du cou, en arrière de l'oreille, selon le schéma suivant:
0.42385369539260864 ||| If an excessive response is obtained, treatment should be stopped and hCG withheld. ||| Treatment with Glivec may be interrupted or the dose may be reduced, as ||| Si une réponse excessive est obtenue, le traitement devra être arrêté et l’ hCG ne devra pas être administrée.
0.24706929922103882 ||| CVMP noted that Compagel gel for horses is a generic of Tensolvet 50000 (authorised in Germany) and that the concerns raised by France and Sweden can only be addressed in the framework of this procedure, in case any differences between the two products would justify different conclusions on the safety or efficacy. ||| The CHMP considered the MAH responses and agreed that although data may suggest that prolactin is involved in breast cancer etiology, further studies are required to establish a formal link, and therefore adopted the following wording, addressing the potential risks of hyperprolactinaemia, although without specific inclusion of prolactinoma and breast cancer: ||| Le CVMP a noté que Compagel gel pour cheval est un générique de Tensolvet 50000 (autorisé en Allemagne) et que les inquiétudes soulevées par la France et la Suède ne peuvent être examinées que dans ce cadre de la présente procédure, dans l’ éventualité où des différences quelconques entre les deux produits justifieraient des conclusions différentes sur les questions de sécurité et d’ efficacité.
0.5183260440826416 ||| Medical instruments for percutaneous tracheostomy ||| Adults receiving peritoneal dialysis ||| Instruments médicaux pour trachéostomie percutanée
0.3224179744720459 ||| RoActemra was more effective than the comparator medicines at reducing the symptoms of rheumatoid arthritis. ||| Unlike some other antipsychotic agents, olanzapine increases responding in an “ anxiolytic” test. ||| RoActemra s’ est avéré plus efficace que les médicaments de comparaison s’ agissant de la réduction des symptômes de la polyarthrite rhumatoïde.
0.25981125235557556 ||| can be used alone if the patient cannot take methotrexate. • psoriatic arthritis (a disease causing red, scaly patches on the skin and inflammation of the joints) in patients who have not responded adequately to other treatments, rod ||| Avonex slows the progression of disability and reduces the number of relapses; • patients who have experienced the signs of MS for the first time, when these are severe enough to justify treatment with injected corticosteroids (anti-inflammatory medicines). ||| administré en monothérapie en cas d'intolérance au méthotrexate; • polyarthrite psoriasique (maladie provoquant l’ apparition de plaques rouges et squameuses sur la peau et l’ inflammation des articulations); chez les patients chez lesquels la réponse à dic
0.27589595317840576 ||| How does QUADRAMET work? ||| How does VASOVIST work? ||| Comment QUADRAMET agit -il?
0.16214513778686523 ||| - The other ingredients are microcrystalline cellulose, croscarmellose sodium, povidone, lactose ||| - The other ingredients are: cellulose, microcrystalline; povidone; sodium starch glycolate; silica, ||| - Les autres composants sont: cellulose microcristalline, croscarmellose sodique, povidone,
0.11395924538373947 ||| 38 United Kingdom ||| 35 United Kingdom ||| 38 Royaume Uni
0.0 ||| Frequency and route of administration ||| Frequency and route of administration ||| Fréquence et voie d’ administration
5.988519684481386e-13 ||| 43 9. ||| 43 9. ||| 45 9.
0.6944152116775513 ||| Very common Common Common Common Common Common Common Common ||| Very common Common Very common Common Very common Common ||| Très fréquent Fréquent Fréquent Fréquent Fréquent Fréquent Fréquent Fréquent
0.4127890467643738 ||| Circadin tablets should not be crushed or cut in half. ||| Empty cartridges must not be refilled. ||| Les comprimés de Circadin ne doivent pas être écrasés ou coupés en deux.
2.867799585044156e-13 ||| Over a subsequent two week period where patients were re-randomized to either active medicinal product or placebo, patients on placebo had increases of 2.4 and 2.0 mmHg in SeSBP and SeDBP compared to +0.1 and -0.3 mmHg changes respectively in those on all doses of irbesartan (see section 4.2). ||| Over a subsequent two week period where patients were re-randomized to either active medicinal product or placebo, patients on placebo had increases of 2.4 and 2.0 mmHg in SeSBP and SeDBP compared to +0.1 and -0.3 mmHg changes respectively in those on all doses of irbesartan (see section 4.2). ||| 41 semaines pendant laquelle les patients ont été re-randomisés sous la substance active ou le placebo, les patients sous placebo ont eu une augmentation de la PAS ass de 2,4 mm Hg et de la PAD ass de 2,0 mm Hg comparée à une modification de +0,1 et - 0,3 mm Hg respectivement pour les patients sous irbésartan toutes doses (voir rubrique 4.2).
0.3614775836467743 ||| Wood veneer parquet flooring ||| Parquet wood flooring ||| Parquets à placage de bois
0.28485214710235596 ||| 180 As a fluoroquinolone antibacterial agent, the bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. ||| Clostridium botulinum type A neurotoxin complex blocks peripheral acetylcholine release at presynaptic cholinergic nerve terminals by cleaving SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within the nerve endings. ||| Son activité bactéricide résulte de l’inhibition de la topo-isomérase de type II (ADN-gyrase) et de la topo-isomérase IV, nécessaires à la réplication, la transcription, la réparation et la recombinaison de l'ADN bactérien.
0.3888217806816101 ||| Sanofi-Aventis Deutschland GmbH Brüningstraße 50, D-65926 Frankfurt am Main Germany. ||| Manufacturer CSL Behring GmbH, Emil-von-Behring-Straße 76, 35041 Marburg, Germany. ||| Sanofi-Aventis Deutschland GmbH Brüningstraße 50, D-65926 Frankfurt am Main Allemagne.
0.03317633271217346 ||| For the full description of the side effects reported with Humalog, please see the Package Leaflet. ||| For the full description of the side effects reported with Metalyse, please see the Package Leaflet. ||| Pour une description complète des effets indésirables observés avec Humalog, veuillez vous reporter à la notice.
0.29641902446746826 ||| The European Investment Bank is building a pipeline of investment projects to develop and scale up production of coronavirus vaccines, tests and treatments, in partnership with Commission, the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI). ||| Finally, the European and Developing Countries Clinical Trials Partnership (EDCTP) is funding three calls of up to €28 million from Horizon 2020 to support research on the coronavirus and strengthen research capacities in sub-Saharan Africa. ||| La Banque européenne d'investissement est en train de constituer une réserve de projets d'investissement afin de développer et d'augmenter la production de vaccins, de tests de dépistage et de traitements contre le coronavirus, en partenariat avec la Commission, l'Organisation mondiale de la santé et la Coalition pour les innovations en matière de préparation aux épidémies (CEPI).
0.3373677730560303 ||| Stalevo should not be used together with other medicines that belong to the group ‘ monoamine oxidase inhibitors ’ (a type of antidepressant). ||| The efficacy of Intrinsa is reduced if your estrogen therapy is of a certain type (‘ conjugated equine estrogens’). ||| Stalevo ne doit pas être utilisé en association avec d’ autres médicaments appartenant à la classe des inhibiteurs de la monoamine oxydase (un type d’ antidépresseur).
0.4112790524959564 ||| Lymphoid blast crisis: a limited number of patients were enrolled in phase I studies (n=10). ||| Study S2 (105) evaluated patients who were splenectomised and continued to have thrombocytopenia. ||| Crise blastique lymphoïde: un nombre limité de patients ont été inclus dans les études de phase I (n=10).
0.010851297527551651 ||| 35 patients in Shenzhen tested negative in a median of 4 days, while the length of illness was 11 days in the 45 patients who did not receive it. ||| Of 35 patients in Shenzhen tested negative in a median of 4 days, while the length of illness was 11 days in the 45 patients who did not receive it. ||| 35 patients à Shenzhen ont été testés négatifs dans un délai moyen de 4 jours alors que la durée de la maladie était de 11 jours chez les 45 patients qui ne l’avaient pas reçu.
0.08794891834259033 ||| - The active substance is recombinant interferon alfa-2b, 60 million IU/ pen ||| - The active substance is recombinant interferon alfa-2b, 10 million IU/ml. ||| - La substance active est l’interféron alfa-2b recombinant, 60 millions d’UI/stylo
0.020011216402053833 ||| The target haemoglobin concentration in two studies was > 13 g/dl; in the remaining three studies it was 12-14 g/dl. ||| The target haemoglobin concentration in two studies was > 13 g/ dl; in the remaining three studies it was 12-14 g/ dl. ||| Dans deux des études, le taux d’ hémoglobine cible était de > 13 g/ dl; dans les trois autres études, il était de 12 à 14 g/ dl.
0.18042638897895813 ||| Provision of educational services relating to fitness ||| Provision of education courses relating to electronics ||| Services d'éducation concernant la forme physique
0.5736861228942871 ||| Target tissues ||| Textile testing ||| Tissus cibles
0.38386204838752747 ||| Some articles on popular sites in China have also cast suspicion on US military athletes participating in the Wuhan 2019 Military World Games, which lasted until the end of October 2019, and have suggested they deployed the virus. ||| Following the outbreak of coronavirus disease 2019, the Italian government confirmed the country's first cases of the disease on 30 January 2020, when the virus was detected in two Chinese tourists visiting Italy. ||| Certains articles de sites populaires en chinois ont également soupçonné les athlètes militaires américains ayant participé aux Jeux mondiaux militaires d'été 2019 à Wuhan qui ont duré jusqu'à la fin octobre 2019 d'avoir introduit le virus.
0.0020030816085636616 ||| 219 Viraferon therapy has not reversed thyroid dysfunction occurring during treatment (also see Children and adolescents, Thyroid monitoring). ||| 181 Viraferon therapy has not reversed thyroid dysfunction occurring during treatment (also see Children and adolescents, Thyroid monitoring). ||| tor cours de traitement par Viraferon n'ont pas été réversibles à l’ arrêt du traitement (voir également Enfants et adolescents, Surveillance de la thyroïde).
0.854790985584259 ||| Tablet coat Hypromellose Titanium dioxide E171 Talc Macrogol 6,000 ||| 19 October 1995 Naftidrofuryl 19 December 1995 Sparfloxacin Anorectics: ||| 14 Pelliculage du comprimé Hypromellose Dioxyde de titane E171 Talc Macrogol 6000
0.36364662647247314 ||| - itraconazole (medicine to treat fungal infections) ||| - lopinavir/ ritonavir (another medicine to treat HIV-infection) ||| - de l’ itraconazole (médicament pour traiter les infections fongiques)
0.3071230947971344 ||| The main areas of disharmony of the existing Summary of Product Characteristics were section 4.1 Therapeutic Indications, section 4.3 Contraindications, and section 4.4 Special Warnings and Precautions for Use. ||| On the basis of the grounds for referral, the point considered by the CPMP was a harmonisation of the Summaries of Product Characteristics, especially regarding the Therapeutic indications, the Posology and the Contraindications. ||| Les principaux domaines de divergence du résumé des caractéristiques du produit existant étaient la section 4.1 « Indications thérapeutiques », la section 4.3 « Contre-indications » et la section 4.4 « Mises en gardes spéciales et précautions particulières d’ emploi ».
0.31758707761764526 ||| If inadequate pain relief is obtained with 2 x 100 microgram sublingual tablets, an increase in dose to the next higher available strength for the next episode of breakthrough pain should be considered. ||| For all practical purposes by the second 72-hour application, a steady state serum concentration is reached and is maintained during subsequent applications of a patch of the same size. ||| Si les deux comprimés sublinguaux de 100 µg ne permettent pas d’ obtenir un soulagement adéquat de la douleur, le passage au dosage immédiatement supérieur doit être envisagé pour le traitement de l’ accès douloureux paroxystique suivant.
0.09258235991001129 ||| SP Europe Rue de Stalle, 73 B-1180 Bruxelles Belgium ||| SP Europe 73, rue de Stalle B-1180 Bruxelles Belgium ||| SP Europe 73, rue de Stalle B-1180 Bruxelles Belgique
0.18958395719528198 ||| Patients who have problems with their liver (including hepatitis B or C infection) may be at an elevated risk of liver damage when taking Sustiva. ||| Patients who have problems with their liver may be at an elevated risk of liver damage when taking Reyataz. ||| Les patients présentant des problèmes de foie (notamment hépatite B ou C) peuvent présenter un risque plus élevé de lésions du foie lors d’ un traitement par Sustiva.
0.5071772336959839 ||| The Ministry of Health issued a warning recommending Brazilians and foreigners arriving in Brazil to stay in isolation for at least 7 days. ||| The Supreme Court of Canada has closed the building to public tours, while maintaining the ability to file documents for cases electronically. ||| Le ministère de la Santé a émis un avertissement recommandant aux Brésiliens et aux étrangers arrivant au Brésil de rester isolés pendant au moins 7 jours.
0.4801260828971863 ||| 233 System Organ Class ||| 40 System Organ Class: ||| Classe de systèmes
0.3003894090652466 ||| Haemophiliac patients should therefore be made aware of the possibility of increased bleeding. ||| Patients of advanced age have an increased risk of bleeding complications with anticoagulation. ||| Les patients hémophiles doivent par conséquent être informés de la possibilité d'augmentation des saignements.
0.4640897512435913 ||| Neoplasms benign, malignant and unspecified (including cysts and polyps) ||| Neoplasms, benign, malignant and unspecified ||| 36 Tumeurs bénignes, malignes et non précisées (incl kystes et polypes)
0.3416661024093628 ||| Pre-existing hypocalcaemia must be treated by adequate intake of calcium and vitamin D before initiating therapy with Aclasta. ||| Physicians should consider the nicotinic acid intake from vitamins and nutritional supplements when prescribing Tredaptive. ||| Une hypocalcémie préexistante doit être traitée par un apport approprié de calcium et de vitamine D avant d’ initier le traitement par Aclasta.
0.007550600450485945 ||| Based on the results of comparative clinical studies, it is considered appropriate to give a lower dosage of Fertavid than generally used for urinary FSH, not only in order to optimise follicular development but also to minimise the risk of unwanted ovarian hyperstimulation. ||| 46 Based on the results of comparative clinical studies, it is considered appropriate to give a lower dosage of Fertavid than generally used for urinary FSH, not only in order to optimise follicular development but also to minimise the risk of unwanted ovarian hyperstimulation. ||| D’ après les résultats des études cliniques comparatives, il est recommandé d'administrer Fertavid à une posologie plus faible que celle généralement utilisée pour la FSH urinaire, non seulement pour optimiser la maturation folliculaire, mais aussi pour minimiser le risque d'hyperstimulation ovarienne non souhaitée.
0.1733606457710266 ||| 99 The usual starting dose of {PRODUCT NAME} is 10 mg once a day. ||| The maximum dose of {PRODUCT NAME} is 80 mg once daily. ||| La dose initiale habituelle de {NOM DU PRODUIT} est de 10 mg une fois par jour.
0.39384257793426514 ||| The adverse reactions listed in Table 1 are based on experience from clinical trials and post- marketing. ||| Chemical and physical in-use stability has been demonstrated for the times and solutions shown in the above Table. ||| Les effets indésirables rapportés après la mise sur le marché sont également décrits dans le Tableau 1 ci-dessous.
0.5444843173027039 ||| The dose you receive is based on your body weight in kilograms. ||| This is calculated from your height and weight. ||| La dose que vous recevez se base sur votre poids corporel en kilogrammes.
0.4390020966529846 ||| The use of Rapamune may lead to increased blood concentrations of cholesterol and triglycerides that may require treatment. ||| The strategy calls for the elimination of pollution from nitrogen and phosphorus flows from fertilisers by 2030. ||| L’utilisation de Rapamune peut conduire à une augmentation des concentrations de cholestérol et de triglycérides, pouvant nécessiter un traitement.
0.5055549740791321 ||| There is no clinical experience in patients with severe hepatic insufficiency (Child-Pugh score > 9). ||| Higher response rates were observed in patients with Genotypic Sensitivity Score (GSS) > 0. ||| On ne dispose d'aucune expérience clinique chez les patients ayant une insuffisance hépatique sévère (score Child-Pugh > 9).
0.6308077573776245 ||| Asthenia, fatigue, increased fat tissue, malaise ||| Fatigue, sweating increased, fall Weight decrease ||| Asthénie, fatigue, accroissement du tissu adipeux, malaise
0.3234499394893646 ||| Syntactic foams made from synthetic resins ||| Statuettes made of synthetic resins ||| Mousses syntactiques à base de résines synthétiques
0.5913906097412109 ||| I Viraferon (3 MIU 3 times a week) I/ R Viraferon (3 MIU 3 times a week) + ribavirin (1,000/ 1,200 mg/ day) no ||| 100 U/ Kg IV every week (recommended dose), 200 U/ Kg IV every week, 200 U/ Kg IV every 2 weeks; or 300 U/ KgIV every 2 weeks. ||| isé I Viraferon (3 MUI 3 fois par semaine) I/ R Viraferon (3 MUI 3 fois par semaine) + ribavirine (1.000/ 1.200 mg/ jour)
0.04056549817323685 ||| Any person intending to import, sell, supply and/ or use Porcilis AR-T DF must consult the relevant Member State’ s competent authority on the current vaccination policies prior to the import, sale, supply and/ or use. ||| Any person intending to import, sell, supply and/ or use Ingelvac CircoFLEX must consult the relevant Member State's competent authority on the current vaccination policies prior to the import, sale, supply and/ or use. ||| Toute personne ayant pour intention d’ importer, de vendre, de délivrer et/ ou d’ utiliser PORCILIS AR- T DF est tenue de consulter au préalable l’ autorité compétente pertinente de l’ État membre sur la politique de vaccination en vigueur.
0.1936904489994049 ||| 108 16. ||| 370 16. ||| 115 16.
0.021782010793685913 ||| It is not known whether amprenavir can be removed by peritoneal dialysis or haemodialysis. ||| It is not known whether abacavir can be removed by peritoneal dialysis or haemodialysis. ||| L’ intérêt de la dialyse péritonéale ou de l’ hémodialyse sur l’ élimination d’ amprénavir n’ est pas connu.
0.43172937631607056 ||| Your doctor will tell you exactly how many tablets of Galvus to take. ||| Your doctor will tell you how much Parareg you must take. ||| Votre médecin vous dira exactement combien de comprimés de Galvus vous devez prendre.
0.23239675164222717 ||| Each syringe contains 22 micrograms, corresponding to 6 million International Units (IU) of interferon beta-1a. ||| 1 pre-filled syringe of 1 ml contains 10 000 international units (IU) corresponding to 84.0 micrograms epoetin alfa ||| Chaque seringue contient 22 microgrammes ce qui correspond à 6 millions d’Unités Internationales (UI) d’interféron bêta-1a.
0.41438594460487366 ||| Cured meats ||| Husked oats ||| Viande fumée
0.3538782000541687 ||| In very rare cases following administration of Profender transient alopecia, pruritus and/or inflammation were observed at the application site. ||| The most common bleeding complications were associated with cardiac invasive procedures (CABG- related or at femoral artery access site). ||| Dans de très rares cas après administration de Profender, une alopécie transitoire, du prurit et/ou une inflammation ont été observés au site d'application.
0.4627363383769989 ||| The usual dose for Agenerase capsules is 20 mg for each kg of body weight, twice a day. ||| or The dosage for pigs, over 2 weeks, is 2 ml of the vaccine ||| La dose habituelle d’Agenerase capsules molles est de 20 mg par kilogramme de poids deux fois par jour.
0.23519283533096313 ||| Supply [transport] of water for domestic use ||| Supply [transport] of water through pipes ||| Distribution d'eau à usage domestique [transport]
0.05251948907971382 ||| Mean (% CV) multiple-dose pharmacokinetic parameters for IntronA and ribavirin capsules when administered to children or adolescents with chronic hepatitis C ||| Mean (% CV) multiple-dose pharmacokinetic parameters for interferon alfa-2b and Rebetol capsules when administered to children or adolescents with chronic hepatitis C ||| Tableau 6 Moyenne (% CV) des paramètres pharmacocinétiques après administration répétée d’ IntronA et de ribavirine en gélules chez les enfants ou adolescents présentant une hépatite C chronique
0.34096312522888184 ||| - against calicivirus infection to reduce clinical signs and excretion, ||| - against leukaemia to prevent persistent viraemia and clinical signs of the related disease. ||| - contre la calicivirose féline pour la réduction des signes cliniques et de l’ excrétion virale,
0.5659778118133545 ||| The incidence of adverse events was not related to dose (in the recommended dose range), gender, age, race, or duration of treatment. ||| No freight vehicle or driver should face discrimination, irrespective of origin and destination, the driver's nationality or the vehicle's country of registration. ||| L’ incidence des événements indésirables était indépendante de la posologie (dans la fourchette des posologies recommandées), du sexe, de l’ âge, de la race ou de la durée du traitement.
0.3943369686603546 ||| If you use more Evoltra than you should If you think you may have been given too much medicine, tell your doctor straight away. ||| If you take more Zeffix than you should Accidentally taking too much of your medicine is unlikely to cause any serious problems. ||| Si vous avez utilisé plus d’ Evoltra que vous n’ auriez dû Si vous pensez que vous avez peut-être reçu trop de médicament, parlez -en à votre médecin immédiatement.
0.12875427305698395 ||| Slovenija Novartis Pharma Services Inc. ||| Eesti Novartis Pharma Services Inc. ||| Slovenija Ireland Novartis Pharma Services Inc.
0.06404434144496918 ||| Viraferon is given in combination with ribavirin. no ||| Viraferon is given in combination with ribavirin. rod ||| Viraferon est donné en association avec la ribavirine.
5.275482199522397e-13 ||| The graph above shows the activity profiles over time of insulin glargine and NPH insulin. ||| The graph above shows the activity profiles over time of insulin glargine and NPH insulin. ||| La figure ci-dessus permet de comparer le profil de l'activité de l'insuline glargine et de l'insuline NPH en fonction du temps.
0.07113178819417953 ||| What benefit has Mimpara shown during the studies? ||| What benefit has Alimta shown during the studies? ||| Quel est le bénéfice démontré par Mimpara au cours des études?
0.32686322927474976 ||| What is the proposed date of application of the exemption of certain software assets from capital deductions? ||| What is the proposed date of application of the specific treatment envisaged for certain loans backed by pensions or salaries? ||| Quelle est la date d'application proposée pour l'exemption de l'obligation de déduction des fonds propres accordée pour certains actifs logiciels?
0.18007555603981018 ||| Brinzolamide has been authorised in the European Union (EU) as Azopt since 2000. ||| Entacapone has been authorised in the European Union (EU) as Comtess/ Comtan since 1998. ||| Le brinzolamide est autorisé dans l’ Union européenne sous le nom d’ Azopt depuis 2000.
0.16269612312316895 ||| How to take Neoclarityn 4. ||| How to store Neoclarityn 6. ||| Comment prendre Neoclarityn 4.
0.43727779388427734 ||| 45 Early on, osteoporosis usually has no symptoms. ||| 40 However, in clinical practice neutropenia could occur earlier. ||| Habituellement l'ostéoporose n'entraîne au début aucun symptôme.
0.3534606099128723 ||| The most common side effects with Clopidogrel BMS (seen in between 1 and 10 patients in 100) are haematoma (a collection of blood under the skin), epistaxis (nosebleeds), gastrointestinal haemorrhage (bleeding in the stomach or gut), diarrhoea, abdominal (tummy) pain, dyspepsia (indigestion), bruising and bleeding where the skin is punctured. ||| Reported bleeding events include: anaemia or drop in the haemoglobin value without obvious source of bleeding, bruising, bleeding from puncture sites, nose bleeding, blood in urine, gastrointestinal bleeding, vaginal bleeding, rectal bleeding, pulmonary haemorrhage, bleeding into chest space and around the heart following surgery, bleeding into the brain. ||| Les effets secondaires les plus courants avec Clopidogrel BMS (observés chez 1 à 10 patients sur 100) sont les suivants: hématomes (une accumulation de sang sous la peau), épistaxis (saignements du nez), hémorragies gastrointestinales (saignement dans l’ estomac ou l’ intestin), diarrhées, douleurs abdominales (dans le ventre), dyspepsie (indigestion), hématomes et saignement aux sites d’ injection sur la peau.
0.3274647295475006 ||| Part of the 2020 commitment of €36 million will also be reoriented to ensure our efforts are as targeted and relevant as possible for the coronavirus response. ||| The measure, with a budget of €250 million, aims at supporting the financing needs of these businesses at a crucial point of their economic development. ||| Une partie de l'engagement de 36 millions d'euros pour l'année 2020 sera également réorientée de façon à ce que les efforts consentis par l'UE soient aussi ciblés et pertinents que possible dans la réaction du coronavirus.
0.3630217909812927 ||| Filters for use with apparatus for steam generating ||| Cartridges filled with toner for computer print-out apparatus ||| Filtres pour appareils produisant de la vapeur
0.480139821767807 ||| EVISTA contains lactose. ||| tablets contain lactose. ||| EVISTA contient du lactose.
0.24445733428001404 ||| Uncommonly Sebivo can cause numbness, tingling, pain and/ or burning sensations in the arms and/ or legs (peripheral neuropathy). ||| Symptoms of peripheral neuropathy are characterised by persistent numbness, tingling, or pain in the feet and/ or hands. ||| De façon peu fréquente, Sebivo peut induire un engourdissement, des fourmillements, une douleur et/ ou une sensation de brûlure dans les bras et/ ou les jambes (neuropathie périphérique).
3.935881026477517e-13 ||| Through Week 240 in nucleoside-naive studies, genotypic evidence of ETVr substitutions at rtT184, rtS202, or rtM250 was identified in 3 patients treated with entecavir, 2 of whom experienced virologic breakthrough (see table). ||| Through Week 240 in nucleoside-naive studies, genotypic evidence of ETVr substitutions at rtT184, rtS202, or rtM250 was identified in 3 patients treated with entecavir, 2 of whom experienced virologic breakthrough (see table). ||| Lors de l’ analyse jusqu’ à 240 semaines dans les études conduites chez les patients naïfs de nucléosides, la présence de substitutions génotypiques de résistance à l'entecavir au niveau des codons T184, S202 ou M250 a été observée chez 3 patients traités par entecavir, 2 d’ entre eux ayant présenté un rebond virologique (voir tableau).
0.3758680820465088 ||| The efficacy and safety of cetuximab have not been documented in patients with tumours where EGFR was not detected. ||| These studies revealed no evidence of impaired fertility or harm to the foetus due to eptifibatide. ||| L’ efficacité et la tolérance du cetuximab n’ ont pas été documentées chez les patients souffrant de tumeurs dans lesquelles l’ EGFR n’ a pas été détecté.
0.8833276033401489 ||| Cloth for tatami mat edging ribbons ||| Tremor includes tremor and parkinsonian rest tremor. ||| Tissus pour rubans de bordure de tatami
4.0052241579748016e-13 ||| Neutrophils produced in response to filgrastim show normal or enhanced function as demonstrated by tests of chemotactic and phagocytic function. ||| Neutrophils produced in response to filgrastim show normal or enhanced function as demonstrated by tests of chemotactic and phagocytic function. ||| 31 possèdent des fonctions normales ou activées comme le démontrent les tests de chimiotactisme et de phagocytose.
0.05402591452002525 ||| Your doctor will tell you how many Ketek tablets to take, at what time and for how long. ||| Your doctor will tell you how many Levviax tablets to take, at what time and for how long. ||| Votre médecin vous indiquera le nombre de comprimés de Ketek à prendre, l’heure de la prise et la durée du traitement.
0.7715198993682861 ||| Bruxism Disorientation Apathy ||| Rash Pruritis Alopecia ||| Baisse de la libido Anxiété
0.0 ||| Uncommon ||| Uncommon ||| fréquent
0.35367709398269653 ||| If you need more information about your animal’ s medical condition or treatment, contact your veterinarian. ||| or If you need more information about your medical condition or your treatment, read the Package ||| Pour plus d’ informations sur la condition ou le traitement de votre animal, veuillez contacter votre vétérinaire.
0.2866150140762329 ||| What benefit has Nobilis Influenza H5N2 shown during the studies? ||| What is the risk associated with Nobilis Influenza H5N2? ||| Quels ont été les effets bénéfiques démontrés par Nobilis Influenza H5N2 au cours des études?
0.4625731110572815 ||| The European Commission presented today its first ever EU Strategy on victims' rights to ensure that all victims of crime can fully rely on their rights, no matter where in the EU the crime took place. ||| To ensure that the most vulnerable continue to get the help they need, Parliament has adopted changes to the rules on the Fund for European Aid to the Most Deprived. ||| La Commission européenne a présenté aujourd'hui sa toute première stratégie de l'UE relative aux droits des victimes, qui vise à garantir que toutes les victimes de la criminalité puissent faire valoir pleinement leurs droits, quel que soit l'endroit de l'UE où l'infraction a été commise.
0.21200409531593323 ||| Education services relating to the agricultural industry ||| Advertising services relating to the transport industries ||| Services d'enseignement relatif à l'industrie agricole
0.2677951455116272 ||| Ritonavir may induce the glucuronidation of zidovudine, resulting in slightly decreased levels of zidovudine. ||| Renal excretion of the glucuronide (and possibly zidovudine itself) is reduced in the presence of probenecid. ||| Le ritonavir peut induire la glycuronidation de la zidovudine, entraînant une légère diminution des concentrations de zidovudine.
0.0 ||| A systematic review has also been performed involving more than 9’ 000 cancer patients participating in 57 clinical trials. ||| A systematic review has also been performed involving more than 9’ 000 cancer patients participating in 57 clinical trials. ||| 142 Une revue systématique a été réalisée impliquant plus de 9000 patients cancéreux ayant participé à 57 essais cliniques.
0.2194535732269287 ||| In a study involving healthy volunteers (N=12), when a 60 mg controlled-release morphine capsule was administered 2 hours prior to a 600 mg gabapentin capsule, mean gabapentin AUC increased by 44% compared to gabapentin administered without morphine. ||| 2 An increased incidence of heart failure has been observed when rosiglitazone was added to treatment regimens with a sulphonylurea (either as dual or triple therapy), and appeared higher with 8 mg rosiglitazone compared to 4 mg rosiglitazone (total daily dose). ||| Dans une étude conduite chez des volontaires sains (N = 12), lorsqu'une gélule de morphine à libération prolongée de 60 mg était administrée 2 heures avant une gélule de gabapentine de 600 mg, l'ASC moyenne de la gabapentine était augmentée de 44% par rapport à celle de la gabapentine administrée sans morphine.
0.37055909633636475 ||| Patients were treated with Herceptin until progression of disease. ||| Skin infections during treatment with imiquimod have been observed. ||| Les patients ont été traités par Herceptin jusqu’ à progression de la maladie.
0.30236637592315674 ||| As for other beta interferons, severe hepatic injury, including cases of hepatic failure, has been reported rarely in patients taking Betaferon. ||| Sickle cells crises, in some cases fatal, have been reported with the use of filgrastim in subjects with sickle cell disease. ||| Comme pour les autres interférons bêta, des atteintes hépatiques graves, y compris des cas d’ insuffisance hépatique, ont été rapportés rarement chez les patients prenant Betaferon.
0.21646934747695923 ||| Uncommon: acute pancreatitis, ileus paralytic, antibiotic associated colitis, colitis, haematemesis, diarrhoea haemorrhagic, gastrointestinal haemorrhage, rectal haemorrhage, enteritis, dysphagia, abdominal discomfort, eructation, gastrointestinal motility disorder, oral pain, retching, change in bowel habit, spleen pain, oesophagitis, gastritis, gastro-oesophageal reflux disease, gastrointestinal pain, gingival bleeding, gingival pain, hiatus hernia, irritable bowel syndrome, oral mucosal petechiae, salivary hypersecretion, tongue coated, tongue discolouration, faecal impaction. ||| Intracranial haemorrhage, intracranial venous sinus thrombosis, thrombotic stroke, cerebral ischaemia, transient ischaemic attack, leukoencephalopathy, neurotoxicity, polyneuropathy, peripheral motor neuropathy, dysaesthesia, aphonia, dysphonia, disturbance in attention, ataxia, balance impaired, postural dizziness, burning sensation, cervical root pain, dyskinesia, hyperaesthesia, motor dysfunction, myasthenic syndrome, oral paraesthesia, psychomotor hyperactivity, anosmia ||| Pancréatite aiguë, iléus paralytique, colite liée aux antibiotiques, colite, hématémèse, diarrhée hémorragique, hémorragies gastro-intestinales, hémorragie rectale, entérite, dysphagie, gêne abdominale, éructation, trouble de la motilité gastro-intestinale, douleur buccale, haut-le-cœ ur, modification du transit, douleur splénique, oesophagite, gastrite, reflux gastro-oesophagien, douleur
0.6658908128738403 ||| Physical storage of electronically stored digital video files ||| Electronic storage of documents and archived e-mails ||| Stockage physique de fichiers vidéos numériques stockés électroniquement
0.6428807973861694 ||| Hyperglycemia ||| Carcinogenesis ||| 25 Hyperglycémie
0.0 ||| General disorders and administration site conditions: ||| General disorders and administration site conditions: ||| Troubles généraux et accidents liés au site d'administration:
0.2970139980316162 ||| 27 reactions resulting in discontinuation from pregabalin treatment groups were dizziness and somnolence. ||| The most common adverse reaction resulting in discontinuation of lacosamide therapy was dizziness. ||| Les effets indésirables les plus fréquents ayant entraîné l’arrêt du traitement par la prégabaline ont été les étourdissements et la somnolence.
0.3932853937149048 ||| Adjustments of daily dosage, including dose reduction should be considered on the basis of clinical status. ||| Clearance is not dependent on the weight of the subject or the dose administered over the dose range studied. ||| La posologie quotidienne peut être adaptée, une réduction de dose pourra être considérée en fonction de l’ état clinique du patient.
0.2874436378479004 ||| Asbestos yarn, not for textile use ||| Elastic yarns, not for use in textiles ||| Fils d'amiante autres qu'à usage textile
0.08402297645807266 ||| They recommended that Extavia be given marketing authorisation. ||| They recommended that Tygacil be given marketing authorisation. ||| Il a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Extavia.
0.09505806863307953 ||| Your doctor or his/ her assistant will instruct you how to self-inject Valtropin. ||| Your doctor or his/her assistant will instruct you how to self- inject IntronA. ||| Votre médecin ou son assistant(e) vous apprendront comment vous injecter vous -même Valtropin.
2.639754192144961e-13 ||| The length of time that the tablet takes to fully disintegrate following oromucosal administration does not appear to affect early systemic exposure to fentanyl. ||| The length of time that the tablet takes to fully disintegrate following oromucosal administration does not appear to affect early systemic exposure to fentanyl. ||| 60 Le temps de désintégration totale du comprimé après administration par voie buccale transmuqueuse ne semble pas avoir d’ influence sur l’ exposition systémique précoce au fentanyl.
0.24322181940078735 ||| What Tekturna looks like and contents of the pack Tekturna 300 mg film coated tablets are light-red, biconvex, ovaloid tablets, imprinted “ IU” on one side and “ NVR” on the other side. ||| What Alendronate HEXAL looks like and contents of the pack Alendronate HEXAL are available as white to off-white, capsule-shaped tablet, embossed "AN 10" on one side and "Arrow logo" on the other. ||| Qu’ est -ce que Tekturna et contenu de l’ emballage extérieur Tekturna 300 mg comprimés pelliculés se présente sous forme de comprimés ovales, biconvexes, rouges clairs, portant l’ inscription « IU » sur une face et « NVR » sur l’ autre face.
0.34699466824531555 ||| Each oro-dispersible tablet contains 15 mg of lansoprazole Each oro-dispersible tablet contains 30 mg of lansoprazole ||| Each capsule contains 15 mg of lansoprazole Each capsule contains 30 mg of lansoprazole ||| Chaque comprimé orodispersible contient 15 mg de lansoprazole Chaque comprimé orodispersible contient 30 mg de lansoprazole
0.17084193229675293 ||| Precision grooving tools [parts of machines] ||| Precision grooving tools [machines] ||| Outils à rainurer de précision [pièces de machines]
0.18634815514087677 ||| 223 ||| 179 ||| 264
0.06858447194099426 ||| - if you are allergic (hypersensitive) to sitagliptin or any of the other ingredients of Januvia. ||| - you are allergic (hypersensitive) to bevacizumab or to any of the other ingredients of Avastin. ||| - si vous êtes allergique (hypersensible) à la sitagliptine ou à l’ un des autres composants contenus
0.3874354064464569 ||| The outbreak of the coronavirus is affecting all countries and member states and the EU are determined to tackle it together. ||| The Western Balkans will require continued support to address the impact of the pandemic once the immediate crisis is over. ||| La pandémie de coronavirus affecte l'Europe toute entière et l'Union européenne est déterminée à y faire face, unie.
0.6044522523880005 ||| Wood lacquers ||| Gold necklaces ||| Laques pour bois
0.2054937779903412 ||| The summary of opinion of the Committee for Orphan Medicinal Products for Firazyr is available here. ||| 2/ 3 The summary of opinion of the Committee for Orphan Medicinal Products for PhotoBarr is available here. ||| Le résumé de l’ avis du comité des médicaments orphelins relatif à Firazyr est disponible ici.
0.45159444212913513 ||| The reason for this was that the national competent authorities of Belgium and Norway considered that this medicinal product could present a potential serious risk to animal health on the ground that the efficacy has not been sufficiently substantiated in the dossier. ||| The clinical relevance of this finding is unknown and cannot be generalised to all patients under all circumstances, as it will depend on the individual risk factors and susceptibilities that may be present at any time in any given patient. ||| Cette décision est justifiée par le fait que les autorités nationales compétentes de Belgique et de Norvège considèrent que ce médicament pourrait présenter un risque potentiel sérieux pour la santé des animaux, le dossier n’ ayant pas apporté la preuve suffisante de l’ efficacité du produit.
0.3021429181098938 ||| Hydrogen peroxide for industrial purposes ||| Calcium peroxide for use in agriculture ||| Peroxyde d'hydrogène à usage industriel
0.5448274612426758 ||| Cardiac fulguration apparatus ||| Hemodialysis apparatus ||| Appareils de fulguration cardiaque
0.08265239000320435 ||| Always take Pelzont exactly as your doctor has told you. ||| Always take Tekturna exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.2630230188369751 ||| Matsukawa et al evaluated in an uncontrolled study the efficacy of lansoprazole 15 mg and 30 mg in 47 patients with NSAID induced gastroduodenal ulcers. ||| Immunogenicity Antibodies directed against the abatacept molecule were assessed by ELISA assays in rheumatoid arthritis patients treated for up to 3 years with abatacept. ||| Matsukawa et al ont évalué, dans une étude non contrôlée, l’ efficacité de lansoprazole 15 mg et 30 mg chez 47 patients souffrant d’ ulcères gastro-duodénaux induits par les AINS.
0.34374701976776123 ||| Each affected region of the skin should be treated with until clearance occurs and then treatment should be discontinued. ||| After this, the patient’ s vision should be checked every month and another injection given if the vision has become worse. ||| Chaque zone cutanée atteinte doit être traitée par {Nom de fantaisie} jusqu’à disparition des lésions, puis le traitement doit être arrêté.
0.28909578919410706 ||| The most common adverse reactions in pivotal study PA.3 in pancreatic cancer patients receiving Tarceva 100 mg plus gemcitabine were fatigue, rash and diarrhoea. ||| Study V evaluated 799 methotrexate-naïve, adult patients with moderate to severely active early rheumatoid arthritis (mean disease duration less than 9 months). ||| Les évènements indésirables les plus fréquents dans l’étude pivot PA.3, chez des patients atteints d’un cancer du pancréas qui recevaient Tarceva 100 mg associé à la gemcitabine, ont été l’asthénie, les éruptions cutanées et les diarrhées.
0.31461769342422485 ||| Cementitious restorative coatings ||| Cementitious waterproofing coatings ||| Revêtements de restauration en ciment
0.2482548952102661 ||| The maximum dose frequency is once per day. ||| The maximum recommended dosing frequency is one tablet per day. ||| La fréquence d'administration maximale est d'une prise par jour.
0.4602750539779663 ||| EBV-associated lymphoproliferative disorder has been reported. ||| Excessive immunosuppression with risk of lymphoproliferative disease. ||| Des syndromes lymphoprolifératifs associés à l’ EBV ont été observés.
0.405621737241745 ||| The rates of cardiovascular death and myocardial infarction were not significantly different between the treatment groups. ||| The incidence of symptomatic VTE, including PE was not significantly different between treatment groups. ||| L’ incidence des décès cardiovasculaires et des infarctus du myocarde n’ a pas été significativement différente entre les groupes.
0.34162068367004395 ||| It works by blocking a substance in the body which is involved in blood clot formation. ||| It blocks an enzyme (protease) that is involved in the reproduction of HIV. ||| Il agit en bloquant une substance présente dans l’organisme qui intervient dans la formation des caillots sanguins.
0.38447070121765137 ||| Robotic compressed air pumps ||| Electrostatic filters for water filtration ||| Pompes robotisées à air comprimé
0.29044052958488464 ||| If inactive (‘ latent’) tuberculosis is diagnosed, appropriate treatment for latent tuberculosis must be started with anti-tuberculosis prophylaxis therapy before the initiation of Humira, and in accordance with local recommendations. ||| If this unwanted ovarian hyperstimulation occurs (i. e. not as part of controlled ovarian hyperstimulation in medically assisted reproduction programs), the administration of Fertavid should be discontinued. ||| En cas de diagnostic d'une tuberculose inactive (« latente »), un traitement anti-tuberculeux approprié, adapté à une tuberculose latente et conforme aux recommandations locales doit être mis en œ uvre avant de commencer le traitement par Humira.
0.26845046877861023 ||| COVERSYL should be introduced at a dose of 4 mg once daily for two weeks, then increased to 8 mg once daily, depending on renal function and provided that the 4 mg dose is well tolerated. ||| In elderly patients treatment should be initiated at a dose of 2 mg which may be progressively increased to 4 mg after one month then to 8 mg if necessary depending on renal function (see table below). ||| Le traitement par COVERSYL devra être débuté à une dose de 4 mg une fois par jour pendant deux semaines, puis augmenté à 8 mg une fois par jour, compte tenu de la fonction rénale et à condition que la dose de 4 mg soit bien tolérée.
0.32829737663269043 ||| These studies measured the number of patients in whom treatment had stopped working after 48 weeks, as determined by a rise in the level of HIV in the blood (viral load). ||| The study measured how many patients responded (no sign of virus in their blood) after 12 out of the 48 weeks of treatment and 6 months after stopping treatment. ||| Ces études ont déterminé le nombre de patients chez lesquels le traitement avait arrêté de faire effet après 48 semaines, ceci correspondant à une augmentation du niveau de VIH dans le sang (charge virale).
0.3837226331233978 ||| Subsequently, in the initial phase of treatment, the activity of protein C is more rapidly suppressed than that of the procoagulant factors. ||| Consequently, the time-action profile of an insulin preparation is determined solely by its absorption characteristics. rod ||| Par conséquent, dans la phase initiale du traitement, l'activité de la protéine C est plus rapidement diminuée que celle des facteurs de
0.3514387011528015 ||| In the event of substantial overdose, vomiting may be considered to remove unabsorbed active substance. ||| When possible, inhaled nitric oxide should be continued until the underlying disease has resolved. ||| En cas de surdosage important, il peut être envisagé de provoquer des vomissements afin d’ éliminer le médicament non absorbé.
0.44081735610961914 ||| Eli Lilly Nederland B. V. ||| Nederland Baxter B. V. ||| Eli Lilly Nederland B.V.
0.41588541865348816 ||| To support EU product legislation, the Commission can request the development of European harmonised standards to facilitate compliance by manufacturers of the relevant requirements. ||| The authorisation of medicinal products by national competent authorities within the Community will thus be supported, as will the implementation of MRAs and international harmonisation. ||| Afin de soutenir la législation de l'UE sur les produits, la Commission peut demander l'élaboration de normes harmonisées européennes pour faciliter le respect des exigences applicables par les fabricants.
0.07149159163236618 ||| The studies measured the level in the blood of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled. ||| The main measure of effectiveness was the change in the blood levels of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well blood glucose is controlled. ||| Les études ont mesuré le taux sanguin d’ une substance appelée hémoglobine glycosulée (HbA1c), ce qui donne une indication de l’ efficacité du contrôle du taux de glucose dans le sang.
0.021981723606586456 ||| The United Kingdom referred the reasons for disagreement to the EMEA on 23 August 2005. ||| The United Kingdom referred the reasons for disagreement to the EMEA on 29 March 2007. ||| Le Royaume-Uni a rapporté les motifs de ces divergences à l’ EMEA le 23 août 2005.
0.2992466986179352 ||| Iron pressing machines ||| Sand sorting machines ||| Machines à repasser
0.8149629235267639 ||| Postural hypotension ||| Kidney Transplant ||| Hypotension orthostatique
0.3991019129753113 ||| Dry mouth is reported in 10% of patients treated with venlafaxine. ||| Depression may occur in 1 patient out of 10 treated for multiple sclerosis. ||| 45 Une sécheresse de la bouche a été rapportée chez 10% des patients traités par la venlafaxine.
0.3009713888168335 ||| The toxicological findings observed appear to have no relevance to human therapeutic use. ||| The available data do not appear to indicate any difference in pharmacokinetics with regard to race. ||| Les résultats des études de toxicologie n’ ont pas d’ implication en thérapeutique humaine.
0.1890736222267151 ||| Eesti Österreich UAB Bayer Eesti filiaal Tel: +372 655 8565 ||| Eesti UAB Bayer Eesti filiaal Tel. +372 6 55 85 65 ||| Eesti UAB Bayer Eesti filiaal Tel: +372 655 8565
0.3364903926849365 ||| Clinically and statistically significant improvement was also noted on all individual components of the ACR response (tender and swollen joint counts, patient and physician global assessment, disability index scores (HAQ), pain assessment and C-Reactive Proteins (mg/ dL). ||| Clinical benefit parameters The performance status scale, for head and neck (PSS-HN) subscales designed to measure understandability of speech, ability to eat in public, and normalcy of diet, was significantly in favor of TPF as compared to PF. ||| Une amélioration cliniquement et statistiquement significative de tous les paramètres de la réponse ACR (nombres d’ articulations gonflées et douloureuses, évaluations globales par le patient et par le médecin, indice d'incapacité (HAQ), évaluation de la douleur et protéine C-réactive (mg/ dl)) a également été observée.
4.61840960440385e-13 ||| Adequate hydration must be ensured. ||| Adequate hydration must be ensured. ||| Une hydratation adéquate doit être maintenue.
0.23433643579483032 ||| 10 pre-filled syringes + 10 needles ||| 2 x 5 pre-filled syringes ||| 10 seringues préremplies + 10 aiguilles
0.555594265460968 ||| have active infection at the site of non-union or active systemic infection; ||| have inadequate skin coverage and vascularity of the non-union site; ||| ont une infection active sur le site de la non-consolidation ou infection systémique active;
0.5706140995025635 ||| Crankcases for land vehicles engines ||| Bubble making wand and solution sets ||| Carters pour moteurs de véhicules terrestres
0.2753693759441376 ||| Steam sterilizers for floors ||| Carbon brushes for starter motors ||| Stérilisateurs à vapeur pour sols
0.0621013417840004 ||| The following substances are included in Annex II of Council Regulation (EEC) No 2377/ 90 in accordance with the following table: ||| The following excipients are included in Annex II of Council Regulation (EEC) No 2377/ 90 in accordance with the following table: ||| Le(s) nom(s) de la/ des substance(s) active(s), {DCI}} est/ sont inclus dans l’ annexe II du règlement (CEE) n° 2377/ 90 du Conseil conformément au tableau suivant:
0.18837547302246094 ||| What is the risk associated with SOMAVERT? ||| What is the risk associated with KOGENATE Bayer? ||| Quel est le risque associé à l’ utilisation de SOMAVERT?
0.520573079586029 ||| Drinks made from dairy products ||| Dairy products and dairy substitutes ||| Boissons à base de produits laitiers
0.4440722167491913 ||| As with other antiepileptic drugs, physiological changes during pregnancy may affect levetiracetam concentration. ||| Atorvastatin is eliminated primarily in bile following hepatic and/ or extrahepatic metabolism. ||| Comme avec d’ autres antiépileptiques, des changements physiologiques pendant la grossesse peuvent affecter la concentration en lévétiracétam.
0.1611490398645401 ||| How has Arixtra been studied? ||| How has Firazyr been studied? ||| Quelles études ont été menées avec Arixtra?
0.6678673624992371 ||| BOTTLE LABEL, 42, 60, 84 or 90 CAPSULES ||| BOX CONTAINING 3, 4, 10 OR 20 VIALS ||| ETIQUETTE DU FLACON, 42, 60, 84 ou 90 GELULES
0.284212201833725 ||| In Parkinson’ s disease, Mirapexin has been studied in five main studies involving 1,546 patients. ||| In Parkinson’ s disease, DaTSCAN has been studied in 254 patients in two studies. ||| Dans la maladie de Parkinson, Mirapexin a été étudié dans le cadre de cinq études principales incluant 1 546 patients.
0.25813931226730347 ||| These are medicines such as ketoconazole and itraconazole (used to treat fungal infections), atazanavir, indinavir, nelfinavir, ritonavir and saquinavir (medicines used in HIV-positive patients), clarithromycin and telithromycin (antibiotics), and nefazodone (used to treat depression). ||| These include: • Non-steroidal anti-inflammatory drugs (NSAIDs) • Other medicines used in the treatment of high blood pressure • Oestrogens • Dopamine, ephedrine, adrenaline, metaraminol, metoxamine, phenylephrine (medicines used for the treatment of heart problems) ||| Il s’ agit, par exemple, de la kétoconazole et de l’ itraconazole (utilisés pour traiter des infections fongiques), de l’ atazanavir, de l’ indinavir, du nelfinavir, du ritonavir et du saquinavir (des médicaments utilisés chez les patients VIH positifs), la clarithromycine et la télithromycine (antibiotiques), et la néfazodone (utilisée pour le traitement de la dépression).
0.016242405399680138 ||| Male patients treated with Paxene are advised not to father a child during and up to six months after treatment. ||| Male patients treated with Paxene are advised not to father a child during and up to six months after the treatment. ||| Il est conseillé aux hommes traités par paclitaxel de ne pas concevoir d’ enfant pendant le traitement et jusqu’ à 6 mois après le traitement.
0.4434435963630676 ||| C/ Batanes, 1 – 28760 Tres Cantos (Madrid) Spain ||| Avda de la Industria 30 28108 Alcobendas (Madrid) Spain ||| C/ Batanes 1 28770 Tres Cantos (Madrid) Espagne
0.2959810495376587 ||| Intervet International Podruznica Krizna 10 SI-1000 Ljubljana Slovenija Tel: +386 (15) 417 567 Fax: +386 (15) 233 567 ||| Palarikova 16 SK-040 01 Kosice Slovak Republic Tel: +421 (55) 676 9405 Fax: +421 (55) 676 9873 ||| Intervet International Podruznica Krizna 10 SI-1000 Ljubljana Slovénie Tél.: +386 (15) 417 567 Fax: +386 (15) 233 567
0.0 ||| Do not take a double dose to make up for a forgotten dose. ||| Do not take a double dose to make up for a forgotten dose. ||| Ne doublez pas la dose suivante pour compenser la dose omise.
0.4662296772003174 ||| Cloths of non-woven textile material for washing the body [other than for medical use] ||| Non-medicated confectionery for use as part of a calorie controlled diet ||| Linges en matières textiles non tissées destinés au lavage du corps, autres qu'à usage médical
0.031339213252067566 ||| 2/ 16 Member State / Marketing Authorisation Number ||| 3/ 16 Member State / Marketing Authorisation Number ||| 2/ 18 État membre / Numéro de l’ autorisation de mise sur le marché
0.41071581840515137 ||| 22 If you are taking any of the following medicines, please be sure to discuss this with your doctor or pharmacist before using Ceplene. ||| • See the Remicade package leaflet for more information. • Please make sure you also have a list of all your other medicines with you at any visit to a health care professional. ||| Si vous prenez l’ un des médicaments suivants, parlez -en avec votre médecin ou votre pharmacien avant d’ utiliser Ceplene.
3.9604582634245045e-13 ||| If your child misses a scheduled injection, talk to your doctor and arrange another visit. ||| If your child misses a scheduled injection, talk to your doctor and arrange another visit. ||| 39 Si votre enfant manque une vaccination prévue, informez-en votre médecin et demandez-lui une nouvelle consultation.
0.12352778017520905 ||| Always take Kivexa exactly as your doctor has told you. ||| Always take Pegasys as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.08087402582168579 ||| Details of the PPP should be agreed wth the National Competent Authorities in each Member State and put in place prior to the marketing of the medicinal product. ||| Details of the PPP should be agreed with the National Competent Authorities in each Member State and put in place prior to the marketing of the product. ||| Les détails du PPG doivent être définis et mis en place en accord avec les autorités nationales compétentes de chaque Etat Membre avant la mise sur le marché du médicament.
0.36115455627441406 ||| Symptoms of the flu-like syndrome associated with interferon beta-1a therapy may prove stressful to patients with cardiac conditions. ||| Fever and chills that do not respond to antibacterial therapy are the most common symptoms of this type of infection. ||| Les symptômes du syndrome pseudo-grippal liés au traitement par interféron bêta-1a peuvent se révéler éprouvants chez les patients cardiaques.
0.2670277953147888 ||| Cotton swabs for medical purposes ||| Quad canes for medical purposes ||| Bâtonnets ouatés à usage médical
0.32043108344078064 ||| In patients with a creatinine clearance between 20 and 50 ml/ min, the initial daily dose of Oprymea should be administered in two divided doses, starting at 0.088 mg of base (0.125 mg of salt) twice a day (0.176 mg of base/ 0.25 mg of salt daily). ||| In order to correct your anaemia, your initial dose will be • 500 micrograms once every three weeks (6.75 micrograms of Aranesp per kilogram of your body weight), or • 2.25 micrograms (once weekly) of Aranesp per kilogram of your body weight. ||| Si la clairance de la créatinine est comprise entre 20 et 50 ml/ min, la dose journalière initiale d’ Oprymea doit être de 0,176 mg de form base (0,25 mg de forme sel), fractionnée en deux prises de 0,088 mg de forme base chacune (0,125 mg de forme sel).
0.3878658413887024 ||| Therefore, Bondronat should not be used during pregnancy. ||| Therefore, REGRANEX should not be used in nursing mothers. ||| Par conséquent, Bondronat ne doit pas être utilisé pendant la grossesse.
0.459126353263855 ||| After inoculation, the virus expresses the protective proteins, but does not replicate in the cat. ||| The vaccine does not contain any live PCV2 and the antigen cannot replicate in the animal. ||| Après inoculation, le virus canarypox exprime les protéines protectrices, mais sans se répliquer chez le chat.
0.39914751052856445 ||| - Cholestagel may be prescribed on its own in addition to a diet low in fat and cholesterol when ||| - if you are on a low-salt diet and you use potassium containing salt substitutes or supplements ||| - Cholestagel peut être prescrit seul en complément d’ un régime faible en graisse et en cholestérol
0.532607913017273 ||| Ammonaps ||| Lap rugs ||| AMMONAPS
0.43129774928092957 ||| Your doctor may consider giving you an alternative medicine or changing the dose of the protease inhibitors. ||| Your doctor will advise on the possible need for extra doses, and future booster dosing. ||| Votre médecin pourra envisager de vous donner un autre médicament ou de changer la dose des inhibiteurs de protéase.
0.10422880947589874 ||| If you take more Karvea than you should If you accidentally take too many tablets, contact your doctor immediately. ||| If you take more Irbesartan BMS than you should If you accidentally take too many tablets, contact your doctor immediately. ||| Si vous avez pris plus de Karvea que vous n'auriez dû Si vous prenez accidentellement un trop grand nombre de comprimés, prévenez immédiatement votre médecin.
0.4386584162712097 ||| Agopton 15 mg: capsules. ||| Agopton and associated names 30 mg capsules ||| Agopton 15 mg: gélules .
0.42212122678756714 ||| Coadministration of atorvastatin 10 mg OD and erythromycin (500 mg QID), or atorvastatin 10 mg OD and clarithromycin (500 mg BID), known inhibitors of cytochrome P450 3A4, were associated with higher plasma concentrations of atorvastatin. ||| Low concentrations of four metabolites have been reported, which were identified as: desethyleneciprofloxacin (M 1), sulphociprofloxacin (M 2), oxociprofloxacin (M 3) and formylciprofloxacin (M 4). ||| L'administration concomitante d'atorvastatine 10 mg une fois par jour et d'érythromycine (500 mg quatre fois par jour) ou d'atorvastatine 10 mg une fois par jour et de clarithromycine (500 mg deux fois par jour), inhibiteurs connus du cytochrome P450 3A4, a entraîné une augmentation des concentrations plasmatiques d'atorvastatine.
0.33313173055648804 ||| Very common: fever Common: chills, pain at the catheter site ||| Very Common: fever Common: chills, catheter site pain ||| Très fréquent: fièvre Fréquent: frissons, douleur au site de perfusion
0.22471654415130615 ||| Italia Lundbeck Italia S. p. A. ||| Italia Ferring S. p. A. ||| 80 Italia Lundbeck Italia S. p. A.
0.31894469261169434 ||| Mobile radio receiving apparatus ||| Electronic telephone exchange apparatus ||| Appareils de réception radio mobiles
0.31351709365844727 ||| 1.5 ml of oral suspension in a pre-filled oral applicator (type I glass) with a plunger stopper (rubber butyl) and a protective tip cap (rubber butyl) in pack sizes of 1, 5, 10 or 25. ||| Each pack of KOGENATE Bayer 250 IU contains a vial and a pre-filled syringe with a separate plunger rod, as well as a vial adapter, a venipuncture set, two alcohol swabs, two dry swabs and two plasters. ||| 20 1,5 ml de suspension buvable en applicateur pré-rempli pour administration orale (verre de type I) avec un bouchon-piston (gomme butyle) et un capuchon protecteur (gomme butyle) en boîte de 1, 5, 10 ou 25.
0.02046884596347809 ||| Optisulin led to a decrease in the level of HbA1c, indicating that blood glucose levels had been controlled to a similar level to that seen with human insulin. ||| Lantus led to a decrease in the level of HbA1c, indicating that blood glucose levels had been controlled to a similar level to that seen with human insulin. ||| Optisulin a permis de faire baisser le niveau d’ HbA1c, ce qui indique une maîtrise des taux de glycémie similaire à celle observée avec l’ insuline humaine.
0.33681321144104004 ||| During the treatment with Revlimid you have an increased risk of developing blood clots in the veins. ||| Patients with tumours can have high level of calcium in their blood, released from the bones. ||| Pendant le traitement par Revlimid, le risque de formation de caillots sanguins dans les veines est augmenté.
0.26394957304000854 ||| 4.2 Pharmacokinetic properties ||| Pharmacokinetic properties ||| 4.2 Propriétés pharmacocinétiques
0.5168191194534302 ||| No development effects were seen at 3.4-fold human exposure at 400 mg twice daily based on AUC0-24 hr (see section 4.6). ||| Through Week 240, 3 of the 10 patients experienced virologic breakthrough (≥ 1 log10 increase above nadir). ||| Aucun effet sur le développement n'a été observé à 3,4 fois l'exposition humaine, obtenue à 400 mg deux fois par jour, sur la base de l'ASC0-24h (voir rubrique 4.6).
0.26758649945259094 ||| Due to the risk of severe hepatoxicity, saquinavir/ritonavir should not be given together with rifampicin. ||| Based on an interaction study with lopinavir/ ritonavir, combination of rosuvastatin and protease inhibitors is not recommended. ||| En raison du risque de toxicité hépatique sévère, l’association saquinavir/ritonavir ne doit pas être co-administrée avec la rifampicine.
0.021742869168519974 ||| 221 4.4 Special warnings and precautions for use ||| 170 4.4 Special warnings and precautions for use ||| Mises en garde spéciales et précautions d’ emploi
0.21673652529716492 ||| FORSTEO contains a clear and colourless solution. ||| Omnitrope is a clear and colourless solution. ||| FORSTEO contient une solution incolore et limpide.
0.18589144945144653 ||| 611 Travel ||| 654 Travel ||| Voyages
0.2616438865661621 ||| You should not take Emtriva if you are already taking other medicines that contain emtricitabine, lamivudine or zalcitabine, which are also used to treat HIV infection, unless otherwise directed by your doctor. ||| Kivexa, or any other medicinal product containing abacavir (Ziagen or Trizivir), MUST NEVER be restarted in patients who have stopped therapy due to a hypersensitivity reaction. ||| Emtriva ne doit pas être utilisé si vous prenez déjà d’autres médicaments contenant de l’emtricitabine, de la lamivudine ou de la zalcitabine, qui sont aussi utilisés pour traiter l’infection par le VIH, sauf s’ils sont recommandés par votre médecin.
0.6942135095596313 ||| But we all must continue the work to make GDPR live up to its full potential." ||| This is our generation's duty and we know we can make this happen. ||| Mais nous devons tous continuer à œuvrer pour que le RGPD réalise son plein potentiel.»
0.6490240693092346 ||| What influence it will have on the implementation rules? ||| How will this be applied in practice? ||| Quelle influence cela aura-t-il sur les règles de mise en œuvre?
6.959758832615626e-13 ||| 6.2 Incompatibilities ||| 6.2 Incompatibilities ||| 53 6.2 Incompatibilités
0.00567440502345562 ||| Please refer to the respective Summary of Product Characteristics of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with Ribavirin and peginterferon alfa-2b. ||| Please refer to the respective Summary of Product Characteristics of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with Rebetol and peginterferon alfa-2b. ||| Veuillez vous référer au Résumé des Caractéristiques du Produit de chaque médicament antirétroviral administré conjointement au traitement de l’ hépatite C afin de connaître et prendre en charge la toxicité spécifique de chaque produit ainsi que la potentielle accumulation des toxicités liée à l’ utilisation concomitante de ribavirine en association avec le peginterféron alfa-2b.
0.8132727146148682 ||| 2 micrograms 4 micrograms 2 micrograms 2 micrograms 2 micrograms 2 micrograms 2 micrograms ||| 20 micrograms 40 micrograms 40 micrograms 20 micrograms. ||| 2 microgrammes 4 microgrammes 2 microgrammes 2 microgrammes 2 microgrammes 2 microgrammes 2 microgrammes
0.2560455799102783 ||| As adjuvant therapy in patients who are free of disease after surgery but are at high risk of systemic recurrence, e. g., patients with primary or recurrent (clinical or pathological) lymph node involvement. ||| The most serious events often occurred in patients exposed to other medicinal products or substances known to be associated with hepatotoxicity or in the presence of co-morbid medical conditions (e. g. metastasising malignant disease, severe infection and sepsis, alcohol abuse). ||| Traitement adjuvant chez des patients dont la rémission a été obtenue par chirurgie, mais considérés comme à haut risque de rechute systémique, par exemple les patients ayant une atteinte primaire ou secondaire des ganglions lymphatiques (clinique ou pathologique).
0.4823657274246216 ||| Please discuss possibility of stopping the treatment with your doctor. ||| Stopping treatment Your doctor will decide when to stop the treatment. ||| Si vous envisagez d’ arrêter le traitement, informez votre médecin.
0.32862383127212524 ||| For complicated respiratory disease the dose can be doubled to 5 mg/ kg per day. ||| A twice daily dosing of 15 mg/ kg body weight is not recommended and should be deleted. ||| Dans le cas de maladies respiratoires complexes, la dose peut être doublée (5 mg/ kg de poids vif/ j).
0.2575855255126953 ||| The use of Truvada is not recommended in patients with severe renal impairment (creatinine clearance < 30 ml/ min) and in patients who require haemodialysis since appropriate dose reductions cannot be achieved with the combination tablet (see sections 4.2 and 5.2). ||| To reduce the risk of meningococcal infection (Neisseria meningitidis), all patients must be vaccinated at least 2 weeks prior to receiving Soliris and must be re-vaccinated according to current medical guidelines for vaccination use (see section 4.4). ||| L’ utilisation de Truvada n’ est pas recommandée chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) et chez les patients qui nécessitent une hémodialyse car les réductions des doses d’ emtricitabine et de ténofovir nécessaires chez ces patients ne peuvent être obtenues avec l’ association fixe (voir rubriques 4.2 et 5.2).
0.0069503881968557835 ||| Relevant examples are cytomegalovirus retinitis, generalised and/ or focal mycobacterial infections, and pneumonia caused by Pneumocystis jiroveci (formerly known as Pneumocystis carinii). ||| Relevant examples are cytomegalovirus retinitis, generalised and/ or focal mycobacterial infections and pneumonia caused by Pneumocystis jiroveci (formerly known as Pneumocystis carinii). ||| Des exemples pertinents sont les rétinites à cytomégalovirus, les infections mycobactériennes généralisées et/ ou localisées, et les pneumopathies à Pneumocystis jiroveci (anciennement appelé Pneumocystis carinii).
0.2666041851043701 ||| Mechanical research in the field of motor sports ||| Research in the field of communications technology ||| Recherche mécanique dans le domaine des sports motorisés
0.11001510918140411 ||| Eesti Österreich Nycomed SEFA AS Pirita tee 20T EE-10127 Tallinn Tel: +372 6112 569 info@nycomed. ee ||| Eesti Nycomed SEFA AS Pirita tee 20T EE-10127 Tallinn Tel: +372 6112 569 info@nycomed.ee ||| Eesti Nycomed SEFA AS Pirita tee 20T EE-10127 Tallinn Tel: +372 6112 569 info@nycomed. ee
0.08928695321083069 ||| Electronic endoscopes for surgical use ||| Endoscopes for surgical use ||| Endoscopes électroniques à usage chirurgical
0.41884008049964905 ||| Also, do not take Remeron during the two weeks after you have stopped taking MAO inhibitors. ||| You should not take any such products up to 2 weeks after you have taken Gliolan. ||| Ne prenez pas non plus Remeron pendant les deux semaines qui suivent l’ arrêt d’ un traitement par des IMAO.
0.0 ||| 149 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 149 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 159 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.31761497259140015 ||| If renal function decreases during treatment, ViraferonPeg therapy should be discontinued. ||| If you have developed Pure Red Cell Aplasia your MIRCERA treatment will be discontinued. ||| Si la fonction rénale diminue pendant le traitement, le traitement par ViraferonPeg doit être interrompu.
0.7301406264305115 ||| Praziquantel (mg/ kg bw) ||| OTFC (normalized to 400 mcg) ||| Praziquantel (mg/ kg)
0.4239782989025116 ||| Anaphylactic reactions, hypersensitivity ||| Anaphylactic reactions during desensitisation: ||| Réactions anaphylactiques, hypersensibilité
1.241140604019165 ||| 41.4 (63/152) 31.2, 51.7 ||| ↑ 2.25 ↑ 1.98 ↑ 2.42 diltiazem ||| 41,4 (63/ 152) 31,2; 51,7
0.5252045392990112 ||| Page 2/ 3 ©EMEA 2008 Why has Equilis Prequenza Te been approved? ||| Page 2/ 3 ©EMEA 2008 Other information about Equilis Te: ||| Pourquoi Equilis Prequenza Te a -t-il été approuvé?
0.426339328289032 ||| Not known: shock haemorrhagic, hypotension, thrombosis. ||| Uncommon: influenza like illness, malaise, pyrexia. ||| Fréquence indéterminée: choc hémorragique, hypotension, thrombose.
0.42979103326797485 ||| Cytarabine has been used as an anti-cancer medicine since the 1970s. ||| Paclitaxel has been available as an anticancer medicine since 1993. ||| La cytarabine est utilisée comme médicament anticancéreux depuis les années 1970.
0.15490314364433289 ||| If you stop taking Ziagen If you have stopped taking Ziagen for any reason, particularly because you think you are having side effects or for other illness, it is important that you contact your doctor before restarting. ||| If you have stopped taking Trizivir for any reason, particularly because you think you are having side effects or for other illness, it is important that you contact your doctor before restarting. ||| Effets pouvant apparaître lorsque le traitement par Ziagen est arrêté Si vous avez arrêté votre traitement par Ziagen quelle qu’en soit la raison, particulièrement parce que vous pensez avoir des effets indésirables ou pour une autre maladie, il est important de contacter votre médecin avant de reprendre votre traitement.
0.32350361347198486 ||| Following monthly administration of darbepoetin alfa, at subcutaneous doses ranging from 0.6 to 2.1 µg/ kg, the terminal half-life was 73 hours (SD 24). ||| Following single oral dose administration (20 mg/ kg) to epileptic children (6 to 12 years), the half-life of levetiracetam was 6.0 hours. ||| 24 mensuelle d’ une dose de darbepoetin alfa allant de 0,6 à 2,1 µg/ kg, la demi-vie terminale est de 73 heures (DS = 24).
0.41089093685150146 ||| Rare: exfoliative dermatitis, dermatitis, pruritus, alopecia. ||| Skin reactions such as erythema, pruritis, urticaria. ||| Rare: dermatite exfoliante, dermatite, prurit, alopécie.
0.4617632031440735 ||| Keep this card with you for 3 months after the last RoActemra dose, since side effects could occur for some time after your last dose of RoActemra. ||| How long Fluticasone furoate GSK takes to work Some people will not feel the full effects until several days after first using Fluticasone furoate GSK. ||| Gardez cette carte avec vous pendant les 3 mois suivant la dernière perfusion de RoActemra, car des effets indésirables peuvent survenir quelque temps après la dernière administration de RoActemra.
0.5378308296203613 ||| The schemes for subsidised loans are complemented by another scheme approved by the Commission on 24 March 2020 , under which guarantees on loans can be provided. ||| The schemes are based on a "match-lending approach" where the provision of loans will generally match private equity investments or other private loans. ||| Les régimes de prêts bonifiés sont complétés par un autre régime autorisé par la Commission le 24 mars 2020 et prévoyant la mise à disposition de garanties sur les prêts.
0.0047129979357123375 ||| It provides contrast enhancement and facilitates visualization and helps with the characterization of focal lesions and abnormal structures in the CNS and liver in patients with known or highly suspected pathology. ||| It provides contrast enhancement and facilitates visualization and helps with characterization of focal lesions and abnormal structures in the CNS and liver in patients with known or highly suspected pathology. ||| Optimark renforce le contraste, facilite la visualisation et aide à la caractérisation des lésions focales et des structures anormales du SNC et du foie chez les patients qui présentent une pathologie connue ou fortement suspectée.
0.5458745956420898 ||| Potential for other medicinal products to affect ABILIFY: ||| Potential for RISPERDAL CONSTA to affect other medicinal products ||| Interactions potentielles ayant un effet sur ABILIFY:
0.49634772539138794 ||| Glass elements for windows ||| Window glass for vehicle windows ||| Éléments de fenêtres en verre
0.1599995195865631 ||| 60 vials with powder for solution for injection ||| 6 vials containing powder for solution for injection ||| 60 flacons de poudre pour solution injectable
0.6370449066162109 ||| Software to control building environmental, access and security systems ||| New rules on cybersecurity of critical infrastructure and services. ||| Logiciels de contrôle de l'environnement, de l'accès et de la sécurité des bâtiments
0.3578054904937744 ||| España Ferrer Internacional, S. A. ||| España Pfizer S. A. ||| España Ferrer Internacional, S.A.
0.5321873426437378 ||| 61 France INFAI France SARL Eurocentre Tertiaire 50, avenue d’Alsace F- 68027 Colmar Tél: +33 389 204382 ||| Philippe DUNETON Directeur Général Agence Française de Sécurité Sanitaire des Produits de Santé 143-147, boulevard Anatole France F - 93285 Saint-Denis CEDEX Tel. ||| 61 France INFAI France SARL Eurocentre Tertiaire 50, avenue d’Alsace F- 68027 Colmar Tél: +33 389 204382 Ireland TECHNOPHARM Ltd.
0.3179706335067749 ||| Should an intolerable skin reaction occur, the cream should be removed by washing the area with mild soap and water. ||| Rinse your mouth with water and spit it out as this may help prevent the occurrence of thrush and hoarseness. ||| En cas de survenue d'une réaction cutanée intolérable, la crème doit être enlevée par lavage avec de l’eau et un savon doux.
0.3245137333869934 ||| During the first week, the usual dose is 1 tablet MIRAPEXIN 0.088 mg once a day (equivalent to 0.088 mg daily): ||| The recommended starting dose of SIFROL is 0.088 mg of base (0.125 mg of salt) taken once daily 2-3 hours before bedtime. ||| La posologie habituelle est de un comprimé de MIRAPEXIN 0,088 mg une fois par jour, le soir, 2 à 3 heures avant le coucher.
0.3261256217956543 ||| Metabolism of nilotinib is mainly hepatic. ||| Metabolism Meloxicam is predominantly found in plasma. ||| Le métabolisme du nilotinib est essentiellement hépatique.
0.2836014926433563 ||| Imatinib was teratogenic in rats when administered during organogenesis at doses ≥ 100 mg/ kg, approximately equal to the maximum clinical dose of 800 mg/ day, based on body surface area. ||| Montelukast was determined not to be phototoxic in mice for UVA, UVB or visible light spectra at doses up to 500 mg/ kg/ day (approximately > 200-fold based on systemic exposure). ||| 103 L’ imatinib est tératogène chez les rats lorsqu’ il est administré au cours de l’ organogenèse, à des doses ≥ 100 mg/ kg, approximativement équivalente à la dose clinique maximale de 800 mg/ j, basée sur la surface corporelle.
0.04653450474143028 ||| Pack sizes of 1 and 10 vials. ||| Pack sizes of 1 and 4 vials. ||| Boîtes de 1 et 10 flacons.
0.0 ||| The safe use of the medicinal product during pregnancy has not been established. ||| The safe use of the medicinal product during pregnancy has not been established. ||| La sécurité d’ emploi du produit pendant la grossesse n'a pas été établie.
0.3543555438518524 ||| The starting dose may be adjusted by your doctor depending on how your anaemia responds to treatment; you will usually receive Retacrit until 1 month after the end of chemotherapy. ||| The dose will usually be 10,000 Units, but it can be higher or lower, depending on your doctor’ s decision and your response to any previous injections of NeuroBloc. ||| La dose d’attaque peut être ajustée par votre médecin selon la manière dont votre anémie réagit au traitement; vous recevrez généralement Retacrit jusqu’à 1 mois après la fin de la chimiothérapie.
0.1435694396495819 ||| Suomi/Finland Oy Eli Lilly Finland Ab Puh/Tel: + 358-(0) 9 85 45 250 ||| Suomi/Finland UCB Pharma Oy Finland Puh/Tel: + 358 / (0)9-2290 100 ||| Suomi/ Finland Oy Eli Lilly Finland Ab Puh/ Tel: + 358-(0) 9 85 45 250
2.7670739506137354e-13 ||| Shunt thromboses may occur, especially in patients who have a tendency to hypotension or whose arteriovenous fistulae exhibit complications (e. g. stenoses, aneurisms), see section 4.4. ||| Shunt thromboses may occur, especially in patients who have a tendency to hypotension or whose arteriovenous fistulae exhibit complications (e. g. stenoses, aneurisms), see section 4.4. ||| 178 Une thrombose de la fistule artério-veineuse peut survenir, en particulier chez les malades hypotendus ou dont la fistule présente des complications (sténose ou anévrisme), voir rubrique 4.4.
0.2651291787624359 ||| If you do not remember until the day that the next injection is due, do not take a double dose (two doses on the same day) to make up for a forgotten dose. ||| If you forget a dose, you should inject it as soon as you remember, unless the next scheduled dose is the next day, in which case you should skip the missed dose. ||| Si vous ne vous oubliez de faire une injection jusqu’au jour où la dose suivante doit être injectée, n’administrez pas une dose double (deux doses le même jour) pour compenser la dose oubliée.
0.07859423011541367 ||| Karvezide is a combination of two active substances, irbesartan and hydrochlorothiazide. ||| Karvezide contains two active substances, irbesartan and hydrochlorothiazide. ||| Karvezide est une association de deux substances actives, l'irbésartan et l'hydrochlorothiazide.
0.2404613494873047 ||| Neolab Limited 57 High Street Odiham, Hampshire RG29 1LF United Kingdom ||| Pharmvit Limited Unit 13, Metropolitan Centre Derby Road, Greenford Middlesex UB6 8UJ United Kingdom ||| Neolab Limited 57 High Street Odiham, Hampshire RG29 1LF Royaume-Uni
0.3550480008125305 ||| Platelets < 10 x 109/ l ||| Platelets (x 10 / l) ||| plaquettes < 10 x 109/ l
0.39887574315071106 ||| The ‘Global Goal: Unite For Our Future' campaign launched by the Commission and the international advocacy organisation Global Citizen on 28 May will culminate in a global pledging summit and concert on Saturday 27 June. ||| On 4 May, our international pledging conference will kick-start global cooperation and support for this work, with the aim to raise €7.5 billion in funding to the benefit of the global community. ||| La campagne «Objectif mondial: Unis pour notre avenir», lancée le 28 mai par la Commission et l'organisation internationale de défense des citoyens Global Citizen, aura pour point culminant un sommet mondial des donateurs et un concert, qui se tiendront le samedi 27 juin.
0.37658417224884033 ||| Likewise, prasugrel did not significantly alter the effect of heparin on measures of coagulation. ||| Similar or higher inhibition of platelet aggregation was observed with prasugrel. ||| De même, le prasugrel n'a pas significativement modifié l'effet de l'héparine sur les paramètres de la coagulation.
0.3378881514072418 ||| It contains the active substance cidofovir (75 mg/ ml). ||| - The active substance is bimatoprost 0.3 mg/ ml. ||| Elle contient le principe actif cidofovir (75 mg/ ml).
0.2821710705757141 ||| The active substance in AZILECT, rasagiline, is a monoamine oxidase-B inhibitor. ||| The active substance in TESLASCAN, mangafodipir, contains manganese, a metal element. ||| Le principe actif d’ AZILECT, la rasagiline, est un inhibiteur de la monoamine oxydase B.
0.5236769318580627 ||| Κύπρος Boehringer Ingelheim Ellas A. E. ||| Κύπρος Lundbeck Hellas A.E Θεμ. ||| Κύπρος Boehringer Ingelheim Ellas A.E.
0.6496336460113525 ||| Do not chew the tablet. ||| Throw the swab away. ||| Ne pas mâcher le comprimé.
0.2892141342163086 ||| In study NR15961, patients concurrently treated with stavudine and interferon therapy with or without ribavirin, the incidence of pancreatitis and/ or lactic acidosis was 3% (12/ 398). ||| In a two-year study in postmenopausal women with osteoporosis (BM 16549) the overall safety of Bondenza 150 mg once monthly and ibandronic acid 2.5 mg daily was similar. ||| Dans l'étude NR15961, l'incidence de pancréatite et/ou d'acidose lactique était de 3% (12/398) chez les patients traités conjointement par stavudine et interféron associé ou non à la ribavirine.
0.08496621251106262 ||| In healthy volunteers Valdoxan preserved sexual function in comparison with paroxetine. ||| In healthy volunteers Thymanax preserved sexual function in comparison with paroxetine. ||| Chez les volontaires sains, Valdoxan a préservé la fonction sexuelle contrairement à la paroxétine.
0.6312061548233032 ||| Coordination groups for mutual-recognition and decentralised procedures (human and veterinary products) ||| Providing and conducting non-denominational, non-religious civil marriage ceremonies ||| Groupes de coordination de la reconnaissance mutuelle et des procédures décentralisées (médicaments à usage humain et vétérinaire)
0.3423283100128174 ||| Blood tests will be done every 2 weeks for the first year of therapy, every 4 weeks for the next 6 months and every 8 weeks thereafter and treatment will be stopped if they become abnormal. ||| After hip replacement surgery treatment should be initiated orally within 1 – 4 hours of completed surgery with a single capsule and continuing with 2 capsules once daily thereafter for a total of 28-35 days. ||| Des examens sanguins doivent être réalisés toutes les 2 semaines la première année de traitement, toutes les 4 semaines les 6 mois suivants et toutes les 8 semaines ensuite.
0.5165503621101379 ||| Duplicating of films ||| Laminating of board ||| Reproduction de films
0.6461927890777588 ||| Biograstim contains sorbitol. ||| ADRs with lisinopril ||| Biograstim contient du sorbitol.
0.36008965969085693 ||| Hepatitis, and rarely jaundice, have been reported in patients on Kaletra therapy in the presence or absence of identifiable risk factors for hepatitis. ||| Experience with Extavia in patients with multiple sclerosis (MS) is limited, consequently those adverse events which occur very rarely may not yet have been observed. ||| Des cas d’ hépatite, et de rares cas d’ ictères ont été rapportés chez des patients traités par Kaletra en présence ou absence de facteurs de risque identifiables d’ hépatite.
0.28522002696990967 ||| EVICEL is supplied as a package containing two separate vials (glass type I) with rubber stoppers (type I), each containing 1 ml, 2 ml or 5 ml solution of Human Fibrinogen and Human Thrombin, respectively. ||| NeuroBloc is a clear and colourless to pale yellow solution supplied in a glass vial that contains 0.5ml (2500Units), 1.0ml (5000 Units) or 2.0ml (10,000 Units) of solution for injection. ||| EVICEL est fourni en emballage contenant deux flacons séparés (verre de type I) munis de bouchons en caoutchouc (type I), contenant chacun 1 ml, 2 ml ou 5 ml de solution de fibrinogène humain et de thrombine humaine respectivement.
0.4575613737106323 ||| Lundbeck A/S Ottiliavej 9 DK-2500 Valby Denmark. ||| Meda AB Pipers väg 2A S-170 09 Solna Sweden ||| Lundbeck A/ S Ottiliavej 9 DK-2500 Valby Danemark.
0.23197895288467407 ||| - One ml solution contains 100 micrograms ziconotide (as acetate). ||| One ml solution contains 25 micrograms ziconotide (as ||| Un ml de solution contient 100 microgrammes de ziconotide (sous forme d'acétate).
0.08286766707897186 ||| Table 3b – Reduced PegIntron Dose for the 1.0 μ g/ kg Monotherapy Regimen ||| Table 3b – Reduced ViraferonPeg Dose for the 1.0 μg/kg Monotherapy Regimen ||| Tableau 3b – Réduction des doses du PegIntron utilisé en monothérapie 1,0 μ g/ kg
0.7317198514938354 ||| The full EPAR for NeuroBloc is available here. ||| Emacs also has a built-in tutorial. ||| L’ EPAR complet relatif à NeuroBloc est disponible ici.
2.2698058439307028e-13 ||| Powder Sodium chloride Calcium chloride dihydrate Glycylglycine Polysorbate 80 Mannitol Sucrose Methionine Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment) ||| Powder Sodium chloride Calcium chloride dihydrate Glycylglycine Polysorbate 80 Mannitol Sucrose Methionine Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment) ||| 58 Glycylglycine Polysorbate 80 Mannitol Saccharose Méthionine Acide chlorhydrique (pour l’ ajustement du pH) Hydroxyde de sodium (pour l’ ajustement du pH)
0.10566497594118118 ||| - The other ingredients are sorbitol (E 420), glycerol, propylene glycol, saccharine sodium, ||| - The other ingredients are glycerol, propylène glycol, saccharine sodium, methyl (4- ||| - Les autres composants sont: sorbitol (E420), glycérol, propylène glycol, saccharine sodique, 4-
0.04880443587899208 ||| Children should not be allowed to play with treated animals until the application site is dry. ||| Children should not be allowed to have contact with treated animals until the application site is dry. ||| Les enfants ne doivent pas jouer avec l’ animal traité jusqu’ à ce que le site d’ application soit sec.
0.039353009313344955 ||| If the patient has multiple lesions Extavia should be discontinued until healing has occurred. ||| If the patient has multiple lesions Betaferon should be discontinued until healing has occurred. ||| Si le patient présente des lésions multiples, le traitement devra être suspendu jusqu’ à guérison de celles -ci.
0.3405367136001587 ||| Acticam must not be administered in conjunction with other NSAIDS or glucocorticosteroids. ||| Dogs treated concomitantly with spironolactone and NSAIDs should be correctly hydrated. ||| Ne pas administrer Acticam conjointement avec d'autres AINS ou des glucocorticoïdes.
0.31541627645492554 ||| United Kingdom Glaxo Wellcome UK Limited, Stockley Park West, Uxbridge Middlesex UB11 1BT United Kingdom ||| Bristol Myers Squibb Pharma EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom ||| Royaume-Uni Glaxo Wellcome UK Limited, trading as Allen & Hanburys; Stockley Park West, Uxbridge, Middlesex UB11 1BT, Royaume- Uni
0.29150137305259705 ||| If you take more Zyrtec than you should ||| If you inject more Binocrit than you should ||| Si vous avez pris plus de Zyrtec que vous n’ auriez dû:
0.2125691920518875 ||| In vitro studies using human liver microsomes indicate that ranolazine is metabolised primarily by CYP3A4, but also by CYP2D6. ||| In vitro and in vivo studies indicate that venlafaxine is biotransformed to its major active metabolite, ODV, by CYP2D6. ||| Les études in vitro utilisant des microsomes hépatiques humains indiquent que la ranolazine est principalement métabolisée par le CYP3A4, mais également par le CYP2D6.
0.38717910647392273 ||| Loratadine has been authorised nationally and through MRP in the EU Member States. ||| Diovan is authorised in the European Union (EU) via national procedures. ||| Loratadine a été autorisée au niveau national et par procédure de reconnaissance mutuelle dans les États membres de l’ UE.
0.40675997734069824 ||| Deutschland UCB GmbH Tel: + 49 / (0)2173 48 4847 ||| Sverige Bayer AB Tel: +46-(0)8 580 223 00 ||| 111 Deutschland UCB GmbH Tel: + 49 / (0) 2173 48 4847
0.08591467142105103 ||| 2 vials containing 120 mg powder for solution for injection 2 vials containing 6 ml solvent 2 syringes (5 ml) 2 reconstitution needles (21G 0.8 x 50 mm) 2 injection needles (27G 0.4 x 25 mm) ||| 1 vial containing 80 mg powder for solution for injection 1 vial containing 6 ml solvent 1 syringe (5 ml) 1 reconstitution needle (21G 0.8 x 50 mm) 1 injection needle (27G 0.4 x 25 mm) ||| 2 flacons contenant 120 mg de poudre pour solution injectable 2 flacons contenant 6 ml de solvant 2 seringues (5 ml) 2 aiguilles pour la reconstitution (21G 0,8 x 50 mm) 2 aiguilles pour l’ injection (27 G 0,4 x 25 mm)
0.16272523999214172 ||| Provision of information relating to road transport ||| Provision of information relating to restaurants ||| Services d'informations liées au transport routier
0.277874231338501 ||| What is ProteqFlu used for? ||| What is MabThera used for? ||| Dans quel cas ProteqFlu est -il utilisé?
0.5641732811927795 ||| Defoliants ||| Dehydration ||| Défoliants
0.42831987142562866 ||| The additional study showed that agomelatine was more effective than sertraline, with a difference in HAM-D scores of 1.68 after six weeks. ||| In the six-month study, the decrease seen at six weeks with 3.8 g Cholestagel (about six tablets) was maintained for six months. ||| L’ étude supplémentaire a montré que l’ agomélatine était plus efficace que la sertraline, avec une différence dans les scores HAM-D de 1,68 après six semaines.
0.24732384085655212 ||| The total clearance of gemfibrozil is in the range 100 to 160 ml/ min, and the elimination half-life is in the range 1.3 to 1.5 hours. ||| The elimination half-life (t½) of sugammadex in adults is 1.8 hours and plasma clearance is estimated to be 88 ml/ min. ||| La clairance totale du gemfibrozil est de l'ordre de 100 à 160 ml/mn et sa demi-vie d'élimination est de 1,3 à 1,5 heure.
0.4684852361679077 ||| Italy notified to the Commission under the amended Temporary Framework a scheme, with an estimated budget of €50 million, to support companies of all sizes active in the agricultural, forestry and fishery sectors in the Friuli Venezia Giulia region, that are facing difficulties due to the coronavirus outbreak. ||| On 25 February 2020, the UK's CMOs advice for all travellers (unwell or not) who had returned to the UK from Hubei province in the previous 14 days, Iran, specific areas designated by the Italian government as quarantine areas in northern Italy and special care zones in South Korea since 19 February, to self-isolate and call NHS 111. ||| L'Italie a notifié à la Commission, au titre de l' encadrement temporaire modifié, un régime doté d'un budget prévisionnel de 50 millions d'euros visant à soutenir les entreprises de toutes tailles des secteurs de l'agriculture, de la sylviculture et de la pêche de la région Frioul-Vénétie Julienne qui rencontrent des difficultés en raison de la pandémie de coronavirus.
0.5027467012405396 ||| Apparatus for the diagnosis of neurological diseases ||| Counselling relating to the psychological relief of medical ailments ||| Appareils pour le diagnostic de maladies neurologiques
0.2902534604072571 ||| If PRCA, a very rare condition, occurs, the Retacrit therapy will be stopped and your doctor will determine the best course of action to treat the anaemia. ||| If your body produces neutralising antibodies, your doctor will discontinue therapy with NeoRecormon, and determine the best course of action to treat your anaemia. ||| En cas d’apparition d’AEPA – une affection rare – le traitement par Retacrit sera arrêté et votre médecin déterminera des mesures à prendre pour traiter l’anémie.
0.026138775050640106 ||| Patients who develop jaundice or other signs suggestive of liver dysfunction should discontinue Xiliarx. ||| Patients who develop jaundice or other signs suggestive of liver dysfunction should discontinue Eucreas. ||| Les patients développant un ictère ou d’ autres signes suggérant un dysfonctionnement hépatique doivent arrêter Xiliarx.
0.3338662385940552 ||| Pharmacodynamic effects: ||| Pharmacodynamic effects M ||| 130 Effets pharmacodynamiques
0.6131754517555237 ||| – Immune thrombocytopenic purpura ||| Treatment of Mucopolysaccharidosis type II ||| Purpura thrombopénique immunologique
0.042639777064323425 ||| Since the VLPs contain no viral DNA, they cannot infect cells, reproduce or cause disease. ||| The VLPs contain no viral DNA, they cannot infect cells, reproduce or cause disease. ||| Puisque les VLP ne contiennent pas d’ ADN viral, elles ne peuvent pas infecter les cellules, ni se multiplier, ni provoquer de maladie.
0.40005484223365784 ||| Providing facilities for playing Go board games ||| Providing outdoor facilities for playing paintball games ||| Mise à disposition d’installations pour jouer au jeu de go
0.6470273733139038 ||| Rice milk ||| Danish bread ||| Lait de riz
0.38432082533836365 ||| Significant improvements at Week 16 from baseline compared to placebo (Studies I and II) and MTX (Study II) were demonstrated in the DLQI (Dermatology Life Quality Index). ||| Induction of clinical remission (defined as CDAI < 150) was evaluated in two studies, CD Study I (CLASSIC I) and CD Study II (GAIN). ||| L’ index de qualité de vie dermatologique DLQI (Dermatology Life Quality Index) a mis en évidence des améliorations significatives à la semaine 16 par rapport à l’ inclusion, comparativement au placebo (études I et II) et au MTX (étude II).
0.13151836395263672 ||| TESAVEL 50 mg film-coated tablets ||| TRAZEC 120 mg film-coated tablets ||| TESAVEL 50 mg, comprimés pelliculés
0.24388787150382996 ||| Female gender and higher CD4 counts at the initiation of therapy place patients at greater risk of hepatic adverse events. ||| Female gender and patients with higher CD4 counts are at increased risk of hepatic adverse events. ||| Les femmes et les patients présentant un taux élevé de CD4 lors de l’ initiation du traitement sont exposés à un risque plus élevé d’ événements indésirables hépatiques.
0.176472470164299 ||| 0.23 ml solution in a vial (type I glass) with a stopper (chlorobutyl rubber), with 1 filter needle, 1 injection needle and 1 syringe (polypropylene). ||| 0.5 ml of suspension in pre-filled syringe (type I glass) with a plunger stopper (chlorobromobutyl) without needle - pack of 1, 10, 25 and 50. ||| Solution de 0,23 ml dans un flacon (en verre de type I) muni d'un bouchon (en caoutchouc chlorobutyl), avec 1 aiguille-filtre, 1 aiguille pour injection et 1 seringue (en polypropylène).
0.5011883974075317 ||| Soliris should be administered by a health care professional. ||| IDflu is administered to you by your doctor or nurse. ||| Soliris doit être administré par un professionnel de santé.
0.2811425030231476 ||| Repair or maintenance of waste compacting machines and apparatus ||| Repair or maintenance of rubber-goods manufacturing machines and apparatus ||| Réparation ou entretien de machines et d'appareils de compactage de déchets
4.324987091554322e-13 ||| Combination therapy: ||| Combination therapy: ||| 102 Traitement combiné:
0.2735425531864166 ||| What Mycamine contains ||| What Binocrit contains ||| Que contient Mycamine
0.5796796679496765 ||| Patients experiencing these side effects should not drive or use machines. ||| People may also acquire resistant bacteria from direct contact with animals. ||| Les patients ressentant de tels effets indésirables ne devraient pas conduire ou utiliser des machines.
0.23837915062904358 ||| Based on the prospective study CNA106030 (PREDICT-1), use of pre-therapy screening for the HLA-B*5701 allele and subsequently avoiding abacavir in patients with this allele significantly reduced the incidence of abacavir hypersensitivity reactions. ||| The effects of alendronate on bone mass and fracture incidence in post-menopausal women were examined in two initial efficacy studies of identical design (n=994) as well as in the Fracture Intervention Trial (FIT: n=6,459). ||| D'après les résultats de l'étude prospective CNA106030 (PREDICT-1), le dépistage de l'allèle HLA-B*5701 avant de débuter le traitement, suivi de la non- prescription d'abacavir chez les patients porteurs de cet allèle, a réduit significativement l'incidence des réactions d'hypersensibilité à l'abacavir.
0.3125506043434143 ||| Hypoglycaemia may be associated with listlessness, confusion, palpitations, headache, sweating and vomiting. ||| Other frequently observed signs are nausea, vomiting, diarrhoea, abdominal pain and severe tiredness. ||| L'hypoglycémie peut être associée à une apathie, une confusion, des palpitations, des céphalées, des sueurs et des vomissements.
0.2586885094642639 ||| When initiating Stalevo therapy for patients currently treated with entacapone and levodopa/ carbidopa in doses not equal to Stalevo 150 mg/ 37.5 mg/ 200 mg, (or 50 mg/ 12.5 mg/ 200 mg, or 100 mg/ 25 mg/ 200 mg or 200 mg/ 50 mg/ 200 mg) tablets, Stalevo dosing should be carefully titrated for optimal clinical response. ||| In this study (baseline blood pressure 171/ 113 mmHg), an Copalia regimen of 5 mg/ 160 mg titrated to 10 mg/ 160 mg reduced sitting blood pressure by 36/ 29 mmHg as compared to 32/ 28 mmHg with a regimen of lisinopril/ hydrochlorothiazide 10 mg/ 12.5 mg titrated to 20 mg/ 12.5 mg. ||| Pour l’ instauration du traitement par Stalevo chez des patients prenant de l'entacapone et de la lévodopa/ carbidopa à des doses différentes des concentrations des comprimés de Stalevo 150 mg/ 37,5 mg/ 200 mg (ou 50 mg/ 12,5 mg/ 200 mg, 100 mg/ 25 mg/ 200 mg ou 200 mg/ 50 mg/ 200 mg), la posologie de ce dernier doit être ajustée prudemment de façon à optimiser la réponse clinique.
0.3574749231338501 ||| The primary endpoint was the proportion of patients who experienced a clinical response, defined as a decrease in CDAI by ≥ 70 points from baseline at the 4-week evaluation and without an increase in the use of medicinal products or surgery for Crohn’ s disease. ||| Regarding the dosing by age group, the MAH defended the same dosing for age group 12 to 18 as in adults because the increase in body weight is compensated by a decrease in clearance, allowing for an equivalent systemic exposure. ||| Le principal critère d’ évaluation était la proportion de patients ayant montré une réponse clinique, définie comme une diminution du CDAI ≥ 70 points par rapport à la valeur de départ lors de l’ évaluation de la semaine 4, et n’ ayant pas fait l’ objet d’ une augmentation de la prise des médicaments ou d’ une chirurgie liée à la maladie de Crohn.
0.2466629147529602 ||| Steady state concentrations of etoricoxib are reached within seven days of once daily administration of 120 mg, with an accumulation ratio of approximately 2, corresponding to a half-life of approximately 22 hours. ||| At steady-state following a dose of 8 mg/ kg every 4 weeks, the effective t1/ 2 decreased with decreasing concentrations within a dosing interval from 14 days to 8 days. ||| A l’ état d’ équilibre, les concentrations d’ étoricoxib sont atteintes en sept jours après l’ administration de 120 mg une fois par jour, avec un rapport d’ accumulation d’ environ 2, ce qui correspond à une demi- vie d’ accumulation d’ environ 22 heures.
0.02967684157192707 ||| In healthy subjects receiving Tredaptive, pretreatment with acetylsalicylic acid 325 mg had no additional beneficial effects in reducing nicotinic acid-induced flushing symptoms compared to Tredaptive alone (see section 4.8). ||| In healthy subjects receiving Pelzont, pretreatment with acetylsalicylic acid 325 mg had no additional beneficial effects in reducing nicotinic acid-induced flushing symptoms compared to Pelzont alone (see section 4.8). ||| Chez des sujets sains recevant Tredaptive, l’ administration préalable de 325 mg d’ acide acétylsalicylique n’ a pas eu d’ effet bénéfique supplémentaire pour réduire les symptômes vasomoteurs induits par l’ acide nicotinique par rapport à Tredaptive administré seul (Voir rubrique 4.8).
0.6258525848388672 ||| What is the role of the EIB Group in the new proposal? ||| What are the main findings of the convergence report? ||| Quel rôle la nouvelle proposition attribue-t-elle au Groupe BEI?
0.2854815125465393 ||| Following antibody induction, oral therapy should commence at a dose of 0.075 mg/kg/day administered as two divided doses (e.g. morning and evening). ||| Dosage: In combination with oral antidiabetic agents it is recommended to initiate Levemir treatment with once daily administration at a dose of 10 U or 0.1-0.2 U/ kg. ||| Après traitement d’ induction par des anticorps, le traitement par  par voie orale débutera à la dose de 0,075 mg/ kg/ jour, administrée en deux prises séparées (par exemple le matin et le soir).
0.24331584572792053 ||| In a 6-week, placebo-controlled trial involving patients with a manic or mixed episode of Bipolar I Disorder, with or without psychotic features, who were partially non-responsive to lithium or valproate monotherapy for 2 weeks at therapeutic serum levels, the addition of aripiprazole as adjunctive therapy resulted in superior efficacy in reduction of manic symptoms than lithium or valproate monotherapy. ||| 54 In an 18-month co-therapy study in manic or mixed episode patients stabilised with olanzapine plus a mood stabiliser (lithium or valproate), long-term olanzapine co-therapy with lithium or valproate was not statistically significantly superior to lithium or valproate alone in delaying bipolar recurrence, defined according to syndromic (diagnostic) criteria. ||| Dans une étude clinique de 6 semaines contrôlée versus placébo, incluant des patients présentant des épisodes maniaques ou mixtes dans le cadre de troubles bipolaires de type I, avec ou sans caractéristiques psychotiques qui étaient partiellement non répondeurs au lithium ou au valproate en monothérapie pendant 2 semaines à des taux sériques thérapeutiques, l’ association d’ aripiprazole a eu
0.4251440763473511 ||| Adding Byetta to metformin is not associated with this risk. ||| Rifampicin is contraindicated in combination with boosted PIs. ||| L’ ajout de Byetta à la metformine n’ est pas associé à ce risque.
0.26844507455825806 ||| Therefore, Xeloda must not be administered concomitantly with sorivudine or its chemically related analogues, such as brivudine (see section 4.3). ||| Zidovudine and stavudine in combination are antagonistic in vitro, therefore the concomitant use of stavudine with Combivir should be avoided (see section 4.4). ||| En conséquence, Xeloda ne doit pas être administré en même temps que la sorivudine ou apparentés, telle que la brivudine (voir rubrique 4.3).
0.03132282570004463 ||| 12 ANNEX II ||| 11 ANNEX II ||| 12 ANNEXE II
0.6273342370986938 ||| The starting point for this must be making our economies, societies and way of life more sustainable and resilient. ||| First, we must do more to improve the lives of the poorest and most vulnerable in our societies. ||| Pour commencer, nous devons rendre nos économies, nos sociétés et nos modes de vie plus durables et résilients.
0.09610310196876526 ||| EU/ 1/ 06/ 368/ 092 (3 cartridges of 3 ml) EU/ 1/ 06/ 368/ 049 (4 cartridges of 3 ml) EU/ 1/ 06/ 368/ 050 (5 cartridges of 3 ml) EU/ 1/ 06/ 368/ 097 (6 cartridges of 3 ml) EU/ 1/ 06/ 368/ 102 (9 cartridges of 3 ml) EU/ 1/ 06/ 368/ 051 (10 cartridges of 3 ml) ||| EU/ 1/ 97/ 030/ 088 (3 cartridges of 3 ml) EU/ 1/ 97/ 030/ 061 (4 cartridges of 3 ml) EU/ 1/ 97/ 030/ 045 (5 cartridges of 3 ml) EU/ 1/ 97/ 030/ 093 (6 cartridges of 3 ml) EU/ 1/ 97/ 030/ 098 (9 cartridges of 3 ml) EU/ 1/ 97/ 030/ 062 (10 cartridges of 3 ml) ||| EU/ 1/ 06/ 368/ 092 (3 cartouches de 3 ml) EU/ 1/ 06/ 368/ 049 (4 cartouches de 3 ml) EU/ 1/ 06/ 368/ 050 (5 cartouches de 3 ml) EU/ 1/ 06/ 368/ 097 (6 cartouches de 3 ml) EU/ 1/ 06/ 368/ 102 (9 cartouches de 3 ml) EU/ 1/ 06/ 368/ 051 (10 cartouches de 3 ml)
0.2443029284477234 ||| 126 In patients with chronic renal failure and clinical evidence of ischaemic heart disease or congestive heart failure, the target haemoglobin should be determined individually. ||| Therefore as with any agent acting on the RAS system, routine monitoring of electrolytes and renal function is indicated in patients with diabetes mellitus, kidney disease, or heart failure. ||| Chez les patients insuffisants rénaux chroniques présentant des manifestations cliniques d'ischémie myocardique ou d'insuffisance cardiaque congestive, le taux d'hémoglobine à atteindre doit être déterminé individuellement.
0.004194148816168308 ||| Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment d’autres médicaments, même s'il s'agit d'un médicament obtenu sans ordonnance.
0.3086797297000885 ||| No survival benefit or other clinically relevant effects of the treatment have been demonstrated in patients with EGFR- negative tumours (see section 5.1). ||| Although hormonal imbalance has been seen in preclinical studies (see section 5.3), no significant undesirable effects associated with menstrual disorders have been observed. ||| Aucun bénéfice en survie ou autres effets cliniquement significatifs du traitement n’ ont été démontrés chez les patients dont l’ expression EGFR de la tumeur était négative (voir rubrique 5.1).
0.26640158891677856 ||| For children who weigh 50 kg or more • The starting dose will normally be 0.5 mg once a day • The dose may be increased every other day in steps of 0.5 mg per day. • The usual maintenance dose is 0.5 mg to 1.5 mg once a day. ||| The recommended dose is 1.30 g/ m2/ day of the free base divided four times daily. • For patients over age 12 and over 50 kg weight, the recommended CYSTAGON dose is 2 g/ day, divided four times daily. ||| Pour un enfant de 50 kg ou plus • La dose initiale sera normalement de 0,5 mg une fois par jour • La dose pourra être augmentée tous les deux jours par paliers de 0,5 mg par jour • La dose d’ entretien usuelle est de 0,5 mg à 1,5 mg une fois par jour.
0.32415759563446045 ||| Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. ||| Resocortol butyrate is a corticosteroid which has a high intrinsic glucocorticoid activity. ||| La loratadine est un antihistaminique tricyclique agissant sélectivement sur les récepteurs H1 périphériques.
0.6327763795852661 ||| Age/ gender: ||| Age and gender: ||| Âge/ sexe:
0.45951420068740845 ||| If the animal is fed at the time of dosing, the absorption may be slightly delayed. ||| Its effect may be delayed if it is taken during or after meals. ||| Si l’ animal est nourri au moment de l’ administration, l’ absorption peut être légèrement retardée.
0.0 ||| Distribution: maraviroc is bound (approximately 76%) to human plasma proteins, and shows moderate affinity for albumin and alpha-1 acid glycoprotein. ||| Distribution: maraviroc is bound (approximately 76%) to human plasma proteins, and shows moderate affinity for albumin and alpha-1 acid glycoprotein. ||| 16 Distribution: le maraviroc est lié approximativement à 76% aux protéines plasmatiques humaines et possède une affinité modérée pour l’ albumine et l’ alpha-1-glycoprotéine acide.
0.6089481711387634 ||| Wipe the rubber seal with alcohol. ||| Dukoral is taken by mouth. ||| 58 Essuyer le joint en caoutchouc avec de l'alcool.
0.5116418600082397 ||| Common reported side effects (likely to occur in fewer than 1 in 10 patients). weakness, pain or muscle stiffness around your body ||| swelling interfering with, but not precluding normal physical activities; small blisters or ulcerations less than 2 cm in diameter) ||| Effets indésirables fréquemment signalés (susceptibles de se produire chez moins de 1 patient sur 10)
0.3854384422302246 ||| (ii) State guarantees for loans taken by companies to ensure banks keep providing loans to the customers who need them. ||| A scheme to provide State guarantees to banks on portfolios of new loans for all types of companies. ||| ii) aides sous la forme de garanties sur les prêts contractés par des entreprises afin de s'assurer que les banques continuent d'accorder des prêts aux clients qui en ont besoin.
0.5520778894424438 ||| 59/ 64 PACKAGE LEAFLET Dicural 50 mg/ ml, solution for injection for cattle ||| 60 DULOXETINE BOEHRINGER INGELHEIM 60 mg is available in packs of 28 and 98 capsules. ||| 62/ 67 NOTICE POUR Dicural 50 mg/ ml solution injectable pour bovins
0.2439803183078766 ||| A test to determine your liver function will be performed before the start of Eucreas treatment, at three-month intervals for the first year and periodically thereafter. ||| Liver function should be monitored during treatment with Zomarist at three-month intervals during the first year and periodically thereafter. ||| Un examen évaluant votre fonction hépatique sera effectué avant de prendre Eucreas, à intervalles de 3 mois pendant la première année puis régulièrement par la suite.
0.24394623935222626 ||| In early and advanced Parkinson’ s disease, efficacy of pramipexole in the controlled clinical trials was maintained for approximately six months. ||| In a clinical trial, administration of Kepivance within 24 hours of chemotherapy resulted in an increased severity and duration of oral mucositis. ||| Au cours des études cliniques contrôlées, l’ efficacité du traitement aux stades précoce et avancé de la maladie de Parkinson a été maintenue pendant 6 mois environ.
0.32737064361572266 ||| EU/ 1/ 04/ 292/ 005 – carton of 14 tablets EU/ 1/ 04/ 292/ 006 – carton of 28 tablets EU/ 1/ 04/ 292/ 007 – carton of 84 tablets ||| EU/ 1/ 04/ 0299/ 001 – pack of 1 with separate needle EU/ 1/ 04/ 0299/ 002 – pack of 1 without needle EU/ 1/ 04/ 0299/ 003 – pack of 10 without needles ||| EU/ 1/ 04/ 292/ 005 – boîte de 14 comprimés EU/ 1/ 04/ 292/ 006 – boîte de 28 comprimés EU/ 1/ 04/ 292/ 007 – boîte de 84 comprimés
0.21429871022701263 ||| For polyarticular juvenile idiopathic arthritis, Humira was compared with placebo, alone or as an add- on to methotrexate, in one main study involving 171 patients aged between four and 17 years. ||| In a cross-study analysis using data from four Phase I studies, the pharmacokinetics of nelarabine and ara-G were characterized in patients aged less than 18 years and adult patients with refractory leukaemia or lymphoma. ||| Dans le cas de la polyarthrite idiopathique juvénile polyarticulaire, Humira a été comparé au placebo, seul ou en association avec le méthotrexate, au cours d’ une étude principale impliquant 171 patients âgés de quatre à dix-sept ans.
0.01951327547430992 ||| Exelon 4.5 mg [folding box only] ||| Exelon 1.5 mg [folding box only] ||| Exelon 4,5 mg [uniquement pour la boîte]
0.22708050906658173 ||| Among patients who were naive to IOP therapy (10 patients), the efficacy of AZOPT was similar to that seen previously in adults, with mean IOP reductions from baseline ranging up to 5 mmHg. ||| Although inhibition of ADP-induced platelet aggregation was lower (25%) than that observed in healthy subjects, the prolongation of bleeding was similar to that seen in healthy subjects receiving 75 mg of clopidogrel per day. ||| Chez les patients naïfs (10 patients), l’ efficacité d’ AZOPT était similaire à celle observée préalablement chez les adultes, avec des réductions moyennes de PIO allant jusqu’ à 5 mmHg.
0.48585182428359985 ||| Developmental toxicity studies were previously conducted in rabbits. ||| Studies with other interferons have demonstrated species specificity. ||| Des études de la toxicité sur le développement ont été précédemment menées chez le lapin.
0.531315803527832 ||| State aid: Commission approves Austrian guarantee schemes ||| Digital Finance: Commission holds closing pan-European ||| Aides d'État: la Commission autorise des régimes de garantie autrichiens
0.5639334917068481 ||| Member States now have the possibility to comment on the Commission's draft proposal. ||| The Commission stands ready to provide any further assistance to China. ||| Les États membres ont maintenant la possibilité de formuler des observations sur le projet de proposition de la Commission.
0.40160998702049255 ||| Neutropenia, thrombocytopenia, anaemia Pancytopenia, febrile neutropenia Thrombocythaemia, lymphopenia, bone marrow depression, eosinophilia, lymphadenopathy ||| Anaemia, neutropenia Thrombocytopenia, lymphadenopathy, lymphopenia Aplastic anaemia* Pure red cell aplasia, idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura ||| et du système lymphatique Neutropénie, thrombopénie, anémie Pancytopénie, neutropénie fébrile Thrombocythémie, lymphopénie, aplasie médullaire, eosinophilie, lymphadénopathie
0.39282262325286865 ||| Analytical orthoprojectors ||| Holographic security apparatus ||| Orthoprojecteurs analytiques
0.40234923362731934 ||| If you have used more Omnitrope than you should, please ask your doctor for advice. ||| If you have severe depression or thoughts about suicide, you must not use Avonex. ||| Si vous avez utilisé une dose d’ Omnitrope trop élevée, demandez l’ avis de votre médecin.
0.03790552169084549 ||| Optic neuropathy, Papilledema, retinal vascular disorder, retinopathy, corneal ulcer ||| Optic neuropathy, papilledema, retinal vascular disorder, retinopathy, corneal ulcer ||| neuropathie optique, œdème papillaire, trouble vasculaire rétinien, rétinopathie, ulcère de la cornée
0.2609923481941223 ||| Caelyx 2 mg/ ml concentrate for solution for infusion Pegylated liposomal doxorubicin hydrochloride ||| One ml of Caelyx contains 2 mg pegylated liposomal doxorubicin hydrochloride. ||| Caelyx 2 mg/ ml solution à diluer pour perfusion Chlorhydrate de doxorubicine liposomal pégylé
0.4175708591938019 ||| Uncommon side effects (may affect fewer than 1 in every 100 people) ||| Rare side effects (less than 1 in 1,000 people affected) ||| Effets indésirables peu fréquents (pouvant affecter moins d’ 1 personne sur 100)
0.27597206830978394 ||| However, significant liver toxicity has not been observed in patients treated in clinical studies, either during administration of Agenerase or after discontinuation. ||| However, clinical experience has shown that reinstitution of the therapy is often possible without recurrence of the intracranial hypertension. ||| 64 Toutefois, aucune hépatotoxicité significative n'a été observée chez les patients traités lors des essais cliniques, que ce soit lors de l'administration d’ Agenerase ou après son arrêt.
0.35035914182662964 ||| Enbrel is available as a single use syringe for patients weighing 62.5 kg or more. ||| Efavirenz film-coated tablets are not suitable for children weighing less than 40 kg. ||| 184 Enbrel est disponible en seringue à usage unique pour les patients pesant 62,5 kg ou plus.
0.2890329360961914 ||| Tell your doctor if you are pregnant, think you may be pregnant or are breast-feeding before you receive treatment with Paxene. ||| You must tell your doctor if you are breast-feeding so that your doctor can decide if Tamiflu is right for you. ||| Si vous êtes ou pensez être enceinte ou si vous allaitez, informez -en votre médecin avant de recevoir le traitement par Paxene.
0.06230758875608444 ||| 108 A. ||| 109 A. ||| 118 A.
0.9688987731933594 ||| 6 to 14 years old ||| 6-11 yrs old ||| âgés de 6 à 14 ans
0.1075977310538292 ||| The epoetin alfa in Binocrit is produced by a method known as ‘ recombinant DNA technology’: it is made by a cell that has received a gene (DNA), which makes it able to produce epoetin alfa. ||| The active substance in Silapo, epoetin zeta, is produced by ‘ recombinant DNA technology’: it is made by a cell that has received a gene (DNA), which makes it able to produce erythropoietin. ||| L’ époétine alfa contenue dans Binocrit est produite au moyen d’ une méthode connue sous la dénomination « technique de l’ ADN recombinant »: elle est fabriquée par une cellule ayant reçu un gène (ADN) lui permettant de produire de l’ époétine alfa.
0.2866627275943756 ||| When a pregnancy is planned or confirmed, the switch to an alternative treatment should be initiated as soon as possible. ||| If the decision to withdraw Tracleer is taken, it should be done gradually while an alternative therapy is introduced. ||| Si une grossesse est projetée ou confirmée, un traitement alternatif doit être initié dès que possible.
0.048081353306770325 ||| In renal transplant patients with severe chronic renal impairment (glomerular filtration rate < 25 ml min-1 1.73 m-2), outside the immediate post-transplant period, doses greater than 1 g administered twice a day should be avoided. ||| In renal transplant patients with severe chronic renal impairment (glomerular filtration rate < 25 ml min-1 1.73 m-2), outside the immediate post-transplant period, doses greater than 1 g administered twice a day should be avoided. ||| Utilisation en cas d'insuffisance rénale Chez les transplantés rénaux atteints d'insuffisance rénale chronique sévère (débit de filtration glomérulaire < 25 ml min-1.1,73m-2), il convient d'éviter d'administrer des doses supérieures à 1 g deux fois par jour, en dehors de la période immédiatement postérieure à la greffe.
0.6476606130599976 ||| Myelodysplastic/ myeloproliferative diseases (MDS/ MPD). ||| Progressive Multifocal Leukoencephalopathy (PML) ||| des syndromes myéloprolifératifs/ myélodysplasiques (SMP/ SMD).
0.0 ||| Therefore, the serum creatinine concentration must be checked regularly (twice per week) in these patients. ||| Therefore, the serum creatinine concentration must be checked regularly (twice per week) in these patients. ||| Il est donc nécessaire de vérifier régulièrement (deux fois par semaine) la créatininémie chez ces patients.
0.005889711901545525 ||| 72 Ciprofloxacin is largely excreted unchanged both renally and, to a smaller extent, faecally. ||| 90 Ciprofloxacin is largely excreted unchanged both renally and, to a smaller extent, faecally. ||| La ciprofloxacine est excrétée principalement sous forme inchangée par voie rénale et, à un moindre degré, par voie fécale.
0.2547929883003235 ||| The product contains approximately 175 IU/ ml antithrombin alfa when reconstituted with 10 ml of Sterile Water for Injection (WFI). ||| The product reconstituted with 10 ml of Sterilised Water for Injections contains approximately 100 IU/ ml human protein C. ||| Ce produit contient environ 175 UI/ ml d’ antithrombine alpha lorsqu’ il est reconstitué avec 10 ml d’ eau pour préparations injectables.
0.5580768585205078 ||| Your doctor may need to monitor your blood coagulation. ||| You should always measure your blood glucose regularly. ||| Votre médecin peut avoir besoin de surveiller votre bilan de coagulation.
0.4935619831085205 ||| Ivermectin 18.7 mg/ g ||| Haemoglobin < 10g/dL ||| Ivermectine Chevaux 18,7 mg/ g
0.6987814903259277 ||| Diagnostic reagents and preparations, except for medical or veterinary use ||| Revenue from export certificates, parallel distributions and other similar administrative charges ||| Réactifs et produits de diagnostic, non à usage médical ou vétérinaire
0.1507483273744583 ||| 48 6.3 Shelf life ||| 305 6.3 Shelf life ||| 6.3 Durée de conservation
0.2587861716747284 ||| Agenerase may be less effective due to decreased amprenavir plasma concentrations in patients taking these medicinal products concomitantly (see section 4.5). ||| Caution should be exercised when these medicinal products are used concomitantly with entacapone (see also sections 4.3 and 4.4). ||| Agenerase peut être moins efficace en raison de la baisse des concentrations plasmatiques d’ amprénavir chez les patients prenant ces médicaments simultanément (voir rubrique 4.5).
0.21225927770137787 ||| State aid: Commission approves €453 million Swedish rebate ||| State aid: Commission approves Belgian €250 million loan ||| Aides d'État: la Commission autorise un régime suédois
0.427432119846344 ||| In horses, after intravenous injection meloxicam is eliminated with a terminal half-life of 8.5 hours. ||| A 4 hour period of haemodialysis removed ≈ 13% of the dose, and 0.3% was removed by CAPD. ||| Chez les chevaux, la demi-vie terminale du méloxicam est de 8,5 heures après injection intraveineuse.
0.5995731353759766 ||| -0.7‡ ||| 0.37 - ||| -0,7‡
0.38570505380630493 ||| Sensitized receiver paper for use in the thermal dye sublimation process ||| Numerically controlled machining stations for boring with palletising system ||| Papier récepteur sensibilisé destiné aux procédés de sublimation thermique
0.11452355980873108 ||| Pharmacotherapeutic group: antithrombotic agents. ||| Pharmacotherapeutic group: antithrombotic agents. ed ||| Classe pharmacothérapeutique: agent anti-thrombotique.
0.7357422113418579 ||| L01BC05 ||| 9.98 E-01 ||| L01BC05.
0.07030169665813446 ||| Do not use STAMARIL after the expiry date which is stated on the carton. ||| Do not use QUADRAMET after the expiry date which is stated on the label. ||| Ne pas utiliser STAMARIL après la date de péremption mentionnée sur la boîte.
0.05566523224115372 ||| 12 film-coated tablets 24 film-coated tablets 30 film-coated tablets 60 film-coated tablets 84 film-coated tablets 120 film-coated tablets 360 film-coated tablets ||| 7 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 56 film-coated tablets 90 film-coated tablets 98 film-coated tablets 280 film-coated tablets ||| 12 comprimés pelliculés 24 comprimés pelliculés 30 comprimés pelliculés 60 comprimés pelliculés 84 comprimés pelliculés 120 comprimés pelliculés 360 comprimés pelliculés
0.3629816770553589 ||| (ii) Support for the construction and upscaling of testing facilities: Member States can grant aid in the form of direct grants, tax advantages, repayable advances and no-loss guarantees to support investments enabling the construction or upscaling of infrastructures needed to develop and test products useful to tackle the coronavirus outbreak, up to first industrial deployment. ||| (i) Support for coronavirus related research and development (R&D): to address the current health crisis,Member State can grant aid in the form of direct grants, repayable advances or tax advantages for coronavirus and other relevant antiviral R&D. A bonus may be granted for cross-border cooperation projects between Member States. ||| ii) Soutien à la construction et à la mise à niveau d'installations d'essai:les États membres peuvent octroyer des aides sous la forme de subventions directes, d'avantages fiscaux, d'avances remboursables et de garanties de couverture de pertes afin de soutenir les investissements permettant la construction ou la mise à niveau d'infrastructures nécessaires pour mettre au point et tester des produits liés à la COVID-19, jusqu'au premier déploiement industriel.
0.012421985156834126 ||| Cardiac disorders Nervous system disorders ||| Nervous system disorders Cardiac disorders ||| Affections cardiaques Affections du système nerveux central
0.2729669213294983 ||| In conclusion, the CHMP considers the efficacy of Oracea to reduce papulopustular lesions in adult patients with facial rosacea to be sufficiently demonstrated. ||| However, after extensive discussions, the CHMP considered that ciprofloxacin still remains a useful therapeutic option in uncomplicated cystitis. ||| En conclusion, le CHMP considère comme suffisamment prouvée l'efficacité d'Oracea dans la réduction des lésions papulopustulaires chez les patients adultes présentant une rosacée faciale.
0.373251348733902 ||| Patients who have not been receiving one of these medicines need to start with a dose of 0.6 micrograms per kilogram body weight twice a month. ||| To avoid the risk of developing kidney stones, patients should drink plenty of liquids (at least 1.5 litres every day for adults). ||| Les patients qui n’ ont pas été traités par l’ un de ces médicaments doivent commencer avec une dose de 0,6 microgramme par kilogramme de poids corporel deux fois par mois.
0.20867234468460083 ||| Alarm systems for watercraft ||| Storage services for aircraft ||| Systèmes d'alarme pour embarcations
0.30045950412750244 ||| Patients who experience syncope in association with pulmonary hypertension should avoid any exceptional straining, for example during physical exertion. ||| Patients who develop fatigue, somnolence or confusion during treatment with ViraferonPeg are cautioned to avoid driving or operating machinery. ||| Les patients présentant des syncopes en rapport avec l’ hypertension pulmonaire doivent éviter tout effort inhabituel, notamment pendant leurs activités physiques.
0.36939114332199097 ||| There was no tumorigenic response in male rats or either sex of mice. ||| There was no significant increase in any other tumour type in either male or female mice or rats. ||| Il n’ y avait pas d’ effet cancérigène chez les rats mâles et chez les souris des deux sexes.
0.5796365737915039 ||| Sugar bowls [not of precious metal] ||| Christmas lights [other than candles] ||| Sucriers autres qu'en métaux précieux
0.22068898379802704 ||| No deaths occurred following a single oral administration of montelukast sodium at doses up to 5000 mg/ kg in mice and rats (15,000 mg/ m2 and 30,000 mg/ m2 in mice and rats, respectively), the maximum dose tested. ||| Dose-related decreases in foetal weights were observed in pups of dams receiving brinzolamide orally ranging from a slight decrease (about 5-6%) at 2 mg/ kg/ day to nearly 14% at 18 mg/ kg/ day. ||| 35 Aucune mortalité n’ est apparue chez les souris et les rats après une administration orale unique de doses de montelukast sodique allant jusqu’ à 5000 mg/ kg (correspondant respectivement à 15000 mg/ m2 et 30000 mg/ m2 chez les souris et les rats), dose maximale testée.
0.8010720014572144 ||| Bonding agents for masonry ||| Jardinieres of earthenware ||| Agents liants pour la maçonnerie
0.49416157603263855 ||| In the body, natural growth hormone promotes growth in children by stimulating the body to produce IGF-I. ||| In the body, LH causes the release of eggs (ovulation) during the menstrual cycle. ||| Dans l’ organisme, l’ hormone de croissance naturelle favorise la croissance chez l’ enfant en stimulant la production d’ IGF-I.
0.0617808923125267 ||| The use of Ribavirin in combination with peginterferon alfa-2b had no observable negative impact on the control of HIV viraemia during therapy or follow-up. ||| The use of ViraferonPeg in combination with ribavirin had no observable negative impact on the control of HIV viraemia during therapy or follow-up. ||| L’ utilisation de Ribavirine en association avec le peginterféron alfa-2b n’ a pas eu d’ impact négatif sur le contrôle de la charge virale VIH pendant le traitement ou la période de suivi.
0.304359495639801 ||| Patients received subsequent courses of MabThera as needed according to the treating clinician’ s assessment of disease activity and irrespective of the peripheral B lymphocyte count. ||| LVEF was evaluated in all patients (using echocardiogram or MUGA) prior to initiation of treatment with lapatinib to ensure baseline LVEF was within the institutions normal limits. ||| Au cours de cette étude, les patients ont été si nécessaire retraités par MabThera sur décision de l'investigateur en fonction de l’ activité de la maladie, et sans tenir compte du taux de lymphocytes B périphériques.
0.41705870628356934 ||| It is important to keep using all your medicines as well as SOMAVERT unless you are told otherwise by your doctor or pharmacist. ||| Tell your veterinarian about all medicines, including over-the-counter products, that you intend to administer to your dog. ||| Il est important de les utiliser tous au même titre que SOMAVERT sauf avis contraire de votre médecin ou de votre pharmacien.
0.3649033308029175 ||| 51 Co-administration of efavirenz with the fixed combination tablet containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate, is not recommended. ||| The combination of emtricitabine and tenofovir disoproxil fumarate was negative in the bacterial reverse mutation assay (Ames assay). ||| La co-administration d’ éfavirenz avec l’ association médicamenteuse fixe contenant de l’ éfavirenz, de l’ emtricitabine et du fumarate de ténofovir disoproxil, n’ est pas recommandée.
0.34146344661712646 ||| Your doctor can decide whether Retacrit is not working properly for you and will end the treatment, if necessary. ||| He/ she will determine whether to monitor your treatment or whether it is necessary for you to stop using Raptiva. ||| Votre médecin peut déterminer si Retacrit n’agit pas correctement et arrêtera le traitement si besoin.
0.19400575757026672 ||| HOW TO TAKE REVATIO ||| HOW TO TAKE TOVIAZ ||| COMMENT PRENDRE REVATIO
0.25862550735473633 ||| Medical services relating to the removal, treatment and processing of human cells ||| Medical services relating to the removal, treatment and processing of umbilical cord blood ||| Services médicaux en matière de prélèvement, de traitement et de transformation de cellules humaines
0.05636896193027496 ||| OPINION OF THE COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS PURSUANT TO ARTICLE 12 OF COUNCIL DIRECTIVE 75/ 319/ EEC AS AMENDED FOR ||| FINAL OPINION OF THE COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS IN ACCORDANCE WITH ARTICLE 12 OF DIRECTIVE 75/ 319/ EEC AS AMENDED ||| AVIS DU COMITÉ DES SPÉCIALITÉS PHARMACEUTIQUES CONFORMÉMENT À L’ ARTICLE 12 DE LA DIRECTIVE 75/ 319/ CEE DU CONSEIL, TELLE QUE MODIFIÉE, POUR
0.08741988986730576 ||| The patient should be advised that in case of sudden visual defect, he should stop taking Tadalafil Lilly and consult a physician immediately (see section 4.3). ||| The patient should be advised that in case of sudden visual defect, he should stop taking Revatio and consult a physician immediately (see section 4.3). ||| Le patient doit être averti qu’ en cas d’ anomalie visuelle soudaine, il doit arrêter la prise de Tadalafil Lilly et consulter immédiatement un médecin (voir rubrique 4.3).
0.17588600516319275 ||| 21%*** ||| 0.0*** ||| 21 %***
0.35803818702697754 ||| Other information about Mycophenolate mofetil Teva: ||| How has Mycophenolate mofetil Teva been studied? ||| Autres informations relatives à Mycophénolate mofétil Teva:
0.41929197311401367 ||| The Kaplan-Meier estimate for continued sustained response over 5 years is 97% (95% CI: ||| The Kaplan-Meier estimate for survival after 36-month follow-up is 68%. ||| La probabilité de réponse virologique maintenue à 5 ans a été estimée à 97% (IC 95%:
0.051850829273462296 ||| dizziness, dyskinesia, somnolence headache hyperkinesias, sudden onset of sleep ||| dizziness, headache, somnolence sudden onset of sleep dyskinesia, hyperkinesia ||| Sensation vertigineuse, dyskinésie, somnolence Céphalées Hyperkinésie, accès de sommeil d’ apparition brutale
0.07174670696258545 ||| au please tell your doctor or pharmacist. ||| please tell your doctor or pharmacist. ||| cette notice, informez-en votre médecin ou votre pharmacien.
0.47825050354003906 ||| Wood shavings ||| Varnish paints ||| Copeaux de bois
0.05671931058168411 ||| Store in the original package. ||| Store in the original pack. ||| Conserver dans la boîte d’ origine.
0.4413231611251831 ||| Bases adapted for the mounting of lamps ||| Spirometers for examining the function of the lungs ||| Supports conçus pour le montage de lampes
0.37474507093429565 ||| Welcoming the toolbox, Commissioner for Internal Market Thierry Breton said: "Contact tracing apps to limit the spread of coronavirus can be useful, especially as part of Member States' exit strategies. ||| Commissioner for Internal Market, Thierry Breton said: "Digital technologies, mobile applications and mobility data have enormous potential to help understand how the virus spreads and to respond effectively. ||| Saluant l'adoption de la boîte à outils, M. Thierry Breton, commissaire au marché intérieur, a déclaré: «L'utilisation d'applications de traçage des contacts pour limiter la propagation du coronavirus peut être utile, en particulier dans le cadre des stratégies de sortie des États membres.
0.31463807821273804 ||| In line with the data submitted, the benefit/ risk in prophylaxis was regarded as favourable in patients with neutrophil count less than 1000/ mm3. ||| 4 The table below gives an overview of the ADRs where the incidence is at least 0.5% higher in the parathyroid hormone group compared to placebo. ||| Conformément aux données proposées, le rapport bénéfice/ risque de la prophylaxie a été reconnu comme favorable chez les patients avec une numération des neutrophiles inférieure à 1000/ mm3.
0.6177364587783813 ||| This will help you to inject the required dose only. ||| • Make sure you get a full dose. ||| Celui-ci vous aidera à injecter précisément la dose requise.
0.5027129650115967 ||| • Treatment of cystic fibrosis ||| • Treatment of dyslipidaemia ||| Treatment of cystic fibrosis
0.48006150126457214 ||| Provision of technical support in the operation of computing networks ||| Purchase of new software for the operation of the Agency ||| Services d’aide technique à l’exploitation des réseaux informatiques
0.2771187722682953 ||| For most patients with early stage Parkinson’s disease, the right dose is reached within 3 or 4 weeks, at doses of 6 mg per day or 8 mg per day respectively. ||| For skin or soft tissue infections without bacteraemia, the recommended dose is 4 mg per kilogram body weight given once every 24 hours for seven to 14 days or until the infection is cleared. ||| Pour la plupart des patients atteints de maladie de Parkinson débutante, la dose adéquate est atteinte après 3 ou 4 semaines, à la dose de 6 mg par jour ou 8 mg par jour respectivement.
4.347825268216643e-13 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. ||| Si vous remarquez des effets indésirables non mentionnés dans cette notice, ou si vous ressentez un des effets mentionnés comme étant graves, veuillez en informer votre médecin.
0.40191155672073364 ||| Furthermore, under the scheme, investment projects will be completed within six months after the date of granting the aid. ||| It is hoped that, following an evaluation of the PERF programme and its achievements, budgetary facilities will be made available to ||| En outre, dans le cadre du régime, les projets d'investissement seront menés à terme dans un délai de six mois suivant la date d'octroi de l'aide.
0.3204869031906128 ||| 36 In hepatically impaired patients, it is recommended that sirolimus whole blood trough levels be closely monitored. ||| In all patients treated with Epoetin alfa HEXAL blood pressure should be closely monitored and treated, if necessary. ||| Chez les patients présentant une insuffisance hépatique, il est recommandé que les concentrations résiduelles de sirolimus dans le sang total soient surveillées étroitement.
5.708862202413734e-13 ||| 22 ||| 22 ||| 21
0.890791654586792 ||| Until June 2005, veralipride was authorised in Spain. ||| Replaced Marios MARSELOS as of June 2002 meeting. ||| Jusqu’ en juin 2005, le véralipride était autorisé en Espagne.
0.19445055723190308 ||| The recommended dose of Telzir for adults and children weighing more than 39 kg is 700 mg twice a day. ||| The recommended dose of Emtriva is one capsule once a day for patients who weigh 33 kg or more. ||| La dose recommandée de Telzir pour les adultes et les enfants de moins de 39 kg est de 700 mg deux fois par jour.
0.3838072419166565 ||| More support for the construction and upgrading of testing facilities for products relevant to tackle the coronavirus outbreak, such as vaccines, medical equipment or devices, protective material and disinfectants. ||| It provides essentials for those in need, food and basic items such as clothes, shoes and toiletries, but also promotes social inclusion through psychological support, language courses etc. ||| Un soutien accru en faveur de la construction et de la modernisation des installations d'essai concernant les produits utiles pour lutter contre la flambée de coronavirus, comme les vaccins, le matériel ou les dispositifs médicaux, le matériel de protection et les désinfectants.
0.20864641666412354 ||| Signs of osteonecrosis are joint stiffness, aches and pains (especially of the hip, knee and shoulder) and difficulty in movement. ||| Allergic reactions have been reported including rare cases of difficulty breathing, hives and angioedema (such as swollen face, tongue or throat). ||| Les signes d’ostéonécrose sont une raideur des articulations, des douleurs (en particulier de la hanche, du genou et de l’épaule) et des difficultés pour se mouvoir.
0.0 ||| Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached ||| Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached ||| Dans les 60 jours si une étape-clé est franchie (pharmacovigilance ou minimisation des risques).
0.3563172221183777 ||| Fisher Clinical Services UK Ltd Langhurstwood Road Horsham West Sussex RH12 4QD UK ||| PackPharm Limited 14D Wendover Road Rackheath Industrial Estate Norwich NR13 6LH United Kingdom ||| Fisher Clinical Services Langhurstwood Road Horsham West Sussex RH12 4QD Royaume-Uni
0.013089517131447792 ||| Each vial contains 400 mg of tocilizumab* in 20 ml (20 mg/ ml). ||| Each vial contains 80 mg of tocilizumab* in 4 ml (20 mg/ ml). ||| Chaque flacon contient 400 mg de tocilizumab∗ dans 20 ml (20 mg/ ml).
0.4651218056678772 ||| We continue working with Member States to discuss possibilities and find workable solutions to preserve this important part of the economy in line with EU rules." ||| This is what we will strive to achieve thanks to the new strategy, by working together with Member States and civil society." ||| Nous continuons à collaborer avec les États membres pour examiner les possibilités et trouver des solutions efficaces pour préserver ce pan important de l'économie, dans le respect des règles de l'UE.»
0.5655962228775024 ||| The hazard ratio for overall survival was 0.96 (95% CI: ||| Median overall survival time was 703 days (95% CI: ||| Le rapport de risque pour la survie globale était de 0,96 (IC95%:
0.26640158891677856 ||| For children who weigh 50 kg or more • The starting dose will normally be 0.5 mg once a day • The dose may be increased every other day in steps of 0.5 mg per day. • The usual maintenance dose is 0.5 mg to 1.5 mg once a day. ||| The recommended dose is 1.30 g/ m2/ day of the free base divided four times daily. • For patients over age 12 and over 50 kg weight, the recommended CYSTAGON dose is 2 g/ day, divided four times daily. ||| Pour un enfant de 50 kg ou plus • La dose initiale sera normalement de 0,5 mg une fois par jour • La dose pourra être augmentée tous les deux jours par paliers de 0,5 mg par jour • La dose d’ entretien usuelle est de 0,5 mg à 1,5 mg une fois par jour.
0.23326820135116577 ||| The secondary definition of response required a 4-point or greater improvement on the ADAS-Cog, no worsening on the CIBIC-Plus, and no worsening on the PDS. ||| Clinically relevant improvement was defined a priori as at least 4-point improvement on the ADAS- Cog, no worsening on the ADCS-CGIC, and no worsening on the ADCS-ADL. ||| La définition secondaire du caractère répondeur nécessite une amélioration de 4 points ou plus de l’ ADAS-Cog sans aggravation des CIBIC-Plus et PDS.
0.4138319492340088 ||| Inorganic fibre mixed fabrics ||| Silk-cotton mixed fabrics ||| Tissus mixtes en fibres inorganiques
0.3230000138282776 ||| 22 An improvement in haemodynamic parameters was observed in patients with PAH after 12 weeks (n=29) in a Phase 2 study (AMB220). ||| A positive predictive value of 50% (52/104; Study 1) was observed for HCV/HIV co-infected patients receiving combination therapy. ||| Dans l'étude de phase 2 (AMB 220), une amélioration des paramètres hémodynamiques a été observée après 12 semaines de traitement chez les patients (n=29) présentant une HTAP.
0.382693886756897 ||| Licensing of rights relating to audio productions ||| Provision of warranties relating to used motor land vehicles ||| Octroi de licences de droits sur des productions audio
0.06617885828018188 ||| It is supplied in packs of 1 vial of powder with 1 pre-filled syringe of solvent and 15 disposable syringes for administration graduated in FSH units. ||| The product is supplied as a pack of 1 vial of powder with 1 pre-filled syringe of solvent for reconstitution and 15 disposable syringes for administration graduated in FSH units. ||| Il existe en boîte d’ un flacon de poudre accompagné d’ une seringue préremplie de solvant et de 15 seringues jetables pour l’ administration, graduées en unités de FSH.
0.42531508207321167 ||| Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein Germany ||| Boehringer Ingelheim Austria Dr. -Boehringer-Gasse 5-11 A-1121 Vienna Austria ||| Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim/ Rhein Allemagne
0.480656236410141 ||| For the different doses film-coated tablets containing 5 mg and 7.5 mg ivabradine are available. ||| There are different syringes for the 5 mg, 7.5 mg and 10 mg doses. ||| Pour les différentes doses thérapeutiques, l’ ivabradine est disponible sous forme de comprimés pelliculés dosés à 5 mg et 7,5 mg.
0.7705437541007996 ||| Suitcases ||| 300 Capsules ||| Valises
0.5269715785980225 ||| The cargo includes over 500,000 protective masks, purchased by Bulgaria with transport costs covered by the EU. ||| Today, a pilot operation has successfully delivered over seven tonnes of personal protective equipment to Bulgaria. ||| Cette cargaison comprend plus de 500 000 masques de protection achetés par la Bulgarie, les frais de transport étant pris en charge par l'UE.
0.41292116045951843 ||| The dose may be increased to 300 mg once a day in patients whose blood pressure is not adequately controlled. ||| No safety problems were associated with doses higher than 75mg/ day, which may also be beneficial for some patients. ||| La dose peut être augmentée à 300 mg une fois par jour chez les patients dont la tension artérielle n’ est pas contrôlée de façon adéquate.
0.5834497213363647 ||| Treatment naïve patients The resistance profile in treatment-naïve patients has not been characterized. ||| Injection-site reactions None of the injection-site adverse reactions were treatment limiting. ||| Patients naïfs Le profil de résistance chez les patients naïfs n’ a pas été caractérisé.
0.027642471715807915 ||| Each pre-filled syringe contains 150 micrograms of darbepoetin alfa in 0.3 ml (500 µg/ ml). ||| Each pre-filled pen contains 60 micrograms of darbepoetin alfa in 0.3 ml (200 µg/ ml). ||| Chaque seringue préremplie contient 150 microgrammes de darbepoetin alfa dans 0,3 ml (500 µg/ ml).
0.29719477891921997 ||| Aseptic procedures should be used for the preparation and administration of Angiox. ||| Use appropriate aseptic technique during the preparation of Xigris for intravenous administration. ||| La préparation et l’ administration d’ Angiox doivent suivre des procédures aseptiques.
0.4042331576347351 ||| Bleaching preparations ||| Bleaching salts ||| Préparations décolorantes
0.20856335759162903 ||| Other information about Volibris: ||| Other information about Rapilysin: ||| Autres informations relatives à Volibris:
0.24677017331123352 ||| If using a transfer needle, insert the transfer needle into the rubber stopper of the solvent vial. ||| If using a transfer needle, screw the transfer needle tightly onto the syringe. ||| Si vous utilisez une aiguille de transfert, insérez l’ aiguille de transfert dans le bouchon en caoutchouc du flacon de solvant.
0.32503950595855713 ||| Standard haematological tests and blood chemistries (complete blood count and differential, platelet count, electrolytes, liver enzymes, serum protein, serum bilirubin and serum creatinine) are to be conducted in all patients prior to and periodically during systemic treatment with IntronA. ||| Toxicology studies conducted with eptifibatide include single and repeated dose studies in the rat, rabbit and monkey, reproduction studies in the rat and rabbit, in vitro and in vivo genetic toxicity studies, and irritation, hypersensitivity and antigenicity studies. ||| Des tests hématologiques et biochimiques standards sanguins (numération formule sanguine, plaquettes, électrolytes, enzymes hépatiques, protéines sériques, bilirubine sérique et créatinine sérique) doivent être réalisés chez tous les patients avant et périodiquement durant tout traitement systémique par IntronA.
0.5750276446342468 ||| Gastrointestinal preparations ||| Gastrointestinal ||| Préparations gastro-entériques
0.7004472017288208 ||| A field trial was also carried out. ||| He was also responsible for a laboratory unit. ||| Un essai sur le terrain a également été mené.
0.3206707239151001 ||| Increase in the number of applications for initial evaluation of veterinary medicines is expected following delays in submission of applications in 2002 ||| The large number of designations granted in 2001 will result in a higher than anticipated number of orphan marketing applications in 2002. ||| Une augmentation du nombre de demandes concernant l’ évaluation initiale des médicaments à usage vétérinaire est attendue, après le ralentissement des soumissions de demandes observé en 2002.
0.9901168942451477 ||| Outer carton for Cozaar 25 mg ||| Carton / Outer Package ||| Etui pour Cozaar 25 mg
0.25450676679611206 ||| Very rare events of cutaneous vasculitis have been reported in patients treated with filgrastim. ||| Cases of pancreatitis have occurred rarely in patients treated with lamivudine and zidovudine. ||| De très rares cas de vascularites cutanées ont été rapportés chez les patients traités avec le filgrastim.
0.24484741687774658 ||| Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of 1-2 X 10-10 M). ||| The mode of action of tacrolimus is stated to be by inhibition of calcium dependent signal transduction pathways in T cells which results in prevention of transcription and synthesis of IL-2, IL- 3, IL-4, IL-5 and other cytokines. ||| 12 L'adalimumab module aussi les réponses biologiques induites ou régulées par le TNF, y compris les variations des taux des molécules d'adhésion responsables de la migration des leucocytes (ELAM-1, VCAM-1, et ICAM-1 avec une CI50 de 1-2 X 10-10 M).
0.47442513704299927 ||| Abraxane induced infertility in male rats (see section 5.3). ||| Intracranial hypertension occurred in three subjects (4%). ||| Fertilité Abraxane est responsable de stérilité chez les rats mâles (voir rubrique 5.3).
0.0008364352397620678 ||| 170 Results from a multiple-dose probe study assessing P450 substrates in chronic hepatitis C patients receiving once weekly ViraferonPeg (1.5 µg/kg) for 4 weeks demonstrated an increase in activity of CYP2D6 and CYP2C8/9. ||| 124 Results from a multiple-dose probe study assessing P450 substrates in chronic hepatitis C patients receiving once weekly ViraferonPeg (1.5 µg/kg) for 4 weeks demonstrated an increase in activity of CYP2D6 and CYP2C8/9. ||| Les résultats d’ une étude exploratoire évaluant des doses multiples de substrats du cytochrome P450 chez des patients atteints d’ hépatite C chronique ayant reçu ViraferonPeg (1,5 µg/ kg) une fois par semaine pendant 4 semaines ont démontré une augmentation de l’ activité du CYP2D6 et CYP2C8/ 9.
0.6900294423103333 ||| Table 3b – Reduced PegIntron Dose for the 1.0 μ g/ kg Monotherapy Regimen ||| 4 Table 3 Xeloda Dose Reduction Schedule (3-weekly Cycle or Continuous Treatment) ||| Tableau 3b – Réduction des doses du PegIntron utilisé en monothérapie 1,0 μ g/ kg
0.25653958320617676 ||| Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by E. coli endotoxin administration in calves, lactating cows and pigs. ||| Antithrombin replacement during administration of anticoagulants that potentiate the anticoagulant activity of antithrombin (e. g., heparin, low molecular weight heparin), may increase the risk of bleeding. ||| Le méloxicam a également des propriétés anti-endotoxiniques puisqu'il a été démontré qu'il inhibe la production de thromboxane B2 induite par administration d'endotoxine d'E. coli chez le veau, la vache laitière et le porc.
1.090337238898731e-12 ||| Mode of action ||| Mode of action ||| 151 Mode d' action
0.12025240063667297 ||| The procedure started on 13 March 2006. ||| The procedure started on 21 June 2007. ||| La procédure a été lancée le 13 mars 2006.
2.286734170076077e-13 ||| Insulin may cause sodium retention and oedema, particularly if previously poor metabolic control is improved by intensified insulin therapy. ||| Insulin may cause sodium retention and oedema, particularly if previously poor metabolic control is improved by intensified insulin therapy. ||| 34 L'insuline peut provoquer une rétention sodée et un œ dème, en particulier si l'équilibre métabolique auparavant médiocre se trouve amélioré par une insulinothérapie intensive.
0.3965769410133362 ||| blood alkaline phosphatase increased, aspartate aminotransferase increased, alanine aminotransferase increased, blood bilirubin increased (including hyperbilirubinaemia), liver function test abnormal ||| Uncommon: blood urea nitrogen increased, creatine phosphokinase increased, haematocrit decreased, haemoglobin decreased, hyperkalaemia, leukocytes decreased, platelets decreased, serum creatinine increased, uric acid increased. ||| l’ aspartate aminotransférase (ASAT), augmentation de l’ alanine aminotransférase (ALAT), augmentation de la bilirubinémie (y compris hyperbilirubinémie), anomalie des tests hépatiques
0.054100845009088516 ||| As renal function decreases with age, this is the only factor to take into consideration (see renal impairment section). ||| As renal function decreases with age, this is the only factor that should be considered (see renal impairment section). ||| Comme la fonction rénale diminue avec l’ âge, il s’ agit du seul facteur à prendre en considération (voir le paragraphe sur l'insuffisance rénale).
0.46046945452690125 ||| Emergency equipment and personnel trained in its use must be readily available. ||| Vaccines are available to provide some protection to workers in a healthcare setting. ||| Le matériel d’ urgence et le personnel formé à son utilisation doivent être disponibles à tout moment.
0.29506605863571167 ||| GlaxoSmithKline AB Box 516 169 29 Solna Sweden ||| GlaxoSmithKline SpA Via Fleming 2 37135 Verona Italy ||| GlaxoSmithKline AB Box 516 169 29 Solna Suède
0.398958295583725 ||| Anti-theft locks for use on automobile steering wheels ||| Thermal insulation jackets for hot water cylinders ||| Antivols à fixer sur le volant des véhicules automobiles
0.00995488278567791 ||| Do not use Humalog Mix25, if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. ||| Do not use Humalog Mix50 Pen, if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. ||| Ne pas utiliser Humalog Mix25, si la suspension présente des grumeaux visibles ou si des particules blanches restent collées au fond de la cartouche ou sur les parois, lui donnant un aspect givré.
0.027310507372021675 ||| 38 As with other vaccines, the administration of Quintanrix should be postponed in subjects suffering from acute severe febrile illness. ||| As with other vaccines, the administration of Quintanrix should be postponed in subjects suffering from acute severe febrile illness. ||| Comme pour les autres vaccins, il est conseillé de reporter l'administration de Quintanrix chez les 'es
0.0943463146686554 ||| WHAT VIRAFERONPEG IS AND WHAT IT IS USED FOR ||| WHAT MICARDISPLUS IS AND WHAT IT IS USED FOR ||| QU’EST -CE QUE VIRAFERONPEG ET DANS QUEL CAS EST-IL UTILISE
0.3535999655723572 ||| Stopping your treatment with Myfenax may increase the chance of rejection of your transplanted organ. ||| Your doctor may consider reducing the infusion rate of Erbitux to manage these symptoms. ||| L’ arrêt de votre traitement par Myfenax peut augmenter le risque de rejet de votre greffon.
0.0048499684780836105 ||| 111 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 112 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 119 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.19581836462020874 ||| Nonafact 100 IU/ ml powder and solvent for solution for injection. ||| TORISEL 25 mg/ ml concentrate and diluent for solution for infusion. ||| Nonafact 100 UI/ ml poudre et solvant pour solution injectable.
0.617302656173706 ||| Hepato-biliary disease has been reported, especially with pre-existing conditions, and concurrent administrations of drugs metabolized via the hepatic system. ||| While animals are the source of the virus, COVID-19 is now spreading from one person to another (human-to-human transmission). ||| Le développement d’ une affection hépatobiliaire a été décrite, en particulier chez l’ animal prédisposé et lors d’ administrations concomitantes de médicaments métabolisés par voie hépatique.
0.6251028776168823 ||| Prioritize solutions to address psychosocial challenges before teaching: Mobilize available tools to connect schools, parents, teachers, and students with each other. ||| Develop distance learning rules and monitor students’ learning process: Define the rules with parents and students on distance learning. ||| Privilégier des solutions visant à répondre aux difficultés psychosociales avant l’enseignement : mobiliser les outils disponibles pour mettre en lien écoles, parents, enseignants et élèves.
0.3854353129863739 ||| Keyboard terminals ||| Kitchen cabinets ||| Terminaux à clavier
0.3245079517364502 ||| Symptoms suggestive of serum sickness include arthritis/ arthralgias, rash (urticaria or other forms), fever and lymphadenopathy. ||| Skin and subcutaneous tissue disorders: alopecia, psoriasiform rash or exacerbation of psoriasis. ||| Les symptômes suggérant une maladie sérique comprennent une arthrite/ arthralgie, un rash (urticaire ou autres formes), une fièvre et une lymphadénopathie.
0.903693437576294 ||| 67.9 (74/ 109) ||| 701 (63-76) - - ||| 67,9 (74/ 109)
0.26965537667274475 ||| No definitive conclusion could be drawn regarding the effects of telbivudine on the pharmacokinetics of pegylated interferon due to high interindividual variability of pegylated interferon alfa 2a concentrations. ||| Tenofovir pharmacokinetics were not substantially altered in subjects with hepatic impairment suggesting that no dose adjustment of tenofovir disoproxil fumarate is required in these subjects. ||| Aucune conclusion définitive ne peut être déterminée quant aux effets de la telbivudine sur la pharmacocinétique de l’ interféron pégylé en raison d’ une importante variabilité interindividuelle des concentrations d’ interféron alpha-2a pégylé.
0.7624489665031433 ||| What is the role of the EIB Group in the new proposal? ||| The EMEA plays a role in both procedures: ||| Quel rôle la nouvelle proposition attribue-t-elle au Groupe BEI?
0.3080671429634094 ||| If no alternative treatment is available, the dosing interval must be adjusted and renal function should be closely monitored (see sections 4.2 and 5.2). ||| As an alternative, in case the oral solution is not available, the dose can be adjusted by increasing the dosage interval, also shown in the table. ||| Si aucune alternative de traitement n’ est disponible, l’ intervalle entre les administrations doit être adapté et la fonction rénale étroitement surveillée (voir rubriques 4.2 et 5.2).
0.3152673840522766 ||| Power transmissions for aircraft ||| Mechanical transmissions for land vehicles ||| Transmissions de puissance pour aéronefs
0.4270021319389343 ||| Following the renewal of the Marketing Authorisation, the Marketing Authorisation Holder will submit annual Periodic Safety Update Reports (PSURs) unless otherwise requested by the CHMP. ||| If formation of neutralising antibodies is suspected, contact the local representative of the Marketing Authorisation Holder (see section 6 of the Package Leaflet) for antibody testing. ||| Suite au renouvellement de l’ Autorisation de Mise sur le Marché, sauf demande contraire du CHMP, le titulaire de l’ Autorisation de mise sur le marché soumettra annuellement des rapports périodiques de tolérance mis à jour (Periodic Safety Update Reports - PSURs).
0.0008741873316466808 ||| 163 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 165 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 173 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTERIEUR OU, EN L’ABSENCE D’EMBALLAGE EXTERIEUR, SUR LE CONDITIONNEMENT PRIMAIRE
0.11310046911239624 ||| What Busilvex is and what it is used for 2. ||| What PegIntron is and what it is used for 2. ||| Qu'est -ce que Busilvex et dans quel cas est -il utilisé 2.
0.5702203512191772 ||| The EMEA continued to receive information visits from national authorities of a number of non-EU countries. ||| • Participation of observers from accession candidate countries in meetings at the EMEA ||| L’ EMEA a continué à recevoir des visites d’ information d’ autorités nationales de plusieurs pays tiers.
0.0 ||| Musculoskeletal, connective tissue and bone disorders: ||| Musculoskeletal, connective tissue and bone disorders: ||| Troubles musculosquelettiques, du tissu conjonctif et des os:
0.312741756439209 ||| If signs of cardiac arrhythmia occur during treatment with moxifloxacin, treatment should be stopped and an ECG should be performed. ||| Patients receiving ciprofloxacin should be well hydrated and excessive alkalinity of the urine should be avoided. ||| 13 En cas de survenue d’ arythmie cardiaque avec la moxifloxacine, le traitement doit être arrêté et un ECG de contrôle effectué.
0.3012051284313202 ||| Repeat injections every 12 to 24 hours (8 to 24 hours for patients under the age of 6) for at least 1 day, until the bleeding episode, as indicated by pain, is resolved or healing is achieved. ||| Re-priming (approximately 6 sprays until a fine mist is seen) is only necessary if the cap is left off for 5 days or the intranasal device has not been used for 30 days or more. ||| 24 heures (toutes les 8 à 24 heures chez les patients âgés de moins de 6 ans) pendant au moins 1 jour, jusqu'à la fin de l'épisode hémorragique, indiquée par la disparition de la douleur ou l'obtention d'une cicatrisation.
0.30674314498901367 ||| LeukoScan has not been employed to diagnose osteomyelitis in patients with sickle cell anaemia. ||| Pravastatin has not been evaluated in patients with homozygous familial hypercholesterolaemia. ||| LeukoScan n’ a pas été utilisé pour le diagnostic de l’ ostéomyélite en cas d’ anémie à hématies falciformes.
0.13025027513504028 ||| In children aged below 12 years, the dose depends on body weight. ||| The dose for children aged six to 16 years depends on body weight. ||| Chez les enfants de moins de 12 ans, la dose dépend du poids.
6.343521628121573e-13 ||| Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta). ||| Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta). ||| Puis, mangez un aliment qui augmente durablement votre glycémie (tel que du pain ou des pâtes).
0.09485413134098053 ||| Insuman Comb 25 is supplied in pre-filled pens, OptiSet, containing 3 ml suspension, (300 IU). ||| Insulin Human Winthrop Rapid is supplied in pre-filled pens, OptiSet, containing 3 ml solution (300 IU). ||| 721 Insuman Comb 25 est fourni en stylo prérempli, OptiSet, contenant 3 ml de suspension (300 UI).
0.32378196716308594 ||| Patients with impaired renal function: ||| Patients with normal renal function: ||| Patients avec insuffisance rénale:
0.5437092781066895 ||| This cartridge is for use with OptiClik only. ||| The battery in your NutropinAq Pen is losing its charge. ||| Cette cartouche doit être utilisée avec OptiClik uniquement.
0.07952103018760681 ||| 26/ 42 ||| 28/ 42 ||| 25/ 42
0.45669931173324585 ||| In the case of major surgical interventions in particular, a precise monitoring of the substitution therapy by means of coagulation analysis is indispensable. ||| However, out of an abundance of caution, we employed an antiviral cleaning crew to disinfect all surfaces in the San Francisco office. ||| 228 chirurgicale majeure tout particulièrement, un contrôle minutieux du traitement substitutif est indispensable à l'aide des tests de coagulation.
0.2815607488155365 ||| AMPOULE TEXT Puregon 150 IU solvent ||| VIAL TEXT Puregon 75 IU powder ||| TEXTE DE L'AMPOULE Puregon 150 UI solvant
0.3594490885734558 ||| Tritanrix HepB is for deep intramuscular injection, preferably in the anterolateral thigh. ||| Ceftriaxone Tyrol Pharma 1g can be administered by the intramuscular route. ||| Tritanrix HepB doit être administré par injection intramusculaire profonde, de préférence dans la face antéro-latérale de la cuisse.
0.5026298761367798 ||| Additional supportive care should be provided as necessary. ||| • Additional testing that might be required for suitability assessment: ||| Tout autre traitement médical nécessaire doit être mis en place.
0.07142546772956848 ||| The full EPAR for Circadin can be found here. ||| The full EPAR for Adenuric can be found here. ||| L’ EPAR complet est disponible à l’ adresse suivante: ici.
3.7544598506522586e-13 ||| 4 Observed for fasting normal levels at baseline (< 5.56 mmol/ l) which increased to high (≥ 7 mmol/ l). ||| 4 Observed for fasting normal levels at baseline (< 5.56 mmol/ l) which increased to high (≥ 7 mmol/ l). ||| 121 4 Observée pour des taux à jeun normaux au début de traitement (< 5.56mmol/ l) qui sont devenus élevés (≥ 7mmol/ l).
0.02718079462647438 ||| Iron salts should be taken after sparfloxacin (at least 2 hours later if possible). ||| Zinc salts should be taken after sparfloxacin (at least 2 hours later if possible). ||| Prendre les sels de fer après la sparfloxacine (plus de 2 heures, si possible).
0.0 ||| ed The pharmacokinetics of darbepoetin alfa has been studied clinically in chronic renal failure patients following intravenous and subcutaneous administration. ||| ed The pharmacokinetics of darbepoetin alfa has been studied clinically in chronic renal failure patients following intravenous and subcutaneous administration. ||| Les propriétés pharmacocinétiques de la darbepoetin alfa ont fait l'objet d'études cliniques chez des patients insuffisants rénaux chroniques après administration intraveineuse et sous-cutanée.
0.0773114264011383 ||| 14 ANNEX III ||| 11 ANNEX III ||| ANNEXE III
0.1887483298778534 ||| 1 ml of suspension contains 10 mg brinzolamide. ||| 1.5 ml of solvent contains 4.5 mg metacresol. ||| 1 ml de suspension contient 10 mg de brinzolamide.
0.35784539580345154 ||| Part the hair at the base of your animal’ s neck in front of the shoulder blades to expose a small area of skin ||| Part the fur on the cat’s neck at the base of the skull until the skin is visible. ||| Ecarter les poils de l'animal afin de libérer une petite zone de peau nue à la base du cou, en avant des omoplates.
0.4124835431575775 ||| Crank pins of metal ||| Anchor chains of metal ||| Manetons métalliques
0.13016103208065033 ||| Tablet core Microcrystalline cellulose Colloidal anhydrous silica Crospovidone Magnesium stearate ||| Lactose monohydrate Microcrystalline cellulose Colloidal anhydrous silica Talc Magnesium stearate ||| Noyau du comprimé Cellulose microcristalline Silice anhydre colloïdale Crospovidone Stéarate de magnésium
0.31253477931022644 ||| Elderly: in elderly patients there is no need to reduce the daily dosage (see section 5.2). ||| Use in elderly patients Elderly should be observed carefully and the dose reduced if necessary (see sections 4.4 and 5.2). ||| Sujets âgés: il n'y a pas lieu de réduire la dose quotidienne chez le sujet âgé (voir paragraphe 5.2);
0.43824201822280884 ||| In dogs, side effects from Dicural are rare, but include loss of appetite, vomiting, diarrhoea and anal irritation. ||| Symptoms in other species vary: in chickens, they cause an upper respiratory tract disease, while in cows and pigs they cause diarrhea. ||| Chez le chien, les effets indésirables de Dicural, qui sont rares, incluent perte d’ appétit, vomissements, diarrhées et irritation anale.
0.16320481896400452 ||| KOGENATE Bayer 500 IU Powder and solvent for solution for injection ||| CEPROTIN 500 IU Powder and solvent for solution for injection Human Protein C ||| KOGENATE Bayer 500 UI Poudre et solvant pour solution injectable
0.6208226680755615 ||| The Commission does not aim to set a uniform European minimum wage, nor to harmonise minimum wage setting systems. ||| Social partners are effectively involved in statutory minimum wage setting to support minimum wage adequacy; ||| La Commission n'a pas pour objectif de fixer un salaire minimum européen uniforme, ni d'harmoniser les systèmes de fixation des salaires minimum.
0.2969900369644165 ||| What should I do if I drop my NutropinAq Pen? ||| How do I replace my NutropinAq Pen? ||| Que dois -je faire si je laisse tomber mon stylo NutropinAq Pen?
0.3530229330062866 ||| Reduced ossification was observed at 1.0 mg/ kg/ day. ||| When observed, blood concentrations exceeding 1.0 ng/ ml were transient. ||| Un retard d’ ossification a été observé à 1,0 mg/ kg/ jour.
0.5085055828094482 ||| It is the first scheme we have approved that will enable capital support to companies under the State aid Temporary Framework. ||| It is good news that under the Coronavirus Response Investment Initiative Member States will have access to more money than initially announced. ||| C'est le premier régime que nous avons autorisé qui permettra d'apporter un soutien en capital aux entreprises en vertu de l'encadrement temporaire des aides d'État.
0.37755727767944336 ||| The addition of a progestagen for at least 12 days per cycle in non-hysterectomised women greatly reduces this risk. ||| In adults below 60 years, the 9-microgram strength provided as good a level of protection as the intramuscular vaccine. ||| Chez les femmes non hystérectomisées, l’ association d’ un progestatif pendant au moins 12 jours par cycle diminue fortement ce risque.
0.006574613973498344 ||| Opened vials Once in use, the vial may be stored for a maximum of 4 weeks not above 25°C in the outer carton away from direct heat (for example next to a heating unit) or direct light (direct sunlight or next to a lamp). ||| Opened vials Once in-use, the vial may be stored for a maximum of 4 weeks not above 25°C in the outer carton away from direct heat (for example next to a heating unit) or direct light (direct sunlight or next to a lamp). ||| Flacons ouverts Après ouverture, un flacon peut se conserver jusqu’à 4 semaines maximum, à une température ne dépassant pas 25°C, éloigné d’une source de chaleur directe (comme un appareil de chauffage) ou d’une source lumineuse directe (comme la lumière solaire ou près d’une lampe).
2.889826507430915e-13 ||| Very rarely patients with asthma may experience worsening of their condition. ||| Very rarely patients with asthma may experience worsening of their condition. ||| 183 Les patientes souffrant d'asthme peuvent très rarement observer une aggravation de leur asthme.
0.5245735049247742 ||| You should wear each patch all the time until you apply a new one. ||| Every time you fully turn the cap, you set 20 units. ||| Vous devez toujours garder votre dispositif jusqu’ au moment d’ en changer.
0.22834664583206177 ||| Very common (≥1/10); common (≥1/100 to < 1/10); uncommon (≥1/1,000 to ≤1/100); rare (≥1/10,000 to ≤1/1,000); very rare (≤1/10,000), not known (cannot be estimated from the available data). ||| Very common (≥ 10%), common (≥ 1% and < 10%), uncommon (≥ 0.1% and < 1%), rare (≥ 0.01% and < 0.1%), very rare (< 0.01%), not known (cannot be estimated from the data available). ||| Très fréquent (≥1/10); fréquent (≥1/100 à < 1/10); peu fréquent (≥1/1 000 à < 1/100); rare (≥1/10 000 à < 1/1 000); très rare (< 1/10 000), fréquence indéterminée (ne peut être estimé à partir des données disponibles).
0.4279554486274719 ||| 400 mg three times a day ||| Day 3 300 mg three times a day ||| 400 mg 3 fois/jour
0.0 ||| Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 ||| Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 ||| 530 Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224
4.350987072802154e-13 ||| - Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being ||| - Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being ||| - Dans les 60 jours suivant une étape importante (pharmacovigilance ou minimisation du risque)
0.057119835168123245 ||| If you think you are having this sort of insulin allergy with Humalog BASAL, tell your doctor at once. ||| If you think you are having this sort of insulin allergy with Humalog, tell your doctor at once. ||| Si vous pensez avoir ce type d’allergie à l’insuline avec Humalog BASAL, consultez votre médecin.
2.842701117902746e-13 ||| Following monthly administration of darbepoetin alfa, at subcutaneous doses ranging from 0.6 to 2.1 µg/ kg, the terminal half-life was 73 hours (SD 24). ||| Following monthly administration of darbepoetin alfa, at subcutaneous doses ranging from 0.6 to 2.1 µg/ kg, the terminal half-life was 73 hours (SD 24). ||| 24 mensuelle d’ une dose de darbepoetin alfa allant de 0,6 à 2,1 µg/ kg, la demi-vie terminale est de 73 heures (DS = 24).
0.49554839730262756 ||| Saunderton High Wycombe Buckinghamshire HP14 4HJ United Kingdom ||| Boundary Way Hemel Hempstead Herts HP2 7UD United Kingdom ||| Saunderton High Wycombe Buckinghamshire, HP 14 4HJ Grande-Bretagne
0.43206077814102173 ||| Results from a series of laboratory safety trials performed with vaccines of similar composition but of different bluetongue serotypes were also presented in order to extrapolate safety conclusions, as the vaccine is intended for use in an emergency situation. ||| In 38 cases, CPC authorities found a number of dubious offers or adverts concerning products misleadingly promoted in the context of the coronavirus, broad claims that a product was able to prevent or cure infection, and excessive prices. ||| Des résultats provenant d’ autres études de sécurité en laboratoire sur des vaccins de composition semblable, mais de sérotype différent ont également été présentés afin d’ extrapoler les conclusions relatives à la sécurité, étant donné que le vaccin doit pouvoir être utilisé en situation d’ urgence.
0.12188759446144104 ||| The pharmacokinetics of insulin products are therefore affected by significant intra- and inter-individual variation. ||| The pharmacokinetics of insulins is therefore affected by significant intra- and inter-individual variation. lP ||| Ceci explique les variations intra- et interindividuelles considérables observées au niveau de la pharmacocinétique des insulines.
0.3152194917201996 ||| Only in case of a flare of severe disease not controlled by , treatment with medium potency topical corticosteroids was initiated. ||| Treatment of the following infections in adults when caused by ciprofloxacin susceptible organisms, when oral therapy is not possible or not reliable: ||| Un traitement par un corticostéroïde de puissance moyenne n’a été instauré qu’en cas de poussée sévère de la maladie non contrôlée par {Nom de fantaisie}.
0.8796464204788208 ||| Specific post- authorisation 9% ||| No special requirements. ic ||| Frais généraux unités/secteurs spécifiques 9%
0.45491349697113037 ||| 73.5% (95% CI: ||| 79-91) 85% (95% CI: ||| 69,4% (95% IC:
0.0 ||| Manufacturer: ||| Manufacturer: ||| 310 Fabricant:
0.40752801299095154 ||| Enzymes for use in the processing of sugar cane ||| Oils for the preservation of masonry ||| Enzymes pour la transformation de la canne à sucre
0.4757852256298065 ||| 27.4, 50.0]. ||| 5.2, 38.1). ||| 27,4; 50,0].
0.7394281625747681 ||| 1 vial of 1 dose (2ml) 10 vials of 1 dose (2 ml) 20 vials of 1 dose (2 ml) 1 vial of 5 doses (10 ml) 10 vials of 5 doses (10 ml) 1 vial of 25 doses (50 ml) 10 vials of 25 doses (50 ml) ||| Packaging: • 5-dose bottle, box of 1 bottle. • 5-dose bottle, box of 10 bottles. • 10-dose bottle, box of 1 bottle. • 10-dose bottle, box of 10 bottles. • 25-dose bottle, box of 1 bottle. • 25-dose bottle, box of 10 bottles ||| 1 flacon d’ une dose (2 ml) 10 flacons d’ une dose (2 ml) 20 flacons d’ une dose (2 ml) 1 flacon de 5 doses (10 ml) 10 flacons de 5 doses (10 ml) 1 flacon de 25 doses (50 ml) 10 flacons de 25 doses (50 ml)
0.3942079544067383 ||| Special caution must be taken when removing and disposing of the needle. ||| Particular care should be taken with regard to the accuracy of dosing. ||| 117 Prendre des précautions particulières concernant le retrait et l’ élimination de l’ aiguille.
4.3821592405138277e-13 ||| In patients with chronic renal failure, maintenance haemoglobin concentration should not exceed the upper limit of the target haemoglobin concentration recommended in section 4.2. ||| In patients with chronic renal failure, maintenance haemoglobin concentration should not exceed the upper limit of the target haemoglobin concentration recommended in section 4.2. ||| Chez les patients atteints d’ insuffisance rénale chronique, le taux d’ hémoglobine durant la phase d’ entretien ne doit pas dépasser la limite supérieure du taux cible d’ hémoglobine recommandé à la rubrique 4.2.
0.42188191413879395 ||| DO NOT use Enbrel if all the powder in the vial is not dissolved within 10 minutes. ||| Once the medicine is reconstituted (made up with the solvent), do not store above 25°C. ||| NE PAS utiliser Enbrel si la poudre dans le flacon ne s’est pas complètement dissoute en 10 minutes.
0.09692448377609253 ||| Insulin Human Winthrop Comb 50 is a biphasic isophane insulin suspension consisting of 50% dissolved insulin and 50% crystalline protamine insulin. ||| Insuman Comb 15 is a biphasic isophane insulin suspension consisting of 15% dissolved insulin and 85% crystalline protamine insulin. ||| Insulin Human Winthrop Comb 50 est une suspension d'insuline isophane biphasique composée de 50% d'insuline dissoute et 50% d'insuline protamine sous forme cristalline.
0.5724908113479614 ||| Refraction disorders: ||| Serious Infections: ||| Anomalies de la réfraction:
0.4795123338699341 ||| 38 • Your doctor will prescribe Emtriva with other antiretroviral medicines. ||| 58 Take special care with Erbitux Erbitux may cause infusion-related side effects. ||| • Votre médecin a prescrit Emtriva avec d’autres médicaments antirétroviraux.
0.26557278633117676 ||| España Orion Corporation Tel: +358 10 4261 ||| Ísland Icepharma Ltd Tel: +354 540 80 00 ||| Orion Corporation Tel: +358 10 4261
0.39571693539619446 ||| Auxiliary fluids for use with additives for wood pulp ||| Humidifiers for use with respiratory therapy apparatus ||| Fluides auxiliaires utilisés avec des additifs pour pâte de bois
0.21337157487869263 ||| Alapis România S. R. L. ||| România Roche România S. R. L. ||| Alapis România S.R.L.
3.2023298943140155e-13 ||| The letter from the company notifying the EMEA of the withdrawal of the application is available here. ||| The letter from the company notifying the EMEA of the withdrawal of the application is available here. ||| La lettre du laboratoire informant l’ EMEA du retrait de sa demande est disponible à l’ adresse suivante: ici.
0.3264564871788025 ||| 22 bubbles must be removed from the cartridge before injection (see instruction for using pen). ||| The IM injection should be given slowly and deeply into the muscle (see section 6.6 for instructions for reconstitution). ||| Les bulles d’ air doivent être éliminées de la cartouche avant l’ injection (voir les instructions d’ utilisation du stylo).
0.42891737818717957 ||| The following information regarding QT-prolongation is of special importance (for contraindications see section 4.3). ||| IMPORTANT: for information on abacavir hypersensitivity, see the description above in the boxed information and Table 1 ||| L’ information suivant sur la prolongation de QT est importante (pour les contre- indications, cf rubrique 4.3).
0.14725276827812195 ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF ETORICOXIB CONTAINING MEDICINAL PRODUCTS (see Annex I) ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF BICALUTAMIDE 150 mg CONTAINING MEDICINAL PRODUCTS (see Annex I) ||| RÉSUMÉ GÉNÉRAL DE L’ ÉVALUATION SCIENTIFIQUE DES MÉDICAMENTS CONTENANT L’ ÉTORICOXIB (voir annexe I)
0.6350716948509216 ||| Reinforcing separating agents ||| Reinsurance brokerage ||| Agents séparateurs de renforcement
0.3232026696205139 ||| After one year (primary analysis) the median relative change from baseline was -76% for Bonviva 150 mg once monthly and -67% for ibandronic acid 2.5 mg daily. ||| After 28 weeks treatment following the dosing guideline outlined in section 4.2, the mean reduction in HbA1c was 2.8% with NovoMix 30 (mean at baseline = 9.7%). ||| A un an (analyse principale), la variation médiane de CTX par rapport à l'inclusion a été respectivement de - 76% et - 67% dans les groupes 150 mg une fois par mois et 2,5 mg une fois par jour.
0.28248175978660583 ||| At two years, the difference in total weight loss between ZIMULTI and placebo was -4.2 kg (CI95% -5.0; -3.4, ol ||| The difference in mean body weight change between the 20 mg and placebo groups was 3.8 kg (CI95% -5.0, -2.6 p < 0.001). ||| A deux ans, la différence sur la réduction de poids totale entre le groupe ZIMULTI et le groupe placebo était de -4,2 kg (IC 95%: -5,0; -3,4; m
0.13422465324401855 ||| The full EPAR for Relistor can be found here. ||| The full EPAR for Tredaptive can be found here. ||| L’ EPAR complet relatif à Relistor est disponible ici.
2.636389912803738e-13 ||| Adverse reactions reported during clinical trials in excess of placebo for 5 mg/ 120 mg {Pharmaceutical form} very common (> 1/ 10); common (> 1/ 100 , 1/1000 , 1/10,000, < 1/ 1000); very rare (< 1/10 ,000) Metabolic and Nutrition Disorders Common: ||| Adverse reactions reported during clinical trials in excess of placebo for 5 mg/ 120 mg {Pharmaceutical form} very common (> 1/ 10); common (> 1/ 100 , 1/1000 , 1/10,000, < 1/ 1000); very rare (< 1/10 ,000) Metabolic and Nutrition Disorders Common: ||| Effets secondaires rapportés pendant les essais cliniques avec une fréquence supérieure à celle observée sous placebo à la dose de 5 mg/ 120 mg {forme pharmaceutique} très fréquent (> 1/ 10); fréquent (> 1/ 100, 1/ 1.000, 1/ 10.000, < 1/ 1.000); très rare (< 1/ 10.000) Troubles du métabolisme et de la nutrition Fréquent:
0.17347455024719238 ||| Fins for windsurfing boards ||| Wet suits for windsurfing ||| Ailerons de planches à voile
0.3608629107475281 ||| Conditioning oil for baseball gloves ||| Ice cube molds for refrigerators ||| Huile d'entretien de gants de base-ball
0.6377596259117126 ||| Handling and disposal Adequate precautions including the use of appropriate safety equipment are recommended for the preparation, administration and disposal of VISTIDE. ||| ⋅ to ensure a full Quality Control system for MRL Summary of Status reports to ensure accuracy and consistency of format and presentation ||| Manipulation et élimination des déchets Des précautions adéquates, comprenant notamment l'usage d'un équipement de sécurité approprié, sont recommandées pour la préparation, l'administration et l'élimination de VISTIDE.
0.25888094305992126 ||| The initiation of treatment with XERISTAR is contraindicated in patients with uncontrolled hypertension that could expose patients to a potential risk of hypertensive crisis (see sections 4.4 and 4.8). ||| Based on the CARE study, the secondary prevention indication was extended to include the reduction of cardiovascular and cerebrovascular events in patients at risk with normal cholesterol levels. ||| L’ instauration du traitement par XERISTAR est contre-indiquée chez les patients présentant une hypertension artérielle non équilibrée qui pourrait les exposer à un risque potentiel de crise hypertensive (voir rubriques 4.4 et 4.8).
0.4621143341064453 ||| 2.5, 5, 7.5 and 10 mg; oval: ||| 0.088, 0.7 and 1.1 mg; oval: ||| 2,5; 5; 7,5 et 10 mg; de forme ovale:
0.19786100089550018 ||| As Tritanrix HepB is not intended for use in adults, information on the safety of the vaccine when used during pregnancy or lactation is not available. ||| As Infanrix hexa is not intended for use in adults, adequate human data on use during pregnancy or lactation and adequate animal reproduction studies are not available. ||| Tritanrix HepB n'étant pas destiné aux adultes, les données sur la sécurité du vaccin utilisé durant la grossesse ou l'allaitement ne sont pas disponibles.
0.08875268697738647 ||| Professional consultancy relating to agriculture ||| Professional consultancy relating to architecture ||| Consultation professionnelle en matière d'agriculture
0.4343799948692322 ||| Secondary malignancies are expected to occur in patients with hairy cell leukaemia. ||| Most bleeding related events were typically associated with severe thrombocytopenia. ||| Les tumeurs malignes secondaires sont prévisibles chez les patients souffrant de leucémie à tricholeucocytes.
0.3149336576461792 ||| Tenofovir AUC was increased by approximately 30% when tenofovir disoproxil fumarate was administered with lopinavir/ ritonavir. ||| The oral bioavailability of tenofovir from tenofovir disoproxil fumarate in fasted patients was approximately 25%. ||| L’ ASC du ténofovir a augmenté d’ environ 30% lorsque le fumarate de ténofovir disoproxil était administré avec l’ association fixe lopinavir/ ritonavir.
0.2203448861837387 ||| Sodium dihydrogen phosphate monohydrate Sodium sulphate Mannitol (E421) Methionine Poloxamer 188 Water for injections ||| Powder Mannitol Sodium chloride Histidine Trehalose Calcium chloride Trometamol Polysorbate 80 Glutathione (reduced) ||| Phosphate monosodique monohydraté Sulfate de sodium Mannitol (E421) Méthionine Poloxamère 188 Eau pour préparations injectables
0.04157329350709915 ||| No studies of the effects of AVONEX on the ability to drive and use machines have been performed. ||| No studies on the effects of IVEMEND on the ability to drive and use machines have been performed. ||| Aucune étude n’ a été réalisée sur les effets d’ AVONEX sur l’ aptitude à conduire des véhicules et à utiliser des machines.
0.09339816868305206 ||| The suspension is contained in type I flint glass vials, sealed with butyl or halobutyl stoppers and secured with aluminium seals. ||| The solution is contained in type I flint glass cartridges, sealed with butyl or halobutyl disc seals and plunger heads and are secured with aluminium seals. ||| La suspension est contenue dans des flacons en verre de type I, fermés par des bouchons en halobutyle et sertis par des capsules en aluminium.
0.05202937126159668 ||| Tell your doctor or a pharmacist as soon as possible if you do not feel well while you are taking Tasmar. ||| Tell your doctor or pharmacist as soon as possible if you do not feel well while you are using Aldara cream. ||| Consultez votre médecin ou un pharmacien dès que possible si vous ne vous sentez pas bien alors que vous prenez Tasmar.
0.35342106223106384 ||| 50 The CHMP assessed the proposal from the MAH to conduct an additional retrospective cohort study based on available medical records, in which information regarding prescription as well as Tanner staging and growth would be available. ||| This process may include checking pseudonymized NHS numbers for positive individuals at RCGP RSC practices, checking current PHE guidance regarding considerations of infectiousness for confirmed cases, and offering the patient an appointment following the previously mentioned process. ||| Le CHMP a évalué la proposition qu’ a fait le TAMM pour mener une étude de cohorte rétrospective supplémentaire, en se basant sur les archives médicales disponibles dans lesquelles l’ information sur la prescription, ainsi que sur la classification de Tanner et la croissance, est accessible.
0.2791142761707306 ||| Concomitant treatment with thrombolytics (e. g. rt-PA or streptokinase) may – increase the risk of bleeding complications – considerably enhance the effect of Refludan on aPTT prolongation. ||| Medicinal products that affect coagulation or those that alter platelet function (e. g. ticlopidine, clopidogrel, LMWH) may increase the risk of bleeding prior to, during or after Metalyse therapy. ||| L'administration concomitante d'agents thrombolytiques (comme le rt-PA ou la streptokinase) est susceptible de: • majorer le risque de complications hémorragiques; • potentialiser considérablement l'allongement du TCA induit par Refludan.
0.28349781036376953 ||| Paxene should only be prepared and administered by personnel appropriately trained in the handling of cytotoxic agents. ||| It will only be handled and administered by people who are trained and qualified in the safe handling of radioactive material. ||| Paxene ne doit être préparé et administré que par du personnel correctement formé à l’ administration des cytotoxiques.
0.4734627902507782 ||| 15. ||| 16. ||| 3.
0.4586026072502136 ||| We suggest you write the date of your most recent test and also of your next test (ask your doctor for the date) on the patient reminder card, to help you remember when your next test is due. ||| 1 - Choose an area for the injection (see advice at the start and the diagrams at the end of this Annex), and make a note of it in your medication record. ||| Nous vous suggérons d’écrire la date de votre examen le plus récent ainsi que celle de votre prochain examen (demandez la date à votre médecin) sur votre carte patient, pour vous aider à vous rappeler quand vous devez faire votre prochain examen de sang.
4.151603377484242e-13 ||| In a clinical study, symptoms of hypoglycaemia or counter-regulatory hormone responses were similar after intravenous insulin glargine and human insulin both in healthy volunteers and patients with type 1 diabetes. ||| In a clinical study, symptoms of hypoglycaemia or counter-regulatory hormone responses were similar after intravenous insulin glargine and human insulin both in healthy volunteers and patients with type 1 diabetes. ||| Dans une étude clinique, les symptômes d’ hypoglycémie et des réponses hormonales compensatrices ont été identiques après l’ administration intraveineuse d’ insuline glargine et d’ insuline humaine, tant chez des volontaires sains que chez des patients atteints de diabète de type 1.
0.32326775789260864 ||| Eculizumab binds to and inhibits a specific protein in the body that causes inflammation. ||| It contains a hormone called epoetin beta, which stimulates the production of red blood cells. ||| L’ eculizumab se lie à une protéine spécifique de l’ organisme qui provoque une inflammation et l’ inhibe.
0.7923985123634338 ||| No clinical data on exposed pregnancies are available for etoricoxib. ||| RISPERDAL CONSTA clinical data in elderly are limited. ||| 19 Il n’ existe aucune donnée clinique chez les femmes enceintes exposées à l’ étoricoxib.
0.4728410542011261 ||| 2 years. ||| 2 years. du ||| 2 ans.
0.04142441600561142 ||| Before you receive Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg 3. ||| How Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg is given 4. ||| Quelles sont les informations à connaître avant de recevoir Vaccin grippal prépandémique (H5N1) (virion fragmenté, inactivé, avec adjuvant) GlaxoSmithKline Biologicals 3,75 µg 3.
0.0 ||| Caution should be exercised when prescribing to pregnant women. ||| Caution should be exercised when prescribing to pregnant women. ||| Insulin Human Winthrop Rapid ne sera prescrit qu’ avec prudence chez la femme enceinte.
0.6247483491897583 ||| Tipranavir ||| Desipramine ||| 12 Tipranavir
0.0 ||| Investigations: ||| Investigations: ||| Examens biologiques:
0.34306228160858154 ||| Dose adjustment of buprenorphine or efavirenz may not be necessary when co-administered. ||| No post weaning functions were affected with darunavir alone or in combination with ritonavir. ||| Une ajustement posologique de la buprénorphine ou de l'éfavirenz peut ne pas être nécessaire quand ils sont co-administrés
0.31933504343032837 ||| You should not be given this medicine when breast-feeding, as small amounts of olanzapine can pass into breast milk. ||| Do not take Arava when you are breast feeding, as leflunomide passes into the breast milk. ||| Ce médicament ne doit pas vous être prescrit si vous allaitez, car de faibles quantités d’ olanzapine peuvent passer dans le lait maternel.
0.8324364423751831 ||| This is a parasite belonging to the ‘ protozoa’ family that invades the digestive system causing diarrhoea. ||| The yamawarawa (山童, the mountain child) in the folklore of Amakusa is believed to haunt the mountains. ||| Il s’ agit d’ un parasite appartenant au groupe des protozoaires, qui envahit le système digestif et provoque la diarrhée.
0.4583311080932617 ||| Taiwanese authorities have been ordered to use all possible means to track whether the messages were linked to instructions given by the Communist Party of China. ||| France and Sweden could not agree to the granting of a marketing authorisation as they considered there were potential serious risks to animal health. ||| Les autorités taïwanaises ont enquêté pour savoir si ces messages sont en lien avec des instructions données par le Parti communiste chinois.
0.8429955840110779 ||| EMEA/ V/ C/ 038 EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) ||| EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) CERENIA ||| EMEA/ V/ C/ 038 RAPPORT EUROPÉEN PUBLIC D’ ÉVALUATION (EPAR)
0.01954946294426918 ||| 107 The clinical data available suggest that those patients whose initial haemoglobin is very low ( 6.8 g/dl or> 4.25 mmol/l). ||| The clinical data available suggest that those patients whose initial haemoglobin is very low ( 6.8 g/dl or> 4.25 mmol/l). ||| Les données cliniques disponibles suggèrent que les patients dont le taux d’ hémoglobine est très faible ( 6,8 g/ dl ou > 4,25 mmol/ l).
0.2989734709262848 ||| Antibiotics for use in dentistry ||| Diuretics for detoxification purposes ||| Antibiotiques à usage dentaire
0.2735387086868286 ||| In patients at increased risk of symptomatic hypotension, initiation of therapy and dose adjustment should be closely monitored. ||| In patients with previous malignant disease, special attention should be given to signs and symptoms of relapse. ||| En cas de risque accru d'hypotension symptomatique, l'initiation du traitement et l'adaptation posologique doivent faire l'objet d'un suivi étroit.
0.36744052171707153 ||| In the case of severe renal insufficiency, Neoclarityn should be used with caution. ||| Therefore the combination of aliskiren with an NSAID requires caution, especially in elderly patients. ||| Neoclarityn doit être utilisé avec précaution en cas d’ insuffisance rénale sévère.
0.9006015658378601 ||| ANTINEOPLASTICS AND IMMUNOSUPRESSANTS Antineoplastics Irinotecan ||| MANAGEMENT OF NEUTROPENIA (Neutrophil counts) ||| ANTICANCEREUX ET IMMUNOSUPPRESSEURS Anticancéreux Irinotecan
0.030362222343683243 ||| Binocrit 6000 IU/ 0.6 ml ||| Binocrit 4000 IU/ 0.4 ml ||| Binocrit 6 000 UI/ 0,6 ml
0.21433061361312866 ||| In vitro enzymatic studies with human liver microsomes revealed that arsenic trioxide has no inhibitory activity on substrates of the major cytochrome P450 enzymes such as 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4/ 5, 4A9/ 11. ||| In vitro data have shown that at therapeutic concentrations, ambrisentan does not inhibit UGT1A1, UGT1A6, UGT1A9, UGT2B7 or cytochrome P450 enzymes 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4. ||| Dans des études enzymatiques menées in vitro sur microsomes hépatiques humains, il a été démontré que le trioxyde d’ arsenic ne possédait pas d’ activité inhibitrice sur les substrats des enzymes principaux de cytochromes P450 tels que 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1,3A4/ 5, 4A9/ 11.
0.3204192519187927 ||| Danmark Baxter A/ S Gydevang 43 DK-3450 Allerød Tlf.: +45-48-16 64 00 ||| Deutschland Mayne Pharma (Deutschland) GmbH D-85540 Haar Tel: +49 89 43 77 770 ||| Danmark Baxter A/ S Gydevang 43 DK-3450 Allerř d Tlf.: +45-48-16 64 00
0.04459758102893829 ||| - if you are allergic (hypersensitive) to rivastigmine or any of the other ingredients of Prometax. ||| - if you are allergic (hypersensitive) to oseltamivir or any of the other ingredients of Tamiflu. ||| - si vous êtes allergique (hypersensible) à la rivastigmine ou à l’ un des autres composants de
0.4051089882850647 ||| The European Commission has today published a draft legal agreement for the future EU-UK partnership. ||| The European Parliament has asked the Commission to assess the contribution of the CAP (2018 proposal) to the European Green Deal. ||| La Commission européenne a publié aujourd'hui un projet d'accord juridique pour le futur partenariat entre l'UE et le Royaume-Uni.
0.1458357274532318 ||| Busilvex is a concentrate to be made up into a solution for infusion (drip into a vein). ||| Mycamine is a powder that is dissolved to make a solution for infusion (drip into a vein). ||| Busilvex est une solution concentrée destinée à être diluée pour perfusion (goutte à goutte dans une veine).
0.3424496054649353 ||| Novo Nordisk A/ S Hallas Allé DK-4400 Kalundborg Denmark ||| AstraZeneca A/ SRoskildevej 22 DK-2620 Albertslund Denmark ||| Novo Nordisk A/S Hallas Allé DK-4400 Kalundborg Danemark
0.4890010356903076 ||| Software for GPS navigation systems ||| Application software for cloud computing services ||| Logiciels pour systèmes de navigation GPS
0.21582123637199402 ||| The main measure of effectiveness was the level of antibodies in the blood against the viruses and bacteria in the vaccine. ||| The main measure of the immune response was the level of antibodies against PCV2 in the piglets’ blood. ||| Le principal critère d’ évaluation de l’ efficacité a été le taux d’ anticorps sanguins dirigés contre les virus et bactéries du vaccin.
0.19437529146671295 ||| Caelyx should be handled and disposed of in a manner consistent with that of other cytotoxic medicinal products. ||| Caelyx must be handled and disposed of in a manner consistent with that of other anticancer medicinal products in accordance with local requirements. ||| Caelyx doit être manipulé et éliminé selon les mêmes principes que les autres médicaments cytotoxiques.
0.0 ||| General disorders and administration site conditions: ||| General disorders and administration site conditions: ||| Troubles généraux et accidents liés au site d'administration:
0.0 ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| PRECAUTIONS PARTICULIÈRES D’ ÉLIMINATION DES MEDICAMENTS NON UTILISES OU DES DECHETS PROVENANT DE CES MEDICAMENTS S’ IL Y A LIEU
0.1592692732810974 ||| In the first study, 19% of the patients adding the approved dose of Rapamune had failed treatment after six months (53 out of 284), compared with 32% of those adding azathioprine (52 out of 161). ||| In the two studies taken together, 55% of the patients receiving Relistor opened their bowels within four hours after first injection (91 out of 165), compared with 15% of the patients receiving placebo (18 out of 123). ||| Dans la première étude, chez 19% (53 sur 284) des patients ayant ajouté la dose approuvée de Rapamune, le traitement avait échoué à six mois, contre 32% (52 sur 161) des patients ayant ajouté l’ azathioprine.
0.002368797780945897 ||| 374 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 378 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 377 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.3468787372112274 ||| tho concomitant methotrexate, the incidence was 12.4%, compared to 0.6% when adalimumab was used as add-on to methotrexate. ||| Approximately 51% was excreted as total topotecan and 3% was excreted as N-desmethyl topotecan in the urine. ||| Chez les patients ne recevant pas simultanément du méthotrexate, la fréquence a été de 12,4%, contre 0,6% lorsque l'adalimumab était ajouté au méthotrexate.
0.752941370010376 ||| - at least once a year in patients with normal renal function ||| • have had external heart massage within the past 10 days ||| - au moins une fois par an chez les sujets présentant une fonction rénale normale
0.24127107858657837 ||| Clinical data obtained from a limited number of patients also indicate that adult PID patients may tolerate an infusion rate of up to 8 ml/kg BW/hr. • If dilution to lower concentrations is required prior to infusion, KIOVIG may be diluted with 5% glucose solution to a final concentration of 50 mg/ml (5% immunoglobulin). ||| The in-use stability of KIOVIG after dilution with a 5% glucose solution to a final concentration of 50 mg/ml (5% immunoglobulin) has been demonstrated for 21 days at 2°C to 8°C as well as at 28°C to 30°C; however, these studies did not include the microbial contamination and safety aspects. ||| Des données cliniques obtenues sur un nombre limité de patients indiquent également que les patients adultes atteints de déficit immunitaire primitif peuvent tolérer une vitesse de perfusion allant jusqu’à 8ml/kg de poids corporel/heure. • Si une dilution est nécessaire avant la perfusion, KIOVIG peut être dilué avec une solution de glucose à 5% jusqu’à une concentration finale de 50 mg/ml (5% d’immunoglobuline).
0.004779655486345291 ||| An additional two studies have looked at the use of PegIntron in combination with ribavirin in 565 patients also infected with HIV, and a further study looked at the use of this combination in 1,354 patients whose previous treatment including interferon alfa (pegylated or non-pegylated) did not work or whose disease had come back after previous treatment. ||| An additional two studies have looked at the use of ViraferonPeg in combination with ribavirin in 565 patients also infected with HIV, and a further study looked at the use of this combination in 1,354 patients whose previous treatment including interferon alfa (pegylated or non-pegylated) did not work or whose disease had come back after previous treatment. ||| Deux autres études ont été menées sur l’ utilisation de PegIntron en association à la ribavirine chez 565 patients également infectés par le VIH et une étude complémentaire a porté sur l’ utilisation de cette association chez 1 354 patients n’ ayant pas répondu à un traitement préalable contenant de l’ interféron alfa (pégylé ou non) ou ayant rechuté après traitement.
0.11445845663547516 ||| Chemical compositions for use in the conditioning of concrete ||| Chemical compositions for use in the manufacture of pigments ||| Compositions chimiques destinées au traitement du béton
0.0 ||| There is limited experience with the use of Optisulin in children less than 6 years old and in patients whose liver or kidneys do not function well. ||| There is limited experience with the use of Optisulin in children less than 6 years old and in patients whose liver or kidneys do not function well. ||| On dispose de peu d'expérience sur l'utilisation d’ Optisulin chez l’ enfant de moins de 6 ans et chez les patients dont le foie ou les reins ne fonctionnent pas bien.
0.391759991645813 ||| Kinzalmono was compared with placebo (a dummy treatment) and with other medicines for hypertension (atenolol, lisinopril, enalapril and amlodipine). ||| clorazepate, diazepam, estazolam, flurazepam, triazolam or oral (taken by mouth) midazolam (used to help you sleep and/or relieve anxiety); ||| Kinzalmono a été comparé à un placebo (traitement factice) et à d’ autres médicaments antihypertenseurs (aténolol, lisinopril, enalapril et amlodipine).
0.2692797780036926 ||| Ketek has been studied in 10 main studies involving a total of over 4,000 patients. ||| Zerene has been studied in a total of 14 studies, involving nearly 3,500 adults and elderly patients. ||| L’ efficacité de Ketek a fait l’ objet de 10 études principales incluant au total plus de 4.000 patients.
0.27086204290390015 ||| Because omalizumab clearance at clinical doses is dominated by the reticular endothelial system (RES) it is unlikely to be altered by renal or hepatic impairment. ||| As etravirine is highly bound to plasma proteins, it is unlikely that it will be significantly removed by haemodialysis or peritoneal dialysis (see section 4.2). ||| La clairance de l’ omalizumab aux doses cliniques faisant intervenir essentiellement le système réticulo-endothélial (SER), il est improbable qu’ elle soit altérée par une insuffisance rénale ou hépatique.
0.12348048388957977 ||| Oral use Read the package leaflet before use ||| Read the package leaflet before use Oral use ||| Lire attentivement la notice avant utilisation.
0.37493032217025757 ||| A local reaction with swelling, pain, pruritis or hair loss at the injections site may be observed. ||| - swelling or bleeding at the site of injection, or chest pain after an injection ||| Une réaction locale avec inflammation, douleur, prurit ou alopécie au site d'injection peut être observée de manière occasionnelle.
0.5506536960601807 ||| From 1985 to 1987, Dr Kennedy was employed as Section Head of Microbiology Research and Development in a multinational pharmaceutical company. ||| From 1987 to 1999 he was Veterinary Assessor at the National Drugs Advisory Board (now the Irish Medicines Board). ||| De 1985 à 1987, le Dr Kennedy a occupé le poste de chef de section Recherche et développement microbiologiques dans une multinationale pharmaceutique.
0.34937095642089844 ||| Regulating modules (Electric -) ||| Mains testers (Electric -) ||| Modules électriques de régulation
0.426268070936203 ||| If you are also taking ciclosporin, then you must take the two medicines approximately 4 hours apart. ||| - If you are taking or have taken within the last 14 days, another medicine known as a monoamine ||| Si vous prenez également de la ciclosporine, vous devrez prendre les deux médicaments à environ 4 heures d’intervalle.
0.554597795009613 ||| Includes lactose monohydrate. ||| • Zinc acetate dihydrate ||| Lactose monohydraté inclus.
0.505889356136322 ||| Includes lactose monohydrate. ||| Lactose-monohydrate. ||| Lactose monohydraté inclus.
0.19933420419692993 ||| White to off-white, biconvex, oval tablet with "BMS 100" debossed on one side and "852" on the other side. ||| White to off-white, elongated, biconvex tablet with a blackcurrant odour, marked “ GS CL2” on one side and “ 5” on the other. ||| Comprimé blanc à blanc cassé, biconvexe, oval, avec impression de "BMS 100" sur l'une des faces et de "852" sur l'autre face.
0.1759691834449768 ||| 94 5.3 Preclinical safety data ||| 5.3 Preclinical safety data ro ||| 102 5.3 Données de sécurité préclinique
0.020098906010389328 ||| 15 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 10 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 15 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.3293873071670532 ||| Electric pumps for swimming pools ||| Disinfectants for swimming pools ||| Pompes électriques pour piscines
0.3467358648777008 ||| As Ytracis is a ‘ precursor’ and will not be given on its own, no studies have been done in humans. ||| As Yttriga is a precursor and will not be given on its own, it has no side effects. ||| Ytracis étant un « précurseur » et ne devant pas être administré seul, aucune étude n’ a été réalisée chez l’ homme.
0.2727442681789398 ||| 7 After removing Insulatard vial from the refrigerator it is recommended to allow the vial to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use. |||  497 Measuring the dose of IntronA Take the pen out of the refrigerator about one-half hour before administering the dose so that the solution in the pen is at room temperature when it is injected. ||| Après avoir sorti un flacon d’ Insulatard du réfrigérateur, il est recommandé d’ attendre que le flacon arrive à température ambiante (sans dépasser 25°C) avant de remettre l’ insuline en suspension, comme indiqué dans les instructions concernant la première utilisation.
0.5104467272758484 ||| España Gilead Sciences, S. L. ||| 26 Danmark Instituto Grifols, S. A. ||| España Gilead Sciences, S.L.
0.36169758439064026 ||| Haematological adverse reactions Dose reduction or treatment interruption for severe neutropenia and thrombocytopenia are 28 recommended as indicated in the table below. ||| Table 4 Summary of pharmacokinetic parameters for ADVATE in 53 paediatric patients with severe to moderately severe haemophilia A ||| Effets indésirables hématologiques En cas de neutropénie ou thrombopénie sévères, il est recommandé de diminuer la dose ou d'interrompre le traitement conformément au tableau ci-dessous.
0.44779694080352783 ||| Today, the European Commission has put forward its proposal for a major recovery plan. ||| The Commission is putting forward its legislative proposal today. ||| La Commission européenne a présenté aujourd'hui sa proposition de grand plan de relance.
0.39263415336608887 ||| In all five studies, patients randomized to the Raptiva dose group achieved statistically significantly better responses than placebo on the primary endpoint (PASI 75 response) (see Table 2 below) and on all the secondary efficacy endpoints. ||| Results from the Short Form Health Survey (SF 36) for all doses/ schedules of Humira in all four studies support these findings, with statistically significant physical component summary (PCS) scores, as well as statistically significant pain and vitality domain scores for the 40 mg every other week dose. ||| Au cours des 5 études, les patients randomisés pour recevoir Raptiva présentaient une réponse statistiquement supérieure à ceux du groupe placebo sur le critère principal d'évaluation (réponse PASI-75) (voir tableau 2) et sur tous les critères secondaires d'évaluation.
0.3108455538749695 ||| Haematopoetic growth factor has been used in patients with resistant myelosuppression. ||| Thiazide diuretic- associated azotaemia may occur in patients with impaired renal function. ||| Pour les myélossupressions persistantes, le recours aux facteurs de croissance hématopoïétiques était nécessaire.
0.6805983185768127 ||| Computer motherboards ||| Computer daughterboards ||| Cartes-mères d'ordinateurs
0.5382300019264221 ||| It works by attaching to certain types of protein on the surface of the bacteria cells. ||| Its effect is dependent on functioning beta cells in the pancreas islets. ||| Il agit en se fixant sur certains types de protéines présentes à la surface des cellules bactériennes.
0.2833208441734314 ||| For any information about this veterinary medicinal product, please contact the Marketing Authorisation Holder. ||| For any information about this medicine, please contact the local EXUBERA Customer Care Centre. ||| Pour toute information complémentaire concernant ce médicament vétérinaire, veuillez prendre contact avec le titulaire de l’ Autorisation de Mise sur le Marché.
0.1636233627796173 ||| 10 million IU/ml ||| 1 million IU/ ml ||| 18 millions d’ UI/ ml
0.343824177980423 ||| Combined therapy should be started as early as possible after symptoms start and continued for at least four weeks. ||| Onset of protection occurs as early as 2 weeks post vaccination and lasts for at least 17 weeks. ||| L’association médicamenteuse doit être débutée le plus tôt possible après le début des symptômes et poursuivie pendant au moins 4 semaines.
0.38966813683509827 ||| An overdose of 12 g has been reported to lead to mild symptoms of toxicity. ||| Mortality was less than 1% but might be increased as a result of secondary infections. ||| Un surdosage de 12 g a provoqué de légers symptômes de toxicité.
0.24319542944431305 ||| Although not studied, coadministration of voriconazole with terfenadine, astemizole, cisapride, pimozide, or quinidine is contraindicated, since increased plasma concentrations of these medicinal products can lead to QTc prolongation and rare occurrences of torsades de pointes (see section 4.3). ||| The risk of myopathy and rhabdomyolysis is also increased by concomitant use of other fibrates, lipid-lowering doses (≥ 1 g/ day) of niacin or by concomitant use of amiodarone or verapamil with higher doses of simvastatin (see sections 4.2 and 4.5). ||| Bien qu’ elle n’ ait pas été étudiée, la co-administration de voriconazole et de terfénadine, d’ astémizole, de cisapride, de pimozide ou de quinidine est contre-indiquée, étant donné que l'augmentation des concentrations plasmatiques de ces médicaments peut entraîner un allongement de l’ intervalle QTc et de rares épisodes de torsades de pointes (voir rubrique 4.3).
0.26304784417152405 ||| How to take Combivir 4. ||| How to take Revlimid 4. ||| Comment prendre Combivir 4.
0.36865729093551636 ||| When completely mixed, the vaccine is a clear pale yellow to light pink liquid. ||| Before mixing with the solvent, the powder vaccine is a white to pale yellow compact crystalline cake. ||| Une fois complètement reconstitué, le vaccin est un liquide clair, jaune pâle à légèrement rose.
0.0674579069018364 ||| 74 9. ||| 79 9. ||| 77 9.
0.6157503128051758 ||| Looking ahead, it is estimated that 9 new centralised applications will be made in 1998 and 11 in 1999. ||| It has also adjourned appeals which were to be heard in March, to dates in June. ||| A l’avenir, 9 nouvelles demandes centralisées devraient, selon les estimations, être effectuées en 1998 et 11 en 1999.
0.6414813995361328 ||| Neutropenia ||| Leukopenia ||| Neutropénie
0.28467637300491333 ||| Ketoconazole / Itraconazole: the AUC and Cmax of ketoconazole were increased by 44% and 19%, respectively when given with amprenavir alone. ||| Co-administration of ketoconazole (200 mg) with aliskiren (300 mg) resulted in an 80% increase in plasma levels of aliskiren (AUC and Cmax). ||| L’ ASC et la Cmax du kétoconazole sont augmentées respectivement de 44% et 19% lorsqu’ il est associé à l’ amprénavir seul.
0.3903524875640869 ||| Fruit jellies [confectionery] ||| Organic digestate [fertilizer] ||| Pâtes de fruits [confiserie]
0.4650222659111023 ||| Hypertension, acute renal failure, respiratory depression and coma may occur, but are rare. ||| In some, the disease may progress to pneumonia, multi-organ failure, and death. ||| De rares cas d’ hypertension, d’ insuffisance rénale aiguë, de dépression respiratoire et de coma ont été signalés.
0.39436933398246765 ||| Only use it if the solution is clear, colourless, with no solid particles visible, and has a water-like consistency. ||| The solution should be clear and colourless, with no lumps, flakes, or particles. ||| Ne l'utilisez que si la solution est claire, incolore, sans particule solide visible, et qu’ elle a la consistance de l'eau.
0.15579743683338165 ||| 10 vials of suspension (25 dose size) + 10 vials of emulsion (25 dose size). ||| 1 vial of suspension (25 dose size) + 1 vial of emulsion (25 dose size). ||| 10 flacons de suspension (taille pour 25 doses) + 10 flacons d’ émulsion (taille pour
0.47718971967697144 ||| 6.1 List of excipients Carbomer, colloidal silicon dioxide (E551), hypromellose (E464), lactose monohydrate, magnesium stearate (E572), methacrylic acid copolymer, macrogol, povidone (E1201), red iron oxide (E172), talc (E533b), titanium dioxide (E171) ||| Polyethylene oxide 200K Sodium chloride Povidone (K29-32) Stearic acid Butyl hydroxytoluene (E321) Ferric Oxide (Yellow) (E172) (3, 12 mg tablet only) Polyethylene Oxide 7000K Ferric Oxide (Red) (E172) Hydroxyethyl Cellulose Polyethylene glycol 3350 Cellulose acetate Iron oxide (Black) (E172) (1.5, 9 mg tablet only) ||| 6.1 Liste des excipients Carbomère, dioxyde de silicium colloïdal (E551), hypromellose (E464), monohydrate de lactose, stéarate de magnésium (E572), copolymère d’ acide méthacrylique, macrogol, povidone (E1201), oxyde de fer rouge (E172), talc (E533b), dioxyde de titane (E171).
0.6042900085449219 ||| If we all stand up for Europe today - with courage, trust and solidarity - I know that tomorrow Europe's soul will shine brighter than ever before. ||| And, dear Chancellor, thanks also to Germany's contribution in recent weeks, this ‘sense of collective responsibility' is back with us again in Europe. ||| Si nous défendons tous l'Europe aujourd'hui - avec courage, confiance, et solidarité, je sais que demain, l'âme de l'Europe brillera plus fort que jamais.
0.086188904941082 ||| Always take (Invented name)® exactly as your doctor has told you. ||| Always take [Invented name] exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.315294086933136 ||| Do not use Liprolog Mix25 ||| Do not use Humalog Mix50 ||| N’utilisez jamais Liprolog Mix25
0.5620311498641968 ||| Smoking should also be stopped as it could decrease the amount of medicine in the blood. ||| It is also important for children and adolescents to drink enough liquids during the course of the day. ||| L’arrêt du tabac est conseillé pendant le traitement car il peut entraîner une baisse de la quantité de médicament dans le sang.
0.18490171432495117 ||| Hypersensitivity to the active substance, other porphyrins or to any of the excipients. ||| - Hypersensitivity to the active substance or to any interferon or to any of the excipients; ||| Hypersensibilité au principe actif et autres porphyrines ou à l’ un des excipients.
0.010642193257808685 ||| Bottle Packs and bottle label, 100 Film-Coated Tablets ||| Bottle Packs and bottle label, 30 Film-Coated Tablets ||| Boîte et étiquette du flacon, 100 comprimés pelliculés
0.17505064606666565 ||| Co-administration of SUTENT with potent CYP3A4 inhibitors, such as ketoconazole, should be avoided (see sections 4.4 and 4.5). ||| Co-administration of REYATAZ with ritonavir and medicinal products that induce CYP3A4 is not recommended (see sections 4.3 and 4.5). ||| L’ administration concomitante de SUTENT et d’ inhibiteurs puissants du CYP3A4 tels que le kétoconazole devra être évitée (voir rubriques 4.4 et 4.5).
3.9044378082227216e-13 ||| As a precautionary measure, always carry a spare insulin delivery device in case your InnoLet is lost or damaged. ||| As a precautionary measure, always carry a spare insulin delivery device in case your InnoLet is lost or damaged. ||| Par mesure de précaution, vous devez toujours avoir un système d’ injection d’ insuline de rechange au cas où vous perdriez ou endommageriez votre InnoLet.
0.6365382671356201 ||| DPP-4 Inhibitor, ATC code: ||| Influenza vaccines, ATC Code J07BB01 ||| Inhibiteur de la DPP-4, code ATC:
0.3146108388900757 ||| Nplate 250 micrograms powder for solution for injection Nplate 500 micrograms powder for solution for injection Romiplostim ||| ALIMTA 100 mg powder for concentrate for solution for infusion ALIMTA 500 mg powder for concentrate for solution for infusion ||| Nplate 250 microgrammes poudre pour solution injectable Nplate 500 microgrammes poudre pour solution injectable Romiplostim
0.2447793185710907 ||| Sodium salts for medical purposes ||| Potassium salts for medical purposes ||| Sels de soude à usage médical
0.2523748278617859 ||| HOW TO STORE ENVIAGE ||| HOW TO STORE TREDAPTIVE ||| COMMENT CONSERVER ENVIAGE
0.47156715393066406 ||| Secretarial employment services ||| Business representative services ||| Services d'emploi de secrétariat
0.5042303800582886 ||| Hepatic impairment. ||| Inflammatory bowel disease. ||| Insuffisance hépatique:
0.20046743750572205 ||| Store in a refrigerator. ||| Store in a refrigerator). ||| 34 A conserver au réfrigérateur.
0.338204562664032 ||| NeoRecormon Multidose 50,000 IU Lyophilisate for injection (5000 IU/ ml) IV/ SC use ||| Suspension for injection diphtheria > 30 IU Tetanus > 40 IU Pertactin 2.5µ 1 presentation ||| NeoRecormon Multidose 50 000 UI lyophilisat injectable (5000 UI/ ml) Voie I. V. / S. C.
0.3227504789829254 ||| In animal studies glucocorticoids have been shown to induce malformations including cleft palate and intra-uterine growth retardation. ||| Administration of pemetrexed to male mice resulted in reproductive toxicity characterised by reduced fertility rates and testicular atrophy. ||| Des études effectuées chez l'animal ont montré la survenue de malformations avec fente palatine et des retards de croissance intra-utérine.
0.45144492387771606 ||| Few patients (1.1%; 0.4% serious) discontinued treatment due to a hepatic event. ||| Corresponding recurrence rates for vehicle were 47% (8/17 patients) and 7.5% (6/80 lesions). ||| Peu de patients (1,1%; 0,4% de cas graves) ont interrompu le traitement en raison 21 d’ événements hépatiques.
0.11366233229637146 ||| Eisai Manufacturing Limited Mosquito Way Hatfield Herts AL10 9SN United Kingdom ||| Eisai Manufacturing Limited European Knowledge Centre Mosquito Way Hatfield Herts AL10 9SN United Kingdom ||| Eisai Manufacturing Limited Mosquito Way Hatfield Herts AL10 9SN Royaume-Uni
0.5148575305938721 ||| - atypical antipsychotic medications (such as clozapine, olanzapine), ||| Alternatives to clarithromycin (e. g. azithromycin) may be considered. ||| - les produits antipsychotiques (tels que olanzapine ou clozapine),
0.12066033482551575 ||| 263 General disorders and administration site conditions ||| 285 General disorders and administration site conditions ||| Troubles généraux et anomalies au site d’ administration
0.23726804554462433 ||| After the needle is in, remove the hand used to pinch the skin and use it to hold the syringe barrel. ||| When using the lavatory, use paper towels to turn off the faucet and open the door, then throw them away. ||| Une fois que l’ aiguille est en place, enlevez la main qui pinçait la peau et servez- vous en pour tenir le réservoir de la seringue.
0.44560545682907104 ||| - if you or your child previously experienced inflammation of the liver (hepatitis), severe skin ||| - If you have ever had a stroke or a transient ischaemic attack (TIA). ||| - Si, lors d’ un précédent traitement par VIRAMUNE, vous ou votre enfant avez présenté une
0.10343733429908752 ||| ge EU/ 1/ 01/ 184/ 038 ||| ed EU/ 1/ 01/ 184/ 016 ||| e EU/ 1/ 01/ 184/ 038
0.025946184992790222 ||| 50 pre-filled syringes 50 x 1 dose (0.5 ml) ||| 20 pre-filled syringes 20 x 1 dose (0.5 ml) ||| 50 seringues préremplies 50 x 1 dose (0,5 ml)
0.4129260778427124 ||| There was no difference between OPTRUMA and placebo treated women in the incidences of vaginal bleeding (spotting) or vaginal discharge. ||| After 8 weeks, two separation anxiety behaviours were significantly improved in the fluoxetine group (inappropriate defecation and destructive behaviour). ||| Il n’ y a pas eu de différence entre OPTRUMA et le placebo en ce qui concerne l’ incidence des saignements vaginaux (“ spottings ”) ou des pertes vaginales.
0.24362502992153168 ||| Cervarix is available in pre-filled syringes with or without needles in packs of 1 and 10. ||| Orgalutran is available in packs of 1 or 5 pre-filled syringes. ||| Cervarix est disponible en seringues préremplies, avec ou sans aiguilles, conditionnées en boîtes de 1 et 10.
0.4673972725868225 ||| Liver transaminases increased ||| Hepatic transaminases increased ||| Augmentation des transaminases hépatiques
0.11344146728515625 ||| Keep out of the reach and sight of children. ||| Keep out of the reach and sight of children ||| Ne le laisser ni à la portée ni à la vue des enfants.
2.7043720995240106e-13 ||| Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme responsible for the conversion of 3-hydroxy-3-methyl-glutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. ||| Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme responsible for the conversion of 3-hydroxy-3-methyl-glutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. ||| 66 L'atorvastatine est un inhibiteur sélectif et compétitif de l'HMG-CoA réductase, enzyme responsable du contrôle du taux de biotransformation de la 3-hydroxy-3-methyl-glutaryl-coenzyme A en mévalonate, un précurseur des stérols et en particulier du cholestérol.
0.46543821692466736 ||| Hypercalcaemia may increase the toxicity of cardiac glycosides during treatment with calcium and vitamin D. ||| Cardiac toxicity Doxorubicin and other anthracyclines can cause cardiotoxicity. ||| L’hypercalcémie peut augmenter la toxicité des digitaliques en cas d’administration simultanée de calcium et de vitamine D.
0.24569836258888245 ||| 221 4.4 Special warnings and precautions for use ||| 4.4 Special warnings and precautions for use i dic ||| Mises en garde spéciales et précautions d’ emploi
0.572292685508728 ||| The following packs are available: ||| The following supplies should be assembled: ||| Les présentations suivantes sont disponibles:
0.45830944180488586 ||| It arises from uncontrolled cell growth of the supporting tissues of these organs. ||| It starts to build up in certain cells of the body’ s immune system. ||| Il résulte de la croissance cellulaire incontrôlée des tissus de support de ces organes.
0.02733873575925827 ||| THE WORDS "KEEP OUT OF REACH AND SIGHT OF CHILDREN" ||| THE WORDS "KEEP OUT OF THE REACH AND SIGHT OF CHILDREN" ||| LA MENTION « TENIR HORS DE LA PORTÉE ET DE LA VUE DES ENFANTS »
3.3757922130416007e-13 ||| If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia. ||| If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia. ||| Si vous n'êtes pas familiarisé avec les symptômes annonciateurs d'hypoglycémie, évitez les situations - comme de conduire un véhicule - qui pourraient constituer un risque pour vous-même ou des tiers du fait de l'hypoglycémie.
0.5713988542556763 ||| 87.2% (85.2, 89.0) ||| 0.147 (0.086 – 0.268) ||| (85,2; 89,0) 57,5%
0.3306960165500641 ||| Transportation of fruit ||| Transportation of plants ||| Transport de fruits
0.12440553307533264 ||| The vaccine may not prevent hepatitis B infection in such cases. ||| The vaccine may not prevent hepatitis B in these individuals. ||| Dans de tels cas, il se peut que la vaccination ne prévienne pas l’ hépatite B.
0.5126622319221497 ||| Porcine ||| Potent ||| Porcin
0.3216835856437683 ||| Patients treated with nelarabine are potentially at risk of suffering from somnolence during and for several days after treatment. ||| The appearance of such infusion-related symptoms during or after you are treated with Zevalin is less frequent and less severe. ||| Les patients traités par nélarabine peuvent éventuellement présenter des somnolences pendant leur traitement ainsi que plusieurs jours après le traitement.
0.34817183017730713 ||| Photographic developing apparatus ||| Photographic duplicating apparatus ||| Appareils de développement photographique
0.6370043158531189 ||| The following pack sizes are available for the 15 mg film-coated tablets in blisters: ||| 71 Taking out a capsule These capsules come in special packaging to prevent children removing them ||| Les présentations suivantes sont disponibles pour les comprimés pelliculés à 15 mg en plaquettes thermoformées:
0.19207805395126343 ||| In order to improve the tolerability of nervous system undesirable effects, bedtime dosing is recommended during the first two to four weeks of therapy and in patients who continue to experience these symptoms (see section 4.8). ||| Dosing at bedtime seems to improve the tolerability of these symptoms and can be recommended during the first weeks of therapy and in patients who continue to experience these symptoms (see section 4.2). ||| Afin d’ améliorer la tolérance des effets indésirables affectant le système nerveux, il est recommandé de prendre le médicament au coucher pendant les deux à quatre premières semaines de traitement et chez les patients continuant à ressentir ces symptômes (voir rubrique 4.8).
0.4649006724357605 ||| The bioavailability of tulathromycin after subcutaneous administration in cattle was approximately 90%. ||| Total duration of treatment (potentially including initial parenteral treatment with ciprofloxacin) ||| La biodisponibilité de la tulathromycine après administration sous-cutanée chez les bovins est approximativement de 90%.
0.016295239329338074 ||| Under no circumstances should Humalog Mix25 be given intravenously. ||| Under no circumstances should Humalog Mix50 be given intravenously. ||| N’administrez jamais Humalog Mix25 par voie intraveineuse.
0.22142452001571655 ||| What ZYPREXA is and what it is used for 2. ||| What RISPERDAL CONSTA is and what it is used for 2. ||| Qu’ est -ce que ZYPREXA et dans quel cas est -il utilisé 2.
0.21253517270088196 ||| Co-administration of tenofovir disoproxil fumarate and didanosine at a dose of 400 mg daily has been associated with a significant decrease in CD4 cell count, possibly due to an intracellular interaction increasing phosphorylated (i. e. active) didanosine. ||| The co-administration of tipranavir with vitamin E in the form of TPGS (d-alphatocopherol polyethylene glycol 1000 succinate) from 2,322 IU/ m² upwards in rats resulted in a significant increase in effects on coagulation parameters, bleeding events and death. ||| La co- administration du fumarate de ténofovir disoproxil avec la didanosine à une dose de 400 mg par jour a été associée à une baisse significative du taux de CD4, pouvant être
0.3168368637561798 ||| In Nigeria, the EU will contribute €50 million to implement the UN Response Plan to the coronavirus and €10 million have been mobilised to help Ethiopia increase the number of diagnostic laboratories, test kits and treatment centres. ||| The EU has also made available €1 billion as a guarantee for the European Investment Fund, which will leverage a loan guarantee of €8 billion to help 100,000 SMEs across the EU, including in tourism. ||| Au Nigéria, l'UE apportera 50 millions d'euros à la mise en œuvre du plan de riposte de l'ONU face au coronavirus, et 10 millions d'euros ont été mobilisés pour aider l'Éthiopie à augmenter son nombre de laboratoires de diagnostic, de kits de diagnostic et de centres de traitement.
0.03383452445268631 ||| If the blood pressure is not sufficiently controlled, the dose can be increased to 300 mg a day or other medicines for hypertension can be added, such as hydrochlorothiazide. ||| If the blood pressure is not sufficiently controlled, the dose can be increased to 300 mg a day or other antihypertensive medicines can be added, such as hydrochlorothiazide. ||| Chez les patients dont la pression artérielle est insuffisamment contrôlée, il est possible d’ augmenter la dose à 300 mg par jour ou d’ ajouter d’ autres médicaments contre l’ hypertension, tel que l'hydrochlorothiazide.
0.1049761101603508 ||| (n = 283) 8.3 (7.0 - 9.4) ||| (n = 288) 7.9 (6.3 - 9.2) ||| (n = 283) 8,3 (7,0 - 9,4)
0.04877828061580658 ||| Efficacy of Azomyr oral solution has not been investigated in separate paediatric trials. ||| Efficacy of Neoclarityn oral solution has not been investigated in separate paediatric trials. ||| L’ efficacité d’ Azomyr solution buvable n’ a pas été évaluée par des études pédiatriques spécifiques.
0.5752342939376831 ||| Active substance: ||| ed Active substance: ||| Principe actif:
0.7453567981719971 ||| 10.0% 2.2% ||| 3.0% 1.2% 0.5% ||| 10,0% 2,2%
0.3468087911605835 ||| Push the plunger slowly to inject the water into the powder vial. ||| Insert the needle into the longer-acting insulin vial and inject the air. ||| Appuyez doucement sur le piston pour injecter l’ eau dans le flacon de poudre.
0.21645060181617737 ||| 5 vials ||| 12 vials ||| 5 flacons
0.38678544759750366 ||| FURTHER INFORMATION Me ||| FURTHER INFORMATION ct du ||| INFORMATIONS SUPPLEMENTAIRES
0.2978163957595825 ||| Clinical effects Patency data from the phase I and II angiographic studies suggest that tenecteplase, administered as a single intravenous bolus, is effective in dissolving blood clots in the infarct-related artery of subjects experiencing an AMI on a dose related basis. ||| In addition, persistence of vaccine-induced immunologic memory for hepatitis B virus surface antigen (HBsAg) has been demonstrated through an anamnestic antibody response to a booster dose of a previous formulation of Merck’ s recombinant hepatitis B vaccine in healthy adults. ||| Effets cliniques Les données relatives aux taux de perméabilité, collectées au cours des essais angiographiques de phase I et II, suggèrent que l'efficacité du ténectéplase administré sous la forme d'un bolus intraveineux unique pour dissoudre les thrombi artériels liés à l'infarctus du myocarde est dose-dépendante.
0.006806175224483013 ||| Xigris 5 mg powder for solution for infusion drotrecogin alfa (activated) ||| Xigris 20 mg powder for solution for infusion drotrecogin alfa (activated) ||| Xigris 5 mg, poudre pour solution pour perfusion drotrécogine alfa (activée)
0.8195624351501465 ||| You may watch television. ||| You will hear a click. ||| Vous pouvez regarder la télévision.
0.3476516604423523 ||| Do not use after the expiry date which is stated on the carton and the bottle after EXP. ||| 2 years After opening, the solution can be used up to the expiry date on the bottle. ||| Ne pas utiliser Lysodren après la date de péremption mentionnée sur la boîte et sur le flacon après EXP.
0.3108363449573517 ||| Surgery As Icandra contains metformin, the treatment should be discontinued 48 hours before elective surgery with general anaesthesia and should not usually be resumed earlier than 48 hours afterwards. ||| As for other anticoagulants, fondaparinux should be used with caution in patients who have undergone recent surgery (< 3 days) and only once surgical haemostasis has been established. ||| Intervention chirurgicale Icandra contenant de la metformine, le traitement doit être interrompu 48 heures avant une intervention chirurgicale programmée avec anesthésie générale et ne doit en règle générale être repris que 48 heures après l'intervention.
0.5008620023727417 ||| Saunderton High Wycombe Buckinghamshire HP14 4HJ United Kingdom ||| Buckinghamshire HP14 4HJ United Kingdom ||| Saunderton High Wycombe Buckinghamshire, HP 14 4HJ Grande-Bretagne
0.25092408061027527 ||| Vaccine recipients should avoid use of salicylates for 6 weeks after vaccination with ProQuad as Reye's syndrome has been reported following the use of salicylates during wild-type varicella infection. ||| Individuals who require vaccination against measles can receive M-M-RVAXPRO regardless of their immune status to mumps or rubella if a monovalent measles vaccine is not readily available. ||| 16 Les sujets vaccinés doivent éviter l'utilisation de salicylés pendant les 6 semaines qui suivent la vaccination avec ProQuad car des cas de syndrome de Reye ont été rapportés après la prise de salicylés lors d'une varicelle.
0.22039063274860382 ||| Store in the original package. ||| Store in the original package ||| Conserver dans la boîte d’ origine.
0.27894899249076843 ||| For specific dosing information in patients with renal impairment, refer to the Summary of Product Characteristics (SPC) of the co-administered protease inhibitor. ||| Please refer to the Aptivus Summary of Product Characteristics for additional information on the use of tipranavir, including genotypic predictors of response, in treatment of lopinavir-resistant HIV-1 infection. ||| Se reporter au Résumé des Caractéristiques du Produit (RCP) de l’inhibiteur de protéase co-administré avec le ritonavir pour les informations spécifiques relatives à la posologie chez les patients ayant une insuffisance rénale.
7.957531118416017e-13 ||| Increased alkaine phosphatase ||| Increased alkaine phosphatase ||| phosphatases alcalines
0.2593490183353424 ||| Oral administration of zaleplon to mice for 65 or 104 consecutive weeks at high dosage levels (≥ 100 mg/ kg/ day) elicited a statistically significant increase in benign but not in malignant liver tumors. ||| In iliac crest bone biopsies obtained after up to 60 months of treatment with strontium ranelate 2 g/ day in phase III trials, no deleterious effects on bone quality or mineralisation were observed. ||| L’ administration orale de zaleplon à des souris durant 65 ou 104 semaines consécutives à des doses élevées (≥ 100 mg/ kg/ jour) a entraîné une augmentation statistiquement significative des tumeurs hépatiques bénignes mais non malignes.
0.459276407957077 ||| 3.0 (1.7-4.3) ||| 5.7 (4.2-7.3) ||| 3,0 (1,7-4,3) 'es
0.5371252298355103 ||| Further to the submission of responses to questions, the clock was re-started on 14 March 2008. ||| Preliminary discussions have begun on drafting guidelines for the following topics in 1996: ||| Après la soumission des réponses aux questions, la procédure a redémarré le 14 mars 2008.
0.459276407957077 ||| 3.0 (1.7-4.3) ||| 5.7 (4.2-7.3) ||| 3,0 (1,7-4,3) 'es
0.34036678075790405 ||| In clinical trials the dose was increased by 0.5 mg each week to 3 mg once a day and then by 1 mg up to the maximum recommended dose of 4 mg once a day as shown in table 1. ||| In this study, the dose of Revatio started at 20 mg three times a day, and was increased to 40 mg and then to 80 mg at weeks 4 and 8. ||| Au cours des essais cliniques, la dose a été augmentée de 0,5 mg par semaine jusqu’ à atteindre la dose de 3 mg une fois par jour, puis de 1 mg jusqu’ à atteindre la dose maximale recommandée de 4 mg une fois par jour, comme le montre le tableau 1.
0.5066331028938293 ||| How is the Commission ensuring support to Italy when it comes to supply of personal protective equipment? ||| What more is being done to support research into the coronavirus, which includes benefitting those outside the EU? ||| Comment la Commission apporte-t-elle un soutien à l'Italie en ce qui concerne l'approvisionnement en équipements de protection individuelle?
0.30327272415161133 ||| Atripla and vigabatrin or gabapentin can be co- administered without dose adjustment. ||| Co-administration of lamivudine with intravenous ganciclovir or foscarnet is not recommended. ||| Atripla et la vigabatrine ou la gabapentine peuvent être co-administrés sans ajustement posologique.
0.4503094553947449 ||| The Health Ministry announced that all arriving passengers from China would be screened. ||| In Hong Kong, authorities are requiring a bracelet and an app for all travellers. ||| [Passage à actualiser] Le ministère de la Santé a annoncé que tous les passagers arrivant de Chine seraient contrôlés.
0.45094823837280273 ||| 67.9 (74/ 109) ||| 122/ 849 (14.4) ||| 67,9 (74/ 109)
0.25251543521881104 ||| At the end of year 2 (12 months after Preotact was discontinued), there was a 12.1% mean increase in dual energy X-ray absorptiometry (DXA) spine BMD for patients who received alendronate for the second year. ||| Among patients from study WV16240, who received Pegasys monotherapy and entered the long-term follow-up study, the rate of sustained HBeAg seroconversion 12 months after the end of therapy was 48% (73/ 153). ||| A la fin de la deuxième année (12 mois après que Preotact ait été arrêté), une augmentation moyenne de 12% de la DMO du rachis par absorptiométrie biphotonique à rayon X (DXA) a été observée dans le groupe de patientes recevant l’ alendronate la deuxième année.
0.5226805806159973 ||| 14 TAXOTERE 75 mg/ m² in combination with cisplatin ||| Dose of ALIMTA 2 (mg/ m) ||| 15 TAXOTERE 75 mg/ m² en association avec le cisplatine
0.0 ||| Keep out of the reach and sight of children. ||| Keep out of the reach and sight of children. ||| Tenir hors de la portée et de lavue des enfants.
0.301731139421463 ||| The pharmacokinetics of romiplostim involved target-mediated disposition, which is presumably mediated by TPO receptors on platelets and other cells of the thrombopoietic lineage such as megakaryocytes. ||| Metabolism Degarelix is subject to common peptidic degradation during the passage of the hepato-biliary system and is mainly excreted as peptide fragments in the faeces. ||| La pharmacocinétique de romiplostim implique vraisemblablement une voie de signalisation médiée par les récepteurs à la thrombopoïétine (TPO) présents au niveau des plaquettes et d’ autres cellules de la lignée plaquettaire telles que les mégacaryocytes.
0.06436741352081299 ||| Quixidar 1.5 mg/ 0.3 ml solution for injection, pre-filled syringe. ||| Arixtra 7.5 mg/ 0.6 ml solution for injection, pre-filled syringe. ||| Quixidar 1,5 mg/ 0,3 ml solution injectable, en seringue pré-remplie.
0.4385891854763031 ||| Outer carton for Cozaar Comp 100 mg/ 25 mg film-coated tablets HDPE bottle ||| DUKORAL – 20x1 dose package (inner carton for 20 sodium hydrogen carbonate sachets) ||| Etui pour Cozaar Comp 100 mg/ 25 mg, comprimé pelliculé en flacon HDPE
0.2776610851287842 ||| At very high doses adverse effects on the nervous system (ataxia, unsteadiness, twitching, tremors, convulsions, etc) may occur in cattle. ||| Typical undesirable effects associated with NSAID use, such as lesions in the alimentary tract, soft faeces, urticaria and lethargy. ||| A de très fortes doses, on peut observer des effets secondaires sur le système nerveux (ataxie, démarche chancelante, raideur, tremblements, convulsions etc.).
0.3906458616256714 ||| With your other hand, pinch a fold of loose skin in the area you have cleaned for injection. ||| You may also have had one or more stents placed to keep open a blocked or narrowed artery supplying blood to the heart. ||| Avec l’autre main, pincez un pli de peau molle dans la région que vous avez nettoyée pour l’injection.
0.13353058695793152 ||| The following related adverse reactions were listed below by system organ class and within each frequency grouping, adverse reactions are presented in order of decreasing seriousness: common (≥ 1/ 100 to < 1/ 10); uncommon (≥ 1/ 1,000 to < 1/ 100); rare (≥ 1/ 10,000 to < 1/ 1,000). ||| Within the organ system classes, adverse reactions are listed under headings of frequency using the following categories: very common (≥ 1/ 10); common (≥ 1/ 100, < 1/ 10); rarely (≥ 1/ 10,000, < 1/ 1,000); very rarely (< 1/ 10,000); not ||| Au sein de chaque groupe de fréquence, les effets indésirables sont présentés suivant un ordre décroissant de gravité: fréquent (≥ 1/ 100, < 1/ 10); peu fréquent (≥ 1/ 1 000, < 1/ 100); rare (≥ 1/ 10 000 < 1/ 1 000).
0.27366578578948975 ||| Patients, receiving Avastin plus chemotherapy, with a history of arterial thromboembolism or age greater than 65 years have an increased risk of developing arterial thromboembolic events during therapy. ||| The experience in patients who are severely immunocompromised, receiving immunosuppressive therapy, and patients with severe neutropenia is limited since this population was excluded from phase 3 trials. ||| Les patients recevant Avastin plus chimiothérapie ayant des antécédents thromboemboliques ou âgés de plus de 65 ans, ont un risque majoré d’ évènement thromboembolique artériel pendant le traitement.
0.22871479392051697 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The French guarantee scheme, which is expected to mobilise €150 million, will support exporting small and midsize companies affected by the coronavirus outbreak. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "Germany will contribute €6 billion to Lufthansa's recapitalisation, together with a €3 billion state guarantee on a loan. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Le régime de garantie français, qui devrait permettre de mobiliser 150 millions d'euros, soutiendra les exportations des petites et moyennes entreprises touchées par la pandémie de coronavirus.
0.8678271174430847 ||| Electric coffee urns ||| Sandwich tn ||| Cafetières électriques
0.026094358414411545 ||| Your doctor will normally advise you to stop taking Copalia as soon as you know you are pregnant. ||| Your doctor will normally advise you to stop taking Imprida as soon as you know you are pregnant. ||| 74 Votre médecin vous recommandera normalement d’ arrêter Copalia dès que vous savez que vous êtes enceinte.
3.6631353332594596e-13 ||| Patients with a history of suicide-related events or those exhibiting a significant degree of suicidal ideation prior to commencement of treatment are known to be at greater risk of suicidal thoughts or suicide attempts, and should receive careful monitoring during treatment. ||| Patients with a history of suicide-related events or those exhibiting a significant degree of suicidal ideation prior to commencement of treatment are known to be at greater risk of suicidal thoughts or suicide attempts, and should receive careful monitoring during treatment. ||| Les patients ayant des antécédants de comportement de type suicidaire ou ceux exprimant des idées suicidaires significatives avant de débuter le traitement présentent un risque plus élevé de survenue d’ idées suicidaires ou de comportement de type suicidaire, et doivent faire l’ objet d’ une surveillance étroite pendant le traitement.
0.4991793632507324 ||| Adsorbents of synthetic materials ||| Decoctions of medicinal herb ||| Adsorbants en matériaux synthétiques
0.33624032139778137 ||| The adverse reactions are classified by System Organ Class and frequency, using the following convention: ||| Adverse reactions are listed by system organ class and ranked by frequency in Table 1, reflecting data from the following sources: ||| Les effets indésirables sont classés par Système Organe Classe et par fréquence en utilisant les catégories suivantes:
0.22003409266471863 ||| No studies were performed that covered fertility and early embryonic development. ||| No studies were performed that covered fertility and early embryonic development (see section 5.3). ||| Aucune étude couvrant la période avant l'implantation jusqu’ au début du développement embryonnaire n’ a été réalisée.
0.5567112565040588 ||| - blurred vision due to swelling (or fluid) in the back of the eye. ||| - Sciatica (pain in lower back or hip and may radiate into the leg) ||| - vision trouble due à un gonflement (accumulation de fluide) à l’ arrière de l’œ il.
0.5069471597671509 ||| Your doctor will carefully monitor the effect of VIRAMUNE and any of these medicines if you are taking VIRAMUNE and any of these medicines together. ||| Some medicines may affect how SINGULAIR works, or SINGULAIR may affect how your child's other medicines work. ||| Votre médecin surveillera avec attention les effets de VIRAMUNE et de ces médicaments si vous prenez VIRAMUNE avec un de ces médicaments.
0.33810317516326904 ||| The company carried out ‘ bioequivalence’ studies to show that taking Stalevo gives the same levels in the blood of levodopa, carbidopa and entecapone as taking the active substances as separate tablets containing entacapone and combination tablets containing both levodopa and carbidopa. ||| The MAH shall ensure that additional risk minimisation activities to address the renal safety concerns related to tenofovir disoproxil fumarate, one of the active substances contained in Atripla, are being implemented for this fixed combination like for all medicinal products containing tenofovir disoproxil fumarate. ||| La société a mené des études de « bioéquivalence » pour démontrer que la prise de Stalevo conduit aux mêmes taux dans le sang de lévodopa, de carbidopa et d'entacapone que la prise des principes actifs sous forme de comprimés contenant uniquement de l’ entacapone et de comprimés contenant tant de la lévodopa que de la carbidopa.
0.055691830813884735 ||| Studies were also done looking at the use of Liprolog in 542 children and adolescents (aged between two and 19 years), and the use of Liprolog in combination with sulphonylureas (antidiabetic medicines taken by mouth). ||| Further studies were also done looking at the use of Humalog in 542 children and adolescents (aged 2 to 19), and the use of Humalog in combination with sulphonylureas (oral anti-diabetes medicines). ||| Des études ont également porté sur Liprolog utilisé chez 542 enfants et adolescents (âgés de 2 à 19 ans) et sur l’ utilisation de Liprolog en combinaison avec des sulfamides hypoglycémiants (médicaments antidiabétiques administrés par la bouche).
0.04921027272939682 ||| Kinzalkomb should not be given to patients with cholestasis, biliary obstructive disorders or severe hepatic insufficiency (see section 4.3) since telmisartan is mostly eliminated with the bile. ||| Micardis is not to be given to patients with cholestasis, biliary obstructive disorders or severe hepatic impairment (see section 4.3) since telmisartan is mostly eliminated with the bile. ||| Le telmisartan étant éliminé majoritairement par voie biliaire, Kinzalkomb ne doit pas être administré à des patients atteints de cholestase, d’ obstruction biliaire, ou d’ insuffisance hépatique sévère (voir rubrique 4.3).
0.26034918427467346 ||| Ertapenem is excreted in human milk. ||| Celecoxib was excreted in rat milk. ||| L'ertapénème est excrété dans le lait maternel.
2.9583456452771106e-13 ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| De plus, un PGR mis à jour devra être soumis: • Lors de la réception de nouvelles informations pouvant avoir un impact sur le profil de sécurité d’ emploi, le plan de pharmacovigilance ou les activités de minimisation des risques; • Dans les 60 jours qui suivent la date à laquelle une étape importante (pharmacovigilance ou minimisation des risques) est franchie; • A la demande de l’ EMEA
0.31388431787490845 ||| If broken tablets, or the vomit, urine or faeces of a treated dog comes into contact with the skin or eyes, rinse immediately with plenty of water. ||| Health organizations recommended that people cover their mouth and nose with a bent elbow or a tissue when coughing or sneezing, and disposing of any tissue immediately. ||| La peau ou les yeux ne peuvent pas être exposés à un contact avec des comprimés cassés, des vomissures, de l’ urine ou des selles d’ un chien en traitement, le cas échéant, rincez immédiatement à grande eau.
0.078404501080513 ||| Baxter AG Industriestrasse 67 A-1221 Vienna Austria ||| Baxter AG Industriestrasse 67 A-1221 Vienna, Austria ||| Baxter AG Industirestrasse 67 A-1221 Vienne Autriche
0.49284934997558594 ||| Based on this analysis there were no cases in the vaccine group and 20 cases in the control group (Efficacy 100%; 97.9% CI: ||| Treatment differences (BYETTA minus comparator) were -4.1 kg in the 26-week study and – 5.4 kg in the 52-week study. ||| Selon cette analyse il n’ y a eu aucun cas dans le groupe vaccin et 20 cas dans le groupe contrôle (Efficacité 100%; IC à 97,9%:
0.42870211601257324 ||| Clear, colourless, neutral solution. ||| Solvent: clear, colourless solution. ||| Solution neutre, limpide et incolore.
0.24428576231002808 ||| - Common: ||| - Milk: ||| - Fréquent:
0.23765933513641357 ||| 3.5% ||| 2.5% ||| 3,5%
0.00047888484550639987 ||| 165 In case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites and proper injection technique and all other relevant factors must be reviewed before dose adjustment is considered. ||| 145 In case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites and proper injection technique and all other relevant factors must be reviewed before dose adjustment is considered. ||| Si l'équilibre glycémique n'est pas optimal ou si le patient a tendance à présenter des épisodes hyperglycémiques ou hypoglycémiques, il faut d'abord vérifier le respect par le patient du traitement prescrit, les sites et les techniques d'injection et l'ensemble des autres facteurs susceptibles d'augmenter la tendance à l'hyper- ou l'hypoglycémie, avant d'envisager l'ajustement de la dose d'insuline.
0.34361207485198975 ||| Automatic temperature regulators [valves] for central heating radiators ||| Suspension rails [not electrified] for electrical lighting fixtures ||| Régulateurs de température automatiques pour radiateurs de chauffage central [vannes]
0.583521842956543 ||| IONSYS should be used with caution in patients with brain tumours. ||| CHAMPIX is indicated for smoking cessation in adults. ||| IONSYS doit être utilisé avec prudence chez les patients atteints d’ une tumeur cérébrale.
0.3664554953575134 ||| How does Tredaptive work? ||| What is Tredaptive? ||| Comment Tredaptive agit -il?
0.031394459307193756 ||| It is recommended that subjects who receive a first dose of Silgard complete the 3-dose vaccination course with Silgard (see section 4.4). ||| It is recommended that subjects who receive a first dose of Gardasil complete the 3-dose vaccination course with Gardasil (see section 4.4). ||| Il est recommandé aux sujets qui ont reçu une première dose de Silgard de terminer le schéma de vaccination en 3 doses avec Silgard (voir rubrique 4.4).
0.31422513723373413 ||| Nervous system disorders Very Common: somnolence, dizziness, ataxia, Common: ||| Nervous system disorders Common: dizziness, paraesthesia Uncommon: seizures ||| Affections du système nerveux Très fréquent: somnolence, étourdissements, ataxie
0.08649320155382156 ||| Chemical and physical in-use stability has been demonstrated for 4 hours when stored at 2 to 8°C. ||| Chemical and physical in-use stability has been demonstrated for 3 hours at temperatures up to 25oC. ||| La stabilité physico-chimique a été démontrée pendant 4 heures quand le produit est conservé entre 2 et 8°C.
0.005618665367364883 ||| Aranesp 15 micrograms solution for injection in a pre-filled pen. ||| Aranesp 30 micrograms solution for injection in a pre-filled pen. ||| Aranesp 15 microgrammes, solution injectable en stylo prérempli.
0.45774078369140625 ||| If you have liver or kidney problems, talk to your doctor, since your dose of Efexor may need to be different. ||| - If you have diarrhoea for more than one day, please tell your doctor, because it might be ||| 47 Si vous avez des problèmes hépatiques ou rénaux, parlez -en à votre médecin, dans la mesure où votre posologie d’ Efexor pourrait nécessiter une adaptation.
0.28196609020233154 ||| 278 Take special care with ViraferonPeg ||| 268 Take special care with PegIntron ||| Faites attention avec ViraferonPeg
0.30186331272125244 ||| White, capsule-shaped tablet, debossed “ Pfizer” on one side and “ VOR200” on the reverse. ||| Pink, capsule shaped, film-coated tablet, debossed with “ 123” on one side, plain on the other side. ||| Comprimés blancs, de forme allongée, et portant l’ inscription « Pfizer » gravée sur une face et « VOR200 » sur l’ autre.
0.4162728786468506 ||| A course of treatment usually lasts for 5 to 14 days. ||| Usually, 7 to 14 days of treatment are sufficient. ||| La durée de traitement est habituellement de 5 à 14 jours.
0.1117347702383995 ||| 4/ 28 ||| 4/ 22 ||| 4/ 30
0.41312116384506226 ||| Since IgG is known to pass the placenta and because of the concomitant use of radiation, Zevalin must not be used during pregnancy. ||| Since LeukoScan cross-reacts with CEA, it should be borne in mind that it may interact with CEA producing tumours. ||| Compte-tenu du franchissement connu de la barrière placentaire par les IgG et du risque concomitant d'irradiation, Zevalin ne doit pas être utilisé chez la femme enceinte.
0.3911379873752594 ||| Efforts will be made to further improve the functioning of the Committee to allow it to handle an increasing workload and to prepare for future challenges, such as emerging therapies. ||| Efforts to prevent the spread of the virus should be sustained, with awareness campaigns to encourage the population to keep up the strong hygiene practices and social distancing. ||| Des efforts seront consentis pour améliorer davantage le fonctionnement du comité afin qu'il puisse traiter une charge de travail croissante et se préparer aux défis futurs, tels que les nouvelles thérapies.
0.07755817472934723 ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF Doxagamma 4 mg prolonged release tablets and associated names (see Annex I) ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF Doxazosin “ Arrow” 4 mg prolonged release tablets and associated names (see Annex I) ||| RÉSUMÉ GÉNÉRAL DE L’ ÉVALUATION SCIENTIFIQUE DES comprimés à libération prolongée Doxagamma 4 mg et des dénominations associées – (voir annexe I)
0.428852915763855 ||| The concomitant use of voriconazole with St John’ s Wort is contraindicated (see section 4.5). ||| Herbal preparations containing St John’ s wort should not be used concomitantly with APTIVUS. ||| L’ administration concomitante de voriconazole et de millepertuis (Hypericum perforatum) est contre- indiquée (voir rubrique 4.5).
0.24779152870178223 ||| Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of  from baseline body weight in 39.9% of 7% patients. ||| In clinical studies of wait-listed and post-liver transplantation patients, four percent (19/ 467) of patients discontinued treatment with adefovir dipivoxil due to renal adverse events. ||| Lors du traitement au long cours par l’ olanzapine (jusqu’ à 12 mois) dans la prévention des récidives chez les patients présentant un trouble bipolaire, une augmentation de poids supérieure ou égale à 7% par rapport au poids initial a été rapportée chez 39,9% des patients.
0.0048954058438539505 ||| Risk Management Plan The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 1.2 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| Risk Management Plan The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 02, of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| Plan de gestion des risques Le titulaire de l’ autorisation de mise sur le marché s’ engage à réaliser les études et les activités additionnelles de pharmacovigilance décrites dans le plan de pharmacovigilance, en accord avec la version 1.2 du plan de gestion des risques (PGR) présenté dans le module 1.8.2 de l’ Autorisation de Mise sur le Marché et des mises à jour du PGR acceptées par le CHMP.
0.10690543055534363 ||| Oral use The film-coated tablets should be swallowed whole Read the package leaflet before use ||| Oral use The capsules should be swallowed whole Read the package leaflet before use ||| Voie orale Les comprimés pelliculés doivent être avalés entiers Lire la notice avant utilisation
0.02018062397837639 ||| EU/ 2/ 99/ 017/ 005 ||| EU/ 2/ 99/ 017/ 004 ||| EU/ 2/ 99/ 017/ 005 IBRAXION
0.2644769549369812 ||| The efficacy of INOmax has been investigated in term and near-term newborns with hypoxic respiratory failure resulting from a variety of etiologies. ||| The safety of Agenerase has been studied in adults and children at least 4 years of age, in controlled clinical trials, in combination with various other antiretroviral agents. ||| L’ efficacité de INOmax a été étudiée chez les nouveau-nés à terme et chez des prématurés proches du terme présentant une détresse respiratoire hypoxémiante d’ étiologie diverse.
0.596610963344574 ||| This does not affect normal operation of the syringe and the syringe can be rotated in the device. ||| This is normal and indicates that the IONSYS is not in contact with the skin. ||| Cela negêne pas le fonctionnement normal de la seringue et la seringue peut pivoter dans le dispositif.
0.22850847244262695 ||| RISPERDAL does not show a clinically relevant effect on the pharmacokinetics of lithium, valproate, digoxin or topiramate. ||| Galantamine and donepezil do not show a clinically relevant effect on the pharmacokinetics of risperidone and on the active antipsychotic fraction. ||| RISPERDAL n’ a pas montré d’ effet cliniquement significatif sur la pharmacocinétique du lithium, du valproate, de la digoxine ou du topiramate.
0.14634791016578674 ||| Very common (> 1/ 10); common (> 1/ 100 , 1/1 ,000, 1/10,000, < 1/ 1,000); very rare (< 1/10 ,000), including isolated reports. ||| Frequencies are defined as: common (> 1/ 100 , 1/1 ,000, 1/10,000, < 1/ 1,000); very rare (< 1/10 ,000). ||| Très fréquent (> 1/ 10); fréquent (> 1/ 100, 1/ 1,000, 1/ 10,000, < 1/ 1,000); très rare (< 1/ 10,000), y compris les cas isolés.
0.0 ||| Nespo is a sterile but unpreserved product. ||| Nespo is a sterile but unpreserved product. ||| Nespo est une solution stérile mais sans conservateur.
0.29427042603492737 ||| In the studies carried out for the development of Ziagen, the combination of the three active substances was shown to be at least as effective as the comparator combinations in keeping viral loads low. ||| Reproduction studies in rats and rabbits revealed that the combination is somewhat more toxic than either of the single components but none of the studies revealed a teratogenic effect of the combination. ||| Dans les études réalisées pour le développement de Ziagen, l’ association des trois principes actifs s’ est révélée au moins aussi efficace que les associations de comparaison en termes de maintien des charges virales à des niveaux bas.
0.0644116997718811 ||| The Aranesp (SureClick) pre-filled pen delivers the complete dose of each presentation. ||| The Nespo (SureClick) pre-filled pen delivers the complete dose of each presentation. ||| 247 Le stylo prérempli Aranesp (SureClick) délivre la totalité de la dose contenue dans chaque présentation.
0.483257532119751 ||| 112 The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating. ||| Sadness, depressed mood; loss of interest in previously pleasurable activities; agitation; irritability; slowed, inhibited actions; poor concentration; anxiety; difficulty in sleeping (insomnia); thoughts or words about death or suicide. ||| Les signes qui annoncent une hypoglycémie peuvent apparaître soudainement et sont les suivants: sueurs froides, pâleur et froideur de la peau, maux de tête, rythme cardiaque rapide, nausées, sensation de faim excessive, troubles visuels passagers, somnolence, fatigue et faiblesse inhabituelles, nervosité ou tremblement, anxiété, confusion, difficultés de concentration.
0.156814306974411 ||| The solution must be clear and colourless. ||| The solution is clear and colourless. ||| La solution doit être transparente et incolore.
0.0035560643300414085 ||| Each ml contains 25 micrograms ziconotide (as ziconotide acetate), (500 micrograms per vial), ||| Each ml contains 100 micrograms ziconotide (as ziconotide acetate), (500 micrograms per vial), ||| Chaque ml de solution contient 25 microgrammes de ziconotide (sous forme d’ acétate), (500 microgrammes par flacon),
0.20667853951454163 ||| As with all insulin preparations, the duration of action of Humalog Mix50 is dependent on dose, site of injection, blood supply, temperature, and physical activity. ||| As with all insulins, the duration of action will vary according to the dose, injection site, blood flow, temperature and level of physical activity. ||| Comme pour toutes les préparations d'insuline, la durée d'action d'Humalog Mix50 dépend de la dose, du site d'injection, de la vascularisation, de la température et de l'activité physique.
0.4112469255924225 ||| 18 - You are now ready to inject. ||| You are now ready to inject. ||| 18 – Tout est à présent prêt pour l’injection.
0.0832168459892273 ||| • convulsions (fits or seizures); a ||| • convulsions (fits or seizures); ||| • convulsions (crises ou attaques);
0.26643285155296326 ||| No survival benefit or other clinically relevant effects of the treatment have been demonstrated in patients with EGFR- negative tumours (see section 5.1). ||| Studies in animals have not shown any teratogenic effects of clinical relevance, however developmental toxicity has been observed (see section 5.3). ||| Aucun bénéfice en survie ou autres effets cliniquement significatifs du traitement n’ ont été démontrés chez les patients dont l’ expression EGFR de la tumeur était négative (voir rubrique 5.1).
0.3959569036960602 ||| Vinyl floor coverings for forming a floor ||| Wall coverings made of metal for constructing walls ||| Dalles en vinyle pour construire une surface au sol
0.16728508472442627 ||| Undesirable effects are ranked under headings of frequency using the following convention;very common (≥ 1/10); common (> 1/100, 1/1,000, ≤ 1/100); rare (> 1/10,000, ≤ 1/1,000); very rare (≤ 1/10,000). ||| Tabulated summary of adverse reactions The following adverse reactions are classified according to the following convention: very common (≥1/10), common≥1/100 to < 1/10), uncommon (≥1/1,000 to < 1/100), rare (≥1/10,000 to < 1/1000), or very rare (< 1/10,000). ||| Les effets indésirables sont classés par fréquence selon la convention suivante: très fréquent (≥ 1/ 10); fréquent (> 1/ 100, 1/ 1000, ≤ 1/ 100); rare (> 1/ 10 000, ≤ 1/ 1000); très rare (≤ 1/ 10 000).
0.1559731364250183 ||| The cartridges for OptiClik are to be used in conjunction with OptiClik only, and as recommended in the information provided by the device manufacturer. ||| 161 Insulin pen The cartridges for OptiClik are to be used in conjunction OptiClik only and as recommended in the information provided by the device manufacturer. ||| Les cartouches pour OptiClik doivent être utilisées avec OptiClik uniquement, et conformément aux instructions du fabricant du dispositif.
0.0893382579088211 ||| Nexavar works by slowing down the rate of growth of cancer cells and cutting off the blood supply that keeps cancer cells growing. ||| It works by slowing down the rate of growth of cancer cells and cutting off the blood supply that keeps cancer cells growing. ||| Nexavar ralentit la vitesse de croissance des cellules cancéreuses et coupe l’ irrigation sanguine permettant aux cellules cancéreuses de croître.
0.06719587743282318 ||| PHARMACEUTICAL FORM AND CONTENTS ||| 4 PHARMACEUTICAL FORM AND CONTENTS ||| FORME PHARMACEUTIQUE ET CONTENU tn
0.47394993901252747 ||| The pivotal study with 295 patients involved un-instrumented postero-lateral lumbar spine fusion in 208 patients treated with Opgenra.. ||| 1.35, 2.06, 35 trials and 6769 patients) was observed in patients treated with recombinant human erythropoietin. ||| L’étude pivot portant sur 295 patients a impliqué une arthrodèse postéro-latérale lombaire non instrumentée chez 208 patients traités avec Opgenra.
0.3943580985069275 ||| - if you have previously had thoughts about killing or harming yourself. ||| - if you have severe depression or think about committing suicide. ||| - si vous avez déjà eu des idées suicidaires ou d’ auto-agression dans le passé.
0.0 ||| Mixing is best done by gently tilting the cartridge or pen (with the cartridge in it) back and forth at least 10 times. ||| Mixing is best done by gently tilting the cartridge or pen (with the cartridge in it) back and forth at least 10 times. ||| 548 Pour ce faire, il convient d'incliner lentement la cartouche ou le stylo (avec la cartouche à l'intérieur) d'avant en arrière à 10 reprises au moins.
0.3146907687187195 ||| Ritonavir increases the serum levels of darunavir as a result of CYP3A inhibition. ||| Decreases in methadone AUC has been observed with other ritonavir-boosted protease inhibitors. ||| Le ritonavir augmente les concentrations sériques du darunavir par inhibition du CYP3A.
0.21860149502754211 ||| Epoetins are growth factors that primarily stimulate red blood cell production. ||| Effect on tumour growth Epoetins are growth factors that primarily stimulate red blood cell production. ||| 24 Les époétines sont des facteurs de croissance qui stimulent principalement la production de globules rouges.
0.0024618208408355713 ||| Dynepo 10,000 IU/ 0.5 ml solution for injection in a pre-filled syringe. ||| Dynepo 1,000 IU/ 0.5 ml solution for injection in a pre-filled syringe. ||| Dynepo 10000 UI/ 0,5 ml, solution injectable en seringue préremplie.
0.30535173416137695 ||| 98 Patients should be monitored closely to ensure that the lowest approved dose of MIRCERA is used to provide adequate control of the symptoms of anaemia. ||| When prescribing ReFacto AF it is important to individually titrate and monitor each patient's factor level in order to ensure an adequate therapeutic response. ||| Les patients doivent faire l’ objet d’ une surveillance étroite afin de s’ assurer que la dose la plus faible approuvée de MIRCERA est utilisée pour permettre un contrôle satisfaisant des symptômes de l’ anémie.
0.22750870883464813 ||| c) Hospital-based teams, which include infectious disease specialists, clinical pharmacists and microbiologists, providing support to prescribers; ||| This team should include infectious disease specialists, clinical microbiologists and pharmacists, and should receive dedicated funding and resources; ||| c) la mise en place d'équipes hospitalières multidisciplinaires comprenant des spécialistes des maladies infectieuses, des pharmaciens et des microbiologistes, afin de soutenir les prescripteurs;
0.1644442081451416 ||| HOW TO TAKE REVATIO ||| HOW TO TAKE DIACOMIT ||| COMMENT PRENDRE REVATIO
0.21517392992973328 ||| Provision of information relating to stock exchange prices ||| Provision of financial information relating to shares ||| Fourniture d'informations en matière de prix des valeurs boursières
0.2929236888885498 ||| While you take Avandamet your doctor needs to know: if you become dehydrated – for example, after severe vomiting, diarrhoea or fever. ||| Soon after beginning and during your treatment with Tasmar, you may have symptoms caused by levodopa such as dyskinesia (involuntary movement) and nausea. ||| Au cours du traitement par Avandamet votre médecin doit être informé: • si vous présentez un risque de déshydratation - par exemple, après des vomissements intenses une diarrhée ou de la fièvre.
0.6024701595306396 ||| 0.6% ||| +8.8% ||| 0,6%
0.35929977893829346 ||| Distribution Median volume of distribution during the terminal phase (Vz) following a single intravenous administration to patients with psoriasis ranged from 57 to 83 ml/ kg. ||| 10 Systemic exposure after administration as a 24 hour constant rate intravenous infusion is dose proportional at doses up to and including 1.8 mg/ m2. ||| Distribution Le volume de distribution médian pendant la phase finale (Vz) après administration unique en intraveineuse à des patients présentant un psoriasis était comprise entre 57 et 83 ml/ kg.
0.13434693217277527 ||| 61 Baseline darunavir phenotype (shift in susceptibility relative to reference) was shown to be a predictive factor of virologic outcome. ||| Baseline saquinavir phenotype (shift in susceptibility relative to reference, PhenoSense Assay) was shown to be a predictive factor of virological outcome. ||| Le phénotype à l’inclusion pour le darunavir (exprimant la réduction de la sensibilité virale par rapport à la référence) est un facteur prédictif de la réponse virologique.
0.3098759055137634 ||| The table below lists the related grade 3 and 4 adverse drug reactions for the 107 patients treated with TRISENOX in clinical trials (frequencies defined as: common ≥ 1/ 100 to < 1/ 10, uncommon ≥ 1/ 1,000 to < 1/ 100). ||| In the 100 mg ICC database (N = 204), the drug-related adverse reactions (MedDRA) listed below were reported with frequencies corresponding to Common (≥ 1/ 100 to < 1/ 10) or Uncommon (≥ 1/ 1,000 ||| Le tableau ci-dessous énumère les réactions médicamenteuses indésirables de grade 3 et 4 rapportées chez les 107 patients traités par TRISENOX dans le cadre d’ essais cliniques (la fréquence a été définie comme suit: fréquent ≥ 1/ 100 à < 1/ 10, peu fréquent ≥ 1/ 1 000 à < 1/ 100).
0.20538917183876038 ||| In children, symptoms of accidental overdoseincluded ataxia, dizziness, vomiting, rash, diarrhea, tremor, and flushing, and elevation in alkaline phosphatase. ||| Adverse events consistent with the safety profile for leflunomide were: abdominal pain, nausea, diarrhoea, elevated liver enzymes, anaemia, leucopenia, pruritus and rash. ||| Chez les enfants, les symptômes incluaient: ataxie, sensations vertigineuses, vomissements, rashs cutanés, diarrhées, tremblements, bouffées de chaleur et élévation des phosphatases alcalines.
0.0772065818309784 ||| 17 ANNEX IV ||| 18 ANNEX IV ||| 17 ANNEXE IV
0.6236367225646973 ||| Rare: vasodilatation. ||| Rare: nervousness ||| vasodilatation.
7.471651877928587e-13 ||| - isoniazid (used to treat tuberculosis), ||| - isoniazid (used to treat tuberculosis), ||| l'isoniazide (utilisé pour traiter la tuberculose),
0.001817497075535357 ||| 443 PARTICULARS TO APPEAR ON THE OUTER PACKAGING PRE-FILLED PEN CARTON ||| 394 PARTICULARS TO APPEAR ON THE OUTER PACKAGING PRE-FILLED PEN CARTON ||| 474 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR STYLO PREREMPLI
0.22488752007484436 ||| In vitro metabolism studies suggest that methylnaltrexone does not inhibit the activity of CYP1A2, CYP2E1, CYP2B6, CYP2A6, CYP2C9, CYP2C19 or CYP3A4, while it is a weak inhibitor of the metabolism of a model CYP2D6 substrate. ||| Therefore, vildagliptin is not likely to affect metabolic clearance of co-medications metabolised by CYP 1A2, CYP 2C8, CYP 2C9, CYP 2C19, CYP 2D6, CYP 2E1 or CYP 3A4/5. ||| Les études de métabolisme in vitro suggèrent que la méthylnaltrexone n’ inhibe pas l’ activité du CYP1A2, CYP2E1, CYP2B6, CYP2A6, CYP2C9, CYP2C19 ou CYP3A4, alors qu’ elle inhibe faiblement le métabolisme d’ un modèle de substrat du CYP2D6.
0.4117734432220459 ||| 0.5 ml of suspension in a vial (type I glass) for 1 dose with a stopper (rubber butyl) in the following pack sizes: lP ||| For the 5 micrograms dose the medication chamber (650 microliter) with the purple coloured latch is used together with the purple control disc. ||| 0,5 ml de suspension en flacon (verre de type I) pour une dose, muni d’ un bouchon (caoutchouc butyl) – Boîtes de 1 et 100.
0.0 ||| 5.3 Preclinical safety data ||| 5.3 Preclinical safety data ||| 145 5.3 Données de sécurité précliniques
0.44681692123413086 ||| (1.6) ||| (glass) ||| (1,6)
0.15417344868183136 ||| Your doctor will advise you and decide how long you should be treated with Lucentis. ||| Your doctor will monitor your condition and recommend how long you should be treated with Macugen. ||| Votre médecin vous conseillera et décidera de la durée nécessaire du traitement par Lucentis.
0.16424795985221863 ||| Gelatin Titanium dioxide (E171) Shellac Propylene glycol Potassium hydroxide Black iron oxide (E172). ||| Hypromellose (E464) Titanium dioxide (E171) Lactose monohydrate Polyethylene glycol 3000 Glycerol triacetate ||| Gélatine Dioxyde de titane (E171) Gomme laque Propylène glycol Hydroxyde de potassium Oxyde de fer noir (E172).
0.23077541589736938 ||| It could infect the drops • Gently press on the base of the bottle to release one drop of AZOPT at a time. • Don’ t squeeze the bottle: it is designed so that a gentle press on the bottom is all that it needs (picture 2) • After using AZOPT, press a finger to the corner of your eye, by the nose (picture 3). ||| Any air bubbles will collect at the top of the cartridge • Keeping the needle upwards, turn the cartridge for one click in the direction of the arrow (picture B) • Still with the needle upwards, press the push-button fully down (picture C) • A drop of insulin must appear at the needle tip. ||| Cela peut infecter le collyre. • Appuyez légèrement sur la base du flacon pour libérer une goutte d’AZOPT à chaque fois. • Ne comprimez pas le flacon: il est conçu pour qu’une légère pression sur la base suffise (figure 2). • Après avoir utilisé AZOPT, appuyez avec un doigt sur le coin de votre œil près du nez (figure 3).
0.30638939142227173 ||| Interior design services for boutiques ||| Advertising services for architects ||| Services de décoration intérieur pour boutiques
0.21097275614738464 ||| Myocardial infarction, congestive heart failure, angina, supraventricular tachycardia, arrhythmia, atrial fibrillation, pericarditis, cardiomyopathy ||| Cerebrovascular haemorrhage, cerbrovascular ischaemia, seizure, impaired consciousness, encephalopathy, neuropathy, polyneuropathy ||| infarctus du myocarde, insuffisance cardiaque congestive, angor, tachycardie supraventriculaire, arythmie, fibrillation auriculaire, péricardite, cardiomyopathie
0.25440409779548645 ||| If possible, take your tablets or the box with you to show the doctor. ||| If possible, take your tablets or the box with you to show the doctor or pharmacist. ||| Si possible, emmenez vos comprimés ou votre flacon avec vous pour les montrer au médecin.
0.3251829147338867 ||| Installation of water pipes ||| Construction of wind power plants ||| Installation de conduites d'eau
0.3445202112197876 ||| 50 mg / 2 ml ||| 1 mg/ 1 ml ||| 50 mg/ 2ml
0.2377597838640213 ||| As renal excretion is the predominant route of elimination, patients with moderate to severe renal dysfunction and those undergoing haemodialysis require a dose interval adjustment (see section 4.2). ||| Primary prevention Reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolemia and at high risk of a first cardiovascular event, as an adjunct to diet (see section 5.1). ||| L’ excrétion rénale étant la voie principale d’ élimination, une adaptation de l’ intervalle entre les prises est nécessaire chez les patients ayant une insuffisance rénale modérée à sévère et chez les patients hémodialysés (voir rubrique 4.2).
0.7255622148513794 ||| Chemical additives for pesticides ||| Additives, chemical, to insecticides ||| Additifs chimiques pour pesticides
0.0 ||| Film-coated tablet [To be completed nationally] ||| Film-coated tablet [To be completed nationally] ||| [A compléter au niveau national]
0.16482925415039062 ||| Design services relating to the reproduction of documents ||| Design services relating to the creation of networks ||| Services de conception en matière de reproduction de documents
0.40753135085105896 ||| Machines for the production of semiconductors ||| Machines for the manufacture of moulds ||| Machines destinées à la fabrication de semi-conducteurs
0.5238560438156128 ||| 15 0 ||| 0 1 ||| 150
0.3243729770183563 ||| 16.7% ||| 14.2% ||| 16,7%
9.76082929760036e-13 ||| Vascular disorders ||| Vascular disorders ||| Urticaire, éruption
0.3109002411365509 ||| Saccharide preparations, other than for medical use ||| Diagnostic substances, other than for medical use ||| Préparations à base de polysaccharide autres qu'à usage médical
0.4215695858001709 ||| Ladders, not of metal, for libraries ||| Mouldings, not of metal, for cornices ||| Échelles non métalliques pour bibliothèques
0.4441448748111725 ||| OVERWRAP ||| OVERDOSE ||| SACHET
0.30440956354141235 ||| LYRICA 150 mg hard capsules Pregabalin ||| CYSTAGON 150 mg hard capsules ||| LYRICA 150 mg gélules Prégabaline
0.49933043122291565 ||| - If you have had severe heart problems, or if you have heart disease that has not been well controlled ||| - you are elderly, if you have had diabetes for a long time or if you suffer from a certain type of ||| - si vous avez eu des problèmes cardiaques, ou si vous avez une maladie du coeur qui n’ a pas été
0.03803201764822006 ||| Despite this, your doctor may prescribe Remeron for patients under 18 because he/ she decides that this is in their best interests. ||| Despite this, your doctor may prescribe XERISTAR for patients under 18 because he/ she decides that this is in their best interests. ||| Néanmoins, il est possible que votre médecin décide de prescrire Remeron à des patients de moins de 18 ans, si il/ elle décide que c'est dans l’ intérêt du patient.
0.23519977927207947 ||| Fabrazyme should not be administered with chloroquine, amiodarone, benoquin or gentamicin due to a theoretical risk of decreased agalsidase beta activity. ||| Valproic acid, fluconazole or methadone when co-administered with zidovudine have been shown to increase the AUC of zidovudine, with a corresponding decrease in its clearance. ||| Fabrazyme ne doit pas être administré en association à la chloroquine, l’amiodarone, le monobenzone ou la gentamicine, en raison d’un risque théorique de réduction de l’activité de l’agalsidase bêta.
0.16515430808067322 ||| - clonidine (used to treat high blood pressure), ||| - diazoxide (used to treat high blood pressure), ||| - de la clonidine (utilisés pour traiter l’ hypertension artérielle),
0.30778640508651733 ||| If your disease responds to TRISENOX, you will be given a second treatment cycle of 25 doses, one infusion every weekday for 5 weeks. ||| If you have not been previously treated with chemotherapy, your first dose of Temodal will be 200 mg/m2 once daily for the first 5 days. ||| Si votre maladie répond au traitement par TRISENOX, vous recevrez un second cycle thérapeutique de 25 doses, soit une perfusion par jour, en semaine, pendant 5 semaines.
0.5944581031799316 ||| Non-nucleoside reverse transcriptase inhibitors (NNRTIs) Efavirenz 600 mg QD ||| 22 Non-nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs): ||| Inhibiteurs non nucléosidiques de la transcriptase inverse (INNTIs) 600 mg d’ éfavirenz une fois
0.08756111562252045 ||| P=0.002 ||| p=0.002 ||| P=0,0006
0.267175555229187 ||| In patients with a manic or mixed episode of bipolar disorder, olanzapine demonstrated superior efficacy to placebo and valproate semisodium (divalproex) in reduction of manic symptoms over 3 weeks. ||| Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. ||| 27 Chez les patients présentant un épisode maniaque ou mixte dans le cadre de troubles bipolaires, l'olanzapine a montré une efficacité supérieure à celle du placebo et du valproate monosodique sur la réduction des symptômes maniaques sur 3 semaines.
0.3111461400985718 ||| As with other serotoninergic medicinal products, discontinuation symptoms may occur in the neonate after maternal duloxetine use near term. ||| In some breast-fed infants, the serum concentrations of lamotrigine reached levels at which pharmacological effects may occur. ||| Des symptômes de sevrage peuvent survenir chez le nouveau-né dont la mère a été traitée par la duloxétine en fin de grossesse.
0.37906792759895325 ||| 135 Nervous system disorders ||| 0.5%) Nervous system disorders ||| Désordres du système nerveux
0.5704151391983032 ||| 1050 IU. ||| 30 million IU ||| 1.050 UI.
4.1742819053766644e-13 ||| EXP {month/ yyyy} Once opened, use within a 10-hour period, stored at +15 to + 25 ºC. ||| EXP {month/ yyyy} Once opened, use within a 10-hour period, stored at +15 to + 25 ºC. ||| EXP {mois/ aaaa} Après ouverture, à utiliser dans les 10 heures et à conserver entre +15 et + 25 ºC.
0.7533300518989563 ||| Turbid white suspension. ||| DUKORAL suspension Oral use. ||| Suspension blanche opalescente.
0.08169439435005188 ||| Lactation It is not known whether nilotinib is excreted in human milk. ||| Lactation: it is not known whether bexarotene is excreted in human milk. ||| Allaitement On ne sait pas si le nilotinib s’ élimine dans le lait maternel de la femme.
0.021576624363660812 ||| For the full list of all side effects reported with Starlix, see the Package Leaflet. ||| For the full list of all side effects reported with Tasmar, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l'utilisation de Starlix, voir la notice.
0.10396762937307358 ||| For Nespo no clinical data on exposed pregnancies are available. ||| For sugammadex no clinical data on exposed pregnancies are available. ||| Aucune donnée clinique n’ est disponible chez la femme enceinte. am
0.31191396713256836 ||| Computer hardware for the dissemination of positioning data ||| Development of software for multimedia data storing and recalling ||| Matériel informatique pour la diffusion de données de localisation
0.43520796298980713 ||| Nateglinide has shown a low potential for protein displacement in in vitro studies. ||| Plasma protein binding is approximately 98% on the basis of in vitro experiments. ||| Les études in vitro ont montré un faible potentiel du natéglinide à déplacer des liaisons protéiques
0.23092961311340332 ||| 7 February 2007 ||| 4 January 2007 ||| 7 février 2007
0.602063775062561 ||| 355 Allergic reactions ||| 569 Storage Instructions ||| Réactions allergiques
0.002556302584707737 ||| Adverse reactions are ranked under headings of frequency using the following conventions: very common (> 1/ 10) common (> 1/ 100 , 1/ 1000 , 1/ 10000, < 1/ 1000), very rare (< 1/ 10000) including isolated reports. ||| Adverse reactions are ranked under headings of frequency using the following conventions: very common (> 1/ 10), common (> 1/ 100 , 1/ 1000 , 1/ 10000, < 1/ 1000), very rare (< 1/ 10000) including isolated reports. ||| Les effets indésirables sont classés en fonction de leur fréquence en appliquant les conventions suivantes: très fréquent (> 1/ 10), fréquent (> 1/ 100, 1/1 000, 1/10 000, < 1/ 1 000), très rare (< 1/ 10 000) y compris les cas isolés.
0.17837834358215332 ||| Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infected patients (adults and children of 2 years of age and older). ||| VIRAMUNE is indicated in combination with other anti-retroviral medicinal products for the treatment of HIV-1 infected adults, adolescents, and children of any age (see section 4.4.). ||| Le ritonavir est indiqué en association avec d’autres antirétroviraux pour le traitement des patients infectés par le VIH-1 (adultes et enfants de 2 ans et plus).
0.030200185254216194 ||| 4.2.4 The TAXOTERE infusion solution should be used within 4 hours and should be aseptically administered as a 1-hour infusion under room temperature (below 25 °C) and normal lighting conditions. ||| 4.2.4 The Docetaxel Winthrop infusion solution should be used within 4 hours and should be aseptically administered as a 1-hour infusion under room temperature (below 25 °C) and normal lighting conditions. ||| La solution pour perfusion de TAXOTERE doit être utilisée dans les 4 heures et doit être 4.2.4 administrée de façon aseptique en perfusion d'une heure à température ambiante (ne dépassant pas 25°C) et dans des conditions normales de lumière.
0.31424015760421753 ||| In patients with polyarticular juvenile idiopathic arthritis, adalimumab antibodies were identified in 27/ 171 subjects (15.8%) treated with adalimumab. ||| Immunogenicity Approximately 5% of ustekinumab-treated patients developed antibodies to ustekinumab, which were generally low-titer. ||| Chez les patients atteints d’ arthrite juvénile idiopathique polyarticulaire, des anticorps anti- adalimumab ont été détectés chez 27 sujets sur 171 (15,8%) traités par l’ adalimumab.
0.2750377953052521 ||| Patients should be advised that during treatment with Mycophenolate mofetil Teva vaccinations may be less effective and the use of live attenuated vaccines should be avoided (see section 4.5). ||| The possibility of an additive effect resulting in postural hypotension should be borne in mind when Nifedipine Pharmamatch retard is used in combination with other beta-blocking medicinal products and antihypertensive agents. ||| Les patients doivent être informés que pendant le traitement par Mycophénolate mofétil Teva, les vaccinations peuvent être moins efficaces et qu’ il faut éviter les vaccins vivants atténués (voir rubrique 4.5).
0.2597277760505676 ||| Clinical resistance: patients in clinical trials initially treated with entecavir 0.5 mg (nucleoside-naive) or 1.0 mg (lamivudine-refractory) and with an on-therapy PCR HBV DNA measurement at or after Week 24 were monitored for resistance. ||| Patients received Kepivance (n = 409) or placebo (n = 241) either before, or before and after, myelotoxic chemotherapy with or without total body irradiation and peripheral blood progenitor cell (PBPC) support. ||| Résistance clinique: les patients des études cliniques initialement traités par entecavir 0,5 mg (naïfs de nucléoside) ou 1,0 mg (résistants à la lamivudine) avec dosage de l’ ADN du VHB par PCR à ou après la semaine 24 de traitement ont bénéficié d’ une analyse virale de résistance.
0.31598788499832153 ||| Pharmaceutical preparations for the prevention of disorders of the endocrine system ||| Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases ||| Produits pharmaceutiques pour la prévention des troubles du système endocrinien
0.19241806864738464 ||| The patch remains on the skin for three or four days and is then replaced by a new patch in a different place. ||| The patch remains on the skin for 24 hours and will then be replaced by a new one at a different site of application. ||| Le patch reste sur la peau pendant trois ou quatre jours avant d’ être remplacé par un nouveau patch, posé à un endroit différent.
4.970238630386259e-13 ||| 41 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 41 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 36 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.2582780122756958 ||| In patients who had been treated before, the time taken for the disease to get worse was, on average, 6.2 months with Velcade and 3.5 months with dexamethasone in the comparative study. ||| Looking at the results of the two studies together, the proportion of patients whose calcium levels were normal within 10 days after treatment was 88% with Zometa compared with 70% for pamidronate. ||| Chez les patients ayant déjà reçu un traitement, le délai avant aggravation de la maladie était en moyenne de 6,2 mois sous Velcade et de 3,5 mois sous dexaméthasone dans l'étude comparative.
0.1804221272468567 ||| Each film-coated tablet contains 500 mg levetiracetam. ||| Each 400 mg film-coated tablet contains 400 mg lumiracoxib. ||| Chaque comprimé pelliculé contient 500 mg de lévétiracétam
0.4699729382991791 ||| Treatment of erectile dysfunction in adult men. ||| - Treatment of duodenal and stomach ulcer ||| Traitement de la dysfonction érectile chez l’ homme adulte.
0.3257969319820404 ||| Non-clinical data reveal no special hazard for humans based on studies of single dose toxicity, repeated dose toxicity, and genotoxicity. ||| 23 Single-dose and repeated-dose toxicity and local tolerance studies revealed no special hazards to humans. ||| Les données non cliniques issues des études de toxicologie en administration unique, toxicologie en administration répétée et de génotoxicité, n’ ont pas révélé de risque particulier pour l’ homme.
0.08225039392709732 ||| For the full list of all side effects reported with Biograstim, see the Package Leaflet. ||| For the full list of all side effects reported with Twinrix Paediatric, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de Biograstim, voir la notice.
0.11147096753120422 ||| The maximum daily dose is 20 mg per day. ||| The maximum dose is 750 mg twice a day. ||| La dose maximale quotidienne est de 20 mg.
0.05583027005195618 ||| Do not take Plavix: • If you are allergic (hypersensitive) to clopidogrel or any of the other ingredients of Plavix; • If you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain; • If you suffer from severe liver disease. ||| • If you are allergic (hypersensitive) to clopidogrel or any of the other ingredients of Plavix; • If you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain; • If you suffer from severe liver disease. ||| Ne prenez jamais Plavix • Si vous êtes allergique (hypersensible) au clopidogrel ou à l'un des autres composants contenus dans Plavix; • Si vous avez une maladie actuellement responsable d'un saignement tel qu’un ulcère de l’estomac ou un saignement dans le cerveau; • Si vous souffrez d’insuffisance hépatique sévère.
0.4975213408470154 ||| Briquetting machines ||| Mining extraction ||| Machines à briqueter
0.39022180438041687 ||| Psychomotor restlessness was also added to the table of adverse drug reactions. ||| The nephroprotection indication presented the major area of disagreement. ||| L'instabilité psychomotrice a également été ajoutée à la liste des effets indésirables.
0.6417946815490723 ||| Pharmacokinetics in isolated limb perfusion: ||| Pharmacokinetic parameters of Privigen in 25 PID patients ||| Pharmacocinétique lors d’ une perfusion du membre isolé:
0.3440563678741455 ||| If you are taking ritonavir therapy for the treatment of HIV, you should not take Revatio. ||| Your doctor will decide if these medicines are suitable for you to take with Telzir and ritonavir. ||| Si vous prenez un traitement par ritonavir afin de traiter une infection à VIH, vous ne devez pas prendre Revatio.
0.38993263244628906 ||| Therefore, women of child- bearing potential should avoid contact with, or wear disposable gloves when administering, the product. ||| Any person, in particular pregnant women, who are not taking Siklos should avoid to come in direct contact with the parts when breaking a tablet. ||| En conséquence, les femmes enceintes ou susceptibles de l’ être devront éviter les contacts avec le produit lors de son application ou porter des gants jetables.
0.47131335735321045 ||| The outside of the backing layer is tan-coloured and imprinted with Neupro 2 mg/ 24 h. ||| The active side of the sponge, which is coated with fibrinogen and thrombin, is marked by a yellow colour. ||| L’ extérieur de la couche de support est de couleur beige et porte l’ impression Neupro 2 mg/ 24 h.
0.07138551771640778 ||| What GANFORT is and what it is used for 2. ||| What FIRMAGON is and what it is used for 2. ||| Qu'est -ce que GANFORT et dans quel cas est -il utilisé 2.
5.909387562619273e-13 ||| Steady state pharmacokinetics are similar in patients age 65 and over and young subjects. ||| Steady state pharmacokinetics are similar in patients age 65 and over and young subjects. ||| A l'état d'équilibre la pharmacocinétique est identique chez les patients âgés de 65 ans et plus et chez les sujets jeunes.
0.5568346977233887 ||| Transdermal patch Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg Germany ||| Biogen Idec Denmark Manufacturing ApS Biogen Idec Allé 1 DK-3400 Hillerød Denmark ||| Dispositif transdermique Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg Allemagne
0.3566511273384094 ||| Instruction in the maintenance of computers ||| Training in the operation of software systems ||| Services de formation en entretien d'ordinateurs
0.6787972450256348 ||| Cerebrovascular adverse events (CVAE) ||| Intraabdominal Infections (IAI) ||| 24 Événements indésirables cérébrovasculaires
0.3226565420627594 ||| 31 Antacid: the effect of an aluminum hydroxide and magnesium hydroxide-containing antacid on the pharmacokinetics of capecitabine was investigated. ||| A study was conducted to assess the effect of cyclosporine, a potent inhibitor of p-glycoprotein, on the pharmacokinetics of sitagliptin. ||| Antiacides: l'effet d'un antiacide contenant de l'hydroxyde d'aluminium et de l'hydroxyde de magnésium sur la pharmacocinétique de la capécitabine a été étudié.
0.03990589454770088 ||| 21 Additional information on individual components Undesirable effects previously reported with one of the individual components may be potential undesirable effects with Kinzalkomb, even if not observed in clinical trials with this product. ||| Additional information on individual components Undesirable effects previously reported with one of the individual components may be potential undesirable effects with PritorPlus, even if not observed in clinical trials with this product. ||| Informations complémentaires sur les principes actifs pris individuellement Les effets indésirables rapportés pour chacune des substances actives prises individuellement peuvent potentiellement survenir au cours de traitements par Kinzalkomb, même s’ ils n’ ont pas été mis en évidence au cours des essais cliniques.
0.21547487378120422 ||| Mild hepatic impairment(Child-Pugh class A) does not affect the pharmacokinetics of aprepitant to a clinically relevant extent. ||| Conclusions regarding the influence of moderate hepatic impairment (Child-Pugh class B) on aprepitant pharmacokinetics cannot be drawn from available data. ||| Une insuffisance hépatique légère (classe A de Child-Pugh) n’affecte pas la pharmacocinétique de l’aprépitant de façon cliniquement significative.
0.2902182340621948 ||| Renal insufficiency: ||| - adrenal insufficiency ||| Insuffisance rénale:
0.592248797416687 ||| 2 morning, 3 evening c: ||| 2 morning, 2 evening ||| 2 le matin, 3 le soir c:
0.29539257287979126 ||| The combined use of voriconazole with darunavir co-administered with 100 mg ritonavir has not been studied. ||| Therefore, the co-administration of boosted saquinavir and tipranavir, co-administered with low dose ritonavir, is not recommended. ||| L’utilisation concomitante de voriconazole avec du darunavir co-administré avec 100 mg de ritonavir n’a pas été étudiée.
0.15949036180973053 ||| - determine how much Insuman Basal per day you will need, ||| - determine how much Insuman Rapid per day you will need, ||| - déterminera la dose quotidienne d'Insuman Basal nécessaire,
0.318573534488678 ||| Cases of radiation pneumonitis have been reported in patients treated with radiation either prior, during or subsequent to their pemetrexed therapy. ||| Diuretic-treated patients In patients concurrently treated with diuretics, as hypotension may occur following initiation of the treatment, caution is recommended. ||| Des cas de pneumopathie radique ont été rapportés chez des patients traités par radiothérapie, soit avant, pendant ou après une chimiothérapie par pemetrexed.
0.23986348509788513 ||| Use in patients with renal and hepatic impairment Patients with kidney or liver dysfunction should be carefully observed for signs of fentanyl toxicity during the Rapinyl titration phase (see section 4.4). ||| In patients with known bone marrow-infiltrating infections or malignancy, consider appropriate therapy for treatment of the underlying condition in addition to administration of filgrastim for treatment of neutropenia. ||| Utilisation chez les patients insuffisants hépatiques ou rénaux L’ apparition éventuelle de signes de toxicité du fentanyl doit faire l’ objet d’ une surveillance stricte chez les patients atteints de troubles hépatiques ou rénaux (voir rubrique 4.4).
0.006612896453589201 ||| 4 In case of signs of upper airway obstruction, the problem should be solved by a specialist before starting treatment with somatropin. ||| 23 In case of signs of upper airway obstruction, the problem should be solved by a specialist before starting treatment with somatropin. ||| En cas de signe d'obstruction des voies aériennes supérieures, le problème devra être résolu par un spécialiste ORL avant d'initier le traitement par l'hormone de croissance.
0.7071700096130371 ||| • Merck KGaA ||| • NeuTec Pharma plc ||| Merck KGaA
0.004113065544515848 ||| Dilution and infusion Aseptically transfer the contents of the reconstituted vial(s) into an intravenous bag (or bottle) containing either 9 mg/ ml (0.9%) sodium chloride for infusion or 50 mg/ ml (5%) glucose for infusion obtaining an anidulafungin concentration of 0.36 mg/ ml. ||| 26 Dilution and infusion Aseptically transfer the contents of the reconstituted vial(s) into an intravenous bag (or bottle) containing either 9 mg/ ml (0.9%) sodium chloride for infusion or 50 mg/ ml (5%) glucose for infusion obtaining an anidulafungin concentration of 0.36 mg/ ml. ||| Dilution et perfusion Transférer de façon aseptique le contenu du ou des flacon(s) reconstitué(s) dans une poche (ou un flacon) pour perfusion IV contenant du chlorure de sodium pour perfusion à 9 mg/ ml (0,9%) ou du glucose pour perfusion à 50 mg/ ml (5%) pour obtenir une concentration d’ anidulafungine de 0,36 mg/ ml.
2.6461466481539353e-13 ||| When changing the route of administration the same dose must be used and the haemoglobin monitored every one or two weeks so that the appropriate dose adjustments can be made to keep the haemoglobin at the desired level. ||| When changing the route of administration the same dose must be used and the haemoglobin monitored every one or two weeks so that the appropriate dose adjustments can be made to keep the haemoglobin at the desired level. ||| 329 Lorsque la voie d'administration est modifiée, il faut utiliser la même dose et contrôler le taux d'hémoglobine une fois par semaine ou toutes les deux semaines, de façon à adapter la dose pour maintenir le taux souhaité.
0.3585902452468872 ||| 360 When you remove the needle cover, there may be a drop of liquid at the end of the needle; this is normal. ||| • If the black plunger is at the beginning of the coloured bar, then there are approximately 40 units of insulin available. ||| Quand vous retirez le capuchon de l’aiguille, il peut y avoir une goutte de liquide à l’extrémité de l’aiguille; c’est normal.
0.0 ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| FABRICANTDE LA SUBSTANCE ACTIVE D’ ORIGINE BIOLOGIQUE ET TITULAIRE DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS
0.3309518098831177 ||| Rheumatoid arthritis The recommended dose is 90 mg once daily. ||| Ankylosing spondylitis The recommended dose is 90 mg once a day. ||| Polyarthrite rhumatoïde La dose recommandée est de 90 mg une fois par jour.
0.17091739177703857 ||| Once opened, the product may be stored for a maximum of 28 days at 2°C to 8°C. ||| 2 years Once opened, the product may be stored for a maximum of 28 days at or below 25°C. ||| Après la première utilisation, le produit peut être conservé pendant 28 jours au maximum entre +2°C à +8°C.
0.38684242963790894 ||| Portable test apparatus ||| Replicating apparatus ||| Appareils de test portables
0.41498392820358276 ||| Tasmar therapy should only be initiated by physicians experienced in the treatment of Parkinson’ s disease to ensure an appropriate risk-benefit assessment. ||| PBPC mobilisation should be considered only in donors who meet normal clinical and laboratory eligibility criteria for stem cell donation. ||| 49 Le traitement par Tasmar ne doit être instauré que par un médecin habitué au traitement de la maladie de Parkinson afin de permettre une évaluation correcte du rapport bénéfice/ risque.
0.4838295578956604 ||| If it is almost time for your next dose, do not take the missed dose. ||| You only need to prepare the suspension once, at the beginning of your course. ||| Si vous êtes proche du oment de la prise suivante, ne prenez pas la dose oubliée.
0.49827659130096436 ||| Providing information relating to travel and transport, via electronic means ||| Transmission of information by data communications for assisting decision making ||| Mise à disposition d'informations en matière de voyages et de transport par voie électronique
0.24947185814380646 ||| Information and consultancy services relating to vehicle repair ||| Information services relating to maintenance of security systems ||| Services de conseil et d'information en matière de réparation de véhicules
9.226757812647035e-13 ||| These effects were mild and transient. ||| These effects were mild and transient. ||| Ces effets sont discrets et transitoires.
0.5986336469650269 ||| Repair or maintenance of integrated circuits manufacturing machines and systems ||| Gaming software that generates or displays wager outcomes of gaming machines ||| Réparation ou entretien de machines et de systèmes de fabrication de circuits intégrés
0.6904876828193665 ||| 1 day. ||| 1 day ||| 1 jour.
0.3914948105812073 ||| If a patient has not responded after this period, the combination therapy may be continued; current clinical experience indicates that treatment for up to 18 months or longer may be necessary to achieve spermatogenesis. ||| For ACS, the duration of the infusion depends on how the ACS is to be treated: it can last for a maximum of 72 hours in patients to be treated with medicines. ||| Si un patient n'a pas répondu après cette période, le traitement combiné peut être poursuivi; l'expérience clinique actuelle montre qu'un traitement pendant 18 mois voire plus peut êre nécessaire pour obtenir une spermatogenèse.
0.5305742025375366 ||| Electronic monitoring services for security purposes ||| Security services for the protection of individuals ||| Services de surveillance électronique à des fins de sécurité
0.32755494117736816 ||| The treatment should be reviewed after 4 to 6 weeks in order to assess the initial response. ||| The patient’ s response and the need for further treatment should be evaluated after three months. ||| Le traitement doit être réétudié après 4 à 6 semaines afin d’ évaluer la réponse initiale.
0.3759284019470215 ||| Tumour development was preceded by pneumocyte proliferation in the lung which was not observed in rats, dogs, or monkeys, indicating that a key event in lung tumour development observed in mice likely was species-specific. ||| Increased post-implantation loss was observed in both the fertility study, which involved treatment of both males and females, and the embryotoxicity study, which involved treatment of females. ||| Le développement des tumeurs a été précédé d'une prolifération de pneumocytes au niveau du poumon qui n'a été observée ni chez le rat, ni chez le chien ou le singe, indiquant que cet évènement clé dans le développement de tumeurs pulmonaires observé chez la souris est probablement spécifique à l'espèce.
0.36483028531074524 ||| However, the retinal changes may also represent a direct drug-induced effect. ||| If such inhibitors occur, the condition may manifest itself as an insufficient clinical response. ||| Les modifications rétiniennes pourraient toutefois résulter également d'un effet direct du produit.
0.43653976917266846 ||| Fire retardant chemicals ||| Antifungal preparations ||| Produits chimiques ignifuges
0.2868673801422119 ||| Hollow glass containers for laboratory use ||| Microwave ovens for laboratory use ||| Récipients creux en verre pour laboratoires
0.2929880619049072 ||| Although the frequency of reports of dizziness in placebo and tadalafil arms in clinical trials was similar, patients should be aware of how they react to CIALIS, before driving or operating machinery. ||| Overall, the safety profile of tacrolimus in these published studies appeared to be similar to what was reported in the large studies, where tacrolimus was used as primary treatment in liver, kidney and heart transplantation. ||| Bien que la fréquence des sensations vertigineuses rapportées dans le bras placebo et le bras tadalafil des études cliniques ait été similaire, les patients doivent connaître la manière dont ils réagissent à CIALIS avant de conduire un véhicule ou d’ utiliser des machines.
0.0 ||| See package leaflet for further information. ||| See package leaflet for further information. ||| Voir la notice pour plus d’ information.
0.1022268608212471 ||| What Kineret looks like and contents of the pack ||| What Aerius looks like and contents of the pack ||| Aspect de Kineret et contenu de l’ emballage extérieur
0.2669370174407959 ||| None of the subjects experienced withdrawal symptoms in this study; however, due to the pharmacokinetic changes, it should be expected that some patients who received this drug combination may experience withdrawal symptoms and require an upward adjustment of the methadone dose. ||| There have been no studies specifically looking at the use of gabapentin in pregnant women, but other medications used to treat seizures have reported an increased risk of harm to the foetus, particularly when more than one seizure medication is taken at the same time. ||| Aucun des sujets dans cette étude n’ a ressenti des symptômes de manque; cependant du fait des modifications pharmacocinétiques, il pourrait arriver que certains patients recevant cette association médicamenteuse ressentent des symptômes de sevrage, nécessitant une augmentation de la posologie de méthadone.
0.1337679624557495 ||| Hepatic impairment: no initial dosage adjustment is necessary. ||| 24 Hepatic impairment - No dosing adjustment is necessary. ||| Insuffisance hépatique: aucune adaptation posologique n'est nécessaire.
0.5340104103088379 ||| Breastfeeding must be discontinued for the duration of therapy. ||| to fishermen for the temporary cessation of fishing activities; ||| Aussi, l’ allaitement doit être suspendu pour la durée du traitement.
0.3449578285217285 ||| Installation of automobile accessories ||| Installation of hydraulic equipment ||| Installation d'accessoires pour voitures
0.1908796727657318 ||| There are no adequate data from the use of ibandronic acid in pregnant women. ||| There is insufficient information on the use of posaconazole in pregnant women. ||| Il n’ existe pas de données suffisantes concernant l’ utilisation de l’ acide ibandronique chez la femme enceinte.
0.3844413459300995 ||| Available data suggest that no dose adjustment is necessary in patients with mild to moderate renal impairment. ||| Experience with other contrast media shows that the risk of hypersensitivity reactions is higher in those patients. ||| Cependant, les données disponibles suggèrent qu’ aucun ajustement posologique n’ est nécessaire chez les patients ayant une insuffisance rénale légère à modérée.
0.3834189772605896 ||| Therapy with AVAGLIM should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5X upper limit of normal) or with any other evidence of liver disease. ||| Ketek should not be taken by patients with a history or a family history of ‘ long QT syndrome’ or with ‘ acquired QT interval prolongation’ (disruption of the heartbeat). ||| 22 les patients ayant des enzymes hépatiques élevées (ALAT > 2,5 fois la limite supérieure de la normale) ou présentant tout autre signe d'une affection hépatique.
0.3769974112510681 ||| The medicine is given by slow intravenous injection (into a vein) over one minute. ||| The intravenous infusion (“ drip”) will be given over approximately 90 minutes. ||| Le médicament est administré en injection intraveineuse (dans une veine) lente pendant une minute.
0.22929702699184418 ||| After a single intramuscular administration of the product at 15 mg/ kg to cattle, mean amoxicillin plasma peak concentration of 2.93 µg/ ml is reached 1.64 hours after dosing. ||| After a single administration of 200 mg suppository, a peak plasma level of about 2 mg/l is reached in 4 hours, with mean AUC of 27 mg h/l. ||| Après administration intramusculaire unique du produit à une dose de 15 mg/ kg à des bovins, le pic plasmatique moyen de l’ amoxiciline de 2,93 µg/ ml est atteint 1,64 heures après l’ injection.
0.42883050441741943 ||| INSTRUCTIONS ON USE ic ed ||| INSTRUCTIONS ON USE lP ina dic Me ||| INDICATIONS D’ UTILISATION C
0.26995640993118286 ||| Immunosuppressants such as cyclosporine, sirolimus, or tacrolimus (medicines used to prevent organ transplant rejection): when you start or stop taking SUSTIVA, your doctor will closely monitor your plasma levels of the immunosuppressant and may need to adjust its dose. ||| When Actos 30mg tablets are taken in combination with other medicines used to treat diabetes (such as insulin, chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to take a smaller dose of your medicines. ||| Lorsque vous commencez ou vous arrêtez de prendre SUSTIVA, votre médecin surveillera étroitement vos concentrations plasmatiques d’ immunosuppresseur et devra peut-être changer sa dose.
0.2653343677520752 ||| The terminal half-life of voriconazole depends on dose and is approximately 6 hours at 200 mg (orally). ||| Cetuximab has a long elimination half-life with values ranging from 70 to 100 hours at the target dose. ||| La demi-vie d’ élimination terminale du voriconazole dépend de la dose administrée et est d’ environ 6 heures pour une dose de 200 mg (voie orale).
0.35754844546318054 ||| The mechanism behind the increased incidence of atrial fibrillation in this single clinical trial is unknown. ||| In a controlled clinical trial in patients with cardiac insufficiency the following adverse events were reported: ||| Le mécanisme de l’ augmentation de cette incidence des fibrillations auriculaires dans cette seule étude clinique n’ est pas connu.
0.0 ||| SPECIFIC OBLIGATIONS TO BE FULFILLED BY THE MARKETING AUTHORISATION HOLDER ||| SPECIFIC OBLIGATIONS TO BE FULFILLED BY THE MARKETING AUTHORISATION HOLDER ||| OBLIGATIONS SPECIFIQUES A REMPLIR L'AUTORISATION DE MISE SUR LE MARCHE
0.5486749410629272 ||| Tapes for strapping [medical] ||| Plaster for casting [not medical] ||| Bandes élastiques à usage médical
4.3102048080841115e-13 ||| Treatment with Aranesp is divided into two stages – correction and maintenance phase. ||| Treatment with Aranesp is divided into two stages – correction and maintenance phase. ||| 41 Le traitement avec Aranesp est divisé en deux phases – phase correctrice et phase d’ entretien.
0.2574164867401123 ||| HOW TO USE OPGENRA ||| HOW TO USE PROTAPHANE ||| COMMENT UTILISER OPGENRA
0.009937127120792866 ||| Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at an increased risk for severe and potentially fatal hepatic adverse events. ||| Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at increased risk for severe and potentially fatal hepatic adverse reactions. ||| Les patients atteints d’une hépatite chronique B ou C et traités par une association d’antirétroviraux présentent un risque accru de développer des effets indésirables hépatiques sévères et potentiellement fatals.
0.26411378383636475 ||| Conditions which may make the early warning symptoms of hypoglycaemia different or less pronounced include long duration of diabetes, intensified insulin therapy, diabetic nerve disease or medications such as beta-blockers. ||| The length of combination anti-retroviral therapy, corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index, among others, may be some of the many risk factors for developing this disease. ||| Certaines conditions telles qu’ un diabète de longue durée, une insulinothérapie intensifiée, une neuropathie diabétique ou un traitement médicamenteux tel que les bêtabloquants peuvent rendre les signes précurseurs de l’ hypoglycémie différents ou moins prononcés.
0.12008850276470184 ||| Providing information relating to the repair or maintenance of sewing machines ||| Providing information relating to the repair or maintenance of fishing tackle ||| Mise à disposition d'informations en matière de réparation ou d'entretien de machines à coudre
0.11463592201471329 ||| Advisory services relating to industrial design ||| Advisory services relating to material testing ||| Services de conseil en matière de dessin industriel
0.6612898111343384 ||| • Seocalcitol ||| - maltodextrin ||| Seocalcitol
0.43268418312072754 ||| Reduction in haemoglobin and platelets were less frequently (< 5%) reported. ||| A small 5%, non-significant increase in triglycerides was noted. ||| Une baisse de l'hémoglobine et du taux des plaquettes a été moins souvent observée (< 5%).
0.339627206325531 ||| After injection, the mean peak (C max) level obtained was 116 ± 38 mU/ l and occurred approximately 13 ± 8 hours after administration. ||| The peak plasma concentration is reached 0.5 - 2 hours after taking 50 - 1000 mg p. o. and varies from 0.3 - 5.9 mg/ l. ||| Après l'injection, le pic moyen (C max) s'élevait à 116 ± 38 mU/ l et se situait environ à 13 ± 8 heures après l'administration.
0.42276495695114136 ||| Spears [valves], not of metal for use with kegs ||| Bags [envelopes, pouches] of leather, for packaging ||| Pointeaux [vannes] non métalliques pour fûts
0.04543624818325043 ||| Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. ||| Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. no ||| Dans chaque groupe de fréquence, les effets indésirables sont présentés par ordre de sévérité décroissante.
0.43179619312286377 ||| Cartridges ||| Armchairs ||| Cartouches
0.16788248717784882 ||| Always use Quixidar exactly as your doctor has told you. ||| Always use Ceplene exactly as your doctor has instructed. ||| Utilisez toujours Quixidar exactement comme votre médecin vous l’a dit.
0.19598624110221863 ||| Bondenza 150 mg film-coated tablets ||| Enviage 150 mg film-coated tablets ||| Bondenza 150 mg, comprimés pelliculés.
0.9135949611663818 ||| Stop taking Avaglim. ||| Inject the Dose). ||| Cessez de prendre Avaglim.
0.41133826971054077 ||| Magnetically encoded credit cards ||| Encoded prepaid credit cards ||| Cartes de crédit encodées magnétiquement
0.15481729805469513 ||| Evoltra treatment should be started and supervised by a doctor who has experience in the management of patients with acute leukaemia. ||| Treatment with MIRCERA must be initiated under the supervision of a doctor who has experience in the management of patients with kidney disease. ||| Le traitement par Evoltra doit être instauré et supervisé par un médecin expérimenté dans la prise en charge de patients souffrant de leucémie aiguë.
0.29218095541000366 ||| 64 Very common ||| 7 Very common ||| Très fréquent
0.29631346464157104 ||| In clinical trials, PhotoBarr PDT has only been tested in patients being treatment naive concerning mucosal ablative therapy. ||| Other experience with CEPROTIN covers case reports and a clinical study in overall 69 paediatric patients with acquired protein C deficiency. ||| Lors des essais cliniques, la PDT avec PhotoBarr a été étudiée uniquement chez les patients traités pour la première fois par ablation mucosale.
0.014970395714044571 ||| There have been reports of serious allergic reactions including anaphylactic reaction, angioedema, dyspnoea, skin rash and urticaria associated with darbepoetin alfa. ||| au There have been reports of serious allergic reactions including anaphylactic reaction, angioedema, dyspnoea, skin rash and urticaria associated with darbepoetin alfa. ||| Des cas de réactions allergiques graves comprenant réactions anaphylactiques, oedème de Quincke, dyspnée, rash cutané et urticaire ont été rapportés avec la darbepoetin alfa.
0.47346633672714233 ||| - Hypersensitivity to the active substance or to any of the excipients (see section 6.1) ||| - your child is allergic to any of the components of the vaccine (see section 6). ||| - Hypersensibilité connue à la substance active ou à l’ un des excipients (voir rubrique 6.1)
0.005438415799289942 ||| Defined as HCV RNA below limit of detection using a research based RT-PCR assay at end of treatment and during follow-up period ||| Defined as HCV-RNA below limit of detection using a research based RT-PCR assay at end of treatment and during follow-up period ||| Définie comme une valeur de l’ ARN-VHC en dessous de la limite de détection par RT-PCR en fin de traitement et durant la période de suivi.
0.4398176372051239 ||| Do not administer in conjunction with bactericidal antibiotics like beta-lactames. ||| - if you are taking anticoagulants such as warfarin to prevent blood clots ||| Ne pas administrer conjointement à des antibiotiques bactéricides comme les ß-lactames.
0.2672041654586792 ||| The use of Truvada is not recommended in patients with severe renal impairment (creatinine clearance < 30 ml/ min) and in patients who require haemodialysis since appropriate dose reductions cannot be achieved with the combination tablet (see sections 4.2 and 5.2). ||| The transition regimen involves escalating the dose of lamotrigine to a maintenance stabilisation dose over six weeks (Table 3) after which other psychotropic medicinal products and/ or AEDs can be withdrawn, if clinically indicated (Table 4). ||| L’ utilisation de Truvada n’ est pas recommandée chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) et chez les patients qui nécessitent une hémodialyse car les réductions des doses d’ emtricitabine et de ténofovir nécessaires chez ces patients ne peuvent être obtenues avec l’ association fixe (voir rubriques 4.2 et 5.2).
0.2615572512149811 ||| Patients taking medicinal products known to affect blood pressure or cardiac function should be closely monitored during treatment with clofarabine (see sections 4.4 and 4.8). ||| Patients with significant risk factors for serious GI events should be treated with piroxicam only after careful consideration (See sections 4.3 and below). ||| Les patients recevant des médicaments connus pour leurs effets sur la pression sanguine ou la fonction cardiaque devront faire l’ objet d’ une surveillance étroite au cours du traitement par clofarabine (voir rubriques 4.4 et 4.8).
0.45408421754837036 ||| Computerised reservation services for travel ||| Ticket procurement services for entertainment events ||| Services de réservations de voyages informatisés
0.3250972628593445 ||| In 1990, he joined the Pharmacy at the Biotechnology Working Party, involved in the generation of Directorate of the French Ministry of Health and in 1993 the many guidelines relating to biotechnology and biological products. ||| Between 1974 and 1996, he held posts in the UK Medicines Division and the Medicines Control Agency, including inspector of pharmaceutical manufacture, reviewer of dossiers and manager of the Biotechnology and Biological Unit. ||| Il a été le représentant britannique du groupe de travail "biotechnologie", impliqué dans la création de nombreuses lignes directrices liées à la biotechnologie et aux produits biologiques.
0.3153732419013977 ||| In the Phase III study in patients with previously untreated multiple myeloma, 27% of patients received prophylactic antivirals in the Vc+M+P arm. ||| In a small cohort of patients with rheumatoid arthritis, 280 patients received subsequent therapy with other DMARDs of whom 185 received a biologic DMARD following MabThera. ||| Dans l’ étude de phase III chez des patients atteints d’ un myélome multiple non traité au préalable, 27% des patients du bras Vc+M+P ont reçu une prophylaxie antivirale.
0.37249478697776794 ||| The clinical studies have been conducted in a patient population with a mean age > 65 years. ||| Optimark has been studied in children of 2 years and older with a similar safety profile as shown in the adult population. ||| Les études cliniques ont été menées dans des populations de patients dont l'âge moyen était supérieur à 65 ans.
0.28203514218330383 ||| 22 Relationship between concentration and effect Using a highly specific NK1-receptor tracer, positron emission tomography (PET) studies in healthy young men have shown that aprepitant penetrates into the brain and occupies NK1 receptors in a dose- and plasma- concentration-dependent manner. ||| Pharmacokinetic/ Pharmacodynamic (PK/ PD) relationship Similar to other beta-lactam antimicrobial agents, the time that the plasma concentration of ertapenem exceeds the MIC of the infecting organism has been shown to best correlate with efficacy in pre- clinical PK/ PD studies. ||| 23 Relation effet/dose A l’aide d’un traceur hautement spécifique du récepteur NK1, des études par tomographie par émission de positrons (TEP) menées auprès de jeunes hommes sains ont montré que l’aprépitant pénètre dans le cerveau et se lie aux récepteurs NK1 de façon dose- et concentrations plasmatiques dépendantes.
0.2739788889884949 ||| Pregabalin appears to be additive in the impairment of cognitive and gross motor function caused by oxycodone. ||| Metformin works mainly by inhibiting glucose production and reducing its absorption in the gut. ||| L'effet de la prégabaline semble s'additionner à celui de l'oxycodone sur l'altération de la fonction cognitive et motrice globale.
0.26175761222839355 ||| 128 If you forget to use Fertavid ||| 50 If you forget to inject Neulasta ||| Si vous oubliez d’ utiliser Fertavid
0.04567404091358185 ||| 110 Adult patients with chronic renal failure ||| 134 Adult patients with chronic renal failure ||| Adultes insuffisants rénaux chroniques
0.012384006753563881 ||| Also, you should know that patients under 18 have an increased risk of side effects, such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when they take this class of medicines. ||| Also, you should know that patients under 18 have an increased risk of side-effects such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when they take this class of medicines. ||| Il est également important de savoir que les patients de moins de 18 ans présentent un risque accru d’ effets indésirables, tels que tentative de suicide, pensées suicidaires et comportement hostile (principalement agressivité, comportement d’ opposition et colère) lorsqu’ ils sont traités par cette classe de médicaments.
0.08927170187234879 ||| The text in the harmonised SPC is not so dissimilar to the currently approved SPCs that it will significantly change clinical practices. ||| The text in the harmonised SPC is not so dissimilar to the currently approved SPCs that it will significantly change clinical practices Section 4.6. ||| Le texte du RCP harmonisé ne diffère pas des RCP actuellement approuvés au point de changer notablement les pratiques cliniques.
0.10625270009040833 ||| Monoclonal antibodies for scientific use ||| Monoclonal antibodies for industrial use ||| Anticorps monoclonaux à usage scientifique
4.3614374264921985e-13 ||| The following medicines are known to interact with Ciprofloxacin Bayer in your body. ||| The following medicines are known to interact with Ciprofloxacin Bayer in your body. ||| 388 Les médicaments suivants sont connus pour interagir avec Ciprofloxacine Bayer.
0.30994170904159546 ||| Concurrent administration of potentially nephrotoxic medicines should be avoided as there might be an increased risk of renal toxicity. ||| If necessary, more frequent blood sugar testing can help to identify mild hypoglycaemic episodes that might otherwise be overlooked. ||| L’ administration simultanée de substances potentiellement néphrotoxiques devrait être évitée car il y aurait un risque d’ augmentation de la toxicité rénale.
0.8081515431404114 ||| Altimeters ||| Applicant ||| Altimètres
0.16746066510677338 ||| You must not take Micardis if you are breast-feeding. ||| You must not take Pritor if you are breast-feeding. ||| Vous ne devez pas prendre Micardis si vous allaitez.
0.2662820816040039 ||| The efficacy of INOmax has been investigated in term and near-term newborns with hypoxic respiratory failure resulting from a variety of etiologies. ||| The use of antipsychotics during the last trimester of pregnancy has resulted in long term but reversible neurological disturbances of extrapyramidal nature in the infant. ||| L’ efficacité de INOmax a été étudiée chez les nouveau-nés à terme et chez des prématurés proches du terme présentant une détresse respiratoire hypoxémiante d’ étiologie diverse.
0.3632049560546875 ||| The effectiveness of ProteqFlu was studied in several studies under laboratory and field conditions. ||| Two studies were conducted to evaluate the efficacy and safety of TESAVEL monotherapy. ||| L’ efficacité de ProteqFlu a été étudiée au cours de plusieurs études dans des conditions de laboratoire et sur le terrain.
0.4041914939880371 ||| Common: febrile neutropenia, pancytopenia. ||| Pancytopenia, anaemia (grade 3-4), leukopenia ||| Fréquent: neutropénie fébrile, pancytopénie.
0.2824488878250122 ||| However, the second study showed that symptoms returned in 21% of the patients taking Thymanax over 24 weeks (34 out of 165), compared with 41% of the patients taking placebo (72 out of 174). ||| 28% of the patients taking Sifrol had symptoms (42 out of 151) compared with 51% of the patients taking levodopa (76 out of 150). ||| Toutefois, la seconde étude a montré que les symptômes réapparaissaient chez 21% des patients prenant Thymanax durant 24 semaines (34 sur 165), contre 41% des patients prenant le placebo (72 sur 174).
0.4141523838043213 ||| If the product accidentally gets into eyes, they should be thoroughly flushed with water. ||| If possible, do not wash these areas of skin for 4 hours after putting it on. ||| En cas de contact oculaire accidentel, rincer abondamment les yeux à l’eau.
0.41336169838905334 ||| Patients who had received 2 to 3 prior therapeutic regimens had a response rate of 32% (10/ 32) and patients who received greater than 7 prior therapeutic regimens had a response rate of 31% (21/ 67). ||| In Trial 4, the response was numerically similar for patients treated with doses of 6 to 9 g/ day, but there was no effect seen in patients treated with doses less than 6 g/ day. ||| 37 Les patients ayant reçu 2 à 3 lignes de traitements antérieurs ont présenté un taux de réponse de 32% (10/ 32), et les patients ayant reçu plus de 7 lignes de traitements antérieurs ont eu un taux de réponse de 31% (21/ 67).
0.27351808547973633 ||| If any of the side effects happens to you, ask your doctor for advice. ||| Please ask your doctor for advice when you experience any of the symptoms described below. ||| Si vous remarquez l’ un de ces effets indésirables, demandez conseil à votre médecin.
0.1723933219909668 ||| Consultancy services relating to food preparation ||| Consultancy services relating to nuclear engineering ||| Services de conseils concernant la préparation d'aliments
0.30146151781082153 ||| What EMEND looks like and contents of the pack The 40 mg hard capsule is opaque with a white body and mustard yellow cap with “464” and “40 mg” printed radially in black ink on the body. ||| Capsules are opaque with a white body and mustard yellow cap with “ 464” and “ 40 mg” printed radially in black ink on the body. ||| La gélule de 40 mg est opaque avec un corps blanc et une coiffe jaune moutarde, portant les mentions « 464 » et « 40 mg » imprimés radialement à l’encre noire sur le corps.
0.37226560711860657 ||| Effective application of EU rules: the Commission will continue to monitor closely the implementation of EU rules by Member States to ensure that national rules are in line with the highest possible standards. ||| MEPs called on the European Commission and the Council to make sure that all actions taken by member states are in line with EU values and treaties. ||| L'application effective des règles de l'UE: la Commission continuera à suivre de près la mise en œuvre des règles de l'UE par les États membres afin de s'assurer que les réglementations nationales obéissent aux normes les plus élevées.
0.21315331757068634 ||| 100 mg ||| 400 mg ||| 12.5mg
0.013590054586529732 ||| Mixtard 40 NovoLet 100 IU/ ml ||| Mixtard 50 NovoLet 100 IU/ ml ||| Mixtard 40 NovoLet 100 UI/ ml
0.1647825986146927 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €8 billion scheme enables Austria to compensate businesses of all sectors at least in part for the damages suffered due to the coronavirus outbreak. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The €150 million public support measure will enable Austria to partly compensate Austrian Airlines for the damage it directly suffered due to the travel restrictions implemented to limit the spread of the coronavirus. ||| Mme Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Ce régime d'un montant de 8 milliards d'euros permet à l'Autriche d'indemniser les entreprises de tous les secteurs, au moins en partie, pour les dommages subis en raison de la pandémie de COVID-19.
0.4575287103652954 ||| The patch should be pressed firmly in place for about 10 seconds, making sure there is good contact with the skin, especially around the edges. ||| One to eight hours later you will be placed on a special table and pictures will be taken with standard nuclear cameras to see where the infections are located. ||| Appuyer fermement sur le dispositif transdermique pendant environ 10 secondes afin de garantir un bon contact avec la peau, en particulier en périphérie.
0.00571068562567234 ||| 32 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 33 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 34 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.34600359201431274 ||| Medical check-ups Before you start taking Activelle, your doctor will inform you about the risks and benefits of the treatment (see also section 4, “Other side effects of combined HRT”). ||| Tell your doctor immediately about any new or unusual symptoms that you notice after stopping treatment (see “ If you stop taking Sebivo” in section 3 of this leaflet). ||| Bilans médicaux Avant de commencer à prendre Activelle, votre médecin vous informera des risques et bénéfices liés au traitement (voir aussi section 4 « Autres effets indésirables des THS »).
0.4575761556625366 ||| Ammonium carbonate ||| Magnesium carbonate ||| Carbonate d'ammonium
0.2970191240310669 ||| Due to the beta-adrenergic component, timolol, the same types of cardiovascular and pulmonary adverse reactions as seen with systemic beta-blockers may occur. ||| However, antibacterial soaps contain common antibacterial agents such as triclosan, which has an extensive list of resistant strains of organisms. ||| Etant donné que le timolol est un bêtabloquant, des effets indésirables cardio-vasculaires et pulmonaires, similaires à ceux rapportés avec les bêta-bloquants par voie générale, sont susceptibles de se produire.
3.577740317547984e-13 ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| Si vous constatez des effets indésirables ou d’ autres effets non mentionnés sur la notice, veuillez en informer votre vétérinaire.
7.675402197496184e-13 ||| 1 pre-filled syringe ||| 1 pre-filled syringe ||| 1 seringue pré- remplie
0.522722065448761 ||| Korean dominos (Glopae) ||| Korean playing cards (Hwatoo) ||| Dominos coréens [Glopae]
0.35914385318756104 ||| What is Daronrix? ||| What is Suboxone? ||| Qu’ est -ce que Daronrix?
0.0 ||| These effects are usually reversible. ||| These effects are usually reversible. ||| Ces effets sont habituellement réversibles.
0.33518195152282715 ||| He joined the EMEA in September 1997 and was appointed Head of Sector for new chemical substances in June 1998 and Head of Sector for orphan drugs and scientific advice in January 2001. ||| He joined the EMEA in June 1995, and was appointed Head of the Veterinary Unit in December of the same year and took on responsibility for information technology in January 2000. ||| Il a rejoint l’ EMEA en septembre 1997 et a été nommé chef du secteur des nouvelles substances chimiques en juin 1998 et chef du secteur des médicaments orphelins et des avis scientifiques en janvier 2001.
0.32992154359817505 ||| There were no toxicological findings observed of relevance to human therapeutic use. ||| There were no new or unexpected findings observed of relevance to human use. ||| Il n’ a pas été observé de données toxicologiques ayant une implication en thérapeutique humaine.
0.3615090250968933 ||| Medicinal Products for Veterinary Use ||| Committee for Veterinary Medicinal Products ||| Médicaments à usage vétérinaire
0.4590190052986145 ||| The ADRs reported in the two studies are summarised and categorised according to the MedDRA System organ class and frequency below. ||| In RA study V, structural joint damage was assessed radiographically and expressed as change in modified Total Sharp Score (see Table 6). ||| Les EI rapportés au cours des deux études sont résumés et présentés ci-dessous par classes de systèmes d’organes (terminologie MedDRA) et par fréquence.
0.0 ||| 191 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 191 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 212 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.30884939432144165 ||| Acticam contains meloxicam which belongs to a class of medicines having anti-inflammatory action. ||| Zerene belongs to a class of substances called benzodiazepine-related medicinal products, which consists of preparations with hypnotic actions. ||| Acticam contient du méloxicam qui appartient à la classe des médicaments anti- inflammatoires.
0.5186798572540283 ||| As with other vaccines your child may have some side effects. ||| These medicines may themselves cause side effects. ||| Comme avec tout médicament, votre enfant peut présenter des effets indésirables.
0.006037251092493534 ||| Marketing Authorisation Holder and Manufacturer Liprolog Mix25 100 U/ml Pen, suspension for injection is made by: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France, • Eli Lilly Italia S.p.A., Via A. ||| Marketing Authorisation Holder and Manufacturer Humalog Mix25 100 U/ml Pen, suspension for injection is made by: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France, • Eli Lilly Italia S.p.A., Via A. ||| Titulaire de l'Autorisation de mise sur le marché et fabricant Liprolog Mix25 100 UI/ml Pen, suspension injectable est fabriqué par: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim – France, • Eli Lilly Italia S.p. A., Via A.
0.12013217061758041 ||| The dosage should be determined on the basis of laboratory measurements of the protein C activity. ||| The dosage should be adjusted on the basis of laboratory measurements of antithrombin activity. ||| La posologie doit être basée sur les résultats du dosage de l’ activité en protéine C.
0.5988640785217285 ||| This task is performed in co-operation with all permanent CPMP working parties. ||| When appropriate, it liaises with other CPMP Working Parties. ||| Ce travail est réalisé en collaboration avec tous les groupes de travail permanents du CPMP.
0.5144062638282776 ||| The pandemic has caused the most significant disruption to the worldwide sporting calendar since the Second World War. ||| By 20 March, the pandemic had impacted education all over the world. ||| La pandémie a causé la plus importante interruption du calendrier sportif mondial depuis la Seconde Guerre mondiale.
0.37175190448760986 ||| Be sure to tell your doctor immediately if you are or may be pregnant or if you are breast- feeding a baby. ||| - Tell your doctor if you (or the child you are caring for) have or have had any serious illness. ||| N'oubliez pas d'avertir immédiatement votre médecin si vous êtes ou pensez être enceinte ou si vous allaitez un enfant.
0.3224385976791382 ||| The total time between reconstitution and completion of the infusion should not exceed 24 hours. ||| The absorption and elimination are complete approximately six to eight months after the last injection. ||| Le délai total entre la reconstitution et la fin de la perfusion ne doit pas dépasser 24 heures.
0.028512906283140182 ||| Januvia is used to treat patients with type 2 diabetes, to improve control of blood sugar levels. ||| Janumet is used to treat patients with type 2 diabetes, to improve control of blood sugar levels. ||| Januvia est utilisé dans le traitement des patients atteints de diabète de type 2, afin d’ améliorer le contrôle des taux de sucre dans le sang.
0.44370555877685547 ||| Vigabatrin should be gradually withdrawn under close medical supervision. ||| Complete resuspension should be ensured by mild agitation before use. ||| Le traitement par le vigabatrin doit être arrêté progressivement sous étroite surveillance médicale.
0.2679155170917511 ||| You should check with your doctor or pharmacist if you are not sure. lo Your weight Below 50 kg ||| You should check with your child’ s doctor or pharmacist if you are not sure. • To be taken by mouth ||| Si vous n’êtes pas sûr, vous devez vérifier auprès de votre médecin ou votre pharmacien. tn
0.25337424874305725 ||| The effect of renal and hepatic dysfunction on pharmacokinetics of tenecteplase in humans is not known. ||| Enterohepatic circulation may play a significant role in the pharmacokinetics of isotretinoin in man. ||| On ne connaît pas l'effet d'une atteinte hépatique ou rénale sur la pharmacocinétique du ténectéplase chez l'homme.
0.2624213993549347 ||| Irbesartan Hydrochlorothiazide BMS is contraindicated during breast-feeding. ||| Irbesartan Hydrochlorothiazide BMS is not indicated in patients with severe hepatic impairment. ||| Irbesartan Hydrochlorothiazide BMS est contre-indiqué pendant l'allaitement (voir rubrique 4.3).
0.29656606912612915 ||| Trizivir is indicated for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. ||| These medicines are used for treating human immunodeficiency virus (HIV) infection. ||| Trizivir est indiqué dans le traitement des patients adultes infectés par le Virus de l’ Immunodéficience Humaine (VIH).
0.27716195583343506 ||| After subcutaneous administration of difloxacin peak plasma levels of 1.4 -1.9 µg/ ml are achieved in 3.1 hours post dosing. ||| The mean elimination half-life of thalidomide in plasma following single oral doses between 50 mg and 400 mg was 5.5 to 7.3 hours. ||| Un pic plasmatique de 1,4 à 1,9 µg/ ml est observé 3,1 heures après injection sous-cutanée de difloxacine.
0.15585744380950928 ||| Oral aprepitant increased the AUC of midazolam 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was co-administered on Days 1 and 5 of a regimen of oral aprepitant 125 mg on Day 1 and 80 mg/ day on Days 2 to 5. ||| In another study with intravenous administration of midazolam, oral aprepitant was given as 125 mg on Day 1 and 80 mg/ day on Days 2 and 3, and midazolam 2 mg was given intravenously prior to the administration of the 3-day regimen of oral aprepitant and on Days 4, 8, and 15. ||| L'aprépitant oral a augmenté l’ ASC du midazolam de 2,3 fois à J1 et de 3,3 fois à J5, lorsqu’ une dose orale unique de 2 mg de midazolam a été associée à J1 et à J5 à 125 mg d’ aprépitant oral à J1 suivi de 80 mg/ jour de J2 à J5.
0.4818853735923767 ||| No, the objective of this pledging event is to speed up innovations and ensure access for all, irrespective of the geographical origin of funds. ||| The aim of this new, comprehensive approach is to shut down any remaining loopholes and remove any weak links in the EU's rules. ||| Non, l'objectif de cette conférence d'appel aux dons est d'accélérer les innovations et d'en garantir l'accès à tous, indépendamment de l'origine géographique des fonds.
0.28693994879722595 ||| 35 As with all insulins, in elderly patients and patients with hepatic or renal impairment, glucose monitoring should be intensified and dosage adjusted on an individual basis. ||| In pediatric patients suffering from renal impairment, the dose will have to be adjusted on an individual basis taking into account the renal clearance of the patient, his age and his body weight. ||| Comme pour toutes les insulines, chez les patients âgés et chez les patients ayant des troubles hépatiques ou rénaux, la surveillance glycémique doit être intensifiée et la posologie ajustée individuellement.
0.42030707001686096 ||| Do not swallow the desiccant contained in the foil wrapper. ||| Unabsorbed copper is then eliminated in the stool. ||| Ne pas avaler le dessicant contenu dans le suremballage en aluminium.
5.159698623219411e-13 ||| Common ||| Common ||| Toux
0.2694800794124603 ||| The recommended dose is 20 mg three times a day. ||| The recommended starting dose is 60 mg three times a day before meals. ||| La dose recommandée est de 20 mg trois fois par jour.
7.951686726605234e-13 ||| 4.1 ||| 4.1 ||| 4,1
0.2846267521381378 ||| Solaria for medical purposes ||| Fish oil for medical purposes ||| Solariums à usage médical
0.41211310029029846 ||| No clinical study safety data are available in patients below 6 years of age. ||| The pivotal clinical studies did not include children below 3 years old. ||| Aucune donnée de tolérance issue d’ une étude clinique n’ est disponible chez les patients de moins de 6 ans.
3.8065679623146276e-13 ||| The frequency of metformin adverse reactions identified from clinical trial and post- marketing data ||| The frequency of metformin adverse reactions identified from clinical trial and post- marketing data ||| Fréquences des effets indésirables de la metformine identifiés dans les essais cliniques et en post commercialisation
0.14442896842956543 ||| Powder Sodium chloride Calcium chloride dihydrate Glycylglycine Polysorbate 80 Mannitol Sucrose Methionine Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment) ||| Meglumine Glycine Ethanol (anhydrous) Poloxamer 188 Sodium Chloride Glycofurol Sodium Hydroxide (for pH adjustment) Hydrochloric Acid (for pH adjustment) Water for Injection ||| 58 Glycylglycine Polysorbate 80 Mannitol Saccharose Méthionine Acide chlorhydrique (pour l’ ajustement du pH) Hydroxyde de sodium (pour l’ ajustement du pH)
0.18825265765190125 ||| This means that it will start to lower your blood sugar about 4 hours after you take it, and the effect will last for approximately 28 hours. ||| This means that it will start to lower your blood sugar 10-20 minutes after you take it, have a maximum effect between 1 and 4 hours and the effect will last for up to 24 hours. ||| Ultratard est une insuline d’ action très longue, ce qui signifie qu’ il commence à faire baisser votre glycémie 4 heures environ après l’ administration et son effet dure environ 28 heures.
0.22709086537361145 ||| The total clearance of gemfibrozil is in the range 100 to 160 ml/ min, and the elimination half-life is in the range 1.3 to 1.5 hours. ||| The serum elimination half-life of filgrastim is approximately 3.5 hours, with a clearance rate of approximately 0.6 ml/ min/ kg. ||| La clairance totale du gemfibrozil est de l'ordre de 100 à 160 ml/mn et sa demi-vie d'élimination est de 1,3 à 1,5 heure.
0.03216731175780296 ||| The effects of AVAMYS were first tested in experimental models before being studied in humans. ||| The effects of NEVANAC were first tested in experimental models before being studied in humans. ||| Les effets d’ AVAMYS ont d’ abord été testés sur des modèles expérimentaux avant d’ être étudiés chez les humains.
0.2590051591396332 ||| Store in a refrigerator (2 °C – 8 °C). ||| Store in a refrigerator (2 °C – 8 °C) Do not freeze ||| A conserver au réfrigérateur (entre 2°C et 8°C).
0.02621719241142273 ||| A starting dose of 2.5-5 mg is recommended in such patients and the initiation of treatment should take place under medical supervision. ||| A starting dose of 2 mg is recommended in such patients and the initiation of treatment should take place under medical supervision. ||| Chez ces patients, il est recommandé de débuter le traitement à la dose de 2,5 à 5 mg/jour, sous surveillance médicale attentive.
0.1451370269060135 ||| Air conditioning installations for household purposes ||| Air conditioning installations for agricultural use ||| Installations de climatisation à usage domestique
0.352426677942276 ||| Fireplace shovels ||| Ship propellers ||| Pelles de cheminée
0.45445531606674194 ||| Fentanyl-ratiopharm should not be used during pregnancy and breast-feeding unless clearly necessary. ||| Pregnancy and breast-feeding Do not take Mycophenolate mofetil Teva if you are breast-feeding. ||| Il ne faut pas utiliser Fentanyl-ratiopharm pendant la grossesse et l’ allaitement, sauf nécessité impérieuse.
0.2638985514640808 ||| Insulatard is given subcutaneously (under the skin) by injection, usually in the thigh. ||| Nespo is injected intravenously (into a vein) or subcutaneously (under the skin). ||| Insulatard est administré par voie sous-cutanée (sous la peau), par une injection généralement effectuée dans la cuisse.
0.5425170660018921 ||| Frequency modulators ||| Radio-frequency filters ||| Modulateurs de fréquences
0.2845667600631714 ||| Since nelfinavir is highly protein bound, dialysis is unlikely to significantly remove it from blood. ||| Because rotigotine is over 90% protein bound, dialysis would not be expected to be beneficial. ||| Le nelfinavir se liant fortement aux protéines, il est peu probable qu’une dialyse puisse significativement l’éliminer du sang.
0.36496254801750183 ||| All changes were considered to be caused by the pharmacological action of valsartan which produces prolonged hypotension, particularly in marmosets. ||| However, paclitaxel belongs to a class of substances which are potentially carcinogenic based on their mechanism of action. ||| On a jugé que toutes ces altérations résultaient de l’activité pharmacologique du valsartan, qui produit une hypotension prolongée, particulièrement chez le ouistiti.
0.3095172643661499 ||| The pre-filled syringe does not contain any preservative and is to be used for one single injection only. ||| If the powder is reconstituted with water for injections, then the vial is for single use only. ||| La seringue préremplie ne contient aucun conservateur et doit être utilisée en une seule injection.
0.013846426270902157 ||| During the marketing of Neoclarityn, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) and rash have been reported very rarely. ||| During the marketing of Azomyr, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) and rash have been reported very rarely. ||| Depuis la commercialisation de Neoclarityn, des cas de réactions allergiques sévères (avec gêne respiratoire, sifflements bronchiques, démangeaisons, plaques d'urticaire et gonflements) et d’ éruption cutanée ont été très rarement rapportés.
0.0 ||| The cause and long-term health effects of these conditions are not known at this time. ||| The cause and long-term health effects of these conditions are not known at this time. ||| Les causes de ces modifications, ainsi que leurs répercussions à long terme sur la santé, ne sont à ce jour pas connues.
0.2784273326396942 ||| Soundproof cabins [structures] made of metal ||| Fireproof cabinets of metal [other than furniture] ||| Cabines insonorisées en métal [structures]
0.18687808513641357 ||| HOW TO STORE CRIXIVAN ||| HOW TO STORE TRITAZIDE ||| COMMENT CONSERVER CRIXIVAN
0.3330199420452118 ||| This is thought to result from the combined effects of nitrates and tadalafil on the nitric oxide/ cGMP pathway. ||| Due to this mode of action, cetrorelix controls the secretion of gonadotropins (LH and FSH). ||| Cela résulterait des effets conjugués des dérivés nitrés et du tadalafil sur la voie monoxyde d’ azote / GMPc.
0.3092155158519745 ||| No specific studies have been performed to evaluate the hepatic, renal, lung, or gastrointestinal routes of excretion/elimination for Soliris. ||| As very few data on the safety of carglumic acid are available, systematic surveillance of liver, renal, cardiac functions and haematological parameters is recommended. ||| Élimination: aucune étude spécifique n’ a été réalisée afin d’ évaluer les voies d’ excrétion/ élimination hépatique, rénale, pulmonaire ou gastro-intestinale de Soliris.
0.07097290456295013 ||| Levitra is not indicated for individuals below 18 years of age. ||| VIAGRA is not indicated for individuals below 18 years of age. ||| Levitra n'est pas indiqué chez les personnes de moins de 18 ans.
0.0 ||| The onset of the adverse event occurred after the sixth or greater dose in only 22 of these reports (15 after the sixth dose, 6 after the seventh doses and 1 after the eight dose). ||| The onset of the adverse event occurred after the sixth or greater dose in only 22 of these reports (15 after the sixth dose, 6 after the seventh doses and 1 after the eight dose). ||| Le début des effets indésirables est survenu après la sixième injection ou les suivantes dans simplement 22 de cas rapportés (15 après la sixième injection, 6 après la septième et 1 après la huitième).
0.6799209117889404 ||| - Avoid introduction of contamination. ||| - reporting of suspicious transactions, ||| - Eviter l’ introduction d’ une contamination.
0.5101750493049622 ||| Pancreatitis* Ischaemic colitus*, ulcerative colitus* Periodontal disorder, dental disorder ||| • Occult blood loss • Hyperparathyroidism/ Osteitis fibrosa cystica ed ||| Pancréatite* Colite ischémique*, colite ulcéreuse* Trouble parodontique, trouble dentaire
0.2528679668903351 ||| Pack sizes of 1 or 3. ||| Pack size of 1 or 12. ||| Boîtes de 1 ou 3.
0.44664984941482544 ||| Despite proof that the dust associated with asbestos mining and milling causes asbestos-related disease, mining began at Wittenoom in 1943 and continued until 1966. ||| In 1960, an article published by Wagner et al. was seminal in establishing mesothelioma as a disease arising from exposure to asbestos. ||| En dépit de la preuve que la poussière associée à l'exploitation de la mine d’amiante et au broyage des fibres était bien la cause des maladies liées à l’amiante, l'extraction commencée à Wittenoom en 1943 a continué jusqu'en 1966.
0.19506172835826874 ||| In standard fertility studies in female rats (dosing for 2 weeks prior to mating) there was abnormal oestrous cyclicity and a decrease in corpora lutea and fertility index at doses of rimonabant that induced maternal toxicity (30 and 60 mg/ kg/ day). ||| GHB had no effect on mating, general fertility or sperm parameters and did not produce embryo-foetal toxicity in rats exposed to up 1000 mg/ kg/ day GHB (1.64 times the human exposure calculated in nonpregnant animals). ||| lus précédant l’accouplement) des anomalies du cycle ovarien, une diminution des corps lutéaux et de l’index de fertilité ont été observées aux doses de rimonabant induisant une toxicité maternelle (30 et 60 mg/kg/jour).
0.2550640106201172 ||| Use of these medicines soon after the discontinuation of natalizumab may lead to an additive immunosuppressive effect. ||| Intravenous administration of calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. ||| L’ utilisation de ces médicaments peu après l’ arrêt du natalizumab peut conduire à un effet immunosuppresseur additif.
0.3191320598125458 ||| The response to treatment and renal function should be closely monitored in all patients with some degree of renal insufficiency) (see also sections 4.4 and 5.2). ||| The benefit of moxifloxacin treatment especially in infections with a low degree of severity should be balanced with the information contained in the warnings and precautions section. ||| La réponse au traitement et la fonction rénale doivent être étroitement surveillées chez tous les patients présentant une insuffisance rénale (voir aussi rubriques 4.4 et 5.2).
0.37021225690841675 ||| 5 x 5 pack: contains 5 vials of parecoxib 20 mg and 5 ampoule with 1 ml sodium chloride 9 mg/ ml (0.9%) solution. ||| 1 vial with 250 IU octocog alfa, 1 vial with 5 ml sterilised water for injections, 1 BAXJECT II device. ||| Conditionnement 5 x 5: contient 5 flacons de 20 mg de parécoxib et 5 ampoules de 1 ml de solution de chlorure de sodium à 9 mg/ ml (0,9%).
0.2114945948123932 ||| Nobilis Influenza H5N2 Emulsion for injection ||| Nobilis Influenza H5N2 emulsion for injection for chickens ||| Nobilis Influenza H5N2 Emulsion pour injection.
0.25189724564552307 ||| If you notice any side effects, please inform your doctor or pharmacist. ||| If you have any liver problems, tell your doctor or pharmacist. ||| Si vous remarquez des effets indésirables, veuillez en informer votre médecin ou votre pharmacien.
0.3506990075111389 ||| No dose reductionsare recommended, but delay or discontinuation of TMZ administration should be decided weekly according to haematological and non-haematological toxicity criteria. ||| NovoSeven is not expected to precipitate haemorrhage, but pre-existing haemorrhage may continue in case of insufficient efficacy or sub-optimal dosage regimen. ||| Aucune réduction de dose n’ est recommandée, mais le report ou l’ interruption de l’ administration de TMZ doit être décidé de manière hebdomadaire selon des critères de toxicité hématologique et non hématologique.
0.601050853729248 ||| 41 CONDITIONS OF THE MARKETING AUTHORISATION ||| 60 INFORMATION FOR THE HEALTHCARE PROFESSIONAL ||| 45 CONDITIONS DE L’ AUTORISATION DE MISE SUR LE MARCHÉ
0.32513925433158875 ||| 6 The table 1 shows the number (%) of patients experiencing bleeding events during the treatment period in the VTE prevention in the two pivotal clinical trials, according to dose. ||| 6 Of the 9 patients in the weekly treatment group with abnormally large spleens at baseline, 3 had spleen volumes that normalized by the end of the study. ||| Le tableau 1 donne le nombre (%) de patients ayant présenté des événements hémorragiques au cours de la période de traitement en fonction de la dose, lors des deux essais cliniques pivots menés dans la prévention des ETEV.
0.5595088005065918 ||| Water supplying ||| Water well drilling ||| Adduction d'eau
0.032568395137786865 ||| Viraferon is a sterile, stable, formulation of highly purified interferon alfa-2b produced by recombinant DNA uc ||| Viraferon is a sterile, stable, formulation of highly purified interferon alfa-2b produced by recombinant DNA t ||| isé Viraferon est une forme stérile, stable d'interféron alfa-2b hautement purifié, obtenu par les techniques de l’ ADN recombinant.
0.06472066044807434 ||| When compared separately to ibuprofen and naproxen, the HR were 0.94 [95% CI 0.44-2.04] p=0.8842 and 1.49 [95% CI 0.76-2.92] p=0.2417, respectively. ||| When compared separately to ibuprofen and naproxen, the HR were 0.47 [95% CI 0.04-5.14] p=0.5328 and 1.36 [95% CI 0.47-3.93] p=0.5658, respectively. ||| Comparé séparément à l’ ibuprofène et au naproxène, le HR a été respectivement de 0,94 [IC 95% 0,44- 2,04] p = 0,8842 et de 1,49 [IC 95% 0,76-2,92] p = 0,2417.
0.2684714198112488 ||| If you are given a medicine that might cause damage to the liver or to the muscles (rhabdomyolysis), you may need to be closely monitored when using Yondelis together with this medicine, as there could be an increased risk of damage. ||| The dose of TOVIAZ must be adjusted, or the medicine not used, in patients with problems with their kidneys or liver, especially when they are also receiving at the same time other medicines that may affect the way TOVIAZ is broken down in the body. ||| Si vous recevez un médicament qui peut provoquer des lésions du foie ou des muscles (rhabdomyolyse), le médecin vous surveillera étroitement pendant l’ utilisation simultanée de Yondelis et de ce médicament, car le risque de lésions peut augmenter.
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| 53 Si vous ressentez un des effets mentionnés comme grave ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.5074495673179626 ||| The treatment duration of Candida infection should be a minimum of 14 days. ||| In this case, the duration of a cycle is 6 weeks. ||| Candidose invasive: la durée du traitement de l’ infection à Candida doit être au moins de 14 jours.
0.3088752031326294 ||| Renal impairment in elderly patients is frequent and asymptomatic. ||| Somnolence, peripheral oedema and asthenia may be more frequent in elderly patients. ||| Chez les patients âgés, la survenue d'une insuffisance rénale est fréquente et asymptomatique.
0.17935648560523987 ||| AVANDAMET 2 mg/ 500 mg film-coated tablets rosiglitazone/ metformin HCl ||| Janumet 50 mg/ 1,000 mg film-coated tablets sitagliptin/ metformin hydrochloride ||| AVANDAMET 2 mg/ 500 mg comprimés pelliculés rosiglitazone/ metformine HCl
0.3939284682273865 ||| Real estate management services relating to commercial buildings ||| Building services relating to building for habitation ||| Services de gérance immobilière en matière d'immeubles commerciaux
0.023225843906402588 ||| The vaccine should not be used after the expiry date which is stated on the syringe label and the outer carton (after EXP). ||| The vaccine should not be used after the expiry date which is stated on the vial label and the outer carton (after EXP). ||| Ne pas utiliser Silgard après la date de péremption mentionnée sur l’étiquette de la seringue et de l'emballage extérieur (après EXP).
0.5264809131622314 ||| Be sure to read the Package Leaflet for interferon alfa -2b before you begin treatment with Rebetol and interferon alfa-2b. ||| Thalidomide Celgene is prescribed and dispensed according to the Thalidomide Celgene Pregnancy Prevention Programme (see section 4.4). ||| Assurez -vous de lire la notice de l’ interféron alfa-2b avant de commencer le traitement avec Rebetol en association avec l’ interféron alfa-2b.
0.06326211988925934 ||| However, this does not preclude the occurrence of hepatic events in patients with cirrhosis (including hepatocarcinoma). ||| However, this does not preclude the occurrence of hepatic events in patients with cirrhosis (including hepatocarcinoma). rod ||| Cependant, cela n’ exclut pas l’ évolution de la maladie hépatique (y compris vers un hépatocarcinome) chez les patients porteurs d’ une cirrhose.
0.11867070198059082 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Zonegran to Eisai Limited on 10 March 2005. ||| The European Commission granted a marketing authorisation valid throughout the European Union to Actelion Registration Ltd on 15 May 2002. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Zonegran à Eisai Limited, le 10 mars 2005.
0.2979181408882141 ||| The active substance in AZILECT, rasagiline, is a monoamine oxidase-B inhibitor. ||| The active substance in KOGENATE Bayer, octocog alfa, is a blood coagulation factor protein. ||| Le principe actif d’ AZILECT, la rasagiline, est un inhibiteur de la monoamine oxydase B.
0.3188548684120178 ||| In study 3, the ACR20 response in patients treated with rituximab alone was 65% compared with 38% on methotrexate alone (p=0.025). ||| Regression to normoalbuminuria (< 30 mg/ day) was more frequent in the Karvea 300 mg group (34%) than in the placebo group (21%). ||| 25 Dans l’ étude 3, la réponse ACR20 des patients traités par le rituximab seul était de 65%, contre 38% sous méthotrexate seul (p = 0,025).
0.0 ||| Peripheral oedema ||| Peripheral oedema ||| Œ dème périphérique
0.43159162998199463 ||| The dosing recommendations for paediatric patients are the same as for adult patients. ||| Please refer to the table below for the dosing recommendations in paediatric patients. ||| Les recommandations sur la posologie chez l’ enfant sont les mêmes que chez l’ adulte.
0.0942843034863472 ||| 11 The prospective randomised (UKPDS) study has established the long-term benefit of intensive blood glucose control in type 2 diabetes. ||| The prospective randomised (UKPDS) study has established the long -term benefit of intensive blood glucose control in type 2 di abetes. ||| L’ étude prospective randomisée UKPDS a démontré le bénéfice à long terme d’ un contrôle glycémique intensif chez les patients diabétiques de type 2.
0.023057688027620316 ||| For the full list of all side effects reported with Tekturna, see the Package Leaflet. ||| For the full list of all side effects reported with Neulasta, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de Tekturna, voir la notice.
0.4808773100376129 ||| Ionic water generators ||| Nuclear generators ||| Générateurs d'eau ionisée
0.0038373044226318598 ||| 30 Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced by 25 to 50% in order to maintain haemoglobin at that level. ||| 95 Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced by 25 to 50% in order to maintain haemoglobin at that level. ||| Lorsque l’ objectif thérapeutique pour un patient donné est atteint, la dose devra être réduite de 25 à 50% afin de maintenir le taux d’ hémoglobine à ce niveau.
0.2689377963542938 ||| The usual dose is one 6 mg subcutaneous injection (injection under your skin) using a pre-filled syringe and it should be given approximately 24 hours after your last dose of chemotherapy at the end of each chemotherapy cycle. ||| Elaprase is administered at a dose of 0.5 mg/ kg body weight every week by intravenous infusion over a 3 hour period, which may be gradually reduced to 1 hour if no infusion-associated reactions are observed (see section 4.4). ||| La dose habituelle est une injection de 6 mg par voie sous-cutanée (injection sous la peau) avec une seringue préremplie, administrée environ 24 heures après votre dernière dose de chimiothérapie à la fin de chacun des cycles.
0.0 ||| Long-term carcinogenicity studies have not been performed. ||| Long-term carcinogenicity studies have not been performed. ||| Aucune étude de cancérogénicité à long terme n’ a été réalisée.
0.2564530372619629 ||| In contrast, the mechanisms by which lamotrigine exerts its therapeutic action in bipolar disorder have not been established, although interaction with voltage gated sodium channels is likely to be important. ||| It is accepted there are also other ways in which spironolactone works on the heart and blood vessels in congestive heart failure (although these mechanisms of action have not yet been fully demonstrated in dogs). ||| A l’ inverse, les mécanismes par lesquels la lamotrigine exerce son action thérapeutique sur les troubles bipolaires n’ ont pas été établis, bien que les interactions canaux sodium voltage-dépendants soient probablement importantes.
0.31904691457748413 ||| Discontinuation of Humira therapy should be considered in patients with confirmed significant haematologic abnormalities. ||| Pre-existing neuropathies resulting from prior therapies are not a contraindication for paclitaxel therapy. ||| L'arrêt du traitement par Humira devra être envisagé pour les patients chez qui des anomalies sanguines significatives seront confirmées.
0.3331605792045593 ||| If you are currently taking any of these medicines, ask your doctor about switching to a different medicine while you are taking Norvir. ||| If you are following a diabetic diet, you should continue with this while you are taking Actos 45mg tablets. ||| Si vous prenez actuellement un de ces médicaments, demandez à votre médecin si vous pouvez changer pour un autre médicament pendant votre traitement par Norvir.
0.3294636905193329 ||| 1 pre-filled syringe contains 30 micrograms of methoxy polyethylene glycol-epoetin beta. ||| The active substance is a covalent conjugate of recombinant interferon alfa-2b* with monomethoxy polyethylene glycol. ||| Une seringue préremplie contient 30 microgrammes de méthoxy polyéthylène glycol-epoetin beta.
0.2833547592163086 ||| In clinical trials in short children/ adolescents born SGA doses of 0.033 and 0.067 mg somatropin/ kg body weight per day have been used for treatment until final height is reached. ||| Rats developed hepatocellular and thyroid follicular cell adenomas at > 2-times the daily human dose [90 mg] based on systemic exposure when dosed daily for approximately two years. ||| Lors d’ études cliniques sur des enfants/ adolescents nés petits pour l’ âge gestationnel, les dosages de 0,033 et 0,067 mg/ kg/ jour ont été utilisés jusqu’ à la taille finale.
0.356553852558136 ||| Following the approval by the Commission of a guarantee scheme on 3 April and a loan and guarantee scheme on 8 April , Poland notified to the Commission a new scheme to support companies affected by the coronavirus outbreak under the Temporary Framework. ||| The Parliament's green light follows the swift approval by EU Member States in the Council for the majority of these initiatives; the CRII+ Initiative and the postponing of the Medical Devices Regulation still require approval by the Council. ||| À la suite de l'autorisation, par la Commission d'un régime de garanties le 3 avril dernier, et d'un régime de prêts et de garanties le 8 avril dernier, la Pologne a notifié à la Commission un nouveau régime au titre de l'encadrement temporaire, destiné à soutenir les entreprises touchées par la pandémie de coronavirus.
0.02356155961751938 ||| Liprolog Mix50 100 U/ ml KwikPen suspension for injection 50% insulin lispro and 50% insulin lispro protamine suspension Subcutaneous use ||| Liprolog Mix50 100 U/ ml Pen suspension for injection 50% insulin lispro and 50% insulin lispro protamine suspension Subcutaneous use ||| Liprolog Mix50 100 UI/ml KwikPen, suspension injectable Insuline lispro 50% et insuline lispro protamine en suspension 50% Voie sous-cutanée.
0.2841242551803589 ||| Alendronate Hypocalcaemia, hypophosphataemia and upper gastrointestinal adverse reactions, such as upset stomach, heartburn, oesophagitis, gastritis, or ulcer, may result from oral overdose. ||| Possible systemic effects include Cushing’ s syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma. ||| Alendronate Une hypocalcémie, une hypophosphorémie et des effets indésirables de la partie haute du tractus gastro-intestinal, tels que mauvaise digestion, brûlures d'estomac, œ sophagite, gastrite, ou ulcère, peuvent se produire en cas de surdosage par voie orale.
7.130799314740421e-13 ||| Fever ||| Fever ||| fièvre
0.05748824030160904 ||| Karvea 75 mg tablets. ||| Karvea 300 mg tablets. ||| Karvea 75 mg comprimés.
0.5811192989349365 ||| 16 (8, 26) 43 (35, 52) 20 (12, 31) 39 (28, 50) 44 (32, 56) ||| 62 (53, 69) 82 (77, 86) 61 (53, 69) 80 (73, 85) 83 (76, 89) ||| 16 (8; 26) 43 (35; 52) 20 (12; 31) 39 (28; 50) 44 (32; 56)
0.5506702661514282 ||| No other metabolites have been detected. ||| Five metabolites have been identified in man. ||| Aucun autre métabolite n'a été mis en évidence.
0.5829782485961914 ||| It makes long-term finance available for sound investments in order to contribute towards EU policy goals. ||| It will help such companies at this critical time and get back to a sustainable and profitable business track. ||| Elle met à disposition des financements à long terme pour des investissements de qualité qui contribuent à la réalisation des grands objectifs de l'UE.
0.265514999628067 ||| Preliminary evidence from a small number of patients treated concomitantly with filgrastim and 5-Fluorouracil indicates that the severity of neutropenia may be exacerbated. ||| In the majority of patients (8/ 10), the pericardial effusion and pericarditis were deemed to be asymptomatic and of little or no clinical significance on echocardiographic assessment. ||| En cas de traitement concomitant par le filgrastim et le 5-fluorouracile, des données préliminaires observées chez un petit nombre de patients indiquent une augmentation possible de la sévérité de la neutropénie.
0.5387901067733765 ||| To this end, the Commission will work closely with all relevant stakeholders in the financial sector to support their role and engagement and to draw up a list of best practices. ||| The Commission has today updated its advice to consumers and has called on platforms to remain vigilant and continue with their efforts to give regular feedback to the Commission and consumer authorities. ||| À cette fin, la Commission travaillera en étroite collaboration avec tous les acteurs concernés du secteur financier pour les aider à jouer leur rôle et à rester engagés, et pour établir une liste des meilleures pratiques.
0.4146958887577057 ||| Worm repellents for use on turf or grass ||| Manures for use on grass or grassland ||| Répulsifs pour vers pour gazon ou pelouse
0.48997262120246887 ||| The EU's collective action will focus on addressing the immediate health crisis and resulting humanitarian needs, strengthening partner countries' health, water and sanitation systems and their research and preparedness capacities to deal with the pandemic, as well as mitigating the socioeconomic impact. ||| Empowering citizens, raising citizens awareness and increasing societal resilience implies enabling citizens to participate in the democratic debate by preserving access to information and freedom of expression, promoting citizens' media and information literacy, including critical thinking and digital skills. ||| L'action collective de l'UE visera principalement à répondre à la crise sanitaire actuelle et aux besoins humanitaires qui en découlent, à renforcer les systèmes de santé, d'approvisionnement en eau et d'assainissement des pays partenaires, ainsi que les capacités de recherche et de préparation de ces pays face à la pandémie, et à atténuer les conséquences socio-économiques de la crise.
0.1915999948978424 ||| 86 ||| 89 ||| 92
0.8421933054924011 ||| Improving the level playing field and protecting EU business and citizens ||| Protecting our economy and people with all available means ||| Améliorer les conditions de concurrence et protéger les entreprises et les populations de l'Union
0.46346670389175415 ||| 8, sector 1 RO-013682 Bucureşti Tel. + 40 21 233 35 30 ||| 8С, ет .7София 1766 Teл.: + 359 2 489 19 50 ||| 8, sector 1 RO-013682 Bucureş ti Tel: + 40 21 233 35 30
0.40623217821121216 ||| Available evidence on reteplase does not indicate an antibody-mediated origin of these hypersensitivity reactions. ||| Data suggest a dose-response relationship between unopposed-CEE and risk of hyperplasia. ||| Les données disponibles sur retéplase n'indiquent pas que le mécanisme de ces réactions d'hypersensibilité soit médié par la formation d'anticorps.
0.29140669107437134 ||| Do not use Fuzeon if you notice any particles in the powder or the solution once the water for injections has been added. ||| If there are particles in the injection solution or if either the powder or solution is discoloured, the solution will not be used. ||| N’utilisez pas Fuzeon si vous remarquez des amas dans la poudre ou dans la solution après avoir ajouté l'eau pour préparations injectables.
0.24430783092975616 ||| MabCampath 30 mg/ ml concentrate for solution for infusion Alemtuzumab Intravenous use ||| Flebogammadif 50 mg/ ml solution for infusion Human normal immunoglobulin For intravenous use ||| MabCampath 30 mg/ml solution à diluer pour perfusion Alemtuzumab Utilisation intraveineuse
3.5806297163376577e-13 ||| It is advisable to test your blood sugar immediately after taking glucose to check that you really have hypoglycaemia. ||| It is advisable to test your blood sugar immediately after taking glucose to check that you really have hypoglycaemia. ||| Il est recomman dé de vérifier votre glycémie immédiatement après avoir pris du sucre, pour confirmer que vous avez réellement une hypoglycémie.
0.37762218713760376 ||| In patients with HT-1, these intermediates are converted to the toxic metabolites succinylacetone and succinylacetoacetate. ||| Calcium folinate is also recognised as antidote to the folic acid antagonists trimetrexate, trimethoprime, and pyrimethamine. ||| Chez les patients avec HT-1, ces produits intermédiaires sont réduits en deux métabolites toxiques, la succinylacétone et le succinylacétoacétate.
0.2843092679977417 ||| The following substances may increase insulin requirement: ||| lon The following substances may increase insulin requirement: ||| Les substances suivantes peuvent augmenter les besoins en insuline:
0.15012967586517334 ||| You should tell your doctor immediately if you experience any of these symptoms. ||| Tell your doctor immediately if you experience any of these side effects. ||| Informez immédiatement votre médecin si vous présentez l’un de ces symptômes.
0.32640355825424194 ||| Commercial information agency services ||| Commercial information research studies ||| Services d'agences d'informations commerciales
0.576499342918396 ||| P- glycoprotein inducers: ||| Anticonvulsant active substances: ||| Inducteurs de la P-glycoprotéine:
0.2976640462875366 ||| If you stop using KOGENATE Bayer 250 IU Do not stop using KOGENATE Bayer 250 IU without consulting your doctor. ||| If you stop using Helixate NexGen 1000 IU Do not stop using Helixate NexGen 1000 IU without consulting your doctor. ||| Si vous arrêtez de prendre KOGENATE Bayer 250 UI Ne pas arrêter d’ utiliser KOGENATE Bayer 250 UI, sans avoir consulter votre médecin
0.07095393538475037 ||| What is the risk associated with Mirapexin? ||| What is the risk associated with Zenapax? ||| Quel est le risque associé à l’ utilisation de Mirapexin?
0.29733818769454956 ||| • if you get a rash all over your body, shortness of breath, wheezing, fast pulse or sweating after your Kineret injection. ||| Common: nausea/ vomiting, abnormal urination, fatigue and dizziness (including when getting up from a lying or sitting position). ||| • en cas d’éruption cutanée généralisée, d’essoufflement, de difficultés respiratoires, d’accélération du pouls ou de sueurs après l’injection de Kineret.
0.38493677973747253 ||| Depending on the evolution of tasks, the Directorate, together with Heads of Unit, will consider the need to adapt the organisation or resources of each sector, and also the need to create new sectors. ||| To comply with the growing needs of the Agency, as well as to take on the specific tasks of the Technical Co-ordination Unit, two recruitment competitions were organised to identify new staff for positions in each of the four sectors. ||| En fonction de l’ évolution des tâches, la direction, avec les chefs d’ unité, se penchera sur la nécessité d’ adapter l’ organisation ou les ressources de chaque secteur et d’ en créer de nouveaux.
0.023877466097474098 ||| In particular, (i) the underlying loan amount per company is linked to cover its liquidity needs for the foreseeable future, (ii) the guarantees will only be provided until the end of this year, (iii) the guarantees are limited to a maximum six-year duration, and (iv) companies pay guarantee premiums as set out in the Temporary Framework. ||| In particular: (i) the underlying loan amount per company is linked to cover its liquidity needs for the foreseeable future, (ii) the guarantees will only be provided until the end of this year, (iii) the guarantees are limited to a maximum of six years, and (iv) guarantee fee premiums do not exceed the levels foreseen by the Temporary Framework. ||| En particulier, i) le montant de prêt sous-jacent par entreprise est lié au montant nécessaire pour couvrir les besoins de liquidités de celle-ci dans un avenir prévisible, ii) les garanties ne seront octroyées que jusqu'à la fin de cette année, iii) les garanties ont une durée maximale de six ans et iv) les entreprises verseront les primes de garantie comme prévu dans l'encadrement temporaire.
0.34253406524658203 ||| 7 However, also following either of the washout procedures, verification by 2 separate tests at an interval of at least 14 days and a waiting period of one-and-a-half months between the first occurrence of a plasma concentration below 0.02 mg/ l and fertilisation is required. ||| Liver function tests should be performed in all patients: at initiation of treatment, and then periodically after around six weeks (end of acute phase), twelve weeks and twenty four weeks (end of maintenance phase) and thereafter when clinically indicated (see also section 4.4). ||| Quelle que soit la procédure, on contrôlera les taux plasmatiques à deux reprises à un intervalle d’ au moins 14 jours et on respectera une période d’ attente d’ un mois et demi entre le 1er taux inférieur à 0,02 mg/ l et la grossesse.
0.38772374391555786 ||| Snow sledges for transportation ||| Sole coverings for skis ||| Traîneaux pour le transport
0.15902237594127655 ||| Casement bolts (Non-metallic -) ||| Drawer sliders (Non-metallic -) ||| Crémones non métalliques
0.7852291464805603 ||| Each one lasts 28 days. ||| He took this for 21 days. ||| Chacune d’elles dure 28 jours.
0.2061898410320282 ||| Patients should be advised that antiretroviral therapies, including emtricitabine, have not been proven to prevent the risk of transmission of HIV to others through sexual contact or blood contamination. ||| Patients should be advised that current antiretroviral therapy does not cure HIV and has not been proven to prevent the transmission of HIV to others through blood or sexual contact. ||| Les patients devront être informés qu’ il n’ a pas été prouvé que les traitements antirétroviraux, y compris l’ emtricitabine, préviennent le risque de transmission du virus VIH par contacts sexuels ou par contamination sanguine.
0.24949531257152557 ||| EU/ 1/ 03/ 259/ 003,004 ||| EU/ 1/ 05/ 327/014 ed ||| EU/ 1/ 03/ 259/ 003, 004
0.3805885314941406 ||| The usual starting dose is 10-20 mg/ day given as a single dose in the evening. ||| The usual dose is one 20 mg tablet to be taken once daily in the ina ||| La dose initiale usuelle est de 10 à 20 mg/jour administrée en une prise unique le soir.
0.29615917801856995 ||| Locking pins of metal ||| Striking plates of metal for locks ||| Goupilles en métal
5.622730471326054e-13 ||| ris EPAR summary for the public ||| ris EPAR summary for the public ||| Résumé de l’ EPAR à l’ intention du public
0.3566686511039734 ||| tho Telithromycin, and its principal human metabolites, were negative in tests on genotoxic potential in vitro and in vivo. ||| Telithromycin, but not its major human metabolites, had inhibitory activity on HERG and Kv1.5 channels. ||| Aucun potentiel génotoxique n’ a été observé sur la télithromycine et ses métabolites.
0.1858634352684021 ||| Depending on clinical response, the dosage may be increased to 8 mg doxazosin once daily. ||| If necessary, the dosage may be increased to 8 mg doxazosin once daily. ||| Selon la réponse clinique obtenue, la posologie peut être accrue à hauteur de 8 mg de doxazosine en une prise quotidienne.
0.0 ||| 2001 ||| 2001 ||| 2003
0.27314192056655884 ||| The hypoglycaemia may in general be accompanied by neurological symptoms like restlessness, tremor, visual disturbances, coordination problems, sleepiness, coma and convulsions. ||| The patient experienced central nervous system symptoms such as restlessness, psychosis, visual hallucinations, proconvulsiveness, somnolence, stupor, and unconsciousness. ||| L’ hypoglycémie peut généralement s’ accompagner de symptômes neurologiques tels qu’ agitation, tremblements, troubles visuels, problèmes de coordination, somnolence, coma et convulsions.
0.25479501485824585 ||| Do not use the preparation if foreign particulate matter is present. ||| Do not use if discolouration or particulate matter is present. ||| Ne pas utiliser la préparation en cas de présence de particules étrangères.
0.009142570197582245 ||| Each film-coated tablet contains 500 mg levetiracetam. ||| Each film-coated tablet contains 1,000 mg levetiracetam. ||| Chaque comprimé pelliculé contient 500 mg de lévétiracétam
2.4566381372735646e-13 ||| Measles virus Enders’ Edmonston strain..................................... ≥ 3.00 log10 CCID50* Mumps virus Jeryl Lynn™ (Level B) strain................................ ≥ 4.30 log10 CCID50* Rubella virus Wistar RA 27/ 3 strain............................................ ≥ 3.00 log10 CCID50* Varicella virus Oka/ Merck strain................................................ .≥ 3.99 log10 PFU** ||| Measles virus Enders’ Edmonston strain..................................... ≥ 3.00 log10 CCID50* Mumps virus Jeryl Lynn™ (Level B) strain................................ ≥ 4.30 log10 CCID50* Rubella virus Wistar RA 27/ 3 strain............................................ ≥ 3.00 log10 CCID50* Varicella virus Oka/ Merck strain................................................ .≥ 3.99 log10 PFU** ||| Virus de la rougeole souche Edmonston Enders................................... ≥ 3,00 log10 DICC50* Virus des oreillons souche Jeryl LynnTM (niveau B).............................. ≥ 4,30 log10 DICC50 Virus de la rubéole souche Wistar RA 27/ 3........................................... ≥ 3,00 log10 DICC50 Virus de la varicelle souche Oka/ Merck................................................ ≥ 3,99 log10 UFP**
0.18685263395309448 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €8 billion scheme enables Austria to compensate businesses of all sectors at least in part for the damages suffered due to the coronavirus outbreak. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This Czech scheme of about €18.5 billion will support companies with up to 500 employees that are most severelyaffected by the coronavirus outbreak by facilitating their access to finance in these difficult times. ||| Mme Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Ce régime d'un montant de 8 milliards d'euros permet à l'Autriche d'indemniser les entreprises de tous les secteurs, au moins en partie, pour les dommages subis en raison de la pandémie de COVID-19.
0.3002714514732361 ||| Treatment with the enzyme has been shown to reduce accumulation of Gb3 in many cell types including endothelial and parenchymal cells. ||| Nifedipine is a calcium antagonist and has a spasmolytic effect on the vascular wall of mainly coronary arteries. ||| L’ administration de cette enzyme réduit donc l’ accumulation de Gb3 dans de nombreux types de cellules, notamment les cellules endothéliales et parenchymales.
0.2629217505455017 ||| Important information about some of the ingredients of Volibris Volibris tablets contain small amounts of a sugar called lactose. ||| Important information about some of the ingredients of Prometax One of the inactive ingredients in Prometax oral solution is sodium benzoate. ||| Informations importantes concernant certains composants de Volibris Les comprimés de Volibris contiennent en faible quantité un sucre appelé lactose.
0.19844922423362732 ||| Polyethylene glycol Hypromellose Titanium dioxide (E171) Talc ||| Polyvinyl alcohol Titanium dioxide (E171) Macrogol 3000 Talc ||| Polyéthylène glycol Hypromellose Dioxyde de titane (E171) Talc
0.31883132457733154 ||| The treatment effect of ibandronic acid was further assessed in an analysis of the subpopulation of patients who at baseline had a lumbar spine BMD T-score below – 2.5. ||| In Psoriasis Study 1, at Week 2 and Week 12, significantly greater improvements from baseline were demonstrated in the DLQI in each ustekinumab treatment group compared with placebo. ||| L’ efficacité de l’ acide ibandronique a été en outre évaluée dans l’ analyse d’ un sous-groupe de patientes qui présentaient comme valeur initiale de la DMO lombaire un T-score inférieur à - 2,5.
0.249670147895813 ||| There are no data available to indicate whether the administration of 23-valent pneumococcal polysaccharide vaccine to unprimed children or to children primed with Prevenar might result in hyporesponsiveness to further doses of Prevenar. ||| In-vitro and in-vivo data suggests that palifermin binds to unfractionated as well as low molecular weight heparins, which should be used with care in patients who are concomitantly administered palifermin. ||| Il n’ y a pas de données disponibles indiquant si l’ administration du vaccin pneumococcique polysaccharidique 23-valent à des enfants ayant ou non reçu une primovaccination par Prevenar pourrait entraîner une diminution de la réponse immunitaire lors de l’ administration ultérieure de doses de Prevenar.
0.3053308129310608 ||| Withdraw the entire volume of solvent into the syringe to be used for reconstitution. ||| The solvent pre-filled syringe provided should be used for reconstitution only. ||| Prélever la totalité du solvant avec la seringue à utiliser pour la reconstitution.
0.4158398509025574 ||| If you are taking Agopton once a day, try to take it at the same time each day. ||| To help you remember to take YENTREVE, you may find it easier to take it at the same times every day. ||| Si vous prenez Agopton une fois par jour, essayez de le prendre à la même heure chaque jour.
0.354469358921051 ||| 11 Hypersensitivity reactions of the skin may occuras itching, rash and urticaria. ||| Tachypnea, respiratory distress, and inspiratory crackles over lower lung fields often are present. ||| 11 Des réactions cutanées d’ hypersensibilité peuvent survenir: prurit, éruption et urticaire.
0.4149124026298523 ||| Breastfeeding must be discontinued for the duration of therapy. ||| Breast-feeding should be terminated prior to treatment. ||| Aussi, l’ allaitement doit être suspendu pour la durée du traitement.
0.5336666703224182 ||| Avoid contact between the product and your fingers. ||| Only use the drops in your eyes. ||| Eviter tout contact entre le produit et vos doigts.
0.3065984547138214 ||| Daily doses over 6 mg risperidone have not been investigated in patients with manic episodes. ||| Toxic signs have not been seen in pigs given 5 times the recommended dose. ||| Des doses journalières supérieures à 6 mg de rispéridone n’ ont pas été étudiées chez des patients présentant des épisodes maniaques.
0.1148119866847992 ||| Daclizumab*………… 5 mg per 1 ml infusion ||| uth Daclizumab*………… 5 mg per 1 ml infusion ||| Daclizumab* …………………… 5 mg par ml de solution
0.33328431844711304 ||| A contact tracing and warning app is voluntarily installed and used to warn users if they have been in proximity for a certain duration to a person who reported to have been tested positive of COVID-19. ||| They should be based on anonymised data: They can alert people who have been in proximity for a certain duration to an infected person to get tested or self-isolate, without revealing the identity of the people infected. ||| Une application d'alerte et de traçage des contacts est volontairement installée et utilisée pour alerter ses utilisateurs au cas où ils se seraient trouvés, pendant un certain temps, à proximité d'une personne ayant signalé avoir été dépistée positive à la COVID-19.
0.5322858691215515 ||| S ≤ 0.5 mg/ l and R > 0.5 mg/ l • Haemophilus influenzae: ||| creatinine clearance (ml/ min) ClCR ≥ 60 30 < ClCR < 60 ||| S ≤ 0,5 mg/ l et R > 0,5 mg/ l • Haemophilus influenzae:
2.5956092743889547e-13 ||| It is recommended to administer the diluted solution through an in-line low protein-binding 0.2 µm filter to remove any protein particles which will not lead to any loss of agalsidase beta activity. ||| It is recommended to administer the diluted solution through an in-line low protein-binding 0.2 µm filter to remove any protein particles which will not lead to any loss of agalsidase beta activity. ||| Il est recommandé d’ administrer la solution diluée avec un filtre en ligne de 0,2 µm à faible fixation protéinique pour retenir les particules protéiniques, ce qui n’ entraînera pas de perte d'activité de l’ agalsidase bêta.
0.5809240341186523 ||| Metabolism Metformin is excreted unchanged in the urine. ||| The mixed vaccine is a whitish emulsion. ||| Métabolisme La metformine est excrétée dans l'urine sous forme inchangée.
0.22924290597438812 ||| 30 During treatment for schizophrenia, manic episode and recurrence prevention in bipolar disorder, daily dosage may subsequently be adjusted on the basis of individual clinical status within the range 5-20 mg/ day. ||| Following induction and consolidation treatment for acute myeloid leukaemia the duration of treatment may be substantially longer (up to 38 days) depending on the type, dose and schedule of cytotoxic chemotherapy used. ||| 32 Dans toutes les indications, la posologie journalière de l’ olanzapine peut être adaptée en fonction de l’ état clinique du patient entre 5 et 20 mg par jour.
0.02122928947210312 ||| This means that it will start to lower your blood sugar about 4 hours after you take it, and the effect will last for approximately 28 hours. ||| This means that it will start to lower your blood sugar about half an hour after you take it, and the effect will last for approximately 24 hours. ||| Ultratard est une insuline d’ action très longue, ce qui signifie qu’ il commence à faire baisser votre glycémie 4 heures environ après l’ administration et son effet dure environ 28 heures.
0.07554082572460175 ||| Berlimed S. A., Poligono Industrial Santa Rosa s/ n, 28806 Alcalá de Henares, Madrid, Spain ||| S. A., Poligono Industrial Santa Rosa s/ n, 28806 Alcalá de Henares, Madrid, Spain ||| Berlimed S. A., Poligono Industrial Santa Rosa s/ n, 28806 Alcala de Henares, Madrid, Espagne
0.5038174390792847 ||| Hepatitis B virus surface antigen recombinant (S protein)* adsorbed 10 micrograms per 0.5 ml ||| Each dose of 1ml of vaccine contains Bluetongue virus serotype 8 antigen............... ...≥ 7.1 CCID50 ||| Antigène de surface de l’ hépatite B recombinant (protéine S)* adsorbé 10 microgrammes pour 0,5 ml
0.45490628480911255 ||| urticaria, psoriasis, ecchymosis and increased bruising, purpura ||| Urticaria, pruritis, rash, hyperhidrosis ||| Urticaire, psoriasis, ecchymoses et contusions
0.07402746379375458 ||| Ribavirin Teva must be used in combination with either peginterferon alfa-2b (1.5 micrograms/ kg/ week) or interferon alfa-2b (3 million international units [MIU] three times a week). ||| Ribavirin Teva should be used in combination with either pegioterferon alfa-2b (1.5 micrograms per kg each week) or interferon alfa-2b (3 million international units (MIU) three times a week, every other day. ||| Ribavirine Teva doit être utilisé en association avec le peginterféron alfa-2b (1,5 microgrammes/ kg/ semaine) ou l’ interféron alfa-2b (3 millions d’ unités internationales (MUI) trois fois par semaine).
0.18912631273269653 ||| Each hard capsule contains 246 mg of anhydrous lactose. ||| Each tablet contains 62 mg lactose anhydrous and 8 mg sucrose. ||| Chaque gélule contient 246 mg de lactose anhydre.
0.46105659008026123 ||| The applicant was asked to provide any additional data, from clinical and observational studies, of relevance for the effects of continuous oestrogen-progestogen combined products on endometrial hyperplasia or endometrial cancer. ||| The documentation submitted with this application consists of literature referring to the use of the originator product Eqvalan, a comparative pharmacokinetic study using Equimectin and Eqvalan, and a supplementary clinical field study. ||| Il a été demandé au demandeur de fournir des données supplémentaires pertinentes, provenant d'études cliniques et observationnelles, sur les effets des médicaments continus combinés d 'œ strogène/ de progestogène sur l'hyperplasie ou le cancer de l'endomètre.
0.01801123283803463 ||| The indication is based on the demonstration of efficacy of Silgard in adult females 16 to 26 years of age and on the demonstration of immunogenicity of Silgard in 9- to 15-year old children and adolescents. ||| The indication is based on the demonstration of efficacy of Gardasil in adult females 16 to 26 years of age and on the demonstration of immunogenicity of Gardasil in 9- to 15-year old children and adolescents. ||| L'indication est fondée sur la démonstration de l'efficacité de Silgard chez les femmes adultes de 16 à 26 ans et sur la démonstration de l'immunogénicité de Silgard chez les enfants et adolescents de 9 à 15 ans.
4.715377394104436e-13 ||| If you forget to take Zeffix If you forget to take your medicine, take it as soon as you remember and then continue to take it as instructed. ||| If you forget to take Zeffix If you forget to take your medicine, take it as soon as you remember and then continue to take it as instructed. ||| Si vous avez oublié de prendre Zeffix En cas d’oubli, prenez la dose oubliée dès que possible, puis poursuivez votre traitement selon la prescription de votre médecin.
0.08208183944225311 ||| Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed. ||| Please tell your doctor, midwife or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed. ||| Utilisation d’ autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.11187697947025299 ||| If this happens, do not drive or use any tools or machines. ||| If this happens to you, do not drive or use any tools or machines. ||| Dans ce cas, ne conduisez pas et n’ utilisez pas d’ outils ni de machines.
0.7201744318008423 ||| Audio devices and radio receivers ||| Data loggers and recorders ||| Dispositifs audio et récepteurs radio
0.43119513988494873 ||| We will work closely together to address today's challenges across the board, including the ongoing COVID-19 pandemic." ||| We are responding today to the urgent needs in fighting the COVID-19 crisis with a substantial and targeted assistance package. ||| Nous collaborerons étroitement de manière à relever les défis qui se posent à nous à tous les niveaux, y compris la pandémie en cours de COVID-19.»
0.0 ||| - isoniazid (used to treat tuberculosis), ||| - isoniazid (used to treat tuberculosis), ||| l'isoniazide (utilisé pour traiter la tuberculose),
0.32752057909965515 ||| Since doxazosin is strongly bound to plasma proteins dialysis is not indicated. ||| The degree to which hydrochlorothiazide is removed by hemodialysis has not been established. ||| Compte tenu de la forte liaison de la doxazosine aux protéines plasmatiques, une dialyse n’est pas indiquée.
0.41031795740127563 ||| France notified to the Commission, under EU State aid rules, an aid measure to Air France in the context of the coronavirus outbreak to enable the company to mitigate the negative consequences of the coronavirus. ||| Reports from CNN and The Washington Post said Chinese government officials, in response to the outbreak, launched a coordinated disinformation campaign seeking to spread doubt about the origin of the coronavirus and its outbreak. ||| La France a notifié à la Commission, conformément aux règles de l'UE en matière d'aides d'État, une mesure d'aide en faveur d'Air France dans le contexte de la pandémie de coronavirus, afin de permettre à l'entreprise d'atténuer les conséquences négatives de la crise sanitaire.
0.2586829364299774 ||| The trials compared the efficacy of Viraferon used alone or in combination with ribavirin. ||| The efficacy of IntronA is enhanced when given in combination with ribavirin. ||| Les études comparaient l’ efficacité du Viraferon utilisé seul ou en association avec la
0.4748377799987793 ||| BYETTA that has been frozen must not be used. ||| Throw away any BYETTA pen that has been frozen. ||| 12 Ne pas utiliser BYETTA s’ il a été congelé.
0.3601740598678589 ||| The benefit of treatment with Zavesca for neurological manifestations in patients with Niemann-Pick type C disease should be evaluated on a regular basis, e. g. every 6 months; continuation of therapy should be re-appraised after at least 1 year of treatment with Zavesca. ||| It is therefore advised that (Invented name)® should be gradually tapered when discontinuing treatment over a period of at least one to two weeks, according to the patient’ s needs (see "Withdrawal Symptoms Seen on Discontinuation of (Invented name)®", section 4.2 Posology and Method of Administration). ||| Le bénéfice d’ un traitement par Zavesca dans les manifestations neurologiques des patients atteints de maladie de Niemann-Pick type C doit être évalué sur une base régulière, par exemple tous les 6 mois; la poursuite du traitement doit être ré-évaluée après au moins 1 an de traitement par Zavesca.
0.10863187164068222 ||| AstraZeneca UK Limited Silk Road Business Park Macclesfield Cheshire SK10 2NA United Kingdom ||| Manufacturer AstraZeneca UK Limited Silk Road Business Park Macclesfield Cheshire SK10 2NA United Kingdom ||| AstraZeneca UK Limited SK - Silk Road Business Park Slovaquie Macclesfield Cheshire SK10 2NA United Kingdom
0.2067842036485672 ||| There have been reports of a high rate of virological failure and of emergence of resistance at an early stage when abacavir was combined with tenofovir disoproxil fumarate and lamivudine as a once daily regimen. ||| A decreased dosage of 250 mg didanosine co-administered with tenofovir disoproxil fumarate therapy has been associated with reports of high rates of virological failure within several tested combinations for the treatment of HIV-1 infection. ||| Des taux élevés d'échec virologique et d’ émergence de résistance ont été rapportés à un stade précoce lorsque l'abacavir était associé au ténofovir disoproxil fumarate et à la lamivudine, selon un schéma posologique en une prise par jour.
0.43477797508239746 ||| Commission a) Opinion received b) Decision c) Notification d) OJ No. ||| Commission a) Sent to Commission b) Date of the Regulation c) OJ No. ||| Commission a) Avis reçu le b) Date de décision c) Notification d) JO nº
0.6326820850372314 ||| In case of accidental contact, rinse with abundant quantities of water. ||| They stay in their own natural reservoirs until there is a chance for spillover. ||| En cas de contact accidentel, rincer abondamment avec de l’ eau.
0.32269254326820374 ||| The vaccine should not be used if foreign particles are present in the suspension. ||| The suspension should not be further diluted with water or any other liquids. ||| Le vaccin ne devra pas être utilisé si des particules étrangères sont présentes dans la suspension.
0.0 ||| Contains protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H20 with m-cresol and phenol as preservatives in water for injections. ||| Contains protamine sulphate, glycerol, zinc oxide, dibasic sodium phosphate 7 H20 with m-cresol and phenol as preservatives in water for injections. ||| Contient du sulfate de protamine, du glycérol, de l’ oxyde de zinc, du phosphate disodique heptahydratéavec du métacrésol et du phénol comme conservateurs dans de l'eau pour préparations injectables.
0.054588694125413895 ||| PROHIBITION OF SALE, SUPPLY AND/ OR USE ||| 6 PROHIBITION OF SALE, SUPPLY AND/ OR USE ||| INTERDICTION DE VENTE, DE DELIVRANCE ET/ OU D’ UTILISATION
0.5191407203674316 ||| Studies in animals have shown reproductive toxicity (see section 5.3). ||| (For pharmacokinetic data in this age group, see section 5.2). ||| Les études chez l’ animal ont montré une toxicité pour la reproduction (cf. rubrique 5.3).
0.582649290561676 ||| - facial swelling, ||| - sweating, ||| - un gonflement du visage
0.0 ||| Store in the original package in order to protect from light. ||| Store in the original package in order to protect from light. ||| À conserver dans l’ emballage d’ origine de façon à protéger de la lumière.
0.05245247483253479 ||| Monitoring of Liver Function There have been rare reports of hepatocellular dysfunction during post-marketing experience with pioglitazone (see section 4.8). ||| Monitoring of liver function There have been rare reports of hepatocellular dysfunction during post-marketing experience with rosiglitazone (see section 4.8). ||| Surveillance de la fonction hépatique De rares cas de dysfonctionnement hépato-cellulaire ont été rapportés après commercialisation de la pioglitazone (voir rubrique 4.8).
0.4528329074382782 ||| ProStrakan Ltd, Galabank Business Park, Galashiels TD1 1QH UK ||| Eli Lilly and Company Ltd Basingstoke RG24 9NL UK ||| ProStrakan Ltd, Galabank Business Park, Galashiels TD1 1QH Royaume-Uni
0.1947852373123169 ||| pre-filled syringe (glass) 0.4 ml with an automatic safety system ||| pre-filled syringe (glass) with an automatic safety system ||| Seringue pré-remplie 0,4 ml (verre) avec système de sécurité automatique
0.7002924084663391 ||| Integrase Inhibitors Raltegravir 400 mg BID ||| HMG Co-A Reductase Inhibitor ||| Inhibiteurs d’ intégrase Raltégravir 400 mg deux fois par jour
0.6510379314422607 ||| Gloves for massage ||| Ice for refreshment ||| Gants pour massages
0.06222356855869293 ||| 450 mg twice daily ||| 400 mg twice daily ||| 450 mg 2 fois par jour
0.28710731863975525 ||| Fuzeon is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected patients who have received treatment with and failed on regimens containing at least one medicinal product from each of the following antiretroviral classes: protease inhibitors, non- nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors, or who have intolerance to previous antiretroviral regimens. ||| Monotherapy with Xeloda after failure of taxanes, anthracycline containing chemotherapy, and for whom anthracycline therapy is not indicated Data from two multicentre phase II clinical trials support the use of Xeloda monotherapy for treatment of patients after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated. ||| Fuzeon est indiqué, en association avec d'autres antirétroviraux, dans le traitement des patients infectés par le VIH-1, exposés et en échec à un traitement comprenant au moins un médicament de chacune des classes antirétrovirales suivantes: inhibiteurs de protéase, analogues non nucléosidiques de la transcriptase inverse et analogues nucléosidiques de la transcriptase inverse, ou présentant une intolérance aux traitements précédemment cités.
0.30554717779159546 ||| Pharmaceutical preparations for treating malignant tumors ||| Chemical preparations for preventing pathogenic infections in plants ||| Préparations pharmaceutiques pour le traitement des tumeurs malignes
1.3915467262268066 ||| K20K/ R, I54I/ L and I93I/ L respectively ||| 150 IU r-hFSH-75 IU r-hLH ||| K20K/ R, I54I/ L et I93I/ L respectivement.
0.26781684160232544 ||| The elimination half-life after oral administration is approximately 3 hours. ||| The elimination half-life is about 2− 3 hours after intravenous administration. ||| Après administration orale, la demi-vie d’ élimination est d’ environ 3 heures.
0.3755568265914917 ||| The recommended dose of robenacoxib is 1 mg/ kg body weight with a range 1-2.4 mg/ kg. ||| The recommended dose of filgrastim is 0.5 MU/ kg/ day (5 μ g/ kg/ day). ||| La dose de robenacoxib recommandée est de 1 mg/ kg de poids corporel, pouvant varier de 1 à 2,4 mg/ kg.
0.7537204027175903 ||| - erection problems (impotence) ||| - Disorientation (confusion) ||| - problèmes d’ érection (impuissance)
0.4550102949142456 ||| If you have missed several doses, please inform your doctor and follow the advice given to you. ||| Take your tablets around the same time every day and follow any dietary advice that your doctor has given you. ||| Si vous avez oublié de prendre plusieurs gélules, consultez votre médecin et suivez ses conseils.
0.9192065000534058 ||| ROUTES OF ADMINISTRATION ||| STATEMENT OF THE MRLs ||| VOIE(S) D’ ADMINISTRATION
0.21841341257095337 ||| An increased incidence of keratoacanthoma in the skin was observed in male rats at doses of 4 and 10 mg/ kg/ day (≥ 4 times the exposure with the MRHD based on AUC). ||| No tumorigenic activity was observed in an oral carcinogenicity study in mice at doses of up to 250 mg/ kg/ day (12.5 to 50 times the human therapeutic dose range). ||| Une incidence accrue des kérato-acanthomes cutanés a été relevée chez les rats mâles aux doses de 4 et 10 mg/ kg/ jour (≥ 4 fois l’ exposition à la dose maximale recommandée chez l’ Homme d’ après l’ ASC).
0.8764546513557434 ||| Maintenance phase: overview of efficacy results MabThera vs. observation (28 months median observation time) ||| Effects on response rate, data from ACCENT II (Week-14 responders) ACCENT II (Week-14 responders) ||| 21 Tableau 5 Phase d’ entretien: résumé des résultats d’ efficacité de MabThera vs observation (durée médiane d’ observation:
0.0 ||| {month/ year} ||| {month/ year} ||| EXP {mois/ année}
0.3676740527153015 ||| What Fertavid contains ||| What Ovitrelle contains ||| Que contient Fertavid
5.658970471042468e-13 ||| Cold insulin is more painful to inject. ||| Cold insulin is more painful to inject. ||| L’ injection d’ une insuline froide est plus douloureuse.
0.39396512508392334 ||| - Signs and symptoms of hepatitis (liver disease) such as yellowing of skin and eyes, dark urine, ||| These can be signs of liver problems such as hepatitis (inflammation of the liver) or liver damage. ||| yeux, urines foncées, démangeaisons, perte d’appétit ou douleur abdominale.
0.4538152813911438 ||| Allow the pre-filled syringe to reach room temperature before injecting. ||| Ensure adequate cleansing of the teat (and udder - if needed) before infusion. ||| Laisser la seringue préremplie atteindre la température ambiante avant l'injection.
0.26490315794944763 ||| If you have liver or kidney problems, speak to your doctor as you may need a lower dose. ||| Your doctor may prescribe you a different dose if you have problems with your kidneys. ||| Si vous avez des problèmes de foie ou de reins, parlez -en à votre médecin car vous pouvez avoir besoin d’ une dose plus faible.
0.27802735567092896 ||| If you use more Insuman Comb 15 than you should ||| 554 If you use more Insuman Basal than you should ||| Si vous avez utilisé plus d’Insuman Comb 15 que vous n’auriez dû
0.5130754709243774 ||| - if you have a tumour of the adrenal gland ||| The prostate gland is just underneath the bladder in men. ||| - si vous avez une tumeur des glandes surrénales.
0.08138923346996307 ||| Entertainment services in the nature of webcam television programmes ||| Entertainment services in the nature of interactive television programmes ||| Services de divertissement sous forme de programmes télévisés par webcam
0.5017209053039551 ||| • Xaliproden hydrochloride ||| Acetylene tetrachloride ||| Xaliproden hydrochloride
0.24324911832809448 ||| Reagents for industrial purposes ||| Decolorants for industrial purposes ||| Réactifs à usage industriel
0.33441221714019775 ||| 52 The combination of hydrochlorothiazide and irbesartan produces dose-related additive reductions in blood pressure across their therapeutic dose ranges. ||| The major routes of metabolism are N-demethylation and hydroxylation, followed by conjugation with sulphate and glucuronic acid. ||| La baisse de la pression artérielle avec l'association irbésartan/ hydrochlorothiazide est dose dépendante aux doses thérapeutiques recommandées.
0.03836337476968765 ||| Each orodispersible tablet contains 1.50 mg aspartame. ||| Each orodispersible tablet contains 1.00 mg aspartame. ||| Chaque comprimé contient 1,50 mg d’ aspartame.
0.10059421509504318 ||| It may harm them, even if their symptoms are the same as yours. ||| tho It may harm them, even if their symptoms are the same as yours. ||| Même en cas de symptômes identiques, cela pourrait lui être nocif.
0.5359538793563843 ||| Frills for clothing ||| Earth for bricks ||| Ruches [habillement]
0.32728704810142517 ||| In an open single-dose study in adult patients with Sickle Cell Syndrome the influence of renal function on pharmacokinetics of hydroxycarbamide was assessed. ||| In the 24-month alendronate combination therapy study (PaTH), the effects of Preotact on bone architecture were also evaluated using QCT. ||| Une étude ouverte portant sur une administration unique d'hydroxycarbamide chez des patients adultes atteints de drépanocytose a évalué l'influence de la fonction rénale sur la pharmacocinétique de l'hydroxycarbamide.
0.5016194581985474 ||| Dispensers for liquid soap [for household purposes] ||| Providing shoes to needy persons [charitable services] ||| Distributeurs de savon liquide à usage domestique
0.18891918659210205 ||| Additional information on the individual components Adverse drug reactions previously reported with one of the individual components (amlodipine or valsartan) may be potential undesirable effects with Copalia as well, even if not observed in clinical trials or during the post-marketing period. ||| Increased side effects may occur in case of recent or concomitant use of hepatotoxic or haematotoxic drugs or when leflunomide treatment is followed by such drugs without a washout period (see also guidance concerning combination with other treatments, section 4.4). ||| 7 Informations supplémentaires sur les composants individuels Les effets indésirables précédemment rapportés avec l'un des composants individuels (amlodipine ou valsartan) peuvent également être des effets indésirables potentiels avec Copalia, même s'ils n'ont pas été observés dans les essais cliniques ou au cours de la commercialisation.
0.14878201484680176 ||| Beneath ground construction work relating to foundation laying ||| Beneath ground construction work relating to sewers ||| Travaux de construction souterrains liés à la pose de fondations
0.19673381745815277 ||| After oral administration of 20 mg/ kg of hydroxycarbamide, a rapid absorption is observed with peak plasma levels of about 30 mg/ l occurring after 0.75 and 1.2 h in children and adult patients with Sickle Cell Syndrome, respectively. ||| In patients with Sickle Cell Syndrome, neutropenia was reported in isolated cases of hydroxycarbamide overdose (1.43 times and 8.57 times of the maximum recommended dose of 35 mg/ kg b. w. / day). ||| Après administration orale à une dose de 20 mg/ kg, l'hydroxycarbamide est rapidement absorbé et atteint des pics de concentration plasmatiques de 30 mg/ L environ respectivement après 0,75 h et 1,2 h chez les enfants et les adultes atteints de drépanocytose.
0.5499668121337891 ||| Not recommended as the exposure to both PIs is expected to be significantly decreased. ||| This is due to air pressure and should not be of concern. ||| Non recommandé car on s’ attend à ce que l'exposition aux deux IPs soit diminuée significativement.
0.2861524224281311 ||| The marketing authorisation holder is Cephalon Europe. ||| The marketing authorisation holder is Bayer Healthcare AG. ||| Le titulaire de l’ autorisation de mise sur le marché est Cephalon Europe.
0.25455453991889954 ||| Attach the needle for reconstitution to the syringe, with the syringe in one hand, pick up the open ampoule, insert the needle and draw up all of the solvent. ||| With the syringe still attached to the vial, check the syringe for air bubbles. • Gently tap the syringe to make any bubbles rise to the top of the syringe. ||| Avec la seringue dans une main, saisissez l’ ampoule de solvant que vous aurez ouverte, introduisez -y l’ aiguille et aspirez tout le solvant.
0.017148053273558617 ||| Advagraf 1 mg Prolonged-release hard capsules Tacrolimus ||| Advagraf 5 mg Prolonged-release hard capsules Tacrolimus ||| Advagraf 1 mg gélules à libération prolongée Tacrolimus
0.38718023896217346 ||| Azithromycin/ Efavirenz (600 mg single dose/ 400 mg once daily) ||| Sitagliptin 50 mg + metformin 500 mg (N=183) Initial therapy (twice daily): ||| Azithromycin/ Efavirenz (600 mg en dose unique/ 400 mg une fois par jour)
0.30794209241867065 ||| Reconstitution with the solvent yields a solution containing efalizumab at 100 mg/ ml. ||| A measuring cup with graduation marks (corresponding to 50 mg lacosamide) is provided with the syrup. ||| La reconstitution avec le solvant permet d'obtenir une solution dont la concentration est de 100 mg/ ml d'efalizumab.
0.054599862545728683 ||| Cases of recurrent inhibitor (low titre) have been observed after switching from one factor VIII product to another in previously treated patients with more than 100 exposure days who have a history of inhibitor development. ||| Cases of recurrence of inhibitors (low titre) have been observed after switching from one recombinant factor VIII product to another in previously treated patients with more than 100 exposure days who have a history of inhibitor development. ||| Des cas de réapparition d’ inhibiteurs (faible titre) ont été observés après le changement d’ un facteur VIII pour un autre, chez des patients préalablement traités ayant plus 59 de 100 jours d’ exposition et qui avaient un historique de développement d’ inhibiteur.
0.2672125995159149 ||| An increase in gastric pH that may result from H2-receptor antagonist therapy is not expected to have an impact on tipranavir plasma concentrations. ||| It may not be excluded that lanzoprazole may affect transport via this protein giving rise to increased plasma concentrations of P-gp substrates such as digoxin. ||| Aucun effet sur les concentrations plasmatiques de tipranavir n’ est attendu de l’ augmentation du pH gastrique pouvant résulter du traitement par les antagonistes des récepteurs H2.
0.04559566080570221 ||| STRONGHOLD is available in packs of three tubes (all tube sizes), six tubes (all tube sizes except 15 mg selamectin), or fifteen tubes (15 mg selamectin tube size only). ||| STRONGHOLD is available in packs of three tubes (for all tube sizes), six tubes (for all tube sizes except 15 mg selamectin), or fifteen tubes (for 15 mg selamectin tube size only). ||| Stronghold est disponible en boîte de trois tubes (toutes les tailles de tubes), six tubes (toutes les tailles excepté le tube à 15 mg de sélamectine), ou quinze tubes (seulement le tube à 15 mg de sélamectine).
0.39472252130508423 ||| Ophthalmologic preparations ||| Haematologic reactions ||| Préparations ophtalmiques
0.7163814306259155 ||| EXP After first opening, use within 28 days. ||| Expiry During use: use within 6 weeks Me ||| EXP Après première ouverture, utiliser dans les 28 jours.
0.3881292939186096 ||| etravirine* AUC ↔ a etravirine* C0h ↔ a Enfuvirtide concentrations not studied, no effect is expected. * based on population pharmacokinetic analyses ||| Maraviroc AUC12: ↔ compared to historical controls Maraviroc Cmax: ↑ compared to historical controls Nevirapine concentrations not measured, no effect is expected. ||| Concentrations d’ enfuvirtide non étudiées, aucun effet n’ est attendu. *sur la base d’ analyses de pharmacocinétique de population
0.15729914605617523 ||| How does Crixivan work? ||| How does Riprazo work? ||| Comment Crixivan agit -il?
0.5781823396682739 ||| - vision disturbances. ||| - Kidney problems. ||| - troubles de la vision
0.482555627822876 ||| The mean (CV%) steady state pharmacokinetic parameters estimates of fondaparinux in patients with VTE receiving the fondaparinux proposed dose regimen once daily are: ||| The seroprotection rate* seroconversion rate* and the seroconversion factor ** for anti-HA antibody in the adults measured by SRH were as follows: ||| paramètres pharmacocinétiques du fondaparinux [moyennes (coef. variation)] estimés à l’ état d’ équilibre sont:
0.4055582284927368 ||| As the 2020 coronavirus pandemic in France took an increasing toll on medical supplies, masks and PPE supplies ran low and caused national outrage. ||| Following the first reported case of COVID-19 in Nigeria on February 28, untested cures and treatments began to spread via platforms like WhatsApp. ||| Alors que la pandémie de coronavirus en 2020 en France a eu un impact croissant sur les fournitures médicales, les masques et les fournitures d'EPI ont été faibles et ont provoqué l'indignation nationale.
0.03149665147066116 ||| 16/ 24 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 30/ 44 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 16/25 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTÉRIEUR
0.4028797149658203 ||| This would be particularly important in patients with a known history of zidovudine induced anaemia. ||| IntronA was also shown to have a benefit in children with chronic hepatitis B. ||| Cela est particulièrement important chez les patients ayant des antécédents d’ anémie induits par la ribavirine.
0.21974371373653412 ||| Specific patient groups Nateglinide should be used with caution in patients with moderate hepatic impairment. ||| 24/ 94 Ropinirole should be administered with caution to patients with moderate hepatic impairment. ||| 19 Population particulière de patients Le natéglinide doit être utilisé avec prudence chez les patients présentant une insuffisance hépatique modérée.
0.2017068862915039 ||| Taking these medicines with STOCRIN could create the potential for serious and/or life-threatening side-effects or stop STOCRIN from working properly. • STOCRIN from working properly. ||| Taking these medicines with SUSTIVA could create the potential for serious and/ or life-threatening side-effects or stop SUSTIVA from working properly. ||| 261 La prise de ces médicaments en association avec STOCRIN risque d’ engendrer des effets indésirables graves et/ ou pouvant mettre votre vie en danger, ou peut empêcher ces médicaments d’ agir correctement.
0.7388436198234558 ||| Computer engineering consultancy services ||| Information technology and audiovisual equipment ||| Services de conseils en ingénierie informatique
0.2993510365486145 ||| If severe skin reactions occur a fourth time or do not resolve to grade 2 during interruption of treatment, permanent discontinuation of cetuximab treatment is required. ||| If the patient stops medication for more than 14 consecutive days, titration should be restarted from the lowest dose Patients with hepatic impairment ||| Si une réaction cutanée sévère survient pour la quatrième fois ou ne régresse pas au grade 2 pendant l’ interruption du traitement, l’ arrêt définitif du traitement par le cetuximab s’ impose.
0.6582450866699219 ||| Fire extinguishing foam compositions ||| Shortage of masks controversy ||| Compositions extinctrices à base de mousse
0.0 ||| 4.6 Pregnancy and lactation ||| 4.6 Pregnancy and lactation ||| 5 4.6 Grossesse et allaitement
0.5499820709228516 ||| Other precautions ||| Other provisions ||| Autres précautions
0.40556636452674866 ||| This may happen: • If you take too little NovoNorm • If you have an infection or a fever • If you eat more than usual • If you exercise less than usual. ||| • If you take too much insulin • If you eat too little or miss a meal • If you exercise more than usual. na ||| Cela peut arriver: • si vous prenez trop peu de NovoNorm • si vous avez une infection ou de la fièvre • si vous prenez un repas plus important que d’ habitude • si vous faîtes moins d’ exercice que d’ habitude.
0.25273096561431885 ||| Each ml contains a maximum of 6.4 x 109 perflutren-containing lipid bubbles, with an average diameter range of 1.1-2.5 micrometres. ||| Perflutren-containing microspheres 5 - 8 x 108, with a mean diameter range of 2.5 - 4.5 µm, equivalent to 0.19 mg perflutren gas per ml. ||| Chaque ml contient au maximum 6,4 x 109 microbulles lipidiques contenant du perflutren, de diamètre moyen compris entre 1,1 et 2,5 µm.
0.2761448621749878 ||| NutropinAq therapy should be discontinued if pregnancy occurs. ||| Gemfibrozil therapy should be discontinued if gallstones are found. ||| Le traitement par NutropinAq doit être interrompu en cas de grossesse.
0.18247175216674805 ||| ed Do not freeze Keep the container in the outer carton During use: do not refrigerate or store above 25°C ||| Do not store above 25°C Do not refrigerate Keep the container in the outer carton, in order to protect from light ||| 22 Ne pas congeler Conserver le contenant dans l’ emballage extérieur En cours d’ utilisation: ne pas réfrigérer ni conserver à plus de +25°C
0.4478699862957001 ||| Hypoglycaemia may be associated with listlessness, confusion, palpitations, headache, sweating and vomiting. ||| These may consist of 3 headaches, muscle pain, extreme anxiety, tension, restlessness, confusion and irritability. ||| L'hypoglycémie peut être associée à une apathie, une confusion, des palpitations, des céphalées, des sueurs et des vomissements.
0.2100680023431778 ||| Diarrhoea, vomiting, nausea, abdominal pain Mouth ulceration, stomatitis ulcerative, stomatitis, right upper ||| Mouth ulceration, stomatitis ulcerative, stomatitis, right upper quadrant pain, dyspepsia, glossitis, gastroesophogeal reflux, rectal ||| Ulcération de la bouche, stomatite ulcéreuse, stomatite, douleur dans Fréquent: la partie supérieure droite de l'abdomen, dyspepsie, glossite, reflux
0.15308715403079987 ||| 16 months. ||| 36 months. ||| 16 mois.
0.33443987369537354 ||| A better-integrated energy system is essential in order to move to climate neutrality by 2050, while also creating jobs, ensuring a fair transition and strengthening innovation in the EU and industrial leadership at a global level. ||| The Recovery and Resilience Facility will support longer-term reform and investments, notably in green and digital technologies, with lasting impact on the productivity and resilience of the economy of the Union. ||| Un système énergétique mieux intégré est essentiel pour parvenir à la neutralité climatique à l'horizon 2050, tout en créant des emplois, en assurant une transition juste et en renforçant l'innovation au sein de l'UE et le leadership industriel au niveau mondial.
0.3369734287261963 ||| It is therefore preferable to take antacids at least two hours after PROTELOS. ||| The Lansoprazole dose should therefore be taken at least an hour prior or after. ||| Il est donc préférable de prendre les antiacides au moins deux heures après PROTELOS.
0.6384899616241455 ||| Some settling of the reconstituted suspension may occur. ||| In-use stability of the reconstituted solution ||| Il est possible que certains amalgames se forment dans la suspension reconstituée.
0.21799859404563904 ||| After intravenous administration of laronidase with an infusion time of 240 minutes and at a dose of 100 U/ kg body weight pharmacokinetic properties were measured at Weeks 1, 12 and 26. ||| The pharmacokinetics of total paclitaxel following 30- and 180-minute infusions of Abraxane at dose levels of 80 to 375 mg/ m2 were determined in clinical studies. ||| Après administration par voie intraveineuse de laronidase en perfusion de 240 minutes et à une dose de 100 U/ kg de poids corporel, les propriétés pharmacocinétiques ont été mesurées à la semaine 1, 12 et 26.
0.3509538173675537 ||| Agomelatine is a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist. ||| Rotigotine is a non-ergolinic D3/ D2/ D1 dopamine agonist for the treatment of Parkinson’ s disease. ||| L'agomélatine est un agoniste mélatoninergique (récepteurs MT1 et MT2) et un antagoniste des récepteurs 5HT2c.
0.5409178733825684 ||| Common (affecting less than 1 in 10 patients): ||| Very common (at least 1 in 10 people) – Bleeding ||| Fréquent (survenant chez moins de 1 patient sur 10):
0.5804728865623474 ||| An accurate measuring device with suitable graduations should be used to ensure administration of the appropriate volume of solution. ||| standard inhalation technique should be employed to ensure both optimal and consistent drug delivery. uc ||| Un dispositif de mesure précis gradué de façon appropriée devra être utilisé afin de s’ assurer de l’ administration du volume de solution adéquat.
0.15845471620559692 ||| Why has Parareg been approved? ||| Why has Reconcile been approved? ||| Pourquoi Parareg a -t-il été approuvé?
0.2694600224494934 ||| It is recommended that Tamiflu oral suspension should be reconstituted by the pharmacist prior to its dispensing to the patient. ||| The Pharmacist should be requested to distribute a PAC to each patient at the time Ranexa is dispensed. ||| Il est recommandé que la suspension buvable Tamiflu soit reconstituée par le pharmacien avant sa délivrance au patient.
0.005256852135062218 ||| 302 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 254 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 323 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTÉRIEUR
0.19826781749725342 ||| Chemical and physical in-use stability of the diluted solution for infusion has been demonstrated for 24 hours at 2 °C to 8 °C. ||| Following dilution, chemical and physical in-use stability in polypropylene infusion bags has been demonstrated for at least 24 hours below 25 °C. ||| La stabilité physico-chimique de la solution diluée pendant 24 heures entre 2°C et 8°C a été démontrée.
0.3297230899333954 ||| The effect of these on the safety and effectiveness of the medicine is not fully known. ||| This does not affect the safety or effectiveness of the medicine. ||| L’ effet de ceux -ci sur la sécurité et l’ efficacité du médicament n’ est pas encore parfaitement connu.
0.10310931503772736 ||| Pharmaceutical preparations for the treatment of kidney disorders ||| Pharmaceutical preparations for the prevention of ocular diseases ||| Produits pharmaceutiques pour le traitement des troubles rénaux
0.6490111351013184 ||| The Framework makes clear that such aid is considered as direct aid to the banks' customers, not to the banks themselves, and gives guidance on how to ensure minimal distortion of competition between banks. ||| The Agency, its management, its staff and its advisors, took all of these changes in their stride, and achieved all that was expected of them, as is described in this report. ||| L'encadrement précise que ce type d'aide est considéré comme une aide directe aux clients des banques, non aux banques elles-mêmes, et fournit des orientations sur la manière de limiter au minimum les distorsions de concurrence entre banques;
0.30055367946624756 ||| When administered orally at 75 mg/ kg/ day (five times the recommended dose) for a period of 90 days in dogs, ibafloxacin was well tolerated. ||| After 15 days of treatment with St John’ s Wort (300 mg three times daily), plasma exposure following a single 400 mg dose of voriconazole decreased by 40-60%. ||| Administrée par voie orale chez le chien à la dose de 75 mg/ kg/ jour (cinq fois la dose recommandée) pendant 90 jours consécutifs, l’ ibafloxacine a été bien tolérée.
0.3471638858318329 ||| If the dose cannot be increased to 2.5 mg twice a day the treatment should be withdrawn. ||| If this dose is well tolerated the dose should be increased to 0.5 mg once daily for the remainder of week 1. ||| Si la dose ne peut pas être augmentée à 2,5 mg deux fois par jour, le traitement doit être arrêté.
0.0 ||| 1 pre-filled syringe with needle guard + 1 needle ||| 1 pre-filled syringe with needle guard + 1 needle ||| 1 seringue préremplie avec dispositif de
0.44453006982803345 ||| This can happen in patients of any age, but is more likely in infants and small children who are usually given a larger dose of Ceftriaxone on a body weight basis. ||| Although limited data suggest that females as well as Asian and Pacific Island patients may have higher exposure to efavirenz, they do not appear to be less tolerant of efavirenz. ||| Cette situation peut se produire quel que soit l’ âge mais est plus probable chez le nourrisson et le petit enfant, qui reçoivent généralement une dose de ceftriaxone plus importante par rapport à leur poids.
5.999563367810323e-13 ||| Peripheral neuropathy ||| Peripheral neuropathy ||| Neuropathie périphérique
0.5387303233146667 ||| Severe rotavirus gastro- enteritis (1st year of life) Rotarix N=9009; Placebo N=8858(§) Efficacy (%) [95% CI] ||| Median plasma HIV-1 RNA Median CD4 cell count Outcomes Confirmed undetectable viral load (< 50 HIV-1 RNA copies/ml)a n (%) ||| Gastro-entérite sévère à rotavirus (1ère année de vie) Rotarix N=9009; Placebo N=8858 (§) Efficacité (%) [IC 95%] 84,7*
0.0 ||| Because of individual variability, titration to optimal therapeutic doses is expected for individual patients. ||| Because of individual variability, titration to optimal therapeutic doses is expected for individual patients. ||| 316 recherche de la dose thérapeutique optimale doit être effectuée pour chaque patient.
0.11327202618122101 ||| What ViraferonPeg looks like and contents of the pack ||| What PegIntron looks like and contents of the pack ||| Qu’ est -ce que ViraferonPeg et contenu de l’ emballage extérieur
0.11154086887836456 ||| • 22.5.2001 • 30.5.2002 ||| • 25.3.2002 • 15.5.2002 ||| 22.5.2001 30.5.2002
0.2811843156814575 ||| In pregnant women, overdoses of calcium and vitamin D should be avoided as permanent hypercalcaemia has been related to adverse effects on the developing foetus. ||| If maternal phenylalanine levels are not strictly controlled before and during pregnancy, this could be harmful to the mother and the foetus. ||| Chez la femme enceinte, tout surdosage en calcium et en vitamine D doit être évité car l’hypercalcémie permanente a été associée à des effets négatifs sur le développement du fœtus.
0.42781949043273926 ||| Plasma concentrations of telmisartan are generally 2 – 3 times higher in females than in males. ||| Foetal exposure in the rats and rabbits was approximately 15 to 20% of that of the mother. ||| Les concentrations plasmatiques du telmisartan sont généralement 2 à 3 fois plus élevées chez la femme que chez l’ homme.
0.2137921154499054 ||| 286 Minor side effects include bruising, pain, redness, swelling and itching at the site of the injection. ||| Common side effects • headache • reactions at the injection site including pain, swelling, itching and redness. ||| Les effets indésirables mineurs comprennent ecchymoses, douleur, rougeur, gonflement et démangeaisons au niveau du site d'injection.
0.17611095309257507 ||| If you have a known hypersensitivity to NSAIDs you should avoid contact with the veterinary medicinal product. ||| People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product. ||| Les personnes présentant une hypersensibilité connue aux AINS devraient éviter tout contact avec le médicament vétérinaire.
0.40866613388061523 ||| Train healthcare professionals regularly on how to implement effective prevention and control strategies [82,85] [expert consensus]. ||| Provide feedback and advice to prescribers on antibiotic choice, dose, duration optimisation and route of administration [31,94]. ||| Formez régulièrement les professionnels de la santé à la mise en œuvre de stratégies efficaces de prévention et de lutte [82,85] [consensus d'experts].
0.32519030570983887 ||| Elderly patients should be observed carefully for signs of fentanyl toxicity. ||| Patients should be advised to self assess for androgenic undesirable effects. ||| Il est donc nécessaire de rechercher soigneusement tout signe de toxicité du fentanyl chez les personnes âgées.
0.013641230762004852 ||| Hypersensitivity reactions (allergic reactions) occur in about 5% of patients taking Kivexa, usually within the first six weeks of treatment. ||| Hypersensitivity reactions (allergic reactions) occur in about 5% of patients taking Ziagen, usually within the first six weeks of treatment. ||| Des réactions d’ hypersensibilité (allergies) surviennent chez environ 5% des patients sous Kivexa, en général au cours des six premières semaines du traitement.
0.3185851573944092 ||| In repeated-dose toxicity studies, dose-related liver changes (weight, centrilobular hypertrophy, occasionally necrosis), induction of hepatic drug metabolising enzymes and slightly decreased erythron parameters were seen in mice, rats and dogs. ||| Preliminary findings from this on-going study showed that lenalidomide produced malformations (short limbs, bent digits, wrist and/or tail, supernumerary or absent digits) in the offspring of female monkeys who received the drug during pregnancy. ||| Lors d’ études de toxicité à doses répétées, des modifications hépatiques dose-dépendants (poids, hypertrophie centro-lobulaire, nécrose occasionnelle), une induction des enzymes hépatiques métabolisant le médicament et une légère diminution des paramètres d’ érythron ont été observés chez la souris, le rat et le chien.
0.05923057347536087 ||| Paediatric use MIRCERA is not recommended for use in children and adolescents below 18 years due to a lack of safety and efficacy data. ||| Paediatric population TRITACE is not recommended for use in children and adolescents below 18 years of age due to insufficient data on safety and efficacy. ||| Utilisation pédiatrique MIRCERA n’ est pas recommandé chez l’ enfant et l'adolescent de moins de 18 ans en l’ absence de données sur la tolérance et l’ efficacité
0.3660902678966522 ||| In case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant Summary of Product Characteristics for these medicinal products. ||| Note for guidance on immune sera of animal origin Points to consider on human somatic cell therapy products (jointly with Efficacy and Safety Working Parties) ||| En cas de co-administration d’ un traitement antiviral de l’ hépatite B ou C, veuillez consulter le Résumé des Caractéristiques du Produit de ces médicaments.
0.29619064927101135 ||| On 20 March 2020, the Commission invited all Member States, as well as the UK, to submit a request to waive customs duties and VAT on the importation of protective and other medical equipment from third countries. ||| On 16-17 April, MEPs are expected to vote on €3 billion in emergency support for the health sectors of the most affected EU countries as well as on a scheme to procure medical supplies for member states facing shortages. ||| Le 20 mars 2020, la Commission a invité tous les États membres ainsi que le Royaume-Uni à présenter une demande visant à exonérer de droits de douane et de TVA les importations d'équipements de protection et d'autres équipements médicaux en provenance de pays tiers, ce qu'ils ont tous fait.
0.8588257431983948 ||| The second dose in both cases is given between one and three months after the first one. ||| The first 2 numbers indicate the month; the next 4 numbers indicate the year. ||| Dans les deux cas, une période d’ attente d’ un à trois mois est nécessaire entre l’ administration des deux doses.
0.416964054107666 ||| If left unaddressed, these difficulties could lead to a large number of bankruptcies of micro and small companies, causing serious disturbances for the entire EU economy. ||| Optimal mitigation policies might reduce peak healthcare demand by 2/3 and deaths by half, but still result in hundreds of thousands of deaths and health systems being overwhelmed. ||| Si aucune mesure n'est prise, ces difficultés pourraient entraîner un grand nombre de faillites de micro et petites entreprises, causant de graves perturbations pour l'ensemble de l'économie de l'UE.
0.21917535364627838 ||| The recommended dosage is a single course of LITAK at a dose of 0.14 mg per kg body weight per day for five consecutive days. ||| The recommended dose is 0.20 mg per kilogram body weight in both children and adults given as a daily infusion for up to seven days. ||| Le traitement recommandé consiste en une cure unique de LITAK pendant 5 jours consécutifs à raison de 0,14 mg par kg de poids corporel par jour.
0.6385422945022583 ||| Arrangement of transportation of passengers by cars ||| Arrangement of travel to and from hotels ||| Organisation du transport de passagers en voiture
0.3546175956726074 ||| Some patients who take alpha-blocker therapy for the treatment of high blood pressure or prostate enlargement may experience dizziness or light-headedness, which may be caused by low blood pressure upon sitting or standing up quickly. ||| Stress urinary incontinence is a medical condition in which patients have accidental loss or leakage of urine during physical exertion or activities such as laughing, coughing, sneezing, lifting, or exercise. ||| Certains patients prenant un médicament alpha-bloquant pour le traitement d’ une pression artérielle élevée ou d’ une hypertrophie de la prostate peuvent ressentir des vertiges ou des sensations d’ ébriété, qui peuvent être dus à une pression artérielle basse lors du passage rapide à la position assise ou à la position debout.
0.27015671133995056 ||| The incidence of efficacy failure at 12 months (defined as death, graft loss, biopsy- confirmed acute rejection, or lost to follow-up) was 14.0% in the Advagraf group (N=214), 15.1% in the Prograf group (N=212) and 17.0% in the ciclosporin group (N=212). ||| Clinically relevant Grade 3 and Grade 4 laboratory toxicities were similar between integrated Phase 2 results from three single agent pemetrexed studies (n = 164) and the Phase 3 single agent pemetrexed study described above, with the exception of neutropenia (12.8% versus 5.3%, respectively) and alanine transaminase elevation (15.2% versus 1.9%, respectively). ||| La fréquence de l’ échec au traitement à 12 mois (défini comme le décès, la perte du greffon, le rejet aigu confirmé par biopsie, ou les patients perdus de vue) était de 14,0% dans le groupe Advagraf (n = 214), de 15,1% dans le groupe Prograf (n = 212) et de 17,0% dans le groupe ciclosporine (n = 212).
0.49533289670944214 ||| [For referral procedures] {PRODUCT NAME} 40mg film-coated tablet ||| Take special care with [Invented name] 400 mg film-coated tablets ||| [For referral procedures] {PRODUCT NAME} 40 mg, comprimé pelliculé
0.2874385714530945 ||| gastritis, oesophagitis including oesophageal ulcerations or strictures, vomiting, dysphagia ||| angioneurotic oedema, pruritus, rash vesicular, urticaria, aggravation of psoriasis ||| gastrite, œ sophagites incluant ulcérations ou sténoses de l’œ sophage, vomissements, dysphagie
5.992571890101051e-13 ||| Alpha interferons may also block the multiplication of viruses. ||| Alpha interferons may also block the multiplication of viruses. ||| Les interférons alpha peuvent également empêcher la multiplication des virus.
0.6502324342727661 ||| Humus top dressing ||| Luminous house numbers ||| Couvertures d'humus
0.2981800138950348 ||| Experience in patients with persistent viral replication: ||| Experience in patients with compensated liver disease: ||| Expérience acquise chez les patients montrant une réplication virale persistante:
2.6988475473541107e-13 ||| Thirteen percent of the emtricitabine dose was recovered in urine as three metabolites. ||| Thirteen percent of the emtricitabine dose was recovered in urine as three metabolites. ||| Treize pour cent de la dose d’ emtricitabine ont été retrouvés dans les urines sous forme de trois métabolites.
0.5597463846206665 ||| Lyophilisate and solvent for suspension for injection ||| A lyophilised vaccine pellet for reconstitution ||| Lyophilisat et chats solvant pour suspension injectable
0.4761999249458313 ||| Press the syringe plunger in slowly. ||| Push the plunger back in to the syringe. ||| Appuyez lentement sur le piston de la seringue.
0.20353542268276215 ||| Treatment with Epoetin alfa HEXAL should be continued until one month after the end of chemotherapy. ||| Epoetin alfa therapy should continue until one month after the end of chemotherapy. ||| Le traitement par Epoetin alfa HEXAL doit être poursuivi pendant un mois après la fin de la chimiothérapie.
0.35223791003227234 ||| Very rare side effects (affects less than 1 patient in 10,000): jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions; swelling in the mouth; blisters of the skin; skin allergy; inflammation of the mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; taste disorders. ||| ge • anaemia, low white blood cell counts; • allergic reactions; • increased lipid values, appetite disorders; lon • anxiety, depression, feeling sleepy and difficulty sleeping; • nerve disorders (such as multiple sclerosis and eye nerve inflammation), taste disturbances; • vision disturbances; • ear discomfort; no ||| Effets indésirables très rares (touchant moins de 1 patient sur 10 000): jaunisse, douleur abdominale sévère avec ou sans douleur dans le dos; fièvre, difficultés respiratoires, parfois associées à de la toux; réactions allergiques généralisées; gonflement de la bouche; décollement de la peau; allergie cutanée; inflammation de la muqueuse buccale (stomatite); baisse de tension; confusion; hallucinations; douleurs articulaires; douleurs musculaires; troubles du goût.
0.7046079039573669 ||| 50/ 250 ||| 500-1,000 ||| 50/ 100
0.6281867623329163 ||| This intends to boost public health emergency preparedness and response work in countries with weak health systems and limited resilience. ||| A massive renovation wave of our buildings and infrastructure and a more circular economy, bringing local jobs; ||| Cela vise à renforcer la préparation et la réponse aux situations d'urgence en matière de santé publique dans les pays où les systèmes de santé sont faibles et dont la résilience est limitée.
0.32687705755233765 ||| Charitable services, namely providing transportation ||| Charitable services, namely providing food and drink catering ||| Services d'œuvres de bienfaisance, à savoir transport
2.5736232806342074e-13 ||| The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex), which may cause allergic reactions. ||| The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex), which may cause allergic reactions. ||| 227 Le capuchon de protection du stylo prérempli contient du caoutchouc naturel (un dérivé du latex) qui peut provoquer des réactions allergiques.
0.6710618734359741 ||| Tubular bandages [supportive] ||| Halal slaughtering services [Dhabihah] ||| Bandages tubulaires de maintien
0.14989428222179413 ||| Patients at the beginning of therapy with voriconazole and patients who develop abnormal liver function tests during VFEND therapy must be routinely monitored for the development of more severe hepatic injury. ||| Carriers of HBV who require treatment with Remicade should be closely monitored for signs and symptoms of active HBV infection throughout therapy and for several months following termination of therapy. ||| Chez les patients commençant un traitement par le voriconazole et les patients dont les tests de la fonction hépatique deviennent anormaux sous VFEND, une surveillance systématique doit être mise en place afin d’ éviter une aggravation des problèmes hépatiques.
6.867044910138786e-13 ||| [To be completed nationally] ||| [To be completed nationally] ||| [À remplir au niveau national]
0.08583655953407288 ||| 19 The programme shall include the full text of the SmPC. ||| The programme shall include the full text of the SmPC. ||| Le programme d’ éducation doit inclure le texte complet du RCP.
0.5198501944541931 ||| N07B C51. ||| A10A C01. no ||| N07BC51.
0.041385747492313385 ||| 47 EMEA General Report 2000 ||| 54 EMEA General Report 2000 ||| 60 Rapport annuel EMEA 2000
0.2578791081905365 ||| If any of the following events occur in temporal relation to receipt of Tritanrix HepB, the decision to give subsequent doses of vaccine containing the pertussis component should be carefully considered. ||| If the decision is made to administer another cyanide antidote with Cyanokit, these medicinal products must not be administered concurrently in the same intravenous line (see section 6.2). ||| Si l'une des réactions décrites ci-dessous apparaît après l’ administration de Tritanrix HepB, la décision d'administrer les doses suivantes du vaccin contenant la valence coquelucheuse doit être soigneusement évaluée:
0.6081416606903076 ||| Lyophilisate for suspension. ||| Phlebitis following intravenous administration. ||| Lyophilisat pour reconstitution.
0.3592004179954529 ||| Palifermin is similar to the protein called keratinocyte growth factor (KGF) that is naturally made by your body in small amounts. ||| Methionine naturally comes from proteins in foods and is usually broken down into homocysteine, then cysteine. ||| Le palifermin est similaire à la protéine naturelle appelée facteur de croissance des kératinocytes (KGF), qui est fabriquée par votre corps en petites quantités.
0.006548283156007528 ||| MIRCERA 100 micrograms/ ml solution for injection ||| MIRCERA 200 micrograms/ ml solution for injection ||| MIRCERA 100 microgrammes/ ml, solution injectable.
0.23003579676151276 ||| Menitorix is a vaccine that can be given to children after the age of 2 months up to 2 years to prevent infectious diseases caused by Haemophilus influenzae type b (Hib) and Neisseria meningitidis group C (MenC) bacteria. ||| Virbagen Omega is also used to treat cats infected with FeLV (feline leukaemia virus) and/ or FIV (feline immunodeficiency virus), in non-terminal cats from the age of 9 weeks. ||| MENITORIX est un vaccin destiné aux enfants à partir de l’ âge de 2 mois et jusqu’ à 2 ans pour prévenir les maladies dues aux bactéries appelées Haemophilus influenzae type b (Hib) et Neisseria meningitidis du groupe C (MenC).
0.28122007846832275 ||| You should continue to take your medicine even if you do not feel better, as it may take a number of weeks for your medicine to work for you. ||| However it is important that you are given a complete course of the treatment, even if you begin to feel better after a few days, otherwise your symptoms may return. ||| En effet, chez certains patients, cela peut prendre quelques semaines avant que ce médicament ne soit efficace.
0.14294025301933289 ||| Helixate NexGen powder should only be reconstituted with the supplied solvent (5.0 ml water for injections) using the supplied sterile Mix2Vial filter transfer device. ||| KOGENATE Bayer powder should only be reconstituted with the supplied solvent (2.5 ml water for injections) in the prefilled syringe and the integrated transfer device (Bio-Set). ||| La poudre d'Helixate NexGen doit uniquement être reconstituée avec le solvant associé (5,0 ml d’ eau pour préparations injectables) en utilisant le dispositif de transfert stérile avec filtre Mix2vial.
0.3629411458969116 ||| Actrapid is often given in combination with longer-acting insulin products. ||| Injections of fast-acting insulin were also used at mealtimes. ||| Actrapid est souvent administré en association avec des préparations d’ insulines d’ action lente.
0.3953950107097626 ||| Cubicin is used in adults to treat infections of the skin and the tissues below the skin. ||| In women, FSH is needed for the growth and development of follicles in the ovaries. ||| Cubicin s’ utilise chez l’ adulte dans le traitement des infections de la peau et des tissus sous-cutanés.
0.346962571144104 ||| You will have to inject Ceplene and IL-2 twice a day by subcutaneous injection (in the layer of tissue just under the skin), according to the directions provided by your doctor. ||| Silgard can be given with Hepatitis B vaccine at a separate injection site (another part of your body, e. g. the other arm or leg) at the same visit. ||| Vous devrez vous injecter Ceplene et l’ IL-2 deux fois par jour par voie sous-cutanée (dans la couche de tissus juste sous la peau), conformément aux directives données par votre médecin.
0.17420580983161926 ||| Clean the site of injection with an alcohol swab. ||| Clean the injection area with an alcohol wipe. ||| Nettoyer le site d’ injection avec un tampon d’ alcool.
0.42401593923568726 ||| Debride fibrous, necrotic or sclerotic tissue and appropriately decorticate bone so that Osigraft is in direct contact with bleeding bone and viable osseous tissue. ||| Teratogenicity was characterised by partially ossified cranial bones, absence of eye sockets, hydrocephaly, bipartite sternebrae, missing lumbar vertebrae. ||| Débrider les tissus fibreux, nécrotiques ou sclérotiques et décortiquer de manière appropriée l’ os, de façon à ce que l’ Osigraft reconstitué soit en contact direct avec l’ os qui saigne et le tissu osseux viable.
0.2140098512172699 ||| How to store Telzir 6. ||| How to store Jalra 6. ||| Comment conserver Telzir 6.
0.0 ||| THE WORDS “ FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable ||| THE WORDS “ FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable ||| LA MENTION « À USAGE VÉTÉRINAIRE » ET CONDITIONS OU RESTRICTIONS DE DÉLIVRANCE ET D’ UTILISATION
0.48713716864585876 ||| EMEA/ CHMP/ 384875/ 2008 ||| EMEA/ H/ C/ 903 ||| EMEA/ CHMP/ 674044/ 2008
0.2064361274242401 ||| Table centres [ornaments] made of wood ||| Model animals [ornaments] made of wood ||| Centres de table [décorations] en bois
0.33569374680519104 ||| The acute toxicity was studied following subcutaneous administration in rats. ||| Effects on the oestrus cycle were observed at 5-fold the human therapeutic exposure. ||| La toxicité aiguë après administration sous-cutanée a été étudiée chez le rat.
0.3714449405670166 ||| The blood glucose-lowering effect of oral hypoglycaemic agents decreases in many patients over time. ||| If you are a man, elevated follicule stimulating hormone blood levels are indicative of testicular damage. ||| L’ effet hypoglycémiant de ce type de produit finit par s’ atténuer avec le temps chez de nombreux
0.41018229722976685 ||| Residues in kidney ranged from below the limit of quantification to 150 µg/ kg at 7 days and were below the limit of quantification at later time points. ||| No subject experienced an increase in QTcF of ≥ 60 msec from baseline or a QTcF interval exceeding the potentially clinically relevant threshold of 500 msec. ||| Les résidus dans les reins étaient compris entre la limite de quantification et 150 µg/ kg à 7 jours et étaient sous la limite de quantification aux dates ultérieures.
0.4888244569301605 ||| After the last day of treatment with Pirsue, milk from treated cows should not be used for 5 days. ||| Only one two-year course of Forsteo should be given to a patient in their lifetime. ||| Après le dernier jour de traitement par Pirsue, le lait des vaches traitées ne doit pas être utilisé pendant 5 jours.
0.4247478246688843 ||| If it appears to be a dry powder you should constitute the oral suspension by following the instructions below. ||| This cup, which is attached to the bottle cap, is the only cup you should use to measure your dose. ||| Si elle se présente sous forme de poudre sèche, vous devez reconstituer la suspension buvable en suivant les indications ci- dessous.
0.3671073913574219 ||| On behalf of the Regional Development Committee, Chair Younous Omarjee, in agreement with the political coordinators, requests that the European Parliament use the "urgent procedure" (defined under Rule 163 ), to allow the proposed measures to be efficiently adopted. ||| Michel Barnier, the European Commission's Chief Negotiator, said: "This text demonstrates that an ambitious and comprehensive agreement on our future relationship is possible, on the basis of the EU's mandate and the political ambition agreed with the UK five months ago." ||| Au nom de la commission du développement régional, son président Younous Omarjee, en accord avec les coordinateurs des groupes politiques, demande que le Parlement européen utilise la "procédure d'urgence" (définie à l'article 163 du règlement), afin de permettre l'adoption la plus efficace des mesures proposées.
0.32985714077949524 ||| GROUNDS FOR AMENDMENT OF THE SUMMARY OF PRODUCT CHARACTERISTICS ||| GROUNDS FOR THE VARIATION OF THE MARKETING AUTHORISATION OF HBVAXPRO ||| MOTIFS DE LA MODIFICATION DU RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT
0.4196241497993469 ||| In all studies, DRAXXIN was at least as effective as the comparator medicines. ||| Dicural was as effective as or slightly more effective than the comparator antibiotics. ||| Dans toutes les études, DRAXXIN s’est montré au moins aussi efficace que les médicaments de comparaison.
2.928538826913775e-14 ||| In in vitro tests, including binding to insulin receptor sites and effects on growing cells, insulin lispro behaved in a manner that closely resembled human insulin. ||| In in vitro tests, including binding to insulin receptor sites and effects on growing cells, insulin lispro behaved in a manner that closely resembled human insulin. ||| 117 Dans les tests in vitro comprenant la fixation sur les récepteurs de l'insuline et les effets sur les cellules en phase de croissance, l’ insuline lispro s'est comportée de façon très semblable à l'insuline humaine.
0.5899487733840942 ||| Only use it if the solution is clear, colourless and has no visible particles in it. ||| With some drinks, the mixture may change colour and possibly become cloudy. ||| Ne l’utilisez que si la solution est limpide, incolore et ne contient pas de particules visibles.
0.22880521416664124 ||| Danmark Baxter A/ S Gydevang 43 DK-3450 Allerød Tlf.: +45-48-16 64 00 ||| Danmark Lundbeck Pharma A/S Dalbergstrøget 5 DK-2630 Taastrup Tlf: +45 4371 4270 ||| Danmark Baxter A/ S Gydevang 43 DK-3450 Allerř d Tlf.: +45-48-16 64 00
0.3915613293647766 ||| Kinzalmono 20 mg tablets telmisartan ||| Xiliarx 50 mg tablets vildagliptin ||| Kinzalmono 20 mg comprimés telmisartan
0.3605750501155853 ||| • 26.8.2002 • OJ C 237, 2.10.2002, p. ||| 7.5.1998 8.5.1998 OJ C 164, 29.5.1998, p. ||| 1.7.2002 22.8.2002 26.8.2002 JO C 237, 2.10.2002, p.
0.11094492673873901 ||| Fentanyl passes into breast milk and may cause sedation and respiratory depression in the breast-fed child. ||| Fentanyl is excreted into breast milk and may cause sedation and respiratory depression in the breast- fed infant. ||| Le fentanyl est excrété dans le lait maternel et peut entraîner une sédation et/ ou une dépression respiratoire chez le nourrisson.
0.013488451018929482 ||| Dafiro 5 mg/ 160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg alone. ||| Exforge 5 mg/ 160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg alone. ||| Dafiro 5 mg/ 160 mg peut être administré chez les patients dont la pression artérielle n'est pas suffisamment contrôlée avec l'amlodipine 5 mg ou le valsartan 160 mg seuls.
0.25973236560821533 ||| After a single dose of radiolabelled glimepiride, 58% of the radioactivity was recovered in the urine, and 35% in the faeces. ||| Metabolites account for approximately 14% of the administered amprenavir dose in the urine, and approximately 75% in the faeces. ||| Après administration de glimépiride radiomarqué, 58% de la radioactivité est retrouvé dans les urines et 35% dans les selles.
0.09534064680337906 ||| Continue to take Januvia as long as your doctor prescribes it so you can continue to help control your blood sugar. ||| Continue to take TESAVEL as long as your doctor prescribes it so you can continue to help control your blood sugar. ||| Continuez à prendre Januvia aussi longtemps que votre médecin vous l’ a prescrit de manière à pouvoir maintenir le contrôle de votre taux de sucre dans le sang.
0.35356783866882324 ||| The skin effects of burning, stinging, tingling, rash and erythema were reported at higher levels in Vaniqa treated patients compared to vehicle, as indicated by the asterisk (*). ||| Visual disturbances (< 1%) associated with the use of Ketek, including blurred vision, difficulty focusing and diplopia, were mostly mild to moderate. ||| Les effets cutanés de type sensations de brûlure, de piqûres, picotements, rash et érythème ont été rapportés à une fréquence plus importante dans le groupe Vaniqa que dans le groupe excipient, effets marqués par (*).
0.7282912731170654 ||| Manual rectifiers ||| Building reinforcing ||| Redresseurs manuels
0.3740442097187042 ||| Gasifiers for laboratory use ||| Incubators for laboratory use ||| Gazéifieurs pour laboratoires
0.01594075933098793 ||| In case of accidental self injection, seek medical advice immediately and show the package insert or the label to the physician. ||| In the case of accidental self injection, seek medical advice immediately and show the package insert or label to a physician. ||| En cas d’ auto-injection accidentelle, demandez immédiatement conseil à un médecin et montrez -lui la notice ou l’ étiquetage.
0.01160632073879242 ||| LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LISTE REPRENANT LES NOMS, LES FORMES PHARMACEUTIQUES, LES DOSAGES DES MÉDICAMENTS, LES VOIES D'ADMINISTRATION, LES TITULAIRES DE L'AUTORISATION DE MISE SUR LE MARCHÉ DANS LES ÉTATS MEMBRES
0.035075441002845764 ||| 1.0 ml (10 million IU/ ml) ||| 1.2 ml (25 million IU/ ml) ||| 1,0 ml (10 millions UI/ ml)
0.3716961443424225 ||| Decontamination showers ||| Disinfectant dressings ||| Douches de décontamination
0.363696813583374 ||| Once a syringe has been removed from the refrigerator and has reached room temperature (up to 25°C) it must either be used within 3 days or disposed of. ||| However, if you are not able to do so, it will remain usable for a period of 3 hours, if kept at 2-8°C (in a refrigerator). ||| Une fois que la seringue a été sortie du réfrigérateur et a atteint la température ambiante (jusqu’ à 25°C), elle doit être utilisée dans les 3 jours ou jetée.
0.020134296268224716 ||| - If you have any further questions, ask your doctor, nurse or pharmacist. ||| - If you have any further questions, ask your doctor, nurse or your pharmacist. ||| - Si vous avez d’ autres questions, si vous avez un doute, demandez plus d’ informations à votre
0.10484479367733002 ||| EU/ 1/ 02/ 211/ 002 ||| or EU/ 1/ 02/ 211/ 003 ||| s EU/ 1/ 02/ 211/ 002
0.32358109951019287 ||| Based on in vitro data, betaine might interact with amino acids mixtures and medicinal products containing vigabatrin and GABA analogues. ||| Etanercept serum values were determined by an ELISA method, which may detect ELISA-reactive degradation products as well as the parent compound. ||| Les données in vitro laissent penser que la bétaïne pourrait interagir avec les mélanges d’ acides aminés et les médicaments contenant de la vigabatrine ou des analogues du GABA.
0.7268596887588501 ||| 112 ANNEX III ||| 115 PART III: ||| 120 ANNEXE III
0.13483105599880219 ||| Always take Pelzont exactly as your doctor has told you. ||| Always takeZeffix exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.3908022940158844 ||| Clinical investigation in women for the indication of ART and anovulation was limited to one treatment cycle. ||| In both arms, quality of life measured by the EORTC questionnaire was comparable and stable during treatment and follow-up. ||| La recherche clinique chez les femmes dans les indications d’ AMP et d’ anovulation a été limitée à un cycle de traitement.
0.30031508207321167 ||| 30 film-coated tablets 60 film-coated tablets 100 film-coated tablets 500 film-coated tablets ||| 4x1 film-coated tablets 30x1 film-coated tablets 100x1 film-coated tablets ||| 30 comprimés pelliculés 60 comprimés pelliculés 100 comprimés pelliculés 500 comprimés pelliculés
4.631681865298332e-13 ||| Metabolism and nutrition disorders ||| Metabolism and nutrition disorders ||| 127 Troubles du métabolisme et de la nutrition
0.5379968285560608 ||| 31 Antacid: the effect of an aluminum hydroxide and magnesium hydroxide-containing antacid on the pharmacokinetics of capecitabine was investigated. ||| Gemcitabine and paclitaxel combination therapy Combination therapy did not alter the pharmacokinetics of either gemcitabine or paclitaxel. ||| Antiacides: l'effet d'un antiacide contenant de l'hydroxyde d'aluminium et de l'hydroxyde de magnésium sur la pharmacocinétique de la capécitabine a été étudié.
1.188354730606079 ||| % Change in Liver Volume ||| Normal Mild Moderate Severe ||| Variation du volume hépatique (%)
0.2618204653263092 ||| For combination with capecitabine, the most frequent treatment-related undesirable effects (≥ 5%) reported in a phase III trial in breast cancer patients failing anthracycline treatment are presented (see capecitabine summary of product characteristics). ||| The CHMP has recommended the removal of the therapeutic indication “ acute and chronic complicated pyelonephritis” for the medicinal products containing norfloxacin taken orally (referred to medicinal products listed in Annex I). ||| Pour l’ association avec la capécitabine, les effets indésirables le plus fréquemment rapportés (≥ 5%) dans un essai de phase III chez des patientes traitées pour un cancer du sein après échec d’ un traitement avec une anthracycline sont présentés (voir résumé des caractéristiques de la capécitabine).
0.5265331268310547 ||| Provision of access to Internet platforms for the purpose of exchanging digital photographs ||| • Introduction of a pilot project for live web broadcasting of meetings. ||| Fourniture d'accès à des plates-formes Internet destinés à échanger des photos numériques
0.44029778242111206 ||| The ampoule contents are added to a sodium chloride or glucose solution contained in a drip bag. ||| Dimeticone or silicone emulsion may be used to treat the cartridge plunger, and/ or the glass cartridge. ||| Le contenu de l’ampoule est ajouté à une poche de perfusion qui renferme une solution de chlorure de sodium ou de glucose.
4.548832014186766e-13 ||| Pull slightly on the plunger to check that a blood vessel has not been punctured. ||| Pull slightly on the plunger to check that a blood vessel has not been punctured. ||| Tirez légèrement sur le piston pour vérifier que vous n’ avez pas percé un vaisseau sanguin.
0.18546999990940094 ||| CELSENTRI should be used with caution in patients aged over 65 years and in patients who have problems with their liver. ||| TORISEL should be used with caution in patients who have severe problems with their kidneys or who have liver problems. ||| CELSENTRI doit être utilisé avec précaution chez les patients de plus de 65 ans et chez les patients présentant des troubles hépatiques.
0.10324478894472122 ||| Why has Targretin been approved? ||| Why has Panretin been approved? ||| Pourquoi Targretin a -t-il été approuvé?
0.3154710531234741 ||| The injections should be preferably administered on the alternate sides of the neck. ||| The injections are administered subcutaneously in the deltoid region of the arm or the thigh. ||| Les injections seront administrées de préférence en alternance, de chaque côté de l’ encolure.
0.14260506629943848 ||| Oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics and danazol. ||| Oral contraeptives, thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol. ||| Contraceptifs oraux, thiazidiques, glucocorticoïdes, hormones thyroïdiennes, sympathomimétiques et danazol.
0.06767551600933075 ||| Each vial contains 2.5 g of powder for solution for infusion. ||| Each vial contains 3 ml of concentrate for solution for infusion. ||| Chaque flacon contient 2,5 g de poudre pour solution pour perfusion.
0.3510929346084595 ||| The additional studies showed that booster vaccinations with Infanrix Hexa were as effective as separate vaccines containing the same active substances one month after the booster vaccination. ||| The published study showed that patients taking combinations of medicines that included Xeloda survived for a similar length of time as those taking combinations including 5-FU. ||| Les études supplémentaires ont démontré que les vaccinations de rappel par Infanrix Hexa étaient aussi efficaces que des vaccins séparés contenant les mêmes principes actifs un mois après la vaccination de rappel.
0.2305641770362854 ||| WHAT QUINTANRIX IS AND WHAT IT IS USED FOR i dic ||| WHAT Ratiograstim IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE QUINTANRIX ET DANS QUEL CAS EST-IL UTILISÉ Ce
0.35899317264556885 ||| 4 Plasma levels of cinacalcet may be lower in smokers due to induction of CYP1A2-mediated metabolism. ||| 1-2 mg/ kg robenacoxib tablets produced a marked inhibition of COX-2 activity in cats and had no effect on COX-1 activity. ||| Le taux plasmatique du cinacalcet peut être diminué chez les fumeurs en raison d’ une induction du métabolisme médiée par le CYP1A2.
0.25413966178894043 ||| In patients with baseline haemoglobin ≤ 10 g/ dl (n=899), the hazard ratio point estimate for survival was 0.98 (95% CI 0.68 to 1.40). ||| The relative risk compared to placebo for a similar composite endpoint (CV death, MI, stroke) was 1.14 (95% CI 0.61 - 2.12) with celecoxib 200 mg twice daily. ||| Chez les patients ayant une hémoglobine initiale ≤ 10 g/ dl (n=899), le risque relatif estimé pour la survie était de 0,98 (IC 95%, 0,68 à 1,40).
0.031064219772815704 ||| When appropriate the dosage can be gradually increases up to a maximum of 60 mg. ||| When appropriate the dosage can be gradually increased up to a maximum of 60 mg. ||| Si nécessaire, la dose peut être augmentée progressivement jusqu’ à une dose maximale de 60 mg/ jour.
0.14985544979572296 ||| Metastatic ovarian cancer (second-line treatment): ||| Advanced ovarian cancer (first-line treatment): ||| Cancer métastatique de l’ ovaire (en seconde intention):
0.2338007390499115 ||| Norge Aventis Pharma Norge AS Tlf: +47 67 10 71 00 ||| Danmark Pfizer ApS Tlf: +45 44 20 11 00 ||| Norge sanofi-aventis Norge AS Tlf: +47 67 1 0 71 00
0.2560817301273346 ||| Each tablet contains 45 mg of pioglitazone (as hydrochloride) and 4 mg of glimepiride. ||| Each tablet contains 100 mg of levodopa, 25 mg of carbidopa and 200 mg of entacapone. ||| Chaque comprimé contient 45 mg de pioglitazone (sous forme de chlorhydrate) et 4 mg de glimépiride.
0.2690795361995697 ||| Patients who have developed severe hypersensitivity reactions should not be re-challenged with docetaxel. ||| Patients with heart failure who have been stabilised with an ACE inihibitor should not be switched to losartan. ||| Le docétaxel ne doit pas être réadministré aux patients ayant présenté des réactions d'hypersensibilité sévères.
0.23361968994140625 ||| Pale red to grey-red, oval-oblong film-coated tablets with imprint “ 20 ” on one side and imprint “ MEM” on the other side. ||| Very dark yellow to brownish-orange film-coated tablet, round with “ NVR” on one side and “ SA” and score on the other side. ||| Comprimés pelliculés rouge pâle à gris-rouge, de forme oblongue ovale, portant l’ inscription « 20 » sur une face et l’ inscription « MEM » sur l’ autre face.
0.37823107838630676 ||| Therefore, under conditions of compromised renal perfusion, administration of lumiracoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. ||| Nitrogen waste, in the form of ammonia, is especially toxic for the brain and leads, in severe cases, to reduced levels of consciousness and to coma. ||| De ce fait, en cas d'altération de la perfusion rénale, l'administration du lumiracoxib peut entraîner une diminution de la synthèse des prostaglandines, et secondairement du débit sanguin rénal, et altérer ainsi la fonction rénale.
0.4857400059700012 ||| Progression-free survival and objective response rate were inferior in the Avastin monotherapy arm compared to the FOLFOX-4 arm. ||| A correlation between the tipranavir mutation score and response to APTIVUS/ ritonavir therapy at week 48 has been established. ||| La survie sans progression et le taux de réponse objective ont été inférieurs dans le groupe avec Avastin en monothérapie comparé à celui avec FOLFOX-4.
0.5166083574295044 ||| Dosage The usual dose of CoAprovel is one or two tablets a day. ||| Subcutaneous use One 1-ml dose of vaccine according to the following schedule: ||| Posologie La posologie habituelle de CoAprovel est de un ou deux comprimés par jour.
0.10298947989940643 ||| Providing information relating to the repair or maintenance of sewing machines ||| Providing information relating to the repair or maintenance of gas water heaters ||| Mise à disposition d'informations en matière de réparation ou d'entretien de machines à coudre
0.35796964168548584 ||| Patients should be titrated in dose increments of ≤ 2.4 μ g/ day, up to a maximum dose of 21.6 μ g/ day. ||| Single doses of up to 100 µl dispersion/ kg and multiple doses up to 150 µl dispersion/ kg were tolerated well in Phase I clinical trials. ||| La dose doit être augmentée par paliers ≤ 2,4 μ g/ jour, jusqu'à une dose maximale de 21,6 μ g/ jour.
0.4774436354637146 ||| You can usually continue to take other medicines whilst you are being treated with Glustin 15 mg tablets. ||| If you could get pregnant you must use adequate contraception whilst you use the medicine. ||| Vous pouvez généralement continuer à prendre d'autres médicaments alors que vous êtes traité avec Glustin 15 mg comprimés.
0.05153407156467438 ||| - There have been reports in the literature showing a correlation between the occurrence of a factor IX ||| - There have been reports in the literature showing a correlation between the occurrence of a factor ||| − Une corrélation entre l'apparition d'un inhibiteur anti-facteur IX et des réactions allergiques a été rapportée dans la littérature.
0.013078374788165092 ||| Benzalkonium chloride, which is commonly used as a preservative in ophthalmic products, has been reported to cause punctate keratopathy and/ or toxic ulcerative keratopathy. ||| 3 Benzalkonium chloride, which is commonly used as a preservative in ophthalmic products, has been reported to cause punctate keratopathy and/ or toxic ulcerative keratopathy. ||| Des kératopathies ponctuées et/ ou kératopathies ulcératives toxiques ont été rapportées avec le chlorure de benzalkonium, couramment utilisé comme conservateur dans les produits ophtalmiques.
0.3035716414451599 ||| VIRACEPT should be taken in combination with other medicines that are active against HIV. ||| It may also be used in combination with antidiabetic medicines that are taken by mouth. ||| VIRACEPT doit être pris en association avec d’autres médicaments actifs contre le VIH.
0.539604663848877 ||| In December 2019, a pneumonia outbreak was reported in Wuhan, China. ||| On 21 February, a large outbreak was reported in Italy, mostly in the north near Milan. ||| En décembre 2019, une épidémie de pneumonie a été signalée à Wuhan, en Chine.
0.5823090672492981 ||| Lime ||| Maize ||| Chaux
0.03183983638882637 ||| Actraphane 40 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA) ||| Protaphane NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA) ||| Actraphane 40 NovoLet 100 UI/ ml suspension injectable en stylo prérempli Insuline humaine (ADNr)
0.5515658259391785 ||| Patients should be carefully monitored during therapy. ||| In this situation the patient must be ventilated. ||| Les patients doivent être surveillés avec attention pendant le traitement.
1.3388220071792603 ||| Product a) Brand name b) INN c) Part A/B ||| Comp any a) Name b) Origin ||| Produit a) Nom de marque b) DCI
0.23910263180732727 ||| The diluent is a clear to slightly turbid, light-yellow to yellow solution. ||| The concentrate is a clear viscous, yellow to brown-yellow solution. ||| Le diluant est une solution limpide à légèrement trouble, jaune-pâle à jaune.
0.1196218878030777 ||| Non-clinical safety data revealed no special hazard for humans based on conventional oral aripiprazole studies of safety pharmacology, repeat-dose toxicity, genotoxicity, carcinogenic potential, and toxicity to reproduction. ||| Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and carcinogenic potential, fertility and embryonal/ foetal development. ||| Les données non cliniques avec l'aripiprazole par voie orale issues des études conventionnelles de pharmacologie de sécurité, toxicologie en administration répétée, génotoxicité, cancérogénèse, et des fonctions de reproduction, n’ ont pas révélé de risque particulier pour l'homme.
0.4444432556629181 ||| Existing hypocalcaemia must be corrected before starting Bonviva injection therapy. ||| Adequate contraceptive precautions should be used when either partner is receiving Busilvex. ||| L'hypocalcémie préexistante doit être corrigée avant de débuter le traitement par Bonviva IV.
0.4614526033401489 ||| In the first study of previously untreated patients, adding Avastin increased survival times from an average of 15.6 to 20.3 months. ||| The studies involved over 10,000 infants, about three quarters of whom received Infanrix Penta, given according to various time schedules. ||| Dans la première étude concernant les patients n'ayant encore bénéficié d'aucun traitement, l'adjonction d'Avastin a augmenté la durée de survie d'une moyenne de 15,6 à 20,3 mois.
0.3382544219493866 ||| When used with an insulin infusion pump, Apidra must not be mixed with other medicinal products. ||| Palivizumab should not be mixed with any medicinal products or diluents other than water for injections. ||| En cas d’ utilisation dans une pompe à perfusion, Apidra ne doit pas être mélangé avec d’ autres médicaments.
0.3476625382900238 ||| Significantly fewer colectomies occurred within 3 months of study infusion in patients who received a single dose of 5 mg/ kg infliximab compared to patients who received placebo (29.2% vs 66.7% respectively, p=0.017). ||| After 12 months, these patients showed a difference of 28% between treatment groups (67% for Visudyne patients compared to 39% for placebo patients, p < 0.001); the benefit was maintained at 24 months (59% versus 31%, p < 0.001). ||| Un nombre significativement plus faible de colectomies est apparu au cours des 3 mois d’ étude chez les patients qui ont reçu une dose unique de 5 mg/ kg d’ infliximab en comparaison aux patients qui ont reçu du placebo (29,2% vs 66,7% respectivement, p=0,017).
0.13010749220848083 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The French scheme will partly compensate airlines for damages suffered due to the coronavirus outbreak. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "Today, we approved a German scheme for guarantees on loans for companies affected by the coronavirus outbreak. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Le régime français compensera en partie les dommages causés par la flambée de coronavirus aux compagnies aériennes.
4.0094552569529263e-13 ||| • CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT ||| • CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT ||| AUTRES CONDITIONS OU RESTRICTIONS EN VUE D'UNE UTILISATION SURE ET EFFICACE DU MEDICAMENT
0.08892731368541718 ||| 25 Latvija Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK Lielbritā nija Tel: + 44 (0) 1628 494026 E-mail: uk_medinfo@allergan. com ||| Eesti Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK Ühendkuningriik Tel: + 44 (0) 1628 494026 E-mail: uk_medinfo@allergan. com ||| Latvija Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK Lielbritānija Tel: + 44 (0) 1628 494026 E-mail: uk_medinfo@allergan.com
0.24335938692092896 ||| Impulse control disorders and compulsive behaviours Pathological gambling, increased libido and hypersexuality have been reported in patients treated with dopamine agonists for Parkinson’ s disease, including SIFROL. ||| Pathological gambling, increased libido and hypersexuality have been reported in Parkinson’ s disease patients treated with dopamine agonists and other dopaminergic treatments such as entacapone in association with levodopa. ||| Troubles du contrôle des impulsions et comportements compulsifs Des cas de jeux pathologiques, de libido accrue, et d’ hypersexualité ont été rapportés chez des patients traités pour la maladie de Parkinson par des agonistes dopaminergiques, dont SIFROL.
0.4603576064109802 ||| Alcohol Increased risk of lactic acidosis in acute alcohol intoxication, particularly in case of: ||| Alcohol intolerance (facial flushing or skin irritation after consumption of an alcoholic beverage) no ||| Alcool Risque majoré d’ acidose lactique lors d’ intoxication alcoolique aiguë, en particulier en cas:
0.0354335680603981 ||| Rebif 44 micrograms solution for injection in pre-filled syringe Interferon beta-1a ||| Rebif22 micrograms solution for injection in pre-filled syringe Interferon beta-1a ||| Rebif 44 microgrammes solution injectable en seringue préremplie Interféron bêta-1a
0.5622102618217468 ||| 28/ 94 The binding of ropinirole to plasma proteins is not high (< 40%), with no effect on the distribution, which is very extensive (volume of distribution in the order of 7 l/ kg). ||| Lowest concentration, which completely inhibits visible growth of at least 50% of isolates 2 Lowest concentration, which completely inhibits visible growth of at least 90% of isolates 3 Some of these pathogens (e. g. ||| Distribution La fixation du ropinirole aux protéines plasmatiques est peu importante (< 40%), sans incidence sur la distribution qui est très large (volume de distribution de l’ ordre de 7 l/ kg).
0.6226553320884705 ||| fatigue, peripheral oedema ||| peripheral coldness ||| Fatigue, œ dème périphérique
0.523192286491394 ||| Timber laminates ||| Latex mattresses ||| Bois laminés
0.330279141664505 ||| Telecommunications multiplexers ||| Telecommunications networks ||| Multiplexeurs pour télécommunications
0.29026007652282715 ||| The adverse drug reaction profile associated with immunosuppressive agents is often difficult to establish owing to the underlying disease and the concurrent use of multiple medications. ||| Due to the exposure to ionising radiation derived from the radiolabel, a risk of mutagenic and carcinogenic effects has to be taken into account. ||| 24 Le profil des effets indésirables liés aux traitements immunosuppresseurs est souvent difficile à établir en raison de la pathologie sous-jacente et de l’ utilisation concomitante de nombreux autres médicaments.
0.18793684244155884 ||| Mean baseline CD4 cell count was 838 cells/ mm3 and mean baseline plasma HIV-1 RNA was 4.7 log10 copies/ ml. ||| The mean baseline CD4 cell count was 341 cells/ mm3 and the mean baseline HIV-RNA level was 60,250 copies/ ml. ||| La valeur moyenne du taux initial de CD4 était de 838 cellules/ mm3 et la charge virale plasmatique avait une valeur moyenne de 4,7 log10 copies/ ml.
0.17035764455795288 ||| Xeloda should only be prescribed by a qualified physician experienced in the utilisation of anti- neoplastic agents. ||| Lapatinib treatment should only be initiated by a physician experienced in the administration of anti- cancer agents. ||| Xeloda doit être seulement prescrit par un médecin qualifié, expérimenté dans l’ utilisation des anti- cancéreux.
0.2936724126338959 ||| This was associated with a reported improvement in symptoms affecting the cardiovascular system (heart and blood vessels) and the development of the nervous system in around three quarters of the patients taking Cystadane. ||| The main measure of effectiveness was the improvement in the signs and symptoms of rheumatoid arthritis, joint damage and the patients’ physical function after up to 54 weeks. ||| Ces baisses ont été accompagnées d’ une amélioration des symptômes affectant le système cardiovasculaire (coeur et vaisseaux sanguins) et le développement du système nerveux chez près des trois quarts des patients traités par Cystadane.
0.09191122651100159 ||| If pregnancy occurs in a partner of a male patient taking lenalidomide, it is recommended to refer the female partner to a physician specialised or experienced in teratology for evaluation and advice. ||| If pregnancy occurs in a woman treated with lenalidomide, treatment must be stopped and the patient should be referred to a physician specialised or experienced in teratology for evaluation and advice. ||| En cas de survenue d’ une grossesse chez la partenaire d’ un homme traité par lénalidomide, il est recommandé d’ adresser la femme à un médecin spécialiste ou expérimenté en tératologie pour évaluation et conseil.
0.2622332274913788 ||| Specifically, the SURE instrument will act as a second line of defence, supporting short-time work schemes and similar measures, to help Member States protect jobs and thus employees and the self-employed against the risk of unemployment and loss of income. ||| This second amendment therefore expands the Temporary Framework to enable well-targeted public interventions in the form of recapitalisation aid to those non-financial companies in need, to help reduce the risk to the EU economy as a whole. ||| Plus précisément, l'instrument SURE fera office de «deuxième ligne de défense», en soutenant les dispositifs de chômage partiel et les mesures similaires, afin d'aider les États membres à préserver les emplois et, ainsi, à protéger les salariés et les travailleurs indépendants contre le risque de chômage et de perte de revenus.
0.23071756958961487 ||| Filgrastim HEXAL must not be diluted with sodium chloride solutions. ||| Biograstim should not be diluted with sodium chloride solution. ||| Filgrastim HEXAL ne doit pas être dilué avec des solutions salines.
0.0023354997392743826 ||| 143 A comparison of serum concentrations of methoxy polyethylene glycol-epoetin beta measured before and after haemodialysis in 41 CKD patients showed that haemodialysis has no effect on the pharmacokinetics of this medicinal product. ||| 31 A comparison of serum concentrations of methoxy polyethylene glycol-epoetin beta measured before and after haemodialysis in 41 CKD patients showed that haemodialysis has no effect on the pharmacokinetics of this medicinal product. ||| Une comparaison des concentrations sériques du méthoxy polyéthylène glycol-epoetin beta mesurées avant et après hémodialyse chez 41 patients atteints d’ une IRC a montré que l’ hémodialyse n’ avait aucun effet sur les paramètres pharmacocinétiques de ce médicament.
0.9055519104003906 ||| c) Mixing insulins ||| a) Tablet, Oral powder ||| c) Mélange d' insulines
0.26187849044799805 ||| It is important that you tell your doctor if you have symptoms of infection, e.g. fever, malaise, wounds, dental problems. ||| If you develop new or worsening symptoms of heart failure (e. g. shortness of breath, or swelling of your feet), you must contact your doctor immediately. ||| Il est important que vous informiez votre médecin si vous présentez des symptômes d’ infection tels que fièvre, malaise, blessures, problèmes dentaires.
0.3872988224029541 ||| Important note • Do not touch the needle or allow it to touch any surface before the injection. • It is normal to see a small air bubble in this syringe. ||| Don’ t use it if any damage is seen or if there is a gap between the rubber plunger and the white label band. ||| Note importante • Ne touchez pas l'aiguille, ne la mettez en contact avec aucune surface avant l'injection. • Il est normal d’observer une petite bulle d'air dans la Figure B1 seringue.
0.2550504803657532 ||| Headache, dizziness, unconsciousness, syncope, dyspnoea, hypotension, palpitation, tachycardia, arrhythmia. ||| Fever, lethargy, malaise, oedema, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis ||| Céphalées, vertiges, perte de connaissance, syncope, dyspnée, hypotension, palpitations, tachycardie, arythmie.
0.8383505344390869 ||| Preparing for injection ||| Following an Injection ||| Préparation de l’ injection
0.47383934259414673 ||| The instrument will support otherwise viable companies that are now faced with solvency issues due to the coronavirus crisis. ||| National authorities should also fight misinformation that could lead to unnecessary stockpiling due to panic buying. ||| L'instrument soutiendra des entreprises aujourd'hui en butte à des problèmes de solvabilité du fait de la crise de la COVID-19, mais par ailleurs viables.
0.0 ||| 38 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 38 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 43 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.30896449089050293 ||| Pharmaceutical preparations for the prevention of diseases of the immune system ||| Topical anti-infective substances for the treatment of infections of the eye ||| Produits pharmaceutiques pour la prévention des maladies du système immunitaire
0.42467570304870605 ||| The Commission published today a Staff Working Document with an analysis of the damage that the coronavirus crisis has caused on the European economy. ||| The Commission has published its yearly Communication on the progress of management of fish stocks in the EU, which is based on data from 2018. ||| La Commission a publié ce jour un document de travail des services de la Commission analysant les dommages que la crise du coronavirus a causés à l'économie européenne.
0.2933064103126526 ||| Maximal enzyme induction is generally not seen for 2-3 weeks but may be sustained for at least 4 weeks after cessation of therapy. ||| A major bleeding episode may be treated for 2 - 3 weeks but can be extended beyond this if clinically warranted. ||| L'induction enzymatique maximale n'est généralement pas effective pendant 2-3 semaines mais elle peut être prolongée pendant au moins 4 semaines après l’ arrêt du traitement.
0.23420289158821106 ||| 4 mg; solvent: ||| 5.8 mg; solvent: ||| 4 mg; Solvant:
0.20117956399917603 ||| EVISTA contains lactose. ||| Iscover contains lactose. ||| EVISTA contient du lactose.
0.3159594237804413 ||| Camphor oil for industrial purposes ||| Rhamnose for industrial purposes ||| Huile de camphre à usage industriel
0.29258882999420166 ||| First, the patient receives Visudyne as an intravenous infusion (drip in to a vein) at a dose of 6 mg per square metre of body surface area over 10 minutes. ||| The recommended dose is 1.5 mg/ m2 body surface area, administered as an intravenous infusion over 24 hours with a three-week interval between cycles. ||| La première étape comprend une perfusion intraveineuse (goutte à goutte dans une veine) de Visudyne à une dose de 6 mg par mètre carré de surface corporelle pendant 10 minutes.
0.24477927386760712 ||| Ropinirole should not be used to treat neuroleptic akathisia, tasikinesia (neuroleptic-induced compulsive tendency to walk), or secondary Restless Legs Syndrome (e. g. caused by renal failure, iron deficiency anaemia or pregnancy). ||| Comtess should not be used in patients with: • liver disease; • phaeochromocytoma (a tumour of the adrenal gland); • a history of neuroleptic malignant syndrome (a dangerous nervous system disorder usually caused by antipsychotic medicines) or rhabdomyolysis (breakdown of muscle fibres). ||| Mises en garde spéciales et précautions d’ emploi Le ropinirole ne devra pas être utilisé pour traiter l’ akathisie, la tasikinésie (tendance compulsive à la marche induite par les neuroleptiques) ou un Syndrome des Jambes Sans Repos secondaire (par exemple: lié à une insuffisance rénale, à une anémie par carence martiale ou à une grossesse).
0.09837821125984192 ||| When ritonavir is used as a pharmacokinetic enhancer, full details on the warnings and precautions relevant to that particular PI must be considered, therefore the Summary of Product Characteristics, section 4.4, for the particular PI must be consulted to determine if the information below is applicable. ||| When ritonavir is used as a pharmacokinetic enhancer with other PIs, full details on the warnings and precautions relevant to that particular PI should be considered, therefore the Summary of Product Characteristics for the particular PI must be consulted. ||| Lorsqu’ il est administré pour potentialiser la pharmacocinétique d’ autres IP, il est nécessaire de tenir compte des mises en garde spéciales et précautions relatives à l’ IP co- administré et donc, de consulter la rubrique 4.4 du Résumé des Caractéristiques du Produit de l’ IP concerné pour déterminer si les informations ci-dessous s’ appliquent.
0.30499979853630066 ||| Safety and efficacy have not been studied in this age group.  Sodium This medicinal product contains less than 1 mmol sodium (23 mg) per dose of up to 17 ml, i. e. essentially ‘ sodium- free’. ||| Important information about some of the ingredients of NeuroBloc The medicinal product contains less than 1 mmol sodium (23 mg) per 10,000 units of NeuroBloc, i. e. essentially “ sodium free”. ||| La sécurité d’emploi et l’efficacité du produit n’ont pas été étudiées dans cette classe d’âge.  Sodium Ce médicament contient moins de 1 mmol de sodium (23 mg) par dose (jusqu’à 17 ml), et peut donc être considéré comme pratiquement « sans sodium ».
0.13587439060211182 ||| If you think you are having this type of reaction, stop your Biograstim injection and get medical help immediately. ||| If you think you are having this type of reaction, stop your Filgrastim ratiopharm injection and get medical help immediately. ||| Arrêtez l'injection de Biograstim si vous pensez avoir une réaction de ce type, et contactez immédiatement votre médecin.
0.2835901379585266 ||| There is no information to suggest that Gardasil affects your ability to drive or use machinery. ||| However, it is not considered likely that NeoSpect will affect your ability to drive or to operate machinery. ||| 67 Il n'y a aucune information permettant d'établir que Gardasil affecte votre capacité à conduire ou à utiliser certains outils ou machines.
0.40765219926834106 ||| Severe rotavirus gastro- enteritis (1st year of life) Rotarix N=9009; Placebo N=8858(§) Efficacy (%) [95% CI] ||| Porcine circovirus type 2 ORF2 protein: minimum RP* 1.0 maximum RP* 3.75 * Relative Potency (ELISA test) by comparison with a reference vaccine ||| Gastro-entérite sévère à rotavirus (1ère année de vie) Rotarix N=9009; Placebo N=8858 (§) Efficacité (%) [IC 95%] 84,7*
0.4143413007259369 ||| Use in children STOCRIN 600 mg film-coated tablets can be taken by children 3 years of age and older who are able to swallow the tablets (see How to take STOCRIN). ||| Taking Revlimid with food and drink The Revlimid capsules can be taken either with or without food (see Section 3, “How and when to take the Revlimid capsule”). ||| Utilisation chez l'enfant STOCRIN 600 mg comprimés pelliculés peut être pris par les enfants de 3 ans et plus, capables d’ avaler des comprimés (voir Comment prendre STOCRIN).
0.5366030931472778 ||| As with all injectable vaccines, there is an extremely small risk of serious allergic reactions (anaphylactic and anaphylactoid reactions). ||| Skin and subcutaneous tissue adverse reactions The majority of skin and subcutaneous adverse reactions were associated with the injection site. ||| Comme avec tous les vaccins injectables, il existe un risque extrêmement faible de réactions allergiques graves (réactions anaphylactique ou anaphylactoïde).
0.6319960355758667 ||| Data transmission services between networked computer systems ||| Disaster recovery services for data communications systems ||| Services de transmission de données d'un réseau de systèmes informatiques
0.4000248908996582 ||| Computer software to enable the transmission of photographs to mobile telephones ||| Computer software for monitoring the use of computers and the internet by children ||| Logiciels permettant la transmission de photos vers des téléphones mobiles
0.3887556791305542 ||| Braziers ||| Puddings ||| Braseros
0.609931230545044 ||| powder: vial (glass); solvent: ampoule (glass) ||| bottle (glass) + syringe (plastic) ||| Poudre: flacon Solvant: ampoule
0.23449330031871796 ||| Metabolism Darifenacin is extensively metabolised by the liver following oral administration. ||| Biotransformation Robenacoxib is extensively metabolised by the liver in dogs. ||| Métabolisme La darifénacine est largement métabolisée par le foie après administration orale.
0.4040505886077881 ||| Patients with moderate or severe heart failure (NYHA class III/ IV) (see sections 4.4 and 4.8). ||| Moderate to severe heart failure (NYHA class III/ IV) (see section 4.4). lon 4.4 Special warnings and precautions for use ||| Patients atteints d’ insuffisance cardiaque modérée ou sévère (de classe III/ IV dans la classification NYHA) (voir rubriques 4.4 et 4.8).
0.49045801162719727 ||| Wilzin are blue capsules (25 mg) or orange capsules (50 mg) containing the active ingredient zinc acetate dihydrate. ||| This humanised monoclonal antibody is composed of human (95%) and murine (5%) antibody sequences. ||| Wilzin se présente sous la forme de gélules de couleur bleue (25 mg) ou orange (50 mg) contenant le principe actif, l’ acétate de zinc dihydraté.
9.669838714476686e-13 ||| Special populations: ||| Special populations: ||| Populations spéciales:
0.38169652223587036 ||| = 274) ||| = 515) ||| (n = 274)
0.2077600061893463 ||| Patients with renal impairment For patients with mild renal impairment (creatinine clearance ≥ 50 to < 80 ml/ min), the recommended initial dose is 3 mg once daily. ||| Renal impairment No dosage adjustment of Exforge is required for patients with mild to moderate renal impairment (GFR > 30 ml/ min/ 1.73 m2). ||| Patient insuffisant rénal Chez les patients présentant une insuffisance rénale légère(clairance de la créatinine > 50 et < 80 ml/ min), la dose initiale recommandée est de 3 mg une fois par jour.
0.08391837030649185 ||| WHAT RILUTEK IS AND WHAT IT IS USED FOR ||| WHAT KETEK IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE RILUTEK ET DANS QUEL CAS EST-IL UTILISE
0.23634791374206543 ||| Telzir is also available as an oral suspension for those patients unable to swallow the tablets. ||| For patients who are unable to swallow the capsules or tablets, Stocrin can be given using the oral solution. ||| Telzir est également disponible sous forme de solution buvable pour les patients qui ne peuvent pas avaler les comprimés.
0.2566157281398773 ||| There have been reports that ophthalmic NSAIDs may cause increased bleeding of ocular tissues (including hyphaemas) in conjunction with ocular surgery. ||| The CPMP considered that loratadine has been shown to significantly reduce the symptoms of seasonal allergic rhinitis (SAR) when accompanied by nasal congestion. ||| Il a été rapporté que les AINS ophtalmiques utilisés à l’ occasion d’ une intervention ophtalmologique peuvent provoquer une augmentation du saignement des tissus oculaires (incluant des hyphémas).
0.6688699722290039 ||| Treatment of patients with chemotherapy induced anaemia: ||| Genotoxicity: a standard battery for genotoxicity testing of ||| 139 Traitement de l’ anémie induite par la chimiothérapie:
0.38008561730384827 ||| It is therefore important that you remain under the supervision of your doctor while taking Kaletra. − Kaletra does not reduce the risk of passing HIV to others. ||| If you stop using TRAVATAN without speaking to your doctor, the pressure in your eye will not be controlled which could lead to loss of sight. ||| Vous devez par conséquent être suivi régulièrement par votre médecin pendant le traitement par Kaletra. − Kaletra ne réduit pas le risque de transmission du VIH à d’ autres personnes.
0.19820696115493774 ||| Do not shake! ||| Do not shake. ||| Ne pas agiter!
0.764445960521698 ||| - low blood pressure ||| blood pressure increased ||| - pression artérielle basse
0.36355841159820557 ||| After reconstitution, each ml of solution contains approximately 500 IU moroctocog alfa. ||| A final concentration of between 0.4 to 1.2 mg/ ml doxorubicin HCl, is required. ||| Après reconstitution, chaque ml de solution contient approximativement 500 UI de moroctocog alpha.
0.4009844958782196 ||| Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: "As part of our efforts to counter the spread of the coronavirus, we have embarked decisively on the worldwide race to find an effective and safe vaccine as quickly as possible. ||| Commissioner for Trade Phil Hogan said: "While most of our efforts have been focused lately on tackling the coronavirus crisis, we have also been working to advance our open and fair trade agenda, which continues to be very important. ||| Mariya Gabriel, commissaire à l'innovation, la recherche, la culture, l'éducation et la jeunesse : « Dans le cadre de nos efforts pour contrer la propagation du coronavirus, nous nous sommes engagés de manière décisive dans la course mondiale pour trouver le plus rapidement possible un vaccin efficace et sûr.
0.5988321304321289 ||| Nycomed Danmark ApS Langebjerg 1 DK-4000 Roskilde Denmark ||| NO - Norway AstraZeneca AS Boks 200 Vinderen 0319 Oslo ||| Nycomed Danmark ApS Langebjerg 1 DK-4000 Roskilde Danemark
0.0 ||| Method of administration Rebif solution for injection in cartridge is intended for multidose use and should only be used with the RebiSmart autoinjector device following adequate training of the patient and/ or carer. ||| Method of administration Rebif solution for injection in cartridge is intended for multidose use and should only be used with the RebiSmart autoinjector device following adequate training of the patient and/ or carer. ||| Mode d’ administration Rebif solution injectable en cartouche est destiné à un usage multidose et devra être utilisé uniquement avec le dispositif d’ auto-injection RebiSmart après formation spécifique du patient et/ ou du soignant.
0.24262098968029022 ||| The Committee decided that Adenuric’ s benefits are greater than its risks for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred. ||| The Committee decided that Aldurazyme’ s benefits are greater than its risks for long-term enzyme replacement therapy in patients with a confirmed diagnosis of MPS I. ||| Le comité a décidé que les bénéfices d’ Adenuric sont supérieurs à ses risques pour le traitement de l’ hyperuricémie chronique, lorsqu’ un dépôt d’ urates s’ est déjà formé.
0.2732613682746887 ||| Animal reproduction studies have not been conducted with Helixate NexGen. ||| Reproduction studies of ViraferonPeg have not been performed. ||| Helixate NexGen n’ a pas fait l’ objet d’ études de reproduction chez l’ animal.
0.3934561610221863 ||| Heat exchangers [parts of machines] ||| Steering gears and rudders [for vessels] ||| Échangeurs thermiques [parties de machines]
0.497791051864624 ||| 100 Haematological abnormalities in HCV/HIV co-infected patients: ||| Benign NSAID-associated gastric and duodenal ulcers: ||| Anomalies hématologiques chez les patients VHC-VIH:
0.03433087468147278 ||| For the full list of all side effects reported with QUADRAMET, see the Package Leaflet. ||| For the full list of all side effects reported with PROCOMVAX, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous QUADRAMET, veuillez vous reporter à la notice.
0.5358368158340454 ||| Within its shelf-life, for the purpose of transport, the solution can be kept at or below 25ºC for a period up to seven days before use. ||| - for less than one day (up to 24 hours): it should be re-applied to the same place or replaced with ||| Sans dépasser sa date de péremption, pour le transport, la solution peut être conservée avant utilisation am
0.12448017299175262 ||| 10/ 06/ 2003 Date of latest renewal: ||| 12/ 11/ 1996 Date of last renewal: ||| 10/ 06/ 2003 Dernière date de renouvellement:
0.3349356949329376 ||| Parts of rubber for stirrups ||| Elbows of metal for pipes ||| Pièces en caoutchouc pour étriers
0.09009845554828644 ||| It is not known whether becaplermin is excreted in human milk. ||| It is not known whether anidulafungin is excreted in human breast milk. ||| Le passage de la bécaplermine dans le lait n'est pas connu.
0.14265146851539612 ||| Why has Livensa been approved? ||| Why has Startvac been approved? ||| Pourquoi Livensa a -t-il été approuvé?
0.4638737440109253 ||| The elimination half-life in patients is approximately 2 weeks. ||| Half life is approximately 50% shorter in healthy subjects. ||| La demi-vie d’ élimination chez les patients est d’ environ 2 semaines.
0.0 ||| Line up the needle with the pen, and keep it straight as you attach it (screw or push on, depending on the needle type). ||| Line up the needle with the pen, and keep it straight as you attach it (screw or push on, depending on the needle type). ||| Alignez l’ aiguille avec le stylo et maintenez -la bien droite lorsque vous la fixez sur le stylo (en la vissant ou en la poussant selon le type d'aiguille).
0.2713863253593445 ||| Liver function (transaminases, bilirubin and alkaline phosphatase) should be monitored before initiation of treatment and monthly thereafter, or as clinically indicated. ||| Standard hypercalcaemia-related metabolic parameters, such as serum levels of calcium, phosphate and magnesium, should be carefully monitored after initiating Zometa therapy. ||| La fonction hépatique (transaminases, bilirubine, phosphatases alcalines) doit être évaluée avant l’ initiation du traitement puis mensuellement ou selon la situation clinique.
0.13794639706611633 ||| Each vial contains 10 ml solution (1000 Units). ||| Each cartridge contains 3 ml solution (300 Units). ||| Chaque flacon contient 10 ml (1000 Unités) de solution.
0.08573172986507416 ||| Page 1 of 1 // 10 Results found ||| Page 1 of 1 // 4 Results found ||| Page 1 de 1 // 8 Résultats trouvés
0.5527387261390686 ||| Additives (Chemical -) for the prevention of sedimentation ||| Pharmacodynamic section of the SPC for anti-bacterial medicinal products ||| Additifs chimiques pour la prévention de la sédimentation
4.5378073043958467e-13 ||| - if you think hypoglycaemia (low blood sugar) is starting. ||| - if you think hypoglycaemia (low blood sugar) is starting. ||| - Si vous estimez qu'une hypoglycémie (abaissement du sucre dans le sang) est imminente.
0.028304055333137512 ||| 27 Dosing adjustment for adult patients with impaired renal function ||| 51 Dosing adjustment for adult patients with impaired renal function ||| 29 Adaptation posologique chez l’ adulte ayant une insuffisance rénale
0.4157145023345947 ||| Bed throws ||| Night sweats ||| Jetés de lit
0.09491608291864395 ||| What is the risk associated with Crixivan? ||| What is the risk associated with Velosulin? ||| Quel est le risque associé à l’ utilisation de Crixivan?
0.867653489112854 ||| Abnormal coordination ||| Abnormal Value ||| Coordination anormale
0.5880380868911743 ||| Conducting feasibility studies relating to computer hardware ||| Maintaining a registry of certified medical technical professionals ||| Exécution de tests de faisabilité pour matériel informatique
0.581018328666687 ||| Polysorbate 80 Potassium Chloride Potassium Dihydrogen Phosphate Simethicone emulsion Sodium chloride Disodium Phosphate Dihydate DL-Alpha-Tocopherol Acetate Water for injection ||| Domperidone Clozapine Calcium folinate Ranitidine Isotretinoin Lisinopril Calcium 500/1000 Calcium 500 + Vitamin D 400 IU Calcium 500 + Vitamin D 200 IU Pravastatin Simvastatin ||| Polysorbate 80 Chlorure de potassium Dihydrogénophosphate de potassium Siméthicone Chlorure de sodium Hydrogénophosphate disodique Acétate de dl-∝ -tocophérol Eau pour injection
0.36761361360549927 ||| Fire resistant lockable containers ||| Fire resistant expansion joints ||| Récipients verrouillables ignifuges
0.265064001083374 ||| In contrast, the mechanisms by which lamotrigine exerts its therapeutic action in bipolar disorder have not been established, although interaction with voltage gated sodium channels is likely to be important. ||| Whilst the pattern of adverse events argues against a role for raised oestrogen levels, it is known that the myocardium has androgen receptors, and it might be affected by long-term androgen deprivation. ||| A l’ inverse, les mécanismes par lesquels la lamotrigine exerce son action thérapeutique sur les troubles bipolaires n’ ont pas été établis, bien que les interactions canaux sodium voltage-dépendants soient probablement importantes.
0.0020176945254206657 ||| 73 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 74 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 79 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMTS PRIMAIRES
0.3959033191204071 ||| Sabumalin is a medicine in a pressurised inhaler that contains salbutamol as active substance. ||| MPL is included in this vaccine as an adjuvant and aluminium phosphate as an adsorbent. ||| Sabumalin est un médicament en inhalateur pressurisé contenant du salbutamol comme principe actif.
0.5075259804725647 ||| Wait and take the next dose at the regular time. ||| Then continue to inject the medicine on the usual day(s). ||| Attendez et prenez la dose suivante à l’heure normale.
0.3186677098274231 ||| Administration of lamivudine at very high dose levels in acute animal studies did not result in any organ toxicity. ||| Co-administration of ritonavir does not lead to any clinically relevant change in nevirapine plasma levels. ||| Chez l’ animal, l’ administration unique de très fortes doses de lamivudine n’ a pas entraîné de toxicité d’ organe spécifique.
0.007834729738533497 ||| 20 requirement includes women of childbearing potential who practice absolute and continuous abstinence. ||| 50 requirement includes women of childbearing potential who practice absolute and continuous abstinence. ||| Cette obligation s’ applique également aux femmes susceptibles de procréer pratiquant une abstinence totale et continue.
0.262051522731781 ||| No studies on the effects on the ability to drive or operate machinery have been performed. ||| No specific studies in animals have been conducted to evaluate the effect on fertility. ||| Les effets sur l’ aptitude à conduire des véhicules ou à utiliser des machines n’ ont pas été étudiés.
0.3679158389568329 ||| Talk to your pharmacist if you have difficulty opening the bottle. ||| Tell your pharmacist if you notice any change in the appearance of the capsules. ||| Consultez votre pharmacien si vous avez du mal à ouvrir le flacon.
0.18792609870433807 ||| HOW TO USE ZENAPAX no ||| HOW TO USE VIRAFERON no ||| COMMENT UTILISER ZENAPAX
0.024700570851564407 ||| The Marketing Authorisation Holder provided written explanations on 28 November 2005. ||| The Marketing Authorisation Holder provided written explanations on 13 October 2005. ||| Le titulaire de l’ autorisation de mise sur le marché a fourni des explications écrites le 28 novembre 2005.
0.25303512811660767 ||| - injection site reaction*, ||| - injection site pain*. ||| - réaction au site d’injection*,
0.4476894736289978 ||| PVC blister sealed with aluminium foil containing 30 tablets. ||| Blisters consisting of PVC/ fluoropolymer foil. ||| Plaquette thermoformée PVC/aluminium contenant 30 comprimés.
0.5190494060516357 ||| it is in my chest ||| it is in the center of my chest ||| c’est dans ma poitrine
0.2896804213523865 ||| Transfusions of cryoprecipitate, fibrinogen, fresh frozen plasma and platelets should be considered with clinical and laboratory reassessment after each administration. ||| 4 recommended that prior to the administration of nitric oxide, pulmonary artery catheterisation or echocardiographic examination of central haemodynamics be performed. ||| Des transfusions de cryoprécipité, de fibrinogène, de plasma frais congelé et de plaquettes doivent être envisagées avec une réévaluation clinique et biologique après chaque administration.
0.3491612672805786 ||| Calcined potassium fertilizer ||| Potassium fertilizers ||| Potassium calciné [fertilisants]
0.280250608921051 ||| Unit doses recommended for Xeomin are not interchangeable with those for other preparations of Botulinum toxin. ||| Comtess is used when these fluctuations cannot be treated with the standard levodopa- containing combination alone. ||| Les doses recommandées de Xeomin ne sont pas interchangeables avec les autres préparations de toxine botulinique.
0.4661872386932373 ||| Waterproofing of clothing ||| Recycling of clothing ||| Imperméabilisation de vêtements
0.24217435717582703 ||| Caution should be taken when it is given with some medicines, such as rifampicin (used in tuberculosis) or ketoconazole (an antifungal medicine). ||| Particular caution should be taken if you use itraconazol (used for certain types of infections) or ketobemidone (used to treat pain), because this may increase the side-effects. ||| Il convient de faire preuve de prudence lors de l’ association de Sutent avec d’ autres médicaments comme la rifampicine (utilisée en cas de tuberculose) ou le kétoconazole (médicament anti-fongique).
0.3325192332267761 ||| Patients with signs or symptoms compatible with autoimmune disorders should be evaluated carefully, and the benefit-risk of continued interferon therapy should be reassessed (see also section 4.4 Chronic hepatitis C, Monotherapy (thyroid abnormalities) and section 4.8). no ||| Follow antibiotic treatment protocols, based on evidence-based guidelines (e.g. for sepsis [74], urinary tract infections [103], skin and soft tissue infections [104]), and apply infection prevention and control measures that are established in your setting [31] [expert consensus]. ||| évocateurs d’ un désordre auto-immun doivent être évalués avec attention et le rapport bénéfice-risque de poursuivre le traitement par interféron doit être reconsidéré (voir aussi rubrique 4.4 Hépatite C chronique, Monothérapie (d'anomalies thyroïdiennes) et rubrique 4.8).
0.2733815312385559 ||| In children 3 years of age and older who have previously untreated chronic hepatitis C, Rebetol is used in combination with interferon alfa-2b for injection. ||| Whenever recommended, children at risk who are ≥ 24 months of age and already primed with Prevenar should receive 23-valent pneumococcal polysaccharide vaccine. ||| Chez les enfants de 3 ans et plus et adolescents, non préalablement traités pour l’ hépatite C chronique, Rebetol est utilisé en association avec l’ interféron alfa-2b, solution injectable.
0.05801685154438019 ||| No studies on the effects on the ability to drive and use machines have been performed. ||| 37 No studies on the effects on the ability to drive and use machines have been performed. ||| 55 Les effets sur l’ aptitude à conduire des véhicules et à utiliser des machines n’ ont pas été étudiés.
0.6689780950546265 ||| Compilation of web pages for the Internet ||| Advertisement for others on the Internet ||| Compilation de pages Web pour Internet
0.2586809992790222 ||| Treatment should be started with Protopy 0.1% twice a day and treatment should be continued until clearance of the lesion. ||| If the treatment cannot be started until the day after surgery, dosing should be started with 2 capsules once daily. ||| Le traitement doit être débuté avec Protopy 0,1% deux fois par jour et doit être poursuivi jusqu’ à guérison des lésions.
0.32875752449035645 ||| Treatment with lacosamide has been associated with dizziness which could increase the occurrence of accidental injury or falls. ||| Feeding can increase the incidence and intensity of such overdose symptoms and occasionally vomiting may occur. ||| Le traitement par le lacosamide a été associé à des sensations vertigineuses susceptibles d’ augmenter la survenue de blessures accidentelles ou de chutes.
0.10193201899528503 ||| This also applies to any unknown or emerging viruses or other types of infections. ||| This also applies to any unknown or emerging viruses or other types of infections. lp ||| Ceci s’applique également aux virus inconnus ou émergents ou à d’autres types d’infections.
0.6342357993125916 ||| MEPs have written a letter to Thierry Breton, Internal Market Commissioner; and Mariya Gabriel, Innovation, Research, Culture, Education and Youth Commissioner, in which they call for: ||| Committee Chair Petra De Sutter (Greens/EFA, BE), as well as a few other MEPs, will be present in the meeting room. ||| Dans une lettre adressée à Thierry Breton, commissaire européen au commerce intérieur et à Mariya Gabriel, commissaire européenne en charge de l'innovation, de la recherche, de la culture et de l'éducation, les députés ont suggéré de :
0.1693519651889801 ||| 48 4) Do not take FOSAVANCE at bedtime or before getting up for the day. ||| 4) Do not take Alendronate HEXAL at bedtime or before getting up for the day. ||| 4) Ne prenez pas FOSAVANCE au coucher ou avant de vous lever pour la journée.
0.4987282156944275 ||| - diarrhoea, constipation, stomach pains, feeling or being sick, wind, dry or sore mouth or throat ||| ed • urinary tract infection, cold blisters, shingles; • dizziness, including vertigo, headache; • eye inflammation; ||| - diarrhées, constipation, douleurs d’estomac, nausées, ballonnements, sècheresse ou douleur de
0.00553280021995306 ||| 43 pharmacokinetic characteristics of stavudine is low, approximately 15% and 25%, respectively, after oral administration. ||| 21 pharmacokinetic characteristics of stavudine is low, approximately 15% and 25%, respectively, after oral administration. ||| Les variations intra- et interindividuelles dans la cinétique de la stavudine sont faibles, généralement et approximativement de 15 et 25%, respectivement, après administration orale.
0.09907609969377518 ||| 07.11.2001 Date of first renewal: ||| 03.04.2001 Date of first renewal: ||| 07.11.2001 Date du premier renouvellement:
0.2637960910797119 ||| Do not use Actrapid ||| Do not use Insulatard ||| N’ utilisez jamais Actrapid
0.2810389995574951 ||| The study included 107 patients with aspergillosis, 18 patients with fusariosis, 11 with chromoblastomycosis or mycotema, and 16 with coccidioidomycosis. ||| Noxafil also successfully treated 11 of 24 patients who had proven or probable fusariosis, 9 of 11 patients with chromoblastomycosis or mycetoma, and 11 of 16 patients with coccidioidomycosis. ||| L’ étude portait sur 107 patients atteints d’ aspergillose, 18 présentant une fusariose, 11 souffrant de chromoblastomycose ou mycétome et 16 atteints de coccidioïdomycose.
0.35227587819099426 ||| The Marketing Authorisation Holder must implement nationally, prior to marketing, and as agreed with the competent authorities in the Member States: ||| The MAH shall agree the details of a distribution system with the National Competent Authorities and must implement such programme nationally to ensure that: ||| Le titulaire de l’ autorisation de mise sur le marché doit mettre en place au plan national, avant commercialisation du médicament et en accord avec les autorités compétentes dans les Etats membres:
0.26627591252326965 ||| The use of CYMBALTA while breastfeeding is not recommended. ||| The vaccine INTANZA may be used during breast-feeding. ||| L’ utilisation de CYMBALTA n’ est pas recommandée pendant l’ allaitement.
0.6201377511024475 ||| assessment Months (95% CI) Overall response rate by ||| Median overall survival (months) (95% CI) Hazard ratio: ||| de l’ investigateur Mois (IC 95%) Réponse globale par
0.4580448269844055 ||| 29 (5.3%) ||| 604 (13.1%) ||| Grade 3 n (%)
0.3122965097427368 ||| Patients receiving rifabutin with APTIVUS/ ritonavir should be closely monitored for emergence of adverse events associated with rifabutin therapy. ||| The combination of INTELENCE and rifabutin should be used with caution due to the risk of decrease in etravirine and rifabutin exposures. ||| Les patients recevant de la rifabutine associée à APTIVUS/ ritonavir doivent être étroitement suivis en cas d’ apparition d’ effets indésirables associés au traitement par la rifabutine.
0.1887218952178955 ||| 12/ 19 B. ||| 6/ 17 A. ||| 14/ 21 B.
0.37276333570480347 ||| If you do not respond to glucagon treatment, you will have to be treated in a hospital. ||| If the condition persists or worsens, you may have to bring your child to the doctor. ||| Si vous ne répondez pas au traitement par glucagon, vous devrez être traité à l’ hôpital.
3.1880113783230857e-13 ||| Place the tip of the pipette on the skin and squeeze firmly several times to empty the contents directly onto the skin. ||| Place the tip of the pipette on the skin and squeeze firmly several times to empty the contents directly onto the skin. ||| Placer l’extrémité de la pipette sur la peau et presser fermement plusieurs fois pour en vider le contenu directement sur la peau.
0.43821021914482117 ||| In particular, the aid will cover 80% of the relevant R  D costs for SMEs, and 60% for large enterprises. ||| In 2019, the decrease is mostly due to a decline in EIB loans to the private sector. ||| En particulier, l'aide couvrira 80 % des coûts de R  D liés à la COVID-19 pour les PME et 60 % pour les grandes entreprises.
0.4099422097206116 ||| Levemir should not be administered intravenously as it may result in severe hypoglycaemia. ||| If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias. ||| Levemir ne doit pas être administré par voie intraveineuse en raison du risque d’hypoglycémie sévère.
0.45036375522613525 ||| MRI is an imaging method that relies on the tiny magnetic fields produced by water molecules in the body. ||| MRI is an imaging method that uses magnetic fields and radio waves. ||| L’ IRM est une méthode d’ imagerie qui repose sur les infimes champs magnétiques produits par les molécules d’ eau qui se trouvent dans l’ organisme.
0.4173547029495239 ||| Therapeutic treatment of the body ||| Therapeutic preparations for the bath ||| Traitement thérapeutique pour le corps
0.32552242279052734 ||| Which measures are being taken to ensure the safe use of Daronrix? ||| What are the special precautions to be taken by the person administering Masivet? ||| Quelles sont les mesures prises pour garantir une utilisation sans danger de Daronrix?
0.02304694429039955 ||| ARIES-1 included 201 patients and compared Volibris 5 mg and 10 mg with placebo. ||| ARIES-2 included 192 patients and compared Volibris 2.5 mg and 5 mg with placebo. ||| L'essai ARIES-1 incluant 201 patients, a comparé Volibris 5 mg et Volibris 10 mg au placebo.
0.5687183737754822 ||| (18) 1.8% ||| e 10.7% ||| (18) 1,8%
0.03665168583393097 ||| Exelon capsules or oral solution should be given twice a day, with morning and evening meals. ||| Prometax capsules or oral solution should be given twice a day, with morning and evening meals. ||| Les gélules ou la solution buvable d’ Exelon doivent être administrées deux fois par jour, au cours du petit déjeuner et du dîner.
0.31190207600593567 ||| Regarding the indication in epilepsy as monotherapy, based on the published studies, the CHMP considered that, although not statistically significant for all studies, the results were sufficiently consistent to support the clinical efficacy and safety of gabapentin as monotherapy. ||| Secondary PFS analyses, based on ‘ on-treatment’ -based response assessments, confirmed the significantly superior clinical benefit for patients treated with Avastin (analyses shown in Table 6), consistent with the statistically significant benefit observed in the pooled analysis. ||| En ce qui concerne l’ indication dans l’ épilepsie en monothérapie, le CHMP a considéré, sur la base des études publiées, que les résultats, bien que non significatifs sur le plan statistique dans toutes les
0.35840559005737305 ||| In case of infections, antibiotic treatment should be initiated as required. ||| Other tests should be performed in order to confirm Hib infection during this period. ||| En cas d'infection, une antibiothérapie doit être instaurée si elle est cliniquement nécessaire.
0.2946151793003082 ||| Contraception should be continued for at least 1 month after stopping treatment with isotretinoin, even in patients with amenorrhea. ||| At least five weeks should elapse between discontinuation of fluoxetine and initiation of treatment with rasagiline. ||| La contraception doit être poursuivie au moins 1 mois après l'arrêt du traitement par isotretinoine, même en cas d'aménorrhée.
0.2718603014945984 ||| When paroxetine is to be co-administered with a known drug metabolising enzyme inhibitor, consideration should be given to using paroxetine doses at the lower end of the range. ||| If necessary, the dosage of the antihyperglycaemic medicinal product should be adjusted during therapy with the other medicinal product and on its discontinuation. ||| Lorsque la paroxétine doit être associée à un inhibiteur enzymatique connu, les doses recommandées les plus faibles seront utilisées.
0.13815543055534363 ||| Currently there is only evidence of the efficacy of the vaccine against challenge with B. canis. ||| 2/ 17 Currently there is only evidence of the efficacy of the vaccine against challenge with B. canis. ||| Actuellement, seule l’ efficacité du vaccin contre B. canis est démontrée, par épreuve virulente.
0.38313329219818115 ||| 45 Eesti Österreich AS Sirowa Tallinn Salve 2c EE-11612 Tallinn Tel: +372 6 830700 ||| sa Novo Nordisk Pharma nv Boulevard International 55 B-1070 Bruxelles Tél/ Tel: + 32 2556 0580 Magyarország ||| 46 Eesti Österreich AS Sirowa Tallinn Salve 2c EE-11612 Tallinn Tel: +372 6 830700
0.41109585762023926 ||| In each of these situations, the potential benefit of treatment with NovoSeven should be weighed against the risk of these complications. ||| Such situation requires rapid notification of safety information that may have the greatest implications for risk-benefit balance in a pandemic. ||| Dans chacune de ces situations, le bénéfice potentiel du traitement avec NovoSeven devra être mesuré en fonction du risque de survenue de ces complications.
0.7521083354949951 ||| a) LeukoScan b) Sulesomab c) Part A ||| a) Bondronat b) Ibandronic Acid ||| a) LeukoScan b) Sulesomab c) Partie A
0.9127242565155029 ||| Laboratórios Vitória Rua Elias Garcia, 28 Venda Nova 2700 Amadora ||| Ziduri Intre Vii Nr.22 Sector 2, Bucurest Romania ||| Labotatórios Vitória Rua Elias Garcia, 28 Venda Nova 2700 Amadora
0.2594975531101227 ||| How to take Karvezide 4. ||| How to receive Focetria 4. ||| Comment prendre Karvezide 4.
0.7691363096237183 ||| Bovine ||| Bovine2 ||| — Bovine
0.3017701804637909 ||| For Section 4.3, the MAH proposal retained only two of the existing 8 contraindications (relating to hypersensitivity and breast feeding) and removed 6 (hepatic or renal impairment, cisplatin for patients with severe renal failure, pregnancy and lactation, combination with yellow fever, usage in children and concomitant administration of gemcitabine and radiotherapy). ||| 10 Although the study failed regarding its primary endpoint, which was a composite of all-cause mortality, non- fatal myocardial infarction, stroke, acute coronary syndrome, major leg amputation, coronary revascularisation and leg revascularisation, the results suggest that there are no long-term cardiovascular concerns regarding use of pioglitazone. ||| Pour la section 4.3, la proposition du titulaire de l’autorisation de mise sur le marché n’a retenu que deux des 8 contre-indications existantes (concernant l’hypersensibilité et l’allaitement) et en a supprimé 6 (insuffisance hépatique ou rénale, cisplatine pour les patients ayant une insuffisance rénale sévère, grossesse et allaitement, association avec la fièvre jaune, usage pour les enfants et administration concomitante de la gemcitabine et de la radiothérapie).
0.505887508392334 ||| Rare ADRs (> 1/ 10,000, < 1/ 1,000): apnoea Very rare ADRs (< 1/ 10,000): anaphylaxis, urticaria ||| Non-neutropenic (ANC, cells/ mm3 > 500) Neutropenic (ANC, cells/ mm3 ≤ 500) At Other Endpoints ||| Effets indésirables rares (> 1/ 10000, < 1/ 1000): apnée Effets indésirables très rares (< 1/ 10000): anaphylaxie, urticaire.
0.03594128042459488 ||| Remove one pre-filled syringe and one alcohol swab and place them on the work surface. ||| Remove one pre-filled syringe and one alcohol swab and place them on your work surface. ||| Retirez une seringue pré-remplie et un tampon alcoolisé et placez- les sur la surface de travail.
0.36702942848205566 ||| If any of the side effects happens to you, ask your doctor for advice. ||| The doctor will treat you, as appropriate, if you have any particular ill effects. ||| Si vous remarquez l’ un de ces effets indésirables, demandez conseil à votre médecin.
0.10333502292633057 ||| Pack sizes of 1 or 3. ||| Pack sizes of 1 or 12. ||| Boîtes de 1 ou 3.
0.045499518513679504 ||| Clinical experience with Fertavid is based on up to three treatment cycles in both indications. ||| Clinical experience with Puregon is based on up to three treatment cycles in both indications. ||| L'expérience clinique avec Fertavid est basée sur un traitement pendant 3 cycles dans les deux indications.
0.38717615604400635 ||| 35 As a precautionary measure, direct contact with the treated animals should be avoided and children should not be allowed to play with treated animals until the application site is dry. ||| Pregnant and breast-feeding women should not have any contact with the product and should also avoid operating rooms and animal recovery areas where the product is being, or has recently been, used. ||| Par mesure de précaution, tout contact direct avec les animaux traités doit être évité et les enfants ne doivent pas être autorisés à jouer avec les animaux traités tant que la zone d’ application n’ est pas sèche.
0.2564534544944763 ||| In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain, small but statistically significant increases in fasting blood glucose were observed in duloxetine- treated patients HbA1c was stable in both duloxetine-treated and placebo-treated patients. ||| A 2-week study in healthy postmenopausal volunteers treated with 20 μ g per day ethinylestradiol showed that pre-treatment with 250 mg fulvestrant resulted in significantly reduced stimulation of the postmenopausal endometrium, compared to pre-treatment with placebo, as judged by ultrasound measurement of endometrium thickness ||| Lors de la phase aiguë de 12 semaines de trois essais cliniques étudiant la duloxétine chez les patients souffrant de douleur neuropathique diabétique, des augmentations faibles, mais statistiquement significatives de la glycémie à jeun ont été observées chez les patients sous duloxétine.
0.4018952250480652 ||| If the test needs to be carried out later in the day, only a light meal like tea and toast is recommended. ||| If treatment is not started on the day of the operation, it should start with two capsules once a day. ||| Au cas où le test est effectué plus tard dans l’après-midi, il est recommandé que vous preniez un léger repas, comme par exemple du thé et des toasts.
0.31388145685195923 ||| 38 In patients with hypertension telmisartan reduces both systolic and diastolic blood pressure without affecting pulse rate. ||| • Treatment of hypertension in patients whose blood pressure is not adequately controlled on losartan or hydrochlorothiazide. ||| Chez les patients hypertendus, le telmisartan diminue la pression artérielle systolique et diastolique sans modifier la fréquence cardiaque.
0.012409413233399391 ||| 59 Marketing Authorisation Holder and Manufacturer ||| 58 Marketing Authorisation Holder and Manufacturer ||| Titulaire de l’ Autorisation de mise sur le marché et fabricant
0.2690449059009552 ||| Very common: reduced number of blood cells (neutropenia or lymphopenia, thrombocytopenia), loss of appetite, headache, vomiting, nausea (feeling sick in your stomach), constipation (difficulty passing stools). ||| Serious infusion reactions have been reported uncommonly; symptoms reported include pyrexia, rigors, tachycardia, urticaria, nausea/ vomiting, angioneurotic oedema with throat tightness, stridor and swollen tongue. ||| 174 Très fréquent: diminution du nombre de cellules sanguines (neutropénie ou lymphopénie, thrombocytopénie), perte d’appétit, mal de tête, vomissements, nausées (sensation d’avoir envie de vomir), constipation (difficulté d’évacuation des selles).
0.09582452476024628 ||| One vial contains 4 mg zoledronic acid (anhydrous), corresponding to 4.264 mg zoledronic acid monohydrate. ||| One ml solution contains 0.05 mg zoledronic acid anhydrous, corresponding to 0.0533 mg zoledronic acid monohydrate. ||| Un flacon contient 4 mg d’ acide zolédronique (anhydre), correspondant à 4,264 mg d’ acide zolédronique monohydraté.
0.5288988351821899 ||| As the company had supplied the additional information requested, the ‘ Exceptional Circumstances ’ ended on 22 May 2008. ||| In addition to the monthly CPMP press releases, a first ‘ EMEA Human Medicines Newsletter’ was circulated in October 1996. ||| Dans la mesure où la société a fourni les informations supplémentaires requises, les « circonstances exceptionnelles » ont pris fin le 22 mai 2008.
0.12289716303348541 ||| Nervous system disorders Very rare (< 1/ 10,000) ||| Gastrointestinal disorders Very rare (< 1/ 10,000) ||| Affections du système nerveux Très rares (< 1/ 10 000)
0.43313050270080566 ||| Your doctor will show you in which area of the skin you should inject Apidra. ||| You will always receive ALIMTA by infusion into one of your veins. ||| Votre médecin vous montrera dans quelle zone vous devez injecter Apidra.
0.47523218393325806 ||| On 16 March, 30 new cases were confirmed, bringing the total number of cases to 93. ||| On 16 March, the health ministry stated that the number of confirmed cases reached 36. ||| Le 16 mars, 30 nouveaux cas ont été confirmés, portant le nombre total de cas à 93.
0.10109838843345642 ||| Other information about Cervarix: ||| Other information about Crixivan: ||| Autres informations relatives à Cervarix:
0.025408394634723663 ||| - A history of severe pre-existing cardiac disease, including unstable or uncontrolled cardiac ||| - A history of severe pre-existing cardiac disease, including unstable or uncontrolled cardiac disease ||| - Antécédents d’ affection cardiaque sévère, dont les maladies cardiaques non contrôlées ou
0.43534648418426514 ||| No definitive conclusion could be drawn regarding the effects of telbivudine on the pharmacokinetics of pegylated interferon due to high interindividual variability of pegylated interferon alfa 2a concentrations. ||| Each of these four genetic patterns associated with reduced susceptibility to amprenavir produces some cross-resistance to ritonavir but susceptibility to indinavir, nelfinavir and saquinavir is generally retained. ||| Aucune conclusion définitive ne peut être déterminée quant aux effets de la telbivudine sur la pharmacocinétique de l’ interféron pégylé en raison d’ une importante variabilité interindividuelle des concentrations d’ interféron alpha-2a pégylé.
0.32011452317237854 ||| From a microbiological point of view, unless the method of opening/ dilution precludes the risk of microbial contamination the product should be used immediately. ||| However, based on the mode of clearance of the active substance there are no theoretical reasons for any requirement for dose adjustments in the elderly. ||| D’ un point de vue de sécurité microbiologique, à moins que la reconstitution et la dilution n’ aient eu lieu dans des conditions empêchant le risque de contamination microbiologique, le produit doit être utilisé immédiatement.
0.2717786133289337 ||| In elderly subjects (over 65 years old), a 15% increase in AUC was observed as compared to younger subjects. ||| The incidence of symptoms observed in subjects > 60 years of age was lower as compared to the 18-60 years old population. ||| Une augmentation d'environ 15% de l’ ASC a été observée chez le sujet âgé sain (plus de 65 ans) comparativement au sujet plus jeune.
0.26237213611602783 ||| Do not refrigerate the solution after reconstitution. ||| Do not refrigerate the solution after preparation. ||| Ne pas réfrigérer la solution après reconstitution.
0.42759281396865845 ||| Reproductive toxicity studies have not been performed with Pegasys. ||| *Psychiatric reactions have been reported during vigabatrin therapy. ||| Il n'a pas été conduit d'études de toxicité sur la reproduction avec Pegasys.
0.5162845849990845 ||| - Itraconazole (unboosted saquinavir) ||| - Methadone, rifampicin, probenecid. ||| - Itraconazole (saquinavir non « boosté »)
0.24602971971035004 ||| Co-administration of amprenavir with methadone leads to a decrease of methadone concentrations. ||| Peak concentrations of raloxifene are reduced with co-administration with ampicillin. ||| L’ administration concomitante d’ amprénavir et de méthadone a entraîné une diminution des concentrations de méthadone.
0.553949236869812 ||| The first cases were approved in record time, within a matter of hours. ||| The Commission received 91 proposals within the very short two-week deadline. ||| Les premiers cas ont été autorisés en un temps record, en l'espace de quelques heures.
5.655445187678632e-13 ||| Pack sizes of 14, 28, 49, 56, and 98 prolonged-release tablets. ||| Pack sizes of 14, 28, 49, 56, and 98 prolonged-release tablets. ||| Conditionnements de 28, 30, 49, 56, et 98 comprimés à libération prolongée.
0.38817882537841797 ||| The total body clearance of ciprofloxacin is independent of the dose and remains unchanged in case of multiple administration. ||| maintained with the lowest strength of the combination given twice daily then the next step could include a test of inhaled corticosteroid alone. ||| La clairance corporelle totale de la ciprofloxacine est indépendante de la dose et ne varie pas lors d'administrations réitérées.
0.5924397110939026 ||| One drop in the eye, twice a day. ||| one drop in the eye or eyes, twice a day – morning and evening. ||| Une goutte dans l’œ il, deux fois par jour.
0.46645423769950867 ||| Pyrexia and headache were the most frequently reported adverse events potentially related to the medicinal product in both studies. ||| The other three main studies involved patients with malignant glioma that had come back or got worse after previous treatment. ||| Dans les deux études, la fièvre et les maux de tête furent les effets indésirables les plus fréquemment rapportés, potentiellement liés au produit.
2.7076634662691335e-13 ||| België/Belgique/Belgien Luxembourg/Luxemburg SA Alcon-Couvreur NV + 32 (0)3 890 27 11 (België/Belgique/Belgien) ||| België/Belgique/Belgien Luxembourg/Luxemburg SA Alcon-Couvreur NV + 32 (0)3 890 27 11 (België/Belgique/Belgien) ||| Lietuva België/Belgique/Belgien Luxembourg/Luxemburg SA Alcon-Couvreur NV + 32 (0)3 890 27 11 (België/Belgique/Belgien)
0.28117501735687256 ||| With the pen still pointing up, press the injection mechanism. ||| The injection button should be fully depressed before using the pen again. ||| Le stylo pointant toujours vers le haut, appuyez sur le mécanisme d'injection.
0.18525591492652893 ||| Adult patients with a history of congestive heart failure, myocardial infarction and/or previous or current arrhythmic disorders, who require IntronA therapy, must be closely monitored. ||| Patients with cardiac disease, such as angina, congestive heart failure or arrhythmia, should be closely monitored for worsening of their clinical condition during treatment with AVONEX. ||| 99 Les patients adultes ayant des antécédents d’ infarctus du myocarde ou d’ insuffisance cardiaque congestive et/ ou ayant souffert ou souffrant de troubles du rythme cardiaque doivent être étroitement surveillés en cas de traitement par IntronA.
0.4120023846626282 ||| The steady-state volume of distribution based on plasma concentrations is approximately 1300 l (healthy subjects). ||| The geometric mean plasma clearance is approximately 50 litres/ hour (coefficient of variation 21.7%). ||| A l’ état d’ équilibre, le volume de distribution déterminé à partir des concentrations plasmatiques est d’ environ 1 300 l (sujets sains).
0.27590954303741455 ||| If bubbles are present, hold the syringe straight up and tap its side until the bubbles float to the top. ||| Gently tap the syringe to make any bubbles rise to the top of the syringe near the needle. ||| En cas de présence de bulles, tenir la seringue droite et tapoter sur les côtés jusqu'à ce que les bulles d'air remontent.
5.35102019118272e-13 ||| Sympathomimetics Sympathomimetics may reduce the antihypertensive effects of ACE inhibitors. ||| Sympathomimetics Sympathomimetics may reduce the antihypertensive effects of ACE inhibitors. ||| Sympathomimétiques Les sympathomimétiques peuvent réduire les effets antihypertenseurs des IEC.
0.3988059461116791 ||| The steady state peak and trough plasma concentrations of eflornithine were approximately 10 ng/ ml and 5 ng/ ml, respectively. ||| Rotigotine plasma concentrations increase dose-proportionally over a dose range of 1 mg/ 24 h to 24 mg/ 24 h. ||| Les concentrations maximales et minimales sont, à l'état d'équilibre, respectivement de l'ordre de 10 ng/ ml et 5 ng/ ml.
0.1023295670747757 ||| 56 Reproductive system and breast disorders Common: ||| Reproductive system and breast disorders Common: ||| Affections des organes de reproduction et du sein Fréquent:
0.29320746660232544 ||| If it is cloudy or discoloured or has flakes or particles in it, you must not use it. ||| DO NOT USE if it is broken or if the liquid looks cloudy or contains particles. ||| Si elle est trouble ou jaunie ou contient des flocons ou des particules, vous ne devez en
0.34529462456703186 ||| Therefore for adult patients the Telzir oral suspension should be taken without food and on an empty stomach (see section 4.2). ||| Therefore, the patient/ caregiver should avoid contact with the eyes after handling of the patch (see section 4.4). ||| Aussi, chez l'adulte, la suspension buvable de Telzir devra être administrée en dehors des repas, l'estomac vide (voir rubrique 4.2).
0.2596755623817444 ||| As a result of enterohepatic recirculation, secondary increases in plasma MPA concentration are usually observed at approximately 6 – 12 hours post-dose. ||| Average serum concentrations observed in post-surgical patients were in the range of 0.4-1.5 ng/ ml over a 24 hour dosing period. ||| Du fait du cycle entéro-hépatique, on observe en général 6-12 heures après l'administration des augmentations secondaires de la concentration plasmatique du MPA.
0.3038328289985657 ||| Do not use Humalog Pen ||| Do not use Humalog Mix25 ||| N’utilisez jamais Humalog Pen
0.7248095273971558 ||| 28 film-coated tablets 30 film-coated tablets 56 film-coated tablets 70x1 film coated-tablets ct ||| 14 tablets 30 tablets 42 tablets 56 tablets 90 tablets 100 tablets Starter pack 42 tablets, non-valproate add-on therapy ||| 14 comprimés pelliculés 28 comprimés pelliculés 30 comprimés pelliculés 56 comprimés pelliculés t
0.19740977883338928 ||| Tablet core: microcrystalline cellulose calcium hydrogen phosphate (anhydrous) croscarmellose sodium magnesium stearate ||| Capsules contain: lactose monohydrate sodium lauryl sulphate povidone K30 croscarmellose sodium magnesium stearate ||| Comprimé nu: cellulose microcristalline hydrogénophosphate de calcium (anhydre) croscarmellose sodique stéarate de magnésium
0.0 ||| NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION ||| NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION ||| DÉNOMINATION DU MEDICAMENT ET VOIE(S) D’ ADMINISTRATION
0.22635069489479065 ||| For consolidation therapy, Zevalin has been studied in one main study involving 414 patients who had achieved a partial or complete remission during induction treatment for non-Hodgkin’ s lymphoma. ||| In a study reflecting clinical practice, the concomitant antiepileptic medication could be withdrawn in a limited number of patients who responded to levetiracetam adjunctive therapy (36 adult patients out of 69). ||| Pour la thérapie de consolidation, Zevalin a fait l’ objet d’ une étude principale incluant 414 patients arrivés au terme d’ une rémission partielle ou complète au cours du traitement d’ induction d’ un lymphome non hodgkinien.
0.20561206340789795 ||| Communications controllers ||| Communications computers ||| Contrôleurs de communication
0.20738843083381653 ||| 70 In juvenile rats, an effect on learning in the Biel maze test, a slight delay in balanopreputial separation and vaginal patency and a decreased postnatal body weight gain in F1 animals were observed at exposures approximately two-times higher than the therapeutic exposures in human adults. ||| In the pre- and post-natal development study in rats, exposure to rimonabant in utero and via lactation produced no alterations on learning or memory, but equivocal effects on motor activity and auditory startle response were observed in the pups as a result of rimonabant exposure. ||| Chez des rats juvéniles, un effet sur l’ apprentissage dans le test du labyrinthe de Biel, un léger retard dans la séparation balano-préputiale et la perméabilité vaginale ainsi qu’ une diminution de la prise de poids corporel post-natal chez les animaux F1 ont été observés à des expositions environ deux fois supérieure aux expositions thérapeutiques chez les adultes humains.
0.21553906798362732 ||| Elderly patients receiving Myfenax as part of a combination immunosuppressive regimen, may be at increased risk of certain infections (including cytomegalovirus tissue invasive disease) and possibly gastrointestinal haemorrhage and pulmonary oedema, compared to younger individuals. ||| The increased incidence of lymphomas and mammary tumours observed in mice treated with abatacept may have been associated with decreased control of murine leukaemia virus and mouse mammary tumour virus, respectively, in the presence of long-term immunomodulation. ||| Les patients âgés traités par Myfenax comme composante d’ un traitement immunosuppresseur, peuvent présenter un risque accru par rapport aux patients plus jeunes d’ apparition de certaines infections (incluant les infections tissulaires invasives à cytomégalovirus) ainsi que d’ hémorragie gastro-intestinale ou d’œ dème pulmonaire.
0.412004292011261 ||| Intermittent allergic rhinitis is defined as the presence of symptoms for less than 4 days per week or for less than 4 weeks. ||| Pandemic flu is a type of influenza that occurs at intervals that vary from less than 10 years to many decades. ||| La rhinite allergique intermittente est définie par la présence de symptômes sur une période de moins de 4 jours par semaine ou sur une période inférieure à
0.2967686653137207 ||| Patients should be evaluated for infections before, during, and after treatment with Enbrel, taking into consideration that the mean elimination half-life of etanercept is approximately 70 hours (range 7 to 300 hours). ||| In patients followed from month 24 onwards and treated with uncontrolled, open-label Visudyne treatment as needed, long-term extension data suggest that month-24 vision outcomes may be sustained for up to 60 months. ||| Les infections doivent être recherchées chez les patients avant, pendant, et après le traitement par Enbrel, en prenant en compte que la demi-vie d’ élimination moyenne d’ etanercept est approximativement de 70 heures (entre 7 et 300 heures).
0.5412875413894653 ||| The EU is responding quickly to help cushion the blow and to help small and medium-sized companies, which are especially vulnerable. ||| With their day-to-day experience, they can certainly contribute to fighting money launderers and those who fund terrorist activities. ||| L'UE réagit rapidement pour tenter d'atténuer le choc et aider les petites et moyennes entreprises, qui sont particulièrement vulnérables.
8.150747871776831e-13 ||| 17 8. ||| 17 8. ||| 19 8.
0.3327416181564331 ||| Installation of apparatus for heating ||| Ionization apparatus for the treatment of water ||| Installation d'appareils de chauffage
0.21144632995128632 ||| White, round, biconvex, coated tablets with ‘ OLZ 5’ debossing on one side and ‘ NEO’ on the other. ||| Red, biconvex, rounded triangular tablet with “ gsk” debossed on one side and “ 8/ 4” on the other side ||| Comprimés enrobés biconvexes, ronds et blancs portant l’ inscription en creux ‘ OLZ 5’ sur une face et ‘ NEO’ sur l’ autre.
0.020932354032993317 ||| 202 Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636 ||| Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636 ||| Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636
0.24268260598182678 ||| If urine succinylacetone is still detectable one month after the start of nitisinone treatment, the nitisinone dose should be increased to 1.5 mg/ kg body weight/ day divided in 2 doses. ||| In patients with a creatinine clearance less than 20 ml/ min, the daily dose of MIRAPEXIN should be administered in a single dose, starting at 0.088 mg of base (0.125 mg of salt) daily. ||| Si la succinylacétone est encore détectable dans les urines un mois après l’ instauration du traitement par la nitisinone, la dose de nitisinone devra être augmentée jusqu’ à 1,5 mg/ kg de poids corporel / jour divisée en 2 prises.
0.3552570641040802 ||| Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use. ||| The repeated dose and reproduction toxicity studies did not reveal any special risk but did not provide adequate documentation of safety margins due to limited exposure in the animal species. ||| Les effets dans des études non cliniques ont uniquement été observés à des expositions jugées suffisamment supérieures à l'exposition humaine maximale indiquant une faible pertinence pour l'usage clinique.
0.2659614384174347 ||| Maintenance of locomotives ||| Maintenance of electronic apparatus ||| Entretien de locomotives
0.5590767860412598 ||| - Clarithromycin 500 mg bid (unboosted saquinavir 1200 mg tid) - Erythromycin (saquinavir/ ritonavir) ||| 1. amlodipine - maleic acid adduct / Michael type adduct; 2. amlodipine - lactose adduct / Maillard product. ||| - Clarithromycine 500 mg deux fois par jour (saquinavir 1200 mg trois fois par jour non « boosté »)
0.39031895995140076 ||| Dextrins for pharmaceutical use ||| trials for pharmaceuticals ||| Dextrines à usage pharmaceutique
0.9950462579727173 ||| KG Leipziger Str. ||| Rosetti nr. ||| Leipziger Str.
0.35858437418937683 ||| Č eská republika Actelion Pharmaceuticals Ltd Tel: +420-2 3413 8150 ||| Κύπρος Norton Healthcare Ltd t/a IVAX Pharmaceuticals UK Тηλ.: +44 8705 02 03 04 ||| 25 Č eská republika Actelion Pharmaceuticals Ltd Tel: +420-2 3413 8150
0.22450491786003113 ||| INFORMATION FOR THE USER TAXOTERE 20 mg concentrate and solvent for solution for infusion docetaxel ||| INFORMATION FOR THE USER Angiox 250 mg powder for concentrate for solution for injection and infusion bivalirudin ||| INFORMATION DE L’ UTILISATEUR TAXOTERE 20 mg, solution à diluer et solvant pour perfusion docétaxel
0.33785712718963623 ||| The company that makes Vectibix will supply the results of additional studies looking at the safety and effectiveness of the medicine in patients with colorectal cancer with and without mutated KRAS, as well as at the quality of life in patients receiving it. ||| The Committee also took note of recent concerns expressed at the impact that the current guidelines on the establishment of MRLs for minor species including salmonidae and other fin fish was having on the availability of medicines for such species. ||| La société qui fabrique Vectibix fournira les résultats de études supplémentaires examinant la sécurité et l’ efficacité du médicament chez les patients souffrant de cancer colorectal avec ou sans gène KRAS muté, ainsi que la qualité de vie des patients auxquels il est administré.
0.0907183438539505 ||| 84 soft capsules ||| 90 soft capsules ||| 84 capsules molles
0.3433692455291748 ||| These plasma concentrations are achieved rapidly when the infusion is preceded by a 180 microgram/ kg bolus. ||| A volume of distribution (Vss) of about 18 litres was determined after an intravenous dose of 250 mg. ||| Ces concentrations plasmatiques sont atteintes rapidement lorsque la perfusion est précédée d’ un bolus intraveineux de 180 microgrammes/ kg.
0.6703121662139893 ||| Table 1 Urinary AER at baseline and at the end of 24 months of treatment Treatment ||| Clinical success rate at Day 14 Clinical success rate 4 weeks after end of treatment ||| Tableau 1 Taux d’ EUA urinaire avant traitement et après 24 mois de traitement Traitement
0.021373342722654343 ||| Fort Dodge Animal Health Holland C. J. van Houtenlaan 36 NL- 1381 CP Weesp The Netherlands ||| Fort Dodge Animal Health Holland C. J. van Houtenlaan 36 NL-1381 CP Weesp The Netherlands ||| Titulaire de l’ autorisation de mise sur le marché Fort Dodge Animal Health Holland C. J. van Houtenlaan 36 NL-1381 CP Weesp Pays-Bas
0.41726982593536377 ||| 2,319.4 ||| 1,969.0 ||| (93,22,
0.381365567445755 ||| Common: headache, dizziness, somnolence, insomnia, migraine Uncommon: paraesthesia ||| Dizziness, paraesthesia, hyperaesthesia, somnolence, insomnia, anxiety ||| Fréquent: céphalée, sensation vertigineuse, somnolence, insomnie, migraine, Peu fréquent: paresthésie
0.29640325903892517 ||| For most patients with early stage Parkinson’s disease, the right dose is reached within 3 or 4 weeks, at doses of 6 mg per day or 8 mg per day respectively. ||| For most patients an effective dose is reached within 3 to 7 weeks at doses of 8 mg/ 24 h up to a maximum dose of 16 mg/ 24 h. ||| Pour la plupart des patients atteints de maladie de Parkinson débutante, la dose adéquate est atteinte après 3 ou 4 semaines, à la dose de 6 mg par jour ou 8 mg par jour respectivement.
0.43781399726867676 ||| 29 Other medicinal products: ||| 8 Other medicinal products ||| Autres médicaments:
0.4309890866279602 ||| 31 Antacid: the effect of an aluminum hydroxide and magnesium hydroxide-containing antacid on the pharmacokinetics of capecitabine was investigated. ||| Gemcitabine and carboplatin combination therapy When given in combination with carboplatin the pharmacokinetics of gemcitabine were not altered ||| Antiacides: l'effet d'un antiacide contenant de l'hydroxyde d'aluminium et de l'hydroxyde de magnésium sur la pharmacocinétique de la capécitabine a été étudié.
0.13162481784820557 ||| Taking other medicines Please tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicines, including vaccinations and medicines obtained without a prescription. ||| Taking/using other medicines Before starting treatment with Agenerase, please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Prise d'autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris les vaccins et un médicament obtenu sans ordonnance, parlez-en à votre médecin ou à votre pharmacien hospitalier.
0.34966468811035156 ||| In the open-label study there was no difference in overall survival between patients treated with recombinant human erythropoietin and controls. ||| The effectiveness of a two-dose primary series has not been established against pneumonia or acute otitis media. ||| Dans l’ étude en ouvert, il n’ y a pas eu de différence sur la survie globale entre les patients traités avec l’ érythropoïétine humaine recombinante et le groupe contrôle.
0.7963378429412842 ||| d sanofi-aventis ||| gonal-f 300 iu ||| tor sanofi-aventis
0.03914232179522514 ||| Use in children and adolescents under 18 years of age ARICLAIM should not be used for children and adolescents under the age of 18 years. ||| Use in children and adolescents under 18 years of age YENTREVE should not be used for children and adolescents under the age of 18 years. ||| Utilisation chez l’ enfant et l’ adolescent de moins de 18 ans ARICLAIM ne doit pas être utilisé chez les enfants et adolescents de moins de 18 ans.
0.06814640015363693 ||| Polyesters for use in the filling of holes in surfaces ||| Polyesters for use in the repair of holes in surfaces ||| Polyesters destinés à reboucher des trous sur des surfaces
0.2370448112487793 ||| If there are bubbles, gently tap the syringe with your finger until the air bubbles rise to the top of the syringe. ||| Gently tap the syringe to make any air bubbles rise to the top of the syringe; be sure that you still hold onto the vial and syringe. ||| S’ il y a des bulles, tapotez doucement la seringue avec votre doigt jusqu’ à ce que les bulles d’ air remontent vers le haut de la seringue.
0.1634221076965332 ||| Insulin glulisine administered 15 minutes after starting the meal gives similar glycemic control as regular human insulin given 2 minutes before the meal (see figure 1). ||| Data indicated that insulin glulisine administered 2 minutes before the meal gives similar postprandial glycemic control compared to regular human insulin given 30 minutes before the meal. ||| L’ insuline glulisine administrée 15 minutes après le début du repas entraîne un contrôle glycémique comparable à l’ insuline rapide humaine administrée 2 minutes avant le repas (voir figure 1).
0.3768489956855774 ||| Levemir should not be administered intravenously as it may result in severe hypoglycaemia. ||| Hypoglycaemia can generally be corrected by immediate carbohydrate intake. ||| Levemir ne doit pas être administré par voie intraveineuse en raison du risque d’hypoglycémie sévère.
0.0 ||| EU/ 2/ 06/ 058/ 003 ||| EU/ 2/ 06/ 058/ 003 ||| EU/ 2/ 06/ 058/ 003 Flexicam
0.482723593711853 ||| We need to act quickly to improve the resilience of our healthcare systems, including through improved trade policy initiatives. ||| We need to be diligent, creative, and flexible in our approaches to opening up our societies again. ||| Nous devons agir rapidement pour améliorer la résilience de nos systèmes de santé, notamment grâce à des initiatives de politique commerciale plus efficaces.
0.42044273018836975 ||| What Ratiograstim contains ||| What is Ratiograstim? ||| Que contient Ratiograstim
0.34287360310554504 ||| Discontinuation of IntronA should be considered in patients who develop new or worsening ophthalmological disorders. ||| Caution should be exercised in patients with diagnosed or suspected Congenital Long QT Syndrome. ||| Un arrêt du traitement par IntronA doit être envisagé chez les patients développant des troubles nouveaux ou lors d’ aggravation de troubles préexistants.
0.16105780005455017 ||| 6 Pharmaco-therapeutic group: ||| 5 Pharmacotherapeutic group: ||| 6 5.1 Propriétés pharmacodynamiques
0.14197224378585815 ||| Reconstitution and dilution should be performed in accordance with good practices rules, particularly for the respect of asepsis. ||| Reconstitution should be performed in accordance with good practices rules, particularly with attention to asepsis. ||| La reconstitution et la dilution doivent être réalisées conformément aux règles de bonnes pratiques, en particulier en ce qui concerne le respect de l’ asepsie.
0.20471841096878052 ||| The full EPAR for Herceptin can be found here. ||| The full EPAR for Olanzapine Teva can be found here. ||| L’ EPAR complet relatif à Herceptin est disponible ici.
0.3005397617816925 ||| In non-clinical experiments lacosamide in combination with levetiracetam, carbamazepine, phenytoin, valproate, lamotrigine, topiramate or gabapentin showed synergistic or additive anticonvulsant effects. ||| The steady-state pharmacokinetics of telbivudine were unaltered following multiple dose administration in combination with lamivudine, adefovir dipivoxil, tenofovir disoproxil fumarate, 19 ciclosporin or pegylated interferon-alfa 2a. ||| Dans les essais non cliniques, le lacosamide associé au lévétiracétam, à la carbamazépine, la phénytoïne, le valproate, la lamotrigine, le topiramate, la gabapentine présente des effets anticonvulsivants synergiques ou additifs.
0.001775359851308167 ||| 322 PARTICULARS TO APPEAR ON THE OUTER PACKAGING UNBLISTERED PRE-FILLED SYRINGE CARTON ||| 327 PARTICULARS TO APPEAR ON THE OUTER PACKAGING UNBLISTERED PRE-FILLED SYRINGE CARTON ||| 347 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR SERINGUE PREREMPLIE NON CONDITIONNEE SOUS PLAQUETTE THERMOFORMEE
2.671099561153689e-13 ||| Studies of sitagliptin in combination with metformin In a 24-week, placebo-controlled clinical study to evaluate the efficacy and safety of the addition of sitagliptin 100 mg once daily to ongoing metformin, sitagliptin provided significant improvements in glycaemic parameters compared with placebo. ||| Studies of sitagliptin in combination with metformin In a 24-week, placebo-controlled clinical study to evaluate the efficacy and safety of the addition of sitagliptin 100 mg once daily to ongoing metformin, sitagliptin provided significant improvements in glycaemic parameters compared with placebo. ||| 10 Etudes de la sitagliptine en association avec la metformine Dans une étude clinique de 24 semaines versus placebo menée pour évaluer l'efficacité et la sécurité d’ emploi de l’ ajout de 100 mg de sitagliptine une fois par jour au traitement en cours par la metformine, la sitagliptine a entraîné des améliorations significatives des paramètres glycémiques par rapport au placebo.
0.4707835614681244 ||| Acid drops [confectionery] ||| Shaped charges [explosives] ||| Bonbons acidulés [confiserie]
0.3378758430480957 ||| Bile acid sequestrants, such as cholestyramine, can remove MPA by decreasing the enterohepatic re- circulation of the drug (see section 5.2).. ||| By blocking BCR-ABL kinase, as well as other kinases, Sprycel helps to control the spread of leukaemia cells. ||| Les agents chélatants des acides biliaires, comme la cholestyramine, peuvent éliminer le MPA en diminuant la recirculation liée au cycle entéro-hépatique du médicament (voir rubrique 5.2).
0.0004987423890270293 ||| The non-confidential version of the decision will be made available under the case number SA.56963 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.56966 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.56963 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.37027138471603394 ||| Articles made of synthetic rubber for insulation purposes ||| Nutritional supplements made of starch adapted for medical use ||| Articles en caoutchouc synthétique destinés à l'isolation
0.07698124647140503 ||| PegIntron is not recommended for use in patients under the age of 18 years. ||| ViraferonPeg is not recommended for use in patients under the age of 18 years. ||| PegIntron n’ est pas recommandé pour une utilisation chez le patient de moins de 18 ans.
0.0032417215406894684 ||| If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist. ||| Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez -en à votre médecin ou à votre pharmacien.
3.120986813171661e-13 ||| Venlafaxine 50 mg TID (Indinavir 800 mg SD) CALCIUM CHANNEL BLOCKERS ||| Venlafaxine 50 mg TID (Indinavir 800 mg SD) CALCIUM CHANNEL BLOCKERS ||| ANTIDEPRESSEURS Venlafaxine 50 mg, trois fois/ jour (Indinavir 800 mg, en dose unique)
0.33851534128189087 ||| Your doctor will monitor your blood regularly for any changes, and will decide if any specific treatment is needed. ||| If any problems occur while you are having your infusion, the medical staff will be on hand to take any necessary action. ||| Votre médecin surveillera régulièrement vos paramètres sanguins pour déterminer tout changement, et décidera si un traitement spécifique est nécessaire.
0.3543089032173157 ||| Plasma concentrations of telmisartan are generally 2 – 3 times higher in females than in males. ||| High increases in plasma methionine levels in a range from 1,000 to 3,000 µM were noted in these patients. ||| Les concentrations plasmatiques du telmisartan sont généralement 2 à 3 fois plus élevées chez la femme que chez l’ homme.
0.3160509467124939 ||| Do not remove the needle shield. ||| Remove the needle shield. ||| N’ enlevez pas le protège aiguille.
0.5298476219177246 ||| EU/1/04/279/023 – 025 EU/1/04/279/029 EU/1/04/279/032 EU/04/279/043 ||| EU/1/04/279/014 – 016 EU/1/04/279/039 ||| EU/1/04/279/023-025 EU/1/04/279/029 EU/1/04/279/032 EU/1/04/279/043
0.4789338707923889 ||| Mullions of metal ||| Monuments of marble ||| Meneaux métalliques
0.5064258575439453 ||| Horizon Europe will finance research and innovation on topics such as life-long good health; environmental and social health determinants; non-communicable and rare diseases; infectious diseases; tools, technologies and digital solutions for health and care and healthcare systems. ||| Transparency, communication and provision of information to patients, healthcare professionals and users of medicines Availability of medicines and innovation Small and medium-sized enterprises EU institutions, agencies and European and international partners Managing the Agency ||| Horizon Europe financera la recherche et l'innovation sur des thèmes tels que la bonne santé tout au long de la vie, les déterminants environnementaux et sociaux de la santé, les maladies non transmissibles et les maladies rares, les maladies infectieuses, les outils, les technologies et les solutions numériques pour la santé et les soins ainsi que les systèmes de soins de santé.
0.546265721321106 ||| - serious kidney or liver problems ||| - severe heart or blood vessels disease ||| - de problèmes rénaux ou hépatiques graves
0.4048535227775574 ||| The experience in humans with overdosage of eptifibatide is extremely limited. ||| Cases of overdose of fluoxetine alone usually have a mild course. ||| Chez l’ homme l’ expérience du surdosage par l’ eptifibatide est extrêmement limitée.
0.29364997148513794 ||| A complete 3-dose vaccination series of RotaTeq should be administered (see section 4.2) to provide the level and duration of protection against rotavirus gastroenteritis that was observed in the clinical studies. ||| The current procedure is a referral following a Mutual Recognition Procedure variation application, which concerned an extension of the indication for Prozac to include the treatment of major depressive episodes in children aged 8 to 17 years. ||| Le schéma de vaccination en 3 doses de RotaTeq doit être administré dans sa totalité (Voir rubriques 4.2) pour acquérir le niveau et la durée de protection contre les gastro-entérites à rotavirus qui ont été observé lors des études cliniques.
0.5188613533973694 ||| Apparatus for heating milk ||| Apparatus for drawing up beer under pressure ||| Appareils pour chauffer du lait
0.4131782054901123 ||| chest ache caused by a shortage of oxygen in the heart muscle (angina pectoris). ||| enlarged lymph nodes (lymphadenopathy) in the region of the injection site ||| douleur thoracique provoquée par un manque d’ oxygène dans le muscle cardiaque (angine de poitrine).
0.5127744674682617 ||| Medicines should not be disposed of via wastewater or in household waste. ||| Baits shall not be distributed in inhabited areas, roads and watery areas. ||| Les médicaments ne doivent pas être jetés au tout à l’égout ou avec les ordures ménagères.
0.21754871308803558 ||| We have approved this measure under the new State aid Temporary Framework in just a few days, and will continue to work with Member States to ensure timely support to the economy through these difficult times." ||| This measure, approved under the extended State aid Temporary Framework, is another example of our close cooperation with Member States to ensure timely support to the economy through these difficult times." ||| Nous avons autorisé cette mesure sur la base du nouvel encadrement temporaire des aides d'État en quelques jours à peine, et nous continuerons d'œuvrer avec les États membres à un soutien en temps utile à l'économie en cette période difficile.»
0.10590587556362152 ||| Additives (Chemical -) for combustion enhancers ||| Additives (Non-chemical -) for combustion enhancers ||| Additifs chimiques pour activateurs de combustion
0.42169463634490967 ||| 3 x 30 film-coated tablets ||| 90 (3 x 30 x 1) film-coated tablets ||| 3 x 30 comprimés pelliculés
0.4031722843647003 ||| Ovitrelle is provided as solution for injection. ||| 182 ABILIFY solution for injection is ready to use. ||| Ovitrelle est présenté sous forme de solution injectable.
0.38749977946281433 ||| For patients with baseline blood phenylalanine levels ≥ 600 µmol/ l, 41.9% (13/ 31) of those treated with sapropterin and 13.2% (5/ 38) of those treated with placebo had blood phenylalanine levels < 600 µmol/ l at the end of the 6-week study period (p=0.012). ||| In patients with parathyroid carcinoma, mean serum calcium declined from 14.1 mg/ dl to 12.4 mg/ dl (3.5 mmol/ l to 3.1 mmol/ l), while in patients with primary HPT, serum calcium levels declined from 12.7 mg/ dl to 10.4 mg/ dl (3.2 mmol/ l to 2.6 mmol/ l). ||| Parmi les patients avec des taux sanguins initiaux de phénylalanine ≥ 600 µmol/ l, 41,9% (13/ 31) de ceux traités par saproptérine et 13,2% (5/ 38) de ceux ayant reçu le placebo ont présenté des taux sanguins de phénylalanine < 600 µmol/ l à la fin de la période d’ étude de 6 semaines (p=0,012).
0.09867776930332184 ||| 100 PARTICULARS TO APPEAR ON IMMEDIATE PACKAGING ||| 25 PARTICULARS TO APPEAR ON IMMEDIATE PACKAGING UNITS ||| 107 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.932368278503418 ||| Mortality ||| Brilliantine ||| Mortalité
0.37925007939338684 ||| Vehicle safety harness for safety seats for children ||| Vehicle safety restraints for use with safety seats ||| Harnais de sécurité de sièges-autos pour enfants
2.8614673022557546e-13 ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 3 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 3 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Système de pharmacovigilance Le titulaire de l’ autorisation de mise sur le marché doit garantir que le système de pharmacovigilance, tel que décrit dans la version 3 présentée dans le Module 1.8.1 de la demande d’ autorisation de mise sur le marché, est en place et fonctionel avant et tout au long de la mise sur le marché du médicament.
0.8948262333869934 ||| body weight (in kg) ||| Body weight in kg Initial dose ||| Poids corporel (en kg)
0.5020120143890381 ||| Vomiting, diarrhoea or softened stools may occur during treatment. ||| Early haemarthrosis, muscle bleeding or oral bleeding ||| Vomissements, diarrhée ou selles molles peuvent apparaître pendant le traitement.
3.8030554183263177e-13 ||| Doxazosin has a beneficial effect on blood lipids with significant increase of HDL/ total cholesterol ratio (app. ||| Doxazosin has a beneficial effect on blood lipids with significant increase of HDL/ total cholesterol ratio (app. ||| La doxazosine a des effets positifs sur les lipides sanguins, à savoir une augmentation significative du rapport HDL / cholestérol total (env.
0.3583822250366211 ||| Engineering services relating to computer programming ||| Design services relating to metal-working tools ||| Services d'ingénierie en matière de programmation informatique
0.007419717498123646 ||| EU/ 1/ 97/ 030/ 077 (3 pens of 3 ml) EU/ 1/ 97/ 030/ 078 (4 pens of 3 ml) EU/ 1/ 97/ 030/ 079 (5 pens of 3 ml) EU/ 1/ 97/ 030/ 103 (6 pens of 3 ml) EU/ 1/ 97/ 030/ 108 (9 pens of 3 ml) EU/ 1/ 97/ 030/ 080 (10 pens of 3 ml) ||| EU/ 1/ 97/ 030/ 065 (3 pens of 3 ml) EU/ 1/ 97/ 030/ 066 (4 pens of 3 ml) EU/ 1/ 97/ 030/ 067 (5 pens of 3 ml) EU/ 1/ 97/ 030/ 100 (6 pens of 3 ml) EU/ 1/ 97/ 030/ 105 (9 pens of 3 ml) EU/ 1/ 97/ 030/ 068 (10 pens of 3 ml) ||| EU/ 1/ 97/ 030/ 077 (3 stylos de 3 ml) EU/ 1/ 97/ 030/ 078 (4 stylos de 3 ml) EU/ 1/ 97/ 030/ 079 (5 stylos de 3 ml) EU/ 1/ 97/ 030/ 103 (6 stylos de 3 ml) EU/ 1/ 97/ 030/ 108 (9 stylos de 3 ml) EU/ 1/ 97/ 030/ 080 (10 stylos de 3 ml)
0.679674506187439 ||| - You have high blood pressure or your blood pressure gets higher ||| 82 If your blood sugar gets too high ||| - Vous avez une pression artérielle élevée ou une pression artérielle qui devient élevée
2.629591423081168e-13 ||| A pharmacokinetic study in patients with chemotherapy-induced anaemia treated with 6.75 µg/ kg darbepoetin alfa administered SC every 3 weeks in combination with chemotherapy was conducted which allowed for full characterisation of the terminal half-life. ||| A pharmacokinetic study in patients with chemotherapy-induced anaemia treated with 6.75 µg/ kg darbepoetin alfa administered SC every 3 weeks in combination with chemotherapy was conducted which allowed for full characterisation of the terminal half-life. ||| Afin de déterminer avec précision la demi-vie terminale, une étude pharmacocinétique a été réalisée chez des patients présentant une anémie chimio-induite, traités par une dose sous-cutanée de m
0.8188508749008179 ||| Powder vial Plastic cap ||| Protective tab Pen Cap ||| Flacon de poudre
0.20432698726654053 ||| Optisulin is a clear, colourless solution for injection containing insulin glargine. ||| Lantus is a clear solution for injection containing the active substance insulin glargine. ||| Optisulin est une solution injectable, limpide et incolore, contenant de l'insuline glargine.
0.753704309463501 ||| The patients can inject Avonex themselves if they have been trained appropriately. ||| They could also choose sites they considered salubrious for their members and sometimes had them modified. ||| Les patients peuvent s’ injecter Avonex eux- mêmes, à condition d’ avoir été formés de manière appropriée pour ce faire.
0.5285208821296692 ||| Irradiation of food ||| Therapy of intoxication ||| Irradiation d'aliments
0.13470083475112915 ||| Depression, irritability, insomnia, anxiety*, concentration impaired, emotional lability* ||| Depression, insomnia, anxiety, emotional lability*, agitation, nervousness ||| Dépression, irritabilité, insomnie, anxiété*, concentration Très fréquent: altérée, instabilité émotionnelle*
0.3132060170173645 ||| After intravenous administration of laronidase with an infusion time of 240 minutes and at a dose of 100 U/ kg body weight pharmacokinetic properties were measured at Weeks 1, 12 and 26. ||| The primary immunisation schedule for chronic haemodialysis patients is four doses of 40 µg at elected date, 1 month, 2 months and 6 months from the date of the first dose. ||| Après administration par voie intraveineuse de laronidase en perfusion de 240 minutes et à une dose de 100 U/ kg de poids corporel, les propriétés pharmacocinétiques ont été mesurées à la semaine 1, 12 et 26.
0.34219563007354736 ||| Symptoms suggestive of serum sickness include arthritis/ arthralgias, rash (urticaria or other forms), fever and lymphadenopathy. ||| Cardiac arrhythmias (including atrial fibrillation, supraventricular tachycardia and extrasystoles) may occur in some patients. ||| Les symptômes suggérant une maladie sérique comprennent une arthrite/ arthralgie, un rash (urticaire ou autres formes), une fièvre et une lymphadénopathie.
0.48273196816444397 ||| Suitcases ||| Contour sheets ||| Valises
0.38710999488830566 ||| 28/ 94 The binding of ropinirole to plasma proteins is not high (< 40%), with no effect on the distribution, which is very extensive (volume of distribution in the order of 7 l/ kg). ||| The mean (standard deviation, SD) dissociation constant (Kd) of binding was 5.1 (3.0) ng/ ml, denoting the concentration at which 50% of binding sites in blood cells were occupied. ||| Distribution La fixation du ropinirole aux protéines plasmatiques est peu importante (< 40%), sans incidence sur la distribution qui est très large (volume de distribution de l’ ordre de 7 l/ kg).
0.6013192534446716 ||| infections, bruising, bleeding, swollen glands ||| Headache, difficulty sleeping, abnormal dreams Nausea ||| d'hématomes, d'hémorragie, ganglions gonflés;
0.6906970739364624 ||| gonal-f 300 iu/ 0.5 ml ||| ovitrelle 250/ 0.5 ml ||| gonal-f 300 ui/ 0,5 ml
0.20116731524467468 ||| Opinion The CPMP, having considered the matter as set out in the appended referral assessment report and having considered the Summary of Product Characteristics provided by the Marketing Authorisation Holders recommends the maintenance of the Marketing Authorisations of all medicinal products referred in Annex II in accordance with the Summary of Product Characteristics set out in Annex III. ||| Therefore, the CHMP has recommended to maintain the Marketing Authorisations for all medicinal products and to grant Marketing Authorisations for all applications referred to in Annex I of the Opinion in accordance with the amendments to the relevant sections of the Summary of Product Characteristics and Package Leaflet, set out in Annex III of the Opinion. ||| Avis Le CPMP, après avoir examiné la question comme indiqué dans le rapport d'évaluation joint ainsi que les Résumés des Caractéristiques du Produit fournis par les titulaires des autorisations de mise sur le marché, recommande le maintien des autorisations de mise sur le marché pour tous les médicaments indiqués en Annexe II conformément au Résumé des Caractéristiques du Produit joint en Annexe III.
0.26707136631011963 ||| An increased incidence of hypertension (all grades) of up to 34% has been observed in Avastin-treated patients in clinical trials compared with up to 14% in those treated with comparator. ||| In this study, the population was not considered representative of a high-risk population of strokes (prevalence of 43% of patients with hypertension compared to a 60% rate in an at risk population). ||| Dans les études cliniques, une augmentation de l’ incidence de l’ hypertension artérielle (tous grades) a été observée jusqu’ à 34% des patients traités par Avastin comparé à 14% des patients du groupe témoin.
0.12692934274673462 ||| 31/ 41 ||| 29/ 41 ||| 32/ 43
0.4980763792991638 ||| Packs of 4, 5 and 10 cartridges are available. ||| It is available in packs of 1, 3, 5 or 10 vials. ||| Disponible en boîtes de 4, 5 et 10 cartouches.
0.36760324239730835 ||| Spool unwinders [hand-operated tools] ||| Bottle openers [hand-operated] ||| Dérouleurs de bobines [outillage manuel]
0.519182562828064 ||| Musculoskeletal, connective tissue and bone disorders Common: myalgia ||| Skin and subcutaneous tissue disorders Musculoskeletal and connective tissue disorders Vascular disorders ||| Affections musculo-squelettiques et systémiques Fréquents: myalgies
0.404268741607666 ||| Taste perversion, circumoral and peripheral paresthesia, headache ||| Flu-like symptoms, peripheral oedema/ fluid retention ||| Altération du goût, paresthésies péribuccales et neuropathies sensitives périphériques, céphalées
0.3547171354293823 ||| Patients treated with Lucentis in PIER received a mean of 10 total treatments out of possible 13 from day 0 to month 24. ||| Patients received a mean of between 8.4-8.6 treatments out of possible 9 total across all treatment arms in the first year. ||| Les patients traités par Lucentis dans l'étude PIER ont reçu en moyenne 10 traitements sur les 13 traitements possibles entre le jour 0 et le mois 24.
0.1742408126592636 ||| Pack-sizes of 40, 60 or 180 tablets. ||| Packs of 30, 56 or 100 tablets. ||| Emballages de 40, 60 ou 180 comprimés.
0.29096847772598267 ||| It is not recommended to breast-feed your baby while taking Vimpat, as it is not known if Vimpat passes into the breast milk. ||| Ask your doctor for advice before breast-feeding your baby, as it is not known if TORISEL passes into breast milk. ||| Il n’est pas recommandé d’allaiter votre enfant pendant le traitement par Vimpat dans la mesure où il n’a pas été établi si Vimpat passe dans le lait maternel.
0.3688125014305115 ||| The following dosing table indicates what volume to administer depending on the weight of the dog: ||| The correct number of tablets or half tablets to use is calculated based on the dog’ s weight. ||| Le tableau posologique suivant indique le volume à administrer en fonction du poids du chien:
0.3197300136089325 ||| Concomitant use of risperidone with other diuretics (mainly thiazide diuretics used in low dose) was not associated with similar findings. ||| There are no data indicating less overall adverse events associated with the use of parecoxib compared to placebo when used in conjunction with opioids. ||| L’ utilisation concomitante de rispéridone avec d’ autres diurétiques (principalement des diurétiques thiazidiques administrés à faible dose) n’ a pas été associée à des observations similaires.
0.2569277286529541 ||| 115 PARTICULARS TO APPEAR ON THE PACKAGING ||| 149 PARTICULARS TO APPEAR ON THE PEN ||| 123 MENTIONS PARTICULIERES DEVANT FIGURER SUR L'EMBALLAGE.
0.1480483114719391 ||| If you are hypersensitive to Trizivir you should return all of your unused Trizivir tablets for disposal. ||| If you are hypersensitive to abacavir you should return all of your unused Kivexa tablets for disposal. ||| Si vous êtes allergique à Trizivir, vous devez rapporter tous les comprimés de Trizivir inutilisés afin qu’ ils soient détruits.
0.3009687066078186 ||| - injection site reaction*, ||| - injection site inflammation*, ||| - réaction au site d’injection*,
0.13821323215961456 ||| Dafiro 5 mg/ 160 mg film-coated tablets ||| Janumet 50 mg/ 1000 mg film-coated tablets ||| Dafiro 5 mg/ 160 mg comprimés pelliculés
0.3493187427520752 ||| France requested CVMP to consider the therapeutic scheme of these veterinary medicinal products and to indicate if the administration of the product once daily is considered appropriate in terms of efficacy and potential selection of antimicrobial resistant bacteria. ||| • That the safety database of Thelin is limited and physicians are encouraged to enrol patients in a surveillance programme to increase knowledge about the incidence of important adverse drug reactions (ADRs). ||| La France a demandé au comité des médicaments vétérinaires (CVMP) d’ examiner le régime thérapeutique de ces médicaments à usage vétérinaire et d’ indiquer si l’ administration du produit une fois par jour est considérée comme appropriée en termes d’ efficacité et de sélection potentielle de bactéries résistantes aux anti-microbiens.
0.40518733859062195 ||| ZYPADHERA 300 mg powder for injection olanzapine IM ||| ZYPREXA 10 mg olanzapine powder for solution for injection IM use ||| ZYPADHERA 300 mg poudre pour injection Olanzapine IM
4.317001671503423e-13 ||| CONDITIONS OF THE MARKETING AUTHORISATION ||| CONDITIONS OF THE MARKETING AUTHORISATION ||| CONDITIONS RELATIVES À L’ AUTORISATION DE MISE SUR LE MARCHÉ
1.0331395864486694 ||| BYETTA Liquid ||| ACOMPLIA Me ||| BYETTA liquide
0.26162779331207275 ||| Since glimepiride belongs to the chemical class of sulfonylurea drugs, caution should be used in patients with G6PD-deficiency and a non-sulfonylurea alternative should be considered. ||| Because 1'-hydroxymidazolam is an active metabolite, the sedative effect of midazolam may be increased and caution should be used when laropiprant is co-administered with midazolam. ||| Comme le glimépiride appartient à cette classe chimique des sulfamides hypoglycémiants, il doit être utilisé avec précaution chez les patients ayant un déficit en G6PD et le recours à un traitement alternatif excluant les sulfamides hypoglycémiants doit être envisagé.
0.05956604331731796 ||| WHAT SILGARD IS AND WHAT IT IS USED FOR ||| WHAT STOCRIN IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE SILGARD ET DANS QUEL CAS EST-IL UTILISE
0.24485228955745697 ||| Cosmetics in the form of milks ||| Spices in the form of powders ||| Cosmétiques sous forme de laits
0.05769849196076393 ||| The most common side effect with Trevaclyn (seen in more than 1 patient in 10) is flushing. ||| The most common side effect with Tredaptive (seen in more than 1 patient in 10) is flushing. ||| L’ effet indésirable les plus couramment observé sous Trevaclyn (chez plus d’ un patient sur 10) est un rougissement.
0.061584919691085815 ||| 450 mg twice daily ||| 500 mg twice daily ||| 450 mg 2 fois par jour
0.14897680282592773 ||| ISENTRESS may not have these effects in all patients. ||| CRIXIVAN may not have these effects in all patients. ||| ISENTRESS peut ne pas avoir ces effets chez tous les patients.
0.32131344079971313 ||| Children Fentanyl-ratiopharm should not be administered to children under 12 years of age because there is limited experience of use in children. ||| Intact CYSTAGON hard capsules should not be administered to children under the age of approximately 6 years due to risk of aspiration (see section 4.2). ||| Enfants Il ne faut pas utiliser Fentanyl-ratiopharm chez les enfants de moins de 12 ans car l’ expérience acquise avec ce médicament chez l’ enfant est limitée.
0.3236919045448303 ||| Your doctor will decide on the dose of RISPERDAL CONSTA that is right for you • Your doctor may prescribe oral RISPERDAL for the first three weeks following your first injection. ||| ra Your doctor should advise you about using contraception before treatment with Zenapax is started, during treatment with Zenapax, and for an additional 4 months following the last dose of Zenapax. ||| Votre médecin vous indiquera la dose de RISPERDAL CONSTA la mieux adaptée pour vous • Votre médecin pourra vous prescrire du RISPERDAL par voie orale pendant les trois premières semaines suivant la première injection.
0.2768985629081726 ||| Radium tubes for medical purposes ||| Prosthetic instruments for dental purposes ||| Ampoules radiogènes à usage médical
0.3954060673713684 ||| The dosage cup or oral syringe should be cleaned immediately with hot water and dish soap after use. ||| Swallow your prescribed dose of Remeron without chewing, with some water or juice. ||| Le verre doseur ou la seringue pour administration orale doit être immédiatement lavé(e) à l'eau chaude et au produit à vaisselle.
0.2650638222694397 ||| Inflammation of the pancreas and lactic acidosis (excess lactic acid in the blood), which sometimes caused death, have been reported rarely when medicines containing tenofovir disoproxil fumarate and didanosine were taken together. ||| These lesions were not observed in macaques; decreases in serum potassium due to hydrochlorothiazide and partly prevented when hydrochlorothiazide was given in combination with irbesartan. ||| Des cas d’ inflammation du pancréas, ainsi que d’ acidose lactique (excès d’ acide lactique dans le sang) ayant parfois entraîné la mort, ont été rarement rapportés lorsque des médicaments contenant du fumarate de ténofovir disoproxil et de la didanosine étaient pris en même temps.
0.140558123588562 ||| - The active substance is temoporfin. ||| The active substance is temoporfin. ||| - La substance active est la témoporfine.
0.2777371406555176 ||| Elderly There are only very limited data on protective efficacy of the vaccine in subjects aged 65 years and more. ||| There is very limited experience of the efficacy and safety of the medicinal product in the elderly (> 65 years of age). ||| Sujet âgé Les données portant sur l’ efficacité protectrice du vaccin chez le sujet âgé de plus de 65 ans sont limitées.
0.4039398729801178 ||| Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs Belgium ||| Pfizer Service Company bvba Hoge Wei, 10 B-1930 Zaventem Belgium ||| Pfizer Manufacturing Belgium NV Rijksweg 12 2870 Puurs Belgique
0.2880837321281433 ||| By blocking their activity, ustekinumab reduces the activity of the immune system and the symptoms of the disease. ||| Aivlosin improves the health and weight of the animals, but may not eliminate completely the bacteria that caused lung infection. ||| En bloquant leur activité, l’ ustekinumab réduit l’ activité du système immunitaire et les symptômes de la maladie.
0.1415954977273941 ||| HOW TO STORE RAPINYL ||| HOW TO STORE RENAGEL ||| COMMENT CONSERVER RAPINYL?
0.337613970041275 ||| Before withdrawing each dose disinfect the rubber seal of the withdrawal device with alcohol to prevent contamination of the contents by repeated needle insertions. ||| Any contrast medium solution left over in the bottle, the connecting tubes and all disposable parts of the injector system must be discarded within 8 hours. ||| Avant de prélever une dose, désinfecter le bouchon en caoutchouc du dispositif de prélèvement avec de l’ alcool afin de prévenir toute contamination du contenu due aux insertions répétées d’ aiguille.
0.0 ||| EMEA/CVMP a) Validation b) Opinion c) Active time d) Clockstop ||| EMEA/CVMP a) Validation b) Opinion c) Active time d) Clockstop ||| EMEA/CVMP a) Validation b) Opinion c) “temps actif”
0.6758646965026855 ||| 4.3 Contraindications ||| 4.4 Special warnings ||| 306 4.3 Contre-indications
0.4435887336730957 ||| EU/ 1/ 08/ 470/ 004 14 film-coated tablets EU/ 1/ 08/ 470/ 005 56 film-coated tablets EU/ 1/ 08/ 470/ 006 168 film-coated tablets ||| EU/1/98/070/008 4x1 film-coated tablets EU/1/98/070/009 30x1 film-coated tablets EU/1/98/070/010 100x1 film-coated tablets ||| EU/ 0/ 00/ 000/ 000 14 comprimés pelliculés EU/ 0/ 00/ 000/ 000 56 comprimés pelliculés EU/ 0/ 00/ 000/ 000 168 comprimés pelliculés
0.21409393846988678 ||| - certain medicines to treat allergies (e. g. terfenadine, astemizole, mizolastine), heart rhythm ||| - medicines to treat epilepsy or another neurologic disorder (e. g. phenytoin, carbamazepine, or ||| - certains médicaments pour les allergies (ex. terfénadine, astémizole, mizolastine), les troubles du
0.05409453809261322 ||| The safety and efficacy of zidovudine has not been established in patients with significant underlying liver disorders. ||| The safety and efficacy of Kivexa has not been established in patients with significant underlying liver disorders. ||| La tolérance et l'efficacité de la zidovudine n'ont pas été établies chez les patients ayant des troubles sous-jacents significatifs de la fonction hépatique.
0.4664589464664459 ||| The optimal number of injection sites is dependent upon the size of the muscle. ||| The dose depends on the weight of the dog being treated.. ||| Le nombre optimum de sites d'injection dépend de la taille du muscle.
5.892137363953942e-13 ||| Usual warning symptoms may disappear in patients with longstanding diabetes. ||| Usual warning symptoms may disappear in patients with longstanding diabetes. ||| Chez les patients atteints d’ un diabète ancien, les signes annonciateurs habituels peuvent disparaître. am
0.6748158931732178 ||| Guidance for an assessor preparing variation assessment reports for veterinary biologicals ||| a) Establishing a multidisciplinary team for your hospital antibiotic stewardship programme. ||| Guide pour la préparation des évaluations des modifications concernant des médicaments vétérinaires biologiques
0.37072670459747314 ||| 22 No incompatibilities between Herceptin and polyvinylchloride, polyethylene or polypropylene bags have been observed. ||| It is unknown whether methoxy polyethylene glycol-epoetin beta is excreted in human breast milk. ||| Il n’a été noté aucune incompatibilité entre Herceptin et les poches à perfusion en chlorure de polyvinyle, en polyéthylène ou en polypropylène.
0.5728306770324707 ||| Self-propelled loading vehicles ||| All-purpose carrying bags ||| Véhicules de chargement automoteurs
0.896385908126831 ||| 134 Method of administration ||| Categories of community health ||| Mode d’administration
0.4692850112915039 ||| No dosage adjustment is necessary for elderly patients. ||| No data is available in patients requiring dialysis. ||| Sujet âgé: aucune adaptation de la posologie n’ est nécessaire chez le sujet âgé.
0.020150549709796906 ||| For the full list of all side effects reported with Kineret, see the Package Leaflet. ||| For the full list of all side effects reported with Neupro, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Kineret, voir la notice.
0.03668808192014694 ||| Nobilis Influenza H5N6 Emulsion for injection ||| Nobilis Influenza H5N6 emulsion for injection ||| Nobilis Influenza H5N6 Emulsion injectable.
0.10652807354927063 ||| The CHMP decided that Orfadin’ s benefits are greater than its risks and recommended that Orfadin be given marketing authorisation. ||| The CHMP decided that Ammonaps’ benefits are greater than its risks and recommended that Ammonaps be given marketing authorisation. ||| Le CHMP a décidé que les bénéfices d’ Orfadin sont plus importants que ses risques et a recommandé l’ octroi d’ une autorisation de mise sur le marché pour ce médicament.
0.161876380443573 ||| Fosaprepitant, a prodrug of aprepitant, when administered intravenously is rapidly converted to aprepitant. ||| Fosaprepitant is the prodrug of aprepitant and when administered intravenously is converted rapidly to aprepitant (see section 5.2). ||| Le fosaprépitant, pro-drogue de l'aprépitant, est rapidement transformé en aprépitant lorsqu'il est administré par voie intraveineuse.
0.42647671699523926 ||| Financial advisory services relating to tax ||| Forensic advice relating to damage assessment ||| Services de conseils financiers en matière fiscale
0.0856768935918808 ||| 5 ml Type 1 clear glass vials fitted with grey butyl rubber stoppers and snap-off aluminium crimp seals. ||| 20 ml type I clear glass vials with grey butyl rubber stopper and aluminium seals with plastic flip-off caps. ||| Flacon de 5 ml en verre transparent de type 1, muni d’ un bouchon en caoutchouc butyl gris et serti d’ un joint amovible en aluminium.
0.31511634588241577 ||| France requested CVMP to consider the therapeutic scheme of these veterinary medicinal products and to indicate if the administration of the product once daily is considered appropriate in terms of efficacy and potential selection of antimicrobial resistant bacteria. ||| The BPWP considered that post marketing safety data generated in only one EU member state can be adequate to define the safety profile of the product provided that the quality of the data and the Pharmacovigilance system is sufficient. ||| La France a demandé au comité des médicaments vétérinaires (CVMP) d’ examiner le régime thérapeutique de ces médicaments à usage vétérinaire et d’ indiquer si l’ administration du produit une fois par jour est considérée comme appropriée en termes d’ efficacité et de sélection potentielle de bactéries résistantes aux anti-microbiens.
0.0 ||| In case of accidental self-injection, seek medical advice immediately and show the package insert or the label to the physician. ||| In case of accidental self-injection, seek medical advice immediately and show the package insert or the label to the physician. ||| En cas d’ auto-injection accidentelle, demandez immédiatement conseil à un médecin et montrez -lui la notice.
0.26512032747268677 ||| Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human erythropoietin and those in the control group. ||| The indication for NeoRecormon treatment of nephrosclerotic patients not yet undergoing dialysis should be defined individually, as a possible acceleration of progression of renal failure cannot be ruled out with certainty. ||| Ces résultats sur la survie globale n’ ont pas pu être expliqués de façon satisfaisante par des différences d’ incidence de survenue de thromboses et de leurs complications associées, entre les patients recevant une érythropoïétine humaine recombinante et ceux des groupes contrôles.
0.07458764314651489 ||| For icatibant, no clinical data on exposed pregnancies are available. ||| For imiquimod no clinical data on exposed pregnancies are available. ||| Aucune donnée n’ est disponible sur l’ exposition des femmes enceintes à l’ icatibant.
0.47505319118499756 ||| - Patients with active peptic ulceration or gastrointestinal bleeding. ||| Secondary prevention after acute myocardial infarction and with heart failure ||| - Ulcère peptidique évolutif ou saignement gastro-intestinal.
0.24867689609527588 ||| Rare side effects (affects 1 to 10 users in 10,000): some patients have experienced allergic reactions soon after injection, consisting of breathlessness, swelling of the face, rash and chest pain. ||| Side effects in women The most commonly reported side effects are ovarian cysts, headache and local reactions at the injection site (pain, redness, bruising, swelling and/ or irritation). ||| Effets indésirables rares (observés chez au moins 1 patient sur 10000 et moins d’1 patient sur 1000): des patients ont présenté des réactions allergiques peu après l’injection à type d’essoufflement, de gonflement du visage, d’éruption cutanée et de douleur dans la poitrine.
8.011297788351746e-13 ||| May be harmful for people with phenylketonuria. ||| May be harmful for people with phenylketonuria. ||| Peut être nocif pour les patients présentant une phénylcétonurie.
0.03524839133024216 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged becoming ‘ sticky’. ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged two lasted a year. ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Comment Plavix agit -il?
0.0 ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence européenne des médicaments (EMEA) http: / /www. emea. europa. eu/.
0.48808759450912476 ||| Hepatic function tests abnormal Hepatitis with mainly cholestatic features (see section 4.4.) ||| Efficacy Results from study 3 (study 100554) in hepatocellular carcinoma ||| Anomalies des tests de la fonction hépatique Hépatite de type cholestatique (voir rubrique 4.4)
0.02722986787557602 ||| For the full list of all side effects reported with Avaglim, see the Package Leaflet. ||| For the full list of all side effects reported with Revlimid, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation d’ Avaglim, voir la notice.
0.19214150309562683 ||| In patients with moderate liver disease, the dose of Onsenal should be halved, and it should be used with caution in patients with mild or moderate kidney problems. ||| No adjustment of the initial dosage of Tekturna is required in patients with mild to severe renal impairment, however caution should be exercised in patients with severe renal impairment. ||| Chez les patients atteints d’ une maladie du foie modérée, la dose d’ Onsenal devra être réduite de moitié et Onsenal doit être utilisé avec précaution chez les patients présentant des troubles légers à modérés des reins.
0.01670505292713642 ||| Each orodispersible tablet contains 0.80 mg aspartame, 0.15 mg sodium methyl parahydroxybenzoate, 0.05 mg sodium propyl parahydroxybenzoate. ||| Each orodispersible tablet contains 1.20 mg aspartame, 0.225 mg sodium methyl parahydroxybenzoate, 0.075 mg sodium propyl parahydroxybenzoate. ||| Chaque comprimé orodispersible contient 0,80 mg d’ aspartam, 0,15 mg de parahydroxybenzoate de méthyle sodé, 0,05 mg de parahydroxybenzoate de propyle sodé.
0.3495319187641144 ||| The Interpretative Communication clarifies the treatment of such moratoria in order to ensure a level playing field across the EU so that households, businesses, and banks benefit from a harmonised application and enforcement of the rules. ||| Adapting the EU's regulatory framework to the current urgency and making use of existing regulatory flexibility to accelerate the development, authorisation and availability of vaccines while maintaining the standards for vaccine quality, safety and efficacy. ||| La communication interprétative précise le traitement à réserver à ces moratoires de façon à garantir une interprétation et une application harmonisées des règles et à assurer ainsi des conditions équitables aux ménages, aux entreprises et aux banques de toute l'UE.
0.276758074760437 ||| The usual starting dose is between 0.1 and 0.4 MU per kg bodyweight each day. ||| The individual insulin requirement is usually between 0.3 and 1.0 IU/ kg/ day. ||| La dose initiale habituelle est comprise entre 0,1 et 0,4 MU par kg de poids et par jour.
0.71463543176651 ||| TAXOTERE vial: polysorbate 80. ||| Trovan i.v. alatrofloxacin Part B ||| Flacon de TAXOTERE: polysorbate 80.
0.6048516035079956 ||| The safety of fluoxetine has not been systematically assessed for chronic treatment longer than 19 weeks. ||| After the last administration of Zactran, cattle should not be slaughtered for 64 days. ||| La tolérance de la fluoxétine n’ a pas été évaluée de façon systématique au-delà de 19 semaines de traitement.
0.3705041706562042 ||| Tenofovir disoproxil fumarate ||| Tenofovir disoproxil ||| 300 mg de fumarate de
0.2634289860725403 ||| The effect of degarelix on insulin and glucose levels has not been studied. ||| Race The effect of race on metabolism of sodium oxybate has not been evaluated. ||| L’ effet de dégarélix sur les concentrations d’ insuline ou de glucose n’ a pas été étudié.
0.402582585811615 ||| Grade 3 and 4 hypertension (requiring oral anti-hypertensive medication) in patients receiving Avastin ranged from 3.0% to 17.9%. ||| Seropositivity rates were 100% and 94.2% respectively for anti-HAV and anti-HBs antibodies at month 24. ||| Une hypertension artérielle de Grade 3 et 4 (nécessitant un traitement anti-hypertenseur oral) est survenue chez 3,0 à 17,9% des patients recevant Avastin.
0.04452730715274811 ||| WHAT TEMODAL IS AND WHAT IT IS USED FOR ||| WHAT XELODA IS AND WHAT IT IS USED FOR ||| QU’EST -CE QUE TEMODAL ET DANS QUEL CAS EST-IL UTILISE
0.3146854043006897 ||| Wheels for aircraft ||| Boots for motorcycling ||| Roues pour aéronefs
0.11262331157922745 ||| Why has Betaferon been approved? ||| Why has Herceptin been approved? ||| Pourquoi Betaferon a -t-il été approuvé?
0.2456270009279251 ||| How to store Dynastat 6. ||| How to store Pritor 6. ||| Comment conserver Dynastat 6.
0.3537307381629944 ||| España Orion Corporation Tel: +358 10 4261 ||| Norge Orion Pharma Animal Health Tlf: +47 4000 4190 ||| Orion Corporation Tel: +358 10 4261
0.0627259761095047 ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF BLEOMYCIN PHARMACHEMIE AND ASSOCIATED NAMES (SEE ANNEX I) ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF FENTANYL- RATIOPHARM AND ASSOCIATED NAMES (SEE ANNEX I) ||| RESUME GENERAL DE L’ EVALUATION SCIENTIFIQUE DE BLEOMYCIN PHARMACHEMIE ET DENOMINATIONS ASSOCIEES (VOIR ANNEXE I)
0.1903514713048935 ||| The other ingredients of Cream are: medium chain triglycerides, oleyl alcohol, propylene glycol, stearyl alcohol, cetyl alcohol, mono-and di-glycerides, sodium cetostearyl sulphate, benzyl alcohol, citric acid anhydrous, sodium hydroxide, purified water. ||| Medium chain triglycerides, Oleyl alcohol, Propylene glycol, Stearyl alcohol, Cetyl alcohol, Mono- and di-glycerides, Sodium cetostearyl sulphate, Benzyl alcohol, Citric acid anhydrous, Sodium hydroxide, Purified water ||| Les autres composants de {Nom de fantaisie} sont: triglycérides à chaînes moyennes, alcool oléylique, propylène glycol, alcool stéarylique, alcool cétylique, mono et diglycérides, cétostéaryl sulfate de sodium, alcool benzylique, acide citrique anhydre, hydroxyde de sodium, eau purifiée.
0.1142403781414032 ||| Pack sizes of 1, 5 and 10. ||| Pack sizes of 1, 5 or 10. ||| Boites de 1, 5 et 10 cartouches.
0.3117023706436157 ||| In patients with CML, 15.6% of the patients taking Glivec had progressed after 5 years, compared to 28.0% of those taking interferon- alpha plus cytarabine. ||| This was true for all HCV genotypes, particularly Genotype 1, in which the relapse rate was reduced by 30% compared with interferon alfa-2b monotherapy. ||| Chez les patients atteints de LMC, 15,6% des patients sous Glivec ont vu leur maladie progresser après 5 ans, par rapport à 28,0% de ceux sous interféron-alpha associé à la cytarabine.
0.3231964707374573 ||| [Invented name] 400 mg film-coated tablets are indicated for the treatment of the following bacterial infections: ||| Duration of administration [Invented name] 400 mg film-coated tablets should be used for the following treatment durations: ||| [Nom de fantaisie] 400 mg, comprimé pelliculé, est indiqué dans le traitement des infections bactériennes suivantes:
0.44869810342788696 ||| Dicural coated tablets should be given once a day for at least 5 days. ||| Rotarix is given as two doses, given at least four weeks apart. ||| Dicural comprimés enrobés doivent être administrés une fois par jour pendant 5 jours minimum.
0.5538995265960693 ||| Italia UCB Pharma S.p.A. ||| • SMB Technology S.A. ||| Italia UCB Pharma S. p. A.
0.42485275864601135 ||| After one to two weeks of therapy, the initial dose may be doubled or halved depending upon the patient's response. ||| In first-time users, the combination treatment is continued for 3 to 6 months, and sometimes for one year depending on your physicians judgement. ||| Après une ou deux semaines de traitement, la dose initiale peut être doublée ou diminuée de moitié selon la réponse du patient.
0.3636176586151123 ||| Cable cutters [machines] ||| Cattle stunning appliances [machines] ||| Coupe-câbles [machines]
0.2784903049468994 ||| 43 In clinical trials, an increased risk of death and serious cardiovascular events was observed when erythropoiesis stimulating agents (ESAs) were administered to target a haemoglobin of greater than 12 g/ dL (7.5 mmol/ l). ||| Reproductive studies When pregnant mice, rats and rabbits were given intramuscular injections of BOTOX during the period of organogenesis, the developmental No Observed Adverse Effect Level (NOAEL) was 4, 1 and 0.125 U/ kg, respectively. ||| Dans le cadre des essais cliniques, un risque accru de décès et d’ accidents cardiovasculaires graves a été observé lorsque des agents stimulant l’ érythropoïèse (ASE) étaient administrés afin de cibler un taux supérieur à 12 g/ dL (7.5 mmol/ l).
0.24164283275604248 ||| When a single 375 mg dose of aprepitant was administered on Day 9 of a 14-day regimen of 600 mg/ day of rifampicin, a strong CYP3A4 inducer, the AUC of aprepitant decreased 91% and the mean terminal half-life decreased 68%. ||| Then a single injection of a medicine used to induce final follicular maturation and containing 250 micrograms r-hCG or 5000 IU up to 10 000 IU human chorionic gonadotrophin (hCG) is administered 24-48 hours after the last GONAL-f injection. ||| Lorsqu’ une dose unique de 375 mg d’ aprépitant a été administrée à J9 d’ un schéma posologique de 14 jours de rifampicine 600 mg/ jour, un puissant inducteur du CYP3A4, l’ ASC de l’ aprépitant a diminué de 91% et la demi-vie terminale moyenne a diminué de 68%.
0.3735005855560303 ||| Dampers for ventilating installations ||| Fitting services for tyres ||| Registres pour installations de ventilation
0.2616031765937805 ||| Much of the joint pathology in rheumatoid arthritis and ankylosing spondylitis and skin pathology in plaque psoriasis is mediated by pro-inflammatory molecules that are linked in a network controlled by TNF. ||| Elevated levels of TNF are also found in the synovium and psoriatic plaques of patients with psoriatic arthritis and in serum and synovial tissue of patients with ankylosing spondylitis. ||| La majorité des atteintes articulaires de la polyarthrite rhumatoïde et de la spondylarthrite ankylosante, et des atteintes cutanées du psoriasis en plaques est médiée par des molécules pro-inflammatoires qui appartiennent à un réseau contrôlé par le TNF.
0.06853654980659485 ||| What is the risk associated with Paxene? ||| What is the risk associated with Xelevia? ||| Quels sont les risques associés à Paxene?
0.2902148962020874 ||| Contains lactose (see leaflet for further information). ||| Contains phenylalanine, see leaflet for further information. ||| Contient du lactose (voir la notice pour plus d’ information).
0.3020694851875305 ||| As with other serotoninergic medicinal products, discontinuation symptoms may occur in the neonate after maternal duloxetine use near term. ||| This risk was increased when rosiglitazone was added to established insulin and in patients receiving nitrates for known ischaemic heart disease. ||| Des symptômes de sevrage peuvent survenir chez le nouveau-né dont la mère a été traitée par la duloxétine en fin de grossesse.
3.271152337717964e-13 ||| Do not use in pregnant cows or heifers, which are intended to produce milk for human consumption, within 2 months of expected parturition. ||| Do not use in pregnant cows or heifers, which are intended to produce milk for human consumption, within 2 months of expected parturition. ||| Ne pas utiliser chez les vaches ou les génisses gravides productrices de lait destiné à la consommation humaine au cours des 2 mois précédant la mise bas.
0.3750738501548767 ||| In this context, the EU will consider progress in rule of law reforms when deciding on assistance. ||| The Commission stands ready to work with Italy on additional measures that may be needed on this basis. ||| Dans ce contexte, l'UE tiendra compte des progrès en matière de réforme de l'état de droit lorsqu'elle décidera de l'aide.
0.33811870217323303 ||| Hepatic impairment: patients with mild to moderate liver disease may be treated with their normally recommended dose of efavirenz. ||| Patients with kidney disease If you have moderate or severe kidney disease, your doctor will prescribe a lower dose. ||| Insuffisance hépatique: les patients présentant une pathologie hépatique légère à modérée, peuvent être traités à la posologie habituellement recommandée d’ éfavirenz.
0.4397353529930115 ||| Patients should be carefully monitored during therapy. ||| Antibody status should be monitored and reported. ||| Les patients doivent être surveillés avec attention pendant le traitement.
0.07498160749673843 ||| WHAT RILUTEK IS AND WHAT IT IS USED FOR ||| WHAT STARLIX IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE RILUTEK ET DANS QUEL CAS EST-IL UTILISE
0.5962210893630981 ||| BRISTOL-MYERS SQUIBB Champ “ Lachaud”, La Goualle F-19250 Meymac France ||| VIOFAR EPE Terma Evaggelistrias GR-136 71 Acharnai Athens Greece ||| 140 BRISTOL-MYERS SQUIBB Champ “ Lachaud”, La Goualle F-19250 Meymac France
0.5324485301971436 ||| Dripping pans ||| Quenching fluids ||| Lèchefrites
0.3387710452079773 ||| Merckle Biotec GmbH Dornierstraße 10 DE-89079 Ulm Germany ||| Baxter Oncology GmbH Kantstrasse 2 33790 Halle/Westfalen Germany ||| Merckle Biotec GmbH Dornierstraße 10 DE-89079 Ulm Allemagne
0.3540427088737488 ||| It is not recommended that you take Sonata with or immediately after eating a large meal as it may work more slowly. ||| Do not worry if the solution remains slightly hazy after mixing with water; this is normal. ||| Il n’ est pas recommandé de prendre Sonata pendant ou immédiatement après un repas copieux, son action pouvant dans ce cas être ralentie.
0.002220781985670328 ||| Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12.5 mg film-coated tablets irbesartan/ hydrochlorothiazide ||| Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12.5 mg film-coated tablets irbesartan/ hydrochlorothiazide ||| Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12,5 mg comprimés pelliculés irbésartan/ hydrochlorothiazide
0.30608510971069336 ||| The referral relates to the concerns raised by Germany that this veterinary medicinal product may present a potential serious risk to public health on the following grounds: ||| 1.1 Concerns raised by Germany Germany considered that the authorisation of Baycox 2.5% solution may present a potential serious risk to the environment on the following grounds: ||| Le motif de la saisine était les inquiétudes exprimées par l’ Allemagne sur le risque potentiel grave de santé publique posé par le médicament vétérinaire aux motifs suivants:
0.22830916941165924 ||| Overall, lymphoma/ lymphoproliferative disease occurred in 0.1% (1/ 701) of patients in the basiliximab group compared with 0.3% (2/ 595) of patients receiving placebo, both in combination with dual and triple immunosuppressive therapy. ||| A significantly (p=0.033) greater incidence of events in the cardiovascular/ thromboembolic category was detected in the parecoxib / valdecoxib treatment group (2.0%) compared to the placebo/ placebo treatment group (0.5%). ||| Au total, des lymphomes/ syndromes lymphoprolifératifs sont apparus chez 0,1% (1/ 701) des patients du groupe traité par le basiliximab, comparé à 0,3% (2/ 595) des patients du groupe placebo en association avec une bi- ou trithérapie immunosuppressive.
0.36555731296539307 ||| Psychiatric disorders ||| Psychiatric disorders rod ||| Troubles psychiatriques
0.6839243173599243 ||| They had been confined from 10 March 2020 following the positive test results of two of their Spanish cohort. ||| The texts of MRAs with Canada and the USA were initialled in June 1997. ||| Ils étaient confinés depuis le 10 mars à la suite du test positif passé sur deux de leurs collègues espagnols.
0.1451607197523117 ||| We cooperate closely with Member States to ensure that national support measures can be put in place as quickly and effectively as possible, in line with EU rules." ||| We have cooperated closely with France to ensure this support could be put in place as quickly and effectively as possible, in line with EU rules." ||| Nous travaillons en étroite collaboration avec les États membres pour faire en sorte que des mesures nationales de soutien puissent être mises en place aussi rapidement et aussi efficacement que possible, dans le respect des règles de l'UE.»
0.2106645405292511 ||| Nplate should be administered once weekly as a subcutaneous injection. ||| The solution for injection should be administered subcutaneously each day. ||| Nplate doit être administré une fois par semaine en injection sous-cutanée.
0.5744706392288208 ||| Replace and tighten the bottle cap. ||| Briefly press and release red button. ||| Remettre et serrer le bouchon du flacon.
0.031199369579553604 ||| Because the number of patients with SMEI is low, the disease is considered ‘ rare’, and Diacomit was designated as an ‘ orphan medicine ’ (a medicine used in rare diseases) on 5 December 2001. ||| Because the number of patients with multiple myeloma is low, the disease is considered ‘ rare’, and Revlimid was designated an ‘ orphan medicine ’ (a medicine used in rare diseases) on 12 December 2003. ||| C’ est pourquoi, Diacomit a été désigné comme étant un « médicament orphelin » (médicament utilisé pour des maladies rares) le 5 décembre 2001.
0.341842383146286 ||| However, animal studies to evaluate this specific risk have not been conducted. ||| However, no proper explanation for these findings in women has been identified. ||| Il n’ a pas été conduit d’ étude spécifique chez l’ animal pour évaluer ce risque.
0.050742924213409424 ||| Deutschland BRISTOL-MYERS SQUIBB GMBH & CO. ||| 158 Deutschland BRISTOL-MYERS SQUIBB GMBH & CO. ||| 116 Deutschland BRISTOL-MYERS SQUIBB GMBH & CO.
0.10241451114416122 ||| (2.1) ||| (1.2) ||| (2,1)
0.7697365283966064 ||| AsV is present in plasma only at relatively low levels. ||| 12/ 21 that reaches in lung are always higher than in plasma. ||| AsV est présent uniquement dans le plasma à des niveaux relativement faibles.
0.26890167593955994 ||| Figurines made of wood ||| Figurines made of lead crystal ||| Figurines en bois
0.09718172997236252 ||| For more information, see section 5.1. ||| For further information, see section 4.4. ||| Pour plus d’ informations, voir rubrique 5.1.
0.20069974660873413 ||| The results of one new study in patients who did not take antidiabetes medicines before were also presented, comparing the effect of sitagliptin plus metformin with that of metformin alone or sitagliptin alone. ||| Hycamtin as an infusion has been studied in 293 women with advanced cervical cancer, where the effectiveness of a combination of Hycamtin and cisplatin was compared with that of cisplatin alone. ||| Les résultats d’ une nouvelle étude chez les patients qui ne prenaient pas de médicaments antidiabétiques auparavant ont également été présentés, en comparant l’ effet de la sitagliptine plus metformine avec celui de la metformine seule ou de la sitagliptine seule.
0.4836096167564392 ||| Progesterone concentrations were not affected when the medicinal products were co-administered. ||| Enterotoxins can produce illness even when the microbes that produced them have been killed. ||| Les concentrations de progestérone n’ ont pas été affectées lorsque les médicaments ont été administrés simultanément.
0.43061357736587524 ||| Supporting fishermen and farmers ||| Supporting farmers and rural areas ||| Soutien aux pêcheurs et aux agriculteurs
0.28674814105033875 ||| Discontinuation of Lamictal in patients with bipolar disorder In clinical trials, there was no increase in the incidence, severity or type of adverse reactions following abrupt termination of lamotrigine versus placebo. ||| In case of Uveitis/ Iritis cidofovir should be discontinued if there is no response to treatment with a topical corticosteroid or the condition worsens, or if iritis/ uveitis reoccurs after successful treatment. ||| Arrêt du traitement par Lamictal chez les patients atteints de troubles bipolaires Dans les essais cliniques, il n’ y a eu aucune augmentation de l’ incidence, de la sévérité ou du type d’ effets indésirables suite à un arrêt brutal de la lamotrigine par comparaison avec le placebo.
0.2740210294723511 ||| In 10% of patients antibodies against natalizumab were detected in 2-year controlled clinical trials in MS patients. ||| In clinical trials, bexarotene was administered for up to 118 weeks to patients with CTCL. ||| Des anticorps anti-natalizumab ont été décelés chez 10% des patients au cours des études contrôlées réalisées sur 2 ans chez des patients atteints de SEP.
0.004033864941447973 ||| 85 Ísland Hörgatún 2 IS-210 Garðabær Sími: + 354 535 70 00 ||| 76 Ísland Hörgatún 2 IS-210 Garðabær Sími: + 354 535 70 00 ||| Ísland Hörgatún 2 IS-210 Garðabær Sími: + 354 535 70 00
0.018285684287548065 ||| Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Using other medicines Please tell your doctor or pharmacist if you are using or have recently used any other medicines, including medicines obtained without a prescription. ||| Utilisation d'autres médicaments Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment un autre médicament, même s'il s'agit d'un médicament obtenu sans ordonnance.
0.1862863153219223 ||| au must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes. ||| Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to ||| Du glucose doit également être administré par voie intraveineuse si le patient ne répond pas au glucagon dans les 10 à 15 minutes.
0.3747999668121338 ||| The safety and efficacy of the combination have not been established in this population, and there are insufficient data to give adequate dose recommendations. ||| There are few studies of the effects of implementing active design concepts, but they are in general agreement that the physical activity of occupants is increased. ||| La sécurité et l'efficacité de l'association dans cette population n'ont pas été établies, et les données sont insuffisantes pour pouvoir recommander une dose adaptée.
0.025089072063565254 |||  European Medicines Agency, 2008. |||  European Medicines Agency, 2009. |||  European Medicines Agency, 2009.
0.23254069685935974 ||| The dose of Kuvan depends on the patient’ s weight. ||| The dose to use depends on the patient’ s weight. ||| La dose de Kuvan dépend du poids du patient.
0.7135398983955383 ||| Scarf: for head and neck. ||| Long sleeved top: for upper body/ arms. ||| Echarpe: pour la tête et le cou.
0.45118093490600586 ||| In all studies, the main measure of effectiveness was the change in four symptoms of allergy affecting the nose. ||| One patient among the 54 in whom the effectiveness of Savene could be measured, had tissue damage requiring surgery. ||| Dans toutes les études, le principal critère d’ évaluation de l’ efficacité était la modification des quatre symptômes allergiques affectant le nez.
0.3676561415195465 ||| To prevent painful injections and minimise leakage from the injection site Puregon should be slowly administered intramuscularly or subcutaneously. ||| Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites. ||| 10 Pour éviter les injections douloureuses et pour limiter les fuites au point d'injection, Puregon doit être administré lentement par voie intramusculaire ou sous-cutanée.
0.06436485052108765 ||| - You are taking medicines to treat depression. ||| - You are taking other medicines to treat depression. ||| - Vous prenez d’ autres médicaments pour traiter la dépression.
0.36989766359329224 ||| Obtain new supplies and start the procedure over again, even if 3 minutes have passed after injection of IL-2. ||| After that, go back to getting the injections every 3 months from the date of the most recent injection. ||| Prenez une nouvelle seringue et un autre flacon et recommencez la procédure, même si 3 minutes se sont écoulées depuis l’ injection de l’ IL-2.
0.24369260668754578 ||| Oral explanations were given by the Marketing Authorisation Holder on 27 June 2006. ||| The Marketing Authorisation Holders presented oral explanations to the CVMP on 18 June 2008. ||| Des explications orales ont été données par le titulaire de l’ autorisation de mise sur le marché le 27 juin 2006.
0.17535926401615143 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Prezista’ s benefits, when taken in combination with ritonavir and other antiretroviral medicinal products, were greater than its risks for the treatment of HIV-1 infection. ||| The Committee for Medicinal Products for Human Use (CHMP) concluded that vildagliptin taken with metformin reduces blood glucose levels and the combination of the two active substances in one tablet may help patients to stick to their treatment. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices démontrés par Prezista administré en association avec le ritonavir et d’ autres médicaments antirétroviraux étaient supérieurs aux risques associés au traitement de l’ infection par le VIH-1.
0.644819974899292 ||| Support will focus on strengthening preparedness and response capacities of countries with the weakest healthcare systems. ||| Investing in more and better connectivity, especially in the rapid deployment of 5G networks; ||| L'aide se concentrera sur le renforcement du niveau de préparation et des capacités de réaction des pays ayant les systèmes de santé les plus faibles.
0.3706236779689789 ||| 15 • Hypersensitivity to other sulphonamide-derived substances (since hydrochlorothiazide is a sulphonamide-derived medicinal product). • Second and third trimester of pregnancy and lactation (see sections 4.4 and 4.6). • Cholestasis and biliary obstructive disorders. • Severe hepatic impairment. • Severe renal impairment (creatinine clearance < 30 ml/ min). • Refractory hypokalaemia, hypercalcaemia. ||| Chlamydia species Mycoplasma species Rickettsia species Legionella species * Activity has been satisfactorily demonstrated in clinical studies. † The efficacy of INVANZ in the treatment of community acquired pneumonia due to penicillin- resistant Streptococcus pneumoniae has not been established. + frequency of acquired resistance > 50% in some Member States # Methicillin-resistant staphylococci (including MRSA) are always resistant to betalactams. ||| 2ème et 3ème trimestres de la grossesse et allaitement (voir rubriques 4.4 et 4.6). • • Cholestase et obstruction biliaire. • Insuffisance hépatique sévère. • Insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min). • Hypokaliémie réfractaire, hypercalcémie.
0.28688332438468933 ||| Each pack contains one bottle of 100 tablets. ||| Each bottle contains 120 soft capsules. ||| Chaque conditionnement contient un flacon de 100 comprimés.
0.007728789001703262 ||| 22 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 25 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 25 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.10550335049629211 ||| Repair or maintenance of painting machines and apparatus ||| Repair or maintenance of photographic machines and apparatus ||| Réparation ou entretien de machines et d'appareils de peinture
0.10181863605976105 ||| Inject the air into the vial: push the needle through the rubber stopper and press the plunger 3. ||| Push the needle through the rubber stopper and introduce the air into the vial by pushing the plunger. ||| 2. injectez l’ air dans le flacon: enfoncez l’ aiguille dans le bouchon en caoutchouc et appuyez sur le piston.
0.4011300802230835 ||| Dosage is individual and determined in accordance with the needs of the patient. ||| It is necessary to consider the clinical condition of the patient when interpreting whole blood levels. ||| La posologie dépend de chaque individu et est déterminée en fonction des besoins du patient.
0.6938776969909668 ||| Any unused product must be discarded. ||| Return any unused product to your pharmacy. ||| ris utilisé doit être jeté.
0.026036255061626434 ||| Many patients had confounding medical conditions, some of which required therapy with agents that have been associated with the development of diabetes mellitus or hyperglycaemia. ||| Many of the patients had confounding medical conditions, some of which required therapy with agents that have been associated with the development of diabetes mellitus or hyperglycaemia. ||| Beaucoup de patients avaient des pathologies associées rendant difficile l’ analyse des cas; parmi ces pathologies associées, certaines nécessitaient un traitement par des médicaments pouvant provoquer un diabète sucré ou une hyperglycémie.
0.3144092559814453 ||| The absolute bioavailability of subcutaneously administered Puregon is approximately 77%. ||| Following subcutaneous administration, the absolute bioavailability is about 70%. ||| 104 La biodisponibilité absolue de Puregon administré par voie sous-cutanée est d'environ 77%.
0.014682353474199772 ||| NeoRecormon 20,000 IU Lyophilisate and solvent for solution for injection in cartridge (20,000 IU/ml) Epoetin beta ||| NeoRecormon 10,000 IU Lyophilisate and solvent for solution for injection in cartridge (10,000 IU/ml) Epoetin beta ||| NeoRecormon 20 000 UI lyophilisat et solvant pour solution injectable en cartouche (20 000 UI/ ml) Epoetin beta
0.2563338577747345 ||| Materials for use in protecting buildings [paints] ||| Protective products for use on metals [paints] ||| Produits destinés à la protection de bâtiments [peintures]
0.15729203820228577 ||| How to use Silgard 4. ||| How to use Prialt 4. ||| Comment utiliser Silgard 4.
0.0 ||| After this period it is essential that imiquimod cream is removed with mild soap and water. ||| After this period it is essential that imiquimod cream is removed with mild soap and water. ||| Après cette période, il est indispensable d'enlever la crème imiquimod avec de l’eau et un savon doux.
0.19628526270389557 ||| How to take Xiliarx 4. ||| How to take Zyrtec 4. ||| Comment prendre Xiliarx 4.
0.12531717121601105 ||| Frames (Non-metallic -) for containers ||| Blocks (Non-metallic -) for construction ||| Châssis non métalliques pour récipients
0.2054699957370758 ||| Women of childbearing potential must use effective contraception during treatment with pemetrexed (see section 4.6). ||| Men with partners of childbearing potential should use medically acceptable contraception while receiving TORISEL (see section 5.3). ||| Les femmes en âge de procréer doivent utiliser un moyen de contraception efficace pendant le traitement par pemetrexed (voir rubrique 4.6).
0.42082899808883667 ||| Adverse reactions are ranked according to frequency using the following convention: ||| Initial dose calculations according to body surface area are as follows: ||| Les effets indésirables sont classés selon leur fréquence, en utilisant la convention qui suit:
0.4219871163368225 ||| At the end of therapy, the doctor will slowly lower the dose of INOmax being given to your baby. ||| At the end of the treatment you should return all unused capsules to the pharmacist. ||| Au terme du traitement, le médecin de votre enfant réduira lentement la dose de INOmax qui lui est administrée.
0.697871208190918 ||| You must use the pen as described in these Instructions for Use. ||| This will take the form of Advance Purchase Agreements. ||| Vous devez utiliser le stylo tel que décrit dans ces Instructions d’ Utilisation.
0.40095216035842896 ||| Chromium plating compositions ||| Chemical condensation preparations ||| Compositions pour le chromage
0.40688472986221313 ||| ProMeris 160 mg Spot-on for small cats {≤ 4 kg} ||| Prac-tic 56.25 mg Spot-on solution for very small dogs ||| ProMeris 160 mg Spot -on pour petits chats {≤ 4 kg}
0.5201857089996338 ||| Immunisation schedules: ||| Vaccination schedule: ||| Schémas vaccinaux:
0.7709397077560425 ||| Reflexology ||| Leukemia ||| Réflexologie
0.34053003787994385 ||| Other information about Nplate: ||| Other information about NeuroBloc: ||| 2/ 3 Autres informations relatives à Nplate:
0.31981801986694336 ||| 8 In patients with severe liver dysfunction a reduction in somatropin clearance has been noted. ||| A renal impairment study after oral dosing of olopatadine has been performed in patients with severe renal impairment. ||| Chez les patients souffrant d’ un dysfonctionnement hépatique sévère, on a observé une réduction de l’ élimination de la somatropine.
0.34667351841926575 ||| Ryan further stated that the current data did not warrant public health officials to declare a global pandemic, saying that such a declaration would mean "we're essentially accepting that every human on the planet will be exposed to that virus." ||| In response to the implementations of travel restrictions, Tedros stated that "there is no reason for measures that unnecessarily interfere with international travel and trade" and that the "WHO doesn't recommend limiting trade and movement." ||| Ryan a ensuite indiqué que les données actuelles ne permettaient pas aux responsables de la santé publique d’annoncer une pandémie mondiale, précisant qu’une telle déclaration signifierait que « nous acceptons dans l’absolu que chaque humain sur la planète soit exposé à ce virus ».
0.31696927547454834 ||| Chemical installations for conditioning drinking water ||| Transportable instruments for processing water ||| Installations chimiques pour le traitement de l'eau potable
6.49623963563245e-13 ||| - thrombocyte count ≥ 100 x 109/l ||| - thrombocyte count ≥ 100 x 109/l ||| 33 taux de plaquettes ≥ 100 x 109/ l,
0.5422399044036865 ||| Orodispersible tablet ||| Dispersible tablet ||| Comprimé orodispersible
0.3260898292064667 ||| HOW TO STORE LIPROLOG Basal ||| HOW TO STORE PROTOPY lp ||| 5 COMMENT CONSERVER LIPROLOG BASAL
0.580264687538147 ||| We will get out of the sanitary crisis, while keeping our fundamental rights intact. ||| We all know that only together we can stop the worldwide spread of the coronavirus. ||| Nous sortirons de la crise sanitaire, tout en préservant nos droits fondamentaux.»
0.30158907175064087 ||| • Metabolism The results from various evaluations of plasma and urine samples indicated that gadofosveset does not undergo measurable metabolism. ||| However, results from Osigraft implantation studies in animals demonstrate that the active substance eptotermin alfa is largely unavailable systemically. ||| • Métabolisme Les résultats de diverses évaluations d’ échantillons de plasma et d’ urine indiquent que le gadofosveset ne subit aucun métabolisme mesurable.
0.4716048538684845 ||| The European Union is on the side of the victims and today's strategy aims at empowering victims, especially the most vulnerable such as victims of gender-based violence or hate crime. ||| The EU's development assistance supports longer-term projects addressing the root causes of instability, conflict, and vulnerability, especially in the most-hit regions. ||| L'Union européenne est du côté des victimes; la stratégie présentée aujourd'hui vise à leur donner les moyens d'agir et prête une attention particulière aux victimes les plus vulnérables, telles que celles ayant subi des violences ou des crimes de haine fondés sur le genre.
0.26594024896621704 ||| 50 capsules ||| 56 capsules ||| 50 gélules
0.3965853452682495 ||| Experience with overdose of SPRYCEL in clinical studies is limited to isolated cases. ||| HEXAVAC has been generally well tolerated in clinical trials. ||| Les observations de surdosage de SPRYCEL dans les études cliniques se limitent à des cas isolés.
0.20400595664978027 ||| EU/ 1/ 05/ 310/ 001 (2 tablets) EU/ 1/ 05/ 310/ 002 (4 tablets) EU/ 1/ 05/ 310/ 003 (6 tablets) EU/ 1/ 05/ 310/ 004 (12 tablets) EU/ 1/ 05/ 310/ 005 (40 tablets) ||| EU/ 1/ 98/ 091/ 009 (14 tablets) EU/ 1/ 98/ 091/ 010 (28 tablets) EU/ 1/ 98/ 091/ 011 (56 tablets) EU/ 1/ 98/ 091/ 012 (98 tablets) ||| EU/ 1/ 05/ 310/ 001 (2 comprimés) EU/ 1/ 05/ 310/ 002 (4 comprimés) EU/ 1/ 05/ 310/ 003 (6 comprimés) EU/ 1/ 05/ 310/ 004 (12 comprimés) EU/ 1/ 05/ 310/ 005 (40 comprimés)
0.057237301021814346 ||| 27 Ireland UCB (Pharma) Ireland Ltd. ||| 188 Ireland UCB (Pharma) Ireland Ltd. ||| Ireland UCB (Pharma) Ireland Ltd.
0.3036036789417267 ||| High-density polyethylene (HDPE) bottles with a polypropylene closure, containing 30 capsules. ||| One or two white High Density Polyethylene (HDPE) bottles, each containing 240 capsules. ||| Flacons en polyéthylène forte densité (HDPE) munis d’ un bouchon en polypropylène, contenant 30 gélules.
0.2930263876914978 ||| 334 1 pre-filled syringe containing clear, colourless solvent 2 Empty syringes 5 Needles 6 Alcohol swabs  If any of the items listed above are missing, do not use the dose tray, but consult your pharmacist.  Inspect the expiry dates on both the vial label and the syringe label. ||| Enbrel vial pre-filled syringe containing clear, colourless solvent (water for injections) syringe plunger 2 alcohol swabs dose preparation guide (underside of the dose tray)  Inspect the expiry dates on both the vial label and the syringe label. ||| 1 Flacon contenant la poudre Enbrel 1 Seringue préremplie contenant un solvant limpide et incolore 2 seringues vides 5 aiguilles 6 tampons imbibés d'alcool • Si un des éléments énumérés ci-dessus est manquant, ne pas utiliser le coffret de traitement et contactez votre pharmacien • Vérifiez les dates de péremption sur l’étiquette du flacon et sur l’étiquette de la seringue.
0.5103719234466553 ||| On the 23 March, it was confirmed that noted Zimbabwean journalist Zororo Makamba was the first person in the country to pass away from the virus. ||| The backlash included a petition for the WHO Director-General Tedros Adhanom to tender his resignation, signed by 733,000 people as of 6 April. ||| Le 23 mars, il a été confirmé que le journaliste Zororo Makamba était la première personne dans le pays à décéder du virus,,.
0.34042495489120483 ||| In controlled clinical trials, the discontinuation rate due to sildenafil was low and similar to placebo. ||| However, more patients in the sitagliptin group discontinued due to lack of efficacy than in the glipizide group. ||| Dans les études cliniques, le taux d'interruption du traitement dû au sildénafil était faible et similaire au placebo.
0.37617573142051697 ||| In addition, focus groups of experts from the CVMP and interested parties will be convened to consider specific topics mutually agreed to by the Committee and interested parties. ||| MEPs also asked the Commission to keep the culture and education committee updated about the number of participants currently on an exchange, their situation and the measures taken to support them. ||| En outre, des groupes de réflexion réunissant des experts du CVMP et des parties intéressées examineront des thèmes spécifiques ayant fait l'objet d'un accord mutuel entre le comité et les parties intéressées.
0.0 ||| THE EUROPEAN AGENCY FOR THE EVALUATION OF MEDICINAL PRODUCTS ||| THE EUROPEAN AGENCY FOR THE EVALUATION OF MEDICINAL PRODUCTS ||| L’ AGENCE EUROPÉENNE POUR L’ ÉVALUATION DES MÉDICAMENTS (EMEA)
0.5426898002624512 ||| The dose can be taken regardless of mealtime. ||| You can drink water during the fasting period. ||| Le comprimé peut être pris au moment ou en dehors des repas.
0.034838467836380005 ||| After administering the dose, discard the ViraferonPeg pre-filled pen and any unused solution contained in it. ||| After administering the dose, discard the PegIntron pre-filled pen and any unused solution contained in it. ||| Après l’ administration de la dose, éliminer le stylo prérempli ViraferonPeg ainsi que toute solution inutilisée restant à l’ intérieur.
0.4136345386505127 ||| Take the long needle and place it firmly onto the tip of the syringe. ||| Place the vial on a rigid, non-slip surface and hold it firmly with one hand. ||| Prenez l’aiguille longue et fixez-la fermement à l’extrémité de la seringue.
0.34890222549438477 ||| Assure that sodium chloride 9 mg/ ml (0.9%) solution for injection is added to the vial along the vial wall in order to prevent foaming. ||| c CANCIDAS is formulated to provide the full labeled vial dose (50 mg) when 10 ml is withdrawn from the vial. ||| S'assurer que la solution de chlorure de sodium à 9 mg/ ml (0,9%) pour injection est versée dans le flacon le long de la paroi de celui -ci, afin de prévenir la formation de mousse.
0.05554819479584694 ||| 585 Your blood sugar level may either rise or fall if you take: ||| 85 Your blood sugar level may either rise or fall if you take: ||| Votre glycémie peut augmenter ou diminuer si vous prenez:
0.35142841935157776 ||| 1/ 41 ||| 1/ 100 ||| 1/ 43
0.0 ||| Unless continued AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. ||| Unless continued AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. ||| A moins que le traitement par ARAII soit considéré comme essentiel, il est recommandé de modifier le traitement antihypertenseur chez les patientes qui envisagent une grossesse pour un médicament ayant un profil de sécurité établi pendant la grossesse.
0.4908197224140167 ||| A similar effect was not seen in rats even at very high systemic exposure. ||| The animals may also show some signs of slight pain for one day. ||| Un effet similaire n’ a pas été observé chez le rat, même après une exposition systémique très élevée.
0.3542962670326233 ||| To obtain satisfactory absorption of alendronate Alendronate HEXAL tablets must be taken on an empty stomach immediately on rising in the morning, with plain water only, at least 30 minutes before the first food, drink or other medication of the day. ||| 6) After swallowing your Alendronate HEXAL, wait at least 30 minutes before taking your first food, drink, or other medicine of the day, including antacids, calcium supplements and vitamins. ||| Alendronat HEXAL doit être pris à jeun en se levant le matin, avec de l’ eau plate uniquement, au moins 30 minutes avant l’ absorption des premiers aliments, boissons ou médicaments de la journée.
0.24779874086380005 ||| Other medically significant sequelae of overdose include delirium, convulsion, coma, possible neuroleptic malignant syndrome, respiratory depression, aspiration, hypertension or hypotension, cardiac arrhythmias (< 2% of overdose cases) and cardiopulmonary arrest. ||| Symptoms may vary from CNS depression (sedation, apnoea, diminished mental alertness, cyanosis, coma, cardiovascular collapse) to CNS stimulation (insomnia, hallucination, tremors, convulsions) with possible fatal outcome. ||| Les autres effets cliniquement significatifs du surdosage sont: délire, convulsions, coma, éventuel syndrome malin des neuroleptiques, insuffisance respiratoire, fausse route, hypertension ou hypotension, arythmies cardiaques (moins de 2% des cas de surdosage) et arrêt cardio-respiratoire.
3.246290768751242e-13 ||| The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch. ||| The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch. ||| Le nom et l'adresse du fabricant responsable de la libération du lot concerné doivent figurer sur la notice imprimée du médicament.
0.2248793989419937 ||| In patients with a suboptimal virological response after 24 weeks of treatment with entecavir, a modification of treatment should be considered (see sections 4.5 and 5.1). ||| Women of child-bearing potential must use a reliable form of contraception during treatment with Panretin gel (see section 4.6) and until one month after cessation of treatment. ||| Chez les patients ayant une réponse virologique sous- optimale après 24 semaines de traitement par entecavir, un changement de traitement doit être envisagé (voir rubriques 4.5 et 5.1).
0.16153216361999512 ||| • A kit containing 90 x 1 PVC/ Aluminium perforated unit dose blisters (3 pouches), 1 insulin inhaler, 1 spare chamber and 6 spare Insulin Release Units (IRU) uc ||| • A pack containing 270 x 1 of 3 mg PVC/Aluminium perforated unit dose blisters (9 pouches) and 6 spare Insulin Release Units (IRU) ||| • Un kit contenant 90 x 1 dose sous plaquette thermoformée prédécoupée en PVC/ Aluminium (3 sachets), 1 inhalateur d’ insuline, 1 chambre d’ inhalation de rechange et 6 Dispositifs de Libération d’ Insuline (DLI) de rechange am
0.4497522711753845 ||| - back or limb pain, swelling of the extremities or joints ||| - swelling, particularly of the ankles and legs ||| - douleur dans le dos ou les membres, gonflement des extrémités ou des articulations;
0.7039413452148438 ||| Promotional management of celebrities ||| Profiles of EMEA personalities ||| Gestion promotionnelle de célébrités
0.45566901564598083 ||| Trevaclyn Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure, indicating little relevance to human use. ||| Patient self-assessments demonstrated a significantly reduced psychological discomfort with the condition, as measured by responses to 6 questions on a visual analogue scale. ||| Trevaclyn Des effets n’ ont été observés chez l’ animal qu’ à des expositions largement supérieures à l’ exposition maximale observée chez l’ homme, et ont peu de signification clinique.
0.2421015501022339 ||| Caution is advised if paliperidone is combined with other medicines know to lower the seizure threshold (i. e. phenothiazines or butyrophenones, tricyclics or SSRIs, tramadol, mefloquine, etc.). ||| Concomitant use of posaconazole and phenytoin and similar inducers (e. g. carbamazepine, phenobarbital, primidone) should be avoided unless the benefit to the patient outweighs the risk. ||| 61 La prudence est recommandée lorsque la palipéridone est associée à d’ autres médicaments connus pour diminuer le seuil épileptogène (par exemple phénothiazines ou butyrophénones, tricycliques ou IRSSs, tramadol, méfloquine, etc).
0.3924064040184021 ||| Extracts of coffee for use as flavours in foodstuffs ||| Smoke distillates from wood for flavouring foodstuffs ||| Extraits de café pour aromatiser les aliments
0.48962658643722534 ||| Surveillance data show that antimicrobial resistance is a growing public health problem in European hospitals and communities. ||| HAIs in hospitals alone cause more deaths in Europe than any other infectious disease under surveillance at ECDC. ||| Les données de surveillance indiquent que la résistance antimicrobienne constitue un problème de santé publique croissant dans les collectivités et les hôpitaux européens.
0.3008674383163452 ||| Gastroresistant formulations containing substances sensitive for degradation in the stomach, such as proton pump inhibitors, should be taken at least 1 hour before or more than 4 hours after BYETTA injection. ||| Enbrel contains no antibacterial preservative, and therefore, solutions prepared with water for injections should be administered as soon as possible and within 6 hours following reconstitution. ||| Les formulations gastrorésistantes contenant des substances sensibles à la dégradation au niveau de l’ estomac, telles que les inhibiteurs des pompes à protons, doivent être prises au moins 1 heure avant l’ injection de BYETTA, ou plus de 4 heures après.
2.286734170076077e-13 ||| Insulin may cause sodium retention and oedema, particularly if previously poor metabolic control is improved by intensified insulin therapy. ||| Insulin may cause sodium retention and oedema, particularly if previously poor metabolic control is improved by intensified insulin therapy. ||| 34 L'insuline peut provoquer une rétention sodée et un œ dème, en particulier si l'équilibre métabolique auparavant médiocre se trouve amélioré par une insulinothérapie intensive.
6.321936789170646e-13 ||| 2 Presentations ||| 2 Presentations ||| 2 Présent ations
0.18637888133525848 ||| Glycerol Phenol Metacresol Zinc chloride Disodium phosphate dihydrate Sodium chloride Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections ||| Mannitol (E421) Carbomer Sodium chloride Tyloxapol Disodium edetate Benzalkonium chloride Sodium hydroxide and/ or hydrochloric acid (for pH adjustment) Purified water ||| Glycérol Phénol Métacrésol Chlorure de zinc Phosphate disodique dihydraté Chlorure de sodium Acide chlorhydrique (pour l’ ajustement du pH) Hydroxyde de sodium (pour l’ ajustement du pH) Eau pour préparations injectables
0.5483521223068237 ||| Design, creation, hosting and maintenance of websites for others ||| Creating, designing and maintaining web sites ||| Conception, création, hébergement et maintenance de sites web pour des tiers
0.3304111361503601 ||| Manual switching apparatus for telecommunication ||| Indicator lights for telecommunication apparatus ||| Commutateurs manuels pour télécommunications
0.19693385064601898 ||| It is not known if paclitaxel passes into breast milk. ||| It is not known whether sildenafil enters the breast milk. ||| Le passage du paclitaxel dans le lait maternel n’ est pas connu.
0.1128229945898056 ||| In both studies, XERISTAR 60 mg once daily and 60 mg twice daily significantly reduced pain compared with placebo. ||| In both studies, duloxetine 60 mg once daily and 60 mg twice daily significantly reduced pain compared with placebo. ||| Dans les deux études, XERISTAR à 60 mg une fois par jour et 60 mg deux fois par jour a significativement réduit la douleur par rapport au placebo.
0.44772106409072876 ||| The main concerns of the CHMP were related to the manufacture of Voraxaze. ||| The Committee also had some concern regarding the use of Voraxaze with folinic acid. ||| Les principales inquiétudes du CHMP portaient sur la fabrication de Voraxaze.
0.5583928823471069 ||| If patients start to take Tyverb again, they may need to use a lower dose. ||| If this is not possible, they should take the tablets less often. ||| En cas de reprise du traitement par Tyverb, il peut s’ avérer nécessaire d’ utiliser une dose plus faible.
0.3081628680229187 ||| As valproate significantly decreases clearance of Inovelon, a lower maximum dose of Inovelon is recommended for patients < 30 kg being co-administered valproate. ||| When efavirenz is co-administered with voriconazole, the voriconazole maintenance dose must be increased to 400 mg twice daily and the efavirenz dose must be ||| Le valproate diminuant significativement la clairance d’ Inovelon, il est recommandé de diminuer la dose maximale d’ Inovelon chez les patients de < 30 kg recevant un traitement concomitant par le valproate.
0.0 ||| If you want more information on the basis of the CVMP recommendations, read the Scientific Discussion (also part of the EPAR). ||| If you want more information on the basis of the CVMP recommendations, read the Scientific Discussion (also part of the EPAR). ||| Si vous souhaitez davantage d'informations sur la base des recommandations du CVMP, veuillez lire la discussion scientifique (également comprise dans l'EPAR).
0.36346814036369324 ||| Before commencing treatment with Protopic ointment, clinical infections at treatment sites should be cleared. ||| Cardiac failure should be adequately controlled before beginning therapy with timolol. ||| Tout signe clinique d'infection au niveau des zones à traiter nécessite un traitement préalable avant utilisation de Protopic pommade.
0.5786266922950745 ||| Reagents for testing the sterility of medical equipment ||| Forecasting services in the nature of fortune telling ||| Réactifs pour tester la stérilité d'équipements médicaux
0.29236283898353577 ||| In addition, dose regimens for daptomycin that might be appropriate for the treatment of enterococcal infections, with or without bacteraemia, have not been identified. ||| No specific symptoms or signs have been identified following acute overdose with abacavir or lamivudine, apart from those listed as undesirable effects. ||| De plus, la posologie de daptomycine qui pourrait être appropriée dans le traitement des infections à entérocoques, avec ou sans bactériémie, n’ a pas été déterminée.
0.5497758388519287 ||| In addition two big research consortia in sub-Saharan Africa, ALERRT and PANDORA-ID-NET, have already redirected their research towards coronavirus working jointly with the Africa Centre of Diseases Control (ACDC), to improve diagnosis and prevent transmission of coronavirus in Africa. ||| The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) is a network of general practices (GPs) with a nationally representative population that provides pseudonymized data for weekly surveillance of infectious diseases. ||| En outre, deux grands consortiums de recherche en Afrique subsaharienne, ALERRT et PANDORA-ID-NET, ont déjà redirigé leurs travaux vers le coronavirus, en coopération avec le Centre africain pour le contrôle et la prévention des maladies (CACM), afin d'améliorer le diagnostic et d'empêcher la transmission du coronavirus en Afrique.
0.6597719192504883 ||| Pharmacotherapeutic group: other antihypertensives, ATC code: ||| YTRACIS radiopharmaceutical precursor, solution. ||| Classe pharmacothérapeutique: autres antihypertenseurs, code ATC:
0.15483281016349792 ||| Blood and the lymphatic system disorders ||| Blood and the lymphatic disorders: ||| Affections hématologiques et du système lymphatique
0.3868451714515686 ||| On rare occasions, a specific and severe type of lymphoma, has been observed in patients taking Humira. ||| who have had hepatitis B might have a repeated attack of hepatitis, which can be fatal in very rare cases. ||| Dans de rares cas, une forme spécifique et sévère de lymphome a été observée chez des patients prenant Humira.
0.5037233829498291 ||| How does BeneFIX work? ||| Will TYSABRI always work? ||| Comment BeneFIX fonctionne -t-il?
0.21741360425949097 ||| STOCRIN must always be taken in combination with other anti-HIV medicines. ||| INTELENCE must always be given in combination with other antiretroviral medicinal products. ||| STOCRIN doit toujours être pris en association avec d’ autres médicaments anti-VIH.
0.046436261385679245 ||| Succursale belge/Belgisch bijhuis Tél/Tel: +32 (0) 2 373 42 11 MSDBelgium_info@merck.com ||| Succursale belge/Belgisch bijhuis Tél/Tel: +32 (0) 800 38693 MSDBelgium_info@merck .com ||| Succursale belge/ Belgisch bijhuis Tél/ Tel: +32 (0) 2 373 42 11 MSDBelgium_info@merck. com
0.1400579810142517 ||| Pink, round, biconvex, engraved with « 75 » on one side and « 1171 » on the other side. ||| Pink, oblong, engraved with « 300 » on one side and « 1332 » on the other side. ||| De couleur rose, ronds, biconvexes, gravés « 75 » sur une face et « 1171 » sur l'autre face.
0.03800705075263977 ||| Read all of this leaflet carefully before you start receiving this vaccine. ||| Read all of this leaflet carefully before you receive this vaccine. ||| Veuillez lire attentivement l'intégralité de cette notice avant de vous faire vacciner.
0.1331602931022644 ||| The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Retacrit has been shown to have a comparable quality, safety and efficacy profile to EPREX/ ERYPO. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that, in accordance with EU requirements, Zarzio has been shown to have a comparable quality, safety and efficacy profile to Neupogen. ||| Le comité des médicaments à usage humain (CHMP) a estimé que, conformément aux exigences de l’ UE, il a été montré que Retacrit présente un profil de qualité, de sécurité d’ emploi et d’ efficacité comparable à celui d'EPREX/ ERYPO.
4.535777677928954e-13 ||| − If you realise you have taken more Kaletra than you were supposed to, contact you doctor right away. − If you cannot contact your doctor, go to the hospital. ||| − If you realise you have taken more Kaletra than you were supposed to, contact you doctor right away. − If you cannot contact your doctor, go to the hospital. ||| 165 Si vous avez pris plus de Kaletra que vous n’ auriez dû − Si vous avez pris plus de Kaletra que vous n’ auriez dû, contactez immédiatement votre médecin. − Si vous ne pouvez joindre votre médecin, allez à l'hôpital.
0.5331419706344604 ||| The cooperation of the EU institutions and of the national competent authorities will be central in achieving this important public and animal health objective. ||| The success of the Agency and of the European system as a whole owes a great deal to their personal commitment as well as that of the committee members and European experts. ||| La coopération des institutions de l'Union européenne et des autorités nationales compétentes sera essentielle pour atteindre cet objectif important pour la santé humaine et animale.
0.4206346869468689 ||| Solvent (with sodium chloride solution 5.4 mg/ ml (0.54%): ||| Adjuvant (in the solvent) 250 (225-275) µg saponin ||| Solvant (chlorure de sodium 5,4 mg/ml (0,54%)):
0.33849480748176575 ||| Advertising services to promote public awareness of environmental issues and initiatives ||| Advertising services to promote public awareness of medical conditions ||| Services de publicité pour la sensibilisation du public aux questions et initiatives environnementales
0.34238284826278687 ||| Duration of treatment For patients who exhibit virological response at Week 12, treatment should be continued for at least another three-month period (i.e., a total of six months). ||| It is recommended that assessments be more frequent when initiating therapy (e. g., monthly) and may decrease in frequency with continued treatment (e. g., every 3 months). ||| 28 Durée du traitement Pour les patients présentant une réponse virologique à la 12ème semaine, le traitement doit être poursuivi au moins 3 mois de plus (soit une durée totale de 6 mois).
0.09404879808425903 ||| B CONDITIONS OF THE MARKETING AUTHORISATION ||| CONDITIONS OF THE MARKETING AUTHORISATION no ||| CONDITIONS RELATIVES À L’ AUTORISATION DE MISE SUR LE MARCHÉ
0.33833497762680054 ||| Accordingly, the metabolic clearance of vildagliptin is not anticipated to be affected by co-medications that are CYP 9 450 inhibitors and/ or inducers. ||| These results indicate that rasagiline’ s therapeutic concentrations are unlikely to cause any clinically significant interference with substrates of these enzymes. ||| Par conséquent, il est peu probable que la clairance métabolique de la vildagliptine soit affectée par l’ administration concomitante d’ inhibiteurs et/ ou d’ inducteurs du CYP450.
0.11753510683774948 ||| For intravenous infusion only Read the package leaflet before use ||| For intravenous use after dilution Read the package leaflet before use ||| Pour perfusion intraveineuse seulement Lire la notice avant utilisation
0.07082800567150116 ||| The full EPAR for Trevaclyn can be found here. ||| The full EPAR for Valdoxan can be found here. ||| L’ EPAR complet relatif à Trevaclyn est disponible ici.
0.3266151547431946 ||| Protopic 0.03% Ointment Tacrolimus monohydrate ||| Protopy 0.1% Ointment Tacrolimus monohydrate Cutaneous use ||| Protopic 0,03% Pommade Tacrolimus monohydrate
0.2638792395591736 ||| Patients undergoing myelosuppressive or myeloablative therapy followed by autologous PBPC transplantation The recommended dose of filgrastim for PBPC mobilisation when used alone is 1.0 MU/ kg/ day (10 μ g/ kg/ day) for 5 - 7 consecutive days. ||| Normal donors prior to allogeneic PBPC transplantation For PBPC mobilisation in normal donors prior to allogeneic PBPC transplantation, filgrastim should be administered at 1.0 MU/ kg/ day (10 μ g/ kg/ day) for 4 - 5 consecutive days. ||| Patients traités par chimiothérapie myélosuppressive ou myéloablative suivie d'une autogreffe de ces cellules souches progénitrices La dose de filgrastim recommandée pour la mobilisation des CSP, utilisé seul, est de 1,0 MU/ kg/ jour (10 μ g/ kg/ jour) pendant 5 à 7 jours consécutifs.
0.4970703721046448 ||| Renal function should be closely monitored (see section 4.4). ||| Long term outcome was not studied (see section 4.4). al ||| La fonction rénale doit être étroitement surveillée (voir rubrique 4.4).
0.7284281253814697 ||| N07B C51. ||| ACD2059g * ||| N07BC51.
0.3143112063407898 ||| Steel cylinders for compressed gas ||| Stacking boxes of compressed fibre ||| Cylindres en acier pour gaz comprimé
0.07691839337348938 ||| Infanrix Penta is a vaccine, which is available as a suspension for injection. ||| Twinrix Paediatric is a vaccine, which is available as a suspension for injection. ||| Infanrix Penta est un vaccin disponible en suspension injectable.
0.30154672265052795 ||| If such reactions occur, treatment with ciprofloxacin must be discontinued immediately and the treating physician informed. ||| If this happens, tell your doctor immediately since the administration of Ciprofloxacin Bayer will have to be stopped. ||| En cas de réaction de ce type, l’ administration de la ciprofloxacine doit être immédiatement arrêtée et le médecin traitant doit être informé.
0.6604107618331909 ||| Voltage-to-current converters ||| Point-to-point receivers ||| Convertisseurs tension-courant
0.0 ||| Psoriatic arthritis and ankylosing spondylitis ||| Psoriatic arthritis and ankylosing spondylitis ||| Rhumatisme psoriasique et spondylarthrite ankylosante
0.4158008098602295 ||| – Mannitol – Sodium hydroxide for adjustment to pH 7 ||| Sodium hydroxide (E524) to adjust pH to 7.5 ||| Mannitol, hydroxyde de sodium pour ajustement du pH à 7.
0.24051424860954285 ||| sp Porcilis Pesti emulsion for injection ||| Porcilis Porcoli emulsion for injection ||| us Porcilis Pesti, émulsion injectable.
0.3974853456020355 ||| Doxycycline is greater than 90% bound to plasma proteins and has an apparent volume of distribution of 50 L. ||| 49 If too much Bonviva is given You may develop low levels of calcium, phosphorus or magnesium in the blood. ||| La doxycycline se lie à raison de plus de 90% aux protéines plasmatiques et son volume de distribution apparent est de 50 L.
0.5354247093200684 ||| Treatment with is therefore not recommended. ||| Caution is therefore recommended. ||| Par conséquent le traitement par n’ est pas recommandé.
0.4994654059410095 ||| Electrostatic paper ||| Holographic plates ||| Papier électrostatique
0.3250470757484436 ||| Patients treated with Siklos had fewer vaso-occlusive crises after treatment with Siklos than before treatment, with the frequency falling by between 66% and 80% in children and adults. ||| Of these 14 Zenapax patients, 4 died more than 90 days after receiving their last dose of Zenapax, making it unlikely that Zenapax had a role in the infection related death. ||| Les patients traités par Siklos présentaient moins de crises vaso-occlusives après le traitement par Siklos qu’ avant le traitement, avec une fréquence chutant de 66% à 80% chez les enfants et les adultes.
0.2232610583305359 ||| Pharmaceutical preparations for treating malignant tumors ||| Pharmaceutical preparations for immunity adjustment ||| Préparations pharmaceutiques pour le traitement des tumeurs malignes
0.0 ||| EXP MM/ YYYY ||| EXP MM/ YYYY ||| EXP: mois/ année
0.008564055897295475 ||| Each tablet contains lisinopril dihydrate equivalent to 2.5 mg anhydrous lisinopril. ||| Each tablet contains lisinopril dihydrate equivalent to 40 mg anhydrous lisinopril. ||| Lisinopril dihydraté, correspondant à 2,5 mg de lisinopril anhydre, pour 1 comprimé.
0.24143312871456146 ||| Safety was assessed in a controlled clinical trial enrolling renal transplant patients  18 years of age considered of high-immunologic risk, defined as a history of one or more acute allograft rejection episodes and/ or the presence of chronic allograft nephropathy on a renal biopsy (see section 5.1). ||| Primary hyperhidrosis of the axillae A double-blind, multi-center clinical study was conducted in patients presenting with persistent bilateral primary axillary hyperhidrosis defined as baseline gravimetric measurement of at least 50mg spontaneous sweat production in each axilla over 5 minutes at room temperature, at rest. ||| La sécurité d’ emploi de Rapamune a été évaluée lors d’ un essai contrôlé réalisé chez des patients < 18 ans transplantés rénaux à haut risque immunologique, défini par un antécédent d’ un ou plusieurs épisodes de rejet aigu d’ allogreffe et/ ou par la présence d’ une néphropathie chronique d’ allogreffe prouvée par biopsie (voir rubrique 5.1).
0.26398777961730957 ||| Radiators for vehicles ||| Ventilators for automobiles ||| Radiateurs pour véhicules
0.15767471492290497 ||| Revasc should not be used in people who may be hypersensitive (allergic) to desirudin or any of the other ingredients, who are pregnant, who have had recent bleeding, who have severe high blood pressure or severe liver or kidney problems, or who have a heart infection. ||| Tracleer should not be used in people who may be hypersensitive (allergic) to bosentan or any of the other ingredients, who have liver enzyme problems, who are or could be pregnant, or who are taking ciclosporin A (a medicine that acts on the immune system). ||| Revasc ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) à la désirudine ou à l’ un des autres ingrédients, chez les femmes enceintes, chez les patients ayant eu une hémorragie récente, chez les patients hypertendus ou présentant de graves troubles hépatiques ou rénaux, ainsi que chez les patients présentant une infection cardiaque.
0.38590604066848755 ||| Cetirizine does not modify the protein binding of warfarin. ||| Raloxifene does not affect the steady-state AUC of digoxin. ||| La cétirizine ne modifie pas la liaison de la warfarine aux protéines.
0.13272398710250854 ||| Tritanrix HepB should be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramuscular administration to these subjects. ||| This vaccine should be given with caution to individuals with thrombocytopaenia or any coagulation disorder because bleeding may occur following an intramuscular administration in these individuals. ||| Tritanrix HepB doit être administré avec précaution chez les sujets souffrant de thrombocytopénie ou d'un trouble de la coagulation dans la mesure où l’ injection intramusculaire peut provoquer des saignements.
0.2015887051820755 ||| Patients with mild renal insufficiency did not have a clinically meaningful increase in the plasma concentration of sitagliptin as compared to normal healthy control subjects. ||| In patients with mild to moderate renal impairment, the pharmacokinetic profile of zaleplon is not significantly different than that in healthy subjects. ||| Les patients atteints d'insuffisance rénale légère n'ont pas présenté d'augmentation cliniquement significative de la concentration plasmatique de sitagliptine par rapport aux sujets témoins sains normaux.
0.3281019628047943 ||| Helixate NexGen powder should only be reconstituted with the supplied solvent (5.0 ml water for injections) using the supplied sterile Mix2Vial filter transfer device. ||| It should only be administered with the Omnitrope Pen 10, an injection device specifically developed for use with Omnitrope 6.7 mg/ ml solution for injection. ||| La poudre d'Helixate NexGen doit uniquement être reconstituée avec le solvant associé (5,0 ml d’ eau pour préparations injectables) en utilisant le dispositif de transfert stérile avec filtre Mix2vial.
0.33530503511428833 ||| In vitro studies did not show any significant involvement of oxidative metabolism by cytochrome P450 enzymes. ||| In vitro receptor binding studies have shown no measurable affinity for other than H1- receptors. ||| Les études in vitro n'ont pas montré l’ existence d’ un métabolisme oxydatif médié par le cytochrome P450.
0.36980825662612915 ||| Your doctor will monitor your response and condition to determine how long Noxafil needs to be given and whether any change is needed to your daily dose. ||| It is very important to follow your doctor’ s instructions as to how many inhalations to take and how often to take your medicine. ||| Votre médecin surveillera votre réponse au traitement et votre état afin de déterminer la durée de votre traitement et si une modification doit être apportée à votre dose quotidienne.
0.39428019523620605 ||| - Patients receiving remission-induction chemotherapy for acute myelogenous leukemia (AML) ||| • Inhalation anthrax (post-exposure prophylaxis and curative treatment) ||| - Patients recevant une chimiothérapie d’ induction- et de consolidation pour une leucémie
0.0 ||| Distribution No profound binding to plasma proteins, except circulating insulin antibodies (if present) has been observed. ||| Distribution No profound binding to plasma proteins, except circulating insulin antibodies (if present) has been observed. ||| 6 Distribution Aucune forte liaison aux protéines plasmatiques, à l’ exception d’ éventuels anticorps anti-insuline présents dans la circulation, n’ a été observée.
0.4614308476448059 ||| • Wash your hands thoroughly • Set up the following items on a clean surface i dic ||| • Assemble and lay out on a clean surface everything you need: ||| • Lavez vos mains soigneusement • Posez le matériel suivant sur une surface propre:
0.1983928382396698 ||| Following IV or IM injection, parecoxib is rapidly converted to valdecoxib, the pharmacologically active substance, by enzymatic hydrolysis in the liver. ||| Fosamprenavir is rapidly and almost completely hydrolysed to amprenavir and inorganic phosphate as it is absorbed through the gut epithelium, following oral administration. ||| Après une injection IV ou IM, le parécoxib est rapidement transformé en valdécoxib, la substance pharmacologiquement active, par hydrolyse enzymatique au niveau du foie.
0.2365163117647171 ||| Dose Take 400 mg (two 5 ml spoonfuls) of the suspension twice a day with food or with a nutritional supplement if you are unable to tolerate food. ||| After the first day, take 100 mg (2.5 ml) once a day with food or nutritional supplement if you are unable to tolerate food. ||| Posologie Prendre 400 mg (deux cuillerées de 5 ml) de suspension deux fois par jour avec un repas ou avec un complément nutritionnel si vous ne pouvez tolérer la nourriture.
0.4389403462409973 ||| "There's no doubt that the Commission is working hard to tackle the existential threat now facing the cultural and creative and the media sectors and that it shares our view that these sectors need to be vibrant, as they are essential pillars of European society and democracy." ||| The fact that the new system has coped well with change is a tribute to the hard work and management skills of all those concerned in the EMEA and in the national authorities, the national experts, the regulatory staff in the pharmaceutical companies and in the European Institutions, especially the European Commission. ||| "Il ne fait aucun doute que la Commission européenne travaille d'arrache-pied pour faire face à la menace existentielle qui pèse désormais sur les secteurs de la culture, de la création et des médias et qu'elle est d'accord sur le fait que ces secteurs doivent être dynamiques, étant donné qu'il s'agit de piliers essentiels de la société et de la démocratie européennes.
0.2740119397640228 ||| The active substance in Adenuric, feboxustat, reduces the formation of uric acid. ||| The active substance in Advate, octocog alfa, is a blood coagulation factor protein. ||| Le principe actif d’ Adenuric, le fébuxostat, réduit la formation d’ acide urique.
0.38740941882133484 ||| Reclaimed oil used in the process of devulcanisation of rubber compounds ||| Compositions for the removal of adhesive as part of a manufacturing process ||| Huile de récupération utilisée pour la dévulcanisation de composés en caoutchouc
0.34905514121055603 ||| Simultaneous use of NovoSeven and coagulation factor concentrates should be avoided. ||| Simultaneous use of prothrombin complex concentrates, activated or not, should be avoided. ||| L’ utilisation simultanée de NovoSeven et des concentrés des facteurs de la coagulation doit être évitée.
3.577740317547984e-13 ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| Si vous constatez des effets indésirables ou d’ autres effets non mentionnés sur la notice, veuillez en informer votre vétérinaire.
0.21082067489624023 ||| Subcutaneous or intravenous use ||| Subcutaneous or intramuscular use ||| Voie sous-cutanée et intraveineuse
0.14802256226539612 ||| The Reference Member State was Netherlands and the Concerned Member States were Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovakia, Slovenia, Spain and Sweden. ||| The application for Mutual Recognition for Adartrel were submitted to Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden and United Kingdom. ||| L’ État membre de référence était les Pays-Bas et les États membres concernés étaient l’ Allemagne, l’ Autriche, la Belgique, Chypre, le Danemark, l’ Espagne, l’ Estonie, la Finlande, la France, la Grèce, la Hongrie, l’ Irlande, l’ Italie, la Lettonie, la Lituanie, le Luxembourg, Malte, la Norvège, la Pologne, le Portugal, la République tchèque, la Slovaquie, la Slovénie et la Suède.
0.10351705551147461 ||| Page 2 of 2 // 16 Results found ||| Page 1 of 2 // 19 Results found ||| Page 2 de 2 // 14 Résultats trouvés
1.093834400177002 ||| 5 MU1 Solvent: ||| Comments OJ No. ||| féline 5 MU1
0.21173729002475739 ||| Each film-coated tablet contains 400 mg of darunavir (as ethanolate). ||| Each pack contains one vial containing 50 mg Caspofungin (as acetate). ||| Chaque comprimé pelliculé contient 400 mg de darunavir (sous forme d’éthanolate).
0.28011325001716614 ||| Boric acid for industrial purposes ||| Galactose for industrial purposes ||| Acide borique à usage industriel
0.09040994942188263 ||| Dosage The usual dose of CoAprovel is one or two tablets a day. ||| Dosage The usual dose of Karvezide is one or two tablets a day. ||| Posologie La posologie habituelle de CoAprovel est de un ou deux comprimés par jour.
0.13160932064056396 ||| Pharmaceutical preparations for treating malignant tumors ||| Pharmaceutical preparations for treating sensory organ disorders ||| Préparations pharmaceutiques pour le traitement des tumeurs malignes
0.3349268436431885 ||| Cerezyme contains no preservatives. ||| Fuzeon contains no preservative. ||| Cerezyme ne contient pas de conservateur.
0.2671019434928894 ||| Smoked cheese ||| Smoked fish ||| Fromage fumé
0.571017861366272 ||| Dexdomitor is compatible with butorphanol and ketamine in the same syringe at least for two hours. ||| in several doses for 2 - 5 days in association with acetylsalicylic acid ||| Dexdormitor est compatible avec le butorphanol et la kétamine dans la même seringue durant au moins deux heures.
0.05237588286399841 ||| GONAL-f 300 IU/ 0.50 ml (22 micrograms/ 0.50 ml) powder and solvent for solution for injection. ||| GONAL-f 1050 IU/ 1.75 ml (77 micrograms/ 1.75 ml) powder and solvent for solution for injection. ||| GONAL-f 300 UI/ 0,50 ml (22 microgrammes/ 0,50 ml) poudre et solvant pour solution injectable.
0.0024551814422011375 ||| 79 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 81 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 80 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
6.937279526872397e-13 ||| Important information about some of the ingredients of CEPROTIN ||| Important information about some of the ingredients of CEPROTIN ||| Informations importantes sur certains des constituants de CEPROTIN:
0.28996580839157104 ||| If overdose occurs the patient should be monitored for evidence of toxicity (see section 4.8), and standard supportive treatment applied as necessary. ||| Administration of RoActemra should be interrupted if a patient develops a serious infection until the infection is controlled (see section 4.8). ||| En cas de surdosage, une surveillance médicale du patient avec un éventuel traitement symptomatique est nécessaire (voir rubrique 4.8).
0.0 ||| Aspartate aminotransferase increased ||| Aspartate aminotransferase increased ||| Augmentation de l’ aspartate aminotransférase
0.5376472473144531 ||| 70-72 1074 Budapest Hungary ||| H-1123 Budapest Hungary ||| 70-72 1074 Budapest Hongrie
0.423286497592926 ||| If you experience a reaction like this, you should tell your doctor immediately. ||| This is something you may not notice, therefore your doctor may monitor this after each injection. ||| Si vous avez une telle réaction, vous devez en informer immédiatement votre médecin.
0.006794737186282873 ||| United Kingdom Lundbeck Limited Lundbeck House Caldecotte Lake Business Park Caldecotte Milton Keynes MK7 8LG - UK Tel: +44 1908 64 9966 ||| United Kingdom Lundbeck Limited Lundbeck House Caldecotte Lake Business Park Caldecotte Milton Keynes MK7 8LG - UK Tel: +44 1908 649966 ||| United Kingdom Lundbeck Limited Lundbeck House Caldecotte Lake Business Park Caldecotte Milton Keynes MK7 8LG - UK Tel: +44 1908 64 9966 Tel: +44 1908 64 9966
0.008904887363314629 ||| 55 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder: ||| 22 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder: ||| 59 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.2315627634525299 ||| In Spain the product has been authorised for the indication the treatment of swine respiratory disease caused by Pasteurella multocida, Bordetella bronchiseptica and Mycoplasma hyopneumoniae. ||| “ For the treatment and prevention of porcine respiratory disease, caused by Pasteurella multocida and Bordetella bronchiseptica, susceptible to doxycycline, when the disease has been diagnosed in the herd .” ||| En Espagne, le produit a été autorisé pour le traitement des pathologies respiratoires porcines causées par Pasteurella multocida, Bordetella bronchiseptica et Mycoplasma hyopneumoniae.
0.19112971425056458 ||| The pH is adjusted with hydrochloric acid, and if necessary sodium hydroxide. ||| The pH may have been adjusted with sodium hydroxide and/ or hydrochloric acid. ||| Le pH est ajusté avec de l’ acide chlorhydrique et, si nécessaire, avec de l’ hydroxyde de sodium.
0.31714892387390137 ||| - If you have kidney problems, your doctor may lower your dose of Doribax to 250 mg given over ||| - If you have liver problems, you may be prescribed a lower dose of Ventavis than for other ||| - Si vous avez des problèmes rénaux, votre médecin peut diminuer votre dose de Doribax à 250 mg
0.3029557168483734 ||| Any child exposed in utero to nucleoside and nucleotide analogues, even HIV negative children, should have clinical and laboratory follow-up and should be fully investigated for possible mitochondrial dysfunction in case of relevant signs or symptoms. ||| Patients were excluded from the study if there was a presence of invasive oesophageal cancer, if they had a history of cancer other than non- melanoma skin cancer or if they had received prior PDT to the oesophagus. ||| Tout enfant exposé in utero à des analogues nucléosidiques ou nucléotidiques, y compris les enfants séronégatifs pour le VIH, devra faire l’ objet d’ un suivi clinique et biologique et d’ un bilan approfondi à la recherche d’ un éventuel dysfonctionnement mitochondrial devant tout signe ou symptôme évocateur.
0.5415568947792053 ||| A similar framework was adopted in the past to address the 2008 financial crisis. ||| The development of an analytical approach to accounting was begun in 1997. ||| Un cadre similaire a été adopté par le passé pour répondre à la crise financière de 2008.
0.4890565276145935 ||| Non-metallic flexible hoses of rubber reinforced with cords ||| Display boards comprising foldable and interconnectable metal rods ||| Tuyaux flexibles non métalliques en caoutchouc renforcé par des cordons
0.6404526233673096 ||| Glucomed and associated names (see Annex I) 625 mg tablets ||| Subjects primed with 3 doses of Menitorix* N= 349 ||| Glucomed et noms associés (voir Annexe 1) 625 mg comprimés
0.00410861661657691 ||| 18/25 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 17/25 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 19 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.09429959207773209 ||| Crospovidone Lactose monohydrate Magnesium stearate Cellulose, Microcrystalline Povidone ||| Tablet core Lactose monohydrate Hyprolose Crospovidone Microcrystalline cellulose Magnesium stearate ||| noyau du comprimé: crospovidone lactose monohydraté stéarate de magnésium cellulose microcristalline
5.046099172192897e-13 ||| This corresponds to 4 mg ketoprofen / kg. ||| This corresponds to 4 mg ketoprofen / kg. ||| Cela correspond à 4 mg de kétoprofrène / kg.
0.35096126794815063 ||| What is MIRCERA? ||| What is PREZISTA? ||| Qu’ est -ce que MIRCERA?
0.4658192992210388 ||| The purpose of the study was to evaluate the durability of sustained virologic response (SVR) and assess the impact of continued viral negativity on clinical outcomes. ||| The health belief model (HBM) is a social psychological health behavior change model developed to explain and predict health-related behaviors, particularly in regard to the uptake of health services. ||| L’ objectif de cette étude était l’ évaluation du maintien de la réponse virologique prolongée (RVP) et l’ estimation de l’ impact d’ une virémie négative continue sur les résultats cliniques.
0.3932682275772095 ||| Parecoxib should be discontinued at the first sign of hypersensitivity. ||| Ensure that the lyophilisate is completely reconstituted before use. ||| Le parécoxib devra être arrêté dès les premiers signes d'hypersensibilité.
0.36306139826774597 ||| 14.8 ||| 13.7 ||| 14,8
0.5353693962097168 ||| In China, there have been incidents of foreigners being refused rooms by hotel staff, and foreign residents, particularly black people, being kicked out of their apartments on short notice by their landlords. ||| Many of China's nearly 300 million rural migrant workers have been stranded at home in inland provinces or trapped in Hubei province.In March 2020, more than 10 million Americans lost their jobs and applied for government aid. ||| En Chine, on a recensé des incidents avec le personnel hôtelier refusant des chambres aux étrangers, et les résidents étrangers, particulièrement les personnes noires, se voyant chasser de leur appartement par leur propriétaire avec un court préavis.
0.07315223664045334 ||| Treatment with Stocrin should be started by a doctor who has experience in the management of HIV infection. ||| Treatment with Isentress should be started by a doctor who has experience in the management of HIV infection. ||| Tout traitement par Stocrin doit être instauré par un médecin expérimenté dans la prise en charge de l’ infection par le VIH.
0.22409847378730774 ||| Belgium notified to the Commission under the Temporary Framework a €4 million aid scheme to support coronavirus related R  D projects in the Brussels-Capital region. ||| Luxembourg notified to the Commission under the Temporary Framework a €30 million aid scheme to support coronavirus related R&D and investments in the production of coronavirus relevant products. ||| La Belgique a notifié à la Commission, au titre de l' encadrement temporaire , un régime d'aide d'un montant de 4 millions d'EUR destiné à financer des projets de R  D liés au coronavirus dans la région de Bruxelles-Capitale.
0.42248547077178955 ||| Most adverse reactions were mild to moderate and transient in nature. ||| Non-haematological adverse reactions are generally mild to moderate in severity. ||| La plupart des effets indésirables ont été légers à modérés et transitoires.
0.2530933916568756 ||| Caution should be exercised when Thymanax is administered to patients who consume substantial quantities of alcohol or who are treated with medicinal products associated with risk of hepatic injury. ||| Caution should especially be exerted when treating elderly patients as they may be at an increased risk of cardiac disorders or when lacosamide is used in combination with products known to be associated with PR prolongation. ||| Thymanax doit être utilisé avec précaution chez les patients consommant des quantités excessives d’ alcool ou prenant des médicaments exposant à un risque d’ atteinte hépatique.
0.8158314228057861 ||| On 13 March 2020, Guinea's first confirmed COVID-19 case was reported. ||| By 1 April, U.S.'s Strategic National Stockpile was nearly emptied. ||| Le 13 mars 2020, les autorités sanitaires ont signalé le premier cas confirmé de coronavirus en Guinée.
0.43315696716308594 ||| Nitric oxide is a compound produced by many cells of the body. ||| Immunoglobulins are normal constituents of the human body. ||| Le monoxyde d'azote est un composé produit par de nombreuses cellules de l’ organisme.
0.14847031235694885 ||| 10 days. ||| 30 days. ||| 10 jours.
0.32992762327194214 ||| When growth factors (other body proteins) attach to the EGFR, the cancer cell is stimulated to grow and divide. ||| Once the antibody has bound to the antigen, the radiation can act locally and destroy the lymphoma B-cells. ||| Quand les facteurs de croissance (autres protéines de l'organisme) se lient aux EGFR, la cellule cancéreuse est stimulée afin de croître et de se diviser.
0.2755044102668762 ||| For most patients with early stage Parkinson’s disease, the right dose is reached within 3 or 4 weeks, at doses of 6 mg per day or 8 mg per day respectively. ||| It is usually given as 180 micrograms once a week for 48 weeks, although some hepatitis C patients may need 16, 24 or 72 weeks of treatment. ||| Pour la plupart des patients atteints de maladie de Parkinson débutante, la dose adéquate est atteinte après 3 ou 4 semaines, à la dose de 6 mg par jour ou 8 mg par jour respectivement.
0.3453952670097351 ||| Three clinical studies were conducted in 1054 patients in an at-home setting to define the period of responsiveness to tadalafil. ||| To assess bone quality, bone biopsies were obtained from 71 postmenopausal women enrolled in BMD trials after 2 years of treatment. ||| Trois études cliniques ont évalué en ambulatoire chez 1 054 patients la période de réponse du tadalafil.
2.899648294911461e-13 ||| The interferons are a family of small protein molecules with molecular weights of approximately 15,000 to 21,000 daltons. ||| The interferons are a family of small protein molecules with molecular weights of approximately 15,000 to 21,000 daltons. ||| Les interférons sont une famille de petites molécules protéiques d'un poids moléculaire
0.3647647500038147 ||| twofold, resulting in a decrease in average plasma mirtazapine concentration of 60% and 45%, respectively. ||| Similarly, the exposure to the active metabolite increased by about 60% and 48% for AUC and Cmax, respectively. ||| de la clairance de la mirtazapine, ainsi qu’ une diminution des concentrations plasmatiques moyennes de mirtazapine de respectivement 60% et 45%.
0.31849026679992676 ||| Impaired hepatic or renal function: ||| 3 Hepatic or renal impairment: ||| Insuffisance rénale ou hépatique:
6.299858638231237e-13 ||| no ||| no ||| 'e
0.3264797031879425 ||| Patients should be closely monitored for a decrease in platelet count and medically managed to avoid bleeding upon discontinuation of treatment with romiplostim. ||| Patients were randomized to stay on their treatment at the time of enrollmet or to be switched to MIRCERA in order to maintain stable haemoglobin levels. ||| Les patients doivent être étroitement surveillés pour déceler toute diminution du taux de plaquettes et pris en charge médicalement pour éviter tout saignement à l’ arrêt du traitement par romiplostim.
0.34267592430114746 ||| 102 It is recommended that patients be treated with Viraferon alone for at least 3 to 4 months, at which point HCV-RNA status should be determined. ||| 63 The optimal duration of therapy with Viraferon alone is not yet fully established, but a therapy of between 12 and 18 months is advised. ||| Il est recommandé que les patients soient traités avec Viraferon seul pendant au moins 3 à 4 mois, puis que le taux d’ ARN-VHC soit déterminé.
0.6955609917640686 ||| Furnace grates ||| Torpedoes ||| Grilles de foyers
0.37187498807907104 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Irbesartan Hydrochlorothiazide Winthrop’ s benefits are greater than its risks for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone. ||| The CHMP included under this session the warning about Primary Hyperaldosteronism, therefore adopted the following harmonised wording: “ The combination ramipril + hydrochlorothiazide does not represent a treatment of choice for primary hyperaldosteronism. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices d'Irbesartan Hydrochlorothiazide Winthrop sont supérieurs à ses risques pour le traitement de l’ hypertension essentielle chez les patients dont la pression artérielle est insuffisamment contrôlée par l'irbésartan seul ou par l'hydrochlorothiazide seul.
0.40412187576293945 ||| SevoFlo should be administered via a vaporiser specifically calibrated for use with sevoflurane so that the concentration delivered can be accurately controlled. ||| To minimise accidental exposure, it is recommended to use Ventavis with nebulisers with inhalation- triggered systems (HaloLite/ Prodose), and to keep the room well ventilated. ||| SevoFlo doit être administré au moyen d’ un vaporisateur spécifiquement étalonné pour ce produit de façon à ce que la concentration libérée puisse être exactement contrôlée.
0.18222668766975403 ||| In patients with severe hepatic impairment, the data available are insufficient to establish recommendations. ||| Data are insufficient to draw conclusions in patients with moderate hepatic impairment. ||| 38 les données disponibles sont insuffisantes pour établir des recommandations.
0.6531143188476562 ||| Entertainment, education and instruction services ||| Entertainment, sporting and cultural activities ||| Services éducatifs, d'enseignement et de divertissement
0.11517970263957977 ||| Each orodispersible tablet contains 10 mg olanzapine ||| Each orodispersible tablet contains 45 mg mirtazapine ||| Chaque comprimé orodispersible contient 10 mg d’ olanzapine
0.6244895458221436 ||| As a result, all the schools and universities were closed, and all public gatherings banned, including sports and cultural events. ||| Municipal, state, and private schools and universities had different reactions regarding the suspension of classes. ||| En conséquence, toutes les écoles et universités ont été fermé et tous les rassemblements publics interdits, y compris les événements sportifs et culturels.
0.4247127175331116 ||| Data obtained with intravenous fentanyl in patients with renal failure suggest that the volume of distribution of fentanyl may be changed by dialysis. ||| Administration of iodinated contrast agent The intravascular administration of iodinated contrast agents in radiological studies can lead to renal failure. ||| 38 avec le fentanyl intraveineux chez des patients souffrant d’ insuffisance rénale suggèrent que le volume de distribution du fentanyl peut être modifié par la dialyse.
0.16761992871761322 ||| 16 It is not known whether ibandronic acid is excreted in human milk. ||| It is not known whether simvastatin or its metabolites are excreted in human milk. ||| On ne sait pas si l’ acide ibandronique est excrété dans le lait maternel.
0.007894973270595074 ||| 64 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 37 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 67 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.13889090716838837 ||| Chemical and physical in-use stability has been demonstrated for 4 hours when stored at 2 to 8°C. ||| Chemical and physical in-use stability has been demonstrated for 3 hours at 23°C. ||| La stabilité physico-chimique a été démontrée pendant 4 heures quand le produit est conservé entre 2 et 8°C.
0.366183340549469 ||| 7 Ethnic groups: ||| Ethnic group: ||| Groupes ethniques:
0.7617206573486328 ||| 4.6 Pregnancy and lactation ||| • Pregnancy, and lactation. ||| 30 4.6 Grossesse et allaitement
0.002433485584333539 ||| 10 film-coated tablets 20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 60 film-coated tablets 100 film-coated tablets 200 film-coated tablets ||| 10 film-coated tablets 20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 100 film-coated tablets 200 film-coated tablets 500 film-coated tablets ||| 10 comprimés pelliculés 20 comprimés pelliculés 30 comprimés pelliculés 50 comprimés pelliculés 60 comprimés pelliculés 100 comprimés pelliculés 200 comprimés pelliculés
0.27163296937942505 ||| 50 mg/ 2ml ||| 30 mg/ ml ||| 50 mg/ 2 ml
0.5518498420715332 ||| While the numbers of subjects with mild and moderate renal impairment were very small, the data suggest an approximate decrease in CL/ F of 40% and 60% respectively, in mild and moderate renal impairment (see section 4.2). ||| The number of countries considered safe for journalists continues to decline, with only 24% percent of the 180 countries classified as "good" or "fairly good" in 2019 and 2020 compared to 26% in 2018 and 27% in 2017. ||| Malgré les très petits nombres de sujets souffrant d’ insuffisance rénale légère ou modérée, les données suggèrent une diminution approximative de la CL/ F de respectivement 40% et 60%, chez les insuffisants rénaux légers et modérés (cf rubrique 4.2).
0.2554816007614136 ||| What is Fevaxyn Pentofel used for? ||| What is Pramipexole Teva used for? ||| Dans quel cas Fevaxyn Pentofel est -il utilisé?
2.765610819781966e-13 ||| From 1988 to 1992, Dr Brosch worked as an assistant professor at the Department of Pharmacology and Toxicology at the University of Vienna, where she was specialised in electrophysiology. ||| From 1988 to 1992, Dr Brosch worked as an assistant professor at the Department of Pharmacology and Toxicology at the University of Vienna, where she was specialised in electrophysiology. ||| Expérience professionnelle: de 1988 à 1992, Mme Brosch a travaillé comme professeur assistant au département Pharmacologie et toxicologie à l'université de Vienne, où elle était spécialisée en électrophysiologie.
0.303084135055542 ||| 21 February 2006 EMEA/ CHMP/ 373108/ 2005 ||| 4 July 2006 EMEA/ 306065/ 2006 ||| 21 février 2006 EMEA/ CHMP/ 373108/ 2005
0.11647439748048782 ||| Collection of domestic waste ||| Collection of industrial waste ||| Ramassage d'ordures ménagères
6.462792540712359e-13 ||| Suspension for injection 5 x 3ml pre-filled pens ||| Suspension for injection 5 x 3ml pre-filled pens ||| Suspension injectable, 5 stylos préremplis de 3 ml
0.4874187409877777 ||| Distribution The average binding of doripenem to plasma proteins was approximately 8.1% and is independent of plasma concentrations. ||| - The proportion of proliferative endometrium (71%) was higher, on the contrary the proportion of ||| Distribution Le taux moyen de fixation du doripénème aux protéines plasmatiques est de 8,1% environ, et est indépendant de la concentration plasmatique.
0.0 ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| PRECAUTIONS PARTICULIÈRES D’ ÉLIMINATION DES MEDICAMENTS NON UTILISES OU DES DECHETS PROVENANT DE CES MEDICAMENTS S’ IL Y A LIEU
0.4467788636684418 ||| With the likelihood of several new centrally-authorised products coming to the market place the number of variations is expected to increase and this is reflected in the numbers forecast for 1998 and 1999. ||| Similarly a limited number of posts have been reserved to allow the EMEA to meet unexpected needs or perform new tasks which may present themselves in the near future (3 posts in reserve in 1998 and 8 posts in reserve in 1999). ||| En raison de la probabilité de mise sur le marché de plusieurs nouveaux produits autorisés au niveau central, le nombre de modifications devrait augmenter, ce qui se reflète dans les chiffres prévus pour 1998 et 1999.
3.1023924748629916e-13 ||| Women who are pregnant or attempting to become pregnant should exercise appropriate precautions to avoid direct exposure to the contents of the bottle. ||| Women who are pregnant or attempting to become pregnant should exercise appropriate precautions to avoid direct exposure to the contents of the bottle. ||| Les femmes enceintes ou souhaitant le devenir devront prendre des précautions appropriées pour éviter une exposition directe au contenu du flacon.
0.36777132749557495 ||| Most commonly reported adverse reactions are of gastrointestinal character and are seen in approximately 7% of the patients. ||| Case fatality rate is estimated at 1-3% of infected individuals, most of whom are elderly with underlying health conditions. ||| Les réactions indésirables les plus fréquentes sont de type digestif et elles sont observées chez approximativement 7% des patients.
0.3969835042953491 ||| This medicinal product is for single use only. ||| The solution for injection is for single use only. ||| Ce médicament est à usage unique.
0.4140472114086151 ||| Probenecid tablets are given to minimise the potential for kidney damage. ||| The effects of barbiturates and neuroleptics may be reduced. ||| Les comprimés de probénécide sont donnés pour minimiser le risque potentiel de lésions rénales.
0.0 ||| {month/ year} ||| {month/ year} ||| EXP {mois/ année}
0.0054557002149522305 ||| Silapo 5000 IU/0.5ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.5 ml solution for injection contains 5000 international units (IU) epoetin zeta (recombinant human erythropoietin). ||| Silapo 1000 IU/0.3ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.3 ml solution for injection contains 1000 international units (IU) epoetin zeta (recombinant human erythropoietin). ||| Silapo 5 000 UI/0,5 ml solution injectable en seringue préremplie 1 seringue préremplie de 0,5 ml de solution injectable contient 5 000 unités internationales (UI) d’époétine zêta (érythropoïétine humaine recombinante).
1.0891984701156616 ||| What are the affected areas? ||| What the EU is doing ||| Quelles sont les régions touchées ?
0.2856036126613617 ||| On a molar basis, phenylacetylglutamine is comparable to urea (each containing 2 moles of nitrogen) and therefore provides an alternate vehicle for waste nitrogen excretion. ||| The major metabolite (a para-hydroxy-sulphate) with high affinity to the soluble human PPARγ, exhibited relatively high potency in a glucose tolerance assay in obese mice. ||| En terme molaire, la phénylacétylglutamine est comparable à l'urée (chacune contenant deux moles d’ azote) et fournit en conséquence une voie alternative d'élimination de l'azote.
0.005424736067652702 ||| Combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia (see section 4.4). ||| Combination antiretroviral therapy has also been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia (see section 4.4). ||| Les traitements par association d’antirétroviraux ont été associés à des anomalies métaboliques telles que des hypertriglycéridémie, hypercholestérolémie, résistance à l'insuline, hyperglycémie et hyperlactatémie (voir rubrique 4.4).
0.3946318030357361 ||| Based on evaluation of the available data and the Rapporteurs’ assessment reports, the CHMP considered that the benefit/ risk profile of paroxetine containing medicinal products remains favourable. ||| The CHMP considered that the assessment raised concerns on the benefit/ risk balance of piroxicam and informed the European Commission accordingly. ||| Sur la base de l’ évaluation des données disponibles et des rapports d’ évaluation des rapporteurs, le CHMP a considéré que le profil bénéfice/ risque des médicaments contenant de la paroxétine demeure favorable.
0.17599472403526306 ||| If you experience clinical symptoms suggesting an injury of the liver, such as loss of appetite, nausea, vomiting and/ or jaundice, you should inform your doctor. ||| If you experience signs of infection of the ulcer (e. g. redness, swelling, fever, pain, odour), you should consult your doctor immediately for specific treatment. ||| Si vous ressentez des symptômes cliniques évoquant une atteinte du foie, tels qu'une perte d'appétit, des nausées, des vomissements et/ ou une jaunisse, vous devez en informer votre médecin.
0.23687291145324707 ||| Onset of these reactions occurred within the first 3 months after initiation of treatment with Januvia, with some reports occurring after the first dose. ||| Among patients receiving Enbrel, the clinical responses generally appeared within 1 to 2 weeks after initiation of therapy and nearly always ||| Ces réactions sont apparues dans les 3 premiers mois après l'initiation du traitement par Januvia, certains cas apparaissant après la première prise.
0.03611232712864876 ||| If your levels of the red blood pigment (haemoglobin) are too high you should not receive Abseamed, since you have an increased risk of blood clotting after the surgery. ||| If your levels of the red blood pigment (haemoglobin) are too high you should not receive Binocrit, since you have an increased risk of blood clotting after the surgery. ||| Vous ne devez pas recevoir de Abseamed si vous avez un taux d'hémoglobine (pigment donnant sa couleur rouge au sang) trop élevé car vous présenteriez alors un risque accru de thromboses post- opératoires.
0.547673225402832 ||| Interactions common to the combination No drug interaction studies were performed with Copalia and other medicinal products. ||| Adverse reactions reported with the use of irbesartan alone General disorders and administration site conditions: ||| Interactions communes à l'association Aucune étude d'interaction n'a été réalisée avec Copalia et d'autres médicaments.
0.22997473180294037 ||| Temodal 100 mg hard capsules have an opaque white body, an opaque pink cap, and are imprinted with black ink. ||| Imprinted capsules with light blue, opaque cap and cream-coloured, opaque body of size 2 filled with yellowish pellets. ||| Les gélules de Temodal 100 mg ont un corps opaque blanc, une coiffe opaque rose, et sont marquées avec une encre noire.
0.17467908561229706 ||| 1 ml contains 330.9 mg gadoversetamide, equivalent to 500 micromoles.  The other ingredients are: versetamide, calcium hydroxide, calcium chloride dihydrate, sodium hydroxide and/ or hydrochloric acid, water for injections. ||| Each vial contains 90 mg ustekinumab (90 mg in 1 ml). • The other ingredients are sucrose, L-histidine, L-histidine monohydrochloride monohydrate, polysorbate 80 and water for injections. ||| 1 ml contient 330,9 mg de gadoversétamide, correspondant à 500 micromoles.  Les autres composants sont: versétamide, hydroxyde de calcium, chlorure de calcium dihydraté, hydroxyde de sodium et/ou acide chlorhydrique, eau pour préparations injectables.
0.0 ||| Every year, the European Medicines Agency (EMEA) will review any new information that may become available and this summary will be updated as necessary. ||| Every year, the European Medicines Agency (EMEA) will review any new information that may become available and this summary will be updated as necessary. ||| Chaque année, l’ Agence européenne du médicament (EMEA) examinera toute information nouvelle éventuellement disponible et, le cas échéant, procèdera à la mise à jour du présent résumé.
0.4984574317932129 ||| Crumb brushes ||| Rubbish bags ||| Ramasse-miettes
0.32405751943588257 ||| Non-clinical data reveal no special hazard for humans based on studies of single dose toxicity, repeated dose toxicity, and genotoxicity. ||| 11 Single-dose and repeated-dose toxicity and local tolerance studies revealed no special hazards to humans. ||| Les données non cliniques issues des études de toxicologie en administration unique, toxicologie en administration répétée et de génotoxicité, n’ ont pas révélé de risque particulier pour l’ homme.
0.3097342550754547 ||| The best sites for injection are tissues with a layer of fat between skin and muscle: thigh, outer surface of the upper arm (you may need the assistance of another person to use this site), lp ||| The recommended sites for injection using the pre-filled pen are the top of the thigh and the back of the arm if given by a nurse or carer (see picture 1). ||| Les meilleurs endroits pour l’injection sont les tissus avec une couche graisseuse entre la peau et le muscle: cuisse, surface extérieure de la partie supérieure du bras (vous mé
0.31900525093078613 ||| Unless compatibility with other infusion solutions/drugs has been confirmed, the infusion solution must always be administered separately. ||| Unless compatibility is proven, the solution for infusion should always be administered separately (see also section 6.2). ||| La solution pour perfusion doit systématiquement être administrée séparément, sauf si la compatibilité avec des médicaments/solutions pour perfusion a été établie.
0.31351712346076965 ||| Rimonabant should be used with caution in this population (see section 5.2). ||| Effect of food Inovelon should preferably be taken with food (see Section 5.2). ||| Le rimonabant doit être utilis é avec prudence dans cette population (voir rubrique 5.2).
0.3471868932247162 ||| The reduction of clarithromycin to 250 mg in the triple combination therapy with amoxicillin 1000 mg, however, is not supported by the Maastricht 2-2000 Consensus Report. ||| The CHMP, considering the previous harmonisations referrals for enalapril, perindopril and lisinopril, adopted the harmonised indication: “ Treatment of symptomatic heart failure”. ||| La réduction de la clarithromycine à 250 mg dans la trithérapie combinée comprenant 100 mg d’ amoxicilline n’ est toutefois pas étayée par le rapport de consensus de Maastricht 2-2000.
0.3676185607910156 ||| According to the Ministry of Health, the number of infected patients would grow exponentially until the end of June. ||| The Institute of the Health Policy expected the number of infected to reach 10% of the country's population. ||| Selon le ministère de la Santé, le nombre de patients infectés augmentera de façon exponentielle d'ici fin juin.
0.23328155279159546 ||| Gloves for protection against accidents ||| Boots for protection against fire ||| Gants pour la protection contre les accidents
0.284646213054657 ||| The rate and extent of absorption of metformin from Eucreas 50 mg/1000 mg were decreased when given with food as reflected by the decrease in Cmax by 26%, AUC by 7% and delayed Tmax (2.0 to 4.0 h). ||| The No Observed Adverse Effect Level (NOAEL) at 15 mg/ kg/ day in rats, is equivalent to an AUC which is considerably higher (x 15000) than the human exposure after ingestion of Circadin 2 mg. ||| La vitesse et l’ importance de l’ absorption de la metformine présente dans Eucreas 50 mg/ 1000 mg sont diminuées lorsque le médicament est pris avec des aliments, avec une diminution de la Cmax de 26%, de l’ ASC de 7% et un allongement du Tmax (2,0 à 4,0 heures).
0.18440616130828857 ||| SUSTIVA hard capsules must only be administered to children who are able to reliably swallow hard capsules. ||| SUSTIVA hard capsules or film-coated tablets must only be administered to children who are able to reliably swallow capsules or tablets. ||| Les gélules de SUSTIVA ne doivent être administrées qu'aux enfants capables de les avaler.
0.06569810211658478 ||| Always take Axura exactly as your doctor has told you. ||| Always take Glivec exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.3200991153717041 ||| HOW TO TAKE FARESTON ||| HOW TO TAKE BONVIVA). ||| COMMENT PRENDRE FARESTON?
0.3438512086868286 ||| MIRCERA 75 micrograms/ 0.3 ml solution for injection in pre-filled syringe. ||| HEXAVAC - single dose pre-filled syringe with 2 separate needles - Pack of 10 ||| MIRCERA 75 microgrammes/ 0,3 ml solution injectable en seringue préremplie.
0.2918156385421753 ||| Metabolism and nutrition disorders Uncommon: hyperkalaemia ||| Metabolism and nutrition disorders: hypoglycaemia ||| Troubles du métabolisme et de la nutrition Peu fréquent: hyperkaliémie
0.5493402481079102 ||| Abnormal heart beats (arrhythmias) ||| - slow irregular heartbeat (bradyarrhythmias) ||| Battements cardiaques anormaux (arythmies)
0.4850947856903076 ||| Hypersensitity reactions unrelated to dose can be observed. ||| Lack of efficacy (therapeutic response decreased) has been reported. ||| Des réactions d’ hypersensibilité indépendantes de la dose peuvent être observées.
0.22757911682128906 ||| Cases of pulmonary oedema have been reported with vasodilators (mainly prostacyclins) when used in patients with pulmonary veno-occlusive disease. ||| Targretin capsules are used by patients with advanced stage cutaneous T-cell lymphoma (CTCL) whose disease has not responded to other therapies. ||| Des cas d’œ dèmes pulmonaires ont été rapportés lors de l’ administration de médicaments vasodilatateurs (principalement des prostacyclines) chez des patients souffrant de maladie pulmonaire veino-occlusive.
0.24460744857788086 ||| Adults and adolescents (12 years of age and older): take two 2.5 mg Azomyr orodispersible tablets once a day. ||| Neoclarityn 2.5 mg orodispersible tablet is indicated for adults and children (6 years of age and older). ||| Adultes et adolescents (12 ans et plus): prendre deux comprimés orodispersibles d’ Azomyr 2,5 mg une fois par jour.
0.29683369398117065 ||| If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopidogrel Winthrop (1 tablet of 300 mg or 4 tablets of 75 mg) once at the start of treatment. ||| Prevention of duodenal or stomach ulcer in patients requiring continued NSAID treatment: one 15 mg oro-dispersible tablet every day, your doctor may adjust your dose to one 30 mg oro-dispersible tablet every day. ||| Si vous avez été victime d'une douleur thoracique grave (angor instable ou crise cardiaque), votre médecin pourra vous prescrire 300 mg de Clopidogrel Winthrop (1 comprimé de 300 mg ou 4 comprimés de 75 mg en une seule fois) pour débuter le traitement.
0.0 ||| OUTER CARTON (for PVC/ Aclar blister) ||| OUTER CARTON (for PVC/ Aclar blister) ||| BOITE (pour plaquette thermoformée PVC/ aclar)
0.04829097166657448 ||| 73 ANNEX III ||| 75 ANNEX III ||| 78 ANNEXE III
0.24757768213748932 ||| Recommended dose modifications for toxicities in patients treated with docetaxel in combination with cisplatin and 5-fluorouracil (5-FU): ||| APTIVUS co-administered with low dose ritonavir decreases the plasma concentrations of omeprazole and esomeprazole (see section 4.5). ||| En cas de toxicités, les ajustements posologiques des patients recevant du docétaxelen association avec 43 le cisplatine et le 5-fluorouracile (5-FU) sont les suivantes:
0.407093346118927 ||| Other important activities in 2002 included preparations for the implementation of the EU directive on the conduct of clinical trials and contributions to the European Commission policy on paediatric medicines. ||| An internal competition will be conducted in 2000 to integrate the Agency’s secretarial and clerical staff within the Regulations and rules applicable to officials and other servants of the European Communities. ||| Les autres activités majeures en 2002 incluaient des préparatifs pour la mise en œ uvre de la directive de l’ UE sur la réalisation d’ études cliniques et des contributions à la politique de la Commission européenne en matière de médicaments pédiatriques.
0.037107665091753006 ||| 110 Adult patients with chronic renal failure ||| 122 Adult patients with chronic renal failure ||| Adultes insuffisants rénaux chroniques
0.4444162845611572 ||| Effects in non-clinical studies were generally observed at exposures in excess of the maximum human exposure. ||| In clinical studies side effects were mainly seen while patients were being given the medicine or shortly after. ||| Les effets observés lors des études précliniques sont généralement survenus à des expositions supérieures à l’ exposition maximale chez l’ homme
0.23267434537410736 ||| You may take a CIALIS tablet at least 30 minutes before sexual activity. ||| You may take a Tadalafil Lilly tablet at least 30 minutes before sexual activity. ||| Vous pouvez prendre un comprimé de CIALIS au moins 30 minutes avant l'activité sexuelle.
0.45327743887901306 ||| As valproate significantly decreases clearance of Inovelon, a lower maximum dose of Inovelon is recommended for patients < 30 kg being co-administered valproate. ||| Taking Alendronate HEXAL with food and drink It is likely that food and beverages (including mineral water) will make Alendronate HEXAL less effective if taken at the same time. ||| Le valproate diminuant significativement la clairance d’ Inovelon, il est recommandé de diminuer la dose maximale d’ Inovelon chez les patients de < 30 kg recevant un traitement concomitant par le valproate.
0.2249276340007782 ||| Single disposable injection device, preloaded inside a hypodermic needle covered with a protective cap. ||| An individual carton box contains a single disposable injection device, preloaded inside a hypodermic needle covered with a protective cap. ||| Dispositif d’ injection prêt à l’ emploi, à usage unique, dont l’ aiguille hypodermique, recouverte par un bouchon protecteur, est préchargée.
0.2916511297225952 ||| For polyarticular juvenile idiopathic arthritis in patients from the age of 4 years, the dose recommended is 0.4 mg of Enbrel per kg bodyweight (up to a maximum of 25 mg), and should be given twice weekly. ||| SIFROL is indicated for symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in dosages up to 0.54 mg of base (0.75 mg of salt) (see section 4.2). ||| Chez les patients atteints d’arthrite juvénile idiopathiques polyarticulaire à partir de l’âge de 4 ans, la dose recommandée est de 0,4 mg d’Enbrel par kg de poids (jusqu’à un maximum de 25 mg), et doit être donnée deux fois par semaine.
0.16656029224395752 ||| How to store Hycamtin 6. ||| How to store Cyanokit 6. ||| Comment conserver Hycamtin 6.
0.2535979747772217 ||| None of the subjects experienced withdrawal symptoms in this study; however, due to the pharmacokinetic changes, it should be expected that some patients who received this drug combination may experience withdrawal symptoms and require an upward adjustment of the methadone dose. ||| The Committee noted that the reduction in the number of tablets that patients need to take may help patients to stick to their treatment, and that the benefit of Trizivir has mainly been shown in patients who have had little or no previous HIV treatment and who have non-advanced disease. ||| Aucun des sujets dans cette étude n’ a ressenti des symptômes de manque; cependant du fait des modifications pharmacocinétiques, il pourrait arriver que certains patients recevant cette association médicamenteuse ressentent des symptômes de sevrage, nécessitant une augmentation de la posologie de méthadone.
0.23410752415657043 ||| 0%); Dyspnoea (G3/ 4: ||| 18%); Diarrhoea (G3/ 4: ||| 0%); Dyspnée (G3/ 4:
0.15639415383338928 ||| 10 doses (10 x 1 ml) ||| 10 doses (10 x 0.5 ml): ||| 10 doses (10 x 1 ml):
0.15615209937095642 ||| Always use Liprolog Mix50 exactly as your doctor has told you. ||| Always use Liprolog Mix25 KwikPen exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.48072874546051025 ||| Symptomatic treatment of seasonal allergic conjunctivitis. ||| - Acute exacerbation of chronic bronchitis, ||| Traitement symptomatique des conjonctivites allergiques saisonnières.
0.20437957346439362 ||| - The active substance is sapropterin dihydrochloride. ||| - The active substance of Zyrtec is cetirizine dihydrochloride. ||| - La substance active est le dichlorhydrate de saproptérine.
0.09131155908107758 ||| - If you are allergic (hypersensitive) to any antibiotic belonging to the subgroup of macrolide ||| - If you are allergic (hypersensitive) to tacrolimus or to any antibiotic belonging to the subgroup ||| - Si vous êtes allergique (hypersensible) aux antibiotiques appartenant à la classe des
0.34476056694984436 ||| Modifications to the existing tasks, and the introduction of new ones, have put the EU regulatory system in a better position to ensure that safe and effective medicines, as well as adequate information about them, are available to European patients. ||| During 2000-2001 the Agency will review its future needs in the context of information being increasingly available in electronic format and the benefits of this not only to simplify work processes, but also to improve public access to documents. ||| Grâce aux modifications apportées aux tâches existantes et à l’ adoption de nouvelles tâches, le système réglementaire de l’ UE est mieux armé en vue de mettre à la disposition des patients européens des médicaments sûrs et efficaces ainsi qu’ une information suffisante à leur sujet) mis.
0.43514347076416016 ||| Electronic logic circuits ||| Medical screw connections ||| Circuits logiques électroniques
0.28191012144088745 ||| Metabolism Rivastigmine is rapidly and extensively metabolised with an apparent elimination half-life in plasma of approximately 3.4 hours after removal of the transdermal patch. ||| In humans the one major circulating metabolite (M1) results from desethylation of vardenafil and is subject to further metabolism with a plasma elimination half life of approximately 4 hours. ||| 69 Métabolisme La rivastigmine est fortement et rapidement métabolisée; la demi-vie d’ élimination apparente dans le plasma est d’ environ 3,4 heures après le retrait du dispositif transdermique.
0.03717572242021561 ||| - If you are allergic (hypersensitive) to pioglitazone, metformin or any of the other ingredients of ||| - if you are allergic (hypersensitive) to sitagliptin or metformin or any of the other ingredients of ||| - si vous êtes allergique (hypersensible) à la pioglitazone, à la metformine ou à l'un des autres
0.7145285606384277 ||| 75 mg comprimidos 75 mg ||| 50 mg 50 mg at reduced ||| Dobupal 75 mg comprimidos 75 mg
0.382559210062027 ||| Where a dose of hepatitis B vaccine is given at birth, Infanrix hexa can be used as a replacement for supplementary doses of hepatitis B vaccine from the age of six weeks. ||| It is strongly recommended to vaccinate all pigs in the herd. lo The dosage for pigs, over the age of 2 weeks, is 2 ml of the vaccine. o ||| Lorsqu’ une dose de vaccin contre l’ hépatite B a été administrée à la naissance, Infanrix hexa peut être utilisé en remplacement de doses supplémentaires de vaccin contre l’ hépatite B dès l’ âge de six semaines.
0.45832040905952454 ||| Growth failure in children due to inadequate growth hormone secretion: ||| - with growth disturbance due to insufficient secretion of growth hormone (GH). ||| Retard de croissance chez l’ enfant lié à une sécrétion insuffisante de l’ hormone de croissance:
0.5685233473777771 ||| rash (13.6%) Stevens Johnson Syndrome/ toxic epidermal necrolysis (0.1%), angioneurotic ||| Dermatitis; Rash erythematous (G3/ 4: < 1%); Nail discolouration; Onycholysis (G3/ 4: ||| rash (13,6%) syndrome de Stevens-Johnson/ syndrome de Lyell (0,1%), angioedème, urticaire
0.11893114447593689 ||| 13/ 42 ||| 15/ 42 ||| 12/ 43
0.3498331308364868 ||| Breast-feeding is not recommended during treatment with Arixtra. ||| Patients taking Xyrem should stop breast feeding. ||| L’allaitement n’est pas recommandé pendant le traitement avec Arixtra.
0.42104291915893555 ||| Due to the lack of data in patients with severely impaired hepatic function, these patients should not be treated with lansoprazole (see section 4.4 “ Special warnings and precautions for use”). ||| All patients who receive PhotoBarr will be photosensitive (sensitive to light) and must observe precautions to avoid direct sunlight and bright indoor light (see above ‘How to prevent a photosensitivity reaction’). ||| En raison du manque de données concernant les patients atteints d’ une insuffisance hépatique sévère, ceux -ci ne devraient pas être traités par lansoprazole (voir rubrique 4.4 « Mises en garde spéciales et précautions particulières d’ emploi »).
6.87726243141229e-13 ||| Slovenská republika GlaxoSmithKline Slovakia s. r. o. ||| Slovenská republika GlaxoSmithKline Slovakia s. r. o. ||| Slovenská republika Ísland GlaxoSmithKline Slovakia s. r. o.
0.5667542219161987 ||| 2.5 x ULN** ||| > 8 × ULN ||| 2,5 x LNS**
0.5132178068161011 ||| Worked as a clinical endocrinologist in a French hospital until 1987 and then joined the Directorate of Pharmacy at the French Ministry of Health. ||| It is a so-called federal scientific institution that operates under the authority of the federal minister of Public Health and the federal minister of Agriculture of Belgium. ||| Elle a travaillé en tant qu’endocrinologue clinique dans un hôpital français jusqu’en 1987, puis a intégré la direction de la pharmacie au ministère français de la Santé.
0.15384626388549805 ||| 6.5 Nature and contents of container ||| 6.5 Nature and content of container ||| 13 6.5 Nature et contenu de l’ emballage extérieur
0.081197589635849 ||| Providing information relating to the repair or maintenance of photographic machines and apparatus ||| Providing information relating to the repair or maintenance of laboratory apparatus and instruments ||| Mise à disposition d'informations en matière de réparation ou d'entretien d'appareils et de machines photographiques
0.3450515866279602 ||| United Kingdom Sanofi Pasteur MSD Ltd, Tel: +44 1628 785 291 ||| Portugal Lilly Portugal - Produtos Farmacêuticos, Lda Tel: + 351 21 412 6600 ||| 70 United Kingdom Sanofi Pasteur MSD Ltd, Tel: +44 1 628 785 291
0.29289841651916504 ||| In dogs given tadalafil daily for 6 to 12 months at doses of 25 mg/ kg/ day (resulting in at least a 3-fold greater exposure [range 3.7 – 18.6] than seen in humans given a single 20 mg dose) and above, there was regression of the seminiferous tubular epithelium that resulted in a decrease in spermatogenesis in some dogs. ||| Carglumic acid is secreted in the milk of lactating rats and although developmental parameters were unaffected, there were some effects on body weight / body weight gain of pups breast-fed by dams treated with 500 mg/ kg/ day and a higher mortality of pups from dams treated with 2000/ kg/ day, a dose that caused maternotoxicity. ||| Chez les chiens ayant reçu quotidiennement du tadalafil pendant 6 à 12 mois à des doses de 25 mg/ kg/ jour (représentant une exposition au moins 3 fois supérieure [de 3,7 à 18,6] à celle observée chez l’ homme à la dose unique de 20 mg) et plus, une régression de l'épithélium des tubes séminifères a été observée, entraînant une diminution de la spermatogénèse chez certains chiens.
0.2483196258544922 ||| Bacterial substances for scientific use ||| Antibacterial substances for medical purposes ||| Substances bactériennes à usage scientifique
0.2830938994884491 ||| However, the incidence of death was higher in oral olanzapine-treated than in placebo-treated patients independent of these risk factors. ||| The frequencies of serious infection and malignancy relative to placebo among abatacept-treated patients over age 65 were higher than among those under age 65. ||| Néanmoins, indépendamment de ces facteurs de risque, l’ incidence de mortalité a été supérieure dans le groupe olanzapine orale (comparativement au placebo).
0.41640108823776245 ||| Elderly patients should be observed carefully for signs of fentanyl toxicity. ||| Prolonged or severe hypoglycaemic episodes may be life threatening. ||| Il est donc nécessaire de rechercher soigneusement tout signe de toxicité du fentanyl chez les personnes âgées.
0.25129234790802 ||| Other information about TOVIAZ: ||| Other information about BeneFIX: ||| Autres informations relatives à TOVIAZ:
0.6533610820770264 ||| Alternatively, 120 mg (20 ml) may be taken in the morning. ||| ed Always carry some sugar (at least 20 grams) with you. ||| Il est également possible de prendre 120 mg (20 ml) le matin.
0.5634326934814453 ||| amblyopia. ||| Mutagenicity. ||| amblyopie.
0.24466373026371002 ||| You should tell your doctor if you are taking other calcium lowering drugs, such as bisphosphonates, as the combination of these drugs with FORCALTONIN might cause the amount of calcium in your blood to become too low. lp ||| If you are concerned about how much you can drink while you are taking TRITAZIDE, discuss this with your doctor as medicines used to reduce blood pressure and alcohol can have additive effects. • TRITAZIDE may be taken with or without food. ||| Si vous utilisez d’ autres médicaments de réduction du taux de calcium, tels que les biphosphonates, mentionnez -le à votre médecin, car la combinaison de ces produits avec le FORCALTONIN peut causer une réduction excessive du taux de calcium sanguin. mé
0.27578604221343994 ||| No specific study has been performed in patients with pulmonary hypertension and concomitant left ventricular dysfunction. ||| Venlafaxine has not been evaluated in patients with a recent history of myocardial infarction or unstable heart disease. ||| Aucune étude spécifique n’ a été réalisée chez des patients souffrant d’ hypertension artérielle pulmonaire associée à une insuffisance cardiaque ventriculaire gauche.
0.0625193864107132 ||| Such tracing apps must be voluntary, transparent, temporary, cybersecure, using anonymised data, should rely on Bluetooth technology and be inter-operable across borders as well as across operating systems. ||| Tracing apps must be voluntary, transparent, temporary, cybersecure, using pseudonymised data, should rely on Bluetooth technology and be inter-operable across borders as well as across operating systems. ||| Ces applications de traçage doivent être utilisées de manière volontaire, transparente, temporaire et sécurisée, utiliser des données anonymisées et reposer sur la technologie Bluetooth.
0.3667224645614624 ||| Eculizumab binds to and inhibits a specific protein in the body that causes inflammation. ||| When rituximab binds to the surface of this cell it causes the cell to die. ||| L’ eculizumab se lie à une protéine spécifique de l’ organisme qui provoque une inflammation et l’ inhibe.
0.08023853600025177 ||| If the rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in four weeks reduce the dose by approximately 25%, depending on the rate of increase. ||| If the rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in 4 weeks, the dose should be reduced by 25 to 50%. ||| Si le taux d’ hémoglobine augmente de plus de 2 g/ dl (1,25 mmol/ l) sur une période de 4 semaines, réduire la dose d’ environ 25% en fonction de l’ importance de cette augmentation.
0.5704814195632935 ||| Ampoule (glass) ||| Pipette (plastic) ||| ampoule (verre)
0.8698054552078247 ||| 6.5 Nature and contents of container lP ||| primary mutations 1 Prior number of NRTIs ||| 6.5 Nature et contenu de l’ emballage extérieur
0.577223539352417 ||| The gel should be administered at the time of feeding. ||| The child should be seated in a reclining position. ||| Il est recommandé d’ administrer le gel au moment du repas.
0.4156557619571686 ||| - if you have liver disease; ||| if you have asthma or diabetes; ||| - si vous avez une maladie du foie;
0.03922131285071373 ||| 13 August 1999 Date of latest renewal: ||| 15 July 1998 Date of latest renewal: ||| 13 août 1999 Date du dernier renouvellement:
0.5700289011001587 ||| - feeling weak, tiredness and lack of energy ||| - severe tiredness or achiness or generally feeling ill ||| - Sensation de faiblesse, fatigue et manque d’ énergie
0.30385375022888184 ||| Suspension for injection 1 vial 1 dose (0.5 ml) ||| Oral suspension 1 tube 1 dose (1.5 ml) ||| Suspension injectable 1 flacon 1 dose (0,5 ml)
2.283186118466618e-13 ||| The EU will support Asia and the Pacific with €1.22 billion, another €291 million will go for the Africa, Caribbean and Pacific region, €918 million to support our partners in Latin America and the Caribbean and €111 million to support Overseas Countries and Territories. ||| The EU will support Asia and the Pacific with €1.22 billion, another €291 million will go for the Africa, Caribbean and Pacific region, €918 million to support our partners in Latin America and the Caribbean and €111 million to support Overseas Countries and Territories. ||| L'UE apportera un soutien d'un montant de 1,22 milliard d'euros en Asie et dans le Pacifique, tandis que 291 millions d'euros sont destinés aux pays d'Afrique, des Caraïbes et du Pacifique, 918 millions d'euros à nos partenaires en Amérique latine et dans les Caraïbes et 111 millions d'euros aux pays et territoires d'outre-mer.
0.3532635569572449 ||| Refill packs for cosmetics dispensers ||| Insulation jackets for industrial pipes ||| Recharges pour distributeurs de cosmétiques
0.5623641014099121 ||| 2 Member State ||| 1 Member State Austria ||| 2 Etat membre
0.32020696997642517 ||| These infants should receive the first dose of vaccine between 6 and 12 weeks after birth. ||| The first dose is given when the baby is between six and 12 weeks of age. ||| Ces enfants doivent recevoir la première dose de RotaTeq entre 6 et 12 semaines après la naissance.
0.3247442841529846 ||| Make sure you tell your doctor if you are taking any medicines which cause sleepiness as thalidomide may increase their effects. ||| If a pregnancy should occur you must tell your doctor immediately and genetic counselling is recommended since Yondelis can cause genetic damage. ||| Veillez à informer votre médecin si vous prenez des médicaments qui provoquent de la somnolence, car le thalidomide peut accroître leurs effets.
0.47023117542266846 ||| Since such public interventions may have a significant impact on competition in the Single Market, they should remain measures of last-resort. ||| Under such circumstances, the key feature of InvestEU of de-risking projects to crowd in private finance is particularly valuable and should be utilised. ||| Étant donné que ces interventions publiques peuvent avoir une incidence significative sur la concurrence dans le marché unique, elles doivent rester des mesures de dernier ressort.
0.1934194266796112 ||| 15 (0.6%) ||| 46 (8.5%) ||| 20 (2,4%)
0.4273587465286255 ||| 4.4 Special warnings and precautions for use ||| 4.5 Special precaution(s) for use ||| 4.4 Mises en garde spéciales et précautionsd’ emploi
5.28195705489648e-13 ||| Consequently, to preserve the efficacy of this drug: ||| Consequently, to preserve the efficacy of this drug: ||| En conséquence, pour préserver l’efficacité de ce médicament:
0.19919563829898834 ||| Cardiac failure aggravated, arrhythmia, syncope, bradycardia, cyanosis, palpitation Rare: ||| Arrhythmia, tachycardia, palpitations, angina pectoris, myocardial infarction. ||| Aggravation d’ une insuffisance cardiaque, arythmie, syncope, bradycardie, cyanose, palpitations
7.322105703873316e-13 ||| OTHER SPECIAL WARNING(S), IF NECESSARY ||| OTHER SPECIAL WARNING(S), IF NECESSARY ||| AUTRE(S) MISE(S) EN GARDE SPÉCIALE(S)
0.09131775796413422 ||| Focetria has been authorised under “ Exceptional Circumstances”. ||| TRISENOX has been authorised under “ Exceptional Circumstances”. ||| Focetria a été autorisé « sous circonstances exceptionnelles ».
0.2078043818473816 ||| Carcinogenicity and fertility studies were not performed with tocilizumab due to the lack of appropriate models for an antibody with no reactivity to rodent IL-6 receptors. ||| Carcinogenicity studies were not performed with ustekinumab due to the lack of appropriate models for an antibody with no cross-reactivity to rodent IL-12/ 23 p40. ||| Aucune étude de cancérogénicité et de fertilité n’ a été effectuée avec le tocilizumab compte tenu du manque de modèles appropriés pour un anticorps ne présentant aucune affinité pour les récepteurs de l’ IL-6 chez les rongeurs.
0.2554466128349304 ||| 115 If you forget to take Keppra: ||| ● If you forget to take Pegasys: ||| Si vous oubliez de prendre Keppra:
0.005211498588323593 ||| 359 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 395 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 363 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.25079840421676636 ||| Patients should be monitored for signs of busulfan toxicity when itraconazole is used as an antifungal prophylaxis with intravenous busulfan. ||| Lansoprazole (like misoprostol) is effective in reducing the risk of gastric or duodenal ulcers in patients who need to continue NSAIDs. ||| Les patients recevant des traitements antifongiques prophylactiques à base d’ itraconazole doivent être surveillés afin de détecter les signes de toxicité due au busulfan intraveineux.
0.3105694055557251 ||| However, the plasma concentration of a metabolite of midazolam, 1'-hydroxymidazolam, was increased approximately 2-fold with multiple doses of laropiprant. ||| However, AUC values of phenytoin and free phenytoin were reduced by 29% and 28% by co-administration of nelfinavir, respectively. ||| 5 concentration plasmatique d’ un métabolite du midazolam, 1’ -hydroxymidazolam, a été multipliée par 2 environ.
0.047081250697374344 ||| After reconstitution, 1 dose (1 ml) contains: ||| After reconstitution, 1 dose (0.5 ml) contains: ||| Après reconstitution, 1 dose (1 ml) contient:
0.2496272623538971 ||| Spool unwinders [hand-operated tools] ||| Tighteners [hand-operated tools] ||| Dérouleurs de bobines [outillage manuel]
0.0 ||| 6.6 Special precautions for disposal and other handling ||| 6.6 Special precautions for disposal and other handling ||| 81 6.6 Précautions particulières d’ élimination et manipulation
0.420430451631546 ||| Treatment with Tandemact requires regular monitoring of glycaemic control. ||| Regular monitoring of platelet count and haematocrit is recommended. ||| Des contrôles réguliers de la glycémie sont nécessaires avec traitement par Tandemact.
2.724330093115124e-13 ||| The use of epoetin alfa in patients scheduled for major elective orthopaedic surgery and not participating in an autologous blood predonation programme is contraindicated in patients with severe coronary, peripheral arterial, carotid or cerebral vascular disease, including patients with recent myocardial infarction or cerebral vascular accident. ||| The use of epoetin alfa in patients scheduled for major elective orthopaedic surgery and not participating in an autologous blood predonation programme is contraindicated in patients with severe coronary, peripheral arterial, carotid or cerebral vascular disease, including patients with recent myocardial infarction or cerebral vascular accident. ||| 22 Si les patients doivent bénéficier d’ une intervention chirurgicale orthopédique majeure programmée et ne participent pas à un programme de prélèvement autologue différé, l'utilisation d'époétine alfa est contre-indiquée en cas de pathologie vasculaire sévère coronarienne, carotidienne, des artères périphériques, ou cérébrale, y compris chez les patients ayant des antécédents récents d'infarctus du myocarde ou d'accident vasculaire cérébral.
0.24342752993106842 ||| Elderly Patients: ||| Elderly patients: ||| Patients âgés:
0.5661947131156921 ||| Medical research ||| Scientific advice ||| Recherche médicale
0.5467099547386169 ||| Office machines ||| Memory cards ||| Machines de bureau
0.006890612654387951 ||| Each powder vial contains 1000 IU octocog alfa. ||| Each powder vial contains 1500 IU octocog alfa. ||| Chaque flacon de poudre contient 1000 UI d’ octocog alfa
0.1974731683731079 ||| Lactic acidosis occurs more often in women, particularly if they are very overweight. ||| Lactic acidosis occurs more often in women, particularly if they are very overweight, and people with liver disease. ||| L’ acidose lactique apparaît plus souvent chez la femme, en particulier lorsqu’ elle est en surpoids.
0.0443592332303524 ||| Store in a refrigerator (2°C – 8°C). ||| Store in a refrigerator (2°C – 8°C) ||| 451 A conserver au réfrigérateur (entre 2ºC et 8ºC).
0.14192596077919006 ||| Pharmacokinetics in special patient groups ||| 66 Pharmacokinetics in special patient groups ||| Pharmacocinétique dans des populations particulières
0.2567164897918701 ||| The reconstituted solution must be further diluted. ||| The reconstituted solution should be administered immediately. ||| La solution reconstituée doit être ensuite diluée.
0.04172346740961075 ||| Porcine circovirus type 2 (PCV2) is known to cause a wide variety of clinical signs and syndromes in pigs, some of which may be caused by PCV2 in combination with other agents. ||| Porcine circovirus type 2 (PCV2), is known to infect, and cause a wide variety of clinical signs and syndromes in pigs, some of which may be caused by PCV2 in combination with other agents. ||| Le circovirus porcin de type 2 (PCV2) est connu pour provoquer toute une variété de signes cliniques et de syndromes chez les porcins, dont certains peuvent être dus au PCV2 associé à d’ autres agents.
0.6254525184631348 ||| → Contact your doctor before taking Volibris. ||| Tell your doctor before your MabThera treatment ||| → Parlez -en à votre médecin avant de prendre Volibris.
0.08637060970067978 ||| Somatropin and analogues; ATC code: ||| Somatropin and analogues, ATC Code: ||| Somatropine et analogues; code ATC:
0.7624560594558716 ||| Freestanding towel racks ||| Laying floor tile ||| Porte-serviettes de bain
0.5785434246063232 ||| Investigations abnormal liver function tests ||| Elevation of liver function values ||| Anomalies des tests fonctionnels hépatiques
0.23285718262195587 ||| Clear and colourless aqueous solution. ||| Aqueous, clear and colourless solution. ||| Solution aqueuse, limpide et incolore.
0.34054118394851685 ||| General disorders and administration site conditions Very common: fatigue. ||| General disorders and administration site conditions Common: asthenia. ||| Troubles généraux et anomalies au site d’ administration Très fréquent: fatigue.
0.28931206464767456 ||| The Netherlands notified to the Commission under the Temporary Framework a guarantee scheme for working capital and investment loans granted by banks, to help Dutch companies meet their liquidity needs in the context of the coronavirus outbreak. ||| Under the scheme approved today, the Polish authorities will be able to grant aid to support Polish companies affected by the coronavirus outbreak by providing liquidity support in the form of guarantees on loans and subsidised interest rates for loans. ||| Les Pays-Bas ont notifié à la Commission, au titre de l' encadrement temporaire , un régime de garantie des crédits de fonds de roulement et des crédits d'investissement accordés par les banques, afin d'aider les entreprises néerlandaises à couvrir leurs besoins de liquidités dans le contexte de la flambée de coronavirus.
0.5574103593826294 ||| Diuretic pharmaceutical preparations ||| Radiopharmaceutical precursor, solution. ||| Préparations pharmaceutiques diurétiques
0.13213315606117249 ||| The clinical results obtained so far do not indicate any interaction of Nespo with other substances. ||| The clinical results obtained so far do not indicate any interaction of NeoRecormon with other medicinal products. ||| s u Les résultats cliniques disponibles à ce jour n’ ont pas mis en évidence d’ interaction entre Nespo et d’ autres substances.
0.5388474464416504 ||| Most patients had relief of symptoms after stopping treatment. ||| All patients recovered fully with supportive care. ||| Chez la plupart des patients, les symptômes disparaissaient à l’ arrêt du traitement.
0.4354850947856903 ||| All these findings were noted at doses which were 2-10 times higher than the human dose of 100 mg/ day. ||| However, at 4 weeks, the efficacy of the 15 mg dose was less than for the comparator at 8 weeks. ||| Ces données ont toutes été observées pour des doses 2 à 10 fois supérieures à la dose thérapeutique de 100 mg/ jour.
0.5037065744400024 ||| The EDGE II study included 4086 RA patients treated with etoricoxib 90 mg daily or diclofenac 150 mg daily for a mean period of 19.2 months (maximum 33.1 months, median 24 months). ||| Study I at 24 weeks, Study II at 26 weeks, and Study III at 24 and 52 weeks b 40 mg Trudexa administered every other week c MTX = methotrexate no ||| L'étude EDGE II a inclus 4 086 patients atteints de PR traités par l'étoricoxib 90 mg/ jour ou par le diclofénac 150 mg/ jour pendant une période moyenne de 19,2 mois (maximum 33,1 mois, médiane 24 mois).
0.11570172756910324 ||| Pharmaceutical preparations for the treatment of kidney disorders ||| Pharmaceutical preparations for the treatment of autoimmune disorders ||| Produits pharmaceutiques pour le traitement des troubles rénaux
0.017508868128061295 ||| 25 PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON, TEXT FOR SONATA 5 MG – PACK SIZES 7, 10 AND 14 CAPSULES ||| 28 PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON, TEXT FOR ZERENE 10 MG – PACK SIZES 7, 10 AND 14 CAPSULES ||| 26 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR DE SONATA 5 MG GELULES – CONDITIONNEMENTS DE 7, 10 ET 14 GELULES
0.4550102949142456 ||| If you have missed several doses, please inform your doctor and follow the advice given to you. ||| Take your tablets around the same time every day and follow any dietary advice that your doctor has given you. ||| Si vous avez oublié de prendre plusieurs gélules, consultez votre médecin et suivez ses conseils.
0.36029547452926636 ||| The time taken to fall asleep was reduced in adults taking Zerene 10 mg, and the effects were maintained for up to four weeks. ||| After the end of the operation, sufficient pain control was seen up to 24 hours in dogs and up to 22 hours in cats. ||| Le temps d’ endormissement a diminué chez les adultes ayant pris Zerene 10 mg et les effets se sont maintenus jusqu‘ à quatre semaines.
0.2914963960647583 ||| In the event that severe, uncontrolled infections occur, it may be necessary to interrupt leflunomide treatment and administer a washout procedure as described below. ||| Nevertheless, patients must be informed of this phenomenon and advised to exercise caution while driving or operating machines during treatment with ropinirole. ||| En cas de survenue d'une infection sévère non contrôlée, il pourrait s'avérer nécessaire d’ interrompre le traitement par le léflunomide et d'accélérer son élimination par la procédure de washout, décrite ci-dessous.
0.37028008699417114 ||| • Equidae ||| • Actelion ||| Equidae
0.0868760272860527 ||| EU/ 1/ 99/ 110/ 003 - bottle EU/ 1/ 99/ 110/ 004 - blister ||| EU/ 1/ 99/ 111/ 008 – bottle EU/ 1/ 99/ 111/ 009 – blister ||| EU/ 1/ 99/ 110/ 003 - flacon EU/ 1/ 99/ 110/ 004 - plaquette thermoformée
0.019466601312160492 ||| Krka, Tovarna Zdravil, D. D., Š marješ ka Cesta 6 Si-8501 Novo Mesto ||| Krka, Tovarna Zdravil, D. D., Š marješ ka Cesta 6 Si-8501 Novo Mesto Slovenia ||| Krka, Tovarna Zdravil, D. D., Š marješ ka Cesta 6 Si-8501 Novo Mesto Slovénie
0.7818077802658081 ||| Women on Exelon should not breast-feed. ||| - Women who are breast-feed ing. ||| Les femmes sous Exelon ne doivent pas allaiter.
0.48505616188049316 ||| 22 Distribution Based on a population pharmacokinetic analysis of 491 subjects receiving Avastin weekly, every 2 weeks, or every 3 weeks, in doses ranging from 1 to 20 mg/ kg, the volume of the central compartment (Vc) was 2.92 l. ||| Figures from China Customs show that some 2.46 billion pieces of epidemic prevention and control materials had been imported between 24 January and 29 February, including 2.02 billion masks and 25.38 million items of protective clothing valued at 8.2 billion yuan ($1 billion). ||| Distribution Lors d'une étude de pharmacocinétique de population réalisée chez 491 sujets recevant Avastin toutes les semaines, toutes les 2 semaines ou toutes les 3 semaines à des doses comprises entre 1 et 20 mg/ kg, le volume du compartiment central (Vc) a été de 2,92 litres.
0.381875216960907 ||| - Changes in blood clotting, reduction in all blood cell counts ||| - changes in blood chemistry, changes in white blood cells; ||| - Anomalies de la coagulation, diminution du nombre de toutes les cellules sanguines
0.48764321208000183 ||| Population pharmacokinetic studies have evaluated the pharmacokinetics of dabigatran in patients of 48 to 120 kg body weight. ||| Approximately linear pharmacokinetics is observed at steady state in the population pharmacokinetic studies. ||| Des études pharmacocinétiques de population ont évalué les paramètres pharmacocinétiques du dabigatran chez des patients pesant de 48 à 120 kg.
0.42549747228622437 ||| The coronavirus outbreak shows the critical importance of sound occupational safety and health measures and conditions in all sectors of activity. ||| The hierarchy of hazard controls is a framework widely used in occupational safety and health to group hazard controls by effectiveness. ||| La pandémie à coronavirus montre qu'il est essentiel que tous les secteurs d'activité soient dotés de mesures et conditions de sécurité et de santé au travail sérieuses.
0.01365563552826643 ||| Anticholinergic activity While olanzapine demonstrated anticholinergic activity in vitro, experience during the clinical trials revealed a low incidence of related events. ||| Anticholinergic activity While olanzapine demonstrated anticholinergic activity in vitro, experience during oral clinical trials revealed a low incidence of related events. ||| Activité anticholinergiqueBien que l’ olanzapine ait montré une activité anticholinergique in vitro, l’ incidence des effets liés à cette activité a été faible au cours des essais cliniques.
0.5346089601516724 ||| Credit agency services ||| Car sharing services ||| Services d'agence de crédit
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| 53 Si vous ressentez un des effets mentionnés comme grave ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.019424978643655777 ||| Each 0.4 ml pre-filled syringe contains 40 micrograms darbepoetin alfa (100 micrograms/ ml). ||| Each 0.5 ml pre-filled syringe contains 50 micrograms darbepoetin alfa (100 micrograms/ ml). ||| ris Chaque seringue préremplie de 0,4 ml contient 40 microgrammes de darbepoetin alfa (40 microgrammes/ ml).
0.20711106061935425 ||| Hepsera should not be used in people who may be hypersensitive (allergic) to adefovir dipivoxil or any of the other ingredients. ||| Tell your doctor at once if you could be allergic (hypersensitive) to adefovir, adefovir dipivoxil or any of the other ingredients of Hepsera. ||| Hepsera ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) à l’ adéfovir dipivoxil ou à l’ un des autres composants.
0.44045138359069824 ||| Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. ||| Do not stop taking this medicine, even if you are feeling well (unless your doctor tells you to do so). ||| Ne pas manipuler ce produit si vous avez une sensibilité connue ou si l'on vous a recommandé de ne pas travailler avec ce type de préparation.
0.3889411687850952 ||| 3 HOW TO TAKE DOXAZOSIN RETARD ARROW 4 MG PROLONGED RELEASE TABLETS AND ASSOCIATED NAMES ||| DOSAGE ADJUSTMENTS FOR CAELYX + BORTEZOMIB COMBINATION THERAPY - PATIENTS WITH MULTIPLE MYELOMA ||| COMMENT PRENDRE LA DOXAZOSINE RETARD ARROW 4 MG EN COMPRIMES A LIBERATION PROLONGEE ET DENOMINATIONS ASSOCIEES?
3.0820509447533617e-13 ||| As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/ or tongue have been reported in patients taking irbesartan. ||| As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/ or tongue have been reported in patients taking irbesartan. ||| Comme avec des médicament similaires, des rares cas d’ allergie cutanée (éruption, urticaire), ainsi que des gonflements localisés de la face, des lèvres et/ ou de la langue ont été rapportés chez des patients prenant de l’ irbesartan.
0.5399928689002991 ||| Aluminium hydrate ||| Polyester filament ||| Hydrate d'alumine
0.09847737848758698 ||| Chemical substances for use as additives to industrial lubricating greases ||| Chemical substances for use as additives to industrial lubricating oils ||| Substances chimiques utilisées comme additifs pour graisses de lubrification industrielles
0.0 ||| 42 10. ||| 42 10. ||| 45 10.
0.18221604824066162 ||| There is insufficient experience of the use of oral or intravenous topotecan in patients with severely impaired renal function (creatinine clearance < 20 ml/ min). ||| On the basis of pharmacokinetics, no dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 30-80 ml/ min.). ||| Il n'existe pas de données suffisantes sur l'utilisation du topotécan oral et intraveineux chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 20 ml/ min).
0.42706140875816345 ||| To help limit the transmission of the virus in Europe and beyond, the EU has closed its external borders to non-essential travel, while ensuring essential goods keep moving across the EU through the introduction of green lanes. ||| Georgia warns its citizens visiting Italy, in particular northern parts of the country, to avoid public places and regularly wash their hands as Italy becomes the newest centre of the epidemy. ||| Afin de limiter la propagation du virus en Europe et dans d'autres parties du monde, l'Union européenne a fermé ses frontières extérieures aux voyages non essentiels, tout en garantissant la circulation des biens de première nécessité sur le marché intérieur.
0.1502307951450348 ||| Lietuva GlaxoSmithKline Lietuva UAB Tel: + 370 5 264 90 00 info.lt@gsk.com ||| GlaxoSmithKline Oy Puh/Tel: + 358 10 30 30 30 Finland.tuoteinfo@gsk.com ||| Lietuva GlaxoSmithKline Lietuva UAB Tel: + 370 5 264 90 00 info. lt@gsk. com
0.04673269763588905 ||| Snack foods consisting principally of pasta ||| Snack foods consisting principally of bread ||| En-cas principalement à base de pâtes alimentaires
0.12851563096046448 ||| The patient should take 30 drops (15 mg) per day for 7 days. ||| The patient should take 40 drops (20 mg) once a day. ||| Le patient doit prendre 30 gouttes (15 mg) par jour pendant 7 jours.
0.739728569984436 ||| Adverse drug reactions ||| Uncommon side effects ||| Affections hépatobiliaires
0.32198941707611084 ||| Occurrence of lactic acidosis (in the absence of hypoxaemia) sometimes fatal, and usually associated with severe hepatomegaly with steatosis have been reported with the use of nucleoside/ nucleotide analogues. ||| Treatment of acute otitis externa, and acute exacerbation of recurrent otitis externa associated with bacteria susceptible to gentamicin and fungi susceptible to miconazole in particular Malassezia pachydermatis. ||| Des cas d’ acidose lactique (en l’ absence d’ hypoxémie), parfois fatals, généralement associés à une hépatomégalie importante et à une stéatose hépatique, ont été rapportés en cas de traitement par des analogues nucléosidiques/ nucléotidiques.
0.005044777877628803 ||| IntronA 30 million IU solution for injection, multidose pen Interferon alfa-2b ||| IntronA 18 million IU solution for injection, multidose pen Interferon alfa-2b ||| IntronA 30 millions d’UI solution injectable, stylo multidose Interféron alfa-2b
0.5664108395576477 ||| Alloys of nickel ||| Trestle columns of metal ||| Alliages de nickel
0.4369943141937256 ||| Shake the reconstituted vaccine solution before use. ||| Inspect the reconstituted product visually before use. ||| Agiter la solution vaccinale reconstituée avant emploi.
0.24640865623950958 ||| Concomitant treatment with inhibitors of the hepatic CYP 3A4 may result in a decrease of terfenadine metabolism. ||| In vitro studies indicate that lacosamide may be a weak inhibitor and inducer of CYP3A4. ||| Un traitement concomitant par des inhibiteurs du CYP 3A4 hépatique peut se traduire par une diminution du métabolisme de la terfénadine.
0.25832194089889526 ||| 82 Psychiatric disorders Common: ||| 113 Psychiatric disorders common ||| Affections psychiatriques Fréquent:
0.15862399339675903 ||| Loperamide was administered to 13% of patients in 5% of courses. ||| Erythropoietin was administered to 10% of patients in 8% of courses. ||| Le lopéramide a été administré à 13% des patients dans 5% des cures.
0.369711309671402 ||| Currently there is only evidence of the efficacy of the vaccine against challenge with B. canis. ||| No case of vaccine induced rabies was reported, confirming the safety of the vaccine in the field. ||| Actuellement, seule l’ efficacité du vaccin contre B. canis est démontrée, par épreuve virulente.
0.25776368379592896 ||| Myfenax is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. ||| Treatment of infections or prophylaxis of infections in neutropenic patients Ciprofloxacin should be co-administered with appropriate antibacterial agent(s) in accordance to official guidance. ||| Myfenax est indiqué en association à la ciclosporine et aux corticoïdes pour la prévention des rejets aigüs d’ organe chez les patients ayant bénéficiés d’ une allogreffe rénale, cardiaque ou hépatique.
0.3980180323123932 ||| If you experience prolonged bleeding when taking Clopidogrel BMS If you cut or injure yourself, it may take longer than usual for bleeding to stop. ||| If you’ re taking Lamictal for epilepsy The seizures in some types of epilepsy may occasionally become worse or happen more often while you’ re taking Lamictal. ||| En cas de survenue d'un saignement prolongé sous Clopidogrel BMS Si vous vous coupez ou si vous vous blessez, l’arrêt du saignement peut demander plus de temps que d’habitude.
0.7580407857894897 ||| • Cyton Biosciences ||| s Biotechnology ||| Cyton Biosciences
0.17743271589279175 ||| Trudexa 40 mg solution for injection in pre-fill ed syringe with needleguard Adalimumab ||| Humira 40 mg solution for injection in pre-filled syringe Adalimumab ||| Trudexa 40 mg, solution injectable en seringue préremplie avec protège aiguille Adalimumab
0.5239545106887817 ||| Ambirix should not be given: ||| • Velmetia should be taken: ||| Ambirix ne doit pas être administré:
0.3661499619483948 ||| Through Week 240 in nucleoside-naive studies, genotypic evidence of ETVr substitutions at rtT184, rtS202, or rtM250 was identified in 3 patients treated with entecavir, 2 of whom experienced virologic breakthrough (see table). ||| In study FVF2598g (MARINA), patients with minimally classic or occult with no classic choroidal neovascularisation (CNV) received monthly intravitreal injections of Lucentis 0.3 mg or 0.5 mg or sham injections. ||| Lors de l’ analyse jusqu’ à 240 semaines dans les études conduites chez les patients naïfs de nucléosides, la présence de substitutions génotypiques de résistance à l'entecavir au niveau des codons T184, S202 ou M250 a été observée chez 3 patients traités par entecavir, 2 d’ entre eux ayant présenté un rebond virologique (voir tableau).
0.3292137384414673 ||| Ladders, not of metal, for libraries ||| Emblems, not of metal, for vehicles ||| Échelles non métalliques pour bibliothèques
0.07842162251472473 ||| Do not mix with any other vaccine or immunological product. ||| Do not mix with any other vaccine/ immunological product. ||| Ne pas mélanger avec d’ autres vaccins ou produits immunologiques.
0.10016069561243057 ||| 28 Special populations ||| 25 Special populations ||| Populations spéciales
0.37121838331222534 ||| Combination therapy with Ribavirin and interferon alfa-2b resulted in a sustained virological response that was ten-fold higher than that with interferon alfa-2b alone (49% vs 5%, p < 0.0001). ||| Discontinuation of therapy as a result of undesirable effects was mainly due to nausea (1% placebo; 5% cinacalcet) and vomiting (< 1% placebo; 4% cinacalcet). ||| Le traitement combiné ribavirine + interféron alfa-2b s’ est traduit par une réponse virologique prolongée dix fois supérieure à celle de l’ interféron alfa-2b seul (49% vs 5%, p < 0,0001).
0.19274672865867615 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €5 billion French loan guarantee will help the Renault group to obtain liquidity that it urgently needs due to the impact of the coronavirus outbreak. ||| Executive Vice President Margrethe Vestager, in charge of competition policy, said: "A few days ago, the German government announced its plans to provide liquidity to the German economy to manage the effects of the economic impact of the Coronavirus outbreak. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Cette garantie sur les prêts d'un montant de 5 milliards d'EUR accordée par la France permettra au groupe Renault d'obtenir les liquidités dont il a absolument besoin en raison de l'incidence de la pandémie de coronavirus.
0.31871095299720764 ||| Penem and carbapenem antibacterial agents may decrease the serum levels of valproic acid. ||| Rifampicin and rifapentine are expected to decrease plasma concentrations of etravirine. ||| Les antibiotiques pénèmes et carbapénèmes peuvent diminuer les taux plasmatiques de l’ acide valproïque.
0.3814470171928406 ||| Marketing authorisation holder Omnipharm Ltd The Spire Egypt Road Nottingham NG7 7GD UK ||| Eli Lilly and Company Ltd Speke Operations Fleming Road Liverpool L24 9LN UK ||| Omnipharm Ltd The Spire Egypt Road Nottingham NG7 7GD Royaume-Uni
0.3470818102359772 ||| Steady-state plasma levels are reached after continuous administration for 7– 8 days. ||| Maximum serum concentration is reached between 6 and 8 hours after administration. ||| Les concentrations plasmatiques à l'état d'équilibre sont atteintes après 7 à 8 jours d'administration continue.
0.43391335010528564 ||| Slowly pull out the plunger to the graduation which marks the dose you need. ||| H Turn the dose selector to select the number of units you need to inject. ||| Tirer lentement le piston jusqu'à la graduation de la dose dont vous avez besoin.
0.36326420307159424 ||| If hypotension occurs with Copalia, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. ||| In haemodialysed patients, a bolus injection may be given during the dialysis session through a suitable venous port in the dialysis line. ||| En cas de survenue d’ une hypotension avec Copalia, placer le patient en position couchée et perfuser au besoin du sérum physiologique en intraveineux.
0.23635774850845337 ||| Mugs, not of precious metal ||| Coffee services, not of precious metal ||| Mugs non en métaux précieux
0.008658768609166145 ||| During the first 21-day chemotherapy cycle, patients treated with either Biograstim or Neupogen had severe neutropenia for an average of 1.1 days, compared with 3.8 days in those receiving placebo. ||| During the first 21-day chemotherapy cycle, patients treated with either Tevagrastim or Neupogen had severe neutropenia for an average of 1.1 days, compared with 3.8 days in those receiving placebo. ||| Au cours du premier cycle de chimiothérapie (21 jours), les patients traités avec Biograstim ou Neupogen ont présenté une neutropénie sévère de 1,1 jour en moyenne, contre 3,8 jours chez ceux recevant un placebo.
0.5069891214370728 ||| Based on the ground for referrals and the CPMP questions, the applicant proposed a Pregnancy Prevention Programme and an updated summary of product characteristics. ||| On the basis of the grounds for referral, the following questions were forwarded to the Marketing Authorisation Holders: ||| Sur la base des motifs de saisine et des questions du CSP, le demandeur a proposé un programme de prévention de la grossesse et un résumé des caractéristiques du produit mis à jour.
0.4384450316429138 ||| A 25% dose reduction may be warranted in patients experiencing significant toxicities (see below). ||| Due to the potential increases in exposure (AUC) in some patients, close monitoring is required. ||| Une réduction de dose de 25% peut être légitime chez les patients souffrant de toxicités importantes (voir ci- dessous).
0.33129748702049255 ||| Data from this study demonstrated a significant advantage for intravenous Bondronat 6 mg over placebo in the reduction in SREs measured by the time-adjusted SMPR (p=0.004). ||| The release characteristics of INVEGA result in minimal peak-trough fluctuations as compared to those observed with immediate-release risperidone (fluctuation index 38% versus 125%). ||| Les données de cette étude ont mis en évidence un avantage significatif de Bondronat 6 mg par voie intraveineuse par rapport au placebo en termes de réduction des SRE, mesurée d’ après le SMPR ajusté en fonction du temps (p = 0,004).
0.07885032892227173 ||| • The other ingredients are croscarmellose sodium, glycerol triacetate (E1518), hypromellose (E464), indigo carmine aluminium lake (E132), lactose monohydrate, magnesium stearate (E572), microcrystalline cellulose (E460), pregelatinised starch (gluten free) and titanium dioxide (E171). ||| The other ingredients are microcrystalline cellulose (E460), lactose anhydrous, medium chain triglycerides, gelatin, croscarmellose sodium, sucrose, colloidal silicon dioxide, magnesium stearate (E572) butylated hydroxytoluene (E321), modified starch (maize), and sodium aluminium silicate (E554). ||| l’hypromellose (E464), la laque aluminique d’indigotine (E132), le lactose monohydraté, le stéarate de magnésium (E572), la cellulose microcristalline (E460), l’amidon prégélatinisé sans gluten, le dioxyde de titane (E171).
0.0 ||| Name and address of the manufacturers of the biological active substance ||| Name and address of the manufacturers of the biological active substance ||| Nom et adresse des fabricants de la substance active d’ origine biologique
4.641135566141319e-13 ||| Patients with chronic renal failure are predisposed to developing metabolic acidosis. ||| Patients with chronic renal failure are predisposed to developing metabolic acidosis. ||| 9 L'insuffisance rénale chronique est un facteur de prédisposition à l’ acidose métabolique.
0.2594207227230072 ||| All patients administered Remicade are to be observed for at least 1-2 hours post infusion for acute infusion-related reactions. ||| Patients had received at least six months of non-operative treatment prior to treatment with InductOs for anterior lumbar spine fusion. ||| Tous les patients recevant Remicade doivent être maintenus en observation pendant au moins 1-2 heures après la perfusion en raison du risque de réactions aiguës liées à la perfusion.
0.46051540970802307 |||  Cardiac disorders: |||  Infections/ surgery: ||| Troubles cardiaques:
0.23306694626808167 ||| Foundry molds [moulds] of metal ||| Foundry molds [moulds], not of metal ||| Moules pour la fonderie métalliques
0.4598507583141327 ||| Chemical additives for drilling fluids ||| Dietary supplements for controlling cholesterol ||| Additifs chimiques pour fluides de forage
0.574526309967041 ||| Amfenac was the major metabolite in plasma, representing approximately 13% of total plasma radioactivity. ||| human normal immunoglobulin, of which at least 97% is IgG. ||| L’ amfénac était le métabolite plasmatique principal, représentant environ 13% de la radioactivité plasmatique totale.
0.002905596047639847 ||| 180 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| 90 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| Si vous remarquez des effets indésirables non mentionnés dans cette notice, ou si vous ressentez un des effets mentionnés comme étant sérieux, veuillez en informer votre médecin ou votre pharmacien.
0.4847296476364136 ||| Gently invert or lightly massage the infusion bag to mix the diluted solution. ||| Gently invert the infusion bag to obtain a homogeneous solution. ||| Retourner doucement ou masser légèrement la poche de perfusion pour mélanger la solution diluée.
0.4224337339401245 ||| How Arixtra is given • Arixtra is given by injection under the skin (subcutaneously) into a skin fold of the lower abdominal area. ||| How ADVATE is given ADVATE is usually injected into a vein (intravenously) by your doctor or nurse. ||| Comment Arixtra est administré • Arixtra est administré par injection sous la peau (sous-cutanée), dans un pli cutané réalisé dans la partie inférieure de l’abdomen.
0.2848009467124939 ||| If you forget to take Neoclarityn oral lyophilisate If you forget to take your dose on time, take it as soon as possible, then go back to your regular dosing schedule. ||| If you stop using Fentanyl-ratiopharm If you wish to interrupt or stop the treatment, you should always talk to your doctor about the reasons for discontinuation and your continued treatment. ||| Si vous oubliez de prendre Neoclarityn lyophilisat oral Si vous oubliez de prendre votre dose à temps, prenez -la dès que possible, puis continuez votre traitement normalement.
0.42148932814598083 ||| There have been reports of sometimes fatal opportunistic infections in patients receiving nelarabine therapy. ||| 31 During or after you are treated with rituximab severe infusion reactions may occur. ||| Des cas d'infections opportunistes, parfois fatales, ont été rapportés chez des patients traités par nélarabine.
0.25698351860046387 ||| Data from a randomised, controlled phase III study (CAIRO) support the use of Xeloda at a starting dose of 1000 mg/ m2 for 2 weeks every 3 weeks in combination with irinotecan for the first-line treatment of patients with metastatic colorectal cancer. ||| Data from a randomised multicentre, phase III study comparing capecitabine to 5-FU and oxaliplatin to cisplatin in patients with advanced gastric cancer supports the use of Xeloda for the first-line treatment of advanced gastric cancer (REAL-2). ||| Les données d’ une étude clinique de phase III (CAIRO) randomisée et contrôlée supportent l’ utilisation de Xeloda à la dose initiale de 1000 mg/ m² pendant deux semaines toutes les trois semaines en association à l’ irinotécan dans le traitement de première ligne de patients atteints de cancer colorectal métastatique.
0.6799856424331665 ||| Theodolites ||| DOSIMETRY ||| Théodolites
0.3387477993965149 ||| Complementing national efforts, the EU budget is uniquely placed to power a fair socio-economic recovery, repair and revitalise the Single Market, to guarantee a level playing field, and support the urgent investments, in particular in the green and digital transitions, which hold the key to Europe's future prosperity and resilience. ||| By increasing trade and deepening economic integration, investing in SMEs, connectivity, embracing the opportunities from the twin ecological and digital transformation and in people, the aim is to create an attractive business environment that brings decent, sustainable jobs and economic opportunities ensuring prosperity for everyone. ||| En complément des efforts nationaux, le budget de l'Union se trouve dans une position sans équivalent pour assurer une reprise socio-économique juste, pour réparer et revitaliser le marché unique, pour garantir des conditions de concurrence équitables et pour soutenir les investissements urgents, en particulier dans les transitions écologique et numérique, qui détiennent les clés de la prospérité et de la résilience de l'Europe à l'avenir.
0.4328935742378235 ||| Your doctor may adjust your dose of Avamys. ||| You should show the doctor your pack of Efient. ||| Votre médecin peut être amené à ajuster votre dose d’ Avamys.
0.32616013288497925 ||| A total of 11 of 31 (36%) patients in the weekly treatment group versus 5 of 31 (16%) patients in the placebo group had an increase in FEV1 of at least 200 cc at or before the end of the study, indicating a dose-related improvement in airway obstruction. ||| However, based on interim data from a long-term follow-up study, 12 (14%) of 84 children had a > 15 percentile decrease in rate of linear growth, of whom 5 (6%) children had a > 30 percentile decrease despite being off treatment for more than 1 year. ||| Un total de 11 patients sur les 31 patients (36%) appartenant au groupe sous traitement hebdomadaire contre 5 patients sur les 31 patients (16%) appartenant au groupe sous placebo ont montré une augmentation du FEV1 d’ au moins 200 cc avant ou au terme de l’ étude.
0.15384523570537567 ||| Shaped strips of rubber for use in the manufacture of doors ||| Substrates of rubber for use in the manufacture of printed circuits ||| Bandes profilées en caoutchouc destinées à la fabrication de portes
0.3853995203971863 ||| It is also very important that you call your doctor if you think you may have an infection. ||| For this reason, it is very important that you inform your doctor about any changes in your health. ||| Il est aussi très important que vous appeliez votre docteur si vous pensez avoir une infection.
0.3663635551929474 ||| If you forget to use Protopy If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue as before. ||| Remember to check with your doctor first if you have not exercised before. • Continue to be active while taking alli and after you stop taking it. ||| pl Si vous oubliez d’utiliser Protopy Si vous avez oublié d'appliquer la pommade à l'heure habituelle, faites-le dès que vous vous rendez st compte de votre oubli, puis continuez comme avant. 'e
0.4185853600502014 ||| Semi-refractory bricks, not of metal ||| Cylindrical cans, not of metal ||| Briques semi-réfractaires non métalliques
0.5195503234863281 ||| The vaccine can be given without regard to food, liquid, or breast milk. ||| This may include the administration of adrenaline and/ or the maintenance of a patent airway. ||| Le vaccin peut être donné sans restriction vis-à-vis de la nourriture, des liquides, ou du lait maternel.
0.03294674679636955 ||| Pack size of 4 cartridges. ||| Pack size of 2 cartridges. ||| Coffret de 4 cartouches.
0.3772071897983551 ||| The schemes aim at providing businesses which are particularly affected by the coronavirus outbreak with sufficient liquidity to cover their immediate working capital and investment needs, thus enabling them to continue their activities, start investments and maintain employment. ||| Short-time work schemes are programmes that under certain circumstances allow firms experiencing economic difficulties to temporarily reduce the hours worked by their employees, which are provided with public income support for the hours not worked. ||| Les régimes ont pour but de fournir aux entreprises qui sont particulièrement touchées par la pandémie de coronavirus des liquidités suffisantes pour couvrir leurs besoins immédiats en fonds de roulement et en investissements, leur permettant ainsi de poursuivre leurs activités, d'investir et de maintenir l'emploi.
0.431069016456604 ||| This means that it helps to prevent blood clots from forming. ||| Lucentis can help to improve the damaged vision or stop it from getting worse. ||| Cela signifie qu’ il contribue à prévenir la formation de caillots sanguins.
0.16033001244068146 ||| Therefore, the Committee decided that the benefits of Eucreas are greater than its risks for the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets. ||| Eucreas is indicated in the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets. ||| Par conséquent, le comité a établi que les bénéfices d'Eucreas sont supérieurs à ses risques pour le traitement des patients diabétiques de type 2 qui n'ont pas la capacité de contrôler suffisamment leur glycémie à leur dose maximale tolérée de metformine orale seule ou qui sont déjà traités au moyen de la combinaison de vildagliptine et de metformine en comprimés distincts.
0.2470882385969162 ||| Route of Administration Oral use Oral use Oral use Oral use Oral use Oral use ||| Route of administration Oral use Oral use Oral use Oral use ||| Voie d’ administration Voie orale Voie orale Voie orale Voie orale Voie orale Voie orale
0.15353329479694366 ||| Gently move the vial in circles a few times, to dissolve the powder (see Diagram 6). |||  With the syringe still attached, gently move the vial in circles a few times, to dissolve the powder (see Diagram 9). ||| Faites tourner doucement le flacon pendant quelques secondes afin de dissoudre la poudre (voir Schéma 6).
0.30176910758018494 ||| In a clinical study conducted with the current formulation, the incidence of pain, redness, swelling, fatigue, gastro-enteritis, headache and fever was comparable to the incidence observed with the former thiomersal and preservative containing vaccine formulation. ||| 5 In a prospective comparative study, which compared the administration of the combined DTPw-HBV vaccine with the simultaneous separate administration of DTPw and HBV vaccine, higher incidences of pain, redness, swelling and fever were reported in the group receiving the combined vaccine. ||| Dans une étude clinique conduite avec la formulation actuelle du vaccin, l’ incidence de la douleur, érythème, gonflement, fatigue, gastro-entérite, maux de tête et fièvre était comparable à celle observée avec l’ ancienne formulation du vaccin contenant du thiomersal et un conservateur.
0.27423912286758423 ||| When driving vehicles or operating machines, it should be taken into account that dizziness or weariness may occur during treatment. ||| Patients must therefore be warned that transient dizzines may occur, in which case they should not drive or use machines. ||| Lors de la conduite de véhicules ou l’ utilisation de machines, il devra être pris en compte que des vertiges ou de la fatigue peuvent survenir lors du traitement.
0.5775541663169861 ||| 2%), respectively, and mean increases in HDL-C were 13 and 16% (placebo: ||| 340 meters) and in the placebo group the mean was 315 meters (median value: ||| 2%), et les réductions moyennes du HDL-cholestérol ont été respectivement de 1 3 et de 16% (placebo:
0.3360111713409424 ||| In patients with chronic hepatitis B there was no observed difference in incidence of these events between placebo and lamivudine treated patients. ||| No significant differences were found in the psychomotor test results between desloratadine and placebo groups, whether administered alone or with alcohol. ||| L’ incidence de ces troubles chez les patients traités pour une hépatite B chronique, était similaire dans les groupes lamivudine et placebo.
0.5427497029304504 ||| EU/ 2/ 99/ 013/ 001-002 ||| l EMEA/ H/ C/ 000482/ II/ 0030/ ||| EU/ 2/ 99/ 013/ 001-002.
0.5630733966827393 ||| Lymphoedema ||| Pimecrolimus ||| Lymphoedème
0.4085112512111664 ||| The recommended dose of Telzir for adults and children weighing more than 39 kg is 700 mg twice a day. ||| Children weighing 14 to 21 kg: one-half of a Ziagen tablet twice daily. ||| La dose recommandée de Telzir pour les adultes et les enfants de moins de 39 kg est de 700 mg deux fois par jour.
0.24232512712478638 ||| Daronrix, suspension for injection in pre-filled syringe Pandemic influenza vaccine (whole virion, inactivated, adjuvanted) ||| CELVAPAN suspension for injection Pandemic influenza vaccine (whole virion, Vero cell derived, inactivated) ||| Daronrix, suspension injectable en seringue préremplie Vaccin grippal pandémique (virion entier, inactivé, avec adjuvant)
0.07003352046012878 ||| (ii) State guarantees for loans taken by companies from banks: Member States will be able to provide State guarantees to ensure banks keep providing loans to the customers who need them. ||| State guarantees for loans taken by companies from banks: Member States will be able to provide State guarantees to ensure banks keep providing loans to the customers who need them. ||| aides sous forme de garanties sur les prêts contractés par des entreprises auprès des banques: les États membres pourront fournir des garanties publiques pour faire en sorte que les banques continuent d'accorder des prêts aux clients qui en ont besoin.
0.17261981964111328 ||| 80 4.2 Posology and method of administration ||| 5.8 Posology and method of administration ||| 83 4.2 Posologie et mode d’administration
0.4294965863227844 ||| This causes a wide range of symptoms, particularly difficulty breathing and difficulty walking. ||| It can cause disability temporarily, such as difficulty walking. ||| Les symptômes sont très variés, notamment des difficultés respiratoires et des problèmes ambulatoires.
0.16629832983016968 ||| It must not be used in patients who are at risk of bleeding, who have certain heart problems, who have recently had a stroke, or whose pulmonary hypertension is caused by a blocked or narrow vein. ||| It must not be used in patients who have a condition that causes excessive bleeding, who have had a stroke or transient ischaemic attack (a temporary reduction in the blood supply to part of the brain), or with severe liver problems. ||| Il ne peut pas être utilisé chez les patients qui présentent un risque d’ hémorragie, qui ont un problème cardiaque, qui ont eu récemment un accident vasculaire ou dont l’ hypertension pulmonaire est due à l’ occlusion ou à la sténose d'une veine.
0.22597172856330872 ||| Your doctor will advise you on appropriate methods of contraception. ||| Your doctor will advise you about suitable contraception. ||| Votre médecin vous conseillera sur les moyens de contraception adaptés à votre cas.
0.2884005904197693 ||| Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels causing them to tighten. ||| Livensa is a transdermal patch which constantly releases small amounts of testosterone that is absorbed through your skin into the bloodstream. ||| L’ angiotensine-II est une substance formée par l’ organisme qui se lie aux récepteurs des vaisseaux sanguins, ce qui entraîne leur constriction.
0.3693544566631317 ||| A reduction in symptoms of pulmonary arterial hypertension was observed with Thelin treatment. ||| Dynastat was effective in relieving moderate to severe pain after an operation. ||| Une diminution des symptômes de l’ hypertension artérielle pulmonaire était observée chez les patients traités par Thelin.
0.14957857131958008 ||| Always use PREZISTA exactly as your doctor has told you. ||| Always use IONSYS exactly as your doctor has instructed you. ||| Respectez toujours la posologie de PREZISTA indiquée par votre médecin.
0.07185906171798706 ||| Saws [hand tools] ||| Squares [hand tools] ||| Scies [outils]
0.14302681386470795 ||| Viracept is an antiviral medicine. ||| Emtriva is an antiviral medicine. ||| Viracept est un médicament antiviral.
0.12086081504821777 ||| Onsenal is a medicine that contains the active substance celecoxib. ||| Sprycel is a medicine that contains the active substance dasatinib. ||| Onsenal est un médicament qui contient le principe actif célécoxib.
0.04217655211687088 ||| EU/ 1/ 01/ 172/ 003 ||| EU/ 1/ 01/ 184/ 006 ||| EU/ /1/ 01/ 172/ 003
0.31886303424835205 ||| 74 Dose reduction for patients who use 0.5 μg/kg PegIntron monotherapy must be accomplished by reducing the prescribed volume by one-half. ||| Patients on higher dosages of the used oral antipsychotic should be considered for the higher Risperdal Consta dose of 37.5 mg .” ||| Pour les patients recevant 0,5 μ g/ kg de PegIntron en monothérapie, la réduction de dose doit être effectuée en réduisant de moitié le volume prescrit.
0.4619750380516052 ||| Do not chew the tablet. ||| Do not push on the plunger. ||| Ne pas mâcher le comprimé.
0.04559721052646637 ||| Opaque blue and white capsule printed with white and blue inks, with "BMS 100 mg" on one half and with "3623" on the other half. ||| Hard capsule Opaque red and blue capsule printed with white ink, with "BMS 300 mg" on one half and with "3622" on the other half. ||| Gélule opaque bleu et blanc imprimée avec des encres blanc et bleu; avec « BMS 100 mg » d’ un côté et « 3623 » de l’ autre côté.
0.2614836096763611 ||| Common side effects (occurring in less than 1 out of 10 patients) are bleeding from the stomach or the intestines and bleeding from the nose, and eye irritation due to keratitis. ||| Other side effects that occured in more than one in a hundred people vaccinated in a trial were feeling or being sick, diarrhoea, muscle pains, fever and weakness. ||| Effets indésirables fréquents (apparaissant chez moins de 1 patient sur 10): saignements de l’estomac ou des intestins, et saignements de nez et irritation des yeux due à une kératite.
0.48678576946258545 ||| TC ||| ANC ||| CT
0.10467271506786346 ||| No studies on the effects on the ability to drive and use machine have been performed. ||| No studies on the effects on the ability to drive have been performed. ||| Aucune étude sur l’ aptitude à conduire des véhicules et à utiliser des machines n’ a été réalisée.
0.4430544376373291 ||| The nature of the syndrome may vary depending upon the mother’ s drug use history (see section 4.6). ||| The probability for sustained virological response varied depending upon the previous treatment regimen; see Table 13. ||| Les caractéristiques du syndrome peuvent varier en fonction des antécédents d’ utilisation des drogues par la mère (voir rubrique 4.6).
0.2730323374271393 ||| Metabolism of 17β-estradiol, occurs mainly in the liver and gut but also in target organs, and involves the formation of less active or inactive metabolites, including estrone, catecholestrogens and several oestrogen sulphates and glucuronides. ||| Mild alterations of blood cell counts (red and white cells, platelets), slight increase of some enzymes (transaminases, γ -GT, amylase) or bilirubin (a bile pigment produced in the liver by breakdown of red blood pigment) in the blood. ||| Le métabolisme du 17ß-estradiol s'effectue principalement dans le foie et l'intestin mais également dans les organes cibles et il implique la formation de métabolites moins actifs ou inactifs, en particulier l’ estrone, les catécholestrogènes et plusieurs sulfates et glycuronides d'estrogènes.
0.47986024618148804 ||| Resistance measuring instruments ||| Resistance testing apparatus ||| Instruments de mesure de la résistance
0.5222408175468445 ||| Five minutes after administration, the baseline values had been reached again. ||| The primary data analysis was conducted after all patients had reached week 52. ||| Un retour aux valeurs initiales est observé cinq minutes après l’ administration du produit.
0.46417003870010376 ||| - higher CD4 cell counts at start of Viramune therapy (women more than 250 cells/ mm³, men more ||| -Elderly subjects In subjects over 65 (median 75 years), the maximum plasma concentration and AUC of telithromycin no ||| - les patients présentant un taux élevé en cellules CD4 lors de l’ initiation du traitement par
0.2539152503013611 ||| Lapatinib inhibits CYP3A (Ki 0.6 to 2.3 µg/ ml) and CYP2C8 (0.3 µg/ ml) in vitro at clinically relevant concentrations. ||| Rosiglitazone showed moderate inhibition of CYP2C8 (IC50 18 µM) and low inhibition of CYP2C9 (IC50 50 µM) in vitro (see section 4.5). ||| In vitro, le lapatinib inhibe les cytochromes CYP3A (Ki = 0,6 à 2,3 µg/ ml) et le cytochrome CYP2C8 (Ki = 0,3 µg/ ml) à des concentrations cliniquement pertinentes.
0.2823282480239868 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. ||| If you are concerned that you may have been given too much ECALTA, tell your doctor or another healthcare professional immediately. ||| Si votre médecin vous à mis en garde au sujet d’une intolérance à certains sucres, veuillez le contacter avant la prise de ce médicament.
0.38458240032196045 ||| There is no specific treatment in the event of overdose. ||| There is no clinical experience with massive overdose. ||| Il n’existe pas de traitement spécifique en cas de surdosage.
0.14365804195404053 ||| 86 ||| 84 ||| 92
0.018999867141246796 ||| 13%; Grade III/ IV 4% vs. ||| 4%; Grade III/ IV 8% vs. ||| 13%; grade III/ IV 4% vs.
0.308858186006546 ||| Agenerase boosted with low-dose ritonavir has been compared with other protease inhibitors in 206 adults who had taken protease inhibitors in the past. ||| The pattern of amino acid substitutions in RT associated with resistance to efavirenz was independent of the other antiviral medications used in combination with efavirenz. ||| Agenerase renforcé par ritonavir à faible dose a été comparé d’ autres inhibiteurs de la protéase chez 206 adultes ayant reçu des inhibiteurs de la protéase au préalable.
0.2437838613986969 ||| Only use each pre-filled syringe for one injection. ||| Only use each syringe for one injection. ||| Une seringue préremplie ne peut servir que pour une seule injection.
0.0 ||| Disorders ||| Disorders ||| Dyspepsie
1.0245449542999268 ||| Special patient groups ||| European Community contribution ||| Groupes particuliers de patients
3.0030594981231284e-13 ||| High potassium levels, fainting (syncope), difficulty falling asleep, feeling of spinning (vertigo), low blood pressure (hypotension), shortness of breath, abdominal pain, diarrhoea, dry mouth, discomfort in the abdomen, bloating, increased sweating, itching, muscle pain (myalgia), kidney impairment including acute kidney failure, and pain in the chest. ||| High potassium levels, fainting (syncope), difficulty falling asleep, feeling of spinning (vertigo), low blood pressure (hypotension), shortness of breath, abdominal pain, diarrhoea, dry mouth, discomfort in the abdomen, bloating, increased sweating, itching, muscle pain (myalgia), kidney impairment including acute kidney failure, and pain in the chest. ||| Augmentation du taux de potassium dans le sang, malaises (syncopes), difficultés à s’ endormir, vertiges, pression artérielle basse (hypotension), essoufflement, douleurs abdominales, diarrhées, bouche sèche, troubles abdominaux, ballonements, augmentation de la transpiration, démangeaisons, douleurs musculaires (myalgies), insuffisance rénale dont insuffisance rénale aiguë, et douleurs dans la poitrine.
0.3080887496471405 ||| Advisory and consultancy services relating to the use of agricultural and horticultural fertilizers ||| Consultancy and advisory services relating to agriculture, horticulture and forestry ||| Services de conseils et d'assistance en matière d'utilisation de fertilisants agricoles et horticoles
0.2585425078868866 ||| Uncommon (less than 1 in 100 patients but more than 1 in 1,000 patients): difficulty in sleeping, changes in liver function tests and accidental falls. ||| Rare (less than 1 in 1,000 patients but more than 1 in 10,000 patients): convulsions, ulcer in the intestine and chest pain (probably caused by coronary spasm). ||| Peu fréquent (moins de 1 patient sur 100 mais plus de 1 patient sur 1 000): troubles du sommeil, modifications des tests de la fonction hépatique et chutes accidentelles.
0.2581254839897156 ||| Research in the field of ecology ||| Research in the field of welding ||| Recherches en matière d’écologie
0.7206652164459229 ||| Please follow the instructions provided with the Avostartclip. ||| Please state clearly address for return of results: ||| Veuillez lire les instructions fournies avec « l’Avostartclip ».
0.4625205397605896 ||| Efient inhibits the clumping of platelets and so reduces the chance of a blood clot forming. ||| When substance P attaches to these receptors, it causes nausea and vomiting. ||| Efient empêche l’ agrégation des plaquettes et réduit ainsi le risque de formation de caillots sanguins.
0.23750749230384827 ||| Very common Common ||| Very Common Common ||| Très fréquent Fréquent
0.03976845368742943 ||| Do not warm Aranesp in any other way (for example, do not warm it in a microwave or in hot water). ||| Do not warm Zarzio in any other way (for example, do not warm it in a microwave or in hot water). ||| Ne réchauffez pas Aranesp d’ une autre façon (par exemple, ne pas la mettre dans le four à micro-ondes ou dans l’ eau chaude).
0.2564923167228699 ||| The public support will take the form of direct grants, repayable advances and tax advantages. ||| The aid will take the form of direct grants or repayable advances. ||| Les aides publiques seront octroyées sous la forme de subventions directes, d'avances remboursables et d'avantages fiscaux.
0.4742320775985718 ||| The safety of immunization with live viral vaccines following MabThera therapy has not been studied. ||| • the production of Bovilis BVD vaccine is in compliance with GMP requirements ||| La tolérance d’ une immunisation par des vaccins viraux vivants faisant suite à un traitement par MabThera n’ a pas été étudiée.
0.43947523832321167 ||| Children weighing at least 30 kg: the adult dosage of 300 mg twice daily should be taken. ||| During pregnancy, the daily intake of calcium should not exceed 1500 mg. ||| Enfants pesant au moins 30 kg: la posologie de l'adulte, de 300 mg deux fois par jour, devra être administrée.
0.0466180257499218 ||| Insulin Human Winthrop Rapid cartridges are not designed to allow any other insulin to be mixed in the cartridge. ||| Insulin Human Winthrop Comb 50 cartridges are not designed to allow any other insulin to be mixed in the cartridge. ||| Les cartouches d’ Insulin Human Winthrop Rapid ne sont pas conçues pour permettre de mélanger une autre insuline dans la cartouche.
0.8430365324020386 ||| 2.1 0.2 0.05 ||| 1.0 0.3 1.5 0.3 ||| 0.2 0.05
0.5605349540710449 ||| Blister for Cozaar 12.5 mg film-coated tablets ||| 12/ 15 Package leaflet Incurin 1 mg tablet ||| Plaquette thermoformée pour Cozaar 12,5 mg, comprimé pelliculé
0.45515263080596924 ||| Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. ||| mycetoma that have not improved during treatment with itraconazole or when itraconazole has had to be stopped; ||| Humira peut être donné en monothérapie en cas d'intolérance au méthotrexate ou lorsque la poursuite du traitement avec le méthotrexate est inadaptée.
0.26286083459854126 ||| Pramipexole Teva 0.35 mg tablets ||| Oprymea 1.1 mg tablets Pramipexole ||| Pramipexole Teva 0,35 mg, comprimé
0.3223559558391571 ||| Emselex 7.5 mg prolonged-release tablets Darifenacin ||| Emselex 7.5 mg prolonged-release tablets Darifenacin (as hydrobromide) ||| Emselex 7,5 mg comprimés à libération prolongée Darifénacine
1.237409046755955e-12 ||| Mode of action ||| Mode of action ||| 151 Mode d' action
0.2779674530029297 ||| Discontinuation of IntronA should be considered in patients who develop new or worsening ophthalmological disorders. ||| In Parkinson`s patients, NMS tends to occur when discontinuing or stopping dopaminergic- enhancing medications. ||| Un arrêt du traitement par IntronA doit être envisagé chez les patients développant des troubles nouveaux ou lors d’ aggravation de troubles préexistants.
0.3317725658416748 ||| Ex vivo, a single topical ocular dose of nepafenac was shown to inhibit prostaglandin synthesis in the iris/ ciliary body (85%-95%) and the retina/ choroid (55%) for up to 6 hours and 4 hours, respectively. ||| Pre-ovulatory conditions are reached when there is ultrasonographic evidence of a dominant follicle of at least 18 mm in diameter and/ or when plasma oestradiol levels of 300-900 picograms/ ml (1000-3000 pmol/ l) are attained. ||| Ex vivo, il a été démontré qu’ une application locale unique de népafénac inhibait la synthèse des prostaglandines dans l’ iris/ corps ciliaire (85%-95%) et la rétine/ choroïde (55%) pour une durée pouvant atteindre respectivement 6 et 4 heures.
0.2997885048389435 ||| An increased incidence of hypertension (all grades) of up to 34% has been observed in Avastin-treated patients in clinical trials compared with up to 14% in those treated with comparator. ||| Data from an open-label clinical trial suggest that subjects with more than 8 AK lesions showed a decreased rate of complete clearance compared to patients with less than 8 lesions. ||| Dans les études cliniques, une augmentation de l’ incidence de l’ hypertension artérielle (tous grades) a été observée jusqu’ à 34% des patients traités par Avastin comparé à 14% des patients du groupe témoin.
0.13297340273857117 ||| Dizziness, sensory disturbances (including paraesthesia), sleep disturbances (including insomnia and intense dreams), agitation or anxiety, nausea and/ or vomiting, tremor, headache, irritability, diarrhoea, hyperhydrosis and vertigo are the most commonly reported reactions. ||| Dizziness, sensory disturbances (including paraethesia), sleep disturbances (including insomnia and intense dreams), agitation or anxiety, nausea and/ or vomiting, tremor, headache and flu syndrome are the most commonly reported reactions. ||| Les réactions de sevrage les plus fréquemment rapportées sont les suivantes: sensations vertigineuses, troubles sensoriels (incluant paresthésie), troubles du sommeil (incluant insomnies et rêves agités), agitation ou anxiété, nausées et/ ou vomissements, tremblements, céphalées, irritabilité, diarrhée, hyperhydrose et vertiges.
0.36534470319747925 ||| If you look from the side through the gap in the stopper, you can control the movement of the needle and the liquid. ||| To keep the needle tip within the liquid, you may have to slowly back it out of the stopper as you draw out the liquid. ||| Si vous regardez latéralement entre les espaces libres du bouchon, vous pouvez contrôler le mouvement de l’ aiguille et du solvant.
0.3005804419517517 ||| In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| In the elderly, progressive deterioration of renal function may lead to a steady decrease in insulin requirements. ||| 173 En cas d'insuffisance rénale, les besoins en insuline peuvent être diminués en raison d'une réduction du métabolisme de l'insuline.
0.31108734011650085 ||| The solution should be clear and colourless and free from visible particles. ||| Clear and colourless solutions without visible particles should be used. ||| La solution doit être transparente, incolore et sans particules visibles.
0.21667692065238953 ||| Stop taking Janumet and see a doctor straight away if you notice any of the following symptoms: • feeling sick (nausea) or being sick (vomiting), abdominal pain, muscular cramps, unexplained weight loss, rapid breathing, and feeling cold or uncomfortable. ||| Your doctor may treat the high blood pressure with drugs or temporarily interrupt your NeoRecormon therapy. • Call a doctor at once if you get headaches, especially sudden, stabbing, migraine-like headaches, confusion, speech disturbance, unsteady walking, fits or convulsions. ||| Arrêtez de prendre Janumet et consultez immédiatement un médecin si vous ressentez l'un des symptômes suivants: • nausées ou vomissements, douleurs abdominales, crampes musculaires, perte de poids inexpliquée, respiration rapide et sensation de froid ou de malaise.
3.2098932886692744e-13 ||| Additional information on the individual components Adverse drug reactions previously reported with one of the individual components (amlodipine or valsartan) may be potential undesirable effects with Exforge as well, even if not observed in clinical trials or during the post-marketing period. ||| Additional information on the individual components Adverse drug reactions previously reported with one of the individual components (amlodipine or valsartan) may be potential undesirable effects with Exforge as well, even if not observed in clinical trials or during the post-marketing period. ||| 20 Informations supplémentaires sur les composants individuels Les effets indésirables précédemment rapportés avec l'un des composants individuels (amlodipine ou valsartan) peuvent également être des effets indésirables potentiels avec Exforge, même s'ils n'ont pas été observés dans les essais cliniques ou au cours de la commercialisation.
0.8731968998908997 ||| 18 months Use product immediately after opening and discard any unused amount. ||| Wait one week and if symptoms improve redose at 50% dose reduction ||| 18 mois Utiliser le produit immédiatement après ouverture et éliminer tout produit non utilisé.
0.28430667519569397 ||| Renal impairment Increased plasma concentrations of duloxetine occur in patients with severe renal impairment on haemodialysis (creatinine clearance < 30 ml/ min). ||| • Renal/ hepatic impairment Increased plasma concentrations of paroxetine occur in patients with severe renal impairment (creatinine clearance less than 30 ml/ min) or in those with hepatic impairment. ||| 37 Insuffisance rénale Les concentrations plasmatiques de duloxétine augmentent chez les patients dialysés pour insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min).
0.4845452904701233 ||| To help limit the transmission of the virus in Europe and beyond, the EU has closed its external borders to non-essential travel, while ensuring essential goods keep moving across the EU through the introduction of green lanes. ||| To ensure that EU-wide supply chains continue to operate, Member States are requested to designate, without delay, all the relevant internal border-crossing points on the trans-European transport network (TEN-T) as ‘green lane' border crossings. ||| Afin de limiter la propagation du virus en Europe et dans d'autres parties du monde, l'Union européenne a fermé ses frontières extérieures aux voyages non essentiels, tout en garantissant la circulation des biens de première nécessité sur le marché intérieur.
0.3311259150505066 ||| Your blood will be tested frequently during treatment to monitor the side effects of Temodal on your blood cells. ||| Your doctor will perform tests to monitor the levels of Rapamune in your blood. ||| Vous serez soumis à de fréquentes prises de sang durant le traitement afin de surveiller les effets indésirables de Temodal sur les cellules sanguines.
0.01053476519882679 ||| 2 Those patients switching from 2000 mg or more of prolonged-release nicotinic acid can initiate Pelzont at the 2000 mg/ 40 mg dose. ||| 2 Those patients switching from 2000 mg or more of prolonged-release nicotinic acid can initiate Trevaclyn at the 2000 mg/ 40 mg dose. ||| Chez les patients ayant reçu précédemment 2000 mg ou plus d’ un traitement par l'acide nicotinique à libération prolongée, le traitement par Pelzont peut être instauré à la dose de 2000 mg/ 40 mg.
2.908227586702339e-13 ||| Tablet core: lactose monohydrate, croscarmellose sodium, hydroxypropylcellulose, microcrystalline cellulose, sodium laurilsulfate, magnesium stearate. ||| Tablet core: lactose monohydrate, croscarmellose sodium, hydroxypropylcellulose, microcrystalline cellulose, sodium laurilsulfate, magnesium stearate. ||| Lactose monohydraté, croscarmellose sodique, hydroxypropylcellulose, cellulose microcristalline, laurylsulfate de sodium, stéarate de magnésium.
0.45632535219192505 ||| The cardiovascular effects seen are considered to be related to the intravenous route of administration. ||| The difference between the apparent total and renal clearances is considered to reflect the uptake by bone. ||| On considère que les effets cardiovasculaires sont liés à l’ administration intraveineuse du produit.
0.25372636318206787 ||| Oral anticoagulants: a reinforced monitoring of the International Normalised Ratio is recommended in case of administration of Agenerase with warfarin or other oral anticoagulants, due to a possible decrease or increase of their antithrombotic effect (see section 4.4). ||| Diuretics (thiazide or loop diuretics) Prior treatment with high dose diuretics may result in volume depletion and a risk of hypotension when initiating therapy with enalapril (see 4.4 Special warnings and special precautions for use). ||| Antiocoagulants oraux: une surveillance accrue de l’ INR est recommandée lors de l’ administration d’ Agenerase avec la warfarine ou avec d’ autres anticoagulants oraux, en raison d’ une possible diminution ou augmentation de leur effet antithrombotique (voir rubrique 4.4).
0.4208899140357971 ||| Prandin 1 mg tablets Repaglinide ||| Rapamune 1 mg tablets Sirolimus ||| Prandin 1 mg, comprimés Répaglinide
0.4935568869113922 ||| If this reaction occurs, they should be advised to rinse out their mouth thoroughly afterwards. ||| It will be passed out of the body in a few days without need for you to take special precautions. ||| Dans ce cas, il doit leur être ensuite conseillé de se rincer soigneusement la bouche.
0.2793758809566498 ||| The replacement interferon beta-1b acts in the same way as naturally produced interferon beta. ||| The replacement dibotermin alfa acts in same way as BMP-2 produced naturally by the body. ||| L’ interféron β -1b ainsi produit agit de la même façon que l’ interféron β naturel.
0.3848147988319397 ||| 1000 patient -ye ars versus diet alone 20.6 events/ 1000 patient-years (p=0.011), and versus the combined sulfonylurea and insulin monotherapy groups 18.9 events/ 1000 patient-years (p=0.021); ||| Median baseline CD4 cell count was 349 cells/ mm3 (range 72 to 807 cells/ mm3) and median baseline plasma HIV-1 RNA was 4.0 log10 copies/ ml (range 2.9 to 5.8 log10 copies/ ml). ||| pour 1000 années-patients, par rapport au régime seul 20,6 événements pour 1000 années- patients (p=0,011), et par rapport à des groupes combinés de monothérapies par sulfamides hypoglycémiants et insuline 18,9 événements pour 1000 années-patients (p=0,021);
0.36684027314186096 ||| Atripla and paroxetine can be co-administered without dose adjustment. ||| 172 Ciprofloxacin should be administered by intravenous infusion. ||| Atripla et la paroxétine peuvent être co-administrés sans ajustement posologique.
0.19952067732810974 ||| Caution should be exercised when prescribing nucleoside analogues to any patient (particularly obese women) with hepatomegaly, hepatitis or other known risk factors for liver disease. ||| This finding should be considered when prescribing raloxifene for postmenopausal women with a history of stroke or other significant stroke risk factors, such as transient ischemic attack or atrial fibrillation. ||| Il conviendra d'être prudent en cas de prescription d'analogues nucléosidiques à des patients (en particulier des femmes obèses) avec une hépatomégalie, une hépatite ou d'autres facteurs de risques connus de maladie hépatique.
0.15910768508911133 ||| Valdoxan has been compared with placebo (a dummy treatment) in five main short-term studies involving a total of 1,893 adults with major depression. ||| NeuroBloc has been compared with placebo (a dummy treatment) in four studies involving a total of 392 adults with cervical dystonia. ||| Valdoxan a été comparé avec un placebo (un traitement fictif) dans cinq études principales de courte durée incluant au total 1 893 adultes souffrant de dépression majeure.
0.3334163427352905 ||| No change in dabigatran exposure was seen in 12 subjects with moderate hepatic insufficiency (Child Pugh B) compared to 12 controls (see sections 4.2 and 4.4). ||| Peripheral neuropathy (mostly Grade 1 or 2 sensory neuropathy) was observed in 68% of patients on Abraxane with 10% being Grade 3, and no cases of Grade 4. ||| Aucune modification de l’exposition au dabigatran n’a été observée chez 12 sujets présentant une insuffisance hépatique modérée (Child Pugh B) comparativement à 12 témoins (voir rubriques 4.2 et 4.4).
0.3347344994544983 ||| While being treated with Ranexa, you should not drink grapefruit juice. ||| You should not take Zyrtec during breast feeding because cetirizine passes into breast milk. ||| Ne pas boire de jus de pamplemousse au cours d’ un traitement par Ranexa.
0.8346939086914062 ||| The company also presented data from published articles. ||| Daily updates have been published by the DHSC. ||| La société a également présenté des données issues d’ articles publiés.
0.2262159287929535 ||| nightmare, depression, depressed mood, anxiety, insomnia, mood altered, abnormal dreams, sleep disorder ||| Uncommon: apathy, depression, depressed mood, libido decreased, nightmare, insomnia, nervousness ||| Cauchemars, dépression, humeur dépressive, anxiété, insomnie, altérations de l’ humeur, rêves anormaux, troubles du sommeil
0.14588001370429993 ||| Mudguards for motorcycles ||| Mudguards for trucks ||| Garde-boue pour motocycles
0.18843808770179749 ||| 28 pre-filled syringes ||| Pre-filled syringes: ||| 28 seringues pré- remplies
0.38716834783554077 ||| It is not known whether the chance of developing an allergic reaction is increased if treatment with Fasturtec is repeated. ||| It is not known whether breast-feeding will lead to exposure of the infant to medicinal product. ||| Il n’ est pas établi que le risque de développer une réaction allergique soit augmenté lorsque le traitement par Fasturtec est réintroduit.
0.3895333409309387 ||| Very rare events of cutaneous vasculitis have been reported in patients treated with filgrastim. ||| A small number of people being treated with Lamictal for bipolar disorder or epilepsy have had these thoughts. ||| De très rares cas de vascularites cutanées ont été rapportés chez les patients traités avec le filgrastim.
3.361426534256168e-13 ||| Methadone AUC may be decreased when co-administered with VIRACEPT; therefore upward adjustment of methadone dose may be required during concomitant use with VIRACEPT (see section 4.5). ||| Methadone AUC may be decreased when co-administered with VIRACEPT; therefore upward adjustment of methadone dose may be required during concomitant use with VIRACEPT (see section 4.5). ||| Lorsque la méthadone est co-administrée avec VIRACEPT, son AUC peut être diminuée; en conséquence, lors d'une utilisation concomitante avec VIRACEPT, il peut être nécessaire d’ajuster la dose de méthadone (augmentation de la posologie) (voir rubrique 4.5).
0.5323407053947449 ||| Re-introduction of treatment: ||| Reconstitution of the solution: ||| Réintroduction de Thelin:
0.16623994708061218 ||| Electrocardiograph monitors ||| Electrocardiographs ||| Moniteurs électrocardiographiques
0.20265746116638184 ||| If the pen does not function well, you can draw the insulin from the cartridge into an injection syringe. ||| If OptiClik does not function well, you can draw the insulin from the cartridge into an injection syringe for injection. ||| Si le stylo à insuline ne fonctionne pas bien, vous pouvez prélever l'insuline contenue dans la cartouche en utilisant une seringue pour injection.
0.146709606051445 ||| Medicinal product subject to medical prescription ||| Medicinal product subject to medical prescription rod ||| Médicament soumis à prescription médicale
0.0887291431427002 ||| 55 B. ||| 51 B. ||| 57 B.
0.3722230792045593 ||| If you do not follow these instructions, you may get severe sunburn that leads to permanent scarring. ||| When you first start your insulin treatment, it may disturb your vision, but the condition usually disappears. ||| Si vous ne respectez pas ces instructions, vous risquez de souffrir de brûlures sévères avec des cicatrices définitives.
0.17980563640594482 ||| Use in hepatic and renal impairment NEVANAC has not been studied in patients with hepatic disease or renal impairment. ||| Patients with renal or hepatic impairment No studies have been performed in patients with clinically relevant hepatic or renal impairment. ||| Utilisation chez les insuffisants hépatiques et rénaux NEVANAC n’ a pas été étudié chez les patients présentant une maladie hépatique ou une insuffisance rénale.
0.10295367240905762 ||| 2 151 000 ||| 2 305 000 ||| 151 000
0.2910861372947693 ||| At therapeutic doses, no clinically significant interactions have been demonstrated with alcohol (for a blood alcohol level of 0.5 g/ L). ||| No interactions are anticipated in humans, since systemic concentrations of bimatoprost are extremely low (less than 0.2 ng/ ml) following ocular dosing. ||| Aux doses thérapeutiques, aucune interaction cliniquement significative n'a été mise en évidence avec la prise d'alcool (pour des concentrations sanguines d'alcool allant jusqu'à 0,5 g/ l).
0.0032078037038445473 ||| 50 The above representation reflects the relative amount of glucose over time required to maintain the subject's whole blood glucose concentrations near fasting levels and is an indicator of the effect of these insulins on glucose metabolism over time. ||| 87 The above representation reflects the relative amount of glucose over time required to maintain the subject's whole blood glucose concentrations near fasting levels and is an indicator of the effect of these insulins on glucose metabolism over time. ||| La représentation ci-dessus reflète en fonction du temps la quantité relative de glucose nécessaire pour maintenir la glycémie du sujet proche de la valeur à jeun et est un indicateur de l'effet de ces insulines sur le métabolisme du glucose en fonction du temps.
0.49691420793533325 ||| In an exchange of views with Wojciech Wiewiórowski, European Data Protection Supervisor (EDPS) and Andrea Jelinek, the Chair of the European Data Protection Board (EDPB), the Civil Liberties MEPs will discuss current developments in the EU on the use of personal data in the fight against COVID-19 that subsequently raise issues around data protection. ||| The European Commission Joint Research Centre at Ispra has established a technical office at the Agency in charge of setting up a telecommunications network and other computer technologies to facilitate the dissemination of information on medicinal products – EudraNet (European Union Drug Regulatory Authorities Network) – which is an inter-networking service provided to EU Medicinal Regulatory Authorities in collaboration with the European Commission Directorate-General III. ||| Au cours d'un échange de vues avec Wojciech Wiewiórowski, Contrôleur européen de la protection des données , et Andrea Jelinek, Président du Comité européen de la protection des données , les députés de la commission des libertés civiles débattront des derniers développements dans l'UE concernant l'utilisation des données personnelles dans la lutte contre le COVID-19 ainsi que des questions que cela soulève en termes de protection des données.
0.4644858241081238 ||| These symptoms do not definitely mean you are allergic to this medicine but you must discuss them with your doctor. ||| A minor infection such as a cold should not be a problem, but talk to your doctor first. ||| Ces symptômes ne signifient pas obligatoirement que vous êtes allergique à ce médicament mais vous devez en discuter avec votre médecin.
0.16393312811851501 ||| Opgenra is a medicine that contains the active substance eptotermin alfa. ||| NovoNorm is a medicine that contains the active substance repaglinide. ||| Opgenra est un médicament contenant le principe actif eptotermine alfa.
0.511831521987915 ||| Interstitial lung disease (including pneumonitis and pulmonary fibrosis)* ||| Acute infection of the sinuses (acute bacterial sinusitis) ||| Maladie interstitielle du poumon (incluant la pneumopathie et la fibrose pulmonaire)*
0.5761715173721313 ||| A 600 mg dose (30 ml) of oral solution contains approximately 47 mg sodium. ||| (75 mg is made up of a 30 mg dose plus a 45 mg dose) ||| Excipients: une dose de 600 mg (30 ml) de solution buvable contient environ 47 mg de sodium.
0.7735679149627686 ||| Pulse oximeters ||| Ship's chronometers ||| Oxymètres de pouls
0.3672908544540405 ||| Adverse reactions known to occur with each component given singly but which have not been seen in clinical trials may occur during treatment with MicardisPlus. ||| Other side effects may be seen in more than 1 patient in 10, depending on the condition that Tevagrastim is being used for. ||| Les effets indésirables déjà observés pour chacune des substances actives prises individuellement peuvent survenir en cas de traitement par MicardisPlus, même s’ ils n’ ont pas été observés au cours du développement clinique.
0.639296293258667 ||| Streptococcus canis (beta) Streptococcus spp. ||| Escherichia coli Corynebacterium equi Staphylococcus spp. ||| Streptococcus canis (Beta) Streptococcus spp.
0.4354237914085388 ||| 17 The integrated safety data of topotecan monotherapy are presented below. ||| Adverse reactions are presented below for each of the component parts of AVANDAMET. ||| 19 Les données de tolérance du topotécan en monothérapie sont présentées ci-dessous.
0.15138331055641174 ||| What Aclasta is and what it is used for 2. ||| What Pradaxa is and what it is used for 2. ||| Qu'est -ce qu’ Aclasta et dans quel cas est -il utilisé 2.
0.6765977144241333 ||| ed 8200 AB Lelystad The Netherlands ||| 4817 ZK Breda The Netherlands al in ||| Box 65 8200 AB Lelystad Pays -Bas
0.4798443913459778 ||| Ceftriaxone is not absorbed after oral application. ||| Cystadane should be taken orally (by mouth). ||| Elle n’est pas absorbée après administration orale.
0.0 ||| From a microbiological point of view, the product should be used immediately. ||| From a microbiological point of view, the product should be used immediately. ||| D’un point de vue microbiologique, le produit doit être utilisé de façon extemporanée.
0.10091961920261383 ||| For the full list of all side effects reported with Aprovel, see the Package Leaflet. ||| For a more complete list of the side effects reported with PhotoBarr, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Aprovel, voir la notice.
0.11376351863145828 ||| Concomitant administration of rosiglitazone with the oral antihyperglycaemic agents glibenclamide and acarbose did not result in any clinically relevant pharmacokinetic interactions. ||| Concomitant administration of rosiglitazone with the oral anti-diabetic agents metformin, glimepiride, glibenclamide and acarbose did not result in any clinically relevant pharmacokinetic interactions. ||| L’ administration concomitante d’ autres antidiabétiques oraux comme le glibenclamide et l’ acarbose n’ entraîne pas d’ interactions pharmacocinétiques significatives avec la rosiglitazone.
0.5180801153182983 ||| Detailed information on this medicine is available on the web site of {MA/Agency}[PIQ-QRD3] ||| 2/ 3 The summaries of opinion of the Committee for Orphan Medicinal Products for Sprycel are available here (CML) and here (ALL). ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de {Nom de l’ état membre/ Agence}.
0.09168347716331482 ||| CYMBALTA 60 mg hard gastro-resistant capsules Duloxetine ||| XERISTAR 30 mg hard gastro-resistant capsules Duloxetine ||| CYMBALTA 60 mg, gélule gastro-résistante Duloxétine
0.162795752286911 ||| Experimental animal studies are insufficient to assess the safety with respect to reproduction, development of the embryo or foetus, the course of gestation and peri- and post-natal development. ||| Evaluation of experimental animal studies has shown reproductive toxicity e.g. birth defects and other effects on the development of the embryo or foetus, the course of gestation or peri- and postnatal development. ||| Les études expérimentales chez l’ animal sont insuffisantes pour évaluer leur sécurité en ce qui concerne la reproduction, le développement de l’ embryon ou du fœ tus, le déroulement de la grossesse et le développement péri- et post-natal.
0.29562556743621826 ||| After having been treated for an acute episode for 6 weeks and stabilized for an additional 8 weeks with INVEGA (doses ranging from 3 to 15 mg once daily) patients were then randomised in a double-blind manner to either continue on INVEGA or on placebo until they experienced a relapse in schizophrenia symptoms. ||| *a) is the initial treatment, a) and b) represent a full course of treatment **An extension study authorised patients benefiting from treatment to continue receiving VELCADE ***If after 2 or 4 cycles of VELCADE, the patients had progressive disease or stable disease, respectively, they could receive dexamethasone ||| Après avoir été traités pour un épisode aigu pendant 6 semaines et avoir été stabilisés pendant 8 semaines supplémentaires par INVEGA (à des doses allant de 3 à 15 mg une fois par jour), les patients étaient ensuite randomisés en double aveugle afin soit de continuer avec INVEGA ou soit avec le placebo jusqu’ à survenue d’ une rechute des symptômes de la schizophrénie.
0.16784217953681946 ||| Skin and subcutaneous tissue disorders Uncommon: ||| Skin, subcutaneous and soft tissue disorders Uncommon ||| Troubles cutanés et sous-cutanés Peu fréquent: sudation
0.44033193588256836 ||| Cancer patients ||| Adult patients ||| Patients cancéreux tn
0.2364693433046341 ||| The effects of overdose on lansoprazole in humans are not known (although the acute toxicity is likely to be low) and, consequently, instruction for treatment cannot be given. ||| Although no clinical information is available, it is likely that, as in animals, elimination of alendronate via the kidney will be reduced in patients with impaired renal function. ||| Les effets d’un surdosage par lansoprazole chez l’homme ne sont pas connus (bien que la toxicité ai- guë soit vraisemblablement faible) et par conséquent, aucune conduite à tenir concernant le traitement ne peut être précisée.
0.00797245092689991 ||| tho For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| ed For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information complémentaire concernant ce médicament, contactez le représentant local du titulaire de l’autorisation de mise sur le marché.
0.0 ||| (10/ 155) ||| (10/ 155) ||| 58% (15/26)
0.4553946256637573 ||| Make sure you get the Liprolog Basal KwikPen that your doctor has told you to use. ||| 646 Your doctor will tell you if you have to mix Sanofi-Aventis human insulins. ||| Assurez-vous que vous avez le stylo de Liprolog BASAL KwikPen 100 UI/ml prescrit par votre médecin.
0.2479911744594574 ||| Soliris was more effective than placebo in improving the symptoms of PNH. ||| Xyrem was more effective than placebo in reducing symptoms. ||| Soliris était plus efficace que le placebo dans l’ amélioration des symptômes de la HPN.
0.5485097765922546 ||| Floor scrubbing machines ||| Climbing footwear ||| Machines à décaper les sols
0.11875186860561371 ||| Effect of other agents on the pharmacokinetics of aprepitant Concomitant administration of EMEND with active substances that inhibit CYP3A4 activity (e. g., ritonavir, ketoconazole, clarithromycin, telithromycin) should be approached cautiously, as the combination results in increased plasma concentrations of aprepitant. ||| Concomitant administration of EMEND with active substances that inhibit CYP3A4 activity (e. g. ritonavir, ketoconazole, clarithromycin, telithromycin) should be approached cautiously as the combination results in increased plasma concentrations of aprepitant (see section 4.5). ||| Effet d’autres médicaments sur la pharmacocinétique de l’aprépitant La co-administration d’ EMEND et de substances actives inhibant l’activité du CYP3A4 (tels que le ritonavir, le kétoconazole, la clarithromycine, la télithromycine) doit être envisagée avec précaution; cette association entraîne une augmentation des concentrations plasmatiques en aprépitant.
0.5411759614944458 ||| Lifethreatening (grade 3-4) or considered medically relevant Infections and infestations ||| 33 Undesirable effects in clinical studies in adult patients Infections and infestations ||| (grade 3-4) ou considéré comme médicalement significatif Sepsis, Infections et infestations
0.24217653274536133 ||| There was no accumulation of the active substance in plasma after multiple doses given every 28 days. ||| No unexpected accumulation in the plasma was observed after multiple dosing at the recommended dose of 100 mg once daily. ||| Aucune accumulation de la substance active n’ a été observée dans le plasma après l'administration de doses multiples tous les 28 jours.
0.01513030007481575 ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C – 8°C, unless dilution has taken place in controlled and validated aseptic conditions. ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, unless reconstitution has taken place in controlled and validated aseptic conditions. ||| S'il n'est pas utilisé immédiatement, la durée et les conditions de conservation après ouverture du flacon sont sous la responsabilité de l'utilisateur et ne doivent normalement pas excéder 24 heures à une température de 2°C à 8°C, sauf si la dilution a été effectuée dans des conditions aseptiques contrôlées et validées.
0.2494366466999054 ||| In the osteoporosis treatment trials, FABLYN therapy resulted in consistent, statistically significant suppression of bone resorption and bone formation, as reflected by changes in serum and urine markers of bone turnover (e. g., C-telopeptide and markers of bone formation: osteocalcin, procollagen type 1 N-terminal propeptide, and bone-specific alkaline phosphatase). ||| Proliferation of activated B- and T-lymphocytes, development of cytotoxic T cells and immunoglobulin-secreting cells is enhanced, monocytes/ macrophages are activated for killing of tumour cells, granulocytes are activated to display enhanced phagocytic activity, respiratory burst and degranulation, and adherence to endothelium. ||| 10 Dans les études du traitement de l’ ostéoporose, FABLYN a induit une diminution régulière, statistiquement significative, de la résorption et de la formation osseuses, ce qui se traduit par des modifications des marqueurs sériques et urinaires du remodelage osseux (par exemple, le télopeptide C et les marqueurs de la formation osseuse: ostéocalcine, propeptide N terminal du procollagène de type 1 et phosphatase alcaline osseuse).
0.4930174946784973 ||| HCV/HIV Co-infection The recommended duration of dosing for HCV/HIV co-infected patients is 48 weeks, regardless of genotype. ||| HCV/ HIV Co-infected patients Two trials have been conducted in patients co-infected with HIV and HCV. ||| 100 Co-infection VHC-VIH La durée de traitement recommandée pour les patients co-infectés VHC-VIH est de 48 semaines, quel que soit le génotype.
0.278683602809906 ||| PhotoBarr is used to remove high -grade dysplasia (cells with atypical changes that increase the risk of developing cancer) in patients with Barrett's oesophagus (gullet). ||| It is used to treat a condition called idiopathic thrombocytopenic purpura (ITP), where the number of platelets in your blood stream is greatly reduced. ||| PhotoBarr est utilisé pour l’ablation de la dysplasie de haut grade (cellules présentant des altérations atypiques suceptibles d’augmenter le risque de cancer) chez les patients présentant un œsophage de Barrett (rétrécissement de l'œsophage).
0.13562220335006714 ||| State aid: Commission approves €30 million Italian scheme to support SMEs in the agriculture and fishery sectors affected by coronavirus outbreak ||| State aid: Commission approves €1.5 million Latvian scheme to support companies active in the agricultural sector affected by coronavirus outbreak ||| Aides d'État: la Commission autorise un régime italien d'un montant de 30 millions d'euros en faveur des PME des secteurs de l'agriculture et de la pêche touchées par la pandémie de coronavirus
0.3998769521713257 ||| Frames for handsaws ||| Bearings for shafts ||| Châssis de scies à main
0.9871063232421875 ||| - Diarrhoea. ||| Kivexa, Ziagen) again. ||| - une diarrhée.
0.860395610332489 ||| Crying, Libido increased, Tearfulness ||| ris • Irritability • Loss of appetite • Drowsiness ||| l’ humeur, Sautes d’ humeur
0.6998913884162903 ||| [48 to 79%]). ||| 47% to 92%). ||| 48 à 79%).
0.0 ||| 10/ 17 9. ||| 10/ 17 9. ||| 10/ 18 9.
0.2890758216381073 ||| The possibility that the patient is taking other medications that interact with methotrexate (eg, medications which may interfere with methotrexate elimination or binding to serum albumin) should always be considered when laboratory abnormalities or clinical toxicities are observed. ||| However, when combined with a CYP3A4 inhibitor, patients who are poor metabolisers of CYP2C9 are at risk of increases in bosentan plasma concentrations that may be of higher magnitude, thus leading to potential harmful adverse events. ||| La possibilité que le patient prenne un autre traitement pouvant interagir avec le méthotrexate (par exemple, tout médicament pouvant interférer avec l’élimination du méthotrexate ou pouvant se lier à l’albumine sérique) doit toujours être prise en compte lorsque des anomalies des tests de laboratoire ou des toxicités cliniques sont observées.
0.33464983105659485 ||| In view of the significant reduction in the AUC (area under the curve) of MPA by cholestyramine, caution should be used in the concomitant administration of Mycophenolate mofetil Teva with medicinal products that interfere with enterohepatic recirculation because of the potential to reduce the efficacy of Mycophenolate mofetil Teva. ||| The rationale for administration of Kuvan in patients with BH4-responsive PKU is to enhance the activity of the defective phenylalanine hydroxylase and thereby increase or restore the oxidative metabolism of phenylalanine sufficient to reduce or maintain blood phenylalanine levels, prevent or decrease further phenylalanine accumulation, and increase tolerance to phenylalanine intake in the diet. ||| Compte tenu de la réduction significative de l’ aire sous la courbe (ASC) du MPA par la cholestyramine, la prudence est de rigueur lors de l'administration simultanée de Mycophénolate mofétil Teva et de médicaments qui interfèrent avec le cycle entéro-hépatique, car l'efficacité de Mycophénolate mofétil Teva pourrait être diminuée.
0.0962684154510498 ||| Keep the syringe in the outer carton in order to protect from light. ||| Keep the blister packs in the outer carton in order to protect from light. ||| Conserver la seringue dans l’emballage extérieur à l’abri de la lumière.
0.0 ||| 4.2 Posology and method of administration ||| 4.2 Posology and method of administration ||| 4.3 Posologie et mode d’ administration
0.5955639481544495 ||| Laser detectors ||| Laser diodes ||| Détecteurs laser
0.0729484036564827 ||| 4/ 28 ||| 4/ 26 ||| 4/ 30
0.6538875102996826 ||| Hypocalcaemia ||| Hypothermia ||| Hypocalcémie
0.28448593616485596 ||| Gum for medical purposes ||| Bone cement for medical purposes ||| Gommes à usage médical
0.7452002763748169 ||| 20 September 2007. ||| in September 1997 ||| 20 septembre 2007
0.26854363083839417 ||| Take special care with Lamictal Your doctor needs to know before you take Lamictal: • if you have problems with your kidneys • if you have ever developed a rash when you’ ve taken lamotrigine or other medicines for epilepsy • if you are already taking medicine that contains lamotrigine. ||| Take special care with Irbesartan Winthrop Tell your doctor if any of the following apply to you: if you get excessive vomiting or diarrhoea if you suffer from kidney problems if you suffer from heart problems if you receive Irbesartan Winthrop for diabetic kidney disease. ||| Faites attention avec Lamictal Votre médecin doit être informé avant que vous ne preniez Lamictal: • si vous avez des problèmes de reins • si vous avez déjà développé une éruption cutanée pendant que vous preniez de la lamotrigine ou tout autre médicament pour l’ épilepsie • si vous prenez déjà un médicament contenant de la lamotrigine
0.2707630693912506 ||| 1 vial containing 2 ml human clottable protein (50 – 90 mg/ ml) Component 2: ||| Excipients Each 200 mg vial contains 3.5 mg (< 1 mmol) sodium. ||| 1 flacon contenant 2 ml de protéine humaine coagulable (50 – 90 mg/ ml) composant 2:
6.209284930842884e-13 ||| Injury, poisoning and procedural complications ||| Injury, poisoning and procedural complications ||| Lésions, intoxications et complications liées aux procédures
0.2756291627883911 ||| After oral administration, erlotinib peak plasma levels are obtained in approximately 4 hours after oral dosing. ||| 18 After single dose administration of fosamprenavir, amprenavir peak plasma concentrations are observed approximately 2 hours after administration. ||| Après administration orale, le pic de concentration plasmatique est obtenu après environ 4 heures.
0.18349295854568481 ||| For patient convenience, Fertavid may be stored at or below 25 ºC by the patient for a single period of not more than 3 months. ||| Orfadin capsules can be stored for a single period of 3 months at a temperature not above 25°C, after which the product must be discarded. ||| Pour plus de facilité pour le patient, Fertavid peut être conservé à une température ne dépassant pas 25 ºC pendant une période unique ne dépassant pas 3 mois.
0.46039921045303345 ||| Before you receive Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg 3. ||| Inactivated recombinant avian influenza virus of H5N3 subtype (strain rg-A/ ck/ VN/ C58/ 04) > 1:40 HI units per dose ||| Quelles sont les informations à connaître avant de recevoir Vaccin grippal prépandémique (H5N1) (virion fragmenté, inactivé, avec adjuvant) GlaxoSmithKline Biologicals 3,75 µg 3.
0.2305063009262085 ||| Cases of pulmonary oedema have been reported with vasodilators (mainly prostacyclins) when used in patients with pulmonary veno-occlusive disease. ||| Endocrine system Thyroid function abnormalities or worsening of pre-existing thyroid disorders have been reported with the use of alpha interferons, including Pegasys. ||| Des cas d’œ dèmes pulmonaires ont été rapportés lors de l’ administration de médicaments vasodilatateurs (principalement des prostacyclines) chez des patients souffrant de maladie pulmonaire veino-occlusive.
0.344846248626709 ||| Formal interaction studies with lansoprazole and NSAIDs have not been conducted. ||| Interaction studies with a 3A4 inhibitor have not been carried out in vivo. ||| Des études cliniques protocolaires d’ interactions entre le lansoprazole et les AINS n’ ont pas été conduites.
0.2804771065711975 ||| In controlled clinical trials, the incidence of diarrhoea in Rasilez HCT-treated patients was 1.3% compared to 1.4% for aliskiren- or 1.9% for hydrochlorothiazide-treated patients. ||| Over the entire study, the rate of febrile neutropenia was 13% of pegfilgrastim-treated patients compared with 20% of filgrastim-treated patients (difference 7%, 95% CI of -19%, 5%). ||| Dans les études cliniques contrôlées, l’ incidence de la diarrhée chez les patients traités par Rasilez HCT a été de 1,3% par rapport à 1,4% pour les patients recevant l’ aliskiren ou de 1,9% pour les patients recevant l’ hydrochlorothiazide.
0.1996186226606369 ||| Adjustment of the dose is not necessary in patients with mild to moderate hepatic impairment or in patients with mild to severe renal impairment including those requiring dialysis. ||| The dose of zaleplon should be reduced in patients with mild to moderate hepatic impairment, and zaleplon is not recommended for use in patients with severe hepatic impairment. ||| Insuffisance hépatique et rénale: un ajustement de la dose n’ est pas nécessaire pour les patients souffrant d’ insuffisance hépatique légère à modérée ou pour les patients souffrant d’ insuffisance rénale légère à sévère, y compris pour les patients dialysés.
0.4612208306789398 ||| Tasmar 200 mg film coated tablets. ||| Irbesartan BMS 75 mg tablets. ||| Tasmar 200 mg, comprimés pelliculés
0.5744251012802124 ||| The Safety Sector provides Secretariat support to the Safety and Pharmacovigilance Working Parties. ||| The Sector for inspections is part of the Unit for Veterinary medicines and inspections ||| Le secteur Sécurité assure un soutien de secrétariat aux groupes de travail “sécurité” et “pharmacovigilance”.
0.0007975019980221987 ||| 68 In smoking subjects with mild hepatic dysfunction, mean elimination half-life (39.3 hr) was prolonged and clearance (18.0 l/ hr) was reduced analogous to non-smoking healthy subjects (48.8 hr and 14.1 l/ hr, respectively). ||| 82 In smoking subjects with mild hepatic dysfunction, mean elimination half-life (39.3 hr) was prolonged and clearance (18.0 l/ hr) was reduced analogous to non-smoking healthy subjects (48.8 hr and 14.1 l/ hr, respectively). ||| Chez les sujets fumeurs avec une insuffisance hépatique modérée, la demi-vie d’ élimination moyenne est prolongée (39,3 heures) et la clairance (18,0 l/ heure) est réduite de la même façon que chez les sujets sains (respectivement 48,8 heures et 14,1 l/ heure).
0.22454872727394104 ||| Co-administration of pregabalin with the oral contraceptives norethisterone and/or ethinyl oestradiol does not influence the steady-state pharmacokinetics of either substance. ||| Co-administration of oral contraceptives (ethinyloestradiol 30 μ g and levonorgestrel 150 μ g) did not affect the pharmacokinetics of sildenafil. ||| 17 L'administration concomitante de prégabaline avec les contraceptifs oraux tels que la noréthistérone et/ou l'éthinylestradiol n'influence pas les paramètres pharmacocinétiques à l'état d'équilibre de l'une ou l'autre de ces substances.
0.36960557103157043 ||| Under the scheme, which will be open to SMEs, the public support will take the form of direct grants. ||| The scheme will take the form of direct grants and will be applied to all sectors and to the whole territory of the UK. ||| L'aide publique accordée au titre de ce régime, qui sera accessible aux PME, prendra la forme de subventions directes.
0.3340386748313904 ||| Insulin therapy may cause sodium retention and oedema. ||| Hypothyroidism may reduce the optimal response to somatropin. ||| Un traitement par insuline peut entraîner une rétention sodée et des œ dèmes.
0.25793522596359253 ||| Since this difference is not considered to be clinically relevant, the combination of PREZISTA co-administered with 100 mg ritonavir and nevirapine can be used without dose adjustments. ||| If this co-administration is judged unavoidable, increased dose of Kaletra at 400 mg/ 400 mg twice daily may be administered with rifampicin under close safety and therapeutic drug monitoring. ||| Etant donné que cette différence n’est pas considérée comme cliniquement significative, l’association de PREZISTA co-administré avec 100 mg de ritonavir et de la névirapine peut être utilisée sans adaptation posologique.
0.5082774758338928 ||| Waterproof trousers ||| Waterproof packings ||| Pantalons imperméables
0.25413084030151367 ||| If you experience clinical symptoms suggesting an injury of the liver, such as loss of appetite, nausea, vomiting and/ or jaundice, you should inform your doctor. ||| If you develop symptoms suggestive of infections, such as fever, persistent cough, weight loss, or listlessness, seek medical attention immediately. ||| Si vous ressentez des symptômes cliniques évoquant une atteinte du foie, tels qu'une perte d'appétit, des nausées, des vomissements et/ ou une jaunisse, vous devez en informer votre médecin.
0.2541595995426178 ||| 18 months ||| 20 months ||| 18 mois.
0.16622574627399445 ||| Structural parts for aircraft ||| Structural parts for trucks ||| Parties structurelles d'aéronefs
0.23856061697006226 ||| In vitro metabolism studies suggest that methylnaltrexone does not inhibit the activity of CYP1A2, CYP2E1, CYP2B6, CYP2A6, CYP2C9, CYP2C19 or CYP3A4, while it is a weak inhibitor of the metabolism of a model CYP2D6 substrate. ||| Therefore, vildagliptin is not likely to affect metabolic clearance of co-medications metabolised by CYP 1A2, CYP 2C8, CYP 2C9, CYP 2C19, CYP 2D6, CYP 2E1 or CYP 3A4/ 5. ||| Les études de métabolisme in vitro suggèrent que la méthylnaltrexone n’ inhibe pas l’ activité du CYP1A2, CYP2E1, CYP2B6, CYP2A6, CYP2C9, CYP2C19 ou CYP3A4, alors qu’ elle inhibe faiblement le métabolisme d’ un modèle de substrat du CYP2D6.
0.08251401782035828 ||| Please read the following instructions carefully before using your Mixtard 30 InnoLet. ||| Please read the following instructions carefully before using your Mixtard 20 NovoLet. ||| Veuillez lire attentivement les instructions ci-dessous avant d’ utiliser votre Mixtard 30 InnoLet.
0.28318509459495544 ||| 479 NL-4817 ZK Breda The Netherlands ||| Minervum 7061 NL-4817 ZK Breda The Netherlands ||| to 4817 ZK Breda Pays-Bas
0.3854859471321106 ||| If any of the side effects happens to you, ask your doctor for advice. ||| Call a doctor immediately as they may be signs of a possible liver problem. ||| Si vous remarquez l’ un de ces effets indésirables, demandez conseil à votre médecin.
0.5533482432365417 ||| Study 0102 ||| Study 396 ||| Etude 0102
0.4031779170036316 ||| Synthetic rubber for use in manufacture ||| Surfactants for use in reinstating concrete ||| Caoutchouc synthétique destiné à la fabrication
0.07060232758522034 ||| 300 mg aliskiren and 25 mg hydrochlorothiazide). ||| 300 mg irbesartan and 25 mg hydrochlorothiazide). ||| 300 mg d'aliskiren et 25 mg d'hydrochlorothiazide).
0.25998055934906006 ||| After that, your doctor will decide how often you should apply the gel depending on the response of your KS and any side effects. ||| Your doctor may decide to change your maintenance dose depending on your response to the treatment and any side effects that you experience. ||| Par la suite, votre médecin décidera de la fréquence d’ application du gel en fonction de la réponse de vos lésions SK et des effets indésirables.
0.003064926713705063 ||| 27 Primary hyperaldosteronism Patients with primary hyperaldosteronism should not be treated with the angiotensin II antagonist valsartan as their renin-angiotensin system is affected by the primary disease. ||| 3 Primary hyperaldosteronism Patients with primary hyperaldosteronism should not be treated with the angiotensin II antagonist valsartan as their renin-angiotensin system is affected by the primary disease. ||| Hyperaldostéronisme primaire Les patients présentant un hyperaldostéronisme primaire ne doivent pas être traités par le valsartan (antagoniste de l'angiotensine II); leur système rénine-angiotensine est altéré par cette maladie.
0.3474789559841156 ||| See ’Take special care with Betaferon’ and follow the instructions under ’Rotating injection sites’ in the Annex at the back of this leaflet. ||| Please check section 5 – How to store Insuman Rapid - of the reverse (insulin) side of this leaflet for OptiSet storage instructions. ||| Voir la rubrique « Faites attention avec Betaferon » et suivre les instructions de la rubrique « Rotation des sites d’injection » de l’annexe située à la fin de cette notice.
0.3340243101119995 ||| Ornamental models made of wood ||| Ornaments made of stone ||| Modèles réduits décoratifs en bois
0.7613742351531982 ||| It appears to be a variant of the amabiko (アマビコ, 海彦, 尼彦, 天日子, 天彦, あま彦, also amahiko), otherwise known as the amahiko-nyūdo (尼彦入道), and arie (アリエ), which are depicted as ape-like, bird-like, or torso-less (cephalopod-like), and usually 3-legged. ||| "There are various other yōkai creatures that are vastly different in appearance, but have the ability to predict, such as the kudan, the jinjahime or ""shrine princess"", the hōnen game (豊年亀) or ""bumper crop year turtle"", and the ""turtle woman""." ||| Il semble que ce soit une variante du amabiko (アマビコ, 海彦 (), 尼彦 (), 天日子 (), 天彦 (), あま彦 () (également amahiko), autrement connu sous le nom amahiko-nyūdo (尼彦入道)) ou arié (アリエ), des créatures représentées comme des singes, des oiseaux ou sans torse (comme des céphalopodes), et généralement à 3 pattes.
0.07984437048435211 ||| What is the risk associated with Dukoral? ||| What is the risk associated with Dafiro? ||| Quel est le risque associé à l'utilisation de Dukoral?
0.4417192041873932 ||| 3 284 000 13 894 000 — 95 000 210 000 17 483 000 ||| 535 000 855 500 477 000 98 500 119 000 213 000 ||| 3 284 000 13 894 000 — 95 000 210 000
0.0 ||| Keep the container in the outer carton in order to protect from light. ||| Keep the container in the outer carton in order to protect from light. ||| A conserver dans l’emballage extérieur d’origine à l’abri de la lumière.
0.0 ||| The potential risk of apnoea and the need for respiratory monitoring for 48-72h should be considered when administering the primary immunisation series to very premature infants (born ≤ 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity. ||| The potential risk of apnoea and the need for respiratory monitoring for 48-72h should be considered when administering the primary immunisation series to very premature infants (born ≤ 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity. ||| Le risque potentiel d'apnée avec nécessité de surveillance respiratoire pendant 48-72 h doit être soigneusement pris en compte lors de l'administration des deux doses vaccinales chez les grands prématurés (nés à 28 semaines de grossesse ou moins) et particulièrement chez ceux ayant des antécédents d'immaturité respiratoire.
0.47313013672828674 ||| To prevent any kind of contamination, the reusable pen should be used only by you. ||| However, reimbursement by means of a voucher can only take place if the passenger agrees to it. ||| Afin de prévenir tout risque de contamination, le stylo réutilisable ne doit être utilisé que par un seul patient.
0.44328123331069946 ||| Portable communications apparatus ||| Insurance of communications apparatus ||| Systèmes de communication portables
0.0 ||| DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED ||| DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED ||| DATE DE LA DERNIÈRE NOTICE APPROUVÉE
0.5027444362640381 ||| Endoscopes for diagnostic use ||| Ovens for laboratory experiments ||| Endoscopes à des fins de diagnostic
0.2797618508338928 ||| Therefore, somewhat greater accumulation of alendronate in bone might be expected in patients with impaired renal function (see section 4.2). ||| This is not likely to be relevant for humans given recommended nasal doses which results in minimal systemic exposure (see section 5.2). ||| En conséquence, on peut s’ attendre à une accumulation quelque peu supérieure de l’ alendronate dans l’ os chez les patients ayant une insuffisance rénale (voir rubrique 4.2).
0.34720587730407715 ||| What CoAprovel looks like and contents of the pack CoAprovel 150 mg/ 12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2875 engraved on the other side. ||| Irbesartan Hydrochlorothiazide Winthrop tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side. ||| A quoi ressemble CoAprovel et contenu de l'emballage extérieur Les comprimés pelliculés de CoAprovel 150 mg/ 12,5 mg sont pêche, biconvexes, de forme ovale, avec un coeur gravé d'un coté et le numéro 2875 gravé sur l'autre coté.
0.311400830745697 ||| Stop taking Avaglim. ||| Stop taking Avandamet. ||| Cessez de prendre Avaglim.
0.4369490444660187 ||| The Marketing Authorisation Holder in agreement with the competent authorities in the Member States shall implement, prior to launch: ||| The Marketing Authorisation Holder shall complete the following programme of studies within the specified time frame. ||| Le Titulaire de l’ autorisation de mise sur le marché, en accord avec les autorités compétentes de chaque État membre, devra mettre en place, avant tout lancement du produit:
0.0 ||| Tietgens Boulevard 40 DK-5220 Odense SØ Tlf: + 45 63 95 10 00 ||| Tietgens Boulevard 40 DK-5220 Odense SØ Tlf: + 45 63 95 10 00 ||| Tietgens Boulevard 40 DK-5220 Odense SØ Denmark Tlf.: + 45 63 95 10 00
0.014094244688749313 ||| Press release21 April 2020Brussels ||| Press release23 April 2020Brussels ||| Communiqué de presse21 avril 2020Bruxelles
0.28861916065216064 ||| No clinically relevant interactions were observed in clinical trials with Aerius tablets in which erythromycin or ketoconazole were co-administered (see section 5.1). ||| In two clinical trials (Finland), Rotarix lyophilised formulation was administered alone (administration of routine paediatric vaccines was staggered). ||| Au cours des études cliniques réalisées avec Aerius comprimés dans lesquels les patients recevaient l’ érythromycine ou du kétoconazole en association, aucune interaction cliniquement significative n’ a été observée (voir rubrique 5.1).
0.3605248034000397 ||| Haematochezia Skin and subcutaneous tissue disorders: ||| Immune system disorders Anaphylaxis, angioedema. ||| Hématochézie Affections de la peau et du tissu sous-cutané:
0.641579270362854 ||| Very rare < 1/ 10,000 ||| Very Common ≥ 1/ 10 ||| Très rare < 1/ 10,000
0.3190661668777466 ||| Electronic carbon dioxide recorders [other than for medical purposes] ||| Carbon dioxide [other than for medical or veterinary use] ||| Enregistreurs électroniques de dioxyde de carbone autres qu'à usage médical
0.20926693081855774 ||| CoAprovel 300 mg/ 12.5 mg tablets irbesartan/ hydrochlorothiazide ||| Irbesartan Hydrochlorothiazide BMS 300 mg/ 25 mg film-coated tablets. ||| CoAprovel 300 mg/ 12,5 mg comprimés irbésartan/ hydrochlorothiazide
0.32225245237350464 ||| In studies of interferon use in non-human primates, abnormalities of the menstrual cycle have been observed (see section 4.4). ||| In animals, exposure to ganirelix at the time of implantation resulted in litter resorption (see section 5.3). ||| Lors des études d’ utilisation de l’ interféron chez les primates autres que l’ homme, des anomalies du cycle menstruel ont été observées (voir rubrique 4.4).
0.28107690811157227 ||| • General Common: weakness (asthenia); chills Uncommon: sensitivity to sunlight Not known: swollen face or tongue, shortness of breath or difficulty breathing, often with skin rashes (this may be a serious allergic reaction) ||| • Heart or circulation disorders Common: increase in blood pressure; flushing; palpitations Uncommon: feeling dizzy (particularly when standing up too quickly), fainting, fast heartbeat Not known: decrease in blood pressure; abnormal, rapid or irregular heart beat, which could lead to fainting ||| 50 • Troubles généraux Fréquent: fatigue (asthénie); frissons Peu fréquent: sensibilité à la lumière du soleil Fréquence indéterminée: gonflement du visage ou de la langue, souffle court ou difficulté à respirer, souvent avec éruptions cutanées (il peut s’ agir d’ une réaction allergique grave)
0.572007417678833 ||| Sinutab Decongestif & Antihistaminicum ||| Monoamine Oxidase Inhibitors: ||| Sinutab Decongestif & 5mg Antihistaminicum
0.27719438076019287 ||| Providing information relating to photographic printing services ||| Providing information relating to bicycle rental services ||| Mise à disposition d'informations en matière de tirage photographique
0.3240654766559601 ||| A booster dose must be considered in these vaccinees if the antibody level against hepatitis B virus surface antigen is less than 10 IU/ l. ||| For most diagnostic investigations using a nuclear medicine procedure, the radiation dose delivered (effective dose/ EDE) is less than 20 mSv. ||| Une dose de rappel doit être recommandée chez ces sujets si le titre d’anticorps contre l’antigène de surface du virus de l’hépatite B est inférieur à 10 UI/l.
0.33859971165657043 ||| INTERMEDIATE CARTON OF MULTIPACKS (WITHOUT BLUE BOX) ||| INTERMEDIATE CARTON (WITHOUT BLUE BOX) MULTIPACKS ONLY (3x112 TABLETS) ||| CARTON INTERMEDIAIRE POUR CONDITIONNEMENT MULTIPLE (SANS LA BLUE BOX)
0.26768991351127625 ||| You will be asked to take premedication consisting of an oral corticosteroid such as dexamethasone, one day prior to Docetaxel Winthrop administration and to continue for one or two days after it in order to minimise certain undesirable effects which may occur after the infusion of Docetaxel Winthrop in particular allergic reactions and fluid retention (swelling of the hands, feet, legs or weight gain). ||| It is therefore recommended that the diabetic patients carry some sugar lumps, sweets, biscuits or sugary fruit juice. • Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional. ||| Il vous sera demandé de prendre une prémédication orale par un corticostéroïde comme la déxaméthasone, un jour avant l'administration de Docétaxel Winthrop et de continuer 1 ou 2 jours après l'administration afin de minimiser certains effets non souhaités qui peuvent survenir après la perfusion de Docétaxel Winthrop, particulièrement réactions allergiques et rétention hydrique (gonflement des mains, des pieds, des jambes ou prise de poids).
0.014932542107999325 ||| VIAGRA 25 mg film-coated tablets Sildenafil ||| VIAGRA 100 mg film-coated tablets Sildenafil ||| VIAGRA 25 mg comprimés pelliculés Sildénafil
0.2804584503173828 ||| Persistent pulmonary hypertension of the newborn (PPHN) occurs as a primary developmental defect or as a condition secondary to other diseases such as meconium aspiration syndrome (MAS), pneumonia, sepsis, hyaline membrane disease, congenital diaphragmatic hernia (CDH), and pulmonary hypoplasia. ||| Reported diagnoses in patients suspected of having ILD-like events included pneumonitis, radiation pneumonitis, hypersensitivity pneumonitis, interstitial pneumonia, interstitial lung disease, obliterative bronchiolitis, pulmonary fibrosis, Acute Respiratory Distress Syndrome (ARDS), alveolitis, and lung infiltration. ||| Le syndrome d’ hypertension artérielle pulmonaire persistante du nouveau-né (HTAPPN) peut être primitif, lié à une anomalie congénitale, ou consécutif à une pathologie intercurrente, telle que syndrome d’ inhalation de liquide méconial, pneumonie, septicémie, maladie des membranes hyalines, hernie diaphragmatique congénitale (HDC) et hypoplasie pulmonaire.
0.8698716163635254 ||| 60 doses (1.2ml) ||| 336 tablets (3x112) ||| 60 doses (1,2 ml)
0.0 ||| As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR). ||| As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR). ||| Selon la recommandation du CHMP concernant le Système de Gestion des Risques liés à des médicaments à usage humain, une actualisation du PGR devra être soumise en même temps que le rapport périodique de sécurité (PSUR, Periodic Safety Report Update).
0.19526880979537964 ||| Diagram 8. ||| Diagram 18. ||| Schéma 8.
0.23105719685554504 ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/ --------------------------------------------------------------------------------------------------------------------- ||| This leaflet was last approved in Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/ __________________________________________________________________________________ ||| 31 Des informations détaillées sur ce médicament sont disponibles sur le site Internet de l’ EMEA: http: / /www. emea. europa. eu/ ----------------------------------------------------------------------------------------------------------------- Les informations suivantes sont destinées exclusivement aux professionnels de santé:
0.14637121558189392 ||| The procedure started on 13 March 2006. ||| The procedure started on 18 October 2007. ||| La procédure a été lancée le 13 mars 2006.
0.30371934175491333 ||| The objective of this workshop was to identify priorities, to facilitate the progress of new and promising therapeutic strategies and revise gene therapy guidelines. ||| The aim is to gather significant funding to ensure the collaborative development and universal deployment of diagnostics, treatments and vaccines against coronavirus. ||| Son objectif consistait à identifier les priorités, à faciliter les progrès de stratégies thérapeutiques nouvelles et prometteuses et à revoir les lignes directrices relatives à la thérapie génique.
0.1571945995092392 ||| Computer software to enable the provision of electronic media via the Internet ||| Computer software to enable the provision of electronic media via communications networks ||| Logiciel informatique qui permet la fourniture de médias électroniques via l'internet
7.996239304378094e-13 ||| Attach the needle ||| Attach the needle ||| Fixez l' aiguille
0.7025183439254761 ||| Cheque authorization services ||| Discotheque services ||| Services d'autorisation de chèques
0.3550456166267395 ||| Catalysts for use in control of hydrocarbon emissions ||| Laboratory reagents for scientific use in analysing hydrocarbons ||| Catalyseurs destinés au contrôle des émissions d'hydrocarbures
0.43894922733306885 ||| The Commission proposes €14.8 billion for humanitarian aid, of which €5 billion come from the European Union Recovery Instrument to reinforce the humanitarian aid instrument. ||| International donors pledged a total of €2.544 billion (of which €595 million in grants), with the European Union and its Member States mobilising €231.7 million in grant funding. ||| La Commission propose une enveloppe de 14,8 milliards d'euros pour l'aide humanitaire, dont 5 milliards d'euros en provenance de l'instrument de l'Union européenne pour la relance, en vue de renforcer l'instrument d'aide humanitaire.
0.17283210158348083 ||| HOW TO TAKE OPRYMEA ||| HOW TO TAKE RAPAMUNE ||| COMMENT PRENDRE OPRYMEA
0.2367704212665558 ||| The first 18 weeks of treatment is a critical period which requires close monitoring. ||| The first 18 weeks of treatment is a critical period which requires close monitoring (see section 4.4). ||| Les 18 premières semaines de traitement sont une période critique qui nécessite une surveillance étroite.
0.7736799716949463 ||| IDA Industrial Park Old Kilmeaden Road Waterford Ireland ||| Ireland Boehringer Ingelheim Ireland Ltd. ||| IDA Industrial Park Old Kilmeaden Road Waterford Irlande
0.3663545250892639 ||| Therefore, in case of an inadvertent administration of Ytracis, the radiotoxicity for the patient must be reduced by immediate (i. e. within 1 hour) administration of preparations containing chelators like Ca-DTPA or Ca- EDTA in order to increase the elimination of the radionuclide from the body. ||| Insulin Human Winthrop Comb 15 must not be used if this cannot be achieved, i. e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the vial. ||| Dans le cas d’ une administration accidentelle d’ YTRACIS, la radiotoxicité pour le patient doit donc être réduite par l’ administration immédiate (par exemple dans l’ heure) de préparations contenant des agents chélateurs tels que le Ca-DTPA ou le Ca-EDTA afin d’ augmenter l’ élimination corporelle du radionucléide.
2.386397286377462e-13 ||| 6 In clinical trials, the incidence of parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placebo. ||| 6 In clinical trials, the incidence of parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placebo. ||| 24 6 Au cours d'essais cliniques, l'incidence des troubles parkinsoniens et des dystonies dans le groupe olanzapine était numériquement supérieure à celle du groupe placebo (pas de différence statistique significative).
0.3459090292453766 ||| Population pharmacokinetic analysis demonstrated that the mean plasma clearance value after SC bolus administration was approximately 14% higher in men than in women and approximately 10% higher in subjects < 65 years than in subjects ≥ 65 years. ||| In a retrospective natural history study in patients with infantile-onset Pompe disease (n=168), the median age at onset of symptoms was 2.0 months and the median age of death was 9.0 months. ||| L’ analyse pharmacocinétique de population a démontré que la clairance plasmatique moyenne après administration en bolus SC a été d’ environ 14% plus élevée chez les hommes que chez les femmes et d’ environ 10% plus élevée chez les sujets de moins de 65 ans comparés à ceux de plus de 65 ans.
0.01880034990608692 ||| 0.3 ml (200 µg/ ml) ||| 0.3 ml (250 µg/ ml) ||| 0,3 ml (200 µg/ ml)
0.008158659562468529 ||| Each coated tablet contains 179 mg lactose monohydrate. ||| Each coated tablet contains 156 mg lactose monohydrate. ||| Chaque comprimé pelliculé contient 179 mg de lactose monohydraté.
0.30159443616867065 ||| 21%*** ||| 50%*** ||| 21 %***
0.3407823145389557 ||| If you become pregnant during this time, despite the use of contraceptive measures, you should tell your doctor immediately. ||| As a routine precaution, if you are over 65 years your blood pressure may be monitored by your doctor. ||| Si vous débutez une grossesse pendant cette période malgré l’ utilisation de mesures contraceptives, vous devez informer immédiatement votre médecin.
0.28294503688812256 ||| Patients at the beginning of therapy with voriconazole and patients who develop abnormal liver function tests during VFEND therapy must be routinely monitored for the development of more severe hepatic injury. ||| Stop the INTEGRILIN infusion immediately if circumstances arise that necessitate thrombolytic therapy or if the patient must undergo an emergency CABG surgery or requires an intraortic balloon pump. ||| Chez les patients commençant un traitement par le voriconazole et les patients dont les tests de la fonction hépatique deviennent anormaux sous VFEND, une surveillance systématique doit être mise en place afin d’ éviter une aggravation des problèmes hépatiques.
0.24468685686588287 ||| Do not use TRISENOX if you notice foreign particulate matter or if discolouration is present. ||| INTEGRILIN should not be used if it is noticed that particulate matter or discoloration is present. ||| N’utilisez pas TRISENOX si vous constatez la présence de particules étrangères ou d’une décoloration.
0.006363110616803169 ||| The usual dose is one 6 mg subcutaneous injection (injection under your skin) using a pre-filled syringe and it should be given approximately 24 hours after your last dose of chemotherapy at the end of each chemotherapy cycle. ||| The usual dose is one 6 mg subcutaneous injection (injection under your skin) using a pre-filled pen and it should be given approximately 24 hours after your last dose of chemotherapy at the end of each chemotherapy cycle. ||| La dose habituelle est une injection de 6 mg par voie sous-cutanée (injection sous la peau) avec une seringue préremplie, administrée environ 24 heures après votre dernière dose de chimiothérapie à la fin de chacun des cycles.
0.3661382794380188 ||| The use of Rebetol is contraindicated during pregnancy. ||| Ribavirin therapy is contraindicated in women who are pregnant. ||| Rebetol est contre-indiqué pendant la grossesse.
0.4022994637489319 ||| Telbivudine is not a substrate, inhibitor or inducer of the cytochrome P450 (CYP450) enzyme system. ||| The heat-labile toxin (LT) of enterotoxigenic E. coli (ETEC) is structurally, functionally and immunologically similar to CTB. ||| La telbivudine n’ est ni un substrat, ni un inhibiteur, ni un inducteur des enzymes du cytochrome P450 (CYP450).
0.3954719305038452 ||| To help limit the transmission of the virus in Europe and beyond, the EU has closed its external borders to non-essential travel, while ensuring essential goods keep moving across the EU through the introduction of green lanes. ||| French health authorities decided in 2011 to not replete their stocks, to reduce acquisitions and storage costs, and to rely more on supplies from China and just-in-time logistics, and to distribute the responsibility to private companies on an optional basis. ||| Afin de limiter la propagation du virus en Europe et dans d'autres parties du monde, l'Union européenne a fermé ses frontières extérieures aux voyages non essentiels, tout en garantissant la circulation des biens de première nécessité sur le marché intérieur.
0.23974797129631042 ||| In controlled clinical trials, angioedema occurred rarely during treatment with Sprimeo with rates comparable to treatment with placebo or hydrochlorothiazide. ||| Discontinuation due to any clinical or laboratory adverse event was less frequent for irbesartan/ hydrochlorothiazide-treated patients than for placebo-treated patients. ||| Dans les études cliniques contrôlées, des angiœ dèmes sont rarement survenus durant le traitement par Sprimeo avec des fréquences comparables à celles observées sous traitement par le placebo ou par l’ hydrochlorothiazide.
0.6096769571304321 ||| Cerezyme is used as long-term enzyme replacement therapy in patients with Gaucher disease. ||| A hand sanitizer or hand antiseptic is a non-water-based hand hygiene agent. ||| Cerezyme est utilisé comme traitement enzymatique substitutif à long terme chez les patients souffrant de la maladie de Gaucher.
0.451116681098938 ||| In the absence of human data, SIFROL should not be used during breast-feeding. ||| SUTENT should not be used in paediatric population until further data become available. ||| En l'absence de données chez l'homme, il faut éviter d'utiliser SIFROL en cas d'allaitement.
0.09026685357093811 ||| Do not use Tamiflu after the expiry date which is stated on the carton and blister after EXP. ||| Do not use PhotoBarr after the expiry date which is stated on the carton and vial after EXP. ||| Ne pas utiliser Tamiflu après la date de péremption mentionnée sur la boîte et le blister après EXP.
0.11346495896577835 ||| Ebixa film-coated tablets are presented as white to off-white, centrally tapered oblong biconvex, film- coated tablets with a single breakline on both sides. ||| The 10 mg film-coated tablets are white to off-white film-coated tablets, centrally tapered oblong, biconvex, with a single breakline on both sides. ||| Les comprimés pelliculés d’ Ebixa se présentent sous la forme de comprimés pelliculés blancs à blanc cassé, de forme oblongue conique selon l’ axe central, biconvexes, avec une ligne de section unique sur les deux faces.
0.4436521828174591 ||| Lubricating graphite ||| Lubricating grease ||| Graphite lubrifiant
1.0168920826919559e-12 ||| 10 A-6250 Kundl Austria Tel: + 43-(0)5338 2000 ||| 10 A-6250 Kundl Austria Tel: + 43-(0)5338 2000 ||| 10 A-6250 Kundl Austria Tel. +43 (0)5338 2000
0.5708750486373901 ||| Hyperkalaemia Increase of serum potassium ||| Pancreatitis. elevations in serum amylase. ||| Hyperkaliémie Augmentation du potassium sérique
0.501751184463501 ||| Taking [Invented name] 400 mg film-coated tablets with food and drink The effect of [Invented name] is not influenced by food including dairy products. ||| Taking Cardoreg 4 mg prolonged release tablets and associated names with food and drink Cardoreg 4 mg prolonged release tablets and associated names can be taken with or after food. ||| Aliments et boissons L’ effet de [Nom de fantaisie] n’ est pas influencé par la prise de nourriture y compris les produits laitiers.
0.4265756905078888 ||| Chest pain 1.3 ||| Chest pain ||| Douleurs thoraciques
0.3988195061683655 ||| The event rate of biopsy confirmed acute rejection within the first 24 weeks after transplantation was 32.6% in the Advagraf group (N=237) and 29.3% in the Prograf group (N=234). ||| The progression-free survival rates at the first scheduled visit (week 8) were 45.5% on Vectibix plus BSC and 24.6% on BSC alone, a difference of 20.9% [95% CI: ||| Le taux de rejets aigus biopsie prouvés au cours des 24 premières semaines suivant la transplantation était de 32,6% dans le groupe Advagraf (n = 237) et de 29,3% dans le groupe Prograf (n = 234).
0.07113774865865707 ||| 127 9. ||| 117 9. ||| 136 9.
0.09462693333625793 ||| Gum for medical purposes ||| Cotton for medical purposes ||| Gommes à usage médical
6.08347356864658e-13 ||| 120 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 120 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 131 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.392234206199646 ||| Treatment with Ziagen has not been shown to reduce the risk of passing HIV infection on to others by sexual contact or by blood transfer. ||| Protect other people Telzir will not stop you passing HIV infection on to other people, by having sex or by blood transfer. ||| Le traitement par Ziagen ne réduit pas le risque de transmission sexuelle ou sanguine du VIH à une autre personne.
0.4879112243652344 ||| Some people feel dizzy or tired when they are treated for high blood pressure. ||| Some people have found themselves sleepy or dizzy when taking AZOPT. ||| Certaines personnes ressentent des vertiges ou une fatigue lors du 74 traitement d’une hypertension artérielle.
0.009926093742251396 ||| Frequencies are defined as: very common (≥ 1/ 10), common (≥ 1/ 100, < 1/ 10), uncommon (≥ 1/ 1,000, < 1/ 100), rare (≥ 1/ 10,000, < 1/ 1,000), very rare (< 1/ 10,000). ||| Frequencies are defined as: very common (≥ 1/ 10), common (≥ 1/ 100, < 1/ 10), uncommon (≥ 1/ 1000, < 1/ 100), rare (≥ 1/ 10,000, < 1/ 1000) and very rare (< 1/ 10,000). ||| Les fréquences sont définies ainsi: très fréquents (> 1/ 10), fréquents (> 1/ 100 et 1/ 1000 et < 1/ 100), rares (≥ 1/ 10 000 et < 1/ 1000) et très rares (< 1/ 10 000).
0.5581701993942261 ||| - Tablet core: ||| Tablet Core: ||| - Noyau du comprimé:
0.5259566307067871 ||| It also found that the measure is proportionate, as the foreseen compensation does not exceed what is necessary to make good the damage, in line with Article 107(2)(b) TFEU. ||| • the CHMP, as a consequence, considered the benefit/ risk balance for the above-mentioned extension of indication to be favourable, ||| Elle a également estimé que la mesure est proportionnée, l'indemnisation prévue n'allant pas au-delà du montant nécessaire pour remédier aux dommages, conformément à l'article 107, paragraphe 2, point b), du TFUE.
0.2860146760940552 ||| Chemical additives for use as defoaming agents ||| Fibrous material for use as soil conditioning agents ||| Additifs chimiques utilisés comme agents de démoussage
0.4604901671409607 ||| Without the recycling process, your liver has to make additional bile acids. ||| The body cannot use this dietary fat for energy or convert it into fat tissue. ||| Sans ce processus de recyclage, le foie doit produire davantage d’ acides biliaires.
0.43391284346580505 ||| Phlebitis was a commonly reported local injection-site adverse reaction in all patient populations. ||| The most frequently reported adverse reaction is myelosuppression with neutropenia as the most common manifestation. ||| La phlébite au site d’ injection a été un effet indésirable local fréquemment signalé dans toutes les populations de patients.
0.3056572675704956 ||| The package also aims to help the EU tourism sector recover from the pandemic, by supporting businesses and ensuring that Europe continues to be the number one destination for visitors. ||| They also underlined that the European Union is committed to international cooperation in tackling this pandemic and will continue to assist vulnerable countries and communities around the world, especially in Africa. ||| Les orientations et recommandations de la Commission visent également à aider le secteur touristique européen à se remettre de la pandémie en soutenant les entreprises et en faisant en sorte que l'Europe reste la première destination touristique.
0.2599763870239258 ||| Very rare: pulmonary oedema in case of shock (anaphylactic; life-threatening), itching rash, serum sickness-like symptoms. ||| Mild systemic allergic reactions (e. g. mild forms of erythema, rash, facial swelling, urticaria, oedema, difficulty breathing). ||| Très rare: œ dème pulmonaire en cas de choc (anaphylactique; mise en jeu du pronostic vital), prurit, symptômes évocateurs d’ une maladie sérique.
0.011165047064423561 ||| 5 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary ||| 3 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary ||| 5 4.10 Surdosage (symptômes, conduite d’ urgence, antidotes), si nécessaire
0.13784703612327576 ||| AVANDAMET combines two antihyperglycaemic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: rosiglitazone maleate, a member of the thiazolidinedione class and metformin hydrochloride, a member of the biguanide class. ||| Velmetia combines two antihyperglycaemic agents with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: sitagliptin phosphate, a dipeptidyl peptidase 4 (DPP-4) inhibitor, and metformin hydrochloride, a member of the biguanide class. ||| 66 AVANDAMET associe 2 agents hypoglycémiants aux mécanismes d'action complémentaires qui améliorent le contrôle glycémique chez les patients diabétiques de type 2: le maléate de rosiglitazone, de la classe des thiazolidinediones et le chlorhydrate de metformine, de la classe des biguanides.
0.2737596035003662 ||| Seretide 25/ 50 micrograms strength is not appropriate in adults and children with severe asthma; it is recommended to establish the appropriate dosage of inhaled corticosteroid before any fixed combination can be used in patients with severe asthma. ||| Therefore, in patients with renal anaemia the medicinal product has to be administered intravenously. In patients with chronic renal failure, maintenance haemoglobin concentration should not exceed the upper limit of the target haemoglobin concentration recommended in section 4.2. ||| Le dosage 50/ 25 microgrammes de Seretide ne convient pas aux adultes et aux enfants atteints d’ asthme sévère; la dose appropriée de corticoïdes inhalés devra être ajustée individuellement avant d’ instaurer un traitement par une association fixe chez des patients atteints d’ asthme sévère.
0.29067301750183105 ||| In cats, the medicine was studied in acute infections of the upper respiratory tract and also some skin conditions caused by certain specific bacteria. ||| In some other dermal toxicity studies, a mild irritant effect on the skin of laboratory animals, including controls, was observed. ||| Chez le chat, le médicament a été étudié dans des cas d’ infections aiguës des voies respiratoires supérieures et de certaines pathologies cutanées dues à des bactéries spécifiques.
0.020918074995279312 ||| Κύπρος Δημητριάδης και Παπαέλληνας Λτδ Τηλ: +357 22 690 690 ||| 29 Κύπρος Δημητριάδης και Παπαέλληνας Λτδ Τηλ: +357 22 690 690 ||| 54 Κύπρος Δημητριάδης και Παπαέλληνας Λτδ Τηλ: +357 22 690 690
0.31200093030929565 ||| Aripiprazole was excreted in the milk of treated rats during lactation. ||| Studies in lactating rats showed that stavudine is excreted in breast milk. ||| Chez la rate traitée en cours de lactation, l’ aripiprazole est excrété dans le lait.
0.15082861483097076 ||| Specific patient groups Nateglinide should be used with caution in patients with moderate hepatic impairment. ||| REYATAZ with ritonavir should be used with caution in patients with mild hepatic impairment. ||| 19 Population particulière de patients Le natéglinide doit être utilisé avec prudence chez les patients présentant une insuffisance hépatique modérée.
0.28238093852996826 ||| Haematological monitoring Rosiglitazone treatment is associated with a dose-related reduction of haemoglobin levels. ||| Self-limiting, mild haemoglobin and haematocrit decrease have been observed on initiating gemfibrozil therapy. ||| Surveillance hématologique Le traitement par rosiglitazone est associé à une baisse dose-dépendante du taux d'hémoglobine.
0.05792902037501335 ||| Contra-indications After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Calcium carbonate, the most suitable harmonised Section 4.3 Contraindications text was approved (See Annex III). ||| Pregnancy and lactation After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Calcium carbonate, the most suitable harmonised Section 4.6 Pregnancy was approved (See Annex III). ||| Contre-indications Après évaluation de la documentation fournie par les TAMM et examen des pratiques cliniques en vigueur dans toute l’ UE à propos de l’ utilisation du carbonate de calcium, le texte harmonisé le plus approprié pour la rubrique 4.3 relative aux contre-indications a été approuvé (voir annexe III).
0.5699836611747742 ||| Luxembourg/ Luxemburg Eli Lilly Benelux S. A. ||| Luxembourg/ Luxemburg Merck Sharp & Dohme B. V. ||| Luxembourg/Luxemburg Eli Lilly Benelux S.A.
0.25315743684768677 ||| As oxybutynin is metabolised by cytochrome P 450 isoenzyme CYP 3A4, interactions with drugs that inhibit this isoenzyme cannot be ruled out. ||| Agenerase must not be administered concurrently with medicinal products with narrow therapeutic windows that are substrates of cytochrome P450 3A4 (CYP3A4). ||| L'oxybutynine étant métabolisée par l'isoenzyme CYP 3A4 du cytochrome P 450, il n’ est pas possible d’ exclure de possibles interactions avec les médicaments qui inhibent cette isoenzyme.
0.27329832315444946 ||| Thus, caution should be exercised when considering the use of STELARA in these patients. ||| Therefore, caution should be exercised when OPTISON is administered to nursing women. ||| En conséquence, des précautions doivent être prises lorsqu’ on envisage un traitement de ces patients par STELARA.
0.014321369118988514 ||| LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCT, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS, IN THE MEMBER STATES ||| LISTE DES DENOMINATIONS, FORMES PHARMACEUTIQUES, DOSAGES DES SPECIALITES, VOIES D’ ADMINISTRATION, TITULAIRES DES AUTORISATIONS DE MISE SUR LE MARCHE DANS LES ETATS MEMBRES
0.16984158754348755 ||| They decided that NutropinAq’ s benefits are greater than its risks for the treatment of growth hormone deficiency in adults and children. ||| Therefore, the CHMP decided that Valdoxan’ s benefits are greater than its risks for the treatment of major depressive episodes in adults. ||| Il a décidé que les avantages de NutropinAq sont supérieurs à ses risques dans le traitement de la déficience en hormone de croissance chez les adultes et les enfants.
0.5241535305976868 ||| Your doctor should decide whether you can take YENTREVE with other medicines. ||| Do not let your family or friends start the IONSYS device for you. ||| 44 C'est à votre médecin de décider si vous pouvez prendre YENTREVE avec d'autres médicaments.
0.27801424264907837 ||| 8 June 2001 ro ||| 8 June 2001 du ||| 8 Juin 2001.
0.22376970946788788 ||| Latches, not of metal ||| Ladders, not of metal ||| Loquets non métalliques
0.38620418310165405 ||| 18 National Competent Authorities (NCA), coordinated by the Reference Member State (RMS), shall ensure that the following conditions are fulfilled by the Marketing Authorisation Holders: ||| CONDITIONS OF THE MARKETING AUTHORISATION National Competent Authorities (NCA) shall ensure that the following conditions are fulfilled by the Marketing Authorisation Holders: ||| 18 Les autorités nationales compétentes (ANC), en coordination avec l’ État membre de référence (EMR), devront s’ assurer que les conditions suivantes sont remplies par les titulaires de l’ autorisation de mise sur le marché:
0.6559633612632751 ||| The same recommendations for monitoring apply in these cases of co-administration. ||| Some Member States already have this type of schemes in place. ||| Les mêmes recommandations de surveillance s’ appliquent à ces associations.
0.02884557843208313 ||| Ritonavir increases the serum levels of darunavir as a result of CYP3A inhibition. ||| Ritonavir increases the serum levels of saquinavir as a result of CYP3A4 inhibition. ||| Le ritonavir augmente les concentrations sériques du darunavir par inhibition du CYP3A.
0.3160587549209595 ||| The following effects have also been reported during post marketing use: abnormal accommodation, ptosis, vomiting, constipation, flu-like symptoms, and asthenia. ||| site disorders, fever, anorexia, vomiting, and emotional lability occurred more frequently in children and adolescents compared to adult patients. ||| Les effets suivants ont également été rapportés durant l’ usage post-marketing: troubles de l’ accommodation, ptose, vomissements, constipation, symptômes pseudo-grippaux et asthénie.
0.5215299129486084 ||| ris Clinical remission ||| ris Clinical Trials ||| Rémission clinique
0.007920426316559315 ||| ViraferonPeg 50 micrograms powder and solvent for solution for injection ||| ViraferonPeg 120 micrograms powder and solvent for solution for injection ||| ViraferonPeg 50 microgrammes poudre et solvant pour solution injectable
3.5369314898767157e-13 ||| Ankylosing spondylitis ||| Ankylosing spondylitis ||| ankylosante Rhumatisme
0.26913368701934814 ||| 55 ||| 57 ||| 56
0.6489092707633972 ||| Promotion of musical concerts ||| Entertainment by means of concerts ||| Promotion de concerts de musique
0.3183755874633789 ||| The initial daily dose should be 100 mg/ kg, up to 250 mg/ kg if necessary. ||| Starting dose is 60 mg daily (10 ml), increasing to 120 mg (20 ml) daily if required. ||| La dose journalière initiale doit être de 100 mg/ kg et peut être augmentée, si nécessaire, jusqu’ à 250 mg/ kg.
0.44594594836235046 ||| This is because micafungin has been shown to increase the risk of liver tumours developing in rats. ||| The virus was also found in feces, which raises a new possibility of feces-to-mouth transmission. ||| Cela est dû au fait qu’ il a été montré que la micafungine augmente le risque de développement de tumeurs du foie chez le rat.
0.3248475193977356 ||| Not Known (can not be estimated from the available data) ||| (cannot be estimated from the available data) ||| pas être estimée à partir des données disponibles)
0.5689868330955505 ||| Plumbing and glazing services ||| Mining and mineral exploration services ||| Services de plomberie et de vitrage
0.013836214318871498 ||| Epivir reduces the amount of HIV virus in your body, and keeps it at a low level. ||| Combivir reduces the amount of HIV virus in your body, and keeps it at a low level. ||| Epivir diminue la charge virale du VIH et la maintient à un faible niveau.
0.014994067139923573 ||| Imprida is not recommended in early pregnancy and may cause serious harm to your baby if taken after 3 months of pregnancy (see section “ Pregnancy and breast-feeding”). ||| Dafiro is not recommended in early pregnancy and may cause serious harm to your baby if taken after 3 months of pregnancy (see section “ Pregnancy and breast-feeding”). ||| Imprida est déconseillé en début de grossesse et peut entraîner de graves problèmes de santé chez l’ enfant à naître si Imprida est pris après 3 mois de grossesse (voir « Grossesse et allaitement »).
0.4438229501247406 ||| 233 System Organ Class ||| 29 System Organ Class: ||| Classe de systèmes
0.4281523823738098 ||| Gently pinch the skin together around the site (to lift it up a bit). ||| Swallow the tablet as a whole (to mask the bitter taste) and with plenty of liquid. ||| Pincez doucement la peau autour du site (pour la soulever légèrement).
0.35913899540901184 ||| Genotypic analysis of 203 evaluable sample pairs with HBV DNA ≥ 1,000 copies/ ml at week 104 demonstrated that the primary mutation associated with telbivudine resistance was rtM204I, often associated with mutations rtL180M and rtL80I/ V and infrequently with rtV27A, rtL82M, rtV173L, rtT184I and rtA200V. ||| HBV strains expressing the rtL180M, rtT184G, rtS202G/ I, rtM204V and rtM250V mutations associated with resistance to entecavir showed a susceptibility to tenofovir ranging from 0.6- to 6.9-fold that of wild- type virus. ||| 29 L’ analyse génotypique des 203 paires d’ échantillons évaluables avec un ADN du VHB ≥ 1 000 copies/ ml à la semaine 104 a montré que la principale mutation associée à une résistance à la telbivudine était la mutation rtM204I, souvent associée aux mutations rtL108M et rtL80I/ V et de façon peu fréquente aux mutations rtV27A, rtL82M, rtV173L, rtT184I et rtA200V.
0.30211150646209717 ||| Thrombocytopaenia, including acute profound thrombocytopaenia, has been observed with eptifibatide administration (see section 4.8). ||| Diarrhoea, including severe diarrhoea, has been reported with lapatinib treatment (see section 4.8). ||| Des thrombocytopénies, comprenant des thrombocytopénies aiguës d’ intensité importante, ont été observées lors de l’ administration de l’ eptifibatide (voir rubrique 4.8).
0.7787657380104065 ||| 2 4 1 3 1 - ||| 4 1 1 1 ||| 4 kg 2 plus 4
0.025177080184221268 ||| Infants whose mothers have taken AIIRAs should be closely observed for hypotension (see also sections 4.3 and 4.4). ||| Infants whose mothers have taken AIIRAs should be closely observed for hypotension (see section 4.3 and 4.4). ||| Les nouveau-nés de mère traitée par un ARAII doivent être surveillés sur le plan tensionnel (voir rubriques 4.3 et 4.4).
0.2983524799346924 ||| Dexdomitor is an α 2-adrenoreceptor agonist, symptoms after absorption may involve clinical effects including dose-dependent sedation, respiratory depression, bradycardia, hypotension, a dry mouth, and hyperglycaemia. ||| However, severe reactions, such as hypotension requiring treatment, dyspnoea requiring bronchodilators, angio- oedema or generalised urticaria require immediate discontinuation of paclitaxel and aggressive symptomatic therapy. ||| Les symptômes après absorption incluent: sédation dose-dépendante, dépression respiratoire, bradycardie, hypotension, sécheresse de la bouche et hyperglycémie.
0.39887967705726624 ||| Ms Fayl held various positions as a documentalist in several European countries, the latest from 1988 to 1995 setting up and running the documentation service in the European Commission Delegation in Norway. ||| From 1993 to 1997, as Scientific Secretary for COST Chemistry Actions at the European Commission in Brussels, she was involved in co-ordination of research networks in Europe and organisation of conferences. ||| Mme Fayl a occupé divers postes en tant que documentaliste dans plusieurs pays européens, le dernier, de 1988 à 1995, consistant à élaborer et à diriger le service de documentation de la délégation de la Commission européenne en Norvège.
0.3489935100078583 ||| A small volume is lost during preparation of PegIntron for injection when the dose is measured and injected. ||| This means that before Remicade is given to you, it is first dissolved in water for injections. ||| Une petite quantité est perdue lors de la préparation de PegIntron solution injectable lorsque la dose est mesurée puis injectée.
0.0 ||| Although Rapamune treatment is not expected to affect your ability to drive, if you have any concerns please consult your doctor. ||| Although Rapamune treatment is not expected to affect your ability to drive, if you have any concerns please consult your doctor. ||| Bien que le traitement par Rapamune ne soit pas considéré comme susceptible d’affecter votre aptitude à conduire, veuillez consulter votre médecin en cas de doute.
0.10869523882865906 ||| 3.6 ||| 3.7 ||| 3.6.
0.4564400613307953 ||| Norton Healthcare Limited Albert Basin, Royal Docks London E16 2QJ UK ||| Rowan House 41 London Street Reading, Berkshire, Rg1 4ps ||| Norton Healthcare Limited Albert Basin, Royal Docks Londres E16 2QJ Royaume-Uni
0.7089440822601318 ||| Contains sodium ||| Calcium tungstate ||| Contient du sodium
0.425448477268219 ||| The dosage of MabCampath will not be increased until the effects are reduced. ||| By lowering the pressure, Azopt reduces the risk of damage. ||| La dose de MabCampath ne sera pas augmentée tant que les effets indésirables n’auront pas été soulagés.
0.3421504497528076 ||| In some, but not all cases, initiation of convulsions appeared to be associated with procedural stress such as handling of the animals. ||| This was mainly caused by more patients stopping Invirase treatment rather than by any differences in the effectiveness of the medicines. ||| Dans certains cas, mais non dans tous, le déclenchement des convulsions semblait associé au stress lié aux conditions expérimentales telles que la manipulation des animaux.
0.15615499019622803 ||| Protaphane may cause hypoglycaemia (low blood sugar). ||| NovoRapid may cause hypoglycaemia (low blood glucose). ||| Protaphane peut entraîner une hypoglycémie (faible taux de sucre dans le sang).
0.11526072025299072 ||| Valtropin 5 mg/ 1.5 ml powder and solvent for solution for injection ||| Raptiva 100 mg/ ml powder and solvent for solution for injection ||| Valtropin 5 mg/ 1,5 ml poudre et solvant pour solution injectable
0.0782141387462616 ||| Summary of Product Characteristics, section 4.2) ||| Summary of Product Characteristics, section 4.2) no ||| Résumé des Caractéristiques du Produit, chapitre 4.2).
0.045258183032274246 ||| ViraferonPeg is recommended for use in fertile women only when they are using effective contraception during the treatment. ||| PegIntron is recommended for use in fertile women only when they are using effective contraception during the treatment. ||| L’ utilisation de ViraferonPeg chez des femmes en âge de procréer est recommandée seulement si elles utilisent une contraception efficace pendant le traitement.
0.09744267165660858 ||| The full EPAR for Fuzeon can be found here. ||| The full EPAR for Beromun can be found here. ||| L’ EPAR complet relatif à Fuzeon est disponible ici.
0.3569694757461548 ||| - painful joints or muscles, muscle weakness ||| - muscle cramps, stiffness in the joints and muscles ||| douleurs articulaires ou musculaires, faiblesse musculaire
0.08567685633897781 ||| 5 ml Type 1 clear glass vials fitted with grey butyl rubber stoppers and snap-off aluminium crimp seals. ||| 20 ml type I clear glass vials with grey butyl rubber stopper and aluminium seals with plastic flip-off caps. ||| Flacon de 5 ml en verre transparent de type 1, muni d’ un bouchon en caoutchouc butyl gris et serti d’ un joint amovible en aluminium.
0.602723240852356 ||| Confidence Interval ||| Correspondence cards ||| IC: intervalle de confiance
0.38803601264953613 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Mirapexin on 23 February 1998. ||| Gonazon implants were authorised by an extension application, granted by the European Commission in January 2007. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Mirapexin le 23 février 1998.
0.37787067890167236 ||| Aerial and surface spreading of fertilizers and other agricultural chemicals ||| Chemical and organic compositions and substances for treatment of leather and textile ||| Épandage, aérien ou non, d'engrais et autres produits chimiques destinés à l'agriculture
0.5069323778152466 ||| Median duration of treatment on dasatinib was 24 months with 51% of patients treated for > 24 months to date. ||| Neutropenia was present for > 7 days in 41% and for 30-35 days in 8% of patients. ||| La durée médiane du traitement sous dasatinib était de 24 mois avec 51% de patients traités pendant plus de 24 mois à ce jour.
0.28889381885528564 ||| Avenida de Burgos 16D, 5º Planta, 28036 Madrid, Spain ||| Avenida de Burgos 16D, 5º Planta, 28036 ||| Avenida de Burgos 16D, 5º Planta, 28036 Madrid, Espagne
0.31951218843460083 ||| Do not put Lantus next to the freezer compartment or next to a freezer pack. ||| Do not put the pre-filled pen next to the freezer compartment of your refrigerator or a freezer pack. ||| Ne pas placer Lantus près du compartiment à glaçons ou d’ une poche de congélation.
0.36688539385795593 ||| Likewise, prasugrel did not significantly alter the effect of heparin on measures of coagulation. ||| In formal testing, fluoxetine did not raise blood alcohol levels or enhance the effects of alcohol. ||| De même, le prasugrel n'a pas significativement modifié l'effet de l'héparine sur les paramètres de la coagulation.
0.016524747014045715 ||| OUTER CARTON TEXT Puregon 200 IU/ 0.5 ml 10 vials ||| OUTER CARTON TEXT Puregon 75 IU/ 0.5 ml 5 vials ||| TEXTE DE L'ETUI Puregon 200 UI/ 0,5 ml 10 flacons
0.5430418252944946 ||| Automatic analyzers for medical diagnosis ||| Diagnostic agent for scintigraphic imaging. ||| Analyseurs automatiques pour diagnostics médicaux
2.64048006549944e-13 ||| Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. ||| Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. ||| accidentellement peut provoquer un œ dème intense susceptible d’ entraîner, par exemple, une nécrose ischémique voire la perte d’ un doigt.
0.02542474865913391 ||| For the full list of all side effects reported with Retacrit, see the Package Leaflet. ||| For the full list of all side effects reported with Preotact, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de Retacrit, voir la notice.
0.5670403242111206 ||| -0.9‡ (-1.1, -0.7) -1.6‡ ||| -0.2 -0.25 -0.3 -0.35 al ||| (-1,1; -0,7) -1,6‡
0.059056416153907776 ||| Store in a refrigerator (2-8 ºC). ||| Store in a refrigerator (2-8 ºC) ||| A conserver au réfrigérateur (2-8°C)
0.11958073079586029 ||| - The other ingredients are sodium chloride, acetic acid, sodium acetate and water for injections. ||| - The other ingredients are fosveset, sodium hydroxide, hydrochloric acid, and water for injections. ||| - Les autres composants sont chlorure de sodium, acide acétique, acétate de sodium et eau pour
0.4863728880882263 ||| For animal treatment only - to be supplied only on veterinary prescription. ||| This veterinary medicinal product is for spot-on application only. ||| Usage vétérinaire A ne délivrer que sur ordonnance vétérinaire.
0.07968242466449738 ||| Latvija UCB Pharma Oy Finland Tel: + 358-(9) 2290 100 ||| Eesti UCB Pharma Oy Finland Tel: +358-(9) 2290 100 ||| 115 Latvija UCB Pharma Oy Finland Tel: + 358-(9) 2290 100
0.26409515738487244 ||| 3 Patients, whose blood glucose control is greatly improved, e. g. by intensified insulin therapy, may experience a change in their usual warning symptoms of hypoglycaemia, and should be advised accordingly. ||| Despite this, your doctor may prescribe (Invented name)® for patients under 18 for moderate to severe major depressive episode in combination with psychological therapy because he/ she decides that this is in their best interests. ||| Les patients dont le contrôle glycémique est nettement amélioré, par exemple dans le cadre d’ une insulinothérapie intensifiée, peuvent constater un changement des signes précurseurs habituels d’ hypoglycémie et doivent donc être avertis de cette éventualité.
0.27363836765289307 ||| Providing information relating to photographic printing services ||| Providing information relating to personal body guarding services ||| Mise à disposition d'informations en matière de tirage photographique
0.3178859353065491 ||| Acquisition ban: To ensure that airBaltic does not use the aid by the State to the detriment of fair competition in the Single Market, until at least 75% of the recapitalisation is redeemed, airBaltic is prevented from acquiring a stake of more than 10% in competitors or other operators in the same line of business. ||| With the amendment, the Commission has clarified that aid should not be conditioned on the relocation of the production activity or of another activity of the beneficiary from another country within the European Economic Area (EEA) to the territory of the Member State granting the aid, since such a condition would be particularly harmful for the internal market. ||| Interdiction d'acquisition: pour faire en sorte qu'airBaltic n'utilise pas les aides octroyées par l'État au détriment de l'exercice d'une concurrence équitable dans le marché unique, tant qu'au moins 75 % de la recapitalisation ne sont pas remboursés, airBaltic ne peut pas acquérir une participation supérieure à 10 % dans des concurrents ou d'autres acteurs de la même ligne d'activité.
0.32814282178878784 ||| Frequency and route of administration ||| Dosage and Frequency of administration ||| Fréquence et voie d’ administration
4.740216465876079e-13 ||| Commission a) Opinion received b) Decision c) Notification d) OJ No. ||| Commission a) Opinion received b) Decision c) Notification d) OJ No. ||| Commission a) Avis reçu le b) Date de décision c) Notification d) JO nº
0.19031409919261932 ||| Myocardial infarction, congestive heart failure, angina, supraventricular tachycardia, arrhythmia, atrial fibrillation, pericarditis, cardiomyopathy ||| Sinusitis, bronchitis, dysphonia, epistaxis, rhinitis, respiratory disorder, nasal congestion, rhinorrhea, nonproductive cough 12 ||| infarctus du myocarde, insuffisance cardiaque congestive, angor, tachycardie supraventriculaire, arythmie, fibrillation auriculaire, péricardite, cardiomyopathie
0.4462648034095764 ||| In 1991 Mrs Mendosa was transferred to the London office of the European Commission Representation in the UK. ||| Ms Nuttall then served with the Food and Agriculture Organisation of the United Nations for five years before joining the EMEA in May 1995. ||| En 1991, Mme Mendosa a été transférée au bureau londonien de la représentation de la Commission européenne au Royaume-Uni.
0.2125970721244812 ||| Do not use TOVIAZ after the expiry date which is stated on the carton and the blister after “EXP”. ||| Do not use M-M-RVAXPRO after the expiry date which is stated on the outer carton after EXP. ||| Ne pas utiliser TOVIAZ après la date de péremption mentionnée sur l’ étui et la plaquette thermoformée après « EXP ».
0.2631978988647461 ||| Following a single oral dose of cysteamine bitartrate equivalent to 1.05 g of cysteamine free base in healthy volunteers, the mean (± sd) values for the time to peak and peak plasma concentration are 1.4 (± 0.5) hours and 4.0 (± 1.0) µg/ ml, respectively. ||| The presence of food delayed the absorption of the melatonin resulting in a later (Tmax=3.0 h versus Tmax=0.75 h) and lower peak plasma concentration in the fed state (Cmax=1020pg/ ml versus Cmax=1176 pg/ ml). ||| Après administration par voie orale chez le volontaire sain d'une dose unique de bitartrate de cystéamine équivalente à 1,05 g de cystéamine exprimée en base libre, les valeurs moyennes (± écart- type) correspondant au temps d’ apparition du pic plasmatique et à la concentration à ce pic sont respectivement de 1,4 (± 0,5) heures et de 4,0 (± 1,0) µg/ ml.
3.125964656396085e-13 ||| Pramipexole may be associated with libido disorders (increased (0.1%) or decreased (0.4%)). ||| Pramipexole may be associated with libido disorders (increased (0.1%) or decreased (0.4%)). ||| 6 Le pramipexole peut être associé à des troubles de la libido (augmentation 0,1% ou diminution 0,4%).
0.6498520374298096 ||| Start on the day after your chemotherapy. ||| 2 mg on the day of dialysis ||| Débutez le traitement le lendemain de la chimiothérapie.
0.4615083932876587 ||| Rosiglitazone was associated with increases in weight. ||| The increase correlated with total bilirubin concentrations. ||| Le traitement par la rosiglitazone s'est accompagné d'une prise de poids.
0.20009031891822815 ||| Each tablet contains 1000 mg nicotinic acid and 20 mg laropiprant. • The other ingredients are: hypromellose (E464), colloidal anhydrous silica (E551), sodium stearyl fumarate, hydroxypropylcellulose (E463), microcrystalline cellulose (E460), croscarmellose sodium, lactose monohydrate, and magnesium stearate. ||| The other ingredients are lactose monohydrate, microcrystalline cellulose, colloidal anhydrous silica, talc and magnesium stearate, all in the tablet core; and methacrylic acid - ethyl acrylate copolymer (1:1), sodium lauryl sulphate, polysorbate 80, talc, triacetin and simethicone emulsion, all in the tablet coating. ||| Chaque comprimé contient 1000 mg d’ acide nicotinique et 20 mg de laropiprant. • Les autres composants sont: hypromellose (E464), silice colloïdale anhydre (E551), fumarate de stéaryle sodique, hydroxypropylcellulose (E463), cellulose microcristalline (E460), croscarmellose sodique, lactose monohydraté et stéarate de magnésium.
0.2689609229564667 ||| In its pilot phase, the S  E Pilot will provide an EU guarantee of up to €50 million backed by the European Fund for Strategic Investments (EFSI), triggering debt financing for skills and education projects in Europe, with the aim of mobilising more than €200 million in total financing. ||| The EU External Investment Plan (EIP) includes a €1.55 billion financial guarantee - the EFSD guarantee -, of which €500 million is being made available for the EU's neighbourhood, to bring in much more public and private investment. ||| Dans sa phase pilote, le nouvel instrument fournira une garantie de l'UE d'un montant maximal de 50 millions d'euros, avec le soutien du Fonds européen pour les investissements stratégiques (FEIS), qui permettra le financement par l'emprunt de projets dans le domaine des compétences et de l'éducation en Europe, l'objectif étant de mobiliser plus de 200 millions d'euros de financements au total.
0.2585359215736389 ||| Porcilis PCV is a vaccine. ||| Purevax RCP is a vaccine. ||| Porcilis PCV est un vaccin.
0.4761955142021179 ||| 63 Stalevo comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets). ||| Packs of 14, 28, 56, 112 (2x56), 168 (3x56) and 180 tablets. ||| Stalevo existe en six conditionnements différents (10, 30, 100, 130, 175 ou 250 compriméss.
0.39507973194122314 ||| If any of these apply to you, tell your doctor before you take Rasilez. ||| Follow all instructions given to you by your doctor carefully before you are given Aclasta. ||| Si vous êtes dans l’ une de ces situations, parlez -en à votre médecin avant de prendre Rasilez.
0.4257669746875763 ||| The majority of adverse reactions have not usually required cessation of therapy. ||| All these target organs have shown partial to full recovery following discontinuation of treatment. ||| La majorité des évènements indésirables n’ a habituellement pas nécessité d’ arrêt de traitement.
0.34637075662612915 ||| Data suggest that gemcitabine can be started after the acute effects of radiation have resolved or at least one week after radiation. ||| A change to treatment should also be considered if levels of the virus remain high after a year of treatment with Hepsera on its own. ||| Les données suggèrent que la gemcitabine peut être débutée après la résolution des effets aigus de l’irradiation ou au moins une semaine après l’irradiation.
0.3534958064556122 ||| The safety and efficacy of filgrastim administration in patients with myelodysplastic syndrome or chronic myelogenous leukaemia have not been established. ||| Safety information following 3 years of raloxifene treatment suggests that raloxifene treatment does not increase pelvic floor relaxation and pelvic floor surgery. ||| L'innocuité et l'efficacité de l’ administration de filgrastim chez les patients atteints de syndrome myélodysplasique ou de leucémie myéloïde chronique n'ont pas été établies.
4.1058514010580693e-13 ||| 4.5 Interactions with other medicinal products and other forms of interaction ||| 4.5 Interactions with other medicinal products and other forms of interaction ||| 24 4.5 Interactions avec d’ autres médicaments et autres formes d’ interaction
0.36574792861938477 ||| With the current knowledge, a possible risk for the development of lymphomas or other malignancies in patients treated with a TNF-antagonist cannot be excluded. ||| AMMONAPS does not completely prevent the occurrence of an acute excess of ammonia in the blood and is not appropriate for treating such a condition, which is a medical emergency. ||| Dans l'état actuel des connaissances, la possibilité d'un risque de développer des lymphomes ou autres maladies malignes chez les patients traités par anti-TNF ne peut être exclue. tn
0.03910908102989197 ||| Infanrix hexa can be considered for the booster if the composition is in accordance with the official recommendations. ||| Infanrix Penta can be considered for the booster if the composition is in accordance with the official recommendations. ||| Infanrix hexa peut être utilisé en tant que rappel si sa composition est conforme aux recommandations locales officielles.
0.7526846528053284 ||| France sanofi-aventis France Tél: ||| Malta sanofi-aventis Malta Ltd. ||| 93 France sanofi-aventis France Tél:
0.12569734454154968 ||| What is the risk associated with Circadin? ||| What is the risk associated with Nonafact? ||| Quels sont les risques associés à Circadin?
0.355477899312973 ||| Each vial contains 90 mg ustekinumab in 1 ml. ||| Insuman Basal contains 100 IU insulin per ml. ||| Chaque flacon contient 90 mg d’ ustekinumab dans 1ml.
0.4215412735939026 ||| Consequently when dosing children with soft capsules, therapeutic drug monitoring may be a useful tool to ensure appropriate lopinavir exposure in an individual patient. ||| However, one review suggests that promoting hand washing with soap is significantly more cost-effective than other water and sanitation interventions. ||| Par conséquent lorsque les enfants sont traités avec les capsules molles, les dosages plasmatiques peuvent être un moyen utile de s’ assurer de l’ exposition à la dose appropriée de lopinavir chez un patient particulier.
0.1591225266456604 ||| Helixate NexGen 250 IU Powder and solvent for solution for injection. ||| Helixate NexGen 250 IU Powder for solution for injection ||| Helixate NexGen 250 UI poudre et solvant pour solution injectable.
0.27240613102912903 ||| Also upon the urgent request of the Commission, the European Committee for Standardization (CEN) and the European Committee for Electrotechnical Standardization (CENELEC), in cooperation with their members made available a number of European standards for certain medical devices and personal protective equipment. ||| Today's Communication confirms the recent statements on using flexibility within accounting and prudential rules, such as those made by the Basel Committee of Banking Supervision, the European Banking Authority (EBA) and the European Central Bank, amongst others. ||| À la demande pressante de la Commission également, le Comité européen de normalisation (CEN) et le Comité européen de normalisation électrotechnique (CENELEC), en coopération avec leurs membres, ont mis à disposition une série de normes européennes relatives à certains dispositifs médicaux et équipements de protection individuelle.
0.40394461154937744 ||| Axura 10 mg/ g oral drops, solution Memantine hydrochloride ||| Micronised amoxicillin (as trihydrate) 150.0 mg/ ml Excipient: ||| Axura 10 mg/ g solution buvable en gouttes Chlorhydrate de mémantine
0.0 ||| THE WORDS “ FOR ANIMAL TREATMENT ONLY” ||| THE WORDS “ FOR ANIMAL TREATMENT ONLY” ||| LA MENTION "À USAGE VÉTÉRINAIRE"
0.3056715130805969 ||| In vitro binding of emtricitabine to human plasma proteins was < 4% and independent of concentration over the range of 0.02-200 µg/ ml. ||| Intravenous studies with lamivudine and zidovudine showed that the mean apparent volume of distribution is 1.3 and 1.6 l/ kg respectively. ||| Distribution: la liaison in vitro de l’ emtricitabine aux protéines plasmatiques humaines a été < 4% et indépendante de la concentration sur l’ intervalle 0,02-200 µg/ ml.
0.0 ||| You should check with your doctor or pharmacist if you are not sure. ||| You should check with your doctor or pharmacist if you are not sure. ||| En cas d’incertitude, consultez votre médecin ou votre pharmacien.
0.02712928131222725 ||| Adults: oral CellCept should be initiated within 72 hours following transplantation. ||| Adults: oral CellCept should be initiated within 5 days following transplantation. ||| Adultes: par voie orale, le traitement par CellCept doit être initié dans les 72 heures suivant la greffe.
0.05369839817285538 ||| 170 ANNEX II ||| 155 ANNEX II ||| 190 ANNEXE II
0.5673165917396545 ||| Time to progression was the primary endpoint. ||| Time to progression (TTP) was the primary endpoint. ||| Le critère principal était le temps jusqu’ à progression.
0.39899730682373047 ||| You might feel drowsy if Olanzapine Mylan is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers). ||| Tell your doctor if:  you are taking medicines for Parkinson’ s disease,  you are taking antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers). ||| La prise de OLANZAPINE MYLAN peut entraîner une somnolence si vous prenez OLANZAPINE MYLAN avec des antidépresseurs ou des médicaments pour l'anxiété ou l'insomnie (tranquillisants).
0.41097718477249146 ||| As patients with severe liver disease were not studied, nateglinide is contraindicated in this group. ||| As there is no experience with Caelyx in patients who have had splenectomy, treatment with Caelyx is not recommended. ||| Le natéglinide n'ayant pas fait l'objet d'études chez les patients atteints d'insuffisance hépatique sévère, il est contre indiqué chez ces patients.
0.49046164751052856 ||| Rice milk ||| Chili sauce ||| Lait de riz
0.31160327792167664 ||| Merck NM P. O. Box 23033 S-10435 Stockholm Sweden ||| Merck Nm Ab Box 23033 Se-104 35 Stockholm Sweden ||| Merck NM P. O. Box 23033 S-10435 Stockholm Suède
0.36769407987594604 ||| Various formulations of fosaprepitant have been administered to a total of 729 individuals including 347 healthy subjects and 149 patients with CINV. ||| The pharmacokinetics of sunitinib and sunitinib malate have been evaluated in 135 healthy volunteers and 266 patients with solid tumours. ||| Différentes formes de fosaprépitant ont été administrées chez un total de 729 sujets dont 347 sujets sains et 149 patients atteints de nausées et vomissements induits par une chimiothérapie.
0.33228158950805664 ||| Berlimed S. A., Poligono Industrial Santa Rosa s/ n, 28806 Alcalá de Henares, Madrid, Spain ||| Merck Sharp & Dohme de España, S. A., Josefa Valcárcel, 38 28027 Madrid Spain ||| Berlimed S. A., Poligono Industrial Santa Rosa s/ n, 28806 Alcala de Henares, Madrid, Espagne
0.2569870948791504 ||| In the HIV-positive population receiving an NRTI regimen, physicians should carefully monitor markers of mitochondrial toxicity and lactic acidosis when ribavirin is administered. ||| In patients with patent nasolacrimal ducts, topical ocular administration of OPATANOL was suggested to reduce the nasal signs and symptoms that frequently accompany seasonal allergic conjunctivitis. ||| Dans cette population de patients VIH positifs recevant un schéma thérapeutique associant au moins un INTI et la ribavirine, les médecins doivent surveiller attentivement les marqueurs de toxicité mitochondriale et d’ acidose lactique.
0.3021641969680786 ||| Kaletra is not recommended for use in children less than 2 years of age because of limited efficacy and safety data. ||| Electroretinography may be useful but should be used only in children less than 3 years of age. ||| L’ utilisation de Kaletra n’ est pas recommandée chez les enfants de moins de deux ans en raison des données limitées d’ efficacité et de sécurité.
0.08419393002986908 ||| PritorPlus 80 mg/ 12.5 mg tablets telmisartan/ hydrochlorothiazide ||| MicardisPlus 80 mg/ 25 mg tablets telmisartan/ hydrochlorothiazide ||| PritorPlus 80 mg/ 12,5 mg comprimés telmisartan/ hydrochlorothiazide
0.5893142223358154 ||| This population included 34 patients 2 to < 12 years old and 20 patients 12-15 years of age. ||| Of these, 2 were children aged 2 and 5 years and 2 were adolescents of 16 years. ||| Cette population incluait 34 patients âgés de 2 ans à moins de 12 ans et 20 patients âgés de 12 à 15 ans.
0.15997393429279327 ||| 28/ 45 ||| 29/ 44 ||| 28/ 46
0.3515878915786743 ||| Tredaptive is normally given together with a statin (the standard medicine used to reduce cholesterol) when the effectiveness of a statin taken alone is inadequate. ||| In monotherapy (used on its own), the committee decided that Actos should be an alternative to the standard treatment, metformin, to be used when patients cannot take metformin. ||| Tredaptive est normalement prescrit avec une statine (le médicament standard utilisé pour diminuer le cholestérol), lorsque l’ efficacité d’ une statine seule est insuffisante.
0.40094026923179626 ||| The recommended dose of Sprimeo is 150 mg once a day, either taken alone or in combination with other medicines for hypertension. ||| The two medicines, IL-2 and Ceplene, are both injected twice a day, with a minimum of 6 hours between injections. ||| La dose recommandée de Sprimeo est de 150 mg une fois par jour, soit seul soit en association avec d’ autres antihypertenseurs.
1.0102874040603638 ||| Dispense onto sponge and wait 15 min. ||| 20-40 Repeat every 24 hours. ||| Répartir sur la matrice et attendre 15 min.
0.37027251720428467 ||| 3.5% ||| 2.15% ||| 3,5%
0.480562686920166 ||| Pressure regulators ||| Liver reactions ||| Régulateurs de pression
0.3721558451652527 ||| Combivir should not be taken with some other medicines. ||| Tasigna can be given with certain other medicines if appropriate. ||| Combivir ne doit pas être associé à certains médicaments.
4.4712923142654903e-13 ||| There is no information to suggest that Gardasil affects your ability to drive or use machinery. ||| There is no information to suggest that Gardasil affects your ability to drive or use machinery. ||| 67 Il n'y a aucune information permettant d'établir que Gardasil affecte votre capacité à conduire ou à utiliser certains outils ou machines.
0.46458035707473755 ||| Testing apparatus for testing printed circuit boards ||| Test probe assemblies for integrated circuits ||| Appareils de test pour circuits imprimés
0.17360608279705048 ||| Hoses (Non-metallic -) for use with watercraft ||| Seals (Non-metallic -) for automotive applications ||| Tuyaux non métalliques pour embarcations
0.29142001271247864 ||| Reproductive toxicity studies have not been performed with Pegasys. ||| No pre-clinical studies have been performed with Aerinaze. ||| Il n'a pas été conduit d'études de toxicité sur la reproduction avec Pegasys.
0.26935893297195435 ||| Care must be taken not to administer Bondenza injection via intra-arterial or paravenous administration as this could lead to tissue damage. ||| The use of rigid catheter as well as intramuscular injections and nonessential handling of the patient should be avoided during treatment with reteplase. ||| Toutes les précautions doivent être prises afin de ne pas administrer Bondenza IV par voie intra-artérielle ou périveineuse, car cela pourrait entraîner une lésion tissulaire.
0.28944164514541626 ||| 48 Because therapy with Neupro is initiated at a low dose and gradually titrated according to clinical tolerability to obtain the optimum therapeutic effect, adjustment of the dose based on gender, weight, or age is not necessary. ||| Patients should be maintained on a single formulation of tacrolimus with the corresponding daily dosing regimen; alterations in formulation or regimen should only take place under the close supervision of a transplant specialist (see sections 4.4 and 4.8). ||| Groupes particuliers de patients Comme le traitement par Neupro débute à faible dose et est augmenté progressivement en fonction de la tolérance clinique pour obtenir un effet thérapeutique optimal, aucun ajustement de la dose en fonction du sexe, du poids ou de l’ âge n’ est nécessaire.
0.1078275591135025 ||| If you take more Keppra than you should: ||| If you take more Xagrid than you should: ||| Si vous avez pris plus de Keppra que vous n’ auriez dû:
0.5667787790298462 ||| Separating apparatus for laboratory use ||| Deodorising apparatus, not for personal use ||| Appareils de séparation pour laboratoire
0.3208142817020416 ||| An increased incidence of keratoacanthoma in the skin was observed in male rats at doses of 4 and 10 mg/ kg/ day (≥ 4 times the exposure with the MRHD based on AUC). ||| Adverse reactions occurring at a numerically higher rate among patients receiving CELSENTRI 300 mg twice daily + OBT than patients on OBT alone with an incidence of ≥ 1% ||| Une incidence accrue des kérato-acanthomes cutanés a été relevée chez les rats mâles aux doses de 4 et 10 mg/ kg/ jour (≥ 4 fois l’ exposition à la dose maximale recommandée chez l’ Homme d’ après l’ ASC).
0.358266681432724 ||| 56 Table 4 ||| 50 Table 8 ||| Tableau 4:
0.35283362865448 ||| In a clinical study in PID patients, the maximum infusion rate was 7.2 ml/kg bw/hr. ||| In a rat pre- and postnatal development study, the no observed effect dose was 30 mg/ kg/ day. ||| Dans une étude clinique sur des patients atteints de DIP, le débit de perfusion maximal était de 7,2 ml/kg de p. c./h.
0.230258971452713 ||| However, systemic clearance of tigecycline was reduced by 25% and 55% and the half-life of tigecycline was prolonged by 23% and 43% in patients with moderate or severe hepatic impairment (Child Pugh B and C), respectively (see section 4.2). ||| The metabolism of entacapone is slowed in patients with mild to moderate hepatic impairment (Child-Pugh Class A and B) leading to an increased plasma concentration of entacapone both in the absorption and elimination phases (see sections 4.2 and 4.3). ||| Cependant, chez les patients avec une insuffisance hépatique modérée ou sévère (score Child Pugh B ou C), la clairance systémique de la tigécycline est réduite de 25% et 55%, et sa demi-vie prolongée, respectivement de 23% et 43% (voir rubrique 4.2).
0.5467649698257446 ||| 47 España Ipsen Pharma S. A. ||| 192 Ελλάδα Aenorasis S.A. ||| España Ipsen Pharma S. A.
0.15579743683338165 ||| 10 vials of suspension (25 dose size) + 10 vials of emulsion (25 dose size). ||| 1 vial of suspension (25 dose size) + 1 vial of emulsion (25 dose size). ||| 10 flacons de suspension (taille pour 25 doses) + 10 flacons d’ émulsion (taille pour
0.3204224705696106 ||| 336 soft capsules (4 bottles of 84 capsules each) ||| 36 soft capsules (6 foil blisters of 6 capsules) ||| 336 capsules molles (4 flacons de 84 capsules molles)
0.035123061388731 ||| However, if you take more Azomyr oral lyophilisate than you were told to, contact your doctor or pharmacist. ||| However, if you take more Neoclarityn oral lyophilisate than you were told to, contact your doctor or pharmacist. ||| Cependant, si vous avez pris plus d’ Azomyr lyophilisat oral que vous n’ auriez dû, prévenez votre médecin ou votre pharmacien.
0.1463598608970642 ||| Some people get depressed when taking IntronA alone or in combination treatment with ribavirin, and in some cases people had thoughts about threatening the life of others, suicidal thoughts or aggressive behaviour (sometimes directed against others). ||| Some people get depressed when taking ViraferonPeg alone or in combination treatment with ribavirin, and in some cases people had suicidal thoughts or aggressive behaviour (sometimes directed against others). ||| Certaines personnes se sont senties déprimées en prenant IntronA seul ou en association avec la ribavirine, et dans certains cas, ont eu des pensées d’atteinte à la vie d’autrui, idées suicidaires ou un comportement agressif (parfois dirigé contre autrui).
0.06377438455820084 ||| The European Commission granted a marketing authorisation valid throughout the European Union for AVAMYS to Glaxo Group Ltd on 11 January 2008. ||| The European Commission granted a marketing authorisation valid throughout the EU for Volibris to Glaxo Group Ltd on 21 April 2008. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour AVAMYS à Glaxo Group Ltd, le 11 janvier 2008.
0.5573144555091858 ||| Demolition services ||| Physical rehabilitation ||| Services de démolition
0.39639702439308167 ||| 23 Biotransformation Metabolism is the major elimination pathway for vildagliptin in humans, accounting for 69% of the dose. ||| Therefore, the rate limiting step in the whole process is the cleavage of 13C-urea by Helicobacter's urease. ||| Biotransformation Le métabolisme est la principale voie d’ élimination de la vildagliptine chez l’ Homme et il représente 69% de la dose.
0.44123706221580505 ||| The European Union and its Member States are playing their part in tackling this health crisis and its severe consequences - at home and abroad. ||| The EU will put all efforts, together with Member States, to help the European tourism ecosystem recover from the crisis. ||| L'Union européenne et ses États membres participent à la lutte contre cette crise sanitaire et ses graves conséquences, tant à l'intérieur qu'à l'extérieur de leurs frontières.
0.24604950845241547 ||| Generally these symptoms are mild to moderate however, in some patients they may be severe in intensity. ||| These reactions were generally mild to moderate; however, on rare occasions they were severe. ||| Ces symptômes sont généralement d’ intensité légère à modérée, mais peuvent être d’ intensité sévère chez certains patients.
0.383021742105484 ||| Saudi Arabia has committed to the global effort to ensure that everyone in the world has access to COVID-19 testing, treatments and therapeutics. ||| Mexico reaffirms its commitment to cooperate in the development of the COVID-19 vaccine and to ensure that access to it will be fair and equitable for everyone. ||| L'Arabie saoudite s'est engagée en faveur de l'action mondiale visant à garantir que partout dans le monde, chacun ait accès au dépistage, aux traitements et aux thérapies concernant la COVID-19.
0.4851343035697937 ||| 0.88 (0.7, 1.11) ||| 0.65 (p < 0.0001) ||| (31,0 - 37,1) 1,11)
0.4307712912559509 ||| Soliris was more effective than placebo in improving the symptoms of PNH. ||| Procoralan therefore reduces or prevents the symptoms of angina. ||| Soliris était plus efficace que le placebo dans l’ amélioration des symptômes de la HPN.
0.5440164804458618 ||| You must not take losartan if you are breast-feeding. ||| If you are using , you must not breast- feed. ||| Vous ne devez pas prendre Cozaar si vous allaitez.
0.04187729209661484 ||| Ireland GlaxoSmithKline (Ireland) Limited Stonemasons Way Rathfarnham, Dublin 16 Ireland ||| GlaxoSmithKline (Ireland) Limited Stonemasons Way, Rathfarnham, Dublin 16 Ireland ||| Allen & Hanbury) Stonemasons Way Rathfarnham Dublin 16 Irlande
0.054533541202545166 ||| France Merck Lipha Santé s. a. s. ||| 188 France Merck Lipha Santé s. a. s. ||| France Merck Lipha Santé s.a.s.
0.28657129406929016 ||| Inhaled insulin frequently induces insulin antibodies, the risk of which to the foetus is not known. ||| Salmeterol acts locally in the lung therefore plasma levels are not an indication of therapeutic effects. ||| L’ insuline inhalée induit fréquemment des anticorps anti-insuline pour lesquels le risque pour le fœ tus n’ est pas connu.
0.6452507972717285 ||| N= 196% ||| N=170 12% 17% ||| N= 196
0.4092395007610321 ||| Instruction in the maintenance of computers ||| Training in the use of optical sensors ||| Services de formation en entretien d'ordinateurs
0.3251011371612549 ||| If you inject more SOMAVERT than you should ||| If you inject more Abseamed than you should ||| Si vous avez injecté plus de SOMAVERT que vous n’ auriez dû
0.5417718887329102 ||| Other medicines used for HIV infection: ||| For active immunisation of chickens: ||| Autres médicaments utilisés pour l'infection par le VIH:
0.33794844150543213 ||| In vitro metabolism studies have shown that CYP2D6 and to a lesser extent, CYP3A4 and CYP1A2 isoenzymes are involved in the metabolism of palonosetron. ||| CYP3A4 and CYP2B6 induction) The steady-state AUC, Cmax and Cmin of the active carbamazepine epoxide metabolite remained unchanged. ||| Les études de métabolisme in vitro ont montré que les isoenzymes CYP2D6 et, dans une moindre mesure, CYP3A4 et CYP1A2, sont impliqués dans le métabolisme du palonosétron.
0.012107104063034058 ||| Approximately 12% of children treated with Ribavirin and interferon alfa-2b developed increase in TSH. ||| Approximately 12% of children treated with interferon alfa-2b and ribavirin developed increase in TSH. ||| Approximativement 12% des enfants traités par ribavirine et l’ interféron alfa-2b ont développé une élévation du taux de TSH.
0.6885353922843933 ||| On Wednesday, Woolworths also limited toilet paper purchases for home delivery to one pack per order. ||| Recycled toilet paper producer Who Gives a Crap said on last Wednesday they'd run out of stock. ||| Mercredi, Woolworths a également restreint les achats de papier toilette pour les livraisons à domicile à un paquet par commande.
0.10194693505764008 ||| Caelyx should not be used in people who may be hypersensitive (allergic) to doxorubicin hydrochloride or any of the other ingredients. ||| Cubicin should not be used in people who may be hypersensitive (allergic) to daptomycin or the other ingredient (sodium hydroxide). ||| Caelyx ne doit pas être utilisé chez les patients susceptibles d’ être hypersensibles (allergiques) au chlorhydrate de doxorubicine ou à l’ un des autres composants.
2.9583456452771106e-13 ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| De plus, un PGR mis à jour devra être soumis: • Lors de la réception de nouvelles informations pouvant avoir un impact sur le profil de sécurité d’ emploi, le plan de pharmacovigilance ou les activités de minimisation des risques; • Dans les 60 jours qui suivent la date à laquelle une étape importante (pharmacovigilance ou minimisation des risques) est franchie; • A la demande de l’ EMEA
0.3586371839046478 ||| Shock absorbing springs being parts of machine suspension ||| Blow pipes being parts of gas cutting apparatus ||| Ressorts d'amortisseurs en tant que pièces de suspension de machines
0.453877717256546 ||| The vials that is not being used is to be stored in a refrigerator (2°C - 8°C). ||| IntronA has to be stored in a refrigerator (2°C-8°C). ||| Les flacons non utilisés sont à conserver au réfrigérateur (entre 2°C et 8°C). e
0.1328115165233612 ||| Mean (SEM) ||| Mean (SD) ||| Moyenne (ESM)
4.577772622776921e-13 ||| This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. na ||| This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. na ||| 6.2 Incompatibilités s n'e Ce médicament ne doit pas être mélangé avec d’ autres médicaments à l’ exception de ceux mentionnés dans la rubrique 6.6.
0.34639012813568115 ||| Piano strings ||| Anal plugs ||| Cordes de pianos
0.28441089391708374 ||| If an adverse event occurs during the administration of Soliris, the infusion may be slowed or stopped at the discretion of the physician. ||| Because of the risk of allergic reaction, the first injection should be supervised by a doctor, and the patient looked after for 30 minutes. ||| Si un effet indésirable se produit pendant l’ administration de Soliris, la perfusion peut être ralentie ou interrompue sur décision du médecin.
0.6450104713439941 ||| They will be mainly implemented through grants and procurement and, in certain cases, with partner organisations. ||| Although in many cases MEPs will be participating remotely, committees are continuing their work. ||| Celles-ci seront pour l'essentiel mises en application au moyen de subventions et de marchés publics et, dans certains cas, en y associant des organisations partenaires.
0.09306509047746658 ||| Suspension for injection 5 x 3ml pre-filled pens ||| Solution for injection 5 x 3ml pre-filled pens ||| Suspension injectable, 5 stylos préremplis de 3 ml
0.16284102201461792 ||| HOW TO STORE CRIXIVAN ||| HOW TO STORE PANDEMRIX ||| COMMENT CONSERVER CRIXIVAN
0.006234892178326845 ||| Aranesp 80 micrograms solution for injection in a pre-filled pen. ||| Aranesp 50 micrograms solution for injection in a pre-filled pen. ||| Aranesp 80 microgrammes, solution injectable en stylo prérempli.
1.1522785425186157 ||| Table 1 Undesirable Effects in Clinical Studies t ||| Frequently Asked Questions about Priming ||| Tableau 1 Effets indésirables observés dans les études cliniques
0.2896040976047516 ||| If symptoms are severe or persist the alpha-2-adreno-receptor antagonist atipamezole hydrochloride may be used at a dose of 0.2 mg/ kg bodyweight by intramuscular injection to reverse these side- effects. ||| All patients must receive 20 mg of dexamethasone intravenously 30 minutes prior to Yondelis; not only as anti-emetic prophylaxis, but also because it appears to provide hepatoprotective effects. ||| Si les symptômes sont sévères ou persistent, il est possible d’ administrer l’ hydrochorure d’ atipamezole, un antagoniste des récepteurs alpha2-adrénergiques, à la dose de 0,2 mg/ kg de poids vif par voie intramusculaire afin d’ inverser ces effets secondaires.
0.43940269947052 ||| No studies have been done on the use of Telzir/ ritonavir with other hormonal therapies, such as hormone replacement therapy (HRT). ||| If you are taking estrogen replacement therapy (ERT) or hormone replacement therapy (HRT), FABLYN may not be suitable for you. ||| Aucune étude n’a été réalisée sur l’utilisation de Telzir/ritonavir avec d’autres traitements hormonaux, comme le traitement hormonal substitutif (THS).
0.06696948409080505 ||| 97.9% ||| 98.9% ||| 97,9%
0.5719387531280518 ||| THE POLICY FUNDAMENTALS OF THE RECOVERY ||| INFORMATION FOR THE HEALTHCARE PROFESSIONALS ||| LES FONDEMENTS DE LA RELANCE
0.5689337253570557 ||| Steele and Stallman's finished implementation included facilities for extending and documenting the new macro set. ||| Two years later, Guy Steele took on the project of unifying the diverse macros into a single set. ||| Après une nuit de hacking entre Steele et Stallman, ce dernier termine le codage, qui inclut des facilités pour étendre et documenter le nouveau jeu de macros.
0.518970787525177 ||| Providing access to platforms on the Internet ||| Rental of electronic memory space on the Internet ||| Fourniture d'accès à des plates-formes sur Internet
0.41162461042404175 ||| The reconstituted solution should be further diluted within an hour. ||| The amount of reconstituted solution should be administered according to section 4.2. ||| La solution reconstituée doit être diluée dans l’ heure qui suit.
0.6369104981422424 ||| This increase is not considered clinically relevant. ||| The safety was considered sufficiently shown. ||| Cette augmentation n’est pas jugée pertinente sur le plan clinique.
0.25117364525794983 ||| EU/ 1/ 03/ 268/ 001 EU/ 1/ 03/ 268/ 002 EU/ 1/ 03/ 268/ 003 EU/ 1/ 03/ 268/ 004 ||| EU/ 1/ 02/ 233/ 005… 1 x 3 ml EU/ 1/ 02/ 233/ 006 5 x 3 ml EU/ 1/ 02/ 233/ 007 10 x 3 ml ||| EU/ 1/ 03/ 268/ 01 EU/ 1/ 03/ 268/ 02 EU/ 1/ 03/ 268/ 03 EU/ 1/ 03/ 268/ 04
1.015668511390686 ||| The Committee for Medicinal products for Human Use (CHMP) decided that Dynepo’ s benefits are ||| The World Health Organization has "Five Moments" for washing hands: ||| Le comité des médicaments à usage humain (CHMP) a estimé que les effets bénéfiques de Dynepo
0.4541201591491699 ||| The study compared the effects of Oxyglobin with no treatment. ||| Any increase in 13CO2 will be measured by isotopic analysis. ||| Cette étude a comparé les effets d’ Oxyglobine par rapport à une absence de traitement.
0.4448949098587036 ||| It is used for short-term treatment of superficial skin infections. ||| It is used for the treatment of hepatitis B virus infection. ||| Il est utilisé pour le traitement à court terme d’ infections cutanées superficielles.
0.4014880061149597 ||| Trazec 180 mg film-coated tablets Nateglinide ||| Xagrid 0.5mg hard capsules (anagrelide) ||| Trazec 180 mg, comprimés pelliculés Natéglinide
0.19028112292289734 ||| Concomitant administration of potent CYP3A4 inhibitors is contraindicated (see sections 4.3 and 4.5). ||| Therefore, concomitant use of aliskiren and P-gp potent inhibitors is contraindicated (see section 4.3). ||| L’ administration concomitante d’ inhibiteurs puissants du CYP3A4 est contre-indiquée (voir rubriques 4.3 et 4.5).
0.534186840057373 ||| The European Commission granted a marketing authorisation valid throughout the EU for Siklos to Addmedica on 29 June 2007. ||| In Jamaica, the EU funded PROMAC programme has financed 29 intensive care unit ventilators. ||| La Commission européenne a délivré une autorisation de mise sur le marché pour Siklos à Addmedica le 29 juin 2007.
0.43176722526550293 ||| Insulin Human Winthrop Comb 25 is a fluid (suspension) for injection under the skin. ||| Do not inject Insulin Human Winthrop Comb 50 into a vein (blood vessel). ||| Insulin Human Winthrop Comb 25 est un liquide (suspension) destiné à être injecté sous la peau.
0.42886635661125183 ||| The younger patients with the severe phenotype (< 2.5 years) and all 4 patients with the intermediate phenotype exhibited a normal rate of mental development, whereas the older patients with a severe phenotype made limited or no gains in cognition. ||| Although patients representing the full range of the disease spectrum were enrolled, the majority of the patients were of the intermediate phenotype, with only one patient exhibiting the severe phenotype. ||| Les patients les plus jeunes avec phénotype sévère (< 2,5 ans) ainsi que l’ ensemble des 4 patients avec phénotype intermédiaire présentaient un développement mental normal, alors que les patients plus âgés avec phénotype sévère ont présenté peu ou pas de gains cognitifs.
0.6440907716751099 ||| 2 010 000 7 630 000 9 640 000 ||| 10 564 000 10 564 000 ||| 2 0 10 000 7 630 000 9 640 000
0.49939340353012085 ||| The use of the vaccine should be based on official recommendations. ||| It will also supply regular updates on the use and the safety of the vaccine. ||| L’ utilisation du vaccin doit s’ appuyer sur les recommandations officielles.
0.15324705839157104 ||| Humalog Mix25 KwikPen is used to treat diabetes. ||| Humalog Mix50 Pen is used to treat diabetes. ||| Humalog Mix25 KwikPen est utilisé dans le traitement du diabète.
0.2689872086048126 ||| Patients receiving radiolabelled Zevalin survived for an average of 37 months until their disease got worse, compared with 14 months in those who did not receive any further treatment. ||| Patients receiving a series of infusions of Remicade also maintained a response to treatment for longer (40 weeks) than those receiving placebo (14 weeks). ||| Les patients ayant été traités avec Zevalin radiomarqué ont bénéficié d’ une période de sursis moyenne de 37 mois avant l’ aggravation de leur maladie, en comparaison aux 14 mois obtenus par les patients qui n’ ont pas reçu de traitement supplémentaire.
0.0031381812877953053 ||| 46 Latvija GlaxoSmithKline Latvia SIA Tel: + 371 67312687 lv-epasts@gsk.com ||| 53 Latvija GlaxoSmithKline Latvia SIA Tel: + 371 67312687 lv-epasts@gsk.com ||| Latvija GlaxoSmithKline Latvia SIA Tel: + 371 67312687 lv-epasts@gsk.com
0.3758004307746887 ||| Taking other medicines It is likely that calcium supplements, antacids, and some oral medicines will interfere with the absorption of ADROVANCE if taken at the same time. ||| Taking FOSAVANCE with food and drink It is likely that food and beverages (including mineral water) will make FOSAVANCE less effective if taken at the same time. ||| Prise d’ autres médicaments S’ ils sont pris ensemble, les compléments calciques, les antiacides et certains médicaments administrés par voie orale, sont susceptibles d’ interférer avec l’ absorption d'ADROVANCE.
0.3229219317436218 ||| If your symptoms are not relieved within 4 weeks, please contact your doctor. ||| If you do not see any benefit after using it for 4 months contact your doctor. ||| Si vos symptô- mes ne sont pas atténués dans un délai de 4 semaines, contactez votre médecin.
0.4911156892776489 ||| The virological responses of HCV monoinfected patients treated with Pegasys monotherapy and with Pegasys and ribavirin combination therapy in relation to genotype and pre-treatment viral load and in relation to genotype, pre-treatment viral load and rapid virological response at week 4 are summarised in Table 7 and Table 8, respectively. ||| In 2016-2017, ECDC coordinated the second point-prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals and the third point-prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities. ||| Les réponses virologiques des patients mono-infectés par le VHC traités par Pegasys en monothérapie et par Pegasys en association avec la ribavirine, en fonction du génotype et de la charge virale initiale, et en fonction du génotype, de la charge virale initiale et de la réponse virologique rapide à la semaine 4, sont présentées respectivement dans le tableau 7 et dans le tableau 8.
0.25250354409217834 ||| HOW TO USE ALDURAZYME ||| HOW TO USE ALDARA CREAM ||| COMMENT UTILISER ALDURAZYME?
0.28080645203590393 ||| No evidence for mutagenic or genotoxic effects of ambrisentan were seen in bacteria or in two in vivo rodent studies. ||| No clinically significant pharmacokinetic drug-drug interactions were observed in studies with digoxin or warfarin. ||| L’ ambrisentan n’ était pas mutagène pour les bactéries et n'a donné aucune preuve de génotoxicité sur les rongeurs dans deux études in vivo.
0.36412739753723145 ||| To mitigate the potential negative impact of this, the Commission has proposed an extension of the current transitional arrangements in the CRR by two years, in line with the international agreement of the Basel Committee. ||| The financial framework for 2021-2027 proposed by the Commission in 2018, as reinforced by the Just Transition Mechanism and the changes proposed today, remains the essential point of reference for the final phase of negotiations. ||| Afin d'atténuer ces effets négatifs potentiels, la Commission a proposé de prolonger de deux ans les dispositions transitoires actuelles du CRR, conformément à ce qui a été convenu par le Comité de Bâle au niveau international.
0.018371161073446274 ||| 20 België/ Belgique/ Belgien Novartis Pharma N. V. ||| 42 België/ Belgique/ Belgien Novartis Pharma N. V. ||| België/ Belgique/ Belgien Novartis Pharma N. V.
0.5345995426177979 ||| Furnace grates ||| Hand grenades ||| Grilles de foyers
0.012698776088654995 ||| 100 mg dispersible/ chewable tablets: ||| 200 mg dispersible/ chewable tablets: ||| Comprimés dispersibles ou à croquer à 100 mg:
0.051489170640707016 ||| 16 October 1998 Date of last renewal: ||| 20 October 1995 Date of last renewal: ||| 16 Octobre 1998 Date de dernier renouvellement:
0.3301682472229004 ||| Myfenax is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. ||| Cetuximab pharmacokinetics were studied when cetuximab was administered as monotherapy or in combination with concomitant chemotherapy or radiation therapy in clinical studies. ||| Myfenax est indiqué en association à la ciclosporine et aux corticoïdes pour la prévention des rejets aigüs d’ organe chez les patients ayant bénéficiés d’ une allogreffe rénale, cardiaque ou hépatique.
0.745879054069519 ||| Trademark agent services ||| Ramen restaurant services ||| Services d'agences de marques
0.2328159511089325 ||| As with other anti-HIV medicines, patients taking Agenerase may be at risk of lipodystrophy (changes in the distribution of body fat), osteonecrosis (death of bone tissue) or immune reactivation syndrome (symptoms of infection caused by the recovering immune system). ||| These could include poorly controlled diabetes, untreated hypothyroidism (low levels of thyroid hormone for which no treatment is being given currently), proteins in urine (nephrotic syndrome), altered protein levels in the blood (dysproteinaemias), and blockage of the bile transport to your gall bladder (obstructive liver disease). ||| Comme d’ autres médicaments anti-VIH, Agenerase peut entraîner un risque de lipodystrophie (anomalie de la distribution des graisses dans le corps), d’ ostéonécrose (mort du tissu osseux) ou d’ apparition du syndrome de réactivation immunitaire (symptômes de l’ infection dus à la reconstitution du système immunitaire).
0.24880118668079376 ||| Zeffix 5 mg/ml oral solution Lamivudine ||| Bridion 100 mg/ ml injection sugammadex IV ||| Zeffix 5 mg/ml Solution Buvable Lamivudine
0.025008704513311386 ||| 67 4.4 Special warnings and precautions for use ||| 37 4.4 Special warnings and precautions for use ||| 4.4 Mises en garde spéciales et précautions d’ emploi
0.002309973118826747 ||| 356 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 347 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 370 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.2809915542602539 ||| Elimination The elimination of entacapone occurs mainly by non-renal metabolic routes. ||| Renal excretion of metabolites was the prevalent route of elimination of radioactivity. ||| 8 L’ élimination de l’ entacapone s’ effectue principalement par voie métabolique non rénale.
0.4921821057796478 ||| Daclizumab*………… 5 mg per 1 ml infusion ||| 1 vial = 2.3 mg ranibizumab. ||| Daclizumab* …………………… 5 mg par ml de solution
0.23872452974319458 ||| 66 300 mg irbesartan once daily in patients not adequately controlled on 300 mg irbesartan alone resulted in further placebo-corrected diastolic blood pressure reductions at trough (24 hours post-dosing) of 6.1 mm Hg. ||| e > 80 ml/ min) undergoing orthopaedic surgery and receiving fondaparinux 2.5 mg once daily, plasma clearance is 1.2 to 1.4 times lower in patients with mild renal impairment (creatinine clearance 50 to ||| L'addition de 12,5 mg d’ hydrochlorothiazide à 300 mg d’ irbésartan chez les patients mal contrôlés par la dose de 300 mg d’ irbésartan seul, en une prise par jour, produit une baisse de la pression artérielle diastolique supplémentaire (24 heures après la prise) d’ au moins 6,1 mm Hg, effet placebo déduit.
0.2619846761226654 ||| In studies of interferon use in non-human primates, abnormalities of the menstrual cycle have been observed (see section 4.4). ||| No observable teratogenicity was detected in reproductive studies performed in pregnant rats and rabbits (see section 5.3). ||| Lors des études d’ utilisation de l’ interféron chez les primates autres que l’ homme, des anomalies du cycle menstruel ont été observées (voir rubrique 4.4).
0.2482548952102661 ||| The maximum dose frequency is once per day. ||| The maximum recommended dosing frequency is one tablet per day. ||| La fréquence d'administration maximale est d'une prise par jour.
0.29961657524108887 ||| Take the syringe for administration, fill it with air to the correct dose. ||| Turn the bottle the correct way up and remove the syringe from the adapter. ||| Prenez la seringue pour l’ administration et remplissez -la d’ air jusqu’ à la dose prescrite.
0.43756839632987976 ||| About 20% of the dose has been accounted for in urine as metabolite. ||| A potentially dangerous amount of fentanyl remains in the system after use. ||| Environ 20% de la dose a été retrouvé dans les urines sous forme de métabolite.
0.3912642300128937 ||| After reconstitution with 1 ml of solvent, 1 ml of the clear solution contains either 10 mg, 15 mg, or 20 mg pegvisomant. ||| Powder in a vial (either 10 mg, 15 mg, or 20 mg pegvisomant) and solvent in a vial (8 ml). ||| Après reconstitution avec 1 ml de solvant, la solution limpide contient soit 10 mg, 15 mg ou 20 mg de pegvisomant par ml.
0.2935601770877838 ||| Other metabolites were detected in plasma, urine and faeces and represent less or equal than 3% of plasma AUC. ||| Soft tissue and skeletal variations in the foetuses were also observed at 10 and 20 mg/kg/day. ||| D’ autres métabolites ont été mis en évidence dans le plasma, l’ urine et les fèces et représentent au maximum 3% de l’ ASC plasmatique.
0.31749290227890015 ||| Many patients had confounding medical conditions, some of which required therapy with agents that have been associated with the development of diabetes mellitus or hyperglycaemia. ||| In some of these the high blood sugar was severe and in some cases also associated with ketoacidosis (change in metabolite levels in the blood). ||| Beaucoup de patients avaient des pathologies associées rendant difficile l’ analyse des cas; parmi ces pathologies associées, certaines nécessitaient un traitement par des médicaments pouvant provoquer un diabète sucré ou une hyperglycémie.
0.17247894406318665 ||| Rental of trains ||| Rental of batteries ||| Location de trains
0.30663028359413147 ||| In such a case, you may develop severe hypoglycaemia (and evenfaint) before you are aware of the problem. ||| If you are especially prone to develop such symptoms, which may even be life-threatening, then you should not receive Zevalin. ||| Dans ces situations, vous pouvez présenter une hypoglycémie sévère (et même de perte de connaissance) sans vous en apercevoir.
0.15979889035224915 ||| The presence of a minor infection is not a contraindication for immunisation. ||| The presence of a minor infection is not a contraindication. ||| Une infection bénigne n’ est pas une contre-indication à la vaccination.
0.44244152307510376 ||| Do not use Mycamine ||| Do not use Bonviva ||| N'utilisez jamais Mycamine
0.32508689165115356 ||| Metabolism and nutrition disorders Common Psychiatric disorders ||| Hypo- thyroidism Metabolism and Nutrition Disorders ||| Fréquent Troubles du métabolisme et de la nutrition
0.12514477968215942 ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Mixtard to Novo Nordisk A/ S on 7 October 2002. ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Betaferon to Schering Aktiengesellschaft on 30 November 1995. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Mixtard à Novo Nordisk A/ S, le 7 octobre 2002.
0.43917903304100037 ||| The development of severe peripheral neurotoxicity requires a reduction of dose (see section 4.2). ||| A low intersubject variability in systemic exposure (coefficient of variation ~25%) was observed. ||| L’ apparition d’ une neurotoxicité périphérique sévère impose une réduction de la dose (cf. paragraphe 4.2).
0.4293668866157532 ||| Automated payment services ||| Money ordering services ||| Services de paiement automatisé
0.16470938920974731 ||| Filgrastim HEXAL must not be diluted with sodium chloride solutions. ||| 31 Filgrastim ratiopharm should not be diluted with sodium chloride solution. ||| Filgrastim HEXAL ne doit pas être dilué avec des solutions salines.
0.10873425006866455 ||| 6.4% ||| 6.1% ||| 6,4%
3.8030554183263177e-13 ||| Doxazosin has a beneficial effect on blood lipids with significant increase of HDL/ total cholesterol ratio (app. ||| Doxazosin has a beneficial effect on blood lipids with significant increase of HDL/ total cholesterol ratio (app. ||| La doxazosine a des effets positifs sur les lipides sanguins, à savoir une augmentation significative du rapport HDL / cholestérol total (env.
0.4125250577926636 ||| systemic lupus erythematosus, angioedema, drug hypersensitivity, seasonal allergy ||| Stevens-Johnson syndrome, angioedema, erythema multiforme, alopecia ||| hypersensibilité médicamenteuse, allergie saisonnière.
0.11071129143238068 ||| PHARMACEUTICAL FORM AND CONTENTS ||| PHARMACEUTICAL FORM AND CONTENTS no ||| FORME PHARMACEUTIQUE ET CONTENU tn
0.4095585346221924 ||| Optimark is also available in glass vials of 10 ml, 15 ml and 20 ml. ||| Gardasil is available in packs of 1, 10 or 20 vials. ||| Optimark est également disponible en flacons de verre de 10 ml, 15 ml et 20 ml.
0.3630644679069519 ||| - the data on celecoxib presented in the APC study, which suggested a dose-related ||| - the data on etoricoxib in the EDGE study and pooled analyses of other clinical trials, which ||| - des données sur le célécoxib présentées dans l’ étude APC, qui ont suggéré une
0.4848591089248657 ||| On 16 February, the 15th infected patient involving a Chinese female national had fully recovered, becoming the 8th patient cured from the virus in Malaysia. ||| On 11 February, a 49-year-old Webasto employee tested positive, as did a family member of a previously diagnosed employee. ||| Le 16 février, le 15e patient infecté impliquant une ressortissante chinoise était complètement rétabli, devenant le 8e patient guéri du virus en Malaisie.
0.20281058549880981 ||| Financial advisory services relating to tax ||| Financial advisory services relating to life assurance ||| Services de conseils financiers en matière fiscale
0.1999368667602539 ||| What Insuman Comb 25 looks like and contents of the pack After mixing, Insuman Comb 25 is a uniformly milky fluid (suspension for injection), with no clumps, particles or flocculation visible. ||| What Insulin Human Winthrop Rapid looks like and contents of the pack Insulin Human Winthrop Rapid is a clear, colourless solution for injection, with no solid particles visible, and of a water-like consistency. ||| Qu’est-ce que Insuman Comb 25 et contenu de l’emballage extérieur Après mélange, Insuman Comb 25 a un aspect laiteux uniforme (suspension injectable), sans agrégats, flocons ou particules visibles.
0.5014469623565674 ||| Common: dry mouth, mouth ulceration, melaena, dyspepsia ||| Chest pain, asthenia, oedema, injection site pain ||| Fréquent: bouche sèche, ulcération de la bouche, melaena, dyspepsie
0.03731904178857803 ||| 120 µg/ 0.3 ml ||| 100 µg/ 0.3 ml ||| 120 µg/ 0,3 ml
0.4904760420322418 ||| (A residual drop may remain in the tip of the tube.) ||| There may be a small amount of solution left in the vial. ||| (Une goutte résiduelle peut rester dans le goulot.)
0.4257076382637024 ||| The systemic exposure at the no effect level in mice and rats was equivalent to 3 and 7 times the human systemic exposure during therapy. ||| The improvement in exercise duration in women was about 33% of the improvement in men at the 1000 mg twice-daily dose level. ||| L’ exposition systémique chez la souris et le rat, à la dose sans effet, était équivalente à respectivement 3 et 7 fois celle observée chez l’ Homme au cours du traitement.
0.9210273623466492 ||| CONT-002 EVRA ||| HEXAL ”). ||| CONT- CONT- 002 003
0.4628448486328125 ||| Undesirable effects were usually managed by dose adjustment. ||| These effects are reversible after lowering the dose. ||| Les effets indésirables étaient habituellement résolus par un ajustement de la dose.
0.6118788719177246 ||| • Clinical trials ||| • Clinical Management ||| • Essais cliniques
0.0 ||| Lot {number} ||| Lot {number} ||| Lot {Numéro}
0.48883000016212463 ||| The no observed adverse effect level (NOAEL) was considered to be less than 75 mg/kg/day, and is approximately 25-fold greater than the human daily exposure based on AUC exposure. ||| On this basis, the absolute risk reduction (ARR) is 5.8% which means the number needed to treat (NNT) is 17 to prevent one hospitalisation. ||| La dose maximale sans effet indésirable observé (no observed adverse effect level, NOAEL) a été estimée à moins de 75 mg/ kg/ jour et est environ 25 fois supérieure à l’ exposition quotidienne telle que définie par l’ ASC, chez l’ être humain.
0.19474777579307556 ||| If you miss a dose of CELSENTRI, take the missed dose as soon as possible and then take your next scheduled dose at its regular time. ||| If you miss a dose of BYETTA, skip that dose and take your next dose at the next prescribed time. ||| Si vous oubliez de prendre une dose de CELSENTRI, prenez la dose oubliée dès que possible et prenez la dose suivante à l’heure habituelle.
0.35634851455688477 ||| If there is no improvement in your infection after two to three days of treatment contact your doctor. ||| Your doctor may recommend that you stop treatment at least 3 weeks prior to this time. ||| S’ il n’ y a pas d’ amélioration de votre infection après deux à trois jours de traitement, veuillez contactez votre médecin.
0.018599050119519234 ||| Desloratadine is not eliminated by haemodialysis; it is not known if it is eliminated by peritoneal dialysis. ||| 16 Desloratadine is not eliminated by haemodialysis; it is not known if it is eliminated by peritoneal dialysis. ||| 3 La desloratadine n’ est pas éliminée par hémodialyse; on ne sait pas si elle est éliminée par dialyse péritonéale.
0.1631373018026352 ||| 32.8% ||| 36.7% ||| 32,8%
2.9717127738616844e-13 ||| Do not use Insulin Human Winthrop Rapid after the expiry date which is stated on the carton and on the label of the cartridge. ||| Do not use Insulin Human Winthrop Rapid after the expiry date which is stated on the carton and on the label of the cartridge. ||| Ne pas utiliser Insulin Human Winthrop Rapid après la date de péremption mentionnée sur la boîte et sur l’étiquette de la cartouche.
0.09696607291698456 ||| Microcrystalline cellulose Croscarmellose sodium Lactose monohydrate Magnesium stearate Colloidal hydrated silica Pregelatinised maize starch Red and yellow ferric oxides ||| Microcrystalline cellulose Croscarmellose sodium Lactose monohydrate Magnesium stearate Colloidal hydrated silica Pregelatinised maize starch Poloxamer 188 ||| Cellulose microcristalline Croscarmellose sodique Lactose monohydraté Stéarate de magnésium Silice colloïdale hydratée Amidon de maïs prégélatinisé Oxyde de fer rouge et oxyde de fer jaune
0.19689294695854187 ||| Carbon fibers [fibres] for textile use ||| Plastic fibers [fibres], not for textile use ||| Fibres de carbone à usage textile
0.05608851835131645 ||| 180 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any o f the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| Si vous remarquez des effets indésirables non mentionnés dans cette notice, ou si vous ressentez un des effets mentionnés comme étant sérieux, veuillez en informer votre médecin ou votre pharmacien.
0.27023664116859436 ||| Exposure to ionising radiation is linked with cancer induction and a potential for development of hereditary defects. ||| The radiation dose resulting from therapeutic exposure may result in higher incidence of cancer and mutations. ||| L'exposition aux rayonnements ionisants peut induire des cancers ou le développement d'anomalies héréditaires.
0.21637678146362305 ||| What is the risk associated with Tritanrix HepB? ||| What is the risk associated with Posaconazole SP? ||| Quel est le risque associé à l'utilisation de Tritanrix HepB?
9.379584782476247e-13 ||| 16 ANNEX III ||| 16 ANNEX III ||| 18 ANNEXE III
0.36293065547943115 ||| Cytogenetic abnormalities were evaluated in 117 of the total population of 176 patients. ||| The total number of patients treated with tigecycline in Phase 3 clinical studies was 1415. ||| Les anomalies cytogénétiques ont été évaluées chez 117 patients sur un total de 176 patients.
0.007533199153840542 ||| 35 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 20 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché.
0.0900173932313919 ||| 61 9. ||| 64 9. ||| 64 9.
0.3050077557563782 ||| Metformin is excreted into milk in lactating rats. ||| Metformin is excreted in human milk in small amounts. ||| Chez le rat, la metformine est excrétée dans le lait.
0.20441065728664398 ||| The treatment should start with 62.5 micrograms (a quarter of the dose) every other day, increasing progressively over 19 days to reach the recommended dose of 250 micrograms (8 MIU) given every other day. ||| 2 Patients should be started at 62.5 microgram (0.25 ml) subcutaneously every other day, and increased slowly to a dose of 250 microgram (1.0 ml) every other day (see Table A). ||| La dose initiale recommandée est de 62,5 microgrammes (un quart de la dose) tous les deux jours; cette dose pourra être augmentée progressivement pendant 19 jours jusqu’ à la dose recommandée de 250 microgrammes (8 millions d’ UI) administrés tous les deux jours.
0.3691985607147217 ||| The Commission is in close contact with the European Data Protection Board for an overview of the processing of personal data at national level in the context of the coronavirus crisis. ||| Solving issues relating to nationally approved medicines at Community level is important example of the role of the EMEA at the centre of the European medicines control system. ||| La Commission est en contact étroit avec le comité européen de la protection des données pour avoir une vue d'ensemble du traitement des données à caractère personnel au niveau national dans le contexte de la crise du coronavirus.
0.2879284620285034 ||| In case of a single severe IAR, the infusion should be stopped until the symptoms are resolved and treatment with antihistamines and paracetamol should be considered. ||| Use aseptic technique when inserting the infusion set. • In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved. ||| En cas de RAP unique et sévère, la perfusion doit être interrompue jusqu’ à la disparition des symptômes et l’ administration d’ antihistaminiques et de paracétamol doit être envisagée.
0.34674474596977234 ||| Talk to your pharmacist if you have difficulty opening the bottle. ||| Tell your pharmacist if you notice any change in the appearance of the syrup. ||| Consultez votre pharmacien si vous avez du mal à ouvrir le flacon.
5.128901318408874e-13 ||| Sexual dysfunction Ejaculation disorder Ejaculation delayed Gynaecological haemorrhage ||| Sexual dysfunction Ejaculation disorder Ejaculation delayed Gynaecological haemorrhage ||| Dysfonctionnemen Symptômes t sexuel ménopausiques Trouble de l’ éjaculation Ejaculation retardée Hémorragie gynécologique
0.279933363199234 ||| Deutschland Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Tel: +49 (0)69 1503 - 1 ||| Sverige Cephalon Pharma Aps Sluseholmen 2-4 DK - SV 2450 Köpenhamn DANMARK Tel: +45 3694 4868 ||| 66 Deutschland Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Tel: +49 (0)69 1503 - 1
0.3475803732872009 ||| Leucopenia, thrombocytopenia, anaemia Pancytopenia, leucocytosis - Acidosis, hyperkalaemia, hypokalaemia, hyperglycaemia, hypomagnesaemia, hypocalcaemia, hypercholesterolaemia, hyperlipidaemia, hypophosphataemia, hyperuricaemia, gout, anorexia ||| - Acidosis, hyperkalaemia, hypokalaemia, hyperglycaemia, hypomagnesaemia, hypocalcaemia, hypercholesterolaemia, hyperlipidaemia, hypophosphataemia, hyperuricaemia, gout, anorexia ||| - Acidose, hyperkaliémie, hypokaliémie, hyperglycémie, hypomagnésémie, hypocalcémie, hypercholestérolémie, hyperlipidémie, hypophosphatémie, hyperuricémie, goutte, anorexie.
0.0 ||| Adults 18 years of age or older: ||| Adults 18 years of age or older: ||| Adultes de 18 ans ou plus
0.21987828612327576 ||| In addition there are no data to support the use of 6 mg/ kg daptomycin once daily in patients with RIE or with cSSTI associated with bacteraemia whose creatinine clearance is < 50 ml/ min. ||| STOCRIN has not been adequately studied in patients with advanced HIV disease, namely in patients with CD4 counts < 50 cells/ mm3, or after failure of protease inhibitor (PI) containing regimens. ||| De plus, il n’ y a pas de donnée pour justifier l’ utilisation de 6 mg/ kg de daptomycine une fois par jour chez les patients présentant une EI du cœ ur droit ou une IcPTM associée à une bactériémie et dont la clairance de la créatinine est < 50 ml/ min.
0.11252592504024506 ||| This medicinal product does not require any special storage conditions. ||| This veterinary medicinal product does not require any special storage conditions. ||| Ce médicament ne requiert aucune précaution particulière de conservation.
0.0 ||| BATCH NUMBER ||| BATCH NUMBER ||| NUMERO DELOT
0.15368543565273285 ||| Hypersensitivity to cefuroxime, other cephalosporins or to any of the excipients. ||| Hypersensitivity to zonisamide, to any of the excipients or to sulphonamides. ||| Hypersensibilité au céfuroxime, à d’ autres céphalosporines ou à l’ un des excipients.
0.13089226186275482 ||| 59 11. ||| 60 11. ||| 63 11.
0.017510170117020607 ||| The increased efavirenz concentrations observed following administration of SUSTIVA with food may lead to an increase in frequency of adverse reactions (see sections 4.4 and 5.2). ||| The increased efavirenz concentrations observed following administration of STOCRIN with food may lead to an increase in frequency of adverse reactions (see sections 4.4 and 5.2). ||| Une augmentation des concentrations d’ éfavirenz observée suite à l'administration de SUSTIVA avec de la nourriture peut entraîner une augmentation de la fréquence des effets indésirables (voir rubriques 4.4 et 5.2).
0.1354418843984604 ||| 41.2% ||| 37.1% ||| 61,6%
0.4595603048801422 ||| HIB infection also causes inflammation of the throat. ||| Hib infection most frequently causes brain inflammation (swelling). ||| L'infection à Hib provoque également une inflammation de la gorge.
0.38492846488952637 ||| Inhalation powder, predispensed ||| Inhalation powder, pre- dispensed ||| Poudre pour inhalation
0.3076789677143097 ||| As part of a reinforced long-term budget of the EU for 2021-2027 the European Maritime and Fisheries Fund (EMFF) will be increased by €500 million to strengthen the resilience of the fisheries sector and provide necessary scope for crises management. ||| The horizontal agreement between the EU and the Republic of Korea marks another key deliverable under the Commission's Aviation Strategy for Europe - designed to generate growth for European businesses, foster innovation and let passengers profit from safer, cleaner and more affordable flights. ||| Dans le cadre d'un budget à long terme renforcé de l'UE pour la période 2021-2027, le Fonds européen pour les affaires maritimes et la pêche (FEAMP) bénéficiera de 500 millions € supplémentaires afin de renforcer la résilience du secteur de la pêche et de lui fournir la marge nécessaire pour permettre la gestion des crises.
0.41783952713012695 ||| Ziagen’ s effects were compared with other antiviral medicines, placebo (a dummy treatment) or no treatment. ||| In all four studies, Apidra was compared with other insulins or insulin analogues (regular human insulin or insulin lispro). ||| Les effets de Ziagen étaient comparés à ceux d’ autres médicaments antiviraux, d’ un placebo (traitement fictif) ou à l’ absence de traitement.
0.40196090936660767 ||| If you forget to take a dose of Corlentor, take the next dose at the usual time. ||| When you do remember to take ADARTREL, take your next dose of ADARTREL at the usual time. ||| Si vous oubliez de prendre une dose de Corlentor, prenez la dose suivante au moment habituel.
0.14011931419372559 ||| Headache, paraesthesia ||| Headache, parathesia ||| Céphalées, paresthésie.
0.3300548791885376 ||| In contrast, the mechanisms by which lamotrigine exerts its therapeutic action in bipolar disorder have not been established, although interaction with voltage gated sodium channels is likely to be important. ||| However, based on the published literature, paclitaxel is a potentially carcinogenic and genotoxic agent at clinical doses, based upon its pharmacodynamic mechanism of action. ||| A l’ inverse, les mécanismes par lesquels la lamotrigine exerce son action thérapeutique sur les troubles bipolaires n’ ont pas été établis, bien que les interactions canaux sodium voltage-dépendants soient probablement importantes.
1.0007749795913696 ||| Occupied as at 31.12.2000 ||| Inspections performed 2000-2002 ||| Occupés au 31.12.2000
0.005576743744313717 ||| 102 In patients treated with other medicinal products associated with liver toxicity, monitoring of liver enzymes is also recommended. ||| 150 In patients treated with other medicinal products associated with liver toxicity, monitoring of liver enzymes is also recommended. ||| Une surveillance des enzymes hépatiques est aussi recommandée chez les patients traités par d'autres médicaments présentant une toxicité hépatique.
0.06522940844297409 ||| Gilead Sciences Limited 13 Stillorgan Industrial Park Blackrock County Dublin Ireland ||| Gilead Science Limited Unit 13 Stillorgan Industrial Park Blackrock County Dublin Ireland ||| Gilead Sciences Limited 13 Stillorgan Industrial Park Blackrock County Dublin Irlande
0.24368923902511597 ||| Member States can also give, up to the nominal value of €800,000 per company zero-interest loans or guarantees on loans covering 100% of the risk, except in the primary agriculture sector and in the fishery and aquaculture sector, where the limits of €100,000 and €120,000 per company respectively, apply. ||| The schemes will provide 100% guarantees for underlying loans up to an amount of €500,000 (except for the agricultural and the fisheries and aquaculture sectors, where the 100% guarantees are limited to underlying loans up to an amount of €100,000 and €120,000, respectively). ||| Les États membres peuvent également octroyer, jusqu'à concurrence d'une valeur nominale de 800 000 EUR par entreprise, des prêts à taux d'intérêt nul ou des garanties sur les prêts couvrant 100 % du risque, sauf dans le secteur agricole primaire et dans le secteur de la pêche et de l'aquaculture, où des limites respectives de 100 000 EUR et de 120 000 EUR par entreprise s'appliquent;
0.27944132685661316 ||| Pink, oval, bi-convex-shaped, SINGULAIR engraved on one side and MSD 711 on the other. ||| Brownish-orange, oval, biconvex film-coated tablet with "COMT" engraved on one side. ||| Rose, ovale, biconvexe, avec SINGULAIR gravé sur une face, MSD 711 sur l’ autre.
0.22845232486724854 ||| Replagal has to be diluted in 9 mg/ ml (0.9%) sodium chloride solution before use. ||| Normal sodium chloride solution 9 mg/ ml (0.9%) may be added to dilute to a concentration convenient for administration. ||| Replagal doit être dilué avant utilisation dans une solution de chlorure de sodium à 9 mg/ ml (0,9%).
0.2949838638305664 ||| There is limited information on the use of AVONEX in pregnancy. ||| There is no information on the use of CELVAPAN below 18 years of age. ||| Les informations sur l’ utilisation d’ AVONEX pendant la grossesse sont limitées.
0.3960561156272888 ||| Worked as a clinical endocrinologist in a French hospital until 1987 and then joined the Directorate of Pharmacy at the French Ministry of Health. ||| He joined the French medicines agency in 1994 as director of pharmacotherapeutic evaluation, a post he holds today. ||| Elle a travaillé en tant qu’endocrinologue clinique dans un hôpital français jusqu’en 1987, puis a intégré la direction de la pharmacie au ministère français de la Santé.
0.7190821766853333 ||| Careful monitoring is recommended in these patients. ||| Greening is also ongoing in other sectors. ||| Il est recommandé de surveiller attentivement ces patients.
0.22167503833770752 ||| No clear evidence of teratogenic activity was found in rats and in rabbits at doses of approximately 3 and 10 times the maximum recommended human dose, based on body surface area. ||| No evidence of carcinogenicity was observed at exposures approximately 15, 13 and 39 times the estimated clinical AUC at the recommended starting dose in mice, male rats and female rats respectively. ||| Aucune activité tératogène n’ a été clairement démontrée chez le rat et le lapin à des doses environ 3 à 10 fois supérieures à la dose maximum recommandée chez l’ homme, basées sur la surface corporelle.
0.3663575351238251 ||| A syringe is used to inject 5 ml of sterile water for injections into the vial. ||| The powder in the vial provides 1 mg per ml of active substance when reconstituted as recommended. ||| Utiliser une seringue pour injecter 5 ml d’ eau stérile pour préparations injectables dans le flacon.
0.09610879421234131 ||| Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. ||| Ask your doctor or pharmacist for advice before taking any medicine when pregnant or breast-feeding. ||| 52 Demandez conseil à votre médecin ou à votre pharmacien avant de prendre tout médicament.
0.5041180849075317 ||| Information and consultancy services relating to vehicle repair ||| Interior design services and information and advisory services relating thereto ||| Services de conseil et d'information en matière de réparation de véhicules
0.26717355847358704 ||| 1.8% NA ||| 6.7% NA ||| 1,8% NA
0.4046233892440796 ||| Calculate the dose and the number of ALIMTA vials needed. ||| Platelet counts should be monitored prior to each dose of VELCADE. ||| Calculer la dose et le nombre de flacons d'ALIMTA nécessaires.
0.6691256761550903 ||| Transfer ibritumomab tiuxetan solution to the reaction vial ||| conjugated to tetanus toxoid as carrier protein 1 ||| Transférer la solution d'ibritumomab tiuxétan dans le flacon de réaction
0.4913193881511688 ||| The outbreak of the coronavirus is affecting all countries and member states and the EU are determined to tackle it together. ||| The number of applications predicted reflects the situation which currently prevails in the animal health industry in the EU. ||| La pandémie de coronavirus affecte l'Europe toute entière et l'Union européenne est déterminée à y faire face, unie.
0.14688271284103394 ||| Chemical and physical in-use stability has been demonstrated for up to 4 days at room temperature (23°C - 27°C). ||| - Chemical and physical in-use stability has been demonstrated for 24 hours at 2°C to 8°C. ||| La stabilité physico-chimique et en cours d’ utilisation a été démontrée pendant un maximum de 4 jours à température ambiante (23°C - 27°C).
0.24835291504859924 ||| (5.4-7.2) ||| (2.8-35.6) ||| (2,0-4,4)
0.36220890283584595 ||| - have a history of haemolytic anaemia (an illness caused by red blood cells being abnormally ||| - in patients with beta thalassaemia major with iron overload due to infrequent blood transfusions ||| - avez des antécédents d’ anémie hémolytique (maladie causée par une destruction anormale des
0.2992019057273865 ||| 6.8 11.4 22.7 ||| 17.8 12.3 8.1 4.9 ||| 6,8 11,4 22,7
0.14712397754192352 ||| Vimpat 200 mg are blue, oval film-coated tablets with a debossed ‘SP’ on one side and ‘200’ on the other side. ||| Vimpat 100 mg are dark yellow, oval film-coated tablets with a debossed ‘SP’ on one side and ‘100’ ||| Les comprimés pelliculés de Vimpat à 200 mg sont ovales et bleus, avec une impression en creux « SP » d’ un côté et « 200 » de l’ autre côté.
0.3206835389137268 ||| - have a history of haemolytic anaemia (an illness caused by red blood cells being abnormally ||| - You have sickle cell anaemia (an abnormality of red blood cells), multiple myeloma (cancer of ||| - avez des antécédents d’ anémie hémolytique (maladie causée par une destruction anormale des
0.1990494430065155 ||| Uncommon side effects These may affect up to 1 in 100 people treated with Arixtra. • swelling (oedema) • headache • pain • feeling sick or being sick (nausea or vomiting) • low number of red blood cells (anaemia) • low number of platelets (blood cells necessary for blood clotting) • increase in some chemical (enzymes) produced by the liver ||| Very common side effects (more than one in 10 patients): • loss of appetite, weight loss (especially when combined with the antiepileptic medicine sodium valproate); • insomnia (sleeplessness), drowsiness; • ataxia (inability to coordinate muscle movements), hypotonia (low muscle strength), dystonia (muscle disorders). ||| Effets indésirables peu fréquents Ils peuvent affecter jusqu’à 1 personne sur 100 traitées par Arixtra. • gonflement (œdème) • maux de tête • douleur • se sentir ou être nauséeux (nausées ou vomissements) • nombre bas de globules rouges (anémie) • nombre bas de plaquettes (cellules nécessaires à la formation de caillots sanguins) • augmentation des enzymes du bilan hépatique
0.4433753490447998 ||| Renal function should be closely monitored (see section 4.4). ||| Therefore, virological response should be closely monitored. ||| La fonction rénale doit être étroitement surveillée (voir rubrique 4.4).
0.015530956909060478 ||| 38 Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998700 medinfo_ireland@merck. com ||| Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998771 medinfo_ireland@merck. com ||| Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998700 medinfo_ireland@merck. com
0.05466657876968384 ||| What is the risk associated with Halocur? ||| What is the risk associated with Aloxi? ||| Quel est le risque associé à l’ utilisation de Halocur?
0.6170110702514648 ||| Do not add any other insulin to the cartridge. ||| Take any remaining tablets and the container with you. ||| Ne mélangez Optisulin à aucune autre insuline ou à aucun
0.5214049816131592 ||| The option is available to recruit additional scientific administrators and one administrator (non- scientific) if a considerable increase in applications should be forthcoming. ||| A slight increase in the number of both initial, and follow-up scientific advice is expected in 2000, with a further increase in 2001 (5%). ||| Des administrateurs scientifiques supplémentaires et un administrateur (non scientifique) pourraient être recrutés pour faire face, le cas échéant, à une forte augmentation du nombre de demandes.
0.07353176921606064 ||| Clopidogrel BMS 300 -mg film-coated tablets clopidogrel ||| Clopidogrel Winthrop 300-mg film-coated tablets clopidogrel ||| Clopidogrel BMS 300 mg, comprimés pelliculés clopidogrel
0.1746743768453598 ||| • 29.01.96 • 11.11.00 • 212 days • 1504 days ||| • 12.10.2000 • 7.11.2001 • 120 days • 271 days ||| 29.01.96 11.11.00 212 jours 1504 jours
0.0 ||| 51 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 51 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 53 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.2980002760887146 ||| Geological surveys or research ||| Geological estimations and research ||| Expertises ou recherches géologiques
0.1489933729171753 ||| Not all pack sizes may be available in your country. ||| Some pack sizes may not be marketed in your country. ||| Toutes les tailles de boîtes peuvent ne pas être disponibles dans votre pays.
0.26343339681625366 ||| Distribution Sitaxentan sodium is more than 99% protein bound to plasma proteins, predominantly albumin. ||| Approximately 90% of rosuvastatin is bound to plasma proteins, mainly to albumin. ||| Distribution Le taux de fixation du sodium sitaxentan aux protéines du plasma (principalement l’ albumine) est de plus de 99%.
0.2903745770454407 ||| How to use STAMARIL 4. ||| How to take INTEGRILIN 4. ||| Comment utiliser STAMARIL 4.
0.0 ||| Deutschland Thomas-Dehler-Straße 27 D-81737 München Tel: + 49-(0)89 627 31-0 ||| Deutschland Thomas-Dehler-Straße 27 D-81737 München Tel: + 49-(0)89 627 31-0 ||| 458 Deutschland Thomas-Dehler-Straße 27 D-81737 München Tel: + 49-(0)89 627 31-0
0.4654725193977356 ||| Swirl very gently until the liquid looks clear and without undissolved powder or particles. ||| The active substance is rapidly redispersed by shaking gently producing a clear solution. ||| Effectuez en douceur des rotations jusqu’ à ce que le liquide paraisse limpide sans poudre ou particules visibles.
4.3115952296076884e-14 ||| It is believed that these symptoms are due to an improvement in the body’ s immune response, enabling the body to fight infections that may have been present with no obvious symptoms. ||| It is believed that these symptoms are due to an improvement in the body’ s immune response, enabling the body to fight infections that may have been present with no obvious symptoms. ||| Ces symptômes seraient dus à une amélioration de la réponse immunitaire, permettant à l’ organisme de combattre les infections qui pouvaient être présentes sans symptômes évidents.
0.01234726794064045 ||| 44 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 32 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 44 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.5261377096176147 ||| While we continue to ensure a high level of preparedness in the EU and support Member States, the protection of health for all will always remain a top priority and we will continue to remain in solidarity with China." ||| Because, after all, not only must we overcome the crisis, but rather we want to and we must also continue courageously along the path of modernisation within the European Union. ||| Même si nous continuons de garantir un degré de préparation élevé au sein de l'UE et d'aider les États membres en la matière, la protection de la santé pour tous restera toujours une priorité absolue, et nous demeurerons solidaires de la Chine».
0.44455447793006897 ||| Surveillance of low-risk patients should inform when we reach this tipping point and when infection rates start to remit. ||| Testing shortage is a key element preventing authorities from measuring the true extent of current epidemic spread. ||| La surveillance des patients à faible risque devrait révéler le moment où nous atteindrons ce point critique et lorsque les taux d’infection commenceront à chuter.
0.3796054720878601 ||| - if you are suffering from severe swelling of the affected arm or leg due to local fluid build-up, ||| - reversible swelling in the rear part of the brain that can be associated with headache, altered ||| - si vous présentez une tuméfaction importante du bras ou de la jambe atteints par suite d’ une
0.3653619885444641 ||| Tablets should be swallowed whole with a glass of plain water (180 to 240 ml) while the patient is sitting or standing in an upright position. ||| - The tablets should be swallowed whole with a full glass of plain water (180 to 240 ml) while the ||| Les comprimés doivent être avalés entiers avec un verre d’ eau plate (180 à 240 ml d'eau du robinet ou eau faiblement minéralisée), la patiente se tenant droite, en position assise ou debout.
0.013549411669373512 ||| Nicotinic acid-related adverse reactions The following nicotinic acid-related adverse reactions have been seen in clinical trials or post-marketing experience with other nicotinic acid medicinal products at unknown frequency or in clinical trials with Tredaptive (or the nicotinic acid component of Tredaptive) in < 1% of the patients treated: ||| Nicotinic acid-related adverse reactions The following nicotinic acid-related adverse reactions have been seen in clinical trials or post-marketing experience with other nicotinic acid medicinal products at unknown frequency or in clinical trials with Pelzont (or the nicotinic acid component of Pelzont) in < 1% of the patients treated: ||| Effets indésirables liés à l’ acide nicotinique Les effets indésirables suivants, liés à l’ acide nicotinique, ont été rapportés dans les études cliniques ou depuis la mise sur le marché avec d’ autres spécialités à base d’ acide nicotinique, à une fréquence inconnue ou dans les études cliniques avec Tredaptive (ou la composante acide nicotinique de Tredaptive) chez moins de 1% des patients traités:
0.11368432641029358 ||| - Try to give yourself the injection at the same time each day. ||| You should try to have the injection at the same time each day. ||| - Essayez de réaliser l’injection à heure fixe.
0.3862147331237793 ||| Viracept has also been studied in 37 children. ||| Cozaar has been studied in children. ||| Viracept a également été étudié chez 37 enfants.
0.0 ||| Aranesp did not reveal any genotoxic potential nor did it have any effect on the proliferation of non- haematological cells in vitro or in vivo. ||| Aranesp did not reveal any genotoxic potential nor did it have any effect on the proliferation of non- haematological cells in vitro or in vivo. ||| 246 L’ utilisation d’ Aranesp n’ a pas permis de mettre en évidence une génotoxicité potentielle ni d’ effet sur la prolifération des cellules non hématologiques in vitro ou in vivo.
0.2653656005859375 ||| After primary immunisation, 95.6% of the subjects had antibody levels of at least 0.35 µg/ ml for all seven serotypes found in Prevenar. ||| Ziagen was of similar effectiveness to indinavir, with around two thirds of the patients having viral loads below 400 copies/ ml after 16 weeks. ||| Après la primovaccination, 95,6% des sujets avaient des taux d’ anticorps d’ au moins 0,35 µg/ ml pour les 7 sérotypes contenus dans Prevenar.
0.16232502460479736 ||| • Do not give Truvada to children and adolescents under 18 years of age. ||| • Do not use Hepsera in children or adolescents under 18 years of age. ||| • Ne pas donner Truvada aux enfants et adolescents de moins de 18 ans.
0.3220410943031311 ||| 30 Pharmacokinetics in elderly patients ||| Pharmacokinetics in elderly ||| Pharmacocinétique chez les patients âgés
0.7707147598266602 ||| Overview of the data on antimicrobial resistance in Europe released in 2014 ||| Measures to ease impact of COVID-19 on aviation industry ||| Aperçu des données sur la résistance aux antimicrobiens en Europe publiées en 2014
0.5805443525314331 ||| Mustache and beard trimmers ||| Roasted coffee beans ||| Rasoirs à moustache et à barbe
0.40316295623779297 ||| Elevated levels of COX-2 are found in many pre-malignant lesions (such as adenomatous colorectal polyps) and epithelial cancers. ||| MRI evaluations for T1-weighted gadolinium (Gd)-enhancing lesions and T2-hyperintense lesions were performed annually. ||| Des taux élevés de COX-2 sont retrouvés dans de nombreuses lésions pré-malignes (tels que les polypes adénomateux colorectaux) et les cancers épithéliaux.
0.37092873454093933 ||| Structures made of non-metallic materials ||| Sculptures of non-precious metal ||| Structures en matériaux non métalliques
0.022458698600530624 ||| A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) that is found on certain cells in the body. ||| A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) that is found in certain cells. ||| Un anticorps monoclonal est un anticorps (type de protéine) conçu pour reconnaître et se fixer sur une structure spécifique (appelée antigène) située dans certaines cellules de l’ organisme.
0.2617468535900116 ||| België/ Belgique/ Belgien UCB Pharma S. A. / N. V. ||| België/ Belgique/ Belgien Luxembourg/ Luxemburg Wyeth Pharmaceuticals S. A. / N. V. ||| 28 België/ Belgique/ Belgien UCB Pharma S. A. / N. V.
0.45669421553611755 ||| Nespo 10 micrograms solution for injection in a pre-filled syringe. ||| Pre-moisten surgical instruments or gloves with a saline solution, if necessary. ||| 10 microgrammes, solution injectable en seringue préremplie.
0.0 ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN ||| MISE EN GARDE SPECIALE INDIQUANT QUE LE MÉDICAMENT DOIT ETRE CONSERVE HORS DE PORTEE ET DE VUE DES ENFANTS
0.20827403664588928 ||| Co-administration of pregabalin with the oral contraceptives norethisterone and/or ethinyl oestradiol does not influence the steady-state pharmacokinetics of either substance. ||| Co-administration of lumiracoxib did not affect the steady state pharmacokinetics or the efficacy of ethinylestradiol and of levonorgestrel. ||| 17 L'administration concomitante de prégabaline avec les contraceptifs oraux tels que la noréthistérone et/ou l'éthinylestradiol n'influence pas les paramètres pharmacocinétiques à l'état d'équilibre de l'une ou l'autre de ces substances.
0.2760809361934662 ||| If you become pregnant during this time, despite the use of contraceptive measures, you should tell your doctor immediately. ||| If you are a man, you must take adequate contraceptive precautions during therapy and for at least three months after treatment. ||| Si vous débutez une grossesse pendant cette période malgré l’ utilisation de mesures contraceptives, vous devez informer immédiatement votre médecin.
0.3661760687828064 ||| EXP After first opening, use within 28 days. ||| EXP After reconstitution, use within 21 days. ||| EXP Après première ouverture, utiliser dans les 28 jours.
0.2257155478000641 ||| Byetta is used to treat type 2 diabetes together with other antidiabetes medicines (metformin and/ or sulphonylureas) in patients whose blood glucose (sugar) levels are not adequately controlled with the maximum tolerated doses of the other medicines. ||| Insuman Rapid can also be used for the treatment of hyperglycaemic coma (coma caused by too much blood glucose [sugar]) and ketoacidosis (high levels of ketones [acids] in the blood), and to control blood glucose before, during or after an operation. ||| Byetta est utilisé en association avec d’ autres médicaments contre le diabète (metformine et/ ou sulphonylurées) pour le traitement du diabète de type 2 chez les patients dont le taux de glucose (sucre) dans le sang n’ est suffisamment contrôlé à l’ aide des doses maximales tolérées des autres médicaments.
1.157271146774292 ||| 5 ml 7.5 ml 10 ml ||| 1 kg 2.5 kg 25 kg ||| 5 ml 7,5 ml 10 ml
0.426144003868103 ||| Each vial contains 10 ml solution (1000 Units). ||| One carton contains 1 or 10 vial(s). ||| Chaque flacon contient 10 ml (1000 Unités) de solution.
0.2601411044597626 ||| Liver enzymes should be checked prior to the initiation of therapy with Glubrava in all patients. ||| Moreover patients should be closely monitored for endophthalmitis in the two weeks following the injection. ||| Chez tous les patients, un dosage des enzymes hépatiques devra être pratiqué avant l'instauration du traitement par Glubrava.
0.6632795929908752 ||| Lactation ||| Vascular ||| Allaitement
0.24494004249572754 ||| SUTENT should be used with caution in patients with a known history of QT interval prolongation, patients who are taking antiarrhythmics, or patients with relevant pre-existing cardiac disease, bradycardia, or electrolyte disturbances. ||| Pegasys is indicated for the treatment of chronic hepatitis C in adult patients who are positive for serum HCV-RNA, including patients with compensated cirrhosis and/ or co-infected with clinically stable HIV (see section 4.4). ||| SUTENT devra être utilisé avec précaution chez les patients ayant déjà présenté un allongement de l’ intervalle QT, ainsi que chez ceux qui prennent des antiarythmiques ou présentant une pathologie cardiaque préexistante, une bradycardie ou des troubles électrolytiques.
0.1859665960073471 ||| Your doctor should not use Xeomin if the vial reconstituted according to the instructions has a cloudy appearance or contains e. g. floccular or particulate matter. ||| Xeomin should not be used if the reconstituted solution (prepared as above) has a cloudy appearance or contains floccular or particulate matter. ||| Votre médecin ne devrait pas utiliser Xeomin si la solution reconstituée conformément aux instructions est trouble ou contient des particules ou matières d’ apparence floconneuse.
0.09226647019386292 ||| The European Commission granted a marketing authorisation valid throughout the European Union for AVAMYS to Glaxo Group Ltd on 11 January 2008. ||| The European Commission granted a marketing authorisation valid throughout the EU for Orlistat GSK to Glaxo Group Limited on 23 July 2007. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour AVAMYS à Glaxo Group Ltd, le 11 janvier 2008.
0.22517311573028564 ||| Hypersensitivity reactions, including anaphylactic/ anaphylactoid reactions, angioedema, exfoliative dermatitis, and hypersensitivity vasculitis, have been associated with the administration of sirolimus (see section 4.8). ||| Tetracycline class adverse reactions may include photosensitivity, pseudotumour cerebri, pancreatitis, and anti-anabolic action which has led to increased BUN, azotaemia, acidosis, and hyperphosphataemia (see section 4.4). ||| Des réactions d’ hypersensibilité, incluant des réactions anaphylactiques/ anaphylactoïdes, des angioedèmes, des dermatites exfoliatrices et des vascularites d’ origine allergique ont été associées à l’ administration de sirolimus (voir rubrique 4.8).
0.1972859650850296 ||| If your blood sugar level falls too much you may become unconscious. ||| 769 If your blood sugar level falls too much you may become unconscious. ||| Si votre taux de sucre dans le sang diminue trop, vous risquez de perdre connaissance.
0.005959600210189819 ||| 536 Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. ||| 444 Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. ||| 554 Vérifiez votre glycémie et votre cétonurie le plus rapidement possible dès que l'un des symptômes ci-dessus apparaît.
0.40506288409233093 ||| Powder Sodium chloride Calcium chloride dihydrate Glycylglycine Polysorbate 80 Mannitol Sucrose Methionine Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment) ||| Mannitol Hydroxypropylcellulose Low-substituted Hydroxypropyl Cellulose (LH-21) Low-substituted Hydroxypropyl Cellulose (LH-11) Talc Macrogol 6000 Castor oil, hydrogenated ||| 58 Glycylglycine Polysorbate 80 Mannitol Saccharose Méthionine Acide chlorhydrique (pour l’ ajustement du pH) Hydroxyde de sodium (pour l’ ajustement du pH)
0.4980342984199524 ||| Hepatobiliary disorders: liver function test abnormal ||| Acute liver failure, hepatitis, abnormal liver function test ||| Affections hépatobiliaires: bilan hépatique anormal
0.42030924558639526 ||| The Commission therefore concluded that the measure will contribute to managing the economic impact of the coronavirus in France. ||| The EIC responded quickly to the coronavirus crisis and demonstrated the agility and impact of EU funding." ||| La Commission est donc parvenue à la conclusion que la mesure aidera à gérer l'incidence économique de la pandémie de coronavirus en France.
0.34235328435897827 ||| The mean total daily decrease in the OFF time was similar in the entacapone group (-0.80h, 95% CI [-1.20, -0.41], p < 0.0001) to that observed in the rasagiline 1 mg group. ||| ut death/ re-MI at Day 30 was significantly reduced from 14.3% on UFH to 11.5% with fondaparinux (hazard ratio 0.79, 95% CI, 0.64, 0.98, p = 0.03). ||| La diminution moyenne quotidienne totale du temps OFF a été similaire dans le groupe entacapone (- 0,80 h, IC à 95% [- 1,20; - 0,41], p < 0,0001) à celle observée dans le groupe rasagiline à 1 mg.
0.0926530510187149 ||| If the product accidentally gets into eyes, they should be thoroughly flushed with water. ||| 62 If the product accidentally gets into eyes, they should be thoroughly flushed with plenty of water. ||| En cas de contact oculaire accidentel, rincer abondamment les yeux à l’eau.
0.45143383741378784 ||| Gastrointestinal disorders Common: ||| Gastrointestinal Common: ||| Peu fréquents: hypotension, vasculite
0.0 ||| 41 A. ||| 41 A. ||| 47 A.
0.2148134559392929 ||| Pharmacokinetics studies have indicated that the increase in blood levels is mainly a result of increase in oral bioavailability of tacrolimus owing to the inhibition of gastrointestinal metabolism. ||| Findings in the rat and monkey studies indicated that there was a substance-related decrease in intestinal absorption of phosphate with potential secondary reduction in bone mineral density. ||| Les études pharmacocinétiques ont montré que l’ augmentation des concentrations sanguines était principalement due à une augmentation de la biodisponibilité orale du tacrolimus en raison de l’ inhibition de son métabolisme gastro-intestinal.
0.3570469319820404 ||| Fatalities have occurred within hours and up to one week following infusion. ||| Symptoms resolve within 12 hours to several days upon cessation of exposure. ||| Des cas d'évolution fatale sont survenus dans les heures et jusqu'à une semaine après la perfusion.
0.1489800363779068 ||| [To be completed nationally] 1. ||| 32 [To be completed nationally] ||| [A compléter au niveau national]
0.3217957019805908 ||| Temodal 250 mg hard capsules have a opaque white body and cap and are imprinted with black ink. ||| These soft capsules are oblong, opaque, off white to cream in colour and marked with the code GX CC1. ||| Les gélules de Temodal 250 mg ont un corps et une coiffe opaques blancs, et sont marquées avec une encre noire.
0.3311762809753418 ||| You may have to take this treatment over a long period of time.  Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.  Do not stop taking Xiliarx unless your doctor tells you to. ||| It is important that, during the first few weeks of the treatment, you talk with your doctor about the effects of Remeron: → 2 to 4 weeks after you have started taking Remeron, talk to your doctor about how this medicine has affected you. ||| Vous pouvez avoir à prendre ce médicament pendant une longue période.  Votre médecin surveillera régulièrement votre état de santé pour vérifier si le traitement a l’ effet désiré.  N’ arrêtez pas de prendre Xiliarx sauf si votre médecin vous dit de le faire.
0.39609095454216003 ||| Uncommonly Sebivo can cause numbness, tingling, pain and/ or burning sensations in the arms and/ or legs (peripheral neuropathy). ||| Do not inject ViraferonPeg into an area where the skin is irritated, red, bruised, infected, or has scars, stretch marks, or lumps. ||| De façon peu fréquente, Sebivo peut induire un engourdissement, des fourmillements, une douleur et/ ou une sensation de brûlure dans les bras et/ ou les jambes (neuropathie périphérique).
0.20762428641319275 ||| Hydrogen peroxide for industrial purposes ||| Titanium dioxide for industrial purposes ||| Peroxyde d'hydrogène à usage industriel
0.10785770416259766 ||| Diarrhoea, constipation, vomiting, nausea, abdominal pain, abdominal distension, dyspepsia ||| abdominal distention, abdominal pain, constipation, diarrhoea, flatulence, nausea, vomiting ||| Diarrhées, constipation, vomissements, nausées, douleurs abdominales, ballonnements, dyspepsie
0.4396704435348511 ||| Visual disturbances. ||| - Visual disturbance ||| du Troubles visuels.
0.33122459053993225 ||| In HIV-infected patients with mild to moderate hepatic impairment, an increase of approximately 30% in lopinavir exposure has been observed but is not expected to be of clinical relevance (see section 5.2). ||| Retrospectively in this registry, a small number of cases of neural tube defects, including meningomyelocele, have been reported but causality has not been established. ||| Insuffisance hépatique: chez les patients infectés par le VIH présentant une insuffisance hépatique légère à modérée, une augmentation de 30% de l’ exposition au lopinavir a été observée, cependant un retentissement clinique n’ est pas attendu (voir rubrique 5.2).
0.4630235433578491 ||| C09A A03 ||| L04A A10. ||| C09AA03
0.7158262729644775 ||| (1.6) ||| (glass); ||| (1,6)
0.2656615674495697 ||| - the scope of the referral was the harmonisation of the Summaries of Products Characteristics, ||| - the scope of the referral was to agree on a summary of Products Characteristics in view of the ||| - le motif de la saisine était l'harmonisation des résumés des caractéristiques du produit, de l'étiquetage et
0.4796616733074188 ||| In some patients the development of optimal blood pressure reduction may require several weeks of therapy. ||| After 3 weeks of Soliris treatment, patients reported less fatigue and improved health- related quality of life. ||| Chez certains patients, l'obtention de la diminution maximale de la pression artérielle peut demander plusieurs semaines de traitement.
0.5132401585578918 ||| Milk: zero days. ||| 15 days; milk: ||| Lait: zéro jour.
0.415474534034729 ||| As a lipophilic compound, dexmedetomidine is well absorbed after intramuscular administration. ||| Following oral administration, adefovir dipivoxil is rapidly converted to adefovir. ||| La dexmédétomidine étant un composé lipophile, elle est bien absorbée après administration intramusculaire.
0.19400152564048767 ||| Videoconferencing services ||| Teleconferencing services ||| Services de visioconférence
0.3692992627620697 ||| Dogs should be monitored carefully and professional judgement should be used to determine the need for dose reduction in the event of possible significant adverse reactions. ||| 3 should have examinations periodically and at the occurrence of clinical symptoms to rule out such potential complications or to initiate appropriate treatment. ||| Les chiens doivent faire l’objet d’un suivi attentif et il convient de s’appuyer sur les compétences professionnelles du vétérinaire pour juger de la nécessité d’une diminution de la dose en présence d’une éventuelle réaction indésirable significative.
0.49556803703308105 ||| Critical Evaluation A number of areas of disharmony in the product information for Tritazide have been evaluated by the CHMP and a revised PI was adopted. ||| This referral is undertaken following concerns related to divergent decisions on approval of the bipolar indication for lamotrigine across EU Member States. ||| Évaluation critique Un certain nombre de divergences dans l’ information produit de Tritazide ont été évaluées par le comité des médicaments à usage humain (CHMP) et une révision de l’ information produit a été adoptée.
0.1480395644903183 ||| 18 Member State ||| 17 Member State ||| 18 État membre
0.6926398277282715 ||| Infections and ||| ris Infections ||| infections virales,
0.3014489412307739 ||| Occurrence of lactic acidosis (in the absence of hypoxaemia) sometimes fatal, and usually associated with severe hepatomegaly with steatosis have been reported with the use of nucleoside/ nucleotide analogues. ||| Similar to the homologous challenge, vaccination against a heterologous challenge reduced virus burden, and reduced haematological (leukopenia) changes associated with highly pathogenic avian influenza infection. ||| Des cas d’ acidose lactique (en l’ absence d’ hypoxémie), parfois fatals, généralement associés à une hépatomégalie importante et à une stéatose hépatique, ont été rapportés en cas de traitement par des analogues nucléosidiques/ nucléotidiques.
0.062067024409770966 ||| In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. ||| In case of accidental self-injection, medical advice should be sought immediately showing the package leaflet or the label to the physician. ||| En cas d'auto-injection accidentelle, demander immédiatement conseil à un médecin et lui montrer la notice ou l´étiquette.
0.2520013153553009 ||| OPTISON is slowly injected into a vein, usually in the right arm. ||| SonoVue is injected into a vein, usually in your arm. ||| OPTISON est injecté lentement dans une veine, généralement dans le bras droit.
0.41108381748199463 ||| Physicians considering treatment in these patients should carefully weigh the risks versus the benefits of re-treatment. ||| Therefore, the treating physician should carefully weigh the risk of administration versus its anticipated benefit. ||| Les médecins envisageant un traitement chez ces patients doivent évaluer avec précaution le rapport bénéfice/risque d’un re-traitement.
0.015011068433523178 ||| The mean half-life of elimination is 7 hours. ||| The mean half-life of elimination is 12 hours. ||| La demi-vie d’ élimination moyenne est de 7 heures.
0.35935381054878235 ||| 9 After opening the tube for application, the tube cap must be replaced and closed tightly to provide an airtight seal. ||| After insertion into the Reco-Pen, the cooling chain may only be interrupted for administration of the product. ||| Après ouverture du tube pour application, revisser soigneusement le bouchon pour éviter tout contact avec l’ air.
0.3422689735889435 ||| If you miss one or more doses of Tarceva, contact your doctor or pharmacist as soon as possible. ||| If a dose of Lucentis is missed Contact your doctor or hospital as soon as possible to re-schedule your appointment. ||| Si vous avez oublié de prendre une ou plusieurs doses de Tarceva, contactez votre médecin ou votre pharmacien dès que possible.
0.4213661849498749 ||| 54 2. ||| 2 5. ||| 55 2.
0.05931159108877182 ||| If renal function decreases during treatment, ViraferonPeg therapy should be discontinued. ||| If renal function decreases during treatment, PegIntron therapy should be discontinued. ||| Si la fonction rénale diminue pendant le traitement, le traitement par ViraferonPeg doit être interrompu.
0.3411025106906891 ||| Patients should be observed for signs and symptoms of heart failure, weight gain or oedema particularly those with reduced cardiac reserve. ||| Cases of decreased sweating and elevated body temperature have been reported mainly in paediatric patients. ||| Il conviendra de rechercher les signes et symptômes d'insuffisance cardiaque, de prise de poids ou d’œ dème, en particulier chez les patients ayant une réserve cardiaque réduite.
0.501758873462677 ||| Excipients: ||| Excipients ||| tp Excipients:
0.32141658663749695 ||| - if you experience symptoms like irregular heart beat, swelling such as of the ankles or legs, ||| - If you observe any signs of infection around the tube, such as skin redness, swelling, pain or ||| - si vous présentez des symptômes tels qu’une irrégularité du rythme cardiaque, un
0.27219951152801514 ||| Which measures are being taken to ensure the safe use of Revlimid? ||| Which measures are being taken to ensure the safe use of Epoetin Alfa Hexal? ||| Quelles sont les mesures prises pour assurer la sécurité de Revlimid?
2.9651113378839633e-13 ||| Clinically significant laboratory abnormalities, most frequently occurring at doses greater than 10 million IU daily, include reduction in granulocyte and white blood cell counts; decreases in haemoglobin level and platelet count; increases in alkaline phosphatase, LDH, serum creatinine and serum urea nitrogen levels. ||| Clinically significant laboratory abnormalities, most frequently occurring at doses greater than 10 million IU daily, include reduction in granulocyte and white blood cell counts; decreases in haemoglobin level and platelet count; increases in alkaline phosphatase, LDH, serum creatinine and serum urea nitrogen levels. ||| 37 Les anomalies biologiques ayant une importance sur le plan clinique, rencontrées surtout aux doses supérieures à 10 millions d’ UI par jour, comprennent une granulocytopénie et une leucopénie; une baisse du taux d’ hémoglobine et une thrombocytopénie; une élévation des phosphatases alcalines, de la LDH, de la créatinine sérique et du taux sanguin d’ urée.
0.4775864779949188 ||| DATE OF REVISION OF THE TEXT no ||| DATE OF REVISION OF THE TEXT a in ic ||| DATE DE MISE A JOUR DU TEXTE
0.0 ||| THE WORDS "KEEP OUT OF REACH AND SIGHT OF CHILDREN" ||| THE WORDS "KEEP OUT OF REACH AND SIGHT OF CHILDREN" ||| LA MENTION « TENIR HORS DE LA PORTÉE ET DE LA VUE DES ENFANTS »
0.3477374315261841 ||| Lipid alterations Undesirable alterations in lipids have been observed in olanzapine-treated patients in placebo-controlled clinical trials (see section 4.8). ||| Infusion-related reactions Exacerbation of infusion-related reactions by coadministration of anaesthetics has been seen in a non- clinical (rat) study (see section 5.3). ||| Anomalies lipidiques Des anomalies lipidiques ont été observées chez des patients traités par l’ olanzapine au cours d’ essais cliniques versus placebo (voir rubrique 4.8).
0.22372925281524658 ||| Orathecin was to be used to treat patients with advanced cancer of the pancreas, who cannot be operated or who have metastasis (cancer cells that spread from the original site to other parts of the body), and who do not respond to the other anticancer drugs used for the treatment of their disease. ||| It is used when other treatments have stopped working or were not tolerated; • multiple myeloma (a cancer of the cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and are unsuitable for a bone marrow transplant. ||| Orathécin devait être utilisé pour le traitement de patients atteints d’ un cancer du pancréas avancé, qui ne peuvent pas être opérés ou qui présentent des métastases (cellules cancéreuses qui se disséminent à partir du site initial vers d’ autres parties du corps) et qui ne répondent pas aux autres anticancéreux utilisés pour le traitement de cette pathologie.
4.0308514447258414e-13 ||| In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. ||| In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. ||| Dans un tel cas, le patient doit recevoir un traitement symptomatique et les mesures d’appoint qui s’imposent.
0.3617548644542694 ||| Therefore, the use of TORISEL in the paediatric population is not recommended until further information on effectiveness and safety is available. ||| Dogs and cats: it was shown that strict compliance with the recommended posology is compulsory to achieve clinical benefit. ||| Ainsi, dans l’ attente d’ informations supplémentaires sur l’ efficacité et la tolérance, l’ utilisation de TORISEL n’ est pas recommandée chez l’ enfant.
0.72409588098526 ||| Secondary prevention of cardiovascular events has been approved in all Member States, Iceland and Norway. ||| From New York City the active design movement spread throughout the United States and the world. ||| Son indication dans la prévention secondaire d’ évènements cardio-vasculaires a été approuvée par tous les États membres, l’ Islande et la Norvège.
0.35772958397865295 ||| - stomach pain, diarrhoea, feeling sick (nausea), vomiting ||| - cough, nasal symptoms (irritation, runny nose), high temperature ||| - maux d'estomac, diarrhées, douleurs abdominales (nausées), vomissements
0.6909095048904419 ||| The EU has also made available more than €11.3 million in small grants to civil society organisations. ||| Leverage US$ 3.6 billion in national co-financing and self-funded vaccine programmes. ||| L'UE a également mis à disposition plus de 11,3 millions d'euros de petites subventions en faveur d'organisations de la société civile.
0.11329012364149094 ||| Eucreas should not be used during pregnancy. ||| Icandra should not be used during pregnancy. ||| Eucreas ne doit pas être utilisé pendant la grossesse.
0.3335500955581665 ||| The strategy also takes advantage of the rapidly decreasing costs of renewable energy across the EU, which results in lower prices for the consumers, increased energy security, and a more inclusive energy system. ||| Together with tentative signs of stabilisation in the manufacturing sector, and a possible bottoming out of the decline in global trade flows, this should allow the European economy to continue expanding. ||| La stratégie tire également parti de la baisse rapide des coûts des énergies renouvelables dans l'UE, qui se traduit par une baisse des prix pour les consommateurs, une sécurité énergétique accrue et un système énergétique plus inclusif.
0.0 ||| In clinical trials using IntronA therapy, 2.8% patients overall developed thyroid abnormalities. ||| In clinical trials using IntronA therapy, 2.8% patients overall developed thyroid abnormalities. ||| Lors des études cliniques avec administration d’ IntronA, au total 2,8% des patients
0.32763341069221497 ||| Didanosine 400 mg single dose (saquinavir/ritonavir 1600/100 mg qd) ||| Rifabutin (saquinavir/ritonavir 1000/100 mg bid) Benzodiazepines ||| Didanosine dose unique de 400 mg (saquinavir/ritonavir 1600/100 mg une fois par jour)
0.039003510028123856 ||| Using other medicines Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or have recently received any other vaccine. ||| Using other vaccines Please tell your doctor if your child is taking or has recently taken any other medicines, including medicines obtained without a prescription or has recently received any other vaccine. ||| Utilisation d'autres médicaments Prévenez votre médecin si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, ou si vous avez reçu récemment tout autre vaccin.
0.0435546338558197 ||| What ABILIFY looks like and contents of the pack ABILIFY 30 mg tablets are round and pink, marked with A-011 and 30 on one side. ||| What ABILIFY looks like and contents of the pack ABILIFY 5 mg tablets are rectangular and blue, marked with A-007 and 5 on one side. ||| Qu'est -ce qu'ABILIFY et contenu de l'emballage extérieur Les comprimés d'ABILIFY 30 mg sont ronds et roses, gravés A-011 et 30 sur un côté.
0.4055313467979431 ||| Tekturna should be taken with a light meal once a day, preferably at the same time each day. ||| CYSTAGON should be taken 4 times a day, every 6 hours, preferably just after or with food. ||| Tekturna doit être pris avec un repas léger une fois par jour, de préférence à la même heure chaque jour.
0.03555874526500702 ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| For any further information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l'autorisation de mise sur le marché.
0.3447647988796234 ||| Therapy with NeoRecormon should be initiated by physicians experienced in the above mentioned indications. ||| In laboratory conditions Purevax RC was demonstrated to provide protection against the diseases listed above. ||| L’ initiation du traitement par NeoRecormon relève de praticiens expérimentés dans les domaines thérapeutiques cités ci-dessus.
0.22643767297267914 ||| Measuring stands ||| Measuring jugs ||| Supports de mesure
0.5858323574066162 ||| 0.5 mg tacrolimus. ||| cetrotide 0.25mg ||| 0,5 mg de tacrolimus.
0.2248266637325287 ||| Among patients with plaque psoriasis who received Enbrel, significant responses relative to placebo were apparent at the time of the first visit (2 weeks) and were maintained through 24 weeks of therapy. ||| Based on available platelet count measurements, the onset of platelet decline was between 8 and 12 weeks after the first dose of Raptiva in 5 patients, but occurred later in the other patients. ||| 202 Parmi les patients atteints de psoriasis en plaque qui recevaient Enbrel, des réponses significatives comparativement au placebo sont apparues à la première visite (2 semaines) et ont été maintenues durant les 24 semaines de traitement.
0.4454261064529419 ||| See the Package Leaflet for the list of the medicines that may interact with Nexavar. ||| Treatment must then be continued with Dicural Coated Tablets (read the Package Leaflet for that product). ||| Pour une liste complète des interactions médicamenteuses, voir la notice.
6.313313587191782e-13 ||| This medicinal product does not require any special storage conditions. ||| This medicinal product does not require any special storage conditions. ||| Ce médicament ne requiert aucune précaution particulière de conservation.
0.519286036491394 ||| In conclusion, the CHMP considers Implanon to be an effective method of contraception with no apparent safety concerns and that the benefit-risk balance of Implanon is positive. ||| The Commission considers that the COVID-19 outbreak qualifies as an exceptional occurrence, as it is an extraordinary, unforeseeable event having a significant economic impact. ||| En conclusion, le CHMP considère que l’ Implanon est une méthode de contraception efficace, qui ne suscite aucune inquiétude apparente sur le plan sécuritaire, et dont le ratio bénéfice-risque est positif.
0.43424683809280396 ||| Do not leave the syringe exposed to direct sunlight. ||| Try to avoid getting saliva in the tubes. ||| De même, ne laissez pas la seringue exposée directement au soleil.
0.86073899269104 ||| No undesirable effects other than those observed and mentioned in section 4.6 “ Adverse Reactions” have been observed. ||| 7 S e r i o u s adverse reactions have been observed among the undesirable effects listed above: ||| Aucun effet indésirable autre que ceux observés et mentionnés dans le paragraphe "effets indésirables" n'a été observé.
0.8146827220916748 ||| Myositis ||| phlebitis ||| myosite
0.21715590357780457 ||| In patients with moderate and mild renal impairment, EVISTA should be used with caution. ||| Prezista should be used with caution by patients with mild or moderate problems with their liver. ||| Chez les patients présentant une insuffisance rénale modérée et légère, EVISTA doit être utilisé avec prudence.
0.44936323165893555 ||| If it is almost time for your next dose, do not take the missed dose. ||| If there is not enough for your dose, change the cartridge. ||| Si vous êtes proche du oment de la prise suivante, ne prenez pas la dose oubliée.
0.5522684454917908 ||| Your doctor or his/her assistant will show you how to self-inject with the PegIntron pre-filled pen. ||| How do you, or the person injecting you, use Nespo pre-filled pen (SureClick)? ||| Votre médecin ou son/ sa assistant(e) vous montrera comment vous injecter avec le stylo prérempli PegIntron.
0.46183711290359497 ||| Mr Dean has spent periods of time in general veterinary practice, as a lecturer in anatomy and radiology at the Royal Veterinary College, London and in technical and business positions in the veterinary pharmaceutical industry. ||| He moved briefly to the pharmaceutical industry from 1 986 to 1987, before returning to clinical work at the Queen Fabiola Children’s University Hospital in Brussels as head of the nutrition and pharmacodynamics unit, a post he continues to hold today. ||| Dean a pratiqué quelque temps la médecine vétérinaire générale, en tant qu'assistant en anatomie et radiologie au Royal Veterinary College de Londres et a occupé des postes techniques et commerciaux dans l'industrie pharmaceutique vétérinaire.
0.2635323703289032 ||| Do not use Fuzeon if you notice any particles in the powder or the solution once the water for injections has been added. ||| If there are particles in the injection solution or if either the powder or solution is discoloured, the product will not be used. ||| N’utilisez pas Fuzeon si vous remarquez des amas dans la poudre ou dans la solution après avoir ajouté l'eau pour préparations injectables.
0.41199105978012085 ||| Floor mats for automobiles ||| Trailers for petrol tankers ||| Tapis de sol pour automobiles
0.55522620677948 ||| Durability of response and estimated survival rates provide additional evidence of dasatinib clinical benefit. ||| Therefore the CHMP considered in vivo data to be necessary to confirm therapeutic equivalence. ||| La durabilité de la réponse et les taux de survie estimés fournissent une preuve supplémentaire du bénéfice clinique de dasatinib.
0.14574682712554932 ||| Animal studies do not indicate harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3 Preclinical safety data). ||| Animal studies are insufficient with respect to effects on pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3). The potential risk for humans is unknown. ||| Les études chez l'animal ne mettent en évidence aucun effet toxique sur la gestation et le développement embryonnaire/ fœ tal, l’ accouchement ou le développement post-natal (voir section 5.3 données de sécurité préclinique).
0.10874699056148529 ||| They should be used with caution in patients with mild to moderate problems with their liver or severe problems with their kidneys. ||| It must not be used in patients who have severe problems with their kidneys or moderate or severe problems with their liver. ||| Ils doivent être utilisés avec précaution chez les patients atteints de troubles du foie légers à modérés ou de troubles graves des reins.
4.1718283558603297e-13 ||| In diabetic patients, good metabolic control over 24 hours can be achieved with a single daily dose. ||| In diabetic patients, good metabolic control over 24 hours can be achieved with a single daily dose. ||| 29 Chez le diabétique, une dose quotidienne unique permet un contrôle métabolique satisfaisant pendant toute la durée du nycthémère.
0.20055052638053894 ||| If you feel dizzy while taking Truvada, do not drive and do not use any tools or machines. ||| If you feel tired or weak, do not drive, and do not use any tools or machines. ||| Si des étourdissements surviennent au cours du traitement par Truvada, ne conduisez pas et n’utilisez pas d’outils ou de machines.
0.05297387018799782 ||| If pregnancy is detected during therapy, Enviage should be discontinued accordingly. ||| If pregnancy is detected during therapy, Rasilez should be discontinued accordingly. ||| Par conséquent, si une grossesse est détectée pendant le traitement, Enviage doit être interrompu.
0.24078738689422607 ||| If you have been told by your doctor that you have an intolerance to some sugars (e. g. lactose), contact your doctor before taking this medicine. ||| If you think you may be allergic to vildagliptin or any of the other ingredients of Galvus, do not take this medicine and talk to your doctor. ||| Si votre docteur vous a déjà dit que vous présentiez une intolérance à certains sucres (par exemple le lactose), vous devez contacter votre médecin avant de prendre ce médicament.
0.16005948185920715 ||| Pharmacotherapeutic group: nucleoside and nucleotide reverse transcriptase inhibitors ||| Pharmacotherapeutic group: nucleoside and nucleotide reverse transcriptase inhibitors ATC code: ||| Classe pharmacothérapeutique: analogues nucléosidiques et nucléotidiques de la transcriptase inverse Code ATC:
0.22595147788524628 ||| Take special care with ReFacto AF ||| Take special care with Cozaar Comp ||| Faites attention avec ReFacto AF
0.5387282371520996 ||| TABLET STRENGTH ||| BLISTER TEXT ||| DOSAGE DU COMPRIME
0.35418829321861267 ||| If you miss a dose of CELSENTRI, take the missed dose as soon as possible and then take your next scheduled dose at its regular time. ||| But if you missed to administer Cetrotide 0.25 mg at the right time it is no problem to administer this dose at a different time of the same day. ||| Si vous oubliez de prendre une dose de CELSENTRI, prenez la dose oubliée dès que possible et prenez la dose suivante à l’heure habituelle.
0.3714510202407837 ||| 240 ml oral solution ||| 170 ml oral solution. ||| 240 ml de solution buvable.
0.4749205708503723 ||| Depending on how you respond to the treatment your doctor may prescribe a higher dose of one 300 mg tablet once daily. ||| 53 Take your tablets around the same time every day and follow any dietary advice that your doctor has given you. ||| En fonction de votre réponse au traitement, il est possible que votre médecin vous prescrive une dose plus élevée d’ un comprimé à 300 mg une fois par jour.
0.2430904656648636 ||| As with other ACE inhibitors , should be given with caution to patients with mitral valve stenosis and obstruction in the outflow of the left ventricle such as aortic stenosis or hypertrophic cardiomyopathy. ||| Severe forms of acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy. ||| Comme les autres IEC,  doit être donné avec précaution chez les patients ayant une sténose de la valve mitrale et une obstruction du débit ventriculaire gauche telle qu’ une sténose aortique ou une cardiomyopathie hypertrophique.
0.3033490777015686 ||| Ranexa is supplied in cartons containing 30, 60, or 100 tablets in blister strips or 60 tablets in plastic bottles. ||| They are provided in blister packs containing 60 tablets or bottles containing 60 tablets with child-resistant tops. ||| Ranexa est disponible en boîtes de plaquettes de 30, 60 ou 100 comprimés ou de flacons en plastique de 60 comprimés.
0.31213676929473877 ||| Skin and subcutaneous tissue disorders Very common: alopecia. ||| Immune system disorders Very rare: anaphylactic reactions. ||| Affections de la peau et du tissus sous-cutané Très fréquent: alopécie.
0.17790240049362183 ||| HOW TO USE OPGENRA ||| HOW TO USE NEUPRO ||| COMMENT UTILISER OPGENRA
0.21337801218032837 ||| If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package insert with you. ||| If someone is accidentally injected with this product, they must seek immediate medical advice even if only a very small amount is injected. ||| Si ce produit vous a accidentellement été injecté, contactez rapidement votre médecin, même s’ il s’ agit d’ une très petite quantité et prenez la notice avec vous.
0.6362839937210083 ||| Pull back the plunger very slightly with one hand. ||| To remove, push tablets through from other side. ||| Poussez très doucement le piston avec une main.
0.24634432792663574 ||| For some medicinal products that can cause serious or life-threatening undesirable effects, such as carbamazepine, phenobarbital, phenytoin, tricyclic antidepressants and warfarin (monitor International Normalised Ratio), concentration monitoring is available; this should minimise the risk of potential safety problems with concomitant use. ||| Concomitant therapy with drugs predominantly metabolised by this isoenzyme, and which have a narrow therapeutic index (such as flecainide, encainide, carbamazepine and tricyclic antidepressants), should be initiated at or adjusted to the low end of their dose range. ||| La surveillance des concentrations est possible pour certaines substances pouvant induire des effets indésirables graves ou mettant en jeu le pronostic vital du patient, telles que la carbamazépine, le 26 phénobarbital, la phénytoïne, les anti-dépresseurs tricycliques, et la warfarine (contrôle de l’ INR – International Normalised Ratio); ceci devrait réduire le risque potentiel de survenue de problèmes de tolérance lors de leur association avec Agenerase.
0.1729162484407425 ||| 13/ 22 ||| 16/ 21 ||| 13/ 24
0.32317662239074707 ||| In order to achieve a correct dose, the preparation of a concentrated (stock) solution might be required (e.g. to treat a total of 500 kg total bird weight, only 50% of the prepared stock solution prepared from the 40 g sachet should be used). ||| When the total amount of solvent is combined with the full amount of ViraferonPeg powder, the solution will be at the correct concentration to measure your dose (i.e., the labelled amount is contained in 0.5 ml). ||| Il peut être nécessaire de préparer une solution concentrée (solution mère) pour obtenir la dose appropriée (p. ex., pour traiter un poids total de 500 kg de poulets, seulement 50% de la solution mère préparée à partir d’ un sachet de 40 g sera utilisée).
0.8842177391052246 ||| Marketing Authorisation Holder: in ||| Marketing authorisation holder Marketing authorisation: ||| Titulaire de l’autorisation de mise sur le marché:
0.11171070486307144 ||| Do not mix any other insulin in a Humalog cartridge. ||| Do not mix any other insulin in a Liprolog cartridge. ||| Ne mélangez aucune autre insuline dans une cartouche d'Humalog.
0.5230357646942139 ||| 9/ 28 ||| 19/28 ||| 9/ 30
0.031999070197343826 ||| 5 x 5 pack: contains 5 vials of parecoxib 20 mg and 5 ampoule with 1 ml sodium chloride 9 mg/ ml (0.9%) solution. ||| 53 5 x 5 pack: contains 5 vials with parecoxib 40 mg and 5 ampoule with 2 ml sodium chloride 9 mg/ ml (0.9%) solution. ||| Conditionnement 5 x 5: contient 5 flacons de 20 mg de parécoxib et 5 ampoules de 1 ml de solution de chlorure de sodium à 9 mg/ ml (0,9%).
0.4834854304790497 ||| Arthralgia, myalgia, musculoskeletal pain ||| Hiccups, Pharyngolaryngeal pain, Dysphonia ||| Arthralgie, myalgie, douleur musculo-squelettique
0.5105007886886597 ||| Virbagen Omega 2.5 MU/ kg was given intravenously for 3 days. ||| Bivalirudin dose is body weight adjusted in mg/ kg. ||| Virbagen Omega 2,5 MU/ kg a été administré par voie intraveineuse pendant 3 jours.
0.004585407208651304 ||| 23 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 22 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 24 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.5517656803131104 ||| Thermocouple heads ||| Thermo-electric compresses ||| Têtes de thermocouples
0.4854060113430023 ||| Guidance frameworks for machine tools ||| Strategy guide books for card games ||| Châssis de guidage pour machines-outils
0.6913173198699951 ||| Whisky glasses ||| Benches with shelves ||| Verres à whisky
3.924934379243017e-13 ||| In clinical interaction studies, aprepitant did not have clinically important effects on the pharmacokinetics of ondansetron, granisetron, or hydrodolasetron (the active metabolite of dolasetron). ||| In clinical interaction studies, aprepitant did not have clinically important effects on the pharmacokinetics of ondansetron, granisetron, or hydrodolasetron (the active metabolite of dolasetron). ||| Au cours des études cliniques d’interaction, l’aprépitant n’a pas eu d’effet cliniquement important sur la pharmacocinétique de l’ondansétron, du granisétron ou de l’hydrodolasétron (le métabolite actif du dolasétron).
0.5606135725975037 ||| Phosphodiesterase type 5 (PDE5) inhibitors - ||| Tumor Necrosis Factor alpha (TNF- α) inhibitors. ||| Inhibiteurs de la phosphodiestérase du type 5 -
0.4204595685005188 ||| Shaving lotion ||| Shaving soap ||| Lotions de rasage
0.5792407989501953 ||| Flasks ||| Scissors ||| Flacons
0.19486504793167114 ||| 0.25 mg ||| 0.35 ml ||| 1,0 mg
0.5010401606559753 ||| Mix the insulin well immediately before each injection. ||| Close the bottle cap firmly immediately after use. ||| 765 Bien mélanger l'insuline immédiatement avant chaque injection.
0.22335542738437653 ||| Red-brown film-coated tablets debossed with “ GSK” on one side and "8" on the other side. ||| White to off-white and triangular-shaped tablet with “ BMS ” debossed on one side and “ 1611” on the other. ||| Comprimé pelliculé Comprimés pelliculés rouge-bruns gravés « GSK » d’ un côté et « 8 » de l’ autre côté.
0.37289854884147644 ||| Competact should not be used where there is alcohol intoxication, diabetic ketoacidosis (high levels of ketones), conditions that may effects the kidneys, and during breast-feeding. ||| if you are taking drugs that suppress the immune system (e.g. steroids, chemotherapy for cancer, some drugs used to suppress thyroid gland functions). ||| Competact ne doit pas être utilisé en cas d’ intoxication alcoolique, de kétoacidose diabétique (niveaux élevés de cétones), d’ affections pouvant toucher les reins, et au cours de l’ allaitement.
0.2610210180282593 ||| Gelatine for medical purposes ||| Glycerine for medical purposes ||| Gélatine à usage médical
0.2261594533920288 ||| The active substance in Suprelorin, deslorelin, acts like the natural hormone gonadotropin-releasing hormone (GnRH) which controls the secretion of other hormones involved in fertility. ||| The active substance in Tracleer, bosentan, inhibits a naturally occurring hormone called endothelin-1 (ET-1), which causes blood vessels to constrict (narrow). ||| Le principe actif de Suprelorin, la desloreline, agit comme la gonadolibérine (GnRH), une hormone naturelle qui contrôle la sécrétion d’ autres hormones jouant un rôle dans la fertilité.
0.29695141315460205 ||| Forsteo was more effective than placebo in reducing vertebral fractures: ||| Synagis was more effective than placebo in reducing RSV-related hospitalisations: ||| Forsteo s’ est avéré plus efficace que le placebo dans la réduction des fractures vertébrales:
0.16462215781211853 ||| If you are unsure, ask your doctor or pharmacist if any of your medicines are NSAIDs. ||| If you are uncertain if your medicines contain these substances, you should check with your doctor or pharmacist. ||| En cas de doute, demandez à votre médecin ou à votre pharmacien si certains de vos médicaments sont des AINS.
0.0699162632226944 ||| type 2 glass vial ||| type 1 glass vial ||| Flacon de verre de
0.05163317173719406 ||| Additives (Chemical -) for the flow control of sealants ||| Additives (Chemical -) for the flow control of coatings ||| Additifs chimiques pour le contrôle de la consistance des mastics
0.5973387956619263 ||| To date, no other relevant epidemiologic data are available. ||| There are, as yet, limited data on safety following repeated use. ||| A ce jour, il n'existe aucune autre donnée épidémiologique pertinente..
0.3413013219833374 ||| Hypersensitivity reactions (allergic reactions) occur in about 5% of patients taking Kivexa, usually within the first six weeks of treatment. ||| These adverse reactions were common (≥1/100 to < 1/10) in clinical trials in patients treated with PegIntron monotherapy. ||| Des réactions d’ hypersensibilité (allergies) surviennent chez environ 5% des patients sous Kivexa, en général au cours des six premières semaines du traitement.
0.5245262384414673 ||| 1 day (single dose) ||| Starting dose (mg/day) ||| mg en dose unique
0.29140347242355347 ||| Docetaxel must not be used in patients with severe liver impairment since there is no data available (see sections 4.2 and 4.4). ||| There is no dose adjustment necessary in these patients unless there are predisposing risk factors (see section 4.4 Muscle disorders). ||| 44 En l’ absence de données disponibles, le docétaxel ne doit pas être administré aux patients présentant une insuffisance hépatique sévère (cf. paragraphes 4.2 et 4.4).
0.3159869611263275 ||| Horizon Europe will finance research and innovation on topics such as life-long good health; environmental and social health determinants; non-communicable and rare diseases; infectious diseases; tools, technologies and digital solutions for health and care and healthcare systems. ||| The CCDC focuses national attention on developing and applying disease prevention and control (especially infectious diseases), environmental health, occupational safety and health, health promotion, prevention and education activities designed to improve the health of the people of the People's Republic of China. ||| Horizon Europe financera la recherche et l'innovation sur des thèmes tels que la bonne santé tout au long de la vie, les déterminants environnementaux et sociaux de la santé, les maladies non transmissibles et les maladies rares, les maladies infectieuses, les outils, les technologies et les solutions numériques pour la santé et les soins ainsi que les systèmes de soins de santé.
0.6800841093063354 ||| Profender spot-on solution for cats ||| Profender spot-on solution ||| Profender solution pour spot-on pour Chats
0.6381651163101196 ||| How to use Panretin 4. ||| The use of Atripla in ||| Comment utiliser Panretin 4.
0.0 ||| Store in the original package in order to protect from moisture. ||| Store in the original package in order to protect from moisture. ||| Conserver dans le conditionnement d’origine afin de protéger de l’humidité.
0.3250808119773865 ||| The consequence of treatment with Busilvex at the recommended dose and schedule is profound myelosuppression, occurring in all patients. ||| consequence of disturbances in fluid balance and occurs only at the start of treatment with somatropin and is dose-dependent. ||| Une myélosuppression profonde rapportée chez tous les patients traités par Busilvex à la posologie recommandée est une conséquence du traitement.
0.1964641511440277 ||| The pre-filled syringe is ready for use. ||| The pre-filled pen is now ready to use. ||| La seringue préremplie de Retacrit est prête à l’emploi.
0.2638266086578369 ||| Discontinuation of Lamictal in patients with bipolar disorder In clinical trials, there was no increase in the incidence, severity or type of adverse reactions following abrupt termination of lamotrigine versus placebo. ||| No evidence of a neutralisation of lepirudin or of an allergic reaction associated with the positive antibody test results was found. – Experience of combined therapy with thrombolytic agents in patients with HIT type II is very limited. ||| Arrêt du traitement par Lamictal chez les patients atteints de troubles bipolaires Dans les essais cliniques, il n’ y a eu aucune augmentation de l’ incidence, de la sévérité ou du type d’ effets indésirables suite à un arrêt brutal de la lamotrigine par comparaison avec le placebo.
0.2957051396369934 ||| Although no spontaneous reports have been received with this agent, the occurrence or aggravation of exertional dyspnea requires treatment discontinuation and investigation in a specialised unit, as it is the first sign of occurrence (see special warnings). ||| Prolonged bleeding time appears a frequent finding (90%): although the exact mechanism of such an effect is unknown and its relation with mitotane or with the underlying disease is uncertain, it should be taken into account when surgery is considered. ||| Bien qu'aucune notification spontanée n’ ait été reçue pour ce produit, la survenue ou l'aggravation d'une dyspnée d'effort impose l'arrêt du traitement et des investigations en milieu spécialisé, car il s’ agit du premier signe clinique, (voir mises en garde particulières).
0.16466617584228516 ||| 18 months Shelf-life after first opening the immediate packaging: ||| 2 years Shelf life after first opening the immediate packaging: ||| Durée de conservation après première ouverture du conditionnement primaire:
0.43622398376464844 ||| The usual dose is 250 mg fulvestrant (one 5 ml injection) given once a month. ||| In ovo route: one single injection of 0.05 ml per egg at 18 days of embryonation. ||| La dose usuelle est de 250 mg de fuvestrant (1 injection de 5 ml) une fois par mois.
0.208568274974823 ||| Bondronat 50 mg film-coated tablets ibandronic acid ||| BONVIVA 150 mg film-coated tablets Ibandronic acid ||| Bondronat 50 mg comprimés pelliculés Acide ibandronique
8.252060059582567e-13 ||| Oral suspension ||| Oral suspension ||| Suspension orale
0.43362390995025635 ||| Marcumar), stopping Xeloda might require that your doctor adjusts your anticoagulant dose. ||| Your doctor may adjust your dose of Fluticasone furoate GSK. ||| Marcoumar®), l’ arrêt de Xeloda peut conduire votre médecin à ajuster les posologies de votre anticoagulant.
0.6114289164543152 ||| – Immune thrombocytopenic purpura ||| Triacellucax bacterial vaccine Part A ||| Purpura thrombopénique immunologique
0.5008731484413147 ||| Truvada should always be used combined with other medicines to treat HIV infection. ||| Could an antibiotic with a narrower spectrum be used to treat the infection? ||| Truvada doit toujours être utilisé en association avec d’ autres médicaments pour le traitement de l’ infection par le VIH.
0.5105435252189636 ||| The resort to combination therapy, however, should be envisaged according to specific factors (including severe neutropenia). ||| Introducing appropriate lifestyle changes (e. g. increased exercise), in conjunction with this weight management programme, may provide additional benefits. ||| Cependant, le recours à une polythérapie doit être envisagé en fonction de facteurs spécifiques (parmi lesquels, la neutropénie sévère).
0.27867934107780457 ||| In healthy subjects, oral prednisone (20 mg three times daily for five days) did not produce a clinically meaningful change in oral bioavailability of alendronate (a mean increase ranging from 20% to 44%). ||| At a concentration of 0.4 mg/ kg/ day oxybutynin administered subcutaneously, the occurrence of organ anomalies is significantly increased, but is observed only in the presence of maternal toxicity. ||| Chez le sujet sain, l’ administration de 20 mg de prednisone par voie orale (3 fois par jour pendant 5 jours) n’ a pas produit de changement cliniquement significatif de la biodisponibilité orale de l’ alendronate (augmentation moyenne comprise entre 20% et 44%).
0.2728496789932251 ||| See the box at the end of this leaflet for further information. ||| Read all the information in this leaflet for guidance. ||| Voir l’ encadré à la fin de cette notice pour plus d’ informations.
0.3525133728981018 ||| The main measure of effectiveness was the speed of response to treatment and the advance in time and synchronisation of the spawning period. ||| The optimum dosage is based upon the degree and chronicity of the anaemia and the desired duration of the effect. ||| La principale mesure d’ efficacité était la vitesse de réponse au traitement et le déclenchement et la synchronisation anticipés de la période de fraie.
0.485505610704422 ||| The main use of the referred interim analyses is in the detection of any new safety signals and as a comparison of the efficacy in relation to earlier findings. ||| Concerns were also raised regarding how to store the inhaler and the effect of the orientation of the inhaler on the delivery of the medicine. ||| Les analyses provisoires mentionnées servent principalement à détecter tout nouveau signal indiquant un problème de sécurité et à comparer l’ efficacité par rapport aux résultats antérieurs.
0.4193010926246643 ||| The terminal half-life of voriconazole depends on dose and is approximately 6 hours at 200 mg (orally). ||| Sildenafil dose should not exceed a maximum of 25 mg in a 48-hour period in ||| La demi-vie d’ élimination terminale du voriconazole dépend de la dose administrée et est d’ environ 6 heures pour une dose de 200 mg (voie orale).
0.3478946089744568 ||| Immune system disorders: hypersensitivity reactions including anaphylactic/ anaphylactoid reactions. ||| Allergy Generalised hypersensitivity reactions (e. g. anaphylactic reaction), or immunological reactions such as vasculitis. ||| Troubles du système immunitaire: réactions d'hypersensibilité incluant des réactions anaphylactiques/ anaphylactoïdes.
0.01355639286339283 ||| RISPERDAL and associated names (see Annex I) 2 mg film-coated tablets ||| RISPERDAL and associated names (see Annex I) 0.5 mg film-coated tablets ||| RISPERDAL et dénominations associées (Voir Annexe I) 2 mg comprimés pelliculés
0.5447424054145813 ||| Co-operation and exchange of scientific information with other CPMP working parties has notably increased during the year. ||| The financing was part of broader EIB activities in the life sciences sector. ||| La coopération et les échanges d’informations scientifiques avec d’autres groupes de travail du CPMP se sont considérablement développés au cours de l’année.
0.17262038588523865 ||| 8 Common: constipation, diarrhoea, dyspepsia, eructation Uncommon: nausea*, vomiting*, acid reflux, dysgeusia, epigastric discomfort, obstipation, gastroesophageal reflux disease, perforating duodenal ulcer, abdominal pain, dry mouth, enterocolitis, flatulence, stomatitis. ||| Uncommon: upper respiratory tract infection, diabetes mellitus, hyperlipidaemia, abnormal dreams, hypoaesthesia, disturbance in attention, somnolence, dyspepsia, eructation, increased aspartate aminotransferase, allergic dermatitis, urticaria, dermatitis, night sweats, myalgia, muscle spasms, asthenia. ||| Fréquents: constipation, diarrhée, dyspepsie, éructation Peu fréquents: nausées*, vomissements*, régurgitation acide, dysgueusie, gêne épigastrique, constipation opiniâtre, reflux gastro-œ sophagien, ulcère duodénal perforant, douleur abdominale, bouche sèche, entérocolite, flatulence, stomatite.
0.780687153339386 ||| Allergen products ||| Other medicinal products ||| Produits allergènes
0.2516961693763733 ||| - itraconazole (medicine to treat fungal infections) ||| - fosamprenavir (another medicine to treat HIV-infection) ||| - de l’ itraconazole (médicament pour traiter les infections fongiques)
0.07068316638469696 ||| The full EPAR for Xiliarx can be found here. ||| The full EPAR for Caelyx can be found here. ||| L’ EPAR complet relatif à Xiliarx est disponible ici.
4.853388741246634e-13 ||| 6.1 List of excipients ||| 6.1 List of excipients ||| 44 6.1 Liste des excipients
0.13069650530815125 ||| - if you have liver disease; ||| - If you have liver disease. ||| - si vous avez une maladie du foie;
0.4630485773086548 ||| It has already been activated to help to deal with influx of refugees in Greece ||| These feelings have also been reported while attempting to quit smoking with Champix. ||| Il a déjà été activé pour soutenir la Grèce lors de la crise migratoire.
0.5341569185256958 ||| These are known effects of hCG treatment. ||| These agents are used to treat cancer. ||| Ce sont des effets connus du traitement par hCG.
0.17362381517887115 ||| Hepatic impairment: the pharmacokinetics of amprenavir are significantly altered in patients with moderate to severe hepatic impairment. ||| Hepatic impairment: stavudine pharmacokinetics in patients with hepatic impairment were similar to those in patients with normal hepatic function. ||| Insuffisants hépatiques: la pharmacocinétique de l'amprénavir est significativement modifiée chez les patients présentant une insuffisance hépatique modérée à sévère.
0.41320303082466125 ||| The bioavailability of tulathromycin after subcutaneous administration in cattle was approximately 90%. ||| Analysis of efficacy of Gardasil against high grade cervical lesions in the PPE population ||| La biodisponibilité de la tulathromycine après administration sous-cutanée chez les bovins est approximativement de 90%.
0.4844757318496704 ||| Several border controls have also been set up to try and limit the spread. ||| Some measures have already been taken to support media freedom and protect journalists. ||| Plusieurs contrôles aux frontières ont également été mis en place pour tenter de limiter la propagation.
0.04510911926627159 ||| Caution should be exercised when Extavia is administered in combination with medicinal products that have a narrow therapeutic index and are largely dependent on the hepatic cytochrome P450 system for clearance, e. g. anti-epileptics. ||| Caution should be exercised when administering Rebif in combination with medicinal products that have a narrow therapeutic index and are largely dependent on the hepatic cytochrome P450 system for clearance, e. g. antiepileptics and some classes of antidepressants. ||| Il convient d’ être prudent en cas d’ administration simultanée avec des médicaments ayant une marge thérapeutique étroite et dont la clairance dépend largement du système du cytochrome P450, par exemple les anti-épileptiques.
0.5168414115905762 ||| LABEL - BOTTLE OF 100 TABLETS 800 mg ||| FOLDING BOX AND LABEL FOR BOTTLE for 110 mg ||| ÉTIQUETTE - FLACON DE 100 COMPRIMES 800 mg
0.3764185309410095 ||| * One International Unit (IU) of protein C corresponds to the amidolytically measured activity of protein C in 1 ml of normal plasma. ||| One vial with powder for solution for injection nominally contains 1000 IU octocog alfa (IU equals International Units). ||| * Une Unité internationale (UI) de protéine C correspond à l’ activité amidolytique de la protéine C mesurée dans 1 ml de plasma normal..
0.5421145558357239 ||| (see section 5.1) ||| (see Table 4) ||| (voir rubrique 5.1)
0.29332250356674194 ||| - For the treatment of advanced breast cancer, TAXOTERE could be administered either alone or in ||| - For the treatment of early breast cancer with lymph node involvement, TAXOTERE could be ||| - Pour le traitement du cancer du sein à un stade avancé, TAXOTERE peut être administré soit
0.0 ||| Do not use after the expiry date stated on the label. ||| Do not use after the expiry date stated on the label. ||| Ne pas utiliser après la date de péremption mentionnée sur la boîte.
0.428808331489563 ||| - The CHMP concluded that the data are supportive of the following indications: ||| The results of these analyses of efficacy are summarised in the table below: ||| - Le CHMP est parvenu à la conclusion que les données soutiennent les indications suivantes:
0.04567338153719902 ||| Do not use after the expiry date stated on the carton and the bottle. ||| Do not use after the expiry date stated on the carton and bag. ||| Ne pas utiliser après la date de péremption (EXP) figurant sur la boîte et le flacon
0.997532069683075 ||| General purpose scouring powder ||| Oral solution Oral use ||| Poudres à récurer à usage général
0.5313271880149841 ||| On this basis, the Commission therefore concluded that the measure is compatible with EU State aid rules. ||| In keeping with our transparency policy, the draft legal agreement has been published online . ||| Sur cette base, la Commission a dès lors conclu que la mesure est compatible avec les règles de l'UE en matière d'aides d'État.
0.4499247074127197 ||| Suturing instruments ||| Styling lotions ||| Instruments de suture
0.23261740803718567 ||| In general, at therapeutic doses, detection of intact orlistat in plasma was sporadic and concentrations were extremely low (< 10 ng/ ml or 0.02 µmol), with no evidence of accumulation, which is consistent with minimal absorption. ||| After a repeated dose regimen of 100 mg/ kg/ day for 5 days, the absorption kinetics did not change but the distribution half life was prolonged significantly (up to 36 h), indicating saturable transport and redistribution processes. ||| En général, aux doses thérapeutiques, la détection plasmatique d’ orlistat sous forme inchangée est sporadique et les concentrations extrêmement faibles (< 10 ng/ ml ou 0,02 μ mol), sans signe d’ accumulation, ce qui est compatible avec une absorption très faible.
0.5089559555053711 ||| For the full list of all side effects reported with TAXOTERE, see the Package Leaflet. ||| Also read the BYETTA Package leaflet that comes with the BYETTA pen carton. ||| Pour avoir le détail de tous les effets indésirables observés lors de l'utilisation de TAXOTERE, voir la notice.
0.0 ||| Parosmia ||| Parosmia ||| d’ organes
0.26281583309173584 ||| You should not take Prandin if you are pregnant or you are planning to become pregnant. ||| You should not take Xeloda if you are pregnant or think you might be. ||| Vous ne devez pas prendre Prandin si vous êtes enceinte ou prévoyez de l’ être.
0.0 ||| Step 6 - Injecting the solution Depress the plunger slowly and steadily, so the solution is correctly injected and the skin tissues are not damaged. ||| Step 6 - Injecting the solution Depress the plunger slowly and steadily, so the solution is correctly injected and the skin tissues are not damaged. ||| 145 Pousser doucement et régulièrement le piston, la solution sera alors injectée correctement et la peau ne sera pas lésée.
0.15983682870864868 ||| Studies in animals have shown reproductive toxicity (see section 5.3). ||| Animal studies of reproductive toxicity are incomplete (see section 5.3). ||| Les études chez l’ animal ont montré une toxicité pour la reproduction (cf. rubrique 5.3).
0.45390403270721436 ||| Fencing weapons ||| Scouring substances ||| Armes d'escrime
0.4864674508571625 ||| Blister for Cozaar 12.5 mg film-coated tablets ||| Irbesartan BMS 300 mg film-coated tablets irbesartan ||| Plaquette thermoformée pour Cozaar 12,5 mg, comprimé pelliculé
0.3402074873447418 ||| Your doctor might prescribe acetylsalicylic acid or modify the shunt. ||| Patients should receive concomitant treatment with acetylsalicylic acid. ||| Votre médecin pourra vous prescrire de l'acide acétylsalicylique (aspirine) ou modifier la fistule.
0.6578288078308105 ||| What is the role of the EIB Group in the new proposal? ||| What are the conclusions of the CHMP? ||| Quel rôle la nouvelle proposition attribue-t-elle au Groupe BEI?
0.27296602725982666 ||| When paroxetine is to be co-administered with a known drug metabolising enzyme inhibitor, consideration should be given to using paroxetine doses at the lower end of the range. ||| If the decision is made to administer another cyanide antidote with Cyanokit, these medicinal products must not be administered concurrently in the same intravenous line. ||| Lorsque la paroxétine doit être associée à un inhibiteur enzymatique connu, les doses recommandées les plus faibles seront utilisées.
0.33360302448272705 ||| In conclusion, the CHMP was of the opinion that the current weight of evidence is that the benefit-risk assessment remains favourable in this restricted target population indication of persistent aggression in Alzheimer’ s dementia for short-term treatment only (6 weeks) and with all restrictions and conditions indicated in the SPC. ||| This Referral procedure relates to a request for Arbritation concerning a type II variation for a new indication in the “ Prevention of cardiovascular events in patients estimated to have a high risk for a first cardiovascular event, as an adjunct to correction of other risk factors”. ||| En conclusion, le CHMP a estimé que les éléments actuels montrent principalement que l’ évaluation des avantages et des risques reste favorable pour l’ indication d’ un traitement à court terme uniquement (6 semaines) ciblant cette population restreinte de patients atteints d’ agressivité persistante liée à la démence de type Alzheimer, avec toutes les restrictions et conditions indiquées dans le RCP.
0.0 ||| 113 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 113 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 119 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.5057802796363831 ||| Another hospital was built afterwards, Leishenshan Hospital, to handle additional patients. ||| The authorities also announced the construction of a temporary hospital, Huoshenshan Hospital, which was completed in 10 days. ||| Un autre hôpital a été construit par la suite : Leishenshan, afin de traiter les patients supplémentaires.
0.24216239154338837 ||| Concomitant administration of rosiglitazone with the oral antihyperglycaemic agents glibenclamide and acarbose did not result in any clinically relevant pharmacokinetic interactions. ||| Results from clinical trials conducted with the oral antidiabetics pioglitazone, metformin and glyburide in combination with vildagliptin have shown no clinically relevant pharmacokinetic interactions in the target population. ||| L’ administration concomitante d’ autres antidiabétiques oraux comme le glibenclamide et l’ acarbose n’ entraîne pas d’ interactions pharmacocinétiques significatives avec la rosiglitazone.
0.2985452711582184 ||| Following the approval of the German measures adopted on 22 March 2020 , Germany notified to the Commission an additional support measure under the Temporary Framework, implemented through the German federal and regional authorities, as well as promotional and guarantee banks. ||| Today, Member States, supported by the Commission, published an EU toolbox for mobile contact tracing and warning apps , following the adoption of a Commission Recommendation for a common EU approach for the use of technology and data in the fight against coronavirus. ||| Après que les mesures allemandes adoptées le 22 mars 2020 ont été autorisées, l'Allemagne a notifié à la Commission une aide supplémentaire au titre de l'encadrement temporaire, mise en œuvre par les autorités fédérales et régionales allemandes, ainsi que par des banques de développement et de cautionnement.
0.18471963703632355 ||| 0.0 ||| 0.5 ||| 0,0
0.3537994921207428 ||| The company that makes Vectibix will supply the results of additional studies looking at the safety and effectiveness of the medicine in patients with colorectal cancer with and without mutated KRAS, as well as at the quality of life in patients receiving it. ||| The company that makes Intelence will supply the final 48-week results of the two main studies with Intelence, and will conduct an additional study to demonstrate that similar results are also seen in patients taking protease inhibitors other than boosted darunavir. ||| La société qui fabrique Vectibix fournira les résultats de études supplémentaires examinant la sécurité et l’ efficacité du médicament chez les patients souffrant de cancer colorectal avec ou sans gène KRAS muté, ainsi que la qualité de vie des patients auxquels il est administré.
0.3162159323692322 ||| While fever may be associated with the flu-like syndrome reported commonly during interferon therapy, other causes of persistent fever must be ruled out. ||| Fever of unknown origin frequently occurs in patients treated for hairy cell leukaemia and is manifested predominantly during the first 4 weeks of therapy. ||| Bien que la fièvre puisse être associée au syndrome pseudo-grippal rapporté communément lors d’ un traitement par interféron, les autres causes de fièvres persistantes doivent être écartées.
0.3318273723125458 ||| Caution must be exercised in handling Temodal 2.5 mg/ml powder for solution for infusion. ||| Alternatively therapy may be initiated with Loxicom 5 mg/ ml solution for injection. ||| Des précautions doivent être prises lors de la manipulation de Temodal 2,5 mg/ ml poudre pour solution pour perfusion.
0.4711412787437439 ||| Significant differences in comparison to the reference product have been identified with regard to the indications’ section of the SPCs. ||| All part of the sections for 4 and 5 of the summary of product characteristics has been harmonised during the procedure. ||| Des différences considérables en comparaison avec le produit de référence ont été identifiées eu égard au paragraphe Indications du RCP.
0.09141995012760162 ||| 7/ 14 ||| 7/ 13 ||| 8/ 14
0.023262090981006622 ||| The arbitration procedure started on 21 February 2008 with the adoption of a list of questions. ||| The arbitration procedure started on 27 April 2006 with the adoption of a list of questions. ||| La procédure d’ arbitrage a débuté le 21 février 2008, avec l’ adoption d’ une liste de questions.
0.38930049538612366 ||| Leasing of showers ||| Leasing of telephone circuits ||| Location de douches
0.0 ||| If the rate of rise in haemoglobin is greater than 2 g/ dl (1.24 mmol/ l) over a month or if the haemoglobin level is increasing and approaching 12 g/ dl (7.45 mmol/ l), the dose is to be reduced by approximately 25%. ||| If the rate of rise in haemoglobin is greater than 2 g/ dl (1.24 mmol/ l) over a month or if the haemoglobin level is increasing and approaching 12 g/ dl (7.45 mmol/ l), the dose is to be reduced by approximately 25%. ||| 147 Si l’ augmentation du taux d’ hémoglobine est supérieure à 2 g/ dl (1,24 mmol/ l) en un mois ou si le taux d’ hémoglobine augmente pour approcher 12 g/ dl (7,45 mmol/ l), la dose doit être réduite d’ environ 25%.
0.4820798635482788 ||| Dose adjustments during treatment: ||| Dosage adjustment in renal failure: ||| Adaptation de la dose au cours du traitement:
3.033178634474776e-13 ||| 10 vials of suspension (5 dose size) + 10 vials of emulsion (5 dose size). ||| 10 vials of suspension (5 dose size) + 10 vials of emulsion (5 dose size). ||| 10 flacons de suspension (taille pour 5 doses) + 10 flacons d’ émulsion (taille pour 5
0.46409744024276733 ||| Some articles on popular sites in China have also cast suspicion on US military athletes participating in the Wuhan 2019 Military World Games, which lasted until the end of October 2019, and have suggested they deployed the virus. ||| During the 2019–20 coronavirus pandemic in China, he resigned from CCTV and found a way to get into Wuhan in hopes of following in the footsteps of disappeared journalist Chen Qiushi. ||| Certains articles de sites populaires en chinois ont également soupçonné les athlètes militaires américains ayant participé aux Jeux mondiaux militaires d'été 2019 à Wuhan qui ont duré jusqu'à la fin octobre 2019 d'avoir introduit le virus.
0.30837482213974 ||| Potential for other medicinal products to affect ABILIFY: ||| 60 Potential for other medicinal products to affect RISPERDAL ||| Interactions potentielles ayant un effet sur ABILIFY:
0.22179290652275085 ||| Both losartan and its active metabolite are ≥ 99% bound to plasma proteins, primarily albumin. ||| Sildenafil and its major circulating N- desmethyl metabolite are approximately 96% bound to plasma proteins. ||| Le losartan et son métabolite actif sont liés à 99% au moins aux protéines plasmatiques, essentiellement à l’ albumine.
0.2741292119026184 ||| - If you have liver disease, tell your doctor. ||| Please tell your doctor if you have serious liver disease. ||| Si vous avez une maladie du foie, informez votre médecin.
0.5227416753768921 ||| Manufacturer Wyeth Lederle S. p. A. ||| Manufacturer Biogen Idec B. V. ||| Fabricant Wyeth Lederle S. p. A.
0.34145647287368774 ||| Agenerase may be less effective due to decreased amprenavir plasma concentrations in patients taking these medicinal products concomitantly (see section 4.5). ||| Rarely, blood clots may occur without unwanted overstimulation of the ovaries (see also “ Take special care with Fertavid”). ||| Agenerase peut être moins efficace en raison de la baisse des concentrations plasmatiques d’ amprénavir chez les patients prenant ces médicaments simultanément (voir rubrique 4.5).
0.3865836560726166 ||| Rapamune is given as an initial dose of 6 mg as soon as possible after the transplant, followed by 2 mg once a day for two to three months. ||| Oral administration of 60ml as soon as possible, preferably given within the first 4 hours, but not later than 12 hours after birth. ||| Rapamune est administré en une dose initiale de 6 mg le plus tôt possible après la transplantation, suivie de 2 mg une fois par jour pendant deux à trois mois.
0.6102863550186157 ||| Immunisation schedules: ||| Induction treatment schedule: ||| Schémas vaccinaux:
0.5482826828956604 ||| Distribution The serum protein binding of ramipril is about 73% and that of ramiprilat about 56%. ||| Protopic is available in two strengths (Protopic 0.03% and Protopic 0.1% ointment). ||| Distribution La liaison du ramipril aux protéines sériques est d’ environ 73%, et celle du ramiprilate d’ environ 56%.
0.32445573806762695 ||| IDA Industrial Park Old Kilmeaden Road Waterford Ireland ||| Bayer Limited The Atrium Blackthorn Road Dublin 18 Ireland ||| IDA Industrial Park Old Kilmeaden Road Waterford Irlande
0.27595680952072144 ||| INTEGRILIN is used in patients with manifestation of severe coronary insufficiency defined as spontaneous and recent chest pain with electrocardiographic abnormalities or biological changes. ||| Chronic forms reveal additional findings of chronic interstitial inflammation and alveolar destruction (honeycombing) associated with dense fibrosis. ||| INTEGRILIN est utilisé pour traiter les patients ayant des signes d’ insuffisance coronarienne sévère définie comme une douleur spontanée et récente dans la poitrine avec des anomalies électrocardiographiques ou des changements biologiques.
0.553845226764679 ||| In the 26-week study, the severity of the vitreous inflammation increased with the number of injections. ||| The general escape clause was activated for the first time after the outbreak of the coronavirus pandemic. ||| Dans l'étude de 26 semaines, la sévérité de l'inflammation vitréenne a augmenté avec le nombre d'injections.
0.3740706145763397 ||| White powder ||| White wine ||| Poudre blanche
0.06574253737926483 ||| Transmission: patients should be advised that current antiretroviral therapy, including Ziagen, have not been proven to prevent the risk of transmission of HIV to others through sexual contact or blood contamination. ||| Miscellaneous: patients should be advised that current antiretroviral therapy, including Trizivir, has not been proven to prevent the risk of transmission of HIV to others through sexual contact or blood contamination. ||| Les patients doivent être informés qu'à ce jour, il n'a pas été démontré de prévention du risque de transmission sexuelle ou sanguine du VIH sous traitement antirétroviral, y compris par Ziagen.
0.3161577582359314 ||| In populations where the dose may be increased to 8 mg once daily, the dose increase should be preceded by an evaluation of the individual response and tolerability. ||| The number of patients studied in each dose group was insufficient to establish the optimal dosing regimen in patients under the age of 12 years (see also section 5.1). ||| Dans les populations pour lesquelles la dose peut être augmentée à 8 mg une fois par jour, l’ augmentation de la dose doit être précédée d’ une évaluation indivuduelle de la réponse et de la tolérance au traitement.
3.089429482638212e-13 ||| Gastrointestinal disorders such as nausea and vomiting are dose-related, and may occur when initiating treatment and/ or increasing the dose (see section 4.8). ||| Gastrointestinal disorders such as nausea and vomiting are dose-related, and may occur when initiating treatment and/ or increasing the dose (see section 4.8). ||| 74 Des troubles gastro-intestinaux tels que nausées et vomissements sont liés à la dose et peuvent survenir lors de l’ instauration du traitement et/ ou de l’ augmentation posologique (voir rubrique 4.8).
0.38639628887176514 ||| A transversal work stream, across the three partnerships, deals with supporting health systems in order to cope with coronavirus, in which the WHO would play a prominent role. ||| The three partnerships would work as autonomously as possible, with a transversal work stream on enhancing the capacity of health systems and knowledge and data sharing. ||| Un axe de travail transversal entre les trois partenariats porte sur le soutien aux systèmes de santé dans la lutte contre le coronavirus, et l'OMS y jouerait un rôle prépondérant.
0.3720417618751526 ||| Your blood will be tested frequently during treatment to monitor the side effects of Temodal on your blood cells. ||| Regular blood tests will be arranged to check whether there is a problem with your white and red blood cell count. ||| Vous serez soumis à de fréquentes prises de sang durant le traitement afin de surveiller les effets indésirables de Temodal sur les cellules sanguines.
0.3464651107788086 ||| Other adverse reactions reported very rarely for desloratadine during the post-marketing period are listed in Table 2. ||| After administration of Helixate NexGen mild to moderate adverse events were observed in rare cases as presented in the following table. ||| Les autres effets indésirables très rarement rapportés pour la desloratadine depuis sa commercialisation sont indiqués dans le tableau 2.
0.4138258099555969 ||| The deltoid muscle is the preferred site for injection in children and adolescents. ||| This is especially important in the elderly and for patients receiving diuretic therapy. ||| Chez les enfants et les adolescents, l'injection se fera de préférence dans le muscle deltoïde.
3.489728037792128e-13 ||| In patients with Parkinson’ s disease, the cells in the brain that produce the neurotransmitter dopamine begin to die and the amount of dopamine in the brain decreases. ||| In patients with Parkinson’ s disease, the cells in the brain that produce the neurotransmitter dopamine begin to die and the amount of dopamine in the brain decreases. ||| Chez les patients atteints de la maladie de Parkinson, les cellules du cerveau qui produisent le neurotransmetteur dopamine commencent à disparaître, ce qui entraîne une diminution de la quantité de dopamine dans le cerveau.
0.1538025438785553 ||| 23 1. ||| 25 1. ||| 27 1.
0.22291481494903564 ||| - anti-epileptic medicines, including carbamazepine, phenytoin and phenobarbital ||| - phenytoin, phenobarbital, carbamazepine (used to treat epilepsy), ||| - médicaments anti-épileptiques, notamment carbamazépine, phénytoïne et phénobarbital
0.1993231475353241 ||| exfoliative dermatitis, Steven-Johnsons syndrome, erythema multifome, urticaria, fixed drug eruption, pemphigus, phototoxicity. ||| diaphoresis, pemphigus, toxic epidermal necrolysis, Stevens-Johnson Syndrome, erythema multiforme. ||| dermatite exfoliative, syndrome de Steven-Johnson, érythème multiforme, urticaire, érythème pigmenté fixe, pemphigus, phototoxicité.
4.0605743051834453e-13 ||| 4.2 Posology and method of administration ||| 4.2 Posology and method of administration ||| 17 4.2 Posologie et mode d’ administration
0.2764536738395691 ||| Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human M ||| Comparisons between aripiprazole and placebo in the proportions of patients experiencing potentially clinically significant changes in routine laboratory parameters revealed no medically important differences. ||| Ces résultats sur la survie globale n’ ont pas pu être expliqués de façon satisfaisante par des différences d’ incidence de survenue de thromboses et de leurs complications en
0.431132435798645 ||| Contrada Fontana del Ceraso I-03012 Anagni-Frosinone - Italy ||| Bristol-Myers Squibb Srl Contrada Fontana Del Ceraso I-03012 Anagni-Frosinone Italy ||| Contrada Fontana del Ceraso I-03012 Anagni-Frosinone - Italie
0.25348687171936035 ||| The use of Zometa in paediatric patients has not been studied. ||| Use in paediatric patients has not been investigated. ||| 19 L’ utilisation de Zometa chez l’ enfant n’ a pas été étudiée.
0.41047704219818115 ||| 33/ 44 ||| 33/ 34 13. ||| 32/ 44
0.2545711100101471 ||| Firazyr is a solution for injection that contains the active substance icatibant. ||| Lyrica is a capsule for oral administration, containing the active substance pregabalin. ||| Firazir est une solution injectable contenant le principe actif icatibant.
0.479669451713562 ||| Japanese rice bowls [chawan] ||| Pipa [Chinese guitars] ||| Bols à riz japonais [chawan]
0.0 ||| This medicine does not require any special storage conditions. ||| This medicine does not require any special storage conditions. ||| Ce médicament ne présente pas de précaution particulière de conservation.
0.41415131092071533 ||| Therefore, you must continue to take appropriate precautions to avoid giving the virus to others. ||| You may need to be given additional medicines to prevent such reactions from occurring. ||| Les précautions nécessaires afin d’ éviter la transmission du virus doivent donc être maintenues.
0.025692544877529144 ||| 54 4.2 Posology and method of administration ||| 74 4.2 Posology and method of administration ||| 56 4.2 Posologie et mode d’administration
0.05150986462831497 ||| Dosage adjustment of pravastatin may be required (refer to the Summary of Product Characteristics for pravastatin). ||| Dosage adjustment of simvastatin may be required (refer to the Summary of Product Characteristics for simvastatin). ||| Un ajustement posologique de la pravastatine peut être nécessaire (voir le Résumé des Caractéristiques de la pravastatine).
0.04156917333602905 ||| In such cases, it is recommended that a specialised haemophilia centre be contacted. ||| In such cases, it is recommended that a specialised haemophilia centre be contracted. ||| Dans ce cas, il est recommandé de contacter un centre spécialisé dans le traitement de l’ hémophilie.
0.09858023375272751 ||| What Fendrix looks like and contents of the pack ||| What Tracleer looks like and contents of the pack ||| Qu’ est -ce que Fendrix et contenu de l’ emballage extérieur
0.20984706282615662 ||| Irbesartan Hydrochlorothiazide Winthrop is contraindicated during breast-feeding. ||| Irbesartan Hydrochlorothiazide Winthrop may be added to other treatments for hypertension. ||| Irbesartan Hydrochlorothiazide Winthrop est contre-indiqué pendant l'allaitement (voir rubrique 4.3).
0.32268327474594116 ||| Bicycle sheds [structures] of non-metallic materials ||| Filtering materials [semi-processed foams or films of plastic] ||| Abris pour vélos [structures] en matériaux non métalliques
0.269736111164093 ||| Patients co-infected with hepatitis C and treated with alpha interferon and ribavirin may constitute a special risk. ||| Patients treated with IntronA and ribavirin combination therapy and zidovudine could be at increased risk of developing anaemia. ||| 29 patients co-infectés par le virus de l'hépatite C et traités par interféron alpha et ribavirine sont particulièrement exposés.
0.4321132302284241 ||| Loratadina Lasa ||| Loratadina Kern ||| Loratadina
0.38338959217071533 ||| These funds for the WHO will contribute to global preparedness, prevention and containment of the virus and support the countries with the weakest health systems. ||| I call on the solidarity and responsibility of the EU pharmaceutical industry to increase the production of medicines needed to treat seriously ill coronavirus patients." ||| Les fonds ainsi destinés à l'OMS permettront de contribuer à la préparation, à la prévention et au confinement du virus au niveau mondial et de soutenir les pays dont les systèmes de santé sont les plus faibles.
0.05090083181858063 ||| SP Europe Rue de Stalle, 73 B-1180 Bruxelles Belgium ||| SP Europe Rue de Stalle 73 B-1180 Bruxelles Belgium. ||| SP Europe 73, rue de Stalle B-1180 Bruxelles Belgique
0.370138019323349 ||| If OptiSet is in cool storage, it should be taken out 1 to 2 hours before injection to allow it to warm up. ||| To obtain optimal absorption, Zerit should be taken at least one hour before a meal and on an empty stomach. ||| Si OptiSet est conservé dans un endroit frais, il devra être sorti 1 à 2 heures avant l’ injection pour lui permettre de se réchauffer.
0.34143689274787903 ||| These changes are not considered clinically relevant and no food restrictions are recommended for administration of Trizivir. ||| The safety of androgen suppression is well known and further information is not necessary for this product. ||| Ces modifications ne sont pas considérées comme cliniquement pertinentes et aucune restriction alimentaire n’ est recommandée lors de l’ administration de Trizivir.
0.3210386633872986 ||| For 1997 an upgrading of this dissemination system will be implemented to assure public availability of the EPAR on the day following publication of the positive decision in the Official Journal of the European Communities. ||| The Agency expects that all national competent authorities will be reporting electronically to the EudraVigilance system by the end of 2006, which is reflected in the forecast increase of electronic reports in the chart below. ||| Ce système sera amélioré en 1997 de telle sorte que l’EPAR soit mis à la disposition du public le lendemain de la publication de la décision d’octroi d’autorisation de mise sur le marché au Journal Officiel des Communautés européennes.
0.4608275294303894 ||| No interactions have been reported during treatment with Dynepo in the course of clinical trials. no ||| There was no clustering of cases among recipients of RotaTeq at any time period after any dose. ||| Aucune interaction n’ a été rapportée pendant le traitement avec Dynepo au cours des essais cliniques. en
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| 53 Si vous ressentez un des effets mentionnés comme grave ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.38453060388565063 ||| Results from the 2- and 4- week studies showed that no pharmacological tolerance developed with any dose of Sonata. ||| In vitro plasma protein binding studies determined that the mean concentration of the free drug was 74%. ||| Les résultats des études de 2 et de 4 semaines ont montré l'absence de tolérance pharmacologique aux doses de Sonata.
0.4273144602775574 ||| If any of these apply to you, or if you are not sure, tell your doctor before taking Ketek. ||| Please consult your doctor, even if these statements were applicable to you at any time in the past. ||| Si vous êtes concerné par une de ces situations ou en cas de doute, parlez-en à votre médecin avant de prendre Ketek.
0.2621936798095703 ||| Elastomeric sealants in the form of extrudable pastes for joints ||| Synthetic resins in the form of solvents for use as coatings ||| Matériaux d'étanchéité élastomères sous forme de pâtes extrudables pour joints
0.27369725704193115 ||| Among entecavir-treated nucleoside-naive patients, ALT elevations had a median time to onset of 23-24 weeks, and 86% (24/ 28) of ALT elevations occurred in HBeAg negative patients. ||| The incidence of CNS bleeds during the 28-day study period was 6 (0.5%) and 5 (0.4%) for drotrecogin alfa (activated)-treated and placebo-treated patients, respectively. ||| 24 nucléosides traités par l'entecavir, une élévation des ALAT est apparue en moyenne 23 à 24 semaines après l'arrêt du traitement, et 86% (24/ 28) de ces élévations des ALAT sont apparues chez des patients AgHBe négatifs.
0.0 ||| follow-up period of 6 months except for patients infected with genotypes 2 or 3 and viral load < 800,000 IU/ ml (Amplicor) who were treated for 24 weeks with a 6-month follow-up period. ||| follow-up period of 6 months except for patients infected with genotypes 2 or 3 and viral load < 800,000 IU/ ml (Amplicor) who were treated for 24 weeks with a 6-month follow-up period. ||| par un virus de génotype 2 ou 3 et une charge virale < 800.000 UI/ ml (Amplicor) qui ont été traités pendant 24 semaines avec une période de suivi de 6 mois.
0.49813413619995117 ||| It was compared with placebo or entacapone (another medicine for Parkinson’ s disease). ||| Hydroxocobalamin (vitamin B12a) has been used as a vitamin supplement since the 1950s. ||| Cette multithérapie a été comparée à un placebo ou à l’ entacapone (autre médicament contre la maladie Parkinson).
0.7773593664169312 ||| Not yet assigned. ||| Not marketed at the moment ||| Non encore attribué.
0.1352156698703766 ||| Each vial contains 100 mg bevacizumab. ||| Each vial contains 20 mg of basiliximab. ||| Chaque flacon contient 100 mg de bevacizumab.
0.4222962260246277 ||| Peak plasma concentrations (Cmax) are achieved at 1.3 hours after dosing. ||| The time to maximum concentration (Tmax) remained constant at approximately 4 hours with increasing dose. ||| Les concentrations plasmatiques maximales (Cmax) sont atteintes 1 à 3 heures après la prise.
0.3385199308395386 ||| The decrease in ANC was reversible upon dose reduction or cessation of therapy (see section 4.2), reached normal values by 8 weeks in the majority of patients and returned to baseline in all patients after about 16 weeks. ||| The occurrence rate rose to 32% when a second course of therapy was given, especially in the areas where second treatment overlaps the first and amounted to 10% for those who received a third treatment course. ||| Le nombre absolu de polynucléaires neutrophiles est retourné à des valeurs normales au bout de 8 semaines chez la majorité des patients et est revenu à sa valeur initiale après environ 16 semaines chez tous les patients.
0.5585377216339111 ||| Similarly, no differences were noted between the groups in study BM 16549 after one and two years. ||| They reached an agreement in principle two years later, in April 2018, leaving for further discussion some outstanding technical issues. ||| De même, aucune différence n’ a été observée entre les groupes lors de l’ étude BM 16549 à un an et à deux ans.
0.202673077583313 ||| Excretion Voriconazole is eliminated via hepatic metabolism with less than 2% of the dose excreted unchanged in the urine. ||| Metabolism Etoricoxib is extensively metabolised with < 1% of a dose recovered in urine as the parent drug. ||| Élimination Le voriconazole est éliminé par métabolisation hépatique; moins de 2% de la dose étant excrétée sous forme inchangée dans les urines.
0.050461698323488235 ||| Volibris should not be used in people who may be hypersensitive (allergic) to soya, ambrisentan or any of the other ingredients. ||| Efficib should not be used in people who may be hypersensitive (allergic) to sitagliptin, metformin or any of the other ingredients. ||| Volibris ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) au soja, à l’ ambrisentan ou à l'un des autres composants.
0.8528716564178467 ||| 4.6 mg 9.5 mg ||| 8.8 ml 17.5 ml 35.1 ml ||| 4,6 mg 9,5 mg
0.33711665868759155 ||| Published data show that in individual cases the tacrolimus dose can be reduced when co-administered with nifedipine. ||| The dose of Copalia to be used depends on the doses of amlodipine or valsartan that the patient was taking before. ||| Les données publiées montrent que dans certains cas, la dose de tacrolimus peut être réduite en cas d’ administration avec la nifédipine.
0.034462377429008484 ||| Do not use Fertavid after the expiry date which is stated on the label after'EXP: '. ||| Do not use Puregon after the expiry date which is stated on the label after'EXP: '. ||| 128 Ne pas utiliser Fertavid après la date de péremption mentionnée sur l’ étiquette après ‘ EXP :’.
0.49619555473327637 ||| Tipranavir is extensively bound to plasma proteins (> 99.9%). ||| Stiripentol binds extensively to circulating plasma proteins (about 99%). ||| Le tipranavir est fortement lié aux protéines plasmatiques (> 99,9%).
0.01680934801697731 ||| 335 Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: + 44-(0)1 707 363 636 ||| 49 Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636 ||| au Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636
0.48989322781562805 ||| Discrete nodules will receive an initial light application of 50 J/ cm (using short diffuser) before the balloon light application. ||| Count each vial in a beta counter or in an appropriate counter for one minute (CPM), record net counts, corrected for background. ||| Les petits nodules recevront une application initiale de lumière à 50 J/ cm (à l’ aide d’ un diffuseur court) avant l’ application de lumière à l’ aide du ballonnet.
1.0468388795852661 ||| Take it back to your supplier. ||| I pay tribute to them all. ||| Dans ce cas, ramenez-la à votre pharmacien.
0.38622647523880005 ||| You will have to inject Ceplene and IL-2 twice a day by subcutaneous injection (in the layer of tissue just under the skin), according to the directions provided by your doctor. ||| ● If you are preparing both of your daily doses at one time, be sure to use new syringes, water for injections, and Fuzeon for each dose. ||| Vous devrez vous injecter Ceplene et l’ IL-2 deux fois par jour par voie sous-cutanée (dans la couche de tissus juste sous la peau), conformément aux directives données par votre médecin.
0.1825500726699829 ||| If you have an allergic reaction after taking Xolair, contact a doctor as soon as you can. ||| If you have an allergic reaction, stop taking Velmetia and call your doctor right away. ||| Si vous présentez une réaction allergique après avoir pris Xolair, contactez un médecin le plus rapidement possible.
0.020298322662711143 ||| Prandin 1 mg tablets Repaglinide ||| Prandin 2 mg tablets Repaglinide ||| Prandin 1 mg, comprimés Répaglinide
0.6221290230751038 ||| The frequencies are defined as: uncommon (≥ 1/ 1,000 to < 1/ 100). ||| tho ♦ Common (less than 1 per 10 but more than 1 per 100 doses of vaccine): • Induration (hard lump) ||| Les fréquences sont définies comme suit: peu fréquent (1/ 1 000 à < 1/ 100).
0.08770334720611572 ||| Adverse reactions reported in excess (> 0.5%) of placebo and as more than an isolated case in patients receiving pioglitazone in double-blind studies in combination with a sulphonylurea, including glimepiride, are listed below as MedDRA preferred term by system organ class and absolute frequency. ||| Adverse reactions reported in excess (> 0.5%) of placebo and as more than an isolated case in patients receiving pioglitazone in combination with metformin in double-blind studies are listed below as MedDRA preferred term by system organ class and absolute frequency. ||| Les effets indésirables rapportés à une fréquence supérieure à 0,5% par rapport au placebo (et supérieure à un cas isolé) chez les patients recevant de la pioglitazone en association avec un sulfamide hypoglycémiant y compris le glimépiride dans le cadre d'études en double aveugle sont listés ci-dessous selon la classification MedDRA (par classe d’ organe et par fréquence en valeur absolue).
0.17654351890087128 ||| Tarceva 100 mg film-coated tablets ||| - Plavix 300 mg film-coated tablets ||| Tarceva 100 mg comprimés pelliculés
0.6767172813415527 ||| Coronavirus Response: Commission adopts banking package to facilitate lending to households and businesses in the EU ||| EU mobilises international donors to support Venezuelan refugees and migrants and countries in the region ||| Réaction face au coronavirus: la Commission adopte un paquet bancaire afin de faciliter l'octroi de prêts aux ménages et aux entreprises dans l'UE
0.4928995668888092 ||| vial (glass) ||| vial (glass) 1g ||| Flacon (verre)
0.39124906063079834 ||| Awnings for tents ||| Ropes for tents ||| Auvents pour tentes
0.002561346162110567 ||| 67 The primary objective of this study was to compare the proportion of patients whose SeDBP was controlled (SeDBP < 90 mmHg) at Week 5 of treatment. ||| 53 The primary objective of this study was to compare the proportion of patients whose SeDBP was controlled (SeDBP < 90 mmHg) at Week 5 of treatment. ||| L'objectif principal de cette étude était de comparer le pourcentage de patients dont la PAD était controlée (PAD < 90 mmHg) après 5 semaines de traitement.
0.19248653948307037 ||| Combination antiretroviral therapy has been associated with the redistribution of body fat (lipodystrophy) in HIV patients. ||| Combination antiretroviral therapy may also cause hyperlipaemia (increased fats in the blood) and resistance to insulin. ||| Les traitements par association d’antirétroviraux ont été associés, chez les patients infectés par le VIH, à une redistribution de la masse grasse corporelle (lipodystrophie).
0.4036504030227661 ||| However, there is an increased risk of birth defects in babies whose mothers took Lamictal during pregnancy. ||| In contrast, patients whose cancer was affecting squamous cells had had shorter survival times if they received Alimta. ||| Cependant, il y a un risque accru de défauts de naissance chez les bébés dont les mères ont pris du Lamictal pendant leur grossesse.
0.09853020310401917 ||| The most common effects when taking Trizivir (seen in more than 1 patient in 10) are headache and nausea (feeling sick). ||| The most common side effects when taking Combivir (seen in more than 1 patient in 10) are diarrhoea and nausea (feeling sick). ||| Les effets indésirables les plus courants lors de la prise de Trizivir (observés chez plus de 1 patient sur 10) sont des maux de tête et des nausées (envie de vomir).
0.42981821298599243 ||| Anxiety, emotional lability, insomnia ||| - Depression, thinking abnormal, insomnia ||| Anxiété, instabilité émotionnelle, insomnie
0.22845441102981567 ||| In some cases underlying intra-abdominal inflammation was present, either from gastric ulcer disease, tumour necrosis, diverticulitis, or chemotherapy-associated colitis. ||| orthostatic effects (including hypotension) myocardial infarction or cerebrovascular accident, possibly secondary to excessive hypotension in high risk patients (see section 4.4), palpitations, tachycardia. ||| Dans certains cas, une inflammation intra abdominale sous-jacente était présente, en raison d’ un ulcère gastrique, d’ une nécrose tumorale, d’ une diverticulite ou d’ une colite associée à une chimiothérapie.
0.3276110887527466 ||| Timolol is a beta-blocker that works by reducing the production of fluid within the eye. ||| Dopamine is a messenger substance in the parts of the brain that control movement and co-ordination. ||| Le timolol est un bêtabloquant qui agit en réduisant la production de liquides à l’ intérieur de l’œ il.
0.07949094474315643 ||| - if you are allergic (hypersensitive) to agomelatine or any of the other ingredients of Valdoxan (see ||| - if you are allergic (hypersensitive) to enfuvirtide or any of the other ingredients of Fuzeon (see ||| - si vous êtes allergique (hypersensible) à l’ agomélatine ou à l’ un des autres composants de
0.4395619034767151 ||| Common metals and their alloys including stainless steel ||| Architectural hardware made of common metals and alloys thereof ||| Métaux communs et leurs alliages, y compris acier inoxydable
0.3253973126411438 ||| Uncommon: pruritus, rash, urticaria, scalp/hair abnormality (including alopecia) Renal and urinary disorders: ||| Eye disorders Very common (≥ 1/ 10): conjunctival hyperaemia, growth of eyelashes, ocular pruritus ||| Peu fréquent: prurit, éruptions cutanées, urticaire, problèmes capillaires et du cuir chevelu (y compris alopécie)
0.2989814877510071 ||| OUTER CARTON (1-VIAL PACK) ||| OUTER CARTON TEXT (5 X 1 VIAL) ||| BOÎTE (PRESENTATION 1 FLACON)
0.3318665027618408 ||| Doxycycline is greater than 90% bound to plasma proteins and has an apparent volume of distribution of 50 L. ||| This metabolite has a low activity compared to the mother compound gemfibrozil and an elimination half-life of approximately 20 hours. ||| La doxycycline se lie à raison de plus de 90% aux protéines plasmatiques et son volume de distribution apparent est de 50 L.
0.25950178503990173 ||| Communication of information by television ||| Transfer of information by radio ||| Communication d'informations par télévision
0.11471591144800186 ||| After dissolving the Luveris powder, draw the solution back into the syringe and re-inject it into the container with the follitropin alfa powder. ||| After dissolving the lutropin alfa powder, draw the solution back into the syringe and re-inject it into the vial containing GONAL-f. ||| Dans ce cas, après avoir dissous la poudre de Luveris, aspirez dans la seringue la solution comme ci-dessus et réinjectez -la dans l'ampoule/ le flacon de poudre de follitropine alfa.
0.3338881731033325 ||| The objective of the measure is to ensure these companies can continue their activities faced with the difficult situation caused by the coronavirus. ||| It ensures that the companies which are most impacted by the coronavirus outbreak will continue their economic activity during and after the crisis. ||| Son objectif est de faire en sorte que ces entreprises puissent poursuivre leur activité malgré la situation difficile crée par le coronavirus.
0.9673542976379395 ||| b) nonacog alpha ||| b) Antianaemic ||| nona cog alpha
0.36563098430633545 ||| There is no evidence that Rasilez HCT would reduce or prevent diuretic-induced hyponatraemia. ||| Haemodialysis would not be expected to remove clinically significant amounts of MPA or MPAG. ||| Il n’ a pas été mis en évidence que Rasilez HCT pouvait réduire ou prévenir l’ hyponatrémie induite par les diurétiques.
0.0 ||| 3 Observed for fasting normal levels at baseline (< 5.17 mmol/ l) which increased to high (≥ 6.2 mmol/ l). ||| 3 Observed for fasting normal levels at baseline (< 5.17 mmol/ l) which increased to high (≥ 6.2 mmol/ l). ||| 3 Observée pour des taux à jeun normaux au début du traitement (< 5.17 mmol/ l) qui sont devenus élevés (≥ 6.2 mmol/ l).
0.24960285425186157 ||| This may be adjusted depending on the duration of the treatment and the response obtained. ||| Thereafter, treatment can be resumed as appropriate depending on the initial severity of the event. ||| Elle peut être ajustée en fonction de la durée du traitement et de la réponse obtenue.
0.7483704090118408 ||| Therefore, the effectiveness of Filgrastim ratiopharm was shown to be equivalent to that of Neupogen. ||| For example, Shu Feng Jie Du capsules and Lian Hua Qing Wen capsules were found to be effective for COVID-19 treatment. ||| Il a donc été démontré que Filgrastim ratiopharm était tout aussi efficace que Neupogen.
0.018260419368743896 ||| 221 4.4 Special warnings and precautions for use ||| 197 4.4 Special warnings and precautions for use ||| Mises en garde spéciales et précautions d’ emploi
0.0008380668004974723 ||| The non-confidential version of the decision will be made available under the case number SA.56807 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.56905 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.56807 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.1389426440000534 ||| • OTHER CONDITIONS |||  OTHER CONDITIONS ||| 25 • AUTRES CONDITIONS
0.4815990924835205 ||| Temodal is an antitumour agent. ||| Diacomit is an anti-epileptic medicine. ||| Temodal est un agent antitumoral.
0.38288265466690063 ||| Cases of pulmonary embolism, in some cases with fatal outcome, have been reported. ||| Some patients have experienced severe back cramps or pain, which led to hospitalisation. ||| Des cas d’ embolie pulmonaire, dont certains d’ issue fatale, ont été rapportés.
0.98347407579422 ||| Purevax RCCh solvent ||| RotaTeq Oral solution Oral use ||| Purevax RCCh solvant
0.25671881437301636 ||| The enhanced increase in the insulin/glucagon ratio during hyperglycaemia due to increased incretin hormone levels results in a decrease in fasting and postprandial hepatic glucose production, leading to reduced glycaemia. ||| Ibandronic acid leads to progressive net gains in bone mass and a decreased incidence of fractures through the reduction of elevated bone turnover towards premenopausal levels in postmenopausal women. ||| En cas d’ hyperglycémie, cette amélioration de l’ augmentation du rapport insuline/ glucagon due à l’ augmentation des taux d’ hormones incrétines entraîne une diminution de la production hépatique de glucose à jeun et post-prandiale, ce qui fait baisser la glycémie.
0.38564515113830566 ||| - general sensation of weakness, fatigue (asthenia), irritation or pain at the injection site ||| • pain in the lower abdominal region, possibly in combination with nausea • vomiting and weight gain. ||| - sensation générale de faiblesse, fatigue (asthénie), irritation ou douleur au site d’ injection
0.3175317645072937 ||| • Effect of other medicinal products on Ketek ||| Effects of other medicinal products on Thelin ||| • Effet des autres médicaments sur Ketek
0.3480401635169983 ||| EFSI, the financial pillar of the Investment Plan for Europe, has made a clear impact on the EU economy and is proving its versatility in response to the coronavirus pandemic. ||| The Commission and the EIB Group launched the Investment Plan for Europe in November 2014 to reverse the downward trend of investment and put Europe on the path to economic recovery. ||| L'EFSI, qui constitue le pilier financier du plan d'investissement pour l'Europe, a eu un impact manifeste sur l'économie de l'UE et montre sa souplesse face à la pandémie de COVID-19.
0.0 ||| (vii) Support for the construction and upscaling of testing facilities to develop and test products (including vaccines, ventilators and protective clothing) useful to tackle the coronavirus outbreak, up to first industrial deployment. ||| (vii) Support for the construction and upscaling of testing facilities to develop and test products (including vaccines, ventilators and protective clothing) useful to tackle the coronavirus outbreak, up to first industrial deployment. ||| vii) soutien à la construction et à l'extension des installations d'essai pour le développement et le test de nouveaux produits (dont les vaccins, les respirateurs et les vêtements de protection) utiles pour faire face à la pandémie de coronavirus, jusqu'au premier déploiement industriel.
0.3265606760978699 ||| Caution should be exercised in patients with severe renal or moderate hepatic impairment. ||| The vaccine should be given with caution to individuals with thrombocytopenia or any coagulation disorder. ||| Une surveillance s’ impose chez les patients ayant une insuffisance rénale sévère ou une insuffisance hépatique modérée.
0.10049721598625183 ||| What Zevalin is and what it is used for 2. ||| What Daronrix is and what it is used for 2. ||| Qu'est-ce que Zevalin et dans quel cas est-il utilisé?
0.36408093571662903 ||| Furthermore, earlier in 2020, the EU already mobilised €11 million in humanitarian and development funding to the UN's Food and Agricultural Organization (FAO) to help it address the locust outbreak in the region and provide support to affected pastoralists and farmers. ||| "The EU and ECB together have mobilised hundreds of billions of euros in financial support to underpin state finances and the economy, which is only possible due to the credit worthiness of the European Union and the large-scale leverage it has when acting together," explained Karas. ||| Par ailleurs, début 2020, l'UE a déjà mobilisé 11 millions d'euros d'aide humanitaire et au développement en faveur de l'Organisation des Nations unies pour l'alimentation et l'agriculture, afin de l'aider à lutter contre l'invasion de criquets dans la région et à fournir un soutien aux pasteurs et aux agriculteurs touchés.
0.3854190707206726 ||| Powder in a vial (Type 1 glass) with a stopper (butyl rubber) and solvent in a pre-filled syringe (Type 1 glass) with attached needle with plunger stopper (chlorobutyl rubber) and needle-shield (natural rubber) in a pack size of 1 and 10. ||| Each package of KOGENATE Bayer contains: • one vial with powder (10 ml clear glass type 1 vial with latex-free grey bromobutyl rubber blend stopper and aluminium seal) • one vial with solvent (10 ml clear glass type 2 vial with latex-free grey chlorobutyl rubber blend stopper and aluminium seal) • an additional package with: ||| Poudre en flacon (verre de type I) avec un bouchon (caoutchouc butyl) et solvant en seringue préremplie (verre de type I) avec aiguille attachée, avec bouchon piston (caoutchouc chlorobutyl) et protège-aiguille (caoutchouc naturel), boîtes de 1 et 10.
0.3110034763813019 ||| In rats, minimal to mild decreases in erythrocyte parameters were accompanied by bone marrow changes; similar changes occurred in monkeys at a lower incidence. ||| Microscopic changes in skeletal muscle were minimal (approximately 0.05% of myofibres affected) and at the higher doses were accompanied by elevations in CPK. ||| Chez le rat, des diminutions minimes à modérées des composantes érythrocytaires ont été accompagnées de modifications de la moelle osseuse.
0.3618465065956116 ||| Ducts of metal for ventilating and air-conditioning installations ||| Composition of adhesives and fillers for repairing seals ||| Conduits métalliques pour installations de ventilation et de climatisation
0.4158816635608673 ||| Rare: acne, clammy skin, exfoliative dermatitis, drug eruption, exanthema, livedo reticularis, papular rash, pruritus, skin discoloration, skin lesion, zosteriform rash. ||| Skin ulcer, Serous drainage, Exfoliative dermatitis (flaking, peeling, desquamation, exfoliation), Skin discoloration (brown discoloration, surrounding hyperpigmentation, paler), Dry skin ||| Rare: acné, moiteur de la peau, dermatite exfoliative, éruption médicamenteuse, exanthème, livedo réticulaire, érythème papulaire, prurit, décoloration de la peau, lésion de la peau, éruption de type zona.
0.21652963757514954 ||| Due to insufficient data on safety and efficacy, Remicade is not recommended for use in any other paediatric indication (for juvenile rheumatoid arthritis, see section 4.8). ||| The use of ivabradine is contra-indicated in heart failure patients with NYHA functional classification III-IV, due to a lack of data on clinical efficacy and safety (see section 4.3). ||| En raison de l’ insuffisance de données de tolérance et d’ efficacité, Remicade n’ est recommandé dans aucune autre indication pédiatrique (pour la polyarthrite juvénile, voir rubrique 4.8).
0.31865209341049194 ||| A mean transient increase in body temperature of 1.5°C, in some pigs up to 3 °C can generally be measured on the day of vaccination or the following day. ||| The temperature should then be increased to > 39°C (but not exceeding 40°C) in two different sites of measurement in the tumour area. ||| Une élévation transitoire de la température d’ en moyenne 1,5°C, jusqu’ à 3 °C chez certaines truies, peut généralement être observée le jour de la vaccination.
0.14563971757888794 ||| 326 ||| 328 ||| 346
0.4123697876930237 ||| The effectiveness of ProteqFlu was studied in several studies under laboratory and field conditions. ||| PTH levels in Mimpara clinical trials were measured at the end of the dosing interval. ||| L’ efficacité de ProteqFlu a été étudiée au cours de plusieurs études dans des conditions de laboratoire et sur le terrain.
0.6276871562004089 ||| From the consultation exercise a joint questionnaire was agreed for use in 1997. ||| These criteria formed the guidance which was published in 2007. ||| Un questionnaire commun développé lors de la consultation, a été approuvé en vue de son utilisation en 1997.
0.32588958740234375 ||| It should not be used in patients with myasthenia gravis (a disease of the nerves causing muscle weakness) or who have had hepatitis (inflammation of the liver) or jaundice when they have taken telithromycin in the past. ||| It is used in patients who have open angle glaucoma (a disease where the pressure in the eye rises because fluid can not drain out of the eye) and in patients with ocular hypertension (the pressure in the eye is higher than normal). ||| Il ne doit pas être utilisé chez les patients atteints de myasthénie (une maladie des nerfs entraînant une faiblesse musculaire) ou qui ont développé une hépatite (inflammation du foie) ou une jaunisse lorsqu’ ils ont pris de la télithromycine dans le passé.
0.20062172412872314 ||| However, in patients with liver iron concentration < 7 mg Fe/ g dw treated with EXJADE (5 and 10 mg/ kg) or deferoxamine (20 to 35 mg/ kg), non-inferiority was not established due to imbalance in the dosing of the two chelators. ||| In addition, in patients with liver iron concentration ≥ 7 mg Fe/ g dw with various rare anaemias or sickle cell disease, EXJADE up to 20 and 30 mg/ kg produced a decrease in liver iron concentration and serum ferritin comparable to that obtained in patients with beta-thalassaemia. ||| Toutefois, chez les patients avec une concentration hépatique en fer < 7 mg Fe/ g de poids sec traité par EXJADE (5 et 10 mg/ kg/) ou par la déféroxamine (20 à 35 mg/ kg), la non- infériorité n’ a pas été établie en raison du déséquilibre des doses de deux chélateurs.
0.5479316711425781 ||| PSUR submission when Prepandrix is used during the influenza pandemic: ||| The recommended post-exposure prevention dose of Tamiflu is: ||| La soumission des PSURs durant la pandémie grippale:
0.34993553161621094 ||| Mindful of the need to progress these procedures efficiently and within the prescribed time frame within Member States, the CVMP at its October 1996 meeting endorsed the establishment of a Veterinary Mutual Recognition Facilitation Group by the Member States. ||| The recommendation for 30 influenza strains, for use in influenza vaccine production in Europe, was reached by consensus of opinion of the experts attending the ad hoc Influenza Working Group in conjunction with the Biotechnology Working Party. ||| Le CVMP, conscient de la nécessité de mener ces procédures à terme de manière efficace et dans les délais imposés par les États membres, a soutenu lors de sa réunion d’octobre 1996 la création d’un groupe de facilitation de la reconnaissance mutuelle des médicaments vétérinaires par les États membres.
0.4314473867416382 ||| Once the Commission approves this programme, it is up to the national authorities to decide which projects will be funded. ||| With this strategy, the Commission proposes to the Council that the EU calls for the following elements to be included: ||| Une fois le programme approuvé par la Commission, il incombe aux autorités nationales de choisir les projets à financer.
0.0052947080694139 ||| Following the first administration, it is advised that the patient be kept under medical supervision for 30 minutes to ensure there is no allergic/ pseudo-allergic reaction reaction to the injection. ||| Following the first administration, it is advised that the patient be kept under medical supervision for 30 minutes to ensure there is no allergic/ pseudo-allergic reaction to the injection. ||| Après la première administration, il est recommandé que la patiente reste sous surveillance médicale pendant 30 minutes pour s'assurer qu'il n'y a pas de réaction allergique/ pseudo- allergique à l'injection.
0.15586188435554504 ||| After reconstitution Chemical and physical in-use stability has been demonstrated for 3 hours at 25°C. ||| Chemical and physical in -use stability has been demonstrated for 3 hours at 23°C. ||| Après reconstitution Une stabilité chimique et physique après reconstitution a été demontrée pendant 3 heures à 25°C.
0.3498728275299072 ||| Do not use Mycamine ||| Do not use Extavia ||| N'utilisez jamais Mycamine
0.4482126533985138 ||| Flap discs for power-operated grinders ||| Gender changers for coaxial cables ||| Disques à lamelles pour meuleuses électriques
0.7029088139533997 ||| Adhesive sealant compounds ||| Fever Elevated liver enzymes ||| Matériaux adhésifs d'étanchéité
0.24414467811584473 ||| capsule contents: pregelatinised starch, talc, povidone, croscarmellose sodium and sodium stearyl fumarate capsule shell: gelatin, yellow iron oxide (E172), red iron oxide (E172), black iron oxide (E172) and titanium dioxide (E171) printing ink: shellac (E904), titanium dioxide (E171) and indigocarmine (E132). ||| 9 Capsule shell: gelatin sorbitol special-glycerin blend (glycerin, sorbitol, sorbitol anhydrides (1,4-sorbitan), mannitol and water) titanium dioxide (E171) printing ink (SDA 35A alcohol (ethanol & ethyl acetate), propylene glycol (E1520), iron oxide black (E172), polyvinyl acetate phthalate, purified water, isopropyl alcohol, macrogol 400, ammonium hydroxide 28%) ||| contenu de la gélule: amidon prégélatinisé, talc, povidone, croscarmellose sodique et fumarate stéarique de sodium enveloppe de la gélule: gélatine, oxyde de fer jaune (E172), oxyde de fer rouge (E172), oxyde de fer noir (E172), dioxyde de titane (E171) encre d’ impression: shellac (E904), dioxyde de titane (E171) et indigotine (E132).
0.15764985978603363 ||| The duration of protection is 6 months. or ||| The duration of protection is 6 months. ||| La durée de la protection est de 6 mois.
0.5041223168373108 ||| On the first day of treatment the patient starts with Neupro 2 mg/ 24 h. ||| 0.75 ml for the injections at day 13, 15 and 17 of therapy. ||| Le premier jour du traitement, le patient débutera avec un dispositif transdermique Neupro 2 mg/ 24 h.
3.228094332639875e-13 ||| Sodium chloride (NaCl) Medium 199 containing principally amino acids, mineral salts, vitamins Water for injections ||| Sodium chloride (NaCl) Medium 199 containing principally amino acids, mineral salts, vitamins Water for injections ||| Chlorure de sodium (NaCl), Milieu 199 contenant principalement des acides aminés, des sels minéraux, des vitamines Eau pour préparations injectables.
0.22695517539978027 ||| Immediately before use, the blister must be carefully peeled open and the dose of orodispersible tablet removed without crushing it. ||| Before using, carefully peel open the blister and remove the dose of orodispersible tablet without crushing it. ||| Juste avant la prise, le blister sera ouvert avec précaution et le comprimé orodispersible sera retiré sans être écrasé.
0.24702996015548706 ||| Microcrystalline cellulose (E460) Lactose anhydrous Medium chain triglycerides Gelatin Croscarmellose sodium Sucrose Colloidal silicon dioxide Magnesium stearate (E572) Butyl hydroxytoluene (E321) Modified starch (maize) Sodium aluminium silicate (E554) ||| 6.1 List of excipients povidone K29/ 32 sodium starch glycolate type A glucose liquid, spray dried erythrosine (E127) titanium dioxide (E171) aspartame (E951) tutti frutti flavour (contains sorbitol) carmellose sodium hydroxyethylcellulose. ||| Cellulose microcristalline (E460) Lactose anhydre Triglycérides à chaînes moyennes Gélatine Croscarmellose sodique Saccharose Silice colloïdale Stéarate de magnésium (E572) Butylhydroxytoluène (E321) Amidon modifié (maïs) Silicate d’ aluminium sodique (E554)
0.01803448423743248 ||| Tel: + 421 (0)2 48 26 11 11 recepcia.sk@gsk.com ||| Tel: + 421 (0)2 49 10 33 11 recepcia.sk@gsk.com ||| Tel: + 421 (0)2 4 8 26 11 11 recepcia. sk@gsk. com
0.5649932622909546 ||| 1.5 g 5-aminolevulinic acid hydrochloride ||| 0.08% butylated hydroxytoluene ||| 1,5 g de chlorhydrate d’ acide 5-aminolévulinique
0.0294265765696764 ||| Remove the needle from the vial of Humalog and insert it into the vial of the longer-acting insulin. ||| Remove the needle from the vial of Liprolog and insert it into the vial of the longer-acting insulin. ||| Retirer l'aiguille du flacon d’ Humalog et l'insérer dans le flacon d'insuline à action plus prolongée.
0.611589252948761 ||| Preparation of Cyanokit ||| Tincture of iodine ||| Préparation de Cyanokit
0.2812713384628296 ||| The results are difficult to interpret due to various reasons such as differences in effect on systolic blood pressure and discontinuation of diuretics in the doxazosin-treated group prior to commencement of the treatment. ||| 15 Concerning discontinuation of long-term treatment of pregabalin there are no data of the incidence and severity of withdrawal symptoms in relation to duration of use and dosage of pregabalin. ||| Les résultats sont difficiles à interpréter pour diverses raisons, notamment les différences d’ effets sur la pression artérielle systolique ou l’ arrêt des diurétiques dans le groupe traité par la doxazosine avant le début du traitement.
0.23975975811481476 ||| The effectiveness of Zometa in patients with hypercalcaemia caused by tumours has been studied in two main studies involving a total of 287 patients. ||| Rapamune has been studied in two main studies involving a total of 1,295 patients who were having a kidney transplant and were at low to moderate risk of rejection. ||| L’ efficacité de Zometa chez les patients présentant une hypercalcémie induite par des tumeurs a été étudiée dans deux études principales portant sur un total de 287 patients.
0.1941259205341339 ||| Adverse reactions are listed below by system organ class and frequency. ||| Adverse reactions are listed below by MedDRA body system organ class and by frequency. ||| Les réactions indésirables sont énumérées ci-après, par classe anatomico-fonctionnelle et par fréquence.
0.4124388098716736 ||| 8 The valid Summary of Product Characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure. ||| the Summary of Products Characteristic, labelling and package leaflet proposed by the Marketing Authorisation Holders has been assessed based on the documentation submitted and the scientific discussion within the Committee, ||| 7 Le résumé des caractéristiques du produit, l’ étiquetage et la notice valides correspondent aux versions finales obtenues au cours de la procédure du groupe de coordination.
0.35989630222320557 ||| Even with the first dose, there is a small chance that you may experience a severe allergic reaction with the following symptoms: tightness in the chest, feeling dizzy, sick or faint, or experiencing dizziness when standing up. ||| You will probably experience one or more of the following mild to moderate reactions at the place where you inject your medicine: ● itchiness ● swelling ● redness ● pain or tenderness ● hardened skin or bumps. ||| Dès la première dose, il existe un faible risque de survenue de réaction allergique sévère, se manifestant par les symptômes suivants: oppression dans la poitrine, vertiges, nausées ou évanouissements, ou vertiges lors du passage en position debout.
0.02142159827053547 ||| 53 Women with anovulation resulting from severe LH and FSH deficiency: ||| 3 Women with anovulation resulting from severe LH and FSH deficiency: ||| Patientes anovulatoires en raison d’ un déficit sévère en LH et en FSH:
0.009698781184852123 ||| Humira, 40 mg every other week, was studied in patients with moderately to severely active psoriatic arthritis in two placebo-controlled studies, PsA studies I and II. ||| Humira, 40 mg every other week, was studied in patients with moderately to severely active psoriatic arthritis in two placebo-controlled studies, PsA I and II. ||| Humira, 40 mg toutes les deux semaines, a été étudié chez des patients ayant un rhumatisme psoriasique modérément à sévèrement actif dans deux études contrôlées contre placebo, les études I et II sur le RPs.
0.0 ||| Its use during the first three months of pregnancy is not recommended. ||| Its use during the first three months of pregnancy is not recommended. ||| Son utilisation au cours des trois premiers mois de la grossesse n’ est pas recommandée.
0.006950953043997288 ||| Some of these changes may be permanent, and may lead to differences in appearance between the eyes if only one eye is treated. ||| Some of these changes may be permanent, and may lead to differences in appearance between the eyes when only one eye is treated. ||| Certains de ces changements peuvent être définitifs et peuvent entraîner des différences d’ apparence entre les yeux si un seul œ il est traité.
3.4889430754192485e-13 ||| Severe allergic reactions to insulin may occur which may become life-threatening. ||| Severe allergic reactions to insulin may occur which may become life-threatening. ||| 456 Des réactions allergiques sévères à l’ insuline peuvent survenir et mettre la vie en danger.
0.20125097036361694 ||| 42.5 mg/g ||| 8.5 mg/g ||| 42,5 mg/g
0.20841506123542786 ||| It is used for the treatment of the following diseases: • moderate to severe rheumatoid arthritis (an immune system disease causing inflammation of the joints) in adults. ||| It is used, most often when other medicines or treatments have failed, in adults with the following diseases: • rheumatoid arthritis (an immune system disease causing inflammation of the joints). ||| Il est utilisé pour le traitement des maladies suivantes: • polyarthrite rhumatoïde modérée à grave (une maladie du système immunitaire provoquant une inflammation des articulations) chez l’ adulte.
0.029459115117788315 ||| Ritonavir is principally metabolised and eliminated by the liver. ||| Nelfinavir is principally metabolised and eliminated by the liver. ||| Le ritonavir est principalement métabolisé et éliminé par le foie.
0.29118943214416504 ||| For pseudoephedrine, the mean Tmax occurred at 6-7 hours post dose and mean peak plasma concentrations (Cmax and AUC) of approximately 263 ng/ ml and 4,588 ng• hr/ ml, respectively, were observed. ||| During Orgalutran treatment the average incidence of LH rises (> 10 IU/ l) with concomitant progesteron rise (> 1 ng/ ml) was 1.2% compared to 0.8% during GnRH agonist treatment. ||| Pour la pseudoéphédrine, le Tmax moyen a été atteint 6 à 7 heures après l'administration et un pic moyen de concentrations plasmatiques (Cmax et ASC) d'approximativement 263 ng/ ml et 4.588 ng• h/ ml, respectivement, ont été observés.
0.3294406533241272 ||| The white powder is contained in a 2 ml glass vial and the clear and colourless solvent is presented in a 2 ml glass ampoule. ||| It is supplied in a pack with a colourless glass ampoule containing 5 ml sterile water for injections. ||| La poudre blanche est contenue dans un flacon de 2 ml et le solvant limpide et incolore dans une ampoule en verre de 2 ml.
0.05989569425582886 ||| Surgery As Icandra contains metformin, the treatment should be discontinued 48 hours before elective surgery with general anaesthesia and should not usually be resumed earlier than 48 hours afterwards. ||| 4 Surgery As Glubrava contains metformin hydrochloride, the treatment should be discontinued 48 hours before elective surgery with general anaesthesia and should not be usually resumed earlier than 48 hours afterwards. ||| Intervention chirurgicale Icandra contenant de la metformine, le traitement doit être interrompu 48 heures avant une intervention chirurgicale programmée avec anesthésie générale et ne doit en règle générale être repris que 48 heures après l'intervention.
0.7428804636001587 ||| 75 Side effects reported commonly ||| 9 Commonly susceptible species: ||| Effets indésirables fréquemment rapportés
0.27245858311653137 ||| The frequency of treatment emergent hepatitis or transaminase elevations in co-infected patients was comparable between REYATAZ and comparator regimens (see section 4.4). ||| INR should be closely monitored during initiation and dose increase of BYETTA therapy in patients on warfarin and/ or cumarol derivatives (see section 4.8). ||| La fréquence des hépatites liées au traitement ou de l'augmentation des transaminases chez les patients co-infectés était comparable entre REYATAZ et les traitements comparateurs (voir rubrique 4.4).
0.4646312892436981 ||| 3 Exacerbations of hepatitis have also been reported in patients who have terminated treatment of hepatitis B. ||| Specific studies have not been conducted in patients who had recently received live viral or live bacterial vaccines. ||| Des cas d’ exacerbations de l’ hépatite ont également été rapportés chez des patients ayant arrêté leur traitement contre l’ hépatite B.
0.3956502377986908 ||| Written explanations were provided by the Marketing Authorisation Holders on 18 March 2008. ||| The Marketing Authorisation Holder submitted written responses to the List of Questions on 12 September 2007. ||| Des explications écrites ont été fournies par les titulaires des autorisations de mise sur le marché le 18 mars 2008.
0.30353569984436035 ||| There are no clinically relevant differences in serum insulin or glucose levels after abdominal, deltoid or thigh administration of Lantus. ||| Animal reproduction studies have not revealed any differences between insulin aspart and human insulin regarding embryotoxicity or teratogenicity. ||| On n’ a pas observé de différences cliniques notables sur le plan des taux sériques d’ insuline et de glucose, suivant que Lantus est administré dans l'abdomen, la région deltoïde ou la cuisse.
0.5138115882873535 ||| Hypercalcemia and/or hypercalciuria reflect the known pharmacodynamic actions of parathyroid hormone in the gastrointestinal tract, the kidney, and the bone. ||| In rodents the target organs identified were the haematopoietic system, the blood coagulation system, liver and thyroid. ||| L’ hypercalcémie et/ ou l’ hypercalciurie reflètent le mode d’ action pharmacodynamique connu de l’ hormone parathyroïde dans le tractus gastro-intestinal, les reins et les os.
0.3051523268222809 ||| Also, urine pH may be elevated by states of renal tubulary acidosis (RTA) or severe infections of the urinary tract with Proteus bacteria. ||| They include weakening of the heart muscle possibly leading to heart failure, inflammation of the lining around the heart (pericarditis), and heart rhythm disturbances. ||| Le pH de l’ urine peut également être élevé lors d’ états d’ acidose tubulaire rénale (ATR) ou d’ infection urinaire sévère à Proteus.
0.07445599138736725 ||| CYMBALTA 60 mg hard gastro-resistant capsules Duloxetine ||| ARICLAIM 60 mg hard gastro-resistant capsules Duloxetine ||| CYMBALTA 60 mg, gélule gastro-résistante Duloxétine
0.2793649137020111 ||| 143 Controlled clinical trials have not shown significant benefits attributable to the administration of epoetins when haemoglobin concentration is increased beyond the level necessary to control symptoms of anaemia and to avoid blood transfusion. ||| The CHMP considered it acceptable to remove this contraindication, as the primary route of elimination of valsartan is via biliary route and renal clearance accounts for less than 30% of plasma clearance. ||| Les essais cliniques contrôlés n’ ont pas montré d’ effets bénéfiques significatifs attribuables à l’ administration des époétines lorsque le taux d’ hémoglobine dépassait le niveau nécessaire au contrôle des symptômes de l’ anémie et pour éviter une transfusion sanguine.
0.011875304393470287 ||| Plavix is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death). ||| Iscover is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death). ||| Cette maladie également appelée athérothrombose peut conduire à la survenue d'événements athérothrombotiques (tels que l'accident vasculaire cérébral, la crise cardiaque, ou le décès).
0.3673127591609955 ||| No effect on the fertility of females has been detected. ||| Effects on somatic development and behaviour of the offspring were not observed. ||| Aucun effet sur la fertilité des femelles n’a été décelé.
3.9134174416657896e-13 ||| Authorisation Holders have been assessed based on the documentation submitted and the scientific discussion within the Committee, ||| Authorisation Holders have been assessed based on the documentation submitted and the scientific discussion within the Committee, ||| autorisations de mise sur le marché ont été évalués sur la base de la documentation présentée et de la discussion scientifique menée au sein du comité,
0.23078247904777527 ||| You should not be given Aclasta if you are breast-feeding. ||| Do not breast-feed if you are being treated with Tarceva. ||| Vous ne devez pas recevoir Aclasta si vous allaitez.
0.6290119886398315 ||| AUC: ↑ 17% (↑ 6 to ↑ 29) ** Cmax: ↔ ** *compared to 200 mg twice daily alone ** compared to 600 mg once daily alone (competitive inhibition of oxidative metabolism) ||| Cmin = the observed plasma concentration at the end of the dose interval bid = twice daily tid = three times daily * results are geometric mean (min - max) † derived from tid or bid dosing schedule †† Ctrough values ||| ASC: ↑ 17% (↑ 6 to ↑ 29) ** Cmax: ↔ ** *compare à 200 mg deux fois par jour seul ** compare à 600 mg une fois par jour seul (inhibition compétitive du métabolisme oxydatif)
0.3719500005245209 ||| Dogs should be carefully observed following administration to ensure that each tablet is swallowed. ||| It is recommended that users visually check their patch daily to ensure continued proper adhesion. ||| Les chiens doivent être attentivement surveillés après l’ administration pour s’ assurer que chaque comprimé est avalé.
0.5064432621002197 ||| Renal and urinary disorders Common ||| Underlying respiratory disorders al ||| Affections du rein et des voies urinaires Fréquent
0.5783432126045227 ||| Office machines ||| Hand scanner ||| Machines de bureau
0.6208863258361816 ||| Zeolite material ||| Glimepiride ||| Matériau zéolitique
0.3044835329055786 ||| The Commission will continue to provide advice to consumers and traders, monitor rogue trading practices and publish relevant updates here , along with all information on its work to prevent consumer scams related to coronavirus. ||| The EU is moreover helping develop a plan to support the economic recovery from the coronavirus, and will train journalists to fight coronavirus-related disinformation and establish an online fact-checking platform. ||| La Commission continuera de fournir des conseils aux consommateurs et aux professionnels, de surveiller les pratiques commerciales malhonnêtes et de publier sur cette page les mises à jour à ce sujet, ainsi que toutes les informations sur son travail de prévention des escroqueries à la consommation liées au coronavirus.
0.20304852724075317 ||| The Committee decided that Optruma’ s benefits are greater than its risks for the treatment and prevention of osteoporosis in postmenopausal women. ||| Therefore, the Committee decided that Fareston’ s benefits are greater than its risks for the first line hormone treatment of hormone-dependent metastatic breast cancer in postmenopausal patients. ||| Le comité a estimé que les bénéfices d’ Optruma sont supérieurs à ses risques pour le traitement et la prévention de l’ ostéoporose chez les femmes post-ménopausées.
0.0913972556591034 ||| Ask your pharmacist how to dispose of medicines you no longer need. ||| Ask your pharmacist how to dispose of medicines that are no longer required. ||| Demandez à votre pharmacien que faire des médicaments inutilisés.
0.005477724596858025 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Protaphane been studied? ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Replagal been studied? ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction et/ ou distribution du présent document autorisée à des fins non commerciales uniquement moyennant mention de l’ EMEA Quelles études ont été menées avec Protaphane?
0.06850051134824753 ||| What Silgard looks like and contents of the pack ||| What Zarzio looks like and contents of the pack ||| 6 1 Qu'est ce que Silgard et contenu de l’emballage extérieur
0.23922118544578552 ||| Arranging and conducting of promotional events ||| Arranging and conducting of congresses ||| Organisation et conduite d'événements promotionnels
0.10089111328125 ||| However, if it is time for your next dose, skip the missed dose and take only a single dose as usual. ||| However, if it is almost time for your next dose, do not take the missed dose and continue as usual. ||| Toutefois, s'il est déjà l'heure de la prise suivante, ne prenez que la dose prévue, comme d'habitude, sans compenser la prise sautée.
0.05320422723889351 ||| Detailed instructions for subcutaneous administration are provided with this leaflet (see HOW TO SELF INJECT INTRONA at the end of the leaflet). ||| Detail ed instructions for subcutaneous administration are provided with this leaflet (see HOW TO SELF INJECT VIRAFERON at the end of the leaflet). ||| Des instructions détaillées pour l’administration par voie sous-cutanée sont fournies dans cette notice (voir COMMENT AUTO-INJECTER INTRONA à la fin de la notice).
2.9642382840845694e-13 ||| • Pain and swelling in the joints, and tendinitis may occur occasionally, particularly if you are elderly and are also being treated with corticosteroids. ||| • Pain and swelling in the joints, and tendinitis may occur occasionally, particularly if you are elderly and are also being treated with corticosteroids. ||| Des douleurs et gonflements des articulations et des tendinites peuvent se produire occasionnellement, en particulier si vous êtes âgé(e) et si vous êtes également traité(e) par des corticostéroïdes.
0.15046046674251556 ||| What Irbesartan BMS looks like and contents of the pack Irbesartan BMS 150 mg film-coated tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2872 engraved on the other side. ||| What SPRYCEL looks like and contents of the pack SPRYCEL 20 mg: the film-coated tablet is white to off-white, biconvex, round with “ BMS ” debossed on one side and “ 527” on the other side. ||| Qu’ est -ce que Irbesartan BMS et contenu de l'emballage extérieur Les comprimés pelliculés de Irbesartan BMS 150 mg sont blancs à blancs cassés, biconvexes, de forme ovale, avec un coeur gravé d'un côté et le numéro 2872 gravé sur l'autre côté.
0.3644205331802368 ||| In normal condition of use, transient apathy and anorexia may occasionally occur, as well as hyperthermia (lasting usually for 1 or 2 days). ||| A local reaction may occur (slight pain at palpation, itching or limited oedema) that disappears within 1 or 2 weeks at most. ||| Dans des conditions normales d’ utilisation, une apathie transitoire, une anorexie ainsi qu’ une hyperthermie (pendant 1 ou 2 jours) peuvent parfois être observées.
0.33163323998451233 ||| Ebixa 5 mg film-coated tablets Ebixa 10 mg film-coated tablets Ebixa 15 mg film-coated tablets Ebixa 20 mg film-coated tablets Memantine hydrochloride ||| AVAGLIM 4 mg/ 4 mg film-coated tablets AVAGLIM 8 mg/ 4 mg film-coated tablets rosiglitazone/ glimepiride ||| Ebixa 5 mg comprimés pelliculés Ebixa 10 mg comprimés pelliculés Ebixa 15 mg comprimés pelliculés Ebixa 20 mg comprimés pelliculés Chlorhydrate de mémantine
0.3412037193775177 ||| Patients with stable coronary artery disease: ||| Patients with acute heart diseases: ||| Patients atteints d’ une maladie coronaire stable:
0.6814965009689331 ||| Do not take Tamiflu ||| Do not use Flebogammadif ||| Ne prenez jamais Tamiflu
0.30997395515441895 ||| Pegfilgrastim appears to be mainly eliminated by neutrophil mediated clearance, which becomes saturated at higher doses. ||| Mavacoxib is excreted via bile and in dogs with hepatic disorders reduced elimination and thus excessive accumulation could occur. ||| Le pegfilgrastim semble s’ éliminer principalement par la clairance neutrophile- dépendante qui est saturée à des doses plus élevées.
0.4952026307582855 ||| Conditions Or Restrictions With Regard To The Safe And Effective Use Of The Medicinal Product ||| Conditions Or Restrictions Regarding Supply And Use Imposed On The Marketing Authorisation Holder ||| Conditions ou restrictions en vue d’une utilisation sûre et efficace du médicament
0.48265522718429565 ||| Hepatic impairment No adjustment of the initial dose is required for patients with mild to severe hepatic impairment (see section 5.2). ||| Minor haemorrhage was defined as any observed bleeding event that did not meet the criteria for a major haemorrhage. ||| Insuffisance hépatique Aucun ajustement de la dose initiale n’ est nécessaire chez les patients présentant une insuffisance hépatique légère à sévère (voir rubrique 5.2).
0.3388739824295044 ||| Quixidar is used to: • prevent the formation of blood clots in the blood vessels of the legs or lungs after orthopaedic surgery (such as hip or knee surgery) or abdominal surgery ro ||| It can be used in patients undergoing haemodialysis (using a blood filtration machine) or peritoneal dialysis (where fluid is pumped into the abdomen and an internal body membrane filters the blood). ||| poumons après une intervention chirurgicale orthopédique (telle que la chirurgie du genou ou de la hanche) ou une chirurgie abdominale. • en prévention de la formation de caillots pendant et peu après une période de mobilité réduite due à une affection médicale aiguë, ic
0.2641637921333313 ||| As with other vaccines, administration of Infanrix Penta should be postponed in subjects suffering from acute severe febrile illness. ||| If stopping treatment, as with other antiepileptic medicines, Keppra should be discontinued gradually to avoid an increase of seizures. ||| Comme pour les autres vaccins, l'administration d'Infanrix Penta doit être différée chez les sujets atteints d'infections fébriles sévères aiguës.
0.0 ||| Dosage Based on your life-style and the results of your blood sugar (glucose) tests and your previous insulin usage, your doctor will: ||| Dosage Based on your life-style and the results of your blood sugar (glucose) tests and your previous insulin usage, your doctor will: ||| En fonction de votre mode de vie, vos analyses de taux de sucre dans votre sang (glycémie) et votre précédente utilisation d'insuline, votre médecin
0.4424470365047455 ||| "While Trump claimed that ""we're going to be able to make that drug available almost immediately"", the leader of the FDA said the drug would still need to be tested in a ""large, pragmatic clinical trial"" on subjects infected with COVID-19." ||| "Zerohedge listed the full contact details of the scientist supposedly responsible, a practice known as doxing, by including the scientist's name, photo, and phone number, suggesting to readers that they ""pay [the Chinese scientist] a visit"" if they wanted to know ""what really caused the coronavirus pandemic""." ||| Alors que Trump affirmait que nous allons pouvoir rendre ce médicament disponible presque immédiatement, le chef de la FDA a déclaré que le médicament devrait encore être testé dans un grand essai clinique pragmatique sur des sujets infectés par Covid-19.
0.4783713221549988 ||| Hence, no dose adjustment is required in these patients. ||| However, exposure is limited to clinical trials. ||| Par conséquent, il n’ est pas nécessaire d’ ajuster la posologie chez ces patients.
0.4028193950653076 ||| Further evidence is also awaited regarding the effect of panitumumab in combination with chemotherapy on PFS in patients with wild-type KRAS tumours. ||| Furthermore, the MAH has proposed to change the Product Information (PI), namely separate administration of pneumococcal and meningococcal conjugate vaccines. ||| Des données supplémentaires sont également attendues concernant les effets sur la SSP du panitumumab en association avec la chimiothérapie chez les patients présentant une tumeur KRAS non mutée.
0.06148780137300491 ||| You should not take Viagra if you are using any of the drugs known as nitric oxide donors such as amyl nitrite (“ poppers”) as the combination may also lead to a potentially dangerous decrease in your blood pressure. ||| − If you are using any of the drugs known as nitric oxide donors such as amyl nitrite (“ poppers”), as the combination may also lead to a potentially dangerous decrease in your blood pressure. ||| 62 Vous ne devez pas prendre VIAGRA si vous prenez l’ un des médicaments connus comme donneurs d’ oxyde nitrique tels que le nitrite d'amyle ("poppers") car cette association peut également entraîner une diminution potentiellement dangereuse de votre pression sanguine.
0.1026771292090416 ||| Important information about some of the ingredients of Insulin Human Winthrop Comb 25 ||| Important information about some of the ingredients of Insulin Human Winthrop Basal ||| Informations importantes concernant certains composants d’Insulin Human Winthrop Comb 25
0.18646103143692017 ||| ReFacto AF can be stored at room temperature (up to 25oC) for a single period up to 3 months. ||| Neupopeg may be exposed to room temperature (not above 30°C) for a maximum single period of up to 72 hours. ||| ReFactoAF peut être conservé à température ambiante (jusqu’à 25 °C) pendant une période unique de 3 mois maximum.
0.39939624071121216 ||| Display frames of metal [furniture] ||| Scale models [ornaments] of plaster ||| Cadres d'affichage en métal [mobilier]
0.18542194366455078 ||| 6/25 Each unit of Opgenra consists of two vials of powder, which are first combined and then reconstituted with 2.5 ml of sodium chloride 9 mg/ml (0.9%) solution for injection prior to use. ||| The calculated amount of interferon for the appropriate dose then is withdrawn from the vial(s), added to 100 ml of 9 mg/ml (0.9%) sodium chloride solution for injection and administered over 20 minutes. ||| Chaque unité d’Opgenra est constituée de deux flacons de poudre qui sont d’abord combinés puis reconstitués avec 2,5 ml d’une solution de chlorure de sodium à 9 mg/ml (0,9%) pour injection, avant utilisation.
3.2691229823016144e-13 ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/. ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/. ||| Des informations détaillées sur ce médicament sont disponibles sur le site web de l’ Agence européenne des médicaments (EMEA) http: / /www. emea. europa. eu/.
0.2956385314464569 ||| Synthetic rubber for use in manufacture ||| Thermal insulating glass for use in building ||| Caoutchouc synthétique destiné à la fabrication
0.2586338222026825 ||| If you have impaired kidney function, your doctor will decide upon a dose that suits your condition. ||| If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet. ||| Si vous présentez une insuffisance rénale, votre médecin décidera de la dose adaptée à votre état.
0.506841242313385 ||| Active ingredient: paclitaxel 6 mg/ml (150 mg/25 ml) ||| 5 mg (250 KIU); (50 KIU/ ml) solvent: ||| Principe actif: paclitaxel 6 mg/ ml (100 mg/ 16,7 ml)
0.6338388919830322 ||| Vitreous enamel paints ||| Flavoured carbonated beverages ||| Émaux vitrifiés [peintures]
0.8844491839408875 ||| Moistening agents ||| Kimono dressing assistance ||| Agents mouillants
0.0 ||| Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies. ||| Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies. ||| L’ utilisation du produit doit être basée sur les tests de sensibilité et doit prendre en compte les politiques antimicrobiennes officielles et locales.
3.577740317547984e-13 ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| Si vous constatez des effets indésirables ou d’ autres effets non mentionnés sur la notice, veuillez en informer votre vétérinaire.
0.23767462372779846 ||| What is Tracleer used for? ||| What is Cholestagel used for? ||| Dans quel cas Tracleer est -il utilisé?
0.40949171781539917 ||| Precision balances ||| Numerical counters ||| Trébuchets [balances]
0.7773629426956177 ||| This is normal. ||| Timing is essential. ||| Cela est normal.
0.5790799856185913 ||| Paroxetine: ||| Midazolam: ||| Paroxétine:
0.44701823592185974 ||| The ADRs reported in the two studies are summarised and categorised according to the MedDRA System organ class and frequency below. ||| Major bleeding was measured by the ACUITY and TIMI major bleeding scales as defined in the footnotes to Table 2. ||| Les EI rapportés au cours des deux études sont résumés et présentés ci-dessous par classes de systèmes d’organes (terminologie MedDRA) et par fréquence.
0.07827403396368027 ||| Maintenance packs Aclar / PVC blisters with aluminium foil backing in a pack containing 28 x 0.5 mg film-coated tablets in secondary heat sealed card packaging. ||| Aclar / PVC blisters with aluminium foil backing in a pack containing 56 x 0.5 mg film-coated tablets in secondary heat sealed card packaging. ||| Conditionnements d’ entretien Plaquettes thermoformées Aclar / PVC avec feuille de protection en aluminium dans un étui thermoscellé contenant 28 comprimés pelliculés à 0,5 mg.
0.28912973403930664 ||| The company that makes Cubicin will carry out further studies with Cubicin to investigate whether it has an effect on the muscle, and to look at its safety and effectiveness in patients with kidney disease and in the elderly. ||| The company that makes Tracleer will provide an educational kit for prescribers and an information booklet for patients in each Member State, explaining the safety of Tracleer (especially its effects on the liver and in pregnancy) and its interactions. ||| La société qui fabrique Cubicin réalisera des études supplémentaires relativement à Cubicin pour investiguer s'il a un effet sur le muscle, et concernant sa sécurité et son efficacité chez les patients atteints d'une affection rénale et chez les personnes âgées.
0.5399215221405029 ||| IntronA is available in six different pack sizes: ||| ProQuad is available in pack of 1, 10 and 20. ||| IntronA est disponible sous six présentations différentes:
0.45068588852882385 ||| In rare cases anaphylactoid reactions ranging to shock may occur. ||| Increases in blood potassium have happened in isolated cases. ||| Dans de rares cas des réactions anaphylactoïdes pouvant aller jusqu’ au choc peuvent survenir.
0.14299190044403076 ||| Blood and lymphatic system disorders Nervous system disorders ||| Blood and lymphatic system disorders Cardiac disorders Vascular disorders ||| Troubles sanguins et du système lymphatique
0.39631861448287964 ||| The active substance in each Sonata hard capsule is zaleplon 5 mg. ||| Revlimid 25 mg hard capsules: • The active substance is lenalidomide. ||| La substance active que contient chaque gélule de Sonata est le zaleplon 5 mg.
0.41605788469314575 ||| Soldering wire of metal ||| Sheeting lines of metal ||| Fils à souder en métal
0.428162157535553 ||| Nowogrodzka PL – 02- 014 Warszawa POOLA Tel: +48(0)22 50 40 890 ||| Jana Paw ł a II 29 PL-00- 867 Warszawa Tel.: + 48 (0) 22 653 68 00 ||| Nowogrodzka 68 PL - 02- 014 Warszawa POOLA Tel: +48(0) 22 50 40 890
0.5792357921600342 ||| Injury, poisoning and procedural complications ||| accidental injury, fracture, abrasion ||| Lésions, intoxications et complications liées aux procédures
0.36736226081848145 ||| If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered. ||| or Inadequate dosage or discontinuation of treatment, especially in type 1 diabetes, may lead to ||| Chez ces patients, en cas d'aggravation confirmée de l'atteinte hépatique, l'interruption ou l'arrêt du traitement devra être envisagé.
0.3920902609825134 ||| Phenytoin may decrease serum levels of ritonavir. ||| Hydroxocobalamin will lower blood cyanide concentrations. ||| La phénytoïne peut diminuer les concentrations plasmatiques de ritonavir.
0.4182032346725464 ||| Breastfeeding should be discontinued prior to, during and following treatment with Evoltra (see section 4.6). ||| This is especially important within the first 14 days of treatment (see more information in How to take VIRAMUNE). ||| L’ allaitement sera interrompu avant, pendant et après le traitement par Evoltra (voir rubrique 4.6).
0.0070986635982990265 ||| 72 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 177 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.05027253180742264 ||| Binocrit 5000 IU/ 0.5 ml solution for injection in a pre-filled syringe ||| Binocrit 10 000 IU/ 1 ml solution for injection in a pre-filled syringe ||| Binocrit 5 000 UI/ 0,5 ml, solution injectable en seringue pré-remplie
0.32011908292770386 ||| Pharmacokinetic data on duloxetine is limited in patients with mild or moderate renal impairment. ||| Clinical response rates in patients experiencing somnolence were 60% on duloxetine and 30% on placebo. ||| Les données pharmacocinétiques sont limitées chez les patients atteints d'insuffisance rénale légère ou modérée.
0.5023382902145386 ||| Not known: renal failure, haematuria, urinary incontinence. ||| - Overflow bladder, anuria or progressive renal insufficiency ||| Fréquence indéterminée: insuffisance rénale, hématurie, incontinence urinaire.
0.023953761905431747 ||| Dyskinesia Parkinsonism aggravated, dizziness, dystonia, hyperkinesia ||| Dyskinesia, Parkinsonism aggravated Dizziness, dystonia, hyperkinesia ||| Dyskinésies Aggravation du syndrome parkinsonien, vertiges, dystonie, hyperkinésie
0.3067336678504944 ||| In a haloperidol-controlled trial, the proportion of responder patients maintaining response to medicinal product at 52-weeks was similar in both groups (oral aripiprazole 77% and haloperidol 73%). ||| In the pivotal placebo-controlled studies with ORACEA in rosacea, 269 patients were treated with ORACEA 40 mg once daily and 268 patients were treated with placebo for 16 weeks. ||| Dans une étude contrôlée versus halopéridol, le pourcentage de patients répondeurs avec maintien de la réponse au traitement à 52 semaines était similaire dans les deux groupes (aripiprazole par voie orale 77% et halopéridol 73%).
0.07674722373485565 ||| Nutritional supplements consisting primarily of calcium ||| Nutritional supplements consisting primarily of magnesium ||| Compléments nutritionnels composés essentiellement de calcium
0.49777212738990784 ||| Publication of calendars ||| Creation of GPS maps ||| Publication de calendriers
0.31295397877693176 ||| Periodic monitoring of serum potassium and ECG is recommended when Kinzalkomb is administered with these medicinal products affected by serum potassium disturbances (e. g. digitalis glycosides, antiarrhythmics) and the following torsades de pointes inducing medicinal products (which include some antiarrhythmics), hypokalaemia being a predisposing factor to torsades de pointes. ||| If serious haemolysis occurs after Soliris discontinuation, consider the following procedures/treatments: blood transfusion (packed RBCs), or exchange transfusion if the PNH RBCs are > 50% of the total RBCs by flow cytometry; anticoagulation; corticosteroids; or reinstitution of Soliris. ||| Une surveillance régulière de la kaliémie et une surveillance électrocardiographique sont recommandées en cas d’ association de Kinzalkomb à des médicaments affectés par les déséquilibres de la kaliémie (par exemple digitaliques, antiarythmiques) et les médicaments suivants pouvant induire des torsades de pointes (incluant certains antiarythmiques), l’ hypokaliémie étant une facteur prédisposant à la survenue de torsades de pointes:
0.09307776391506195 ||| WHAT FABRAZYME IS AND WHAT IT IS USED FOR ||| WHAT MYOZYME IS AND WHAT IT IS USED FOR ||| QU’EST-CE QUE FABRAZYME ET DANS QUEL CAS EST-IL UTILISE?
0.035816408693790436 ||| The dose of Stocrin needs to be reduced in patients taking voriconazole (used to treat fungal infections). ||| The dose of Sustiva needs to be reduced in patients taking voriconazole (used to treat fungal infections). ||| La dose de Stocrin doit être réduite chez les patients sous voriconazole (utilisé pour traiter les infections fongiques).
0.3002167344093323 ||| The increased efavirenz concentrations observed following administration of SUSTIVA with food may lead to an increase in frequency of adverse reactions (see sections 4.4 and 5.2). ||| The choice of new antiretroviral agent(s) to be used in combination with efavirenz should take into consideration the potential for viral cross-resistance (see section 5.1). ||| Une augmentation des concentrations d’ éfavirenz observée suite à l'administration de SUSTIVA avec de la nourriture peut entraîner une augmentation de la fréquence des effets indésirables (voir rubriques 4.4 et 5.2).
0.25172826647758484 ||| Distribution As systemic exposure is low with tacrolimus ointment, the high binding of tacrolimus (> 98.8%) to plasma proteins is considered not to be clinically relevant. ||| However, renal clearance contributes less than 25% of maraviroc total clearance in the absence of CYP3A4 inhibitors, therefore the impact of renal impairment on maraviroc elimination should be minimal. ||| Distribution Compte tenu de la faible exposition systémique après application de tacrolimus pommade, il n'est pas considéré que la forte fixation du tacrolimus aux protéines plasmatiques (> 98,8%) ait une conséquence clinique.
0.30033448338508606 ||| Insert the short injection needle into the pinched skin, holding the syringe like a pencil, use a quick “dart like” motion to insert the injection needle either straight up and down (90 degrees angle) or at a slight angle (45 degrees angle) into the skin, as shown by your health care professional (7). ||| Start again with another dose tray.  Holding the glass barrel of the syringe (not the white collar) in one hand, and the vial adaptor (not the vial) in the other, connect the syringe to the vial adaptor by inserting the tip into the opening and turn clockwise until completely secured (see Diagram 7). ||| Effectuez un mouvement rapide comme pour lancer une fléchette afin d’ enfoncer l’ aiguille d’ injection verticalement (angle de 90 degrés) ou selon un léger angle (45 degrés) dans la peau, comme vous l’ a montré votre professionnel de santé (7).
0.2948075234889984 ||| 1.5 ml of solvent in a pre-filled syringe (Type I glass) closed with a tip cap (FluroTec coated butyl rubber) ||| 15 ml colourless European Pharmacopoeia Type I drawn glass vial closed with Teflon-coated chlorobutyl/ natural rubber stopper and aluminium flip-off overseal. ||| 1.5 ml de solvant dans une seringue préremplie (verre de type I) dont l’ embout est protégé par un opercule (butylcaoutchouc revêtu de FluroTec)
0.3206072449684143 ||| ed Quintanrix is a vaccine used in children to prevent five infectious diseases: diphtheria, tetanus (lockjaw), pertussis (whooping cough), hepatitis B and Haemophilus influenzae type b (a type of bacteria). ||| Titers of Ig G antigen specific antibody to mumps, rubella, varicella, tetanus toxoid, influenza and streptococcus pneumococci remained stable over 24 weeks following exposure to MabThera in rheumatoid arthritis patients. ||| isé Quintanrix est un vaccin utilisé chez l'enfant pour prévenir cinq maladies: la diphtérie, le tétanos, la coqueluche, l'hépatite B, et les infections à Haemophilus influenzae type b (un type de bactérie).
0.3830554783344269 ||| The Applicant also described the proposed Risk Management Plan, the amendments to the Product Information and the education programme directed at healthcare professionals, patients and carers to be introduced at product launch. ||| The Working Party will complete the preparation of a guideline on post- marketing surveillance, and reporting requirements for authorities, and will further review and update the measures in force for rapid alert reporting in the veterinary sector. ||| Le demandeur a par ailleurs décrit le plan de gestion des risques proposé, les modifications des informations sur le produit et le programme de formation destiné aux professionnels de santé, aux patients et aux soignants, à mettre en place lors du lancement du médicament.
3.5550078505974803e-13 ||| The needle cover of the pre-filled syringe contains dry natural rubber (a derivative of latex), which may cause allergic reactions. ||| The needle cover of the pre-filled syringe contains dry natural rubber (a derivative of latex), which may cause allergic reactions. ||| 58 Le capuchon de protection de la seringue préremplie contient du caoutchouc naturel (un dérivé du latex) qui peut provoquer des réactions allergiques.
0.37320607900619507 ||| Before you use ORENCIA, your doctor will examine you for tuberculosis or do a skin test. ||| Your doctor will also ask you to come in for tests to monitor body iron load. ||| Avant d’ utiliser ORENCIA, votre médecin vous examinera ou vous fera passer un test cutané de dépistage de la tuberculose.
0.30281367897987366 ||| Cubicin is used in adults to treat infections of the skin and the tissues below the skin. ||| Altargo is used to treat bacterial infections affecting small areas of skin. ||| Cubicin s’ utilise chez l’ adulte dans le traitement des infections de la peau et des tissus sous-cutanés.
0.5655529499053955 ||| The solution should be clear and colourless to light yellow. ||| The clear solution is orange to dark orange in colour. ||| La solution doit être limpide et incolore à légèrement jaune.
0.47578656673431396 ||| There are no adequate data from the use of hydroxocobalamin in pregnant women and the potential risk for humans is unknown. ||| There are many years of experience with the use of this vaccine, and there are no known adverse reactions associated with the vaccine. ||| Il n’ existe pas de données suffisamment pertinentes sur l’ utilisation de l’ hydroxocobalamine chez la femme enceinte et le risque potentiel en clinique n’ est pas connu.
0.5559223890304565 ||| Abstral ||| Offal ||| Rapinyl
0.24109140038490295 ||| If you take more Seretide than you should It is important to take Seretide as your doctor recommended. ||| If you take more Viani than you should It is important to take Viani as your doctor recommended. ||| Si vous avez pris plus de SERETIDE que vous n’ auriez dû Il est important de prendre Seretide comme votre médecin vous l’ a recommandé.
0.3439984917640686 ||| Manufacturer Novartis Farmacéutica, S. A. ||| Manufacturer Novartis Farma S. p. A. ||| 129 Fabricant Novartis Farmacéutica, S. A.
0.04185798019170761 ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| The 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| L’ évolution des 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel.
0.2799980044364929 ||| Each vial contains 45 mg ustekinumab in 0.5 ml. ||| One 0.8 ml vial contains 40 mg adalimumab ||| Chaque flacon contient 45 mg d’ ustekinumab dans 0,5 ml.
0.49560287594795227 ||| CARTON LABEL (CYCLOOLEFINE-COPOLYMER) SYRINGE/ OUTER PACKAGING ||| 31 PIOGLITAZONE IN TRIPLE ORAL COMBINATION THERAPY WITH METFORMIN AND SULPHONYLUREA ||| ÉTUI CARTON (SERINGUE EN CYCLOOLÉFINE-COPOLYMÈRE) / EMBALLAGE EXTÉRIEUR
0.312487930059433 ||| Since this difference is not considered to be clinically relevant, the combination of PREZISTA co-administered with 100 mg ritonavir and nevirapine can be used without dose adjustments. ||| Therefore, as dosage adjustments of these may be necessary, it is recommended that separate preparations of abacavir, lamivudine and zidovudine be administered to ||| Etant donné que cette différence n’est pas considérée comme cliniquement significative, l’association de PREZISTA co-administré avec 100 mg de ritonavir et de la névirapine peut être utilisée sans adaptation posologique.
0.5267824530601501 ||| Other common side effects are blurred vision, bradycardia (very slow heart rate), irregular heartbeat, headache (generally during the first month of treatment) and dizziness. ||| • mild lethargy and drowsiness • slight increase of body temperature. • slight increase of respiratory rate • slight sinus tachycardia. ||| D’ autres effets indésirables tels que la vision trouble, la bradycardie (fréquence cardiaque très faible), des battements cardiaques irréguliers, des céphalées (généralement pendant le premier mois de traitement) et des vertiges ont été rapportés.
0.308336079120636 ||| Sanohex is used to treat the breathing difficulties caused by asthma and chronic obstructive pulmonary disease (COPD). ||| Twinrix Paediatric is used to protect against hepatitis A and hepatitis B infection (diseases that affect the liver). ||| Sanohex est utilisé pour le traitement des difficultés à respirer dues à l’ asthme et à la maladie pulmonaire obstructive chronique (MPOC).
0.4548196792602539 ||| 102 Table 10 Efficacy Responses in Placebo-Controlled AS Study – Study I Reduction of Signs and Symptoms ||| 47 Table 9 ACR Response in Placebo-Controlled Psoriatic Arthritis Studies (Percent of Patients) ||| Tableau 10 – Réponses d'efficacité de l'étude SA contrôlée contre placebo – Etude I Réduction des signes et symptômes
0.32567790150642395 ||| Tritazide is used in the treatment of hypertension and it is indicated in patients whose blood pressure is not adequately controlled with ramipril alone or hydrochlorothiazide alone. ||| From the efficacy and safety data provided, Rapinyl seems to be comparable to other fentanyl containing products (Actiq and Effentora) for the treatment of BTP in cancer patients. ||| Tritazide est utilisé pour le traitement de l’ hypertension et il est indiqué chez les patients dont la pression artérielle n’ est pas suffisamment contrôlée par le ramipril seul ou par l’ hydrochlorothiazide seul.
0.8680888414382935 ||| Do not take VIRAMUNE ||| days after receiving BEROMUN ||| Ne prenez jamais VIRAMUNE
0.44964826107025146 ||| Technical consultancy relating to the application and use of computer software ||| Consultancy services relating to the education and training of management and of personnel ||| Services de conseils techniques en matière d'application et d'utilisation de logiciels
0.31640326976776123 ||| Tyre removers [machines] ||| Street sweeping vehicles [machines] ||| Machines à démonter les pneus
0.10931231081485748 ||| Once opened, the product may be stored for a maximum of 28 days at 2°C to 8°C. ||| After reconstitution: the product may be stored for a maximum of 24 hours at 2°C to 8°C. ||| Après la première utilisation, le produit peut être conservé pendant 28 jours au maximum entre +2°C à +8°C.
0.35109245777130127 ||| If you experience these symptoms you should contact your doctor who will determine the best course of action to treat your anaemia. ||| Always take Diovan exactly as your doctor has told you in order to get the best results and reduce the risk of side effects. ||| Si vous développez ces symptômes, vous devez contacter votre médecin qui déterminera la prise en charge la plus adaptée de votre anémie.
0.2665634751319885 ||| Severe CNS effects, particularly depression, suicidal ideation and attempted suicide have been observed in some patients during Rebetol combination therapy with interferon alfa-2b, and even after treatment discontinuation mainly during the 6-month follow-up period. ||| 44/ 94 Paradoxical worsening of Restless Legs Syndrome symptoms occurring with earlier onset (augmentation), and reoccurrence of symptoms in the early morning hours (early morning rebound), may be observed during treatment with ropinirole. ||| Des effets sévères sur le SNC, principalement dépression, idées suicidaires et tentative de suicide ont été observés chez certains patients traités par Rebetol en association avec l’ interféron alfa-2b, pendant le traitement mais également après l’ arrêt, et dans ce cas principalement pendant les 6 mois ayant suivi l’ arrêt.
0.7772597670555115 ||| 4 weeks after first opening. ||| 2 years After opening: ||| 4 semaines après la première ouverture.
0.23831963539123535 ||| Sirolimus: in renal transplant patients, concomitant administration of mycphenolate mofetil and CsA resulted in reduced MPA exposures by 30-50% compared with patients receiving the combination of sirolimus and similar doses of Myfenax (see also section 4.4). ||| In this trial 57% of the patients had baseline HbA1c above 9%; in these patients treatment with NovoMix 30 in combination with metformin resulted in significantly lower HbA1c than metformin in combination with sulfonylurea. ||| Sirolimus: chez les transplantés rénaux, l’ administration concomitante de mycophénolate mofétil et de ciclosporine A a entraîné une diminution de l’ exposition au MPA de 30-50% comparé aux patients recevant l’ association de sirolimus et de doses similaires de Myfenax (voir également rubrique 4.4).
0.3625839948654175 ||| Your doctor may decide that it would be more convenient for you to inject Neulasta yourself. ||| Your doctor has decided it would be best f or you to inject Neulasta yourself. ||| Votre médecin peut estimer préférable que vous pratiquiez vous -même les injections de Neulasta.
0.015860002487897873 ||| Therapy with AVAGLIM should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5X upper limit of normal) or with any other evidence of liver disease. ||| Therapy with Tandemact should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5 X upper limit of normal) or with any other evidence of liver disease. ||| 22 les patients ayant des enzymes hépatiques élevées (ALAT > 2,5 fois la limite supérieure de la normale) ou présentant tout autre signe d'une affection hépatique.
0.4091443419456482 ||| Signs and symptoms of overdose (duloxetine alone or with mixed drugs) included somnolence, coma, serotonin syndrome, seizures,, vomiting andtachycardia. ||| water) or have salt deficiency due to diuretic therapy (water tablets), low-salt diet, diarrhoea, vomiting, or haemodialysis. ||| Les signes et symptômes d’ un surdosage (duloxétine seule ou en association avec d’ autres médicaments) incluaient somnolence, coma, syndrome sérotoninergique, convulsions, vomissements et tachycardie.
0.6038002967834473 ||| On 2 April, 771 new cases were confirmed, bringing the total number of confirmed cases to 3,548. ||| Information on underlying conditions was only available for 7,162 (5.8%) of 122,653 cases reported to CDC. ||| Le 2 avril, 771 nouveaux cas ont été confirmés, portant le nombre total de cas confirmés à 3 548.
0.46894294023513794 ||| Provision of investment savings plans ||| Business appraisals for financial valuation ||| Fourniture de plans d'épargne d'investissement
0.0 ||| 6.5 Nature and contents of container ||| 6.5 Nature and contents of container ||| 8 6.5 Nature et contenu de l’ emballage extérieur
0.3570708632469177 ||| Because tacrolimus and Prograf/ Prograft have already been used in the EU, the company presented the results of studies that had been carried out with Prograf/ Prograft previously, as well as data from the published literature. ||| Because zidovudine has been available in the European Union (EU) since the mid-1980s, and lamivudine has been approved in the EU since 1996 as Epivir, the company presented information obtained in earlier studies of the two substances taken together. ||| Comme le tacrolimus et Prograf/ Prograft ont déjà été utilisés dans l'UE, la société a présenté les résultats d’ études déjà réalisées avec Prograf/ Prograft, ainsi que des données de la documentation publiée.
0.5442965030670166 ||| • 3.1.2002 • 24.5.2002 • OJ L 137, 25.5.2002 ||| 5.1.1998 18.3.1998 19.3.1998 OJ C 126, 24.4.1998. ||| 3.1.2002 24.5.2002 JO L137, 25.5.2002
0.003188945585861802 ||| A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) that is found on certain cells in the body. ||| A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) that is found in certain cells in the body. ||| Un anticorps monoclonal est un anticorps (type de protéine) conçu pour reconnaître et se fixer sur une structure spécifique (appelée antigène) située dans certaines cellules de l’ organisme.
0.40493258833885193 ||| Driving and using machines Gemzar may make you feel sleepy, particularly if you have consumed any alcohol. ||| Driving and using machines Your ability to concentrate and react may be reduced if you have hypoglycaemia. ||| Conduite de véhicules et utilisation de machines Gemzar peut entraîner une sensation de somnolence, particulièrement si vous avez consommé de l’alcool.
0.0635383203625679 ||| Yellow and white oval shaped tablet engraved with the company logo and the code'H9 '. ||| Red and white oval shaped two layer tablet engraved with the company logo and the code'H4 '. ||| Comprimé ovale bicouche jaune et blanc gravé du logo du laboratoire et du code ‘ H9’.
0.27223068475723267 ||| A cross-study analysis in 217 patients with advanced solid tumours indicated that gender did not affect the pharmacokinetics of HYCAMTIN capsules to a clinically relevant extent. ||| 19 In clinical studies, subgroup analyses based on age and gender did not indicate any difference in safety and efficacy in insulin glargine-treated patients compared to the entire study population. ||| Une analyse croisée incluant 217 patients avec des tumeurs solides à un stade avancé indiquait que le sexe ne modifiait pas la pharmacocinétique d’ HYCAMTIN gélule de manière cliniquement pertinente.
0.32725420594215393 ||| disease ||| depression ||| Parkinson
0.5736571550369263 ||| Reservation services for concert and theatre tickets ||| Auditioning for tv game shows ||| Services de réservation de places de concert et de théâtre
0.4623996615409851 ||| PhD in organic chemistry from the Free University of Berlin. ||| Graduated in pharmacology from Kings College, London University. ||| Diplôme de chimiste et de pharmacienne de l’ université libre de Berlin.
0.35972023010253906 ||| High doses of other forms of interferons alpha and beta are known to produce dose- related anovulatory and abortifacient effects in rhesus monkeys. ||| Dosage in the female There are great inter- and intra-individual variations in the response of the ovaries to exogenous gonadotrophins. ||| 204 D’ autres formes d’ interférons alpha et bêta à hautes doses sont connues pour entraîner des effets dose- dépendants d’ anovulation ou d’ avortement chez le singe rhésus.
6.081664577321788e-13 ||| Specific in vivo drug interaction studies have not been performed. ||| Specific in vivo drug interaction studies have not been performed. ||| Il n 'pas été conduit d' médicamenteuses in vivo.
0.21188712120056152 ||| 88 The end-user may remove the medicinal product from refrigeration for storage at a room temperature not above 25°C for one single period of 1 month. ||| You may remove MIRCERA from the refrigerator and store it at a room temperature not above 25 °C for a single period of one month. ||| L’ utilisateur peut conserver le médicament en dehors du réfrigérateur et à température ambiante ne dépassant pas +25°C durant une période unique d’ un mois.
0.1857241690158844 ||| Each ml of oral solution contains 10 mg of lamivudine. ||| Each ml of Norvir contains 80 mg of ritonavir. ||| Chaque ml de solution buvable contient 10 mg de lamivudine.
0.18431562185287476 ||| Revasc should not be used in people who may be hypersensitive (allergic) to desirudin or any of the other ingredients, who are pregnant, who have had recent bleeding, who have severe high blood pressure or severe liver or kidney problems, or who have a heart infection. ||| It must not be used in patients who have had angioedema (swelling under the skin) with aliskiren, who have severe kidney or liver problems, or whose blood potassium levels are too low or blood calcium levels are too high. ||| Revasc ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) à la désirudine ou à l’ un des autres ingrédients, chez les femmes enceintes, chez les patients ayant eu une hémorragie récente, chez les patients hypertendus ou présentant de graves troubles hépatiques ou rénaux, ainsi que chez les patients présentant une infection cardiaque.
0.40007999539375305 ||| You should not breast-feed if you are taking Xeloda. ||| If you are pregnant, you must not take Thalidomide Celgene. ||| Vous ne devez pas allaiter si vous êtes traitée par Xeloda.
0.5795949697494507 ||| Note: bosentan is not removed through dialysis. ||| Rebif solution is clear to opalescent. ||| Note: le bosentan n’ est pas éliminé au cours de la dialyse.
0.4035254418849945 ||| 233 System Organ Class ||| 32 System Organ Class ||| Classe de systèmes
0.23732897639274597 ||| Your Insulatard NovoLet is designed to work accurately and safely. ||| Your OptiSet is designed to work accurately and safely. ||| Votre Insulatard NovoLet est conçu pour fonctionner avec une grande précision et en toute sécurité.
0.6922038793563843 ||| Diagram S ||| Diag ram R ||| Figure S
0.2635277509689331 ||| The appropriate combination of pipettes ||| appropriate combination of pipettes ||| Utiliser la combinaison appropriée de pipettes
0.0 ||| 6.4 Special precautions for storage ||| 6.4 Special precautions for storage ||| 90 6.4 Précautions particulières de conservation
0.05035021901130676 ||| This means that, because the disease is rare, it has not been possible to obtain complete information about Xagrid. ||| This means that, because the disease is rare, it has not been possible to obtain complete information about Evoltra. ||| Autrement dit, en raison de la rareté de la maladie, il n’ a pas été possible d’ obtenir des informations complètes sur Xagrid.
0.4906739890575409 ||| Hydrochloric acid 30%, water for injections. ||| Phosphoric acid (for pH-adjustment). ||| Acide chlorhydrique 30%, eau pour préparations injectables
0.106548011302948 ||| Protopic 0.03% Ointment Tacrolimus monohydrate ||| Protopy 0.03% Ointment Tacrolimus monohydrate ||| Protopic 0,03% Pommade Tacrolimus monohydrate
0.14453089237213135 ||| Cleaning of buildings ||| Cleaning of hospitals ||| Nettoyage de bâtiments
0.0 ||| Diarrhoea, vomiting, nausea, abdominal pain Mouth ulceration, stomatitis ulcerative, stomatitis, right upper quadrant pain, dyspepsia, glossitis, gastroesophogeal reflux, rectal disorder, gastrointestinal disorder, constipation, loose stools, toothache, tooth disorder ||| Diarrhoea, vomiting, nausea, abdominal pain Mouth ulceration, stomatitis ulcerative, stomatitis, right upper quadrant pain, dyspepsia, glossitis, gastroesophogeal reflux, rectal disorder, gastrointestinal disorder, constipation, loose stools, toothache, tooth disorder ||| Diarrhées, vomissements, nausées, douleur abdominale Ulcération buccale, stomatite ulcéreuse, stomatite, douleur dans la partie supérieure droite de l’ abdomen, dyspepsie, glossite, reflux gastro-oesophagien, trouble rectal, trouble gastro-intestinal, constipation, selles moles, douleur dentaire, affection dentaire
3.1750988014993264e-13 ||| Following a single subcutaneous injection of fondaparinux 2.5 mg to young healthy subjects, peak plasma concentration (mean Cmax = 0.34 mg/ l) is obtained 2 hours post-dosing. ||| Following a single subcutaneous injection of fondaparinux 2.5 mg to young healthy subjects, peak plasma concentration (mean Cmax = 0.34 mg/ l) is obtained 2 hours post-dosing. ||| Après une injection unique sous-cutanée de 2,5 mg de fondaparinux chez le volontaire sain jeune, la concentration plasmatique maximale (Cmax moyenne = 0,34 mg/ l) est obtenue 2 heures après l’ administration.
0.28598159551620483 ||| Administration with food decreases the rate of capecitabine absorption (see section 5.2). ||| Even a light meal improves absorption of tenofovir from the combination tablet (see section 5.2). ||| La prise de nourriture diminue l’ absorption de la capécitabine (voir rubrique 5.2).
0.909012496471405 ||| ris Heinrich Mack Nachf. ||| PatrickLe Courtois Head: ||| Heinrich Mack Nachf.
0.0772220641374588 ||| No clinically significant pharmacokinetic interaction. ||| No clinically significant pharmacokinetic change. ||| Aucune interactions pharmacocinétique cliniquement significative.
7.813111594333344e-13 ||| Metabolism and nutrition disorders Very common: ||| Metabolism and nutrition disorders Very common: ||| 40 Troubles du métabolisme et de la nutrition Très fréquent:
0.02388002723455429 ||| This means that due to the rarity of the disease, it has not been possible to obtain complete information on this medicinal product. ||| This means that due to the rarity of the disease it has not been possible to obtain complete information on this medicinal product. ||| Cela signifie qu’ à cause de la rareté de cette maladie pour des raisons scientifiques, il est impossible d’ obtenir des informations complètes sur ce médicament.
0.41907310485839844 ||| Procedures for proper handling and disposal of cytotoxic medicinal products should be followed. ||| Antipyretic treatment should be initiated according to local treatment guidelines. ||| Suivre les procédures adéquates de manipulation et d’ élimination des médicaments cytotoxiques.
0.1624774932861328 ||| EU/ 1/ 03/ 268/ 001 EU/ 1/ 03/ 268/ 002 EU/ 1/ 03/ 268/ 003 EU/ 1/ 03/ 268/ 004 ||| EU/ 1/ 02/ 218/ 004 EU/ 1/ 02/ 218/ 005 EU/ 1/ 02/ 218/ 006 EU/ 1/ 02/ 218/ 011 ||| EU/ 1/ 03/ 268/ 01 EU/ 1/ 03/ 268/ 02 EU/ 1/ 03/ 268/ 03 EU/ 1/ 03/ 268/ 04
0.5153377056121826 ||| There are no dose modifications recommended for severe lymphopenia given the mechanism of action of MabCampath. ||| Dosage adjustments during treatment No dose reductions of MabThera are recommended. ||| Aucune modification de dose n’ est recommandée en cas de lymphopénie sévère compte tenu du mécanisme d’ action de MabCampath.
0.06732366234064102 ||| After delivery, insulin requirements normally return rapidly to pre-pregnancy values. ||| After delivery, insulin requirements return rapidly to pre-pregnancy values. ||| Après l’accouchement, les besoins en insuline reviennent généralement rapidement au niveau antérieur à la grossesse.
7.001680051715864e-13 ||| Store in a refrigerator (2 °C – 8 °C). ||| Store in a refrigerator (2 °C – 8 °C). ||| A conserver au réfrigérateur (entre 2°C et 8°C).
0.3011280596256256 ||| Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded. ||| The enzyme responsible for the metabolism of desloratadine has not been identified yet, and therefore, some interactions with other medicinal products can not be fully excluded. ||| Malgré cela la possibilité d’une transmission d’agents infectieux ne peut pas être totalement exclue lors de l’administration de médicaments préparés à partir de sang ou de plasma humain.
0.6079023480415344 ||| A total of 20 patients were included in the second study. ||| The first study included 72 patients and the second included 78. ||| Un total de 20 patients fut inclus dans la deuxième étude.
0.1715002804994583 ||| Therefore, in patients with renal anaemia the medicinal product has to be administered intravenously. ||| In patients with chronic renal failure the medicinal product has to be administered intravenously (see section 4.4). ||| Le médicament doit donc être administré par voie intraveineuse chez ces patients.
0.4452929198741913 ||| Or Wyeth Pharmaceuticals New Lane Havant Hants, PO9 2NG United Kingdom ||| Boundary Way Hemel Hempstead Herts, HP2 7UD United Kingdom. ||| Ou Wyeth Pharmaceuticals New Lane Havant Hants, PO9 2NG Royaume-Uni
0.0 ||| Etoricoxib was associated with a statistically significantly lower rate of discontinuations due to hepatic- related adverse experiences than diclofenac. ||| Etoricoxib was associated with a statistically significantly lower rate of discontinuations due to hepatic- related adverse experiences than diclofenac. ||| En ce qui concerne les arrêts de traitement en raison d'événements indésirables hépatiques, l'étoricoxib a été associé à un taux statistiquement significativement plus faible que le diclofénac.
0.017104174941778183 ||| Hypersensitivity to the active substance, to other quinolones or to any of the excipients (see section 6.1). ||| • Hypersensitivity to the active substance, to other quinolones or to any of the excipients (see section 6.1). ||| Hypersensibilité à la substance active, aux autres quinolones ou à l’un des excipients (voir rubrique 6.1).
0.31173187494277954 ||| The gel should be administered at the time of feeding. ||| Oral use It is recommended that the gel is administered at the time of feeding. ||| Il est recommandé d’ administrer le gel au moment du repas.
0.15847674012184143 ||| The vaccine should be inspected visually for any foreign particulate matter and/ or coloration prior to administration. ||| The reconstituted vaccine should be inspected visually for any foreign particulate matter and/ or variation of physical aspect prior to administration. ||| 7/ 50 Le vaccin doit être inspecté visuellement pour rechercher toutes particules étrangères et/ ou coloration avant administration.
0.34393393993377686 ||| Only use each pre-filled syringe for one injection. ||| Always use a new sterile needle for each injection. ||| Une seringue préremplie ne peut servir que pour une seule injection.
0.5374979972839355 ||| Rental of freezers for commercial use ||| Overnight storage of letters in depots ||| Location de congélateurs à usage commercial
0.28556376695632935 ||| INTEGRILIN 2 mg/ ml solution for injection eptifibatide ||| INCRELEX 10 mg/ml solution for injection Mecasermin ||| INTEGRILIN 2 mg/ ml solution injectable eptifibatide
3.5726166491313605e-13 ||| Lipids: increases in total cholesterol of 10 - 20% have been observed in some uninfected volunteers receiving efavirenz. ||| Lipids: increases in total cholesterol of 10 - 20% have been observed in some uninfected volunteers receiving efavirenz. ||| Lipides: des augmentations du cholestérol total de 10 - 20% ont été observées chez certains volontaires non infectés recevant de l'éfavirenz.
0.40188002586364746 ||| Rare side effects (affects 1 to 10 users in 10,000): some patients have experienced allergic reactions soon after injection, consisting of breathlessness, swelling of the face, rash and chest pain. ||| The following undesirable events have occurred very rarely following the administration of hepatitis B containing vaccines: ♦ seizures or fits ♦ bleeding or bruising more easily than normal ||| Effets indésirables rares (observés chez au moins 1 patient sur 10000 et moins d’1 patient sur 1000): des patients ont présenté des réactions allergiques peu après l’injection à type d’essoufflement, de gonflement du visage, d’éruption cutanée et de douleur dans la poitrine.
0.04499569162726402 ||| The scheme was approved under the State aid Temporary Framework to support the economy in the context of the COVID-19 outbreak adopted by the Commission on 19 March 2020. ||| The loan was approved under the State aid Temporary Framework to support the economy in the context of the COVID-19 outbreak adopted by the Commission on 19 March 2020. ||| Ce régime a été autorisé en vertu de l' encadrement temporaire des aides d'État visant à soutenir l'économie dans le contexte de la flambée de COVID-19 , adopté par la Commission le 19 mars 2020.
0.27535292506217957 ||| Thyrogen solution should never be injected into a vein. ||| Optaflu should under no circumstances be injected into a blood vessel. ||| Ne jamais injecter la solution de Thyrogen dans une veine.
0.18838758766651154 ||| No breakpoint for Brachyspira hyodysenteriae has been ||| No breakpoint for Brachyspira hyodysenteriae has been established. ||| Aucun point de rupture n’ a été établi pour Brachyspira hyodysenteriae.
0.6793013215065002 ||| Engraving ||| After injecting ||| Gravure
0.3699480891227722 ||| If you have accidentally taken too many tablets, contact your doctor, pharmacist, or hospital. ||| If the inspection window is not yellow, you must contact your doctor, nurse or pharmacist. ||| Si vous avez accidentellement pris trop de comprimés, consultez votre médecin, votre pharmacien ou l’hôpital.
0.004450858570635319 ||| Dispose of your used Mixtard 40 NovoLet carefully without the needle attached. ||| Dispose of your used Mixtard 50 NovoLet carefully without the needle attached. ||| Eliminez votre Mixtard 40 NovoLet usagé prudemment, sans l’ aiguille attachée.
0.25147485733032227 ||| Preotact contains metacresol, which may cause allergic reactions. ||| Paxene contains polyoxyl castor oil, which can cause an allergic reaction. ||| Preotact contient du métacresol, substance pouvant provoquer des réactions allergiques.
0.2412569671869278 ||| In case of severe extrapyramidal symptoms, an anticholinergic medicinal product should be administered. ||| In such infections ciprofloxacin must be co-administered with other appropriate antibacterial agents. ||| En cas d’ apparition de symptômes extrapyramidaux sévères, un médicament anticholinergique doit être administré.
0.5261845588684082 ||| The safety and efficacy of Zometa in paediatric patients have not been established. ||| More than 99% of efficacy and safety data were generated in Caucasians. ||| La sécurité d’ emploi et l’ éfficacité de Zometa n’ ont pas été établies chez l’ enfant.
0.31088173389434814 ||| How to store Prepandrix 6. ||| How to store Twinrix Adult 6. ||| Comment conserver Prepandrix 6.
5.122701308285516e-13 ||| The clinical relevance of this is unknown. ||| The clinical relevance of this is unknown. ||| La pertinence clinique en est inconnue.
0.3841358423233032 ||| Phase II trials are used to establish an initial reading of efficacy and further explore safety in small numbers of people having the disease targeted by the NCE. ||| If safety and efficacy are adequately proved, clinical testing may stop at this step and the NCE advances to the new drug application (NDA) stage to begin marketing. ||| Les essais de phase II permettent d’établir une mesure initiale de l’efficacité et d’explorer la sécurité chez un petit nombre de patients atteints de la maladie ciblée par la NCE.
0.6790941953659058 ||| Interaction with other medicinal products: ||| Combinations with other treatments ||| Interactions avec d'autres médicaments:
0.46912384033203125 ||| Fluticasone Furoate GSK is used to treat the symptoms of allergic rhinitis. ||| Pharmacodynamic effects FORSTEO is a bone formation agent to treat osteoporosis. ||| Fluticasone Furoate GSK est utilisé pour traiter les symptômes de la rhinite allergique.
0.26478758454322815 ||| The effectiveness of the solution for injection was compared with placebo over a period of two hours in two studies involving 805 patients with schizophrenia or related conditions who were experiencing symptoms of agitation. ||| A review of the studies by three independent experts found that only 145 of these patients were candidates for amputation or surgical removal of the tumour that would have resulted in significant loss of function (disability). ||| L’ efficacité de la solution injectable a été comparée avec celle du placebo au cours d’ une période de deux heures, dans le cadre de deux études portant sur 805 patients souffrant de schizophrénie ou de maladies liées à la schizophrénie atteints de symptômes d’ agitation.
0.5021113753318787 ||| Rainwater drainage apparatus of plastics materials ||| Heat insulated domestic vessels of earthenware ||| Appareils de drainage des eaux de pluie en matières plastiques
0.2373322695493698 ||| Crop lifters [machines] ||| Tree pruners [machines] ||| Releveurs d'épis [machines]
0.7548857927322388 ||| Very common: asthenia/ fatigue; taste perversion; abdominal pain. ||| • rash, itching, hair loss; • fatigue; • fever. t uc ||| Très fréquent: asthénie/ fatigue, altération du goût, douleurs abdominales.
0.7183163166046143 ||| Praziquantel (mg/ kg bw) ||| Apparent clearance l/ hr/ kg ||| Praziquantel (mg/ kg)
0.06028764694929123 ||| You should not use Januvia if you are breast-feeding or plan to breast-feed. ||| You should not use Jalra if you are breast-feeding or plan to breast-feed. ||| Vous ne devrez pas prendre Januvia si vous allaitez ou envisagez d'allaiter.
0.3182588815689087 ||| Ελλάδα Lundbeck Hellas S. A. ||| 81 Ελλάδα Pfizer Hellas A. E. ||| 87 Ελλάδα Lundbeck Hellas S. A.
0.23493430018424988 ||| Design and development of medical technology ||| Design and development of industrial products ||| Conception et développement de technologies médicales
7.230757876133809e-13 ||| 105 1. ||| 105 1. ||| 118 1.
0.0 ||| Any unused product or waste material should be disposed of in accordance with local requirements. ||| Any unused product or waste material should be disposed of in accordance with local requirements. ||| us Tout produit non utilisé ou déchet doit être éliminé conformément à la réglementation en vigueur.
0.2233828604221344 ||| Severe CNS effects, particularly depression, suicidal ideation and attempted suicide have been observed in some patients during Rebetol combination therapy with interferon alfa-2b, and even after treatment discontinuation mainly during the 6-month follow-up period. ||| Continuous infusion with filgrastim over a period of up to 28 days, in patients recovering from autologous bone-marrow transplantation, resulted in no evidence of drug accumulation and comparable elimination half-lives. ||| Des effets sévères sur le SNC, principalement dépression, idées suicidaires et tentative de suicide ont été observés chez certains patients traités par Rebetol en association avec l’ interféron alfa-2b, pendant le traitement mais également après l’ arrêt, et dans ce cas principalement pendant les 6 mois ayant suivi l’ arrêt.
0.014720939099788666 ||| After removing Insulatard Penfill from the refrigerator it is recommended to allow the Penfill to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use. ||| After removing Protaphane Penfill from the refrigerator it is recommended to allow the Penfill to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use. ||| Après avoir sorti Insulatard Penfill du réfrigérateur, il est recommandé d’ attendre qu’ il arrive à température ambiante (sans dépasser 25°C) avant de remettre l’ insuline en suspension, comme indiqué dans les instructions concernant la première utilisation.
0.5408238172531128 ||| Issuing of statements of accounts ||| Issuance of tokens of value ||| Émission de relevés de comptes
0.27560052275657654 ||| The CPMP having considered the grounds for appeal in relation to the draft Summary of Product Characteristics as set out in the appended assessment report has concluded that its opinion of 19 November 1997 should be revised and that the draft Summary of Product Characteristics should be amended. ||| On 21 June 2007 the CHMP, in order to focus and facilitate the translations of the specific amendments in the Summary of Product Characteristics, adopted a revised opinion with amended Annex II and Annex III, which was further reconsidered in October 2007. ||| Le CPMP ayant considéré les motifs de recours en rapport avec le projet de résumé des caractéristiques du produit tel que présenté dans le rapport d'évaluation joint a conclu que son avis du 19 novembre 1997 devait être révisé et que le projet de résumé des caractéristiques du produit devait être modifié.
0.40882349014282227 ||| Provision of information relating to the maintenance of vehicles ||| Provision of advice relating to the recruitment of graduates ||| Service d'informations concernant la maintenance de véhicules
0.37174829840660095 ||| Two of the studies recruited patients who were being treated with chemotherapy. ||| Patients who previously failed bosentan therapy were excluded from the study. ||| s études ont recruté des patients sous chimiothérapie.
0.006382969673722982 ||| In female versus male subjects the mean elimination half life was somewhat prolonged (36.7 versus 32.3 hrs) and the clearance was reduced (18.9 versus 27.3 l/ hr). ||| In female versus male subjects the mean elimination half life was somewhat prolonged (36.7 versus 32.3 hr) and the clearance was reduced (18.9 versus 27.3 l/ hr). ||| Chez la femme, par rapport à l’ homme, la demi-vie d’ élimination moyenne est légèrement prolongée (36,7 vs 32,3 heures) et la clairance est réduite (18,9 vs 27,3 l/ heure).
0.4007264971733093 ||| The CVMP recommended the refusal of the granting of the Marketing Authorisation and the suspension of the Marketing Authorisation for Equimectin where appropriate. ||| The CHMP agreed on the following proposal for conditions of the renewal of the Marketing Authorisation previously presented by the RMS: ||| Le CVMP a recommandé de refuser l’ octroi de l’ autorisation de mise sur le marché ainsi que de suspendre l’ autorisation de mise sur le marché d’ Equimectine, si nécessaire.
0.12064091116189957 ||| Financial information services relating to lost credit cards ||| Financial information services relating to stolen credit cards ||| Services d'informations financières concernant la perte de cartes de crédit
0.2877640724182129 ||| Mowing machines [electric] ||| Metal welding machines [gas] ||| Faucheuses électriques
0.20471294224262238 ||| MicardisPlus is used to treat high blood pressure (essential hypertension) in patients whose blood pressure is not controlled enough when either telmisartan or hydrochlorothiazide is used alone. ||| Trazec is used together with metformin (another antidiabetes medicine) to lower blood glucose (sugar) in patients whose diabetes cannot be controlled by metformin alone. ||| MicardisPlus est utilisé pour traiter une pression artérielle élevée (hypertension artérielle essentielle) chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le telmisartan ou l’hydrochlorothiazide seuls.
0.39563605189323425 ||| Xelevia was more effective than placebo when it was taken alone or in combination with other antidiabetes medicines. ||| Activated charcoal, which may be used with sorbitol, may be as or more effective than emesis or lavage. ||| Xelevia s’ est avéré plus efficace que le placebo, qu’ il ait été administré seul ou en association avec un autre médicament contre le diabète.
0.08401879668235779 ||| 8 Penile erection is a haemodynamic process. ||| Penile erection is a haemodynamic process. ||| L'érection du pénis est un processus hémodynamique.
0.5294149518013 ||| Coronavirus: Commission boosts urgently needed research and ||| Coronavirus: Commission proposes to activate ||| Coronavirus: La Commission stimule les travaux de recherche urgents
0.4133308529853821 ||| The exercise permitted a clearer view in preparation of the EMEA contribution to the fee reform proposals. ||| Work on the definition of a common electronic format for dossiers to be submitted for regulatory approval will continue. ||| Cet exercice a permis de préparer dans de bonnes conditions la contribution de l’EMEA aux propositions de réforme des redevances.
0.43648990988731384 ||| Pruban contains the active principle resocortol butyrate. ||| Humalog BASAL consists of insulin lispro protamine suspension. ||| Pruban contient le principe actif butyrate de résocortol.
0.3134511709213257 ||| Common: hypertriglyceridaemia, hyperglycaemia ||| hypertriglyceridaemia, hypercholesterolaemia, hyperlipidaemia ||| Fréquent: hypertriglycéridémie, hyperglycémie
0.09406448900699615 ||| What Apidra is and what it is used for 2. ||| What Karvezide is and what it is used for 2. ||| Qu’ est -ce qu’ Apidra et dans quel cas est -il utilisé 2.
0.4850046634674072 ||| If you are taking didanosine, it should be taken one hour before or at least two hours after taking Kaletra (with food). ||| Using Effentora with food or drink • Effentora may be used before or after, but not during, meals. ||| Si vous prenez de la didanosine, vous devez la prendre une heure avant ou au moins deux heures après la prise de Kaletra (avec un repas).
0.17351645231246948 ||| Why has Aivlosin been approved? ||| Why has Ovitrelle been approved? ||| Pourquoi Aivlosin a -t-il été approuvé?
0.013128271326422691 ||| Although the risk of immunocompromised humans becoming infected with Bordetella bronchiseptica is extremely low, it is advised that cats, which are in close contact with immunocompromised humans are not vaccinated with this vaccine. ||| 17 Although the risk of immunocompromised humans becoming infected with Bordetella bronchiseptica is extremely low, it is advised that cats that are in close contact with immunocompromised humans are not vaccinated with this vaccine. ||| Bien que le risque que des personnes immunodéprimées deviennent infectées par Bordetella bronchiseptica soit extrêmement faible, il est conseillé de ne pas vacciner les chats en contact avec des personnes immunodéprimées avec ce vaccin.
0.31523245573043823 ||| There have been reports that ophthalmic NSAIDs may cause increased bleeding of ocular tissues (including hyphaemas) in conjunction with ocular surgery. ||| For TPO receptor stimulators there is a theoretical concern that they may stimulate the progression of existing haematopoietic malignancies or MDS. ||| Il a été rapporté que les AINS ophtalmiques utilisés à l’ occasion d’ une intervention ophtalmologique peuvent provoquer une augmentation du saignement des tissus oculaires (incluant des hyphémas).
0.2601727843284607 ||| Conditions which may make the early warning symptoms of hypoglycaemia different or less pronounced include long duration of diabetes, intensified insulin therapy, diabetic nerve disease or medications such as beta-blockers. ||| The length of combination antiretroviral therapy, corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index, among others, may be some of the many risk factors for developing this disease. ||| Certaines conditions telles qu’ un diabète de longue durée, une insulinothérapie intensifiée, une neuropathie diabétique ou un traitement médicamenteux tel que les bêtabloquants peuvent rendre les signes précurseurs de l’ hypoglycémie différents ou moins prononcés.
0.21769209206104279 ||| uth Rimonabant should be used with caution in combination with potent CYP3A4 inhibitors (e. g. ketoconazole, itraconazole, ritonavir, telithromycin, clarithromycin, nefazodone)(see section 4.5). ||| • A dose reduction of Ranexa may be needed in combination with: • Moderate CYP3A4 inhibitors (e. g. diltiazem, erythromycin, fluconazole) • P-gp inhibitors (e. g. ciclosporin, quinidine, verapamil) ||| sa • Interactions médicamenteuses Le rimonabant doit être utilisé avec prudence en association aux inhibiteurs puissants du CYP3A4 (par exemple kétoconazole, itraconazole, ritonavir, télithromycine, clarithromycine, nefazodone) (voir rubrique 4.5).
0.11159144341945648 ||| How has Sprycel been studied? ||| How has Zactran been studied? ||| Quelles études ont été menées sur Sprycel?
0.5047099590301514 ||| b Visually inspect the reconstituted solution for particulate matter or discoloration during reconstitution and prior to infusion. ||| - For reconstitution use only the sterilised water for injections and the reconstitution device ||| La solution reconstituée sera examinée visuellement afin de rechercher la présence de particules ou une coloration anormale durant la reconstitution et avant la perfusion.
0.5273343324661255 ||| blood creatinine increased, blood urea increased, renal failure aggravated ||| weight decreased, weight increased, liver function tests abnormal ||| aggravation de l’ insuffisance rénale thrombose au site
0.5294476747512817 ||| In 2018 alone, the European Commission's funding to the United Nations (UN) amounted to €2.9 billion. ||| The European Union remains world's leading donor of Official Development Assistance with €75.2 billion in 2019 ||| Pour la seule année 2018, la contribution de la Commission européenne aux Nations unies s'est élevée à 2,9 milliards d'euros.
0.29842066764831543 ||| Following oral administration, the elimination half-life of emtricitabine is approximately 10 hours. ||| Following an oral dose, the apparent terminal elimination half-life is approximately 6.5 h. ||| Après administration orale, la demi- vie d’ élimination de l’ emtricitabine est d’ environ 10 heures.
0.3661065995693207 ||| Marketing Authorisation Holder and Manufacturer ||| Marketing Authorisation Holder/ Applicant ||| Titulaire de l'autorisation de mise sur le marche et fabricant
0.21546043455600739 ||| You must not breast-feed while on treatment with Faslodex. ||| You should stop breast-feeding while receiving treatment with Temodal. ||| Vous ne devez pas allaiter pendant le traitement par Faslodex.
0.1705402135848999 ||| Uncommon side effects (may occur in more than 1 in 1,000 patients but less that 1 in 100 patients) ||| Uncommon side effects are experienced in less than 1 in 100 patients but in at least 1 per 1,000 patients. ||| Effets indésirables peu fréquents d’ Arava (1 pour 1 000 à moins de 1 patient sur 100):
0.45171600580215454 ||| Generics Uk Limited Albany Gate, Darkes Lane, Potters Bar Herts EN6 1AG United Kingdom ||| Pentagon Park Boundary Way Hemel Hempstead Herts., HP2 7UD United Kingdom. ||| Generics Uk Limited Albany Gate, Darkes Lane, Potters Bar Herts EN6 1AG Royaume-Uni
0.21886980533599854 ||| 10.5 ||| 12.5 ||| 10,5
0.4557509422302246 ||| The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 2 of the Risk Management Plan (RMP) presented in ||| Official batch release: in accordance with Article 114 of Directive 2001/ 83/ EC as amended, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose ||| Le titulaire de l’ AMM s’ engage à réaliser les études et les activités de pharmacovigilance supplémentaires détaillées dans le Plan de Pharmacovigilance, tel qu’ accepté dans la version 2 du Plan
0.48040032386779785 ||| ACE2 receptors are highly expressed in the heart and are involved in heart function. ||| KGF receptors are known to be expressed on the lens of the eye. ||| Les récepteurs de l’ACE 2 sont fortement exprimés dans le cœur et dans les fonctions cardiaques impliquées.
0.5654401183128357 ||| Supply [transport] of water for domestic use ||| Rescue [transport] of vehicles in the water ||| Distribution d'eau à usage domestique [transport]
0.38119128346443176 ||| If you suffer from renal impairment (kidney problems), your doctor should closely monitor your kidney function and if necessary adapt the memantine doses accordingly. ||| Dosage adjustment If you are older than 65 years your doctor may prescribe you a dose based on your kidney function and severity of disease. ||| 62 Si vous souffrez d’ une insuffisance rénale (problèmes aux reins), votre médecin doit surveiller de près votre fonction rénale et si nécessaire adapter les doses de mémantine en conséquence.
0.2244386523962021 ||| Garden sprinklers [automatic] ||| Water sprinkling devices [automatic] ||| Arrosages automatiques de jardins
0.43516701459884644 ||| - muscle pain, inflammation of the joints, increased muscle tone, or cramp ||| - Changes in heart rhythm, flushes, high or low blood pressure, ||| - douleurs musculaires, inflammation des articulations, augmentation du tonus musculaire et
0.2510635554790497 ||| Advertising services relating to the sale of motor vehicles ||| Training services relating to the cleaning of restaurants ||| Services publicitaires dans le domaine de la vente de véhicules à moteur
0.224270299077034 ||| Decreases in haemoglobin and haematocrit, thrombocytopenia, leucopenia/ neutropenia, and cases of agranulocytosis or pancytopenia, have been reported very rarely. ||| Haematological toxicity Very rarely, neutropenia, agranulocytosis, thrombocytopenia and anaemia have been reported in patients receiving ACE inhibitors (see section 4.8). ||| Une diminution de l’ hémoglobine et de l’ hématocrite, une thrombocytopénie, leucopénie/ neutropénie, et des cas d’ agranulocytose ou de pancytopénie, ont très rarement été rapportées.
0.32470250129699707 ||| These include amfetamine, benzatropine, buproprion, cocaine, mazindol, methylphenidate, phentermine and sertraline. ||| Terfenadine, astemizole, cisapride, pimozide, halofantrine and quinidine (CYP3A4 substrates): ||| Ceci inclut les amphétamines, la benzatropine, l’amfébutamone, la cocaïne, le mazindol, le méthylphénidate, la phentermine et la sertraline.
0.19400973618030548 ||| Caution is recommended when nelfinavir is co-administered with other proton pump inhibitors (see section 4.5). ||| Dose adjustments are required when voriconazole is co-administered with efavirenz (see sections 4.2 and 4.4). ||| 23 administré avec d’autres inhibiteurs de la pompe à protons (voir rubrique 4.5).
0.3003252148628235 ||| A syringe is used to inject 5 ml of sterile water for injections into the vial. ||| To reconstitute the vaccine, inject 3 ml of solvent into the small vial with the powder. ||| Utiliser une seringue pour injecter 5 ml d’ eau stérile pour préparations injectables dans le flacon.
0.40262770652770996 ||| Following the approval of the German measures adopted on 22 March 2020 , Germany notified to the Commission an additional support measure under the Temporary Framework, implemented through the German federal and regional authorities, as well as promotional and guarantee banks. ||| This guidance follows the recent publication of the Commission Recommendation on a common EU approach for the use of mobile applications and mobile data, and is accompanying an EU toolbox on contact tracing apps , which is also published today. ||| Après que les mesures allemandes adoptées le 22 mars 2020 ont été autorisées, l'Allemagne a notifié à la Commission une aide supplémentaire au titre de l'encadrement temporaire, mise en œuvre par les autorités fédérales et régionales allemandes, ainsi que par des banques de développement et de cautionnement.
0.3147699236869812 ||| Immunisation shall be postponed in subjects with febrile illness or acute infection. ||| Gastric lavage may be indicated if performed soon after ingestion or in symptomatic patients. ||| La vaccination doit être différée en cas de maladie fébrile ou d'infection aiguë.
0.5653462409973145 ||| Repair of spectacles ||| Reclamation of land ||| Réparation de lunettes
0.33900731801986694 ||| Tell your doctor if you are breast-feeding. ||| Ask your doctor for advice before breast-feeding your baby. ||| Prévenez votre médecin si vous allaitez.
0.07998105883598328 ||| Each ml of solution for infusion contains 10 mg lacosamide. ||| Each ml of solution for infusion contains 2 mg cetuximab. ||| Chaque ml de solution pour perfusion contient 10 mg de lacosamide.
0.4195305109024048 ||| The reconstituted solution should be further diluted within an hour. ||| Allow the reconstituted solution to stand for 5 minutes. ||| La solution reconstituée doit être diluée dans l’ heure qui suit.
0.3635731041431427 ||| Simí: +354 540 8000 ISmail@merck.com ||| Ísland Icepharma hf.Simi: +354 540 8000 ISmail@merck.com ||| Simí: +354 540 8000 ISmail@merck. com
0.2933114171028137 ||| Twinrix Adult is a white, slightly milky liquid presented in a glass vial (1 ml). ||| The Hib component is a white powder presented in a glass vial with Bioset®. ||| Twinrix Adulte est une suspension blanche, légèrement laiteuse présentée dans un flacon en verre (1ml).
0.3630317747592926 ||| Parts of rubber for stirrups ||| Bags of paper for foodstuffs ||| Pièces en caoutchouc pour étriers
0.15695756673812866 ||| 14 Undesirable effects reported in clinical trials or from the post-marketing experience are listed in the following table per body system and per frequency and this is for all age groups. ||| Undesirable effects reported in clinical studies (adults and children) or from post-marketing experience are listed in the following table per System Organ Class and per frequency. ||| Les effets indésirables rapportés lors des essais cliniques ou depuis la mise sur le marché sont listés ci- après par système organe et par fréquence pour tous les groupes d’ âge.
0.061504341661930084 ||| 79 10. ||| 78 10. ||| 89 10.
0.24186283349990845 ||| Waarderweg 39 Postbus 581 2003 PC Haarlem The Netherlands ||| Waarderweg 39 Postbox 581 NL 2031 BN Haarlem The Netherlands ||| Waarderweg 39 Postbus 581 2003 PC Haarlem Pays-Bas
0.5863097310066223 ||| Arranging the distribution of advertising samples ||| Arranging subscriptions to information packages ||| Organisation de la distribution d'échantillons publicitaires
0.25249671936035156 ||| Following an oral dose of 14C-labelled clopidogrel in man, approximately 50% was excreted in the urine and approximately 46% in the faeces in the 120-hour interval after dosing. ||| Patients must also receive an intramuscular injection of vitamin B12 (1000 micrograms) in the week preceding the first dose of pemetrexed and once every three cycles thereafter. ||| Après l'administration par voie orale d'une dose de clopidogrel marqué au 14C chez l'homme, 50% environ de la dose sont éliminés dans les urines et 46% environ dans les selles au cours des 120 heures qui suivent l'administration.
0.2559128403663635 ||| • flushed appearance, inflammation of the throat and nasal passages, swelling of the legs and ankles or other signs of fluid retention, low blood pressure, palpitations, heartburn, tiredness, itching, nausea, anaemia (low blood count). ||| Influenza; blocked nose, sore throat and discomfort when swallowing; headache; swelling of arms, hands, legs, ankles or feet; tiredness; redness and warm feeling of the face and/ or neck. ||| • Sensation de bouffées de chaleur, inflammation de la gorge et des voies nasales, gonflement des jambes et des chevilles, ou d’autres signes d’œdème, chute de la pression artérielle, palpitations, brûlures d’estomac, fatigue, démangeaisons, nausées, anémie (taux de globules rouges faible).
0.18848799169063568 ||| Biodegradable cups ||| Biodegradable knives ||| Tasses biodégradables
0.259928435087204 ||| In study 6, significantly more severe allergic asthma patients on Xolair were able to reduce their fluticasone dose to ≤ 500 micrograms/ day without deterioration of asthma control (60.3%) compared to the placebo group (45.8%, p < 0.05). ||| When a more stringent criterion is considered, which combines both lumbar spine and total hip BMD, 83.9% (p < 0.001) and 65.7% of patients receiving Bondenza 150 mg once monthly or ibandronic acid 2.5 mg daily, respectively, were responders at one year. ||| Dans l’ étude 6, un nombre significativement supérieur de patients atteints d’ asthme allergique sévère traités par Xolair ont pu réduire leur dose de fluticasone à ≤ 500 microgrammes/ jour sans détérioration du contrôle de l’ asthme (60,3%) par rapport aux patients du groupe placebo (45,8%, p < 0,05).
0.02652539126574993 ||| Exforge is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280 tablets and in multipacks comprising 4 cartons, each containing 70 tablets. ||| 73 Dafiro is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280 tablets and in multipacks comprising 4 cartons, each containing 70 tablets. ||| Exforge est présenté dans des emballages contenant 7, 14, 28, 30, 56, 90, 98 ou 280 comprimés ainsi qu’ en conditionnements multiples comprenant 4 boîtes, contenant chacune 70 comprimés.
0.34598830342292786 ||| It is available as prefilled injection pens that provide either 5 or 10 micrograms of exenatide in each dose. ||| In order to avoid injection of large volumes 3 to 4 lyospheres of Puregon may be dissolved in 1 ml of solvent. ||| Il est commercialisé en stylos d’ injection prêts à l’ emploi, contenant 5 ou 10 microgrammes d’ exénatide par dose.
0.43206048011779785 ||| One pre-filled syringe containing 1 ml solution for injection. ||| two alcohol swabs, one pre-filled syringe containing the medicinal product ||| Une seringue préremplie contient 1 ml de solution injectable.
0.11369270086288452 ||| 35/ 41 ||| 34/ 41 ||| 36/ 43
0.34554529190063477 ||| Use in paediatric patients Safety and effectiveness of Trevaclyn in paediatric patients have not been established. ||| Paediatric No studies with sitagliptin have been performed in paediatric patients. ||| Enfants et adolescents La sécurité d'emploi et l’ efficacité de Trevaclyn chez l’ enfant et l’ adolescent n’ ont pas été établies.
0.08626895397901535 ||| Important information about some of the ingredients of Zerene ||| Important information about some of the ingredients of Zonegran ||| Information importante sur les composants de Zerene:
0.4029480814933777 ||| Dry mouth is reported in 10% of patients treated with venlafaxine. ||| 13 Kidney stones have occurred in patients treated with Zonegran. ||| 45 Une sécheresse de la bouche a été rapportée chez 10% des patients traités par la venlafaxine.
0.4159258008003235 ||| However, adding Procoralan to amlodipine did not provide extra benefit. ||| Therefore, co-administration of probenecid with Doribax is not recommended. ||| Toutefois, l’ association de Procoralan avec de l’ amlodipine n’ a pas apporté de bénéfice supplémentaire.
0.6093152761459351 ||| If you forget to use Insulin Humaninthrop Rapid ||| 103 Information on how to use Actrapid InnoLet ||| Si vous oubliez d’ utiliser Insulin Human Winthrop Rapid
0.3934379816055298 ||| Lantus 100 Units/ ml Solution for injection in a pre-filled pen. ||| Insulin Human Winthrop SoloStar is white with a colour on the injection button. ||| Lantus 100 Unités/ ml Solution injectable en stylo prérempli.
0.05109463632106781 ||| Rental of waste compacting machines and apparatus ||| Rental of waste crushing machines and apparatus ||| Location d'appareils et de machines de compactage de déchets
0.8178074359893799 ||| Do not throw away. ||| Inject straight away. ||| Ne le jetez pas.
0.2804364562034607 ||| Biochemical markers of bone turnover (such as urinary CTX and serum Osteocalcin) showed the expected pattern of suppression to premenopausal levels and reached maximum suppression within a period of 3 - 6 months of using 2.5 mg ibandronic acid daily. ||| In case of positive semiquantitative dipstick results (protein > 30 mg/dl), urinalysis should be performed to determine urinary protein creatinine (UPC) ratio, and a blood sample to measure creatinine, albumin and BUN. ||| Comme attendu, il a été observé un retour aux valeurs pré-ménopausiques des marqueurs biochimiques du remodelage osseux (tels que CTX urinaire et ostéocalcine sérique), la réduction maximale étant atteinte en l’ espace de 3 à 6 mois avec l’ acide ibandronique 2,5 mg une fois par jour.
0.42398446798324585 ||| Note for Guidance on evaluation of anticancer medicinal Released for consultation products in man (CPMP/EWP/205/95 rev. ||| EMEA/CPMP/BPWG/1089/00 Note for guidance on the clinical investigation of plasma derived fibrin sealants ||| Points to consider on the evaluation of medicinal products for the treatment of irritable bowel syndrome.
0.432889461517334 ||| The Committee for Medicinal products for Human Use (CHMP) decided that Trizivir’ s benefits are greater than its risks for the treatment of HIV infection in adults. ||| There are also large variations in antibiotic use among EU Member States, as shown by data from the European Surveillance of Antimicrobial Consumption (ESAC) project; ||| Le comité des médicaments à usage humain (CHMP) a décidé que les bénéfices de Trizivir sont supérieurs aux risques qu’ il présente dans le cadre du traitement de l’ infection par le VIH chez les adultes.
0.2299608439207077 ||| 42 10. ||| 42 12. ||| 45 10.
0.6814388632774353 ||| • blister-like lesions on the skin (pustular rashes). ||| - oedema (swelling of the feet or ankles), ||| • lésions cutanées vésiculeuses (éruption pustuleuse).
0.004639690741896629 ||| 277 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 274 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 298 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.2606053650379181 ||| - you are elderly, ||| - if you are elderly. ||| - vous êtes âgé,
0.3680996596813202 ||| EXJADE is also indicated for the treatment of chronic iron overload due to blood transfusions when deferoxamine therapy is contraindicated or inadequate in the following patient groups: ||| Due to overlap with other infections such as adenovirus, imaging without confirmation by PCR is of limited specificity in identifying COVID-19. ||| EXJADE est aussi indiqué dans le traitement de la surcharge en fer chronique secondaire à des transfusions sanguines lorsque le traitement par la déféroxamine est contre-indiqué ou inadapté chez les groupes de patients suivants:
0.3278118968009949 ||| The recommended dosing frequency according to renal function must not be exceeded (see sections 4.4 and 5.2). ||| The duration of treatment with the intravenous formulation should be no longer than 6 months (see section 5.3). ||| La fréquence recommandée des administrations selon la fonction rénale ne doit pas être dépassée (voir rubriques 4.4 et 5.2).
0.4013563096523285 ||| Algarovilla for use in tanning ||| Algarovilla for animal consumption ||| Algarobilla pour la tannerie
0.057485681027173996 ||| Latvija Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820 ||| България Gilead Sciences International Ltd Тел.: + 44 (0) 20 7136 8820 ||| 39 Latvija Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820
0.10874146223068237 ||| Gastrointestinal disorders: ||| Gastro-intestinal disorders: ||| Nausées Douleur abdominale
0.040025144815444946 ||| - if you are a girl or a woman of childbearing age, you must have a negative pregnancy test before treatment, ||| - if you are a girl or a woman of childbearing age, you must have a negative pregnancy test before ||| - si vous êtes une fille ou une femme en âge d’ avoir des enfants, traitée par Viraferon en association à
0.19654548168182373 ||| Ophthalmologic disorders, including retinal haemorrhages, cotton wool spots, and retinal artery or vein obstruction have been reported in rare instances after treatment with alpha interferons (see section 4.8). ||| Cases of retroperitoneal fibrosis, pulmonary infiltrates, pleural effusion, pleural thickening, pericarditis and cardiac valvulopathy have been reported in some patients treated with ergot-derived dopaminergic agents. ||| Des troubles oculaires comprenant des hémorragies rétiniennes, des nodules cotonneux, et des occlusions de l'artère ou de la veine rétinienne ont été rarement rapportés après
0.8372698426246643 ||| Dysuria ||| Insuman Rapid ||| Dysurie
0.26319196820259094 ||| How to use Quixidar ||| How to use Viraferon ||| Comment utiliser Quixidar
0.1791321188211441 ||| 30 mg ||| 20 mg ||| 15 mg
0.07811334729194641 ||| Lantus should not be used in people who may be hypersensitive (allergic) to insulin glargine or to any of the other ingredients. ||| Insuman should not be used in people who may be hypersensitive (allergic) to insulin human or any of the other ingredients. ||| Lantus ne doit pas être utilisé chez les personnes présentant une hypersensibilité (allergie) à l’ insuline glargine ou à l’ un des autres ingrédients.
0.26928699016571045 ||| Educational services relating to first aid ||| Educational services relating to brewing ||| Services de formation en matière de premiers soins
0.5440731048583984 ||| This can sometimes lead to serious medical conditions. ||| Some of these cases can be fatal. ||| Cela peut conduire parfois à de graves problèmes médicaux.
0.5060720443725586 ||| Occlusive dressings are not recommended. ||| Injection needles are not included. ||| Les pansements occlusifs ne sont pas recommandés.
0.20274454355239868 ||| - Please speak with your doctor if you have a history of liver disease. ||| Consult your doctor if you have a history of kidney disease. ||| - Veuillez informer votre médecin si vous avez des antécédents de maladie du foie.
0.29865288734436035 ||| There are no clinically relevant differences in serum insulin or glucose levels after abdominal, deltoid or thigh administration of Lantus. ||| Further in vitro studies suggest that metabolism of iloprost in the lungs is similar after intravenous administration or inhalation. ||| On n’ a pas observé de différences cliniques notables sur le plan des taux sériques d’ insuline et de glucose, suivant que Lantus est administré dans l'abdomen, la région deltoïde ou la cuisse.
0.8412331342697144 ||| AUC: ↓ 50% Norbuprenorphine: ||| of Meningitec** or Menjugate** N=96 ||| ASC: ↓ 50% Norbuprénorphine:
0.2534300982952118 ||| For instructions on how to look after your insulin inhaler see “Instructions for Use” at the end of the package leaflet. ||| Detailed instructions for the use of the product is provided with the package leaflet (refer to “How to self inject IntronA”). ||| Pour les instructions d’ entretien de votre inhalateur d’ insuline, veuillez vous reporter aux « Instructions d’ Utilisation » à la fin de la notice.
0.24188455939292908 ||| In the first study, 19% of the patients adding the approved dose of Rapamune had failed treatment after six months (53 out of 284), compared with 32% of those adding azathioprine (52 out of 161). ||| In invasive candidiasis, 73% of the adults treated with Cancidas who could be assessed had a favourable response (80 out of 109), compared with 62% of the adults treated with amphotericin B (71 out of 115). ||| Dans la première étude, chez 19% (53 sur 284) des patients ayant ajouté la dose approuvée de Rapamune, le traitement avait échoué à six mois, contre 32% (52 sur 161) des patients ayant ajouté l’ azathioprine.
0.5505433678627014 ||| A List of Questions was adopted by CVMP and sent to the applicant on 12 December 2007. ||| The CHMP adopted a List of Questions (LoQ) to be addressed by the Applicant. ||| Une liste de questions a été adoptée par le CVMP et envoyée au demandeur le 12 décembre 2007.
0.2013796865940094 ||| Can be used during pregnancy and lactation. ||| Do not use during pregnancy and lactation. ||| Peut être utilisé pendant la gestation et la lactation.
0.49720749258995056 ||| Psychiatric Disorders Insomnia (10.4%) 1 ||| General Disorders and Administration Site Conditions Fatigue (10.9%) ||| Affections psychiatriques Insomnie
0.3801782429218292 ||| During its meeting on 18-21 September 2006 the CHMP, having considered the Rapporteur and the Co-Rapporteur assessment reports, the scientific discussion within the Committee and the comments from the Marketing Authorisation Holders (MAH), was of the opinion that the benefit/ risk ratio of Agopton and associated names is considered to be positive for the following indications: ||| During its April 2005 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Crestor 5 mg or Crestor 10 mg as start dose. ||| Au cours de sa réunion tenue du 18 au 21 septembre 2006, le CHMP, sur la base de la discussion scientifique menée en son sein, des rapports d’ évaluation du rapporteur et du co-rapporteur, et des commentaires fournis par les titulaires de l’ autorisation de mise sur le marché (TAMM), a considéré que le profil bénéfice/ risque d’ Agopton et des dénominations associées était favorable pour les indications suivantes:
0.3791671395301819 ||| Haematological improvement (major or minor) as determined by the IRC was achieved in 49% of patients receiving azacitidine compared with 29% of patients treated with combined CCR (p < 0.0001). ||| The secondary endpoint, PFS, demonstrated a 29% risk reduction of progression or death and a 22 month improvement in median PFS (35.5 months for TPF and 13.1 for PF). ||| Une amélioration hématologique (majeure ou mineure) déterminée par le CRI a été obtenue chez 49% des patients sous azacitidine contre 29% des patients les groupes sous CCR poolés (p < 0,0001).
0.3675892949104309 ||| If you do not get adequate pain relief from one tablet your doctor may ask you to take two tablets to treat an episode of breakthrough pain. ||| If you stop using AZOPT without speaking to your doctor, the pressure in your eye will not be controlled which could lead to loss of sight. ||| Si un comprimé ne suffit pas à obtenir un soulagement adéquat de la douleur, votre médecin pourra vous demander de prendre deux comprimés pour traiter un accès douloureux paroxystique.
0.23671452701091766 ||| • 13.2.2002 • 210 days • 183 days ||| • 19.07.00 • 195 days • 321 days ||| 16.1.2001 13.2.2002 210 jours 183 jours
0.36720240116119385 ||| Therefore, it is important to consider this diagnosis in patients who present with diarrhoea during or shortly following treatment. ||| As demodicosis is a multi-factorial disease, where possible, it is advisable to also treat any underlying disease appropriately. ||| Il est donc important d’ évoquer ce diagnostic chez les patients présentant une diarrhée, pendant ou peu de temps après le traitement.
0.6101046800613403 ||| Commercial information agency services ||| Inventory management services ||| Services d'agences d'informations commerciales
0.01153876818716526 ||| 80 Incidence of undesirable effects considered related to treatment with Nespo from controlled clinical studies are: ||| 56 Incidence of undesirable effects considered related to treatment with Nespo from controlled clinical studies are: ||| L'incidence des effets indésirables considérés comme étant reliés au traitement par Nespo dans les études cliniques contrôlées est: am
0.18309351801872253 ||| Oral bioavailability may be limited in paediatric patients aged 2- < 12 years with malabsorption and very low body weight for age. ||| Oral bioavailability may, however, be limited in paediatric patients with malabsorption and very low body weight for their age. ||| La biodisponibilité orale peut être limitée chez les enfants âgés de 2 ans à moins de 12 ans qui souffrent de malabsorption et qui présentent un très faible poids corporel pour leur âge.
0.07988223433494568 ||| Each hard capsule contains 2 50 mg temozolomide ||| Each hard capsule contains 100 mg temozolomide ||| Chaque gélule contient 250 mg de témozolomide
0.23322728276252747 ||| It is mainly in cells infected by virus that the mechanism of replication is stopped both by destruction of mRNA and by inactivation of translation proteins (2'5 'oligo-adenylate synthetase activation). ||| It is considered that there are multiple mechanisms responsible for resistance development to macrolide compounds: namely alteration of the ribosomal target site, utilisation of active efflux mechanism and production of inactivating enzymes. ||| C’ est essentiellement dans les cellules infectées par le virus que le mécanisme de réplication est stoppé à la fois par destruction des mRNA et par inactivation des protéines de traduction (activation de la 2’ 5’ oligo-adénylate synthétase).
0.48530250787734985 ||| Sulphamethoxazole/ Trimethoprim 800 mg/ 160 mg BID (maraviroc 300 mg BID) ||| 540mg of Norfloxacin pivaloil-oxy- methyl-ester as 400mg of Norfloxacin ||| Sulfaméthoxazole/ Triméthoprime 800 mg/ 160 mg deux fois
4.541478955052969e-13 ||| The physician should be consulted when using other medications in addition to Liprolog Mix50. ||| The physician should be consulted when using other medications in addition to Liprolog Mix50. ||| 28 Le médecin doit être consulté en cas de prise simultanée d'autres médicaments avec Liprolog Mix50.
0.12248910963535309 ||| The active substance is fentanyl. ||| The active substance is pregabalin. ||| La substance active est le fentanyl.
0.817490816116333 ||| 9/ 30 Hypercalcemia of malignancy: ||| AIDS-related Kaposi’s sarcoma: ||| Hypercalcémie d’ origine maligne:
0.2773910164833069 ||| Patients with severe hepatic impairment must be carefully monitored for drug toxicity (see also section 4.8). ||| Suspension or modification of therapy should be considered when drug-induced bone marrow depression is detected (see section 4.2). ||| Les insuffisants hépatiques graves doivent être étroitement surveillés en raison de la toxicité du médicament (voir aussi rubrique 4.8).
0.4665834605693817 ||| Mechanism of action Tocilizumab binds specifically to both soluble and membrane-bound IL-6 receptors (sIL-6R and mIL-6R). ||| FORSTEO (rhPTH(1-34)) is the active fragment (1-34) of endogenous human parathyroid hormone. ||| Mécanisme d’ action Le tocilizumab se lie de manière spécifique aux récepteurs solubles et membranaires de l’ IL-6 (sIL-6R et mIL-6R).
0.10518133640289307 ||| Shock absorbing cylinders [parts of machines] ||| Shock absorber plungers [parts of machines] ||| Cylindres pour amortisseurs [pièces de machines]
0.013842904940247536 ||| 20 150 IU/ kg 3x/ week or 450 IU/ kg once weekly ||| 140 150 IU/ kg 3x/ week or 450 IU/ kg once weekly ||| 20 150 UI/ kg 3 x/ semaine ou 450 UI/ kg 1 x/ semaine
0.40943798422813416 ||| These increases could be associated with jaundice. ||| The effect of pressor amines may be decreased. ||| Ces élévations peuvent être associées à un ictère.
0.1479920744895935 ||| The table below gives the frequency of treatment emergent adverse reactions from placebo-controlled clinical trials. ||| The table below shows the frequencies of adverse reactions which have been reported in pooled placebo-controlled clinical trials. ||| Le tableau ci-dessous présente la fréquence des effets indésirables rapportés lors des essais cliniques contrôlés par placebo.
5.196451450563411e-13 ||| Sustained virological response rates in children and adolescents were similar to those in adults. ||| Sustained virological response rates in children and adolescents were similar to those in adults. ||| 20 prolongée chez les enfants et les adolescents sont similaires à ceux observés chez l’ adulte.
0.28237879276275635 ||| Unprocessed herbs ||| Processed herbs ||| Herbes à l'état brut
0.32498133182525635 ||| In animal studies glucocorticoids have been shown to induce malformations including cleft palate and intra-uterine growth retardation. ||| However, in preclinical wound healing models EGFR selective tyrosine kinase inhibitors were shown to retard wound healing. ||| Des études effectuées chez l'animal ont montré la survenue de malformations avec fente palatine et des retards de croissance intra-utérine.
0.41052788496017456 ||| It is given by subcutaneous injection (under the skin). ||| Raptiva is given by injection under the skin. ||| Luveris est administré par voie sous-cutanée (sous la peau).
0.49775606393814087 ||| Also upon the urgent request of the Commission, the European Committee for Standardization (CEN) and the European Committee for Electrotechnical Standardization (CENELEC), in cooperation with their members made available a number of European standards for certain medical devices and personal protective equipment. ||| Close relations will be maintained with the Commission services responsible for overseeing the financial activities of the Agency (Directorates-General for Personnel and Administration DG IX and for Budget DG XIX), with the Committees on Budgets and Budgetary Control of the European Parliament, with the Council’s Budgetary Committee and the European Court of Auditors. ||| À la demande pressante de la Commission également, le Comité européen de normalisation (CEN) et le Comité européen de normalisation électrotechnique (CENELEC), en coopération avec leurs membres, ont mis à disposition une série de normes européennes relatives à certains dispositifs médicaux et équipements de protection individuelle.
0.6631872653961182 ||| Pfizer Limited pr ||| ed Pfizer Ltd. ||| Pfizer Limited am
0.3190150260925293 ||| Microporous synthetic sheets for use in manufacture ||| Elastomeric polymers for use in manufacture ||| Feuilles synthétiques microporeuses destinées à la fabrication
0.42958807945251465 ||| The Commission welcomes today's votes by the European Parliament which allow for the rapid implementation of a number of Commission proposals to tackle the coronavirus crisis. ||| Today's Communication confirms the guidance given by European authorities [1] and international bodies [2] regarding the flexibility in the EU's current accounting rules and prudential requirements. ||| La Commission se félicite des votes intervenus aujourd'hui au Parlement européen, grâce auxquels un certain nombre de propositions de la Commission visant à faire face à la crise du coronavirus pourront être mises en œuvre rapidement.
0.20672741532325745 ||| 25 May 2005 ||| 24 August 2005 ||| 25 mai 2005
0.30250686407089233 ||| Do not remove the cover from the syringe until you are ready to inject. ||| You should only open the sachet when you are ready to apply the patch. ||| Ne retirez pas le capuchon de la seringue avant d’ être prêt à injecter.
0.0 ||| Vaccines work by ‘ teaching’ the immune system (the body’ s natural defences) how to defend itself against diseases. ||| Vaccines work by ‘ teaching’ the immune system (the body’ s natural defences) how to defend itself against diseases. ||| Les vaccins « apprennent » au système immunitaire (les défenses naturelles de l’ organisme) à se défendre contre les maladies.
0.30188897252082825 ||| The active substance is choriogonadotropin alfa, each vial contains 285 micrograms. ||| The syringes contain 8.8, 22 or 44 micrograms of the active substance, interferon beta-1a. ||| La substance active est la choriogonadotropine alfa; chaque flacon contient 285 microgrammes.
0.30696481466293335 ||| In another clinical trial, non-responder patients with advanced fibrosis or cirrhosis (Ishak score of 3 to 6) and baseline platelet counts as low as 50,000/ mm3 were treated for 48 weeks. ||| 102 Data on clinical efficacy in patients with glioblastoma multiforme (Karnofsky performance status [KPS] ≥ 70), progressive or recurrent after surgery and RT, were based on two clinical trials with oral TMZ. ||| Dans une autre étude clinique, des patients non-répondeurs avec une fibrose sévère ou une cirrhose (Score d’ Ishak de 3 à 6) et une numération plaquettaire initiale basse de 50 000/ mm3 ont été traités pendant 48 semaines.
0.4031260311603546 ||| Marketing Authorisation Holder SP Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgium. ||| UCB Pharma SA (Brussels) Allée de la Recherche, 60 B-1070 Brussels ||| Titulaire de l’ Autorisation de mise sur le marché SP Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgique.
0.17082375288009644 ||| Tables adapted for use by those with mobility difficulties ||| Chairs adapted for use by those with mobility difficulties ||| Tables conçues pour les personnes à mobilité réduite
0.39313018321990967 ||| There are limited safety and tolerability data for administration of the capsule contents in paediatric patients. ||| These dose recommendations for lung, pancreas and intestinal transplantation are based on limited prospective clinical trial data. ||| Les données de sécurité et de tolérance concernant l'administration du contenu de la gélule chez les patients pédiatriques sont limitées.
0.25447386503219604 ||| Viraferon alone or in combination with ribavirin has been studied in 4 randomised Phase III clinical trials in 2,552 interferon-naïve patients with chronic hepatitis C. ||| In a randomised, double-blind study of micafungin versus fluconazole in the first-line treatment of oesophageal candidiasis, 518 patients received at least a single dose of study drug. ||| Viraferon seul ou en association avec la ribavirine a été étudié au cours de 4 études cliniques randomisées de Phase III chez 2.552 patients naïfs à l’ interféron atteints d’ une hépatite C e
0.2647078037261963 ||| Common side effects (occurring in less than 1 out of 10 patients) are bleeding from the stomach or the intestines and bleeding from the nose, and eye irritation due to keratitis. ||| In more severe cases symptoms may include enlargement of the ovaries, accumulation of fluid in the abdomen and/ or chest, weight gain and the occurrence of blood clots in the circulation. ||| Effets indésirables fréquents (apparaissant chez moins de 1 patient sur 10): saignements de l’estomac ou des intestins, et saignements de nez et irritation des yeux due à une kératite.
0.44218096137046814 ||| IntronA is available in six different pack sizes: ||| RotaTeq is available in pack size of 1, 10. ||| IntronA est disponible sous six présentations différentes:
0.4587843418121338 ||| - Try to give yourself the injection at the same time each day. ||| It should be administered at the same time each day. ||| - Essayez de réaliser l’injection à heure fixe.
0.31859689950942993 ||| The measure of effectiveness was the production of protective levels of antibodies against tetanus toxoid after vaccination. ||| Dogs were poisoned by intravenous administration of a lethal dose of potassium cyanide. ||| La production de niveaux protecteurs d’ anticorps contre le toxoïde de tétanos après vaccination constituait la mesure d’ efficacité.
0.3475680351257324 ||| Abraxane is a white to yellow powder for suspension for infusion available in glass vials containing 100 mg paclitaxel. ||| REYATAZ oral powder is supplied in bottles containing 180 g of powder together with a plastic measuring spoon. ||| Abraxane est une poudre blanche à jaune pour suspension injectable par perfusion disponible dans des flacons de verre contenant 100 mg de paclitaxel.
0.35333913564682007 ||| A new Recovery and Resilience Facility of €560 billion to be used for investments and reforms for recovery and resilience, including in relation to the green and digital transitions, in line with the objectives identified in the European Semester. ||| Provision of regulatory input and advice to the European Commission ’ s DG Research on innovation and technology platforms for human and veterinary medicines, aimed at supporting innovation and facilitating the availability of medicines. ||| une nouvelle facilité pour la reprise et la résilience, dotée de 560 milliards €, à utiliser pour des investissements et des réformes favorisant la reprise et la résilience, notamment en ce qui concerne les transitions écologique et numérique, conformément aux objectifs définis dans le cadre du Semestre européen.
0.5882874131202698 ||| The medicine can only be obtained with a prescription. lp ||| This is to be returned to the pharmacist for disposal. ||| Le médicament n'est délivré que sur ordonnance.
0.20772066712379456 ||| Keep the needle under the skin for at least 6 seconds to make sure the entire dose is injected. ||| You must keep the needle in the skin and press down the injection button for at least 10 seconds. ||| tp Après l'injection, l'aiguille doit demeurer sous la peau pendant au moins 6 secondes pour garantir l’ injection de la totalité de la dose.
3.7544598506522586e-13 ||| 4 Observed for fasting normal levels at baseline (< 5.56 mmol/ l) which increased to high (≥ 7 mmol/ l). ||| 4 Observed for fasting normal levels at baseline (< 5.56 mmol/ l) which increased to high (≥ 7 mmol/ l). ||| 121 4 Observée pour des taux à jeun normaux au début de traitement (< 5.56mmol/ l) qui sont devenus élevés (≥ 7mmol/ l).
0.28658682107925415 ||| Swaging machines for use in the assembly of hoses ||| Holders for use in the securing of window coverings ||| Machines à rétreindre destinées à l'assemblage de tuyaux
0.3135652542114258 ||| What Irbesartan Hydrochlorothiazide Winthrop contains ||| Irbesartan Hydrochlorothiazide Winthrorp ||| Que contient Irbesartan Hydrochlorothiazide Winthrop
0.05459477752447128 ||| 9 July 2001 Date of first renewal: ||| 27 July 2000 Date of first renewal: ||| 9 juillet 2001 Date du premier renouvellement:
0.9821813106536865 ||| Relative Risk (95% CI) ||| Overall Response Rate (%): ||| Risque relatif (IC à 95%)
0.6509130597114563 ||| - Albumin ≥ 25 g/ l. ||| th (7.5 mmol/ l). ||| Albumine ≥ 25 g/ l.
0.32892856001853943 ||| Hypertension The recommended starting dose of Diovan is 80 mg once daily. ||| The recommended starting dose is 25 mg Risperdal Consta every two weeks. ||| Hypertension La posologie initiale recommandée de Diovan est de 80 mg une fois par jour.
0.0 ||| Januvia can be taken with or without food. ||| Januvia can be taken with or without food. ||| 15 Januvia peut être pris au cours ou en dehors des repas.
0.26542574167251587 ||| 29 Me dic ina lP rod uc t ||| 15 Me dic ina lp rod uc ||| 29 Ce mé dic am ent
0.3080744445323944 ||| However, if it is time for your next dose, skip the missed dose and take only a single dose as usual. ||| However, if your child misses a dose, just resume the usual schedule of one sachet once daily. ||| de la dose suivante, sautez la dose omise et prenez uniquement la dose normale, comme d'habitude.
0.385944128036499 ||| Doses (in mg/ kg) must be calculated and rounded to the nearest whole tablet size. ||| For smaller or higher weights, a precise calculation should be performed (2 ml/ 10 kg). ||| Les doses (en mg/ kg) doivent être calculées et arrondies au comprimé le plus proche.
0.047474563121795654 ||| Pink oval-shaped, marked "GS" on one side and "GYG" on the other. ||| Yellow oval-shaped, marked "GS" on one side and "TES" on the other. ||| Comprimé rose, de forme ovale, gravé « GS » sur une face et « GYG » sur l’ autre face.
0.07944616675376892 ||| Retacrit 3000 IU/ 0.9ml solution for injection in pre-filled syringe ||| Retacrit 30000 IU/ 0.75ml solution for injection in pre-filled syringe ||| Retacrit 3 000 UI/ 0,9 ml solution injectable en seringue préremplie
5.820764334939221e-13 ||| Keep the pre-filled pen in the outer carton in order to protect from light. ||| Keep the pre-filled pen in the outer carton in order to protect from light. ||| Conserver le stylo pré-rempli dans l'emballage extérieur à l’ abri de la lumière.
0.22568538784980774 ||| What YENTREVE contains The active substance is duloxetine. ||| What ISENTRESS contains The active substance is raltegravir. ||| Que contient YENTREVE La substance active est la duloxétine.
0.309781551361084 ||| Although the policy is to buy industrial standard software where possible, the unique position of the EMEA requires specific development in several areas such as tracking of applications, finance monitoring, tracking of business processes, etc. ||| The sector brings together a number of services that were previously under different responsibilities within the EMEA, in particular facilities management, archiving, reprographics and mail room services. ||| La politique suivie consiste à acheter des logiciels standard dans la mesure du possible, mais le caractère unique de l’EMEA nécessite des programmes particuliers dans plusieurs domaines tels que le suivi des demandes, le contrôle financier, le suivi des processus de gestion, etc.
0.3205643892288208 ||| Inovelon was not teratogenic in mice, rats or rabbits. ||| Tekturna was not teratogenic in rats or rabbits (see section 5.3). ||| Inovelon ne s’ est pas avéré tératogène pour les souris, les rats et les lapins.
0.2592643201351166 ||| Once endorsed by the Council, it will allow Member States to undertake measures to deal adequately with the crisis, while departing from the budgetary requirements that would normally apply under the European fiscal framework. ||| The Commission has therefore insisted that Member States refrain from adopting/implementing such untargeted national measures and requested that they cooperate for implementation of an effective EU-wide approach, based on solidarity among Member States. ||| Une fois approuvée par le Conseil, cette activation permettra aux États membres de prendre des mesures afin de faire face de manière adéquate à la crise, tout en dérogeant aux obligations budgétaires qui s'appliqueraient normalement au titre du cadre budgétaire européen.
0.25772279500961304 ||| Hypersensitivity to ibandronic acid or to any of the excipients. ||| Hypersensitivity to reteplase, polysorbate 80 or any of the other ingredients. ||| Hypersensibilité à l’ acide ibandronique ou à l’ un des excipients.
0.09625913202762604 ||| What Micardis looks like and contents of the pack ||| What Janumet looks like and contents of the pack ||| Qu’ est -ce que Micardis et contenu de l’ emballage extérieur
0.0026459763757884502 ||| 54 In patients with chronic renal failure and clinical evidence of ischaemic heart disease or congestive heart failure, the target haemoglobin should be determined individually. ||| 66 In patients with chronic renal failure and clinical evidence of ischaemic heart disease or congestive heart failure, the target haemoglobin should be determined individually. ||| pl Chez les patients insuffisants rénaux chroniques présentant des manifestations cliniques d'ischémie st myocardique ou d'insuffisance cardiaque congestive, le taux d'hémoglobine à atteindre doit être déterminé individuellement.
0.14132636785507202 ||| Amusement park services with a theme of films ||| Amusement park services with a theme of television productions ||| Services de parcs d'attractions ayant un thème de films
0.2941587567329407 ||| Clinical pharmacology ||| Human pharmacology ||| Pharmacologie clinique:
0.38536909222602844 ||| Hydrocortisone aceponate Miconazole as nitrate Gentamicin as sulphate ||| Orbifloxacin Mometasone furoate (as monohydrate) Posaconazole ||| Acéponate d’ hydrocortisone Nitrate de miconazole Sulphate de gentamicine
0.3883707523345947 ||| Keep this leaflet for future reference each time you use OptiSet. ||| Read the package leaflet fully before using OptiSet for the first time. ||| Gardez cette notice pour vous y référer à chaque fois que vous utiliserez OptiSet.
0.3669202923774719 ||| Uncommonly, in some patients bone damage in the jaw (osteonecrosis) may occur. ||| - Occlusion in the connection between artery and vein (shunt thrombosis) may occur especially if ||| Peu fréquemment, une lésion osseuse de la mâchoire (ostéonécrose) peut survenir chez certains patients.
0.38861680030822754 ||| No overall differences in safety or effectiveness were observed between these patients and younger patients. ||| No clinically significant differences were seen when the safety data were analysed by gender or race. ||| Aucune différence globale de tolérance ou d’ efficacité n’ a été observée entre ces patients et des patients plus jeunes.
0.6815876364707947 ||| Common (1/ 100, < 1/ 10) ||| Genotype 2/ 3/ 4 (n=26) ||| (1/ 100, < 1/ 10)
0.30795979499816895 ||| L01BC05 ||| G03XC01 ||| L01BC05.
0.2208223044872284 ||| The deltoid muscle is the preferred site for injection in children and adolescents. ||| The upper arm muscle is the preferred site for injection in adults. ||| Chez les enfants et les adolescents, l'injection se fera de préférence dans le muscle deltoïde.
0.4684715270996094 ||| Therefore treatment is intended to be administered by a healthcare provider (see section 6.6). ||| For medical or healthcare professionals, more detailed direction for the proper use of Keppra is provided in section 6. ||| Aussi, le médicament devra être administré par un professionnel de santé (voir rubrique 6.6).
0.44225049018859863 ||| This intends to boost public health emergency preparedness and response work in countries with weak health systems and limited resilience. ||| 1. protecting people in the EU from serious cross-border health threats and improving crisis management capacity; ||| Cela vise à renforcer la préparation et la réponse aux situations d'urgence en matière de santé publique dans les pays où les systèmes de santé sont faibles et dont la résilience est limitée.
0.31360453367233276 ||| For additional information on the effect of ritonavir on co-administered protease inhibitor metabolism, see section 4.5 and refer to the Summary of Product Characteristics of the particular co-administered PIs. ||| For information concerning special warnings and precautions for use of Yttrium (90Y)-labelled medicinal products refer to the Summary of Product Characteristics/ package leaflet of the medicinal product to be radiolabelled. ||| Pour plus d’informations sur les effets du ritonavir sur le métabolisme des inhibiteurs de protéase co-administrés, se reporter à la rubrique 4.5 et au résumé des caractéristiques du produit des IPs co-administrés.
0.13616515696048737 ||| Upon oral administration a steady state is reached after the second treatment day and no accumulation occurs after multiple dosing. ||| After multiple oral administration, steady state is reached after the first dosing and no accumulation occurs in dogs. ||| Après administration orale, un état d’ équilibre est atteint après le second jour de traitement et il n’ y a pas d’ accumulation après administration répétée.
0.41088131070137024 ||| Re-introduction of treatment: ||| Discontinuation of treatment: ||| Réintroduction de Thelin:
0.29724985361099243 ||| What is MIRCERA? ||| What is VIRAMUNE? ||| Qu’ est -ce que MIRCERA?
0.38186612725257874 ||| migraine, headache, feeling sick (nausea), diarrhoea, constipation, upper abdominal pain, excessive sweating (hyperhidrosis), back pain, tiredness, anxiety, increased levels of liver enzymes in your blood. ||| diabetes mellitus, gout, anorexia, decreased appetite, decreased weight, increased weight, hyperglycaemia, insulin resistance, decreased high density lipoprotein, increased appetite, polydipsia, increased blood lactate dehydrogenase ||| (insomnie), migraine, mal de tête, envie de vomir (nausée), diarrhée, constipation, douleur abdominale haute, transpiration excessive (hyperhidrose), mal de dos, fatigue, anxiété, augmentation des taux sanguins des enzymes du foie.
0.5321434736251831 ||| Automobile repair and maintenance ||| Architectural and engineering services ||| Réparation et/ou entretien d'automobiles
0.3134629726409912 ||| 22 Pregnancy and breast-feeding The effect of ECALTA in pregnant women is not known. ||| The effect of ECALTA in breast-feeding women is not known. ||| Les effets d’ ECALTA sur la femme enceinte ne sont pas connus.
0.2570623755455017 ||| Rifampicin is a potent CYP3A4 inducer. ||| Amprenavir is a substrate of and inhibits CYP3A4. ||| La rifampicine est un inducteur puissant du CYP3A4.
2.841604447405277e-13 ||| The use of this veterinary medicinal product is only allowed under the particular conditions established by European Community legislation on the control of Avian Influenza. ||| The use of this veterinary medicinal product is only allowed under the particular conditions established by European Community legislation on the control of Avian Influenza. ||| L’ utilisation de ce médicament vétérinaire n’ est autorisée que sous certaines conditions définies par la législation communautaire européenne sur le contrôle de l’ influenza aviaire.
0.03235676512122154 ||| 184 If re-treatment with Enbrel is indicated, the above guidance on treatment duration should be followed. ||| If re-treatment with Enbrel is indicated, the above guidance on treatment duration should be followed. ||| Si la reprise du traitement par Enbrel est indiquée, le schéma de durée de traitement décrit ci-dessus doit être suivi.
0.44256484508514404 ||| Compared to the two control groups that received either Menitorix or MMR alone the immune responses to the antigens in both vaccines were not affected by concomitant administration. ||| These units are exclusive to Apidra and are not the same as IU or the units used to express the potency of other insulin analogues. ||| Comparé aux deux groupes contrôles ayant reçu soit Menitorix soit le ROR seul, les réponses immunitaires aux antigènes des deux vaccins n’ ont pas été affectées par cette administration simultanée.
0.21712557971477509 ||| Apparatus for use in the repair of bones ||| Apparatus for use in the prevention of snoring ||| Appareils destinés à la reconstruction des os
0.05563634634017944 ||| 50% of the insulin lispro in Humalog Mix50 Pen is available in a suspension together with protamine sulphate, so that its action is prolonged. ||| The insulin lispro in Humalog BASAL Pen is available in a suspension together with protamine sulphate, so that its action is prolonged. ||| Humalog Mix50 Pen contient 50% d'insuline lispro en suspension avec du sulfate de protamine; son action est donc prolongée.
0.1596718281507492 ||| Arthralgia Myalgia Muscle spasm Back pain Muscular weakness ||| Arthralgia Myalgia Pain in extremity Muscle spasm Back pain Bone pain ||| Arthralgie Myalgie Spasme musculaire Dorsalgie Faiblesse musculaire Fatigue/ Asthénie
0.4635191857814789 ||| Handle bar grips [parts of motorcycles] ||| Jewelry cases [caskets or boxes] ||| Poignées de guidons [pièces de motocyclettes]
0.0541701465845108 ||| 7.5 events/1,000 patient-years, diet alone 12.7 events/1,000 patient-years, p=0.017; ||| 7.5 events/ 1000 patient-years, diet alone12.7 events/ 1000 patient-years, p=0.017; ||| 7,5 événements pour 1 000 années-patients, régime seul 12,7 événements pour 1 000 années- patients, p=0,017;
0.020948270335793495 ||| AUC: ↓ 38% (↓ 28 to ↓ 47) Cmax: ↓ 32% (↓ 15 to ↓ 46) Cmin: ↓ 45% (↓ 31 to ↓ 56) Efavirenz: ||| AUC: ↓ 39% (↓ 27 to ↓ 50) Cmax: ↓ 29% (↓ 15 to ↓ 40) Cmin: ↓ 46% (↓ 31 to ↓ 58) Efavirenz: ||| ASC: ↓ 38% (↓ 28 à ↓ 47) Cmax: ↓ 32% (↓ 15 à ↓ 46) Cmin: ↓ 45% (↓ 31 à ↓ 56) Efavirenz:
0.6011890172958374 ||| ADVERSE REACTIONS ||| UNDESIRABLE EFFECTS ||| EFFETS SECONDAIRES
0.2355264574289322 ||| Polska Pfizer Polska Sp. z o. o. ||| Polska Roche Polska Sp.z o.o. ||| Polska Pfizer Polska Sp. z o.o.
0.48446977138519287 ||| Treatment should be reserved for patients in whom it is considered of particular importance to avoid homologous blood transfusion taking into consideration the risk/ benefit assessment for homologous transfusions. ||| Social distancing (also known as physical distancing) includes infection control actions intended to slow the spread of disease by minimizing close contact between individuals. ||| Le traitement par NeoRecormon doit être réservé aux malades pour lesquels il est particulièrement important d’ éviter le recours aux transfusions homologues en tenant compte du rapport bénéfice/ risque de la transfusion homologue.
0.1316007822751999 ||| 221 4.4 Special warnings and precautions for use ||| 4.4 Special warnings and precautions for use ct ||| Mises en garde spéciales et précautions d’ emploi
0.0 ||| If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered. ||| If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered. ||| Chez ces patients, en cas d'aggravation confirmée de l'atteinte hépatique, l'interruption ou l'arrêt du traitement devra être envisagé.
0.1366385817527771 ||| 23 1. ||| 21 1. ||| 27 1.
0.38780367374420166 ||| On this basis, the Commission has approved the measure under EU State aid rules. ||| In 2013, the European Commission issued a guidance document to assist EU countries in this process. ||| Sur cette base, la Commission a autorisé la mesure en vertu des règles de l'UE en matière d'aides d'État.
0.1530907154083252 ||| Biograstim does not contain any preservative. ||| Tevagrastim does not contain any preservative. ||| Biograstim ne contient aucun conservateur.
0.5356630086898804 ||| Patients should be warned to report any febrile illness to their physicians. ||| Those having contact with or exposure to such a patient are required to wear a mask. ||| Les patients doivent être avertis qu’ il convient d’ informer leur médecin de toute maladie fébrile.
0.5206589698791504 ||| This level is about 1/ 100 the mean concentration measured in male rats. ||| * Important: these inclusion rates are assumes a pig eats equivalent of 5% bodyweight per day. ||| Ce taux correspond environ au 1/ 100 de la concentration moyenne mesurée chez le rat mâle.
0.3405855894088745 ||| Based on the available information and a literature search, no major safety issue seems to be associated with the administration of gabapentin. ||| The grounds for the referral were concerns regarding that there was not enough data showing that Sabumalin is equivalent to the reference medicine. ||| À partir des informations disponibles et d’ une recherche dans les publications existantes, aucun problème majeur afférent à la sécurité ne semble associé à l’ administration de la gabapentine.
0.022752974182367325 ||| Even with the first dose, there is a small chance that you may experience a severe allergic reaction with the following symptoms: tightness in the chest, feeling dizzy, sick or faint, or experiencing dizziness when standing up. ||| Even with the first dose, there is a rare chance that you may experience a severe allergic reaction with the following symptoms: tightness in the chest, feeling dizzy, feeling sick or faint, or experience dizziness on standing. ||| Dès la première dose, il existe un faible risque de survenue de réaction allergique sévère, se manifestant par les symptômes suivants: oppression dans la poitrine, vertiges, nausées ou évanouissements, ou vertiges lors du passage en position debout.
0.24527069926261902 ||| What Thelin tablets look like and contents of the pack Thelin 100 mg film-coated tablets are yellow-to-orange, capsule-shaped tablets, marked with T-100 on one side. ||| What Epivir looks like and the contents of the pack Epivir 150 mg film-coated tablets are supplied in white polyethylene bottles or blister packs containing 60 tablets. ||| À quoi ressemblent les comprimés de Thelin et le contenu de l’ emballage Comprimés enrobés de 100 mg de Thelin jaunes à orange en forme de gélule, marqués « T-100 » d’ un côté.
0.7295030355453491 ||| - convulsions. ||| • Convulsions. ||| - convulsions
0.13468556106090546 ||| Treatment with Nexavar should be supervised by doctors who have experience of anticancer treatments. ||| Nexavar treatment should be supervised by a physician experienced in the use of anticancer therapies. ||| Il convient que le traitement par Nexavar soit supervisé par des médecins expérimentés dans les traitements anti-cancéreux.
0.5398851633071899 ||| Green transition and digital transformation will be integrated into their recovery strategies. ||| Research is gradually shifting to more ecologically valid virtual reality techniques. ||| La transition verte et la transformation numérique seront intégrées dans leurs stratégies de relance.
0.4167311489582062 ||| Testing of vehicles ||| Scrapping of vehicles ||| Test de véhicules
0.5533373355865479 ||| This instrument will also focus on the EU priorities of the green and digital transitions and on supporting cross-border economic activities. ||| (3) economic and social considerations, prioritising cross-border movement in key areas of health, social and economic activity. ||| L'instrument mettra aussi l'accent sur les transitions écologique et numérique, qui sont des priorités de l'Union, et sur le soutien aux activités économiques transfrontières.
0.04211055487394333 ||| Roche Pharma AG Emil-Barell-Strasse 1 D-79639 Grenzach-Wyhlen Germany ||| Roche Pharma AG Emil-Barell-Str.1 D-79639 Grenzach-Wyhlen Germany ||| Roche Pharma AG Emil-Barell-Strasse 1 D-79639 Grenzach-Wyhlen Allemagne
0.5730539560317993 ||| - the Committee agreed that evidence of efficacy with chlormezanone is limited and of poor ||| - the Committee considered the risk/ benefit balance of chlormezanone. ||| - le CPMP a reconnu que les preuves d’ efficacité de la chlormézanone sont limitées et d’ un niveau
4.745424431011613e-13 ||| No studies on the effects on the ability to drive and use machines have been performed. ||| No studies on the effects on the ability to drive and use machines have been performed. ||| Les effets de sur l'aptitude à conduire des véhicules et à utiliser des machines n’ ont pas été étudiés.
0.15818309783935547 ||| After reconstitution Chemical and physical in-use stability has been demonstrated for 3 hours at 25°C. ||| Mixed solution: chemical and physical in-use stability has been demonstrated for 28 days at 2-8°C. ||| Après reconstitution Une stabilité chimique et physique après reconstitution a été demontrée pendant 3 heures à 25°C.
0.45416921377182007 ||| Regular monitoring should be undertaken by the veterinarian. ||| Storage is supervised by the specialists at the hospital. ||| Une surveillance régulière devra être effectuée par le vétérinaire.
0.2916269600391388 ||| Patients with moderate to severe renal impairment: there are no data to document the efficacy/ safety ratio in patients with renal impairement. ||| Patients with renal impairment There is no evidence of a reduction in tolerability associated with an increase in exposure to ibandronate in patients with various degrees of renal impairment. ||| Insuffisance rénale modérée à sévère: les données disponibles ne permettent pas de documenter le rapport bénéfice/ risque en cas d’ insuffisance rénale.
0.2754875719547272 ||| 7 tablets 14 tablets 28 tablets 35 tablets 56 tablets 70 tablets ||| 8 tablets 10 tablets 12 tablets 14 tablets 24 tablets ||| 7 comprimés 14 comprimés 28 comprimés 35 comprimés 56 comprimés 70 comprimés
0.6602144241333008 ||| PHARMACEUTICAL FORM AND CONTENTS ||| PHARMACEUTICAL FORM AND CONTENTS Inhalation powder pre-dispensed ||| FORME PHARMACEUTIQUE ET CONTENU tn
0.42199814319610596 ||| Twinrix Adult, suspension for injection Hepatitis A (inactivated) and hepatitis B(rDNA) (HAB) vaccine (adsorbed). ||| Hepatitis A virus (inactivated)1,2 Hepatitis B surface antigen3,4 1 Produced on human diploid (MRC-5) cells 2 ||| Twinrix Adulte, suspension injectable Vaccin de l'hépatite A (inactivé) et de l'hépatite B (ADNr) (HAB) (adsorbé).
0.5679255723953247 ||| Interior venetian blinds ||| Vinyl place mats ||| Stores vénitiens d'intérieur
0.4118567109107971 ||| It is important to underline that as long as there is a risk of infection, traveling entails some risks. ||| In all cases, it is necessary to ensure that the risks of the radiation are less than from the disease itself. ||| Il est important de souligner que tant qu'il existe un risque d'infection, voyager comporte certains risques.
5.009774062605943e-13 ||| Only solutions which are colourless, clear or slightly opalescent, should be injected. ||| Only solutions which are colourless, clear or slightly opalescent, should be injected. ||| Seules les solutions incolores, limpides ou légèrement opalescentes peuvent être 'e
0.3397742211818695 ||| Stop taking TRITAZIDE and see a doctor straight away, if you notice any of the following serious side effects - you may need urgent medical treatment: • Swelling of the face, lips or throat which make it difficult to swallow or breathe, as well as itching and rashes. ||| In case vomiting, diarrhoea, softening stools repeatedly occurs or in case the dog stops eating for two consecutive days, stop the administration of Yarvitan to your dog and seek the advice of your veterinary surgeon as soon as possible. ||| Arrêtez de prendre TRITAZIDE et consultez immédiatement un médecin si vous remarquez l’ un ou l’ autre des effets secondaires graves suivants: vous pourriez avoir besoin d’ un traitement médical urgent: • Gonflement du visage, des lèvres ou de la gorge rendant difficile la déglutition ou la respiration, ainsi que des démangeaisons et des éruptions cutanées.
0.0720001608133316 ||| Always take Kinzalkomb exactly as your doctor has told you. ||| Always take Kinzalmono exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.017016354948282242 ||| infusion or injection is 10 mg. ||| infusion or injection is 20 mg. ||| injection est de 10 mg.
0.19140884280204773 ||| ♦ Uncommon (less than 1 per 100 but more than 1 per 1000 doses of vaccine): • Generalised skin reactions such as itching, hives or rash ||| ♦ Uncommon (side effects which may occur in less than 1 per 100 but more than 1 per 1,000 doses of vaccine): • pneumonia (serious lung infection) • respiratory disorder ||| ♦ Peu fréquents (moins d’ 1 fois sur 100 mais plus d’ une fois sur 1000 doses de vaccins administrées): • Réactions cutanées généralisées incluant démangeaison (prurit), urticaire ou éruption cutanée
0.32366669178009033 ||| If solid parts of the lyophilisate are seen or the suspension is not homogeneous, the product should be discarded. ||| If particulate matter is present or the solution is coloured, then the ampoule should not be used. ||| Si des particules solides du lyophilisat sont visibles ou si la suspension n’ est pas homogène, le produit doit être éliminé.
0.4119616150856018 ||| Why has Mimpara been approved? ||| Why has Flebogammadif been approved? ||| Pourquoi Mimpara a -t-il été approuvé?
0.3493082523345947 ||| There is no basis for Mycophenolate mofetil Teva dose adjustment following cardiac transplant rejection. ||| Pregnancy For tenofovir disoproxil fumarate limited clinical data on exposed pregnancies are available. ||| Il n'y a pas d'argument justifiant l'ajustement de la dose de Mycophénolate mofétil Teva en cas de rejet de greffe cardiaque.
0.5544240474700928 ||| "She also instructed ""all colleagues in non-critical functions"" to work from home with immediate effect until 5 April, while those ""who ensure critical functions"" would need to work in two shifts to minimize the risk of contagion." ||| "Workplace closures include closure of ""non-essential"" businesses and social services (""non-essential"" means those facilities that do not maintain primary functions in the community, as opposed to essential services)." ||| Elle a également demandé à tous les collègues exerçant des fonctions non critiques de travailler à domicile avec effet immédiat jusqu'au 29 mars, tandis que ceux qui assurent des fonctions critiques devraient travailler en deux équipes pour minimiser le risque de contagion.
0.07749174535274506 ||| What Mycamine is and what it is used for 2. ||| What Temodal is and what it is used for 2. ||| Qu'est -ce que Mycamine et dans quel cas est -il utilisé 2.
0.3940635919570923 ||| Each pack of Tyverb contains 70 tablets in aluminium foil blisters of 10 tablets each. ||| Each carton of tablets contains one blister strip of 20 or 21 tablets. ||| Chaque boîte de Tyverb contient 70 comprimés sous plaquettes en aluminium thermoformées de 10.
4.577081985993048e-13 ||| • Renal impairment Therapeutic experience is limited in patients with renal impairment (see section 4.4). ||| • Renal impairment Therapeutic experience is limited in patients with renal impairment (see section 4.4). ||| Chez l’ insuffisant rénal o L’expérience de ce traitement est limitée chez les patients présentant une insuffisance rénale (voir rubrique 4.4).
0.2998177111148834 ||| Jalra is not recommended for patients who have moderate or severe problems with their kidneys, including those on haemodialysis (a blood clearance technique) with end-stage renal disease. ||| (2) The same dose adjustments, which are also based solely on modelling are recommended for patients on haemodialysis or continuous ambulatory peritoneal dialysis (CAPD). ||| L’ utilisation de Jalra n’ est pas recommandée chez les patients présentant des troubles rénaux modérés ou sévères, notamment chez les patients hémodialysés (technique d’ épuration du sang) présentant une insuffisance rénale au stade terminal.
0.3580062985420227 ||| Wearing disposable gloves, apply the cream gently to the lesion. ||| Wear waterproof gloves and soak up the liquid with an appropriate absorbent. ||| Après avoir mis des gants jetables, appliquer doucement la crème sur la lésion.
0.4967785179615021 ||| For further information on how to use Orgalutran, see the Package Leaflet. ||| See section 3 “ How to use Fasturtec” and practical information on preparation and handling given below. ||| Pour plus d’ informations sur les modalités d’ utilisation d’ Orgalutran, veuillez vous reporter à la notice.
0.35306188464164734 ||| Distribution Median volume of distribution during the terminal phase (Vz) following a single intravenous administration to patients with psoriasis ranged from 57 to 83 ml/ kg. ||| 23 Systemic exposure after administration as a 24 hour constant rate intravenous infusion is dose proportional at doses up to and including 1.8 mg/ m2. ||| Distribution Le volume de distribution médian pendant la phase finale (Vz) après administration unique en intraveineuse à des patients présentant un psoriasis était comprise entre 57 et 83 ml/ kg.
0.4953329563140869 ||| [For referral procedures] {PRODUCT NAME} 40mg film-coated tablet ||| Take special care with [Invented name] 400 mg film-coated tablets ||| [For referral procedures] {PRODUCT NAME} 40 mg, comprimé pelliculé
0.04680318385362625 ||| It must not be used by patients who have severe liver problems. ||| It should not be used in patients who have severe liver problems. ||| Il ne doit pas être administré aux patients atteints de graves troubles du foie.
0.4256739616394043 ||| It is not known whether the chance of developing an allergic reaction is increased if treatment with Fasturtec is repeated. ||| As for the coronavirus, it is too soon to evaluate the extent of its negative economic impact." ||| Il n’ est pas établi que le risque de développer une réaction allergique soit augmenté lorsque le traitement par Fasturtec est réintroduit.
0.25301826000213623 ||| All patients and parents/ caregivers should be advised that if the patient develops signs and symptoms suggestive of blood dyscrasias or infections (e. g., persistent fever, sore throat, bruising, bleeding, paleness) whilst on Enbrel, they should seek immediate medical advice. ||| The following reactions have also occurred in isolated patients with normal or low blood pressure: hypertensive crisis with encephalopathy-like symptoms (e. g. headaches and confused state) and generalised tonoclonal seizures, requiring the immediate attention of a physician and intensive medical care. ||| Tous les patients et les parents/ entourage doivent être informés qu’ en cas d’ apparition de signes ou de symptômes évoquant une atteinte hématologique ou une infection (tels que fièvre persistante, douleurs pharyngées, ecchymoses, saignement, pâleur) chez le patient sous Enbrel, ils doivent immédiatement consulter un médecin.
0.48908016085624695 ||| inflammation of the pancreas, vomiting blood, decrease of appetite ||| - acute kidney failure; increased urea in the blood ||| inflammation du pancréas, vomissement de sang, perte de l’appétit
0.04771006852388382 ||| Which measures are being taken to ensure the safe use of Intrinsa? ||| Which measures are being taken to ensure the safe use of Revatio? ||| Quelles sont les mesures prises pour garantir une utilisation sans danger d’ Intrinsa?
0.07044069468975067 ||| The matter was referred to the Co-ordination Group for Mutual Recognition and Decentralised Procedures CMD(v) and subsequently to the Committee for Medicinal Products for Veterinary Use. ||| The matter was referred to the Co-ordination Group for Mutual Recognition and Decentralised Procedures, CMD(v), and subsequently to the Committee for Medicinal Products for Veterinary Use (CVMP). ||| Cette question a été renvoyée au groupe de coordination pour la reconnaissance mutuelle et les procédures décentralisées [vétérinaire CMD(v)] et ultérieurement au comité des médicaments vétérinaires.
0.0290905199944973 ||| Each capsule contains 100 mg of atazanavir (as sulphate). ||| Each capsule contains 200 mg of atazanavir (as sulphate) ||| Chaque gélule contient 100 mg d'atazanavir (sous forme
0.4470513164997101 ||| Optic neuropathy, Papilledema, retinal vascular disorder, retinopathy, corneal ulcer ||| Cellulitis, Vesiculobullous rash, Maculopapular rash, Allergic reaction ||| neuropathie optique, œdème papillaire, trouble vasculaire rétinien, rétinopathie, ulcère de la cornée
0.357330858707428 ||| Chemical substances for use in treating poisonous gases ||| Chemical compositions for controlling a spillage of hazardous wastes ||| Substances chimiques destinées au traitement des gaz toxiques
1.2531719207763672 ||| ALT/ AST > 3xULN ||| T4/ T1 to 0.8 ||| ALAT/ASAT > 3 xLSN
0.7012152671813965 ||| Neutropenia ||| Desalination ||| Neutropénie
0.5547752380371094 ||| Hepatic coma ||| Hepatic failure Jaundice ||| Coma hépatique
0.06095268204808235 ||| Optisulin 100 Units/ ml solution for injection in a cartridge Insulin glargine ||| Lantus 100 Units/ ml Solution for injection in a cartridge Insulin glargine ||| Optisulin 100 Unités/ ml solution injectable en cartouche Insuline glargine
0.4274083375930786 ||| Gastrointestinal disorders Very common Nausea Common ||| Nausea Abdominal pain Disorders of the eye Common: ||| Affections gastro-intestinales Très fréquent Nausées Fréquent
0.018762126564979553 ||| Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. ||| Patients with rare hereditary problems of fructose intolerance, glucose- galactose malabsorption or sucrase-isomaltase insufficiency should not take this vaccine. ||| Les patients présentant des problèmes héréditaires rares d'intolérance au fructose, de malabsorption du glucose-galactose ou une insuffisance en sucrase-isomaltase ne doivent pas prendre ce médicament.
2.1785539680834604e-13 ||| In two of two placebo and two of three comparator controlled trials with over 2,900 schizophrenic patients presenting with both positive and negative symptoms, olanzapine was associated with statistically significantly greater improvements in negative as well as positive symptoms. ||| In two of two placebo and two of three comparator controlled trials with over 2,900 schizophrenic patients presenting with both positive and negative symptoms, olanzapine was associated with statistically significantly greater improvements in negative as well as positive symptoms. ||| 92 Dans les deux études versus placebo et dans deux études sur trois réalisées versus produits de référence chez 2900 patients schizophrènes présentant à la fois une symptomatologie positive et négative, l’ olanzapine a été associée à une amélioration de la symptomatologie positive et négative statistiquement plus importante que celles observées sous placebo ou sous produits de référence.
0.3544235825538635 ||| Installation of water pipes ||| Construction of nuclear power plants ||| Installation de conduites d'eau
0.2967306971549988 ||| Education services relating to industry ||| Education services relating to customer satisfaction ||| Services de formation industrielle
0.11369892954826355 ||| A positive opinion was adopted by majority on 13 December 2007. ||| A positive opinion was adopted by consensus on 15 November 2007. ||| Un avis favorable a été adopté à la majorité, le 13 décembre 2007.
0.32268422842025757 ||| Body weight had a minor effect on the plasma clearance of dabigatran resulting in higher exposure in patients with low body weight (see section 4.2 and 4.4). ||| This small increase in exposure did not result in a statistically significant difference in 24 hour serum cortisol levels between the two groups (see section 4.4). ||| Le poids corporel a exercé un effet mineur sur la clairance plasmatique du dabigatran, résultant en une exposition plus élevée chez les patients dont le poids corporel était faible (voir rubriques 4.2 et 4.4).
0.6632828712463379 ||| GlaxoSmithKline s. a. / n. v., Rue du Tilleul 13 B-1332 Genval Belgium ||| France Allergan France S. A. S ZAC Font de l’ Orme 1198 Av. ||| GlaxoSmithKline s. a. / n. v., Rue du Tilleul 13, B-1332 Genval, Belgique
0.269582599401474 ||| Caution should therefore be observed in the administration of Firazyr to patients with acute ischemic heart disease or unstable angina pectoris (see section 5.3). ||| The possibility that Gadovist may cause torsade de pointes arrhythmias in an individual patient cannot be excluded (see section 5.3 Preclinical safety data). ||| Il convient donc d’ être prudent lors de l’ administration de Firazyr aux patients présentant une cardiopathie ischémique aiguë ou une angine de poitrine instable (voir rubrique 5.3).
0.0 ||| [To be completed nationally] ||| [To be completed nationally] ||| [À remplir au niveau national]
0.0 ||| Depression, irritability, insomnia, anxiety*, concentration impaired, emotional lability* ||| Depression, irritability, insomnia, anxiety*, concentration impaired, emotional lability* ||| Dépression, irritabilité, insomnie, anxiété*, concentration Très fréquent: altérée, instabilité émotionnelle*
0.43997615575790405 ||| All interaction studies, when otherwise not stated, were performed using Kaletra capsules, which gives an approximately 20% lower exposure of lopinavir than the 200/ 50 mg tablets. ||| The recommended posology of 200-400 mg ciprofloxacin twice daily is in line with current medical practice, supported by the published literature presented from the mid 1990’ s to date. ||| Toutes les études d’ interaction, en l’ absence d’ indication contraire, ont été réalisées avec Kaletra capsule molle qui produit une exposition au lopinavir d’ environ 20% inférieure à celle produite par les comprimés à 200/ 50 mg.
0.3449063301086426 ||| This was associated with a reported improvement in symptoms affecting the cardiovascular system (heart and blood vessels) and the development of the nervous system in around three quarters of the patients taking Cystadane. ||| In addition, between one and two thirds of the patients in the five main trials showed a reduction in the number of white blood cells containing the Philadelphia chromosome. ||| Ces baisses ont été accompagnées d’ une amélioration des symptômes affectant le système cardiovasculaire (coeur et vaisseaux sanguins) et le développement du système nerveux chez près des trois quarts des patients traités par Cystadane.
0.0750175416469574 ||| 10/ 34 10 DATE OF REVISION OF THE TEXT ||| 4/ 17 10 DATE OF REVISION OF THE TEXT ||| DATE DE MISE À JOUR DU TEXTE
0.3622175455093384 ||| Enbrel is reconstituted with 1 ml bacteriostatic water for injections before use, and administered by subcutaneous injection. ||| Method of administration • Subcutaneous administration Fondaparinux is administered by deep subcutaneous injection while the patient is lying down. ||| Enbrel est reconstitué avec 1 ml d’ eau bactériostatique pour préparations injectables avant utilisation, et administration de l’ injection sous-cutanée.
0.0539788082242012 ||| What is the risk associated with Fendrix? ||| What is the risk associated with Cervarix? ||| Quel est le risque associé à l’ utilisation de Fendrix?
0.28572651743888855 ||| This means that after reconstitution of the powder with the solvent provided the solution is injected with a short needle into the fatty tissue just under the skin. ||| After the addition of the solvent, the mixture should be well shaken until the powder is completely dissolved in the solvent. ||| Cela signifie qu‘ après reconstitution de la poudre avec le solvant fourni, la solution est injectée avec une aiguille courte dans le tissu adipeux qui se trouve juste sous la peau.
0.41996997594833374 ||| • If no insulin comes out, check for air bubbles and repeat the safety test two more times to remove them. • If still no insulin comes out, the needle may be blocked. ||| Remove the syringe from the carton and check that: • the expiry date has not passed • the solution is clear and colourless and doesn’ t contain particles • the syringe has not been opened or damaged ||| • Si aucune insuline n’apparaît, vérifiez la présence éventuelle de bulles d’air et répétez encore deux fois le test de sécurité afin de les éliminer. • Si l’insuline n’apparaît toujours pas, il se peut que l’aiguille soit bouchée.
0.34469175338745117 ||| Therefore, patients should be advised to exercise caution until they are familiar with the potential effects of the medicine (see section 4.8). ||| Patients and carers should exercise caution until they are familiar with the potential effects of this medicinal product. ||| Par conséquent, il est recommandé que les patients prennent des précautions particulières jusqu’ à ce qu’ ils soient familiarisés avec les effets potentiels de ce médicament (voir rubrique 4.8).
0.019581211730837822 ||| 89 Exacerbation of anaemia due to ribavirin has been reported when zidovudine is part of the regimen used to treat HIV although the exact mechanism remains to be elucidated. ||| The exacerbation of anaemia due to ribavirin has been reported when zidovudine is part of the regimen used to treat HIV although the exact mechanism remains to be elucidated. ||| Une aggravation de l’anémie liée à la ribavirine a été rapportée lorsque la zidovudine fait partie du traitement de l’infection par le VIH, bien que le mécanisme exact reste à élucider.
9.635822955517126e-13 ||| 3) Injecting Humira ||| 3) Injecting Humira ||| 3) Injection d’Humira
0.0 ||| In the following cases, Quintanrix should not be given to your child. ||| In the following cases, Quintanrix should not be given to your child. ||| isé Dans les cas suivants, Quintanrix ne doit pas être administré à votre enfant.
0.36273878812789917 ||| In all five studies, patients randomized to the Raptiva dose group achieved statistically significantly better responses than placebo on the primary endpoint (PASI 75 response) (see Table 2 below) and on all the secondary efficacy endpoints. ||| A subgroup analysis of the virologic response (defined as a viral load < 50 HIV-1 RNA copies/ml) at week 24 by baseline viral load and baseline CD4 count (pooled DUET data) is presented in the table below. ||| Au cours des 5 études, les patients randomisés pour recevoir Raptiva présentaient une réponse statistiquement supérieure à ceux du groupe placebo sur le critère principal d'évaluation (réponse PASI-75) (voir tableau 2) et sur tous les critères secondaires d'évaluation.
0.3006080985069275 ||| Semi-refractory bricks, not of metal ||| Fired refractory materials, not of metal ||| Briques semi-réfractaires non métalliques
0.26163917779922485 ||| Clinical pharmacodynamic data: treatment with nelfinavir alone or in combination with other antiretroviral agents has been documented to reduce viral load and increase CD4 cell counts in HIV-1 seropositive patients. ||| Clinical Trials Patients at low to moderate immunological risk were studied in the phase 3 ciclosporin elimination-Rapamune maintenance trial, which included patients receiving a renal allograft from a cadaveric or living donor. ||| Données de pharmacodynamie clinique: il a été montré que le traitement par le nelfinavir, seul ou en association avec d’autres antirétroviraux, réduit la charge virale et augmente le taux de cellules CD4 chez les patients séropositifs pour le VIH-1.
0.10143916308879852 ||| The vaccine is a powder for suspension for injection contained in a single-dose vial, which should be mixed with solvent provided with the vial of powder. ||| The vaccine is a powder for suspension for injection contained in a single-dose vial, which should be mixed with solvent provided. ||| Le vaccin est une poudre pour suspension injectable contenue dans un flacon unidose, qui doit être mélangée au solvant fourni avec le flacon de poudre.
0.01624741591513157 ||| GLASS BOTTLE 50 mg/mL ||| GLASS BOTTLE 100 mg/mL ||| FLACON EN VERRE 50 mg/ml
0.5646339654922485 ||| Low levels of serotonin in the central nervous system may be associated with depression, anxiety or aggression. ||| Alzheimer's disease has been associated with depression, suicidal ideation and suicide. ||| Des taux faibles de sérotonine dans le système nerveux central peuvent s’ accompagner de dépression, d’ anxiété ou d’ agressivité.
0.14388717710971832 ||| Gastrointestinal disorders Common: gastrointestinal symptoms, nausea Uncommon: diarrhoea, vomiting, abdominal pain ||| 5 Common: gastrointestinal symptoms, diarrhoea, nausea Uncommon: vomiting, abdominal pain* ||| Fréquent: symptômes gastro-intestinaux, nausées Peu fréquent: diarrhée, vomissements, douleurs abdominales
0.6261972188949585 ||| On-site water purification services ||| On-line communication services ||| Services d'épuration de l'eau sur place
0.31120002269744873 ||| Ambrisentan is primarily bound to albumin (96.5%) and to a lesser extent to alpha1-acid glycoprotein. ||| Irbesartan is mainly metabolised by CYP2C9 and to a lesser extent by glucuronidation. ||| L’ ambrisentan est lié principalement à l’ albumine (96,5%) et dans une moindre mesure, à la glycoprotéine acide alpha1.
0.25729769468307495 ||| A clinical trial of adjunctive treatment of partial seizures in paediatric subjects, ranging in age from 3 to 12 years, showed a numerical but not statistically significant difference in the 50% responder rate in favour of the gabapentin group compared to placebo. ||| However, in an analysis of approximately 200 prospectively followed pregnancies exposed during the first trimester to or another closely related HMG-CoA reductase inhibi tor, the incidence of congenital anomalies was comparable to that seen in the general population. ||| Une étude clinique dans le traitement des épilepsies partielles en association à d'autres traitements, chez des enfants âgés de 3 à 12 ans, a montré une différence numérique, mais non statistiquement significative, des taux de répondeurs à 50% en faveur du groupe gabapentine comparativement au placebo.
0.08415231853723526 ||| Avandamet is a medicine containing two active substances, rosiglitazone and metformin hydrochloride. ||| Efficib is a medicine containing two active substances, sitagliptin and metformin hydrochloride. ||| Avandamet est un médicament contenant deux principes actifs, la rosiglitazone et le chlorhydrate de metformine.
0.6022639274597168 ||| Three main studies were carried out in 523 patients. ||| Thirty subjects completed 48 weeks of treatment. ||| Trois études principales ont été menées chez 523 patients.
0.2545539438724518 ||| According to in vitro studies, significant displacement is not anticipated at therapeutic concentrations of the medicinal products. ||| Because of the study sample size and duration, the effects of Soliris on thrombotic events could not be determined. ||| Selon des études in vitro, aucun déplacement significatif ne devrait se produire aux concentrations thérapeutiques des médicaments.
0.20910832285881042 ||| Gas burners for industrial purposes ||| Electric roasters for industrial purposes ||| Brûleurs de gaz à usage industriel
0.37343674898147583 ||| HOW TO INJECT AVONEX ||| HOW TO SELF- INJECT PEGASYS ||| COMMENT INJECTER AVONEX
0.39200061559677124 ||| Adhesive sealant compounds ||| Chemical anchoring compounds ||| Matériaux adhésifs d'étanchéité
0.7391741275787354 ||| Not all pack sizes or presentations may be marketed. ||| What sorts of goods are cargo ships carrying? ||| Toutes les présentations peuvent ne pas être commercialisées.
0.3855937719345093 ||| 24.3 to 64.9; p < 0.001) for the 5 mg dose, and 52.5 m (95% CI: ||| 29.6 to 89.3; p < 0.001) for the 5 mg group, in ARIES 1 and 2 respectively. ||| 24,3 à 64,9; p < 0,001) dans le groupe Volibris 5 mg et de 52,5 m (IC 95%:
0.28825199604034424 ||| Zonegran is a benzisoxazole derivative, which contains a sulphonamide group. ||| Quixidar contains a synthetic substance called fondaparinux sodium. ||| Zonegran est un dérivé du benzisoxazole qui comporte un radical sulfamide.
0.019380532205104828 ||| 48 PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING ||| 46 PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING ||| 50 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.12013217061758041 ||| The dosage should be determined on the basis of laboratory measurements of the protein C activity. ||| The dosage should be adjusted on the basis of laboratory measurements of antithrombin activity. ||| La posologie doit être basée sur les résultats du dosage de l’ activité en protéine C.
0.6706929206848145 ||| Representatives from Iceland and Norway now officially participate in meetings of the Board as observers. ||| The 151 research teams from across the EU and beyond that are participating in these projects are working on: ||| Les représentants de l’Islande et de la Norvège participent désormais officiellement aux réunions du Conseil, en tant qu’observateurs.
0.30251747369766235 ||| Interaction with indinavir/ ritonavir not studied Ritonavir induces glucuronidation and as a result is expected to decrease the plasma concentrations of atovaquone. ||| Thiazolidinediones act primarily by reducing insulin resistance and sulphonylureas act primarily by stimulating release of insulin from functioning pancreatic β -cells. ||| Le ritonavir induit une glucuronidation et par conséquent, il est attendu qu'il diminue les concentrations plasmatiques de l'atovaquone.
0.09269389510154724 ||| What Humalog BASAL KwikPen is and what it is used for 2. ||| What Humalog BASAL Pen is and what it is used for 2. ||| Qu'est-ce qu’Humalog BASAL KwikPen et dans quel cas est-il utilisé 2.
0.3276097774505615 ||| • Educational leaflet • Summary of product characteristics (SPC) and Package Leaflet and Labelling • Cool boxes for patients clearly labelled with a visual aid indicating correct use of product. ||| The MAH shall ensure that all doctors who prescribe MabCampath are provided with a healthcare professional information pack containing the following: • Educational brochure • Summary of Product Characteristics (SPC) and Package Leaflet and Labelling ||| • Livret pédagogique • Résumé des caractéristiques du produit (RCP), notice et étiquetage • Glacières à l’ intention des patients avec un étiquetage clair fournissant des indications visuelles sur la bonne utilisation du produit.
0.034993916749954224 ||| NovoMix 70 Penfill 100 U/ ml suspension for injection in a cartridge Insulin aspart ||| NovoMix 30 Penfill 100 U/ ml Suspension for injection in a cartridge Insulin aspart ||| NovoMix 70 Penfill 100 U/ ml suspension injectable en cartouche Insuline asparte
0.37570157647132874 ||| Together with ALT, a complete blood cell count, including differential white blood cell count and platelets, must be performed before start of leflunomide treatment as well as every 2 weeks for the first 6 months of treatment and every 8 weeks thereafter. ||| Patients were followed every 3 months until 4 consecutive, quarterly follow-up endoscopic biopsy results were negative for HGD, and then biannually until the last enrolled patient had completed a minimum of 24 months of follow-up evaluations after randomisation. ||| En même temps que les ALAT, une numération globulaire complète, comportant une numération et une formule leucocytaire et une numération plaquettaire, doit être réalisée avant le début du traitement par le léflunomide, puis toutes les 2 semaines pendant les 6 premiers mois, puis toutes les 8 semaines.
0.34869974851608276 ||| VIAGRA 25 mg film-coated tablets Sildenafil ||| ORACEA 40 mg modified-release hard capsules doxycycline ||| VIAGRA 25 mg comprimés pelliculés Sildénafil
0.9725711941719055 ||| 120 5.3 Preclinical safety data ||| Parallel distribution notifications 2000-2002 ||| 5.3 Données de sécurité précliniques
0.4624325633049011 ||| Hepsera is supplied in high-density polyethylene (HDPE) bottles with a child-resistant closure. ||| Bags/ containers that come in contact with TORISEL must be made of glass, polyolefin, or polyethylene. ||| Hepsera est fourni en flacon en polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant.
0.11560152471065521 ||| Custom construction of roads ||| Custom construction of buildings ||| Construction de routes sur commande
4.642369930314694e-13 ||| Neoplasms benign, malignant and unspecified (including cysts and polyps) ||| Neoplasms benign, malignant and unspecified (including cysts and polyps) ||| 36 Tumeurs bénignes, malignes et non précisées (incl kystes et polypes)
0.4819583296775818 ||| Do not use any other solvent. ||| Do not mix with other products. ||| Ne pas utiliser d’ autre solvant.
0.25426381826400757 ||| Careful monitoring of therapeutic and adverse effects is recommended when erythromycin or itraconazole is used concomitantly administered with ritonavir. ||| The administration of lorazepam solution for injection had no effect on the pharmacokinetics of aripiprazole solution for injection when administered concomitantly. ||| Une surveillance étroite des effets thérapeutiques et indésirables est recommandée en cas d’administration concomitante de ces médicaments avec le ritonavir.
0.24920275807380676 ||| The dose may later be increased to 300 mg once daily depending on blood pressure response. ||| The dose can be further increased by 250 mg twice daily every two weeks depending upon the clinical response. ||| La dose peut être ultérieurement augmentée jusqu'à 300 mg en une prise par jour en fonction de la réponse sur la pression artérielle.
0.5490074753761292 ||| Neoclarityn 0.5 mg/ ml oral solution ||| Saquinavir soft gelatin capsule 1200 mg single dose ||| Neoclarityn 0,5 mg/ ml solution buvable
0.32514697313308716 ||| The company that makes Vectibix will supply the results of additional studies looking at the safety and effectiveness of the medicine in patients with colorectal cancer with and without mutated KRAS, as well as at the quality of life in patients receiving it. ||| Protocols for a study or studies to investigate the long term safety and efficacy of patients treated with Opgenra and also actual drug utilisation in real life will be submitted by the MAH and agreed with the CHMP before product launch and before the study is started. ||| La société qui fabrique Vectibix fournira les résultats de études supplémentaires examinant la sécurité et l’ efficacité du médicament chez les patients souffrant de cancer colorectal avec ou sans gène KRAS muté, ainsi que la qualité de vie des patients auxquels il est administré.
0.26303404569625854 ||| 13 Diarrhoea with mixed cell inflammation of the caecum or colon was observed in monkeys and was associated with an inflammatory response, and may have been due to a disruption of the normal intestinal flora. ||| As an aid in the prevention strategy to reduce the clinical signs and mortality from respiratory disease in flocks, where infection in ovum with Mycoplasma gallisepticum is likely because the disease is known to exist in the parent generation. ||| Des singes ont présenté une diarrhée avec inflammation de cellules mixtes du caecum ou du côlon qui a été associée à une réponse inflammatoire et peut avoir pour origine une rupture de la flore intestinale normale.
0.4635483920574188 ||| Foscan is administered via an in-dwelling intravenous cannula in a large proximal limb vein, preferably in the antecubital fossa, as a single slow intravenous injection over not less than 6 minutes. ||| Around two days later, the dysplasia, plus small areas of normal tissue above and below it, is illuminated with light from a laser at a specific wavelength using a fibre-optic cable through an endoscope. ||| Il faut administrer Foscan au moyen d’ un cathéter intraveineux placé à demeure dans une grosse veine proximale d’ un membre, de préférence au pli du coude, par injection intraveineuse unique lente d’ au moins 6 minutes.
0.3605073392391205 ||| Construction of steel structures for buildings ||| Doors made of wood for buildings ||| Construction de structures en acier pour bâtiments
0.43356242775917053 ||| Emtriva 200 mg hard capsules may be taken with or without food. ||| Do not store Xyrem solutions diluted with water for more than 24 hours. ||| Emtriva 200 mg gélules peut être pris au cours ou en dehors des repas.
0.05099564045667648 ||| In case of accidental contact, rinse with abundant quantities of water. ||| In case of accidental eye contact, rinse with abundant quantities of water. ||| En cas de contact accidentel, rincer abondamment avec de l’ eau.
0.0005577412666752934 ||| The non-confidential version of the decision will be made available under the case number SA.56790 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.56791 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.56790 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.4659608006477356 ||| sodium phosphate monobasic monohydrate. ||| colloidal anhydrous silica and magnesium stearate. ||| phosphate monosodique monohydraté.
0.2838098704814911 ||| Following monthly administration of darbepoetin alfa, at subcutaneous doses ranging from 0.6 to 2.1 µg/ kg, the terminal half-life was 73 hours (SD 24). ||| From studies with intravenous zidovudine, the mean terminal plasma half-life was 1.1 hours and the mean systemic clearance was 1.6 l/ h/ kg. ||| 24 mensuelle d’ une dose de darbepoetin alfa allant de 0,6 à 2,1 µg/ kg, la demi-vie terminale est de 73 heures (DS = 24).
0.04601795971393585 ||| ► In insulin infusion pumps ► If InnoLet is dropped, damaged or crushed there is a risk of leakage of insulin ► If it hasn’ t been stored correctly or been frozen (see 6 How to store Mixtard) ► If it’ s not uniformly white and cloudy when it’ s resuspended. ||| In insulin infusion pumps If InnoLet is dropped, damaged or crushed there is a risk of leakage of insulin If it hasn’ t been stored correctly or been frozen (see 6 How to store Protaphane) If it’ s not uniformly white and cloudy when it’ s resuspended. ||| ► dans une pompe à perfusion d’ insuline ► si InnoLet est tombé, a été endommagé ou a été écrasé, car il y a un risque de fuite d’ insuline ► s’ il n’ a pas été conservé correctement ou s’ il a été congelé (voir 6 Comment conserver Mixtard) ► s’ il n’ apparaît pas uniformément blanc et opaque après remise en suspension.
0.354744553565979 ||| In subjects with mild, moderate, or severe renal impairment, systemic exposure to vildagliptin was increased (Cmax 8-66%; AUC 32-134%) and total body clearance was reduced compared to subjects with normal renal function. ||| Also, patients with erectile dysfunction in all severity categories reported improved erections whilst taking tadalafil (86%, 83%, and 72% for mild, moderate, and severe, respectively, as compared to 45%, 42%, and 19% with placebo). ||| Chez les patients présentant une insuffisance rénale légère, modérée ou sévère, l’ exposition systémique à la vildagliptine a été augmentée (Cmax 8-66%; ASC 32-134%) et la clairance corporelle totale a été diminuée comparativement à des sujets ayant une fonction rénale normale.
0.2969842851161957 ||| Caution should be used when administering CELSENTRI in patients with a history of postural hypotension or on concomitant medicinal products known to lower blood pressure. ||| General CNS activity Given the primary CNS effects of olanzapine, caution should be used when it is taken in combination with other centrally acting medicines and alcohol. ||| La prudence est de rigueur lors de l’ administration de CELSENTRI chez des patients présentant des antécédents d’ hypotension orthostatique ou recevant des médicaments associés connus pour abaisser la tension artérielle.
0.7125394344329834 ||| - fasting or malnutrition, ||| • difficulty sleeping, abnormal dreams ||| - de jeûne ou de dénutrition,
0.30329811573028564 ||| In study NR15961, patients concurrently treated with stavudine and interferon therapy with or without ribavirin, the incidence of pancreatitis and/ or lactic acidosis was 3% (12/ 398). ||| The negative predictive value for sustained response in HCV/ HIV co-infected patients treated with ViraferonPeg in combination with ribavirin was 99% (67/ 68; Study 1) (see section 5.1). ||| Dans l'étude NR15961, l'incidence de pancréatite et/ou d'acidose lactique était de 3% (12/398) chez les patients traités conjointement par stavudine et interféron associé ou non à la ribavirine.
0.3559025526046753 ||| Flebogammadif may reduce the effectiveness of certain type of vaccines such as measles, rubella, mumps and varicella. ||| Treatment with lansoprazole may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter. ||| Flebogammadif peut atténuer l’ efficacité de certains vaccins tels que la rougeole, la rubéole, les oreillons et la varicelle.
0.05082705616950989 ||| Pipes of metal including those from alloy steel and titanium ||| Sheets of metal including those from alloy steel and titanium ||| Tuyaux en métal, y compris en alliage d'acier et en titane
0.1482437700033188 ||| Polska Pfizer Polska Sp. z o. o. ||| Polska UCB Pharma Sp. z o. o. ||| Polska Pfizer Polska Sp. z o.o.
0.12786710262298584 ||| Chemicals for use in the refining of oils ||| Chemicals for use in the formation of gas wells ||| Produits chimiques destinés au raffinage du pétrole
4.640053532373178e-13 ||| The primary activity of insulin, including insulin glargine, is regulation of glucose metabolism. ||| The primary activity of insulin, including insulin glargine, is regulation of glucose metabolism. ||| 40 Le principal effet de l'insuline, y compris l'insuline glargine, est de réguler le métabolisme du glucose.
0.17711950838565826 ||| XERISTAR should not be used in the treatment of children and adolescents under the age of 18 years. ||| The use of MicardisPlus in children and adolescents up to the age of 18 years is not recommended. ||| L’ utilisation de XERISTAR est déconseillée chez les enfants et adolescents de moins de 18 ans.
0.15967363119125366 ||| Consultancy services relating to food preparation ||| Consultancy services relating to transportation ||| Services de conseils concernant la préparation d'aliments
0.26244258880615234 ||| Rare side effects These may affect up to 1 in 1,000 people: • fluid in the lungs (pulmonary oedema) causing breathlessness • heart failure • swelling of the retina at the back of the eye (macular oedema) • liver doesn’t function as well as it should (increase in liver enzymes). ||| Serious side effects (very rare: affects less than 1 user in 10,000) • Blood clots in arteries leading to heart attack or stroke • Blood clots in veins that can lead to blood clots in the lungs • Blood clots in liver predominantly in patients with liver disease or undergoing liver surgery. ||| Les effets indésirables rares Ceux -ci peuvent toucher jusqu'à 1 personne sur 1 000: • liquide dans les poumons (oedème pulmonaire) causant essoufflement • insuffisance cardiaque • gonflement de la rétine à l’ arrière de l'oeil (oedème maculaire) • le foie ne fonctionne pas aussi bien qu'il le devrait (augmentation des enzymes hépatiques).
0.004223204683512449 ||| Each film-coated tablet contains 50 mg of vildagliptin and 1000 mg of metformin hydrochloride (corresponding to 780 mg of metformin). ||| Each film-coated tablet contains 50 mg of vildagliptin and 850 mg of metformin hydrochloride (corresponding to 660 mg of metformin). ||| Chaque comprimé pelliculé contient 50 mg de vildagliptine et 1000 mg de chlorhydrate de metformine (correspondant à 780 mg de metformine).
0.4991700053215027 ||| Instruments for measuring milk quality parameters ||| Distance and dimension measuring instruments ||| Instruments de mesure des paramètres de qualité du lait
0.32088544964790344 ||| Lubricating agents, other than for medical use ||| Perforating machines, other than for office use ||| Agents lubrifiants autres qu'à usage médical
0.36027953028678894 ||| Subgroup analyses suggested that the route and type of concomitant estrogen (transdermal oestradiol, oral conjugated equine estrogen (CEE), oral non-CEE) can influence patient response. ||| Efavirenz is a non-competitive inhibitor of HIV-1 reverse transcriptase (RT) and does not significantly inhibit HIV-2 RT or cellular DNA polymerases (α, β, γ or δ). ||| Les analyses de sous-groupes indiquent que la voie d’ administration et le type d’ estrogènes associés (estradiol transdermique, estrogènes conjugués équins oraux, autres estrogènes oraux) pourraient influencer la réponse des patientes.
0.4528759717941284 ||| Planes ||| Watches ||| Rabots
0.8947003483772278 ||| Unopened Vials: ||| Vials for NovoSeven: ||| Flacons non ouverts:
3.730259916061296e-13 ||| In case of oral treatment, second generation fluoroquinolones are superior to norfloxacin because they present higher serum and tissue levels. ||| In case of oral treatment, second generation fluoroquinolones are superior to norfloxacin because they present higher serum and tissue levels. ||| En cas de traitement oral, les fluoroquilones de deuxième génération sont supérieures à la norfloxacine parce qu’ elles présentent des taux sériques et des concentrations tissulaires plus élevés.
0.22717894613742828 ||| State aid: Commission approves €50 million Italian support scheme for production and supply of medical equipment and masks during Coronavirus outbreak ||| State aid: Commission approves €30 million Luxembourg scheme to support research and development and investments in the production of coronavirus relevant products ||| Aides d'État: La Commission autorise le régime d'aide italien d'un montant de 50 millions d'euros en faveur de la production et de la fourniture d'équipements médicaux et de masques durant la flambée de coronavirus
0.3918076753616333 ||| Enfuvirtide is a member of the therapeutic class called fusion inhibitors. ||| Visudyne is a light-activated medicinal product used in photodynamic therapy. ||| 7 Mécanisme d'action: l'enfuvirtide appartient à la classe thérapeutique des inhibiteurs de fusion.
0.5836403965950012 ||| Hypolipidemic agents ||| Autoimmune hepatitis ||| Agents hypolipémiants
0.0024989305529743433 ||| This is most likely to occur in those patients with more severe degrees of heart failure, as reflected by the use of high doses of loop diuretics, hyponatremia or functional renal impairment. ||| This is most likely to occur in those patients with more severe degrees of heart failure, as reflected by the use of high doses of loop diuretics, hyponatraemia or functional renal impairment. ||| Elle est le plus susceptible de survenir chez ceux présentant les stades les plus sévères d'insuffisance cardiaque, comme le montre l'utilisation de doses élevées de diurétiques de l'anse, l’ existence d’ une hyponatrémie ou une altération de la fonction rénale.
0.2719166874885559 ||| Beta-blockers may increase the hypoglycaemic effect of antidiabetic agents. ||| NSAIDs may reduce the effect of diuretics and antihypertensive medicinal products. ||| Les bêta-bloquants sont susceptibles d’ augmenter l’ effet hypoglycémiant des antidiabétiques.
0.45095640420913696 ||| Activated charcoal may be useful in the treatment of overdose. ||| Adequate intake of calcium and vitamin D is important in all patients. ||| Le charbon actif peut s’ avérer utile pour le traitement d’ un éventuel surdosage.
0.6819769144058228 ||| Results from 3 years fracture study MF 4411 (%, 95% CI) for patients with lumbar spine BMD T-score below – 2.5 at baseline ||| Mean change in visual acuity from baseline to month 24 in study FVF2598g (MARINA) and study FVF2587g (ANCHOR) ||| Résultats de l’ étude MF 4411 sur les fractures à 3 ans (%, IC à 95%) chez les patientes qui présentaient comme valeur initiale de la DMO lombaire un T-score inférieur à – 2,5
5.377634101910722e-13 ||| For animal treatment only. ||| For animal treatment only. ||| À usage vétérinaire
0.13425540924072266 ||| Each tablet contains 100 mg of etravirine. ||| Each tablet contains 750 mg of ranolazine. ||| Chaque comprimé contient 100 mg d’ étravirine.
0.38001707196235657 ||| Based on these data the efficacy of tacrolimus appears to be well established. ||| The results of these studies indicate that Nimesulide 3% is well tolerated. ||| Sur la base de ces données, l’ efficacité du tacrolimus semble bien établie.
0.2910202443599701 ||| Advisory services relating to computer software used for printing ||| Providing technical advice relating to computer hardware and software ||| Services de conseil concernant des logiciels utilisés pour l'impression
0.364835649728775 ||| If you are affected your doctor may suggest that you take SUSTIVA at bedtime. ||| Check with your doctor, as Avaglim may not be suitable for you. ||| Si vous présentez ces symptômes, il se peut que votre médecin vous conseille de prendre SUSTIVA au coucher.
0.08848966658115387 ||| EXP {month/ year} ||| EXP {month/year} ||| EXP (mois/ année)
0.31590068340301514 ||| Patients should be aware of the risk of pregnancy and if a patient wishes to become pregnant or if pregnancy occurs, the treatment should be discontinued (see section 4.6). ||| Pregnancy The vaccine should not be administered to pregnant females; furthermore, pregnancy should be avoided for 3 months following vaccination (see sections 4.3 and 4.6). ||| Si une patiente désire une grossesse ou si une grossesse survient, le traitement devra être arrêté (voir paragraphe 4.6).
0.1839306652545929 ||| Why has Betaferon been approved? ||| Why has Orgalutran been approved? ||| Pourquoi Betaferon a -t-il été approuvé?
0.763857901096344 ||| ≥ 30 IU ≥ 60 IU ≥ 4 IU ||| 50 IU 100 IU 200 IU 400 IU ||| ≥ 30 UI ≥ 60 UI
0.3503681719303131 ||| The tablets are packed in PVC/ PVDC opaque blister strips with aluminium foil backing. ||| The containers are closed with butyl rubber stoppers and sealed with aluminium caps. ||| Les comprimés sont conditionnés sous plaquettes thermoformées opaques en PVC/ PVDC avec film en aluminium.
0.3345643877983093 ||| Water pumps ||| Electric water pumps ||| Pompes à eau
0.0 ||| 5.2 Pharmacokinetic properties ||| 5.2 Pharmacokinetic properties ||| 12 5.2 Propriétés pharmacocinétiques
0.3398204743862152 ||| Micrometer screws ||| Metal padlocks ||| Vis micrométriques
0.004528670571744442 ||| 4 There is limited experience in patients with reduced hepatic function, therefore CELSENTRI should be used with caution in this population (see sections 4.2 and 5.2). ||| 20 There is limited experience in patients with reduced hepatic function, therefore CELSENTRI should be used with caution in this population (see sections 4.2 and 5.2). ||| L’ expérience chez les patients avec une fonction hépatique altérée est limitée, par conséquent, CELSENTRI doit être utilisé avec prudence dans cette population (voir rubriques 4.2 et 5.2).
0.4734254479408264 ||| Eye drops, solution 1 x 2.5 ml 3 x 2.5 ml ||| 50 tubes 50 x 1 dose (1.5 ml) ||| Collyre en solution 1 x 2,5 ml 3 x 2,5 ml
0.05167810618877411 ||| Karvea is not recommended in early pregnancy and may cause serious harm to your baby after 3 months of pregnancy, see section Pregnancy and breastfeeding. ||| Irbesartan BMS is not recommended in early pregnancy and may cause serious harm to your baby after 3 months of pregnancy, see section Pregnancy and breastfeeding. ||| Karvea est déconseillé en début de grossesse et peut entraîner des problèmes de santé chez l’ enfant à naître si Karvea est pris après 3 mois de grossesse, voir section grossesse-allaitement.
0.6910809278488159 ||| The two cases were people who were in contact with someone in Italy who tested positive. ||| The figures are based on how many people said they’d had them. ||| Les deux cas étaient des personnes en contact avec une personne en Italie dont le test était positif.
0.4060575067996979 ||| Efficacy as monotherapy treatment of typical absence seizures was demonstrated. ||| There was significant treatment interaction by antihypertensive baseline therapy. ||| L’ efficacité du traitement en monothérapie sur les crises d’ absence typiques a été démontrée.
0.12362829595804214 ||| a) 02.10.96 b) 10.12.97 c) 191 days d) 245 days ||| a) 28.3.1996 b) 11.6.1997 c) 212 days d) 229 days ||| a) 02.10.96 b) 10.12.97 c) 191 Jours d) 245 Jours
2.856606010764873e-13 ||| Preliminary information suggests a relationship may exist between the presence of major deletion mutations in a patient's factor IX gene and an increased risk of inhibitor formation and of acute hypersensitivity reactions. ||| Preliminary information suggests a relationship may exist between the presence of major deletion mutations in a patient's factor IX gene and an increased risk of inhibitor formation and of acute hypersensitivity reactions. ||| Les données préliminaires permettent de penser qu’ il pourrait exister une relation entre la présence de mutations de délétion majeures sur le gène du facteur IX d’ un patient et un risque accru de formation d’ un
0.4680202901363373 ||| Hence, no dose adjustment is required in these patients. ||| In addition, clinical tolerance was good in all patients. ||| Par conséquent, il n’ est pas nécessaire d’ ajuster la posologie chez ces patients.
0.2403760552406311 ||| Other information about LITAK: ||| Other information about PROTELOS: ||| Autres informations relatives à LITAK:
0.37946414947509766 ||| Xarelto should be used with caution in patients with severe kidney problems. ||| InductOs is used in addition to standard treatment and care of shin bone fractures. ||| Xarelto doit être utilisé avec précaution chez les patients présentant de graves problèmes de reins.
0.758712649345398 ||| On 16 November 2007 responses to the questions were received from MAH and the clock restarted. ||| We’ll be sending an invitation to your calendars for next Thursday, 14:00 UTC/07:00 PT for a special staff meeting. ||| Le 16 novembre 2007, les TAMM ont fait parvenir des réponses aux questions et le décompte du délai a repris.
0.38628968596458435 ||| Having assessed the data available, the CHMP agreed that valsartan 80 mg can be used as a starting dose in patients with reduced kidney function. ||| Therefore the CHMP was of the opinion that starting doses should be restricted to 2 mg for the first day in bipolar mania. ||| 2 données disponibles, le CHMP a accepté que le valsartan 80 mg puisse être utilisé comme dose de départ chez les patients dont la fonction rénale est réduite.
0.5824949741363525 ||| Dizziness, tiredness ||| Sleeplessness, anxiety. ||| • étourdissements, fatigue.
0.45792466402053833 ||| Providing information relating to the distribution of electricity ||| Collection of information relating to the environment ||| Mise à disposition d'informations en matière de distribution d'électricité
0.7651268243789673 ||| Concentr ate for infusion ||| A bsorption: ||| Solution à diluer pour perfusion
0.0 ||| 5.3 Preclinical safety data ||| 5.3 Preclinical safety data ||| 108 5.3 Données de sécurité préclinique
0.0 ||| The incidence of adverse events listed above have the potential to occur with a higher frequency in patients who have a poor performance status (see section 4.4). ||| The incidence of adverse events listed above have the potential to occur with a higher frequency in patients who have a poor performance status (see section 4.4). ||| Les effets indésirables listés ci-dessus peuvent potentiellement se produire à une fréquence plus élevée chez les patients ayant un faible indice de performance (voir rubrique 4.4).
0.5624840259552002 ||| ↑ 47% ||| ↓ 43% ||| 27% ↔
0.31334972381591797 ||| In three of these studies, Byetta was compared with placebo (a dummy treatment), when they were given as an ‘ add-on’ to metformin (336 patients), sulphonylureas (377 patients) or both types of medicine (733 patients). ||| In a clinical study of the medicinal product, antibodies to the protein eptotermin alfa were detected in 194 out of 207 (94%) patients treated with it and 18 out of 86 (21%) treated with autograft bone (control group). ||| Dans trois de ces études, Byetta a été comparée à un placebo (traitement fictif) en tant qu’ adjuvant de la metformine (336 patients), de sulphonylurées (377 patients) ou des deux types de médicament (733 patients).
0.6824930906295776 ||| Dysuria ||| Apidra ||| Dysurie
0.3667547106742859 ||| Today's package includes measures for private storage aid (PSA) in the dairy and meat sectors, the authorisation of self-organisation market measures by operators in hard hit sectors and flexibility in fruits and vegetables, wine and some other market support programmes . ||| This will be used primarily for the direct payments to farmers, including eco-schemes, as well as for market related expenditure such the wine national support programmes, the support to producer organisations in the fruit & vegetables sector, the school schemes, support to the outermost regions and the smaller Aegean islands, agricultural information, etc. ||| Le train de mesures présenté aujourd'hui comprend des mesures portant sur l' aide au stockage privé dans les secteurs des produits laitiers et de la viande, sur l'autorisation d'adopter des mesures d'auto-organisation du marché par les opérateurs dans les secteurs durement touchés et sur la flexibilité dans les programmes de soutien du marché pour les fruits et légumes, le vin et autres produits.
0.4912506341934204 ||| The publication by the EMEA of a catalogue is a positive action by the EMEA towards better access to documents and transparency, in line with Declaration No 17 of the Amsterdam Treaty on European Union. ||| The results published by the European Environment Agency (EEA) and the European Commission give a good indication where swimmers can find the best quality bathing waters. ||| La publication par l’EMEA de ce catalogue est une action concrète destinée à l’amélioration de l’accès aux documents et de la transparence, conformément à la déclaration n° 17 du traité d’Amsterdam.
0.27631476521492004 ||| If the haemoglobin increase is < 1 g/ dl (< 0.62 mmol/ l) and the reticulocyte count has increased < 40,000 cells/ µl above baseline, increase the dose to 300 IU/ kg 3 times per week. ||| If the haemoglobin exceeds 13 g/ dl (8.1 mmol/ l), discontinue therapy until it falls below 12 g/ dl (7.5 mmol/ l) and then reinstitute epoetin alfa therapy at a dose 25% below the previous level. ||| Si la hausse du taux d’ hémoglobine est < 1 g/ dl (< 0,62 mmol/ l) et que le taux de réticulocytes a augmenté < 40 000 cellules/ µl au-dessus des valeurs initiales, il convient d’ augmenter la dose à 300 UI/ kg 3 fois par semaine.
0.38084208965301514 ||| Bacteriological preparations for use in agriculture ||| Chemically treated peat for use in agriculture ||| Préparations bactériologiques destinées à l'agriculture
0.15548227727413177 ||| Revasc 15mg/ 0.5ml powder and solvent for solution for injection Desirudin ||| BEROMUN 1 mg/ 5 ml powder and solvent for solution for infusion Tasonermin ||| Revasc 15 mg/ 0,5 ml poudre et solvant pour solution injectable Désirudine
0.3915083706378937 ||| Hepatic function Transient, asymptomatic elevations of hepatic transaminases, ALT, AST have been seen commonly, especially in early treatment. ||| No clinically significant differences were observed for QT, PR, QRS, or QTcB measurements between duloxetine- treated and placebo-treated patients. ||| 64 Des élévations transitoires et asymptomatiques des transaminases (ALAT et ASAT) ont été fréquemment observées notamment en début de traitement.
0.3411487340927124 ||| Electronic game software for wireless devices ||| Computer software for wireless content delivery ||| Ludiciels électroniques pour dispositifs sans fil
0.37099820375442505 ||| Reagents for industrial purposes ||| Reagent paper for veterinary purposes ||| Réactifs à usage industriel
0.38858556747436523 ||| Each tablet contains 10 mg adefovir dipivoxil. ||| One vial contains 3.2 mg of ibritumomab tiuxetan ||| Chaque comprimé contient 10 mg d’ adéfovir dipivoxil.
0.2811182141304016 ||| Actos tablets contain lactose monohydrate and therefore should not be administered to patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption. ||| Medicinal products containing duloxetine Duloxetine is used under different trademarks in several indications (treatment of diabetic neuropathic pain, major depressive episodes as well as stress urinary incontinence). ||| En raison de la présence de lactose monohydraté, les comprimés d’ ACTOS ne doivent pas être utilisés chez les patients présentant des troubles héréditaires rares d’ intolérance au galactose, un déficit en lactase ou une malabsorption du glucose et du galactose.
0.3450181484222412 ||| The effect of alternate-day administration of 250 microgram (8.0 million IU) of Betaferon on drug metabolism in multiple sclerosis patients is unknown. ||| Overdose as high as 19.2 MBq/ kg of [90Y]-radiolabelled Zevalin occurred in clinical trials. ||| L’ effet sur le métabolisme des médicaments d’ une administration tous les deux jours de Betaferon à la dose de 250 microgrammes (8,0 millions d’ UI) chez les patients atteints de sclérose en plaques n’ est pas connu.
0.3968479633331299 ||| < 1 0 < 1 0 < 1 ||| 2 0 < 1 < 1 ||| < 1 0 < 1 0
0.0 ||| Pure Red Cell Aplasia caused by anti-erythropoietin antibodies has been reported in association with ESAs. ||| Pure Red Cell Aplasia caused by anti-erythropoietin antibodies has been reported in association with ESAs. ||| 184 Des cas d'érythroblastopénie dus à des anticorps anti-érythropoïétine ont été rapportés lors de traitement par des ASE.
0.14752355217933655 ||| What benefit has TOVIAZ shown during the studies? ||| What benefit has CYSTAGON shown during the studies? ||| Quel est le bénéfice démontré par TOVIAZ au cours des études?
0.22862055897712708 ||| Infections and infestations Common: ||| Infections and Infestations Non known: ||| Infections et infestations
0.25557875633239746 ||| Simultaneous administration of Ciprofloxacin and phenytoin may result in increased or reduced serum levels of phenytoin such that monitoring of drug levels is recommended. ||| When aripiprazole was administered concomitantly with either valproate or lithium, there was no clinically important change in valproate or lithium concentrations. ||| L’administration simultanée de ciprofloxacine et de phénytoïne peut entraîner une augmentation ou une réduction des taux sériques de phénytoïne, si bien qu’il est recommandé de contrôler la concentration du médicament.
3.098545183453927e-13 ||| Multi-packs of 196 (2 packs of 98 film-coated tablets) – without blue box - 50 mg/ 850 mg film- coated tablets ||| Multi-packs of 196 (2 packs of 98 film-coated tablets) – without blue box - 50 mg/ 850 mg film- coated tablets ||| Conditionnement multiple de 196 comprimés pelliculés (2 étuis de 98) – sans Blue Box – pour Janumet 50 mg/ 850 mg, comprimés pelliculés
0.1390620619058609 ||| Justification for not including Braille accepted ||| Justification for not including Braille accepted. ||| Justification de ne pas inclure le Braille acceptée
0.4262176752090454 ||| There have not been any reported instances of systemic toxicity resulting from accidental injection of BOTOX. ||| There were no significant changes in ECG parameters and no signs of digoxin toxicity were observed. ||| Il n'a été enregistré aucun cas de toxicité systémique résultant d'une injection accidentelle de BOTOX.
0.7363449335098267 ||| See the package leaflet for further information. ||| You can follow the meeting from this link . ||| Voir la notice pour un complément d’ information.
0.07111267745494843 ||| What is the risk associated with Imprida? ||| What is the risk associated with Raptiva? ||| Quels sont les risques associés à l’ utilisation d’ Imprida?
0.1525518000125885 ||| Garden stakes of non-metallic materials ||| Bed springs of non-metallic materials ||| Piquets de jardin en matériaux non métalliques
0.29794183373451233 ||| It is recommended that a test for FeLV antigenaemia be carried out prior to vaccination. ||| It is recommended to confirm the diagnosis by conducting an IGF-1 generation test. ||| Il est recommandé de vérifier le statut antigénique vis-à-vis du FeLV avant la vaccination.
0.0016914039151743054 ||| Each vial contains nominally 250 IU nonacog alfa (recombinant coagulation factor IX). ||| Each vial contains nominally 500 IU nonacog alfa (recombinant coagulation factor IX). ||| Chaque flacon contient nominalement 1000 UI de nonacog alfa (Facteur IX de coagulation recombinant).
0.498150497674942 ||| The volume of distribution at steady state adjusted for bioavailability is 0.57 l/ kg in patients with Sickle Cell Syndrome (amounting to approximately 72 and 90 l in children and adults, respectively). ||| Disposition parameters were not influenced to a clinically relevant extent by age (1– 11 years), body weight (9– 37 kg) or body surface area (0.44 – 1.20 m2) in this age group. ||| Le volume de distribution à l'état d'équilibre, après ajustement en fonction de la biodisponibilité, est de 0,57 L/ kg chez les patients atteints de drépanocytose (soit approximativement 72 L chez l'enfant et 90 L chez l'adulte).
0.3104887008666992 ||| Most of the patients received the study medication on top of conventional therapy including platelet inhibitors, lipid lowering agents and beta-blockers. ||| Serious reactions have been treated successfully with supportive therapy such as oxygen, beta-agonists, and corticosteroids. ||| La plupart des patients recevaient le traitement étudié en plus de leur thérapie usuelle incluant des antiagrégants plaquettaires, des hypolipémiants et des bêta- bloquants.
0.22034838795661926 ||| Caution should be used when co-administering medicinal products that induce CYP3A or potentially toxic medicinal products which are themselves metabolised by CYP3A (see section 4.3 and below). ||| EMEND should be used with caution in patients receiving concomitant orally administered active substances that are metabolised primarily through CYP3A4 (see section 4.5). ||| Des précautions doivent être prises lorsque sont administrés conjointement des médicaments inducteurs du CYP3A ou des médicaments potentiellement toxiques qui sont eux-mêmes métabolisés par le CYP3A (voir rubrique 4.3 et ci-dessous).
0.10945741832256317 ||| Effects of other medicinal products on duloxetine Antacids and H2 antagonists: co-administration of duloxetine with aluminium- and magnesium- containing antacids or duloxetine with famotidine had no significant effect on the rate or extent of duloxetine absorption after administration of a 40 mg oral dose. ||| Effects of other medicinal products on duloxetine Antacids and H2 antagonists: co-administration of DULOXETINE BOEHRINGER INGELHEIM with aluminium- and magnesium-containing antacids or with famotidine had no significant effect on the rate or extent of duloxetine absorption after administration of a 40 mg oral dose. ||| Effets des autres médicaments sur la duloxétine Anti-acides et anti-H2: la co-administration de la duloxétine avec des anti-acides à base de sels d'aluminium et de magnésium, ou avec la famotidine, n'a pas eu d'effet significatif sur le taux ou le délai d'absorption de la duloxétine après administration orale d'une dose de 40 mg.
0.5003529191017151 ||| S.A. ||| S R.O. ||| S. A.
0.0 ||| • EMADINE is not recommended for use in patients over 65 years of age, as it has not been studied in clinical trials in this age group. ||| • EMADINE is not recommended for use in patients over 65 years of age, as it has not been studied in clinical trials in this age group. ||| • EMADINE n’est pas recommandé chez les sujets de plus de 65 ans, étant donné que ce groupe n’a pas été étudié au cours des essais cliniques.
0.28821635246276855 ||| Nelarabine is indicated for the treatment of patients with T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. ||| Case reports of malignancies (including skin cancer, cutaneous T-Cell lymphoma (CTCL), Non- Hodking lymphoma (NHL) and systemic malignancies) have been received during the clinical development and post-marketing experience in association with the use of Protopic. ||| La nélarabine est indiquée dans le traitement des patients ayant une leucémie aiguë lymphoblastique à cellules T (LAL-T) ou un lymphome lymphoblastique à cellules T, non répondeurs ou en rechute après au moins deux lignes de chimiothérapie.
0.3656255602836609 ||| Your doctor will advise you if you should stop feeding for a short time after your ultrasound examination. ||| In some cases, your doctor may choose to use two injections to complete the ultrasound examination. ||| Votre médecin vous indiquera si vous devez arrêter l'allaitement sur une courte période après l'échographie.
0.10780976712703705 ||| IONSYS should not be used in patients who may be particularly susceptible to the intracranial effects of CO2 retention, such as those with evidence of increased intracranial pressure, impaired consciousness, or coma. ||| Effentora should only be administered with extreme caution in patients who may be particularly susceptible to the intracranial effects of CO2 retention, such as those with evidence of increased intracranial pressure or impaired consciousness. ||| IONSYS ne doit pas être utilisé chez des patients qui peuvent avoir une sensibilité particulière aux effets intracrâniens de la rétention de CO2, comme ceux présentant des signes d’ augmentation de la pression intracrânienne, une altération de la conscience ou ceux se trouvant dans le coma.
0.5862420201301575 ||| The specificity estimates were all above 90% with corresponding lower confidence limits ranging from 85% to 90%. ||| ASAS 50 and 70 responses used the same criteria with a 50% improvement or a 70% improvement, respectively. ||| Les estimations de spécificité ont toutes été supérieures à 90% avec un intervalle de confiance allant de 85% à 90%.
0.08723856508731842 ||| If the rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in four weeks reduce the dose by approximately 25%, depending on the rate of increase. ||| If the rise in haemoglobin is greater than 2 g/ dl (1.3 mmol/ l) in 4 weeks, the dose should be reduced by 25 to 50%. ||| Si le taux d’ hémoglobine augmente de plus de 2 g/ dl (1,25 mmol/ l) sur une période de 4 semaines, réduire la dose d’ environ 25% en fonction de l’ importance de cette augmentation.
0.452380508184433 ||| The increase in the number of mutual recognition procedures is expected to continue in 2000-2001. ||| With the increasing workload it will be necessary to review the processing of variation applications in 1997. ||| L’augmentation du nombre de procédures de reconnaissance mutuelle devrait se poursuivre en 2000-2001.
0.009136456996202469 ||| In healthy elderly (65 and over) versus non-elderly subjects, the mean elimination half-life was prolonged (51.8 versus 33.8 hr) and the clearance was reduced (17.5 versus 18.2 l/ hr). ||| 96 In healthy elderly (65 and over) versus non-elderly subjects, the mean elimination half-life was prolonged (51.8 versus 33.8 hr) and the clearance was reduced (17.5 versus 18.2 l/ hr). ||| 142 Chez le sujet sain âgé (65 ans et plus), par rapport au sujet sain jeune, la demi-vie moyenne d’ élimination de l’ olanzapine est prolongée (51,8 versus 33,8 heures) et la clairance est réduite (17,5 vs 18,2 l/ heure).
0.010740402154624462 ||| 52 Although there is elimination of radioactivity in urine after administration of radiolabelled etanercept to patients and volunteers, increased etanercept concentrations were not observed in patients with acute renal or hepatic failure. ||| Although there is elimination of radioactivity in urine after administration of radiolabelled etanercept to patients and volunteers, increased etanercept concentrations were not observed in patients with acute renal or hepatic failure. ||| Bien que l’ on détecte de la radioactivité dans les urines après l’ administration d’ etanercept radiomarqué à des patients et à des volontaires sains, aucune augmentation des concentrations d’ etanercept n’ a été observée chez les patients présentant une insuffisance rénale ou hépatique aiguë.
0.150518536567688 ||| Dental apparatus and instruments ||| Optical apparatus and instruments ||| Appareils et instruments dentaires
0.13564611971378326 ||| Neoclarityn orodispersible tablet is packed in unit dose blisters in packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 doses of orodispersible tablet. ||| Neoclarityn oral lyophilisate is packed in unit dose blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, and 100 doses of oral lyophilisate. ||| Neoclarityn comprimés orodispersibles est conditionné en dose unitaire sous plaquette thermoformée dans des étuis de 5, 6, 10, 12, 15, 18, 20, 30, 50, 90 et 100 comprimés orodispersibles.
0.04343453422188759 ||| The vials that are being used or about to be used are not to be kept in a refrigerator. ||| 163 The vials that are being used or about to be used are not to be kept in a refrigerator. ||| Les flacons en cours d’ utilisation ou sur le point d’ être utilisés, ne sont pas à conserver au réfrigérateur.
0.19199658930301666 ||| The recommended starting dose of TOVIAZ is 4 mg once a day. ||| The recommended dose of Rasilez HCT is one tablet per day. ||| La dose initiale recommandée de TOVIAZ est de 4 mg une fois par jour.
0.30346181988716125 ||| There is limited experience on the use of the medicinal product in patients with renal or hepatic impairment therefore caution with its use in such patients is advised. ||| • This pen is not recommended for use by blind or visually impaired persons without the assistance of a person trained in the proper use of the product. ||| Au vu du peu d’information sur l’emploi du médicament chez des patients atteints d’insuffisances rénale ou hépatique, il est conseillé de l’utiliser avec précaution chez ces patients.
0.2694157361984253 ||| Dosing of nevirapine at 150 mg/ m2 BID (after a two-week lead in at 150 mg/ m2 QD) produced geometric mean or mean trough nevirapine concentrations between 4- 6 µg/ ml (as targeted from adult data). ||| The antiviral response to tenofovir disoproxil fumarate was durable through 48 weeks (DAVG48 was -0.57 log10 copies/ ml, proportion of patients with HIV-1 RNA below 400 or 50 copies/ ml was 41% and 18% respectively). ||| Des doses de névirapine de 150 mg/ m2 deux fois par jour (après une période d’ initiation de 150 mg/ m2 une fois par jour) ont conduit à une moyenne géométrique ou une concentration plasmatique résiduelle moyenne entre 4 et 6 µg/ ml (comme attendu d’ après les données chez l’ adulte).
0.2120945304632187 ||| 163 ● Inject the solution by gently pushing the plunger all the way down. ● Pull the needle straight out of the skin. ● Press the injection site with a small bandage or sterile gauze if necessary for several seconds. ||| • Remove the needle from your skin. • Gently press the injection site with a small bandage or sterile gauze if necessary for a few seconds. • Do not massage the injection site. ||| • Injectez la solution en enfonçant doucement le piston jusqu’au bout. • Retirez l’aiguille en tirant tout droit. • Appuyez sur le site d’injection avec un petit pansement ou une compresse stérile si nécessaire pendant quelques secondes.
0.25266480445861816 ||| In 3% of the women treated with Puregon in clinical studies, signs and symptoms related to ovarian hyperstimulation syndrome (e. g. feeling sick, weight gain, diarrhoea) have been reported. ||| In clinical trials in complicated skin and soft tissue infections, the most common type of infection in tigecycline treated-patients was cellulitis (59%), followed by major abscesses (27.5%). ||| Chez 3% des femmes traitées par Puregon au cours des études cliniques, on a rapporté des signes et des symptômes liés au syndrome d’ hyperstimulation ovarienne (p. ex. sensation de malaise, prise de poids, diarrhée).
1.0616021156311035 ||| Its purpose is to explain ||| It explains how ||| Il explique comment
0.5589584112167358 ||| Construction of public works ||| Construction of cubicles ||| Construction de travaux publics
0.19709227979183197 ||| HOW TO STORE TORISEL ||| HOW TO STORE SINGULAIR ||| COMMENT CONSERVER TORISEL
0.2453422248363495 ||| 27 Table 2: ||| 7 Table 2: ||| Tableau 2:
0.020600315183401108 ||| In patients with an allergy to animal insulin intradermal skin testing is recommended prior to a transfer to Insulin Human Winthrop Comb 15, since they may experience immunological cross-reactions. ||| In patients with an allergy to animal insulin intradermal skin testing is recommended prior to a transfer to Insulin Human Winthrop Basal, since they may experience immunological cross-reactions. ||| Chez les patients présentant une allergie à l'insuline d'origine animale, il est recommandé de procéder à des tests intradermiques avant de passer à Insulin Human Winthrop Comb 15, en raison de la possibilité de réactions immunologiques croisées.
0.29997518658638 ||| COVERSYL should be introduced at a dose of 4 mg once daily for two weeks, then increased to 8 mg once daily, depending on renal function and provided that the 4 mg dose is well tolerated. ||| If the 50- mg/ m2 daily dose is well tolerated but does not provide an adequate clinical response, the daily dose can be increased to 70 mg/ m2 daily (not to exceed an actual daily dose of 70 mg). ||| Le traitement par COVERSYL devra être débuté à une dose de 4 mg une fois par jour pendant deux semaines, puis augmenté à 8 mg une fois par jour, compte tenu de la fonction rénale et à condition que la dose de 4 mg soit bien tolérée.
0.002010446973145008 ||| 118 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| 103 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| Si l’un des effets mentionnés s’aggrave ou si vous notez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.4186725318431854 ||| The use of vardenafil with Kaletra is contraindicated (see section 4.3). ||| For dosing instructions for Ceplene in combination with IL-2, see posology below. ||| L'association du vardénafil et de Kaletra est contre-indiquée (voir rubrique 4.3).
0.48664289712905884 ||| What CIALIS looks like and contents of the pack CIALIS 20 mg comes as yellow film-coated tablets. ||| What Neupro looks like and contents of pack 187 Neupro is a transdermal patch. ||| A quoi ressemble CIALIS et contenu de l’ emballage CIALIS 20 mg se présente sous forme de comprimés pelliculés jaunes.
0.25096946954727173 ||| Reduction of blood pressure with 0.5 mg/ kg (low), 1.5 mg/ kg (medium) and 4.5 mg/ kg (high) target titrated doses of irbesartan was evaluated in 318 hypertensive or at risk (diabetic, family history of hypertension) children and adolescents aged 6 to 16 years over a three week period. ||| Cardiovascular effects seen in animals (dogs) at exposure levels similar (0.25 mmol/ kg) and higher (1.25 mmol/ kg), respectively, to maximum clinical exposure levels were a dose dependent transient increase in blood pressure (5% and 10%, above saline control) and myocardial contractility (5% and 16%, above saline control). ||| La baisse de pression artérielle avec des doses, obtenues après titration, d'irbésartan de 0,5 mg/ kg (faible), 1,5 mg/ kg (moyenne) et 4,5 mg/ kg (forte) a été évaluée chez 318 enfants et adolescents hypertendus ou à risque (diabétiques, antécédents familiaux d'hypertension) âgés de 6 à 16 ans sur une période de trois semaines.
0.1951596736907959 ||| Cold frames (Non-metallic -) for horticultural use in seed germination ||| Cold frames (Non-metallic -) being protective enclosures for horticultural use ||| Châssis de couche non métalliques à usage horticole pour la germination des graines
3.376925204311848e-13 ||| Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. ||| Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. ||| L’ injection accidentelle/ l’ auto-injection peuvent provoquer de fortes douleurs et un gonflement intense, notamment en cas d’ (auto)injection dans une articulation ou un doigt de la main, et peut conduire dans de rares cas à la perte du doigt si un examen médical n'est pas effectué rapidement.
0.4988073706626892 ||| Ultratard is a cloudy, white, aqueous suspension. lon 4. ||| CELVAPAN is an off-white, opalescent, translucent liquid. ||| Ultratard est une suspension aqueuse, blanche et opaque. 'es 4.
0.1435098648071289 ||| Ask your pharmacist how to dispose of medicines no longer required. ||| 251 Ask your pharmacist how to dispose of medicines that are no longer required. ||| Demandez à votre pharmacien ce qu'il faut faire des médicaments inutilisés.
0.0 ||| This also applies to unknown or emerging viruses and other pathogens. ||| This also applies to unknown or emerging viruses and other pathogens. ||| Ceci s’ applique également aux virus inconnus ou émergents et à d’ autres agents pathogènes.
0.3700907230377197 ||| This increases the amount of oxygen carried in the blood in the arteries, helping to reduce the symptoms of anaemia. ||| With this condition, parts of the bone tissue die because of reduced blood supply to the bone. ||| Il en résulte une augmentation de la quantité d’ oxygène transportée dans le sang à travers les artères, ce qui contribue à réduire les symptômes d’ anémie.
0.21456646919250488 ||| Waterproofing of clothing ||| Cleaning of footwear ||| Imperméabilisation de vêtements
0.29507777094841003 ||| Pharmacokinetics in children and the elderly: in children between the ages of 2 and 13 years, the clearance of orally administered nelfinavir is approximately 2 to 3 times higher than in adults, with large intersubject variability. ||| Elderly (≥ 65 years) As metformin is excreted via the kidney, and elderly patients have a tendency to decreased renal function, elderly patients taking Zomarist should have their renal function monitored regularly (see section 4.4). ||| Pharmacocinétique chez les enfants et les sujets âgés: chez les enfants âgés de 2 à 13 ans, la clairance du nelfinavir administré par voie orale est 2 à 3 fois plus élevée que chez l’adulte avec une grande variabilité interindividuelle.
0.5089860558509827 ||| The target haemoglobin concentration in two studies was > 13 g/ dL; ||| Patients who have baseline neutrophil counts < 1.5 x 109/ l. ||| La concentration visée d’ hémoglobine dans deux
0.014070927165448666 ||| 44 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 33 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 44 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.06776759028434753 ||| 73 ANNEX II ||| 85 ANNEX II ||| 77 ANNEXE II
0.0024517534766346216 ||| 12 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 20 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 12 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR OU, EN L’ ABSENCE D’ EMBALLAGE EXTÉRIEUR, SUR LE CONDITIONNEMENT PRIMAIRE
0.37203019857406616 ||| The pharmacokinetics are not altered with repeat dosing. ||| Pharmacokinetics were dose proportional and did not change over time. ||| La pharmacocinétique n’ est pas modifiée lors de prises répétées.
0.46015775203704834 ||| The CHMP was assessing the responses given by the Company to a list of questions. ||| The CHMP assessed the dossier and the available data, including the issues raised by the objecting CMS. ||| Le CHMP était en train d’ évaluer les réponses apportées par la société à une liste de questions.
0.41931256651878357 ||| 35 LABELLING ||| 24 25 LABELLING ||| 38 ETIQUETAGE
0.21788902580738068 ||| This product contains 2.9 mg of phenylalanine per 5 mg dose of Azomyr orodispersible tablet. ||| NeoRecormon Multidose contains up to 5.0 mg phenylalanine/ vial as an excipient. ||| Ce produit contient 2,9 mg de phenylalanine par comprimé orodispersible d’ Azomyr 5 mg.
0.5668456554412842 ||| Epilepsy is caused by excessive electrical activity in the brain. ||| - Influenza is an infection caused by the influenza virus. ||| L’ épilepsie est due à un excès d’ activité électrique dans le cerveau.
0.37428566813468933 ||| A minority of patients with orthostatic hypotension experienced syncopal events. ||| Four of these patients had clinical signs of thrombocytopenia. ||| Une minorité de patients ayant une hypotension orthostatique ont présenté des syncopes.
0.4114503264427185 ||| Pigs: ||| Tablets: ||| Porcs:
0.017490871250629425 ||| The Commission found that the Austrian schemes are in line with the conditions set out in the Temporary Framework. ||| The Commission found that the Polish schemes are in line with the conditions set out in the Temporary Framework. ||| La Commission a estimé que les régimes autrichiens étaient conformes aux conditions énoncées dans l'encadrement temporaire.
0.012326456606388092 ||| Silapo 10000 IU Injection Epoetin zeta iv/sc use ||| Silapo 6000 IU Injection Epoetin zeta iv/sc use ||| Silapo 10 000 UI solution injectable Époétine zêta Voie IV / SC
0.39578038454055786 ||| The inter-individual variation in kinetics may be large, up to 70 CV% for AUC. ||| Due to intra-patient variability, occasional individual haemoglobin values for a patient above and ic ||| La variation inter-individuelle de cinétique peut être importante, jusqu'à 70 CV% pour l'aire sous la courbe.
0.3619823157787323 ||| Hold the syringe with the needle in the vial pointing up. ||| - Turn the vial and the syringe upside down in one hand. ||| Maintenir la seringue avec l’aiguille dans le flacon, pointe vers le haut.
0.37497255206108093 ||| - The other ingredients of EVISTA tablets are: ||| - The other ingredients of the tablets are: ||| - Les autres composants des comprimés d’EVISTA sont:
0.7382662296295166 ||| Deliver over 3.2 billion doses of life-saving vaccines to 55 countries. ||| Some 400 million passenger trips/year will benefit from new or improved transport infrastructure ||| à distribuer plus de 3,2 milliards de doses de vaccins vitaux à 55 pays;
0.21296565234661102 ||| Nevertheless, in very rare instances, after microbiological documentation of the causative organism and evaluation of the risk/benefit balance, ciprofloxacin may be prescribed to these patients for the treatment of certain severe infections, particularly in the event of failure of the standard therapy or bacterial resistance, where the microbiological data may justify the use of ciprofloxacin. ||| In assessing the benefit/ risk of Oracea, the current situation of limited treatment options for rosacea was taken into consideration, as well as the fact that Oracea is expected to provide an alternative to the international guidelines recommending off-label use of doxycycline (or other tetracycline derivates) for the treatment of rosacea, with the associated decrease in risk for adverse events. ||| Dans de très rares cas, après isolement du germe en cause et évaluation du rapport risques/bénéfices, la ciprofloxacine pourra toutefois être prescrite à ces patients pour traiter certaines infections sévères, en particulier après échec du traitement conventionnel ou en présence d’une résistance bactérienne, si les résultats microbiologiques justifient le recours à la ciprofloxacine.
0.10781776160001755 ||| The patient should take one 20 mg film-coated tablet per day. ||| The patient should take one 15 mg film-coated tablet per day for 7 days. ||| Le patient doit prendre un comprimé pelliculé à 20 mg par jour.
0.37351804971694946 ||| Seats for railway cars ||| Booking of seats for rail travel ||| Sièges pour wagons de train
0.4680047333240509 ||| Cetrotide was as effective as the comparator treatments in preventing a surge (sudden increase) in the production of luteinising hormone. ||| - Nifedipine Pharmamatch retard is used to reduce the frequency of occurence of a tight, painful ||| Cetrotide s’ est avéré aussi efficace que les traitements auxquels il était comparé dans la prévention de la survenue d’ un pic (accroissement brutal) de la production d’ hormone lutéinisante.
0.5418153405189514 ||| Micronised amoxicillin (as trihydrate) ||| - Silica, colloidal anhydrous ||| Amoxicilline micronisée (sous forme de trihydrate)
0.5208425521850586 ||| In addition, 61% of patients had normal ALT at week 48. ||| In the once weekly group, 75% of patients required dose reductions. ||| En outre, 61% des patients présentaient un taux d’ ALAT normal à la semaine 48.
0.40123826265335083 ||| MicardisPlus is a combination of an angiotensin II receptor antagonist, telmisartan, and a thiazide diuretic, hydrochlorothiazide. ||| Pharmacotherapeutic group: angiotensin II antagonists, plain (valsartan), combinations with dihydropyridine derivatives (amlodipine), ATC code: ||| MicardisPlus est une association d’ un antagoniste des récepteurs de l’ angiotensine II, le telmisartan, et d’ un diurétique thiazidique, l’ hydrochlorothiazide.
0.4171321392059326 ||| These groups are leading efforts to develop and make available tests, treatments and vaccines for frontline health workers and those most vulnerable to the virus around the world. ||| With the measures we adopt today, we speed up the entry of safe, essential medical equipment and devices such as masks, gowns and suits in the EU market. ||| Ces entités déployent actuellement des efforts pour mettre au point et mettre à disposition des tests, des traitements et des vaccins pour les professionnels de la santé en première ligne et les personnes les plus vulnérables au virus dans le monde.
0.3197779655456543 ||| The mean steady-state trough concentration prior to the morning dose was 5.5 ± 4.0 μ g/ ml. ||| The mean apparent total body clearance following a 400 mg dose ranges from 179 to 246 ml/ min. ||| A l’ état d’ équilibre, les concentrations moyennes avant la prise du matin étaient de 5,5 ± 4,0 μ g / ml.
0.2309531271457672 ||| In aspirin-sensitive asthmatic patients receiving concomitant inhaled and/ or oral corticosteroids, treatment with montelukast, compared with placebo, resulted in significant improvement in asthma control (FEV1 8.55% vs -1.74% change from baseline and decrease in total β -agonist use -27.78% vs 2.09% change from baseline). ||| Vildagliptin added to patients whose glycaemic control was not satisfactory despite treatment with metformin monotherapy resulted after 6-month treatment in additional statistically significant mean reductions in HbA 1c compared to placebo (between group differences of -0.7% to -1.1% for vildagliptin 50 mg and 100 mg, respectively). ||| 24 Chez les patients asthmatiques intolérants à l’ aspirine recevant de façon concomitante un traitement par corticoïdes inhalés et/ ou per os, le traitement par montelukast a entraîné une amélioration significative par rapport au placebo du contrôle de l’ asthme (VEMS +8,55% contre -1,74% par rapport aux valeurs initiales et diminution de la consommation totale de bêta-mimétique, -27,78% contre 2,09% par rapport aux valeurs initiales).
0.5069239139556885 ||| The RSV hospitalisation rate was 9.7% in the placebo group and 5.3% in the Synagis group. ||| 3.4% in the orlistat group compared to 5.4% in the placebo-treated group). ||| Le taux d'hospitalisation a été de 9,7% dans le groupe placebo et de 5,3% dans le groupe Synagis.
0.47886452078819275 ||| Fentanyl passes into breast milk and may cause sedation and respiratory depression in the breast-fed child. ||| Parkinson’ s disease is a progressive brain disorder that causes shaking, slow movement and muscle stiffness. ||| Le fentanyl est excrété dans le lait maternel et peut entraîner une sédation et/ ou une dépression respiratoire chez le nourrisson.
0.3560974597930908 ||| In all cases, doses should be adjusted depending on the levels of haemoglobin (a protein in red blood cells that carries oxygen around the body), which should be monitored every two weeks until they are stable, and then periodically. ||| Patients should be monitored during treatment to see how they respond, but also to check their blood levels of platelets (the components that help clotting) and neutrophils (the white blood cells that fight infection): if these are too low the treatment should be interrupted or stopped. ||| Dans tous les cas, les doses doivent être ajustées en fonction du taux d’ hémoglobine (protéine présente dans les globules rouges qui transporte l’ oxygène dans le corps), qui doit être mesuré toutes les deux semaines jusqu’ à ce qu’ il soit stable, puis périodiquement par la suite.
0.5403655171394348 ||| How to use M-M-RVAXPRO 4. ||| Solvent for M-M-RVAXPRO Water for injections ||| Comment utiliser M-M-RVAXPRO 4.
0.259299635887146 ||| Therapy with NeoRecormon should be initiated by physicians experienced in the above mentioned indications. ||| Nespo treatment should be initiated by physicians experienced in the above mentioned indications. du ||| L’ initiation du traitement par NeoRecormon relève de praticiens expérimentés dans les domaines thérapeutiques cités ci-dessus.
0.35313332080841064 ||| Patients who have developed severe hypersensitivity reactions should not be re-challenged with docetaxel. ||| Patients switched to therapy should not receive anti- lymphocyte treatment concomitantly. ||| Le docétaxel ne doit pas être réadministré aux patients ayant présenté des réactions d'hypersensibilité sévères.
0.0043682679533958435 ||| Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription ||| Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription ||| Utilisation d'autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.36269986629486084 ||| Power-operated nailing guns ||| Power-operated potters' wheels ||| Pistolets à clouer électriques
0.33089500665664673 ||| Rebif 22 micrograms is a solution for injection in a pre-filled syringe with a fixed needle for self-administration. ||| This NeoRecormon presentation is a two-chamber cartridge containing lyophilisate for solution for injection and preserved solution. ||| Rebif 22 microgrammes se présente sous la forme d’une solution injectable en seringue préremplie avec une aiguille fixe permettant l’auto-administration.
0.38181278109550476 ||| Insulins have no specific overdose definitions because serum glucose concentrations are a result of complex interactions between insulin levels, glucose availability and other metabolic processes. ||| The ultrasound echoes from blood and biological soft tissues such as fat and muscles are generated at interfaces due to small differences in the ultrasonic properties of the tissues. ||| En effet, la glycémie résulte d'interactions complexes entre les taux d'insuline sérique, la disponibilité du glucose et d'autres processus métaboliques.
0.2415650337934494 ||| 28 Potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances that may increase potassium levels If a medicinal product that affects potassium levels is to be prescribed in combination with valsartan, monitoring of potassium plasma levels is advised. ||| Conversely, based on the experience with the use of other medicinal products that blunt the renin-angiotensin system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other medicinal products that may increase serum potassium levels (e. g. heparin sodium) may lead to increases in serum potassium. ||| Diurétiques épargneurs de potassium, suppléments potassiques, substituts du sel contenant du potassium et autres substances susceptibles d'augmenter les taux de potassium Une surveillance de la kaliémie est conseillée en cas d’ association concomitante d’ un médicament modifiant les taux de potassium avec le valsartan.
0.13045915961265564 ||| In the end of May the Commission announced the next steps in the Coronavirus Global Response, namely the launch of a new campaign with the international advocacy organisation Global Citizen, "Global Goal: Unite For Our Future", that will culminate in a Global Pledging Summit on 27 June. ||| The pledging marathon that started on 4 May will now see the launch of a new campaign with the international advocacy organisation Global Citizen, "Global Goal: Unite For Our Future", that will culminate in a Global Pledging Summit on Saturday 27 June. ||| À la fin du mois de mai, la Commission a annoncé la prochaine étape de la Réponse mondiale au coronavirus, à savoir le lancement d'une nouvelle campagne avec l'organisation internationale de défense des citoyens Global Citizen, «Objectif mondial: Unis pour notre avenir», qui aboutira à un sommet mondial des donateurs le 27 juin.
0.6338301301002502 ||| First dose: ||| Fourth dose: ||| Première dose:
0.0 ||| All interaction studies, when otherwise not stated, were performed using Kaletra capsules, which gives an approximately 20% lower exposure of lopinavir than the 200/ 50 mg tablets. ||| All interaction studies, when otherwise not stated, were performed using Kaletra capsules, which gives an approximately 20% lower exposure of lopinavir than the 200/ 50 mg tablets. ||| Toutes les études d’ interaction, en l’ absence d’ indication contraire, ont été réalisées avec Kaletra capsule molle qui produit une exposition au lopinavir d’ environ 20% inférieure à celle produite par les comprimés à 200/ 50 mg.
0.30925267934799194 ||| Pistons for cylinders ||| Cylinders for mills ||| Pistons de cylindres
3.0639846129026926e-13 ||| In some cases, your doctor may recommend that you take iron supplements. ||| In some cases, your doctor may recommend that you take iron supplements. ||| Dans certains cas, votre médecin vous recommandera une supplémentation en fer.
0.0 ||| Shelf-life after first opening the container: ||| Shelf-life after first opening the container: ||| Durée de conservation après ouverture:
0.4634506106376648 ||| What is OPATANOL? ||| What is TRAVATAN? ||| Qu’ est -ce qu’ OPATANOL?
0.11902415752410889 ||| MIRAPEXIN should not be used during breast-feeding. ||| TESAVEL should not be used during breast-feeding. ||| MIRAPEXIN ne doit pas être utilisé pendant l’ allaitement.
0.6042832136154175 ||| 50 mg / 2 ml ||| 2 x 80 mg hard capsule ||| 50 mg/ 2ml
0.2407304048538208 ||| How to take Circadin 4. ||| How to take Procoralan 4. ||| Comment prendre Circadin 4.
0.37364622950553894 ||| It is not recommended for patients who have very severe problems with their kidneys that requires dialysis or severe liver problems. ||| Doctors should monitor the kidneys carefully in patients with moderate or severe kidney problems. ||| Il n’ est pas recommandé chez les patients atteints de très graves problèmes de reins nécessitant une dialyse ni chez ceux souffrant de graves problèmes de foie.
0.31202536821365356 ||| The most common side effects seen with RILUTEK (in more than 1 patient in 10) are nausea (feeling sick), asthenia (weakness) and abnormal liver tests (increased in liver enzymes levels). ||| Life-threatening bleeding events (including intracranial bleeding) were uncommonly reported (≥ 1/ 1,000 to < 1/ 100) in patients with acute coronary syndrome included in clinical studies. ||| Les effets indésirables les plus fréquemment observés avec RILUTEK (observés chez plus de 1 patient sur 10) sont la nausée (envie de vomir), l’ asthénie (faiblesse) et une anomalie des tests hépatiques (augmentation du taux d’ enzymes du foie).
0.24948854744434357 ||| FOLDING BOX FOR 1 VIAL AND 1 AMPOULE AS INTERMEDIATE PACK (WITHOUT BLUE BOX) ||| CARTON AND LABEL FOR 50 g BOTTLE AS INTERMEDIATE PACK / COMPONENT OF A MULTIPACK (WITHOUT BLUE BOX) ||| ETUI CARTON POUR 1 FLACON ET 1 AMPOULE COMME CONDITIONNEMENT INTERMEDIAIRE (SANS LA BLUE BOX)
0.07934817671775818 ||| 54 9. ||| 56 9. ||| 60 9.
0.2759989798069 ||| Bondenza 3 mg solution for injection in pre-filled syringes is a clear colourless solution. ||| ProQuad powder and solvent for suspension for injection in a pre-filled syringe. ||| Bondenza 3 mg solution injectable en seringue pré-remplie est une solution incolore et limpide.
0.07734033465385437 ||| Changes in strength, brand (manufacturer), type (fast-, dual-, long-acting insulin etc.), origin (animal, human or analogue insulin) and/ or method of manufacture (recombinant DNA versus animal source insulin) may result in a need for a change in dosage. ||| Changes in strength, brand (manufacturer), type (regular, NPH, lente, etc.), species (animal, human, human insulin analogue), and/ or method of manufacture (recombinant DNA versus animal-source insulin) may result in the need for a change in dosage. ||| 38 rapide, intermédiaire, prolongée, etc.), d’ origine (animale, humaine ou analogue de l’ insuline humaine) et/ ou de méthode de fabrication (ADN recombinant ou insuline d’ origine animale) peuvent nécessiter un changement de posologie.
0.40305760502815247 ||| Cefuroxime axetil kills bacteria and it can be used against various sorts of infections. ||| This medicinal product contains the azo colouring agent E110 which may cause allergic reactions. ||| CEFUROXIME AXETIL agit en tuant les bactéries et peut être utilisé dans différents types d’ infections.
0.25073012709617615 ||| 56 For the purpose of ambulatory use, the patient may remove Binocrit from the refrigerator and store it not above 25°C for one single period of up to 3 days. ||| Once the cartridge is mixed it can be stored outside the refrigerator at temperatures below 25°C for up to 7 days during the 28 day use period.(see section 6.3). ||| Pour l’ usage ambulatoire, le patient peut sortir Binocrit du réfrigérateur et le conserver à une température ne dépassant pas 25°C pour une seule période de 3 jours maximum.
0.014259837567806244 ||| 144 6.6 Special precautions for disposal ||| 204 6.6 Special precautions for disposal ||| 156 6.6 Précautions particulières d’ élimination
0.012735404074192047 ||| Clean the rubber stoppers on the vials with alcohol swabs and allow them to dry before use. ||| Clean the rubber stoppers on the vials with the alcohol swabs and allow them to dry before use. ||| Nettoyez les bouchons en caoutchouc des flacons avec des tampons imbibés d’ alcool et laissez sécher avant l’ utilisation.
0.06995199620723724 ||| Up to three vials of product may be dissolved in 1 ml of solvent. ||| Up to 3 containers of powder may be dissolved in 1 ml of solvent. ||| Jusqu’ à 3 flacons de poudre peuvent être dissous dans 1 ml de solvant.
0.26045623421669006 ||| In addition, no osteosarcomas have been observed in clinical trials or during the post treatment follow-up study. ||| In the target animal safety study and the clinical trials, including long-term treatment, no signs of bone marrow suppression were observed. ||| De plus, aucun cas d’ ostéosarcome n'a été observé lors des essais cliniques ou au cours de l’ étude de suivi après l’ arrêt du traitement.
0.14492586255073547 ||| Frequency not ||| Frequency Not ||| Fréquence
0.2586701512336731 ||| Use in patients with severe renal impairment (creatinine clearance < 30 ml/ min/ 1.73 m2) is not recommended (see sections 4.4 and 5.2). ||| Severe renal impairment (creatinine clearance < 30 ml/ min) (see sections 4.2 and 5.2). ||| Son utilisation est déconseillée chez les patients atteints d’ insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min/ 1,73m2; cf rubriques 4.4 et 5.2).
0.4563853144645691 ||| 0.6%); Cough (G3/ 4: ||| 76.4%); 0.2%) Anaemia (G3/ 4: ||| 0,6%); Toux (G3/ 4:
0.3003949522972107 ||| To compare the efficacy of anagrelide and hydroxyurea in terms of the platelet count after 6 months of treatment. ||| Fluoride ion concentrations are influenced by the duration of anaesthesia and the concentration of sevoflurane. ||| Comparer l’ efficacité de l’ anagrélide et de l’ hydroxyurée en termes de numération plaquettaire après 6 mois de traitement.
0.18541663885116577 ||| It is available as a concentrate to be made up into a solution for infusion (drip into a vein) and as 50 mg tablets. ||| It is available as a powder to be made up into a solution for infusion (drip into a vein). ||| Il est disponible en solution à diluer pour perfusion (goutte-à-goutte dans une veine) et en comprimés de 50 mg.
0.5002143979072571 ||| The working parties continued to provide recommendations to the CPMP, mainly in the form of CPMP and ICH guidelines. ||| The working group considered 19 issues at the request of the CPMP and 39 issues at the request of the Member States. ||| Ces groupes de travail ont continué à fournir des recommandations au CPMP, essentiellement sous la forme de lignes directrices du CPMP et de l’ICH.
0.35015445947647095 ||| Further training, language courses and retraining for staff ||| 112 Further training, language courses and retraining for staff 1120 ||| Formation continue, cours de langues et recyclage pour le personnel
0.4821471571922302 ||| Conducting of entertainment activities ||| Conducting of medical examinations ||| Conduite d’activités de divertissement
0.9182576537132263 ||| 750 mg 250 mg/ 5 ml 2 mg/ ml 2 mg/ ml ||| 0.5 g / 10 ml 2.5 g / 50 ml 5 g / 100 ml 10 g / 200 ml 20 g / 400 ml ||| 400 mg/ 200 Solution pour perfusion ml
0.6444251537322998 ||| ⋅ to complete the processing of all (100%) applications for new MRLs within the legislative time frame ||| Decisions to maintain meetings with external individual visitors (fewer than 5) are taken on a case -by -case basis. ||| ⋅ traiter toutes les demandes (100%) de LMR pour des produits nouveaux dans les délais réglementaires
0.3640183210372925 ||| Blood counts should be assessed prior to starting treatment with Diacomit. ||| Patients treated with Humira should be given the special alert card. ||| La numération-formule sanguine doit être vérifiée avant l’ instauration du traitement par Diacomit.
0.03969767689704895 ||| Orfadin should not be used in people who may be hypersensitive (allergic) to nitisinone or any of the other ingredients. ||| Invirase should not be used in people who may be hypersensitive (allergic) to saquinavir or any of the other ingredients. ||| Orfadin ne doit pas être utilisé chez les patients susceptibles de présenter une hypersensibilité (allergie) à la nitisinone ou à l’ un de ses autres composants.
0.31843656301498413 ||| ivabradine pharmacokinetic is minimal, in relation with the low contribution of renal clearance (about 20%) to total elimination for both ivabradine and its main metabolite S 18982 (see section 4.2). ||| Risperidone Venlafaxine increased the risperidone AUC by 50%, but did not significantly alter the pharmacokinetic profile of the total active moiety (risperidone plus 9-hydroxyrisperidone). ||| 60 ml/ min) sur la pharmacocinétique de l’ ivabradine est minime, compte tenu de la faible contribution de la clairance rénale (environ 20%) dans l’ élimination totale de l’ ivabradine et de son principal métabolite S18982 (voir rubrique 4.2).
0.4379950761795044 ||| 34 RENAAL-Study The Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan RENAAL study was a controlled clinical study conducted worldwide in 1513 Type 2 diabetic patients with proteinuria, with or without hypertension. ||| Week 12 Virological Response (VR) and Sustained Virological Response (SVR) in Patients with Virological Response at Week 12 after Treatment with Pegasys and Ribavirin Combination Therapy in Nonresponders to Peginterferon alfa-2b plus Ribavirin. ||| Etude RENAAL L’ étude RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan) était une étude clinique contrôlée internationale menée chez 1 513 patients diabétiques de type 2 présentant une protéinurie avec ou sans hypertension.
0.004585404880344868 ||| 23 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 22 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 24 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.29398781061172485 ||| Hepsera is supplied in high-density polyethylene (HDPE) bottles with a child-resistant closure. ||| Norvir oral solution is supplied in amber coloured multiple-dose polyethylene terephthalate (PET) bottles in a 90 ml size. ||| Hepsera est fourni en flacon en polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant.
0.09405921399593353 ||| Truvada should always be used combined with other medicines to treat HIV infection. ||| Emtriva should always be combined with other medicines to treat HIV infection. ||| Truvada doit toujours être utilisé en association avec d’ autres médicaments pour le traitement de l’ infection par le VIH.
0.174251988530159 ||| Kivexa 600 mg/ 300 mg film-coated tablets abacavir/ lamivudine ||| Kaletra 100 mg/ 25 mg film-coated tablets lopinavir/ ritonavir ||| Kivexa 600 mg/ 300 mg – comprimés pelliculés abacavir/ lamivudine
0.3627157211303711 ||| Your Bondronat tablets should be taken after an overnight fast (at least 6 hours) and before the first food or drink of the day. ||| Ibandronic acid was taken 60 minutes before the first food or drink of the day (post-dose fasting period). ||| Aliments et boissons Vos comprimés de Bondronat doivent être pris le matin (après un jeûne d’ au moins 6 heures) et avant la première prise d’ aliments ou de boissons de la journée.
0.6340639591217041 ||| Strain specific anti-HA ||| Anti-rust greases ||| 5 Anticorps anti-HA spécifiques
0.3371604382991791 ||| If you notice any symptoms of infection, please tell your doctor immediately. ||| If you experience severe muscle pain, you should seek medical attention immediately. ||| Si vous remarquez des symptômes d’ infection, veuillez en informer immédiatement votre médecin.
0.23762372136116028 ||| What is Kineret? ||| What is Posatex? ||| Qu’ est -ce que Kineret?
0.3576909899711609 ||| It is not recommended to co- administer efavirenz and VIRAMUNE, because of additive toxicity and no benefit in terms of efficacy over either NNRTI alone. ||| Renal disease has no influence on the atorvastatin plasma concentrations nor lipid effects of {PRODUCT NAME}; thus, no adjustment of dose is required. ||| L’ association éfavirenz et VIRAMUNE n’ est pas recommandée à cause d’ une toxicité accrue et de l’ absence de bénéfice en terme d’ efficacité par rapport à l’ administration d’ un INNTI seul.
0.4467577040195465 ||| Antiacids can interfere with gastro-intestinal absorption of quinolones. ||| Raised blood levels of immunosuppressants (decreased hepatic metabolism). ||| Les antiacides peuvent interférer avec l’ absorption gastro-intestinale des quinolones.
0.34919458627700806 ||| The following have not been reported in association with administration of Menitorix but have occurred very rarely during routine use of licensed meningococcal group C conjugate vaccines: ||| Long- term persistence of antibodies has not been investigated after administration of a primary series in infants plus booster or after administration of single priming doses to older children. ||| Les effets suivants n’ ont pas été rapportés en association avec l’ administration du Menitorix mais sont survenus très rarement lors de l’ utilisation en routine de vaccins conjugués méningococciques du groupe C commercialisés:
0.20994225144386292 ||| Fluid creams [cosmetics] ||| Tanning milks [cosmetics] ||| Crèmes fluides [cosmétiques]
0.1815032660961151 ||| Latvija Bauskas 58a -401 Rīga, LV-1004 Tel: + 371-7 21 38 25 ||| 70 Latvija Bauskas 58a-401 Rī ga, LV-1004 Tel: + 371-7 21 38 25 ||| 33 United Kingdom Latvija Bauskas 58a° -401 Rīga LV-1004 Tel: + 371-7 21 38 25
0.21949349343776703 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Tekturna to Novartis Europharm Limited on 22 August 2007. ||| Other information about Exjade The European Commission granted a marketing authorisation valid throughout the European Union for Exjade to Novartis Europharm Limited on 28 August 2006. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Tekturna à Novartis Europharm Limited le 22 août 2007.
0.5226260423660278 ||| Leads for use with implantable cardiac stimulators ||| Brushes adapted to receive a cleaning agent ||| Électrodes pour stimulateurs cardiaques implantables
3.0217237674719233e-13 ||| Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human M ||| Overall survival outcome in the trials could not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human M ||| Ces résultats sur la survie globale n’ ont pas pu être expliqués de façon satisfaisante par des différences d’ incidence de survenue de thromboses et de leurs complications en
0.39819690585136414 ||| In intensified post-marketing surveillance in HIT type II, fatal bleeding was reported in 1% and intracranial bleeding in 0.2% of patients. ||| In ADDRESS, the percent of treated patients experiencing a serious bleeding event by site of haemorrhage was similar to that observed in PROWESS. ||| Lors de la surveillance post-marketing intensive, dans la TIH de type II, ont été rapportées des hémorragies fatales chez 1% des patients et des hémorragies intracrâniennes chez 0,2% des patients.
0.30387258529663086 ||| On June 6, 1995 Denmark presented a referral under Article 12 of Council Directive 75/ 319/ EEC as amended, and asked the CPMP to formulate an opinion on risks and benefits of ZAGAM 200 mg (Sparfloxacin) tablets. ||| Sanofi Pasteur MSD on behalf of all the Marketing Authorisation Holders, (see Annex I of opinion) applied for harmonisation according to Article 30 of Directive 2001/ 83/ EC, as amended, of their medicinal products STAMARIL and associated names. ||| Le 6 juin 1995, le Danemark a saisi le C. S. P., en application de l'article 12 de la directive 75/ 319/ CEE du Conseil telle que modifiée, pour qu’ il émette un avis sur les risques et les bénéfices des comprimés de ZAGAM à 200 mg (Sparfloxacine).
0.34566730260849 ||| Iron alum ||| Aluminium alum ||| Alun de fer
6.867044910138786e-13 ||| [To be completed nationally] ||| [To be completed nationally] ||| [À remplir au niveau national]
0.009801935404539108 ||| Each film-coated tablet contains 15 mg of memantine hydrochloride equivalent to 12.46 mg memantine. ||| Each film-coated tablet contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine. ||| Chaque comprimé pelliculé contient 15 mg de chlorhydrate de mémantine équivalent à 12,46 mg de mémantine base.
0.5012212991714478 ||| 10, A-6250 Kundl, Austria ||| 61, D-81673 München, Germany. ||| 10, A-6250 Kundl, Autriche
0.2676798701286316 ||| Plasma levels of certain HIV-1 protease inhibitors, which are metabolised predominantly by CYP3A4, can be increased by the co-administration of low-dose ritonavir, which is an inhibitor of this metabolism. ||| The administration of mitotane alters the extra-adrenal metabolism of cortisol in humans, leading to a reduction in measurable 17-hydroxy corticosteroids, even though plasma levels of corticosteroids do not fall. ||| Les concentrations plasmatiques des certains inhibiteurs de la protéase du VIH-1, qui sont métabolisés principalement par le CYP3 A4, peuvent être augmentées par la co-administration de faibles doses de ritonavir qui est un inhibiteur de ce métabolisme.
0.4612613916397095 ||| Elderly Patients: ||| Hypertensive Patients: ||| Patients âgés:
0.2286946177482605 ||| It is not known whether teriparatide is excreted in human milk. ||| It is not known whether anagrelide hydrochloride is excreted in milk. ||| Le passage du tériparatide dans le lait maternel n’ est pas connu.
0.2576020359992981 ||| MicardisPlus is used to treat high blood pressure (essential hypertension) in patients whose blood pressure is not controlled enough when either telmisartan or hydrochlorothiazide is used alone. ||| MicardisPlus fixed dose combination (80 mg telmisartan/ 12.5 mg hydrochlorothiazide) is indicated in patients whose blood pressure is not adequately controlled on telmisartan alone. ||| MicardisPlus est utilisé pour traiter une pression artérielle élevée (hypertension artérielle essentielle) chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le telmisartan ou l’hydrochlorothiazide seuls.
0.3629024624824524 ||| Do not use Paxene: ||| Do not use RotaTeq if: ||| N’ utilisez pas Paxene:
0.3233274817466736 ||| In the 30-week placebo-controlled clinical trials, concomitant use of BYETTA and HMG CoA reductase inhibitors was not associated with consistent changes in lipid profiles (see section 5.1). ||| Eligible patients for these trials had chronic hepatitis C confirmed by a positive HCV-RNA polymerase chain reaction assay (PCR) (> 100 copies/ ml), a liver biopsy consistent with ||| Des études cliniques contrôlées versus placebo d’ une durée de 30 semaines ont montré que l’ utilisation concomitante de BYETTA et des inhibiteurs de la HMG CoA réductase n’ était pas associée à des modifications significatives des paramètres lipidiques (voir rubrique 5.1).
0.3738785982131958 ||| CELSENTRI should be used with caution in patients aged over 65 years and in patients who have problems with their liver. ||| INCRELEX is used to treat children or adolescents who are very short for their age because their bodies do not make enough IGF-1. ||| CELSENTRI doit être utilisé avec précaution chez les patients de plus de 65 ans et chez les patients présentant des troubles hépatiques.
0.59782874584198 ||| In addition the CHMP identified the additional points to be harmonised in the various SPC sections. ||| Some ICH guidelines will have to be consolidated with pre-existing CPMP guidelines. ||| En outre, le CHMP a identifié les points supplémentaires suivants à harmoniser dans les différentes sections du RCP.
4.718374671010273e-13 ||| Close monitoring of haematologic parameters is advised in these patients. ||| Close monitoring of haematologic parameters is advised in these patients. ||| Une étroite surveillance hématologique est conseillée chez ces patients.
0.23645347356796265 ||| HOW TO STORE RAPINYL ||| HOW TO STORE ICANDRA ||| COMMENT CONSERVER RAPINYL?
0.006119448225945234 ||| In patients with secondary hyperparathyroidism Renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 – dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels. ||| In patients with secondary hyperparathyroidism Renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels. ||| Chez des patients souffrant d’ une hyperparathyroïdie secondaire, Renagel doit être utilisé dans le cadre d’ une approche thérapeutique multiple, pouvant inclure des suppléments calciques, de la vitamine 1,25 – dihydroxy D3 ou un analogue, pour réduire les concentrations d’ hormone parathyroïdienne intacte (PTHi).
0.035555027425289154 ||| 40 6.5 Nature and contents of container ||| 44 6.5 Nature and contents of container ||| 6.5 Nature et contenu de l’ emballage extérieur
0.21359124779701233 ||| Severe effects have been reported, including allergic and anaphylactic reactions. ||| Serious cases of allergic reactions, including anaphylactic reactions, have also been reported. ||| Des effets sévères ont été rapportés, notamment des réactions allergiques et anaphylactiques.
0.7475723028182983 ||| Peripheral Neuropathic Pain: ||| - Post-traumatic Stress Disorder ||| Douleur neuropathique périphérique:
0.07784909009933472 ||| Consultancy and information services relating to arranging, conducting and organisation of workshops ||| Consultancy and information services relating to arranging, conducting and organisation of concerts ||| Services de conseils et d'information en matière de préparation, de coordination et d'organisation d'ateliers
0.04517178237438202 ||| In more than 1 in 10 patients In more than 1 in 100 patients, but less than 1 in 10 In more than 1 in 1,000 patients, but less than 1 in 100 In more than 1 in 10,000 patients, but less than 1 in 1,000 ||| In more than 1 in 10 patients In more than 1 in 100 patients, but less than 1 in 10 In more than 1 in 1,000 patients, but less than 1 in 100 In more than 1 in 10,000 patients but less than 1 in 1000 patients In less than 1 in 10,000 patients ||| Chez plus d’ un patient sur 10 Chez plus d’ un patient sur 100 mais moins d’ un sur 10 Chez plus d’ un patient sur 1 000 mais moins d’ un sur 100 Chez plus d’ un patient sur 10 000 mais moins d’ un sur 1 000
0.27476298809051514 ||| Disconnect the syringe from the vial adapter. ||| Separate the syringe from the adapter. ||| Détacher la seringue de l’ adaptateur.
0.312716007232666 ||| As with other vaccines against pertussis (whooping cough) disease, following side effects may occur very rarely within 2 to 3 days after vaccination: • collapse or periods of unconsciousness or lack of awareness • seizures or fits with or without fever If your child gets any of these side effects you should contact a doctor urgently. ||| 48 Uncommon: bruising; black tarry stools (faeces) or blood in stools, which can be a sign of internal bleeding Not known: reduced number of platelets in your blood, leading to an increased risk of bruising or bleeding; blood disorders which may lead to an increased risk of infection ||| Comme pour les autres vaccins contre la coqueluche, les effets secondaires suivants peuvent se produire très rarement dans les 2 à 3 jours suivant la vaccination: • Collapsus ou perte de connaissance ou trouble de la vigilance • Convulsions (avec ou sans fièvre) Si votre enfant présente un de ces effets indésirables contactez un médecin en urgence.
0.7586761116981506 ||| 800 000 13 085 ||| 65 866 000 100.00% ||| 6 800 000 13 085
0.3285720944404602 ||| From the start of part 2, the median time to flare was  116 days for patients who received Enbrel and 28 days for patients who received placebo. ||| The median time to first symptom of dermatologic reaction was 10 days, and the median time to resolution after the last dose of Vectibix was 28 days. ||| A partir du début de la deuxième phase de l'étude, la médiane du délai de rechute clinique a été supérieure ou égale à 116 jours pour les patients ayant reçu Enbrel et 28 jours pour les patients sous placebo.
0.5075439810752869 ||| Cake frosting [icing] ||| Drying racks [photography] ||| Glaçages pour gâteaux
0.09735548496246338 ||| ic EU/ 1/ 99/ 128/ 012 ||| l EU/ 1/ 99/ 128/ 022 ||| EU/ 1/ 99/ 128/ 012
0.2501605153083801 ||| Adjustment of the dose is required in patients with creatinine clearance < 50 ml/ min, including those with end-stage renal disease (ESRD) on haemodialysis. ||| When initiating treatment with Zometa in patients with multiple myeloma or metastatic bone lesions from solid tumours, serum creatinine and creatinine clearance (CrCl) should be determined. ||| Une adaptation de la posologie est nécessaire chez les patients ayant une clairance de la créatinine < 50 ml/ min, y compris chez les patients au stade d’ insuffisance rénale terminale (IRT) hémodialysés.
0.14300867915153503 ||| In children less than two years of age, the most common side effects are diarrhoea (3.7%), fever (2.3%) and insomnia (difficulty sleeping; 2.3%). ||| In infants and toddlers aged 6 to 23 months, the most frequent adverse events reported in excess of placebo were diarrhoea (3.7%), fever (2.3%) and insomnia (2.3%). ||| Chez l’ enfant de moins de 2 ans, les effets indésirables les plus fréquents sont la diarrhée (3,7%), la fièvre (2,3%) et l’ insomnie (difficulté à trouver le sommeil; 2,3%).
0.07660311460494995 ||| Do not use after the expiry date stated on the label. ||| Do not use after the expiry date stated on the carton. ||| Ne pas utiliser après la date de péremption mentionnée sur la boîte.
0.0 ||| 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 69 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.09695962816476822 ||| Injection site reactions occurred frequently after administration of Betaferon. ||| Injection site reactions occurred frequently after administration of Extavia. ||| Les réactions au site d’ injection sont fréquentes après administration de Betaferon.
0.4585798382759094 ||| Because Agenerase oral solution contains vitamin E, you should not take additional vitamin E supplements. ||| because together with Aerinaze, these medicines may raise your blood pressure. ||| Agenerase solution buvable contient de la vitamine E, vous ne devez donc pas prendre de supplément en vitamine E.
0.4454250633716583 ||| Do not use Insuman Rapid ||| Do not use Insuman Comb 25 ||| N’utilisez jamais Insuman Rapid
0.003047058591619134 ||| Aranesp 130 micrograms solution for injection in a pre-filled pen Darbepoetin alfa ||| Aranesp 150 micrograms solution for injection in a pre-filled pen Darbepoetin alfa ||| Aranesp 130 microgrammes solution injectable en stylo prérempli Darbepoetin alfa
0.9664632081985474 ||| Administrative services relating to dental health insurance ||| List of national public health agencies ||| Services d'administration d'assurance de soins dentaires
0.3366844654083252 ||| * For HBeAg-positive patients: ||| HBeAg-positive patients: ||| *Pour les patients AgHBe+:
0.008823567070066929 ||| Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. ||| Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. ||| Les données précliniques des études conventionnelles de pharmacologie de sécurité, de toxicologie après administration répétée et de génotoxicité n’ ont révélé aucun risque particulier pour l’ homme.
0.09567077457904816 ||| Humalog is a replacement insulin which very similar to the insulin made by the pancreas. ||| Mixtard is a replacement insulin which is identical to the insulin made by the pancreas. ||| Humalog est une insuline de substitution analogue à 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
0.24439026415348053 ||| Undesirable effects known to be associated with antipsychotic therapy and also reported during treatment with aripiprazole include neuroleptic malignant syndrome, tardive dyskinesia, seizure, cerebrovascular adverse events and increased mortality in elderly demented patients, hyperglycaemia and diabetes mellitus (see section 4.4). ||| Very rare: jaundice, hepatitis, fulminant hepatic necrosis Musculoskeletal and connective tissue disorders Very rare: rhabdomyolysis, which can be associated with acute renal failure secondary to myoglobinuria, myopathy (see section 4.4) Isolated cases of tendon disorders, sometime complicated by rupture ||| Des effets indésirables connus pour être associés aux traitements antipsychotiques ont également été rapportés au cours du traitement par l'aripiprazole (syndrome malin des neuroleptiques, dyskinésies tardives, convulsions, événements indésirables cérébrovasculaires et augmentation de la mortalité chez les patients âgés souffrant de démence, hyperglycémie et diabète) (cf rubrique 4.4).
0.3395857810974121 ||| However, systemic clearance of tigecycline was reduced by 25% and 55% and the half-life of tigecycline was prolonged by 23% and 43% in patients with moderate or severe hepatic impairment (Child Pugh B and C), respectively (see section 4.2). ||| Clopidogrel significantly reduced the relative risk of death from any cause by 7% (p = 0.029), and the relative risk of the combination of re-infarction, stroke or death by 9% (p = 0.002), representing an absolute reduction of 0.5% and 0.9%, respectively. ||| Cependant, chez les patients avec une insuffisance hépatique modérée ou sévère (score Child Pugh B ou C), la clairance systémique de la tigécycline est réduite de 25% et 55%, et sa demi-vie prolongée, respectivement de 23% et 43% (voir rubrique 4.2).
0.39221084117889404 ||| Protective screens of metal ||| Protective helmets for sports ||| Écrans métalliques de protection
0.33240407705307007 ||| If you forget to use Effentora If the breakthrough pain is still ongoing, you may take Effentora as prescribed by your physician. ||| If you stop taking Kuvan Do not stop taking Kuvan without prior discussion with your doctor, as phenylalanine levels in the blood may increase. ||| Si vous oubliez de prendre Effentora Si l’ accès douloureux paroxystique est encore présent, vous pouvez prendre Effentora tel que prescrit par votre médecin.
0.03282162919640541 ||| Frequencies of adverse drug reactions from clinical trials that are considered related to Actrapid, are listed below. ||| Frequencies of adverse drug reactions from clinical trials that are considered related to Insulatard are listed below. ||| Les fréquences des effets indésirables issus des études cliniques, et considérés comme imputables à Actrapid, sont répertoriées ci-dessous.
0.16020013391971588 ||| Common: amnesia, ataxia, convulsion, dizziness, headache, hyperkinesia, tremor, balance disorder, disturbance in attention, memory impairment Post-marketing experience: paraesthesia ||| Common: severe neuropathy (mainly peripheral), dizziness, nervousness, insomnia, depression, abnormal thinking, hypokinesia, abnormal gait, hypaesthesia, taste perversion, headache ||| Très fréquent: somnolence Fréquents: amnésie, ataxie, convulsion, vertige, céphalée, hyperkinésie, tremblement, trouble de l’ équilibre, trouble de l’ attention, troubles de la mémoire Données post - commercialisation: paresthésie
0.25456106662750244 ||| Bulgaria: ||| Malta: ||| 46 Bulgarie:
0.4698588252067566 ||| What Biograstim is used for Your doctor has prescribed Biograstim for you to help your body make more white blood cells. ||| The amount of Biograstim you need will depend on the condition you are taking Biograstim for and on your bodyweight. ||| Dans quel cas Biograstim est -il utilisé Votre médecin vous a prescrit Biograstim pour aider votre corps à fabriquer plus de globules blancs.
0.30599725246429443 ||| Viraferon 25 million IU/ 2.5 ml solution for injection ||| Viraferon 60 million IU solution for injection multidose pen ||| Viraferon 25 millions d’ UI/ 2,5 ml solution injectable
0.23001524806022644 ||| Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicines (insulins, oral hypoglycaemic agents) may cause an increased blood-glucose lowering effect with risk of hypoglycaemia. ||| The concomitant use of oxybutynin with other anticholinergic medicinal products or with other agents that compete for CYP3A4 enzyme metabolism may increase the frequency or severity of dry mouth, constipation, and drowsiness. ||| Des études épidémiologiques ont suggéré que l’ utilisation concomitante d’ IEC et d’ antidiabétiques (insuline, hypoglycémiants oraux) peut provoquer une majoration de l’ effet hypoglycémiant avec un risque d’ hypoglycémie.
0.24472975730895996 ||| Clinical experience with epoetins suggest hypertension and thrombosis risk may be reduced by titrating the dose to maintain haemoglobin levels between 10 to 12 g/ dl. ||| In clinical trials at the recommended dose (2 mg/ kg), robenacoxib reduced pain and inflammation in dogs undergoing orthopaedic or soft tissue surgery. ||| L’ expérience clinique de l’ époïétine semble indiquer que le risque d’ hypertension et de thrombose peut être réduit par titration de la dose pour maintenir un taux d’ hémoglobine compris entre 10 et 12 g/ dl.
0.3093670606613159 ||| However, as tenofovir is structurally related to nucleoside analogues, this risk cannot be excluded. ||| As described in section 5.1, some of this toxicity may be mediated by peroxynitrite. ||| Cependant, le ténofovir étant structurellement apparenté aux analogues nucléosidiques, ce risque ne peut être exclu.
0.267924040555954 ||| When pregnancy is detected, lisinopril treatment should be discontinued as soon as possible (see section 4.6). ||| Lapatinib should be discontinued if changes in liver function are severe and patients should not be retreated (see section 4.4). ||| En cas de découverte d’une grossesse, le lisinopril devra être arrêté dès que possible (cf. rubrique 4.6).
0.4632895588874817 ||| Design and development of computer hardware for the manufacturing industry ||| Development of application software for delivery of multimedia content ||| Conception et développement de matériel informatique pour l'industrie manufacturière
0.35226142406463623 ||| Use the injection technique advised by your doctor or diabetes nurse Keep the needle under your skin for at least 6 seconds to make sure that the full dose has been delivered. ||| You may have a bowel movement within a few minutes to a few hours of the injection; therefore, it is recommended to have a toilet facility or bedpan near you. ||| Utilisez la méthode d’ injection conseillée par votre médecin ou votre infirmière d’ éducation gardez l’ aiguille sous la peau pendant au moins 6 secondes afin d’ être certain que la totalité de la dose a été délivrée.
0.3648289442062378 ||| Alternating pressure mattresses for medical use ||| Constant humidity incubators for laboratory use ||| Matelas à pression alternée à usage médical
0.3715846538543701 ||| Both lamivudine and zidovudine are excreted in breast milk at similar concentrations to those found in serum. ||| It has been demonstrated that risperidone and 9-hydroxy-risperidone are also excreted in human breast milk in small quantities. ||| La lamivudine et la zidovudine sont toutes deux excrétées dans le lait maternel à des concentrations analogues à celles obtenues dans le sérum.
0.5884588956832886 ||| - severe cardiac rhythm abnormalities, irregular heart beat (Torsades de Pointes) ||| stranguria); central nervous system signs (incoordination, disorientation). ||| - anomalies sévères du rythme cardiaque, battements cardiaques irréguliers (torsades de pointes).
0.013577797450125217 ||| Important information about some of the ingredients of Insuman Comb 15 ||| Important information about some of the ingredients of Insuman Comb 25 ||| 667 Informations importantes concernant certains composants d’Insuman Comb 15
0.4272783398628235 ||| Cancer patients ||| Male patients ||| Patients cancéreux tn
0.179273322224617 ||| Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein Germany ||| Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/ Rhein Germany ||| Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim/ Rhein Allemagne
0.5127087831497192 ||| The duration of protection is 6 months. or ||| The mean residence time is approximately 5 hours. ||| La durée de la protection est de 6 mois.
0.02557501755654812 ||| For the full list of all side effects reported with Kentera, see the Package Leaflet. ||| For the full list of all side effects reported with Avonex, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Kentera, veuillez vous reporter à la notice.
0.35590165853500366 ||| 8 Patients treated with vildagliptin reported significantly lower incidences of gastrointestinal adverse reactions versus those treated with metformin. ||| More patients treated with Herceptin and paclitaxel progressed in the central nervous system than those treated with paclitaxel alone. ||| Les effets indésirables gastro-intestinaux ont été observés avec une incidence significativement plus faible chez les patients traités par vildagliptine par rapport à ceux traités par metformine.
0.7247166633605957 ||| New York morgue shortages led the city to propose temporary burial in parks. ||| Bolsonaro said that closing shopping malls and commerce hurt the economy. ||| La pénurie de morgues à New York a conduit la ville à proposer un enterrement temporaire dans les parcs.
0.22512248158454895 ||| Gender, weight and ethnicity have no clinically relevant influence on aliskiren pharmacokinetics. ||| Gender and race Gender and race have no clinically relevant influence on exenatide pharmacokinetics. ||| Le sexe, le poids et l’ origine ethnique n’ ont aucune influence cliniquement pertinente sur la pharmacocinétique de l’ aliskiren.
0.29408779740333557 ||| Myocet liposomes egg phosphatidylcholine, cholesterol, citric acid, sodium hydroxide, water for injections ||| cellulose, edetate disodium, citric acid, stearic acid and colorant (Indigo Carmine E132 Aluminum lake). ||| Myocet liposomes lécithine d’œ uf, cholestérol, acide citrique, hydrate de sodium, eau pour préparations injectables
0.5751246809959412 ||| Organic pigments ||| Luminescent pigments ||| Pigments organiques
0.10747385025024414 ||| 250 micrograms/ 0.5 ml ||| 80 micrograms/0.5 ml ||| 250 microgrammes/ 0,5 ml
0.3872484564781189 ||| - if you have a history of autoimmune disease, or have had an organ transplant and are taking medicine that ||| - if you are infected with HIV, hepatitis C or D, or are being treated with any antiviral medicines. ||| - si vous avez une maladie auto-immune, ou avez eu une transplantation d’organe et prenez un
0.2639434039592743 ||| For NutropinAq, no clinical data on exposed pregnancies are available. ||| For AVANDAMET no preclinical or clinical data on exposed pregnancies or lactation are available. ||| Il n’ existe pas de données cliniques décrivant les effets de NutropinAq en cas de grossesse.
0.4746057689189911 ||| - if you are allergic to brinzolamide or any of the other ingredients. ||| - if you are allergic to mouse or hamster proteins ||| - Si vous êtes allergique au brinzolamide ou à l’un des autres composants.
0.17120963335037231 ||| 512 If you forget to use Insulin Human Winthrop Basal ||| If you forget to use Insulin Hun Winthrop Basal ||| Si vous oubliez d’utiliser Insulin Human Winthrop Basal
0.35140204429626465 ||| The Commission will continue to assist Member States in implementing the restriction on non-essential travel to the EU, including through regular videoconference meetings with Home Affairs Ministers. ||| The Commission invited Heads of State or Government on 16 March 2020 to introduce a temporary restriction on non-essential travel to the EU for an initial period of 30 days. ||| La Commission continuera d'aider les États membres à mettre en œuvre la restriction des déplacements non essentiels vers l'UE, notamment par des réunions régulières en vidéoconférence avec les ministres de l'intérieur.
0.014084020629525185 ||| Etoricoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity. ||| Celecoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity. ||| L’ étoricoxib doit être arrêté dès les premiers signes de rash cutané, de lésions des muqueuses, ou de tout autre signe d’ hypersensibilité.
0.27280133962631226 ||| In the unlikely event of a radiation overdose being administered with LeukoScan [99mTc], the absorbed dose to the patient may be reduced by increased oral or intravenous intake of fluids to promote excretion of the radiolabel. ||| If there is no change in oxygenation during administration of INOmax at 1 ppm, the FiO2 should be increased by 10%, the INOmax is discontinued, and the neonates monitored closely for signs of hypoxaemia. ||| Dans l'hypothèse, improbable, d'un surdosage en radioactivité avec LeukoScan-(99mTc), on peut réduire la dose absorbée par le patient en augmentant l'apport oral ou intraveineux de liquides afin de favoriser l'excrétion du radiotraceur.
0.017809368669986725 ||| Each capsule contains 25 mg lenalidomide. ||| Each capsule contains 5 mg lenalidomide. ||| Chaque gélule contient 25 mg de lénalidomide.
0.26398754119873047 ||| After injection of immunoglobulin the transitory rise of the various passively transferred antibodies in the patients blood may result in misleading positive results in serological testing. ||| Peripheral blood lymphocytes further showed no significant decrease in number or in proliferative responses to in vitro mitogenic stimulation when compared with untreated patients’ cells. ||| Après injection d’ immunoglobuline, l’ augmentation transitoire de la concentration de divers anticorps transférés peut être responsable de résultats faussement positifs lors de dosages sérologiques.
0.36149176955223083 ||| The mean systemic clearance of lamivudine is approximately 0.32 l/ h/ kg, predominantly by renal clearance (> 70%) via the organic cationic transport system. ||| In this study, a modification of the Zevalin therapeutic regimen with a lower [90Y]-Zevalin activity per body weight (11 MBq/ kg) was used. ||| La clairance systémique moyenne de la lamivudine est d’ environ 0,32 l/ h/ kg, avec une élimination essentiellement rénale (> 70%) par le système de transport cationique.
0.2551268935203552 ||| Please speak to your doctor about this if you have concerns. ||| Speak to your doctor if you would like further information on this. ||| Veuillez consulter votre médecin si vous êtes concerné.
0.38632732629776 ||| Distribution The volume of distribution of rosiglitazone is approximately 14 l in healthy volunteers. ||| Distribution The estimated volume of distribution in humans is 0.25 l/ kg. ||| Distribution Chez le volontaire sain, le volume de distribution de la rosiglitazone est d’ environ 14 l.
3.1070748729954134e-13 ||| - you are taking or have taken certain other medicines (see section 2, "Using other medicines"). ||| - you are taking or have taken certain other medicines (see section 2, "Using other medicines"). ||| - vous utilisez ou avez utilisé certains autres médicaments (voir rubrique, "Utilisation d' autres
0.003987826872617006 ||| 164 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON ||| 149 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON ||| 186 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
0.39279937744140625 ||| When the receptors are blocked, histamine cannot have its effect, and this leads to a decrease in the symptoms of allergy. ||| When this area develops cancer, levels of these hormones can increase, causing the symptoms of the disease. ||| Lorsque les récepteurs sont bloqués, l’ histamine ne peut plus jouer son rôle habituel et les symptômes allergiques sont alors diminués.
0.45583146810531616 ||| The next day, Pakistan reported nine new cases in Karachi, meaning that there was a total of 16 cases of COVID-19, with Sindh having the highest number of cases, 13 altogether. ||| According to the statement issued by the Sindh health ministry, 37 new cases of the contagion have emerged, taking the total number of coronavirus cases in Sindh to 245 with 151 in Sukkur, 93 in Karachi and one in Hyderabad. ||| Le lendemain, le Pakistan signale neuf nouveaux cas à Karachi, ce qui porte le total à 16 cas de Covid-19, la province du Sind ayant le plus grand nombre de cas, 13 au total.
0.3713248372077942 ||| See package leaflet for further information. ||| For instructions see bottom of leaflet. ||| Voir la notice pour plus d’ information.
0.6144200563430786 ||| These loans should be used by Member States to finance short-time work schemes for employees or similar measures for the self-employed. ||| Critical personnel will be exempted from the Working Hours Act and Annual Holidays Act, both in the private and public sector. ||| Les États membres devraient utiliser ces prêts pour financer des dispositifs de chômage partiel destinés aux salariés ou des mesures similaires en faveur des travailleurs indépendants.
1.2052578926086426 ||| International non-proprietary names: ||| Linearity/ Non-linearity ||| Dénomination commune internationale:
0.4204206168651581 ||| Immune system disorders ||| Reproductive system disorders ||| Affections du système
0.1668650507926941 ||| Immediately after injection of OPTISON, 10 ml of sodium chloride 9 mg/ ml (0.9%) solution for injection or glucose 50 mg/ ml (5%) solution for injection should be injected at a rate of 1 ml/ s. ||| The recommended dose is 10 microlitre dispersion/ kg by slow bolus intravenous injection, followed by a 10 ml bolus of sodium chloride 9 mg/ ml (0.9%) or glucose 50 mg/ ml (5%) solution for injection. ||| Immédiatement après l'injection d'OPTISON, rincer en injectant 10 ml de solution injectable de chlorure de sodium à 9 mg/ ml (0,9%) ou de glucose à 50 mg/ ml (5%) avec une vitesse d'injection de 1 ml/ s.
0.3125971257686615 ||| Epoetin zeta is identical in its amino acid sequence and similar in carbohydrate composition to endogenous human erythropoietin that has been isolated from the urine of anaemic patients. ||| Iloprost is not a gene mutagen in bacterial and mammalian cells in vitro and is not clastogenic in human lymphocytes up to cytotoxic concentrations and in the micronucleus test in vivo. ||| L’ époétine zêta est identique en terme de séquence d’ acides aminés et similaire en terme de composition glucidique à l’ érythropoïétine humaine endogène humaine isolée dans l’ urine de patients anémiques.
8.721016530460757e-13 ||| See leaflet for further information. ||| See leaflet for further information. ||| Lactose Voir la notice pour plus d’ information.
0.0 ||| In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. ||| In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. ||| En l’ absence d’ études de compatibiltiés, ce médicament vétérinaire ne doit pas être mélangé avec un autre médicament vétérinaire.
0.11562307178974152 ||| Insuman Rapid is supplied in pre-filled pens, OptiSet, containing 3 ml solution (300 IU). ||| Insulin Human Winthrop Rapid is supplied in pre-filled pens, SoloStar, containing 3 ml solution (300 IU). ||| Insuman Rapid est fourni en stylo prérempli, OptiSet, contenant 3 ml de solution (300 UI).
0.4695473611354828 ||| Hepatitis B surface antigen1, 2, 3 1 adjuvanted by AS04C containing: ||| HPV type 16 L1 protein1,2 HPV type 18 L1 protein1,2 1 adjuvanted by AS04 containing: ||| Antigène de surface du virus de l’ hépatite B1,2,3 1 adjuvanté par AS04C contenant:
0.7993423938751221 ||| Because this crisis is different from any other one we have known. ||| This crisis is deeper and it is way broader than the one ten years ago. ||| Parce que cette crise est différente de toutes celles que nous avons affrontées précédemment.
0.3353346586227417 ||| Dose reduction with each cycle or within a cycle may be applied based upon the grade of toxicity experienced by the patient. ||| Titration and maintenance dose Depending on the patient’ s tolerability to the active substance, the dose is subsequently increased. ||| Une réduction de dose à chaque cycle ou au cours d’un cycle pourra être envisagée en fonction du grade de toxicité présenté par la patiente.
0.49472227692604065 ||| If you realise that you have missed your appointment for the laser treatment, contact your doctor immediately. ||| If you become pregnant whilst taking this medicine you should contact your doctor as soon as possible. ||| Si vous réalisez que vous avez oublié le rendez-vous pour le traitement laser, contactez votre médecin immédiatement.
0.7937026023864746 ||| 0.1%); Congestive heart failure ||| 93 • Malignant external otitis ||| Insuffisance cardiaque congestive
0.26505401730537415 ||| Nederland UCB Pharma B.V. ||| Nederland MEDA Pharma B. V. ||| Nederland UCB Pharma B. V.
0.22424477338790894 ||| Providing temporary use of online, non-downloadable computer software for language translation ||| Providing temporary use of on-line non-downloadable software for the management of data ||| Mise à disposition temporaire en ligne de logiciels non téléchargeables pour la traduction de langues
0.2590545415878296 ||| Adults When used in dual combination with metformin or a thiazolidinedione, the recommended daily dose of vildagliptin is 100 mg, administered as one dose of 50 mg in the morning and one dose of 50 mg in the evening. ||| Adults Based on the patient’s current dose of metformin, Icandra may be initiated at either the 50 mg/850 mg or 50 mg/1000 mg tablet strength twice daily, one tablet in the morning and the other in the evening. ||| Adultes En association à la metformine ou à une thiazolidinedione, la dose quotidienne recommandée de vildagliptine est de 100 mg, administrée en une dose de 50 mg le matin et une dose de 50 mg le soir.
0.07393893599510193 ||| Rosiglitazone was associated with increases in weight. ||| 12 Rosiglitazone was associated with increases in weight. ||| Le traitement par la rosiglitazone s'est accompagné d'une prise de poids.
0.009107311256229877 ||| All patients, particularly those receiving concurrent insulin but also sulphonylurea therapy, those at risk for heart failure, and those with reduced cardiac reserve, should be monitored for signs and symptoms of adverse reactions relating to fluid retention, including weight gain and heart failure. ||| All patients, particularly those receiving concurrent insulin or sulphonylurea therapy, those at risk for heart failure, and those with reduced cardiac reserve, should be monitored for signs and symptoms of adverse reactions relating to fluid retention, including weight gain and heart failure. ||| Chez tous les patients, en particulier ceux prenant également de l’ insuline mais aussi ceux traités par sulfamide hypoglycémiant, ainsi que les patients à risque d’ insuffisance cardiaque, il conviendra de rechercher les signes et symptômes d’ effets indésirables liés à une rétention hydrique, dont la prise de poids et l’ insuffisance cardiaque.
0.43543440103530884 ||| If such reactions occur, treatment with ciprofloxacin must be discontinued immediately and the treating physician informed. ||| Treatment with Foscan is a two-step process: the medicine is given first, before it is activated using a laser. ||| En cas de réaction de ce type, l’ administration de la ciprofloxacine doit être immédiatement arrêtée et le médecin traitant doit être informé.
0.021913286298513412 ||| Combination antiretroviral therapy has been associated with the redistribution of body fat (lipodystrophy) in HIV patients. ||| Combination antiretroviral therapy has been associated with the redistribution of body fat (lipodystrophy) in HIV infected patients. ||| Les traitements par association d’antirétroviraux ont été associés, chez les patients infectés par le VIH, à une redistribution de la masse grasse corporelle (lipodystrophie).
0.3268163502216339 ||| Twinrix Adult is a white, slightly milky liquid presented in a glass vial (1 ml). ||| The solvent is presented in a 2 ml ampoule, Type I flint glass. ||| Twinrix Adulte est une suspension blanche, légèrement laiteuse présentée dans un flacon en verre (1ml).
6.265391851167923e-13 ||| B Remove the protective tab from a new disposable needle. ||| B Remove the protective tab from a new disposable needle. ||| B Retirez l’onglet de protection d’une aiguille neuve à usage unique.
0.2971948981285095 ||| Aseptic procedures should be used for the preparation and administration of Angiox. ||| Use appropriate aseptic technique during the preparation of Xigris for intravenous administration. ||| La préparation et l’ administration d’ Angiox doivent suivre des procédures aseptiques.
0.22747990489006042 ||| For patients requiring dental procedures, there are no data available to suggest whether discontinuation of bisphosphonate treatment reduces the risk of osteonecrosis of the jaw. ||| Valtropin is not indicated for the treatment of patients with growth failure due to Prader-Willi syndrome unless they also have a diagnosis of growth hormone deficiency. ||| Chez les patients nécessitant une intervention dentaire, aucune donnée ne permet de suggérer que l’ arrêt du traitement par
0.07622818648815155 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Sebivo to Novartis Europharm Limited on 24 April 2007. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Faslodex to AstraZeneca UK Limited on 10 March 2004. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Sebivo à Novartis Europharm Limited, le 24 avril 2007.
0.20557904243469238 ||| - The active substance is nilotinib. ||| - The active substance is daclizumab. ||| - La substance active est le nilotinib.
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| 53 Si vous ressentez un des effets mentionnés comme grave ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.4153369665145874 ||| Cozaar Comp 50 mg/ 12.5 mg and Cozaar Comp 100 mg/ 25 mg also contain, Titanium dioxide (E171), Quinoline yellow aluminum lake (E104), and Carnauba wax (E903) ||| Each tablet contains lactose monohydrate (approximately 90 mg), Lecithin (Soya) (E322) (approximately 0.25 mg) and Allura red AC Aluminium Lake (E129) (approximately 0.45 mg). ||| Cozaar Comp 50 mg/ 12,5 mg contient 4,24 mg (0,108 mEq) de potassium Cozaar Comp 100 mg/ 12,5 mg contient 8,48 mg (0,216 mEq) de potassium et Cozaar Comp 100 mg/ 25 mg contient 8,48 mg (0,216 mEq) de potassium
0.02382436767220497 ||| The insulin contained in Insuman Rapid is made by a biotechnology process and is identical with the body's own insulin. ||| The insulin contained in Insuman Basal is made by a biotechnology process and is identical with the body's own insulin. ||| L'insuline contenue dans Insuman Rapid est produite par biotechnologie et est identique à l'insuline de l'organisme.
0.038957152515649796 ||| Eesti Österreich GE Healthcare Estonia OÜ Mustamäe tee 46 EE – 10621 Tallinn Tel: + 372 6260 061 ||| Eesti GE Healthcare Estonia OÜ Mustamäe tee 46 EE – 10621 Tallinn Tel: + 372 6260 061 ||| Eesti GE Healthcare Estonia OÜ Mustamäe tee 46 EE – 10621 Tallinn Tel: + 372 6260 061
0.35202866792678833 ||| Fasting should be continued for at least 30 minutes after taking the tablet. ||| All other patients should be observed for at least 20 minutes after administration. ||| Le jeûne doit être poursuivi au moins 30 minutes après la prise du comprimé.
0.9280884265899658 ||| ut Solution for injection. ||| ideation or suicide attempt. lp ||| to Solution injectable.
0.27175378799438477 ||| The mixture should then be well shaken until the powder is completely dissolved. ||| Once diluted, the solution should be mixed gently but not shaken. ||| Le mélange doit alors être bien agité jusqu’ à ce que la poudre soit complètement dissoute.
0.6121127605438232 ||| a) Solution for injection b) Multidose c) 2 ||| a) G03G b) Treatment of infertility ||| a) Solution injectable b) Multidose c) 2
0.28496962785720825 ||| Your doctor will take regular blood samples to measure how your anaemia is responding and may adjust your dose as necessary. ||| Before starting treatment, your doctor may order blood tests to assess kidney function and may advise you to take the tablets less often. ||| Votre médecin effectuera des prises de sang régulières afin de contrôler la correction de l’ anémie et adaptera si nécessaire la posologie.
5.385157922886685e-13 ||| NAME OF THE MARKETING AUTHORISATION HOLDER ||| NAME OF THE MARKETING AUTHORISATION HOLDER ||| NOM DU TITULAIRE DE L’ AUTORISATION DE MISE SUR LE MARCHE
0.0921325534582138 ||| Insulin Human Winthrop Comb 50 is supplied in vials containing 5 ml suspension (500 IU). ||| Insulin Human Winthrop Infusat is supplied in vials containing 10 ml solution (1000 IU). ||| Insulin Human Winthrop Comb 50 est fourni en flacon contenant 5 ml de suspension (500 UI).
2.91365672908106e-13 ||| Renal impairment As metformin is excreted by the kidney, serum creatinine concentrations should be monitored regularly: ||| Renal impairment As metformin is excreted by the kidney, serum creatinine concentrations should be monitored regularly: ||| 3 Insuffisance rénale Dans la mesure où la metformine est éliminée par le rein, les concentrations de créatinine sérique doivent être mesurées régulièrement:
0.49712175130844116 ||| Hooks [haberdashery] ||| Gold thread [jewellery] ||| Crochets [mercerie]
0.7095727920532227 ||| Physical activity is an important part of a weight loss programme. ||| Research and innovation are fundamental pillars of this European response. ||| L’activité physique est une partie importante d'un programme de perte de poids.
0.38070493936538696 ||| If the test needs to be carried out later in the day, only a light meal like tea and toast is recommended. ||| For example overnight fasting is recommended if the dog is to be treated in the morning. ||| Au cas où le test est effectué plus tard dans l’après-midi, il est recommandé que vous preniez un léger repas, comme par exemple du thé et des toasts.
0.08544377237558365 ||| Blurred vision, conjunctivitis, eye pain, abnormal vision, lacrimal gland disorder ||| Vision blurred Conjunctivitis, vision abnormal, lacrimal gland disorder, eye pain ||| Vision trouble, conjonctivite, douleur oculaire, vision 13
0.21410971879959106 ||| If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Iscover. ||| If you think you may be pregnant, or if you intend to breast-feed, ask your doctor for advice before taking RILUTEK. ||| Si vous êtes enceinte ou si vous pensez que vous êtes enceinte, vous devez en avertir votre médecin ou votre pharmacien avant de prendre Iscover.
0.3879310190677643 ||| The solvent for reconstitution is presented in 1 ml pre-filled syringes (Type I glass) with a rubber stopper. ||| The veterinary medicinal product is packaged in individual-dose transparent plastic pipettes overpacked in an aluminium foil package. ||| Le solvant pour reconstitution est présenté en seringue préremplie de 1 ml (verre type I) avec bouchon en caoutchouc.
0.8848457336425781 ||| Freezing destroys the vaccine. ||| - The FORSTEO appears damaged ||| La congélation détruit le vaccin.
0.02717455103993416 ||| Tepoxalin must not be administered in conjunction with other NSAIDs or glucocorticosteroids. ||| Previcox must not be administered in conjunction with other NSAIDs or glucocorticosteroids. ||| Le tepoxalin ne doit pas être administré en association avec d’ autres AINS ou avec des glucocorticoïdes.
0.40126171708106995 ||| Athletes should be informed that treatment with pseudoephedrine could lead to positive doping tests. ||| Moreover, patients are likely to experience improved sleep as they respond to paroxetine therapy. ||| Les sportifs doivent être informés que le traitement par la pseudoéphédrine peut entraîner une réaction positive aux contrôles antidopage.
0.3876810669898987 ||| Respiratory, thoracic and mediastinal disorders ||| Respiratory, thoracic, and mediastinal ||| Affections respiratoires, thoraciques, médiastinales
0.1458670198917389 ||| Chemical preparations for pesticidal purposes ||| Chemical preparations for veterinary purposes ||| Préparations chimiques antiparasitaires
0.3309364914894104 ||| Atazanavir increased opacity of bovine corneas in an in vitro ocular irritation study, indicating it may be an ocular irritant upon direct contact with the eye. ||| A retinal toxicity study in normal dogs with intravenous verteporfin and ambient light on the eye showed no treatment-related ocular toxicity. ||| L'atazanavir a augmenté l'opacité cornéenne chez le bœ uf lors d'une étude in vitro d'irritation oculaire et ceci indique qu'il pourrait être irritant lors d'un contact direct avec l 'œ il.
0.24807465076446533 ||| It is not known whether the risk of myopathy during treatment with telbivudine is increased with concurrent administration of other medicinal products associated with myopathy (e. g. statins, fibrates, or ciclosporin). ||| Lacosamide should be used with caution in patients treated with medicinal products known to be associated with PR prolongation (e. g. carbamazepine, lamotrigine, pregabalin) and in patients treated with class I antiarrhythmic drugs. ||| On ignore si le risque de myopathie associé au traitement par telbivudine augmente en cas d’ administration concomitante avec d’ autres médicaments favorisant une myopathie (par ex. statines, fibrates ou ciclosporine).
0.2691652178764343 ||| The pharmacokinetics of ribavirin are altered in patients with renal dysfunction due to reduction of apparent clearance in these patients (see section 5.2). ||| 32 All of these additive factors of anaemia should also be carefully considered when deciding to increase the dose of erythropoietin in cancer patients. ||| Les paramètres pharmacocinétiques de la ribavirine sont altérés chez les patients ayant un dysfonctionnement rénal à cause d’ une diminution de la clairance apparente (voir rubrique 5.2).
0.15825513005256653 ||| Wholesale services in relation to veterinary instruments ||| Wholesale services in relation to weapons ||| Services de vente en gros concernant les instruments vétérinaires
0.3365069329738617 ||| Luveris in association with a follicle stimulating hormone (FSH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. ||| In postmenopausal women with osteoporosis, OPTRUMA reduces the incidence of vertebral fractures, preserves bone mass and increases bone mineral density (BMD). ||| Luveris, en association avec une préparation à base d'hormone folliculo-stimulante (FSH), est recommandé pour stimuler le développement folliculaire chez les femmes qui présentent un déficit sévère en LH et en FSH.
0.3696795701980591 ||| Marketing Authorisation Holder Otsuka Pharmaceutical Europe Ltd. ||| Marketing Authorisation Holder Procter & Gamble Pharmaceuticals UK Ltd. ||| 180 Titulaire de L'autorisation de mise sur le marché Otsuka Pharmaceutical Europe Ltd.
0.2757774889469147 ||| Chronic treatment with vigabatrin may be associated with a slight decrease in haemoglobin which rarely attains clinical significance. ||| Mitotane plasma levels higher than 20 mg/ l may be associated with severe undesirable effects and offer no further benefit in terms of efficacy. ||| Le traitement au long cours par le vigabatrin peut être associé à une légère diminution du taux d'hémoglobine dont l’ importance clinique a été rarement significative.
0.08113643527030945 ||| E-28750 San Agustín de Guadalix – Madrid Tel: + 34-91 848 85 00 t ||| Nacional I E-28 750 San Agustín de Guadalix - Madrid Tel: + 34-91 848 85 00 ||| Nacional I E-28750 San Agustín de Guadalix – Madrid Tel: + 34-91 848 85 00
0.37950217723846436 ||| Sectional buildings (Non-metallic -) ||| Structural support members (Non-metallic -) ||| Constructions modulaires non métalliques
0.5783718228340149 ||| - vision disturbances. ||| - heart rhythm disturbances ||| - troubles de la vision
6.935031433667749e-13 ||| 69 10. ||| 69 10. ||| 75 10.
0.18527930974960327 ||| Treatment of established post-menopausal osteoporosis in order to reduce the risk of vertebral fractures. ||| Treatment of postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures (see section 5.1). ||| Traitement de l’ ostéoporose post-ménopausique avérée, en vue de réduire le risque de fractures vertébrales.
0.5013227462768555 ||| Tell your doctor. ||| Please tell your doctor ||| Informez votre médecin.
0.18860891461372375 ||| 19 May 2006 ro ||| 23 May 2005 rod ||| 19 Mai 2006 am
0.0 ||| Name and address of the manufacturer responsible for batch release ||| Name and address of the manufacturer responsible for batch release ||| Nom et adresse du fabriquant responsable de la libération des lots
0.09196220338344574 ||| sanofi-aventis GmbH Tel: +43 1 80 185 – 0 ||| ra sanofi-aventis GmbH Tel: +43 1 80 185 – 0 ge ||| Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0
0.7470250129699707 ||| Cumulative rates for this composite endpoint over 3 years were 2.3% (21/ 933 subjects) and 1.9% (12/ 628 subjects), respectively. ||| In total, the Scoreboard awarded 158 green cards (153 in 2018), 107 yellow cards (137 in 2018) and 59 red cards (59 in 2018). ||| Les taux cumulés pour ce critère composite sur 3 ans étaient respectivement de 2,3% (21 cas/ 933 sujets) et de 1,9% (12 cas/ 628 sujets).
0.1696392148733139 ||| Latches, not of metal ||| Dowels, not of metal ||| Loquets non métalliques
0.0807395875453949 ||| Simulations suggest that the prolonged dose interval is not optimal and could result in increased toxicity and possibly inadequate response. ||| Limited clinical study data suggest that the prolonged dose interval is not optimal and could result in increased toxicity and possibly inadequate response. ||| Les simulations indiquent que le prolongement de l’ intervalle entre les administrations n’ est pas optimal et pourrait aboutir à une toxicité accrue et, éventuellement, à une réponse inadéquate au traitement.
0.40068528056144714 ||| The volume of distribution for venlafaxine at steady-state is 4.4±1.6 L/ kg following intravenous administration. ||| Steady-state trough plasma concentrations reached levels approximately 4-fold above the in vitro IC90 values for anti-HIV activity. ||| Le volume de distribution de la venlafaxine à l’ état d’ équilibre est de 4,4±1,6 L/ kg après administration par voie intraveineuse.
0.3909724950790405 ||| An early concern among Icelandic residents placed in home-based quarantine has been employees' rights to paid leave while being quarantined; it was announced on 5 March that the COVID-19 outbreak will likely result in changes to legislation within the next weeks. ||| As of March 12, more than 370 million children and youth are not attending school because of temporary or indefinite country wide school closures mandated by governments in an attempt to slow the spread of COVID-19. ||| L'une des premières préoccupations des résidents islandais placés en quarantaine à domicile a été le droit des employés à un congé payé pendant leur mise en quarantaine; il a été annoncé le 5 mars que l'épidémie de Covid-19 entraînera probablement des modifications de la législation dans les prochaines semaines.
0.1107405424118042 ||| As the prostaglandins are substances that trigger inflammation, pain, exudation and fever, meloxicam reduces those responses. ||| Prostaglandins are substances that trigger pain, swelling and inflammation, and the action of Quadrisol reduces these responses. ||| Les prostaglandines étant des substances qui déclenchent l’ inflammation, la douleur, l’ exsudation et la fièvre, le méloxicam atténue ces symptômes.
0.29094478487968445 ||| In patients with Parkinson's disease, the cells that produce dopamine begin to die and the amount of dopamine in the brain decreases. ||| As a result, the tumour cells are not stimulated to grow by oestrogen and the growth of the tumour is reduced. ||| Chez les patients atteints de la maladie de Parkinson, les cellules qui produisent la dopamine commencent à mourir et la quantité de dopamine dans le cerveau diminue.
0.004546324722468853 ||| 61 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder: ||| 41 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder: ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché:
0.2848148047924042 ||| Dehumidifiers for household use ||| Sanitizers for household use ||| Déshumidificateurs à usage ménager
4.919236675990368e-13 ||| Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| 218 Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000
0.04302537441253662 ||| However, the reconstituted solution in the vial may be held for up to 3 hours at room temperature (15ºC-30ºC). ||| However, the reconstituted solution in the vial may be held for up to 3 hours at room temperature (15 to 30ºC). ||| Cependant, la solution reconstituée en flacon peut être conservée pendant 3 heures à température ambiante (15°C - 30°C).
0.00518586952239275 ||| 16 Patients in the Enbrel in combination with methotrexate therapy group had significantly higher ACR 20, ACR 50, ACR 70 responses and improvement for DAS and HAQ scores at both 24 and 52 weeks than patients in either of the single therapy groups (results shown in table below). ||| 70 Patients in the Enbrel in combination with methotrexate therapy group had significantly higher ACR 20, ACR 50, ACR 70 responses and improvement for DAS and HAQ scores at both 24 and 52 weeks than patients in either of the single therapy groups (results shown in table below). ||| Les patients traités par Enbrel associé au méthotrexate avaient des réponses ACR 20, ACR 50 et ACR 70 ainsi qu’ une amélioration des scores DAS et HAQ significativement plus élevées à la fois à 24 et 52 semaines, comparativement aux patients de chacun des groupes en monothérapie (résultats présentés dans le tableau ci-dessous).
0.11379356682300568 ||| What Osigraft is and what it is used for 2. ||| What Rapilysin is and what it is used for 2. ||| Qu’ est -ce qu’ Osigraft et dans quel cas est -il utilisé 2.
0.8031736016273499 ||| 31 PACKAGE LEAFLET ||| PEN LABEL SOLOSTAR ||| 30 NOTICE NOTICE:
0.24852365255355835 ||| Gently move the vial in circles a few times, to dissolve the powder (see Diagram 6). ||| Remove the needle cover by firmly pulling it straight off the syringe (see Diagram 2). ||| Faites tourner doucement le flacon pendant quelques secondes afin de dissoudre la poudre (voir Schéma 6).
0.46792250871658325 ||| The pharmacokinetic profile has been characterized following oral administration. ||| The pharmacokinetic profiles indicated dose proportionality. ||| Le profil pharmacocinétique a été caractérisé suite à une administration orale.
0.25800615549087524 ||| 65 The following table summarises the adverse reactions reported with a greater frequency in adolescent patients (aged 13-17 years) than in adult patients or adverse reactions only identified during short-term clinical trials in adolescent patients. ||| However, in these trials, a higher rate of injection-site adverse experiences of mild-to-moderate intensity was reported among subjects 50-59 years of age compared with subjects ≥ 60 years of age (see section5.1). ||| Le tableau suivant résume les effets indésirables rapportés avec une fréquence plus importante chez les patients adolescents (âgés de 13 à 17 ans) que chez les patients adultes ou les effets indésirables uniquement observés lors des essais cliniques de courte durée réalisés chez les patients adolescents.
0.5246543884277344 ||| The 16 viruses that displayed > 20-fold change in susceptibility all contained mutations at positions 10, 54, 63 plus 82 and/ or 84. ||| The substitutions observed in decreasing frequency were at aa positions 38, 43, 36, 40, 42 and 45. ||| Les 16 souches virales ayant montré une modification supérieure à 20 fois de leur sensibilité comportaient toutes des mutations au niveau des positions 10, 54, 63 et 82 et/ ou 84.
0.0 ||| What Axura is and what it is used for 2. ||| What Axura is and what it is used for 2. ||| Qu’est-ce qu’Axura et dans quel cas est-il utilisé 2.
0.38355693221092224 ||| Three years after treatment, the incidence of malignancies was 7.8% in the placebo group compared with 6.4% in the Zenapax group. ||| Following cladribine, the incidence of second malignancies ranges from 0% to 9.5% after a median observation period of 2.8 to 8.5 years. ||| 3 années après le traitement, l’ incidence des cancers était de 7,8% chez les patients du groupe placebo comparé à 6,4% chez les patients du groupe Zenapax.
0.013310277834534645 ||| One pre-filled syringe contains 100 micrograms of methoxy polyethylene glycol-epoetin beta* at a concentration of 333 micrograms/ ml. ||| One pre-filled syringe contains 200 micrograms of methoxy polyethylene glycol-epoetin beta* at a concentration of 667 micgrograms/ ml. ||| Une seringue préremplie contient 100 microgrammes de méthoxy polyéthylène glycol-epoetin beta* soit une concentration de 333 microgrammes/ ml.
3.214506026812114e-13 ||| Combination antiretroviral therapy may also cause raised lactic acid and sugar in the blood, hyperlipaemia (increased fats in the blood) and resistance to insulin. ||| Combination antiretroviral therapy may also cause raised lactic acid and sugar in the blood, hyperlipaemia (increased fats in the blood) and resistance to insulin. ||| Les traitements par associations d'antirétroviraux peuvent aussi entraîner la présence d'acide lactique, une augmentation du sucre dans le sang, une hyperlipidémie (augmentation des lipides dans le sang) et une résistance à l'insuline.
0.011695221066474915 ||| B Pull the plunger to draw in a volume of air that is equal to the amount of solvent in the solvent vial (ml equals cc on the syringe). ||| • Pull the plunger to draw in a volume of air that is equal to the amount of solvent in the solvent vial (ml equals cc on the syringe). ||| B Tirez le piston afin d’ introduire un volume d’ air dans la seringue égal à la quantité de solvant présente dans le flacon de solvant (les ml équivalent aux cc indiqués sur la seringue).
0.015654467046260834 ||| Each capsule contains 180 mg temozolomide. ||| Each capsule contains 250 mg temozolomide. ||| Chaque gélule contient 180 mg de témozolomide.
0.00627162167802453 ||| 38 When administration is halted, the eyrthropoietic parameters return toward baseline levels within the recovery period of 1-3 months. ||| 46 When administration is halted, the eyrthropoietic parameters return toward baseline levels within the recovery period of 1-3 months. ||| Lorsque le traitement est suspendu, les paramètres érythropoïétiques tendent à retourner vers les taux de base durant la période de récupération de 1 à 3 mois.
0.34778857231140137 ||| Following intravenous administration, choriogonadotropin alfa is distributed to the extracellular fluid space with a distribution half-life of around 4.5 hours. ||| 50 U of BOTOX is injected intradermally, evenly distributed in multiple sites approximately 1-2 cm apart within the hyperhidrotic area of each axilla. ||| Après administration par voie intraveineuse, la choriogonadotropine alfa a une demi-vie de distribution dans le liquide extracellulaire d’ environ 4,5 heures.
0.444742351770401 ||| Medical devices for reconstitution and administration are provided with each package of Helixate NexGen 2000 IU. ||| This volume has been established based on the fill volume of the Docetaxel Winthrop 20 mg vial. ||| Les dispositifs médicaux de reconstitution et d’ administration sont fournis dans chaque boîte de Helixate NexGen 2000 UI.
0.5112009048461914 ||| Inter-patient variability in nilotinib pharmacokinetics was moderate to high. ||| However telbivudine pharmacokinetics are similar between both populations. ||| La variabilité interindividuelle de la pharmacocinétique du nilotinib était modérée à élevée.
0.4182030260562897 ||| The required dosage for children is calculated according to your child's age and body weight or your child’ s body surface area. ||| The dose of CYSTAGON prescribed for you or your child will depend on your or your child's age and weight. ||| Chez l’ enfant, la dose doit être calculée en fonction de l’ âge et du poids du patient ou de sa surface corporelle.
0.4300992488861084 ||| Spending could also be directed towards providing support to workers, in particular the self-employed and companies in specific sectors and areas that face disruption of production or sales and are therefore affected by a liquidity squeeze, in particular SMEs. ||| Plans address the levels of risk associated with various worksites and job tasks, including sources of exposure, risk factors arising from home and community settings, and risk factors of individual workers such as old age or chronic medical conditions. ||| Les dépenses pourraient également être orientées vers un soutien aux travailleurs, en particulier les indépendants et les entreprises actives dans des secteurs et domaines spécifiques dont la production ou les ventes sont perturbées et qui connaissent dès lors une compression de liquidités, notamment les PME.
0.34827977418899536 ||| Cushions (Heating -), non-electric, other than for medical purposes ||| Heating cushions [pads], non-electric for medical purposes ||| Coussins chauffants non électriques autres qu'à usage médical
0.5391820669174194 ||| Use in the elderly No dose adjustment is necessary for elderly patients (see section 5.2). ||| Use in the elderly Zometa can be given to elderly people. ||| Utilisation chez les personnes âgées Aucune adaptation posologique n’ est nécessaire chez les patients âgés (voir rubrique 5.2).
0.3298337757587433 ||| The doses in rats and rabbits provided systemic exposures of 1 to 4 and 5 times higher, respectively, than the maximum recommended human dose (300 mg). ||| This administration corresponds to free active substance systemic exposure levels of at least 9 times the expected levels in human after 1 month and less than the expected level in humans after 6 months, respectively. ||| Chez le rat et le lapin, les doses utilisées ont entraîné des expositions systémiques respectivement 1 à 4 fois et 5 fois supérieures à celles obtenues à la dose maximale recommandée chez l’ homme (300 mg).
0.017875228077173233 ||| An increased 3H-thymidine incorporation in the erythroid nucleated spleen cells has been found in vitro (mouse spleen cell culture) after incubation with epoetin beta. ||| 87 An increased 3H-thymidine incorporation in the erythroid nucleated spleen cells has been found in vitro (mouse spleen cell culture) after incubation with epoetin alfa. ||| In vitro, une augmentation de l'incorporation de 3H-thymidine dans la rate érythronucléée (culture de cellules spléniques de la souris) a été rapportée après incubation avec l'epoetin beta.
0.5212377905845642 ||| 33 Causes of a hyperglycaemia • Having forgotten to take your insulin • Repeatedly taking less insulin than you need • An infection or a fever ||| Affecting the body • Headaches • An increase in blood-test results that show how your liver is working • Increased blood pressure ||| • Oubli de votre dose d’ insuline • Prise à plusieurs reprises d’ une dose d’ insuline inférieure à vos besoins nt
0.37654227018356323 ||| Close monitoring for clinical signs and symptoms of CHF should be performed, especially in patients with cardiac risk factors and/ or history of coronary artery disease. ||| Patients (and caregivers of patients) should be advised to seek medical advice should signs of depression and/ or suicidal ideation or behaviour emerge. ||| Une surveillance stricte est recommandée chez les patients présentant des signes cliniques et symptômes d’ ICC, en particulier chez les patients ayant des facteurs de risque cardiaques et/ ou des antécédents de maladie coronarienne.
3.0692660327354127e-13 ||| Some people get depressed when taking IntronA alone or in combination treatment with ribavirin, and in some cases people had thoughts about threatening the life of others, suicidal thoughts or aggressive behaviour (sometimes directed against others). ||| Some people get depressed when taking IntronA alone or in combination treatment with ribavirin, and in some cases people had thoughts about threatening the life of others, suicidal thoughts or aggressive behaviour (sometimes directed against others). ||| Certaines personnes se sont senties déprimées en prenant IntronA seul ou en association avec la ribavirine, et dans certains cas, ont eu des pensées d’atteinte à la vie d’autrui, idées suicidaires ou un comportement agressif (parfois dirigé contre autrui).
4.976005501741709e-13 ||| Lactic acidosis generally occurred after a few or several months of treatment. ||| Lactic acidosis generally occurred after a few or several months of treatment. ||| L'acidose lactique apparaît généralement après quelques, voire, plusieurs mois de traitement.
0.2773732841014862 ||| Following intravenous administration, choriogonadotropin alfa is distributed to the extracellular fluid space with a distribution half-life of around 4.5 hours. ||| Absorption Kentera has a concentration of oxybutynin sufficient to maintain continuous transport over the 3 to 4 day dosing interval. ||| Après administration par voie intraveineuse, la choriogonadotropine alfa a une demi-vie de distribution dans le liquide extracellulaire d’ environ 4,5 heures.
0.3000725507736206 ||| Alginates for industrial purposes ||| Albumin for industrial purposes ||| Alginates à usage industriel
0.8400377631187439 ||| • Daniel BRASSEUR (Belgium), Chairman ||| European Parliament Gianmartino BENZI Dietrich HENSCHLER Alternates ||| · Daniel BRASSEUR (Belgique), Président
0.1680152267217636 ||| Ytracis is a solution containing the active substance yttrium (90Y) chloride. ||| The active substance in Ytracis, yttrium (90Y) chloride, is a radioactive compound. ||| Ytracis est une solution contenant le principe actif chlorure d’ yttrium (90Y).
0.6963515281677246 ||| Electrical lighting fixtures ||| Landscape lighting design ||| Appareils d'éclairage électriques
0.28467652201652527 ||| As clinical efficacy studies were performed with abrupt cessation of treatment, no information is available on whether tapering of the dosage would reduce recurrence rate. ||| The systemic exposure with half doses is not documented and insufficient efficacy related to half doses may lead the patients to cumulate other treatments. ||| L'impact de la réduction progressive des doses sur la fréquence des récidives n’ est pas connu compte tenu de l'arrêt brutal du traitement au cours des essais cliniques.
0.14930349588394165 ||| Marketing Authorisation Holder Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB United Kingdom ||| Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB United Kingdom ||| Titulaire de l’ Autorisation de mise sur le marché Novartis Europharm Limited Wimblehurst Road Horsham
0.009292470291256905 ||| Osteoarthritis The recommended dose is 30 mg once daily. ||| Osteoarthritis The recommended dose is 60 mg once daily. ||| Arthrose La dose recommandée est de 30 mg une fois par jour.
0.008983798325061798 ||| Before use, the beige to orange beige powder is mixed with the sodium chloride solvent provided in a vial to make a beige to pink beige suspension. ||| Before use, the beige to orange beige powder is mixed with the sodium chloride solvent provided in a syringe to make a beige to pink beige suspension. ||| Avant utilisation, la poudre beige à beige orange est mélangée avec la solution de chlorure de sodium fournie dans l’ autre flacon pour donner une suspension beige à beige-rosé.
0.02442321553826332 ||| The Commission found that the Czech measure is in line with the conditions set out in the Temporary Framework. ||| The Commission found that the Greek measure is in line with the conditions set out in the Temporary Framework. ||| La Commission a estimé que la mesure prise par la République tchèque était conforme aux conditions énoncées dans l'encadrement temporaire.
0.3798699378967285 ||| Do not open or crush the capsules and breathe the powder inside the capsules or allow it to touch your skin. ||| It is not necessary to blow hard into the tubes, just breathe normally and cap them quickly. ||| Ne pas ouvrir ou ne pas écraser pas les gélules, ne pas respirer la poudre contenue dans la gélule, éviter tout contact de votre peau avec la poudre.
0.015219418331980705 ||| 38 Uncommon - Local hypersensitivity Local hypersensitivity reactions (redness, swelling and itching at the injection site) may occur during treatment with insulin. ||| Uncommon - Local hypersensitivity Local hypersensitivity reactions (redness, swelling and itching at the injection site) may occur during treatment with insulin. ||| Peu fréquent - Hypersensibilité locale Des réactions d’ hypersensibilité locale (rougeur, tuméfaction et démangeaisons au site d’ injection) peuvent survenir au cours de l'insulinothérapie.
0.43306297063827515 ||| - in an ampoule (5 ml) for 10 doses in a pack of 50 ||| Apply a 1 cm strip (0.2 g) of cream per 10 cm2 of lesion. ||| - dans une ampoule (5 ml) pour 10 doses en boîte de 50
0.1343005895614624 ||| Thus the data on a limited number of exposed pregnancies indicate no adverse effects on pregnancy or on the health of the foetus/ newborn. ||| 98 Data on a large number of exposed pregnancies do not indicate any adverse effect of insulin lispro on pregnancy or on the health of the foetus/ newborn. ||| L'utilisation de l 'hydroxycarbamide au cours d'un nombre limité de grossesses n'a apparemment révélé aucun effet délétère de l'hydroxycarbamide sur la grossesse ou pour le fœ tus/ nouveau-né.
0.725246787071228 ||| 78 uncommon: paresthesia (abnormal feelings of the skin), rare: convulsions, movements disorders very rare: syncope, tremor, dysgeusia (altered taste) ||| Grade 1 = soreness/ erythema; Grade 2 = erythema, ulcers, can eat solids; Grade 3 = ulcers, requires liquid diet only; Grade 4 = alimentation not possible ||| Fréquent: vertige, céphalée Peu fréquent: paresthésie (sensation anormale au niveau de la peau) Rare: convulsions, mouvements anormaux Très rare: syncope, tremblement, dysgueusie (altération du goût)
0.20144423842430115 ||| The European Commission has approved an HRK 30 million (approximately €4 million) Croatian scheme to support the fishery and aquaculture sector in Croatia in the context of the coronavirus outbreak. ||| The European Commission has approved a CZK 200 million (approximately €7.3 million) Czech aid scheme to support research and development (R&D) activities related to the coronavirus outbreak. ||| La Commission européenne a autorisé un régime croate d'un montant de 30 millions de HRK (environ 4 millions d'euros) visant à soutenir le secteur croate de la pêche et de l'aquaculture dans le contexte de la pandémie de coronavirus.
0.011559149250388145 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or hospital pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or pharmacist. ||| Si vous ressentez un des effets mentionnés comme graves ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin, votre infirmière ou votre pharmacien hospitalier.
0.23669840395450592 ||| SINGULAIR is not expected to affect your ability to drive a car or operate machinery. ||| OSSEOR is not known to affect your ability to drive or use machines. ||| Il n'est pas attendu que Singulair ait un effet sur l'aptitude à conduire un véhicule ou à utiliser des machines.
0.3362503945827484 ||| - tiredness, abdominal pain, or jaundice (yellow discolouration of the eyes or skin), as these ||| - Tingling or numbness feeling, flushing (becoming red in the skin), impaired concentration, ||| - fatigue, douleurs abdominales ou jaunisse (coloration jaune des yeux ou de la peau), qui
0.29983580112457275 ||| In the HALT-C study, patients with chronic hepatitis C and advanced fibrosis or cirrhosis who were non-responders to previous treatment with interferon alfa or pegylated interferon alfa monotherapy or in combination therapy with ribavirin were treated with Pegasys 180 mcg/ week and ribavirin 1000/ 1200 mg daily. ||| If PCI was performed, patients received either intravenous fondaparinux (fondaparinux patients) or weight adjusted intravenous UFH (enoxaparin patients) as adjunctive therapy, dependent on the timing of the last lo subcutaneous dose and planned use of GP IIb/ IIIa inhibitor. ||| Dans l’étude HALT-C, des patients ayant une hépatite chronique C et une fibrose avancée ou une cirrhose non-répondeurs à un précédent traitement par interféron alpha ou interféron alpha pégylé en monothérapie ou en association avec la ribavirine ont été traités par Pegasys 180 microgrammes par semaine et par la ribavirine 1000/1200 mg par jour.
0.5648282170295715 ||| Because the number of babies born with patent ductus arteriosus is low, the disease is rare, and Pedea was designated an ‘ orphan medicine’ (a medicine used in rare diseases) on 14 February 2001. ||| Amabie (アマビエ) is a legendary Japanese mermaid or merman with three legs, who allegedly emerges from the sea and prophesies either an abundant harvest or an epidemic. ||| En raison du nombre limité de nourrissons nés avec un canal artériel persistant, la maladie est rare; Pedea a donc été déclaré « médicament orphelin » (médicament utilisé dans les maladies rares) le 14 février 2001.
0.0 ||| Incidence of Related Adverse Events with Fabrazyme Treatment ||| Incidence of Related Adverse Events with Fabrazyme Treatment ||| 14 Incidence des effets indésirables liés au traitement par Fabrazyme
0.3027738928794861 ||| Following organ transplantation a starting dose of 20 mg per day is recommended in patients receiving immunosuppressive therapy (see section 4.5). ||| In paediatric patients, the oral suspension should be taken with food in order to aid palatability and assist compliance (see section 5.2). ||| Posologie après transplantation: à la suite d’ une transplantation d'organe, la dose initiale recommandée chez les patients recevant un traitement immunosuppresseur est de 20 mg par jour (cf. rubrique 4.5).
0.24036356806755066 ||| Creatinine clearance (ml/ min) ||| Baseline Creatinine Clearance (ml/ min) ||| Clairance de la créatinine (Cl en ml/ min)
0.31298762559890747 ||| In addition the CVMP took into consideration Commission Decision 97/ 534/ EEC on transmissible spongiform encephalopathies and revised its BSE guidelines accordingly to ensure that no specified risk material is used as a source of starting material in the manufacture of medicine. ||| The CHMP also made recommendations for changes, or so called “ key elements”, to be included in the product information of piroxicam, as well as for some other non-selective NSAIDs which were published on the EMEA website in September 2006 (Doc ref: ||| Le CVMP a également révisé ses lignes directrices sur l’ESB à la lumière de la décision 97/534/CE de la Commission sur les encéphalopathies spongiformes transmissibles de manière à garantir qu’aucune substance présentant un risque identifié ne soit utilisée comme source de matière première dans la fabrication de médicaments.
0.2206307202577591 ||| Excipient: ||| Excipents: ||| Excipients:
2.9583456452771106e-13 ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| In addition, an updated RMP should be submitted • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| De plus, un PGR mis à jour devra être soumis: • Lors de la réception de nouvelles informations pouvant avoir un impact sur le profil de sécurité d’ emploi, le plan de pharmacovigilance ou les activités de minimisation des risques; • Dans les 60 jours qui suivent la date à laquelle une étape importante (pharmacovigilance ou minimisation des risques) est franchie; • A la demande de l’ EMEA
0.4410158693790436 ||| Known hypersensitivity to sulphonamides. ||| Monitoring for saquinavir toxicity recommended. ||| Hypersensibilité connue aux sulfamides.
0.2613069415092468 ||| For patients originally assigned to entecavir treatment, the reduction in HBV DNA at 48 weeks was -4.20 log10 copies/ ml, ALT normalisation had occurred in 37% of patients with abnormal baseline ALT and none achieved HBeAg seroconversion. ||| For the 77 patients who continued entecavir treatment beyond 52 weeks (median 96 weeks), 40% of patients had HBV DNA < 300 copies/ ml by PCR and 81% had ALT normalisation (≤ 1 times ULN) at end of dosing. ||| Pour les patients recevant un traitement par l'entecavir, la réduction du taux d'ADN du VHB à 48 semaines a été de -4,20 log10 copies/ ml, la normalisation des ALAT a été atteinte chez 37% des patients ayant des ALAT initialement élevées, et aucun n'a présenté de séroconversion HBe.
0.3247508406639099 ||| LFTs should be performed prior to the initiation of treatment with Eucreas in order to know the patient’s baseline value. ||| Sufficient time should be allowed to determine a patient’ s responsiveness to a dosage of Dynepo before adjusting the dose. ||| Des contrôles de la fonction hépatique doivent être effectués avant l’ instauration d’ un traitement par Eucreas afin de connaître les valeurs initiales du patient.
0.15109416842460632 ||| The most common side effects (seen in between 1 and 10 patients in 100) are reactions at the injection site, headache, somnolence (sleepiness), nausea (feeling sick), abdominal (tummy) pain, pelvic (lower abdominal) pain, ovarian hyperstimulation syndrome (e. g. feeling sick, weight gain, diarrhoea), ovarian cyst, and breast pain. ||| Other side effects seen very commonly (in more than 1 patient in 10) are infection, cardiac arrhythmia (unstable heartbeat), nausea (feeling sick), vomiting, liver damage, fatigue (tiredness), chills, pain in the limb, nerve injury, skin reactions, oedema (swelling) and wound infection. ||| Les effets indésirables les plus courants (observés chez 1 à 10 patientes sur 100) sont des réactions au site d’ injection, des céphalées, une somnolence (envie de dormir), des nausées (sensation d’ écœ urement), des douleurs abdominales (du ventre), des douleurs pelviennes (du bas-ventre), un syndrome d’ hyperstimulation ovarienne (c’ est-à-dire, nausées, prise de poids, diarrhée), des kystes ovariens et des douleurs mammaires.
0.3773495554924011 ||| Patients ≥ 60 years of age treated with Xeloda plus docetaxel also had more early withdrawals from treatment due to adverse reactions compared to patients < 60 years of age. ||| Rapamune tablets administered to 12 renal transplant patients > 65 years of age also gave similar results to adult patients (n = 167) 18 to 65 years of age. ||| Les patients de 60 ans ou plus traités par l’ association Xeloda/ docétaxel ont également eu plus d’ arrêts prématurés de traitements dus à des effets indésirables, par rapport aux patients âgés de moins de 60 ans.
0.14224760234355927 ||| Take special care with Cetrotide: ||| Take special care with Cetrotide ||| 37 Faites attention avec Cetrotide
7.625868252841839e-13 ||| If you forget to take Omnitrope ||| If you forget to take Omnitrope ||| Si vous oubliez de prendre Omnitrope
0.2221226990222931 ||| - Initiation of peginterferon alfa-2b is contraindicated in HCV/ HIV patients with cirrhosis and a ||| - Initiation of PegIntron is contraindicated in HCV/ HIV patients with cirrhosis and a Child-Pugh ||| Instauration du traitement par peginterféron alfa-2b chez les patients co-infectés VHC-VIH
0.004749435931444168 ||| Actraphane 10 Penfill 100 IU/ ml suspension for injection in a cartridge. ||| Actraphane 30 Penfill 100 IU/ ml suspension for injection in a cartridge. ||| Actraphane 10 Penfill 100 UI/ ml suspension injectable en cartouche
0.0 ||| 45 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 45 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 46 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTÉRIEUR
0.7271511554718018 ||| 87% / 11% / 2% / 0% 33% 36% 1% ||| 53% 33% 27% 23% 13% 29% ||| 87% / 11% / 2% / 0% 33% 36%
0.35535702109336853 ||| Thus, after you give yourself the injection, discard the ViraferonPeg pre-filled pen with any solution that is left in it. ||| The ViraferonPeg pre-filled pen should be stored in the refrigerator, but take it out and allow it to come to room temperature before you use it. ||| Par conséquent, éliminez le stylo prérempli ViraferonPeg ainsi que toute solution inutilisée restant à l’ intérieur après que vous vous êtes fait l’ injection.
0.40581780672073364 ||| Storage containers made of paper ||| Printed packaging materials of paper ||| Boîtes de rangement en papier
0.6606866121292114 ||| Rental of futon ||| Boxes of earthenware ||| Location de futons
0.0 ||| You should check with your doctor or pharmacist if you are not sure. ||| You should check with your doctor or pharmacist if you are not sure. ||| En cas d’incertitude, consultez votre médecin ou votre pharmacien.
0.15578997135162354 ||| d) 112 Days ||| d) 35 Days ||| d) 112 Jours
0.2795601785182953 |||  Remove the needle cover by firmly pulling it straight off the syringe taking care not to touch the needle or allow the needle to touch any surfaces (see Diagram 2). ||| Immediately activate needle protection device upon withdrawal of the needle from patient by pushing lever arm completely forward until needle tip is fully covered (see Figure 2). ||| • Retirez le protège-aiguille d’un mouvement ferme, dans l’axe de la seringue, en veillant à ne pas toucher l’aiguille avec les doigts et évitez tout contact de l’aiguille avec d’autres surfaces (voir Schéma 2).
0.6206424236297607 ||| CLINICAL EFFICACY RESULTS AT 12 MONTHS: ||| SCIENTIFIC CONCLUSIONS PRESENTED BY THE EMEA ||| 121 RÉSULTATS D’ EFFICACITÉ CLINIQUE A 12 MOIS:
0.5349741578102112 ||| - from 16 years or if bodyweight above 57 kg: ||| - if you have low weight (60 kg or less). ||| - à partir de 16 ans ou si le poids corporel dépasse 57 kg:
0.3052639961242676 ||| However, in humans the use of sevoflurane increases both the intensity and duration of neuromuscular blockade induced by nondepolarising muscle relaxants. ||| Fluticasone furoate undergoes incomplete absorption and extensive first-pass metabolism in the liver and gut resulting in negligible systemic exposure. ||| Chez l’ homme toutefois, le sévoflurane augmente à la fois l’ intensité et la durée du blocage neuromusculaire induit par les myorelaxants non dépolarisants.
0.2990456223487854 ||| Extrusion moulding machines ||| Compression moulding machines ||| Machines de moulage par extrusion
0.3816816210746765 ||| Post- marketing surveillance data includes reports that the use of the medicinal product in combination with a synthetic bone void filler, may lead to an increase in local inflammation, infection and occasionally migration of the implanted materials (see section 4.4). ||| integration of this functionality directly into iOS and AndroidGoogle and Apple plan to address the take-up and persistent surveillance problems by first distributing the system through operating system updates, and later removing it in the same way once the threat has passed. ||| Des données de surveillance après commercialisation indiquent que l’emploi du médicament associé à un produit synthétique de comblement de cavités osseuses peut provoquer une augmentation des inflammations et des infections localisées au site ainsi qu’à une migration occasionnelle du matériau implanté (voir rubrique 4.4).
0.631671130657196 ||| €100 million will be donated to CEPI and €158 million to the World Health Organization. ||| $15 million USD of this funding will be for education and skills development, and $10 million USD for human capital. ||| La CEPI bénéficiera de 100 millions d'euros et l'Organisation mondiale de la santé de 158 millions d'euros.
0.31639569997787476 ||| EXPIRY DATE dic ||| EXPIRY DATE du ||| DATE DE PEREMPTION Ce
0.28719961643218994 ||| In vivo, ibandronic acid prevents experimentally induced bone destruction caused by cessation of gonadal function, retinoids, tumours or tumour extracts. ||| The non-genotoxic mechanism of pregabalin-induced tumour formation in mice involves platelet changes and associated endothelial cell proliferation. ||| In vivo, l’ acide ibandronique prévient la destruction osseuse provoquée expérimentalement par l’ arrêt de la fonction gonadique, les rétinoïdes, les tumeurs ou les extraits de tumeurs.
0.3110182285308838 ||| 21 In view of the above, in some clinical situations blood transfusion should be the preferred treatment for the management of anaemia in patients with cancer. ||| 3 In any patient treated with abacavir, the clinical diagnosis of suspected hypersensitivity reaction must remain the basis of clinical decision-making. ||| Compte tenu des résultats cités ci-dessus, la transfusion sanguine devrait être le traitement de choix dans la gestion de l’ anémie des patients cancéreux lors de certaines situations cliniques.
0.5263160467147827 ||| - Coma, bleeding in the brain, stroke, paralysis, brain disorder, speech and language ||| anger, apathy, confusion, increased libido, panic attack, short term memory loss ||| - Coma, hémorragie cérébrale, accident vasculaire cérébral, paralysie, troubles cérébraux,
2.7868446482795517e-13 ||| Clinically significant laboratory abnormalities, most frequently occurring at doses greater than 10 million IU lon daily, include reduction in granulocyte and white blood cell counts; decreases in haemoglobin level and platelet count; increases in alkaline phosphatase, LDH, serum creatinine and serum urea nitrogen levels. ||| Clinically significant laboratory abnormalities, most frequently occurring at doses greater than 10 million IU lon daily, include reduction in granulocyte and white blood cell counts; decreases in haemoglobin level and platelet count; increases in alkaline phosphatase, LDH, serum creatinine and serum urea nitrogen levels. ||| Les anomalies biologiques ayant une importance sur le plan clinique, rencontrées surtout aux doses supérieures à 10 millions d’ UI par jour, comprennent une granulocytopénie et une leucopénie; une baisse du taux d’ hémoglobine et une thrombocytopénie; une élévation des phosphatases alcalines, de 224 la LDH, de la créatinine sérique et du taux sanguin d'urée.
0.19296330213546753 ||| Excretion Voriconazole is eliminated via hepatic metabolism with less than 2% of the dose excreted unchanged in the urine. ||| Elimination Valdecoxib is eliminated via hepatic metabolism with less than 5% unchanged valdecoxib recovered in the urine. ||| Élimination Le voriconazole est éliminé par métabolisation hépatique; moins de 2% de la dose étant excrétée sous forme inchangée dans les urines.
0.0922454446554184 ||| Acticam 1.5 mg/ ml oral suspension for dogs ||| Rheumocam 1.5 mg/ ml oral suspension for dogs ||| ACTICAM 1,5 MG/ ML SUSPENSION ORALE POUR CHIENS
0.0 ||| DATE OF FIRST AUTHORISATION / RENEWAL OF AUTHORISATION ||| DATE OF FIRST AUTHORISATION / RENEWAL OF AUTHORISATION ||| DATE DE PREMIERE AUTORISATION/ DE RENOUVELLEMENT DE L’ AUTORISATION
0.3383861184120178 ||| Formal cardiological assessment should be considered in patients in whom there are cardiovascular concerns following baseline screening. ||| Liver function tests/ investigations should be performed in cases where indications of liver dysfunction occur. ||| Une évaluation cardiologique formelle doit être envisagée chez les patients présentant des troubles cardiovasculaires après l’ évaluation cardiaque initiale.
0.2754475772380829 ||| GONAL-f 150 IU powder for solution for injection Follitropin alfa Subcutaneous use. ||| Bondronat 2 mg concentrate for solution for infusion ibandronic acid I. V. use ||| GONAL-f 150 UI poudre pour solution injectable Follitropine alfa Voie sous-cutanée
0.01733577810227871 ||| A marked change in glycaemic control may cause temporary visual impairment, due to temporary alteration in the turgidity and refractive index of the lens. ||| 72 A marked change in glycaemic control may cause temporary visual impairment, due to temporary alteration in the turgidity and refractive index of the lens. ||| Un changement prononcé de l'équilibre glycémique peut entraîner une altération transitoire de la vision, due à une atteinte temporaire de la turgescence et de l'index de réfraction du cristallin.
0.34383395314216614 ||| Efficacy of oseltamivir in the treatment of subjects with chronic cardiac disease and/ or respiratory disease has not been established. ||| Epidemiological studies have shown that long term treatment with hydrochlorothiazide reduces the risk of cardiovascular mortality and morbidity. ||| L'efficacité d'oseltamivir chez les patients ayant des pathologies chroniques cardiaque et/ ou respiratoire, n'a pas été établie.
0.8430525660514832 ||| Electronic bulletin board services [telecommunications services] ||| Voice over Internet Protocol [VoIP] communication services ||| Services d'affichage électronique [télécommunications]
0.1540851891040802 ||| 5.1 0.6 ||| 0.6 1.4 ||| 5,1 0,6
0.23158174753189087 ||| How to store TESAVEL 6. ||| How to store VELCADE 6. ||| Comment conserver TESAVEL 6.
0.2561052441596985 ||| In four Phase I clinical trials, steady state exposure to sorafenib was similar in patients with mild or moderate renal impairment compared to the exposures in patients with normal renal function. ||| The majority of the adverse reactions were transient The adverse reaction profile in clinical trials with patients with benign prostatic hyperplasia corresponded to the one seen in hypertension. ||| Insuffisants rénaux: dans quatre essais cliniques de phase I, l’ exposition au sorafénib, à l'état d'équilibre, était comparable chez les patients atteints d’ une insuffisance rénale légère à modérée et chez ceux ayant une fonction rénale normale.
0.031912773847579956 ||| If you see any signs of a severe rash with blistering or fever, stop taking Atripla and tell your doctor at once. ||| If you see any signs of a severe rash with blistering or fever, stop taking STOCRIN and tell your doctor at once. ||| Si vous constatez des signes d’ éruptions cutanées sévères avec des vésicules, de la fièvre, arrêtez de prendre Atripla et contactez immédiatement votre médecin.
0.05913115665316582 ||| EU/ 1/ 01/ 172/ 003 ||| EU/ 1/ 01/ 184/ 070 ||| EU/ /1/ 01/ 172/ 003
0.4106442332267761 ||| Enzymes [other than for medical use] for labelling protein fractions ||| Esters produced from fatty acids [for use in manufacture] ||| Enzymes autres qu'à usage médical pour le marquage des fractions protéiques
0.5422053933143616 ||| 133 Maintenance ||| 759 Maintenance ||| 138 Entretien
0.32371407747268677 ||| The solution should be clear and colourless and free from visible particles. ||| Only clear and colourless solutions without visible particles should be used. ||| La solution doit être transparente, incolore et sans particules visibles.
0.38495486974716187 ||| Telmisartan may increase the hypotensive effect of other antihypertensive agents. ||| Treatment with hydrochlorothiazide may cause electrolyte imbalance in your body. ||| Le telmisartan peut augmenter l’ effet hypotenseur d’ autres agents antihypertenseurs.
0.048418883234262466 ||| Medicines should not be disposed of via wastewater or household waste. ||| Medicine should not be disposed of via wastewater or household waste. ||| 28 Les médicaments ne doivent pas être jetés au tout à l’ égout ou avec les ordures ménagères.
0.5890078544616699 ||| (a) Poultry (b) Antibacterial for systematic use ||| (a) Dogs (b) Treatment of anxieties ||| a) Volailles b) Antibacterien par voie générale
0.0 ||| Paediatric population ||| Paediatric population ||| 110 Population pédiatrique
0.47589918971061707 ||| Commercial monitors ||| Thermal controls ||| Moniteurs commerciaux
0.29649654030799866 ||| Three years after treatment, the incidence of malignancies was 7.8% in the placebo group compared with 6.4% in the Zenapax group. ||| HIV-1 transmission rates were similarly low in both treatment groups (1.3% in the VIRAMUNE group, 1.4% in the placebo group). ||| 3 années après le traitement, l’ incidence des cancers était de 7,8% chez les patients du groupe placebo comparé à 6,4% chez les patients du groupe Zenapax.
0.02511313185095787 ||| 20 single doses, 0.5 ml pre-filled syringes with 2 needles each. ||| 10 single doses, 0.5 ml pre-filled syringes with 1 needle each. ||| 20 seringues préremplies unidoses de 0,5 ml avec 2 aiguilles chacune.
0.28648167848587036 ||| What TORISEL contains ||| What RELISTOR contains ||| Que contient TORISEL
0.743233323097229 ||| accurate information for users on the coronavirus pandemic; ||| PSUR submission during the influenza pandemic: ||| des informations précises sur la pandémie de coronavirus pour les utilisateurs;
0.19204074144363403 ||| Actinic keratosis ||| Actinic keratosis: ||| Kératose actinique
0.4787161350250244 ||| Blister Pack of 14 x 0.5 mg and 28 x 0.5 mg varenicline film-coated tablets, Heat Sealed Card ||| Solution for injection 40 IU/ml vi als, 100 IU/m vials + Cartridges 3 Presentations ||| Plaquette thermoformée de 14 et 28 comprimés pelliculés à 0,5 mg de varénicline, étui thermoscellé
0.21869489550590515 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Irbesartan Hydrochlorothiazide Winthrop’ s benefits are greater than its risks for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone. ||| The Committee for Medicinal Products for Human Use (CHMP) concluded that Jalra’ s benefits in the treatment of type 2 diabetes mellitus are greater than its risks when used as dual oral therapy in combination with metformin, a sulphonylurea or a thiazolidinedione. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices d'Irbesartan Hydrochlorothiazide Winthrop sont supérieurs à ses risques pour le traitement de l’ hypertension essentielle chez les patients dont la pression artérielle est insuffisamment contrôlée par l'irbésartan seul ou par l'hydrochlorothiazide seul.
0.28798139095306396 ||| See the Package Leaflet for the list of the medicines that may interact with Nexavar. ||| The effects of the medicine that is radiolabelled with Ytracis will be fully explained in its Package Leaflet. ||| Pour une liste complète des interactions médicamenteuses, voir la notice.
0.5997573137283325 ||| L-arginine Phosphoric acid Polysorbate 20. ||| Benzyl alcohol6 Hydrochloric acid7 ||| L-arginine Acide phosphorique Polysorbate 20.
0.04321255534887314 ||| The effects of Valdoxan were first tested in experimental models before being studied in humans. ||| The effects of Busilvex were first tested in experimental models before being studied in humans. ||| Les effets de Valdoxan ont d’ abord été testés sur des modèles expérimentaux avant d’ être étudiés chez l'homme.
0.48292139172554016 ||| Non-small cell lung cancer (Tarceva administered as single agent in study BR.21): ||| 10 Medicinal product by therapeutic area (dose of Invirase used in study) Corticosteroids ||| Cancer bronchique non à petites cellules (Tarceva en monothérapie dans l’étude BR.21):
0.7435450553894043 ||| ed is 2. ||| s ori 11. ||| é ris 2.
0.26774507761001587 ||| There is no basis for Mycophenolate mofetil Teva dose adjustment following cardiac transplant rejection. ||| Dose adjustment of Mycophenolate mofetil Teva does not appear to be necessary. ||| Il n'y a pas d'argument justifiant l'ajustement de la dose de Mycophénolate mofétil Teva en cas de rejet de greffe cardiaque.
0.43650680780410767 ||| Retapamulin ||| Rosuvastatin ||| Rétapamuline
0.26808154582977295 ||| If the haemoglobin increase is < 1 g/ dl (< 0.62 mmol/ l) and the reticulocyte count has increased < 40,000 cells/ µl above baseline, increase the dose to 300 IU/ kg 3 times per week. ||| If the haemoglobin exceeds 13 g/ dl (8.1 mmol/ l), discontinue therapy until it falls below 12 g/ dl (7.5 mmol/ l) and than reinstitute epoetin alfa therapy at a dose 25% below the previous dose. ||| Si la hausse du taux d’ hémoglobine est < 1 g/ dl (< 0,62 mmol/ l) et que le taux de réticulocytes a augmenté < 40 000 cellules/ µl au-dessus des valeurs initiales, il convient d’ augmenter la dose à 300 UI/ kg 3 fois par semaine.
0.21248707175254822 ||| Other information about Tekturna: ||| Other information about Targretin: ||| Autres informations relatives à Tekturna:
0.016558701172471046 ||| Each 1 ml pre-filled syringe contains 500 micrograms darbepoetin alfa (500 micrograms/ ml). ||| Each 0.5 ml pre-filled syringe contains 100 micrograms darbepoetin alfa (200 micrograms/ ml). ||| é Chaque seringue préremplie de 1 ml contient 500 microgrammes de darbepoetin alfa
0.4146660566329956 ||| Contra-indications After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Calcium carbonate, the most suitable harmonised Section 4.3 Contraindications text was approved (See Annex III). ||| SPC Section 4.8 - Undesirable effects The MAH was asked to identify differences between the listed adverse events in the nationally approved SPCs and the MAH’ s CDS, and to organise Section 4.8 according to the MedDRA system organ class. ||| Contre-indications Après évaluation de la documentation fournie par les TAMM et examen des pratiques cliniques en vigueur dans toute l’ UE à propos de l’ utilisation du carbonate de calcium, le texte harmonisé le plus approprié pour la rubrique 4.3 relative aux contre-indications a été approuvé (voir annexe III).
0.34071892499923706 ||| Animal Health Tel: +353 (0)1 467 6500 ||| Germanja Tel: +49 (0)89 454406 ||| Animal Health Tél: +353 (0)1 467 6500
0.25639715790748596 ||| How to store RELISTOR 6. ||| How to store RISPERDAL 6. ||| Comment conserver RELISTOR 6.
0.0922628790140152 ||| WHAT KINERET IS AND WHAT IT IS USED FOR ||| WHAT CEPLENE IS AND WHAT IT IS USED FOR ||| QU’EST-CE QUE KINERET ET DANS QUEL CAS EST-IL UTILISE?
0.06806972622871399 ||| 203 9. ||| 207 9. ||| 208 9.
0.6306878328323364 ||| 5.5 mg 2.0 IU ||| 1.2 mg (60 KIU) ||| 5.5 mg 2.0 UI
0.009688736870884895 ||| However, lipid effects were greater when {PRODUCT NAME} and colestipol were coadministered than when either medicinal products was given alone. ||| However, lipid effects were greater when {PRODUCT NAME} and colestipol were coadministered than when either medicinal product was given alone. ||| Toutefois, les effets hypolipidémiants sont plus importants lorsque {PRODUCT NAME} et le colestipol sont administrés ensemble par rapport à chacun des médicaments administrés seul.
0.21963807940483093 ||| Advisory services relating to the installation of gearboxes ||| Business advisory services relating to the selection of computers ||| Services de conseils liés à la pose de boîtes de vitesses
0.9625175595283508 ||| [For referral procedures] {PRODUCT NAME} 40mg film-coated tablet ||| 32 --------------------[perforation to separate from patient information]------------------ ||| [For referral procedures] {PRODUCT NAME} 40 mg, comprimé pelliculé
0.00540450494736433 ||| 363 IMPORTANT INFORMATION Always first attach a new needle before using OptiSet. ||| 344 IMPORTANT INFORMATION Always first attach a new needle before using OptiSet. ||| 377 INFORMATIONS IMPORTANTES Toujours fixer une nouvelle aiguille avant d’ utiliser OptiSet.
0.46176350116729736 ||| Adhesive plastic film used for mounting images ||| Translucent flexible material for insulating windows ||| Films plastiques adhésifs pour le montage d'images
0.20457911491394043 ||| What is Purevax RCPCh FeLV used for? ||| What is Purevax RCPCh FeLV? ||| Dans quel cas Purevax RCPCh FeLV est -il utilisé?
0.47945234179496765 ||| Inorganic fertilizers ||| Antibacterial gels ||| Fertilisants inorganiques
0.7218369841575623 ||| ZOSTAVAX reduced the incidence of zoster by 64% (95% CI: ||| SARS has higher mortality than COVID-19 (10.91% versus 1.44%). ||| ZOSTAVAX a réduit l’ incidence du zona de 64% (IC à 95%:
7.122632019775088e-13 ||| 84 10. ||| 84 10. ||| 92 10.
0.33164072036743164 ||| It is used when the patient is considered to be at high risk of developing MS. ||| It must not be used in patients who have an active infection that the doctor considers important. ||| Il est utilisé lorsque le patient présente un risque élevé de développer une SEP.
0.03091519884765148 ||| Do not use Protaphane after the expiry date which is stated on the label and the carton. ||| Do not use Liprolog after the expiry date which is stated on the label and the carton. ||| Ne pas utiliser Protaphane après la date de péremption mentionnée sur l’ étiquette et sur la boîte.
0.4687601923942566 ||| Pharmacia NV/ SA Rijksweg 12 2870 Puurs Belgium ||| Meda AB Pipers väg 2 S-170 09 Solna Sweden ||| Pharmacia NV/ SA Rijksweg 12 2870 Puurs Belgique
0.5851750373840332 ||| Barium nitrate ||| Lithium tantalate ||| Nitrate de baryum
0.3602985143661499 ||| There are no studies completed assessing long-term cardiovascular outcome in patients receiving rosiglitazone in combination with metformin. ||| No significant difference was seen in the progression of diabetic retinopathy when Optisulin was compared to NPH insulin. ||| Les résultats d'étude évaluant le devenir cardiovasculaire à long terme des patients traités par rosiglitazone en association avec la metformine ne sont pas disponibles.
0.21933230757713318 ||| Caution should be exercised when the following active substances are administered concomitantly with levodopa therapy. ||| Reduction of the pramipexole dose should be considered when these medicinal products are administered concomitantly. ||| La prudence est de mise en cas d’ association des principes actifs suivants et de lévodopa:
0.3358941078186035 ||| Cleaning cloths impregnated with disinfectant for hygiene purposes ||| Disposable wipes impregnated with cleansing compounds for use on the face ||| Lingettes nettoyantes imprégnées de désinfectants, à usage hygiénique
8.174930459133034e-13 ||| Tell your doctor immediately: ||| Tell your doctor immediately: ||| 50 Prévenez votre médecin immédiatement:
0.26445522904396057 ||| BeneFIX is given by a slow infusion into a vein (usually up to 4 ml per minute). ||| Advate is given by injection into a vein at a rate of up to 10 ml per minute. ||| BeneFIX est administré par perfusion intraveineuse (dans une veine) à maximum 4 ml par minute.
0.1898442953824997 ||| The rate (95% confidence interval) of non-melanoma skin cancers was 8.8 (5,7, 13.5) per 1,000 patient-years among Humira-treated patients and 2.6 (0.8, 8.0) per 1,000 patient-years among control patients. ||| Of these skin cancers, squamous cell carcinomas occurred at rates (95% confidence interval) of 2.5 (1.1, 5.6) per 1,000 patient-years among Humira-treated patients and 0 per 1,000 patient-years among control patients. ||| Le taux (intervalle de confiance de 95%) de cancers de la peau non mélanomes était de 8,8 (5,7 - 13,5) pour 1000 patient-années pour les patients traités par Humira et de 2,6 (0,8 – 8,0) pour 1000 patient-années parmi les patients du groupe contrôle.
0.27158236503601074 ||| Financial valuation services ||| Financial intermediary services ||| Services d'estimations financières
0.2795877456665039 ||| 3.3%) Fatigue (G3/ 4: ||| 0.3%) Arthralgia (G3/ 4: ||| 3,3%) Fatigue (G3/ 4:
0.0 ||| AUC: ↓ 69% (↓ 55 to ↓ 79) Cmax: ↓ 60% (↓ 50 to ↓ 68) Cmin: ↓ 63% (↓ 44 to ↓ 75) Desacetyl diltiazem: ||| AUC: ↓ 69% (↓ 55 to ↓ 79) Cmax: ↓ 60% (↓ 50 to ↓ 68) Cmin: ↓ 63% (↓ 44 to ↓ 75) Desacetyl diltiazem: ||| ASC: ↓ 69% (↓ 55 à ↓ 79) Cmax: ↓ 60% (↓ 50 à ↓ 68) Cmin: ↓ 63% (↓ 44 à ↓ 75) Désacetyl diltiazem:
0.02761993557214737 ||| If you are allergic (hypersensitive) to insulin or any of the other ingredients of Insulin Human Winthrop Basal. ||| If you are allergic (hypersensitive) to insulin or any of the other ingredients of Insulin Human Winthrop Infusat. ||| si vous êtes allergique (hypersensible) à l'insuline ou à tout autre composant contenu dans Insulin Human Winthrop Basal
0.23961102962493896 ||| Interaction with other medicinal products and other forms of interaction ||| Interaction with other medicaments and other forms of interaction. ||| Interaction avec d'autres médicaments et autres formes d'interaction
0.009971643798053265 ||| Long-term exposure (at least 48 weeks) The proportion of patients who had adverse, clinically significant changes in weight gain, glucose, total/ LDL/ HDL cholesterol or triglycerides increased over time. ||| 37 Long-term exposure (at least 48 weeks) The proportion of patients who had adverse, clinically significant changes in weight gain, glucose, total/ LDL/ HDL cholesterol or triglycerides increased over time. ||| 122 Utilisation prolongée (au moins 48 semaines) La proportion de patients ayant présenté des modifications indésirables cliniquement significatives du poids (augmentation), du glucose, du cholestérol total/ HDL/ LDL ou des triglycérides a augmenté au cours du temps.
0.37782514095306396 ||| The calculation of the required dosage of factor VIII is based on the empirical finding that 1 International Unit (IU) factor VIII per kg body weight raises the plasma factor VIII activity by 1.5% to 2.5% of normal activity. ||| One International Unit (IU) of factor IX activity is related to the quantity of factor IX in the International Standard for factor II, VII, IX and X in human plasma (approved by the WHO) which approximates to the quantity of factor IX in one ml of normal human plasma. ||| 32 Le calcul de la dose nécessaire en facteur VIII se base sur le résultat empirique qu’ 1 Unité Internationale (UI) de facteur VIII par kg de poids corporel augmente l’ activité en facteur VIII plasmatique de 1,5% à 2,5%.
0.21150422096252441 ||| AVANDAMET has no or negligible influence on the ability to drive and use machines. ||| KOGENATE Bayer has no influence on the ability to drive or to use machines. ||| AVANDAMET n'a aucun effet notable sur l’ aptitude à conduire des véhicules et à utiliser des machines.
0.3934177756309509 ||| Coloured paints for facades ||| Decorative boxes of glass ||| Peintures colorées pour façades
0.29011261463165283 ||| An increased incidence of hypertension (all grades) of up to 34% has been observed in Avastin-treated patients in clinical trials compared with up to 14% in those treated with comparator. ||| 7 A meta-analysis of 54 epidemiological studies reported that there is a slightly increased risk (RR = 1.24) of having breast cancer diagnosed in women who are currently using COCs. ||| Dans les études cliniques, une augmentation de l’ incidence de l’ hypertension artérielle (tous grades) a été observée jusqu’ à 34% des patients traités par Avastin comparé à 14% des patients du groupe témoin.
0.34702247381210327 ||| The 24-week results for the three assessment tools are summarised in Table 2. ||| Response rates at the end of follow-up for the two studies are presented in Table 5. ||| Le Tableau 2 présente les résultats à 24 semaines pour les trois échelles d’ évaluation.
0.5855473875999451 ||| When the enzyme is blocked, the DNA strands break. ||| Finally, the toxin is released into the cytosol. ||| Lorsque l’ enzyme est bloquée, les brins d’ ADN se cassent.
6.256990368533333e-13 ||| Horses ||| Horses ||| Chevaux.
0.3434288799762726 ||| Complementing national efforts, the EU budget is uniquely placed to power a fair socio-economic recovery, repair and revitalise the Single Market, to guarantee a level playing field, and support the urgent investments, in particular in the green and digital transitions, which hold the key to Europe's future prosperity and resilience. ||| The plans must effectively address the relevant challenges identified in the European Semester, whether they contribute to strengthening the growth potential and resilience of the Member State and to enhancing cohesion; and must contain measures that significantly contribute to addressing the green and the digital transitions to a large extent. ||| En complément des efforts nationaux, le budget de l'Union se trouve dans une position sans équivalent pour assurer une reprise socio-économique juste, pour réparer et revitaliser le marché unique, pour garantir des conditions de concurrence équitables et pour soutenir les investissements urgents, en particulier dans les transitions écologique et numérique, qui détiennent les clés de la prospérité et de la résilience de l'Europe à l'avenir.
0.20759323239326477 ||| Cardiac disorders Nervous system disorders ||| Immune system disorders Vascular disorders ||| Affections cardiaques Affections du système nerveux central
2.702176048023641e-13 ||| Write the date of reconstitution and expiry on the label (expiry is 1 month after reconstitution). ||| Write the date of reconstitution and expiry on the label (expiry is 1 month after reconstitution). ||| Inscrire la date de reconstitution et la date de péremption (date de reconstitution + 1 mois) sur l'étiquette.
0.641386866569519 ||| Secretarial employment services ||| Facsimile communication services ||| Services d'emploi de secrétariat
0.3133973181247711 ||| Haematology During the first month following treatment, myelosuppression is most notable and red blood cell or platelet transfusions may be required. ||| For post-operative pain relief in cats, safety has only been documented after thiopental/ halothane anaesthesia. ||| Hématologie Au cours du premier mois suivant le traitement, la myélosuppression est particulièrement importante et des transfusions de globules rouges ou de plaquettes peuvent s'avérer nécessaires.
0.0 ||| Do not take a double dose to make up for forgotten individual doses. ||| Do not take a double dose to make up for forgotten individual doses. ||| Ne prenez pas de dose double pour compenser la dose que vous avez oublié de prendre.
0.3647359609603882 ||| Do not use Helixate NexGen 1000 IU if you are allergic (hypersensitive) to octocog alfa, to mouse or hamster protein or to any of the other ingredients of Helixate NexGen 1000 IU. ||| Concurrent use of Equilis Prequenza Te and Tetanus-Serum from Intervet may reduce active immunity against tetanus compared to horses vaccinated with Equilis Prequenza Te in the absence of tetanus antitoxin serum. ||| N'utilisez jamais Helixate NexGen 1000 UI si vous êtes allergique (hypersensible) à l’ octocog alfa, aux protéines de hamster ou de souris ou tout autre constituant d'Helixate NexGen 1000 UI.
0.47635430097579956 ||| If you take too many sachets of OSSEOR, tell your doctor or pharmacist. ||| Take the AZILECT carton/ bottle with you to show the doctor or pharmacist. ||| Si vous avez pris trop de sachets de OSSEOR, prévenez votre médecin ou votre pharmacien.
0.5473530292510986 ||| Determine the dose and the number of ORENCIA vials needed (see section 4.2). ||| CLASSIC I and GAIN induction of remission and response rates are presented in Table 9. dic Me ||| Déterminer la dose et le nombre de flacons d'ORENCIA nécessaires (voir rubrique 4.2).
0.38464078307151794 ||| Finland ||| Portugal ||| Finlande
0.08229680359363556 ||| BATCH NUMBER lo ||| BATCH NUMBER ol ||| NUMÉRO DE LOT
0.13174335658550262 ||| Put the needle fully into the skin as shown by your nurse or doctor. ||| Put the ne edle fully into the skin as shown by your nurse or doctor. ||| Introduisez complètement l'aiguille dans la peau comme vous l’a montré votre médecin ou l’infirmière.
0.004239599220454693 ||| 54 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 48 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.4095379412174225 ||| Psychiatric disorders ||| Psychiatric services ||| Troubles psychiatriques
0.28307008743286133 ||| It is not recommended that you take Zerene with or immediately after eating a large meal as it may work more slowly. ||| If you have eaten a heavy meal, it will be necessary to fast for 6 hours before the test. ||| Il n’ est pas recommandé de prendre Zerene pendant ou immédiatement après un repas copieux, son action pouvant dans ce cas être ralentie.
0.3543815016746521 ||| Rash: in clinical studies, 26% of patients treated with 600 mg of efavirenz experienced skin rash compared with 17% of patients treated in control groups. ||| In both studies, images obtained in healthy volunteers (45 in total) were compared to those in patients with Parkinson’ s disease (180 patients) or essential tremor (29 patients). ||| Eruptions cutanées: au cours des études cliniques, 26% des patients traités par 600 mg d’ éfavirenz ont présenté des éruptions cutanées contre 17% des patients des groupes témoins.
0.17409661412239075 ||| 5 (1.1) 2 (0.4) ||| 4 (2.6) 3 (2.0) ||| 5 (1,1) 2 (0,4)
0.3918757438659668 ||| In the open-label study there was no difference in overall survival between patients treated with recombinant human erythropoietin and controls. ||| Inhalational anthrax Use in humans is based on in-vitro susceptibility data and on animal experimental data together with limited human data. ||| Dans l’ étude en ouvert, il n’ y a pas eu de différence sur la survie globale entre les patients traités avec l’ érythropoïétine humaine recombinante et le groupe contrôle.
0.44459909200668335 ||| Since IgG is known to pass the placenta and because of the concomitant use of radiation, Zevalin must not be used during pregnancy. ||| However, since market introduction, increased INR has been reported during concomitant use of warfarin and BYETTA. ||| Compte-tenu du franchissement connu de la barrière placentaire par les IgG et du risque concomitant d'irradiation, Zevalin ne doit pas être utilisé chez la femme enceinte.
0.8584024310112 ||| Pregnancy and Breastfeeding ||| Pregnancy and Lactation ||| Grossesse et allaitement
0.5571630597114563 ||| For the different dosage regimens, AVANDAMET is available in appropriate strengths. ||| Limited experience with Agenerase oral solution indicate a similar safety profile as for the capsules. ||| AVANDAMET est disponible en dosages adaptés aux différentes posologies.
0.005829867906868458 ||| 54 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 149 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.37945014238357544 ||| vial of 5 ml ||| 5 vials of 10 ml ||| Flacon de 5 ml
0.27024489641189575 ||| Pancreatitis ||| pancreatitis ||| Pancréatite.
0.0029804573860019445 ||| MIRCERA 100 micrograms/ml solution for injection methoxy polyethylene glycol-epoetin beta ||| MIRCERA 300 micrograms/ml solution for injection methoxy polyethylene glycol-epoetin beta ||| MIRCERA 100 microgrammes/ ml, solution injectable méthoxy polyéthylène glycol-epoetin beta
0.05678734928369522 ||| As with other vaccines, administration of Infanrix Penta should be postponed in subjects suffering from acute severe febrile illness. ||| As with other vaccines, the administration of ENGERIX B should be postponed in subjects suffering from acute severe febrile illness. ||| Comme pour les autres vaccins, l'administration d'Infanrix Penta doit être différée chez les sujets atteints d'infections fébriles sévères aiguës.
0.5558493733406067 ||| Catheters ||| Miniskirts ||| Cathéters
0.4059854745864868 ||| In the second clinical study (ASSERT), 279 patients were randomized to receive either placebo (Group 1, n=78) or 5 mg/ kg infliximab (Group 2, n=201) at 0, 2 and 6 weeks and every 6 weeks to week 24. ||| For Time to clinical cure, Doxyprex at 200ppm and at 300ppm groups were cured at 3.2 and 3.33 days respectively compared to the TM550 group at 8.2 days, the Stabox group at 11.75 days and the control group at 13.67 days. ||| Dans la seconde étude clinique (ASSERT), 279 patients ont été randomisés pour recevoir soit du placebo (Groupe 1, n=78), soit 5 mg/ kg d’ infliximab (groupe 2, n=201) aux semaines 0, 2 et 6 puis toutes les 6 semaines jusqu’ à la semaine 24.
0.39007705450057983 ||| In patients with HT-1, these intermediates are converted to the toxic metabolites succinylacetone and succinylacetoacetate. ||| Sirolimus did not affect the pharmacokinetics of either diltiazem or its metabolites desacetyldiltiazem and desmethyldiltiazem. ||| Chez les patients avec HT-1, ces produits intermédiaires sont réduits en deux métabolites toxiques, la succinylacétone et le succinylacétoacétate.
0.02618512138724327 ||| No clinically relevant interactions were observed in clinical trials with Aerius tablets in which erythromycin or ketoconazole were co-administered (see section 5.1). ||| No clinically relevant interactions were observed in clinical trials with Neoclarityn tablets in which erythromycin or ketoconazole were co-administered (see section 5.1). ||| Au cours des études cliniques réalisées avec Aerius comprimés dans lesquels les patients recevaient l’ érythromycine ou du kétoconazole en association, aucune interaction cliniquement significative n’ a été observée (voir rubrique 5.1).
0.7040430307388306 ||| 67.2, 100) and 100% (95% CI: ||| 51/ 127, 40%; with ZDV: ||| 67,2 - 100) et de 100% (IC à 95%:
0.024881448596715927 ||| Liprolog Mix25 100 U/ ml KwikPen suspension for injection 25% insulin lispro and 75% insulin lispro protamine suspension (rDNA origin) ||| Liprolog Mix25 100 U/ ml Pen suspension for injection 25% insulin lispro and 75% insulin lispro protamine suspension (rDNA origin) ||| Liprolog Mix25 100 UI/ml KwikPen, suspension injectable Insuline lispro 25% et insuline lispro protamine en suspension 75% (ADN d'origine recombinante)
3.443649174410951e-13 ||| Zerit has been studied in combination with other antiretroviral agents, e. g. didanosine, lamivudine, ritonavir, indinavir, saquinavir, efavirenz, and nelfinavir. ||| Zerit has been studied in combination with other antiretroviral agents, e. g. didanosine, lamivudine, ritonavir, indinavir, saquinavir, efavirenz, and nelfinavir. ||| Zerit a été étudié en association avec d’ autres agents antirétroviraux, par exemple la didanosine, la lamivudine, le ritonavir, l’ indinavir, le saquinavir, l'éfavirenz et le nelfinavir.
0.47280436754226685 ||| In clinical studies, delayed hypersensitivity reactions have been reported. ||| These changes were mainly attributed to age-related changes in renal function. ||| Lors des études cliniques, des réactions d’ hypersensibilité retardée ont été rapportées.
0.2877689003944397 ||| How to take Aerius orodispersible tablet 4. ||| How to store orodispersible tablet 6. ||| Comment prendre Aerius comprimés orodispersibles 4.
0.24053865671157837 ||| The use of Kentera in patients with hepatic impairment should be carefully monitored. ||| The administration of Keppra to patients with renal impairment may require dose adjustment. ||| L'utilisation d'Kentera chez les patients présentant une insuffisance hépatique doit être suivie avec attention.
0.2090541422367096 ||| In a specific interaction study, where sildenafil (100 mg) was co-administered with amlodipine in hypertensive patients, there was an additional reduction on supine systolic blood pressure of 8 mmHg. ||| In clinical trials, after 12 weeks of therapy with losartan 50 mg/ hydrochlorothiazide 12.5 mg, trough sitting diastolic blood pressure was reduced by an average of up to 13.2 mmHg. ||| Dans une étude d'interaction spécifique où le sildénafil (100 mg) a été administré avec l'amlodipine chez des patients hypertendus, on a observé une diminution supplémentaire de la pression artérielle systolique de 8 mmHg en position couchée.
0.14364799857139587 ||| INSTRUCTIONS IN USE ||| INSTRUCTIONS ON USE ||| INDICATIONS D’ UTILISATION
0.4437882900238037 ||| Laminated building glass incorporating fine electrical conductors ||| Textile finishing wax having water repellant properties ||| Verre feuilleté de construction contenant des conducteurs électriques fins
0.4391136169433594 ||| Solvent: ||| Fever: ||| - Solvant:
0.295708030462265 ||| A limited accumulation of irbesartan (18%) in plasma was observed upon repeated once daily dosing. ||| In pigs, after a single oral dose of radiolabelled material > 90% absorption was demonstrated. ||| Une accumulation limitée d'irbésartan (18%) dans le plasma a été observée avec des doses répétées en une prise par jour.
0.5957280397415161 ||| powder: vial (glass); solvent: ampoule (glass) ||| bottle (glass) + spoon (plastic) ||| Poudre: flacon Solvant: ampoule
0.0 ||| It is indicated only when the disorder is severe, disabling or subjecting the individual to extreme distress. ||| It is indicated only when the disorder is severe, disabling or subjecting the individual to extreme distress. ||| Zerene est indiqué seulement dans les cas sévères, invalidants ou à l'origine d'une souffrance majeure.
0.5743875503540039 ||| revascularization * excludes major bleeding component. ||| Granulation tissue (increased formation of), Malaise ||| * exclut la composante saignement majeur.
0.306097149848938 ||| Study 301 (n = 220) was of longer duration (21 days), involved more cautious up-titration and lower doses of IT ziconotide, and enrolled the most refractory population of patients studied in the three studies. ||| Degarelix is eliminated in a biphasic fashion, with a median terminal half- life (t½) of approximately 43 days for the starting dose or 28 days for the maintenance dose, as estimated based on population pharmacokinetics modelling. ||| L’ étude 301 (n = 220) était plus longue (21 jours), portait sur une augmentation des doses moins rapide avec administration de doses plus faibles de ziconotide par voie intrarachidienne et concernait la population de patients la plus réfractaire recrutée dans les trois études.
0.0 ||| Immune system disorders Uncommon - Urticaria, rash Very rare - Anaphylactic reactions Symptoms of generalised hypersensitivity may include generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation, reduction in blood pressure and fainting/ loss of consciousness. ||| Immune system disorders Uncommon - Urticaria, rash Very rare - Anaphylactic reactions Symptoms of generalised hypersensitivity may include generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation, reduction in blood pressure and fainting/ loss of consciousness. ||| Affections du système immunitaire Peu fréquent – Urticaire, rash Très rare - Réactions anaphylactiques Les symptômes d’ hypersensibilité généralisée peuvent inclure des éruptions cutanées généralisées, démangeaisons, sueurs, troubles gastro-intestinaux, oedème angioneurotique, difficultés respiratoires, palpitations, baisse de la pression artérielle et évanouissement/ perte de connaissance.
0.2423514872789383 ||| No adverse effects on fertility or reproduction were observed in rats at doses up to 2000 mg/ kg (approximately five times the maximum daily human dose on a mg/ m2 of body surface area basis). ||| Doses up to 25 mg/ kg/ day (18 times the exposure [AUC] in humans at a subcutaneous dose of 0.3 mg/ kg) did not affect fertility or general reproductive performance. ||| Aucun effet indésirable n'a été observé sur la fertilité ou la reproduction chez des rats traités par des doses allant jusqu'à 2.000 mg/ kg (environ cinq fois la dose quotidienne maximale humaine exprimée en mg/ m2 de surface corporelle).
0.10301503539085388 ||| The Scientific Conclusions and the grounds for the amendment of the Summaries of Product Characteristics were set out in Annex B to that opinion. ||| The scientific conclusions and the grounds for the amendment of the Summary of Product Characteristics are set out in Annex II. ||| Les conclusions scientifiques ainsi que les motifs de modification des résumés des caractéristiques du produit sont exposés à l'annexe B de cet avis.
0.32300296425819397 ||| Hypersensitivity (allergic reactions) has sometimes been seen in patients treated with factor VIII-containing products. ||| Abnormal sensations (paraesthesia) were seen very commonly in adults with growth hormone deficiency. ||| Une hypersensibilité (réactions allergiques) a parfois été observée chez des patients traités avec des produits contenant un facteur VIII.
0.6659377217292786 ||| Critical evaluation ||| Analysis population ||| Évaluation critique
0.3400752544403076 ||| Brinzolamide has not been studied in pre-term infants (less than 36 weeks gestational age) or those less than 1 week of age. ||| There is only limited experience with the use of sugammadex in infants (30 days to 2 years), and term newborn infants (less than 30 days) have not been studied. ||| Le brinzolamide n’ a été étudié ni chez les prématurés (moins de 36 semaines d’ âge gestationnel), ni chez les enfants âgés de moins d’ une semaine.
0.18242144584655762 ||| 51 (24.4%) 53 (25.4%) 41 (19.6%) 59 (28.2%) ||| 102 (23.9%) 138 (32.4%) 80 (18.8%) 104 (24.4%) ||| 51 (24,4%) 53 (25,4%) 41 (19,6%) 59 (28,2%)
0.2789354920387268 ||| Similarly, mean free and total cobalamins-(III) Cmax values of 197 and 995 µg eq/ ml, respectively, were determined following the dose of 10 g Cyanokit. ||| The mean Cmax and AUC0-∞ of doripenem in healthy subjects across studies following administration of 500 mg over 1 hour are approximately 23 µg/ml and 36 µg.h/ml, respectively. ||| De même, des valeurs moyennes de Cmax des cobalamines-(III) libres et totales de respectivement 197 et 995 µg éq/ ml ont été trouvées, après une dose de 10 g de Cyanokit.
0.5556379556655884 ||| Slowly pull the plunger until all the liquid is in the syringe. ||| At each spot, part the coat until the skin is visible. ||| Prélever la totalité de la solution dans la seringue en tirant doucement sur le piston.
0.17680683732032776 ||| • flushed appearance, inflammation of the throat and nasal passages, swelling of the legs and ankles or other signs of fluid retention, low blood pressure, palpitations, heartburn, tiredness, itching, nausea, anaemia (low blood count). ||| These include: swelling of the tumour, palpitations, shortness of breath, diarrhoea, pain (including pain at the site of metastases (secondaries)), muscle or joint pain, low TSH, excessive sweating, pruritis (itching) and flushing. ||| • Sensation de bouffées de chaleur, inflammation de la gorge et des voies nasales, gonflement des jambes et des chevilles, ou d’autres signes d’œdème, chute de la pression artérielle, palpitations, brûlures d’estomac, fatigue, démangeaisons, nausées, anémie (taux de globules rouges faible).
0.603909969329834 ||| Observers ||| Capsules ||| Membres
0.6238794922828674 ||| Vacuum measuring instruments ||| Automotive refinishing ||| Instruments de mesure à vide
0.0 ||| In the same clinical trials, cerebrovascular adverse events (CVAE e. g., stroke, transient ischemic attack), including fatalities, were reported. ||| In the same clinical trials, cerebrovascular adverse events (CVAE e. g., stroke, transient ischemic attack), including fatalities, were reported. ||| 51 Des événements indésirables vasculaires cérébraux (tels qu’ accidents vasculaires cérébraux, accidents ischémiques transitoires), dont certains à issue fatale, ont été rapportés dans ces mêmes essais cliniques.
0.11071129143238068 ||| PHARMACEUTICAL FORM AND CONTENTS ||| PHARMACEUTICAL FORM AND CONTENTS no ||| FORME PHARMACEUTIQUE ET CONTENU tn
0.3235939145088196 ||| If these symptoms occur, the administration should be immediately discontinued. ||| Treatment should be discontinued if lack of response is observed. ||| Si ces symptômes apparaissent, l'administration doit être interrompue immédiatement.
0.4448622465133667 ||| Take the syringe and pull sheath away from the reconstitution needle - donot twist. ||| 71 ● Gently tap the vial of Fuzeon to loosen the powder. ||| Prendre la seringue et retirer le capuchon protecteur de l’ aiguille – ne pas tordre l’ aiguille.
0.5820357203483582 ||| The first infected patient lived in the capital, Nuuk, and was placed in home isolation. ||| The virus is named after the city of Norwalk, Ohio, where an outbreak occurred in 1968. ||| La personne infectée est mise à l'isolement à son domicile de Nuuk, la capitale du pays.
0.41964292526245117 ||| Why has Rabigen SAG2 been approved? ||| Why has Eurican Herpes 205 been approved? ||| Pourquoi Rabigen SAG2 a -t-il été approuvé?
0.4876162111759186 ||| No specific interaction studies have been performed (see section 5.2) ||| It has been observed following use (see section 4.8). ||| Aucune étude d’interaction spécifique n’a été réalisée (voir rubrique 5.2)
0.78431236743927 ||| Tell your doctor. ||| Relax your muscle. ||| Informez votre médecin.
0.256186306476593 ||| When Xeloda and cisplatin are used in combination, the use of vitamin B6 (pyridoxine) is not advised for symptomatic or secondary prophylactic treatment of hand– foot syndrome, because of published reports that it may decrease the efficacy of cisplatin. ||| Although specific interaction studies have not been conducted, the concomitant use of other potent CYP3A4 inhibitors (such as itraconazole) can be expected to produce vardenafil plasma levels comparable to those produced by ketoconazole. ||| Lorsque Xeloda et cisplatine sont associés, l’ utilisation de la vitamine B6 (pyridoxine) en traitement symptomatique ou en traitement prophylactique secondaire du syndrome main-pied n’ est pas recommandée, car les publications montrent qu’ elle peut diminuer l’ efficacité du cisplatine.
0.0 ||| 28, hard gastro-resistant capsules 56, hard gastro-resistant capsules 84, hard gastro-resistant capsules 98, hard gastro-resistant capsules 100, hard gastro-resistant capsules (5 cartons of 20 capsules) 500, hard gastro-resistant capsules (25 cartons of 20 capsules). ||| 28, hard gastro-resistant capsules 56, hard gastro-resistant capsules 84, hard gastro-resistant capsules 98, hard gastro-resistant capsules 100, hard gastro-resistant capsules (5 cartons of 20 capsules) 500, hard gastro-resistant capsules (25 cartons of 20 capsules). ||| 28 gélules gastro-résistantes 56 gélules gastro-résistantes 84 gélules gastro-résistantes 98 gélules gastro-résistantes 100 gélules gastro-résistantes (pack multiple contenant 5 boîtes de 20 gélules) 500 gélules gastro-résistantes (pack multiple contenant 25 boîtes de 20 gélules)
0.793559193611145 ||| QUESTIONS AND ANSWERS ON RECOMMENDATION FOR REFUSAL OF MARKETING APPLICATION for ALPHEON ||| PROGRAMMES AND REVENUE FROM SERVICES 60 CONTRIBUTIONS TO COMMUNITY PROGRAMMES AND REVENUE FROM SERVICES 600 ||| QUESTIONS ET RÉPONSES SUR LA RECOMMANDATION DE REFUS DE L’ AUTORISATION DE MISE SUR LE MARCHÉ pour ALPHEON
0.2850189805030823 ||| The measure of effectiveness was the production of protective levels of antibodies against tetanus toxoid after vaccination. ||| Quintarix was as effective as the two separate vaccines at producing protective levels of antibodies. ||| La production de niveaux protecteurs d’ anticorps contre le toxoïde de tétanos après vaccination constituait la mesure d’ efficacité.
0.08196784555912018 ||| Each capsule contains 200 mg of ribavirin. ||| Each capsule contains 50 mg of amprenavir. ||| Chaque gélule contient 200 mg de ribavirine.
0.24349460005760193 ||| Do not remove the needle shield. ||| Do not touch the exposed needle. ||| N’ enlevez pas le protège aiguille.
0.5759998559951782 ||| Moraxella catarrhalis * Neisseria meningitidis Pasteurella spp. ||| Diphtheria toxoid1 Tetanus toxoid1 Bordetella pertussis antigens ||| Moraxella catarrhalis* Neisseria meningitidis Pasteurella spp.
0.5274307131767273 ||| Charms, other than for jewellery, key rings or key chains ||| Pouches for holding make-up, keys and other personal items ||| Breloques autres que pour articles de bijouterie et porte-clés
0.4939345121383667 ||| - Treatment of essential hypertension in patients whose blood pressure is not adequately controlled on ||| * End stage renal disease ** In case use of the oral solution is not possible ||| - Traitement de l’ hypertension essentielle chez les patients dont la tension artérielle n’ est pas bien
0.044317081570625305 ||| 80 4.2 Posology and method of administration ||| 28 4.2 Posology and method of administration ||| 83 4.2 Posologie et mode d’administration
0.5732154250144958 ||| Viani Diskus and associated names (see Annex I) 50/ 100 microgram/ dose inhalation powder, pre- dispensed. ||| What ZOSTAVAX contains After reconstitution, 1 dose (0.65 ml) contains: ||| Viani Diskus et noms associés (voir Annexe I) 100/ 50 microgrammes/ dose, poudre pour inhalation en récipient unidose.
0.011425651609897614 ||| * Any subject with an undetectable HCV-RNA level at the Follow-Up Week 12 visit and missing data at the Follow- Up Week 24 visit was considered a sustained responder. ||| * Any subject with an undetectable HCV-RNA level at the Follow-Up Week 12 visit and missing data at the Follow-Up Week 24 visit was considered a sustained responder. ||| 42 données étaient manquantes à la 12ème semaine de suivi et après était considéré comme non répondeur à la 24 semaine de suivi post-thérapeutique.
0.39926812052726746 ||| By blocking their activity, ustekinumab reduces the activity of the immune system and the symptoms of the disease. ||| This means that it reduces the activity of the immune system (the body ’ s natural defences). ||| En bloquant leur activité, l’ ustekinumab réduit l’ activité du système immunitaire et les symptômes de la maladie.
0.10681814700365067 ||| Studies in animals have shown reproductive toxicity including teratogenicity (see section 5.3). ||| Studies in animals have shown reproductive toxicity including foetal malformations (see section 5.3). ||| Des études effectuées chez l'animal ont mis en évidence une toxicité sur la reproduction comprenant une tératogénicité (voir rubrique 5.3).
0.6509001851081848 ||| Pharmacokinetic Parameter ||| Patient Characteristics ||| 11 Paramètres Pharmacocinétiques
0.046226974576711655 ||| Latvija SIA “Merck Sharp & Dohme Latvija” Tel: +371 7364 224 msd_lv@merck.com ||| Latvija SIA “ Merck Sharp & Dohme Latvija” Tel: +371 67364 224 msd_lv@merck. com ||| Latvija SIA “ Merck Sharp & Dohme Latvija” Tel: +371 7364 224 msd_lv@merck. com
0.19099707901477814 ||| Zometa concentrate is contraindicated in breast-feeding women and in patients with clinically significant hypersensitivity to zoledronic acid, other bisphosphonates or any of the excipients in the formulation of Zometa. ||| Cidofovir administration is contraindicated in patients unable to receive probenecid because of a clinically significant hypersensitivity to the active substance or medicinal product or to other sulfa- containing medicines. ||| Zometa solution à diluer est contre-indiqué chez la femme allaitante et chez les patients présentant une hypersensibilité cliniquement significative à l’ acide zolédronique, à d’ autres bisphosphonates ou à l’ un des excipients présents dans la formulation de Zometa.
3.176301994860242e-13 ||| The treatment required depends on the nature and severity of side-effects (see also “ Take special care with BeneFIX ”). ||| The treatment required depends on the nature and severity of side-effects (see also “ Take special care with BeneFIX ”). ||| Le traitement dépendra de la nature et de la gravité des effets indésirables (voir aussi « Faites attention avec BeneFIX ».
0.03890743479132652 ||| Orange Capsule Shell Gelatin Red Iron Oxide (E172) Titanium dioxide (E171) ||| 17 Capsule Shell Gelatin Red Iron Oxide (E172) Titanium dioxide (E171) ||| Enveloppe de la gélule orange Gélatine Oxyde de fer rouge (E172) Dioxyde de titane (E171)
0.03255750983953476 ||| In this study alendronate daily reduced the incidence of ≥ 1 new vertebral fracture by 47% (alendronate 7.9% versus placebo 15.0%). ||| In this study alendronate daily reduced the incidence of ≥ 1 new 18 vertebral fracture by 47% (alendronate 7.9% vs. placebo 15.0%). ||| Dans cette étude, l’ administration quotidienne d’ alendronate a réduit l’ incidence d’ au moins une nouvelle fracture vertébrale de 47% (alendronate 7,9% et placebo 15,0%).
3.5678830224462887e-13 ||| Detailed instructions for subcutaneous administration are provided with this leaflet (see HOW TO SELF INJECT INTRONA at the end of the leaflet). ||| Detailed instructions for subcutaneous administration are provided with this leaflet (see HOW TO SELF INJECT INTRONA at the end of the leaflet). ||| Des instructions détaillées pour l’administration par voie sous-cutanée sont fournies dans cette notice (voir COMMENT AUTO-INJECTER INTRONA à la fin de la notice).
0.22422939538955688 ||| Concrete pipes ||| Concrete vibrators ||| Tuyaux en béton
0.3129006624221802 ||| 2 and any complications of the thromboembolic event have been managed, the thalidomide treatment may be restarted at the original dose dependent upon a benefit risk assessment. ||| The main measure of effectiveness was the number of patients with no bleeding (haemostasis) at the site of application, four minutes after having received Evicel or manual compression. ||| Après stabilisation de l’ état du patient sous traitement anticoagulant, et après 2 maîtrise des complications liée à l’ événement thromboembolique, le traitement par thalidomide peut être repris à la dose initiale, après évaluation du rapport bénéfice / risque.
0.5684986710548401 ||| - have heart problems ||| - severe headache ||| - avez des problèmes cardiaques
0.3296070098876953 ||| After this period it is essential that imiquimod cream is removed with mild soap and water. ||| Method of administration It is recommended that Atripla be swallowed whole with water. ||| Après cette période, il est indispensable d'enlever la crème imiquimod avec de l’eau et un savon doux.
0.48173731565475464 ||| • Experience with hepatitis B vaccine: ||| 36 Treatment of influenza B infection: ||| • Expérience avec le vaccin de l’ hépatite B:
0.022470202296972275 ||| Date of first authorisation / renewal of the authorisation ||| Date of first authorisation/ renewal of the authorisation ||| DATE DE PREMIÈRE AUTORISATION OU DE RENOUVELLEMENT D’ AUTORISATION
0.32666611671447754 ||| Via Felice Casati, 16 20124 Milano Italy ||| Via Isonzo, 6 16147 Genova Italy ||| Via Felice Casati, 16 20124 Milano Italie
0.0738782286643982 ||| Always take OSSEOR exactly as your doctor has told you. ||| Always take ORACEA exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.4090450704097748 ||| If Norvir is taken in combination with other antiretroviral medicines, it is important that you also carefully read the leaflets that are provided with these other medicines. ||| Using Fuzeon with food and drink You can take Fuzeon with or without food but you still need to follow the instructions given in the package leaflets for your other medicines. ||| Si Norvir est administré en association avec d'autres médicaments antirétroviraux, il est important de lire également attentivement la notice de ces autres médicaments.
0.30362072587013245 ||| As these data come from the spontaneous reporting system, the frequency of the adverse reactions is unknown: hypertriglyceridemia, anaemia, blood lactic acid increased, and pneumonia. ||| The toxicology profile is principally determined by the pharmacological activity of the drug: behavioural changes, hypoprolactinaemia, decrease in blood pressure and heart rate, ptosis and salivation. ||| Ces données étant issues d’un système de notification spontanée, la fréquence de ces effets indésirables est inconnue: hypertriglycéridémie, anémie, augmentation de l’acide lactique dans le sang, et pneumonie.
0.33830490708351135 ||| Under certain circumstances (e. g. presence of a low-titre inhibitor) doses larger than those calculated using the formula may be necessary. ||| If these levels are found, in the absence of strenuous exercise, to be significantly elevated (> 5 x ULN), treatment should be stopped. ||| Dans certaines circonstances (présence d'un d’ inhibiteur à faible titre), des doses plus importantes que les quantités calculées à l’ aide de la formule peuvent être nécessaires.
0.4529018998146057 ||| Ball screw cartridges ||| Cast metal fireplaces ||| Cartouches de vis à billes
0.6245509386062622 ||| Hydroponic fertilizers ||| Polyfunctional acrylics ||| Engrais hydroponiques
0.4067714214324951 ||| A durable response for at least one year was documented in a trial (INCAS) for the triple therapy arm with VIRAMUNE, zidovudine and didanosine compared to zidovudine + didanosine or VIRAMUNE + zidovudine in 151 HIV-1 infected, treatment naive patients with CD4+ cell counts of 200- 600 cells/ mm3 (mean 376 cells/ mm3) and a mean baseline plasma HIV-1 RNA concentration of 4.41 log10 copies/ ml (25,704 copies/ ml). ||| 37 Clinical experience Efficacy of PREZISTA co-administered with 100 mg ritonavir in ART-naïve patients The evidence of efficacy of PREZISTA/ritonavir 800/100 mg q.d. is based on the analyses of 48 week data from the ongoing, randomised, controlled, open-label Phase III trial ARTEMIS in antiretroviral treatment-naïve HIV-1 infected patients comparing PREZISTA/ritonavir 800/100 mg q.d. with lopinavir/ritonavir 800/200 mg per day (given as a twice-daily or as a once-daily regimen). ||| L'étude INCAS, comparant trois associations, VIRAMUNE + zidovudine + didanosine, zidovudine + didanosine et VIRAMUNE + zidovudine, chez 151 patients naïfs infectés par le VIH-1 (taux de CD4+ compris entre 200 et 600 cellules/ mm3 [valeur moyenne 376 cellules/ mm3], concentration plasmatique moyenne initiale d'ARN de VIH-1:
0.46785062551498413 ||| The primary activity of insulin lispro is the regulation of glucose metabolism. ||| Vitamin D increases the intestinal absorption of calcium. ||| L'activité principale de l'insuline lispro est la régulation du métabolisme glucidique.
0.47543567419052124 ||| Mechanical egg timers ||| Powered sanitary installations ||| Minuteurs mécaniques
3.0132003120929285e-13 ||| Zero days The vaccine does not contain any ingredients that are likely to pose a risk for consumers of vaccinated birds. ||| Zero days The vaccine does not contain any ingredients that are likely to pose a risk for consumers of vaccinated birds. ||| Le vaccin ne contient aucun ingrédient susceptible de poser un risque pour les consommateurs d’ oiseaux vaccinés.
7.101395209721528e-13 ||| 73 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 73 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 78 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.08966444432735443 ||| 30 Children and adolescents Olanzapine is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy. ||| Dosage in children and neonates VISTIDE is not recommended for use in children below 18 years of age due to a lack of data on safety and efficacy. ||| 32 Enfants et adolescents L’ utilisation de l’ olanzapine chez les enfants et les adolescents âgés de moins de 18 ans n’ est pas recommandée du fait du manque de données sur la sécurité d’ emploi et l’ efficacité.
0.04755663871765137 ||| STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENTS ||| STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENT ||| LISTE DU (DES) SUBSTANCE(S) ACTIVE(S) ET AUTRE(S) INGRÉDIENT(S)
0.19593104720115662 ||| CellCept 250 mg capsules: ||| CellCept 500 mg tablets: ||| CellCept 250 mg gélules:
0.03555174544453621 ||| ► In insulin infusion pumps ► If InnoLet is dropped, damaged or crushed there is a risk of leakage of insulin ► If it hasn’ t been stored correctly or been frozen (see 6 How to store Actrapid) ► If it does not appear water clear and colourless. ||| ► In insulin infusion pumps ► If InnoLet is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn ’ t been stored correctly or if it has been frozen (see 6 How to store Levemir) ► If the insulin does not appear water clear and colourless. ||| dans une pompe à perfusion d’ insuline ► si InnoLet est tombé, a été endommagé ou a été écrasé, car il y a un risque de fuite d’ insuline ► s’ il n’ a pas été conservé correctement ou s’ il a été congelé (voir 6 Comment conserver ► Actrapid). s’ il n’ apparaît pas limpide et incolore. ►
0.44460833072662354 ||| (28.4) ||| 82 (31.3) ||| (28,4)
0.07882116734981537 ||| 27/ 61 ||| 26/ 61 ||| 25/ 57
0.2742939889431 ||| Uncommon: pulmonary embolism, dyspnoea, pulmonary oedema, epistaxis, haemoptysis and hiccough. ||| Uncommon: intracranial haemorrhage, migraine, tremor, hypoaesthesia, hyperaesthesia. ||| Peu fréquent: embolie pulmonaire, dyspnée, œ dème pulmonaire, épistaxis, hémoptysie et hoquet.
0.3226257860660553 ||| If you experience incomplete bladder emptying during urination, the use of oxybutynin may increase this problem. ||| Injectable calcitonin may cause transient dizziness which may impair the reaction of the patient. ||| - Si, pendant que vous urinez, vous notez que votre vessie ne se vide pas complètement, l’ utilisation
0.41021353006362915 ||| Health care workers may be regularly exposed to various types of illnesses and are at risk of getting sick. ||| Older people and those with underlying conditions are the most at risk of serious complications including death. ||| Les travailleurs de la santé peuvent être régulièrement exposés à divers types de maladies et risquent de tomber malades.
0.6069655418395996 ||| Suppression of H. pylori might give false negative results. ||| Resistant E. coli may then spread between people. ||| L’ éradication de H. pylori pourrait produire des résultats faussement négatifs.
0.6216025352478027 ||| TAXOTERE is given as a one-hour infusion every three weeks. ||| Single dose, every 6 months after the last (re-)vaccination. ||| TAXOTERE est administré en perfusion pendant une heure toutes les trois semaines.
0.3826419711112976 ||| The outbreak of the Coronavirus is first and foremost a public health emergency. ||| With the outbreak of the coronavirus crisis this remains of utmost importance. ||| La pandémie de coronavirus est avant tout une urgence de santé publique.
0.2684778869152069 ||| Every year, the European Medicines Agency (EMEA) will review any new information that may become available and this summary will be updated as necessary. ||| Page 2/ 3 Medicines Agency (EMEA) will review additional information that will become available according to an agreed timetable and this summary will be updated as necessary. ||| L’ Agence européenne du médicament (EMEA) réexaminera chaque année toute nouvelle information qui pourrait être fournie et, si nécessaire, remettra ce résumé à jour.
0.26067984104156494 ||| Revasc is then given twice daily for 9 and up to a maximum of 12 days, or until the patient is able to walk, whichever occurs first. ||| Treatment with desirudin is then continued twice daily post-operatively for 9 days up to a maximum of 12 days or until the patient is fully ambulant, whichever occurs first. ||| Revasc sera ensuite administré deux fois par jour pendant 9 à 12 jours maximum ou jusqu’ à la déambulation active et complète du patient (considérer le plus court de ces deux délais).
0.301302969455719 ||| Resuspending the insulin ||| Suspending the insulin ||| Remise en suspension de l’ insuline
0.6908491253852844 ||| CARTON FOR ZALASTA 7.5 mg TABLETS ||| SINGLE DOSE SACHETS 250 MG ||| ETUI DES COMPRIMES DE ZALASTA 7,5 mg
0.4285331070423126 ||| In these studies, the median age was 68 years (range 21-100); 51% were females. ||| The mean age (range) of patients who died was 86 years (range 67-100). ||| Dans ces études, l’ âge médian était de 68 ans (de 21 à 100 ans); 51% étaient de sexe féminin.
0.0 ||| Some materials (allergens) like pollens, house dust or animal fur may cause allergic reactions resulting in itching, redness as well as swelling of the surface of your eye. ||| Some materials (allergens) like pollens, house dust or animal fur may cause allergic reactions resulting in itching, redness as well as swelling of the surface of your eye. ||| Certaines substances (allergènes) comme les pollens, la poussière de maison ou les poils d'animaux peuvent être à l'origine de réactions allergiques pouvant entraîner des démangeaisons, des rougeurs et des gonflements de la surface de votre œ il.
0.04129474237561226 ||| 73 If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| > If you have any further questions on the use of this product ask your doctor or pharmacist. ||| Pour toute autre question concernant l’ utilisation de ce produit, demandez conseil à votre médecin ou à votre pharmacien.
0.3757481873035431 ||| The dosage of Siklos can be adjusted to body weight by increments of 250 mg by using a quarter of a tablet. ||| It is recommended that the maximum volume administered per site of injection should not exceed 20 ml in cattle and 5 ml in swine. ||| La dose de Siklos peut être ajustée au poids corporel par palier de 250 mg en utilisant le quart d'un comprimé.
0.7160390615463257 ||| • Immediately inject the solution: ||| Administer injection following instructions above. ||| 212 • Injectez immédiatement la solution:
0.360736221075058 ||| The capsules should be swallowed whole together with water. ||| Your tablets should be swallowed whole with a sufficient amount of liquid. ||| Les gélules doivent être avalées entières avec de l’eau.
0.4948386251926422 ||| Ultratard is a cloudy, white, aqueous suspension. lon 4. ||| MASIVET is a light-orange, round, film-coated tablet. ||| Ultratard est une suspension aqueuse, blanche et opaque. 'es 4.
0.3274714946746826 ||| If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/ relative should tell your doctor if you have ever had a stroke or "mini" stroke. ||| • If your doctor tells you that you have a serious problem with your immune system (due to disease for example, leukaemia or HIV or due to a medicine you are taking or have previously taken). ||| Si vous êtes une personne agée souffrant de démence (perte de la mémoire et d'autres capacités mentales) et si vous avez déjà eu un accident vasculaire cérébral ou accident ischémique transitoire ("attaque"), vous ou votre entourage soignant devez en informer votre médecin.
0.0648643746972084 ||| Before the first use store your Liprolog Basal KwikPen in a refrigerator (2°C – 8°C). ||| Before the first use store your Humalog BASAL KwikPen in a refrigerator (2°C – 8°C). ||| Avant la première utilisation, conservez Liprolog BASAL KwikPen au réfrigérateur, à une température comprise entre 2°C et 8°C.
0.6937408447265625 ||| If an excessive response is obtained, treatment should be stopped and hCG withheld (see section 4). ||| which is produced by your liver, may rise (this will show up in blood tests), ||| Si une réponse excessive est obtenue, le traitement sera interrompu et l’hCG ne devra pas être administrée (se reporter à la rubrique 4).
0.41077882051467896 ||| Zometa should not be used in that patient population until further data becomes available. ||| 37 SUTENT should not be used in paediatric population until further data become available. ||| Zometa ne devra pas être utilisé chez cette population de patients jusqu’ à ce que des données supplémentaires soient disponibles.
0.34999996423721313 ||| The metabolism of aprepitant occurs largely via oxidation at the morpholine ring and its side chains and the resultant metabolites were only weakly active. ||| Following a subcutaneous dose of Preotact, C-terminal fragments make up about 60-90% of the circulating forms of the molecule. ||| Le métabolisme de l’ aprépitant intervient largement via l’ oxydation au niveau du cycle de la morpholine et de ses chaînes latérales, les métabolites qui en résultent n’ étant que faiblement actifs.
0.37212860584259033 |||  375 Injecting the solution Select the injection site. ||| Injecting the solution Select the injection site. ||| Injection de la solution Choisissez le site d’injection.
0.024381514638662338 ||| After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Pravachol the following was considered to be the most suitable harmonised Section 4.2 Posology text: ||| After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Pravachol, the following was considered to be the most suitable harmonised Section 4.1 indications text: ||| Après étude de la documentation fournie par le TAMM et évaluation des pratiques cliniques actuelles dans toute l’ UE à propos de l'utilisation du pravachol, le texte suivant a été considéré comme le texte harmonisé le plus approprié pour la rubrique 4.2 Posologie:
0.0 ||| Musculoskeletal and connective tissue disorders: ||| Musculoskeletal and connective tissue disorders: ||| Troubles musculaires et articulaires:
0.08012467622756958 ||| Advisory services relating to pollution control ||| Advisory services relating to weight control ||| Services de conseil en matière de contrôle de la pollution
0.3083215057849884 ||| Isolated cases of systemic allergic reactions (anaphylactic reaction, face oedema, angioneurotic oedema) have been reported Metabolism and nutrition disorders: ||| Common: thrombocytopenia Post-marketing experience: leukopenia, neutropenia, pancytopenia (with bone marrow suppression identified in some of the cases) ||| Très rare: quelques rares cas de réactions allergiques systémiques ont été recensés (choc anaphylactique, oedème du visage, oedème angioneurotique).
0.18647411465644836 ||| Spline shank bits [parts of machines] ||| Standard shank drills [parts of machines] ||| Mèches cannelées [pièces de machines]
0.23095420002937317 ||| - if you are allergic (hypersensitive) to nilotinib or any of the other ingredients of Tasigna listed ||| - if you are allergic (hypersensitive) to the active substance abacavir, which is also included in ||| - si vous êtes allergique (hypersensible) au nilotinib ou à l’ un des autres composants contenus
0.4279034733772278 ||| A moderate to strong complete membrane staining is detected in > 10% of the tumour cells. ||| It improves large artery elasticity and decreases the media: lumen ratio of small arteries. ||| Une coloration modérée à forte de toute la membrane est observée dans plus de 10% des cellules tumorales
0.39006948471069336 ||| - if you have nausea (feeling sick in your stomach) and/or vomiting which are very common side ||| - if you are bleeding a lot or have any serious bleeding disorder (e. g. haemophilia) ||| - si vous avez des nausées (sensation d’ avoir envie de vomir) et/ ou vomissez ce qui correspond à
0.5041389465332031 ||| On 21 February, Israel confirmed the first case of COVID-19. ||| New Zealand was the 48th country to have a confirmed case of COVID-19. ||| Le 21 février, Israël a confirmé le premier cas de COVID-19.
0.3202355206012726 ||| If more than four episodes of breakthrough pain are experienced per day over a period of more than four consecutive days, then the dose of the long acting opioid used for persistent pain should be re- evaluated. ||| Up to two additional treatment courses (one injection and one or two laser treatments) can be given, separated by at least three months, as long as the risk of narrowing of the gullet is taken into account. ||| Si le patient présente plus de quatre accès douloureux paroxystiques par jour pendant plus de quatre jours consécutifs, la dose du morphinique à longue durée d’ action utilisé pour traiter la douleur chronique doit être réévaluée.
0.011648265644907951 ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE no ||| FABRICANT(S) DU PRINCIPE ACTIF D’ ORIGINE BIOLOGIQUE ET TITULAIRE(S) DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBÉRATION DES LOTS
0.4677596688270569 ||| The efficacy of Remicade through week 54 was assessed in the ACT 1 study. ||| The primary efficacy endpoint of the study was to determine the ORR using the IWRC (see Table 1). ||| L’ efficacité de Remicade a été évaluée dans l’ étude ACT 1. durant 54 semaines.
0.5109012722969055 ||| Protective immunity appears from about 10 days after injection. ||| In contrast, muscle relaxation recovered spontaneously after 7.1 minutes. ||| L’ immunité protectrice apparaît dans les 10 jours suivant l’ injection.
0.3958660364151001 ||| Replaced Alex NICHOLSON as of the November 2002 meeting, who replaced Frances ROTBLAT as of the May 2002 meeting ||| Dr Patrick Lecourtois was replaced by Dr Eric ABADIE as of the 22 September 1997 meeting. ||| 4 A remplacé Alex NICHOLSON à partir de la réunion de novembre 2002, qui a remplacé Frances ROTBLAT à partir de la réunion de mai 2002.
0.8696821331977844 ||| d sanofi-aventis ||| omalizumab. ||| tor sanofi-aventis
0.2913556694984436 ||| CEPROTIN is also used for the short-term prevention of clotting in patients with severe congenital protein C deficiency in certain situations when there is an increased risk of clotting, such as surgery or when treatment with a coumarin is not sufficient or possible. ||| The non-CFC propellant, Norflurane, has been shown to have no toxic effect at very high vapour concentrations, far in excess of those likely to be experienced by patients, in a wide range of animal species exposed daily for periods of two years. ||| CEPROTIN est en outre utilisé pour la prévention à court terme de la coagulation chez les patients atteints de déficit congénital grave en protéine C dans certains cas de figure associés à un risque accru de coagulation, notamment une opération chirurgicale ou lorsque le traitement par une coumarine est insuffisant ou impossible.
0.2860894799232483 ||| The recommended dose of FORSTEO is 20 micrograms administered once daily by subcutaneous injection in the thigh or abdomen. ||| RISPERDAL CONSTA is given as an intramuscular injection into the buttocks every two weeks, administered by a health care professional. ||| La posologie recommandée de FORSTEO est de 20 microgrammes administrés une fois par jour, par injection sous-cutanée dans la cuisse ou l'abdomen.
0.32089880108833313 ||| If in cases of deep pyoderma, sufficient improvement is not seen after a treatment course of 21 days, it is recommended that the treatment is reconsidered. ||| Because of a long incubation period for Hepatitis B, it is possible for unrecognised infection to be present at the time the vaccine is given. ||| Si dans les cas de pyodermite profonde, une amélioration suffisante n’ a pas été observée après une durée de traitement de 21 jours, il est recommandé de reconsidérer le traitement.
3.543535094258782e-13 ||| th reduced by 40% of the previous dose (e. g., for first dose reduction, to 300 μ g in the once every three weeks group and 1.35 μ g / kg in the once weekly group) if haemoglobin increased by more than 1 g/ dl ||| th reduced by 40% of the previous dose (e. g., for first dose reduction, to 300 μ g in the once every three weeks group and 1.35 μ g / kg in the once weekly group) if haemoglobin increased by more than 1 g/ dl ||| 23 réduction dans le groupe administration une fois toutes les trois semaines et à 1,35 µg/ kg dans le groupe administration hebdomadaire) lorsque l’ augmentation du taux d’ hémoglobine a été supérieure à 1g/ dl sur une période de 14 jours.
0.588964581489563 ||| Wrap belts for kimonos (datemaki) ||| Mung bean pancakes (bindaetteok) ||| Ceintures pour kimonos [datemaki]
0.30036789178848267 ||| After reconstitution an immediate use is recommended. ||| After dilution, an immediate use is recommended. ||| 42 Après reconstitution, une utilisation immédiate est recommandée.
0.1505410522222519 ||| This is increased to 20 drops once a day (1x 10 mg) in the second week and to 30 drops once a day taken in the third week. ||| This is increased to one tablet once a day (1x10 mg) in the second week and to 1and a half tablet once a day in the third week. ||| Cette dose passe à 20 gouttes une fois par jour (1x 10 mg) au cours de la deuxième semaine et à 30 gouttes une fois par jour au cours de la troisième semaine.
0.3442438244819641 ||| RILUTEK should not be used in patients with any other form of motor neurone disease. ||| Gardasil will not protect against other diseases that are not caused by Human Papillomavirus. ||| RILUTEK ne doit pas être utilisé chez les patients atteints d’ un autre type de maladie du motoneurone.
0.3893614411354065 ||| Always put the dosing cup back onto the cap after use and cleaning. ||| Shake the bottle thoroughly before first administration and prime the pump. ||| Toujours replacer le gobelet-doseur sur le bouchon après utilisation et rinçage.
0.43663913011550903 ||| Decreased serum estradiol and progesterone concentrations have been reported in women treated with human leukocyte interferon. na ||| Increases in serum chemistry values including creatinine and potassium have been observed (see lo ||| Des concentrations sériques diminuées en estradiol et progestérone ont été rapportées chez des femmes traitées avec un interféron leucocytaire humain.
5.046064477723378e-13 ||| Antiviral activity according to baseline genotype and phenotype: ||| Antiviral activity according to baseline genotype and phenotype: ||| Activité antivirale selon le génotype et le phénotype à l’ inclusion:
0.16732415556907654 ||| 90 Ísland Vistor hf. ||| Ísland Vistor hf. ||| Ísland Vistor hf.
4.1700789956550244e-13 ||| Any unused product or waste material should be disposed of in accordance with local requirements. ||| Any unused product or waste material should be disposed of in accordance with local requirements. ||| us Tout produit non utilisé ou déchet doit être éliminé conformément à la réglementation en vigueur.
0.3700655698776245 ||| Approximately 0.6% of the dose is recovered in urine following oral administration. ||| SUTENT dosing was reduced or temporarily delayed in approximately 2.7% of this patient population. ||| 18 environ 0,6% de la dose est retrouvé dans les urines.
0.3322300910949707 ||| If hypocalcaemia persists, reduce the dose or discontinue administration of Parareg. ||| Therefore, patients may terminate Lamictal without a step-wise reduction of dose. ||| Si l’ hypocalcémie persiste, il faut réduire la dose de Parareg ou interrompre le traitement.
0.2851078510284424 ||| Kineret is used to treat the signs and symptoms of rheumatoid arthritis in combination with another medicine called methotrexate. ||| Therapy of Helicobacter pylori infection is intended to be combined with concurrent administration of lansoprazole with two antibiotics. ||| Kineret permet de traiter les signes et symptômes de la polyarthrite rhumatoïde en association avec un autre médicament: le méthotrexate.
0.3125571012496948 ||| Treatment and prevention of respiratory infections caused by Escherichia coli susceptible to trimethoprim and sulfamethoxazole where the disease has been diagnosed in the flock. ||| Dexrazoxane has been in use since the 1990s as a medicine to help prevent the cardiomyopathy (harm to the heart muscle) associated with the use of anthracycline medicines. ||| Traitement et prévention des infections respiratoires provoquées par Escherichia coli et sensibles au triméthoprime et au sulfaméthoxazole lorsque la maladie a été diagnostiquée dans le troupeau.
0.19519540667533875 ||| Red-brown film-coated tablets debossed with “ GSK” on one side and "8" on the other side. ||| Blue, oval film-coated tablet debossed with ‘ SP’ on one side and ‘ 200’ on the other side. ||| Comprimé pelliculé Comprimés pelliculés rouge-bruns gravés « GSK » d’ un côté et « 8 » de l’ autre côté.
0.3189219832420349 ||| Use of efavirenz in combination with saquinavir as the sole protease inhibitor is not recommended. ||| No dose recommendations can be made for the use of Atripla in combination with itraconazole. ||| L’ utilisation de l’ éfavirenz associé au saquinavir comme seul inhibiteur de protéase n’ est pas recommandée.
0.12764543294906616 ||| Maintenance and repair of spacecraft ||| Maintenance and repair of water vehicles ||| Entretien et réparation d'engin spatial
0.2729377746582031 ||| Estrada de Alfragide, nº 67 Alfrapark, Edifício D, P-2610-008 Amadora Tel: + 351 (0) 21 472 7100 ||| Avda. de Europa, 22 Parque Empresarial ” La Moraleja” E-28108 Alcobendas, Madrid Tel: + 34 91 663 25 00 ||| Estrada de Alfragide, n° 67 Alfrapark, Edifício D, P-2610-008 Amadora Tel: + 351 (0) 21 472 7100
0.28342729806900024 ||| Insulating doors of non-metallic materials ||| Architectural fasteners of non-metallic materials ||| Portes isolantes en matériaux non métalliques
0.004761785268783569 ||| EU/ 1/ 02/ 218/ 001 30 film-coated tablets. ||| EU/ 1/ 02/ 219/ 001 30 film-coated tablets. ||| EU/ 1/ 02/ 218/ 001 30 comprimés pelliculés.
0.2395276576280594 ||| syringe, 2 injection needles and 1 cleansing swab; ||| with 1 injection syringe, 2 injection needles and 1 cleansing swab. ||| parentérale; sans ou avec 1 seringue, 2 aiguilles et 1 tampon nettoyant.
0.46939682960510254 ||| Romiplostim is produced by recombinant DNA technology in Escherichia coli (E. coli). ||| Menitorix will only confer protection against Haemophilus influenzae type b and Neisseria meningitidis group C. ||| Le romiplostim est produit par la technique de l’ ADN recombinant dans des cellules d’ Escherichia coli (E. coli).
0.43046286702156067 ||| Rental of drainage pumps ||| Rental of chafing dishes ||| Location de pompes de drainage
0.033089689910411835 ||| Tepoxalin must not be administered in conjunction with other NSAIDs or glucocorticosteroids. ||| Metacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids. ||| Le tepoxalin ne doit pas être administré en association avec d’ autres AINS ou avec des glucocorticoïdes.
0.6605002880096436 ||| Emulsion for injection ||| Subsequent injections ||| nS Emulsion injectable.
0.48446378111839294 ||| This is due in particular to the fact that those countries were delisted by FATF based on a former procedure that did not assess the effective application of AML/CFT measures. ||| I-DESI includes the same five dimensions as the DESI, but it is built on a slightly different set of indicators due to some of the DESI indicators not being available in non-EU countries. ||| Cela est notamment dû au fait que ces pays ont été retirés de la liste du GAFI sur la base d'une ancienne procédure qui n'évaluait pas l'application effective des mesures en matière de LBC/FT.
0.034462377429008484 ||| Do not use Fertavid after the expiry date which is stated on the label after'EXP: '. ||| Do not use Puregon after the expiry date which is stated on the label after'EXP: '. ||| 128 Ne pas utiliser Fertavid après la date de péremption mentionnée sur l’ étiquette après ‘ EXP :’.
0.3454311192035675 ||| 19.17 mg methyl parahydroxybenzoate (E218) 2.13 mg propyl parahydroxybenzoate (E216) ||| Methyl parahydroxybenzoate (E 218) Propyl parahydroxybenzoate (E 216) ||| 19,17 mg/ ml de parahydroxybenzoate de méthyle (E218) 2,13 mg de parahydroxybenzoate de propyle (E216)
0.2809918522834778 ||| Because of the potential for serious adverse reactions in infants, breast-feeding must be discontinued while taking Siklos. ||| If trabectedin is used at the end of pregnancy, potential adverse reactions should be monitored carefully in the newborns. ||| En raison du risque de réactions indésirables sévères pour le nourrisson, l'allaitement doit être arrêté pendant la prise de Siklos.
0.1655462384223938 ||| perforating duodenal ulcer, nausea*, vomiting*, acid reflux, dysgeusia, epigastric discomfort, obstipation, gastroesophageal reflux disease, abdominal pain, dry mouth, enterocolitis, flatulence, stomatitis ||| dry mouth, oesophagitis, vomiting, diarrhoea, nausea, dyspepsia, upper abdominal pain, abdominal discomfort, stomach discomfort, frequent bowel movements, gastrointestinal disorder, oral hypoaesthesia, oral paraesthesia, flatulence ||| ulcère duodénal perforant, nausées*, vomissements*, régurgitation acide, dysgueusie, gêne épigastrique, constipation opiniâtre, reflux gastro-œsophagien, douleur abdominale, bouche sèche, entérocolite, flatulence, stomatite
0.2102099359035492 ||| Transient treatment-related physical signs, some of which suggest neural toxicity, such as open-mouth breathing, salivation, white foamy emesis, ataxia, trembling, decreased activity, and/ or hunched posture were observed in dogs at exposure levels approximately 23 times the clinical exposure level. ||| If the animal licks the application site after treatment, transient neurological signs, such as ataxia, generalised tremors, ocular signs (dilated pupils, little pupillary reflex, nystagmus), abnormal respiration, salivation and vomiting, may occur infrequently. ||| 12 des niveaux d'exposition d'environ 23 fois l'exposition clinique: respiration bouche ouverte, écoulement de salive, vomissements mousseux blancs, ataxie, tremblements, diminution de l'activité et/ou posture recroquevillée.
0.43474823236465454 ||| including infections of the fallopian tubes and infections of the uterus mucous membrane. ||| The infections consisted mostly of upper respiratory tract infections and urinary tract infections. ||| les infections des trompes et les infections de la muqueuse utérine.
0.4435049295425415 ||| Olanzapine Teva orodispersible tablet contains tartrazine lake (E102): may cause allergic reactions. ||| Excipients Ferriprox oral solution contains the colouring agent Sunset Yellow (E110) which may cause allergic reactions. ||| Olanzapine Teva, comprimé orodispersible, contient de la tartrazine laque (E102), qui peut provoquer des réactions allergiques.
0.0033065080642700195 ||| 111 Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & ΥΙΟΣ Ε .Π .Ε. ||| 126 Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & ΥΙΟΣ Ε .Π .Ε. ||| 116 Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & ΥΙΟΣ Ε .Π .Ε.
0.3152664303779602 ||| Maintenance doses of corticosteroids have been shown to reduce tacrolimus blood levels. ||| Inducers of metabolism Clinically the following substances have been shown to decrease tacrolimus blood levels: ||| Il a été observé que les doses d’ entretien de corticoïdes diminuent les concentrations sanguines de tacrolimus.
0.4071321487426758 ||| For more detailed dose recommendations, including those for children, see the Package Leaflet of the anti-HIV medicines Norvir is given in combination with. ||| See the Package Leaflet for a full list of these medicines; • St John’ s wort (a herbal preparation used to treat depression). ||| Pour des informations posologiques plus détaillées, notamment les doses recommandées chez l’enfant, se reporter à la notice des autres médicaments anti-VIH avec lesquels Norvir est administré.
0.2927713990211487 ||| Children and adolescents In a single-dose pharmacokinetic study in 13 patients with type 2 diabetes and between the ages of 12 and 16 years, administration of exenatide (5µg) resulted in slightly lower mean AUC (16% lower) and Cmax (25% lower) compared to those observed in adults. ||| 12 Elderly Plasma concentrations following a 1 g and 2 g intravenous dose of ertapenem are slightly higher (approximately 39% and 22%, respectively) in healthy elderly adults (≥ 65 years) relative to young adults (< 65 years). ||| Enfants et adolescents Lors d’ une étude de pharmacocinétique en dose unique réalisée chez 13 patients diabétiques de type 2 âgés de 12 à 16 ans, l’ administration de l’ exénatide (5 µg) s’ est traduite par une ASC et une Cmax légèrement plus basses (de 16% pour l’ ASC et de 25% pour la Cmax) que celles observées chez l’ adulte.
0.004515296779572964 ||| 172 Danmark BRISTOL-MYERS SQUIBB Tlf: + 45 45 93 05 06 ||| 178 Danmark BRISTOL-MYERS SQUIBB Tlf: + 45 45 93 05 06 ||| Danmark BRISTOL-MYERS SQUIBB Tlf: + 45 45 93 05 06
0.0 ||| Read the package leaflet before use ||| Read the package leaflet before use ||| Lire la notice de l’emballage avant utilisation.
0.5160121917724609 ||| Silver embroidery ||| Embroidery ||| Broderies en argent
0.33144816756248474 ||| The number of infusions that you receive will depend on how you are responding to treatment; you should continue to receive this medicine until Avastin fails to stop your tumour growing. ||| They can test this vaccine to see how people react to it, allowing them to predict how people will react when the flu strain causing a pandemic is included. ||| Le nombre total des perfusions que vous recevrez dépendra de votre réponse au traitement; vous devez continuer à recevoir Avastin jusqu’ à ce qu’ il ne puisse plus stopper la croissance de votre tumeur.
0.40234822034835815 ||| The usual starting dose is 10-20 mg/ day given as a single dose in the evening. ||| The usual dose is one tablet in the morning and one tablet in the evening. ||| La dose initiale usuelle est de 10 à 20 mg/jour administrée en une prise unique le soir.
0.3168945908546448 ||| The infusion bottle/bag containing the diluted infusion solution should be inserted into a closable opaque bag for protection from light. ||| Each syringe is packed in a sealed plastic tray which also contains one injection needle for intramuscular use. ||| Conserver à l’ abri de la lumière le flacon/ la poche pour perfusion qui contient la solution diluée pour perfusion dans un sac opaque refermable.
0.3154623210430145 ||| The adhesive side of the patch should be applied to a clean, dry area of skin on the lower abdomen below the waist. ||| The patch is applied to dry, clean skin on the lower abdomen (the tummy, below the waist). ||| Appliquer la face adhésive du dispositif transdermique sur une zone de peau propre et sèche, sur la partie inférieure de l’ abdomen, sous la taille.
0.27528321743011475 ||| 240 Driving and using machines MIRCERA does not affect your ability to drive and use machines. ||| Driving and using machines EVISTA has no known effects on driving or using machines. ||| Conduite de véhicules et utilisation de machines MIRCERA n’ affecte pas votre aptitude à conduire ou utiliser certains outils ou machines.
0.181648850440979 ||| How does Norvir work? ||| How does Evra work? ||| Comment Norvir agit -il?
0.39398375153541565 ||| Information services relating to the transportation of goods ||| Agency services for arranging the transportation of persons ||| Services d'informations liées au transport de marchandises
0.4496634006500244 ||| The company that makes Binocrit will provide information packs for healthcare workers in all Member States, including information on the safety of the medicine. ||| The company that makes Thelin will provide educational information to doctors and patients (patient information card). ||| La société qui fabrique Binocrit fournira des documents d’ information aux personnels de santé de tous les États membres, contenant notamment des informations sur la tolérance du médicament.
0.2817475497722626 ||| When an optimal response is obtained, a single injection of 5,000 IU to 10,000 IU hCG should be administered 24-48 hours after the last GONAL-f and lutropin alfa injections. ||| A commonly used dose for superovulation involves the administration of 150-225 IU (0.25-0.38 ml) of GONAL-f daily, commencing on days 2 or 3 of the treatment cycle. ||| Quand une réponse optimale est obtenue, une injection unique de 5.000 à 10.000 UI d’ hCG devra être administrée 24 à 48 heures après les dernières injections de GONAL-f et de lutropine alfa.
0.506104588508606 ||| 1) Directive 2001/ 83/ EC on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. ||| - Council Regulation (EEC) No 2377/90 as amended (OJ L 224, 18.8.1990, p.1) ||| 1), Directive 2001/ 83/ CE instituant un code communautaire relatif aux médicaments à usage humain (JO L 311, 28.11.2001, p.
0.38743335008621216 ||| On 9 March 2020, Cyprus confirmed its first two cases: a 25-year-old man from Limassol who had returned from Italy and a 64-year-old health professional from Nicosia who had returned from the UK. ||| On 6 March, Togolese authorities announced the first COVID-19 case, a 42-year-old Togolese woman who travelled between Germany, France, Turkey, and Benin before returning to Togo. ||| Le 9 mars, Chypre confirme ses premiers cas de coronavirus: un homme de 25 ans habitant à Limassol qui revenait d'Italie et un homme âgé de 64 ans, professionnel de santé de Nicosie qui revenait du Royaume-Uni.
0.22108100354671478 ||| The CHMP opinion was converted into a Decision by the European Commission on 13 April 2007. ||| On the basis of the CHMP Opinion, the European Commission issued a Decision on 28 November 2005. ||| La Commission européenne a pris sa décision le 13 avril 2007 en s’ appuyant sur l’ avis du CHMP.
0.3816131055355072 ||| 0.51 0.46 ||| 0.86 0.026 ||| 0,51 0,46
0.2002035528421402 ||| Co-administration of sirolimus (2 mg single dose) with multiple-dose administration of oral voriconazole (400 mg every 12 hours for 1 day, then 100 mg every 12 hours for 8 days) in healthy subjects has been reported to increase sirolimus Cmax and AUC by an average of 7-fold and 11-fold respectively. ||| The efficacy of alendronate 10 mg and alendronate 5 mg once daily in men and women treated with steroids (at least 7.5 mg/ day of prednisone or equivalent, median dose 10 mg/ day) was demonstrated in two one-year studies of practically identical design. ||| Voriconazole (inhibiteur du CYP3A4): la co-administration d’ une dose unique de 2 mg de sirolimus et de doses répétées de voriconazole par voie orale (400 mg toutes les 12 heures pendant 1 jour, puis 100 mg toutes les 12 heures pendant 8 jours) chez des sujets sains entraîne une augmentation moyenne des Cmax et ASC du sirolimus respectivement par des facteurs de 7 et 11.
0.2963882088661194 ||| 19 (0.7) ||| 19(10.9) ||| 19 (0,7)
0.27113884687423706 ||| The affinity of brinzolamide and metabolite to RBC and tissue CA results in low plasma concentrations. ||| The sequential enzymatic biotransformation of capecitabine to 5-FU leads to higher concentrations within tumour tissues. ||| L’affinité du brinzolamide et de son métabolite pour les globules rouges et l'AC tissulaire conduit à de faibles concentrations plasmatiques.
0.3716663122177124 ||| 17 The following adverse reactions have been reported during clinical studies and/ or post-marketing use for CRIXIVAN. ||| The following adverse reactions have been identified during post-approval use of SUTENT. ||| 20 Les effets indésirables suivants ont été rapportés lors des études cliniques et/ ou depuis la commercialisation de CRIXIVAN.
0.4057207405567169 ||| Ibraxion is shaken before use and injected subcutaneously (under the skin) into the neck at the front of the shoulder. ||| Spondylolisthesis can be treated using surgery to fuse (join) the vertebrae above and below the site where the slip occurred. ||| Ibraxion doit être agité avant usage puis injecté par voie sous-cutanée (sous la peau) dans la nuque, au niveau de l’ épaule.
0.926984429359436 ||| [See Annex I - To be completed nationally.] ||| II. F.1 Stability of the final product ||| [Voir Annexe I – À compléter au niveau national]
0.31479859352111816 ||| Your doctor may need to monitor your blood coagulation. ||| Your doctor will need to check your blood pressure. ||| Votre médecin peut avoir besoin de surveiller votre bilan de coagulation.
0.24470572173595428 ||| Construction of steel structures for buildings ||| Installation of fittings for buildings ||| Construction de structures en acier pour bâtiments
0.083213672041893 ||| Preparing Liprolog Mix25 KwikPen • The KwikPen should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend insulin until it appears uniformly cloudy or milky. ||| Preparing Humalog Mix25 Pen • The Pen should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend insulin until it appears uniformly cloudy or milky. ||| Préparation de Liprolog Mix25 KwikPen • Faites rouler le stylo KwikPen 10 fois entre les paumes de vos mains et retournez le 10 fois à 180° juste avant son utilisation, afin de remettre l'insuline en suspension jusqu'à ce qu'elle ait un aspect uniformément trouble ou laiteux.
0.23674894869327545 ||| Since Cerenia has not been studied in very young dogs or pregnant or lactating bitches, any use of Cerenia in these animals should be discussed with your veterinarian. ||| As no studies have been made in breeding animals with Convenia and it has an exceptionally long duration in the body, Convenia should not be used in pregnant or lactating dogs or cats. ||| Étant donné que Cerenia n’ a pas été étudié chez le très jeune chiot ou chez la chienne gestante ou allaitante, il est recommandé de n’ utiliser Cerenia qu’ après discussion avec votre vétérinaire.
0.5266075730323792 ||| Semi-trailers ||| Semi-conductors ||| Semi-remorques
0.42819181084632874 ||| * Dialysis clearance of perindoprilat is 70 ml/ min. ||| with creatinine clearance < 50 ml/ minute and/ or on haemodialysis. ||| * la clairance de dialyse du perindoprilate est de 70 ml/ min.
0.05003853887319565 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Apidra to Sanofi-Aventis Deutschland GmbH on 27 September 2004. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Insuman to Sanofi-Aventis Deutschland GmbH on 21 February 1997. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Apidra à Sanofi-Aventis Deutschland GmbH, le 27 septembre 2004.
0.058292657136917114 ||| What benefit has Posatex shown during the studies? ||| What benefit has Humalog shown during the studies? ||| Quels bénéfices ont été démontrés par Posatex au cours des études?
0.26333940029144287 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Nexavar’ s benefits are greater than its risks for the treatment of hepatocellular carcinoma, and of advanced renal cell carcinoma in patients who have failed prior interferon alfa or interleukin-2 based therapy, or who are considered unsuitable for such therapy. ||| Several findings suggest that rhACE2 may be a promising drug for those with intolerance to classic renin-angiotensin system inhibitors (RAS inhibitors) or in diseases where circulating angiotensin II is elevated.Infused rhACE2 has been evaluated in clinical trials for the treatment of acute respiratory distress syndrome. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de Nexavar étaient supérieurs à ses risques en ce qui concerne le traitement du carcinome hépatocellulaire et du carcinome rénal avancé pour les patients chez qui un traitement par interféron-alpha ou interleukine-2 avait échoué ou chez les patients ne pouvant recevoir un tel traitement.
0.2556415796279907 ||| Hypoglycaemia may occur if the insulin dose is too high in relation to the insulin requirement. ||| It may occur if the insulin dose is too high in relation to the insulin requirement. ||| Une hypoglycémie peut survenir si la dose d'insuline est trop élevée par rapport aux besoins en insuline.
0.43374496698379517 ||| An assay of the radiochemical purity of the prepared injection can be performed using the following chromatographic procedures. ||| The analysis of plasma samples was conducted in a central laboratory using a one-stage clotting assay. ||| Une évaluation de la pureté radiochimique de la préparation injectable peut être effectuée en utilisant les procédés chromatographiques suivants.
0.34147170186042786 ||| Liver function ||| Liver effects ||| Fonction hépatique
0.4896165728569031 ||| - If you notice any unusual bruising, excessive bleeding after injury or if you seem to be ||| - If your eyesight becomes impaired or if you have any other eye disturbances whilst taking ||| - si vous observez un hématome (bleu) inhabituel, un saignement excessif après une blessure
0.18880802392959595 ||| No special precautions for storage. ||| 36 No special precautions for storage. ||| Pas de précautions particulières de stockage.
0.31736594438552856 ||| Furthermore, suicidal ideation or attempts were reported more frequently compared to adult patients (2.4% vs 1%) during treatment and during the 6 month lp ||| Following a single 10 mg oral dose, half-life increased by about 50% and clearance decreased by 40% in 16 elderly subjects compared to the normal subjects. ||| En outre, les idées suicidaires ou tentatives de suicides au cours du traitement et lors du suivi de 6 mois après traitement ont été rapportées plus fréquemment chez les enfants et adolescents que chez
0.49545323848724365 ||| The rate of haematological response was 70% with a duration of 2– 3 months. ||| The incidence of Grade 4 neutropenia lasting 7 days or more was 22%. ||| Le taux de réponse hématologique était de 70% sur une durée de 2 à 3 mois.
0.3671562075614929 ||| What CIALIS looks like and contents of the pack CIALIS 20 mg comes as yellow film-coated tablets. ||| What Ranexa looks like and contents of the pack Ranexa prolonged-release tablets are oval shaped tablets. ||| A quoi ressemble CIALIS et contenu de l’ emballage CIALIS 20 mg se présente sous forme de comprimés pelliculés jaunes.
0.45934271812438965 ||| What is Purevax RC used for? ||| What is Porcilis PCV? ||| Dans quel cas Purevax RC est -il utilisé?
0.3265424072742462 ||| In patients undergoing induction of ovulation, the incidence of multiple pregnancies and births (mostly twins) is increased compared with natural conception. ||| Women with a history of tubal disease are at risk of ectopic pregnancy, whether the pregnancy is obtained by spontaneous conception or with fertility treatments. ||| Chez les patientes suivant un traitement d’ induction de l’ ovulation, l’ incidence des grossesses et des naissances multiples (souvent gémellaires) est accrue comparée à une conception naturelle.
0.07315392792224884 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Zonegran to Eisai Limited on 10 March 2005. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Avastin to Roche Registration Limited on 12 January 2005. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Zonegran à Eisai Limited, le 10 mars 2005.
0.08306671679019928 ||| Focetria suspension for injection Pandemic Influenza Vaccine (surface antigen, inactivated, adjuvanted) ||| Focetria suspension for injection in multidose container Pandemic Influenza Vaccine (surface antigen, inactivated, adjuvanted) ||| Vaccin grippal pandémique (antigène de surface, inactivé, avec adjuvant)
0.42382389307022095 ||| - sleeping problems, sleepiness, depression, a feeling of confusion or disorientation, anxiety, ||| Anger, lack of interest, feeling confused, increased sex drive, panic attack, loss of memory. ||| - troubles du sommeil, somnolence, dépression, sensation de confusion ou de désorientation,
0.27303630113601685 ||| Approximately 40% of the dose is excreted in the urine and 42% in the faeces over a 10 day period and mainly in the form of conjugated metabolites. ||| Approximately 60% and 15% of the dose are excreted in the urine and faeces, respectively, within 10 days after administration. ||| Approximativement 40% de la dose est excrétée dans les urines et 42% dans les fécès sur une période de 10 jours et principalement sous forme de métabolites conjugués.
0.32979729771614075 ||| One pack of 20 multidose vials (type I glass) of 5 ml suspension (10 x 0.5 ml doses) with a stopper (bromobutyl rubber) ||| 500 IU: one vial (glass type I) of powder + one vial (glass type I) of 5 ml solvent with stoppers (bromobutyl). ||| Une boîte de 20 flacons multidose (verre de type I) contenant 5 ml de suspension (10 doses de 0,5 ml) avec un bouchon (caoutchouc bromobutyle).
0.7396817207336426 ||| 2 micrograms 4 micrograms 2 micrograms 2 micrograms 2 micrograms 2 micrograms 2 micrograms ||| 20 micrograms 40 micrograms 40 micrograms 20 micrograms ||| 2 microgrammes 4 microgrammes 2 microgrammes 2 microgrammes 2 microgrammes 2 microgrammes 2 microgrammes
0.287156343460083 ||| Velosulin contains metacresol, which may cause allergic reactions. ||| Agopton contains mannitol, which may have a mild laxative effect. ||| to Velosulin contient du métacrésol qui peut entraîner des réactions allergiques.
0.327811598777771 ||| Aerius is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). ||| MIRCERA is used to treat only the symptomatic anaemia caused by your chronic kidney disease. ||| Aerius est aussi utilisé pour soulager les symptômes associés à l'urticaire (atteinte cutanée provoquée par une allergie).
0.0 ||| For a full list of excipients, see section 6.1. ||| For a full list of excipients, see section 6.1. ||| Pour tous les excipients, cf. chapitre 6.1.
0.3294065296649933 ||| Do not use Actrapid ||| Do not use Liprolog ||| N’ utilisez jamais Actrapid
0.7225986123085022 ||| Veterinary medicinal product subject to prescription. ||| Medicinal product by therapeutic ||| Médicament vétérinaire soumis à prescription médicale.
0.4850679934024811 ||| After finalisation of the procedure the Spanish Agency for Medicines and Health Products initiated a referral for arbitration to the CHMP under article 36.1 of Directive 2001/ 83/ EC. ||| In the 5 March issue of Eurosurveillance 2020, Spiteri et al. reported on the first European confirmed COVID-19 cases according to the WHO case definition. ||| Après finalisation de la procédure, l’ Agence espagnole du médicament et des produits sanitaires a demandé l’ arbitrage du comité des médicaments à usage humain (CHMP), en vertu de l’ article 36, paragraphe 1, de la directive 2001/ 83/ CE.
0.6028186082839966 ||| Relocation services for businesses ||| Providing theme park services ||| Services de relogement pour entreprises
0.5514051914215088 ||| Catalysts for use in control of ozone emissions ||| Control of infestations of fleas in agriculture ||| Catalyseurs destinés au contrôle des émissions d'ozone
0.2603992223739624 ||| In rats, at similar exposure levels, an increased incidence of thyroid adenomas was seen, probably related to an increase in release of thyroid stimulating hormone secondary to an increase in thyroxine clearance. ||| 24 While opioids generally increase the tone of urinary tract smooth muscle, the net effect tends to be variable, in some cases producing urinary urgency, in others, difficulty in urination. ||| 27 adénomes de la thyroïde a été observée, due probablement à une augmentation de la sécrétion de l’ hormone thyréotrope secondaire à une augmentation de la clairance de la thyroxine.
0.0 ||| is or Excipients: sodium phosphate monobasic, sodium phosphate dibasic, sodium chloride, polysorbate 80, water for injections. ||| is or Excipients: sodium phosphate monobasic, sodium phosphate dibasic, sodium chloride, polysorbate 80, water for injections. ||| au Excipients: phosphate monosodique anhydre, phosphate disodique anhydre, chlorure de sodium, polysorbate 80, eau pour préparations injectables.
0.09185273945331573 ||| The patient should be advised that in case of sudden visual defect, he should stop taking Tadalafil Lilly and consult a physician immediately (see section 4.3). ||| The patient should be advised that in the case of sudden visual defect, he should stop taking Vivanza and consult immediately a physician (see section 4.3). ||| Le patient doit être averti qu’ en cas d’ anomalie visuelle soudaine, il doit arrêter la prise de Tadalafil Lilly et consulter immédiatement un médecin (voir rubrique 4.3).
0.4897168278694153 ||| Provision of access to television via decoding apparatus ||| Transmitting and receiving apparatus for television broadcasting ||| Services d'accès à la télévision via des appareils de décodage
0.5318634510040283 ||| Beef tallow for industrial purposes ||| Loose hemp for use as animal bedding ||| Suif de bœuf à usage industriel
0.11506369709968567 ||| STOCRIN should not be taken with ATRIPLA since it contains efavirenz, the active ingredient of STOCRIN. ||| SUSTIVA should not be taken with ATRIPLA since it contains efavirenz, the active ingredient of SUSTIVA. ||| STOCRIN ne doit pas être pris avec ATRIPLA qui contient de l'éfavirenz, le même principe actif que STOCRIN.
0.0 ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN ||| MISE EN GARDE SPECIALE INDIQUANT QUE LE MEDICAMENT DOIT ETRE CONSERVÉ HORS DE PORTÉE ET DE VUE DES ENFANTS
0.11242498457431793 ||| 30 België/ Belgique/ Belgien Abbott SA Parc Scientifique Rue du Bosquet, 2 B-1348 Louvain-la-Neuve Tél/ Tel: + 32 10 475311 ||| Luxembourg/Luxemburg Abbott SA Parc Scientifique Rue du Bosquet, 2 B-1348 / Louvain-la-Neuve Belgique/Belgien Tél/Tel: + 32 10 475311 ||| België/ Belgique/ Belgien Abbott SA Parc Scientifique Rue du Bosquet, 2 B-1348 Louvain-la-Neuve Tél/ Tel: + 32 10 475311
0.5234383940696716 ||| Therefore, drug interactions would not be expected to occur. ||| An influence by food or drinks is thus not to be expected. ||| Aussi, des interactions médicamenteuses sont peu probables.
0.5859881639480591 ||| Fabric glue for household use ||| Flour ready for baking ||| Colle pour tissu à usage domestique
0.3303276300430298 ||| In case of deterioration or worsening of right heart failure transfer to other medicinal products should be considered. ||| Minor symptoms such as flushing or skin reactions do not require interruption of therapy. ||| En cas de détérioration ou d’ aggravation de l’ insuffisance cardiaque droite, le relais par un autre traitement devra être envisagé.
0.3158591687679291 ||| Retail services relating to food ||| Retail services relating to furs ||| Services de vente au détail d'aliments
0.1073073297739029 ||| KG D-55216 Ingelheim am Rhein Germany ||| 173 D-55216 Ingelheim am Rhein Germany ||| 116 D-55216 Ingelheim am Rhein Allemagne
0.1647455394268036 ||| Saunderton High Wycombe Buckinghamshire HP14 4HJ United Kingdom ||| Saunderton High Wycombe Buckinghamshire HP14 4HJ ||| Saunderton High Wycombe Buckinghamshire, HP 14 4HJ Grande-Bretagne
0.3193691074848175 ||| 81 When imatinib was combined with high dose chemotherapy in Ph+ ALL patients, transient liver toxicity in the form of transaminase elevation and hyperbilirubinaemia were observed. ||| Resistance has been seen in vitro and in some HIV-1 infected patients due to the development of the M184V/ I mutation with emtricitabine or the K65R mutation with tenofovir. ||| Lorsque l’ imatinib était associé à des doses élevées de chimiothérapie chez des patients atteints de LAL Ph+, une toxicité hépatique transitoire se traduisant par une élévation des transaminases et une hyperbilirubinémie a été observée.
0.29364901781082153 ||| Paediatric patients OPTISON is not recommended for use in children below 18 years due to lack of data on safety and efficacy. ||| 126 • The use of ZYPREXA in elderly patients with dementia is not recommended as it may have serious side effects. ||| Enfants Ce médicament ne doit pas être utilisé chez l’ enfant en dessous de 18 ans, compte tenu de l’ absence de données concernant sa sécurité et son efficacité.
0.17985831201076508 ||| International Non-Proprietary Name (INN): paroxetine ||| International Non-Proprietary Name (INN): piroxicam ||| Dénomination commune internationale (DCI): paroxétine
0.19330701231956482 ||| LITAK 2 mg/ ml solution for injection cladribine ||| Bridion 100 mg/ ml solution for injection sugammadex ||| LITAK 2 mg/ ml solution injectable cladribine
0.13305985927581787 ||| 1 D-79639 Grenzach-Wyhlen Germany ||| 1 D-79639 Grenzach- Wyhlen Germany ||| 1 D-79639 Grenzach-Wyhlen, Allemagne
5.836369256807805e-13 ||| Dispose of waste material in accordance with local requirements. ||| Dispose of waste material in accordance with local requirements. ||| Éliminer les déchets en accord avec la réglementation locale.
0.03461279347538948 ||| 22 bubbles must be removed from the cartridge before injection (see instruction for using pen). ||| Air bubbles must be removed from the cartridge before injection (see instruction for using pen). ||| Les bulles d’ air doivent être éliminées de la cartouche avant l’ injection (voir les instructions d’ utilisation du stylo).
0.2978363037109375 ||| HOW TO USE LIPROLOG Basal PEN ||| HOW TO USE HUMALOG BASAL KWIKPEN ||| COMMENT UTILISER LIPROLOG BASAL PEN
0.011485172435641289 ||| Use the injection technique advised by your doctor or diabetes nurse Keep the needle under your skin for at least 6 seconds to make sure that the full dose has been delivered. ||| Use the injection technique advised by your doctor or diabetes nurse ► Keep the needle under your skin for at least 6 seconds to make sure that the full dose has been delivered. ||| Utilisez la méthode d’ injection conseillée par votre médecin ou votre infirmière d’ éducation gardez l’ aiguille sous la peau pendant au moins 6 secondes afin d’ être certain que la totalité de la dose a été délivrée.
0.11008191853761673 ||| Important information about some of the ingredients of Ratiograstim This medicine contains sorbitol (a type of sugar). ||| Important information about some of the ingredients of Zarzio This medicine contains sorbitol (a type of sugar). ||| Informations importantes concernant certains composants de Ratiograstim Ce médicament contient du sorbitol (un type de sucre).
0.5066715478897095 ||| The median duration of follow-up for the combined protocols (005, 007, 013, and 015) was 3.6 years. ||| The median duration of follow-up for these studies was 4.0, 3.0, 3.0, and 3.0 years for Protocol 005, Protocol 007, Protocol 013, and Protocol 015, respectively. ||| La durée médiane de suivi pour l'analyse combinée des protocoles (005, 007, 013 et 015) a été de 3,6 ans.
0.0865672379732132 ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF BOTOX ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF ORACEA ||| RÉSUMÉ GÉNÉRAL DE L’ ÉVALUATION SCIENTIFIQUE DE BOTOX
0.0 ||| 6.6 Special precautions for disposal and other handling ||| 6.6 Special precautions for disposal and other handling ||| 81 6.6 Précautions particulières d’ élimination et manipulation
0.19974684715270996 ||| Before administration, visually inspect the solution for particulate matter and discolouration. ||| Visually inspect the diluted product for particles or discolouration prior to administration. ||| Avant administration, inspecter visuellement la solution afin de déceler la présence de particules et d’ une coloration.
0.0 ||| If you or the child have an infection of any kind. ||| If you or the child have an infection of any kind. ||| Si vous ou l’ enfant avez une infection quelle qu’elle soit.
0.09288813173770905 ||| 7/ 24 6.5 Nature and composition of immediate packaging ||| 24/ 125 6.5 Nature and composition of immediate packaging ||| 6.5 Nature et composition du conditionnement primaire
0.00396051537245512 ||| 356 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 248 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 370 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.43380075693130493 ||| Adjustment of dosage should be made at intervals of 4 weeks or more. ||| Upward dosage adjustment should not be made more frequently than every 4 weeks. ||| L’ ajustement de la posologie se fera à intervalles d’ au moins 4 semaines.
0.0 ||| Serious cardiovascular events, including cerebrovascular haemorrhage, sudden cardiac death, transient ischaemic attack, unstable angina and ventricular arrhythmia have been reported post marketing in temporal association with another medicinal product in this class. ||| Serious cardiovascular events, including cerebrovascular haemorrhage, sudden cardiac death, transient ischaemic attack, unstable angina and ventricular arrhythmia have been reported post marketing in temporal association with another medicinal product in this class. ||| Rapports après commercialisation d’ autres produits de la même classe: Troubles vasculaires: des évènements cardiovasculaires graves tels que, hémorragies cérébrovasculaires, mort subite d'origine cardiaque, accident ischémique transitoire, angor instable et arythmie ventriculaire ont été rapportés lors de l’ utilisation d’ autres médicaments commercialisés de la même classe.
0.3510630130767822 ||| 4 Plasma levels of cinacalcet may be lower in smokers due to induction of CYP1A2-mediated metabolism. ||| CYP450-catalysed (oxidative) metabolism of deferasirox appears to be minor in humans (about 8%). ||| Le taux plasmatique du cinacalcet peut être diminué chez les fumeurs en raison d’ une induction du métabolisme médiée par le CYP1A2.
0.1496705859899521 ||| Powder for concentrate for solution for injection or infusion ||| Powder for solution for injection or infusion ||| Poudre pour solution à diluer pour solution injectable ou pour perfusion
0.39107954502105713 ||| - Keep out of the reach and sight of children. ||| It must be kept out of the sight and reach of children. ||| - Tenir hors de la portée et de la vue des enfants.
0.41517242789268494 ||| Caustic potash (potassium hydroxide) ||| Potassium hydroxide (for pH-adjustment). ||| Potasse caustique [hydroxyde de potassium]
0.28449147939682007 ||| Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. ||| Tulathromycin is a semi-synthetic macrolide antimicrobial agent, which originates from a fermentation product. ||| La loratadine est un antihistaminique tricyclique agissant sélectivement sur les récepteurs H1 périphériques.
0.0 ||| Iceland ||| Iceland ||| Grèce
0.2832360565662384 ||| When concomitant administration with co-trimoxazole is warranted, patients should be monitored clinically. ||| When co-administered with Atripla, sertraline dose increases should be guided by clinical response. ||| Lorsque l’ administration concomitante de Trizivir et de cotrimoxazole est indiquée, une surveillance clinique est nécessaire.
0.3319573998451233 ||| Pregnancy Post-marketing reports from approximately 300 pregnancies exposed to infliximab, do not indicate unexpected effects on pregnancy outcome. ||| Very limited clinical data on pregnancies exposed to Replagal (n=4) have shown no adverse effects on the mother and newborn child. ||| Grossesse Des rapports post-marketing portant sur environ 300 grossesses sous infliximab n’ ont pas révélé d’ effets inattendus sur le déroulement de la grossesse.
0.3680261969566345 ||| In this leaflet: ||| In this leaflet ct ||| au Dans cette notice:
0.2697659134864807 ||| The exposure to nilotinib in healthy subjects was increased 3-fold when co-administered with the strong CYP3A4 inhibitor ketoconazole. ||| When concomitant administration of potent CYP3A4 inducers with aripiprazole occurs, the aripiprazole dose should be increased. ||| Chez des sujets sains, l’ exposition au nilotinib était multipliée par 3 en cas d’ administration concomitante de kétoconazole, un inhibiteur puissant du CYP3A4.
0.3114568591117859 ||| The benefit-risk balance of sildenafil has not been established in patients with class I functional classification of pulmonary arterial hypertension. ||| Gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (WHO grade III and IV). ||| 3 Le rapport bénéfice/ risque du sildénafil n’ a pas été établi chez les patients en classe I de la classification fonctionnelle de l’ hypertension artérielle pulmonaire.
0.5489409565925598 ||| Intravenous use ||| Subcutaneous use ||| Intra-veineuse
0.2723832130432129 ||| In response to the questions, the applicant submitted the dossier and argued on the basis of a comparison of the compositions that there are no differences between Compagel Gel for Horses and the reference product that could justify different conclusions on the safety and efficacy. ||| In conclusion, the CHMP considered that the Applicant responses to the List of Outstanding Issues did allow the committee to conclude that the test and the reference product are similar when used without a spacer, with regards to safety aspects. ||| En réponse aux questions, le demandeur a soumis le dossier et a indiqué sur la base d’ une comparaison des compositions qu’ il n’ y avait pas de différence entre le Compagel Gel for Horses et le produit de référence susceptible de justifier des conclusions différentes en termes d’ innocuité et d’ efficacité.
0.10194054245948792 ||| Focetria has been authorised under “ Exceptional Circumstances”. ||| Onsenal has been authorised under ‘ Exceptional Circumstances’. ||| Focetria a été autorisé « sous circonstances exceptionnelles ».
0.6420353055000305 ||| Germicidal lamps ||| Chromic anhydride ||| Lampes germicides
0.4232107996940613 ||| No initial dose adjustment of Rasilez HCT is required in elderly patients. ||| Breast-feeding women may require adjustments in insulin dose and diet. tn ||| 31 Aucun ajustement de la dose initiale de Rasilez HCT n’ est nécessaire chez les patients âgés.
0.14714738726615906 ||| 112 For the purpose of ambulatory use, the patient may remove Binocrit from the refrigerator and store it not above 25°C for one single period of up to 3 days. ||| For the purpose of ambulatory use, Kineret may be removed from the refrigerator for 12 hours at temperature not above 25°C, without exceeding the expiry date. ||| Pour l’ usage ambulatoire, le patient peut sortir Binocrit du réfrigérateur et le conserver à une température ne dépassant pas 25°C pour une seule période de 3 jours maximum.
0.34559354186058044 ||| The pivotal clinical evaluation of Diacomit was in children of 3 years of age and over with SMEI. ||| In the 1-year clinical studies growth and sexual development of paediatric patients treated with EXJADE were not affected. ||| Les études pivots de Diacomit ont été menées chez des enfants âgés de trois ans et plus et présentant une EMSN.
0.17237943410873413 ||| 3.5% ||| 3.9% ||| 3,5%
0.3060327172279358 ||| When used to treat osteoporosis, Optruma was more effective than placebo in reducing the number of vertebral fractures. ||| By reducing gastric acidity, lansoprazole creates an environment in which appropriate antibiotics can be effective against H. pylori. ||| Dans le traitement de l’ ostéoporose, Optruma s’ est avéré plus efficace que le placebo dans la réduction du nombre de fractures vertébrales.
4.72944437519135e-13 ||| The level of efficacy attained may vary depending on the degree of antigenic homology between the vaccine strain and circulating field strains. ||| The level of efficacy attained may vary depending on the degree of antigenic homology between the vaccine strain and circulating field strains. ||| Le niveau d’ efficacité atteint peut varier en fonction du degré d’ homologie antigénique existant entre la souche vaccinale et les souches sauvages circulantes.
0.3797706663608551 ||| It blocks the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses. ||| It helps control HIV infection by inhibiting or interfering with the protease enzyme that HIV needs to multiply. ||| Elle bloque l’ activité de la transcriptase inverse, une enzyme produite par le VIH qui lui permet d’ infecter les cellules et de produire plus de virus.
0.385801762342453 ||| If you do not follow these instructions, you may get severe sunburn that leads to permanent scarring. ||| This could cause fever (high body temperature) as you may be more likely to develop infections. ||| Si vous ne respectez pas ces instructions, vous risquez de souffrir de brûlures sévères avec des cicatrices définitives.
0.8825281858444214 ||| Insomnia Migraine ||| Dizziness, Migraine ||| Insomnie Migraine
0.0 ||| In HIV infected patients at steady state, mean Cmax, mean Cmin, and mean AUC were linear with 200 mg, 400 mg, and 600 mg daily doses. ||| In HIV infected patients at steady state, mean Cmax, mean Cmin, and mean AUC were linear with 200 mg, 400 mg, and 600 mg daily doses. ||| 160 Chez les patients infectés par le VIH, les valeurs moyennes à l'état d’ équilibre de la Cmax, de la Cmin et de l'aire sous la courbe sont linéaires aux doses quotidiennes de 200, 400 et 600 mg.
0.4471922516822815 ||| Sanofi Winthrop Industrie 6, boulevard de l'Europe F-21800 Quétigny France ||| UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l’ Alleud, Belgium. ||| Sanofi Winthrop Industrie 6, Boulevard de l’Europe F-21800 Quétigny France
0.039535220712423325 ||| It is used in combination with other antiviral medicines to treat adults infected with human immunodeficiency virus (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). ||| It is used in combination with other antiviral medicines to treat adults and children who are infected with human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency syndrome (AIDS). ||| Il est utilisé en association avec d’ autres antiviraux pour le traitement des adultes infectés par le virus de l’ immunodéficience humaine (VIH-1), un virus responsable du syndrome d’ immunodéficience humaine acquise (SIDA).
0.681175172328949 ||| Exposures of ambrisentan as measured by AUC(0-inf) and Cmax were increased by 35% and 20%, respectively. ||| Mean percent change in AUC, Cmax, Cmin with confidence intervals if availablea (mechanism) ||| Les imprégnations en ambrisentan mesurées par l’ ASC(0-inf) et la Cmax ont été légèrement augmentées respectivement de 35% et de 20%.
0.25052201747894287 ||| The activity of GLP-1 and GIP is limited by the DPP-4 enzyme, which rapidly hydrolyzes the incretin hormones to produce inactive products. ||| Adalimumab binds specifically to TNF and neutralizes the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors. ||| L'activité du GLP-1 et du GIP est limitée par l'enzyme DPP-4, qui hydrolyse rapidement les hormones incrétines en produits inactifs.
0.09422934800386429 ||| Insulin Human Winthrop Rapid cartridges are not designed to allow any other insulin to be mixed in the cartridge. ||| Insuman Comb 50 cartridges are not designed to allow any other insulin to be mixed in the cartridge. ||| Les cartouches d’ Insulin Human Winthrop Rapid ne sont pas conçues pour permettre de mélanger une autre insuline dans la cartouche.
0.1978568434715271 ||| The medicine is given by slow intravenous injection (into a vein) over one minute. ||| Each injection is given intravenously (into a vein) slowly but within 2 minutes. ||| Le médicament est administré en injection intraveineuse (dans une veine) lente pendant une minute.
0.007687140256166458 ||| 9/ 18 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 9/ 17 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 9/ 18 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR {NATURE/ TYPE}
0.03195672854781151 ||| • The solution should be inspected visually for particulate matter and discolouration prior to administration. ||| The solution should be visually inspected for particulate matter and discolouration prior to administration. ||| • Avant administration, la solution doit faire l’ objet d’ un contrôle visuel afin de détecter la présence de particules ou une éventuelle décoloration.
0.0067091952078044415 ||| The duration of therapy was 48 weeks with a follow-up period of 6 months except for patients infected with genotypes 2 or 3 and viral load < 800,000 IU/ml (Amplicor) who were treated for 24 weeks with a 6-month follow-up period. ||| The duration of therapy was 48 weeks with a follow-up period of 6 months except for patients infected with genotypes 2 or 3 and viral load < 800,000 IU/ ml (Amplicor) who were treated for 24 weeks with a 6 month follow-up period. ||| La durée du traitement était de 48 semaines avec une période de suivi de 6 mois à l’ exception des patients infectés par un virus de génotype 2 ou 3 et une charge virale < 800 000 UI/ ml (Amplicor) qui ont été traités pendant 24 semaines avec une période de suivi de 6 mois.
0.4030226469039917 ||| Therefore, women of childbearing potential should not receive the treatment until pregnancy is excluded and should be advised to use a reliable contraceptive method. ||| In general, intensified blood glucose control and monitoring of pregnant women with diabetes are recommended throughout pregnancy and when contemplating pregnancy. ||| Par conséquent, les femmes susceptibles d'être enceintes ne doivent pas recevoir ce traitement tant qu'une grossesse n’ est pas exclue et il doit leur être conseillé d’ utiliser un moyen efficace de contraception.
0.27326396107673645 ||| In conclusion, the efficacy data are considered too weak to support a paediatric indication of oesophagitis in children and adolescents. ||| Based on the in vitro and clinical data, the potential for maraviroc to affect the pharmacokinetics of coadministered medicinal products is low. ||| En conclusion, les données d'efficacité sont considérées trop faibles pour justifier une indication pédia- trique de l'œsophagite chez les enfants et les adolescents.
0.27910199761390686 ||| Reactions (redness, swelling, inflammation, itching and bruising) at the injection site may occur. ||| Reactions (redness, swelling, itching) at the injection site may occur lon and will normally disappear during use. ||| Des réactions (rougeur, gonflement, inflammation, démangeaison et ecchymose) peuvent survenir au site d’injection.
0.33814215660095215 ||| Evaluations by the EMEA for centrally authorised medicines are recognised by the national authorities of central and eastern European countries through a simplified procedure at the request of the EU marketing authorisation holder. ||| The EMEA receives safety reports from within the EU and outside concerning centrally authorised medicinal products and coordinates action relating to the safety and quality of medicinal products. ||| Les évaluations par l'EMEA des médicaments autorisés centralement sont reconnues par les autorités nationales des pays d'Europe centrale et orientale par le biais d'une procédure simplifiée, à la demande du titulaire de l'autorisation de mise sur le marché communautaire.
0.31104984879493713 ||| Rental of rowing boats ||| Rental of diving helmets ||| Location de bateaux à rames
0.3683277368545532 ||| Gas mixtures for medical use ||| Suction bags for medical use ||| Mélanges de gaz à usage médical
0.5168083906173706 ||| Mode of action ||| 16 Mode of action ||| 151 Mode d' action
0.3010236620903015 ||| Relays, electric ||| Wires, electric ||| Relais électriques
0.3119208812713623 ||| However, if a child does not tolerate the oral solution, the doctor may recommend opening the hard capsule and mixing the contents with a small amount (1-2 teaspoons) of food (e.g., applesauce, grape jelly, yogurt or infant formula). ||| SINGULAIR granules can be administered either directly in the mouth, or mixed with a spoonful of cold or room temperature soft food (e. g., applesauce, ice cream, carrots and rice). ||| Cependant, si un enfant ne supporte pas la solution buvable, le médecin peut recommander l'ouverture de la gélule et le mélange de son contenu avec une faible quantité de nourriture (1-2 cuillères à café) (par exemple, compote de pomme, gelée de raisin, yaourt ou lait maternisé).
6.174612145366798e-13 ||| 35 1. ||| 35 1. ||| 35 B.
0.6406014561653137 ||| A total of 14 applications were made, a 55% rise over the number forecast for this year. ||| The figures went down since, with record lows of 14.9%, just before the pandemic hit. ||| ce qui représente une augmentation de 55% par rapport aux prévisions pour
0.41181403398513794 ||| In eight patients receiving 40 mg twice daily in the fasted state, steady-state AUC0-12h was 1284±227 ng⋅ h/ ml (18%) (mean ± SD [% CV]), Cmax was 536±146 ng/ ml (27%), and Cmin was 9±8 ng/ ml (89%). ||| AUC0-12h 116,067 nM*h (90% confidence interval = 101,680, 132,490), peak plasma concentrations 19001 nM (90% confidence interval = 17,538, 20,588), and plasma concentrations at 12 hours post dose 2274 nM (90% confidence interval = 1,701, 3,042). ||| Chez huit patients recevant 40 mg deux fois par jour à jeun, l'AUC0-12h à l'état équilibre était de 1284±227 ng. h/ ml (18%) (moyenne±écart-type [%coefficient de variation]), la Cmax était de 536±146 ng/ ml (27%), et la Cmin était de 9±8 ng/ ml (89%).
0.3539273142814636 ||| All changes were considered to be caused by the pharmacological action of valsartan which produces prolonged hypotension, particularly in marmosets. ||| Local skin reactions, such as erythema, are probably an extension of the pharmacologic effect of imiquimod cream. ||| On a jugé que toutes ces altérations résultaient de l’activité pharmacologique du valsartan, qui produit une hypotension prolongée, particulièrement chez le ouistiti.
0.2332782745361328 ||| Dog: ||| Adult: ||| Chien:
0.13219505548477173 ||| International Non-Proprietary Name (INN): paroxetine ||| International Non-Proprietary Name (INN): montelukast ||| Dénomination commune internationale (DCI): paroxétine
0.4497937262058258 ||| Disinfection is less effective than sterilization because it does not kill bacterial endospores. ||| Do not dilute with glucose solutions since these cause aggregation of the protein. ||| La désinfection est moins efficace que la stérilisation car elle ne tue pas les endospores bactériennes.
0.2716168463230133 ||| Very common: if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium. ||| In some patients with congestive heart failure who have normal or low blood pressure, additional lowering of systemic blood pressure may occur with . ||| 100 Très fréquents: si vous souffrez d’ une élévation de la pression artérielle et d’ un diabète de type 2 avec atteinte rénale, les tests sanguins peuvent montrer une élévation du taux de potassium.
0.3780827820301056 ||| 94.1 100.0 ||| 12.0 10.9 ||| 94,1 100,0
7.15570831755219e-13 ||| ra 4. ||| ra 4. ||| pl 4.
0.289244145154953 ||| Reduction of hypercalcaemia in patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated. ||| Recommended dose adjustments during treatment and restart of treatment Dose adjustments, as summarised below, are recommended to manage grade 3 or 4 neutropenia or thrombocytopenia, or other grade 3 or 4 toxicity judged to be related to lenalidomide. ||| Traitement de l’ hypercalcémie chez les patients présentant: • un cancer de la parathyroïde • une hyperparathyroïdie primaire, chez qui la parathyroïdectomie serait indiquée sur la base des taux de calcium sérique (définis par les recommandations thérapeutiques en vigueur) mais chez qui la parathyroïdectomie est contre-indiquée ou n’ est pas cliniquement appropriée
0.719596266746521 ||| Spray crystallized maltose for industrial use ||| The need to monitor serum ferritin monthly ||| Maltose cristallisé par atomisation à usage industriel
0.4575105905532837 ||| Animal reproduction studies showed that degarelix caused infertility in male animals. ||| In studies in pregnant animals, interferons have sometimes caus ed miscarriage. ||| Les études de reproduction chez l’ animal ont montré que dégarélix entraînait une infertilité chez les mâles.
0.0035817567259073257 ||| 277 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 237 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 298 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.5262348651885986 ||| YTRACIS is contraindicated in the following cases: ||| Velmetia is contraindicated in patients with: ||| YTRACIS est contre-indiqué dans les cas suivants:
0.5615054368972778 ||| Additional vitamin D supplements may be considered on an individual basis. ||| Depending on your individual situation a blood transfusion may be preferable. ||| Un apport supplémentaire en vitamine D sera envisagé après une évaluation individuelle.
0.4449116587638855 ||| Restless Legs Syndrome System Organ Class Psychiatric disorders ||| Parkinson’ s disease System Organ Class Psychiatric disorders ||| Classe de système d’ organe Troubles psychiatriques
0.3908535838127136 ||| Dehydration and pulmonary oedema have rarely been reported. ||| Hyperkalaemia has been observed in isolated cases. ||| Une déshydratation et un oedème pulmonaire ont rarement été rapportés.
0.4605953097343445 ||| -10.3(39.0) ||| (46.0-61.0) ||| -10,3(39)
0.2230915129184723 ||| Industrial analysis services ||| Business analysis services ||| Services d'analyse industrielle
0.20056778192520142 ||| Why has Abilify been approved? ||| Why has Atriance been approved? ||| Pourquoi Abilify a -t-il été approuvé?
0.21845370531082153 ||| Interaction studies have shown that pioglitazone has no relevant effect on either the pharmacokinetics or pharmacodynamics of digoxin, warfarin, phenprocoumon and metformin. ||| Animal experiments revealed that epoetin beta does not increase the myelotoxicity of cytostatic medicinal products like etoposide, cisplatin, cyclophosphamide, and fluorouracil. ||| Des études d’ interaction ont montré que la pioglitazone n’ avait pas d’ effet significatif sur la pharmacocinétique et la pharmacodynamie de la digoxine, de la warfarine, de la phenprocoumone et de la metformine.
0.14186695218086243 ||| For agomelatine, no clinical data on exposed pregnancies are available. ||| Pregnancy For olopatadine, no clinical data on exposed pregnancies are available. ||| Il n'existe pas de données cliniques sur l'utilisation de l’ agomélatine chez la femme enceinte.
0.42803895473480225 ||| Sun tanning appliances ||| Hair styling appliances ||| Appareils de bronzage
0.4209611415863037 ||| Cardiac disorders: rare: syncope, artrial fibrillation, cerebrovascular accident ||| Weight increased, Cardiac murmur, alkaline phosphatase increase Cardiac disorders Common: ||| Rare: syncope, fibrillation auriculaire, accident vasculaire cérébral
0.10636460036039352 ||| Helixate NexGen has also been studied as a continuous infusion in 15 patients with haemophilia A undergoing major surgery. ||| KOGENATE Bayer has also been studied as a continuous infusion in 15 patients with haemophilia A undergoing major surgery. ||| Helixate NexGen a également été étudié comme perfusion continue auprès de 15 patients souffrant d’ hémophilie A subissant une intervention chirurgicale importante.
0.08854655921459198 ||| EU/ 1/ 06/ 376/ 001 14 tablets EU/ 1/ 06/ 376/ 002 28 tablets EU/ 1/ 06/ 376/ 003 56 tablets EU/ 1/ 06/ 376/ 004 56 x 1 tablets EU/ 1/ 06/ 376/ 005 98 tablets ||| EU/ 1/ 06/ 369/ 006 14 tablets EU/ 1/ 06/ 369/ 007 28 tablets EU/ 1/ 06/ 369/ 008 56 tablets EU/ 1/ 06/ 369/ 009 56 x 1 tablets EU/ 1/ 06/ 369/ 010 98 tablets ||| EU/ 1/ 06/ 376/ 001 14 comprimés EU/ 1/ 06/ 376/ 002 28 comprimés EU/ 1/ 06/ 376/ 003 56 comprimés EU/ 1/ 06/ 376/ 004 56 x 1 comprimés EU/ 1/ 06/ 376/ 005 98 comprimés
0.17942321300506592 ||| On 2nd September 2004, Italy (Agencizia Italiana del Farmaco) presented to the EMEA a referral under Article 30 of Directive 2001/ 83/ EC, in order to harmonise the nationally authorised summaries of product characteristics, PL and labelling of the medicinal product Neurontin and associated names. ||| On 8 June 2007, the European Commission presented to the EMEA a referral under Article 30 of Directive 2001/ 83/ EC, as amended, in order to harmonise the nationally authorised Summaries of Product Characteristics (SPC), Labelling and Package Leaflet including quality aspects of the medicinal product Gemzar. ||| Le 2 septembre 2004, l’ Italie (Agenzia Italiana del Farmaco) a saisi l’ EMEA en vertu de l’ article 30 de la directive 2001/ 83/ CE, en vue d’ une harmonisation de la notice et de l’ étiquetage du médicament Neurotin et dénominations associées et des résumés nationaux autorisés de leurs caractéristiques.
0.3055993914604187 ||| Myfenax is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. ||| Bicalutamide is an oral-androgen used in the management of locally advanced prostate cancer, as an immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. ||| Myfenax est indiqué en association à la ciclosporine et aux corticoïdes pour la prévention des rejets aigüs d’ organe chez les patients ayant bénéficiés d’ une allogreffe rénale, cardiaque ou hépatique.
0.13593782484531403 ||| Sometimes, the ovaries can over- respond to treatment (ovarian hyperstimulation syndrome), and both doctors and patients must be aware of this possibility. ||| Ovarian hyperstimulation syndrome occurs when the ovaries over-respond to treatment,. both doctors and patients must be aware of this possibility. ||| Il arrive que les ovaires répondent de façon exagérée au traitement (syndrome d’ hyperstimulation ovarienne): médecins et patientes doivent donc tenir compte de cette possibilité.
0.9559208750724792 ||| The hazard ratio for overall survival was 0.96 (95% CI: ||| This gives Evra a ‘ Pearl Index ’ of 0.90. ||| Le rapport de risque pour la survie globale était de 0,96 (IC95%:
0.0 ||| pre-filled syringe (glass) ||| pre-filled syringe (glass) ||| (verre) Seringue pré-remplie
0.36838585138320923 ||| Cytomegalovirus viraemia ||| Cytomegalovirus infection ||| Infection à Cytomégalovirus
0.6055859327316284 ||| Two primary immunisation schedules can be recommended: ||| Minimum requirements for a qualified training centre are: ||| Deux schémas de primo vaccination peuvent être proposés
0.5868279933929443 ||| Musical toys ||| Gold alloys ||| Jouets musicaux
0.33490464091300964 ||| Long-term studies have not been performed to evaluate the carcinogenic potential of infliximab. ||| There are no adequate studies of the attenuated (vaccine) strain of measles virus in pregnancy. ||| Des études à long terme pour évaluer le potentiel carcinogène de l’ infliximab n’ ont pas été effectuées.
0.8546195030212402 ||| HOW TO STORE LEVVIAX no ||| ho Syringe BEFORE USE ||| COMMENT CONSERVER LEVVIAX
0.4030638337135315 ||| Glass slabs for use in building ||| Lead strips for use on windows ||| Dalles en verre destinées au bâtiment
0.5102889537811279 ||| The rate of absorption was affected, resulting in a 36% decrease in Cmax and an increase in Tmax by 2 hours. ||| In bone, percentage of injected activity increases from 3.1% at 5 min to 18% at 6 hours and then decreases with time. ||| Le taux d’ absorption a été modifié, entraînant une diminution de 36% de la Cmax et une augmentation de 2 heures du Tmax.
0.09635279327630997 ||| Arranging and conducting of promotional events ||| Arranging and conducting of marketing events ||| Organisation et conduite d'événements promotionnels
0.26309603452682495 ||| Results of animal reproduction studies indicate that recombinant interferon alfa-2b was not teratogenic in rats or rabbits, nor did it adversely affect pregnancy, foetal development or reproductive capacity in offspring of treated rats. ||| Fertility Isotretinoin, in therapeutic dosages, does not affect the number, motility and morphology of sperm and does not jeopardise the formation and development of the embryo on the part of the men taking isotretinoin. ||| Les résultats d'études de reproduction animale indiquent que l'interféron alfa-2b n'a pas d'effets tératogènes chez les rats et les lapins et n'affecte pas de manière défavorable la gestation, le développement foetal et la capacité reproductrice de la progéniture des rats traités.
0.6578499674797058 ||| In 6 of these patients follow-up now exceeds 4 years. ||| There was also 2 more recoveries bringing the total to 6. ||| Chez 6 de ces patients, le suivi à ce jour est supérieur à 4 ans.
0.4663277268409729 ||| 233 System Organ Class ||| 46 System Organ Class ||| Classe de systèmes
0.0 ||| Shelf-life of the veterinary medicinal product as packaged for sale: ||| Shelf-life of the veterinary medicinal product as packaged for sale: ||| Durée de conservation du médicament vétérinaire conditionné pour la vente:
0.3920275568962097 ||| As part of EU response to COVID-19 in Burkina Faso, Commissioner Urpilainen announced today the approval by Team Europe of a new budget support including a fixed tranche of €60 million that will be quickly disbursed in July. ||| 1958: Viktor Zhdanov, Deputy Minister of Health for the USSR, called on the World Health Assembly to undertake a global initiative to eradicate smallpox, resulting in Resolution WHA11.54. ||| Dans le cadre de la réaction de l'UE face à la COVID-19 au Burkina Faso, la commissaire Urpilainen a annoncé aujourd'hui l'approbation, par l'équipe d'Europe, d'une nouvelle aide budgétaire comprenant une tranche fixe de 60 millions d'euros qui sera décaissée rapidement, au mois de juillet.
0.42589831352233887 ||| Nickel oxides ||| Iron oxides ||| Oxyde de nickel
0.444511353969574 ||| Your or your child's doctor will arrange for the blood tests to be done. ||| Your doctor or their assistant will help you to learn the process of self-administration. ||| Votre médecin ou le pédiatre programmera les examens sanguins à pratiquer.
0.29020318388938904 ||| Reproduction toxicology studies performed with different zinc salts showed no clinically relevant evidence of embryotoxicity, foetotoxicity or teratogenicity. ||| Laboratory studies with either imidacloprid or moxidectin in rats and rabbits have not produced any evidence of teratogenic, foetotoxic or maternotoxic effects. ||| Les études de toxicologie sur la reproduction, réalisées avec différents sels de zinc, n’ ont mis en évidence aucun signe d’ embryotoxicité, de fœ totoxicité ou de tératogénicité, qui soit pertinent sur le plan clinique.
0.462279736995697 ||| In clinical trials treatment-related tumour haemorrhage occurred in approximately 2% of patients with GIST. ||| - 425 medical patients who are at risk for thromboembolic complications treated up to 14 days ||| Dans les essais cliniques, des hémorragies tumorales liées au traitement sont survenues chez environ 2% des patients atteints de GIST.
0.014941141940653324 ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 1.2 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Pharmacovigilance System The MAH must ensure that the system of Pharmacovigilance, as described in version 2.1 presented in Module 1.8.1 of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Système de pharmacovigilance Le titulaire de l’ autorisation de mise sur le marché doit s’ assurer que le système de pharmacovigilance, décrit dans la version 1.2 du Module 1.8.1. de l’ Autorisation de Mise sur le Marché, est en place et fonctionnel avant et pendant la mise sur le marché du produit.
0.19331710040569305 ||| How has Tredaptive been studied? ||| How has PegIntron been studied? ||| Quelles études ont été menées sur Tredaptive?
0.027532054111361504 ||| White, biconvex, ovaloid film-coated tablet imprinted with “ LCI” on one side and “ NVR” on the other. ||| Light yellow, biconvex, ovaloid film-coated tablet imprinted with “ CVV” on one side and “ NVR” on the other. ||| Comprimé pelliculé blanc, biconvexe, ovaloïde portant l’ inscription « LCI » sur une face et « NVR » sur l’ autre face.
0.4874888062477112 ||| It is a member of a class of medicinal products called protease inhibitors. ||| Paroxetine containing medicinal products are approved for the treatment of: ||| VIRACEPT est un antiviral appartenant à une classe de médicaments appelés inhibiteurs de la protéase.
0.33003631234169006 ||| The input from the Secretariat to the redrafting of the ‘Notice to Applicants’ in Volume VI of the Rules Governing Medicinal Products in the European Union will be finalised once the amendment of Council Regulation (EEC) No 2377/90 under discussion has been adopted. ||| The CHMP was requested to give an opinion as to whether the marketing authorisation for Hexavac should be maintained, varied, suspended or withdrawn in the context of an Article 18 of Council Regulation (EEC) No 2309/ 93, as amended, procedure. ||| La contribution du Secrétariat à la nouvelle rédaction de l’Avis aux demandeurs du volume VI des Règles concernant les médicaments dans la Communauté européenne sera finalisée une fois que la modification du règlement (CEE) n° 2377/90 du Conseil, qui est en cours de discussion, aura été adoptée.
0.42638087272644043 ||| The Commission proposes €14.8 billion for humanitarian aid, of which €5 billion come from the European Union Recovery Instrument to reinforce the humanitarian aid instrument. ||| The BlueInvest Platform of the European Commission and the European Investment Fund has provided grants of €22 million in 2019 and €20 million in 2020, to innovative, starting blue economy entrepreneurs. ||| La Commission propose une enveloppe de 14,8 milliards d'euros pour l'aide humanitaire, dont 5 milliards d'euros en provenance de l'instrument de l'Union européenne pour la relance, en vue de renforcer l'instrument d'aide humanitaire.
0.03815099969506264 ||| Before removing the needle from the vial, check the syringe for air bubbles that reduce the amount of Humalog Mix50 in it. ||| Before removing the needle from the vial, check the syringe for air bubbles that reduce the amount of Liprolog in it. ||| Avant de retirer l'aiguille du flacon, vérifier que la seringue ne contient pas de bulles d'air qui pourraient réduire la quantité d’ Humalog Mix50.
0.28678643703460693 ||| It can not be excluded that other inducers, e. g. phenytoin, carbamazepine, phenobarbital, St John’ s wort, may have a similar effect. ||| Therefore, montelukast is not anticipated to markedly alter the metabolism of medicinal products metabolized by this enzyme (e. g., paclitaxel, rosiglitazone, and repaglinide.) ||| Il n’ est pas exclu que d’ autres inducteurs comme par exemple la phénytoïne, la carbamazépine, le phénobarbital, le millepertuis, puissent présenter un effet similaire.
0.6190363764762878 ||| Within the class of quinolones cross-resistance has been observed. ||| This is similar to that seen in a sulphonylurea active comparator group. ||| Il existe une résistance croisée entre la ciprofloxacine et les autres fluoroquinolones.
0.109426349401474 ||| - if you have kidney problems. ||| - if they have kidney problems. ||| - si vous avez des troubles rénaux.
0.032821327447891235 ||| Children 1 through 5 years of age: take 2.5 ml (½ of a 5 ml spoonful) of syrup once a day. ||| Children 1 through 5 years of age: take 2.5 ml (½ of a 5 ml spoonful) of oral solution once a day. ||| Enfants de 1 à 5 ans: prendre 2,5 ml (½ cuillère de 5 ml) de sirop une fois par jour.
0.11137863248586655 ||| EU/ 1/ 96/ 008/ 004 ||| 1 EU/ 1/ 96/ 008/ 011 ||| EU/ 1/ 96/ 008/ 004 Puregon
0.13472002744674683 ||| 3000 IU/ 0.3 ml ||| 10000 IU / 1.0 ml ||| 3 000 UI /
0.06816048175096512 ||| The Committee recommended that Nexavar be given marketing authorisation. ||| The Committee recommended that Renagel be given marketing authorisation. ||| Le comité a recommandé l'octroi d'une autorisation de mise sur le marché pour Nexavar.
5.215347468126574e-13 ||| 79 ||| 79 ||| 119
0.2501961588859558 ||| RISPERDAL does not show a clinically relevant effect on the pharmacokinetics of lithium, valproate, digoxin or topiramate. ||| Co- administration of Rasilez had no significant impact on atorvastatin, valsartan, metformin or amlodipine pharmacokinetics. ||| RISPERDAL n’ a pas montré d’ effet cliniquement significatif sur la pharmacocinétique du lithium, du valproate, de la digoxine ou du topiramate.
4.317001671503423e-13 ||| CONDITIONS OF THE MARKETING AUTHORISATION ||| CONDITIONS OF THE MARKETING AUTHORISATION ||| CONDITIONS RELATIVES À L’ AUTORISATION DE MISE SUR LE MARCHÉ
0.12130395323038101 ||| 36 11. ||| 36 12. ||| 38 11.
0.31129661202430725 ||| The dose may be reduced or treatment interrupted in patients who have certain side effects affecting the blood or the nerves. ||| Food and/ or drink will increase acid production in the stomach and the effect of the vaccine may be impaired. ||| La dose peut être réduite, ou le traitement interrompu, si la patiente manifeste certains effets indésirables affectant le sang ou les nerfs.
0.7864238023757935 ||| Amphibious airplanes ||| Thermionic valves ||| Avions amphibies
0.37665465474128723 ||| The results may be affected in general by all treatments interfering with H. pylori status or urease activity. ||| These results may have been confounded by baseline differences in BMD and vertebral fractures. ||| Les résultats peuvent généralement être affectés par tous les traitements interférant avec H. pylori ou l’ activité de l’ uréase.
0.5985847115516663 ||| Processed sweet potatoes ||| Potatoes, fresh ||| Patates douces préparées
0.5380868911743164 ||| Smoked cheese ||| Smoking of cheese ||| Fromage fumé
0.8003508448600769 ||| Diagram T ||| Disease Stratum ||| 548 Figure T
0.40283268690109253 ||| Ritonavir increases the serum levels of darunavir as a result of CYP3A inhibition. ||| YENTREVE increases the levels of serotonin and norepinephrine in the nervous system. ||| Le ritonavir augmente les concentrations sériques du darunavir par inhibition du CYP3A.
0.08784781396389008 ||| Very rare (seen in less than 1 in 10,000 people) ||| Very rare (seen in less than 1 in 10,000 people) no ||| Très rares (observés chez moins d’ une personne sur 10 000)
0.16107964515686035 ||| Transportation of fruit ||| Transportation of books ||| Transport de fruits
0.17671093344688416 ||| 6.7 Nature and contents of container ||| 6.4 Nature and contents of container ||| 6.5 Nature et contenu de l’ emballage extérieur
0.07209877669811249 ||| Protaphane NovoLet 100 IU/ ml suspension for injection in a pre-filled pen. ||| Mixtard 20 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen. ||| Protaphane NovoLet 100 UI/ ml suspension injectable en stylo prérempli
0.30809223651885986 ||| Mineral preparations for use in manufacturing ||| Mineral substances for use in filtering ||| Préparations minérales utilisées dans la fabrication
0.5574781894683838 ||| The conclusion of the Horizontal Agreement offers important opportunities to other EU airlines, and is therefore beneficial to airlines on both sides. ||| This analysis found that the non-euro area Member States are overall well integrated economically and financially in the EU. ||| La conclusion de l'accord horizontal offre d'importantes perspectives aux autres compagnies aériennes de l'UE et profite, par conséquent, aux compagnies aériennes des deux parties.
0.17086230218410492 ||| If the product is not used during the seven-day period, it cannot be put back in the refrigerator for a new storage period and must be discarded. ||| Once the product is stored at room temperature it must not be returned to the refrigerator and must be discarded, if not used by the end of the 9-month period. ||| Si le produit n’ est pas utilisé pendant cette période de sept jours, il ne peut pas être remis au réfrigérateur pour une nouvelle période de conservation et doit être éliminé. dic
0.2645409107208252 ||| When administered without food, the relative bioavailability of darunavir in the presence of low dose ritonavir is 30% lower as compared to intake with food. ||| 30 Oral Tablet In healthy subjects, the mean extent of bioavailability of sirolimus after single-dose administration of the tablet formulation is about 27% higher relative to the oral solution. ||| 70 Lorsqu’il est administré sans nourriture, la biodisponibilité relative du darunavir associé à une faible dose de ritonavir est 30% inférieure à celle d’une administration avec de la nourriture.
0.0025907568633556366 ||| 146 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 152 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 154 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.7724159955978394 ||| Maximum residue limits for new substances ||| Maximum amount of fat allowed from snacks per day ||| Limites maximales de résidus pour les nouvelles substances
0.32579052448272705 ||| Other information about Pritor: ||| Other information about Convenia: ||| Autres informations relatives à Pritor:
0.3464636504650116 ||| Spinning machines ||| Piercing machines ||| Machines de filature
0.0020333738066256046 ||| 124 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 122 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 146 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.13102121651172638 ||| Chemicals for use in the refining of oils ||| Chemicals for use in the formation of water wells ||| Produits chimiques destinés au raffinage du pétrole
0.1588088870048523 ||| How does Enbrel work? ||| How does Renagel work? ||| Comment Enbrel agit -il?
0.14151906967163086 ||| Tools [parts of machines] ||| Press tools [parts of machines] ||| Outils [parties de machines]
0.12317799031734467 ||| • The other ingredients are: ||| - The other ingredients are: ||| - Les autres composants sont:
0.2401273250579834 ||| In mice, a 2-year carcinogenicity study with pravastatin demonstrates at doses of 250 and 500 mg/kg/day (≥ 310 times the maximum human mg/kg dose), a statistically significant increases in the incidence of hepatocellular carcinomas in males and females, and lung adenomas in females only. ||| In clinical trials conducted in a broad range of indications and at a wide range of doses (from 6 MIU/m2/week in hairy cell leukaemia up to 100 MIU/m2/week in melanoma), the most commonly reported undesirable effects were fever, fatigue, headache and myalgia. ||| Chez la souris, une étude de carcinogénicité sur deux ans avec la pravastatine, a démontré aux doses de 250 et 500 mg/kg/jour (≥ 310 fois la dose maxima le chez l'homme en mg/kg), des augmentations statistiquement significatives de l'incidence des carcinomes hépatocellulaires chez les mâles et chez les femelles, et des adénomes pulmonaires chez les femelles uniquement.
0.4576440453529358 ||| Air regeneration ||| Electricity distribution ||| Régénération d'air
0.27501440048217773 ||| 33 days ||| 13 days ||| 33 jours
0.12205016613006592 ||| Solution for injection, Part of a multi-pack of 5 x (1 x 10 ml) vials. ||| Suspension for injection Part of a multi-pack of 2 x (5 x 3ml) cartridges. ||| Solution injectable, Fait partie de l’ emballage multiple de 5 boîtes de 1 flacon de 10ml.
0.9574394226074219 ||| 10 A-6250 Kundl Austria ||| 06516 Carros France ||| 10 A-6250 Kundl Autriche
0.12576016783714294 ||| For a full description of the doses, see the Package Leaflet. ||| For the full list of restrictions, please see the Package Leaflet. ||| Pour une description complète des posologies, veuillez vous reporter à la notice.
0.6588331460952759 ||| How to use Insuman Comb 50 4. ||| 106 Information on how to use Insulatard InnoLet ||| Comment utiliser Insuman Comb 50 4.
0.2799501121044159 ||| Doses of 4 or 8 mg/ kg of tocilizumab or placebo were given every four weeks as blinded therapy for 52 weeks in combination with stable MTX (10 mg to 25 mg weekly). ||| The dose of acetylsalicylic acid given before Rapilysin should be at least 250 mg – 350 mg and should be followed by 75 – 150 mg/ day, at least until discharge from hospital. ||| Les posologies de 4 ou 8 mg/ kg de tocilizumab ou un placebo ont été administrés toutes les quatre semaines en aveugle pendant 52 semaines en association avec une dose stable de MTX (10 mg à 25 mg une fois par semaine).
0.12492352724075317 ||| Do not use Zeffix after the expiry date which is stated on the bottle and the carton. ||| - Do not use Prometax after the expiry date, which is stated on the box and sachet. ||| Ne pas utiliser Zeffix après la date de péremption mentionnée sur le flacon et la boîte.
0.0033589452505111694 ||| 178 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder: ||| 170 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder: ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’Autorisation de Mise sur le Marché:
0.3932666778564453 ||| After 12 months treatment with bimatoprost eye drops alone, the incidence was 1.5% and did not increase following 3 years treatment. ||| Among 480 patients with > 2 log viral reduction but detectable virus at Week 12, altogether 188 patients continued therapy. ||| Après un traitement de 12 mois par un collyre contenant du bimatoprost seulement, l’ incidence a été de 1,5% et n’ a pas augmenté pendant les 3 années de traitement.
0.4441685676574707 ||| Therefore, the EU needs to have a multi-faceted approach to properly tackle money laundering and terrorist financing. ||| As we re-establish connectivity, these guidelines will provide authorities and stakeholders a standard framework. ||| L'Union se doit par conséquent d'adopter une approche pluridimensionnelle pour combattre efficacement le blanchiment de capitaux et le financement du terrorisme.
0.3675380349159241 ||| Press the syringe tip into the vial access device and twist in a clockwise motion to ensure that the syringe is securely attached to the white luer cap of the vial access device. ||| If you do not see the arrow in the centre of the dose window, push in the injection button fully and turn the dose knob until the arrow is seen in the centre of the window. ||| Introduire l’ extrémité de la seringue dans l’ orifice de connexion de l’ adaptateur en poussant et visser dans le sens des aiguilles d’ une montre pour assurer que la seringue est correctement fixée à l’ embout luer blanc de l’ adaptateur.
5.342102628314027e-13 ||| Slovenija Merck Sharp & Dohme, inovativna zdravila d. o. o. ||| Slovenija Merck Sharp & Dohme, inovativna zdravila d. o. o. ||| Slovenija Merck Sharp & Dohme, inovativna zdravila d.o.o.
0.051960594952106476 ||| What benefit has Tamiflu shown during the studies? ||| What benefit has Optaflu shown during the studies? ||| Quel est le bénéfice démontré par Tamiflu au cours des études?
0.4451373517513275 ||| Levels of xenophobia have also risen in East Asia, with some restaurants and other businesses in Japan and China refusing service to foreign customers. ||| There has been a worldwide spike in racist incidents targeting people of East Asian origin, including in major cities such as New York, London and San Francisco. ||| Les niveaux de xénophobie ont également augmenté en Asie orientale, avec certains restaurants et autres entreprises refusant de servir les clients étrangers au Japon et en Chine.
0.9650859832763672 ||| Remeron and associated names (see Annex I) 30 mg orodispersible tablets [See Annex I - To be completed nationally] ||| Operation of the Committee on Orphan Medicinal Products............... 31 Applications for orphan designation............................................................... ..32 ||| Remeron et noms associés (voir Annexe 1) 30 mg, comprimés orodispersibles [Voir annexe 1 – A compléter au niveau national]
0.039240170270204544 ||| Caution is therefore recommended since these patients may be volume and/ or salt depleted. ||| Caution is recommended therefore, since these patients may be volume and/or salt depleted. ||| Une attention particulière est recommandée chez ces patients pouvant faire l’ objet d’ une déplétion hydrosodée.
0.14011427760124207 ||| 88.6 ||| 81.0 ||| 88,6
0.30638980865478516 ||| You should tell your doctor if: • you are allergic to doxorubicin or any of the ingredients contained in Myocet. • you are pregnant, or think you may be pregnant, or are breast-feeding. • you have a history of cardiovascular disease (for example heart attacks, heart failure or long- standing high blood pressure) • you have problems with your liver. ||| 98 Inform your doctor if you have a disease of • the bone marrow, • kidney, • liver, • heart, • thyroid, • or if you have experienced depression, • or if you have any history of epileptic seizures, so that he/she can closely monitor your treatment and any worsening of these conditions. ||| Informez votre médecin: • si vous êtes allergique à la doxorubicine ou à l’ un des excipients contenus dans Myocet. • si vous êtes enceinte, pensez l’ être ou allaitez. • si vous avez des antécédents de maladie cardio-vasculaire (par exemple crise cardiaque, insuffisance cardiaque ou hypertension artérielle de longue durée) • si vous avez des problèmes de foie
6.794824035025182e-13 ||| Musculoskeletal, connective tissue and bone disorders ||| Musculoskeletal, connective tissue and bone disorders ||| Affections musculo- squelettiques, systémiques et osseuses
0.6098654270172119 ||| What Ratiograstim contains ||| What Flebogammadif contains ||| Que contient Ratiograstim
0.33604124188423157 ||| If the combination proves necessary, careful monitoring of serum lithium levels is recommended. ||| Determination of serum concentrations, especially of theophylline, and dose adjustments may be necessary. ||| Si l’ association se révèle nécessaire, une surveillance stricte de la lithémie est recommandée.
0.2755773961544037 ||| It can also be used to prevent the recurrence of these episodes (when symptoms come back) in adults with bipolar disorder (a mental illness with alternating periods of high mood and depression) who have responded to an initial course of treatment. ||| There are reports of patients who have taken the recommended dose for more than 5 days of treatment (up to 64 days) with adverse events reported including bone marrow suppression, with or without infection, in some cases severe and prolonged and resulting in death. ||| Il peut également servir à empêcher la récidive de ces épisodes (la réapparition des symptômes) chez les patients adultes atteints de troubles bipolaires (maladie mentale avec alternance de périodes d’ euphorie et de dépression) ayant répondu à une première cure thérapeutique.
0.07832416892051697 ||| The marketing authorisation was renewed on 12 March 2004 and on 12 March 2009. ||| The marketing authorisation was renewed on 13 March 2002 and 13 March 2007. ||| L’ autorisation de mise sur le marché a été renouvelée le 12 mars 2004 et le 12 mars 2009.
0.5198125839233398 ||| Baskets for barrels ||| Mangers for horses ||| Paniers pour tonneaux
0.343114972114563 ||| Boilers, other than parts of machines ||| Locks of metal, other than electric ||| Chaudières autres que parties de machines
0.32767677307128906 ||| - If you notice any adverse change in your thinking, mood or memory, please tell your doctor. ||| If you notice a change in the way your heart beats (heart rhythm changes), please inform your doctor. ||| mémoire, signalez -le à votre médecin. si vous recevez une chimiothérapie, signalez -le à votre médecin.
0.04631929099559784 ||| In the treatment of central neuropathic pain due to spinal cord injury the incidence of adverse events in general, CNS adverse events and especially somnolence was increased (See 4.4). ||| In the treatment of central neuropathic pain due to spinal cord injury the incidence of adverse events in general, CNS adverse events and especially somnolence was increased. ||| Dans le traitement des douleurs neuropathiques centrales dues à une lésion de la moelle épinière, l’incidence des événements indésirables en général, les événements indésirables touchant le SNC et la somnolence en particulier, ont été accrus (voir 4.4).
0.22239983081817627 ||| - The active substance is olanzapine. ||| - The active substance is irbesartan. ||| - La substance active est l’ olanzapine.
0.625606119632721 ||| TESAVEL 25 mg tablets Sitagliptin ||| Sitagliptin with Metformin1 ||| TESAVEL 25 mg, comprimés Sitagliptine
0.2674316167831421 ||| Furthermore, the Temporary Framework complements the many other possibilities already available to Member States to mitigate the socio-economic impact of the coronavirus outbreak, in line with EU State aid rules. ||| In this context, the Commission notes that this amendment to the Temporary Framework complements rather than replaces existing possibilities under EU State aid rules for Member States to provide support. ||| En outre, l'encadrement temporaire complète les nombreuses autres possibilités dont disposent déjà les États membres pour atténuer les répercussions socio-économiques de la pandémie de coronavirus, conformément aux règles de l'UE en matière d'aides d'État.
0.27917715907096863 ||| Caution should be used when thalidomide is given in combination with medicinal products that cause drowsiness. ||| Digestive tolerance of cysteamine is improved when the medicinal product is taken just after or with food. ||| Il convient d’ utiliser le thalidomide avec précaution lors de l’ association à des médicaments susceptibles d’ entraîner une somnolence.
0.40931519865989685 ||| With low doses of nicotinic acid or lower rates of absorption, the first pathway predominates. ||| Food intake (standard meal or high fat meal) does not modify the bioavailability or the absorption rate. ||| La première voie prédomine en cas de doses faibles d’ acide nicotinique ou de vitesses d’ absorption faibles.
0.40952152013778687 ||| Similarly a larger treatment effect was observed in those patients with visual hallucinations (see Table 6). ||| The following table displays adverse events which were reported in ≥ 10% of patients, by study treatment: ||| De façon similaire, un effet plus important a été observé chez les patients avec hallucinations visuelles (voir Tableau 6).
0.47228002548217773 ||| - The other ingredients are microcrystalline cellulose, sodium laurilsulfate, hypromellose, ||| Minor circulating metabolites include varenicline N-carbamoylglucuronide and N- glucosylvarenicline. ||| - Les autres composants sont la cellulose microcristalline, le laurilsulfate de sodium,
0.0038215017411857843 ||| 35 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 50 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché.
0.16741958260536194 ||| You must wait at least 14 days after you have stopped taking an MAOI before you can take YENTREVE. ||| Also, you need to wait at least 5 days after you stop taking ARICLAIM before you take a MAOI. ||| Vous devez attendre au moins 14 jours après avoir cessé de prendre un IMAO avant de prendre YENTREVE.
0.3267344832420349 ||| This ensures that you get an accurate dose by: • making sure that pen and needle work properly • removing air bubbles If you are using a new OptiSet the initial safety test must be done with the 8 units preset by the manufacturer, otherwise the pen will not function properly. ||| 129 − Using Kaletra as recommended should give you the best chance of delaying the development of resistance to the product. − If a side effect is preventing you from taking Kaletra as directed tell your doctor right away. − Always keep enough Kaletra on hand so you don’t run out. ||| Etant certain que le stylo et l’aiguille fonctionnent correctement • éliminant les bulles d’air • Si vous utilisez un nouvel OptiSet le test de sécurité initial doit être fait avec les 8 unités préselectionnées par le fabricant, sinon le stylo ne fonctionnera pas correctement.
0.24192564189434052 ||| The use of Truvada is not recommended in patients with severe renal impairment (creatinine clearance < 30 ml/ min) and in patients who require haemodialysis since appropriate dose reductions cannot be achieved with the combination tablet (see sections 4.2 and 5.2). ||| However, based on clinical experience, Kaletra dose increase to 533/ 133 mg twice daily (~6.5 ml) may be considered when co-administered with nevirapine, particularly for patients in whom reduced lopinavir susceptibility is likely. ||| L’ utilisation de Truvada n’ est pas recommandée chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) et chez les patients qui nécessitent une hémodialyse car les réductions des doses d’ emtricitabine et de ténofovir nécessaires chez ces patients ne peuvent être obtenues avec l’ association fixe (voir rubriques 4.2 et 5.2).
0.20218709111213684 ||| Do not chew the tablet. ||| Do not chew the capsules. ||| Ne pas mâcher le comprimé.
0.21517795324325562 ||| Why has Tracleer been approved? ||| Why has Cholestagel been approved? ||| Pourquoi Tracleer a -t-il été approuvé?
0.048355478793382645 ||| 165 9. ||| 147 9. ||| 187 9.
0.1446964144706726 ||| What is the risk associated with Mirapexin? ||| What is the risk associated with Virbagen Omega? ||| Quel est le risque associé à l’ utilisation de Mirapexin?
0.30360913276672363 ||| Each vial provides 120 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended. ||| 1 pre-filled syringe contains 180 micrograms of peginterferon alfa – 2a. ||| Chaque flacon permet de délivrer 120 microgrammes/ 0,5 ml de peginterféron alfa-2b après reconstitution selon les recommandations.
0.3586885333061218 ||| Entacapone increases the bioavailability of levodopa from standard levodopa/ benserazide preparations 5– 10% more than from standard levodopa/ carbidopa preparations. ||| The fixed-dose combination tablet of abacavir/ lamivudine (FDC) has been shown to be bioequivalent to lamivudine and abacavir administered separately. ||| L’ entacapone augmente plus la biodisponibilité de la lévodopa à partir des préparations standard de lévodopa/ benserazide (de 5 à 10% de plus) qu’ à partir des préparations standard de lévodopa/ carbidopa.
0.5005428194999695 ||| The diluent is a clear to slightly turbid, light-yellow to yellow solution, essentially free from visible particulates. ||| 54 The reconstituted vaccine is slightly more turbid than the solvent and is milky white in appearance. ||| Le diluant est un liquide limpide à légèrement trouble, de couleur jaune pâle à jaune, totalement exempt de particules visibles.
0.35783252120018005 ||| (iii) Conditions regarding the exit of the State from the capital of the companies concerned: Beneficiaries and Member States are required to develop an exit strategy, in particular as regards large companies that have received significant recapitalisation aid from the State. ||| (ii) Conditions on the State's entry in the capital of companies and remuneration: The State must be sufficiently remunerated for the risks it assumes through the recapitalisation aid. ||| iii) Conditions relatives à la sortie de l'État du capital des entreprises concernées: les bénéficiaires et les États membres sont tenus d'établir une stratégie de sortie du capital, notamment en ce qui concerne les grandes entreprises qui ont reçu des aides à la recapitalisation substantielles de l'État.
0.28815728425979614 ||| Zerit is also available as a powder to make up into an oral solution. ||| It is available as a powder and solvent that are made up into a solution for injection. ||| Zerit existe aussi sous forme de poudre pour solution buvable à reconstituer.
0.2723832130432129 ||| In response to the questions, the applicant submitted the dossier and argued on the basis of a comparison of the compositions that there are no differences between Compagel Gel for Horses and the reference product that could justify different conclusions on the safety and efficacy. ||| In conclusion, the CHMP considered that the Applicant responses to the List of Outstanding Issues did allow the committee to conclude that the test and the reference product are similar when used without a spacer, with regards to safety aspects. ||| En réponse aux questions, le demandeur a soumis le dossier et a indiqué sur la base d’ une comparaison des compositions qu’ il n’ y avait pas de différence entre le Compagel Gel for Horses et le produit de référence susceptible de justifier des conclusions différentes en termes d’ innocuité et d’ efficacité.
0.18300440907478333 ||| 5 WITHDRAWAL PERIOD ||| WITHDRAWAL PERIOD ||| DELAI D’ ATTENTE
0.1842757910490036 ||| Why has OSSEOR been approved? ||| Why has EQUIOXX been approved? ||| Pourquoi OSSEOR a -t-il été approuvé?
0.3203805088996887 ||| Taking Ketek at bedtime may reduce the potential impact of side effects such as visual disturbances and loss of consciousness. ||| As with any eye drops, temporary blurred vision or other visual disturbances may affect the ability to drive or use machines. ||| La prise de Ketek au moment du coucher peut diminuer les conséquences possibles d’ effets indésirables tels que troubles visuels et perte de connaissance.
0.35285377502441406 ||| If the product is not used during the seven-day period, it cannot be put back in the refrigerator for a new storage period and must be discarded. ||| At the end of this period, the product should not be put back in the refrigerator and should be disposed of.. ||| Si le produit n’ est pas utilisé pendant cette période de sept jours, il ne peut pas être remis au réfrigérateur pour une nouvelle période de conservation et doit être éliminé. dic
0.47745031118392944 ||| The CHMP recommended the granting of the type II variation to extend the indication. ||| A separate file for justification of exemption from phase II was not specifically given. ||| Le CHMP a recommandé l’ autorisation de la variation de type II permettant d’ étendre l’ indication.
0.4368070960044861 ||| Anaphylactic reactions, hypersensitivity ||| Hypersensitivity/ allergic reactions ||| Réactions anaphylactiques, hypersensibilité
0.06358955800533295 ||| Based on experience with glimepiride and with other sulphonylureas the following adverse reactions have to be mentioned. ||| Based on the experience with glimepiride and with other sulphonylureas the following interactions have to be mentioned. ||| Sue la base de l’ expérience acquise avec le glimépiride et les autres sulfamides hypoglycémiants, les effets indésirables suivants sont à souligner:
0.3624182939529419 ||| Approximately 60% of an oral dose is absorbed. ||| Approximately 10- 20% is excreted in urine. ||| Environ 60% de la dose orale est absorbée.
0.4847497344017029 ||| Cardiac disorders ||| Ovarian cysts ||| Affections cardiaques1
0.46474671363830566 ||| Considering the design of the study, no conclusions can be drawn from the results of the separate analysis. ||| No firm conclusion could be drawn due to the limited data derived from this study. ||| Au vu du plan de l’ étude, aucune conclusion ne peut être tirée des résultats des analyses séparées.
0.2758113741874695 ||| In case there is a need for a more rapid response to therapy, the regimen 160 mg at week 0 (dose can be administered as four injections in one day or as two injections per day for two consecutive days), 80 mg at week 2, can be used with the awareness that the risk for adverse events is higher during induction. na ||| In exceptional circumstances in adults, when travel is anticipated within one month or more after initiating the vaccination course, but where insufficient time is available to allow the standard 0, 1, 6 month schedule to be completed, a schedule of three intramuscular injections given at 0, 7 and 21 days may be used. ||| S'il est nécessaire d'obtenir une réponse plus rapide au traitement, le schéma 160 mg à la semaine 0 (la dose peut être administrée sous forme de 4 injections par jour ou de 2 injections par jour pendant deux jours consécutifs), 80 mg à la semaine 2, peut être utilisé sachant que le risque d'événements indésirables est alors plus élevé pendant cette phase d'induction.
0.33660590648651123 ||| Switchboxes [electricity] ||| Metallic wires [electric] ||| Boîtes à clapets [électricité]
0.40335220098495483 ||| Find a comfortable, well-lit place and put everything you need where you can reach it. ||| Find a comfortable, well-lit, clean surface and put all the equipment you need within reach. ct du ||| Trouvez un endroit confortable et bien éclairé et posez tout ce dont vous avez besoin à portée de main.
0.2554936408996582 ||| Ciprofloxacin may inhibit the excretion of methotrexate via the kidney, causing an increased methotrexate level in the blood. ||| Probenecid Probenecid inhibits the renal excretion of ciprofloxacin resulting in an increase in the plasma concentration of ciprofloxacin. ||| La ciprofloxacine peut inhiber l’ excrétion du méthotrexate par les reins, augmentant ainsi le taux sanguin de ce médicament.
0.0 ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| 60 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché:
0.12406729906797409 ||| Since intramuscular administration into the gluteal muscle could lead to a suboptimal response to the vaccine, this route should be avoided. ||| Since intradermal injection or intramuscular administration into the gluteal muscle could lead to a suboptimal response to the vaccine, these routes should be avoided. ||| Etant donné qu’ une injection intramusculaire dans le muscle fessier peut conduire à une moins bonne réponse au vaccin, cette voie d’ administration doit être évitée.
0.28607407212257385 ||| Zometa is contraindicated in breast-feeding women (see section 4.3). ||| Doxycycline is contraindicated in children below age 12 (see section 4.3). ||| Zometa est contre-indiqué chez la femme qui allaite (voir rubrique 4.3).
0.2700134515762329 ||| As with other vaccines against pertussis (whooping cough) disease, following side effects may occur very rarely within 2 to 3 days after vaccination: • collapse or periods of unconsciousness or lack of awareness • seizures or fits with or without fever If your child gets any of these side effects you should contact a doctor urgently. ||| 61 If you receive Erbitux in combination with an anticancer medicine containing 5-fluorouracil, it is more likely that you experience the following side effects of this other medicine: • chest pain • heart attack • heart failure • redness and swelling of the palms of the hands or the soles of the feet which may cause the skin to peel (hand-foot syndrome) ||| Comme pour les autres vaccins contre la coqueluche, les effets secondaires suivants peuvent se produire très rarement dans les 2 à 3 jours suivant la vaccination: • Collapsus ou perte de connaissance ou trouble de la vigilance • Convulsions (avec ou sans fièvre) Si votre enfant présente un de ces effets indésirables contactez un médecin en urgence.
0.2822972536087036 ||| Sensors for use with machine tools ||| Punches for use with machine tools ||| Capteurs pour machines-outils
0.6821408271789551 ||| You can divide the total daily dose in two or three intakes. ||| The tablet can be divided into four equal parts. ||| La dose totale journalière peut être administrée en deux ou trois prises.
1.1625549793243408 ||| - 12.10.1999 - 08.03.2000 - 148 days -0 ||| - 06.11.2000 - - - ||| 25.2.1997 8.3.2000 281 days 825 days
0.1956740766763687 ||| The frequency of benign mammary fibroadenomas observed in the rat was increased with high exposures (60-fold the exposure at the therapeutic dose) but remains in the range of that of controls. ||| The plasma exposure at the assumed threshold for tumour development in rats (i.e. the dose where no FAH and liver tumours were detected) was in the same range as the clinical exposure. ||| La fréquence des fibro-adénomes mammaires bénins observés chez le rat a été augmentée aux expositions élevées (60 fois la dose thérapeutique) mais est restée dans l'ordre de grandeur de celle des témoins.
0.2753000855445862 ||| Baskets for household purposes ||| Trays for household purposes ||| Corbeilles à usage ménager
0.06269682198762894 ||| 47 EMEA General Report 2000 ||| 68 EMEA General Report 2000 ||| 60 Rapport annuel EMEA 2000
0.339401513338089 ||| Elderly patients Safety and efficacy of Myocet have been assessed in 61 patients with metastatic breast cancer, age 65 and over. ||| Indication was prevention and treatment of purpura fulminans and thrombotic disease, enrolling overall 14 subjects of 2 days old throughout adolescence. ||| Personnes âgées La tolérance et l’ efficacité de Myocet ont été évaluées chez 61 patients, souffrant d’ un cancer du sein métastatique et âgées de 65 ans et plus.
0.7491165399551392 ||| October 2002 ||| September 29 ||| 07 Octobre 2002
0.0 ||| 6.2 Incompatibilities ||| 6.2 Incompatibilities ||| 6.2 Incompatibilités mé
0.42272117733955383 ||| The volume of the syringe should be small enough so that the prescribed dose can be withdrawn from the vial with reasonable accuracy. ||| The red light will pulse as above to indicate the approximate number of doses delivered up to the query. ||| Le volume de la seringue doit être suffisamment faible pour permettre le prélèvement de la dose prescrite dans le flacon avec une précision raisonnable.
0.4533393383026123 ||| Available evidence on reteplase does not indicate an antibody-mediated origin of these hypersensitivity reactions. ||| Adverse reactions to OPTISON are rare and usually of a non-serious nature. ||| Les données disponibles sur retéplase n'indiquent pas que le mécanisme de ces réactions d'hypersensibilité soit médié par la formation d'anticorps.
0.2197132706642151 ||| Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: "As part of our efforts to counter the spread of the coronavirus, we have embarked decisively on the worldwide race to find an effective and safe vaccine as quickly as possible. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "There is a global consensus on the importance of enhancing and accelerating coronavirus related research and the production of relevant products to address the current emergency health crisis. ||| Mariya Gabriel, commissaire à l'innovation, la recherche, la culture, l'éducation et la jeunesse : « Dans le cadre de nos efforts pour contrer la propagation du coronavirus, nous nous sommes engagés de manière décisive dans la course mondiale pour trouver le plus rapidement possible un vaccin efficace et sûr.
0.3392801284790039 ||| Amlodipine/ Valsartan Over 1,400 hypertensive patients received Exforge once daily in two placebo-controlled trials. ||| 4.8 Undesirable effects In clinical trials, over 2500 patients received Trevaclyn alone or with an HMG-CoA reductase inhibitor. ||| Amlodipine/ valsartan Plus de 1 400 patients hypertendus ont reçu Exforge une fois par jour au cours de deux essais contrôlés contre placebo.
0.013159445486962795 ||| Duloxetine normalised pain thresholds in several preclinical models of neuropathic and inflammatory pain and attenuated pain behaviour in a model of persistent pain. ||| 57 Duloxetine normalised pain thresholds in several preclinical models of neuropathic and inflammatory pain and attenuated pain behaviour in a model of persistent pain. ||| 32 La duloxétine a normalisé les seuils de douleur dans plusieurs modèles précliniques de douleur neuropathique et inflammatoire et a atténué le comportement algique dans un modèle de douleur persistante.
0.4006221294403076 ||| Lamivudine is predominately cleared unchanged by renal excretion. ||| Telmisartan does not accumulate significantly in plasma on repeated administration. ||| La lamivudine est essentiellement éliminée par excrétion rénale sous forme inchangée.
0.5786897540092468 ||| - allergic rhinitis (see section 5.1) ||| - acute alcohol intoxication, alcoholism (see section 4.4) ||| - la rhinite allergique (voir rubrique 5.1)
0.2391958236694336 ||| Allow the vaccine to reach a temperature of 15°C-25°C and shake well before use. ||| Allow the vaccine to reach a temperature of 15°C-25°C. ||| Laisser le vaccin atteindre une température de 15 à 25°C et agiter correctement avant l’ emploi.
0.29796239733695984 ||| 37 apply to the administration of recombinant human erythropoietin to patients with cancer, treated with chemotherapy to achieve haemoglobin concentrations less than 13 g/ dl, is unclear because few patients with these characteristics were included in the data reviewed. ||| However, it is not currently certain to what extent topical treatment with Panretin gel would increase 9-cis-retinoic acid plasma concentrations, in women with KS above naturally occurring levels; therefore, alitretinoin should not be used in pregnant women. ||| Il est difficile de savoir dans quelle mesure ces résultats peuvent s’ appliquer à l’ administration d’ une érythropoïétine humaine recombinante chez les patients cancéreux traités par chimiothérapie avec pour objectif un taux d’ hémoglobine inférieur à 13 g/ dl car les données passées en revue incluaient peu de patients réunissant ces caractéristiques.
0.14658042788505554 ||| Minimum of 3 replicate analyses of one and the same sample during operation ||| Minimum of 3 replicate analyses on the same sample during operation ||| Minimum de trois analyses répétées sur le même échantillon pendant l'opération Sécurité d'accès:
0.31507664918899536 ||| Adverse reactions are listed below by system organ class and frequency. ||| 34 Adverse reactions are listed by MedDRA system organ class and absolute frequency. ||| Les réactions indésirables sont énumérées ci-après, par classe anatomico-fonctionnelle et par fréquence.
0.04966140538454056 ||| Azomyr orodispersible tablet is an antiallergy medicine that does not make you drowsy. ||| Neoclarityn orodispersible tablet is an antiallergy medicine that does not make you drowsy. ||| Azomyr comprimés orodispersibles est un médicament contre l’ allergie qui ne vous rend pas somnolent.
0.13189302384853363 ||| España Abbott Laboratories, S.A. ||| România Abbott Laboratories S.A. ||| España Abbott Laboratories, S. A.
0.3385385274887085 ||| 4.5 Interaction with other medicinal products and other forms of interaction t ||| 4.5 Interaction with other Medicinal Products and other forms of Interaction ||| 4.5 Interaction avec d'autres médicaments et autres formes d' interaction
0.20271798968315125 ||| The effectiveness of Adenuric has been studied in two main studies involving a total of 1,834 patients with hyperuricaemia and gout. ||| The safety and effectiveness of Protopy has been studied in more than 13,500 patients treated with tacrolimus ointment in clinical trials. ||| L’ efficacité d’ Adenuric a fait l’ objet des deux études principales incluant au total 1.834 patients atteints d’ hyperuricémie et de goutte.
0.28365960717201233 ||| In patients with end stage renal disease undergoing haemodialysis, there is a 25% to 45% reduction in the clearance, and doses of 135 micrograms result in similar exposure as 180 micrograms doses in patients with normal renal function (see section 4.2). ||| Steady state volume of distribution is about 35 l and plasma protein binding is 95% irrespective of the concentration and is not modified with age and in patients with renal impairment but the free fraction is doubled in patients with hepatic impairment. ||| Chez des patients présentant une fonction rénale normale une exposition similaire est observée pour des doses de 135 microgrammes et de 180 microgrammes (voir rubrique 4.2).
0.302266389131546 ||| The hepatic clearance of systemically available tacrolimus could be reduced in subjects with severe hepatic impairment, or in subjects who are co- treated with drugs that are potent inhibitors of CYP3A4. ||| 4 Medicinal products that interfere with enterohepatic circulation: caution should be used with medicinal products that interfere with enterohepatic circulation because of their potential to reduce the efficacy of Myfenax. ||| La clairance hépatique du tacrolimus systémique disponible peut être réduite chez les patients présentant une insuffisance hépatique sévère, ou chez les patients traités par de puissants inhibiteurs du CYP3A4.
0.40943971276283264 ||| During the combined 42-day periods following each dose, there were 6 cases of intussusception in 34,837 recipients of RotaTeq compared with 5 cases in 34,788 placebo recipients. ||| In this study, 10,269 patients were treated with 40 mg/day and 10,267 patients were treated with placebo for a mean duration of 5 years. ||| Dans la période combinée de 42 jours suivant l’ administration de chaque dose, il y a eu 6 cas d’ invagination intestinale chez les 34 837 nourrissons recevant Rotateq comparé à 5 cas chez les 34 788 nourrissons recevant le placebo.
0.3722847104072571 ||| Hold the syringe barrel and gently take the cover from the needle without twisting. ||| 3 - Remove the cap from the needle by pulling and not twisting it. ||| Prendre le corps de la seringue et retirer avec précaution le capuchon de l’ aiguille sans le tourner.
0.3378952145576477 ||| International Non-proprietary Name (INN): agomelatine ||| International Non-proprietary Name (INN): interferon alfa-2a ||| Dénomination commune internationale (DCI): agomélatine
0.009973729029297829 ||| Other side effects include • Systemic allergic reactions Associated symptoms may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema, shortness of breath, a fall in blood pressure with rapid heart beat and sweating. • Eye reactions A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. ||| 719 Other side effects include • Systemic allergic reactions Associated symptoms may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema, shortness of breath, a fall in blood pressure with rapid heart beat and sweating. • Eye reactions A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. ||| Les symptômes associés peuvent comprendre des réactions cutanées étendues (rash et démangeaison sur l’ ensemble du corps), un gonflement sévère de la peau ou des muqueuses (œ dème de Quincke), une gêne respiratoire, une diminution de la pression artérielle avec des battements cardiaques rapides et une transpiration abondante.
0.4583570063114166 ||| 30 tablets ||| 2 tablets ||| 30 Comprimés
0.12575297057628632 ||| Chemical substances for use in electroplating processes ||| Chemical substances for use in bioluminescent processes ||| Substances chimiques destinées aux procédés de galvanoplastie
0.8964486122131348 ||| Do not use INCRELEX ||| PREZISTA cannot work properly without ||| N’utilisez jamais INCRELEX
0.28889161348342896 ||| What Exelon looks like and contents of the pack Exelon oral solution is supplied as 50 ml or 120 ml of a clear, yellow solution (2.0 mg/ ml base) in an amber glass bottle with a child-resistant cap, foam liner, dip tube and self aligning plug. ||| Each pack of KOGENATE Bayer 2000 IU contains a vial with Bio-Set transfer device and a pre-filled syringe with a separate plunger rod, as well as a venipuncture set, two alcohol swabs, two dry swabs and two plasters. ||| Qu’ est ce que Exelon et contenu de l’ emballage extérieur Exelon solution buvable se présente sous la forme de 50 ml ou 120 ml de solution limpide, jaune (2,0 mg de base/ ml) dans un flacon en verre brun avec un couvercle de sécurité pour les enfants, un joint-mousse d’ étanchéité, un tube plongeur et un bouchon de prélèvement.
0.12332935631275177 ||| If any of these apply to you, tell your doctor before you take Rasilez. ||| If any of these apply to you, tell your doctor before you take Tekturna. ||| Si vous êtes dans l’ une de ces situations, parlez -en à votre médecin avant de prendre Rasilez.
0.4330500066280365 ||| Docetaxel is more than 95% bound to plasma proteins. ||| Lacosamide has a low protein binding of less than 15%. ||| Le docétaxel se lie à plus de 95% aux protéines plasmatiques.
0.3533356785774231 ||| The incidence of heart failure on triple oral therapy was 1.4% in the main double blind study, compared to 0.4% for metformin plus 7 sulphonylurea dual therapy. ||| Treatment with adefovir dipivoxil resulted in improvement in the liver fibrosis from baseline to 96 weeks therapy when analysed using the Ishak score (median change: ||| L’ incidence de l’ insuffisance cardiaque en trithérapie orale était de 1.4% dans la principale étude en double aveugle comparé à 0,4% pour l’ association metformine et sulfamide hypoglycémiant.
0.2980709671974182 ||| A small number of hepatically impaired patients (serum bilirubin between 1.5 and 10 mg/ dl) were given 1.5 mg/ m2 for five days every three weeks. ||| Eighty-nine percent (50/ 56) of patients who lost clinical response on infliximab 5 mg/ kg maintenance therapy after week 14 responded to treatment with infliximab 10 mg/ kg. ||| Un faible nombre de patients insuffisants hépatiques (bilirubinémie entre 1,5 et 10 mg/ dl) ont reçu une dose de 1,5 mg/ m² pendant 5 jours, toutes les 3 semaines.
0.4743681252002716 ||| Manufacturer Catalent UK Packaging Ltd., Wingates Industrial Park, Westhoughton, Bolton, Lancs, BL5 3XX United Kingdom ||| Helsinn Birex Pharmaceuticals Ltd., Damastown, Mulhuddart, Dublin 15, Ireland. ||| Fabricant Catalent UK Packaging Ltd., Wingates Industrial Park, Westhoughton, Bolton, Lancs, BL5 3XX Royaume-Uni
0.09080876410007477 ||| Always take Micardis exactly as your doctor has told you. ||| Always take Xenical exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.344730943441391 ||| Your doctor will advise whether you should continue to take Zeffix while you are pregnant. ||| Your doctor will advise you whether you should stop taking Combivir. ||| Ce dernier vous dira s’ il est préférable de continuer ou non à prendre Zeffix pendant votre grossesse.
0.3248361349105835 ||| What is the risk associated with Kinzalkomb? ||| What is the risk associated with Ingelvac CircoFLEX? ||| Quel est le risque associé à Kinzalkomb?
0.035099998116493225 ||| The cartridges are to be used in conjunction with an insulin pen such as OptiPen and other pens suitable for Optisulin cartridges. ||| The cartridges are to be used in conjunction with an insulin pen such as OptiPen and other pens suitable for Insuman cartridges. ||| Les cartouches doivent être utilisées avec un stylo à insuline tel qu’ Optipen ou avec d’ autres stylos compatibles avec les cartouches Optisulin.
0.03726588562130928 ||| ► In insulin infusion pumps ► If Penfill or the device containing Penfill is dropped, damaged or crushed there is a risk of leakage of insulin ► If it hasn’ t been stored correctly or been frozen (see 6 How to store Insulatard) ► If it’ s not uniformly white and cloudy when it’ s resuspended. ||| In insulin infusion pumps If Penfill or the device containing Penfill is dropped, damaged or crushed there is a risk of leakage of insulin If it hasn’ t been stored correctly or been frozen (see 6 How to store Protaphane) If it’ s not uniformly white and cloudy when it’ s resuspended. ||| dans une pompe à perfusion d’ insuline si la cartouche Penfill ou le dispositif contenant la cartouche est tombé, a été endommagé ou a été écrasé, car il y a un risque de fuite d’ insuline s’ il n’ a pas été conservé correctement ou s’ il a été congelé (voir 6 Comment conserver Insulatard) s’ il n’ apparaît pas uniformément blanc et opaque après remise en suspension.
0.4111638069152832 ||| Aspartate aminotransferase increased ||| Amylase increased Aspartate aminotransferase increased ||| Augmentation de l’ aspartate aminotransférase
0.3113448917865753 ||| • Metabolism The results from various evaluations of plasma and urine samples indicated that gadofosveset does not undergo measurable metabolism. ||| Malignant cell growth Since investigations showed that G-CSF can promote growth of myeloid cells in vitro the following warnings should be considered. ||| • Métabolisme Les résultats de diverses évaluations d’ échantillons de plasma et d’ urine indiquent que le gadofosveset ne subit aucun métabolisme mesurable.
0.39942485094070435 ||| Other information about ViraferonPeg: ||| Other information about Rabigen SAG2: ||| Autres informations relatives à ViraferonPeg:
0.039145585149526596 ||| Which measures are being taken to ensure the safe use of Intrinsa? ||| Which measures are being taken to ensure the safe use of Gliolan? ||| Quelles sont les mesures prises pour garantir une utilisation sans danger d’ Intrinsa?
0.6193262338638306 ||| Constipation, nausea, vomiting ||| Very Common: nausea, vomiting ||| Constipation, nausées, vomissements
0.3052675127983093 ||| The rate of emergence of resistance may be higher in the youngest age groups, and in immunosupressed patients. ||| The majority of the difference in clearance between young and elderly patients is due to the differences in renal function. ||| Le taux d’ émergence de la résistance peut être plus élevé dans le plus jeune des groupes d’ âge, et chez les patients immunodéprimés.
0.34061670303344727 ||| The active substance is released from the patch constantly over 3 to 4 days and is absorbed through your skin. ||| This dose of radioactivity is safe and will be gone from the body in about 24 hours. ||| La substance active est libérée du dispositif transdermique de manière continue pendant 3 à 4 jours et est absorbée à travers la peau.
0.07110915333032608 ||| Article 4 - Confidentiality ||| Article 8 - Confidentiality ||| Article 4 - confidentialité
4.389238809649615e-13 ||| Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Utilisation d'autres médicaments Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment un autre médicament, même s'il s'agit d'un médicament obtenu sans ordonnance.
0.31381577253341675 ||| Contraception should be continued for at least 1 month after stopping treatment with isotretinoin, even in patients with amenorrhea. ||| In view of the lack of data, clopidogrel cannot be recommended during the first 7 days after acute ischaemic stroke. ||| La contraception doit être poursuivie au moins 1 mois après l'arrêt du traitement par isotretinoine, même en cas d'aménorrhée.
0.5117599964141846 ||| Anti-vibration mountings for machines ||| Antiparasitic collars for animals ||| Supports anti-vibrations pour machines
3.1238439569467036e-13 ||| These increases in estrogenic concentration should be taken into consideration when selecting post-menopausal hormone therapy for use with etoricoxib because the increase in oestrogen exposure might increase the risk of adverse events associated with HRT. ||| These increases in estrogenic concentration should be taken into consideration when selecting post-menopausal hormone therapy for use with etoricoxib because the increase in oestrogen exposure might increase the risk of adverse events associated with HRT. ||| Ces augmentations de la concentration en œ strogènes doivent être prises en considération lors du choix d’ un traitement hormonal de la ménopause en cas de traitement par l’ étoricoxib, car l’ augmentation de l’ exposition aux œ strogènes pourrait accroître le risque d’ effets indésirables associés au THS.
3.8830258995183053e-13 ||| The absolute bioavailability of subcutaneously administered Puregon is approximately 77%. ||| The absolute bioavailability of subcutaneously administered Puregon is approximately 77%. ||| 104 La biodisponibilité absolue de Puregon administré par voie sous-cutanée est d'environ 77%.
0.44553646445274353 ||| Active immunisation of horses against equine influenza and tetanus ||| This helps to protect against equine influenza and tetanus. ||| Immunisation active des chevaux contre la grippe équine et le tétanos.
0.43944960832595825 ||| - The paralytic efficacy of Xeomin and Botox was analysed by electromyography (EMG) in vivo in ||| The potency (IU) is determined using the European Pharmacopoeia one-stage clotting assay. ||| - L’ efficacité paralysante de Xeomin et Botox a été analysée par électromyographie (EMG) in vivo
0.21845370531082153 ||| Interaction studies have shown that pioglitazone has no relevant effect on either the pharmacokinetics or pharmacodynamics of digoxin, warfarin, phenprocoumon and metformin. ||| Animal experiments revealed that epoetin beta does not increase the myelotoxicity of cytostatic medicinal products like etoposide, cisplatin, cyclophosphamide, and fluorouracil. ||| Des études d’ interaction ont montré que la pioglitazone n’ avait pas d’ effet significatif sur la pharmacocinétique et la pharmacodynamie de la digoxine, de la warfarine, de la phenprocoumone et de la metformine.
0.16954025626182556 ||| MicardisPlus should not be used in people who may be hypersensitive (allergic) to telmisartan, hydrochlorothiazide, sulfonamides or any of the other ingredients (including sorbitol). ||| Atripla should not be used in people who may be hypersensitive (allergic) to efavirenz, emtricitabine, tenofovir disoproxil or any of the other ingredients. ||| MicardisPlus ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) au telmisartan, à l’ hydrochlorothiazide, aux sulfonamides ou à l’ un des autres composants (y compris le sorbitol).
0.5698983669281006 ||| Computerised reservation services for travel ||| Booking agency services for theatre tickets ||| Services de réservations de voyages informatisés
0.13672499358654022 ||| Do not take Baraclude if you are allergic (hypersensitive) to entecavir or any of the other ingredients of Baraclude. ||| Do not take LYRICA if you are allergic (hypersensitive) to pregabalin or any of the other ingredients of Lyrica. ||| Ne prenez jamais Baraclude si vous êtes allergique (hypersensible) à la substance active ou à l’ un des autres composants contenus dans Baraclude
0.8932508230209351 ||| Acquisition for financial investment ||| Other operating expenditure ||| Acquisition pour investissements financiers
0.33110594749450684 ||| Bortezomib causes reduction of tumour growth in vivo in many preclinical tumour models, including multiple myeloma. ||| In vivo, bexarotene causes tumour regression in some animal models and prevents tumour induction in others. ||| Le bortézomib entraîne une réduction de la croissance tumorale in vivo dans de nombreux modèles précliniques de tumeurs, dont le myélome multiple.
0.7709165811538696 ||| Because this crisis is different from any other one we have known. ||| This is the Europe that I believe can emerge from this crisis. ||| Parce que cette crise est différente de toutes celles que nous avons affrontées précédemment.
0.7901369333267212 ||| Median (Range) 23.4 (10.4-34.6) 10.2 (5.8-14.7) 36.6 (20.6-96.6) ||| [ENHANCE] N=2378 19 (0.8%) 18 (0.8%) 11 (0.5%) 4 (0.2%) ||| Médiane (intervalle) 23,4 (10,4-34,6) 10,2 (5,8-14,7) 36,6 (20,6-96,6)
0.030467502772808075 ||| If you want more information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| If you have any questions about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché.
0.27164626121520996 ||| Children and adolescents below 18 years of age: ||| Children under 5 years of age: ||| 2 Enfants et adolescents de moins de 18 ans:
0.37018704414367676 ||| The most significant drug-related adverse events were common allergic reactions, mainly rashes and urticaria. ||| Severe hypoglycaemic attacks, especially if recurrent, may lead to neurological damage. ||| Les effets indésirables les plus significatifs attribuables au produit étaient les réactions allergiques fréquentes, principalement des rashs et une urticaire.
0.0 ||| Italia GlaxoSmithKline S.p.A. ||| Italia GlaxoSmithKline S.p.A. ||| Italia GlaxoSmithKline S. p. A.
0.07478318363428116 ||| This dosage recommendation for 30 mg tablets applies to children over 12 years only if their body weight exceeds 50 kg. ||| This dosage recommendation for the suspension applies to children over 12 years only if their body weight exceeds 50 kg. ||| Cette recommandation posologique relative aux comprimés à 30 mg s'adresse aux enfants âgés de plus de 12 ans, et seulement ceux dont le poids corporel dépasse 50 kg.
0.4423968195915222 ||| Stocrin is an antiviral medicine. ||| Clopidogrel is a prodrug. ||| Stocrin est un médicament antiviral.
0.4401506185531616 ||| The application of this treatment in the context of the coronavirus pandemicwould incentivise banks to extend lending to employees and pensioners. ||| The aid will be granted by State-owned SACE, through financial institutions, to companies affected by the coronavirus outbreak. ||| L'application de ce traitement plus favorable dans le contexte de la pandémie de COVID-19 encouragerait les banques à accorder des prêts aux salariés et aux retraités.
0.17284142971038818 ||| Renal insufficiency: ||| 31 Renal insufficiency: ||| Insuffisance rénale:
0.21859046816825867 ||| Trazec contains lactose monohydrate. ||| CIALIS contains lactose monohydrate. ||| Traezc contient du lactose monohydraté.
0.40562939643859863 ||| Washing installations for vehicles ||| Servers for home automation ||| Installations de lavage pour véhicules
0.5693259239196777 ||| Mitochondrial toxicity: ||| Uncommon: thrombocytopenia. ||| Toxicité mitochondriale:
0.34696170687675476 ||| Boring robots for repairing the interiors of pipes ||| Spray installations for the automatic watering of fields ||| Robots de forage pour réparer l'intérieur de tuyaux
0.21345174312591553 ||| Polyurethane film for use as building insulation ||| Polyurethane foam sheeting for use as building insulation ||| Films de polyuréthane pour l'isolation des bâtiments
0.24461349844932556 ||| The recommended vaccination schedule for Twinrix Adult is three doses, with a gap of one month between the first two doses and a gap of five months between the second and third. ||| The vaccination schedule consists of two doses: the first dose is given at 10 to 14 weeks of age, and then a second dose is given four to 10 weeks after the first. ||| Le schéma de vaccination recommandé pour Twinrix Adulte est de trois doses, avec un intervalle d’ un mois entre les deux premières doses et un intervalle de cinq mois entre la seconde et la troisième.
0.5476416349411011 ||| Zyrtec Portugal: ||| Zirtek tablets Italy: ||| Virlix, Zyrtec Portugal:
0.6538358330726624 ||| The way Ferriprox causes neutropenia is not known. ||| Grade 4 (neuropathy which is disabling) ||| La façon dont Ferriprox provoque la neutropénie est inconnu.
0.23338627815246582 ||| Usually only one dose is given For people with kidney problems, the dose does not need to be reduced, if hepatic function is normal. ||| The same dose is used in patients with kidney or liver problems, and should only be lowered if the patient does not tolerate the normal dose. ||| En cas d’insuffisance rénale, la posologie ne doit pas être diminuée si la fonction hépatique est normale.
0.4164329469203949 ||| Antibiotics for use in dentistry ||| Antibiotics for human use ||| Antibiotiques à usage dentaire
0.11495929211378098 ||| 223 ||| 235 ||| 264
0.4123244881629944 ||| Other transporter-related interactions cannot be excluded. ||| Interaction via effects on transport proteins cannot be excluded. ||| D’ autres interactions relatives aux transporteurs ne peuvent pas être exclues.
0.5626252293586731 ||| Handle the crimp with care. ||| Lightly pinch the skin. ||| Manipuler le sertissage avec précaution.
0.004266500473022461 ||| EU/ 1/ 06/ 368/ 092 (3 cartridges of 3 ml) EU/ 1/ 06/ 368/ 049 (4 cartridges of 3 ml) EU/ 1/ 06/ 368/ 050 (5 cartridges of 3 ml) EU/ 1/ 06/ 368/ 097 (6 cartridges of 3 ml) EU/ 1/ 06/ 368/ 102 (9 cartridges of 3 ml) EU/ 1/ 06/ 368/ 051 (10 cartridges of 3 ml) ||| EU/ 1/ 06/ 368/ 091 (3 cartridges of 3 ml) EU/ 1/ 06/ 368/ 040 (4 cartridges of 3 ml) EU/ 1/ 06/ 368/ 041 (5 cartridges of 3 ml) EU/ 1/ 06/ 368/ 096 (6 cartridges of 3 ml) EU/ 1/ 06/ 368/ 101 (9 cartridges of 3 ml) EU/ 1/ 06/ 368/ 042 (10 cartridges of 3 ml) ||| EU/ 1/ 06/ 368/ 092 (3 cartouches de 3 ml) EU/ 1/ 06/ 368/ 049 (4 cartouches de 3 ml) EU/ 1/ 06/ 368/ 050 (5 cartouches de 3 ml) EU/ 1/ 06/ 368/ 097 (6 cartouches de 3 ml) EU/ 1/ 06/ 368/ 102 (9 cartouches de 3 ml) EU/ 1/ 06/ 368/ 051 (10 cartouches de 3 ml)
0.013030635192990303 ||| Olanzapine Teva 10 mg orodispersible tablet is a yellow, flat, round tablet, plain on both sides. ||| Olanzapine Teva 5 mg orodispersible tablet is a dark yellow, flat, round tablet, plain on both sides. ||| Olanzapine Teva 10 mg, comprimés orodispersibles, se présente sous forme de comprimé rond plat jaune, les deux faces sont lisses.
0.18268457055091858 ||| - If you are pregnant. ||| - if you are pregnant; ||| - Si vous êtes enceinte
0.0935179740190506 ||| Saws [machines] ||| Rams [machines] ||| Scies [machines]
0.4360769987106323 ||| How does M-M-RVAXPRO work? ||| What M-M-RVAXPRO contains ||| Comment M-M-RVAXPRO fonctionne -t-il?
0.5035593509674072 ||| - Caution to be exercised when therapy is administered to patients who consume substantial quantities of ||| Singapore provided financial support for those infected who quarantined themselves and imposed large fines for those who failed to do so. ||| - Les précautions à prendre lors de l’ administration du traitement aux patients consommant des
0.34203553199768066 ||| - Methylparahydroxybenzoate (E 218) ||| Methyl parahydroxybenzoate (0.125%) ||| - Parahydroxybenzoate de méthyle
0.46711069345474243 ||| Common Common Common ||| Common Common Common Common ||| Fréquent Fréquent
0.2662855088710785 ||| The TAXOTERE infusion solution should be used within 4 hours and should be aseptically administered as a 1-hour infusion under room temperature (below 25 °C) and normal lighting conditions. ||| If reconstitution is performed under strict aseptic conditions Hycamtin infusion may be completed within 12 hours at room temperature (or 24 hours if stored at 2-8oC). ||| La solution pour perfusion de TAXOTERE doit être utilisée dans les 4 heures et doit être administrée de façon aseptique en perfusion d'une heure à température ambiante (ne dépassant pas 25°C) et dans des conditions normales de lumière.
0.2783322036266327 ||| Based on simulation data, an alternating daily dosing regimen of 800 mg and 400 mg in patients with severe renal impairment can approximate the AUC (0-48h) in healthy subjects receiving 800 mg once daily. ||| Based on the population pharmacokinetic analysis, no dosage adjustment according to age or weight is warranted in patients aged 2 to < 12 years old at the 200 mg b. i. d. oral suspension dosing regimen. ||| A partir de données de simulation, une dose de 800 mg/ jour en alternance 1 jour sur 2 avec une dose de 400 mg/ jour chez les insuffisants rénaux sévères correspond approximativement à l’ ASC (0-48 h) obtenue chez les sujets sains recevant une dose de 800 mg/ jour.
0.2528459429740906 ||| sanofi-aventis GmbH Tel: +43 1 80 185 – 0 ||| Sverige sanofi-aventis AB Tel: +46 (0)8 634 50 00 ||| Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0
0.34682995080947876 ||| If you forget to use Cerezyme If you have missed an infusion, please contact your doctor. ||| If this applies to you, tell your doctor and do not apply Exelon transdermal patches. ||| 34 Si vous oubliez d’ utiliser Cerezyme Si vous avez manqué une perfusion, veuillez contacter votre médecin.
0.17215381562709808 ||| Patients treated with immunosuppressants, including CellCept, are at increased risk for opportunistic infections (bacterial, fungal, viral and protozoal), fatal infections and sepsis (see section 4.8). ||| Infections and infestations As is well known for other potent immunosuppressive agents, patients receiving tacrolimus are frequently at increased risk for infections (viral, bacterial, fungal, protozoal). ||| Les patients traités par des immunosuppresseurs, dont Cellcept, ont un risque accru d’ infections opportunistes (bactérienne, fongique, virale et protozoaire), d’ infections mortelles et de sepsis (voir rubrique 4.8).
0.31099721789360046 ||| In those patients where the same IV line is to be used to inject another medicinal product, the line must be adequately flushed prior to and after Dynastat injection with a solution of known compatibility. ||| Keppra can be given as an infusion using the same doses at the same frequency when the use of the tablets or the oral solution is temporarily not possible. ||| 32 utilisée pour injecter un autre médicament, la tubulure de perfusion doit être rincée avant et après l’ injection de Dynastat avec une solution de compatibilité connue.
0.0 ||| The following medicines are known to interact with Ciprofloxacin Bayer in your body. ||| The following medicines are known to interact with Ciprofloxacin Bayer in your body. ||| 388 Les médicaments suivants sont connus pour interagir avec Ciprofloxacine Bayer.
0.37930774688720703 ||| The gene is carried within a ‘ vector’, a type of virus that has been altered genetically so that it can carry a gene (DNA) into the cells of the body. ||| This is a complex procedure where the bone marrow of the patient, including the leukaemia cells, is destroyed and replaced by stem cells that ‘ recolonise’ the bone marrow. ||| Ce gène est transporté par un « vecteur », un type de virus ayant été modifié génétiquement de sorte qu’ il puisse transporter un gène (ADN) dans les cellules de l’ organisme.
0.2842814326286316 ||| With your other hand, pinch a fold of loose skin in the area you have cleaned for injection. ||| If you are exceptionally thin, use only the thigh or outer surface of the arm for injection. ||| Avec l’autre main, pincez un pli de peau molle dans la région que vous avez nettoyée pour l’injection.
0.3681323826313019 ||| It is intended to introduce a reinforced management support function in 2003 to respond to the growing range of EMEA activities and the need to ensure internal coordination within the Agency. ||| It will also issue its Citizenship report by the end of 2020, which will set out future concrete actions to further advance the rights attached to the status of EU citizenship, including democratic participation. ||| Il est prévu d’ introduire une fonction renforcée de soutien de la gestion en 2003 afin de répondre à l’ élargissement des activités de l’ EMEA et à la nécessité de garantir une coordination interne au sein de l’ Agence.
0.4194689095020294 ||| As valproate significantly decreases clearance of Inovelon, a lower maximum dose of Inovelon is recommended for patients < 30 kg being co-administered valproate. ||| Using Suboxone with food and drink Do not take Suboxone together with alcoholic beverages as alcohol may possibly increase drowsiness induced by Suboxone. ||| Le valproate diminuant significativement la clairance d’ Inovelon, il est recommandé de diminuer la dose maximale d’ Inovelon chez les patients de < 30 kg recevant un traitement concomitant par le valproate.
0.3319842219352722 ||| In the MaxCmin2 study, the safety and efficacy of saquinavir soft capsules/ritonavir 1000/100 mg twice daily plus 2 NRTIs/NNRTIs was compared with lopinavir/ritonavir 400/100 mg twice daily plus 2 NRTIs/NNRTIs in 324 (both protease inhibitor treatment naïve and experienced) subjects. ||| 13 Based upon dosimetry studies with [111In]-radiolabelled Zevalin, the estimated radiation dosimetry for individual organs following administration of [90Y]-radiolabelled Zevalin at activities of 15 MBq/ kg and 11 MBq/ kg was calculated according to Medical Internal Radiation Dosimetry (MIRD) (Table 2). ||| Dans l’étude clinique MaxCmin2, l’efficacité et la tolérance du saquinavir sous forme de capsules molles/ritonavir 1000/100 mg deux fois par jour plus deux INTI/INNTI a été comparée à celle du lopinavir/ritonavir 400/100 mg deux fois par jour plus deux INTI/INNTI chez 324 sujets (ayant ou non déjà reçu un traitement par inhibiteur de protéase).
0.13194718956947327 ||| What are the consequences of the refusal for patients undergoing clinical trials/ compassionate use programmes with Valdoxan/ Thymanax? ||| What are the consequences of the refusal for patients undergoing clinical trials/ compassionate use programmes with Alpheon? ||| Quelles sont les conséquences du refus pour les patients participant aux essais cliniques ou bénéficiant de programmes d’ utilisation empathique de Valdoxan/ Thymanax?
0.7124819159507751 ||| Phase IV trials are post-approval trials that may be a condition attached by the FDA, also called post-market surveillance studies. ||| Tertiary education, also known as higher education, refers to the non-compulsory educational levels that follow completion of secondary school or high school. ||| Les essais de phase IV sont menés après l’approbation et peuvent être une condition imposée par la FDA. Ils sont également appelés études de surveillance post-commercialisation.
0.40080398321151733 ||| necessary to adapt the dose of that you receive. ||| necessary to adapt the dose of Advagraf that you receive. ||| être nécessaire d’ adapter la posologie de  que vous prenez.
5.5599253499794e-13 ||| 24 A. ||| 24 A. ||| 25 A.
0.38866597414016724 ||| The functioning of contact tracing and warning apps across borders is illustrated in this infographic . ||| It provides a practical guide for Member States in the implementation of contact tracing and warning apps. ||| Le fonctionnement des applications d'alerte et de traçage des contacts par-delà les frontières est illustré par cette infographie .
0.39607131481170654 ||| Non-clinical data reveal no special hazard for humans based on general safety studies. ||| Pre-clinical data reveal no special hazard for humans. ||| Les données non-cliniques obtenues aux cours d'études de sécurité générale ne révèlent aucun danger spécifique chez l'homme.
0.5706131458282471 ||| Disorders ||| Revenues ||| Dyspepsie
0.054442148655653 ||| 8/ 39 ANNEX II ||| 9/ 34 ANNEX II ||| 8/ 43 ANNEXE II
0.025326304137706757 ||| Österreich TIBOTEC, eine Division von JANSSEN -CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300 ||| T IBOTEC, eine Division von JANSSEN-CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300 ||| TIBOTEC, eine Division von JANSSEN-CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300
0.031059304252266884 ||| This might just be for the first injection or it may be a gradual change over several weeks or months. • Inject Liprolog Basal under the skin. ||| This might just be for the first injection or it may be a gradual change over several weeks or months. • Inject Humalog BASAL under the skin. ||| Ce changement peut être effectué à la première injection ou progressivement au cours de premières semaines ou premiers mois. • Injectez Liprolog BASALsous la peau.
0.8726376295089722 ||| Restricted to duly designated competent administrative authorities. ||| Consolidating partnership with national competent authorities and Commission ||| Limitée aux autorités administratives compétentes dûment désignées.
0.489579975605011 ||| - you, suffer from a certain type of nervous disease (diabetic autonomic neuropathy), ||| - patients with exudative (wet) age-related macular degeneration (AMD) with predominantly ||| - vous souffrez d’ une certaine maladie neurologique (neuropathie diabétique autonome),
0.15652315318584442 ||| In study WV16240, the primary efficacy endpoints were HBeAg seroconversion and HBV-DNA below 105 copies/ ml. ||| In study WV16241, the primary efficacy endpoints were ALT normalisation and HBV-DNA below 2 x 104 copies/ ml. ||| Dans l'étude WV16240, les critères principaux d'efficacité étaient la séroconversion AgHBe et un taux d'ADN du VHB inférieur à 105 copies/ ml.
0.03810589015483856 ||| au 1 ml suspension contains 100 IU (3.5 mg) of insulin human, rDNA ||| 1 ml suspension contains 100 IU (3.5 mg) of insulin human, rDNA ||| au 1 ml de suspension contient 100 UI (3,5 mg) d’ insuline humaine, ADNr
0.36239778995513916 ||| Hair clippers for animals [hand instruments] ||| Inner tubes [for aircraft wheel tires] ||| Tondeuses pour la coupe du poil des animaux
0.4261409044265747 ||| What Tarceva contains: ||| What Rapilysin contains: ||| Que contient Tarceva:
0.2872712016105652 ||| In rabbits, lapatinib was associated with maternal toxicity at 60 and 120 mg/ kg/ day (8% and 23% of the expected human clinical exposure, respectively) and abortions at 120 mg/ kg/ day. ||| In the fertility studies the NOAEL was 300 U/ kg/ day for general toxicity in both males and females and 1000 U/ kg/ day for fertility and reproductive performance. ||| Chez la lapine, le lapatinib a été associé à une toxicité maternelle aux doses de 60 et 120 mg/ kg/ jour (respectivement 8% et 23% de l'exposition clinique attendue chez l'Homme) et à des avortements à la dose de 120 mg/ kg/ jour.
0.06708459556102753 ||| 755 Step 2. ||| 467 Step 2. ||| Etape 2.
0.2713141441345215 ||| Tell your doctor immediately if you are having any thoughts or feelings about hurting yourself. ||| Tell your doctor immediately if you think you are experiencing any of these side effects. ||| Informez immédiatement votre médecin si vous avez des pensées suicidaires ou d'autoagression.
0.3664744794368744 ||| Studies in vitro have shown that sildenafil is selective for PDE5. ||| In in vitro studies, the protein binding of amprenavir is approximately 90%. ||| Des études in vitro ont montré que le sildénafil était sélectif pour la PDE5.
0.01385150384157896 ||| In the presence of bacterial urease the ratio of the 13C/ 12C-carbon isotopes is significantly changed. ||| In the presence of bacterial urease the ratio of the 13C/12C-carbon isotopes is significantly changed. ||| En présence de l'uréase bactérienne, la proportion des carbones isotopes 13C/ 12C est modifiée de manière significative.
0.2200157344341278 ||| In vitro metabolism studies have shown that CYP2D6 and to a lesser extent, CYP3A4 and CYP1A2 isoenzymes are involved in the metabolism of palonosetron. ||| Based on in vitro studies, CYP3A4 and CYP2D6 enzymes are responsible for dehydrogenation and hydroxylation of aripiprazole, and N-dealkylation is catalysed by CYP3A4. ||| Les études de métabolisme in vitro ont montré que les isoenzymes CYP2D6 et, dans une moindre mesure, CYP3A4 et CYP1A2, sont impliqués dans le métabolisme du palonosétron.
0.22451482713222504 ||| 12.2 ||| 15.2 ||| 12,2
0.6976779699325562 ||| Paint additives in the nature of balancers ||| Chemistry of the new active substance ||| Additifs pour peintures sous forme de stabilisateurs
0.4929623007774353 ||| Myfenax 250mg hard capsules Mycophenolate mofetil ||| Thalidomide Celgene 50 mg hard capsules Thalidomide ||| Myfenax 250mg Gélules Mycophénolate mofétil
0.07220396399497986 ||| Treatment with Ovitrelle should be performed under the supervision of a physician experienced in the treatment of fertility problems. ||| Treatment with Fertavid should be initiated under the supervision of a physician experienced in the treatment of fertility problems. ||| Le traitement par Ovitrelle doit être effectué sous la surveillance d’ un médecin ayant l’ expérience du traitement des problèmes de fertilité.
0.22960227727890015 ||| In these studies, no evidence of altered pharmacokinetics of micafungin was observed. ||| No gender-related differences were observed in the pharmacokinetics of palifermin. ||| Dans ces études, aucun signe de modification de la pharmacocinétique de la micafungine n’ a été observé.
0.36268678307533264 ||| The amount of alcohol in this product may alter the effects of other medicines. ||| The amount of alcohol in this product may impair your ability to drive or use machines. ||| La quantité d’ alcool contenue dans ce médicament peut modifier les effets des autres médicaments.
0.37932008504867554 ||| Strict observance of the reduced light regime is required. ||| Regular determination of resistance is therefore recommended. ||| Il est nécessaire de respecter strictement le régime de faible luminosité.
0.24563325941562653 ||| It is recommended to administer the diluted solution through an in-line low protein-binding 0.2 µm filter to remove any protein particles which will not lead to any loss of agalsidase beta activity. ||| CellCept 500 mg powder for concentrate for solution for infusion does not contain an antibacterial preservative; therefore, reconstitution and dilution of the product must be performed under aseptic conditions. ||| Il est recommandé d’ administrer la solution diluée avec un filtre en ligne de 0,2 µm à faible fixation protéinique pour retenir les particules protéiniques, ce qui n’ entraînera pas de perte d'activité de l’ agalsidase bêta.
0.3995462954044342 ||| When these stools were tested for the presence of live vaccine strain, only 17% were positive. ||| There is no established test assessing for the virus or antibodies in the blood, although tests are being developed. ||| Quand la présence de souche vaccinale vivante a été recherchée dans les selles, seules 17% des selles étaient positives.
0.18043343722820282 ||| Thrombocytopenia ||| Thrombocytopenia: ||| Thrombopénie
0.3672483265399933 ||| The simultaneous oral administration of 10 mg of Rapamune oral solution and 120 mg of diltiazem significantly affected the bioavailability of sirolimus. ||| Treatment consists of two intravenous administrations of rituximab and one administration of [90Y]- radiolabelled Zevalin in the following order: ||| Diltiazem (inhibiteur du CYP3A4): l’ administration orale simultanée de 10 mg de Rapamune solution buvable et de 120 mg de diltiazem modifie de manière significative la biodisponibilité du sirolimus.
0.6081150770187378 ||| Laboratory tests Drotrecogin alfa (activated) has minimal effect on the PT. ||| Mechanism of action: efavirenz is an NNRTI of HIV-1. ||| Examens biologiques La drotrécogine alfa (activée) a un effet minime sur le TP.
0.25536179542541504 ||| Telzir in combination with low dose ritonavir is indicated for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adults, adolescents and children of 6 years and above in combination with other antiretroviral medicinal products. ||| Atripla is a treatment for Human Immunodeficiency Virus (HIV) infection in adults aged 18 and over who have previously been treated with other antiretroviral medicines and have their HIV-1 infection under control for at least three months. ||| Telzir associé à de faibles doses de ritonavir et à d’ autres antirétroviraux est indiqué dans le traitement des adultes, adolescents et enfants âgés de 6 ans et plus, infectés par le Virus de l'Immunodéficience Humaine de Type 1 (VIH-1).
0.3460139036178589 ||| Gemfibrozil increases the risk of myopathy when given concomitantly with some HMG-CoA reductase inhibitors. ||| Increased doses of Botulinum neurotoxin type A may result in pronounced neuromuscular paralysis distant from the injection site. ||| Le gemfibrozil augmente le risque de myopathie quand il est associé à certains inhibiteurs de l’ HMG- CoA réductase.
0.03373242914676666 ||| 72 Olanzapine can be given without regards for meals as absorption is not affected by food. ||| Olanzapine can be given without regards for meals as absorption is not affected by food. ||| L'olanzapine p eut être administrée pendant ou en dehors des repas, la prise de nourriture n'ayant pas d'incidence sur l'absorption.
0.4940384030342102 ||| (28.4) ||| 12 (27.3) ||| (28,4)
0.3766744136810303 ||| Treatment of postmenopausal osteoporosis in patients at risk of vitamin D insufficiency. ||| Complications of chronic overdosage could include peripheral neuropathy and hepatic dysfunction. ||| Traitement de l’ ostéoporose post-ménopausique chez les patientes à risque d'insuffisance en vitamine D.
0.03277353569865227 ||| Rue de l’ Institut 89 B-1330 Rixensart, Belgium ||| 26 Rue de l’ Institut 89 B-1330 Rixensart, Belgium ||| Rue de l'Institut, 89 1330 Rixensart, Belgique
0.0 ||| Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. ||| Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. ||| Les données précliniques issues des études pharmacologiques de sécurité d’emploi, de toxicité à dose répétée et de génotoxicité ne mettent pas en évidence de risque particulier pour l’être humain.
0.01823517121374607 ||| The final opinion was converted into a Decision by the European Commission on 21 August 2006. ||| The final opinion was converted into a Decision by the European Commission on 11 July 2008. ||| L’ avis définitif est devenu décision de la Commission européenne en date du 21 août 2006.
0.06570807099342346 ||| 203 9. ||| 198 9. ||| 208 9.
0.6137485504150391 ||| Epistaxis Throat tightness ||| Fatigue Fall Skin laceration ||| Epistaxis Gêne pharyngée
0.3492451310157776 ||| Depending on your response to Emselex, your doctor may increase your dose to 15 mg daily, two weeks after starting therapy. ||| Depending on your response, your doctor may decrease your dose to 4 mg/kg then increase back to 8 mg/kg when appropriate. ||| En fonction de votre réponse à Emselex, votre médecin pourra augmenter la dose à 15 mg par jour, deux semaines après le début du traitement.
0.05691995471715927 ||| OPINION FOLLOWING AN ARTICLE 5(11)1 REFERRAL FOR Belanette and associated names (see Annex I) ||| OPINION FOLLOWING AN ARTICLE 5(11) 1 REFERRAL FOR Yasminelle and associated names (see Annex I) ||| AVIS SUITE À SAISINE FORMÉE SUR LE FONDEMENT DE L’ ARTICLE 5, PARAGRAPHE 111 Belanette et dénominations associées (voir annexe I)
0.2405681610107422 ||| For polyarticular juvenile idiopathic arthritis, Humira was compared with placebo, alone or as an add- on to methotrexate, in one main study involving 171 patients aged between four and 17 years. ||| Only one case (a buffalo hump) was reported in 113 (< 1%) antiretroviral naive subjects treated with amprenavir in combination with lamivudine/ zidovudine for a median duration of 36 weeks. ||| Dans le cas de la polyarthrite idiopathique juvénile polyarticulaire, Humira a été comparé au placebo, seul ou en association avec le méthotrexate, au cours d’ une étude principale impliquant 171 patients âgés de quatre à dix-sept ans.
0.2360767275094986 ||| In dogs with non- resectable mast cell tumours, Grade 2 or 3, expressing a mutated tyrosine kinase c-kit receptor, treatment with Masivet showed a significantly longer Time-to-Tumour Progression (TTP) with a median of 241 days as compared to 83 days for placebo. ||| In the HPV naïve population (naïve to 14 common HPV types and had a negative Pap test at Day 1), Silgard reduced the proportion of women who experienced, a definitive cervical therapy procedure (Loop Electro-Excision Procedure or Cold-Knife Conization) by 41.9% (95% CI: ||| Chez les chiens présentant des tumeurs à mastocytes non résécables, de stade 2 ou 3 et exprimant un récepteur tyrosine kinase c-kit muté, le traitement par Masivet a montré un délai avant progression de la tumeur significativement plus long, avec une médiane de 241 jours, contre 83 jours pour les chiens sous placebo.
0.5520523190498352 ||| (5.3, 24.3) ||| (1.30, 2.32) ||| (5,3 - 24,3)
0.2899840772151947 ||| Valdoxan should be used with caution in patients with a history of mania or hypomania and should be discontinued if a patient develops manic symptoms. ||| Patients with liver disease being treated with Ziagen will be monitored closely for side effects, which may occur more frequently with higher doses of abacavir. ||| Valdoxan doit être utilisé avec précaution chez les patients présentant des antécédents de manie ou d'hypomanie et doit être interrompu en cas d’ apparition de symptômes maniaques.
0.07514218240976334 ||| is if you are allergic to Nespo (darbepoetin alfa), r-HuEPO or to any of the other ingredients in Nespo. ||| • if you are allergic to Aranesp (darbepoetin alfa), r-HuEPO or to any of the other ingredients in Aranesp. ||| to • si vous êtes allergique à Nespo (darbepoetin alfa), à la r-HuEPO ou à l’un des autres composants contenus dans Nespo.
0.0 ||| Approximately 1.4% of the total oral dose is metabolised. ||| Approximately 1.4% of the total oral dose is metabolised. ||| Environ 1,4% de la dose orale totale est métabolisé.
0.25051265954971313 ||| Frames (Non-metallic -) for shop fronts ||| Rails (Non-metallic -) for folding doors ||| Châssis non métalliques pour devantures
0.3108736574649811 ||| You must report any of the following symptoms immediately to the doctor or nurse/ technologist, and get immediate treatment as they can be or can become very serious: side effects affecting the heart (fainting, extra heart beats, chest pain) or the respiratory system (shortness of breath, tightening of the airways, swollen or tight throat, itchy or runny nose, sneezing). ||| Other side effects have been reported with the use of either the measles, mumps, and rubella vaccine manufactured by Merck & Co., Inc. or of its monovalent (single) components: burning and/ or stinging of short duration at the injection site, joint pain and/ or swelling (which could be transient or chronic), rash, unusual bleeding or bruising under the skin, and swelling of the testicles. ||| Vous devez signaler immédiatement les symptômes suivants au médecin/à l’infirmier/au manipulateur en radiologie et vous faire traiter sans attendre, ces symptômes pouvant être ou devenir très graves: effets secondaires touchant le cœur (évanouissement, extrasystole, douleur dans la poitrine) ou les voies respiratoires (essoufflement, oppression des voies respiratoires, gonflement de la gorge ou sensation de gorge noué, démangeaison ou écoulement nasal, éternuements).
0.0 ||| Check if you have enough insulin for your dose. ||| Check if you have enough insulin for your dose. ||| A.Vérifiez si vous avez suffisamment d’ insuline pour votre dose.
0.15946422517299652 ||| Olanzapine Teva 2. 5 mg film-coated tablets are available in cartons of 28, 30, 35, 56 or 70 film-coated tablets. ||| Irbesartan Winthrop 75 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets. ||| Olanzapine Teva 2,5 mg, comprimés pelliculés, est disponible en boîtes de 28, 30, 35, 56 ou 70 comprimés pelliculés.
0.32678619027137756 ||| Hepatic transaminase elevations that occur with elevated bilirubin in patients receiving REYATAZ should be evaluated for alternative etiologies. ||| 3 Clinical efficacy has been demonstrated for susceptible isolates of Enterobacter cloacae and Enterobacter aerogenes in approved clinical indications. ||| Des élévations des transaminases hépatiques associées à des élévations de la bilirubine, chez les patients recevant REYATAZ, doivent faire l'objet d'une recherche d'autres étiologies.
0.605791449546814 ||| Other routes of administration have not been evaluated. ||| Their implementation will be reviewed nationally. ||| Les autres voies d’administration n’ont pas été testées.
0.30355000495910645 ||| The recommended dose of robenacoxib is 1 mg/ kg body weight with a range 1-2 mg/ kg. ||| In infants to adolescents, the initial dose of Cyanokit is 70 mg/ kg body weight not exceeding 5 g. ||| La dose de robenacoxib recommandée est de 1 mg/ kg de poids corporel, pouvant varier de 1 à 2 mg/ kg.
0.10090595483779907 ||| What is the risk associated with Trevaclyn? ||| What is the risk associated with Vectibix? ||| Quel est le risque associé à l'utilisation de Trevaclyn?
0.3530529737472534 ||| Navigating apparatus [compasses] ||| Navigating apparatus [sextants] ||| Appareils de navigation [boussoles]
0.08129504323005676 ||| For agomelatine, no clinical data on exposed pregnancies are available. ||| For Naglazyme, no clinical data on exposed pregnancies are available. ||| Il n'existe pas de données cliniques sur l'utilisation de l’ agomélatine chez la femme enceinte.
0.26260435581207275 ||| The Commission has adopted a Temporary Framework to enable Member States to use the full flexibility foreseen under State aid rules to support the economy in the context of the coronavirus outbreak. ||| It enables Member States to use the full flexibility foreseen under State aid rules to support the economy, while limiting negative consequences to the level playing field in the Single Market. ||| La Commission a adopté un encadrement temporaire afin de permettre aux États membres d'exploiter pleinement la flexibilité prévue par les règles en matière d'aides d'État pour soutenir l'économie dans le contexte de la flambée de COVID-19.
0.2867748737335205 ||| Your Protaphane NovoLet is designed to work accurately and safely. ||| OptiSet is designed to work accurately and safely. ||| Votre Protaphane NovoLet est conçu pour fonctionner avec une grande précision et en toute sécurité.
0.0 ||| Withdrawal period: ||| Withdrawal period: ||| Temps d’attente:
1.237409046755955e-12 ||| Mode of action ||| Mode of action ||| 151 Mode d' action
0.20997390151023865 ||| Agenerase capsules are contraindicated in patients with severe hepatic impairment when used in combination with ritonavir (see section4.3). ||| Medicinal products known to be associated with neuropathy should be used with caution in patients receiving thalidomide (see section 4.5). ||| Les capsules d'Agenerase sont contre-indiquées lorsqu'elles sont administrées en association au ritonavir chez les patients ayant une insuffisance hépatique sévère (voir rubrique 4.3).
0.002390062203630805 ||| The clinical consequences are likely to be limited, but clinical monitoring is recommended and an increase of olanzapine dose may be considered if necessary (See section 4.2). ||| The clinical consequences are likely to be limited, but clinical monitoring is recommended and an increase of olanzapine dose may be considered if necessary (see section 4.2). ||| Il est probable que les conséquences cliniques soient limitées, mais une surveillance clinique est recommandée et une augmentation de la posologie de l'olanzapine peut être envisagée, si nécessaire (voir rubrique 4.2).
0.06437556445598602 ||| - If you are allergic (hypersensitive) to ziconotide or any of the other ingredients of Prialt. ||| - if you are allergic (hypersensitive) to rasagiline or any of the other ingredients of AZILECT. ||| - si vous êtes allergique (hypersensible) au ziconotide ou à l'un des autres composants contenus
0.028066501021385193 ||| 10ml (3.5 mg/ ml) ||| 10 ml (3.5 mg/ ml) ||| 10 ml (3,5 mg/ ml)
0.28715792298316956 ||| Rats, dogs and monkeys tolerated daily doses of 2, 2.5 and 8 mg/ kg/ d respectively without harmful effects. ||| Lapatinib was studied in pregnant rats and rabbits given oral doses of 30, 60, and 120 mg/ kg/ day. ||| Le rat, le chien et le singe ont toléré des doses quotidiennes totales de 2; 2,5 et 8 mg/ kg/ j respectivement, sans effets néfastes.
0.24078185856342316 ||| However, subgroup analysis did not identify an increased magnitude of PR prolongation in patients with concomitant administration of carbamazepine or lamotrigine in clinical trials. ||| Although no causal relationship has been established, close monitoring of prothrombin time or INR is advisable for patients concomitantly treated with oral anticoagulants. ||| Toutefois, les analyses de sous- groupes au cours des essais cliniques n’ ont pas identifié d’ augmentation de l’ importance de l’ allongement de PR chez les patients en cas d’ administration concomitante de carbamazépine ou lamotrigine.
0.4349769651889801 ||| 61%, range 39-222), whereas in volunteers Cmax was 40 μ g/ ml and AUCinf was 2400 μ g/ h/ ml. ||| Mean (± SD) Cmax was 4.59 ± 1.5 μ g/ ml, AUC was 55.8 ± 12.1 μ g*hr/ ml. ||| 39-222), alors qu’ il était de 40 µg/ ml chez les volontaires sains et que l’ ASCinf était de 2400 µg/ ml..
0.23947292566299438 ||| Appliances for water filtration [other than machines] ||| Appliances for water distribution [automatic] ||| Appareils de filtration d'eau autres que machines
0.4076846241950989 ||| Pistons for cylinders ||| Component parts for pistols ||| Pistons de cylindres
0.24374103546142578 ||| 203 9. ||| 340 8. ||| 208 9.
0.007903954945504665 ||| 30 Children and adolescents Olanzapine is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy. ||| 2 Children and adolescents Olanzapine is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy. ||| 32 Enfants et adolescents L’ utilisation de l’ olanzapine chez les enfants et les adolescents âgés de moins de 18 ans n’ est pas recommandée du fait du manque de données sur la sécurité d’ emploi et l’ efficacité.
0.27925360202789307 ||| Portugal Alodial Farmacêutica, Lda. ||| Janssen Farmacêutica Portugal Lda. ||| Alodial Farmacêutica, Lda.
0.45042189955711365 ||| Before connecting the syringe onto the Bioset®, make sure the two containers are aligned (see Picture 1). ||| For user convenience, the needle ‘ bevel up’ position is orientated to the lever arm, as shown in Figure 3. ||| Avant de fixer la seringue sur le Bioset®, assurez -vous que les deux récipients sont alignés (voir image 1).
0.7826073169708252 ||| Fatigue/ Asthenia: ||| ed • Diphtheria: ||| Fatigue/ asthénie:
0.0 ||| Common (≥ 1/ 100 to < 1/ 10) ||| Common (≥ 1/ 100 to < 1/ 10) ||| Fréquent (≥ 1/ 100 à
0.34431537985801697 ||| In patients receiving cytotoxic chemotherapy, a transient increase in neutrophil counts is typically seen 1 - 2 days after initiation of filgrastim therapy. ||| When dexmedetomidine and ketamine are used sequentially, with a 10 minute interval, cats may occasionally experience AV-block or extrasystole. ||| Chez les patients traités par chimiothérapie cytotoxique, une augmentation transitoire du nombre des neutrophiles est typiquement observée 1 ou 2 jour(s) après le début du traitement par filgrastim.
0.012739446014165878 ||| What Karvea looks like and contents of the pack Karvea 150 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2772 engraved on the other side. ||| What Aprovel looks like and contents of the pack Aprovel 150 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2772 engraved on the other side. ||| Qu’ est -ce que Karvea et contenu de l'emballage extérieur Les comprimés de Karvea 150 mg sont blancs à blancs cassés, biconvexes, de forme ovale, avec un coeur gravé d'un côté et le numéro 2772 gravé sur l'autre côté.
0.3454461395740509 ||| It is not recommended for patients who have very severe problems with their kidneys that requires dialysis or severe liver problems. ||| • have problems with your heart or circulatory system as there is only limited experience in patients with serious problems of this type. ||| Il n’ est pas recommandé chez les patients atteints de très graves problèmes de reins nécessitant une dialyse ni chez ceux souffrant de graves problèmes de foie.
3.9956861604129035e-13 ||| 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary ||| 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary ||| 3 4.10 Surdosage (symptômes, procédures d’ urgence, antidotes)
0.01179908774793148 ||| Take the long needle and place it firmly onto the tip of the syringe. ||| Take the short needle and place it firmly onto the tip of the syringe. ||| Prenez l’aiguille longue et fixez-la fermement à l’extrémité de la seringue.
0.6700555086135864 ||| Will it use the reserve of the European Development Fund? ||| The EIB also supports investments outside the EU. ||| Va-t-elle utiliser la réserve du Fonds européen de développement?
0.0 ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN ||| MISE EN GARDE SPECIALE INDIQUANT QUE LE MEDICAMENT DOIT ETRE CONSERVÉ HORS DE PORTÉE ET DE VUE DES ENFANTS
0.3198510408401489 ||| If the product is not used right away, it should be shaken vigorously to re-suspend. ||| If necessary, the plunger may be squeezed further, to adjust the volume to be administered. ||| Si le produit n’ est pas utilisé immédiatement, il doit être vigoureusement mélangé pour être remis en suspension.
0.49702146649360657 ||| The benefit-risk balance may be found in module 6 of this EPAR. ||| The modified TSS at 12 months is presented in the Table below. ||| Le rapport bénéfice-risque figure dans le module 6 de cet EPAR.
0.1142197847366333 ||| What is the risk associated with Efient? ||| What is the risk associated with Profender? ||| Quel est le risque associé à l'utilisation d’ Efient?
0.45711052417755127 ||| Clinical studies with  did not include a sufficient number of patients in this age range to determine whether they respond differently from younger patients. ||| Although no clinical studies designed to compare adolescents to adults have been conducted, data from the adolescent trials were compared to those of the adult trials. ||| Les études cliniques avec {Nom de fantaisie} n’ont pas inclus un nombre suffisant de patients dans cette tranche d’âge pour pouvoir déterminer si ces sujets répondent différemment ou pas par rapport aux patients plus jeunes.
0.35947185754776 ||| Your doctor may need to monitor your blood coagulation. ||| Your doctor may want to monitor you for inhibitor development. ||| Votre médecin peut avoir besoin de surveiller votre bilan de coagulation.
0.4191104769706726 ||| The Member States should ensure that all conditions or restrictions with regard to the safe and effective use of the medicinal product described below are implemented: ||| Management of these risks as well as of the factors that contribute to control of communicable diseases are under the responsibility of each EU Member State. ||| Les Etats Membres doivent s’ assurer que toutes les conditions ou restrictions en vue d’ une utilisation sûre et efficace du médicament décrites ci-dessous sont mises en place:
0.6780434250831604 ||| - have liver disease ||| - flu-like illness ||| - avez une maladie du foie,
0.3250323534011841 ||| Bitumen latex emulsions for construction purposes ||| Synthetic resin adhesives for laminating purposes ||| Émulsions de latex-bitume pour la construction
0.3417889177799225 ||| This can only be accepted if preparation of the solution takes place under strictly aseptic conditions and the solution is protected from light. ||| If the reconstituted solution is not used immediately, in-use storage times and conditions prior to use are the responsibility of the user. ||| Ceci n’ est applicable que si la préparation de la solution a lieu dans des conditions aseptiques strictes et si la solution est maintenue à l’ abri de la lumière.
0.6450690031051636 ||| Although the applicant was willing to remove the indications objected to by the objecting CMS, the RMS and the other positive CMSs were in favour of retaining these indications. ||| Recommendations for mask use by the general public vary, with some authorities recommending against their use, some recommending their use, and others requiring their use. ||| Malgré la volonté du demandeur de retirer les indications sur lesquelles portent les objections de l’ État membre concerné, l’ État membre de référence et les autres États membres concernés d’ avis positif étaient d’ accord pour maintenir ces indications.
0.3804421126842499 ||| Janssen-Cilag AS Hoffsveien 1D 0275 Oslo Norway ||| Janssen-Cilag AB, Box 7073 192 07 Sollentuna, Sverige ||| Janssen-Cilag AS Hoffsveien 1D 0275 Oslo Norvège
0.10612275451421738 ||| 8 6.6 Special precautions for disposal and other handling ||| 10 6.6 Special precautions for disposal and handling ||| 6.6 Précautions particulières d'élimination et manipulation
0.39651283621788025 ||| 185 PRCA may be caused by the production to antibodies against the erythropoietin product and, in the following, to your own erythropoietin. ||| Ambrisentan and its metabolites are eliminated primarily in the bile following hepatic and/ or extra-hepatic metabolism. ||| L’AEPA peut être causée par la production d’anticorps contre l’érythropoïétine et, par la suite, contre votre propre érythropoïétine.
0.2995077967643738 ||| The echocardiography studies involved a total of 317 patients, and compared the effects of SonoVue with those of another contrast agent and of placebo (a dummy treatment). ||| To assess the effects of Zometa versus pamidronate 90 mg, the results of two pivotal multicentre studies in patients with TIH were combined in a pre-planned analysis. ||| Les études sur l’ échocardiographie, réalisées sur 317 patients, ont comparé les effets de SonoVue à ceux d’ un autre agent de contraste et d’ un placebo (traitement fictif).
0.47420138120651245 ||| In the studies conducted by the MAH to date with HBVAXPRO and Procomvax, seroprotective levels have been achieved in the large majority of vaccinees. ||| The RCGP RSC practices have been advised on the clinical coding that has been made available for COVID-19 across all CMR systems. ||| Dans les études menées par le TAMM à ce jour sur HBVAXPRO et Procomvax, des seuils de séroprotection ont été obtenus chez la grande majorité des vaccinés.
0.35767558217048645 ||| In rats and mice the combination of ramipril and hydrochlorothiazide has no acute toxic activity up to 10,000 mg/kg. ||| Reproduction toxicity Zoledronic acid was teratogenic in the rat at subcutaneous doses ≥ 0.2 mg/ kg. ||| Chez le rat et la souris, l’ association de ramipril et d’ hydrochlorothiazide n’ a présenté aucune activité toxique aiguë jusqu’ à 10 000 mg/ kg.
0.907343864440918 ||| Telecommunication of information (including web pages) ||| Wide area network (WAN) routers ||| Télécommunication d'informations y compris pages Web
0.30229389667510986 ||| In addition to the existing possibilities already foreseen by existing EU State aid rules, on 19 March 2020, the Commission adopted a State aid Temporary Framework to enable Member States to use the full flexibility foreseen under State aid rules to support the economy in the context of the coronavirus outbreak. ||| Activities in terms of the number of applications for designation are expected to stabilise at the 2005 level, although the outcome of the European Commission’ s report on orphan medicinal products regulation in early 2006 will be decisive for long-term trends and the potential evolution of the orphan policy at Community level. ||| Outre les possibilités déjà prévues par les règles existantes de l'UE en matière d'aides d'État, le 19 mars 2020, la Commission a adopté un encadrement temporaire des aides d'État afin de permettre aux États membres d'exploiter pleinement la flexibilité prévue par les règles en matière d'aides d'État pour soutenir l'économie dans le contexte de la pandémie de coronavirus.
0.0015499737346544862 ||| The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 4 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in Version 5 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| Le titulaire de l'AMM s'engage à réaliser les études et activités complémentaires de pharmacovigilance décrites dans le Plan de Pharmacovigilance, tel qu'accepté dans la version 4 du Plan de Gestion du Risque (PGR) décrit dans le Module 1.8.2 du dossier de demande d'AMM et conformément aux mises à jour ultérieures du PGR acceptées par le CHMP.
0.3376944065093994 ||| In a laboratory study, the use of an acepromazine/ oxymorphone/ thiopental/ sevoflurane anaesthetic regimen resulted in prolonged recoveries in all the dogs treated, compared to recoveries in dogs anaesthetised with sevoflurane alone. ||| • GONAL-f is used to bring about the development of several follicles (and therefore several eggs) for women undergoing assisted reproductive technologies such as in vitro fertilisation, gamete intra-fallopian transfer or zygote intra-fallopian transfer. ||| Durant une étude en laboratoire chez les chiens, l’ utilisation d’ un protocole anesthésique associant l’ acépromazine, l’ oxymorphone, le thiopental et le sévoflurane a entraîné une prolongation du délai de réveil chez tous les animaux par comparaison à ce qui a été observé avec une anesthésie au sévoflurane seulement.
0.5339800119400024 ||| Marketing Authorisation Holder SP Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgium. ||| Office for Official Publications of the European Communities 2, rue de Mercier – L - 2985 Luxembourg ||| Titulaire de l’ Autorisation de mise sur le marché SP Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgique.
0.5196565985679626 ||| Upper Arm ||| Outer carton ||| Haut du bras
0.42258667945861816 ||| EU/ 1/ 02/ 219/ 028 56 x 1 film-coated tablets. ||| EU/ 1/ 07/ 433/ 001 1 x 5 ml ||| EU/ 1/ 02/ 219/ 028 56 x 1 comprimés pelliculés.
0.28996819257736206 ||| Do not take Agopton: ||| Do not take Levviax: ||| Ne prenez jamais Agopton:
0.2620702087879181 ||| Rheumocam contains the active substance meloxicam in a strength of 1.5 mg/ ml. ||| The active substance of Omnitrope is somatropin (3.3 mg/ ml) in a cartridge. ||| Rheumocam contient le principe actif méloxicam à raison de 1,5 mg/ ml.
0.514106273651123 ||| Animal reproduction studies were not conducted with ibritumomab tiuxetan. ||| Preclinical safety studies were performed using olanzapine pamoate monohydrate. ||| Aucune étude animale de reproduction n'a été réalisée avec l'ibritumomab tiuxétan.
0.2236190289258957 ||| 79 ||| 59 ||| 119
0.3123745024204254 ||| Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children aged 6 years and above (see section 5.1). ||| Pegasys is contraindicated in neonates and young children up to 3 years old, because of the excipient benzyl alcohol (see sections 4.3 and 4.4). ||| La gabapentine est indiquée en thérapie d’ appoint dans le traitement des épilepsies partielles avec ou sans généralisation secondaire chez l’ adulte et l’ enfant âgé de 6 ans et plus (voir rubrique 5.1).
0.2739971876144409 ||| Given the importance of tests in the current situation and the rapid development of the pandemic, the Commission is also insisting on pooling resources for the validation of coronavirus tests at EU-level. ||| In parallel to this, the EMEA worked to ensure a smooth implementation at a practical level and expects its implementation to reduce the number of GMP inspections needed to be performed by EU ||| Compte tenu de l'importance des tests dans la situation actuelle et de l'évolution rapide de la pandémie, la Commission insiste en outre sur la mise en commun des ressources pour la validation des tests liés au coronavirus au niveau de l'Union.
0.13275659084320068 ||| France notified to the Commission under the amended Temporary Framework an "umbrella" scheme to support non-financial companies affected by the coronavirus outbreak. ||| Italy notified to the Commission under the Temporary Framework a €9 billion "umbrella" scheme to support companies affected by the coronavirus outbreak. ||| La France a notifié à la Commission, au titre de l'encadrement temporaire modifié, un régime-cadre visant à soutenir les entreprises non financières touchées par la pandémie de coronavirus.
0.6976908445358276 ||| 4.82 to 30.2, p = 0.0001). ||| 1.6 mm, 3.5 mm) [p < 0.0001]. ||| 4,82 à 30,2, p= 0,0001).
0.42900362610816956 ||| Sodium phosphate ||| Manganese metaphosphate ||| Phosphate de sodium
0.18063217401504517 ||| Co-administration of potent CYP3A4 inhibitors (e. g. ketoconazole, itraconazole, ritonavir) with sildenafil for pulmonary arterial hypertension is contraindicated (see section 4.3). ||| Concomitant use of vardenafil with potent CYP 3A4 inhibitors such as itraconazole and ketoconazole (oral use) should be avoided (see sections 4.3 and 4.4). ||| L’ administration concomitante d’ inhibiteurs puissants du CYP3A4 (par ex. kétoconazole, itraconazole, ritonavir) avec du sildénafil pour le traitement d’ une hypertension artérielle pulmonaire est contre-indiquée (voir rubrique 4.3).
0.5652862787246704 ||| Therefore the combination of perindopril with the above-mentioned drugs is not recommended (see section 4.4). ||| These drugs are also referred to under section 4.3 (Contra-indications). ||| De ce fait, l’ association du perindopril avec les médicaments mentionnés ci-dessus n’ est pas recommandée (cf. section 4.4).
0.0944170281291008 ||| IThe reconstituted vaccine must not be used if any particulate matter is noted or if the appearance of the solvent or powder or of the reconstituted vaccine differs from that described above. ||| Do not use the reconstituted vaccine if you notice any particulate matter or if the appearance of the solvent or powder or of the reconstituted vaccine differs from that described above. ||| Le vaccin reconstitué ne doit pas être utilisé si une particule étrangère est présente ou si l'aspect du solvant, de la poudre ou du vaccin diffère de ce qui est décrit ci-dessus.
0.37473630905151367 ||| While this is not documented with Irbesartan BMS, a similar effect should be anticipated with angiotensin-II receptor antagonists. ||| Because MabCampath is a recombinant humanized protein, a P450 mediated drug-drug interaction would not be expected. ||| Bien que cela n’ aie pas été documenté avec Irbesartan BMS, un phénomène similaire est à prévoir avec les antagonistes des récepteurs de l'angiotensine-II.
0.3443167805671692 ||| The other two studies showed that Kineret was more effective than placebo when used as an add-on to methotrexate. ||| In addition, GANFORT was shown to be as effective as bimatoprost and timolol given at the same time. ||| Les deux autres études ont montré que Kineret était plus efficace que le placebo lorsqu’ il était utilisé en complément du méthotrexate.
0.17224203050136566 ||| 2.11 ||| 1.12 ||| 2,11
0.42292845249176025 ||| Pramipexole has been associated with somnolence and episodes of sudden sleep onset, particularly in patients with Parkinson’ s disease. ||| Depression is associated with an increased risk of suicidal thoughts, self harm and suicide (suicide-related events). ||| L’ administration de pramipexole a été associée à des cas de somnolence et des accès de sommeil d’ apparition soudaine, en particulier chez des patients atteints de la maladie de Parkinson.
0.2741383910179138 ||| Preliminary data indicates that interferon alpha therapy may be associated with an increased rate of kidney graft rejection. ||| Increased haematopoietic activity of the bone marrow in response to growth factor therapy has been associated with transient positive bone imaging findings. ||| Les données préliminaires indiquent que le traitement par interféron alpha peut être associé à un risque de rejet de greffe de rein plus élevé.
0.349549263715744 ||| Due to the risk of severe hepatoxicity, saquinavir/ritonavir should not be given together with rifampicin. ||| There are no adequate data from the use of the combination of levodopa/ carbidopa/ entacapone in pregnant women. ||| En raison du risque de toxicité hépatique sévère, l’association saquinavir/ritonavir ne doit pas être co-administrée avec la rifampicine.
0.5055789351463318 ||| 0.3% ||| 4.0%) ||| 0,3%
0.004058442078530788 ||| Because co-administration of bile acid sequestrants may reduce the bioavailability of acidic medicinal products such as nicotinic acid, it is recommended that Pelzont be administered > 1 hour before or > 4 hours after administration of a bile acid sequestrant. ||| Because co-administration of bile acid sequestrants may reduce the bioavailability of acidic medicinal products such as nicotinic acid, it is recommended that Trevaclyn be administered > 1 hour before or > 4 hours after administration of a bile acid sequestrant. ||| Effets d’ autres médicaments sur l’ acide nicotinique Chélateurs des acides biliaires: la biodisponibilité des médicaments acides tels que l’ acide nicotinique pouvant être diminuée en cas d’ administration concomitante de chélateurs des acides biliaires, Pelzont doit être pris plus d'une heure avant ou quatre heures après un chélateur des acides biliaires.
0.2735268473625183 ||| 27 August 2007 ||| 26 August 2008 ||| 27 août 2007
0.28852152824401855 ||| Lamivudine has no pharmacokinetic interaction with alpha-interferon when the two medicinal products are concurrently administered. ||| Vectibix administered as a single agent or in combination with chemotherapy exhibits nonlinear pharmacokinetics. ||| Aucune interaction pharmacocinétique n’ a été observée entre la lamivudine et l’ interféron alpha lorsque ces deux médicaments sont co-administrés.
0.00964443664997816 ||| The effect of CYMBALTA 60 mg once a day in elderly depressed patients (≥ 65 years) was specifically examined in a study that showed a statistically significative difference in the reduction of the HAMD17 score for duloxetine-treated patients compared to placebo. ||| The effect of XERISTAR 60 mg once a day in elderly depressed patients (≥ 65 years) was specifically examined in a study that showed a statistically significative difference in the reduction of the HAMD17 score for duloxetine-treated patients compared to placebo. ||| L’ effet de CYMBALTA à la posologie de 60 mg une fois par jour chez les patients âgés déprimés (≥ 65 ans) a été spécifiquement examiné dans une étude qui a montré une différence statistiquement significative dans la réduction du score sur l’ échelle HAMD-17 chez les patients traités par la duloxétine comparés à ceux sous placebo.
0.1605989634990692 ||| After removing Insulatard NovoLet from the refrigerator it is recommended to allow the NovoLet to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use. ||| After removing NovoMix 30 Penfill from the refrigerator it is recommended to allow NovoMix 30 Penfill to reach room temperature before resuspending the insulin as instructed for the first time use. ||| Après avoir sorti Insulatard NovoLet du réfrigérateur, il est recommandé d’ attendre qu’ il arrive à température ambiante (sans dépasser 25°C) avant de remettre l’ insuline en suspension, comme indiqué dans les instructions concernant la première utilisation.
0.3537915349006653 ||| Teratology studies have been conducted in rats and rabbits at doses of up to 1500 mg/ kg/ day and 500 mg/ kg/ day, respectively. ||| In clinical studies, the 650 mg/ m2 and 1,500 mg/ m2 dose have both been used in patients in the age range 16 to 21 years. ||| 41 Des études de tératogenèse ont été conduites chez le rat et le lapin à des doses allant respectivement jusqu'à 1500 mg/ kg/ j et 500 mg/ kg/ j.
0.10961522907018661 ||| Nervous system disorders Common: headache ||| Nervous system disorder Common: headache ||| Affections du système nerveux Fréquent: céphalées.
0.4122716188430786 ||| Periodic determination of serum electrolytes should be performed at appropriate intervals in such patients. ||| Neurological evaluations were performed every 12 weeks and at times of suspected relapse. ||| Les électrolytes sériques doivent être contrôlés à intervalles réguliers chez ces patients.
0.24060195684432983 ||| Lucentis is administered as a single injection into your eye. ||| Lucentis is given as an injection into the affected eye. ||| Lucentis est administré sous forme d'une injection unique dans l 'œ il.
0.3934100568294525 ||| Pharmacokinetic data on duloxetine is limited in patients with mild or moderate renal impairment. ||| The pharmacokinetic profile is comparable in healthy volunteers and in patients with epilepsy. ||| Les données pharmacocinétiques sont limitées chez les patients atteints d'insuffisance rénale légère ou modérée.
0.004192681051790714 ||| 111 Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & ΥΙΟΣ Ε .Π .Ε. ||| 99 Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & ΥΙΟΣ Ε .Π .Ε. ||| 116 Κύπρος ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & ΥΙΟΣ Ε .Π .Ε.
0.386702299118042 ||| Symptomatic heart failure It is recommended that , generally associated with a non- potassium-sparing diuretic and/or digoxin and/or a beta blocker, be introduced under close medical supervision with a recommended starting dose of 2 mg taken in the morning. ||| During therapy, the cholesterol-lowering diet should be continued, and serum total-C, LDL-C and triglyceride levels should be determined periodically during treatment to confirm favourable initial and adequate long-term responses. ||| Insuffisance cardiaque symptomatique Il est recommandé d’ initier le traitement par , généralement utilisé en association avec un diurétique épargneur de potassium et/ ou de la digoxine et/ ou un bêta-bloquant, sous stricte surveillance médicale, à la posologie initiale de 2 mg en une prise matinale.
0.6667506694793701 ||| The majority of the population enrolled was Asian. ||| Almost a third of them are in China. ||| La majorité de la population incluse était d’ origine
0.03180639445781708 ||| Do not take a double dose to make up for a forgotten tablet. ||| Do not take a double dose to make up for a forgotten capsule. ||| Ne prenez pas une double dose pour compenser le comprimé oublié.
0.3395004868507385 ||| If you are taking any of these medicines, your doctor may need to check the level of anticonvulsant medicine in your blood to ensure that it is not affected while taking STOCRIN. ||| You should not take the medicines listed below at the same time as you are using Fentanyl- ratiopharm, unless you are closely monitored by your doctor. ||| Si vous prenez l'un de ces médicaments, votre médecin devra peut-être mesurer la concentration du médicament anticonvulsivant dans votre sang pour s’ assurer que celle -ci n’ est pas affectée par la prise de SUSTIVA.
0.35452568531036377 ||| a pan-European coordinated approach for the use of mobile applications for empowering citizens to take effective and more targeted social distancing measures and for warning, preventing and contact tracing; and ||| This work should include, more effective safeguards for elections that are also fit for the digital age to address among others, developing the transparency of political ads and communications and help identify manipulative content. ||| une approche coordonnée paneuropéenne de l'utilisation d'applications mobiles permettant aux citoyens de prendre des mesures efficaces et plus ciblées de distanciation sociale, et servant à l'alerte, à la prévention et au traçage des contacts, et
0.008040936663746834 ||| One ml of solution contains 10 mg of cetirizine dihydrochloride, one drop of solution contains 0.5 mg cetirizine dihydrochloride ||| One ml of solution contains 10 mg cetirizine dihydrochloride, one drop of solution contains 0.5 mg cetirizine dihydrochloride ||| Un ml de solution contient 10 mg de dichlorhydrate de cétirizine, une goutte de solution contient 0,5 mg de dichlorhydrate de cétirizine.
0.18196766078472137 ||| Treatment of patients with chemotherapy induced anaemia Retacrit should be administered by the subcutaneous route to patients with anaemia (e. g. haemoglobin concentration ≤ 10 g/ dl (6.2 mmol/ l). ||| or Nespo should be administered by the subcutaneous route to patients with anaemia (e. g. haemoglobin concentration ≤ 10 g/ dl (6.2 mmol/ l)) in order to increase haemoglobin to not greater than 12 g/ dl ||| − Traitement de l’ anémie induite par la chimiothérapie Retacrit doit être administrée par voie sous-cutanée aux patients atteints d’ anémie (taux d’ hémoglobine ≤ 10 g/ dl [6,2 mmol/ l], par ex.).
0.5120857357978821 ||| Effentora 200 micrograms buccal tablets ||| Effentora 400 micrograms ||| Effentora 200 microgrammes, comprimés gingivaux
0.31722569465637207 ||| There are no data available to indicate whether the administration of 23-valent pneumococcal polysaccharide vaccine to unprimed children or to children primed with Prevenar might result in hyporesponsiveness to further doses of Prevenar. ||| The CHMP considered that although bleomycin is not an obvious first line component for systemic treatment of cervical cancer, bleomycin remains a useful cytostatic drug that has to remain available to patients for this indication. ||| Il n’ y a pas de données disponibles indiquant si l’ administration du vaccin pneumococcique polysaccharidique 23-valent à des enfants ayant ou non reçu une primovaccination par Prevenar pourrait entraîner une diminution de la réponse immunitaire lors de l’ administration ultérieure de doses de Prevenar.
0.47027841210365295 ||| See sections 4.4, 4.8 and 6.1. ||| (See sections 4.5 and 5.2.) ||| Voir rubriques 4.4, 4.8 et 6.1.
0.1334976702928543 ||| 300mg/ 12.5 mg ||| 150mg/ 12.5mg ||| 300mg/ 12,5m g
0.5864890217781067 ||| I would strongly emphasise once again that we want an agreement - which is why we are urgently working on this - but not at any price. ||| We must be up to the task ahead and it's a huge challenge, but I'm looking forward to the next six months. ||| Qu'il me soit permis de le redire très clairement: nous voulons un accord - et nous y travaillons d'arrache-pied -, mais pas à n'importe quel prix.
0.18015488982200623 ||| Identification sheaths for electric wires ||| Sheaths for electrical wires ||| Gaines d'identification pour fils électriques
0.0 ||| Not known: ||| Not known: ||| Très rare:
3.5008972175225306e-13 ||| paediatric and adult patients in the area under the curve from time 0 to infinity (AUC[0-∞]) was observed; however, this difference was less than the 2-fold range in AUC(0- ∞) observed for the ro ||| paediatric and adult patients in the area under the curve from time 0 to infinity (AUC[0-∞]) was observed; however, this difference was less than the 2-fold range in AUC(0- ∞) observed for the ro ||| 0 à l’ infini (AUC[0-∞]) entre l’ enfant et l’ adulte; toutefois, cette différence était moins de deux fois inférieure à l’ AUC (0-∞) observée chez l’ enfant.
0.5236544013023376 ||| The immunogens are incorporated in an adjuvant based on dl-α -tocopherol. ||| It binds with high affinity to the VEGF-A isoforms (e. g. ||| Les antigènes sont incorporés dans un adjuvant à base de dl-α -tocophérol.
5.047451172301987e-13 ||| Film-coated tablet [To be completed nationally] ||| Film-coated tablet [To be completed nationally] ||| [A compléter au niveau national]
0.4047057032585144 ||| Lighting apparatus and installations ||| Electrical insulation articles and materials ||| Appareils et installations d'éclairage
0.2105162888765335 ||| If an anaphylactic reaction or other serious allergic reaction occurs, administration of Humira should be discontinued immediately and appropriate therapy initiated. ||| In case of suspected or confirmed pulmonary adverse events, discontinuation of treatment with filgrastim should be considered and appropriate medical care given. ||| En cas de survenue d'une réaction anaphylactique ou d'une autre réaction allergique grave, l'administration d’ Humira doit être immédiatement interrompue et un traitement approprié mis en œ uvre.
0.37825947999954224 ||| Some patients who stop taking XERISTAR suddenly have had symptoms such as dizziness, fatigue, tingling feelings like pins and needles, sleep disturbances (vivid dreams, nightmares, inability to sleep), feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), tremor (shakiness), headaches, feeling irritable, diarrhoea, excessive sweating or vertigo. ||| Common • Indigestion, feeling sick (nausea), being sick (vomiting), dry mouth. • Rash, dryness of the skin. • Feeling weak, faint or unsteady, lack of energy or strength, low blood pressure. • Fever, feeling generally unwell. • A spinning feeling in your head, making it difficult to stand up and move normally. • Having difficulty in seeing or speaking, which is temporary. ||| Certains patients, après avoir arrêté brutalement XERISTAR, ont ressenti des signes tels qu’ étourdissements, fatigue, picotements, fourmillements, troubles du sommeil (rêves agités, cauchemars, insomnie), agitation, anxiété, envie de vomir (nausées) ou vomissements, tremblements, maux de tête, irritabilité, diarrhées, transpiration excessive ou vertiges.
0.4347293972969055 ||| Thermal binding machines [other than for office use] ||| Taping [tying] machines other than for office use ||| Relieuses à chaud autres que pour le bureau
0.05995235592126846 ||| WHAT AGOPTON IS AND WHAT IT IS USED FOR ||| WHAT ALTARGO IS AND WHAT IT IS USED FOR ||| QU’EST CE QU’AGOPTON ET DANS QUELS CAS EST-IL UTILISE
0.01727624610066414 ||| 20 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE ||| 28 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE ||| 21 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.35626840591430664 ||| - tiredness, abdominal pain, or jaundice (yellow discolouration of the eyes or skin), as these ||| Nausea (unsettled stomach), decrease of blood pressure, skin reactions (for example rash, looking like sunburn). ||| - fatigue, douleurs abdominales ou jaunisse (coloration jaune des yeux ou de la peau), qui
0.5536680221557617 ||| Pack-sizes of 40, 60 or 180 tablets. ||| Packs of 28 or 84 tablets. ||| Emballages de 40, 60 ou 180 comprimés.
0.0 ||| Elderly patients appear to be at increased risk of neutropenia and thrombocytopenia, compared with younger patients. ||| Elderly patients appear to be at increased risk of neutropenia and thrombocytopenia, compared with younger patients. ||| Les patients âgés semblent avoir un risque augmenté de neutropénie et de thrombocytopénie, comparativement aux patients plus jeunes.
0.6376504302024841 ||| - antiepileptic medicines containing: ||| Active substance specific immunoglobulins: not applicable ||| - antiépileptique contenant
0.25172358751296997 ||| Calcichew-D3 (and associated names) tablets should be used cautiously in immobilised patients with osteoporosis due to increased risk of hypercalcaemia. ||| Because of the potential for serious adverse reactions to mycophenolate mofetil in breast-fed infants, CellCept is contraindicated in nursing mothers (see section 4.3). ||| Calcichew-D3 (et dénominations associées) doit être utilisé avec précaution chez les patients immobilisés, atteints d’ostéoporose, en raison de l’augmentation du risque d’hypercalcémie.
0.722653865814209 ||| Elderly Patients: ||| Use in elderly patients ||| Patients âgés:
0.032771021127700806 ||| Do not use Circadin after the expiry date which is stated on the carton. ||| Do not use Cervarix after the expiry date which is stated on the carton. ||| Ne pas utiliser Circadin après la date de péremption mentionnée sur la boîte.
0.0047945184633135796 ||| Pelzont is used in addition to diet and exercise in patients with dyslipidaemia (abnormally high levels of fat in the blood), particularly ‘ combined mixed dyslipidaemia’ and ‘ primary hypercholesterolaemia’. ||| Trevaclyn is used in addition to diet and exercise in patients with dyslipidaemia (abnormally high levels of fat in the blood), particularly ‘ combined mixed dyslipidaemia’ and ‘ primary hypercholesterolaemia’. ||| Pelzont est utilisé en complément d’ un régime et d’ exercice chez les patients souffrant de dyslipidémie (taux de graisses dans le sang anormalement élevé), en particulier de « dyslipidémie mixte ou combinée » et d '« hypercholestérolémie primaire ».
0.5137016177177429 ||| Irrigation bags for watering trees ||| Powders for killing fleas on animals ||| Sacs d'irrigation pour l'arrosage d'arbres
0.011857722885906696 ||| ra In clinical trials conducted in the hepatitis C population, patients were treated with Viraferon alone or in combination with ribavirin for one year. ||| 107 In clinical trials conducted in the hepatitis C population, patients were treated with Viraferon alone or in combination with ribavirin for one year. ||| Dans les études cliniques conduites dans la population atteinte d’ hépatite C, les patients étaient traités par Viraferon seul ou en association avec la ribavirine pendant un an.
3.5083776704115943e-13 ||| Co-administration of INVEGA once daily with carbamazepine 200 mg twice daily caused a decrease of approximately 37% in the mean steady-state Cmax and AUC of paliperidone. ||| Co-administration of INVEGA once daily with carbamazepine 200 mg twice daily caused a decrease of approximately 37% in the mean steady-state Cmax and AUC of paliperidone. ||| La co-administration d’ INVEGA une fois par jour avec de la carbamazépine administrée deux fois par jour à la dose de 200 mg a entraîné une diminution d'environ 37% de la Cmax et de l’ AUC moyennes de la palipéridone à l’ état d’ équilibre.
0.0 ||| 6.4 Special precautions for storage ||| 6.4 Special precautions for storage ||| 90 6.4 Précautions particulières de conservation
0.2808944284915924 ||| Patients treated with Siklos had fewer vaso-occlusive crises after treatment with Siklos than before treatment, with the frequency falling by between 66% and 80% in children and adults. ||| The incidence of undesirable effects in patients with myoclonic seizures was lower than that in adult patients with partial onset seizures (33.3% versus 46.4%). ||| Les patients traités par Siklos présentaient moins de crises vaso-occlusives après le traitement par Siklos qu’ avant le traitement, avec une fréquence chutant de 66% à 80% chez les enfants et les adultes.
0.0 ||| disorders ||| disorders ||| Nausée
0.42926424741744995 ||| Compilation of web pages for the Internet ||| Compilation of directories for publication on the internet ||| Compilation de pages Web pour Internet
0.39404207468032837 ||| Treatment with NeoRecormon should start as early as possible, preferably by day 3 of life. ||| Before starting breast-feeding, your last treatment with Remicade must be at least 6 months ago. ||| Il est recommandé de commencer le traitement par NeoRecormon le plus tôt possible, de préférence avant le 3ème jour de vie.
0.0037701136898249388 ||| 63 Stalevo comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets). ||| 77 Stalevo comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets). ||| Stalevo existe en six conditionnements différents (10, 30, 100, 130, 175 ou 250 compriméss.
0.005710687022656202 ||| 32 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 33 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 34 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.03338586911559105 ||| When prescribing MIRAPEXIN in a patient with Parkinson’ s disease with renal impairment a reduced dose is suggested in line with section 4.2. ||| -4- When prescribing MIRAPEXIN in a patient with Parkinson’ s disease with renal impairment a reduced dose is suggested in line with section 4.2. ||| Il est recommandé de réduire la dose selon le schéma décrit au paragraphe 4.2 en cas d'utilisation de MIRAPEXIN chez les patients atteints de la maladie de Parkinson insuffisants rénaux.
0.23090118169784546 ||| If you have liver or kidney problems, speak to your doctor as you may need a lower dose. ||| If you have a kidney disease, your doctor should monitor you more carefully for a decrease in red blood cell count. ||| Si vous avez des problèmes de foie ou de reins, parlez -en à votre médecin car vous pouvez avoir besoin d’ une dose plus faible.
0.6796555519104004 ||| Baraclude 0.05 mg/ ml ||| 18.2 mg Benzyl alcohol: ||| Baraclude 0,05 mg/ ml
0.39868852496147156 ||| - You have high blood pressure or your blood pressure gets higher ||| - if you have low blood pressure or uncontrolled high blood pressure. ||| - Vous avez une pression artérielle élevée ou une pression artérielle qui devient élevée
0.3621150553226471 ||| Manufacturer Bristol-Myers Squibb S. r. l. ||| Bristol-Myers Squibb S.r.l. ||| Fabricant Bristol-Myers Squibb S. r. l.
0.09534689784049988 ||| Do not use Zarzio after the expiry date which is stated on the carton and on the syringe label after EXP. ||| Do not use Irbesartan BMS after the expiry date which is stated on the carton and on the blister after EXP. ||| Ne pas utiliser Zarzio après la date de péremption mentionnée sur la boîte et l’ étiquette de la seringue après EXP.
0.89631587266922 ||| How to store Humalog Mix50 Pen 6. ||| NovoMix 50 FlexPen Pen cap ||| Comment conserver Humalog Mix50 Pen 6.
0.3905813694000244 ||| Data broadcasting services ||| Internet radio broadcasting services ||| Services de diffusion de données
0.15722140669822693 ||| pancreatitis, gastritis, gastrooesophageal reflux disease, aphthous stomatitis, retching, dry mouth, abdominal distension, abdominal discomfort, flatulence, dyspepsia, constipation, increased lipase ||| Common: abdominal pain, stomatitis, dyspepsia, loose stools, abdominal pain upper, flatulence, abdominal distension, hiccups, mouth ulceration, pharyngolaryngeal pain, dry mouth. ||| pancréatite, gastrite, reflux gastro- oesophagien, stomatite aphteuse, haut le coeur, sécheresse buccale, distension abdominale, gêne abdominale, flatulences, dyspepsie, constipation, augmentation de la lipase
0.3587767481803894 ||| Blood pressure should be closely monitored and adequately controlled in all epoetin treatment naïve as well as pre-treated patients before, at initiation of, and during treatment with Retacrit. ||| Iron supplementation should be started as soon as possible, even several weeks prior to initiating the autologous predeposit, in order to achieve high iron stores prior to starting Abseamed therapy. ||| La tension artérielle doit être étroitement surveillée et contrôlée adéquatement chez tous les patients naïfs de traitement recevant de l’ époïétine ainsi que chez les patients déjà traités avant, à l’ initiation et tout au long du traitement par Retacrit.
0.2816150486469269 ||| However, it should be noted that the incidence of somnolence is increased at doses higher than 1.5 mg/ day (see section 4.8). ||| However, it should be noted that within the first month after treatment a proportion of treated bitches also experienced an induced heat (see section 4.5). ||| Cependant, il est à noter que l’ incidence des cas de somnolence est augmentée à des doses supérieures à 1,5 mg/ jour (voir rubrique 4.8).
0.8599538803100586 ||| Manual clippers ||| Photograph album pages ||| Tondeuses à main
0.0008238720474764705 ||| 163 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 152 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 173 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTERIEUR OU, EN L’ABSENCE D’EMBALLAGE EXTERIEUR, SUR LE CONDITIONNEMENT PRIMAIRE
0.09433667361736298 ||| - if you have had or now have liver problems. ||| - If you have or have had liver problems. ||| - si vous avez ou avez eu des problèmes hépatiques.
0.310343861579895 ||| Maintenance and repair of electronic display panels ||| Maintenance and repair of wave energy power plants ||| Entretien et réparation de panneaux d'affichage électroniques
0.07612365484237671 ||| Do not use Zeffix after the expiry date which is stated on the bottle and the carton. ||| Do not use Remeron after the expiry date which is stated on the carton and the blister or bottle. ||| Ne pas utiliser Zeffix après la date de péremption mentionnée sur le flacon et la boîte.
0.2855958938598633 ||| Suvaxyn Aujeszky 783 + O/ W, powder for injection. ||| Suvaxyn Aujeszky 783 + O/ W is a vaccine. ||| Suvaxyn Aujeszky 783 + O/ W, poudre injectable
0.0 ||| For a full list of excipients, see section 6.1. ||| For a full list of excipients, see section 6.1. ||| Excipients Pour la liste complète des excipients, voir rubrique 6.1
0.42950576543807983 ||| 42 The glucodynamic response to insulin lispro is not affected by renal or hepatic function impairment. ||| Electrolyte imbalance, development of an acidotic state, and possible nervous system effects may occur. ||| La réponse glucodynamique à l’ insuline lispro n’ est pas affectée par une altération de la fonction rénale ou hépatique.
0.7184693813323975 ||| The injection button should be pressed in completely. ||| It is a premixed suspension. ||| 235 Le bouton d'injection doit être enfoncé à fond.
0.2778283953666687 ||| au 2. ||| au 3. ||| tor 2.
0.3885592520236969 ||| The information supplied by the company supports the use of Ytracis as a precursor for radiolabelling medicines with 90Y. ||| Furthermore the IWP is preparing guidance on DNA vaccines and the use of adjuvants in veterinary biologicals. ||| Les informations fournies par la société justifient l’ utilisation d’ Ytracis comme précurseur pour le marquage radioactif d’ autres médicaments avec l’ 90Y.
0.14504800736904144 ||| Milk ferments for pharmaceutical purposes ||| Almond milk for pharmaceutical purposes ||| Ferments lactiques à usage pharmaceutique
0.30210280418395996 ||| Patients should be warned to report any febrile illness to their physicians. ||| Patients should be instructed to consult their physician immediately should pregnancy occur. ||| Les patients doivent être avertis qu’ il convient d’ informer leur médecin de toute maladie fébrile.
0.0771256610751152 ||| Please read the following instructions carefully before using your Actraphane 30 NovoLet. ||| Please read the following instructions carefully before using your Actraphane 30 InnoLet. ||| Veuillez lire attentivement les instructions ci-dessous avant d’ utiliser votre Actraphane 30 NovoLet.
0.5020610690116882 ||| As of 10 April 2020, approximately 97,000 deaths had been attributed to COVID-19. ||| Yesterday, Bangladesh has confirmed five new deaths due to COVID-19 on the day. ||| Au 10 avril 2020, approximativement 97 000 décès avaient été imputés à la COVID-19.
8.00095504172732e-13 ||| Oral use Read the package leaflet before use. ||| Oral use Read the package leaflet before use. ||| Lire la notice avant utilisation.
0.48191267251968384 ||| A carry-forward from the 1996 budget to 1997 of ECU 1.62 million was approved by the Board at its February meeting. ||| A dossier in CTD format and a proposal for a harmonised SPC were submitted by the MAH on 22 September 2004. ||| Un report de 1,62 million d’ écus du budget de 1996 à celui de 1997 a été approuvé par le Conseil d’ administration au cours de sa réunion de février.
0.14991161227226257 ||| How has Baraclude been studied? ||| How has Abraxane been studied? ||| Quelles études ont été menées sur Baraclude?
4.5236758132796706e-13 ||| For a full list of excipients see section 6.1. ||| For a full list of excipients see section 6.1. ||| Pour tous les excipients, voir section 6.1.
0.27089396119117737 ||| In the unlikely event of overdose with Aloxi, this should be managed with supportive care. ||| In case of suspected overdose, Tarceva should be withheld and symptomatic treatment initiated. ||| Dans le cas peu probable d'un surdosage avec Aloxi, un traitement symptomatique et de soutien doit être instauré.
0.3315376043319702 ||| As a consequence, additional efficacy and safety data were required for the approval of Rapinyl for the management of breakthrough pain in the target population and the procedure was referred to the CHMP. ||| AVANDAMET has a place in the treatment of patients with type 2 diabetes after careful individual benefit-risk assessment and provided that the precautions and warnings included in the product information are adhered to. ||| Par conséquent, davantage de données d’ efficacité et de sécurité étaient requises pour l’ approbation de Rapinyl pour la prise en charge des douleurs paroxystiques dans la population cible et la procédure a été transmise au comité des médicaments à usage humain (CHMP).
0.3212617337703705 ||| (39-06) 59 94 39 45/46 Fax (39-06) 59 94 32 17 E-mail: alimentivet@sanita.it ||| Tel: + 353 91 841788 Fax: + 353 91 842937 e-mail: sales@chanellegroup. ie ||| (39-06) 59 94 39 45/ 46 Fax (39-06) 59 94 32 17 e-mail: alimentivet@sanita. it
2.862187754599371e-13 ||| Transient treatment-related physical signs, some of which suggest neural toxicity, such as open-mouth breathing, salivation, white foamy emesis, ataxia, trembling, decreased activity, and/ or hunched posture were observed in dogs at exposure levels approximately 23 times the clinical exposure level. ||| Transient treatment-related physical signs, some of which suggest neural toxicity, such as open-mouth breathing, salivation, white foamy emesis, ataxia, trembling, decreased activity, and/ or hunched posture were observed in dogs at exposure levels approximately 23 times the clinical exposure level. ||| 12 des niveaux d'exposition d'environ 23 fois l'exposition clinique: respiration bouche ouverte, écoulement de salive, vomissements mousseux blancs, ataxie, tremblements, diminution de l'activité et/ou posture recroquevillée.
0.22628992795944214 ||| Like all medicines, Glustin 15 mg tablets can have side effects, although not everybody gets them. ||| Like all medicines, {PRODUCT NAME} 20 mg can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Glustin 15 mg comprimés est susceptible d'avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.1602482795715332 ||| Azomyr orodispersible tablet is an antiallergy medicine that does not make you drowsy. ||| Neoclarityn is an antiallergy medicine that does not make you drowsy. ||| Azomyr comprimés orodispersibles est un médicament contre l’ allergie qui ne vous rend pas somnolent.
0.1366562396287918 ||| General disorders and administration site conditions Common: ||| General disorders and administration site conditions Common: fatigue ||| Troubles généraux et anomalies au site d’administration Fréquents:
0.3748505711555481 ||| Assistance to industrial enterprises in the conduct of their business ||| Management assistance in the establishment of commercial undertakings ||| Assistance aux entreprises industrielles concernant la conduite de leurs affaires
0.003838186850771308 ||| 1 ml suspension contains 100 IU (3.5 mg) of insulin human (rDNA) (30% as soluble insulin and 70% as isophane insulin). ||| 1 ml suspension contains 40 IU (1.4 mg) of insulin human (rDNA) (30% as soluble insulin and 70% as isophane insulin). ||| 1 ml de suspension contient 100 UI (3,5 mg) d’ insuline humaine, (ADNr) (30% d’ insuline soluble et 70% d’ insuline isophane).
0.2852700352668762 ||| Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted 39 with Exelon in patients with dementia associated with Parkinson’ s disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms. ||| Use of InductOs in patients undergoing cervical spine surgery in concentrations or amounts greater than those recommended in section 4.2 for the approved indications has been associated with reports of localised oedema (see section 4.4). ||| Le Tableau 3 liste le nombre et le pourcentage de patients ayant présentés des effets indésirables prédéfinis qui pourraient être le reflet d’ une aggravation des symptômes parkinsoniens dans le cadre de l’ étude clinique spécifique conduite pendant 24 semaines avec Exelon chez les patients atteints de démence associée à la maladie de Parkinson.
0.39445728063583374 ||| Patients should not chew or suck the tablet, because of a potential for oropharyngeal ulceration. ||| Do not be concerned if you see small white granules or balls in your stools after taking Efexor depot. ||| Les patientes ne doivent pas mâcher ou sucer le comprimé en raison du risque potentiel d’ ulcérations oropharyngées.
0.2593596279621124 ||| The incidence of adverse reactions showed no association with gender, age, body mass index, race or ethnicity. ||| No association was found between adverse reactions and age, ethnicity, duration of exposure or daily dose. ||| Aucun lien n’ a été observé entre l’ incidence des effets indésirables et le sexe, l’ âge, l’ indice de masse corporelle, la race ou l’ origine ethnique.
0.09492592513561249 ||| Each hard capsule contains 150 mg of pregabalin. ||| Each hard capsule contains 200 mg of efavirenz. ||| Chaque gélule contient 150 mg de prégabaline.
0.2726227641105652 ||| Simultaneous administration of Ciprofloxacin and phenytoin may result in increased or reduced serum levels of phenytoin such that monitoring of drug levels is recommended. ||| Concomitant use of thiazide diuretics may increase the risk of lithium toxicity and enhance the already increased risk of lithium toxicity with ACE inhibitors. ||| L’administration simultanée de ciprofloxacine et de phénytoïne peut entraîner une augmentation ou une réduction des taux sériques de phénytoïne, si bien qu’il est recommandé de contrôler la concentration du médicament.
0.20705972611904144 ||| (351-1) 323 95 00 Fax: ||| (358-9) 160 33 85 Fax: ||| (30-1) 652 55 62 Fax:
0.034866929054260254 ||| Epoetin alfa HEXAL 6000 IU/ 0.6 ml solution for injection in a pre-filled syringe The syringes contain 0.6 ml (6000 IU) of solution. ||| Epoetin alfa HEXAL 3000 IU/ 0.3 ml solution for injection in a pre-filled syringe The syringes contain 0.3 ml (3000 IU) of solution. ||| Epoetin alfa HEXAL 6 000 UI/ 0,6 ml, solution injectable en seringue pré-remplie Les seringues contiennent 0,6 ml (6 000 UI) de solution.
0.10496607422828674 ||| Each ml of oral solution contains 10 mg of lamivudine. ||| Each one ml of oral solution contains 40 mg of ribavirin. ||| Chaque ml de solution buvable contient 10 mg de lamivudine.
0.3695750832557678 ||| In all evaluated patients, the estimated renal clearance of bexarotene was less than 1 ml/ minute. ||| During the pill-free week, a two-fold increase in lamotrigine levels has been observed. ||| Chez tous les patients évalués, la clairance rénale du bexarotène était estimée inférieure à 1 ml / minute.
0.5104905366897583 ||| A doctor in Uzbekistan died on Saturday after unsuccessfully trying to treat a coronavirus infection that he kept secret, the Central Asian nation's healthcare ministry said. ||| On June 18, 1981, the US government announced the creation of a vaccine targeted against FMD, the world's first genetically engineered vaccine. ||| Il s'agit d'un médecin ouzbek de 39 ans, en contact avec le patient 0, décédé après avoir tenté sans succès de traiter une infection à coronavirus qu'il a gardée secrète, selon ministère de la Santé.
0.1934705674648285 ||| Implants [prosthesis] for use in facial surgery ||| Implants [prosthesis] for bone surgery ||| Implants pour la chirurgie de la face [prothèses]
0.0 ||| 106 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 106 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 116 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTÉRIEUR
0.33838677406311035 ||| Temodal 2.5 mg/ml is supplied as a pack of 1 vial. ||| Mycamine is supplied in a box containing 1 vial. ||| Temodal 2,5 mg/ ml est présenté en boîte de un flacon.
0.2811024785041809 ||| Hydrochloric acid ||| Perchloric acid ||| Acide chlorhydrique
0.26463690400123596 ||| Each film-coated tablet contains 100 mg of leflunomide and 138.42 mg of lactose. ||| One vial of powder contains 150 IU of follitropin alfa and 75 IU of lutropin alfa. ||| Chaque comprimé pelliculé contient 100 mg de léflunomide, et 138, 42 mg de lactose.
0.15831798315048218 ||| Preotact should therefore not be used in patients with severe renal impairment (see section 4.3). ||| Temsirolimus should be used with caution in patients with severe renal impairment (see section 4.4). ||| En conséquence, Preotact ne doit pas être utilisé chez les patientes ayant une insuffisance rénale sévère (voir rubrique 4.3).
0.28653663396835327 ||| Please follow these recommendations closely as they will give you the best chance to delay development of a resistance to the medicinal product. ||| This way, you can be sure your medicine is fully effective and you reduce the risk of the virus developing resistance to the treatment. ||| Veuillez suivre étroitement ses recommandations car elles vous donneront la meilleure chance de retarder le développement d'une résistance au médicament.
0.33766356110572815 ||| If you miss/ your child misses the visit scheduled for the second injection, talk to your doctor and arrange another visit as soon as possible. ||| If no improvement is noted within 4 weeks, consult your veterinary surgeon who will need to re-evaluate the dog’ s treatment. ||| Si vous manquez ou si votre enfant manque la visite prévue pour la deuxième injection, informez -en votre médecin et demandez -lui une nouvelle consultation le plus rapidement possible.
0.45217686891555786 ||| Ranolazine undergoes rapid and extensive metabolism. ||| Pregabalin undergoes negligible metabolism in humans. ||| Biotransformation: la ranolazine subit un métabolisme rapide et important.
0.21332937479019165 ||| VIRAMUNE must be permanently discontinued in any patient experiencing severe rash or a rash accompanied by constitutional symptoms (such as fever, blistering, oral lesions, conjunctivitis, facial oedema, muscle or joint aches, or general malaise), including Stevens-Johnson syndrome, or toxic epidermal necrolysis. ||| Patients should be informed of the signs of immediate-type hypersensitivity reactions including hives, pruritus, generalised urticaria, angioedema, hypotension (e. g. dizziness or syncope), shock and acute respiratory distress (e. g. tightness in the chest, wheezing). ||| L'administration de VIRAMUNE doit être définitivement interrompue dans tous les cas de survenue d'une éruption cutanée sévère ou d’ une éruption accompagnée de symptômes généraux (tels que fièvre, phlyctènes, lésions buccales, conjonctivite, œ dème de la face, douleur musculaire ou articulaire ou malaise général), y compris en cas de syndrome de Stevens-Johnson, ou de syndrome de Lyell.
0.29450085759162903 ||| * Your doctor may decide that you can take rifabutin and/or voriconazole with a booster (lower dose) of Norvir but a full dose of Norvir must not be taken together with these two medicines. ||| There are some medications that must not be taken with Invirase/ritonavir (see section "Do not take Invirase") or that require dosage reduction of that medicine or Invirase or ritonavir. ||| * Votre médecin pourra déterminer que vous pouvez prendre la rifabutine et/ou le voriconazole avec une dose de potentialisation pharmacocinétique (dose plus faible) de Norvir, mais Norvir à dose maximale ne doit pas être pris avec ces deux médicaments.
0.30743905901908875 ||| 5 Potent CYP3A4 inhibitors such as ketoconazole and itraconazole would be expected to have effects similar to ritonavir (see section 4.3). ||| The following section describes the undesirable effects reported for levodopa/ carbidopa and for entacapone used in combination with levodopa/ DDC inhibitor. ||| Des effets similaires à celui exercés par le ritonavir sont attendus avec les inhibiteurs puissants du CYP3A4 tels que le kétoconazole et l’ itraconazole (voir rubrique 4.3).
0.5793735980987549 ||| In any case, initiation of susceptible NRTI’ s should always be preferred to maintenance of lamivudine therapy. ||| considered to be sufficient to support the 50U/ axilae proposed by the applicant. ||| Dans tous les cas, l’ utilisation d’ INTIs actifs sur le virus est toujours préférable au maintien du traitement par lamivudine.
0.15808945894241333 ||| Push the plunger slowly to inject the water into the powder vial. ||| Push the plunger of the syringe down to inject air into the vial. ||| Appuyez doucement sur le piston pour injecter l’ eau dans le flacon de poudre.
0.3927282691001892 ||| Misuse of Nespo by healthy persons may lead to an excessive increase in packed cell volume. ||| This is of benefit in reducing effects on nearby muscles when small muscle groups are being injected. ||| Un usage détourné de Nespo chez des sujets sains peut entraîner une augmentation excessive de l’ hématocrite.
0.3296387493610382 ||| Emadine is not recommended for patients older than 65 years or in patients who have problems with their liver or kidneys. ||| Patients with severe liver problems or kidney problems should not take more than 10 mg in one dose. ||| Emadine n’ est pas recommandé chez les patients de plus de 65 ans ou chez les patients atteints de troubles hépatiques ou rénaux.
0.20531514286994934 ||| 4.2 Posology and method of administration ||| Posology and method of administration ||| 4.2 Posologie et mode d’ administration am
0.5853583216667175 ||| How to use Insuman Comb 50 4. ||| 106 Information on how to use Protaphane InnoLet ||| Comment utiliser Insuman Comb 50 4.
0.10693900287151337 ||| 91 SUMMARY OF PRODUCT CHARACTERISTICS ||| SUMMARY OF PRODUCT CHARCTERISTICS ||| 93 RESUME DES CARACTERISTIQUES DU PRODUIT
0.11424566805362701 ||| How has Axura been studied? ||| How has Ebixa been studied? ||| Quelles études ont été menées sur Axura?
0.15337595343589783 ||| Do not use NeoRecormon: • if you are allergic (hypersensitive) to epoet in beta or any of the other ingredients of NeoRecormon or benzoic acid, a metabolite of benzyl alcohol • if you have blood pressure problems that cannot be controlled • if you are donating your own blood before surgery, and: ||| Do not use Abraxane • if you are allergic (hypersensitive) to paclitaxel or any of the other ingredients of Abraxane • if you are breast feeding • if you have a low white blood cell count (baseline neutrophil counts < 1.5 x 109/l - your doctor will advise you on this) ||| N'utilisez jamais NeoRecormon: • si vous êtes allergique (hypersensible) à l'epoetin beta ou à l'un des excipients contenus dans NeoRecormon ou à l’ acide benzoïque, un métabolite de l’ alcool benzylique. • si vous avez des problèmes de pression artérielle mal contrôlée • si vous donnez votre propre sang avant une intervention chirurgicale et que:
0.10048133134841919 ||| What Silapo looks like and contents of the pack ||| What Aranesp looks like and contents of the pack ||| Qu’est-ce que Silapo et contenu de l’emballage extérieur
0.35575687885284424 ||| PegIntron is best used for this treatment in combination with ribavirin. ||| RoActemra is not recommended for use with other biological agents. ||| L’ utilisation optimale de PegIntron pour ce traitement est l’ association avec la ribavirine.
0.29276442527770996 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Suvaxyn Aujeszky 783 + O/ W to Fort Dodge Animal Health Holland on 7 August 1998. ||| The European Commission granted a marketing authorisation valid throughout the EU for Irbesartan Hydrochlorothiazide Winthrop to Sanofi Pharma Bristol-Myers Squibb SNC on 19 January 2007. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Suvaxyn Aujeszky 783 + O/ W à Fort Dodge Animal Health Holland le 7 août 1998.
0.07217869907617569 ||| 4 6.2 Incompatibilities ||| 7 6.2 Incompatibilities ||| 6.2 Incompatibilités
0.07044415175914764 ||| What Axura is and what it is used for 2. ||| What Raptiva is and what it is used for 2. ||| Qu’est-ce qu’Axura et dans quel cas est-il utilisé 2.
0.00796858686953783 ||| EU/ 1/ 06/ 366/ 011 14 tablets EU/ 1/ 06/ 366/ 012 28 tablets EU/ 1/ 06/ 366/ 013 30 tablets EU/ 1/ 06/ 366/ 014 50 tablets EU/ 1/ 06/ 366/ 015 90 tablets EU/ 1/ 06/ 366/ 016 98 tablets ||| EU/ 1/ 06/ 366/ 017 14 tablets EU/ 1/ 06/ 366/ 018 28 tablets EU/ 1/ 06/ 366/ 019 30 tablets EU/ 1/ 06/ 366/ 020 50 tablets EU/ 1/ 06/ 366/ 021 90 tablets EU/ 1/ 06/ 366/ 022 98 tablets ||| EU/ 1/ 06/ 366/ 011 14 comprimés EU/ 1/ 06/ 366/ 012 28 comprimés EU/ 1/ 06/ 366/ 013 30 comprimés EU/ 1/ 06/ 366/ 014 50 comprimés EU/ 1/ 06/ 366/ 015 90 comprimés EU/ 1/ 06/ 366/ 016 98 comprimés
0.20606642961502075 ||| Package with 1 sponge of 9.5 cm x 4.8 cm Package with 2 sponges of 4.8 cm x 4.8 cm Package with 1 sponge of 3.0 cm x 2.5 cm Package with 5 sponges of 3.0 cm x 2.5 cm ||| Medicated sponge 1 sponge of 9.5 cm x 4.8 cm 2 sponges of 4.8 cm x 4.8 cm 1 sponge of 3.0 cm x 2.5 cm 5 sponges of 3.0 cm x 2.5 cm ||| Emballage contenant 1 éponge de 9.5 cm x 4.8 cm Emballage contenant 2 éponges de 4.8 cm x 4.8 cm Emballage contenant 1 éponge de 3.0 cm x 2.5 cm Emballage contenant 5 éponges de 3.0 cm x 2.5 cm
0.46302711963653564 ||| Tobacco pipe scrapers ||| Pipe tobacco ||| Cure-pipes à tabac
0.12503786385059357 ||| 37.1 ||| 37.5 ||| 37,1
1.0118776559829712 ||| In some cases that means more expensive tickets. ||| But they have more money, in cash. ||| Dans certains cas, cela signifie des billets plus chers.
0.18444578349590302 ||| Tritazide is used in the treatment of hypertension and it is indicated in patients whose blood pressure is not adequately controlled with ramipril alone or hydrochlorothiazide alone. ||| Cozaar Comp is indicated for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on losartan or hydrochlorothiazide alone. ||| Tritazide est utilisé pour le traitement de l’ hypertension et il est indiqué chez les patients dont la pression artérielle n’ est pas suffisamment contrôlée par le ramipril seul ou par l’ hydrochlorothiazide seul.
0.23762023448944092 ||| Protective coatings for balconies [other than in the nature of paints or oils] ||| Protective coatings in the form of sprays for use on metals [paints] ||| Revêtements de protection pour les balcons [autres que peintures ou huiles
0.001492554321885109 ||| 171 childbearing potential and their partners must each use an effective contraceptive during treatment and for 4 months after treatment has been concluded. ||| 194 childbearing potential and their partners must each use an effective contraceptive during treatment and for 4 months after treatment has been concluded. ||| Les patientes en âge de procréer et leurs partenaires doivent chacun utiliser une contraception efficace pendant toute la durée du traitement et pendant les 4 mois qui suivent son arrêt.
0.19542035460472107 ||| 3 ml type I glass vial, closed with bromobutyl rubber stopper, and sealed with aluminium cap with coloured plastic flip-off top. ||| Type II colourless 250 ml glass vial closed with bromobutyl rubber stopper and an aluminium cap with a plastic lid. ||| Flacons de 3 ml en verre de type I, munis de bouchon en caoutchouc bromobutyle, scellés par une capsule en aluminium, protégée par un capuchon amovible (en plastique coloré).
0.3487222492694855 ||| Although the recommended dose is 50 mg, this can be adjusted to a higher or lower dose according to the patient’ s response to the treatment, provided that the dose does not go below 25 mg or above 75 mg. ||| Although there may be an increased potential for undesirable effects at higher doses in some patients, if after two weeks there is insufficient response to 20mg, the dose may be increased gradually up to a maximum of 60mg. ||| Bien que la dose recommandée soit de 50 mg; la posologie peut être revue à la hausse ou à la baisse en fonction de la réponse thérapeutique du patient, pour autant que la dose ne soit pas inférieure à 25 mg ou supérieure à 75 mg.
0.13939538598060608 ||| Docetaxel Winthrop must NOT be administered if you are pregnant or if you are planning to become pregnant. ||| TAXOTERE must NOT be administered if you are pregnant or if you are planning to become pregnant. ||| Docétaxel Winthrop NE DOIT PAS vous être administré si vous êtes enceinte ou si vous envisagez de l'être.
0.0036217384040355682 ||| 13 In a clinical trial, approximately 1.2% of patients treated with ViraferonPeg or interferon alfa-2b in combination with ribavirin reported life-threatening psychiatric events during treatment. ||| 128 In a clinical trial, approximately 1.2% of patients treated with ViraferonPeg or interferon alfa-2b in combination with ribavirin reported life-threatening psychiatric events during treatment. ||| Dans un essai clinique, approximativement 1,2% des patients traités avec ViraferonPeg ou interféron alfa-2b en association avec ribavirine ont rapporté au cours du traitement des effets psychiatriques affectant le pronostic vital.
0.02524113841354847 ||| 90 As with any insulin therapy, lipodystrophy may occur at the injection site and delay local insulin absorption. ||| As with any insulin therapy, lipodystrophy may occur at the injection site and delay local insulin absorption. ||| Comme avec toute insulinothérapie, une lipodystrophie peut survenir au site d'injection, ce qui peut retarder la résorption locale de l'insuline.
0.275161474943161 ||| In several controlled studies, epoetins have not been shown to improve overall survival or decrease the risk of tumour progression in patients with anaemia associated with cancer. ||| In controlled clinical trials conducted in diabetic patients, no changes of blood glucose level and no increase in the incidence of hypoglycaemia were ascertained. ||| Dans plusieurs études contrôlées au cours desquelles des érythropoïétines ont été administrées, il n’ a pas été observé une amélioration de la survie globale ou une diminution du risque de progression tumorale chez les patients atteints d’ une anémie associée à un m
0.5518550872802734 ||| Medical apparatus for hyperhidrosis treatment ||| Patients with prior antiretroviral therapy ||| Appareils médicaux pour le traitement de l'hyperhidrose
0.28200286626815796 ||| Due to their effect on renal prostaglandines, prostaglandin synthetase inhibitors like nimesulide may increase the nephrotoxicity of cyclosporines. ||| Thiazolidinediones act primarily by reducing insulin resistance and sulphonylureas primarily by inducing insulin release from pancreatic beta cells. ||| En raison de leur effet sur les prostaglandines rénales, les inhibiteurs de la cyclooxygénase, tels que le nimésulide, peuvent augmenter la néphrotoxicité des ciclosporines.
4.4424088973399334e-13 ||| This can take the form of direct grants, tax advantages, repayable advances and no-loss guarantees. ||| This can take the form of direct grants, tax advantages, repayable advances and no-loss guarantees. ||| Ces aides peuvent prendre la forme de subventions directes, d'avantages fiscaux, d'avances remboursables et de garanties de couverture des pertes.
0.3391404151916504 ||| Luer tapers for medical use ||| Wrist braces for medical use ||| Connexions Luer à usage médical
0.45416608452796936 ||| The distribution and metabolism of azagly-nafarelin have not been studied in the target species. ||| There was no difference between the atosiban and beta-mimetic groups with regard to this parameter. ||| La distribution et le métabolisme de l’ azagly-nafaréline n’ ont pas été étudiés dans les espèces revendiquées.
0.3971248269081116 ||| Italia sanofi-aventis S. p. A. ||| Nederland sanofi-aventis Netherlands B. V. ||| Italia sanofi-aventis S.p.A.
0.4487462043762207 ||| Patients treated with a dosage of 4 mg or less oral risperidone should receive 25 mg RISPERDAL CONSTA, while patients treated with higher oral doses should be considered for the higher RISPERDAL CONSTA dose of 37.5 mg. ||| In hepatic transplant patients, administration of 1 g BID intravenous CellCept followed by 1.5 g BID oral CellCept resulted in MPA AUC values similar to those found in renal transplant patients administered 1 g CellCept BID. ||| Les patients traités par une dose inférieure ou égale à 4 mg de rispéridone orale doivent recevoir RISPERDAL CONSTA 25 mg, les patients traités par des doses orales plus élevées la dose plus élevée de RISPERDAL CONSTA 37,5 mg doit être envisagée.
0.24554648995399475 ||| In patients with polyarticular juvenile idiopathic arthritis, adalimumab antibodies were identified in 27/ 171 subjects (15.8%) treated with adalimumab. ||| Abatacept has been studied in patients with active rheumatoid arthritis in placebo-controlled clinical trials (1,955 patients with abatacept, 989 with placebo). ||| Chez les patients atteints d’ arthrite juvénile idiopathique polyarticulaire, des anticorps anti- adalimumab ont été détectés chez 27 sujets sur 171 (15,8%) traités par l’ adalimumab.
0.12592366337776184 ||| 2 Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. ||| Adjustment of dosage may be also necessary if patients undertake increased physical activity or change their usual meal plan. ||| Un ajustement de la posologie peut également être nécessaire si le patient modifie son activité physique ou son régime alimentaire.
0.4978463649749756 ||| DuoTrav can only be obtained with a prescription. ||| Try to take Competact tablets daily as prescribed. ||| Ce médicament peut uniquement être obtenu sur ordonnance.
0.27658408880233765 ||| Routine servicing of dust extraction apparatus ||| Routine servicing of ventilating apparatus ||| Entretien courant d'appareils de dépoussiérage
0.11950559914112091 ||| CVMP noted that Compagel gel for horses is a generic of Tensolvet 50000 (authorised in Germany) and that the concerns raised by France and Sweden can only be addressed in the framework of this procedure, in case any differences between the two products would justify different conclusions on the safety or efficacy. ||| (333 mg/ g + 67 mg/ g) Oral Paste for Horses is a generic of Tribrissen oral paste (authorised in the Netherlands) and that the concerns raised by France can only be addressed in the framework of this procedure, in case any differences between both products would justify different conclusions on the safety or efficacy. ||| Le CVMP a noté que Compagel gel pour cheval est un générique de Tensolvet 50000 (autorisé en Allemagne) et que les inquiétudes soulevées par la France et la Suède ne peuvent être examinées que dans ce cadre de la présente procédure, dans l’ éventualité où des différences quelconques entre les deux produits justifieraient des conclusions différentes sur les questions de sécurité et d’ efficacité.
0.0 ||| After reconstitution immediate use recommended. ||| After reconstitution immediate use recommended. ||| 71 Après reconstitution, une utilisation immédiate est recommandée.
0.9004126787185669 ||| - Baxter minibag NaCl 0.9% ||| baseline HbA1c (%) ||| - Baxter minibag NaCl 0,9%
0.5004252791404724 ||| These reactions have usually been mild and usually did not result in discontinuation of BYETTA. ||| Ecchymoses are observed commonly but usually do not require any specific action. ||| Ces réactions ont généralement été d’ intensité légère et n’ ont généralement pas conduit à l’ arrêt de BYETTA.
0.6528047323226929 ||| Restoring the normal functioning of the Schengen area of free movement is our first objective as soon as the health situation allows it. ||| Managing the demands of a complex Agency and the environment within which it operates is in itself a challenging task. ||| Rétablir le fonctionnement normal de la libre circulation dans l'espace Schengen sera notre premier objectif, dès que la situation sanitaire le permettra.
0.004659505560994148 ||| 18/ 50 ENGERIX B can also be administered together with measles-mumps-rubella vaccines, Haemophilus influenzae b vaccine and hepatitis A vaccine. ||| 39/ 50 ENGERIX B can also be administered together with measles-mumps-rubella vaccines, Haemophilus influenzae b vaccine and hepatitis A vaccine. ||| ENGERIX B peut également être administré avec le vaccin rougeole-oreillons-rubéole, le vaccin Hib et le vaccin contre l’ hépatite A.
0.2068295180797577 ||| Advisory services relating to the design of ponds ||| Advisory services relating to the care of birds ||| Services de conseils en matière de conception de bassins
0.4784429371356964 ||| While the direct investment impact is particularly high in those countries, the calculations found that cohesion regions (mostly Eastern European countries) are likely to benefit more from a long-term effect. ||| As one can see in the table, some Member States - for example Italy and Spain, which are currently the two EU countries most affected by the Coronavirus, still have significant uncommitted amounts on which they can rely under these extraordinary circumstances. ||| Alors que l'impact en termes d'investissements directs est particulièrement élevé dans ces pays, les calculs font apparaître que les régions bénéficiant de la politique de cohésion (pour la plupart dans les pays d'Europe de l'Est) sont susceptibles de profiter davantage d'un effet à long terme.
0.9569518566131592 ||| PhD in organic chemistry from the Free University of Berlin. ||| Spanish language PDF book by the Spanish Pediatry Association. ||| Diplôme de chimiste et de pharmacienne de l’ université libre de Berlin.
0.2725577652454376 ||| 60 For treatment of overdose (accidental ingestion) in the opioid-naive person, intravenous access should be obtained and naloxone or other opioid antagonists should be employed as clinically indicated. ||| Patients treated with Kuvan must continue a restricted phenylalanine diet and undergo regular clinical assessment (such as monitoring of blood phenylalanine and tyrosine levels, nutrient intake, and psycho-motor development). ||| Le traitement du surdosage chez une personne qui n'a jamais reçu de traitement morphinique (ingestion accidentelle), nécessite de mettre en place une voie d'abord veineuse et administrer de la naloxone ou un autre antagoniste des morphiniques, selon l'état clinique.
0.19080054759979248 ||| Rhodium and its alloys ||| Palladium and its alloys ||| Rhodium et ses alliages
0.1507994830608368 ||| The pharmacokinetics of natalizumab in paediatric MS patients or in patients with renal or hepatic insufficiency has not been studied. ||| The pharmacokinetics of duloxetine and its metabolites have not been studied in patients with mild or severe hepatic insufficiency. ||| Les paramètres pharmacocinétiques du natalizumab n’ ont pas été étudiés chez l’ enfant et chez l’ insuffisant rénal ou hépatique.
0.0075422488152980804 ||| 89 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 99 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 93 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.41537895798683167 ||| The pharmacokinetic results indicated that half-life was shorter (5.3 h) than for adults (7.2 h) and apparent clearance was faster (1.5 ml/ min/ kg) than for adults (0.96 ml/ min/ kg). ||| At the 20mg dose, elderly (≥ 65 years old) patients had higher frequencies of headaches (16.2% versus 11.8%) and dizziness (3.7% versus 0.7%) than younger patients (< 65 years old). ||| Les résultats pharmacocinétiques indiquaient que la demi-vie était plus courte (5,3 heures) que chez l’ adulte (7,2 heures) et la clairance apparente plus rapide (1,5ml/ min/ kg) que chez l’ adulte (0 ,96 ml/ min/ kg).
0.0 ||| Keep the vial in the outer carton in order to protect from light. ||| Keep the vial in the outer carton in order to protect from light. ||| Garder le flacon dans son emballage d’ origine pour le protéger de la lumière.
0.0 ||| NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER ||| NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER ||| NOM ET ADRESSE DU TITULAIRE DE L’ AUTORISATION DE MISE SUR LE 46 MARCHE
0.20461101830005646 ||| Pregnancy and breast-feeding Lysodren may harm the foetus. ||| Pregnancy and breast-feeding Tygacil may cause foetal harm. ||| Lysodren peut induire des malformations chez le fœ tus.
0.10007469356060028 ||| 32/ 44 ||| 36/ 44 ||| 31/ 44
0.32811617851257324 ||| The first study compared Avonex with placebo (a dummy treatment) in 301 patients with relapsing MS. ||| The second study looked at using Flebogammadif for immunomodulation in 20 patients with ITP. ||| La première étude comparait Avonex à un placebo (un traitement fictif) chez 301 patients atteints de SEP de type récurrent.
0.40726301074028015 ||| Doors for railway cars ||| Insulators for railway tracks ||| Portes pour wagons de train
0.5376778841018677 ||| Appropriate studies have been made to show the effectiveness in the various target animals. ||| The physical product manufactured for sale in the various markets appears to be identical. ||| Des études appropriées ont été réalisées pour démontrer l’ efficacité sur les différents animaux cibles.
0.42240726947784424 ||| Etoricoxib may mask fever and other signs of inflammation. ||| Linezolide: risk of vasoconstriction and increase in blood pressure. ||| L’ étoricoxib peut masquer une fièvre et d’ autres signes d’ inflammation.
0.38210099935531616 ||| Clarithromycin increases the Cmin of tipranavir by more than 100%. ||| Pprotein binding of ciprofloxacin is low (20-30%). ||| La clarithromycine augmente la Cmin du tipranavir de plus de 100%.
0.6033592224121094 ||| (ii) With respect to the direct grants, the support per company will not exceed €800 000 (around GBP 734 000) per company as foreseen by the Temporary Framework. ||| The proposed 2021 EU budget amounts to €166.7 billion in commitments (-9.7% compared to 2020) and €163.5 billion in payments (+0.8% compared to 2020). ||| ii) en ce qui concerne les subventions directes, le soutien par entreprise ne pourra dépasser 800 000 € (environ 734 000 GBP), comme le prévoit l'encadrement temporaire.
0.3844720721244812 ||| NeoSpect should not be used in women who are pregnant or breast-feeding. ||| Pergoveris is not indicated if you are pregnant or are breast-feeding. ||| NeoSpect ne doit pas être utilisé chez les femmes enceintes ou pendant l’ allaitement.
0.22365331649780273 ||| Caution should be exercised when ciprofloxacin or potent CYP1A2 inhibitors (e.g. fluvoxamine) are combined with erlotinib. ||| Tasmar should not be given in conjunction with non-selective monoamine oxidase (MAO) inhibitors (e. g. phenelzine and tranylcypromine). ||| Une attention particulière doit être exercée lors de l’association de la ciprofloxacine ou des inhibiteurs puissants du CYP1A2 à l’erlotinib (ex: fluvoxamine).
2.5127816494219246e-13 ||| If you get side effects → Tell your doctor or pharmacist if any of the side effects gets severe or troublesome, or if you notice any side effects not listed in this leaflet. ||| If you get side effects → Tell your doctor or pharmacist if any of the side effects gets severe or troublesome, or if you notice any side effects not listed in this leaflet. ||| S vous avez un de ces effets → Parlez-en à votre m édecin ou pharmacien si l’un de ces effets indésirables devient sévère ou gênant, ou si vous remarquez des effets indésirables non mentionnés dans cette notice.
0.31464117765426636 ||| Distribution In in-vitro studies, only a small fraction of rufinamide (34%) was bound to human serum proteins with albumin accounting for approximately 80% of this binding. ||| In a radiotracer study in three healthy volunteers, the parent compound (rufinamide) was the main radioactive component in plasma, representing about 80% of the total radioactivity, and the metabolite CGP 47292 constituting only about 15%. ||| Distribution Dans les études in vitro, seule une petite fraction de rufinamide (34%) était liée aux protéines sériques humaines, l’ albumine représentant environ 80% de cette liaison.
0.23924899101257324 ||| Hydrochloric acid 30%, water for injections. ||| hydrochloric acid and water for injections. ||| Acide chlorhydrique 30%, eau pour préparations injectables
0.10416559875011444 ||| 32% in trial C/ I98-580). ||| 32% in trial C/I 98-580). ||| 32% dans l’ étude C/ I98-580).
0.5631778240203857 ||| Laboratoires Janssen Cilag 1 rue Desmoulins TSA 91003 92787 Issy les Moulineaux Cedex 9, France ||| Marketing Authorisation Holder Les Laboratoires Servier 22, rue Garnier 92200 Neuilly-sur-Seine France ||| Laboratoires Janssen- Rispéridone Cilag 1 rue Desmoulins TSA 91003 92787 Issy les Moulineaux Cedex 9, France
0.1100563183426857 ||| (N = 56) Median time to regression of symptoms, by patient (hours) All episodes ||| (N = 56) Median time to overall patient improvement, by physician (hours) All episodes ||| (N = 56) Temps médian avant régression des symptômes, par le patient (heures) Tous les épisodes
0.3514274060726166 ||| Serious skin reactions, including erythema multiforme, exfoliative dermatitis and Stevens-Johnson syndrome have been reported through post-marketing surveillance in patients receiving parecoxib. ||| Acute chest syndrome is a frequent life-threatening complication of Sickle Cell Syndrome and is characterized by chest pain or fever or dyspnoea with recent infiltrate on chest X-ray. ||| Des réactions cutanées graves, incluant un érythème polymorphe, une dermatite exfoliative, un syndrome de Stevens-Johnson ont été rapportées depuis sa commercialisation chez des patients recevant du parécoxib.
3.3235491182087573e-13 ||| Caution should be exercised in patients with elevated ALT and/ or AST, in patients with signs and symptoms of hepatic impairment, in patients with pre-existing conditions associated with limited hepatic functional reserve, and in patients who are being treated with potentially hepatotoxic medicinal products. ||| Caution should be exercised in patients with elevated ALT and/ or AST, in patients with signs and symptoms of hepatic impairment, in patients with pre-existing conditions associated with limited hepatic functional reserve, and in patients who are being treated with potentially hepatotoxic medicinal products. ||| La prudence s’ impose chez les patients présentant une élévation des ALAT et/ ou des ASAT, chez les patients présentant des signes et des symptômes évocateurs d’ une atteinte hépatique, chez les patients atteints d’ une insuffisance hépatique pré-traitement et chez les patients traités par des médicaments potentiellement hépatotoxiques.
0.43271639943122864 ||| Read all of this leaflet carefully, including the Instructions for Use of Insulin Human Winthrop Basal, pre-filled pen, SoloStar, before you start using this medicine. ||| The Applicant/ MAH proposed to take the Ciprofloxacin Modified Release Tablets out of this Referral procedure to significantly simplify the exercise of harmonisation. ||| Veuillez lire attentivement l'intégralité de cette notice, y compris les instructions d’utilisation du stylo prérempli d’Insulin Human Winthrop Basal, SoloStar, avant d'utiliser ce médicament.
0.06323660910129547 ||| Which measures are being taken to ensure the safe use of Revlimid? ||| Which measures are being taken to ensure the safe use of Effentora? ||| Quelles sont les mesures prises pour assurer la sécurité de Revlimid?
0.3237338066101074 ||| Since deferiprone is eliminated mainly via the kidneys, there may be an increased risk of complications in patients with impaired renal function. ||| The risk to develop shingles seems to be linked to a decline in the specific immunity (the way the body defends itself) against varicella-zoster virus. ||| Dans la mesure où la défériprone est principalement éliminée par les reins, un risque accru de complications peut exister chez les patients présentant une altération de la fonction rénale.
0.06268160790205002 ||| Maropitant is metabolised in the liver and therefore should be used with caution in patients with hepatic disease. ||| Maropitant is metabolised in the liver and therefore should be used with caution in dogs with liver disease. ||| Le maropitant est métabolisé par le foie et doit donc être utilisé avec précaution chez les patients souffrant de troubles hépatiques.
0.6210695505142212 ||| • Section 5.1 has been updated to include the results of the EUROPA trial as follows: ||| It is important that the recommendations in sections 4.2 and 6.6 be followed closely. ||| • La rubrique 5.1 a été mise à jour afin d’ inclure les résultats de l’ étude EUROPA comme suit:
0.36970892548561096 ||| YTRACIS is intended for in vitro radiolabelling of medicinal products, which are subsequently administered by approved route. ||| INOmax is administered to your baby using an approved (CE-marked) delivery system designed to deliver nitric oxide. ||| YTRACIS est destiné au radiomarquage in vitro de médicaments d'administration autorisé pour ces médicaments.
0.6362422108650208 ||| CAPD** ||| PPE* ||| DPAC**
0.23141789436340332 ||| What is Mixtard? ||| What is Bondronat? ||| Qu’ est -ce que Mixtard?
0.06607052683830261 ||| 84 Patients with existence of or history of severe psychiatric conditions: ||| Patients with existence of or history of severe psychiatric conditions: ||| Patients présentant ou ayant des antécédents de troubles psychiatriques sévères:
0.32826748490333557 ||| The resulting solution is clear and ranges in colour from colourless to light straw-coloured. ||| The solution is clear, colourless to pale yellow in colour with strawberry/banana flavouring. ||| La solution obtenue est limpide entre incolore et légèrement jaune paille.
0.22243669629096985 ||| Do not use Gardasil if: ||| Do not use Silgard if: ||| N’ utilisez jamais Gardasil si
0.06343255192041397 ||| What is the risk associated with Imprida? ||| What is the risk associated with Avastin? ||| Quels sont les risques associés à l’ utilisation d’ Imprida?
0.4608749747276306 ||| The solution should be clear immediately after removal from the refrigerator. ||| Reconstitute immediately after removal from the refrigerator (or other cold storage). ||| La solution doit être limpide dès sa sortie du réfrigérateur.
0.04795452952384949 ||| Silapo should not be used in people who may be hypersensitive (allergic) to epoetin zeta or any of the other ingredients. ||| Binocrit should not be used in people who may be hypersensitive (allergic) to epoetin alfa or any of the other ingredients. ||| Silapo ne doit pas être utilisé chez des personnes pouvant présenter une hypersensibilité (allergie) à l’ époétine zêta ou à l’ un des autres composants.
0.22621174156665802 ||| Helixate NexGen powder should only be reconstituted with the supplied solvent (5.0 ml water for injections) using the supplied sterile Mix2Vial filter transfer device. ||| After labelling with the radioactive sodium pertechnetate (99mTc) solution for injection, radiolabelled NeoSpect will be injected before the scan is taken. ||| La poudre d'Helixate NexGen doit uniquement être reconstituée avec le solvant associé (5,0 ml d’ eau pour préparations injectables) en utilisant le dispositif de transfert stérile avec filtre Mix2vial.
4.640757179583122e-13 ||| Significance level at α =0.05. ||| Significance level at α =0.05. ||| Niveau de significativité à α =0.05.
0.8357951641082764 ||| The schemes have a total budget of approximately €20 billion. ||| The total ESI budget is €2.7 billion. ||| Ces régimes sont dotés d'un budget total d'environ 20 milliards d'euros.
0.11025238037109375 ||| 43 9. ||| 42 9. ||| 45 9.
0.12213422358036041 ||| 114 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS GONAL-f 75 IU AMPOULE LABEL ||| 15 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS LUVERIS 75 IU, SOLVENT VIALS ||| 121 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES ETIQUETTE DE L’ AMPOULE DE GONAL-f 75 UI
0.26552385091781616 ||| Effect of other agents on the pharmacokinetics of aprepitant Concomitant administration of EMEND with active substances that inhibit CYP3A4 activity (e. g., ritonavir, ketoconazole, clarithromycin, telithromycin) should be approached cautiously, as the combination results in increased plasma concentrations of aprepitant. ||| The long elimination half-lives of both fluoxetine and norfluoxetine should be borne in mind (see'Pharmacokinetic properties') when considering pharmacodynamic or pharmacokinetic drug interactions (e. g. when switching from fluoxetine to other antidepressants). ||| Effet d’autres médicaments sur la pharmacocinétique de l’aprépitant La co-administration d’ EMEND et de substances actives inhibant l’activité du CYP3A4 (tels que le ritonavir, le kétoconazole, la clarithromycine, la télithromycine) doit être envisagée avec précaution; cette association entraîne une augmentation des concentrations plasmatiques en aprépitant.
0.0 ||| Caution should be exercised when prescribing to pregnant women. ||| Caution should be exercised when prescribing to pregnant women. ||| Insulin Human Winthrop Rapid ne sera prescrit qu’ avec prudence chez la femme enceinte.
0.22835808992385864 ||| au please tell your doctor or pharmacist. ||| Advise immediately your doctor or your pharmacist. ||| cette notice, informez-en votre médecin ou votre pharmacien.
0.6301281452178955 ||| Febrile neutropenia, anaemia ||| Pericarditis, cardiac tamponade ||| Neutropénie fébrile, anémie
0.44373536109924316 ||| 24 Dose-proportional increases in exposure of Pegasys are seen in healthy subjects and in patients with chronic hepatitis B or C after once-weekly dosing. ||| Fatal outcomes have been reported for acute overdoses as low as 450mg but survival has also been reported following acute overdose of 1,500 mg. ||| Des augmentations dose-dépendantes de l’exposition à Pegasys sont constatées chez les sujets sains et chez les patients atteints d’hépatite chronique B ou C après administration hebdomadaire.
0.35190334916114807 ||| − The CHMP considered the referral made under article 31of Directive 2001/ 83/ EC, as amended, for medicinal products containing piroxicam. ||| • the CHMP considered the referral made under Article 6(13) of Commission Regulation (EC) N 1084/ 2003 for Viani Evohaler and associated names (see Annex I) ||| − Le CHMP a examiné la demande de saisine effectuée conformément à l’ article 31 de la directive 2001/ 83/ CE, telle qu’ amendée, pour les médicaments contenant du piroxicam.
0.00355632440187037 ||| As with other anti-HIV medicines, patients taking Agenerase may be at risk of lipodystrophy (changes in the distribution of body fat), osteonecrosis (death of bone tissue) or immune reactivation syndrome (symptoms of infection caused by the recovering immune system). ||| As with other anti-HIV medicines, patients taking Ziagen may be at risk of lipodystrophy (changes in the distribution of body fat), osteonecrosis (death of bone tissue) or immune reactivation syndrome (symptoms of infection caused by the recovering immune system). ||| Comme d’ autres médicaments anti-VIH, Agenerase peut entraîner un risque de lipodystrophie (anomalie de la distribution des graisses dans le corps), d’ ostéonécrose (mort du tissu osseux) ou d’ apparition du syndrome de réactivation immunitaire (symptômes de l’ infection dus à la reconstitution du système immunitaire).
0.4871358871459961 ||| Referring only to subjects who developed zoster, there was a decrease in the risk of subsequently developing PHN. ||| Consistent with the prevalence of HSDD, there are limited data above the age of 60. ||| Si on considère seulement les sujets ayant présenté un zona, une diminution du risque de développer des DPZ par la suite a été observée.
0.2965906858444214 ||| In both studies, the main measure of effectiveness was the number of patients who formed blood clots in the veins or who died of any cause during the treatment period. ||| The study lasted 4 weeks, and measured the percentage of patients who had no trace of opioids in their urine at the end of the study. ||| Dans les deux études, le principal critère d’ évaluation de l’ efficacité était le nombre de patients chez lesquels s’ étaient formés des caillots sanguins dans les veines ou qui sont décédés d’ une cause quelconque durant la période de traitement.
0.6526714563369751 ||| Efficacy data are connected to several shortcomings and the amount of data available is sparse. ||| • Increase of 20% is forecast due to the larger number of authorised products ||| Les données d’ efficacité illustrent plusieurs anomalies et la quantité de données disponibles est très limitée.
0.288821816444397 ||| Cases of pulmonary oedema have been reported with vasodilators (mainly prostacyclins) when used in patients with pulmonary veno-occlusive disease. ||| COX-2 inhibitors have been introduced in medical practice for treatment of patients with chronic inflammatory degenerative diseases such as rheumatoid arthritis and osteoarthritis. ||| Des cas d’œ dèmes pulmonaires ont été rapportés lors de l’ administration de médicaments vasodilatateurs (principalement des prostacyclines) chez des patients souffrant de maladie pulmonaire veino-occlusive.
0.5234031081199646 ||| 52 Docetaxel Winthrop 75 mg/ m² in combination with capecitabine ||| Swine Enzootic Pneumonia 2.125 mg/kg bodyweight ||| 55 Docétaxel Winthrop 75 mg/ m² en association avec la capécitabine
0.2435252070426941 ||| If the condition of the kidney is very poor (creatinine clearance of < 10 ml/ min), the daily dose of ceftriaxone should not exceed 2 g in adult patients. ||| In advanced Parkinson’ s disease, doses higher than 1.1 mg (1.5 mg of salt) per day can be useful in patients where a reduction of the levodopa therapy is intended. ||| Si l’insuffisance rénale est sévère (clearance de la créatinine < 10 ml/min.) la dose journalière de ceftriaxone ne doit pas dépasser 2 g chez l’adulte.
0.6491255760192871 ||| - shaking (tremor) ||| Polishing (cleaning) ||| - tremblements
0.26925012469291687 ||| Abraxane is an albumin-bound nanoparticle formulation of paclitaxel, which may have substantially different pharmacological properties compared to other formulations of paclitaxel (see sections 5.1 and 5.2).. ||| Concomitant administration of calcium folinate with 5-fluorouracil has been shown to enhance the efficacy and toxicity of 5-fluorouracil [(see sections 4.2, 4.4 and 4.8)]. ||| Abraxane est une formulation de nanoparticules de paclitaxel lié à l’ albumine pouvant avoir des propriétés pharmacologiques très différentes des autres formulations de paclitaxel (voir les sections 5.1 et 5.2).
0.27729159593582153 ||| Consulting services in the field of culinary arts ||| Consultancy services in the field of food and drink catering ||| Services de conseils dans le domaine de l'art culinaire
0.270288348197937 ||| Interaction with indinavir/ ritonavir not studied Ritonavir induces glucuronidation and as a result is expected to decrease the plasma concentrations of atovaquone. ||| If omeprazole or other proton pump inhibitors are taken concomitantly with Invirase/ ritonavir, monitoring for potential saquinavir toxicities is recommended. ||| Le ritonavir induit une glucuronidation et par conséquent, il est attendu qu'il diminue les concentrations plasmatiques de l'atovaquone.
0.5679886341094971 ||| Intravenous use. ||| Subcutaneous use: ||| Voie intraveineuse.
0.40993884205818176 ||| Takeda Italia Farmaceutici S. p. A., Via Crosa, 86, 28065 Cerano (NO), Italy. ||| Sigma-Tau Industrie Farmaceutiche Riunite S. p. A. - Viale Shakespeare 47, 00144 Rome Italy ||| Takeda Italia Farmaceutici SpA, Via Crosa, 86, I-28065 Cerano (NO), Italie.
0.006055907346308231 ||| 216 Always use Puregon exactly as your doctor has told you. ||| 234 Always use Puregon exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.30286744236946106 ||| The second study compared the effectiveness of Evicel with that of Surgicel (a material used to help control bleeding) in reducing bleeding during abdominal surgery (surgery of organs in the tummy). ||| The second study looked at the use of Forsteo in 437 men with osteoporosis, comparing its effect on the density of bones in the spine with that of placebo. ||| La seconde étude comparait l’ efficacité d’ Evicel à celle de Surgicel (un matériau utilisé pour aider à contrôler le saignement) pour réduire le saignement au cours d’ une intervention chirurgicale abdominale (chirurgie des organes du ventre).
0.15061260759830475 ||| Frames (Non-metallic -) for containers ||| Forms (Non-metallic -) for concrete ||| Châssis non métalliques pour récipients
0.41680029034614563 ||| - general sensation of weakness, fatigue (asthenia), irritation or pain at the injection site ||| - acne, red or itchy or mottled skin, rash at the infusion site ||| - sensation générale de faiblesse, fatigue (asthénie), irritation ou douleur au site d’ injection
0.40368974208831787 ||| Dental drills ||| Dental bridges ||| Forets dentaires
3.053675476545614e-13 ||| This document is a summary of the European Public Assessment Report (EPAR). ||| This document is a summary of the European Public Assessment Report (EPAR). ||| Résumé EPAR à l’ intention du public Ce document est un résumé du rapport européen public d'évaluation (EPAR).
0.31330394744873047 ||| Bimatoprost did not impair fertility in rats up to doses of 0.6 mg/ kg/ day (approximately 103-times the intended human exposure). ||| At the level with no embryo/ fetal effect, the systemic exposure was 8.6 (rat) and 2.2 (rabbit) times that in man following a 200 mg therapeutic dose. ||| Le bimatoprost n’ a pas eu d’ incidence sur la fertilité des rats pour des doses allant jusqu’ à 0,6 mg/ kg/ jour (environ 103 fois supérieures à l’ exposition humaine).
0.37585312128067017 ||| In common with other quinolones, sparfloxacin has demonstrated arthrotoxic potential in growing animals. ||| However, the combination of gemcitabine and cisplatin had a better toxicity profile than MVAC. ||| Comme les autres quinolones, la sparfloxacine a montré un effet arthrotoxique chez les animaux en cours de croissance.
0.3804669976234436 ||| Neutropenia (ANC < 1.5 x 109/ l) was reported in 2.4% patients receiving Kineret compared with 0.4% of placebo patients. ||| Veino occlusive disease (VOD) was reported in 15% (4/ 27) and 7% (2/ 28) of the autologous and allogenic transplant respectively. ||| Une neutropénie (PNN < 1,5 x 109/ l) a été observée chez 2,4% des patients traités par Kineret contre 0,4% des patients sous placebo.
0.4869195818901062 ||| INCRELEX is given by injection under the skin, and the injection site should be changed with each injection. ||| The tube from the injector to the patient (patient's tube) must be changed after every examination. ||| INCRELEX est administré par injection sous-cutanée, et il convient de changer de site d’ injection à chaque injection.
0.1790887862443924 ||| Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use. ||| Other preclinical effects were observed only at exposures that were sufficiently in excess of the maximum human exposure so that concern for human safety is negligible. ||| Les effets dans des études non cliniques ont uniquement été observés à des expositions jugées suffisamment supérieures à l'exposition humaine maximale indiquant une faible pertinence pour l'usage clinique.
0.0 ||| r Denmark ||| r Denmark ||| Danemark
0.020767876878380775 ||| Dicural 150 mg Coated tablets for dogs ||| Dicural 50 mg Coated tablets for dogs ||| Dicural 150 mg comprimés enrobés pour chiens
0.030616067349910736 ||| 72 Store in a refrigerator. ||| 65 Store in a refrigerator. ||| 77 A conserver au réfrigérateur.
0.3599691092967987 ||| At 24 weeks, 56% of patients in the Enbrel-treated group had achieved the PASI 75 compared to 5% of placebo-treated patients. ||| The duration of treatment in postmenopausal women was 60 months, 2,852 were randomized to FABLYN and 2,852 were randomized to placebo. ||| A 24 semaines, 56% des patients dans le groupe traité par Enbrel avaient atteint le PASI 75 comparativement à 5% des patients traités par placebo.
0.5866470336914062 ||| Bridles [harness] ||| Nuts [fruits] ||| Brides [harnais]
0.3033571243286133 ||| You might feel drowsy if Olanzapine Mylan is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers). ||| Driving and using machines Comtess taken together with levodopa may lower your blood pressure, which may make you feel light-headed or dizzy. ||| La prise de OLANZAPINE MYLAN peut entraîner une somnolence si vous prenez OLANZAPINE MYLAN avec des antidépresseurs ou des médicaments pour l'anxiété ou l'insomnie (tranquillisants).
0.010356221348047256 ||| 74 España Novartis Farmacéutica, S. A. ||| 68 España Novartis Farmacéutica, S. A. ||| España Novartis Farmacéutica, S. A.
0.14306849241256714 ||| Do not put Insuman Comb 15 next to the freezer compartment or a freezer pack. ||| Do not put Insulin Human Winthrop Comb 25 next to the freezer compartment or a freezer pack. ||| Ne pas placer Insuman Comb 15 près du compartiment à glaçons ou d'une poche de congélation.
0.5443304777145386 ||| Based on in vitro studies, etoricoxib is not expected to inhibit cytochromes P450 (CYP) 1A2, 2C9, 2C19, 2D6, 2E1 or 3A4. ||| As of 2009, the known SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3. ||| Sur la base d’ études in vitro, une inhibition des cytochromes P450 (CYP) 1A2, 2C9, 2C19, 2D6, 2E1 ou 3A4 par l’ étoricoxib n’ est pas attendue.
0.0 ||| 10 cartridges ||| 10 cartridges ||| 10 stylos
0.006224344484508038 ||| 51 Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. ||| 65 Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. ||| Un ajustement de la posologie peut également être nécessaire si le patient modifie son activité physique ou son régime alimentaire.
0.1394340544939041 ||| d) 112 Days ||| d) 28 Days ||| d) 112 Jours
0.0 ||| Combination therapy: ||| Combination therapy: ||| Traitement combiné:
0.5808751583099365 ||| - in whom glycaemic control is markedly improved, ||| - in whom an autonomic neuropathy is present, ||| - chez les patients dont l'équilibre glycémique a été nettement amélioré,
0.054915305227041245 ||| Do not use Janumet after the expiry date which is stated on the blister and the carton. ||| Do not use Plavix after the expiry date which is stated on the carton and on the blister. ||| Ne pas utiliser Janumet après la date de péremption mentionnée sur la plaquette thermoformée et la boîte.
0.39755314588546753 ||| Chemical and physical in-use stability has been demonstrated for 4 hours when stored at 2 to 8oC after reconstitution and subsequent dilution in the diluent. ||| These samples were chilled, homogenised and stored at -80°C until analysis 4 to 6 months later (storage stability confirmed). ||| La stabilité chimique et physique du produit a été démontrée pendant 4 heures quand le produit est stocké à 2-8°C après reconstitution et dilution dans le diluant.
0.2683074176311493 ||| Losartan/ HCTZ tablets must not be used in patients with severe renal impairment (i. e. creatinine clearance < 30 ml/ min) (see section 4.3). ||| • Treatment of UA/ NSTEMI and STEMI - fondaparinux should not be used in patients with creatinine clearance < 20 ml/ min (see section 4.3). ||| Les comprimés de losartan/ HCTZ ne doivent absolument pas être utilisés chez les patients atteints d'insuffisance rénale sévère (clairance de la créatinine < 30 ml/ mn) (voir rubrique 4.4).
0.072886623442173 ||| 393 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS |||  304 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 396 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.19881825149059296 ||| The active substance in Raptiva, efalizumab, is a monoclonal antibody. ||| The active substance in Zonegran, zonisamide, is an anti-epileptic. ||| La substance active contenue dans Raptiva, l’ efalizumab, est un anticorps monoclonal.
0.3581598699092865 ||| After inoculation, the virus expresses the protective proteins, but does not replicate in the cat. ||| If the enzyme is not present, GAGs cannot be broken down and they build up in the cells. ||| Après inoculation, le virus canarypox exprime les protéines protectrices, mais sans se répliquer chez le chat.
0.025927888229489326 ||| Lamictal 50 mg Tabletten zur Herstellung einer 50 mg Suspension zum Einnehmen ||| Lamictal 25 mg Tabletten zur Herstellung einer 25 mg Suspension zum Einnehmen ||| Lamictal 50 mg Tabletten zur Herstellung einer Suspension zum Einnehmen
0.21725766360759735 ||| In long-term carcinogenicity studies in rats and mice with adefovir dipivoxil, no treatment-related increase in tumour incidence was found in mice or rats (systemic exposures approximately 10 and 4 times those achieved in humans at the therapeutic dose of 10 mg/ day, respectively). ||| In this study most psoriatic arthritis patients receiving Enbrel were able to mount effective B-cell immune response to pneumococcal polysaccharide vaccine, but titers in aggregate were moderately lower and few patients had two-fold rises in titers compared to patients not receiving Enbrel. ||| Dans les études du potentiel carcinogène à long terme de l’ adéfovir dipivoxil conduites chez le rat et la souris, aucune augmentation liée au traitement de l’ incidence de tumeurs n’ a été retrouvée (expositions systémiques respectives environ 10 et 4 fois supérieures à l’ exposition humaine après administration de la dose thérapeutique de 10 mg/ jour).
0.3276823163032532 ||| All of the studies lasted six months and compared the effects of Prometax with those of placebo (a dummy treatment). ||| All subdomains of the HAQ were improved in patients treated with Enbrel compared to controls at 3 and 6 months. ||| Toutes les études ont duré six mois et ont comparé les effets de Prometax à ceux d’ un placebo (traitement fictif).
1.275901042804839e-12 ||| • Immediately inject the solution: ||| • Immediately inject the solution: ||| 212 • Injectez immédiatement la solution:
0.13966277241706848 ||| Advisory services relating to beauty treatment ||| Advisory services relating to medical problems ||| Services de conseils concernant les soins de beauté
0.43583494424819946 ||| • Controlling the safety of medicines for humans and animals, in particular through a pharmacovigilance network and the establishment of safe limits for residues in food-producing animals ||| Questions refer to exports of, and payments for, protective gear, medicines, medical equipment, or the provision of medical assistance to the population in need in areas subject to EU sanctions. ||| — le contrôle de la sécurité des médicaments à usage humain et à usage vétérinaire, grâce, en particulier, à un réseau de pharmacovigilance et à l’ établissement de limites sûres pour les résidus dans les animaux producteurs d’ aliments.
0.06404869258403778 ||| The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. ||| Microbiology The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. ||| 133 La prévalence de la résistance acquise peut varier en fonction de la géographie et du temps pour certaines espèces; il est donc utile de disposer d’informations sur la prévalence de la résistance locale, surtout pour le traitement d’infections sévères.
